Citrus Sinensis ID: 041479
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 771 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.977 | 0.746 | 0.380 | 1e-154 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.993 | 0.742 | 0.363 | 1e-148 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.968 | 0.728 | 0.368 | 1e-142 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.862 | 0.678 | 0.311 | 1e-89 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.853 | 0.525 | 0.332 | 2e-87 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.872 | 0.598 | 0.330 | 3e-85 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.852 | 0.526 | 0.319 | 4e-84 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.922 | 0.736 | 0.313 | 2e-81 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.854 | 0.598 | 0.336 | 2e-80 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.894 | 0.706 | 0.319 | 3e-80 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 545 bits (1403), Expect = e-154, Method: Compositional matrix adjust.
Identities = 359/943 (38%), Positives = 495/943 (52%), Gaps = 189/943 (20%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+QALL FKS+V +D LS+WN S C W GVTC K +RV L L L G
Sbjct: 23 ETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP----------D 110
SP IGNL+FL ++L +N F IP E+G+L RL ++ N L+G IP +
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 111 SRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP---------------HLNM---- 151
RL N+L G++PSELGSL L L N G +P H N+
Sbjct: 143 LRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEI 202
Query: 152 ------------FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
Q+ + +G P L N++S++ + N G L P +G LPN+
Sbjct: 203 PSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLL 262
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------- 237
+ GN F G+IP ++SN S LE L N+LTG IP
Sbjct: 263 SFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLGSDS 322
Query: 238 ----EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293
E L SL NCT LE + + N L G LP S+AN S+ L L + ISGSIP +IG
Sbjct: 323 SRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIG 382
Query: 294 NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353
NL NL + +++ +L +P S+G LL L+ LSLF N +S IP+ +GN T L L+L
Sbjct: 383 NLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSN 442
Query: 354 NSIRGSVPSALGSCH---QLW----------------------LDLSHNHLTGPIPLAVG 388
N G VP++LG+C +LW LD+S N L G +P +G
Sbjct: 443 NGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIG 502
Query: 389 NPKSIPHLDLSKNELSGEIPSSLA-------------WIFG------------------- 416
+++ L L N+LSG++P +L +G
Sbjct: 503 ALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNN 562
Query: 417 --------YISIFAKL---NLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLP 465
Y + F+KL NLS+NNL+G VP K IF+NA+ +S GN LCGGI +L
Sbjct: 563 DLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLK 622
Query: 466 PC---TPSELKKREKSKGFKLMILLLSGLVGLILV----MSLLIINRLRRQRTVTSSESS 518
PC PS +KK S+ K++I + G+ L+L+ ++L+ + + ++ + + S
Sbjct: 623 PCLSQAPSVVKK-HSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPS 681
Query: 519 SRKDLLLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGAL 562
+ + L +SY L AT VYK +L ++ +AVKVL + +RGA+
Sbjct: 682 TLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAM 741
Query: 563 KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC--------- 613
KSFMAEC++L++IRHRNLVK++TACS+ DFQGN FRAL+YEFM +GSL+
Sbjct: 742 KSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEI 801
Query: 614 ---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670
R L+ L RLNIAIDVAS L+YLH HC +PI HCDLKPSNVLLD+D+TAH+ DFGL
Sbjct: 802 HRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLA 861
Query: 671 RFI---PEVMSSNQCSSVGLKGTVGYATPEY---------------GILLLEIFTGKRPT 712
R + E NQ SS G++GT+GYA PEY GILLLE+FTGKRPT
Sbjct: 862 RLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPT 921
Query: 713 SDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAE 755
+++F L+++ K ALP++IL ++D L G++ G E
Sbjct: 922 NELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE 964
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 527 bits (1357), Expect = e-148, Method: Compositional matrix adjust.
Identities = 353/972 (36%), Positives = 496/972 (51%), Gaps = 206/972 (21%)
Query: 1 EPDKQALLAFKSKV-DDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGT 59
E D QALL FKS+V +++ L++WN S FC W+GVTC + +RVI LNL G LTG
Sbjct: 29 ETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 60 ASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS-------- 111
SP IGNL+FLRL+NL N+F S IP ++GRLFRL+++ + N L+G+IP S
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLS 148
Query: 112 --------------------------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGP 145
L N L GN P+ LG+L + L A N G
Sbjct: 149 TVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208
Query: 146 IP-------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV 198
IP + FQ+++ S +G P L NI+S+E +++N G L G+ LPN+
Sbjct: 209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNL 268
Query: 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP--------------------- 237
R LLL NQF G IP +++N S LE D ++N L+G IP
Sbjct: 269 RRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGN 328
Query: 238 ------EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTE 291
E + ++ NCT LE + + N L G LP S+AN S+ L L++ N ISG+IP +
Sbjct: 329 NSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHD 388
Query: 292 IGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNL 351
IGNL +L +++E +L +P+S G LL LQV+ L+ N IS EIPS GN T L +L+L
Sbjct: 389 IGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHL 448
Query: 352 CGNSIRGSVPSALGSCH---QLWLD----------------------LSHNHLTGPIPLA 386
NS G +P +LG C LW+D LS+N LTG P
Sbjct: 449 NSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEE 508
Query: 387 VGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAK----------------------- 423
VG + + L S N+LSG++P ++ +F +
Sbjct: 509 VGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNVDFS 568
Query: 424 --------------------LNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
LNLS N +G VP +F+NA+A+S GN +CGG+ E++
Sbjct: 569 NNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQ 628
Query: 464 LPPC-TPSELKKRE----KSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESS 518
L PC + +KR+ + K + + ++ L+ +I+V SL + +++ + S
Sbjct: 629 LKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPS 688
Query: 519 SRKDLLL---NVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQR 559
L + VSYE L AT V+KG+L + +AVKVL L +
Sbjct: 689 DSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKH 748
Query: 560 GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLE-------- 611
GA KSFMAEC+ + IRHRNLVK+IT CS+ D +GN FRALVYEFM GSL+
Sbjct: 749 GATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDL 808
Query: 612 ----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667
R L+ +LNIAIDVASALEYLH HC P+ HCD+KPSN+LLD+D+TAH+ DF
Sbjct: 809 ERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDF 868
Query: 668 GLTRFIPEVMSS---NQCSSVGLKGTVGYATPEY---------------GILLLEIFTGK 709
GL + + + NQ SS G++GT+GYA PEY GILLLE+F+GK
Sbjct: 869 GLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGK 928
Query: 710 RPTSDMFTEGLDLHNFVKMALP-----------DQILQVLDPLFLVGGVQEGEETAEENI 758
+PT + F +LH++ K L D+ L+ L L G++ EE + +
Sbjct: 929 KPTDESFAGDYNLHSYTKSILSGCTSSGGSNAIDEGLR----LVLQVGIKCSEEYPRDRM 984
Query: 759 KKGQIRESLIAI 770
+ + LI+I
Sbjct: 985 RTDEAVRELISI 996
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1303), Expect = e-142, Method: Compositional matrix adjust.
Identities = 347/941 (36%), Positives = 475/941 (50%), Gaps = 194/941 (20%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E DKQALL FKS+V + L +WNDS+ C W GV C LK++RV ++L G LTG
Sbjct: 38 ETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVV 97
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP----------- 109
SP++GNL+FLR +NL N F IP E+G LFRL+++ ++N G IP
Sbjct: 98 SPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLST 157
Query: 110 -----------------------DSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPI 146
L N L G P+ LG+L + L N G I
Sbjct: 158 LDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEI 217
Query: 147 P-------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
P + F++++ G P + N++S+ + ++ N G L P G LPN++
Sbjct: 218 PGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQ 277
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------- 237
IL + N F G IP ++SN S L LD +N LTG IP
Sbjct: 278 ILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNY 337
Query: 238 --EDLD---SLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292
DLD +L NC+ L+ +++ N L G LP +AN S+ L L + N ISGSIP I
Sbjct: 338 SSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGI 397
Query: 293 GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352
GNL +L + + + +L +P S+G L +L+ + L+ N +S EIPSSLGN + LT L L
Sbjct: 398 GNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLL 457
Query: 353 GNSIRGSVPSALGSC------------------HQLW-------LDLSHNHLTGPIPLAV 387
NS GS+PS+LGSC H+L L++S N L GP+ +
Sbjct: 458 NNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDI 517
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAK-------------------LNLSY 428
G K + LD+S N+LSG+IP +LA + + L+LS
Sbjct: 518 GKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLDLSK 577
Query: 429 NNL------------------------DGDVPRKMIFKNASAISEAGNEKLCGGISELKL 464
NNL DG VP + +F+N SA+S GN LCGGI L+L
Sbjct: 578 NNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQL 637
Query: 465 PPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSL---------LIINRLRRQRTVTSS 515
PC+ EL +R S K++ + +S ++ +L++ L L + +R
Sbjct: 638 QPCS-VELPRRHSSVR-KIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDR 695
Query: 516 ESSSRKDLLLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQR 559
S K +SY+ L K T V+KG L +A+KVL L +R
Sbjct: 696 SFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKR 755
Query: 560 GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLE-------- 611
GA KSF+AEC+AL IRHRNLVK++T CS+SDF+GN FRALVYEFM +G+L+
Sbjct: 756 GAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEI 815
Query: 612 ----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667
+ R L RLNIAIDVASAL YLH +C PI HCD+KPSN+LLD D+TAH+ DF
Sbjct: 816 EETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDF 875
Query: 668 GLTRFIPEVMSSN---QCSSVGLKGTVGYATPEY---------------GILLLEIFTGK 709
GL + + + Q SS G++GT+GYA PEY GI+LLEIFTGK
Sbjct: 876 GLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGK 935
Query: 710 RPTSDMFTEGLDLHNFVKMALPD-QILQVLDPLFLVGGVQE 749
RPT+ +F +GL LH+F K AL Q L + D L G +
Sbjct: 936 RPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQ 976
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 280/898 (31%), Positives = 405/898 (45%), Gaps = 233/898 (25%)
Query: 29 VNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEI 88
V+ C W GV C+ + +VI L++SG++L G SP I NLT L +++L +N F IP EI
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 89 GRLFR-LRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP 147
G L L+ + + N L G NIP ELG L + L L +N
Sbjct: 111 GSLHETLKQLSLSENLLHG--------------NIPQELGLLNRLVYLDLGSN------- 149
Query: 148 HLNMFQVSVYSLTGSIPIQLL---NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLA 204
L GSIP+QL + +S++Y +S N L GE+P + L +R LLL
Sbjct: 150 ----------RLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLW 199
Query: 205 GNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL------------------------ 240
N+ G +P S+SN++ L+W+D +N L+G +P +
Sbjct: 200 SNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNT 259
Query: 241 ------DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG- 293
SL N + L+ + L+ NSL G + +S+ + S +L +++ N I GSIP EI
Sbjct: 260 NLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISN 319
Query: 294 -----------------------NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
L L + + L IP+ +G + +L +L + N
Sbjct: 320 LLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRN 379
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSC---------H------------- 368
N+S IP S GN + L L L GN + G+VP +LG C H
Sbjct: 380 NLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVS 439
Query: 369 -----QLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIP--------------- 408
+L+L+LS NHL+GPIPL + + +DLS NELSG+IP
Sbjct: 440 NLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLS 499
Query: 409 ---------SSLAWI--------------------FGYISIFAKLNLSYNNLDGDVPRKM 439
SSL + F S LN S+N L G+V K
Sbjct: 500 RNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKG 559
Query: 440 IFKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMS 499
F + S G+ LCG I ++ KK+ K L +LL ++ V
Sbjct: 560 SFSKLTIESFLGDSLLCGSIKGMQ-------ACKKKHKYPSVLLPVLLSLIATPVLCVFG 612
Query: 500 LLIINRLR--------RQRTVTSSESSSRKDLLL-NVSYESLVKAT-------------- 536
++ R R + V E ++ D +SY+ L+ AT
Sbjct: 613 YPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRF 672
Query: 537 --VYKGILDLDQTFIAVKVLFLHQRGALK---SFMAECQALRNIRHRNLVKIITACSTSD 591
VYKG+L + T +AVKVL + AL+ SF ECQ L+ RHRNL++IIT CS
Sbjct: 673 GHVYKGVLR-NNTKVAVKVL--DPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPG 729
Query: 592 FQGNYFRALVYEFMHHGSLES-------CPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
F ALV M +GSLE + L ++ +NI DVA + YLHH+ +
Sbjct: 730 FN-----ALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKV 784
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRF---IPEVMSSNQCSSVG-----LKGTVGYATP 696
VHCDLKPSN+LLD++MTA + DFG++R + E +S++ S G L G+VGY P
Sbjct: 785 VHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAP 844
Query: 697 EY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739
EY G+LLLEI +G+RPT + EG LH F+K PD + +++
Sbjct: 845 EYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIE 902
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 258/775 (33%), Positives = 388/775 (50%), Gaps = 117/775 (15%)
Query: 55 NLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--- 111
NL G IG L L ++ L +N FS +P EIG RL+ I + N L G+IP S
Sbjct: 420 NLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGR 479
Query: 112 -----RLIL--NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH-------LNMFQVSVY 157
RL L N+L GNIP+ LG+ + + LA+N +G IP L +F +
Sbjct: 480 LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN 539
Query: 158 SLTGSIP---IQLLNITSMEY--------------------FHVSENQLVGELPPHIGFT 194
SL G++P I L N+T + + F V+EN G++P +G +
Sbjct: 540 SLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKS 599
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
N+ L L NQF G IP + S+L LD + NSL+G+IP +L C L + L
Sbjct: 600 -TNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGL---CKKLTHIDL 655
Query: 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPI 314
+ N LSG +P L L L +S+N GS+PTEI +L N++ + ++ L +IP
Sbjct: 656 NNNYLSGVIPTWLGKLP-LLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQ 714
Query: 315 SVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW--L 372
+G L L L+L EN +S +PS++G + L EL L N++ G +P +G L L
Sbjct: 715 EIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSAL 774
Query: 373 DLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
DLS+N+ TG IP + + LDLS N+L GE+P + G + LNLSYNNL+
Sbjct: 775 DLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQI----GDMKSLGYLNLSYNNLE 830
Query: 433 GDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELK-KREKSKGFKLMILLLSGL 491
G + ++ F A + GN LCG L C + K +R S ++I +S L
Sbjct: 831 GKLKKQ--FSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSL 884
Query: 492 VGLILVMSLLII---------NRLRRQRTVTSSESSSRKDLLL-------NVSYESLVKA 535
+ L++ ++I+ ++R + SS SSS + L ++ ++ +++A
Sbjct: 885 AAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEA 944
Query: 536 T----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRN 579
T VYK L +T K+L+ + KSF E + L IRHR+
Sbjct: 945 THYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRH 1004
Query: 580 LVKIITACSTSDFQGNYFRALVYEFMHHGSL-------ESCPR--ILSFLRRLNIAIDVA 630
LVK++ CS+ + + L+YE+M +GS+ E+ + +L + RL IA+ +A
Sbjct: 1005 LVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLA 1061
Query: 631 SALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT 690
+EYLH+ C PIVH D+K SNVLLD+++ AH+GDFGL + + +N S+ G+
Sbjct: 1062 QGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGS 1121
Query: 691 VGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL 730
GY PEY GI+L+EI TGK PT MF E D+ +V+ L
Sbjct: 1122 YGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVL 1176
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 263/795 (33%), Positives = 385/795 (48%), Gaps = 122/795 (15%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L L G +L G IGN+ L+ + L QN + IP E+G+L ++ I F+ N L G+I
Sbjct: 282 LALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEI 341
Query: 109 P-------DSRLIL---NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH-----LNMFQ 153
P + RL+ NKL G IP+EL L L L+ N TGPIP +M Q
Sbjct: 342 PVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQ 401
Query: 154 VSVY--SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGN 211
+ ++ SL+G IP L + + SENQL G++PP I N+ +L L N+ FGN
Sbjct: 402 LQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFI-CQQSNLILLNLGSNRIFGN 460
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN---------------------CTYLE 250
IP + L L N LTG P +L LVN C L+
Sbjct: 461 IPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQ 520
Query: 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310
+ L+ N S LPN ++ S +L +S+N ++G IP+EI N K L + + + I
Sbjct: 521 RLHLAANQFSSNLPNEISKLS-NLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIG 579
Query: 311 NIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALG--SCH 368
++P +G L +L++L L EN S IP ++GN T LTEL + GN GS+P LG S
Sbjct: 580 SLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSL 639
Query: 369 QLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSY 428
Q+ ++LS+N +G IP +GN + +L L+ N LSGEIP++ F +S N SY
Sbjct: 640 QIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTT----FENLSSLLGCNFSY 695
Query: 429 NNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSE--------LKKREKSKG 480
NNL G +P IF+N + S GN+ LCGG L C PS LK +G
Sbjct: 696 NNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSLKAGSARRG 751
Query: 481 FKLMILLLSGLVGLILVMSLLIINRLRRQRTVTS-------------------SESSSRK 521
++I+ +L+++ ++++ LR T+ E + K
Sbjct: 752 RIIIIVSSVIGGISLLLIA-IVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVK 810
Query: 522 DLLLNVS--YESLVK-----ATVYKGILDLDQTFIAVKVL-------FLHQRGALKSFMA 567
D+L ++S + TVYK ++ +T IAVK L + SF A
Sbjct: 811 DILEATKGFHDSYIVGRGACGTVYKAVMPSGKT-IAVKKLESNREGNNNNSNNTDNSFRA 869
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC-----PRILSFLRR 622
E L IRHRN+V++ + C QG+ L+YE+M GSL + + R
Sbjct: 870 EILTLGKIRHRNIVRLYSFCY---HQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTR 926
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682
IA+ A L YLHH CK I+H D+K +N+L+D + AH+GDFGL + I +S
Sbjct: 927 FAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSK--- 983
Query: 683 SSVGLKGTVGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVK 727
S + G+ GY PEY G++LLE+ TGK P + +G DL + +
Sbjct: 984 SVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL-EQGGDLATWTR 1042
Query: 728 MALPDQIL--QVLDP 740
+ D L ++LDP
Sbjct: 1043 NHIRDHSLTSEILDP 1057
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (802), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 250/782 (31%), Positives = 378/782 (48%), Gaps = 125/782 (15%)
Query: 55 NLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--- 111
NL G I L L ++ L +N FS IP EIG L+ I N +G+IP S
Sbjct: 419 NLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGR 478
Query: 112 -------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMF-----QVSVY-- 157
L N+L G +P+ LG+ + L LA+N +G IP F Q+ +Y
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFT---------------LP------ 196
SL G++P L+++ ++ ++S N+L G + P G + +P
Sbjct: 539 SLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNS 598
Query: 197 -NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
N+ L L NQ G IP ++ +L LD ++N+LTG IP LV C L + L+
Sbjct: 599 QNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPL---QLVLCKKLTHIDLN 655
Query: 256 VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPIS 315
N LSG +P L S L L +S+N S+PTE+ N L++++++ L +IP
Sbjct: 656 NNFLSGPIPPWLGKLS-QLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQE 714
Query: 316 VGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW--LD 373
+G L L VL+L +N S +P ++G + L EL L NS+ G +P +G L LD
Sbjct: 715 IGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALD 774
Query: 374 LSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
LS+N+ TG IP +G + LDLS N+L+GE+P S+ G + LN+S+NNL G
Sbjct: 775 LSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSV----GDMKSLGYLNVSFNNLGG 830
Query: 434 DVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKSKGFK----LMILLLS 489
+ ++ F A S GN LCG P + ++ K +G ++I +S
Sbjct: 831 KLKKQ--FSRWPADSFLGNTGLCGS------PLSRCNRVRSNNKQQGLSARSVVIISAIS 882
Query: 490 GLVG---LILVMSLLIINRLRRQRTVTSSESS----------SRKDLLLN------VSYE 530
L +ILV++L R + V ++ + K L N + +E
Sbjct: 883 ALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942
Query: 531 SLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN 574
+++AT VYK L+ +T K+L+ + KSF E + L
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGR 1002
Query: 575 IRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGS-----------LESCPRILSFLRRL 623
IRHR+LVK++ CS+ + L+YE+M +GS LE ++L + RL
Sbjct: 1003 IRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059
Query: 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683
IA+ +A +EYLHH C PIVH D+K SNVLLD++M AH+GDFGL + + E +N S
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119
Query: 684 SVGLKGTVGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKM 728
+ + GY PEY GI+L+EI TGK PT +F +D+ +V+
Sbjct: 1120 NTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179
Query: 729 AL 730
L
Sbjct: 1180 HL 1181
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 274/873 (31%), Positives = 408/873 (46%), Gaps = 162/873 (18%)
Query: 3 DKQALLAFKSKVDDDPFGALSTWNDSVN--FCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
+ +AL+A K + L W+D N C W GV C V+ LNLS NL G
Sbjct: 29 EGKALMAIKGSFSN-LVNMLLDWDDVHNSDLCSWRGVFCDNVSYSVVSLNLSSLNLGGEI 87
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------- 111
SP IG+L L+ I+LQ N + IP EIG L ++ + N L G IP S
Sbjct: 88 SPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKLKQLET 147
Query: 112 -RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHL--------------NM----- 151
L N+L G +P+ L + K L LA N+ TG I L NM
Sbjct: 148 LNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTL 207
Query: 152 ------------FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
F V +LTG+IP + N TS + +S NQ+ GE+P +IGF V
Sbjct: 208 SSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFL--QVA 265
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259
L L GN+ G IP I L LD ++N L G IP L N ++ + L N L
Sbjct: 266 TLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILG---NLSFTGKLYLHGNML 322
Query: 260 SGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIII------------------ 301
+G +P+ L N S L YL ++ N + G+IP E+G L+ L +
Sbjct: 323 TGPIPSELGNM-SRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSC 381
Query: 302 -AIEKF-----ILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNS 355
A+ +F +L +IP++ L L L+L NN +IP LG+ L +L+L GN+
Sbjct: 382 AALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNN 441
Query: 356 IRGSVPSALGSC-HQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAW- 413
GS+P LG H L L+LS NHL+G +P GN +SI +D+S N LSG IP+ L
Sbjct: 442 FSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQL 501
Query: 414 ------------IFGYIS-------IFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEK 454
+ G I LN+S+NNL G VP F + S GN
Sbjct: 502 QNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPY 561
Query: 455 LCGG-ISELKLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVT 513
LCG + + C P K R S+G + I+L G++ L+ ++ L + +++++ +
Sbjct: 562 LCGNWVGSI----CGPLP-KSRVFSRGALICIVL--GVITLLCMIFLAVYKSMQQKKILQ 614
Query: 514 SSESSSR---KDLLLNV-----SYESLVK----------------ATVYKGILDLDQTFI 549
S + K ++L++ +++ +++ +TVYK L + I
Sbjct: 615 GSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRP-I 673
Query: 550 AVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGS 609
A+K L+ L+ F E + + +IRHRN+V + + GN L Y++M +GS
Sbjct: 674 AIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP--TGNL---LFYDYMENGS 728
Query: 610 L-----ESCPRI-LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH 663
L S ++ L + RL IA+ A L YLHH C I+H D+K SN+LLD + AH
Sbjct: 729 LWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAH 788
Query: 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------------GILLLEIFTG 708
+ DFG+ + IP +S +S + GT+GY PEY GI+LLE+ TG
Sbjct: 789 LSDFGIAKSIP---ASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTG 845
Query: 709 KRPTSDMFTEGLDLHNFV-KMALPDQILQVLDP 740
K+ + +LH + A + +++ +DP
Sbjct: 846 KKAVDNE----ANLHQLILSKADDNTVMEAVDP 874
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 260/773 (33%), Positives = 372/773 (48%), Gaps = 114/773 (14%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L L L G +G+L L + L +N + IP EIG L I F+ NAL G+I
Sbjct: 270 LALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEI 329
Query: 109 PDS----------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP-------HLNM 151
P L N+L G IP EL +L L L+ N TGPIP L M
Sbjct: 330 PLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFM 389
Query: 152 FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGN 211
Q+ SL+G+IP +L + + +S+N L G +P ++ N+ IL L N GN
Sbjct: 390 LQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLH-SNMIILNLGTNNLSGN 448
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN---------------------CTYLE 250
IP I+ L L A N+L G P +L VN C+ L+
Sbjct: 449 IPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQ 508
Query: 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310
+ L+ N +G LP + S L L +S+N ++G +P+EI N K L + +
Sbjct: 509 RLQLADNGFTGELPREIGMLS-QLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSG 567
Query: 311 NIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH-- 368
+P VG L +L++L L NN+S IP +LGN + LTEL + GN GS+P LGS
Sbjct: 568 TLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGL 627
Query: 369 QLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSY 428
Q+ L+LS+N LTG IP + N + L L+ N LSGEIPSS F +S N SY
Sbjct: 628 QIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSS----FANLSSLLGYNFSY 683
Query: 429 NNLDGDVPRKMIFKNASAISEAGNEKLCGGI--SELKLPPCTPSELKKREKSKGFKLMIL 486
N+L G +P + +N S S GNE LCG ++ P PS+ + +I
Sbjct: 684 NSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIA 740
Query: 487 LLSGLVGLILVMSLLIINRLRRQ--RTVTSSESSSR-KDLLLNV--------SYESLVKA 535
+ + ++G + +M + +I L R+ RTV SS + ++ L++ +++ LV A
Sbjct: 741 ITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAA 800
Query: 536 T----------------VYKGILDLDQTFIAVKVLFLHQRG----ALKSFMAECQALRNI 575
T VYK +L T K+ H+ G SF AE L NI
Sbjct: 801 TDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNI 860
Query: 576 RHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL------ESCPRILSFLRRLNIAIDV 629
RHRN+VK+ C + QG+ L+YE+M GSL SC L + +R IA+
Sbjct: 861 RHRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEILHDPSCN--LDWSKRFKIALGA 913
Query: 630 ASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKG 689
A L YLHH CK I H D+K +N+LLD+ AH+GDFGL + I ++ S S++ G
Sbjct: 914 AQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPHSKSMSAIA--G 970
Query: 690 TVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK 727
+ GY PE YG++LLE+ TGK P + +G D+ N+V+
Sbjct: 971 SYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPI-DQGGDVVNWVR 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (768), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 273/854 (31%), Positives = 390/854 (45%), Gaps = 164/854 (19%)
Query: 24 TWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSN 83
T + S ++C W GV+C V+ LNLS NL G SP IG+L L I+L+ N S
Sbjct: 48 TTSPSSDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQ 107
Query: 84 IPHEIGRLFRLRHIIFNSNALQGQIPDS--------RLIL--NKLEGNIPSELGSLLKFK 133
IP EIG L+++ + N L G IP S +LIL N+L G IPS L + K
Sbjct: 108 IPDEIGDCSSLQNLDLSFNELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLK 167
Query: 134 GLGLANNYFTGPIPHL---------------NM----------------FQVSVYSLTGS 162
L LA N +G IP L N+ F V SLTGS
Sbjct: 168 ILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGS 227
Query: 163 IPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKL 222
IP + N T+ + +S NQL GE+P IGF V L L GNQ G IP I L
Sbjct: 228 IPETIGNCTAFQVLDLSYNQLTGEIPFDIGFL--QVATLSLQGNQLSGKIPSVIGLMQAL 285
Query: 223 EWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN 282
LD + N L+G IP L +L T+ E + L N L+G++P L N S L YL ++ N
Sbjct: 286 AVLDLSGNLLSGSIPPILGNL---TFTEKLYLHSNKLTGSIPPELGNMSK-LHYLELNDN 341
Query: 283 PISGSIPTEIGNLKNLIIIAIEKFIL------------------------IRNIPISVGY 318
++G IP E+G L +L + + L IP +
Sbjct: 342 HLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQK 401
Query: 319 LLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSC-HQLWLDLSHN 377
L + L+L NNI IP L L L+L N I G +PS+LG H L ++LS N
Sbjct: 402 LESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRN 461
Query: 378 HLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISI----------------- 420
H+TG +P GN +SI +DLS N++SG IP L + I +
Sbjct: 462 HITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANC 521
Query: 421 --FAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKS 478
LN+S+NNL GD+P+ F S S GN LCG PC S R
Sbjct: 522 LSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLN---SPCHDSRRTVRVSI 578
Query: 479 KGFKLMILLLSGLVGLILVMSLLIINRLRR---------QRTVTSSESSSRKDLLLNVS- 528
++ + + GLV IL+M L+ R + VT S+ K ++L+++
Sbjct: 579 SRAAILGIAIGGLV--ILLMVLIAACRPHNPPPFLDGSLDKPVT---YSTPKLVILHMNM 633
Query: 529 ----YESLVK----------------ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAE 568
YE +++ +TVYK +L + +A+K L+ H ++K F E
Sbjct: 634 ALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLK-NCKPVAIKRLYSHNPQSMKQFETE 692
Query: 569 CQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL------ESCPRILSFLRR 622
+ L +I+HRNLV + A S S F Y+++ +GSL + + L + R
Sbjct: 693 LEMLSSIKHRNLVS-LQAYSLSHLGSLLF----YDYLENGSLWDLLHGPTKKKTLDWDTR 747
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682
L IA A L YLHH C I+H D+K SN+LLD D+ A + DFG+ + + S
Sbjct: 748 LKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAK---SLCVSKSH 804
Query: 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK 727
+S + GT+GY PE YGI+LLE+ T ++ D +LH+ +
Sbjct: 805 TSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDES----NLHHLIM 860
Query: 728 MALP-DQILQVLDP 740
++++++ DP
Sbjct: 861 SKTGNNEVMEMADP 874
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 771 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 1.0 | 0.741 | 0.436 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 1.0 | 0.404 | 0.436 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 1.0 | 0.745 | 0.443 | 0.0 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.979 | 0.784 | 0.415 | 1e-178 | |
| 357505893 | 1003 | Receptor kinase-like protein [Medicago t | 0.970 | 0.745 | 0.418 | 1e-174 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.988 | 0.753 | 0.402 | 1e-173 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.994 | 0.762 | 0.412 | 1e-173 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.964 | 0.723 | 0.404 | 1e-173 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.992 | 0.746 | 0.405 | 1e-172 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.992 | 0.747 | 0.399 | 1e-170 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/960 (43%), Positives = 550/960 (57%), Gaps = 189/960 (19%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+ ALLA K+++ DP G ++WNDSV+FC W GVTC ++QRV LNL+ +L G+
Sbjct: 38 ETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGSL 97
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------- 111
SP IGNLTFL +NL+ NNF IP E+GRL RLR + +N+ G+IP +
Sbjct: 98 SPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVY 157
Query: 112 -RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH---------------------- 148
RL N L G IPS LGS K + L N TGP+P
Sbjct: 158 FRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSI 217
Query: 149 ---------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L + + +G IP + N++S+E F + N+L G LP + FTLPN++
Sbjct: 218 PQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQ 277
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPED-------------------- 239
+L + N F G++P S+SNAS L D ++ TG + D
Sbjct: 278 VLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKG 337
Query: 240 -------LDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292
L+SL+ C L+V+ LS + G LPNS+AN S+ L L + N +SG+IP I
Sbjct: 338 EADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGI 397
Query: 293 GNLKNL--IIIAIEKF-----ILIRN-----------------IPISVGYLLKLQVLSLF 328
GNL NL +I+A F +LI N IP S+G + +L L L
Sbjct: 398 GNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQ 457
Query: 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW--LDLSHNHLTGPIPLA 386
N++S +IPSS GN +L EL+L NS+ G++P + L L+L+ N LTG +P
Sbjct: 458 NNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSE 517
Query: 387 VGNPKSIPHLDLSKNELSGEIPSSLAWIF------------------GYISI-------- 420
V K++ HLD+S+N+LSGEIP L +IS+
Sbjct: 518 VRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDL 577
Query: 421 -----------------FAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
+ LNLS+NN +G +P K +F NA++ S AGN KLCGGI EL
Sbjct: 578 SRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELH 637
Query: 464 LPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDL 523
LP C ++ K E +G KLMI LL+G +GL+L+MSLL+INRLRR + S S+S KDL
Sbjct: 638 LPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASSKDL 697
Query: 524 LLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMA 567
+LNVSY+ L KAT VYKGIL D+T +AVKV+ LHQRGA+KSF A
Sbjct: 698 ILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKA 757
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLES------CP------- 614
EC+ALRNIRHRNLVK++T CS+ D+QGN F+ALVYEFM +GSLE+ P
Sbjct: 758 ECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVL 817
Query: 615 RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
RILS +RLNIAIDVASAL+YLHHHC KPIVHCDLKPSN+LLDNDMTAH+GDFGL RFIP
Sbjct: 818 RILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIP 877
Query: 675 EVMSS---NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMF 716
E +Q SS+GLKGT+GYA PE YGILLLE+FTGKRPT MF
Sbjct: 878 EAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMF 937
Query: 717 TEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEE-----NIKKGQIRESLIAIL 771
++ L+LHNFVKMALP++I ++DP FL +E E TA + ++K+ ++ E LI+IL
Sbjct: 938 SDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISIL 997
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/960 (43%), Positives = 548/960 (57%), Gaps = 189/960 (19%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+ ALLA K+++ DP G ++WNDSV+FC W GVTC ++QRV LNLS +L G+
Sbjct: 69 ETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVGSL 128
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------- 111
SP IGNLTFL +NL+ NNF IP E+GRL RLR + +N+ G+IP +
Sbjct: 129 SPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVY 188
Query: 112 -RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH---------------------- 148
RL N L G IPS LGS K + L N TGP+P
Sbjct: 189 FRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSI 248
Query: 149 ---------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L + + +G IP + N++S+E F + N+L G LP + FTLPN++
Sbjct: 249 PQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQ 308
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPED-------------------- 239
+L + N F G +P S+SNAS L D ++ TG + D
Sbjct: 309 VLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKG 368
Query: 240 -------LDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292
L+SL+ C L+V+ LS + G LPNS+AN S+ L L + N +SG+IP I
Sbjct: 369 EADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGI 428
Query: 293 GNLKNL--IIIAIEKF-----ILIRN-----------------IPISVGYLLKLQVLSLF 328
GNL NL +I+A F +LI N IP S+G + +L L L
Sbjct: 429 GNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQ 488
Query: 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW--LDLSHNHLTGPIPLA 386
N++S +IPSS GN +L EL+L NS+ G++P + L L+L+ N LTG +P
Sbjct: 489 NNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSE 548
Query: 387 VGNPKSIPHLDLSKNELSGEIPSSLAWIF------------------GYISI-------- 420
V K++ HLD+S+N+LSGEIP L +IS+
Sbjct: 549 VRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDL 608
Query: 421 -----------------FAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
+ LNLS+NN +G +P K +F NA++ S AGN KLCGGI EL
Sbjct: 609 SRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELH 668
Query: 464 LPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDL 523
LP C ++ K E +G KLMI LL+G +GL+L+MSLL+INRLRR + S S+S KDL
Sbjct: 669 LPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASSKDL 728
Query: 524 LLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMA 567
+LNVSY+ L KAT VYKG L D+T +AVKV+ LHQRGA+KSF A
Sbjct: 729 ILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKA 788
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLES----CP--------- 614
EC+ALRNIRHRNLVK++T CS+ D+QGN F+ALVYEFM +GSLE+ P
Sbjct: 789 ECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVL 848
Query: 615 RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
RILS +RLNIAIDVASAL+YLHHHC KPIVHCDLKPSN+LLDNDMTAH+GDFGL RFIP
Sbjct: 849 RILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIP 908
Query: 675 EVMSS---NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMF 716
E +Q SS+GLKGT+GYA PE YGILLLE+FTGKRPT MF
Sbjct: 909 EAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMF 968
Query: 717 TEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEE-----NIKKGQIRESLIAIL 771
++ L+LHNFVKMALP++I ++DP FL +E E TA + ++K+ ++ E LI+IL
Sbjct: 969 SDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISIL 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/962 (44%), Positives = 556/962 (57%), Gaps = 191/962 (19%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D ALLA K+++ DP G +S+WNDS++FC W G+ C +QRVI LNLS L G+
Sbjct: 36 ETDHLALLAIKAQIKLDPLGLMSSWNDSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSL 95
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------- 111
SP IGN++FLR I+L+QN F IP EIGRL RL++I F++N+ G+IP +
Sbjct: 96 SPQIGNMSFLRGISLEQNYFHGEIPQEIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLM 155
Query: 112 -RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH---------------------- 148
RL NKL G IP +LGSL K + + L N G +P
Sbjct: 156 LRLGFNKLTGQIPYQLGSLQKLERVQLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSI 215
Query: 149 ---------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
LN + + +L+G IP + N++S+ F + NQL G LP +G TLPN++
Sbjct: 216 PDALGRLKTLNFLGLGLNNLSGMIPPTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQ 275
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLT------GLIP---------------- 237
+L + N F G +P SISNAS L LD ++ T G +P
Sbjct: 276 VLNIGHNFFSGPLPVSISNASNLLELDIDTSNFTKVTIDFGGLPNLWSLALSSNPLGKGE 335
Query: 238 -EDL---DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293
+DL DSL C L ++ LS + G +P+S+ N S+ L L + N +SGSIPT I
Sbjct: 336 ADDLSFIDSLTKCRNLRLLDLSNSHFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIE 395
Query: 294 NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353
NL NL + +EK L +IP +G L LQ L L EN +S IPSSLGN T L E +L
Sbjct: 396 NLLNLAELTVEKNYLSGSIPSVLGNLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQK 455
Query: 354 NSIRGSVPSALGSCHQLW--------------------------LDLSHNHLTGPIPLAV 387
N I GS+PS+ G+ L L+L+ N LTGP+P
Sbjct: 456 NQIMGSIPSSFGNLKYLQNLDLSQNLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEA 515
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAW---------------------------------- 413
N ++ +LD+S+N+L G+IPSSL
Sbjct: 516 QNLMNLGYLDVSENKLYGQIPSSLGSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLS 575
Query: 414 ---IFGYISIFAK------LNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKL 464
+ G I F K LNLS+N+ +G+VPR+ F NA+AIS +GN++LCGGI +LKL
Sbjct: 576 RNNLSGQIPQFLKRLALISLNLSFNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKL 635
Query: 465 PPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQ--RTVTSSESSSRKD 522
P C + K + S+ KLMI +L+ L+ L+ VMS+L+INRLR++ ++ +S SS+++
Sbjct: 636 PRCVVNRSKNGKTSRRVKLMIAILTPLLVLVFVMSILVINRLRKKNRQSSLASSLSSKQE 695
Query: 523 LLLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFM 566
LLL VSY +L KAT VY+GILD ++T +AVKVLF+ QR LKSFM
Sbjct: 696 LLLKVSYRNLHKATAGFSSANLIGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFM 755
Query: 567 AECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC----PR------- 615
AEC+ L+NIRHRNLVKI+TACS+ DFQGN F+ALVYEFM +G+LES PR
Sbjct: 756 AECEILKNIRHRNLVKILTACSSVDFQGNDFKALVYEFMPNGTLESWLHSFPRTNGINED 815
Query: 616 --ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
ILSF +RLNIAIDVA+AL YLH+ C KP+VHCDLKPSNVLLDNDMTAH+GDFGL RFI
Sbjct: 816 LKILSFHQRLNIAIDVAAALNYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFI 875
Query: 674 PEVMS---SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715
E ++ N+ SSVGLKGTVGYA PE YGILLLE+FTGKRPT DM
Sbjct: 876 EEAINPSHRNESSSVGLKGTVGYAAPEYGMGSKPSMNGDVYSYGILLLEMFTGKRPTDDM 935
Query: 716 FTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEG------EETAEENIKKGQIRESLIA 769
F +GLDLHNFVK ALPDQI +V+DPLF+ GG + E IKK Q++ESLIA
Sbjct: 936 FHDGLDLHNFVKTALPDQISEVVDPLFVTGGEGDEEETGHLENRTRGQIKKDQMQESLIA 995
Query: 770 IL 771
IL
Sbjct: 996 IL 997
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 632 bits (1631), Expect = e-178, Method: Compositional matrix adjust.
Identities = 386/930 (41%), Positives = 521/930 (56%), Gaps = 175/930 (18%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D QALL FKSK+ DPF L +WN++++FCQW GVTC L ++RV +L+L ++G+
Sbjct: 38 ETDLQALLEFKSKITHDPFQVLRSWNETIHFCQWQGVTCGLLHRRVTVLDLHSLKISGSI 97
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD-----SRLIL 115
SPYIGNL+FLR +N+Q N+F IP +IG L RL + N+N++ G+IP S L+
Sbjct: 98 SPYIGNLSFLRALNIQNNSFGHEIPQQIGYLRRLEELRLNNNSVGGKIPTNISRCSNLVF 157
Query: 116 -----NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH---------------------- 148
NKLEGN+P ELG L + L + N TG IPH
Sbjct: 158 ISLGKNKLEGNVPEELGVLSNLQVLSIFGNKLTGSIPHSLGNLSQLQRLSLAENRMVGEV 217
Query: 149 ---------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L + L+G+IP L N++S+ + EN G LP IGF LPN+R
Sbjct: 218 PNSLGWLRNLTFLSLRSNRLSGTIPSSLFNLSSIRNLDIGENNFHGNLPSDIGFLLPNIR 277
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------- 237
++ N+F G IP S+SNA+ LE L N+LTG +P
Sbjct: 278 WFAISSNEFTGKIPVSLSNATNLESLLLLQNNLTGEVPSLAKLDRLRVFSLTSNNLGTGK 337
Query: 238 -EDLD---SLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293
+DL SL N T LE + ++ N+ G LP+S+AN S+ LR L + N I GSIP+ I
Sbjct: 338 ADDLSFLHSLTNTTALEELGVNGNNFGGMLPDSIANLSTTLRILLLDNNRIIGSIPSGIE 397
Query: 294 NLKNLIIIAIEKFILIRN-----IPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE 348
NL +++E F + N IP S+G L L VL+L N +S IPSSLGN T L +
Sbjct: 398 NL-----VSLEDFEVWNNQLSGFIPDSIGKLQNLVVLALNSNMLSGHIPSSLGNLTNLIQ 452
Query: 349 LNLCGNSIRGSVPSALGSCHQL--------------------------WLDLSHNHLTGP 382
L + N++ G +PS LG C + +LDLS N+LTG
Sbjct: 453 LLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGSIPPEVISISSLSIYLDLSQNNLTGT 512
Query: 383 IPLAVGNPKSIPHLDLSKNELSGEIPSSLAWI--------------------FGYISIFA 422
+P+ VGN KS+ D+S N+LSGEIP +L +
Sbjct: 513 LPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISLEILNMAGNNFQGLIPSSLSSLRALQ 572
Query: 423 KLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKSKGFK 482
L+LS N+L G VP K IFKNASA S GN LCGGI E +LP C + KK + K
Sbjct: 573 ILDLSNNHLSGMVPSKGIFKNASATSVEGNNMLCGGIPEFQLPVCNSARHKKNRLTPVLK 632
Query: 483 LMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDLLLNVSYESLVKAT------ 536
+I +SG+ LIL++ L RQ+ V + + + ++ +SY++L KAT
Sbjct: 633 TVISAISGMAFLILMLYLFWF----RQKKVNETTADFSEKKIMELSYQNLHKATDGFSSA 688
Query: 537 ----------VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITA 586
VYKG LD + T IAVKV L +RG KSF+AEC+ALRNIRHRNL+K++TA
Sbjct: 689 NIIGMGSFGSVYKGRLDREGTLIAVKVFNLMRRGGFKSFLAECEALRNIRHRNLLKVLTA 748
Query: 587 CSTSDFQGNYFRALVYEFMHHGSLESC-------------PRILSFLRRLNIAIDVASAL 633
CS+ D+ GN F+ALVYEFM +GSLE R L+FL+RLNIAIDVASAL
Sbjct: 749 CSSLDYHGNDFKALVYEFMVNGSLEEWLHPPVATNEAELETRKLNFLQRLNIAIDVASAL 808
Query: 634 EYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN--QCSSVGLKGTV 691
YLHHHC+ IVHCDLKPSN+LLD ++T H+GDFGL RF+ + ++ Q SS+G++GTV
Sbjct: 809 YYLHHHCEPQIVHCDLKPSNILLDEELTGHVGDFGLARFLLDATQNHYTQSSSIGVRGTV 868
Query: 692 GYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736
GYA PE YGILLLE+FTGKRP DMF +G +LHNFVK ALP+Q+++
Sbjct: 869 GYAPPEYGMSSEVSTYGDVYSYGILLLEMFTGKRPMDDMFKDGFNLHNFVKAALPNQVVE 928
Query: 737 VLDPLFLVGGVQEGEETAEENIKKGQIRES 766
++DP L+ ++EG ET+ ++ G+ + S
Sbjct: 929 IVDP-NLLPEIEEG-ETSTDSADTGRCKTS 956
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357505893|ref|XP_003623235.1| Receptor kinase-like protein [Medicago truncatula] gi|355498250|gb|AES79453.1| Receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1595), Expect = e-174, Method: Compositional matrix adjust.
Identities = 379/906 (41%), Positives = 500/906 (55%), Gaps = 158/906 (17%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D ALL FKS++ DPF ALS WNDS++ C WLG+TC++ RV+ L L+ L GT
Sbjct: 41 ETDLHALLDFKSRITQDPFQALSLWNDSIHHCNWLGITCNISNGRVMHLILADMTLAGTL 100
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD--SRLIL--- 115
SP IGNLT+L +NL+ N+F P ++G L L+H+ + N+ G IP S+ I
Sbjct: 101 SPSIGNLTYLTKLNLRNNSFHGEFPQQVGNLLYLQHLNISYNSFSGSIPSNLSQCIELSI 160
Query: 116 -----NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH-------LNMFQVSVYSLTGSI 163
N G IP+ +G+ L LA N G IP+ L +F ++ L G+I
Sbjct: 161 LSSGHNNFTGTIPTWIGNFSSLSLLNLAVNNLHGTIPNEVGKLSRLTLFALNGNHLYGTI 220
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223
P+ + NI+S+ + S+N L G LP +GFTLPN+ N F G IP S+SNAS+LE
Sbjct: 221 PLSVFNISSLSFLTFSQNNLHGNLPYDVGFTLPNLETFAGGVNDFTGTIPESLSNASRLE 280
Query: 224 WLDFANNSLTGLIPED---------------------------LDSLVNCTYLEVVSLSV 256
LDFA N+L G +P++ L SL+NCT LEV+ L+
Sbjct: 281 ILDFAENNLIGTLPKNIGRLTLLKRLNFDTNRLGNGEDGELNFLTSLINCTALEVLGLAE 340
Query: 257 NSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISV 316
N G LP+S+ N S +L L + N I GSIP I NL NL + +EK L +P ++
Sbjct: 341 NQFGGKLPSSIGNLSINLNALDLGENAIYGSIPIGISNLVNLTSLGMEKNNLSGFVPDTI 400
Query: 317 GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL------ 370
G L KL L L+ N S IPSS+GN T LT+L + N+ GS+P++L +C +L
Sbjct: 401 GMLQKLVDLELYSNKFSGVIPSSIGNLTRLTKLLIADNNFEGSIPTSLENCQRLLMLNLS 460
Query: 371 --------------------WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPS- 409
+LDLSHN LTG +P +G ++ +LDLSKN+LSG IPS
Sbjct: 461 HNMLNGSIPRQVFALSSLSIYLDLSHNSLTGSLPFEIGKLVNLANLDLSKNKLSGMIPSS 520
Query: 410 -----SLAWI--------------------------------------FGYISIFAKLNL 426
SL W+ G I LNL
Sbjct: 521 IGSCVSLEWLHMQGNFFEGNIPSTIQNLRGIQHIDLSCNNLSGKIPEFLGEIKGLMHLNL 580
Query: 427 SYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKSKGFKLMIL 486
SYNNLDG++P IFKNA++ S GN KLCGG+ EL LP CT K+EK K++I
Sbjct: 581 SYNNLDGELPMNGIFKNATSFSINGNIKLCGGVPELNLPACT----IKKEKFHSLKVIIP 636
Query: 487 LLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDLLLNVSYESLVKAT---------- 536
+ S L+ L+ + LII ++R R TS E+++ +DL LN+SY +VK T
Sbjct: 637 IASALIFLLFLSGFLIIIVIKRSRKKTSRETTTIEDLELNISYSEIVKCTGGFSNDNLIG 696
Query: 537 ------VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VYKG L D T IA+KVL L QRGA KSF+ EC AL+ IRHRNL+KIITA S+
Sbjct: 697 SGSFGSVYKGTLSSDGTTIAIKVLNLEQRGASKSFIDECNALKVIRHRNLLKIITAISSI 756
Query: 591 DFQGNYFRALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
D QG F+ALVYEFM +GSLE + L+F++RLNIAIDVA ALEYLHH C+ PI
Sbjct: 757 DHQGKDFKALVYEFMSNGSLEDWLHPINQKKTLTFVQRLNIAIDVACALEYLHHFCETPI 816
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS---NQCSSVGLKGTVGYATPE---- 697
VHCD+KPSNVLLDNDM A +GDFGL F+ E + S LKG+VGY PE
Sbjct: 817 VHCDIKPSNVLLDNDMVARVGDFGLATFLFEESCDSPKHSTMSASLKGSVGYIPPEYGMG 876
Query: 698 -----------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746
YGILLLEIFTGKRPT++MF G+ + F +ALP+ + ++DP L
Sbjct: 877 GHPSALGDVYSYGILLLEIFTGKRPTNEMFEGGMGIQQFTALALPNHAIDIIDPSLLYDQ 936
Query: 747 VQEGEE 752
+G++
Sbjct: 937 EFDGKD 942
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1589), Expect = e-173, Method: Compositional matrix adjust.
Identities = 384/953 (40%), Positives = 529/953 (55%), Gaps = 191/953 (20%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+ +LLAFK+++ D P ALS+WN S +FC+W GV C ++QR++ LNL LTG
Sbjct: 32 ETDRLSLLAFKAQITD-PLDALSSWNASTHFCKWSGVICGHRHQRIVELNLQSSQLTGNL 90
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP------DSRLI 114
SP+IGNL+FLR++NL+ N FS +IP E+GRLFRL+ ++ +N G+IP + L+
Sbjct: 91 SPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVLGNNTFSGEIPVNISSCSNLLV 150
Query: 115 L----NKLEGNIPSELGSLLKFKGLGLANNYFTGPIP----------------------- 147
L N L G IP++LGSL K L N G IP
Sbjct: 151 LHLGSNNLTGKIPAQLGSLSKLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGI 210
Query: 148 --------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L F V+ L+G+IP + NI+S+ Y + +NQL G LPP +G LPN+
Sbjct: 211 PESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLA 270
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------- 237
L++ N G IP ++SNASK+ +D + N+LTG IP
Sbjct: 271 YLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIPDLASLPDLQKLLVHHNDLGNGE 330
Query: 238 ED----LDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293
ED L +L N T LE + ++ N+ G LP ++NFS++L+ + N I GSIPTEIG
Sbjct: 331 EDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPTEIG 390
Query: 294 NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353
NL +L +++E L IP S+G L L L L EN IS IPSSLGN T L E++
Sbjct: 391 NLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVSFAQ 450
Query: 354 NSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAV------------------------- 387
N+++G++P++LG+ H+L LDLS N+L+GPIP V
Sbjct: 451 NNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEV 510
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAW---------------------------------- 413
G ++ L +SKN LSGEIP SL
Sbjct: 511 GQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPVPDLSSLRALQMLLLSY 570
Query: 414 --IFGYISIFAK-------LNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKL 464
+ G I F K L+LSYN+ +G+VP + +F+N S IS GN+KLCGGI +L L
Sbjct: 571 NNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDL 630
Query: 465 PPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDLL 524
P CT +E + + L+I + G +G++L+ S L+ R+ + S +
Sbjct: 631 PKCTSNEPARPKSHTKLILIIAIPCGFLGIVLMTSFLLF--YSRKTKDEPASGPSWESSF 688
Query: 525 LNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMAE 568
++Y+ L++AT VY+G L D +AVKVL L ++GA KSFMAE
Sbjct: 689 QRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAE 748
Query: 569 CQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC------------PRI 616
C AL NIRHRNLVK+ITACS++DFQGN F+ALVYEFM +GSLE R
Sbjct: 749 CAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPETRN 808
Query: 617 LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676
L ++RLNIAIDVASAL+YLH+HC+ P+VHCDLKPSNVLL +DMTA +GDFGL RF+PE
Sbjct: 809 LDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEA 868
Query: 677 ---MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE 718
+ +++ SSVGLKGT+GYA PE YGILLLE+FTG+RPT MF +
Sbjct: 869 SNQLPADESSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKD 928
Query: 719 GLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771
G +LHN+ KM LPD +L+ +DP ++E EE N ++ E +++I+
Sbjct: 929 GHNLHNYAKMVLPDNVLEFVDPT-----LREHEEM-NHNDDSHKVMECMVSII 975
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 394/955 (41%), Positives = 534/955 (55%), Gaps = 188/955 (19%)
Query: 3 DKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASP 62
D+ +LLAFK+++ DDP GALS+WN+S++FC+W G C ++QRV+ L+L L G+ SP
Sbjct: 16 DRLSLLAFKAQITDDPLGALSSWNESLHFCEWSGAKCGRRHQRVVELDLHSCKLAGSLSP 75
Query: 63 YIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD-----SRLILNK 117
+IGNL+FLR+++L N+FS NIP E+GRL RL+ + +N G+IP S L L
Sbjct: 76 HIGNLSFLRILDLSNNSFSQNIPQELGRLLRLQQLNLENNTFSGEIPANISNCSNLQLID 135
Query: 118 LEGN-----IPSELGSLLKFKG------------------------LGLANNYFTGPIPH 148
L+GN IP+ELGSLL + +G+ +N+ G IP+
Sbjct: 136 LKGNNLIGKIPAELGSLLNLQACLLVTNHLVGEIPLSFENLSSVEIIGVGDNHLQGSIPY 195
Query: 149 -------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRIL 201
L V + +L+G+IP + N++S+ F V+ NQ G LP +G LP++ +L
Sbjct: 196 GIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAINQFHGSLPSDLGQKLPSLEVL 255
Query: 202 LLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------ED- 239
+ N+F G IP +ISNAS L +DF NNS TG +P E+
Sbjct: 256 VFYANRFNGPIPVTISNASTLSVIDFGNNSFTGKVPPFANLPNLQYLGIDSNELGNGEEG 315
Query: 240 ----LDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNL 295
L SL N T LE + +S N+L G P ++NFSS L M N + GSIP +IGNL
Sbjct: 316 DLSFLQSLANYTNLEELGMSDNNLGGMFPEIISNFSSQFTTLSMGRNQVRGSIPVDIGNL 375
Query: 296 KNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNS 355
+L + +E L IP S+G L L L+L EN IS IPSSLGN T L EL L N+
Sbjct: 376 ISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLVENKISGNIPSSLGNVTSLVELYLSANN 435
Query: 356 IRGSVPSALGSCHQLW--------------------------LDLSHNHLTGPIPLAVGN 389
++G +PS+L +C L LDLSHN L GP+P VG
Sbjct: 436 LQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQVIGMASLSVSLDLSHNQLIGPLPSEVGR 495
Query: 390 PKSIPHLDLSKNELSGEIPSSLA--------------------WIFGYISIFAKLNLSYN 429
++ +LD+S N LSGEIP SL + + LNLSYN
Sbjct: 496 LVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHLEGNFLQGSIPELLSSLRALQYLNLSYN 555
Query: 430 NLDGDVPR------------------------KMIFKNASAISEAGNEKLCGGISELKLP 465
NL G +PR + +F N SA+S GN+KLCGGIS+L L
Sbjct: 556 NLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQRVFGNVSAVSVLGNDKLCGGISQLNLS 615
Query: 466 PCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDLLL 525
CT +EL+K + S KL+I + G + +L++S L+I+ R+ + +S +S
Sbjct: 616 RCTSNELRKPKFSTKLKLVISIPCGFIIALLLISSLLIHSWRKTKNEPASGASWEVS-FR 674
Query: 526 NVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMAEC 569
V+YE L +AT VYK IL D +AVKV L ++GA KS+MAEC
Sbjct: 675 RVTYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMAEC 734
Query: 570 QALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC------------PRIL 617
AL NIRHRNLVKI+TACS+ DF+GN F+ALVYEFM +GSLE L
Sbjct: 735 AALINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQGNL 794
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV- 676
+ ++RLN+AIDVASAL+YLH+HC+ +VHCDLKPSNVLLD DMTAH+GDFGL RF PE
Sbjct: 795 NLIQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPEAS 854
Query: 677 --MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG 719
+SSNQ SS+GLKGTVGYA PE YGILLLEI TGK PT F EG
Sbjct: 855 VQLSSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSFKEG 914
Query: 720 LDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKK---GQIRESLIAIL 771
L+LH +VKMALPD++++V+DP+ L +++ A + +K+ ++ E L++I+
Sbjct: 915 LNLHKYVKMALPDRVVEVVDPILLR-EIEQTSANASDGMKRIGNDKVLECLVSIM 968
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1586), Expect = e-173, Method: Compositional matrix adjust.
Identities = 374/925 (40%), Positives = 513/925 (55%), Gaps = 181/925 (19%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+ +LLAFK+ + DDP LS+WN+S++FC+W G+TC ++QRVI ++L L+G+
Sbjct: 33 ETDRLSLLAFKAHITDDPLHILSSWNESLHFCKWSGITCGSRHQRVIEIDLESSRLSGSL 92
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------- 111
+ +IGNL+FLR++NLQ N+ S IP EIGRLFRLR +I N+ G+IP +
Sbjct: 93 TAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRTLILRRNSFSGEIPVNISYCSNLLT 152
Query: 112 -RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPI------------------------ 146
RL N L G +P+EL SL K + NY TG I
Sbjct: 153 LRLGRNNLTGKLPAELKSLSKLQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHGEI 212
Query: 147 -------PHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L F + + +G IP + N++S+ V NQL G LPP +G +LP +
Sbjct: 213 PNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPKLE 272
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------E 238
+L L N+F G+IP +ISNAS L LD + N+ TG +P E
Sbjct: 273 VLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGKVPSLARLHNLSYIGIHKNNLGNGE 332
Query: 239 DLD-----SLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293
D D +L N T LE+++++ N+L G LP L+NFS+ L ++ N I G IP+EI
Sbjct: 333 DDDLSFLYTLANNTNLEILAITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEID 392
Query: 294 NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353
NL L + E+ L +IP S+G L L L L +NNIS IPSSLGN T L+ ++L
Sbjct: 393 NLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTISLKV 452
Query: 354 NSIRGSVPSALGSCHQLW--------------------------LDLSHNHLTGPIPLAV 387
N++ GS+PS+LG+C Q+ LDLS N TG +P+ V
Sbjct: 453 NNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLPMEV 512
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAW---------------------------------- 413
G ++ +LD+SKN+LSGEIP SL
Sbjct: 513 GGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNLS 572
Query: 414 ----------IFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
F KL+LSYN+ +G+VP + +FKNASA S +GN+ LCGGI E+
Sbjct: 573 HNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIPEIN 632
Query: 464 LPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDL 523
LP CT ++ K + S +L+I++ V +L+++ ++ + R + SS
Sbjct: 633 LPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVLLLTSALLFCCLKMRKNKEASGSSLDIF 692
Query: 524 LLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMA 567
VSY++L+KAT VYKGIL D+T IAVKVL L +GA +SFM
Sbjct: 693 FQKVSYQNLLKATDGFSSANLIGAGSFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMT 752
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC------------PR 615
ECQAL N+RHRNLVK++TACS+SDF+ N F+ALVYE+M +GSLE PR
Sbjct: 753 ECQALANVRHRNLVKVLTACSSSDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPR 812
Query: 616 ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF-IP 674
ILS + RL+I+IDVASAL+YLH+ C+ P+VHCDLKPSN+LLD+DMTAH+GDFGL RF I
Sbjct: 813 ILSLIERLSISIDVASALDYLHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIA 872
Query: 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG 719
S+ SS+G++GTVGYA PE YGILLLE+FTGK+PT MF +G
Sbjct: 873 APHHSSPSSSIGIRGTVGYAAPEYGMGSDVSTYGDVYTYGILLLELFTGKKPTDAMFKDG 932
Query: 720 LDLHNFVKMALPDQILQVLDPLFLV 744
L+LH KMA+PD++ DP L+
Sbjct: 933 LNLHILAKMAMPDRLALAADPFLLI 957
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1576), Expect = e-172, Method: Compositional matrix adjust.
Identities = 389/959 (40%), Positives = 523/959 (54%), Gaps = 194/959 (20%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+ +LLA KS++ +DPFG LS+WN+S++FC W GV C +++RV+ ++L L G+
Sbjct: 33 ETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQLVGSL 92
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP------DSRLI 114
SP+IGNL+FLR++ L+ N FS NIP E+G LFRLR + +N G+IP + LI
Sbjct: 93 SPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCSNLLI 152
Query: 115 L----NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH---------------------- 148
L N L G +P ELGSL K + NY G IP
Sbjct: 153 LSLSGNNLTGKLPIELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYLQGGI 212
Query: 149 ---------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L F ++TG IP + N++S+ F V NQL G LPP +G TLPN+
Sbjct: 213 PNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTLPNLE 272
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSL---------------- 243
ILL++ N+F G+IP + SNAS + ++ +NN+LTG +P DL SL
Sbjct: 273 ILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLIVDVNYLGNG 331
Query: 244 -----------VNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292
N T LE +S++ N+ G LP ++NFS +L+ + N I GSIP+ I
Sbjct: 332 NDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIPSGI 391
Query: 293 GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352
GNL L + +E L IP S+G L L VL+L N IS IPSS+GN T L E+ L
Sbjct: 392 GNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEVYLS 451
Query: 353 GNSIRGSVPSALGSCHQLW--------------------------LDLSHNHLTGPIPLA 386
N+++G +PS+LG+C L L LS N LTG +PL
Sbjct: 452 ANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSLPLE 511
Query: 387 VGNPKSIPHLDLSKNELSGEIPSSLA---------------------------------- 412
VG ++ + +LS N LSGEIP +L
Sbjct: 512 VGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQILNL 571
Query: 413 ----------WIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISEL 462
+ + L+LS+NNL+G+VP + IF AS S GN+KLCGG+ +L
Sbjct: 572 SHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGMPQL 631
Query: 463 KLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKD 522
L CT + +K + S KL+I + G VG+ILV+S ++ L+ +++ +S S +
Sbjct: 632 NLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPAS-GSPWES 690
Query: 523 LLLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFM 566
V+YE L++AT VYKGIL D +AVKV L + GA KSFM
Sbjct: 691 TFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFM 750
Query: 567 AECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC------------P 614
AEC AL NIRHRNLVK++TACS DFQGN F+ALVYEFM +GSLE
Sbjct: 751 AECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAHRR 810
Query: 615 RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
R LS L+RLNIAIDVASAL+YLH+HC+ IVHCDLKPSNVLLD D+TAH+GDFGL R +P
Sbjct: 811 RDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARLLP 870
Query: 675 EV---MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMF 716
+ + +Q SS+GLKGT+GYA PE YGILLLE+FTG+RPT +F
Sbjct: 871 QASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDGLF 930
Query: 717 TEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKK----GQIRESLIAIL 771
+GL+LHNF K ALP + +VLDP+ V E EET+ + ++ G E L AI+
Sbjct: 931 KDGLNLHNFAKTALPISVAEVLDPVL----VTEAEETSGDASRRMSHIGNHMECLAAIV 985
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1558), Expect = e-170, Method: Compositional matrix adjust.
Identities = 383/958 (39%), Positives = 519/958 (54%), Gaps = 193/958 (20%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+ +LLAFK+++ D P G LS+WN+S++FC+W GV C K++RV+ L+L L G+
Sbjct: 32 ETDRLSLLAFKTQISD-PLGKLSSWNESLHFCEWSGVICGRKHRRVVELDLHSSQLAGSL 90
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD--SR------ 112
SP+IGNL+FLR++NL++N+FS IP E+GRLFR++ + +N G+IP SR
Sbjct: 91 SPHIGNLSFLRILNLEKNSFSYLIPQELGRLFRIQELSLGNNTFSGEIPVNISRCTNLLS 150
Query: 113 --LILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP----------------------- 147
L N L G +P+E GSL K + L N+ G IP
Sbjct: 151 IGLASNNLTGKLPAEFGSLSKLQVLNFQRNHLFGEIPPSYGNLSELQIIRGVRNNLQGGI 210
Query: 148 --------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
L F V SL+G+IP + N++S+ F NQL G LPP +G TLPN+
Sbjct: 211 PDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSAPLNQLYGILPPELGLTLPNLD 270
Query: 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP---------------------E 238
+ NQF G IP ++SNASK+ L NNS TG +P E
Sbjct: 271 TFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVPSLAGLHNLQRLVLNFNNLGNNE 330
Query: 239 DLD-----SLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293
D D L N T LE+++++ N+ G LP + NFS+ LR + + N + GSIPTEIG
Sbjct: 331 DDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFSTKLRIMIIGENNLRGSIPTEIG 390
Query: 294 NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353
L L + +E L IP S+G L +L V ++ N IS IPSSLGN T L E+
Sbjct: 391 KLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKISGNIPSSLGNITSLLEVYFFA 450
Query: 354 NSIRGSVPSALGSCHQL--------------------------WLDLSHNHLTGPIPLAV 387
N+++G +PS+LG+C L +LDL+ N L GP+P V
Sbjct: 451 NNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGISSLSMYLDLAENQLIGPLPSEV 510
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLA----------------------------------- 412
G + L++ KN LSGEIP L+
Sbjct: 511 GKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNFFQGSIPESLSSLRALQILNLS 570
Query: 413 ---------WIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
+ L+LS+NNL+G+VP + +F AS S GN+KLCGG +L
Sbjct: 571 HNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFARASGFSMLGNKKLCGGRPQLN 630
Query: 464 LPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQRTVTSSESSSRKDL 523
L CT + +K + S KL+I + G VG+IL++S ++ L+ +++ +S S +
Sbjct: 631 LSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLFFLLKEKKSRPAS-GSPWEST 689
Query: 524 LLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGALKSFMA 567
V+YE L++AT VYKGIL D +AVKV L + GA KSFMA
Sbjct: 690 FQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFMA 749
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLES------------CPR 615
EC AL NIRHRNLVK++TACS DFQGN F+ALVYEFM +GSLE R
Sbjct: 750 ECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAHVRR 809
Query: 616 ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
LS L+RLNIAIDVASAL+YLH+HC+ + HCDLKPSNVLLD DMTAH+GDFGL R +P+
Sbjct: 810 DLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARLLPQ 869
Query: 676 V---MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT 717
+ +Q SS+GLKGT+GYA PE YGILLLE+FTG+RPT+ +F
Sbjct: 870 ASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTNGLFK 929
Query: 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKK----GQIRESLIAIL 771
+GL+LHNF K ALP + +VLDP+ V E EET+ + ++ G E L AI+
Sbjct: 930 DGLNLHNFAKTALPISVAEVLDPVL----VTEAEETSGDASRRMSHIGNHMECLAAIV 983
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 771 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.556 | 0.424 | 0.338 | 2.4e-119 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.583 | 0.439 | 0.345 | 2.9e-118 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.214 | 0.163 | 0.572 | 3.9e-114 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.214 | 0.163 | 0.544 | 6e-110 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.549 | 0.411 | 0.350 | 4e-106 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.827 | 0.622 | 0.360 | 1.8e-101 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.565 | 0.371 | 0.319 | 5e-80 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.821 | 0.631 | 0.291 | 2.4e-58 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.525 | 0.404 | 0.330 | 3.9e-72 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.516 | 0.317 | 0.331 | 1.6e-70 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 2.4e-119, Sum P(3) = 2.4e-119
Identities = 163/481 (33%), Positives = 241/481 (50%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E D+QALL FKS+V +D LS+WN S C W GVTC K +RV L L L G
Sbjct: 23 ETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP-----DSRLI- 114
SP IGNL+FL ++L +N F IP E+G+L RL ++ N L+G IP SRL+
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 115 ----LNKLEGNIPSEXXXXXXXXXXXXANNYFTGPIPHLNMFQVSVY--SLTGSIPIQLL 168
N+L G++PSE G + N+ Q+++Y ++ G +P L
Sbjct: 143 LRLDSNRLGGSVPSEL-----------------GSLT--NLVQLNLYGNNMRGKLPTSLG 183
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
N+T +E +S N L GE+P + L + L L N F G P ++ N S L+ L
Sbjct: 184 NLTLLEQLALSHNNLEGEIPSDVA-QLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIG 242
Query: 229 NNSLTGLIPEDLDSLVNCTYXXXXXXXXXXXXGTLPNSLANFSSHLRYLYMSANPISGSI 288
N +G + DL L+ G++P +L+N S+ L L M+ N ++GSI
Sbjct: 243 YNHFSGRLRPDLGILL--PNLLSFNMGGNYFTGSIPTTLSNIST-LERLGMNENNLTGSI 299
Query: 289 PTEIGNLKNLXX----XXXXXXXXXRNIPI--SVGYLLKLQVLSLFENNISREIPSSLGN 342
PT GN+ NL R++ S+ +L+ L + N + ++P S+ N
Sbjct: 300 PT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIAN 358
Query: 343 FTF-LTELNLCGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSK 400
+ L L+L G I GS+P +G+ L L L N L+GP+P ++G ++ +L L
Sbjct: 359 LSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFS 418
Query: 401 NELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEA--GNEKLCGG 458
N LSG IP A+I G +++ L+LS N +G VP + N S + E G+ KL G
Sbjct: 419 NRLSGGIP---AFI-GNMTMLETLDLSNNGFEGIVPTSL--GNCSHLLELWIGDNKLNGT 472
Query: 459 I 459
I
Sbjct: 473 I 473
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 587 (211.7 bits), Expect = 2.9e-118, Sum P(3) = 2.9e-118
Identities = 164/475 (34%), Positives = 234/475 (49%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTA 60
E DKQALL FKS+V + L +WNDS+ C W GV C LK++RV ++L G LTG
Sbjct: 38 ETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVV 97
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEG 120
SP++GNL+FLR +NL N F IP E+G LFRL+++ ++N G IP ++L+
Sbjct: 98 SPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIP---VVLS---- 150
Query: 121 NIPSEXXXXXXXXXXXXANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSE 180
N S G + L + + +LTG P L N+TS++
Sbjct: 151 NCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIY 210
Query: 181 NQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL 240
NQ+ GE+P I L + +A N+F G P I N S L +L NS +G + D
Sbjct: 211 NQIEGEIPGDIA-RLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDF 269
Query: 241 DSLVNCTYXXXXXXXXXXXXGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLXX 300
SL+ GT+P +L+N SS LR L + +N ++G IP G L+NL
Sbjct: 270 GSLL--PNLQILYMGINSFTGTIPETLSNISS-LRQLDIPSNHLTGKIPLSFGRLQNLLL 326
Query: 301 XXXXXXXXXRNIPISVGYL------LKLQVLSLFENNISREIPSSLGNF-TFLTELNLCG 353
+ +L +LQ L++ N + ++P + N T LTEL+L G
Sbjct: 327 LGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGG 386
Query: 354 NSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLA 412
N I GS+P +G+ L LDL N LTG +P ++G + + L N LSGEIPSSL
Sbjct: 387 NLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSL- 445
Query: 413 WIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISE--LKLP 465
G IS L L N+ +G +P + + G KL G I ++LP
Sbjct: 446 ---GNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELP 497
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 3.9e-114, Sum P(3) = 3.9e-114
Identities = 103/180 (57%), Positives = 134/180 (74%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
TV+K +L + +AVKVL + +RGA+KSFMAEC++L++IRHRNLVK++TAC++ DFQGN
Sbjct: 714 TVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGN 773
Query: 596 YFRALVYEFMHHGSLESC--P----------RILSFLRRLNIAIDVASALEYLHHHCKKP 643
FRAL+YEFM +GSL+ P R L+ L RLNIAIDVAS L+YLH HC +P
Sbjct: 774 EFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 833
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS---NQCSSVGLKGTVGYATPEYGI 700
I HCDLKPSN+LLD+D+TAH+ DFGL R + + NQ SS G++GT+GYA PEYG+
Sbjct: 834 IAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGM 893
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 6.0e-110, Sum P(3) = 6.0e-110
Identities = 98/180 (54%), Positives = 133/180 (73%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
TV+K +L + +AVKVL + +RGA+KSFMAEC++L++ RHRNLVK++TAC+++DFQGN
Sbjct: 716 TVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGN 775
Query: 596 YFRALVYEFMHHGSLESC------------PRILSFLRRLNIAIDVASALEYLHHHCKKP 643
FRAL+YE++ +GS++ PR L+ L RLNI IDVAS L+YLH HC +P
Sbjct: 776 EFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEP 835
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS---NQCSSVGLKGTVGYATPEYGI 700
I HCDLKPSNVLL++D+TAH+ DFGL R + + NQ SS G++GT+GYA PEYG+
Sbjct: 836 IAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGM 895
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 4.0e-106, Sum P(2) = 4.0e-106
Identities = 157/448 (35%), Positives = 237/448 (52%)
Query: 1 EPDKQALLAFKSKV-DDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGT 59
E D QALL FKS+V +++ L++WN S FC W+GVTC + +RVI LNL G LTG
Sbjct: 29 ETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGV 88
Query: 60 ASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLE 119
SP IGNL+FLRL+NL N+F S IP ++GRLFRL+++ + N L+G+IP S ++L
Sbjct: 89 ISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRL- 147
Query: 120 GNIPSEXXXXXXXXXXXXANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVS 179
S + G + L + +S +LTG+ P L N+TS++ +
Sbjct: 148 ----STVDLSSNHLGHGVPSEL--GSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFA 201
Query: 180 ENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPED 239
NQ+ GE+P + L + +A N F G P ++ N S LE L A+NS +G + D
Sbjct: 202 YNQMRGEIPDEVA-RLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRAD 260
Query: 240 LDSLVNCTYXXXXXXXXXXXXGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLX 299
L+ G +P +LAN SS R+ +S+N +SGSIP G L+NL
Sbjct: 261 FGYLL--PNLRRLLLGTNQFTGAIPKTLANISSLERF-DISSNYLSGSIPLSFGKLRNLW 317
Query: 300 XXXXXXXXXXRNIPISVGYL------LKLQVLSLFENNISREIPSSLGNF-TFLTELNLC 352
N + ++ +L+ L + N + E+P+S+ N T LT L L
Sbjct: 318 WLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLG 377
Query: 353 GNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSL 411
N I G++P +G+ L L L N L+G +P++ G ++ +DL N +SGEIPS
Sbjct: 378 QNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPS-- 435
Query: 412 AWIFGYISIFAKLNLSYNNLDGDVPRKM 439
FG ++ KL+L+ N+ G +P+ +
Sbjct: 436 --YFGNMTRLQKLHLNSNSFHGRIPQSL 461
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 1.8e-101, Sum P(2) = 1.8e-101
Identities = 250/694 (36%), Positives = 348/694 (50%)
Query: 46 VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHII-FNSNAL 104
++ +NL NL+G I NL+ LR ++++N IP + L +I +N
Sbjct: 226 LLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRF 285
Query: 105 QGQIPDS-----RLILNKLEGNIPSEXXXXXXXXXXXXANNYFTGPIPHLNMFQVSVYSL 159
G+IP S L + ++ GN+ S Y N+FQ
Sbjct: 286 HGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWR-----NLFQTREQDD 340
Query: 160 TGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNA 219
G I L N + ++ ++ EN L G LP ++ L L N+ G+IP I N
Sbjct: 341 WGFIS-DLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNL 399
Query: 220 SKLEWLDFANNSLTGLIPEDLDSLVNCTYXXXXXXXXXXXXGTLPNSLANFSSHLRYLYM 279
L+ L NN+ G +P L L N G++P ++ N + L L +
Sbjct: 400 IGLQHLYLCNNNFRGSLPSSLGRLKNL---GILLAYENNLSGSIPLAIGNLTE-LNILLL 455
Query: 280 SANPISGSIPTEIGNLKNLXXXXXXXXXXXRNIPISVGYLLKLQVL-SLFENNISREIPS 338
N SG IP + NL NL IP + + L ++ ++ +NN+ IP
Sbjct: 456 GTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQ 515
Query: 339 SLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLD 397
+G+ L E + N + G +P+ LG C L +L L +N L+G IP A+G K + LD
Sbjct: 516 EIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLD 575
Query: 398 LSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCG 457
LS N LSG+IP+SLA I++ LNLS+N+ G+VP F AS IS GN KLCG
Sbjct: 576 LSSNNLSGQIPTSLA----DITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCG 631
Query: 458 GISELKLPPCTPSELKKREKSKGFKXXXXXXXXXXXXXXXXXXXXXNRLRRQRTVTSSES 517
GI +L LP C P L+ R+ ++ R + S +
Sbjct: 632 GIPDLHLPRCCPL-LENRKHFPVLPISVSLAAALAILSSLYLLITWHK--RTKKGAPSRT 688
Query: 518 SSRKDLLLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQRGA 561
S + L VSY LVKAT VYKG L++ Q +AVKVL L A
Sbjct: 689 SMKGHPL--VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNI-QDHVAVKVLKLENPKA 745
Query: 562 LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC--P----- 614
LKSF AEC+ALRN+RHRNLVKI+T CS+ D +GN F+A+VY+FM +GSLE P
Sbjct: 746 LKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQ 805
Query: 615 ---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
R L+ RR+ I +DVA AL+YLH H +P+VHCD+K SNVLLD+DM AH+GDFGL R
Sbjct: 806 ADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR 865
Query: 672 FIPEVMSSNQ--CSSVGLKGTVGYATPEYGILLL 703
+ + S Q SS+G GT+GYA PEYG+ L+
Sbjct: 866 ILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLI 899
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 5.0e-80, Sum P(2) = 5.0e-80
Identities = 151/473 (31%), Positives = 224/473 (47%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWN--DSVNFCQWLGVTCSLKYQRVILLNLSGQNLTG 58
EP+ +AL +FK+ + +DP G LS W S+ C W G+TC V+ ++L + L G
Sbjct: 28 EPEIEALKSFKNGISNDPLGVLSDWTIIGSLRHCNWTGITCD-STGHVVSVSLLEKQLEG 86
Query: 59 TASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKL 118
SP I NLT+L++++L N+F+ IP EIG+L L +I L LN
Sbjct: 87 VLSPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLI--------------LYLNYF 132
Query: 119 EGNIPSEXXXXXXXXXXXXANNYFTGPIPH-------LNMFQVSVYSLTGSIPIQLLNIT 171
G+IPS NN +G +P L + +LTG IP L ++
Sbjct: 133 SGSIPSGIWELKNIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLV 192
Query: 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS 231
++ F + N L G +P IG TL N+ L L+GNQ G IP N L+ L N
Sbjct: 193 HLQMFVAAGNHLTGSIPVSIG-TLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENL 251
Query: 232 LTGLIPEDLDSLVNCTYXXXXXXXXXXXXGTLPNSLANFSSHLRYLYMSANPISGSIPTE 291
L G IP ++ NC+ G +P L N L+ L + N ++ SIP+
Sbjct: 252 LEGDIPAEIG---NCSSLVQLELYDNQLTGKIPAELGNLVQ-LQALRIYKNKLTSSIPSS 307
Query: 292 IGNLKNLXXXXXXXXXXXRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNL 351
+ L L I +G+L L+VL+L NN + E P S+ N LT L +
Sbjct: 308 LFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTV 367
Query: 352 CGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSS 410
N+I G +P+ LG L L N LTGPIP ++ N + LDLS N+++GEIP
Sbjct: 368 GFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRG 427
Query: 411 LAWIFGYISIFAKLNLSYNNLDGDVPRKMI-FKNASAISEAGNEKLCGGISEL 462
FG +++ +++ N+ G++P + N +S A N L G + L
Sbjct: 428 ----FGRMNL-TFISIGRNHFTGEIPDDIFNCSNLETLSVADNN-LTGTLKPL 474
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 2.4e-58, P = 2.4e-58
Identities = 204/699 (29%), Positives = 310/699 (44%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINL-QQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
L +SG L G P IGNLT LR + + N F +P EIG L L + L G+
Sbjct: 195 LAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGE 254
Query: 108 IP---------DSRLI-LNKLEGNIPSEXXXXXXXXXXXXANNYFTGPIP-------HLN 150
IP D+ + +N G + E +NN FTG IP +L
Sbjct: 255 IPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLT 314
Query: 151 MFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFG 210
+ + L G IP + ++ +E + EN G +P +G + ++ L+ N+ G
Sbjct: 315 LLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGEN-GKLNLVDLSSNKLTG 373
Query: 211 NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYXXXXXXXXXXXXGTLPNSLANF 270
+P ++ + +KLE L N L G IP DSL C G++P L
Sbjct: 374 TLPPNMCSGNKLETLITLGNFLFGSIP---DSLGKCESLTRIRMGENFLNGSIPKGLFGL 430
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLXXXXXXXXXXXRNIPISVGYLLKLQVLSLFEN 330
L + + N +SG +P G NL +P ++G +Q L L N
Sbjct: 431 PK-LTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGN 489
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
IPS +G L++++ N G + + C L ++DLS N L+G IP +
Sbjct: 490 KFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITA 549
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISE 449
K + +L+LS+N L G IP S++ + S L+ SYNNL G VP F + S
Sbjct: 550 MKILNYLNLSRNHLVGSIPGSISSMQSLTS----LDFSYNNLSGLVPGTGQFSYFNYTSF 605
Query: 450 AGNEKLCGGISELKLPPCTPSELK--KREKSKGFKXXXXXXXXXXXXXXXXXXXXXNRLR 507
GN LCG L PC K + SKG +
Sbjct: 606 LGNPDLCGPY----LGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAII 661
Query: 508 RQRTVT-SSESSSRK------------DLLLNVSYESLV----KATVYKGILDLDQTFIA 550
+ R++ +SES + + D+L ++ ++++ VYKG++ + +A
Sbjct: 662 KARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMP-NGDLVA 720
Query: 551 VKVLFLHQRGALKS--FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG 608
VK L RG+ F AE Q L IRHR++V+++ CS + LVYE+M +G
Sbjct: 721 VKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETN-----LLVYEYMPNG 775
Query: 609 SLESCPR-----ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH 663
SL L + R IA++ A L YLHH C IVH D+K +N+LLD++ AH
Sbjct: 776 SLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAH 835
Query: 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILL 702
+ DFGL +F+ + +++C S + G+ GY PEY L
Sbjct: 836 VADFGLAKFLQD-SGTSECMSA-IAGSYGYIAPEYAYTL 872
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 3.9e-72, Sum P(2) = 3.9e-72
Identities = 147/445 (33%), Positives = 213/445 (47%)
Query: 6 ALLAFKSKVDDDPFGALST-WNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYI 64
ALL+ KS D L T WN S FC W GVTC + + V L+LSG NL+GT S +
Sbjct: 30 ALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDV 89
Query: 65 GNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD---SRLIL------ 115
+L L+ ++L N S IP +I L+ LRH+ ++N G PD S L+
Sbjct: 90 AHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDL 149
Query: 116 --NKLEGNIPSEXXXXXXXXXXXXANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSM 173
N L G++P NYF+G IP + Y G+ P+ +
Sbjct: 150 YNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIP-------ATY---GTWPV-------L 192
Query: 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAG-NQFFGNIPHSISNASKLEWLDFANNSL 232
EY VS N+L G++PP IG L +R L + N F +P I N S+L D AN L
Sbjct: 193 EYLAVSGNELTGKIPPEIG-NLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGL 251
Query: 233 TGLIPEDLDSLVNCTYXXXXXXXXXXXXGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292
TG IP ++ L GT+ L SS L+ + +S N +G IPT
Sbjct: 252 TGEIPPEIGKLQKLD---TLFLQVNAFTGTITQELGLISS-LKSMDLSNNMFTGEIPTSF 307
Query: 293 GNLKNLXXXXXXXXXXXRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352
LKNL IP +G + +L+VL L+ENN + IP LG L L+L
Sbjct: 308 SQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLS 367
Query: 353 GNSIRGSVPSALGSCHQLWLDLS-HNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSL 411
N + G++P + S ++L ++ N L G IP ++G +S+ + + +N L+G IP L
Sbjct: 368 SNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKEL 427
Query: 412 AWIFGYISIFAKLNLSYNNLDGDVP 436
FG + +++ L N L G++P
Sbjct: 428 ---FGLPKL-SQVELQDNYLTGELP 448
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 1.6e-70, Sum P(2) = 1.6e-70
Identities = 142/429 (33%), Positives = 200/429 (46%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
++ L +G IGN T L+ I+ N S IP IGRL L + N L G
Sbjct: 437 IMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGN 496
Query: 108 IPDSR----------LILNKLEGNIPSEXXXXXXXXXXXXANNYFTGPIP----HL-NMF 152
IP S L N+L G+IPS NN G +P +L N+
Sbjct: 497 IPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLT 556
Query: 153 QVSVYS--LTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFG 210
+++ S GSI L +S F V+EN G++P +G + N+ L L NQF G
Sbjct: 557 RINFSSNKFNGSIS-PLCGSSSYLSFDVTENGFEGDIPLELGKST-NLDRLRLGKNQFTG 614
Query: 211 NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYXXXXXXXXXXXXGTLPNSLANF 270
IP + S+L LD + NSL+G+IP +L C G +P L
Sbjct: 615 RIPRTFGKISELSLLDISRNSLSGIIPVELGL---CKKLTHIDLNNNYLSGVIPTWLGKL 671
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLXXXXXXXXXXXRNIPISVGYLLKLQVLSLFEN 330
L L +S+N GS+PTEI +L N+ +IP +G L L L+L EN
Sbjct: 672 PL-LGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEEN 730
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW--LDLSHNHLTGPIPLAVG 388
+S +PS++G + L EL L N++ G +P +G L LDLS+N+ TG IP +
Sbjct: 731 QLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIS 790
Query: 389 NPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAIS 448
+ LDLS N+L GE+P + G + LNLSYNNL+G + ++ F A +
Sbjct: 791 TLPKLESLDLSHNQLVGEVPGQI----GDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADA 844
Query: 449 EAGNEKLCG 457
GN LCG
Sbjct: 845 FVGNAGLCG 853
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 771 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-81 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-65 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-26 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-09 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.003 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.003 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.003 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.003 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 279 bits (716), Expect = 2e-81
Identities = 222/759 (29%), Positives = 347/759 (45%), Gaps = 113/759 (14%)
Query: 35 LGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRL 94
+G SLK L+L G L G + NLT L + L N IP E+G++ L
Sbjct: 160 IGSFSSLKV-----LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSL 214
Query: 95 RHIIFNSNALQGQIPDS----------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTG 144
+ I N L G+IP L+ N L G IPS LG+L + L L N +G
Sbjct: 215 KWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSG 274
Query: 145 PIP-------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPN 197
PIP L +S SL+G IP ++ + ++E H+ N G++P + +LP
Sbjct: 275 PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT-SLPR 333
Query: 198 VRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL----------------- 240
+++L L N+F G IP ++ + L LD + N+LTG IPE L
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 241 ----DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLK 296
SL C L V L NS SG LP+ + +L +S N + G I + ++
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL-VYFLDISNNNLQGRINSRKWDMP 452
Query: 297 NLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSI 356
+L ++++ + +P S G +L+ L L N S +P LG+ + L +L L N +
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGSK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511
Query: 357 RGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIF 415
G +P L SC +L LDLSHN L+G IP + + LDLS+N+LSGEIP +L
Sbjct: 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL---- 567
Query: 416 GYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELKKR 475
G + ++N+S+N+L G +P F +A + AGN LCGG + LPPC K+
Sbjct: 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC-----KRV 622
Query: 476 EKSKGFKLMIL-LLSGLVGLILVMSLLIINRLRRQRTVTS-----------------SES 517
K+ + I L + L LV + R R + S+S
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKS 682
Query: 518 SSRKDLLLNVSYESLV----KATVYKGILDLDQTFIAVKVLFLHQRGAL-KSFMAECQAL 572
+ D+L ++ E+++ K YKG + VK ++ ++ S +A+ +
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE--INDVNSIPSSEIAD---M 737
Query: 573 RNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASA 632
++H N+VK+I C + +G Y L++E++ +L R LS+ RR IAI +A A
Sbjct: 738 GKLQHPNIVKLIGLCRSE--KGAY---LIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKA 792
Query: 633 LEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG 692
L +LH C +V +L P +++D H L +P ++ C+ +
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLL----CTDTKCFISSA 843
Query: 693 YATPE---------------YGILLLEIFTGKRPTSDMF 716
Y PE +G++L+E+ TGK P F
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 1e-65
Identities = 155/439 (35%), Positives = 227/439 (51%), Gaps = 38/439 (8%)
Query: 7 LLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGN 66
LL+FKS ++D P LS WN S + C W G+TC+ RV+ ++LSG+N++G S I
Sbjct: 34 LLSFKSSIND-PLKYLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFR 91
Query: 67 LTFLRLINLQQNNFSSNIPHEIGRL-FRLRHIIFNSNALQGQIPDSRLIL--------NK 117
L +++ INL N S IP +I LR++ ++N G IP + N
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNM 151
Query: 118 LEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFH 177
L G IP+++GS K L L N L G IP L N+TS+E+
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNV-----------------LVGKIPNSLTNLTSLEFLT 194
Query: 178 VSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP 237
++ NQLVG++P +G + +++ + L N G IP+ I + L LD N+LTG IP
Sbjct: 195 LASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
Query: 238 EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKN 297
L +L N YL L N LSG +P S+ + L L +S N +SG IP + L+N
Sbjct: 254 SSLGNLKNLQYL---FLYQNKLSGPIPPSIFSLQK-LISLDLSDNSLSGEIPELVIQLQN 309
Query: 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357
L I+ + IP+++ L +LQVL L+ N S EIP +LG LT L+L N++
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369
Query: 358 GSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFG 416
G +P L S L+ L L N L G IP ++G +S+ + L N SGE+PS F
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE----FT 425
Query: 417 YISIFAKLNLSYNNLDGDV 435
+ + L++S NNL G +
Sbjct: 426 KLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-34
Identities = 97/293 (33%), Positives = 151/293 (51%), Gaps = 13/293 (4%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISN-ASKLEWLDF 227
N + + +S + G++ I F LP ++ + L+ NQ G IP I +S L +L+
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAI-FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
+NN+ TG IP LE + LS N LSG +PN + +FSS L+ L + N + G
Sbjct: 126 SNNNFTGSIPRGSIPN-----LETLDLSNNMLSGEIPNDIGSFSS-LKVLDLGGNVLVGK 179
Query: 288 IPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLT 347
IP + NL +L + + L+ IP +G + L+ + L NN+S EIP +G T L
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239
Query: 348 ELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406
L+L N++ G +PS+LG+ L +L L N L+GPIP ++ + + + LDLS N LSGE
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 407 IPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGI 459
IP + + L+L NN G +P + + + + K G I
Sbjct: 300 IPELVI----QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQ 593
TVY +A+K++ +L + E + L+ + H N+VK+ +
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH- 65
Query: 594 GNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
LV E+ GSL + LS L I + + LEYLH + I+H DL
Sbjct: 66 ----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDL 118
Query: 650 KPSNVLLDND-MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTG 708
KP N+LLD+D + DFGL++ + +S++ + GT Y PE +L ++
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL----TSDKSLLKTIVGTPAYMAPEV-LLGKGYYSE 173
Query: 709 KRPTSDMF 716
K SD++
Sbjct: 174 K---SDIW 178
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 50/222 (22%)
Query: 537 VYKGILDLDQTF----IAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
VYKG L +AVK L ++ F+ E + +R + H N+VK++ C+
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE-- 72
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCK 641
+ + +V E+M G L LS+LR+ L+ A+ +A +EYL
Sbjct: 73 -EEPLY--IVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
K +H DL N L+ ++ + DFGL+R + + G K + + PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLKE 177
Query: 698 -----------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVK 727
+G+LL EIFT G++P M ++ ++K
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 35/205 (17%)
Query: 536 TVYKGILDLDQTF----IAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VYKG L D +AVK L + F+ E ++ + H N+V+++ C+
Sbjct: 14 EVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQG 73
Query: 591 DFQGNYFRALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
+ Y +V E+M G L L+ L +A+ +A +EYL K VH
Sbjct: 74 --EPLY---IVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVH 125
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------- 697
DL N L+ ++ + DFGL+R I E G K + + PE
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYE--DDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 698 ------YGILLLEIFT-GKRPTSDM 715
+G+LL EIFT G++P M
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 57/200 (28%), Positives = 82/200 (41%), Gaps = 40/200 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
VY +A+KV+ + + + E + L+ ++H N+V++ F+
Sbjct: 13 GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV-----FE 67
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHC 647
LV E+ G L +L RL+ + SALEYLH IVH
Sbjct: 68 DEDKLYLVMEYCEGGDLF---DLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHR 121
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE------Y-- 698
DLKP N+LLD D + DFGL R + P + GT Y PE Y
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV------GTPEYMAPEVLLGKGYGK 175
Query: 699 -------GILLLEIFTGKRP 711
G++L E+ TGK P
Sbjct: 176 AVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 47/222 (21%)
Query: 536 TVYKGILDLD----QTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VYKG L + +AVK L ++ F+ E + +R + H N+VK++ C+
Sbjct: 14 EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE- 72
Query: 591 DFQGNYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
+ +V E+M G L P+ LS L+ A+ +A +EYL K +
Sbjct: 73 --EEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFI 125
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFI-------------------PEVMSSNQCSSVG 686
H DL N L+ ++ + DFGL+R + PE + + +S
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS-- 183
Query: 687 LKGTVGYATPEYGILLLEIFT-GKRPTSDMFTEGLDLHNFVK 727
K V ++ +G+LL EIFT G+ P M ++ ++K
Sbjct: 184 -KSDV-WS---FGVLLWEIFTLGEEPYPGM--SNAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 54/235 (22%)
Query: 537 VYKGILDLDQ---TFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYKG L T +AVK L K F+ E + ++ + H N+V+++ C+
Sbjct: 11 VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--- 67
Query: 593 QGNYFRALVYEFMHHGSL------------ESCPRILSFLRRLNIAIDVASALEYLHHHC 640
+ + LV E+M G L LS L+ AI +A +EYL
Sbjct: 68 EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--- 122
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI--------------------PEVMSSN 680
K VH DL N L+ D+ + DFGL+R + PE +
Sbjct: 123 SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182
Query: 681 QCSSVGLKGTVGYATPEYGILLLEIFT-GKRPTSDMFTEGL--DLHNFVKMALPD 732
+S K V ++ +G+LL EIFT G P + E + L ++ P+
Sbjct: 183 IFTS---KSDV-WS---FGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE 230
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 59/198 (29%), Positives = 82/198 (41%), Gaps = 33/198 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
TVYK +AVK+L ++ E + LR + H N+V++I A D
Sbjct: 13 GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72
Query: 593 QGNYFRALVYEFMHHGSLESCPR---ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
LV E+ G L LS IA+ + LEYLH + I+H DL
Sbjct: 73 -----LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRDL 124
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------ 697
KP N+LLD + + DFGL + + + SS GT Y PE
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLT----TFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 698 ----YGILLLEIFTGKRP 711
G++L E+ TGK P
Sbjct: 181 DVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 34/204 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
+VY + +AVK + L L++ E + L +++H N+V+ + +
Sbjct: 14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE- 72
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRRLNI------AIDVASALEYLHHHCKKPIVH 646
N + E++ GSL S +L +L + L YLH + IVH
Sbjct: 73 -KNTLN-IFLEYVSGGSLSS---LLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVH 124
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------- 697
D+K +N+L+D+D + DFG + + ++ + SV +GT + PE
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV--RGTPYWMAPEVIRGEEYGR 182
Query: 698 ------YGILLLEIFTGKRPTSDM 715
G ++E+ TGK P S++
Sbjct: 183 AADIWSLGCTVIEMATGKPPWSEL 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 50/205 (24%)
Query: 536 TVYKGILDLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VYK A+K + K + E + LR+ +VK G
Sbjct: 16 VVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---------CYG 66
Query: 595 NYFR----ALVYEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKK 642
+++ ++V E+M GSL +L++ IA + L+YLH K+
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHT--KR 119
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS-VGLKGTVGYATPE---- 697
I+H D+KPSN+L+++ + DFG+++ + + +QC++ V GTV Y +PE
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFV---GTVTYMSPERIQG 174
Query: 698 --Y---------GILLLEIFTGKRP 711
Y G+ LLE GK P
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 39/196 (19%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
V G Q +AVK L A ++F+AE + +RH NLV+++ QGN
Sbjct: 22 VMLGDY-RGQK-VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV----LQGNP 74
Query: 597 FRALVYEFMHHGSLESCPR-----ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+V E+M GSL R +++ ++L A+DV +EYL +K VH DL
Sbjct: 75 L-YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAA 130
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------------- 697
NVL+ D+ A + DFGL + ++Q G K V + PE
Sbjct: 131 RNVLVSEDLVAKVSDFGLAK------EASQGQDSG-KLPVKWTAPEALREKKFSTKSDVW 183
Query: 698 -YGILLLEIFT-GKRP 711
+GILL EI++ G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 47/216 (21%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++G L ++ +A+K+L + F E QAL+ +RH++L+ + CS +
Sbjct: 20 GEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--- 75
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKP 643
+ ++ E M GSL L+FLR +++A VA + YL ++
Sbjct: 76 PVY--IITELMEKGSL------LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
+H DL N+L+ D+ + DFGL R I E + + + K T PE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGT 180
Query: 698 ---------YGILLLEIFT-GKRPTSDMFT-EGLDL 722
+GILL E+FT G+ P M E D
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ 216
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 53/208 (25%)
Query: 532 LVKATVYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACST 589
+V ++G +D +A+K++ + GA+ F+ E + + + H NLV++ C+
Sbjct: 19 VVHLGKWRGKID-----VAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHH 639
Q F +V E+M +G L L++LR L++ DV A+EYL +
Sbjct: 71 ---QRPIF--IVTEYMANGCL------LNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-- 697
+H DL N L+ D + DFGL R+ V+ SS G K V +A PE
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 698 -------------YGILLLEIFT-GKRP 711
+G+L+ E+F+ GK P
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 46/206 (22%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
VYK +A+KV+ L + + + E Q L+ +H N+VK G+
Sbjct: 15 EVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY---------GS 65
Query: 596 YFRA----LVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIV 645
Y + +V EF GSL+ + S + L + ++ LEYLH I+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDL--LKSTNQTLTESQIAYVCKELLKGLEYLH---SNGII 120
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGL-TRFIPEVMSSNQCSSVGLKGTVGYATPE------Y 698
H D+K +N+LL +D + DFGL + + GT + PE Y
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV------GTPYWMAPEVINGKPY 174
Query: 699 ---------GILLLEIFTGKRPTSDM 715
GI +E+ GK P S++
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 57/186 (30%), Positives = 80/186 (43%), Gaps = 39/186 (20%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A+KVL + +R ++ + E L I H +VK+ A FQ LV E+
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYAP 76
Query: 607 HGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660
G L S LS R + A ++ ALEYLH I++ DLKP N+LLD D
Sbjct: 77 GGELFS---HLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADG 130
Query: 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------------GILLLEI 705
+ DFGL + ++ ++ GT Y PE G+LL E+
Sbjct: 131 HIKLTDFGLAK--ELSSEGSRTNTF--CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEM 186
Query: 706 FTGKRP 711
TGK P
Sbjct: 187 LTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 49/198 (24%)
Query: 547 TFIAVKVLFLHQRGALK--SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
T +AVK L + G + +F+ E Q ++ +RH LV++ CS + +V E+
Sbjct: 31 TKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS----EEEPIY-IVTEY 82
Query: 605 MHHGSLESCPRILSFLR-------RLNIAID----VASALEYLHHHCKKPIVHCDLKPSN 653
M GSL L FL+ RL +D +A + YL + +H DL N
Sbjct: 83 MSKGSL------LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARN 133
Query: 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------Y 698
+L+ ++ + DFGL R I + G K + + PE +
Sbjct: 134 ILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF 190
Query: 699 GILLLEIFT-GKRPTSDM 715
GILL EI T G+ P M
Sbjct: 191 GILLTEIVTYGRVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYKG+ F+A+K + L + ALKS M E L+N++H N+VK I + TSD
Sbjct: 14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRRLN---IAIDVA---SALEYLHHHCKKPIVH 646
Y + E+ +GSL +I+ +A+ V L YLH ++ ++H
Sbjct: 74 L--YI---ILEYAENGSLR---QIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIH 122
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------- 697
D+K +N+L D + DFG+ + +V S + S V GT + PE
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVV---GTPYWMAPEVIEMSGAST 178
Query: 698 ------YGILLLEIFTGKRPTSD 714
G ++E+ TG P D
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 48/173 (27%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLE------SCPRI 616
+ E + L+ +RH N+V++ TS +G+ + +V+E+M H G L+ + +I
Sbjct: 46 IREIKLLQKLRHPNIVRLKEIV-TSKGKGSIY--MVFEYMDHDLTGLLDSPEVKFTESQI 102
Query: 617 LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI--- 673
++++L L+YLH I+H D+K SN+L++ND + DFGL R
Sbjct: 103 KCYMKQL------LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153
Query: 674 -PEVMSSNQCSSVGLKGTVGYATPE-------Y---------GILLLEIFTGK 709
++ T+ Y PE Y G +L E+F GK
Sbjct: 154 NSADYTNRVI-------TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 44/197 (22%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
VY+G+ +AVK L ++ F+ E ++ I+H NLV+++ C+ + +
Sbjct: 22 VYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---EPPF 77
Query: 597 FRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKPIV 645
+ ++ EFM +G+L L +LR L +A ++SA+EYL KK +
Sbjct: 78 Y--IITEFMTYGNL------LDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H DL N L+ + + DFGL+R + + G K + + PE
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH---AGAKFPIKWTAPESLAYNKFS 183
Query: 698 -------YGILLLEIFT 707
+G+LL EI T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 43/173 (24%)
Query: 565 FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR-- 622
F+ E + + + H LV++ C+ +V E+M +G L L++LR
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYIVTEYMSNGCL------LNYLREHG 94
Query: 623 --------LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
L + DV + YL K +H DL N L+D+ + DFGL+R+
Sbjct: 95 KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY-- 149
Query: 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRP 711
V+ SSVG K V ++ PE +G+L+ E+++ GK P
Sbjct: 150 -VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 36/198 (18%)
Query: 536 TVYKGILDLDQTFIAVKVLF-LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
TVYK I A+KV++ H+ + E + LR++ H N+VK C
Sbjct: 89 TVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHN 144
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNV 654
+ L+ EFM GSLE I ++A + S + YLH ++ IVH D+KPSN+
Sbjct: 145 GEIQVLL-EFMDGGSLEG-THIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNL 199
Query: 655 LLDNDMTAHMGDFGLTRFIPEVMSSNQC-SSVGLKGTVGYATPE---------------- 697
L+++ + DFG++R + + M + C SSV GT+ Y +PE
Sbjct: 200 LINSAKNVKIADFGVSRILAQTM--DPCNSSV---GTIAYMSPERINTDLNHGAYDGYAG 254
Query: 698 ----YGILLLEIFTGKRP 711
G+ +LE + G+ P
Sbjct: 255 DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 64/222 (28%)
Query: 534 KATVYKGILDLDQTFIAVKVLF-LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
Y + D+ +AVK L A K F E + L N +H N+VK C+ D
Sbjct: 23 LGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR-----------------------LNIAIDV 629
+V+E+M HG L FLR L IA+ +
Sbjct: 83 P-----IMVFEYMEHGDLN------KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 630 ASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKG 689
AS + YL + VH DL N L+ D+ +GDFG++R +V + + G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYT---TDYYRVGG 182
Query: 690 T----VGYATPE---------------YGILLLEIFT-GKRP 711
+ + PE +G++L EIFT GK+P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 38/202 (18%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++G+ + + T +AVK L + G + K F+AE Q ++ +RH L+++ C+ +
Sbjct: 22 VWEGLWN-NTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--P 75
Query: 595 NYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
Y +V E M +GSL R L + +++A VAS + YL +H DL
Sbjct: 76 IY---IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDL 129
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------ 697
NVL+ + + DFGL R I + G K + + PE
Sbjct: 130 AARNVLVGENNICKVADFGLARVI---KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 698 ---YGILLLEIFT-GKRPTSDM 715
+GILL EI T G+ P M
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 27/155 (17%)
Query: 536 TVYKGILDL--DQTF--IAVKVLFLHQRGALKS-FMAECQALRNIRHRNLVKIITACSTS 590
V D D T +AVK L +S F E + LR + H N+VK C
Sbjct: 19 KVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVC--- 75
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHC 640
+ G L+ E++ GSL +L+R L + + ++YL
Sbjct: 76 EKPGGRSLRLIMEYLPSGSLRD------YLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
+ +H DL N+L++++ + DFGL + +PE
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G L++ +A+K + + GA+ + F+ E Q + + H LV++ C+
Sbjct: 20 VWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE----- 70
Query: 595 NYFRALVYEFMHHGSLESCPR----ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
LV+EFM HG L R S L + +DV + YL ++H DL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------- 697
N L+ + + DFG+TRF V+ SS G K V +++PE
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 698 --YGILLLEIFT-GKRP 711
+G+L+ E+F+ GK P
Sbjct: 185 WSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 563 KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPR-----IL 617
++F+AE + +RH NLV+++ +G + +V E+M GSL R +L
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLY--IVTEYMAKGSLVDYLRSRGRSVL 99
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
L ++DV A+EYL + VH DL NVL+ D A + DFGLT+ E
Sbjct: 100 GGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS 153
Query: 678 SSNQCSSVGLKGTVGYATPE-----------YGILLLEIFT-GKRP 711
S+ + +K T A E +GILL EI++ G+ P
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 70.5 bits (171), Expect = 8e-13
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRH-RNLVKIITACSTS 590
VY D+ +A+KVL + ++ F+ E Q L ++ H N+VK+
Sbjct: 14 GEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF---- 66
Query: 591 DFQGNYFRALVYEFMHHGSLES------CPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
FQ LV E++ GSLE LS L I + SALEYLH K I
Sbjct: 67 -FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 645 VHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPE--VMSSNQCSSVGLKGTVGYATPEYGIL 701
+H D+KP N+LLD + + DFGL + +P+ SS GT GY PE +L
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE--VL 180
Query: 702 LLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731
L +SD+++ G+ L+ + P
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 65/222 (29%), Positives = 94/222 (42%), Gaps = 63/222 (28%)
Query: 536 TVYKGILDLDQ-TFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY + +LD +AVK + + +K E + L ++H NLVK
Sbjct: 15 KVYTAV-NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---------- 63
Query: 593 QGNYF-----RALVYEFMHH---GSLESC---PRIL--SFLRRLNIAIDVASALEYLHHH 639
Y+ R VY FM + G+LE RIL +R + + L YLH H
Sbjct: 64 ---YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLHSH 118
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG-----LKGTVGYA 694
IVH D+KP+N+ LD++ +GDFG V N +++G L GT Y
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCA-----VKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 695 TPE------------------YGILLLEIFTGKRPTSDMFTE 718
PE G ++LE+ TGKRP S++ E
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 39/175 (22%)
Query: 559 RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRI-L 617
+G++++ + E + L+ + H LV + + FQ LV + + G L R L
Sbjct: 41 KGSVRNVLNERRILQELNHPFLVNL---WYS--FQDEENMYLVVDLLLGGDL----RYHL 91
Query: 618 SFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
S + + ++ ALEYLH K I+H D+KP N+LLD H+ DF +
Sbjct: 92 SQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148
Query: 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ + GT GY PE G+ E GKRP
Sbjct: 149 -----KVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-12
Identities = 23/39 (58%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 3 DKQALLAFKSKVDDDPFGALSTWNDS-VNFCQWLGVTCS 40
D+ ALLAFKS ++ DP GALS+WN S + C W GVTC
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 40/183 (21%)
Query: 558 QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPR-- 615
Q+ +K+ +E + L+++ H N+V+ + T + ++ E++ GS+ SC R
Sbjct: 48 QKDMVKALRSEIETLKDLDHLNIVQYL-GFET----TEEYLSIFLEYVPGGSIGSCLRTY 102
Query: 616 ------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
++ F V L YLH K I+H DLK N+L+D D + DFG+
Sbjct: 103 GRFEEQLVRFFTE-----QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGI 154
Query: 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPT 712
++ ++ ++Q S ++G+V + PE G ++LE+F G+RP
Sbjct: 155 SKKSDDIYDNDQNMS--MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
Query: 713 SDM 715
SD
Sbjct: 213 SDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 37/174 (21%)
Query: 563 KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPR-----IL 617
++F+ E + + H+NLV+++ G Y +V E M G+L + R ++
Sbjct: 44 QAFLEETAVMTKLHHKNLVRLLGVIL---HNGLY---IVMELMSKGNLVNFLRTRGRALV 97
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
S ++ L ++DVA +EYL K +VH DL N+L+ D A + DFGL R +
Sbjct: 98 SVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154
Query: 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDM 715
++ K V + PE YG+LL E+F+ G+ P M
Sbjct: 155 DNS-------KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 58/228 (25%), Positives = 82/228 (35%), Gaps = 66/228 (28%)
Query: 536 TVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSD 591
TV A+K+L L + +K E + L R H ++K+ T
Sbjct: 16 TVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY---YTFQ 72
Query: 592 FQGN-YFRALVYEFMHHGSLESCPRILSFLRRL---------NIAIDVASALEYLHHHCK 641
+ N YF V E+ +G L L ++R+ A ++ ALEYLH
Sbjct: 73 DEENLYF---VLEYAPNGEL------LQYIRKYGSLDEKCTRFYAAEILLALEYLH---S 120
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFG-------------------LTRFIPEVMSSNQC 682
K I+H DLKP N+LLD DM + DFG E
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715
S V GT Y +PE G ++ ++ TGK P
Sbjct: 181 SFV---GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 47/190 (24%), Positives = 76/190 (40%), Gaps = 42/190 (22%)
Query: 549 IAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH 607
+AVK L + + F+ E + ++ H NL+++ T +V E
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM------MVTELAPL 79
Query: 608 GSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA 662
GSL + + A+ +A+ + YL K +H DL N+LL +D
Sbjct: 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKV 136
Query: 663 HMGDFGLTRFIPE-----VMSSNQCSSVGLKGTVGYATPE---------------YGILL 702
+GDFGL R +P+ VM + LK + PE +G+ L
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEH------LKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
Query: 703 LEIFT-GKRP 711
E+FT G+ P
Sbjct: 191 WEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 40/202 (19%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
VY D +K + L + + E + L+ + H N++K F+
Sbjct: 15 KVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY-----ESFE 69
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRR---------LNIAIDVASALEYLHHHCKKPI 644
+V E+ G L +I + L+ + + AL+YLH + I
Sbjct: 70 EKGKLCIVMEYADGGDLSQ--KIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKI 124
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------Y 698
+H D+KP N+ L ++ +GDFG+++ V+SS + + GT Y +PE Y
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISK----VLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 699 ---------GILLLEIFTGKRP 711
G +L E+ T K P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 62/210 (29%), Positives = 89/210 (42%), Gaps = 52/210 (24%)
Query: 537 VYKGILDLDQTFIAVKV----LFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYKG+L T +AVK L + + F+ E + L+ H N+VK+I C
Sbjct: 11 VYKGVLK-GNTEVAVKTCRSTLPPDLK---RKFLQEAEILKQYDHPNIVKLIGVCVQK-- 64
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCKK 642
Q Y +V E + GSL L+FLR+ L +++D A+ +EYL
Sbjct: 65 QPIY---IVMELVPGGSL------LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT-VGYATPE---- 697
+H DL N L+ + + DFG++R E S GLK + + PE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 698 -----------YGILLLEIFT-GKRPTSDM 715
YGILL E F+ G P M
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 8/114 (7%)
Query: 564 SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL-ESCPR-ILSFLR 621
+ E L+ + H N+VK CS QG L+ E++ GSL + P+ L+ +
Sbjct: 52 GWKKEINILKTLYHENIVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ 108
Query: 622 RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
L A + + YLH + +H DL NVLLDND +GDFGL + +PE
Sbjct: 109 LLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 2e-11
Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
VYK +A+K + L G + + E L+ ++H N+VK++ T
Sbjct: 14 VVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKL 73
Query: 594 GNYFRALVYEFMHH---GSLESCPRILS--FLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
LV+E+ L+ P LS ++ I + L Y H H I+H D
Sbjct: 74 -----YLVFEYCDMDLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR---ILHRD 123
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFI 673
LKP N+L++ D + DFGL R
Sbjct: 124 LKPQNILINRDGVLKLADFGLARAF 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 48/191 (25%)
Query: 549 IAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
+A+K + GA+ + F+ E + + + H LV++ C+ Q + +V EFM
Sbjct: 31 VAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ---QKPLY--IVTEFME 82
Query: 607 HGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
+G L L++LR+ L++ DV +EYL + +H DL N L+
Sbjct: 83 NGCL------LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLV 133
Query: 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGIL 701
+ + DFG+TR+ V+ SS G K V ++ PE +G+L
Sbjct: 134 SSTGVVKVSDFGMTRY---VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVL 190
Query: 702 LLEIFT-GKRP 711
+ E+FT GK P
Sbjct: 191 MWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 345 FLTELNLCGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403
F+ L L +RG +P+ + L ++LS N + G IP ++G+ S+ LDLS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 404 SGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKM---IFKNASAISEAGNEKLCGGIS 460
+G IP SL G ++ LNL+ N+L G VP + + AS + N LCG
Sbjct: 479 NGSIPESL----GQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS-FNFTDNAGLCGIPG 533
Query: 461 ELKLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQ 509
L C P S G K+ I V + ++ + RRQ
Sbjct: 534 ---LRACGPH------LSVGAKIGI-AFGVSVAFLFLVICAMCWWKRRQ 572
|
Length = 623 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 52/213 (24%)
Query: 536 TVYKGILDL-DQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVK---IITACS 588
V +G L L + I V + L F+ E + H N+++ ++T
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHH 638
++ E+M +GSL+ FLR + + +AS ++YL
Sbjct: 79 PV--------MIITEYMENGSLDK------FLRENDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE- 697
VH DL N+L+++++ + DFGL+R + + S ++ G K + + PE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED--SEATYTTKGGKIPIRWTAPEA 179
Query: 698 --------------YGILLLEIFT-GKRPTSDM 715
+GI++ E+ + G+RP DM
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 51/215 (23%), Positives = 82/215 (38%), Gaps = 47/215 (21%)
Query: 533 VKATVYKGILDLDQTFIAVKVLFLHQRGA-LKSFMAECQALRNIRHRNLVKIITACSTSD 591
A VY I + +A+K + L + + E QA+ H N+VK T+
Sbjct: 13 ATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS----- 67
Query: 592 FQGNYFRALVYEFMHHGSL--------------ESCPRILSFLRRLNIAIDVASALEYLH 637
F LV ++ GSL E+ I + L+ +V LEYLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI--IATVLK------EVLKGLEYLH 119
Query: 638 HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+ + +H D+K N+LL D + + DFG++ + + + GT + PE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 698 ----------------YGILLLEIFTGKRPTSDMF 716
+GI +E+ TG P S
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
ATV+KG L + +A+K + L H+ GA + + E L+N++H N+V + T
Sbjct: 19 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT---- 74
Query: 594 GNYFRALVYEFMHHG---SLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
LV+E++ L++C ++S + L Y H + I+H DLK
Sbjct: 75 -ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLK 130
Query: 651 PSNVLLDNDMTAHMGDFGLTRF--IPEVMSSNQCSSVG------LKGTVGYATP----EY 698
P N+L++ + DFGL R +P SN+ ++ L G+ Y+TP
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190
Query: 699 GILLLEIFTGKRPTSDMFTEGLDLH 723
G +L E+ TG RP T +LH
Sbjct: 191 GCILYEMATG-RPMFPGSTVKEELH 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 62/242 (25%), Positives = 99/242 (40%), Gaps = 43/242 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V+ A+KV+ + ++ + + E L + +VK+ +
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS----- 61
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVAS---ALEYLHHHCKKPIVHCD 648
FQG LV E++ G L S + L I +A ALEYLH + I+H D
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRD 118
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFI----PEVMSSNQCSSVGLKGTVGYATPEYGILLLE 704
LKP N+L+D++ + DFGL++ ++ ++ + GT Y PE ++L +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE--VILGQ 176
Query: 705 IFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEE---NIKKG 761
G T D ++ G L+ FLVG ET EE NI G
Sbjct: 177 ---GHSKTVDWWSLGCILYE-----------------FLVGIPPFHGETPEEIFQNILNG 216
Query: 762 QI 763
+I
Sbjct: 217 KI 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 56/191 (29%), Positives = 79/191 (41%), Gaps = 48/191 (25%)
Query: 548 FIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
+ A+K+L + LK + E + L++IRH LV + + FQ + LV E+
Sbjct: 28 YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGS-----FQDDSNLYLVMEY 82
Query: 605 MHHGSLESCPRILSFLRRLN---------IAIDVASALEYLHHHCKKPIVHCDLKPSNVL 655
+ G L S LR+ A V ALEYLH IV+ DLKP N+L
Sbjct: 83 VPGGEL------FSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLL 133
Query: 656 LDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGI 700
LD+D + DFG + + + L GT Y PE GI
Sbjct: 134 LDSDGYIKITDFGFAKRVKGRTYT-------LCGTPEYLAPEIILSKGYGKAVDWWALGI 186
Query: 701 LLLEIFTGKRP 711
L+ E+ G P
Sbjct: 187 LIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 537 VYKGILDLDQTF---IAVKVLFL--HQRGALKSFMAECQALRNIRHRNLVKIITACST-S 590
V +G L D +AVK + L H ++ F++E +++ H N++K+I C S
Sbjct: 15 VMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74
Query: 591 DFQGNYFRALVYEFMHHGSLES---------CPRILSFLRRLNIAIDVASALEYLHHHCK 641
Q ++ FM HG L S P L L +D+A +EYL +
Sbjct: 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--- 131
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
+ +H DL N +L DMT + DFGL++ I
Sbjct: 132 RNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 49/216 (22%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNL 580
+Y+ L K ATVYKG L +A+K + L H+ GA + + E L++++H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 581 V---KIITACSTSDFQGNYFRALVYEFMHHG---SLESCPRILS------FLRRLNIAID 628
V II T LV+E++ ++ C LS FL +L
Sbjct: 66 VTLHDIIHTKKT--------LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQL----- 112
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF--IPEVMSSNQCSSVG 686
L Y H + ++H DLKP N+L+ + DFGL R +P SN+ ++
Sbjct: 113 -LRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW 168
Query: 687 ------LKGTVGYATP----EYGILLLEIFTGKRPT 712
L G+ Y+T G + E+ TG RP
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 47/203 (23%)
Query: 545 DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
D+ +AVK L A K F E + L N++H ++VK C D +V+E+
Sbjct: 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL-----IMVFEY 88
Query: 605 MHHGSLESCPRI-------------------LSFLRRLNIAIDVASALEYLHHHCKKPIV 645
M HG L R L + L+IA +AS + YL + V
Sbjct: 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFV 145
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKG-TVGYATPE------- 697
H DL N L+ ++ +GDFG++R +V S++ G + + PE
Sbjct: 146 HRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 202
Query: 698 --------YGILLLEIFT-GKRP 711
+G++L EIFT GK+P
Sbjct: 203 TTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 41/258 (15%)
Query: 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRH 577
R+ L L V V+ G + T +A+K L + G + ++F+ E Q ++ +RH
Sbjct: 5 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRH 60
Query: 578 RNLVKIITACSTSDFQGNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASA 632
LV++ S +V E+M GSL + L + +++A +AS
Sbjct: 61 EKLVQLYAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 633 LEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG 692
+ Y+ + VH DL+ +N+L+ ++ + DFGL R I + + + G K +
Sbjct: 115 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIK 168
Query: 693 YATPE---------------YGILLLEIFT-GKRPTSDMFT-EGLD-LHNFVKMALPDQI 734
+ PE +GILL E+ T G+ P M E LD + +M P +
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 228
Query: 735 LQVLDPLFLVGGVQEGEE 752
+ L L +E EE
Sbjct: 229 PESLHDLMCQCWRKEPEE 246
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 17/153 (11%)
Query: 535 ATVYKGILDLDQTFIAVKV----LFLHQRGALKSFMAECQALRNIRHRNLVKIITAC-ST 589
+V +G L+ D + + V V + + R ++ F++E ++ H N++++I C T
Sbjct: 13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72
Query: 590 SDFQGNYFRALVYEFMHHGSLES---------CPRILSFLRRLNIAIDVASALEYLHHHC 640
+ +G ++ FM HG L S CP+ L + D+AS +EYL
Sbjct: 73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---S 129
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
K +H DL N +L+ +M + DFGL++ I
Sbjct: 130 SKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 536 TVYKGILDLDQTFIAVK-VLF-LHQRGALKSFMAECQALRNIR---HRNLVKIITACSTS 590
TVYK F+A+K V L + G S + E L+ + H N+V+++ C
Sbjct: 14 TVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73
Query: 591 DFQGNYFRALVYEFMH---HGSLESCP-RILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
LV+E + L CP L ++ + +++LH H IVH
Sbjct: 74 RTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVH 130
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTR 671
DLKP N+L+ +D + DFGL R
Sbjct: 131 RDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 36/80 (45%), Positives = 48/80 (60%)
Query: 286 GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTF 345
G IP +I L++L I + + NIP S+G + L+VL L N+ + IP SLG T
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 346 LTELNLCGNSIRGSVPSALG 365
L LNL GNS+ G VP+ALG
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 48/205 (23%)
Query: 543 DLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602
+ D+ +AVK L A + F E + L ++H+++V+ C+ +V+
Sbjct: 32 EQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL-----LMVF 86
Query: 603 EFMHHGSLE------------------SCPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
E+M HG L P L+ + L IA +AS + YL
Sbjct: 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHF 143
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT--VGYATPE----- 697
VH DL N L+ + +GDFG++R I S VG + + + PE
Sbjct: 144 VHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDYYRVGGRTMLPIRWMPPESILYR 199
Query: 698 ----------YGILLLEIFT-GKRP 711
+G++L EIFT GK+P
Sbjct: 200 KFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 39/162 (24%), Positives = 68/162 (41%), Gaps = 35/162 (21%)
Query: 537 VYKGILD---LDQTF--IAVKVLF----LHQRGALKSFMAECQALRNIRHRNLVKIITAC 587
VY+G+ + +A+K + + +R F+ E ++ ++V+++
Sbjct: 22 VYEGLAKGVVKGEPETRVAIKTVNENASMRER---IEFLNEASVMKEFNCHHVVRLLGVV 78
Query: 588 STSDFQGNYFRALV-YEFMHHGSLESCPR-------------ILSFLRRLNIAIDVASAL 633
ST LV E M G L+S R + + + +A ++A +
Sbjct: 79 STGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 634 EYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
YL K VH DL N ++ D+T +GDFG+TR I E
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 4e-10
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 33/164 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALK---SFMA--ECQALRNIRHRNLVKIITACST 589
A VYK +A+K + L +R K +F A E + L+ ++H N++ ++
Sbjct: 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAI---DVAS-------ALEYLHHH 639
LV+EFM LE ++ +I + D+ S LEYLH +
Sbjct: 74 KSNI-----NLVFEFME-TDLEK------VIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI---PEVMSSN 680
I+H DLKP+N+L+ +D + DFGL R M+
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 45/210 (21%)
Query: 537 VYKGILDL---DQTFIAVKVLFL----HQRGALKSFMAECQALRNIRHRNLVK---IITA 586
V +G L L + F+A+K L QR + F++E + H N++ ++T
Sbjct: 20 VCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 587 CSTSDFQGNYFRALVYEFMHHGSLESCPRI----LSFLRRLNIAIDVASALEYLHHHCKK 642
++ EFM +G+L+S R + ++ + + +A+ ++YL +
Sbjct: 77 SRPV--------MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS-NQCSSVGLKGTVGYATPE---- 697
VH DL N+L+++++ + DFGL+RF+ + S SS+G K + + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 698 -----------YGILLLEIFT-GKRPTSDM 715
YGI++ E+ + G+RP DM
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDM 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 48/207 (23%)
Query: 536 TVYKGI----LDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTS 590
TVYKG+ + + +A+KVL A K + E + ++ H ++V+++ C +S
Sbjct: 22 TVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSS 81
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHC 640
Q L+ + M G L L ++R LN + +A + YL
Sbjct: 82 QVQ------LITQLMPLGCL------LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE--- 126
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
+K +VH DL NVL+ + DFGL + + + + + G K + + E
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALESIL 184
Query: 698 ------------YGILLLEIFT-GKRP 711
YG+ + E+ T G +P
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 39/205 (19%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
VY+G+ D F AVK + L + A+K E L ++H N+V+ + D
Sbjct: 16 VYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75
Query: 592 FQGNYFRALVY-EFMHHGSLESCPRILSFLRRLNIAI---DVASALEYLHHHCKKPIVHC 647
++ E + GSL + I + + LEYLH + VH
Sbjct: 76 ------NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHR 126
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------- 697
D+K +N+L+D + + DFG+ + +V+ + S KG+ + PE
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSF--KGSPYWMAPEVIAQQGGYGL 181
Query: 698 ------YGILLLEIFTGKRPTSDMF 716
G +LE+ TGK P S +
Sbjct: 182 AADIWSLGCTVLEMATGKPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 39/144 (27%), Positives = 61/144 (42%), Gaps = 17/144 (11%)
Query: 563 KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG---SLESCPRILSF 619
K+ + E + LR +RH N+V + A G + LV+E++ LE+ P L
Sbjct: 45 KTALREVKVLRQLRHENIVNLKEAFRRK---GRLY--LVFEYVERTLLELLEASPGGLPP 99
Query: 620 LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679
+ + A+ Y H I+H D+KP N+L+ + DFG R + +S
Sbjct: 100 DAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 680 NQCSSVGLKGTVGYATPEYGILLL 703
V T Y PE LL+
Sbjct: 157 PLTDYV---ATRWYRAPE---LLV 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 38/192 (19%)
Query: 547 TFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
T +AVK L + G + +SF+ E Q ++ +RH LV++ S +V E+
Sbjct: 31 TKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIY------IVTEY 81
Query: 605 MHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659
M GSL + R L +++A VA+ + Y+ + +H DL+ +N+L+ +
Sbjct: 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDG 138
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLE 704
+ + DFGL R I + + + G K + + PE +GILL E
Sbjct: 139 LVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 705 IFT-GKRPTSDM 715
+ T G+ P M
Sbjct: 196 LVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 549 IAVKVLFLHQRGA-LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH 607
+AVK L G + E + LRN+ H N+VK C+ + GN + L+ EF+
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPS 92
Query: 608 GSL-ESCPR---ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH 663
GSL E PR ++ ++L A+ + ++YL + VH DL NVL++++
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149
Query: 664 MGDFGLTRFI 673
+GDFGLT+ I
Sbjct: 150 IGDFGLTKAI 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 51/205 (24%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGAL-KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V K + +AVK + L A+ K + E L +V F G
Sbjct: 16 VVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV---------GFYG 66
Query: 595 NYFR----ALVYEFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCK 641
++ ++ E+M GSL+ RIL IA+ V L YLH K
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK-----IAVAVLKGLTYLHEKHK 121
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
I+H D+KPSN+L+++ + DFG++ ++++S + V GT Y PE
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV---GTSSYMAPERIQG 173
Query: 698 --Y---------GILLLEIFTGKRP 711
Y G+ L+E+ TG+ P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 34/84 (40%), Positives = 51/84 (60%), Gaps = 4/84 (4%)
Query: 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN 269
G IP+ IS L+ ++ + NS+ G IP SL + T LEV+ LS NS +G++P SL
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPP---SLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 270 FSSHLRYLYMSANPISGSIPTEIG 293
+S LR L ++ N +SG +P +G
Sbjct: 489 LTS-LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 44/210 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
A Y + D+ +AVK L A K F E + L N++H ++VK C D
Sbjct: 24 AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL- 82
Query: 595 NYFRALVYEFMHHGSLE----------------SCPRILSFLRRLNIAIDVASALEYLHH 638
+V+E+M HG L + P L+ + L+IA +A+ + YL
Sbjct: 83 ----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL-- 136
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKG-TVGYATPE 697
+ VH DL N L+ ++ +GDFG++R +V S++ G + + PE
Sbjct: 137 -ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 698 ---------------YGILLLEIFT-GKRP 711
G++L EIFT GK+P
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 529 YESLVK------ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMA--ECQALRNIRHRNL 580
YE L K V+K + +A+K + + A E + L+ ++H N+
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73
Query: 581 VKIITACSTSDFQGNYFRA---LVYEFMHH---GSLE------SCPRILSFLRRLNIAID 628
V +I C T N ++ LV+EF H G L + I ++ L
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML----- 128
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ L Y+H + I+H D+K +N+L+ D + DFGL R
Sbjct: 129 -LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 38/194 (19%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
V+KG L D+T +AVK LK F++E + L+ H N+VK+I C+
Sbjct: 11 VFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ------ 63
Query: 596 YFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCKKPIV 645
R +Y M L LSFLR+ + A+D A+ + YL K +
Sbjct: 64 --RQPIYIVME---LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPE-VMSSNQCSSVGLKGTV------GYATPE- 697
H DL N L+ + + DFG++R + + SS+ + +K T G + E
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 698 ----YGILLLEIFT 707
YGILL E F+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 24/144 (16%)
Query: 567 AECQALRNIRHRNLVK----IITACSTSDFQGNYFRALVYEFMHHGSLES----CPRILS 618
+E LR ++H N+V+ II + + + +V E+ G L C +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLY-------IVMEYCEGGDLAQLIQKCKKERK 100
Query: 619 FLRR---LNIAIDVASALEYLHH--HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
++ I + AL H+ ++H DLKP+N+ LD + +GDFGL + +
Sbjct: 101 YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160
Query: 674 PEVMSSNQCSSVGLKGTVGYATPE 697
S+ + GT Y +PE
Sbjct: 161 GH--DSSFAKT--YVGTPYYMSPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 37/89 (41%), Positives = 54/89 (60%), Gaps = 5/89 (5%)
Query: 180 ENQ-LVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE 238
+NQ L G +P I L +++ + L+GN GNIP S+ + + LE LD + NS G IPE
Sbjct: 426 DNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 239 DLDSLVNCTYLEVVSLSVNSLSGTLPNSL 267
L L T L +++L+ NSLSG +P +L
Sbjct: 485 SLGQL---TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLV---KIITACSTS 590
ATVYKGI ++ +A+KV+ + + G + + E L+ ++H N+V II T
Sbjct: 19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78
Query: 591 DFQGNYFRALVYEFM--HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
F Y + ++M H G L L + L L Y+H + I+H D
Sbjct: 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHG---QHILHRD 128
Query: 649 LKPSNVLLDNDMTAHMGDFGLTR 671
LKP N+L+ + DFGL R
Sbjct: 129 LKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 19/267 (7%)
Query: 194 TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253
L + L L N+ NI + + L LD NN++T + P N L+ +
Sbjct: 91 NLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSN---LKELD 146
Query: 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP 313
LS N + +LP+ L N + L+ L +S N +S +P + NL NL + + I ++P
Sbjct: 147 LSDNKIE-SLPSPLRNLPN-LKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS-GNKISDLP 202
Query: 314 ISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLD 373
+ L L+ L L NN E+ SSL N L+ L L N + S + LD
Sbjct: 203 PEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLD 261
Query: 374 LSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIP--------SSLAWIFGYISIFAKLN 425
LS+N ++ L G+ ++ LDLS N LS +P L +L
Sbjct: 262 LSNNQISSISSL--GSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELK 319
Query: 426 LSYNNLDGDVPRKMIFKNASAISEAGN 452
L+ L+ ++ + A+S +
Sbjct: 320 LNSILLNNNILSNGETSSPEALSILES 346
|
Length = 394 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 40/148 (27%), Positives = 63/148 (42%), Gaps = 25/148 (16%)
Query: 535 ATVYKGILDLDQTFIAVK--VLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYK L +A+K L G K+ + E + L+ + H N++K++ F
Sbjct: 13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV-----F 67
Query: 593 QGNYFRALVYEFMHHGSLE---------SCPRILSFLRRLNIAIDVASALEYLHHHCKKP 643
+ LV+EFM + I S+L +L L + H H
Sbjct: 68 RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL------LQGLAFCHSH---G 118
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
I+H DLKP N+L++ + + DFGL R
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 55/161 (34%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 544 LDQTFIAVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFRA 599
D F AVKVL + ++ K MAE L +N++H LV + + T+D YF
Sbjct: 18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYF-- 73
Query: 600 LVYEFMHHGSLES-CPRILSFL--RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
V ++++ G L R SF R A ++ASAL YLH I++ DLKP N+LL
Sbjct: 74 -VLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILL 129
Query: 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
D+ + DFGL + E + ++ +S GT Y PE
Sbjct: 130 DSQGHVVLTDFGLCK---EGIEHSKTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 49/215 (22%)
Query: 532 LVKATVYKGILDLDQTF-IAVKVLFLHQRGALK-SFMAECQALRNI-RHRNLVKIITACS 588
+V+AT Y G+ D +AVK+L + + + M+E + + ++ H N+V ++ AC+
Sbjct: 51 VVEATAY-GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLH 637
G ++ E+ +G L L+FLRR L+ + VA + +L
Sbjct: 110 IG---GPIL--VITEYCCYGDL------LNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 638 HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS-SNQCSSVGLKGTVGYATP 696
K +H DL NVLL + + DFGL R ++M+ SN + V + P
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMAP 212
Query: 697 E---------------YGILLLEIFT-GKRPTSDM 715
E YGILL EIF+ G P M
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/168 (34%), Positives = 78/168 (46%), Gaps = 35/168 (20%)
Query: 545 DQTFIAVKVLFLHQRGALKS-----FMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFR 598
D +F AVKVL ++ LK MAE L +N++H LV + + T+ + YF
Sbjct: 19 DGSFYAVKVL--QKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYF- 73
Query: 599 ALVY----EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
L Y E H E C PR + A +VASA+ YLH I++ DLKP
Sbjct: 74 VLDYVNGGELFFHLQRERCFLEPRARFY------AAEVASAIGYLH---SLNIIYRDLKP 124
Query: 652 SNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCSSVGLKGTVGYATPE 697
N+LLD+ + DFGL + PE +S C GT Y PE
Sbjct: 125 ENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC------GTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 35/136 (25%)
Query: 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
L N L G IP D+ L +L+ ++LS NS+ G +P SL + +S L L +S N
Sbjct: 423 LGLDNQGLRGFIPNDISKL---RHLQSINLSGNSIRGNIPPSLGSITS-LEVLDLSYNSF 478
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG--- 341
+GSIP S+G L L++L+L N++S +P++LG
Sbjct: 479 NGSIPE------------------------SLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
Query: 342 ----NFTFLTELNLCG 353
+F F LCG
Sbjct: 515 LHRASFNFTDNAGLCG 530
|
Length = 623 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 38/192 (19%)
Query: 547 TFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
T +A+K L + G + ++F+ E Q ++ +RH LV + S +V EF
Sbjct: 31 TKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIY------IVTEF 81
Query: 605 MHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659
M GSL E + L + +++A +A + Y+ + +H DL+ +N+L+ ++
Sbjct: 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDN 138
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLE 704
+ + DFGL R I + + + G K + + PE +GILL E
Sbjct: 139 LVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 195
Query: 705 IFT-GKRPTSDM 715
+ T G+ P M
Sbjct: 196 LVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 33/111 (29%), Positives = 50/111 (45%), Gaps = 11/111 (9%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRILSFLRR 622
M E + L+ +RH NLV +I + + LV+EF+ H LE P L R
Sbjct: 48 MREIRMLKQLRHENLVNLIEVFRR---KKRLY--LVFEFVDHTVLDDLEKYPNGLDESRV 102
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
+ +E+ H H I+H D+KP N+L+ + DFG R +
Sbjct: 103 RKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 43/121 (35%), Positives = 61/121 (50%), Gaps = 27/121 (22%)
Query: 568 ECQALRNIRHRNLVK---IITACSTS-DF---QGNYFRALVYEFMHH---GSLESC---- 613
E + LR + HRN+V I+T + DF +G ++ LV+E+M H G LES
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGLVHF 113
Query: 614 --PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
I SF+++L L Y H KK +H D+K SN+LL+N + DFGL R
Sbjct: 114 SEDHIKSFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
Query: 672 F 672
Sbjct: 165 L 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 35/163 (21%)
Query: 537 VYKGIL-----DLDQTFIAVKVLFLHQRGALKS-FMAECQALRNIRHRNLVKIITACSTS 590
VYKG L L T +A+K L + ++ F E + + +++H N+V ++ C+
Sbjct: 21 VYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80
Query: 591 DFQGNYFRALVYEFMHHGSL-------------------ESCPRILSFLRRLNIAIDVAS 631
+++E++ HG L E+ L L+IAI +A+
Sbjct: 81 QPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135
Query: 632 ALEYLH-HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
+EYL HH VH DL N L+ +T + DFGL+R I
Sbjct: 136 GMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 45/209 (21%)
Query: 536 TVYKGIL---DLDQTFIAVKVLFLHQRGALKS-FMAECQALRNIRHRNLVKIITACSTSD 591
+V KG+ + +AVK L A K F+ E + + H +V++I C
Sbjct: 10 SVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC---- 65
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR---------LNIAIDVASALEYLHHHCKK 642
+G LV E G L L +L++ +A VA + YL K
Sbjct: 66 -KGEPL-MLVMELAPLGPL------LKYLKKRREIPVSDLKELAHQVAMGMAYLE---SK 114
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----- 697
VH DL NVLL N A + DFG++R + + ++ G + + + PE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG-RWPLKWYAPECINYG 173
Query: 698 ----------YGILLLEIFT-GKRPTSDM 715
YG+ L E F+ G +P +M
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
ATV+KG L + +A+K + L H+ GA + + E L++++H N+V + T
Sbjct: 20 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT---- 75
Query: 594 GNYFRALVYEFMHHG---SLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
+ LV+E++ ++ C I+S + L Y H ++ ++H DLK
Sbjct: 76 -DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLK 131
Query: 651 PSNVLLDNDMTAHMGDFGLTRF--IPEVMSSNQ 681
P N+L++ + DFGL R +P SN+
Sbjct: 132 PQNLLINERGELKLADFGLARAKSVPTKTYSNE 164
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 15/137 (10%)
Query: 549 IAVKVLF--LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY-FRALVYEFM 605
+AVK+L + ++ F+ E ++ H N++K+I S +G ++ FM
Sbjct: 30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM 89
Query: 606 HHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
HG L + P L + ID+AS +EYL K +H DL N +L
Sbjct: 90 KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCML 146
Query: 657 DNDMTAHMGDFGLTRFI 673
+ +MT + DFGL++ I
Sbjct: 147 NENMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
ATVYKG L +A+K + L H+ GA + + E L++++H N+V + T
Sbjct: 20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79
Query: 594 GNYFRALVYEFMHHG---SLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
LV+E++ L+ C ++ N+ + + L L++ ++ ++H DLK
Sbjct: 80 -----TLVFEYLDKDLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 651 PSNVLLDNDMTAHMGDFGLTRF--IPEVMSSNQCSSVG------LKGTVGYATP----EY 698
P N+L++ + DFGL R IP SN+ ++ L G+ Y+T
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191
Query: 699 GILLLEIFTGK 709
G + E+ TG+
Sbjct: 192 GCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 32/181 (17%)
Query: 549 IAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG 608
+AVK L L+ F E + L++++H N+VK C ++ G LV E++ +G
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRNLRLVMEYLPYG 92
Query: 609 SLESCPRILSFLRRLNIAIDVASALEYLHHHCK-------KPIVHCDLKPSNVLLDNDMT 661
SL +L++ +D L Y CK K VH DL N+L++++
Sbjct: 93 SLRD------YLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR 146
Query: 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIF 706
+GDFGLT+ +P+ + G YA PE +G++L E+F
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELF 205
Query: 707 T 707
T
Sbjct: 206 T 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-08
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 568 ECQALRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMHH--GSLESCPRILSFLRR 622
E + LR++RH N++ I+ S DF Y +V E M + P+ L+
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVY---IVTELMETDLHKVIKSPQPLTDDHI 105
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
+ L+YLH ++H DLKPSN+L++++ + DFGL R +
Sbjct: 106 QYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 22/173 (12%)
Query: 535 ATVYKGILDLDQTFIAVK---VLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+ VY+ LD +A+K + L A + E L+ + H N++K A D
Sbjct: 16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY-YASFIED 74
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRL-------NIAIDVASALEYLHHHCKKPI 644
+ N +V E G L + +RL + + SALE++H + +
Sbjct: 75 NELN----IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRV 127
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+H D+KP+NV + +GD GL RF SS ++ L GT Y +PE
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 55/194 (28%), Positives = 76/194 (39%), Gaps = 48/194 (24%)
Query: 548 FIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
+ A+K L + +K E L + H +V ++ CS D YF + EF
Sbjct: 45 YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM--CSFQDENRVYF---LLEF 99
Query: 605 MHHGSLESCPRILSFLRRL-NIAIDVAS--------ALEYLHHHCKKPIVHCDLKPSNVL 655
+ G L + LR+ DVA A EYLH K I++ DLKP N+L
Sbjct: 100 VVGGEL------FTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLL 150
Query: 656 LDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGI 700
LDN + DFG + +P+ + L GT Y PE G+
Sbjct: 151 LDNKGHVKVTDFGFAKKVPD-------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 701 LLLEIFTGKRPTSD 714
LL E G P D
Sbjct: 204 LLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 536 TVYKGILDLDQTFIAVKVLFL---------HQRGALKSFMAECQALRNIRHRNLVKIITA 586
+VY G+ +AVK + L +R L + E L+ ++H N+V+ +
Sbjct: 15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYL-G 73
Query: 587 CSTSDFQGNYFRALV------YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHC 640
S N F V ++G+ E + +F+R+ + L YLH+
Sbjct: 74 SSLDADHLNIFLEYVPGGSVAALLNNYGAFEE-TLVRNFVRQ------ILKGLNYLHN-- 124
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE--VMSSNQCSSVGLKGTVGYATPE- 697
+ I+H D+K +N+L+DN + DFG+++ + + + + L+G+V + PE
Sbjct: 125 -RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 698 --------------YGILLLEIFTGKRPTSDM 715
G L++E+ TGK P D
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 18/151 (11%)
Query: 533 VKATVYKG--ILDLDQTFIAVKVLFLHQRGALKSFMA---ECQALRNIRHRNLVKIITAC 587
V TV+KG I + D I V + + R ++F A+ ++ H +V+++ C
Sbjct: 19 VFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC 78
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPR----ILSFLRRLNIAIDVASALEYLHHHCKKP 643
+ Q LV + GSL R L R LN + +A + YL H
Sbjct: 79 PGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
+VH +L N+LL +D + DFG+ +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLY 160
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 47/169 (27%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSD--------FQGNYFRALVYEFMHHGSLESCPRIL 617
+ E Q L + R +V + A T D G + +Y G E
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----- 102
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
R + A ++ LE LH ++ IV+ DLKP N+LLD+ + D GL +PE
Sbjct: 103 ---RAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156
Query: 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ G GTVGY PE G LL E+ G+ P
Sbjct: 157 TIK-----GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 49/200 (24%)
Query: 545 DQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602
+ T +AVK L + G + ++F+ E ++ ++H LV++ + + Y ++
Sbjct: 29 NSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIY---IIT 80
Query: 603 EFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKPIVHCDLKP 651
E+M GSL L FL+ ++ + +A + Y+ +K +H DL+
Sbjct: 81 EYMAKGSL------LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRA 131
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------------- 697
+NVL+ + + DFGL R I + + + G K + + PE
Sbjct: 132 ANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 698 -YGILLLEIFT-GKRPTSDM 715
+GILL EI T GK P M
Sbjct: 189 SFGILLYEIVTYGKIPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 45/171 (26%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLR---RLN 624
E + L+ + H ++++ + D F ++ E++ G L S+LR R +
Sbjct: 51 EKRVLKEVSHPFIIRLF--WTEHD---QRFLYMLMEYVPGGEL------FSYLRNSGRFS 99
Query: 625 ------IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678
A ++ ALEYLH K IV+ DLKP N+LLD + + DFG F ++
Sbjct: 100 NSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRD 153
Query: 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714
+ L GT Y PE GIL+ E+ G P D
Sbjct: 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNL 580
SYE L K ATVYKG ++ +A+KV+ L + G + + E L+ ++H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 581 VKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHC 640
V + T + LV+E++H + + L N+ + + L L +
Sbjct: 66 VLLHDIIHTKETL-----TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF--IPEVMSSNQ 681
++ I+H DLKP N+L+ + + DFGL R +P SN+
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 47/208 (22%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKS-FMAECQALRNIRHRNLVKIITACSTSDFQGN 595
V+ G L D T +AVK LK+ F+ E + L+ H N+V++I C+ Q
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPI 68
Query: 596 YFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HHCKKPI 644
Y +V E + G L+FLR + + + A+ +EYL HC
Sbjct: 69 Y---IVMELVQGGDF------LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT-VGYATPE------ 697
+H DL N L+ + DFG++R E S+ G+K V + PE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+GILL E F+ G P +++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANL 200
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 24/70 (34%), Positives = 45/70 (64%)
Query: 42 KYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNS 101
K + + +NLSG ++ G P +G++T L +++L N+F+ +IP +G+L LR + N
Sbjct: 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
Query: 102 NALQGQIPDS 111
N+L G++P +
Sbjct: 500 NSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 51/179 (28%), Positives = 73/179 (40%), Gaps = 26/179 (14%)
Query: 556 LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL----- 610
L +R + M E + L + R +V + A FQ LV M+ G L
Sbjct: 31 LKKRKGYEGAMVEKRILAKVHSRFIVSLAYA-----FQTKTDLCLVMTIMNGGDLRYHIY 85
Query: 611 ---ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667
E P R + S LE+LH I++ DLKP NVLLDND + D
Sbjct: 86 NVDEENPG-FPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDL 141
Query: 668 GLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEGLDLHNFV 726
GL + + Q + G GT G+ PE +L E + + D F G+ L+ +
Sbjct: 142 GLAVELKD----GQSKTKGYAGTPGFMAPE--LLQGEEYDF---SVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 45/205 (21%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
+VYK I +A+KV+ + L+ + E L+ +VK + G+
Sbjct: 18 SVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK---------YYGS 66
Query: 596 YFRA----LVYEFMHHGSLESCPRILSFLRRLN---IAI---DVASALEYLHHHCKKPIV 645
YF+ +V E+ GS+ +I + + L IA LEYLH +
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKI 121
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H D+K N+LL+ + A + DFG++ ++ + GT + PE
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 698 -------YGILLLEIFTGKRPTSDM 715
GI +E+ GK P SD+
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 33/115 (28%), Positives = 50/115 (43%), Gaps = 23/115 (20%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG---SLESCPRIL----- 617
+ E +AL+ +H +VK++ G LV E+M L R L
Sbjct: 47 LREIKALQACQHPYVVKLLDV--FPHGSGFV---LVMEYMPSDLSEVLRDEERPLPEAQV 101
Query: 618 -SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
S++R L + Y+H I+H DLKP+N+L+ D + DFGL R
Sbjct: 102 KSYMRML------LKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 44/144 (30%), Positives = 64/144 (44%), Gaps = 30/144 (20%)
Query: 549 IAVKVLFLHQRGAL----KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
+AVK L ++GA K F+ E + N H N+VK++ C ++ Q ++ E
Sbjct: 29 VAVKTL---RKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQ-----YIIMEL 80
Query: 605 MHHGSLESCPR----------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNV 654
M G L S R +L+ L+I +DVA YL + +H DL N
Sbjct: 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNC 137
Query: 655 LL-----DNDMTAHMGDFGLTRFI 673
L+ D D +GDFGL R I
Sbjct: 138 LVSEKGYDADRVVKIGDFGLARDI 161
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIITACSTSD 591
+ VYK I LD +A+K + + + K+ + E L+ + H N++K + +
Sbjct: 16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLAS----- 70
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRL-------NIAIDVASALEYLHHHCKKPI 644
F N +V E G L + +RL + + SALE++H K I
Sbjct: 71 FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRI 127
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+H D+KP+NV + +GD GL RF SS ++ L GT Y +PE
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 56/166 (33%), Positives = 79/166 (47%), Gaps = 31/166 (18%)
Query: 545 DQTFIAVKVLFLHQRGAL------KSFMAECQAL-RNIRHRNLVKIITACSTSD---FQG 594
++ F AVKVL Q+ A+ K M+E L +N++H LV + + T+D F
Sbjct: 19 EEKFYAVKVL---QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75
Query: 595 NYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+Y E +H E C PR + A ++ASAL YLH IV+ DLKP
Sbjct: 76 DYING--GELFYHLQRERCFLEPRARFY------AAEIASALGYLH---SLNIVYRDLKP 124
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
N+LLD+ + DFGL + E + N +S GT Y PE
Sbjct: 125 ENILLDSQGHIVLTDFGLCK---ENIEHNGTTST-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 22/173 (12%)
Query: 535 ATVYKGILDLDQTFIAVK---VLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+ VY+ LD+ +A+K + + A + + E L+ + H N++K + +
Sbjct: 16 SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDS----- 70
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRL-------NIAIDVASALEYLHHHCKKPI 644
F + +V E G L + +RL + + SA+E++H + +
Sbjct: 71 FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRV 127
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+H D+KP+NV + +GD GL RF SS ++ L GT Y +PE
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 44/190 (23%), Positives = 82/190 (43%), Gaps = 43/190 (22%)
Query: 557 HQRGALKS----------FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
H + A+KS F+AE ++ ++H LV++ + ++ E+M
Sbjct: 30 HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIY------IITEYME 83
Query: 607 HGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
+GSL L+ + +++A +A + ++ +K +H DL+ +N+L+ +
Sbjct: 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLC 140
Query: 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIF 706
+ DFGL R I + + + G K + + PE +GILL EI
Sbjct: 141 CKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
Query: 707 T-GKRPTSDM 715
T G+ P M
Sbjct: 198 TYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 47/169 (27%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSD--------FQGNYFRALVYEFMHHGSLESCPRIL 617
+ E Q L + + +V + A T D G + +Y + G E
Sbjct: 48 LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE----- 102
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
R L A ++ LE LH ++ V+ DLKP N+LLD+ + D GL IPE
Sbjct: 103 ---RALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156
Query: 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
S G GTVGY PE G L+ E+ G+ P
Sbjct: 157 SIR-----GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 34/90 (37%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 134 GLGLANNYFTGPIP-------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGE 186
GLGL N G IP HL +S S+ G+IP L +ITS+E +S N G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 187 LPPHIGFTLPNVRILLLAGNQFFGNIPHSI 216
+P +G L ++RIL L GN G +P ++
Sbjct: 482 IPESLG-QLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 7e-07
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 25/111 (22%)
Query: 570 QALRNIRHRNLVKIITACSTSDFQGNYFRA-------LVYEFMHHGSLESCPR--ILSFL 620
Q L + H N+VK++ N +A LV+E+M L + R IL +
Sbjct: 61 QELGD--HPNIVKLL----------NVIKAENDKDIYLVFEYME-TDLHAVIRANILEDV 107
Query: 621 RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ I + AL+Y+H ++H DLKPSN+LL++D + DFGL R
Sbjct: 108 HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 37/127 (29%), Positives = 52/127 (40%), Gaps = 18/127 (14%)
Query: 600 LVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659
L Y + G R + A + LE+LH ++ IV+ DLKP NVLLD+
Sbjct: 80 LKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDH 131
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEG 719
+ D GL V G GT GY PE +L E++ + D F G
Sbjct: 132 GNVRISDLGLA-----VELKGGKKIKGRAGTPGYMAPE--VLQGEVYDF---SVDWFALG 181
Query: 720 LDLHNFV 726
L+ +
Sbjct: 182 CTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 16/140 (11%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
VYK F A K++ + L+ FM E L +H N+V + A ++
Sbjct: 21 VYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF---YENKL 77
Query: 597 FRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLK 650
+ ++ EF G+L+S +L R L + + AL +LH H ++H DLK
Sbjct: 78 W--ILIEFCDGGALDSI--MLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLK 130
Query: 651 PSNVLLDNDMTAHMGDFGLT 670
N+LL D + DFG++
Sbjct: 131 AGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 42/158 (26%), Positives = 63/158 (39%), Gaps = 40/158 (25%)
Query: 545 DQTFIAVKVLFLHQRGA----LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600
T +AVK+L + A F E + H N+VK++ C+ L
Sbjct: 34 PFTMVAVKML---KEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM-----CL 85
Query: 601 VYEFMHHGSLES-----CPRI--------------------LSFLRRLNIAIDVASALEY 635
++E+M +G L PR LS +L IA VA+ + Y
Sbjct: 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
L ++ VH DL N L+ +M + DFGL+R I
Sbjct: 146 L---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 46/178 (25%)
Query: 546 QTFIAVKVLFLH-------QRGALKSF---MAECQALR-NIRHRNLVKIITACSTSDFQG 594
Q +A+K + +H +R KS ++E ++ +RH N+V+
Sbjct: 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVR------------ 73
Query: 595 NYFRALV-----YEFM----------HHGSLESCPRILSFLRRLNIAIDVASALEYLHHH 639
Y++ + Y M H SL+ + + R NI + + AL YLH
Sbjct: 74 -YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK- 131
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+K IVH DL P+N++L D + DFGL + S S V GT+ Y+ PE
Sbjct: 132 -EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESKLTSVV---GTILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 40/202 (19%)
Query: 536 TVYKGILDLDQ-TFIAVKVLFL--HQRGALKSFMAECQALRNIR---HRNLVKIITACST 589
TVYK D F+A+K + + ++ G S + E L+ + H N+V+++ C+T
Sbjct: 15 TVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73
Query: 590 SDFQGNYFRALVYEFMHH---GSLESCP-------RILSFLRRLNIAIDVASALEYLHHH 639
S LV+E + L+ P I +R+ L++LH +
Sbjct: 74 SRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF------LRGLDFLHAN 127
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN--------QCSSVGLKGTV 691
C IVH DLKP N+L+ + + DFGL R M+ + V L+ T
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST- 183
Query: 692 GYATP----EYGILLLEIFTGK 709
YATP G + E+F K
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 37/153 (24%), Positives = 58/153 (37%), Gaps = 36/153 (23%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-------HRNLVKIITACS 588
+VY +A+K + + S+ EC LR ++ H N+VK+
Sbjct: 14 SVYLARNKETGELVAIKKM----KKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEV-- 66
Query: 589 TSDFQGNYFRALVYEFMHH----------GSLESCPRILSFLRRLNIAIDVASALEYLHH 638
F+ N V+E+M G S I S + + + L ++H
Sbjct: 67 ---FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQ------ILQGLAHIHK 117
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
H H DLKP N+L+ + DFGL R
Sbjct: 118 H---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 62/219 (28%)
Query: 533 VKATVYKGILDLDQTF-IAVKVLFL--HQRGALKSFMAECQALRNI-RHRNLVKIITACS 588
VKA G+ + ++T +AVK+L ++ L ++E + ++ I +H+N++ ++ C+
Sbjct: 29 VKAE-AVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVCT 86
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR-------------------------L 623
+G + +V E+ HG+L FLR +
Sbjct: 87 Q---EGPLY--VVVEYAAHGNLRD------FLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683
+ A VA +E+L K +H DL NVL+ D + DFGL R I + + +
Sbjct: 136 SFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFT 707
+ L V + PE +G+LL EIFT
Sbjct: 193 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 40/200 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
ATVYKG +A+K + L + G + + E ++ ++H N+V++ T +
Sbjct: 14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73
Query: 594 GNYFRALVYEFM------------HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCK 641
LV+E+M G+L+ + SF +L I + H +
Sbjct: 74 -----MLVFEYMDKDLKKYMDTHGVRGALDPN-TVKSFTYQLLKGIA------FCHEN-- 119
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF--IPEVMSSNQCSSVG------LKGTVGY 693
++H DLKP N+L++ + DFGL R IP SN+ ++ L G+ Y
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 694 ATP----EYGILLLEIFTGK 709
+T G ++ E+ TG+
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 42/141 (29%), Positives = 59/141 (41%), Gaps = 31/141 (21%)
Query: 592 FQGNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
FQ V E+++ G L +S R R A ++ L++LH KK I++
Sbjct: 65 FQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGIIYR 120
Query: 648 DLKPSNVLLDNDMTAHMGDFGL--TRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
DLK NVLLD D + DFG+ E +S C GT Y PE
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------GTPDYIAPEILKGQKYN 174
Query: 698 -------YGILLLEIFTGKRP 711
+G+LL E+ G+ P
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 54/161 (33%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 544 LDQTFIAVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFRA 599
LD AVKVL + R K MAE L +N++H LV + + T++ YF
Sbjct: 18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--KLYF-- 73
Query: 600 LVYEFMHHGSL---ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
V +F++ G L R R A ++ASAL YLH IV+ DLKP N+LL
Sbjct: 74 -VLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILL 129
Query: 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
D+ + DFGL + E ++ + ++ GT Y PE
Sbjct: 130 DSQGHVVLTDFGLCK---EGIAQSDTTTT-FCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 42/182 (23%), Positives = 80/182 (43%), Gaps = 45/182 (24%)
Query: 561 ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFL 620
++++F+AE ++ ++H LVK+ + ++ EFM GSL L FL
Sbjct: 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY------IITEFMAKGSL------LDFL 91
Query: 621 RR-----------LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
+ ++ + +A + ++ ++ +H DL+ +N+L+ + + DFGL
Sbjct: 92 KSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 148
Query: 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTS 713
R I + + + G K + + PE +GILL+EI T G+ P
Sbjct: 149 ARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205
Query: 714 DM 715
M
Sbjct: 206 GM 207
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 547 TFIAVKVLFLHQRGAL-KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605
T +A KV+ + + ++ K + E Q + R +V A F + EFM
Sbjct: 31 TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA-----FLNENNICMCMEFM 85
Query: 606 HHGSLESCPRILSFLRRL---NIAIDVASALEYLH--HHCKKPIVHCDLKPSNVLLDNDM 660
GSL+ + + IA+ V L YL+ H I+H D+KPSN+L+++
Sbjct: 86 DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR----IMHRDIKPSNILVNSRG 141
Query: 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEI 705
+ DFG++ E+++S + V GT Y +PE GI ++E+
Sbjct: 142 QIKLCDFGVS---GELINSIADTFV---GTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195
Query: 706 FTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738
GK P + F+ D M + D + Q++
Sbjct: 196 ALGKFPFA--FSNIDDDGQDDPMGILDLLQQIV 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 36/182 (19%)
Query: 563 KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC-PRILSFLR 621
K + E + ++ + +VK A + + A+ E+ GSL+S ++
Sbjct: 44 KQILRELEINKSCKSPYIVKYYGAF-LDESSSSIGIAM--EYCEGGSLDSIYKKVKKRGG 100
Query: 622 RLN------IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
R+ IA V L YLH + I+H D+KPSN+LL + DFG++ E
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GE 154
Query: 676 VMSSNQCSSVGLKGTVGYATPE------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729
+++S + GT Y PE Y I TSD+++ GL L +
Sbjct: 155 LVNSLAGTFT---GTSFYMAPERIQGKPYSI-----------TSDVWSLGLTLLEVAQNR 200
Query: 730 LP 731
P
Sbjct: 201 FP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 25/163 (15%)
Query: 545 DQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602
DQ + +K + + Q + + ECQ L+ + H N+++ +F + +V
Sbjct: 24 DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY-----ENFLEDKALMIVM 78
Query: 603 EFMHHGSLESCPRILSFLRRLNIAIDVASALEY-------LHHHCKKPIVHCDLKPSNVL 655
E+ G+L + +R N +D + L + LHH K I+H DLK N+L
Sbjct: 79 EYAPGGTLA---EYIQ--KRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNIL 133
Query: 656 LD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
LD + M +GDFG+++ + S ++ +V GT Y +PE
Sbjct: 134 LDKHKMVVKIGDFGISK---ILSSKSKAYTV--VGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 28/120 (23%)
Query: 565 FMAECQALRNIRHRNLVKIITACS-TSDFQGNYFRALVYEFMHHGS----LESC------ 613
F+ E Q R+++H NL++ + C+ + + LV EF G L SC
Sbjct: 42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELM 95
Query: 614 ---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670
P L +A ++A L +LH + +H DL N LL D+T +GD+GL+
Sbjct: 96 TPDPTTLQ-----RMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 45/195 (23%)
Query: 549 IAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKI--ITACSTSDFQGNY-----FRAL- 600
+AVK + L ++K + E + +R + H N+VK+ + S SD + ++
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 601 -VYEFM--------HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
V E+M G L L + L L+Y+H ++H DLKP
Sbjct: 93 IVQEYMETDLANVLEQGPLSEEHARLFMYQLLR-------GLKYIH---SANVLHRDLKP 142
Query: 652 SNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
+NV ++ D+ +GDFGL R + S S GL T Y +P
Sbjct: 143 ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAID 201
Query: 699 ----GILLLEIFTGK 709
G + E+ TGK
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 30/164 (18%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL---ESCPRILSFLRR 622
+ E + L+N RH L + A T D V E+ + G L S R+ + R
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRERVFTEERA 97
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682
++ SALEYLH + +V+ D+K N++LD D + DFGL + E + S+
Sbjct: 98 RFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGI-SDGA 150
Query: 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ GT Y PE G+++ E+ G+ P
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 43/185 (23%), Positives = 81/185 (43%), Gaps = 53/185 (28%)
Query: 563 KSFMAECQALRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSF 619
+ F++E + H N++ ++T +V E+M +GSL++ F
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPV--------MIVTEYMENGSLDA------F 95
Query: 620 LRR----------LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
LR+ + + +AS ++YL VH DL N+L+++++ + DFGL
Sbjct: 96 LRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGL 152
Query: 670 TRFI---PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKR 710
+R + PE + + G K + + PE YGI++ E+ + G+R
Sbjct: 153 SRVLEDDPEAAYTTR----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
Query: 711 PTSDM 715
P +M
Sbjct: 209 PYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 36/138 (26%), Positives = 54/138 (39%), Gaps = 29/138 (21%)
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR---LNIAIDVASALEYLHHHCKKPIVHCD 648
FQ + LV E+++ G S + L L +V +E LH ++ I+H D
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRD 122
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------- 697
+KP N+L+D + DFGL+R E + GT Y PE
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNGLE--------NKKFVGTPDYLAPETILGVGDDKMS 174
Query: 698 ----YGILLLEIFTGKRP 711
G ++ E G P
Sbjct: 175 DWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 13/109 (11%)
Query: 568 ECQALRNIRHRNLVKI--ITACSTSDFQGNYFRALVYEFMHH---GSLESCPRILSFLRR 622
E L ++H N+V + + S D + +V E++ H +E+ +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLD---KIY--MVMEYVEHDLKSLMETMKQPFLQSEV 108
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ + + S + +LH + I+H DLK SN+LL+N + DFGL R
Sbjct: 109 KCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 48/167 (28%), Positives = 66/167 (39%), Gaps = 39/167 (23%)
Query: 568 ECQALRNIRHRNLVKIITACSTSD--------FQGNYFRALVYEFMHHGSLESCPRILSF 619
E Q L + R +V + A T D G + +Y + G E
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE------- 102
Query: 620 LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679
R + A ++ LE LH ++ IV+ DLKP N+LLD+ + D GL IPE
Sbjct: 103 -RAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---- 154
Query: 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ G GTVGY PE G L+ E+ GK P
Sbjct: 155 GETIR-GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 37/180 (20%)
Query: 565 FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLE----SCPRILSFL 620
F+ E Q R + H N+++ + C S Y LV EF G L+ S +++ +
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESI---PYL--LVLEFCPLGDLKNYLRSNRGMVAQM 96
Query: 621 RR----LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT------ 670
+ +A +VAS L +LH + +H DL N L D++ +GD+GL
Sbjct: 97 AQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153
Query: 671 -------------RFI-PEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFT-GKRPTSDM 715
R++ PE++ + T G+ + E+FT +P D+
Sbjct: 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 47/207 (22%), Positives = 95/207 (45%), Gaps = 41/207 (19%)
Query: 537 VYKGILDL---DQTFIAVKVL----FLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
V++GIL + + +A+K L QR + F++E + H N++++ +
Sbjct: 21 VFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMGQFSHHNIIRLEGVVT- 76
Query: 590 SDFQGNYFRAL-VYEFMHHGSLESCPRI----LSFLRRLNIAIDVASALEYLHHHCKKPI 644
+ A+ + E+M +G+L+ R S + + + +A+ ++YL
Sbjct: 77 -----KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------- 697
VH DL N+L+++++ + DFGL+R + + +S G K + + PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG-KIPIRWTAPEAIAYRKF 187
Query: 698 --------YGILLLEIFT-GKRPTSDM 715
+GI++ E+ + G+RP DM
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 14/126 (11%)
Query: 552 KVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA--LVYEFMHH- 607
KV ++R + S + E L N+RH N+V++ G + + LV E+
Sbjct: 39 KVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVV-----VGKHLDSIFLVMEYCEQD 93
Query: 608 -GSL-ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665
SL ++ P S + + + + L+YLH + I+H DLK SN+LL + +
Sbjct: 94 LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIA 150
Query: 666 DFGLTR 671
DFGL R
Sbjct: 151 DFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 535 ATVYKGIL--DLDQTFIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIITACST 589
TVYKGI + + I V + L++ K+ FM E + ++ H +LV+++ C +
Sbjct: 21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80
Query: 590 SDFQGNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
Q LV + M HG L E I S L LN + +A + YL ++ +
Sbjct: 81 PTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-LNWCVQIAKGMMYLE---ERRL 130
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
VH DL NVL+ + + DFGL R +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 43/145 (29%)
Query: 600 LVYEFMHHGSLESCPRILSFLR------RLNIAI------------DVASALEYLHHHCK 641
L Y F G L IL FLR RL+ + ++A AL++LH
Sbjct: 63 LHYAFQTEGKLY---LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
I++ DLKP N+LLD + + DFGL++ E + + + GTV Y PE
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEK-KAYSFCGTVEYMAPEVVNR 172
Query: 698 -----------YGILLLEIFTGKRP 711
+G+L+ E+ TG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 36/147 (24%), Positives = 68/147 (46%), Gaps = 17/147 (11%)
Query: 537 VYKGI---LDLDQTFIAVKVLFLHQRGALKS-FMAECQALRNIRHRNLVKIITACSTSDF 592
VY+G+ + ++ +AVK +++ F+ E +R H ++VK+I + +
Sbjct: 22 VYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPV 81
Query: 593 QGNYFRALVYEFMHHGSLESCPRI----LSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
+V E G L S ++ L + + +++AL YL K VH D
Sbjct: 82 W------IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRD 132
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPE 675
+ NVL+ + +GDFGL+R++ +
Sbjct: 133 IAARNVLVSSPDCVKLGDFGLSRYLED 159
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 54/227 (23%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGAL-KSFMAECQALRNIRHRNLVKIITACSTS---D 591
TVYK L + +AVKV+ L L K M+E ++I+ C +
Sbjct: 16 TVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKCDSPYIIG 63
Query: 592 FQGNYFR----ALVYEFMHHGSLESCPRILS-FLRRLNIAIDVASALEYLHHHCKKPIVH 646
F G +F ++ EFM GSL+ +I L R IA+ V L YL I+H
Sbjct: 64 FYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR--IAVAVVKGLTYL---WSLKILH 118
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------YGI 700
D+KPSN+L++ + DFG++ ++++S + V GT Y PE YGI
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYV---GTNAYMAPERISGEQYGI 172
Query: 701 L---------LLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738
+E+ G+ P + + +P Q+LQ +
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKN----QGSL---MPLQLLQCI 212
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 22/100 (22%)
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGL 687
++ ALE+LH K IV+ D+K N+LLD++ + DFGL++ E +S + +
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK---EFLSEEKERTYSF 166
Query: 688 KGTVGYATPE----------------YGILLLEIFTGKRP 711
GT+ Y PE GIL+ E+ TG P
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 17/95 (17%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI------------PEV 676
V A EYLH+ + I++ DLKP N+LLD++ + DFG + + PE
Sbjct: 102 VVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158
Query: 677 MSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRP 711
++ + G +V Y + GILL E+ TG+ P
Sbjct: 159 VAPEIILNKGYDFSVDYWS--LGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRL--NIAIDV 629
+ NI H + K C + Y+R ++ E + + E RI ++L NI D+
Sbjct: 77 IHNIDHLGIPKYY-GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDM 135
Query: 630 ASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL-TRFI 673
+ LEY+H H I H D+KP N+++D + ++ D+G+ + FI
Sbjct: 136 LTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 37/177 (20%)
Query: 562 LKSFMAECQALRNI-RHRNLVKIITACSTSD---------FQGN---YFRALVYEFMHHG 608
L ++E + ++ I +H+N++ ++ AC+ +GN Y RA M +
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY- 119
Query: 609 SLESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665
S ++C L+F ++ A VA +EYL + +H DL NVL+ D +
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIA 176
Query: 666 DFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT 707
DFGL R + + + ++ L V + PE +G+LL EIFT
Sbjct: 177 DFGLARDVHNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 13/112 (11%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRILSFLRR 622
+ E + L+ ++H NLV +I F+ LV+E+ H LE PR +
Sbjct: 48 LREIRMLKQLKHPNLVNLIEV-----FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI 102
Query: 623 LNIAIDVASALEYLH-HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
I A+ + H H+C +H D+KP N+L+ + DFG R +
Sbjct: 103 KKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 39/208 (18%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGAL------KSFMAECQALRNIRHRNLVKIITACST 589
TVY G+ + Q IAVK + L L + E L++++H N+V+ + C
Sbjct: 15 TVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-- 71
Query: 590 SDFQGNYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
N ++ EF+ GS+ S P + I + YLH++C +
Sbjct: 72 --LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLHNNC---V 123
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV--GLKGTVGYATPEY---- 698
VH D+K +NV+L + + DFG R + V S++ + GT + PE
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 699 -----------GILLLEIFTGKRPTSDM 715
G + E+ TGK P + M
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 26/106 (24%)
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684
IA+ + ALEYLH ++H D+KPSNVL++ + + DFG++ ++ + ++ +
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 685 VGLKGTVGYATPE-------------------YGILLLEIFTGKRP 711
G Y PE GI ++E+ TG+ P
Sbjct: 165 ----GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 537 VYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKII-TACSTSDFQ 593
VYK +A+K + +H + G + + E + L+ ++H N+V +I A D
Sbjct: 24 VYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83
Query: 594 GNYFRALVY---EFMHH---GSLESCPRI-LSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
R VY +M H G LE+ P + L+ + + + + YLH + I+H
Sbjct: 84 KRK-RGSVYMVTPYMDHDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLH---ENHILH 138
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTR 671
D+K +N+L+DN + DFGL R
Sbjct: 139 RDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 60/246 (24%), Positives = 87/246 (35%), Gaps = 70/246 (28%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
VYK +A+KV+ L + E L+ RH N+V + G+
Sbjct: 18 DVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA---------YFGS 68
Query: 596 YFRA----LVYEFMHHGSLESCPRILSFLRR----LNIAI---DVASALEYLHHHCKKPI 644
Y R +V E+ GSL+ I R L IA + L YLH K
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD---IYQVTRGPLSELQIAYVCRETLKGLAYLHETGK--- 122
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFG----LTR-------FI-------PEVMSSNQCSSVG 686
+H D+K +N+LL D + DFG LT FI PEV + +
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182
Query: 687 LKGTVGYATPEYGILLLEIFTGKRPTSDM------FTEG----------------LDLHN 724
K + +A GI +E+ + P D+ F H+
Sbjct: 183 GKCDI-WAL---GITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 725 FVKMAL 730
F+K L
Sbjct: 239 FIKKCL 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 8/76 (10%)
Query: 600 LVYEFMHHGSLESCPRILSF----LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVL 655
LV E++ G ++S I + + I+ +VA AL+YLH H I+H DLKP N+L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLHRH---GIIHRDLKPDNML 136
Query: 656 LDNDMTAHMGDFGLTR 671
+ N+ + DFGL++
Sbjct: 137 ISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 23/106 (21%)
Query: 621 RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680
R + A ++ LE L ++ IV+ DLKP N+LLD+ + D GL IPE +
Sbjct: 103 RAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159
Query: 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
G GTVGY PE G L+ E+ G+ P
Sbjct: 160 -----GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 32/124 (25%)
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS-SVG--LKGTVG 692
+HH K ++H D+K +N+LL ++ +GDFG ++ M + S VG GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-----MYAATVSDDVGRTFCGTPY 210
Query: 693 YATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV 737
Y PE G+LL E+ T KRP +G ++ + L +
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP-----FDGENMEEVMHKTLAGR---- 261
Query: 738 LDPL 741
DPL
Sbjct: 262 YDPL 265
|
Length = 496 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 54/227 (23%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNI-RHR 578
+D++ ++ ++KA + K L +D A+K + + + + F E + L + H
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 579 NLVKIITACSTSDFQGNYFRALVYEFMHHGSL-------------------ESCPRILSF 619
N++ ++ AC + +G + A+ E+ HG+L S LS
Sbjct: 69 NIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 620 LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR----FIPE 675
+ L+ A DVA ++YL +K +H DL N+L+ + A + DFGL+R ++ +
Sbjct: 124 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 676 VMSSNQCSSVGLKG------TVGYATPEYGILLLEIFT-GKRPTSDM 715
M + ++ T YG+LL EI + G P M
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 35/176 (19%)
Query: 562 LKSFMAECQALRNI-RHRNLVKIITACSTSD---------FQGN---YFRALVYEFMHHG 608
L ++E + ++ I +H+N++ ++ AC+ +GN Y RA M +
Sbjct: 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126
Query: 609 SLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGD 666
+ LSF ++ A VA +EYL K +H DL NVL+ D + D
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIAD 183
Query: 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT 707
FGL R I + + ++ L V + PE +G+LL EIFT
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 28/118 (23%), Positives = 58/118 (49%), Gaps = 18/118 (15%)
Query: 565 FMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL----ESC------- 613
+ E L + H+N++ I+ C + ++Y +M+ G+L + C
Sbjct: 55 LLQESCLLYGLSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN 110
Query: 614 PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
P+ LS + +++AI +A + YLH K+ ++H D+ N ++D ++ + D L+R
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 36/115 (31%), Positives = 55/115 (47%), Gaps = 24/115 (20%)
Query: 568 ECQALRNIRHRNLVKI--ITACSTSDFQGNYFRALVYEFM----HH-----GSLESCPRI 616
E + LR+ +H N++ I I +DF+ Y +V + M HH L I
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVY---VVMDLMESDLHHIIHSDQPLTE-EHI 109
Query: 617 LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
FL +L L+Y+H ++H DLKPSN+L++ D +GDFG+ R
Sbjct: 110 RYFLYQL------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 27/112 (24%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRA----LVYEFMHHGSLESCPRILSF---- 619
E + L+ +RH N + +++G Y R LV E+ L S IL
Sbjct: 65 EVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEY----CLGSASDILEVHKKP 111
Query: 620 LRRLNIAI---DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG 668
L+ + IA L YLH H + +H D+K N+LL T + DFG
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 32/136 (23%), Positives = 60/136 (44%), Gaps = 13/136 (9%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
VYK +A+K + L ++ + + E +++ +H N+V +
Sbjct: 35 VYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPNIVDYY---DSYLVGDEL 90
Query: 597 FRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652
+ +V E+M GSL ++ + + +V LEYLH + ++H D+K
Sbjct: 91 W--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSD 145
Query: 653 NVLLDNDMTAHMGDFG 668
N+LL D + + DFG
Sbjct: 146 NILLSKDGSVKLADFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 26/103 (25%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCS 683
A ++ L++LH ++ I++ DLK NVLLD++ + DFG+ + + V +S C
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC- 157
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE G+LL E+ G+ P
Sbjct: 158 -----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 40/202 (19%)
Query: 537 VYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
VYK I +A+KV+ L ++ E Q L R + K + F
Sbjct: 17 VYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS-----FLKG 71
Query: 596 YFRALVYEFMHHGS----LESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
++ E+ GS L+ ++F+ R +V LEYLH K +H D
Sbjct: 72 SKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVLLGLEYLHEEGK---IHRD 123
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------Y---- 698
+K +N+LL + + DFG++ ++S GT + PE Y
Sbjct: 124 IKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 699 -----GILLLEIFTGKRPTSDM 715
GI +E+ G+ P SD+
Sbjct: 180 DIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 30/149 (20%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VYK L +A+K + L G + + E L+ + H N+V+++
Sbjct: 15 VYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV----HSE 70
Query: 595 N--YFRALVYEFMHHG---SLESCPR-------ILSFLRRLNIAIDVASALEYLHHHCKK 642
N Y LV+EF+ ++S P I S+L +L + Y H H
Sbjct: 71 NKLY---LVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL------LQGIAYCHSH--- 118
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
++H DLKP N+L+D + + DFGL R
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 34/111 (30%), Positives = 46/111 (41%), Gaps = 14/111 (12%)
Query: 34 WLGVTCSLKYQR----VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIG 89
W G C + + L L Q L G I L L+ INL N+ NIP +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 90 RLFRLRHIIFNSNALQGQIPDS--------RLIL--NKLEGNIPSELGSLL 130
+ L + + N+ G IP+S L L N L G +P+ LG L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 532 LVKATVYKGILDLDQT---FIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIIT 585
L K T K IL ++ + A+K+L + + + + E + L+N RH +T
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH----PFLT 58
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSL---ESCPRILSFLRRLNIAIDVASALEYLHHHCKK 642
A S FQ + V E+ + G L S R+ S R ++ SAL YLH
Sbjct: 59 ALKYS-FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SC 114
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+V+ DLK N++LD D + DFGL + E +S GT Y PE
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT-FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 568 ECQALRNIRHRNLVKIITAC---STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN 624
E L+ I HR ++ +I A ST ++ ++ ++ + ++ RRL
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL- 194
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684
AL YLH + I+H D+K N+ LD A +GDFG + + QC
Sbjct: 195 -----LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC-- 244
Query: 685 VGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEGLDL 722
G GT+ +PE +L L+ + K +D+++ GL L
Sbjct: 245 YGWSGTLETNSPE--LLALDPYCAK---TDIWSAGLVL 277
|
Length = 392 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 39/207 (18%)
Query: 533 VKATVYKGILDLDQTFIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSD 591
VK VYK + Q +A+KVL +++ M E + + + + +V++I C
Sbjct: 11 VKKGVYK--MRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA 68
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHC-------KKPI 644
LV E G L FL I V++ +E +H K
Sbjct: 69 LM------LVMEMASGGPLNK------FLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------- 697
VH DL NVLL N A + DFGL++ + S + S G K + + PE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPLKWYAPECINFRKF 175
Query: 698 --------YGILLLEIFT-GKRPTSDM 715
YGI + E F+ G++P M
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 39/141 (27%), Positives = 60/141 (42%), Gaps = 31/141 (21%)
Query: 592 FQGNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
FQ V E+++ G L +SC + R A ++ L++LH K IV+
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLH---SKGIVYR 120
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
DLK N+LLD D + DFG+ + + + + C GT Y PE
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC------GTPDYIAPEILLGQKYN 174
Query: 698 -------YGILLLEIFTGKRP 711
+G+LL E+ G+ P
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 25/116 (21%)
Query: 568 ECQALRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILS--- 618
E + LR++ H N++ I+ F Y +VYE M H + S + LS
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVY---IVYELMDTDLHQIIRS-SQTLSDDH 109
Query: 619 ---FLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
FL +L L+Y+H ++H DLKPSN+LL+ + + DFGL R
Sbjct: 110 CQYFLYQL------LRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 44/204 (21%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS---DFQ 593
V+KGI + Q +A+K++ L + AE + +I+ + +++ C + +
Sbjct: 20 VFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--ITVLSQCDSPYVTKYY 68
Query: 594 GNYFRA----LVYEFMHHGSLESCPRILSFLRRLNIAI---DVASALEYLHHHCKKPIVH 646
G+Y + ++ E++ GS R F IA ++ L+YLH K +H
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKK---IH 124
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------- 697
D+K +NVLL + DFG + ++ Q GT + PE
Sbjct: 125 RDIKAANVLLSEQGDVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 698 ------YGILLLEIFTGKRPTSDM 715
GI +E+ G+ P SDM
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 31/190 (16%)
Query: 529 YESLVKA------TVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNL 580
YE + K VYK + IA+K + L Q G + + E L+ ++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 581 VKIITACSTSDFQGNYFRA-LVYEFMH---HGSLESCPRILSFLRRLNIAI-DVASALEY 635
V++ D + R LV+E++ ++S P R + + + + Y
Sbjct: 64 VRL------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTA-HMGDFGLTR--------FIPEVMSSNQCSSVG 686
H H ++H DLKP N+L+D A + DFGL R F EV++ +
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174
Query: 687 LKGTVGYATP 696
L G+ Y+TP
Sbjct: 175 LLGSRHYSTP 184
|
Length = 294 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 42/175 (24%), Positives = 80/175 (45%), Gaps = 28/175 (16%)
Query: 516 ESSSRKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLF-LHQRGALKSFMAECQALRN 574
E +D++ ++ +++A + K D + A+K+L + F E + L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKK---DGLKMNAAIKMLKEFASENDHRDFAGELEVLCK 58
Query: 575 I-RHRNLVKIITACSTSDFQGNYFRALVY-------EFMHHGS-LESCP---------RI 616
+ H N++ ++ AC +G + A+ Y +F+ LE+ P
Sbjct: 59 LGHHPNIINLLGACEN---RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 617 LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
L+ + L A DVA+ ++YL +K +H DL NVL+ ++ + + DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 30/163 (18%)
Query: 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIIT 585
YE + + KG + T +AVK + ++ +L+ F+ E ++ ++V+++
Sbjct: 23 YEGNARDII-KGEAE---TRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVVRLLG 76
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSLESCPRIL-------------SFLRRLNIAIDVASA 632
S +V E M HG L+S R L + + +A ++A
Sbjct: 77 VVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 633 LEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
+ YL+ K VH DL N ++ +D T +GDFG+TR I E
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 14/130 (10%)
Query: 549 IAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITAC----STSDFQGNYFRALV 601
+AVK L F +Q A +++ E L+ + H+N++ ++ S +FQ Y LV
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY---LV 104
Query: 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
E M + L R + + +++LH I+H DLKPSN+++ +D T
Sbjct: 105 MELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 161
Query: 662 AHMGDFGLTR 671
+ DFGL R
Sbjct: 162 LKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 24/114 (21%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH----------GSLESCPRIL 617
E L+ + H N+VK++ T + + LV+EF+H S P I
Sbjct: 49 EISLLKELNHPNIVKLLDVIHT---ENKLY--LVFEFLHQDLKKFMDASPLSGIPLPLIK 103
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
S+L +L L + H H ++H DLKP N+L++ + + DFGL R
Sbjct: 104 SYLFQL------LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 30/164 (18%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL---ESCPRILSFLRR 622
+ E + L+N RH L + + T D V E+++ G L S R+ S R
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRL-----CFVMEYVNGGELFFHLSRERVFSEDRT 97
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682
++ SAL+YLH IV+ DLK N++LD D + DFGL + E + ++
Sbjct: 98 RFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGI-TDAA 150
Query: 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ GT Y PE G+++ E+ G+ P
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 35/128 (27%), Positives = 54/128 (42%), Gaps = 15/128 (11%)
Query: 547 TFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
T +AVK + L LK E R ++H N++ +T+ F + +V
Sbjct: 26 TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-----FIVDSELYVVSPL 80
Query: 605 MHHGSLE-----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659
M +GS E P L L I DV +AL+Y+H K +H +K S++LL D
Sbjct: 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGD 137
Query: 660 MTAHMGDF 667
+
Sbjct: 138 GKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 8e-05
Identities = 36/119 (30%), Positives = 48/119 (40%), Gaps = 35/119 (29%)
Query: 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT-AHMGDFGLTRFIPEVMSSNQC 682
I + AL LH K I+H D+K NVL D ++ D+GL C
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL------------C 157
Query: 683 SSVGLK----GTVGYATPE------Y---------GILLLEIFTGKRPTSDMFTEGLDL 722
+G GT+ Y +PE Y G+L E+ TGK P + E LDL
Sbjct: 158 KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 19/148 (12%)
Query: 553 VLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG---NYFRALVYEFMHHGS 609
VL + Q+G + E L+N+ H +++++ + ++ + +Y ++ +
Sbjct: 95 VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---T 148
Query: 610 LESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
S P L + L I + L YLH I+H D+K N+ +++ +GD G
Sbjct: 149 KRSRP--LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203
Query: 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+F + +GL GTV PE
Sbjct: 204 AQF-----PVVAPAFLGLAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 50/213 (23%), Positives = 83/213 (38%), Gaps = 54/213 (25%)
Query: 536 TVYKGILDLD-QTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VY DL Q IA+K + ++ E ++HRN+V+ + + S +
Sbjct: 23 IVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS----EN 77
Query: 595 NYFRALVYEFMHH---GSLESCPR-----------ILSFLRRLNIAIDVASALEYLHHHC 640
+F+ FM GSL + R + F + + L+YLH
Sbjct: 78 GFFKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLH--- 125
Query: 641 KKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-- 697
IVH D+K NVL++ + DFG ++ + + N C+ GT+ Y PE
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI---NPCTET-FTGTLQYMAPEVI 181
Query: 698 ---------------YGILLLEIFTGKRPTSDM 715
G ++E+ TGK P ++
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 10/109 (9%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL---ESCPRILSFLRR 622
+ E + L+N RH +TA S FQ + V E+ + G L S R+ S R
Sbjct: 43 LTENRVLQNSRH----PFLTALKYS-FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 97
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
++ SAL+YLH +K +V+ DLK N++LD D + DFGL +
Sbjct: 98 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 26/106 (24%)
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684
+ + + AL YL K ++H D+KPSN+LLD + DFG++ + + + +
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 685 VGLKGTVGYATPE-------------------YGILLLEIFTGKRP 711
G Y PE GI L+E+ TG+ P
Sbjct: 175 ---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 26/141 (18%)
Query: 548 FIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
+AVK+L + A F+ E + + +++ N+++++ C + D ++ E+M
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-----CMITEYME 100
Query: 607 HGSLE----------------SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
+G L + P + S L +A+ +AS ++YL VH DL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSV-SIANLLYMAVQIASGMKYL---ASLNFVHRDLA 156
Query: 651 PSNVLLDNDMTAHMGDFGLTR 671
N L+ N T + DFG++R
Sbjct: 157 TRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 33/142 (23%), Positives = 64/142 (45%), Gaps = 23/142 (16%)
Query: 545 DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603
+AVK+L + A F+ E + + ++ N+++++ C TSD ++ E
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-----CMITE 99
Query: 604 FMHHGSL--------------ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
+M +G L ++ +S+ + +A +AS ++YL VH DL
Sbjct: 100 YMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL 156
Query: 650 KPSNVLLDNDMTAHMGDFGLTR 671
N L+ + T + DFG++R
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 33/179 (18%)
Query: 557 HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRI 616
+ + + E Q L+N++H +V+ C D + F E+M GS++ +
Sbjct: 43 ETKKEVNALECEIQLLKNLQHERIVQYY-GCLRDDETLSIF----MEYMPGGSVKDQLKA 97
Query: 617 LSFL-----RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
L R+ I +EYLH + IVH D+K +N+L D+ +GDFG ++
Sbjct: 98 YGALTETVTRKYTRQI--LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
Query: 672 FIPEV-MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714
+ + S SV GT + +PE G ++E+ T K P ++
Sbjct: 153 RLQTICSSGTGMKSV--TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 45/221 (20%)
Query: 536 TVYKG-ILDLDQTFIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIITACSTSD 591
VY G ++D D I V L++ L+ F+ E +++ H N++ ++ C S+
Sbjct: 10 CVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCK 641
G+ +V +M HG L +F+R + + VA +EYL
Sbjct: 70 --GSPL--VVLPYMKHGDL------RNFIRSETHNPTVKDLIGFGLQVAKGMEYL---AS 116
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI--PEVMSSNQCSSVGL------------ 687
K VH DL N +LD T + DFGL R I E S + + L
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 688 -KGTVGYATPEYGILLLEIFT-GKRPTSDMFTEGLDLHNFV 726
K T +G+LL E+ T G P D+ + D+ ++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYL 215
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 36/153 (23%), Positives = 64/153 (41%), Gaps = 30/153 (19%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGAL-----KSFMAECQALRNIRHRNLVKIITACSTS 590
TVYKG+ + + + V R A K + E + ++ + ++ +++ C TS
Sbjct: 22 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHC 640
Q L+ + M G L L ++R LN + +A + YL
Sbjct: 82 TVQ------LITQLMPFGCL------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 126
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
++ +VH DL NVL+ + DFGL + +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 22/101 (21%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685
A ++ SAL +LH K I++ DLK NVLLD++ + DFG+ + + N ++
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIF--NGKTTS 154
Query: 686 GLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE G+LL E+ G P
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 36/187 (19%)
Query: 550 AVKVL----FLHQRGALKSFMAECQALRNIRHRN-LVKIITACSTSDFQGNYFRALVYEF 604
A+KVL + + + E Q L +R LV + A FQ + L+ ++
Sbjct: 32 AMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQTDTKLHLILDY 86
Query: 605 MHHGSLES--CPRILSFLRRLNIAI-DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
++ G L + R + + I ++ AL++LH + I++ D+K N+LLD++
Sbjct: 87 VNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGH 143
Query: 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLE 704
+ DFGL++ E ++ + + GT+ Y PE G+L E
Sbjct: 144 VVLTDFGLSK---EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200
Query: 705 IFTGKRP 711
+ TG P
Sbjct: 201 LLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 26/103 (25%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCS 683
A ++A L +LH K I++ DLK NV+LD + + DFG+ + + C
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC- 162
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE +G+LL E+ G+ P
Sbjct: 163 -----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/72 (38%), Positives = 37/72 (51%), Gaps = 9/72 (12%)
Query: 627 IDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG 686
+ +A AL+YLH +K I+H DLK NV L +GD G+ R + NQC
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-----ENQCDMAS 160
Query: 687 -LKGTVGYATPE 697
L GT Y +PE
Sbjct: 161 TLIGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 35/138 (25%), Positives = 64/138 (46%), Gaps = 11/138 (7%)
Query: 538 YKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS----DFQ 593
Y +LD + + F +Q A +++ E ++ + H+N++ ++ + +FQ
Sbjct: 37 YDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653
Y LV E M + L R + + +++LH I+H DLKPSN
Sbjct: 96 DVY---LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSN 149
Query: 654 VLLDNDMTAHMGDFGLTR 671
+++ +D T + DFGL R
Sbjct: 150 IVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 26/103 (25%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCS 683
A +V AL +LH H +++ DLK N+LLD + + DFG+ + + V ++ C
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC- 157
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE G+L+ E+ G+ P
Sbjct: 158 -----GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 31/144 (21%)
Query: 547 TFIAVKVLFLHQR-----GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601
+AVKVL R A + F+ E + L + N+ +++ C+ ++
Sbjct: 47 VLVAVKVL----RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMI 97
Query: 602 YEFMHHGSL-------------ESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
E+M +G L +C + LSF L +A +AS + YL VH
Sbjct: 98 MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHR 154
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTR 671
DL N L+ + T + DFG++R
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 572 LRNIRHRNLVKIITAC----STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAI 627
++ + H+N++ ++ S +FQ Y LV E M + L R +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVY---LVMELMDANLCQVIQMDLDHERMSYLLY 125
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ +++LH I+H DLKPSN+++ +D T + DFGL R
Sbjct: 126 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 39/131 (29%), Positives = 56/131 (42%), Gaps = 28/131 (21%)
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS-SNQ 681
L + VA +++L K +H D+ NVLL + A + DFGL R ++M+ SN
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSNY 268
Query: 682 CSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNF 725
+ V + PE YGILL EIF+ GK P + +
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKM 327
Query: 726 VK----MALPD 732
VK M+ PD
Sbjct: 328 VKRGYQMSRPD 338
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/96 (32%), Positives = 42/96 (43%), Gaps = 11/96 (11%)
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYAT 695
LH H IV+ D+KP NVLLD+ + D GL + + + Q + GT GY
Sbjct: 109 LHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-----GTNGYMA 162
Query: 696 PEYGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731
PE IL E + D F G ++ V P
Sbjct: 163 PE--ILKEEPY---SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 52/224 (23%)
Query: 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKS---FMAECQALRNIRHRNLVKIIT 585
YE + K V D +T +A+K + ++ +++ F+ E ++ ++V+++
Sbjct: 23 YEGIAKGVVK----DEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHVVRLLG 76
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSLESCPRIL-------------SFLRRLNIAIDVASA 632
S QG ++ E M G L+S R L S + + +A ++A
Sbjct: 77 VVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 633 LEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKG--T 690
+ YL+ VH DL N ++ D T +GDFG+TR I E + G KG
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLP 184
Query: 691 VGYATPE---------------YGILLLEIFT-GKRPTSDMFTE 718
V + +PE +G++L EI T ++P M E
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 45/181 (24%)
Query: 562 LKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPR----- 615
L ++E + ++ I +H+N++ ++ C+ +G + ++ E+ G+L R
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPP 115
Query: 616 --------------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
LSF ++ A VA +EYL + +H DL NVL+ D
Sbjct: 116 GPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNV 172
Query: 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIF 706
+ DFGL R + ++ + S+ L V + PE +GIL+ EIF
Sbjct: 173 MKIADFGLARGVHDIDYYKKTSNGRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230
Query: 707 T 707
T
Sbjct: 231 T 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 22/101 (21%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685
A +++ L +LH ++ I++ DLK NV+LD++ + DFG+ + E M +
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160
Query: 686 GLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE YG+LL E+ G+ P
Sbjct: 161 -FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 42/160 (26%)
Query: 547 TFIAVKVLFLHQRGA----LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602
T +AVK+L + A L+ ++E L+ + H +++K+ ACS L+
Sbjct: 31 TTVAVKML---KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL-----LLIV 82
Query: 603 EFMHHGSLES---------CPRILSFLRR------------------LNIAIDVASALEY 635
E+ +GSL S + S R ++ A ++ ++Y
Sbjct: 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQY 142
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
L + +VH DL NVL+ + DFGL+R + E
Sbjct: 143 L---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 7/82 (8%)
Query: 118 LEGNIPSELGSLLKFKGLGLANNYFTGPIP-------HLNMFQVSVYSLTGSIPIQLLNI 170
L G IP+++ L + + L+ N G IP L + +S S GSIP L +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 171 TSMEYFHVSENQLVGELPPHIG 192
TS+ +++ N L G +P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 47/225 (20%), Positives = 75/225 (33%), Gaps = 71/225 (31%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALK-SFMAECQALRNI-RHRNLVKIITACSTSDFQG 594
VYK +A+K++ + E LR H N+ F G
Sbjct: 22 VYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNILRKYSNHPNIA---------TFYG 70
Query: 595 NYFRA----------LVYEFMHHGSL-ESCPRILSFLRRLN------IAIDVASALEYLH 637
+ + LV E GS+ + + +RL I + L YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 638 HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR-----------FI-------PEVMSS 679
+ ++H D+K N+LL + + DFG++ FI PEV++
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187
Query: 680 NQCSSVGLKGTVGYATPEY---------GILLLEIFTGKRPTSDM 715
++ Y GI +E+ GK P DM
Sbjct: 188 DE-----------QPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 12/107 (11%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLN 624
E + L+++RH N++ + + S + YF V E + H L S P F++
Sbjct: 59 ELKLLKHLRHENIISL-SDIFISPLEDIYF---VTELLGTDLHRLLTSRPLEKQFIQYF- 113
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ L+Y+H +VH DLKPSN+L++ + + DFGL R
Sbjct: 114 -LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 23/101 (22%)
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGL 687
++ ALE+LH K I++ D+K N+LLD++ + DFGL++ E +
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAYSF 166
Query: 688 KGTVGYATPE-----------------YGILLLEIFTGKRP 711
GT+ Y P+ G+L+ E+ TG P
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 610 LESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
L + R L + +A + SA++Y+H + I+H D+K NVL++ +GDFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 670 TRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEGL 720
F S+ G+ GTV PE +L + +T P+ D+++ GL
Sbjct: 307 ACFARGSWSTP--FHYGIAGTVDTNAPE--VLAGDPYT---PSVDIWSAGL 350
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 35/182 (19%)
Query: 558 QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV---YEFMHHGSLESCP 614
QRG + E LR I H +++++ F N F L+ Y+ + L +
Sbjct: 126 QRGGTAT---EAHILRAINHPSIIQLK-----GTFTYNKFTCLILPRYKTDLYCYL-AAK 176
Query: 615 RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
R ++ L I V A++YLH + I+H D+K N+ +++ +GDFG F
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233
Query: 675 EVMSSNQCSSVGLKGTVGYATPEY---------------GILLLEIFTGKRPTSDMFTEG 719
++ N G GT+ PE GI+L E+ T S +G
Sbjct: 234 DI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH--DSLFEKDG 288
Query: 720 LD 721
LD
Sbjct: 289 LD 290
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 27/139 (19%), Positives = 53/139 (38%), Gaps = 13/139 (9%)
Query: 541 ILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLV--KIITACSTSDFQGNYFR 598
+L +K R E L+ + + L K++ + + G +
Sbjct: 16 LLGTKDEDYVLK--INPSREKGADREREVAILQLLARKGLPVPKVLA---SGESDGWSY- 69
Query: 599 ALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658
L+ E++ +L+ +S + +IA +A L LH + H DL P N+L+D+
Sbjct: 70 -LLMEWIEGETLDE----VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124
Query: 659 DMTAHMGDFGLTRFIPEVM 677
+ D+ + P
Sbjct: 125 GKILGIIDWEYAGYGPPAF 143
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 29/136 (21%)
Query: 603 EFMHHGSLESCPRILSFLRRL------NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
E M GSL+ ++L R+ I+I V L YL K I+H D+KPSN+L+
Sbjct: 79 EHMDGGSLD---QVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRPT--SD 714
++ + DFG++ + + M++ S V GT Y +PE G T SD
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMAN---SFV---GTRSYMSPER-------LQGTHYTVQSD 180
Query: 715 MFTEGLDLHNFVKMAL 730
+++ GL L V+MA+
Sbjct: 181 IWSLGLSL---VEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 16/140 (11%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
VYK A KV+ L+ +M E L + H N+VK++ A ++ N
Sbjct: 21 VYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY---YENNL 77
Query: 597 FRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLK 650
+ ++ EF G++++ +L R L + AL YLH + I+H DLK
Sbjct: 78 W--ILIEFCAGGAVDAV--MLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLK 130
Query: 651 PSNVLLDNDMTAHMGDFGLT 670
N+L D + DFG++
Sbjct: 131 AGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 44/202 (21%), Positives = 80/202 (39%), Gaps = 38/202 (18%)
Query: 537 VYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
VY+G +A+K++ L + E L +R I + G+
Sbjct: 17 VYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK------YYGS 70
Query: 596 YFRA----LVYEFMHHGSLESCPRILSFLRRLNIAI---DVASALEYLHHHCKKPIVHCD 648
Y + ++ E+ GS+ + + + I++ +V AL+Y+H K ++H D
Sbjct: 71 YLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH---KVGVIHRD 126
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------- 697
+K +N+L+ N + DFG + +++ N GT + PE
Sbjct: 127 IKAANILVTNTGNVKLCDFG----VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182
Query: 698 -----YGILLLEIFTGKRPTSD 714
GI + E+ TG P SD
Sbjct: 183 ADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCS 683
A ++ AL +LH ++ I++ DLK NVLLD D + D+G+ + P +S C
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC- 157
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLH 723
GT Y PE G+L+ E+ G+ P D+ T+ D++
Sbjct: 158 -----GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF-DIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 548 FIAVKVLFLH--QRGALKSFMAECQALRNIR---HRNLVKIITACSTSDFQGNYFRALVY 602
F+A+K + + + G S + E LR++ H N+V++ C+ S LV+
Sbjct: 29 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 88
Query: 603 EFMHHG---SLESCPRILSFLRRL-NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658
E + L+ P + ++ + L++LH H +VH DLKP N+L+ +
Sbjct: 89 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS 145
Query: 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+ DFGL R + S Q + + T+ Y PE
Sbjct: 146 SGQIKLADFGLAR-----IYSFQMALTSVVVTLWYRAPE 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 16/140 (11%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
VYK A KV+ L+ +M E + L H +VK++ A + G
Sbjct: 28 VYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY---WDGKL 84
Query: 597 FRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLK 650
+ ++ EF G++++ +L R L I + AL+YLH I+H DLK
Sbjct: 85 W--IMIEFCPGGAVDAI--MLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLK 137
Query: 651 PSNVLLDNDMTAHMGDFGLT 670
NVLL D + DFG++
Sbjct: 138 AGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 37/134 (27%), Positives = 57/134 (42%), Gaps = 12/134 (8%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRAL---VYEFMHHGSLESCPRILSFLRRLN 624
E AL + H N++KI + + +Y FM+ + + R L R
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-A 271
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG-LTRFIPEVMSSNQCS 683
I + A+EY+H K ++H D+K N+ L+ D +GDFG F E +
Sbjct: 272 IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE----REAF 324
Query: 684 SVGLKGTVGYATPE 697
G GTV +PE
Sbjct: 325 DYGWVGTVATNSPE 338
|
Length = 501 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 31/161 (19%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRN 579
YE L K TV+K +A+K + L G S + E L+ ++H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 580 LVKIITACSTSDFQGNYFRALVYEFMHHG---SLESC------PRILSFLRRLNIAIDVA 630
+V++ + LV+E+ +SC + SF+ +L
Sbjct: 61 IVRLYDV-----LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------L 109
Query: 631 SALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
L + H H ++H DLKP N+L++ + + DFGL R
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 48/182 (26%), Positives = 74/182 (40%), Gaps = 50/182 (27%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEF-----------MHHGSLESCPRILSFL 620
L ++H N+V + FQ N +V E+ G L S +ILS+
Sbjct: 53 LAKMKHPNIVTFF-----ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107
Query: 621 RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSS 679
+ ++ L+++H + I+H D+K N+ L N M A +GDFG+ R + + M
Sbjct: 108 ------VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158
Query: 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHN 724
GT Y +PE G +L E+ T K P EG +LH
Sbjct: 159 AYTCV----GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-----FEGNNLHQ 209
Query: 725 FV 726
V
Sbjct: 210 LV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 22/101 (21%)
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685
A ++ L++LH K I++ DLK NV+LD D + DFG+ + V N+ S+
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRAST- 155
Query: 686 GLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE +G+LL E+ G+ P
Sbjct: 156 -FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 22/100 (22%)
Query: 627 IDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG 686
I + L +LH K I+H D+K N+ LD +GD G+ + ++S N +
Sbjct: 108 IQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK----LLSDNTNFANT 160
Query: 687 LKGTVGYATPEY---------------GILLLEIFTGKRP 711
+ GT Y +PE G++L E TGK P
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 20/111 (18%)
Query: 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683
I I + L+ LH ++ I+H DLK +N+LL + +GD G+++ + + M+ Q
Sbjct: 107 RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI- 162
Query: 684 SVGLKGTVGYATPEYGILLLEIFTGKRP---TSDMFTEGLDLHNFVKMALP 731
GT Y P E++ G RP SD+++ G L+ A P
Sbjct: 163 -----GTPHYMAP-------EVWKG-RPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 47/205 (22%), Positives = 89/205 (43%), Gaps = 46/205 (22%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACST---SDFQ 593
VYKGI + + +A+K++ L + AE + +I+ + +++ C + + +
Sbjct: 20 VYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--ITVLSQCDSPYITRYY 68
Query: 594 GNYFRA----LVYEFMHHGS----LESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
G+Y + ++ E++ GS L+ P +++ I ++ L+YLH K +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREILKGLDYLHSERK---I 123
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H D+K +NVLL + DFG + ++ Q GT + PE
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 698 -------YGILLLEIFTGKRPTSDM 715
GI +E+ G+ P SD+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 37/139 (26%), Positives = 55/139 (39%), Gaps = 22/139 (15%)
Query: 549 IAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH 607
+AVK L F+ E + H+N+V++I F+ R ++ E M
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS----FERLP-RFILLELMAG 93
Query: 608 GSLESC----------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657
G L+S P L+ L A DVA +YL + +H D+ N LL
Sbjct: 94 GDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLT 150
Query: 658 N---DMTAHMGDFGLTRFI 673
A + DFG+ R I
Sbjct: 151 CKGPGRVAKIADFGMARDI 169
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 45/199 (22%), Positives = 82/199 (41%), Gaps = 19/199 (9%)
Query: 550 AVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA----LVYEFM 605
A+KV+ L E +++ +H N+V + G+Y R + EF
Sbjct: 38 AIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA---------YFGSYLRRDKLWICMEFC 88
Query: 606 HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665
GSL+ + L IA L+ L++ K +H D+K +N+LL ++ +
Sbjct: 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLA 148
Query: 666 DFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEGLDLHNF 725
DFG++ I ++ + GT + PE + +E G D++ G+
Sbjct: 149 DFGVSAQITATIAKRK----SFIGTPYWMAPE--VAAVERKGGYNQLCDIWAVGITAIEL 202
Query: 726 VKMALPDQILQVLDPLFLV 744
++ P L + LFL+
Sbjct: 203 AELQPPMFDLHPMRALFLM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNI-RHRN 579
D++ ++ ++KA + K L +D A+K + + + + F E + L + H N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 580 LVKIITACSTSDFQGNYFRALVY-------EFMHHGS-LESCP---------RILSFLRR 622
++ ++ AC +G + A+ Y +F+ LE+ P LS +
Sbjct: 58 IINLLGACEH---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
L+ A DVA ++YL +K +H DL N+L+ + A + DFGL+R
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 35/138 (25%), Positives = 63/138 (45%), Gaps = 22/138 (15%)
Query: 568 ECQALRNIRHRNLVKIITA-------CSTSDF-QGNYFRALVYEFMHHGSLESCPRILSF 619
E Q L + H +VK + C +++ +G + E H G S ++ +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 620 LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679
+L + + Y+H ++ I+H DLK N+ L N++ +GDFG++R + M S
Sbjct: 112 FIQLLLGVH------YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL---MGS 158
Query: 680 NQCSSVGLKGTVGYATPE 697
++ GT Y +PE
Sbjct: 159 CDLATT-FTGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 9/78 (11%)
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTV 691
ALE+LH + IV+ DLKP N+LLD + DFGL++ ++ N+ ++ GT
Sbjct: 108 ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNT-FCGTT 160
Query: 692 GYATPEYGILLLEIFTGK 709
Y PE +LL E K
Sbjct: 161 EYLAPE--VLLDEKGYTK 176
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 47/168 (27%), Positives = 68/168 (40%), Gaps = 33/168 (19%)
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLN---------IAIDVASALEYLHHHCKK 642
F+ + LV EF+ G +FLRR A + EYL
Sbjct: 100 FKDESYLYLVLEFVIGGEF------FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SL 150
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILL 702
IV+ DLKP N+LLD D M DFG + + + L GT Y PE +L
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-------DTRTYTLCGTPEYIAPE---IL 200
Query: 703 LEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEG 750
L + GK +D +T G+ ++ + P +PL + + EG
Sbjct: 201 LNVGHGK--AADWWTLGIFIYEILVGCPP---FYANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 34/105 (32%), Positives = 46/105 (43%), Gaps = 25/105 (23%)
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684
IA+ AL YL K I+H D+KPSN+LLD + + DFG++ + V S +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRD 167
Query: 685 VGLKGTVGYATPE------------------YGILLLEIFTGKRP 711
G + Y PE GI L E+ TGK P
Sbjct: 168 AGCR---PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACST---SDFQ 593
V+KGI + Q +A+K++ L + AE + +I+ + +++ C + + +
Sbjct: 20 VFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--ITVLSQCDSPYVTKYY 68
Query: 594 GNYFRA----LVYEFMHHGS----LESCP----RILSFLRRLNIAIDVASALEYLHHHCK 641
G+Y + ++ E++ GS LE P +I + LR ++ L+YLH K
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR------EILKGLDYLHSEKK 122
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGIL 701
+H D+K +NVLL + DFG + ++ Q GT + PE ++
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPE--VI 173
Query: 702 LLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744
+ K +D+++ G+ K P L + LFL+
Sbjct: 174 KQSAYDSK---ADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 16/136 (11%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFL-----RR 622
E Q L+N+RH +V+ C + ++ E+M GS++ + L RR
Sbjct: 54 EIQLLKNLRHDRIVQYY-GCLRDPEEKKL--SIFVEYMPGGSIKDQLKAYGALTENVTRR 110
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV-MSSNQ 681
I + YLH + IVH D+K +N+L D+ +GDFG ++ I + MS
Sbjct: 111 YTRQI--LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165
Query: 682 CSSVGLKGTVGYATPE 697
SV GT + +PE
Sbjct: 166 IKSV--TGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 49/173 (28%), Positives = 71/173 (41%), Gaps = 46/173 (26%)
Query: 567 AECQALRNI----RHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR 622
A +A RNI +H +V +I A FQ L+ E++ G L L R
Sbjct: 45 AHTKAERNILEAVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL------FMHLER 93
Query: 623 LNIAI-DVAS--------ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
I + D A ALE+LH ++ I++ DLKP N+LLD + DFGL +
Sbjct: 94 EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-- 148
Query: 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
E + + GT+ Y PE G L+ ++ TG P
Sbjct: 149 -ESIHEGTVTHT-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 55/189 (29%), Positives = 76/189 (40%), Gaps = 32/189 (16%)
Query: 574 NIRHRNLVKIITACSTSDFQG-NYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAI 627
++ +++I A SD Q NY R Y+ + +++ L+ L L+
Sbjct: 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTY 244
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGL 687
VA +E+L K VH DL NVLL + DFGL R I + SN S
Sbjct: 245 QVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI--MHDSNYVSKGST 299
Query: 688 KGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVK---- 727
V + PE YGILL EIF+ G P M + +N +K
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TFYNKIKSGYR 358
Query: 728 MALPDQILQ 736
MA PD Q
Sbjct: 359 MAKPDHATQ 367
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 26/137 (18%)
Query: 545 DQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601
A+KVL + +R + AE L + +VK+ + FQ LV
Sbjct: 25 TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEHLYLV 79
Query: 602 YEFMHHGSLESCPRILSFLRRLNI---------AIDVASALEYLHHHCKKPIVHCDLKPS 652
E+M G L ++ L R ++ ++ AL+ +H K +H D+KP
Sbjct: 80 MEYMPGGDL------MNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPD 130
Query: 653 NVLLDNDMTAHMGDFGL 669
N+L+D D + DFGL
Sbjct: 131 NILIDADGHIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 14/130 (10%)
Query: 549 IAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITAC----STSDFQGNYFRALV 601
+A+K L F +Q A +++ E ++ + H+N++ ++ S +FQ Y +V
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY---IV 107
Query: 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
E M + L R + + +++LH I+H DLKPSN+++ +D T
Sbjct: 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 164
Query: 662 AHMGDFGLTR 671
+ DFGL R
Sbjct: 165 LKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 47/180 (26%), Positives = 75/180 (41%), Gaps = 39/180 (21%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL----ESCPRILSFLRR- 622
E +R ++H+N+V+ I Q Y ++ EF G L + C ++ +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLY---ILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 623 --LNIAIDVASALEYLHHHCKKP----IVHCDLKPSNVLLD-------------NDMT-- 661
++I + AL Y H+ P ++H DLKP N+ L N++
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178
Query: 662 --AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEG 719
A +GDFGL++ I ++ C GT Y +PE LLL SDM+ G
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCV-----GTPYYWSPE---LLLHETKSYDDKSDMWALG 230
|
Length = 1021 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 44/149 (29%), Positives = 67/149 (44%), Gaps = 20/149 (13%)
Query: 535 ATVYKGILDLD----QTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACST 589
TVYKGI D + +A+KVL + A K + E + + + +++ C T
Sbjct: 21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80
Query: 590 SDFQGNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
S Q LV + M +G L E+ RI S LN + +A + YL + +
Sbjct: 81 STVQ------LVTQLMPYGCLLDYVRENKDRIGS-QDLLNWCVQIAKGMSYLE---EVRL 130
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
VH DL NVL+ + + DFGL R +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 44/178 (24%), Positives = 73/178 (41%), Gaps = 38/178 (21%)
Query: 536 TVYKGILDLDQTFIAVKVLF------LHQRGALKSFMAECQALRNIRHRNLVKII----T 585
V +A+K L +H + + E + L+++ H N++ ++
Sbjct: 30 QVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENVIGLLDVFTP 85
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHH 639
A S DFQ Y LV M G+ I+ ++L+ + + L+Y+H
Sbjct: 86 ASSLEDFQDVY---LVTHLM--GA--DLNNIVKC-QKLSDDHIQFLVYQILRGLKYIH-- 135
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
I+H DLKPSN+ ++ D + DFGL R + M+ G T Y PE
Sbjct: 136 -SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-------GYVATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 40/169 (23%)
Query: 571 ALRNIRHRNLVKIITACSTS---DFQGNYFR----ALVYEFMHHGSLESCPRILSFLRRL 623
A+RN R L +++ C++ F G ++ ++ E M GSL+ ++L +R+
Sbjct: 45 AIRNQIIREL-QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD---QVLKEAKRI 100
Query: 624 ------NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
++I V L YL K I+H D+KPSN+L+++ + DFG++ + + M
Sbjct: 101 PEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158
Query: 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+++ GT Y +PE G+ L+E+ G+ P
Sbjct: 159 ANS------FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 42/189 (22%), Positives = 72/189 (38%), Gaps = 34/189 (17%)
Query: 549 IAVKVL-FLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605
+A+K+L F E + H N+V ++ + G F V+E++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP--GLLFA--VFEYV 61
Query: 606 HHGSLE---SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DND 659
+L + L + + V AL H + IVH DLKP N+++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118
Query: 660 MTAHMGDFGLTRFIP---EVMSSNQCSSVGLKGTVGYATPE---------------YGIL 701
A + DFG+ +P + + + + GT Y PE +G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 702 LLEIFTGKR 710
LE TG+R
Sbjct: 179 FLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNI 625
+ E + LR ++ N+V++ A F+ LV+E++ LE + + + +
Sbjct: 48 LRELKMLRTLKQENIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV 102
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685
+ ++ +H K IVH D+KP N+L+ ++ + DFG R + E ++N V
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162
Query: 686 GLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEG 719
T Y +PE LLL GK DM++ G
Sbjct: 163 ---ATRWYRSPE---LLLGAPYGK--AVDMWSVG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 24/71 (33%), Positives = 33/71 (46%), Gaps = 5/71 (7%)
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTV 691
L+Y+H ++H DLKP N+L++ D + DFGL R E N T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 692 GYATPEYGILL 702
Y PE I+L
Sbjct: 174 WYRAPE--IML 182
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 40/181 (22%), Positives = 74/181 (40%), Gaps = 45/181 (24%)
Query: 562 LKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRI---- 616
L ++E + ++ I +H+N++ ++ AC+ Q +V E+ G+L R
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPP 118
Query: 617 ---------------LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
++F ++ VA +EYL + +H DL NVL+ +
Sbjct: 119 GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNV 175
Query: 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIF 706
+ DFGL R + + + ++ L V + PE +G+L+ EIF
Sbjct: 176 MKIADFGLARDVNNIDYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233
Query: 707 T 707
T
Sbjct: 234 T 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 7/71 (9%)
Query: 627 IDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG 686
+ SA+ Y+H K I+H D+K N+ L +GDFG+++ ++ S +
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK----ILGSEYSMAET 160
Query: 687 LKGTVGYATPE 697
+ GT Y +PE
Sbjct: 161 VVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/64 (31%), Positives = 32/64 (50%), Gaps = 4/64 (6%)
Query: 221 KLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMS 280
L+ LD +NN LT + + L+V+ LS N+L+ P + + S LR L +S
Sbjct: 1 NLKSLDLSNNRLTVIPDG---AFKGLPNLKVLDLSGNNLTSISPEAFSGLPS-LRSLDLS 56
Query: 281 ANPI 284
N +
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 40/200 (20%)
Query: 537 VYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VYKG +A+K + L + G + + E L+ ++H N+V + Q
Sbjct: 16 VYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL----MQE 71
Query: 595 NYFRALVYEFMH---HGSLESCPRILSFLRRLNIAIDVASALEYLHH--------HCKKP 643
+ L++EF+ L+S P+ +D YL+ H ++
Sbjct: 72 SRLY-LIFEFLSMDLKKYLDSLPK--------GQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRF--IP------EVMSSNQCSSVGLKGTVGYAT 695
++H DLKP N+L+DN + DFGL R IP EV++ + L G+ Y+T
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 696 P----EYGILLLEIFTGKRP 711
P G + E+ T K+P
Sbjct: 182 PVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 34/147 (23%), Positives = 64/147 (43%), Gaps = 31/147 (21%)
Query: 548 FIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
+AVK+L + A F+ E + L ++ N+++++ C D ++ E+M
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYME 102
Query: 607 HGSL----------------------ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
+G L C +S+ L++A+ +AS ++YL
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTR 671
VH DL N L+ ++T + DFG++R
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 36/125 (28%), Positives = 49/125 (39%), Gaps = 21/125 (16%)
Query: 603 EFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA 662
E HH E R ++ ALE LH K +++ DLKP N+LLD
Sbjct: 79 ELFHHLQREGR---FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHI 132
Query: 663 HMGDFGLTRF-------------IPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGK 709
+ DFGL + PE ++ G V + T G+LL E+ TG
Sbjct: 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT--LGVLLYEMLTGL 190
Query: 710 RPTSD 714
P D
Sbjct: 191 PPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 12/134 (8%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR---LN 624
E Q L+N++H +V+ C + + E+M GS++ + L
Sbjct: 54 EIQLLKNLQHERIVQYY-GCLRD--RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 110
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV-MSSNQCS 683
+ + YLH + IVH D+K +N+L D+ +GDFG ++ + + MS
Sbjct: 111 YTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167
Query: 684 SVGLKGTVGYATPE 697
SV GT + +PE
Sbjct: 168 SV--TGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 25/117 (21%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN-IAID-- 628
LR ++H N+V ++ + Y L++++ H + I+ F R+ ++I
Sbjct: 56 LRELKHENVVSLVEVFLEHADKSVY---LLFDYAEHDLWQ----IIKFHRQAKRVSIPPS 108
Query: 629 -VASAL-------EYLHHHCKKPIVHCDLKPSNVLLDNDMTAH----MGDFGLTRFI 673
V S L YLH ++H DLKP+N+L+ + +GD GL R
Sbjct: 109 MVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 47/191 (24%)
Query: 550 AVKVL---FLHQRGALKSFMAE---CQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603
A+K L + R ++S M E + + RH LV + AC FQ V E
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLF-AC----FQTEDHVCFVME 82
Query: 604 F-------MH-HGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVL 655
+ MH H + S PR + + A V L+YLH + IV+ DLK N+L
Sbjct: 83 YAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGLQYLHEN---KIVYRDLKLDNLL 133
Query: 656 LDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGI 700
LD + + DFGL + E M +S GT + PE G+
Sbjct: 134 LDTEGFVKIADFGLCK---EGMGFGDRTST-FCGTPEFLAPEVLTETSYTRAVDWWGLGV 189
Query: 701 LLLEIFTGKRP 711
L+ E+ G+ P
Sbjct: 190 LIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 48/232 (20%)
Query: 506 LRRQRTVTSSESSSRKDLLLNVSYESL---VKATVYKGILDLDQTFIAVKVLFLHQRGAL 562
L + RT+ S +K +E + TVY I +A+K + L Q+
Sbjct: 5 LEKLRTIVSVGDPKKK----YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK 60
Query: 563 KSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL-----ESC---P 614
+ + E +R +H N+V + + D +V E++ GSL E+C
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDEL-----WVVMEYLAGGSLTDVVTETCMDEG 115
Query: 615 RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674
+I + R + ALE+LH ++H D+K N+LL D + + DFG I
Sbjct: 116 QIAAVCR------ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI- 165
Query: 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ Q + GT + PE GI+ +E+ G+ P
Sbjct: 166 ---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 42/183 (22%), Positives = 78/183 (42%), Gaps = 35/183 (19%)
Query: 549 IAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG 608
+AVK + L ++ + E +R+ H N+V + + D +V EF+ G
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW-----VVMEFLEGG 104
Query: 609 SLESCPRILSFLRR-----LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH 663
+L I++ R + + V AL YLH+ + ++H D+K ++LL +D
Sbjct: 105 ALTD---IVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIK 158
Query: 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTG 708
+ DFG + + + + L GT + PE GI+++E+ G
Sbjct: 159 LSDFGFCAQVSKEVPKRK----SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
Query: 709 KRP 711
+ P
Sbjct: 215 EPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 4/50 (8%)
Query: 620 LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
L R IA ++ A+E +H K +H D+KP N+L+D D + DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 26/101 (25%)
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR--FIPEVMSSNQCSSV 685
+++ AL YLH ++ I++ DLK NVLLD++ + D+G+ + P +S C
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--- 157
Query: 686 GLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE G+L+ E+ G+ P
Sbjct: 158 ---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 28/144 (19%)
Query: 530 ESLVKAT---VYKGI-------LDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRN 579
ESL + T ++KGI +L +T + +KVL R +SF + + H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 580 LVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----LNIA--IDVASAL 633
LV C D +V E++ GSL+ ++L++ +NI+ ++VA L
Sbjct: 61 LVLNYGVCVCGDES-----IMVQEYVKFGSLD------TYLKKNKNLINISWKLEVAKQL 109
Query: 634 EY-LHHHCKKPIVHCDLKPSNVLL 656
+ LH K + H ++ NVLL
Sbjct: 110 AWALHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 35/116 (30%), Positives = 50/116 (43%), Gaps = 21/116 (18%)
Query: 616 ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
LS++ + + VA+ +E+L K VH DL NVL+ + DFGL R I
Sbjct: 235 ALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDI-- 289
Query: 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDM 715
+ SN S + + PE +GILL EIFT G P ++
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 28/140 (20%)
Query: 568 ECQALRNIRHRNLVKIIT----ACSTSDFQGNYFRALVYEFMHH--GSLESCPRI----L 617
E + L++++H N++ ++ A S +F Y LV M ++ C ++ +
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHV 122
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
FL + L+Y+H I+H DLKPSN+ ++ D + DFGL R + M
Sbjct: 123 QFL-----IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 174
Query: 678 SSNQCSSVGLKGTVGYATPE 697
+ G T Y PE
Sbjct: 175 T-------GYVATRWYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 771 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.89 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.86 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.8 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.55 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.53 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.31 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.27 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.16 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.13 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.92 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.92 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.89 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.83 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.61 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.57 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.56 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.56 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.5 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.39 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.33 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.16 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.06 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.04 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-92 Score=866.84 Aligned_cols=738 Identities=30% Similarity=0.504 Sum_probs=512.3
Q ss_pred ccHHHHHHHHhcCCCCCCCCCCCCCCCCCCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCccc
Q 041479 2 PDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFS 81 (771)
Q Consensus 2 ~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 81 (771)
.|++||++||+++. +|.+.+++|+..++||.|.||+|... .+|+.|||++|++++.+++.|..+++|+.|+|++|+++
T Consensus 29 ~~~~~l~~~~~~~~-~~~~~~~~w~~~~~~c~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 29 EELELLLSFKSSIN-DPLKYLSNWNSSADVCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred HHHHHHHHHHHhCC-CCcccCCCCCCCCCCCcCcceecCCC-CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 58899999999984 67888899988889999999999864 69999999999999999999999999999999999999
Q ss_pred ccCCccc-cCCCCCCEEecccCcCcccCCcc--------cccCCcccccCCccccCCCCCCEEecccccCcCCC------
Q 041479 82 SNIPHEI-GRLFRLRHIIFNSNALQGQIPDS--------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPI------ 146 (771)
Q Consensus 82 ~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~--------~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~l------ 146 (771)
+.+|..+ .++++|++|+|++|.+++.+|.. .+..|.+++.+|..++++++|++|+|++|.+++.+
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 186 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN 186 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhh
Confidence 8888775 49999999999999998877753 25567777777877888888888888888776433
Q ss_pred -CccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEE
Q 041479 147 -PHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWL 225 (771)
Q Consensus 147 -p~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 225 (771)
++|+.|+++.|.+.+.+|..+.++++|++|+|++|++++.+|..+. .+++|++|++++|++++.+|..|.++++|+.|
T Consensus 187 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 265 (968)
T PLN00113 187 LTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265 (968)
T ss_pred CcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHh-cCCCCCEEECcCceeccccChhHhCCCCCCEE
Confidence 3467777777777777777777777777777777776666666655 66666666666666666666666666666666
Q ss_pred EccccccCCCCCcCccc---------------------ccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcC
Q 041479 226 DFANNSLTGLIPEDLDS---------------------LVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284 (771)
Q Consensus 226 ~Ls~N~l~~~~p~~~~~---------------------l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l 284 (771)
++++|++++..|..+.. +.++++|+.|++++|.+++.+|..+..++ +|+.|++++|.+
T Consensus 266 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l 344 (968)
T PLN00113 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKF 344 (968)
T ss_pred ECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCC
Confidence 66666665555544311 13445566666666666655666665554 577777777777
Q ss_pred cccCcccccccCCcceEecCCccceeccCccc------------------------cCCCCCCEEEccCCcc--------
Q 041479 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISV------------------------GYLLKLQVLSLFENNI-------- 332 (771)
Q Consensus 285 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~------------------------~~l~~L~~L~Ls~N~l-------- 332 (771)
++.+|..++.+++|+.|++++|.+.+.+|..+ ..+++|+.|++++|++
T Consensus 345 ~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~ 424 (968)
T PLN00113 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424 (968)
T ss_pred cCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhH
Confidence 77777777777777777777666654443322 2222233333333222
Q ss_pred ---------------------------------------------------------------cccCCcccccccccccc
Q 041479 333 ---------------------------------------------------------------SREIPSSLGNFTFLTEL 349 (771)
Q Consensus 333 ---------------------------------------------------------------~~~~p~~~~~l~~L~~L 349 (771)
++.+|..|..+++|+.|
T Consensus 425 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L 504 (968)
T PLN00113 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504 (968)
T ss_pred hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEE
Confidence 22333333344445555
Q ss_pred cccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcC
Q 041479 350 NLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSY 428 (771)
Q Consensus 350 ~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~ 428 (771)
+|++|++.+.+|..+..++.| .|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+. .++.|+.|++++
T Consensus 505 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----~l~~L~~l~ls~ 580 (968)
T PLN00113 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG----NVESLVQVNISH 580 (968)
T ss_pred ECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh----cCcccCEEeccC
Confidence 555555555555555555556 666666666666666666677777777777777766666554 667777888888
Q ss_pred CCCCCCCCccccccccccccccCCCcccCCCCCCCCCCCCCCccccccccccceeeehhhhhHHHHHHHHH-HHHHHhhh
Q 041479 429 NNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMS-LLIINRLR 507 (771)
Q Consensus 429 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~~~~~~~-~~~~~r~~ 507 (771)
|++.|.+|....+.++....+.||+.+|+..+....++|... .......+++++++++++++++++ +++++|+|
T Consensus 581 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (968)
T PLN00113 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655 (968)
T ss_pred CcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----cccceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence 888887887767777777788999999987654456677421 111111122222222222222222 22222222
Q ss_pred cccc-c--ccCCC-cc-------------c----ccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHH
Q 041479 508 RQRT-V--TSSES-SS-------------R----KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFM 566 (771)
Q Consensus 508 ~~~~-~--~~~~~-~~-------------~----~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~ 566 (771)
++.+ + ..... .. . ........+|+|.+|+||+|++..+++.||||++..... ...
T Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~ 731 (968)
T PLN00113 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPS 731 (968)
T ss_pred hcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccH
Confidence 2111 1 00000 00 0 011123358999999999999988888999999864332 123
Q ss_pred HHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 041479 567 AECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646 (771)
Q Consensus 567 ~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 646 (771)
.|++++++++|||||+++|+|.+.+ ..|+|||||++|+|.++.+.++|.++.+|+.|+|+|++|||+.+.++|+|
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 4688999999999999999998776 57999999999999988778999999999999999999999877789999
Q ss_pred cCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCC
Q 041479 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711 (771)
Q Consensus 647 rdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P 711 (771)
||+||+||+++.++.+++. ||.+...... ....||+.||||| |||++|||+||+.|
T Consensus 807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred CCCCHHhEEECCCCceEEE-eccccccccC--------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 9999999999999888876 6665432211 1235889999999 79999999999999
Q ss_pred CCccccCCccHHHHHHhhCCC-chhhhcCccc--------------cccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 712 TSDMFTEGLDLHNFVKMALPD-QILQVLDPLF--------------LVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------------~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
|+........+.+|+...... .....+|+.+ ...+.+||+.||++||||+||++.|+++
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 976555555677776654431 2222233322 1234589999999999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=424.46 Aligned_cols=380 Identities=31% Similarity=0.488 Sum_probs=272.5
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCccc----------c
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSR----------L 113 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------l 113 (771)
.+++.|+|++|++++.+|+.|+.+++|++|+|++|++++.+|..|+++++|++|++++|.+++.+|... +
T Consensus 188 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 267 (968)
T PLN00113 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267 (968)
T ss_pred cCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEEC
Confidence 567777777777777777777777777777777777777777777777777777777777776665432 4
Q ss_pred cCCcccccCCccccCCCCCCEEecccccCcCCC-------CccceeeecccccccccCccccCCCCCCEEecccCcCccc
Q 041479 114 ILNKLEGNIPSELGSLLKFKGLGLANNYFTGPI-------PHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGE 186 (771)
Q Consensus 114 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~l-------p~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 186 (771)
..|.+.+.+|..+.++++|+.|++++|++++.+ +.|+.|+++.|.+++..|..+.++++|+.|++++|.+++.
T Consensus 268 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 347 (968)
T PLN00113 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347 (968)
T ss_pred cCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCc
Confidence 456666666777777777777777777666433 3466666666666666666666666666666666666666
Q ss_pred CChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcc---------------------cccC
Q 041479 187 LPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLD---------------------SLVN 245 (771)
Q Consensus 187 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---------------------~l~~ 245 (771)
+|..+. .+++|+.|++++|++++.+|..+..+++|+.|++++|++++..|..+. .+.+
T Consensus 348 ~p~~l~-~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~ 426 (968)
T PLN00113 348 IPKNLG-KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426 (968)
T ss_pred CChHHh-CCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhc
Confidence 665554 566666666666666655555555555555555555555554444331 0134
Q ss_pred CCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEE
Q 041479 246 CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVL 325 (771)
Q Consensus 246 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 325 (771)
+++|+.|++++|.+++.+|..+..++ +|+.|++++|++.+.+|..+ ..++|+.|++++|.+.+.+|..+..+++|+.|
T Consensus 427 l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L 504 (968)
T PLN00113 427 LPLVYFLDISNNNLQGRINSRKWDMP-SLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504 (968)
T ss_pred CCCCCEEECcCCcccCccChhhccCC-CCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEE
Confidence 44555555555555555554444443 46666666666655555544 34677778888888888888889999999999
Q ss_pred EccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccc
Q 041479 326 SLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404 (771)
Q Consensus 326 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 404 (771)
+|++|++++.+|..+..+++|++|+|++|.+++.+|..+..++.| .|||++|++++.+|..+..+++|+.|++++|+++
T Consensus 505 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~ 584 (968)
T PLN00113 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584 (968)
T ss_pred ECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcce
Confidence 999999999999999999999999999999999999999999999 9999999999999999999999999999999999
Q ss_pred ccCCcchhhhhcccccccEEECcCCCC
Q 041479 405 GEIPSSLAWIFGYISIFAKLNLSYNNL 431 (771)
Q Consensus 405 ~~~p~~l~~~~~~l~~L~~L~Ls~N~l 431 (771)
+.+|..- .+..+....+.+|+.
T Consensus 585 ~~~p~~~-----~~~~~~~~~~~~n~~ 606 (968)
T PLN00113 585 GSLPSTG-----AFLAINASAVAGNID 606 (968)
T ss_pred eeCCCcc-----hhcccChhhhcCCcc
Confidence 9999742 233444556677764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=344.96 Aligned_cols=232 Identities=25% Similarity=0.292 Sum_probs=198.4
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+......+|+|..|+|||++++.+++.+|+|.+... +....++..+|+++++.++||+||++||+|+.... ...|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence 455667799999999999999999999999999554 34567899999999999999999999999987651 3799
Q ss_pred EEEeccCCCCCCCc---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+||||++|+|+... +++++...-+|+.+|++||.|||+. .+||||||||+|||+...|.+||||||.++.+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999998873 4589999999999999999999974 58999999999999999999999999999876543
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc---ccCCccHHHHHHhhCCCchhh-hc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM---FTEGLDLHNFVKMALPDQILQ-VL 738 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~---~~~~~~~~~~~~~~~~~~~~~-~~ 738 (771)
...+++||..||||| ||+.++|+++|+.||... +..-..+..+.....|+..++ .+
T Consensus 233 -----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred -----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence 234578999999999 799999999999999754 223334555555556666666 48
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+++++.....|+++||++|||+.++++
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999998899999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=360.97 Aligned_cols=239 Identities=35% Similarity=0.542 Sum_probs=196.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+....-+|+|++|+||+|...++ +.||||++........++|..|++++++++|||+|+|+|||.+.+. ..++||
T Consensus 77 Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~LVY 151 (361)
T KOG1187|consen 77 FSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLLVY 151 (361)
T ss_pred CchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEEEE
Confidence 33445689999999999999887 5999998865543214569999999999999999999999998762 379999
Q ss_pred EeccCCCCCCC----cc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc-c
Q 041479 603 EFMHHGSLESC----PR-ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE-V 676 (771)
Q Consensus 603 e~~~~g~L~~~----~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~-~ 676 (771)
|||++|+|+++ .. .++|..|.+||.++|+||+|||+.+.++|+||||||+|||+|+++.+||+|||+|+..+. .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 99999999776 22 789999999999999999999999888999999999999999999999999999975543 2
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccc-cCCccHHHHHHhhCCC-chhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMF-TEGLDLHNFVKMALPD-QILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 739 (771)
.. . .....||.+|+||| |||+++|++||+.|.+... .....+.+|+...... ...+++|
T Consensus 232 ~~--~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 232 TS--V--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred cc--e--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 11 1 11116999999999 7999999999998887543 2333488888666653 6778888
Q ss_pred cccc--c------------cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFL--V------------GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~--~------------~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.+. . .+.+|++.+|.+||+|.+|+++|+.+
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 8764 1 12299999999999999999999764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.28 Aligned_cols=230 Identities=31% Similarity=0.359 Sum_probs=194.2
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.+|.|.+|+||+|.++... .||||++..... ...++|.+|+.+|.+++|||||+++|+|.+... ..++|||||
T Consensus 48 ~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~iVtEy~ 122 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCIVTEYM 122 (362)
T ss_pred hcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEEEEEeC
Confidence 3899999999999998654 599999965432 226799999999999999999999999987642 368999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeeeCCCC-ceEEecccCccccCcccC
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKP-IVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 678 (771)
++|+|.++ .+.+++..+++++.|||+|+.|||+. + ||||||||+|||++.++ .+||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999776 35799999999999999999999996 5 99999999999999997 99999999998665432
Q ss_pred Ccccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.......||+.||||| |||++||++||+.||.+... .......+....++.++..+++.
T Consensus 199 ---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~ 274 (362)
T KOG0192|consen 199 ---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPH 274 (362)
T ss_pred ---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHH
Confidence 1222357999999999 79999999999999998755 33344444556666667668888
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+...+.+||..||++||++.+++..|+.+
T Consensus 275 l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 275 LSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 88888899999999999999999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=340.60 Aligned_cols=231 Identities=22% Similarity=0.236 Sum_probs=194.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccch-------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
..+..-++|+|.+|.|-+|..+.+++.||||++....- ....+..+|+++|++++|||||++++++...+
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d--- 249 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD--- 249 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC---
Confidence 34566789999999999999999999999999965421 11234579999999999999999999998887
Q ss_pred ceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEeccc
Q 041479 595 NYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND---MTAHMGDFG 668 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfG 668 (771)
+.|||||||+||+|.++ .+.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 250 --s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 --SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred --ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 67999999999999877 55677888899999999999999997 99999999999999765 789999999
Q ss_pred CccccCcccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
+|+..+.. ....+.||||.|.||| +||++|-+++|..||++.+.......++.++.+
T Consensus 325 lAK~~g~~-----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 325 LAKVSGEG-----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred hhhccccc-----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99987643 2345689999999999 699999999999999998765544566677777
Q ss_pred C--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 P--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+ +..+.-++.+-...+.+++..||++|||+.|+++
T Consensus 400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 6 3455666666666777999999999999999985
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=349.93 Aligned_cols=370 Identities=20% Similarity=0.224 Sum_probs=288.2
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCc
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPS 124 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~ 124 (771)
.+++||+++|.|+.+-+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+ ..-.+
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~--------------sv~se 143 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS--------------SVTSE 143 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc--------------cccHH
Confidence 4666888888888777777888888888888888887 47766666667888888888755 34455
Q ss_pred cccCCCCCCEEecccccCcC----CCC---ccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCC
Q 041479 125 ELGSLLKFKGLGLANNYFTG----PIP---HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPN 197 (771)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~----~lp---~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~ 197 (771)
++..++.|+.||||.|.|+. .+| +++.|+|+.|.|+......|.++.+|..|.|+.|.++ ++|...|.+|++
T Consensus 144 ~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~ 222 (873)
T KOG4194|consen 144 ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPK 222 (873)
T ss_pred HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcch
Confidence 67788888888888888873 233 3788888888888888888888888888888888888 888888867888
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhccccccee
Q 041479 198 VRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277 (771)
Q Consensus 198 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L 277 (771)
|+.|+|..|+|.-..--+|.+|++|+.|.|..|.|..+-...| ..|.++++|+|+.|+++..-..+++++. +|+.|
T Consensus 223 L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~F---y~l~kme~l~L~~N~l~~vn~g~lfgLt-~L~~L 298 (873)
T KOG4194|consen 223 LESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAF---YGLEKMEHLNLETNRLQAVNEGWLFGLT-SLEQL 298 (873)
T ss_pred hhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcce---eeecccceeecccchhhhhhcccccccc-hhhhh
Confidence 8888888888875556778888888888888888887766666 7778888888888888866666777776 68888
Q ss_pred ecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccce
Q 041479 278 YMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 278 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
+||+|.|..+-++++.-.++|+.|+|++|++....+.+|..+..|++|+|++|+++..-..+|..+++|+.|||++|.|+
T Consensus 299 ~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls 378 (873)
T KOG4194|consen 299 DLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELS 378 (873)
T ss_pred ccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEE
Confidence 88888888888888888888888888888888888888888888888888888888766778888888888888888888
Q ss_pred ecCCc---ccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCC
Q 041479 358 GSVPS---ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 358 ~~~p~---~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
..+.+ .|..++.| .|+|.+|+|..+...+|.++..|++|||.+|.|..+-|++|. .+ .|++|-+..-.+-|
T Consensus 379 ~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe----~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 379 WCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFE----PM-ELKELVMNSSSFLC 453 (873)
T ss_pred EEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccc----cc-hhhhhhhcccceEE
Confidence 76554 45556666 688888888766666788888888888888888777777654 55 66777776666656
Q ss_pred CCCccc
Q 041479 434 DVPRKM 439 (771)
Q Consensus 434 ~~p~~~ 439 (771)
++.-.|
T Consensus 454 DCql~W 459 (873)
T KOG4194|consen 454 DCQLKW 459 (873)
T ss_pred eccHHH
Confidence 655433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.72 Aligned_cols=181 Identities=30% Similarity=0.465 Sum_probs=160.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
++...-.+|.|.||+||+|+++.++..||||.+... ..+..+....|+.+++.++|||||++++++.+++ +.|
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~-----~i~ 85 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD-----FIY 85 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----eEE
Confidence 344445599999999999999999999999999776 4667788999999999999999999999999888 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC------CceEEecccCc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND------MTAHMGDFGLT 670 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~------~~~kl~DfGla 670 (771)
+|||||.||||.++ .+.+++.....++.|+|.|+++||+. +||||||||+|||++.. -.+||+|||+|
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999887 45789999999999999999999985 99999999999999764 46899999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~ 715 (771)
|.+.... ...+.||++.||||| .|+++|++++|+.||+..
T Consensus 163 R~L~~~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPGS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCchh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9887532 344578999999999 599999999999999753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=349.52 Aligned_cols=388 Identities=21% Similarity=0.212 Sum_probs=336.9
Q ss_pred cEEEEEcCCCCCcccCCccccCC--CCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccC
Q 041479 45 RVILLNLSGQNLTGTASPYIGNL--TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNI 122 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~ 122 (771)
+...||.+.+.|..+.-..+.++ +.-++||+|+|+|+.+.+..|.++++|+.+++.+|.++ .+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt---------------~I 117 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT---------------RI 117 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh---------------hc
Confidence 56778888888875422222222 22456999999999999999999999999999999987 67
Q ss_pred CccccCCCCCCEEecccccCcC-------CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCC
Q 041479 123 PSELGSLLKFKGLGLANNYFTG-------PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTL 195 (771)
Q Consensus 123 p~~~~~l~~L~~L~Ls~N~l~~-------~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l 195 (771)
|.......+|+.|+|.+|.|+. -+|.|+.+|||.|.|+......|..-.++++|+|++|.|+ .+...-|.++
T Consensus 118 P~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~l 196 (873)
T KOG4194|consen 118 PRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSL 196 (873)
T ss_pred ccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccc-cccccccccc
Confidence 7766677789999999999983 4677999999999999777778888889999999999999 8888888899
Q ss_pred CCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChh-hhhccccc
Q 041479 196 PNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNS-LANFSSHL 274 (771)
Q Consensus 196 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~~L 274 (771)
.+|..|.|++|+|+...+..|.+|++|+.|||..|+|.-.-- ..|.+|++|+.|.|..|.++ .+.++ |..+ .++
T Consensus 197 nsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~---ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l-~km 271 (873)
T KOG4194|consen 197 NSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG---LTFQGLPSLQNLKLQRNDIS-KLDDGAFYGL-EKM 271 (873)
T ss_pred chheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh---hhhcCchhhhhhhhhhcCcc-cccCcceeee-ccc
Confidence 999999999999998888999999999999999999984322 34588999999999999999 55554 4555 489
Q ss_pred ceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCc
Q 041479 275 RYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGN 354 (771)
Q Consensus 275 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 354 (771)
++|+|+.|+++..-..++.+++.|+.|++++|.+...-+.++...++|++|+|++|+|+...+..|..+..|++|+|++|
T Consensus 272 e~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~N 351 (873)
T KOG4194|consen 272 EHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHN 351 (873)
T ss_pred ceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cceecCCcccccccce-eeecccCcccCCCCc---CCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCC
Q 041479 355 SIRGSVPSALGSCHQL-WLDLSHNHLTGPIPL---AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNN 430 (771)
Q Consensus 355 ~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~ 430 (771)
+|+..-..+|..+++| .|||++|.|++.+.+ .|.++++|+.|+|.+|+|. .+|.. .|..+..|+.|||.+|.
T Consensus 352 si~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~kr---Afsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 352 SIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKR---AFSGLEALEHLDLGDNA 427 (873)
T ss_pred chHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchh---hhccCcccceecCCCCc
Confidence 9998888899999999 899999999987765 5888999999999999999 56552 46699999999999999
Q ss_pred CCCCCCccccccccccccccCCCcccC
Q 041479 431 LDGDVPRKMIFKNASAISEAGNEKLCG 457 (771)
Q Consensus 431 l~~~~p~~~~~~~~~~~~~~~n~~lc~ 457 (771)
|...-|..+.-..+..+.+.....+|+
T Consensus 428 iaSIq~nAFe~m~Lk~Lv~nSssflCD 454 (873)
T KOG4194|consen 428 IASIQPNAFEPMELKELVMNSSSFLCD 454 (873)
T ss_pred ceeecccccccchhhhhhhcccceEEe
Confidence 987777766655777777777777886
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.02 Aligned_cols=231 Identities=26% Similarity=0.361 Sum_probs=196.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..-.+|+|-||.||.|.+.... .||||.++... ...++|.+|+++|++++|+|||+++|+|..++ .+||||||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE~ 282 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTEY 282 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCC-cccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEEe
Confidence 3456899999999999998765 89999997663 34588999999999999999999999998876 57999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+.|+|.++ ...+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+||...+..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-- 357 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-- 357 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc--
Confidence 999999777 34578889999999999999999996 89999999999999999999999999999544332
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
.....+..-...|.||| |||++||++| |+.||..+. .....+.+..+.+-..++.+.+.+.
T Consensus 358 -Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--n~ev~~~le~GyRlp~P~~CP~~vY 434 (468)
T KOG0197|consen 358 -YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--NEEVLELLERGYRLPRPEGCPDEVY 434 (468)
T ss_pred -eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--HHHHHHHHhccCcCCCCCCCCHHHH
Confidence 22333444577899999 8999999999 999998753 3346677777777666777788888
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.++..||..+|++|||.+.+...|+++
T Consensus 435 ~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 435 ELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 888999999999999999999998875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.68 Aligned_cols=228 Identities=21% Similarity=0.214 Sum_probs=187.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+...--+|+|+||+||.++..++++.||+|++... +....+...+||++.+.++|||||+++++|++.+ ..|
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~-----nVY 94 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN-----NVY 94 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-----ceE
Confidence 34445589999999999999888899999999654 4567789999999999999999999999998887 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||.|+|+.|+|..+ .+.+++.++..+..||+.||.|||+. +|+|||||..|++++++..+||+|||+|..+...
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999766 56899999999999999999999996 8999999999999999999999999999877643
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.. ...+.||||.|.||| +||++|-|+.|++||+.-. -...+..+....+ ..+..++..
T Consensus 172 ~E----rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vkety~~Ik~~~Y--~~P~~ls~~ 244 (592)
T KOG0575|consen 172 GE----RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKETYNKIKLNEY--SMPSHLSAE 244 (592)
T ss_pred cc----ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHHHHHHHHhcCc--ccccccCHH
Confidence 32 234578999999999 5999999999999997521 1112223332222 223344444
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
-++.+.++|.+||++|||+++|+.
T Consensus 245 A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 245 AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 445566899999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=302.18 Aligned_cols=234 Identities=21% Similarity=0.234 Sum_probs=188.0
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|.|.||+|||++...++..||.|.+.-+ +.+..++...|+.++++++|||||+++++-...+.+ ..+|||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e---vlnivm 99 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE---VLNIVM 99 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch---hhHHHH
Confidence 344579999999999999999999999999644 356678999999999999999999999854433322 478999
Q ss_pred EeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 603 EFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKP--IVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 603 e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
|||.+|||.+. .+.+++..+++++.|++.||.++|+.. ++ |+||||||.||+++.+|.+|++|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999776 456899999999999999999999853 34 999999999999999999999999999987
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHH-HHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHN-FVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~ 737 (771)
.... ....+.+|||+||+|| +||++|||+.-..||.+- .-..+.+ +..+.+|+-..+.
T Consensus 179 ~s~~----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 179 SSKT----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred cchh----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCcHHH
Confidence 6543 2345678999999999 699999999999999653 1112222 2233333333366
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
.+..+...+..|+..||+.||+...+++.++
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 6777777777999999999999666665554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=299.61 Aligned_cols=179 Identities=21% Similarity=0.277 Sum_probs=153.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..-..+|+|++|+|||++++++|+.||||++.... +...+-.+|||+++++++|||+|.++++|.... .+++|
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-----klhLV 79 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-----KLHLV 79 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc-----eeEEE
Confidence 34566899999999999999999999999995543 334567899999999999999999999987765 78999
Q ss_pred EEeccCCCCCC---CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+|||+..-|.+ +...++.....+|..|++.|+.|+|++ +||||||||+|||++.+|.+|+||||+|+.+.....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 99998765543 355688889999999999999999987 899999999999999999999999999998774332
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
. -+..+.|.+|+||| .||++.||++|++-|.+
T Consensus 157 ~----YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 157 N----YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred h----hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 1 22457899999999 49999999999987764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.36 Aligned_cols=236 Identities=23% Similarity=0.250 Sum_probs=195.3
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
..+.....+|.|..|+||+|+....++.||||++..++- ...+.+.+|+..|+.++|||||+++..|..++ ..|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----ELW 100 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----eeE
Confidence 445667788999999999999999999999999987753 34688999999999999999999999998887 899
Q ss_pred EEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 600 LVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 600 lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
+||.||.+|++.+. ...+++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999765 44588888999999999999999997 99999999999999999999999999987766
Q ss_pred cccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC------
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP------ 731 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------ 731 (771)
..+..........+||+.||||| ||++..|+++|..||.+..+..+ +..-..+..|
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-Ll~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-LLLTLQNDPPTLLTSG 256 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-HHHHhcCCCCCccccc
Confidence 55533333326678999999999 79999999999999988655443 3333444443
Q ss_pred --CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 --DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 --~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+..++.....|+++||++|||+++++.
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 2233444445555566999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.30 Aligned_cols=234 Identities=25% Similarity=0.328 Sum_probs=192.8
Q ss_pred ccccccccccceEEEEEecC-----CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..-++|+|.||.||+|+... ..+.||||.++..... ..++|.+|+++++.++|||||+|+|+|.+++ -.
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~-----P~ 564 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD-----PL 564 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-----ee
Confidence 45679999999999998753 3468999999776544 7889999999999999999999999999988 67
Q ss_pred EEEEEeccCCCCCCC-------------ccc----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc
Q 041479 599 ALVYEFMHHGSLESC-------------PRI----LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-------------~~~----l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~ 661 (771)
|+|+|||..|||.++ ... ++..+.+.||.|||.|++||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999776 123 78889999999999999999986 8999999999999999999
Q ss_pred eEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHH
Q 041479 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNF 725 (771)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~ 725 (771)
+||+|||++|.....+.+.. .....-..+||+|| |||++||+++ |+.||.+.. ....+..+
T Consensus 642 VKIsDfGLsRdiYssDYYk~--~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKV--RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQEVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcc--cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hHHHHHHH
Confidence 99999999997654443221 11122367899999 8999999999 999997753 23223333
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.+ -..++.+...+..++..||+..|++||+++||-.+|+.+
T Consensus 719 ~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 719 RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 33433 556667777777888899999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.34 Aligned_cols=237 Identities=24% Similarity=0.283 Sum_probs=188.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+....-+|.|.+|+||.+....++...|||.+...+....+.+.+|+.+|++++|||||+++|.....+. ..++++|
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i~m 95 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNIFM 95 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEeee
Confidence 4455668999999999999998888999999977643336779999999999999999999997444331 2579999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 677 (771)
||+++|+|.++ ...+++..+.++..|+++||+|||++ +||||||||+|||++. ++.+||+|||+++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 99999999877 22689999999999999999999986 9999999999999999 799999999999876541
Q ss_pred CCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
...........||+.||||| +||++.||+||+.||.+.......+.........+.+++.+++.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 11122233567999999999 69999999999999987411111122222222223566666666
Q ss_pred ccccCcccChhchhhcCCHHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.+....+|++.||++|||+.++++.
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhC
Confidence 6677779999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=302.95 Aligned_cols=225 Identities=25% Similarity=0.226 Sum_probs=180.7
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
..++...-.+|.|++|+||.++.+++++.||+|+++... .+..+...+|..++.+++||.||+++..|.+.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~----- 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE----- 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-----
Confidence 345556667899999999999999999999999996553 345678899999999999999999999877766
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.+|+|+||+.||+|..+ .+.+++..+..++.+|+.||.|||+. +|||||+||+|||+|.+|+++++|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 89999999999999766 44789999999999999999999985 9999999999999999999999999999854
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
-... ....++|||+.||||| +||++|||++|.+||.+... ......+..... ...+..+
T Consensus 176 ~~~~----~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-~~~~~~I~~~k~-~~~p~~l 249 (357)
T KOG0598|consen 176 LKDG----DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-KKMYDKILKGKL-PLPPGYL 249 (357)
T ss_pred ccCC----CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-HHHHHHHhcCcC-CCCCccC
Confidence 3322 2233479999999999 69999999999999965311 111122222221 2233445
Q ss_pred CccccccCcccChhchhhcC
Q 041479 739 DPLFLVGGVQEGEETAEENI 758 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rp 758 (771)
++..+....+.++.||++|.
T Consensus 250 s~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 SEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CHHHHHHHHHHhccCHHHhc
Confidence 55555566688899999995
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.90 Aligned_cols=231 Identities=22% Similarity=0.244 Sum_probs=196.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|..|.||.|+...+++.||||++........+-.+.|+.+|+..+|+|||.+++.|...+ ..|+|
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWVV 348 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWVV 348 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEEE
Confidence 3444567899999999999999999999999998877666678899999999999999999999988776 78999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||||+||+|.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||+..+|.+||+|||++..+.....
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999999999887 44689999999999999999999986 999999999999999999999999999987765443
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 743 (771)
...+.+|||+||||| +|++++||+-|++||-...+.. .++-++....| -..++.+++.++
T Consensus 425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-AlyLIa~ng~P~lk~~~klS~~~k 500 (550)
T KOG0578|consen 425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPKLKNPEKLSPELK 500 (550)
T ss_pred ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-HHHHHhhcCCCCcCCccccCHHHH
Confidence 345678999999999 7999999999999995321111 13333444444 466778888888
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+...+||+.|+.+||++.|+++
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhc
Confidence 8888999999999999999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.27 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=186.3
Q ss_pred CCcccccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 516 ESSSRKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 516 ~~~~~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
...+|........+|+|+.|.||.|+++ ++.||||+++.-+ ..+|+-|++++||||+.+.|+|....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP---- 185 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP---- 185 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc----
Confidence 3445555556667899999999999987 4479999885332 24788899999999999999998776
Q ss_pred eeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 596 YFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.+|||||||..|.|... .+.+.....+.+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++.
T Consensus 186 -cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 186 -CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred -eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 78999999999999876 45677788899999999999999997 899999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
+.+. .....++||+.||||| ||||+|||+||+.||.|+-...+.+ .+-...+.-..+..
T Consensus 262 ~~~~-----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw-GVGsNsL~LpvPst 335 (904)
T KOG4721|consen 262 LSDK-----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW-GVGSNSLHLPVPST 335 (904)
T ss_pred hhhh-----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-eccCCcccccCccc
Confidence 6543 3445688999999999 8999999999999998865444322 11122222334444
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
+...++.++.+||+..|..||++++++..|+
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 5555666677999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.80 Aligned_cols=182 Identities=26% Similarity=0.311 Sum_probs=156.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.||.||||++..+++.||+|+++... ++......+||.||++++|||||+|.+...+... ..+||
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~---~siYl 195 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS---GSIYL 195 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC---ceEEE
Confidence 444556899999999999999999999999997765 5667888999999999999999999999887621 16899
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|+|||++ ||..+ .-.++..++..++.|++.||+|||+. +|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999986 66554 33689999999999999999999985 9999999999999999999999999999988765
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
... ..+..+-|.+|+||| .|||+.||++|++.+.+
T Consensus 272 ~~~---~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 272 GSA---PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred CCc---ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 432 234567899999999 39999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.56 Aligned_cols=234 Identities=23% Similarity=0.260 Sum_probs=188.4
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.-...+|+|++++||+|+.+.++++||||++... ++...+...+|-.+|.++ .||.||+|+.-|.+..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~----- 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE----- 147 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-----
Confidence 3444555689999999999999999999999999644 344456778899999999 7999999999877666
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.+|+|+||+++|+|.++ .+.+++.....++.||..||+|||+. |||||||||+|||+|+++++||+|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 78999999999999776 45788889999999999999999986 9999999999999999999999999999988
Q ss_pred CcccCC---------cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 041479 674 PEVMSS---------NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 674 ~~~~~~---------~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 729 (771)
.+.... .......++||..|.+|| |||++|.|+.|++||.+.. +...+.++....
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-eyliFqkI~~l~ 303 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EYLIFQKIQALD 303 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HHHHHHHHHHhc
Confidence 654322 111125689999999999 7999999999999997642 233455555444
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+. +++.+++....+..+.+..||++|+|+.++-+
T Consensus 304 y~--fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 304 YE--FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred cc--CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 42 23333344444555888999999999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.37 Aligned_cols=229 Identities=24% Similarity=0.242 Sum_probs=187.0
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc----ch-hhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH----QR-GALKSFMAECQALRNIR-HRNLVKIITACSTSDFQG 594 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 594 (771)
..+...-++|+|.+|+||.|.+..+++.||||++... .. ...+...+|+.++++++ ||||+++++++....
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~--- 93 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT--- 93 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC---
Confidence 3455667899999999999999999999999977553 11 23456678999999999 999999999998877
Q ss_pred ceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCc
Q 041479 595 NYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLT 670 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla 670 (771)
..|+||||+.||+|.++ ..++.+.+..+++.|++.|++|+|+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 94 --~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 --KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred --eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 68999999999999877 46788999999999999999999985 99999999999999999 99999999999
Q ss_pred cccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQ 733 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 733 (771)
..... ........+||+.|+||| +||++|.|++|+.||++... ......+..+ +..
T Consensus 169 ~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~ki~~~--~~~ 241 (370)
T KOG0583|consen 169 AISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRKIRKG--EFK 241 (370)
T ss_pred cccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHHHhcC--Ccc
Confidence 87631 122334568999999999 59999999999999987211 1112222222 234
Q ss_pred hhhhc-CccccccCcccChhchhhcCCHHHHH
Q 041479 734 ILQVL-DPLFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 734 ~~~~~-~~~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
++..+ ++.......+|+..||.+|+|+.+++
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 44555 77777777799999999999999998
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.42 Aligned_cols=361 Identities=24% Similarity=0.376 Sum_probs=302.3
Q ss_pred CcEEEEEcCCCCCcc-cCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccC
Q 041479 44 QRVILLNLSGQNLTG-TASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNI 122 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~ 122 (771)
+=|.-+|+|+|.++| ..|.....++.++.|-|...++. .+|++++.+.+|++|.+++|++. .+
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~---------------~v 70 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI---------------SV 70 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH---------------hh
Confidence 456778999999995 67889999999999999999998 59999999999999999999986 44
Q ss_pred CccccCCCCCCEEecccccCc-CCCC-------ccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhC
Q 041479 123 PSELGSLLKFKGLGLANNYFT-GPIP-------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFT 194 (771)
Q Consensus 123 p~~~~~l~~L~~L~Ls~N~l~-~~lp-------~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~ 194 (771)
-.+++.|+.|+.+.+.+|++. ..+| .|.++|||+|++. ..|..+..-.++-+|+||+|+|. +||..+|.+
T Consensus 71 hGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfin 148 (1255)
T KOG0444|consen 71 HGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFIN 148 (1255)
T ss_pred hhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHh
Confidence 556777778888888888775 2233 3677777777777 67888888889999999999998 899999989
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccc-ccCChhhhhcccc
Q 041479 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS-GTLPNSLANFSSH 273 (771)
Q Consensus 195 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~~ 273 (771)
|..|-.||||+|++. .+|+.+..|..|++|+|++|.+... .+..+..+++|++|++++.+=+ .-+|.++..+. +
T Consensus 149 LtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hf---QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~-N 223 (1255)
T KOG0444|consen 149 LTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHF---QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLH-N 223 (1255)
T ss_pred hHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHH---HHhcCccchhhhhhhcccccchhhcCCCchhhhh-h
Confidence 999999999999998 6777888999999999999988643 2344567788999999887643 25888888886 8
Q ss_pred cceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccC
Q 041479 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353 (771)
Q Consensus 274 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 353 (771)
|..+|||.|.+. ..|+.+.++.+|+.|+|++|.++ .+....+...+|++|+||.|+++ .+|.+++.+++|+.|++.+
T Consensus 224 L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~ 300 (1255)
T KOG0444|consen 224 LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANN 300 (1255)
T ss_pred hhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhcc
Confidence 999999999998 88999999999999999999985 35556667788999999999998 7899999999999999999
Q ss_pred ccce-ecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCC
Q 041479 354 NSIR-GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431 (771)
Q Consensus 354 N~l~-~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l 431 (771)
|+++ .-+|+.++.+..| .+..++|+|. ..|..+..+..|+.|.|++|++- .+|+.+- -++.|+.|||..|+=
T Consensus 301 NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIH----lL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 301 NKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIH----LLPDLKVLDLRENPN 374 (1255)
T ss_pred CcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhh----hcCCcceeeccCCcC
Confidence 9886 3478889999888 7888889887 78999999999999999999998 7888765 778899999999864
Q ss_pred CCCCC
Q 041479 432 DGDVP 436 (771)
Q Consensus 432 ~~~~p 436 (771)
--.+|
T Consensus 375 LVMPP 379 (1255)
T KOG0444|consen 375 LVMPP 379 (1255)
T ss_pred ccCCC
Confidence 33334
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.75 Aligned_cols=227 Identities=21% Similarity=0.267 Sum_probs=175.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHH-HHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALK-SFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~-~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.||.||+|+...+++.||||+++..-....+ .=+||+..+++++ |||||++.+++.+.+. .+|+||||
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~----~L~fVfE~ 91 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR----ILYFVFEF 91 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc----eEeeeHHh
Confidence 4589999999999999999999999999765433322 2368999999999 9999999999877652 68999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+. +|.+. .+.+++..+..|+.||++||+|+|.+ |++|||+||+|||+.....+||+|||+||.+.....
T Consensus 92 Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP-- 165 (538)
T KOG0661|consen 92 MDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP-- 165 (538)
T ss_pred hhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCC--
Confidence 975 77655 56799999999999999999999986 999999999999999888999999999997655433
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCcc--------------------ccCCccHHH
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDM--------------------FTEGLDLHN 724 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~--------------------~~~~~~~~~ 724 (771)
-+..+.|++|+||| +||+++|+.+-++-|.+. |..+..++.
T Consensus 166 ---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 166 ---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred ---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 23467899999999 599999999988866542 222222222
Q ss_pred HHHhhCC----CchhhhcCc---cccccCcccChhchhhcCCHHHHHHH
Q 041479 725 FVKMALP----DQILQVLDP---LFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 725 ~~~~~~~----~~~~~~~~~---~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
...-.+| ..+.+.+.. +....+.+|+.+||++|||+.++++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 2222222 122222222 12233449999999999999998863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=277.21 Aligned_cols=229 Identities=24% Similarity=0.285 Sum_probs=176.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|++..+++.||||+++.++. +......|||+.++.++||||+.++++|...+ ..-+|+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l~lVf 80 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NLSLVF 80 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ceEEEE
Confidence 34568999999999999999999999999987753 33567899999999999999999999987766 578999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||+. +|+.. ...++..++..++.++.+|++|||+. .|+|||+||.|+|++++|.+||+|||+|+.+.....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99975 77655 44688999999999999999999986 899999999999999999999999999998876544
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCc--------------------cccCCccH
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD--------------------MFTEGLDL 722 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~--------------------~~~~~~~~ 722 (771)
...+ .+-|.+|+||| .||++.||+-|.+-|.+ .|++-..+
T Consensus 157 ~~~~----~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTH----QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cccc----ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 3222 26799999999 39999999999764432 23332333
Q ss_pred HHHHHhh-CCCchhh-hc---CccccccCcccChhchhhcCCHHHHHHH
Q 041479 723 HNFVKMA-LPDQILQ-VL---DPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 723 ~~~~~~~-~~~~~~~-~~---~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.++++-. +|..... .+ .....+...+++..||.+|+|+.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 3333222 2211111 11 1111133448999999999999999853
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.79 Aligned_cols=222 Identities=23% Similarity=0.206 Sum_probs=184.3
Q ss_pred cccccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 518 SSRKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 518 ~~~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
...+++...-++|.|+||+|..++.+.++..||+|++...+ .++.+....|..+++.+.||.+|++++.+.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--- 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--- 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC---
Confidence 44567788889999999999999999999999999997664 456677889999999999999999999988877
Q ss_pred ceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 595 NYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
..||||||++||.|..+ .+++++..+..++.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||.|+
T Consensus 118 --~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 118 --NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred --eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceE
Confidence 78999999999999877 45799999999999999999999985 99999999999999999999999999999
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
.+... ..+.||||-|+||| |||++|||+.|.+||.+.... ....+++.+.+. .+.
T Consensus 193 ~v~~r-------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-~iY~KI~~~~v~--fP~ 262 (355)
T KOG0616|consen 193 RVSGR-------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-QIYEKILEGKVK--FPS 262 (355)
T ss_pred EecCc-------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-HHHHHHHhCccc--CCc
Confidence 76543 23468999999999 799999999999999764332 224445555443 334
Q ss_pred hcCccccccCcccChhchhhc
Q 041479 737 VLDPLFLVGGVQEGEETAEEN 757 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~R 757 (771)
.+++..+....+.++.|-++|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 445555444456667777777
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.05 Aligned_cols=236 Identities=25% Similarity=0.279 Sum_probs=185.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--------------hhhHHHHHHHHHHHhccCCCCceeEEEEee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------------RGALKSFMAECQALRNIRHRNLVKIITACS 588 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 588 (771)
+.....+|.|.+|.|-+|+...+++.||||++.... ....++..+||.+|++++|||||+|+++-.
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 445567899999999999999999999999995432 112368899999999999999999999976
Q ss_pred cCCCCCceeEEEEEEeccCCCCCCC--ccc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 041479 589 TSDFQGNYFRALVYEFMHHGSLESC--PRI-LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665 (771)
Q Consensus 589 ~~~~~~~~~~~lv~e~~~~g~L~~~--~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 665 (771)
+.... ..|||+|||..|.+... .+. ++..++.+|+.++..||+|||.| +||||||||+|+|++++|.+||+
T Consensus 179 DP~s~---~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 179 DPESD---KLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred CcccC---ceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence 65433 78999999999999766 334 88999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCcccCC-cccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHH
Q 041479 666 DFGLTRFIPEVMSS-NQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNF 725 (771)
Q Consensus 666 DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 725 (771)
|||.+......... ........+|||.||||| +||++|-++.|+.||-+.+-.. .+.++
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-l~~KI 331 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-LFDKI 331 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-HHHHH
Confidence 99999865333111 111122357999999999 5999999999999997642211 13333
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+...+..+....+.+..+.+..++|.+||.+|.++.+|..
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 3333333333344555666677999999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.21 Aligned_cols=237 Identities=22% Similarity=0.261 Sum_probs=182.0
Q ss_pred ccccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCcee
Q 041479 525 LNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..-.+|+|++|+||+|.+. .+++.||||++.... ....+.+.+|+.++..+ +|||||+++++|...+. .
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~----~ 86 (338)
T cd05102 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG----P 86 (338)
T ss_pred eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC----c
Confidence 3455899999999999752 334589999996543 33456799999999999 89999999999865431 5
Q ss_pred EEEEEEeccCCCCCCCc---------------------------------------------------------------
Q 041479 598 RALVYEFMHHGSLESCP--------------------------------------------------------------- 614 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~--------------------------------------------------------------- 614 (771)
.++||||+++|+|.++.
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999985431
Q ss_pred --ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccccccccccc
Q 041479 615 --RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG 692 (771)
Q Consensus 615 --~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~ 692 (771)
..+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ........+++.
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~~ 241 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPLK 241 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCCCCCcc
Confidence 2367778899999999999999985 999999999999999999999999999986533221 111122346788
Q ss_pred ccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhh
Q 041479 693 YATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEE 756 (771)
Q Consensus 693 y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~ 756 (771)
||||| |||++|||++ |..||.+.... ..+............+..+++.+...+.+||+.||++
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 99999 6999999997 99999764222 1222333322233334455666667778999999999
Q ss_pred cCCHHHHHHHHHHhC
Q 041479 757 NIKKGQIRESLIAIL 771 (771)
Q Consensus 757 Rpt~~~vl~~L~~~l 771 (771)
|||+.|+++.|++++
T Consensus 321 RPs~~el~~~l~~~~ 335 (338)
T cd05102 321 RPTFSALVEILGDLL 335 (338)
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=308.20 Aligned_cols=235 Identities=26% Similarity=0.346 Sum_probs=187.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.......+|+|.||+||+|+|- | .||||++.... ....+.|..|+.++++-||.||+=+.|||.... . .
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-----~-A 463 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-----L-A 463 (678)
T ss_pred Hhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----e-e
Confidence 3445567899999999999995 4 69999997664 456789999999999999999999999998876 3 8
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||..+|+|.+|+.+ ...++..+...|+.|||+|+.|||. ++|||||||..||++.++++|||+|||++..-..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999999999877 4468888999999999999999998 4999999999999999999999999999864321
Q ss_pred ccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC---ch
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD---QI 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---~~ 734 (771)
.. .........|..-||||| ||+|+|||+||..||... ..+..+...-+++... ..
T Consensus 541 w~--g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 541 WS--GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred ec--cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEecccccCccchhh
Confidence 10 011122345888999999 799999999999999843 3333344444443332 22
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.......++.+...||..++++||...+++..|++++
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 3333345666677999999999999999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=303.36 Aligned_cols=221 Identities=26% Similarity=0.324 Sum_probs=182.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||||+-+.+.+.||+|.+.... ++..+...+|++++++++|||||.+++.|++.. +.|+|.||
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-----~~~vVte~ 82 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-----HLWVVTEY 82 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-----eEEEEehh
Confidence 45799999999999999999999999996543 456788999999999999999999999988876 88999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|.| +|..+ .+.+++..+..++.++..||.|||+. +|+|||+||.|||++..+.+|+||||+|+.+... .
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~----t 154 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN----T 154 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC----c
Confidence 977 98766 45799999999999999999999996 9999999999999999999999999999976653 3
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPLFLV 744 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 744 (771)
...+...|||.||||| +||++||+++|++||... .+.+.++.-.. ...+...++.+..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVKPPSTASSSFVN 229 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCCCcccccHHHHH
Confidence 3345567999999999 599999999999999531 23444433332 2223344555555
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+.+||.+|.|-.+++.
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHhhcChhhcccHHHHhc
Confidence 555778999999999877763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.33 Aligned_cols=226 Identities=27% Similarity=0.417 Sum_probs=141.3
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc---------ccc
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS---------RLI 114 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---------~l~ 114 (771)
..+++|++++|+++ ..|++++.+..++.|+.|+|+++ .+|.+++++.+|..|+.++|.+....++. ...
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhcc
Confidence 45777888888887 67778888888888888888887 57888888888888888888876322221 122
Q ss_pred CCcccccCCccccCCCCCCEEecccccCcCCCCc------cceeeecccccccccCccccCCCCCCEEecccCcCcccCC
Q 041479 115 LNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELP 188 (771)
Q Consensus 115 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~------L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 188 (771)
.|+++ ..|+.+.++.+|..|++.+|+++...|. |+.+|...|-+. .+|..++.+.+|+.|+|..|+|. .+|
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 33443 4566666666666666666666644432 555555555544 55666666666666666666665 565
Q ss_pred hhhhhCCCCCcEEEeecCcccccCCcccc-CCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhh
Q 041479 189 PHIGFTLPNVRILLLAGNQFFGNIPHSIS-NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSL 267 (771)
Q Consensus 189 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 267 (771)
++. ++..|..|+++.|+|. .+|.... ++++|.+|||..|+++.. |+.+ .-+.+|+.||+|+|.|+ .+|.++
T Consensus 223 -ef~-gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~-Pde~---clLrsL~rLDlSNN~is-~Lp~sL 294 (565)
T KOG0472|consen 223 -EFP-GCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEV-PDEI---CLLRSLERLDLSNNDIS-SLPYSL 294 (565)
T ss_pred -CCC-ccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccC-chHH---HHhhhhhhhcccCCccc-cCCccc
Confidence 333 5556666666666665 3444433 666666666666666633 3333 45566666666666666 566666
Q ss_pred hhcccccceeecccCcC
Q 041479 268 ANFSSHLRYLYMSANPI 284 (771)
Q Consensus 268 ~~l~~~L~~L~Ls~N~l 284 (771)
+++ +|+.|-+-+|.+
T Consensus 295 gnl--hL~~L~leGNPl 309 (565)
T KOG0472|consen 295 GNL--HLKFLALEGNPL 309 (565)
T ss_pred ccc--eeeehhhcCCch
Confidence 665 355555555554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.17 Aligned_cols=234 Identities=26% Similarity=0.355 Sum_probs=188.9
Q ss_pred ccccccccccccceEEEEEecCCCe---E-EEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQT---F-IAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~---~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
......+|+|.||.||+|+++..+. . ||||..... .....++|++|+++|++++|||||+++|++....
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~---- 234 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE---- 234 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----
Confidence 3344789999999999999987532 3 899999752 3567889999999999999999999999998876
Q ss_pred eeEEEEEEeccCCCCCCCc----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 596 YFRALVYEFMHHGSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
.+|+|||+|+||+|.++. ..++..++..++.++|+||+|||+. +++||||.++|+|++.++.+||+|||+++
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 579999999999998882 2488999999999999999999985 89999999999999999999999999988
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHH-HhhCCCch
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFV-KMALPDQI 734 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~-~~~~~~~~ 734 (771)
.-.... .. .....-...|+||| |||++||+++ |..||.+... .....++ ...++-..
T Consensus 311 ~~~~~~---~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 311 AGSQYV---MK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKIVKNGYRMPI 384 (474)
T ss_pred CCccee---ec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHHHhcCccCCC
Confidence 543111 10 10112467899999 7999999999 8999987532 2344444 55665555
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+......+...+.+||..+|++||||.++.+.++.+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 555455555666799999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=277.89 Aligned_cols=245 Identities=17% Similarity=0.178 Sum_probs=200.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+..+|+|+++.||.++.-.+++.||+|++.....++.+..++|++..++++||||+++++++..+...+....|++++|.
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 44589999999999998888899999999888878889999999999999999999999998776666677899999999
Q ss_pred cCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 606 HHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
..|+|.+. +..+++.+.+.|+.++++||++||+. .++.+||||||.|||+.+.+.+++.|||.+....-...
T Consensus 106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~ 184 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE 184 (302)
T ss_pred ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence 99998665 34689999999999999999999997 45799999999999999999999999999886543221
Q ss_pred C-----cccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHH-hhCCCch
Q 041479 679 S-----NQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK-MALPDQI 734 (771)
Q Consensus 679 ~-----~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~-~~~~~~~ 734 (771)
. ..........|..|+||| +||++|+|+.|..||+.++..|..+.-.+. +.+..+-
T Consensus 185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~ 264 (302)
T KOG2345|consen 185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN 264 (302)
T ss_pred chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC
Confidence 1 111223445789999999 699999999999999877766554432222 2332222
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
....+..+......|++.||.+||++.+++..+++++
T Consensus 265 ~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 265 SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 3336666667777999999999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.35 Aligned_cols=231 Identities=18% Similarity=0.170 Sum_probs=182.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch---hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR---GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+++|.++.||+|.+ +++.||||++..... ...+.|.+|++++++++|||||+++|++.+.. .+....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5678999999999988 466999999965432 22578889999999999999999999987621 11125789999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ .+.+++....+++.+++.|++|+|+. .+++||||||+||++++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999876 34688999999999999999999973 278899999999999999999999999998654321
Q ss_pred ccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 681 QCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
....|++.|+||| |||++|||++|+.||.+..... ....+.....+...+...++.+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcCCCCCCCCcCcHHHH
Confidence 1235889999999 6999999999999997642211 12222223333333334566676
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.+||+.||++|||+.|+++.|+++
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 777899999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.91 Aligned_cols=230 Identities=19% Similarity=0.191 Sum_probs=190.8
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.+.|....++|.|..|.|..|++..+|+.+|||++.... ......+.+||.+|+-+.||||++++++|++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~----- 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ----- 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-----
Confidence 456777889999999999999999999999999996552 233567889999999999999999999998876
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
++|+|.||+++|.|+++ .+.+++.++.+++.||..|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|...
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence 88999999999999988 56799999999999999999999996 8999999999999999999999999999864
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
.+.. -..+.||+|.|.||| .|||+|.++||+.||+|-.- ...+.++..+. .+.+..
T Consensus 163 ~~gk-----lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-r~LLlKV~~G~--f~MPs~ 234 (786)
T KOG0588|consen 163 VPGK-----LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-RVLLLKVQRGV--FEMPSN 234 (786)
T ss_pred cCCc-----cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-HHHHHHHHcCc--ccCCCc
Confidence 4322 223468999999999 49999999999999986211 11122222222 344566
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.++..++..+|+..||++|.|+.||.+
T Consensus 235 Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 235 ISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhh
Confidence 6666666666999999999999999985
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=278.94 Aligned_cols=183 Identities=25% Similarity=0.299 Sum_probs=155.7
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+.....+++|.+|.||+|+++.+++.||+|+++... .+..-..+|||.++.+++|||||.+..+....+.. .+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d---~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD---KI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc---ee
Confidence 34555667899999999999999999999999997765 34455678999999999999999999998776644 57
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||||||++ ||... .+++...++..++.|+++|++|||.. .|+|||+|++|+|+.+.|.+||+|||+||.++
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999999986 66544 56788999999999999999999986 89999999999999999999999999999876
Q ss_pred cccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
.... ..+..+-|.+|+||| +|||+.|++++++-|.+
T Consensus 229 sp~k----~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 229 SPLK----PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred CCcc----cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 5432 223456799999999 59999999999886643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=298.56 Aligned_cols=225 Identities=20% Similarity=0.273 Sum_probs=190.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.-+|.|.||.||||.+..+++.||+|++.... +...++..+|+.++.+++|+||.++||.|..+. .++++||||
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~LwiiMey~ 93 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLWIIMEYC 93 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHHHHHHHh
Confidence 45799999999999999999999999998764 456789999999999999999999999998877 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
.||++.+. ...+++.++.-|..++..|+.|+|++ +.+|||||+.||++..+|.+|++|||++..+.....
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~---- 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK---- 166 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh----
Confidence 99998776 33347777888899999999999997 899999999999999999999999999987654332
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCc
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGV 747 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (771)
...+++||++||||| +|++.+||++|.+|+.+..+... + .......|+.....+++.+++.+.
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-l-flIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-L-FLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-E-EeccCCCCCccccccCHHHHHHHH
Confidence 235689999999999 69999999999999998776432 1 112223344455567777888888
Q ss_pred ccChhchhhcCCHHHHHH
Q 041479 748 QEGEETAEENIKKGQIRE 765 (771)
Q Consensus 748 ~cl~~~p~~Rpt~~~vl~ 765 (771)
.|+.+||+.||++.++++
T Consensus 245 ~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHhhcCcccCcCHHHHhh
Confidence 999999999999999985
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=322.18 Aligned_cols=233 Identities=27% Similarity=0.305 Sum_probs=187.2
Q ss_pred cccccccccceEEEEEecCCC-----eEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLDQ-----TFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~-----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.-.+|.|.||.||+|+..+-. ..||||.+... +.+...+|++|+.+|++++|||||+++|+|.+.. ..+
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-----~~~ 771 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-----PPL 771 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-----CcE
Confidence 456899999999999987643 34999999654 4567789999999999999999999999999866 579
Q ss_pred EEEEeccCCCCCCC----------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 600 LVYEFMHHGSLESC----------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 600 lv~e~~~~g~L~~~----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
|++|||++|||..+ ...+...+.+.++.|||+|+.||+++ ++|||||.++|+|++.+..+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999776 23477888999999999999999986 899999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCc
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQ 733 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 733 (771)
|+.+.....+..... ..-...||||| |||++||++| |..||.+.....+ +..+..+. +-+
T Consensus 849 ArDiy~~~yyr~~~~--a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGE--AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVLEGG-RLD 924 (1025)
T ss_pred hHhhhhchheeccCc--cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHHhCC-ccC
Confidence 995544332222111 12346899999 8999999999 9999987643332 33344444 433
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+..+...+..++..||+.+|++||+++++++++..+
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 3444444555778899999999999999999988876
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=303.89 Aligned_cols=237 Identities=22% Similarity=0.244 Sum_probs=184.7
Q ss_pred cccccccccccceEEEEEe-----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 524 LLNVSYESLVKATVYKGIL-----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.....+|+|++|+||+|++ .+++..||||+++... ....+.+.+|+++++.+ +|||||+++++|.+.+
T Consensus 38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~----- 112 (375)
T cd05104 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG----- 112 (375)
T ss_pred ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-----
Confidence 3345689999999999974 3456689999996432 33456889999999999 8999999999998776
Q ss_pred eEEEEEEeccCCCCCCCc--------------------------------------------------------------
Q 041479 597 FRALVYEFMHHGSLESCP-------------------------------------------------------------- 614 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~-------------------------------------------------------------- 614 (771)
..++|||||++|+|.++.
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 679999999999985431
Q ss_pred ----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 615 ----------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 615 ----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 1367888899999999999999985 999999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. .......++..|+||| |||++|||++ |..||.+.... ..+.++.........+...+..+
T Consensus 270 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 346 (375)
T cd05104 270 Y--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYRMLSPECAPSEM 346 (375)
T ss_pred c--cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCccCCCCCCCCHHH
Confidence 1 1111233567899999 6999999998 88898764322 23444444444333344455666
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..++.+||+.||++|||+.|+++.|++.|
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~~~~ 375 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIEQQL 375 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence 67778999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.74 Aligned_cols=340 Identities=26% Similarity=0.367 Sum_probs=295.4
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++-|.|...+|. .+|++++.|.+|++|.+++|++.+ +-++++.|+.|+.+++..|++. ..-+|
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~N~LK-------------nsGiP 96 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVRDNNLK-------------NSGIP 96 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhhccccc-------------cCCCC
Confidence 57788888888887 788999999999999999999985 6778999999999999999975 23478
Q ss_pred ccccCCCCCCEEecccccCcCCCC------ccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCC
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIP------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPN 197 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp------~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~ 197 (771)
..+..|..|..||||+|++++... ++.+|+||+|+|..+...-|.+|+.|-+||||+|++. .+|+.+- .|.+
T Consensus 97 ~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~R-RL~~ 174 (1255)
T KOG0444|consen 97 TDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIR-RLSM 174 (1255)
T ss_pred chhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHH-HHhh
Confidence 888899999999999999985333 3678999999998655566789999999999999999 9999997 8999
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccccccC-CCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccce
Q 041479 198 VRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLT-GLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRY 276 (771)
Q Consensus 198 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~ 276 (771)
|++|+|++|.+.-..-..+..+++|++|.+++.+=+ ..+|.++ ..+.+|..+|+|.|.+. .+|+.+..+. +|+.
T Consensus 175 LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl---d~l~NL~dvDlS~N~Lp-~vPecly~l~-~Lrr 249 (1255)
T KOG0444|consen 175 LQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL---DDLHNLRDVDLSENNLP-IVPECLYKLR-NLRR 249 (1255)
T ss_pred hhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch---hhhhhhhhccccccCCC-cchHHHhhhh-hhhe
Confidence 999999999987555556777889999999987644 2356555 66788999999999999 9999999987 7999
Q ss_pred eecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccc-cCCcccccccccccccccCcc
Q 041479 277 LYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISR-EIPSSLGNFTFLTELNLCGNS 355 (771)
Q Consensus 277 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~ 355 (771)
|+||+|+|+ .+.-..+...+|+.|+|+.|.+ ..+|.++..+++|+.|++.+|+++- -+|..++.+..|+.+..++|.
T Consensus 250 LNLS~N~it-eL~~~~~~W~~lEtLNlSrNQL-t~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 250 LNLSGNKIT-ELNMTEGEWENLETLNLSRNQL-TVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNK 327 (1255)
T ss_pred eccCcCcee-eeeccHHHHhhhhhhccccchh-ccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence 999999999 5666777889999999999999 5789999999999999999999872 379999999999999999999
Q ss_pred ceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCc
Q 041479 356 IRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPS 409 (771)
Q Consensus 356 l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 409 (771)
+. ..|..+..|..| .|.|++|+|. .+|+++.-++.|+.|||..|.=--.+|.
T Consensus 328 LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 328 LE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred cc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 98 899999999999 8999999998 7899999999999999999976534443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=303.71 Aligned_cols=238 Identities=24% Similarity=0.288 Sum_probs=185.9
Q ss_pred ccccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
+...-.+|+|.+|.||+|++.. +.+.||||++.... ....+.+.+|+++++.+ +|||||+++++|.+.+
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~---- 115 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG---- 115 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC----
Confidence 4445668999999999998643 23579999996543 34456789999999999 8999999999988776
Q ss_pred eeEEEEEEeccCCCCCCCc-------------------------------------------------------------
Q 041479 596 YFRALVYEFMHHGSLESCP------------------------------------------------------------- 614 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~------------------------------------------------------------- 614 (771)
..++|||||++|+|.++.
T Consensus 116 -~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 116 -PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred -CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 679999999999985431
Q ss_pred ------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 615 ------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 615 ------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
..+++.++.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--~~ 269 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YV 269 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--ee
Confidence 1367788899999999999999985 999999999999999999999999999976533221 11
Q ss_pred ccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......+++.||||| |||++|||++ |+.||.+..... .+........+...+..+++.+...+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCCCCCHHHHHHH
Confidence 111223567899999 6999999998 999997643322 23344444444444445566777777
Q ss_pred cccChhchhhcCCHHHHHHHHHHhC
Q 041479 747 VQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+||+.||++|||+.++++.|++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 7999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=306.53 Aligned_cols=234 Identities=22% Similarity=0.335 Sum_probs=193.7
Q ss_pred ccccccccceEEEEEecCCC---eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQ---TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|.|.||.||+|+++..+ ..||||.++.+. ++++.+|+.|+.||.++.||||++|.|+..... ..+||.
T Consensus 635 ~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-----PvMIiT 709 (996)
T KOG0196|consen 635 KVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-----PVMIIT 709 (996)
T ss_pred EEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----eeEEEh
Confidence 45799999999999998755 589999998775 567789999999999999999999999987766 678999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||++|+|+.+ ...+.+.+.+.+.++||.|+.||-++ +.|||||.++|||++.+-.+||+|||++|.+.+..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999888 23588889999999999999999986 99999999999999999999999999999875544
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
...+...+..=..+|.||| |||++||.++ |+.||-|+.. .+..+-+...++-+.+--+...+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHHHHHHhccCCCCCCCCcHHH
Confidence 2233333333467899999 8999999999 9999977633 33444455555433333344556
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+++..||++|-++||+..+++..|+++|
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 67888999999999999999999999975
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=290.64 Aligned_cols=231 Identities=20% Similarity=0.220 Sum_probs=185.7
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.||.|..+.... ...||||.++.... ..+.+|.+||++|.+++|||||+++|+|..++ .+++|+|||
T Consensus 544 ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----PicmI~EYm 617 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCMITEYM 617 (807)
T ss_pred hhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHHHHHHH
Confidence 468999999999998865 46999999987653 45689999999999999999999999999887 679999999
Q ss_pred cCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 606 HHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 606 ~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++|+|.++. ....-...++|+.|||.|++||.+. ++||||+.+.|+|+|.++++||+|||++|-+.....+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999998871 1234556788999999999999985 99999999999999999999999999999665444321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh--CCCCCCccccCCccHHHHHHhhCC-------Cchhh
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT--GKRPTSDMFTEGLDLHNFVKMALP-------DQILQ 736 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t--g~~P~~~~~~~~~~~~~~~~~~~~-------~~~~~ 736 (771)
. ....+-..+||||| ||+++||+++ .+.||++...+. ..+-....++ ...+.
T Consensus 695 v--qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 695 V--QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred e--ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcceeccCCC
Confidence 1 11234567999999 8999999988 889998764432 3444444333 22344
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
++...+.+.+.+||..|..+||+.+++...|++.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 5555555677799999999999999999988863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.24 Aligned_cols=391 Identities=27% Similarity=0.387 Sum_probs=272.0
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCccc----------cc
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSR----------LI 114 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------l~ 114 (771)
-+..|++++|.++ .+.+.+.++..|.+|++++|+++ ..|.+++.+..++.|+.++|+++ .+|+.+ ..
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 4677999999999 66677899999999999999999 58999999999999999999987 344332 33
Q ss_pred CCcccccCCccccCCCCCCEEecccccCcCCCC------ccceeeecccccccccCccccCCCCCCEEecccCcCcccCC
Q 041479 115 LNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP------HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELP 188 (771)
Q Consensus 115 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp------~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 188 (771)
.|.+. .+|+.++.+..|+.|+..+|+++...+ .+..+++.+|+++...|..+. ++.|+.||...|.++ ++|
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP 199 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP 199 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence 34443 456666666677777777777663222 256667777777754444333 777777787777776 788
Q ss_pred hhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhh
Q 041479 189 PHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268 (771)
Q Consensus 189 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 268 (771)
+.++ .+.+|..|||.+|+|. ..| .|.+++.|++|+++.|+|..+ |... +.++++|.+|||..|+++ .+|+.+.
T Consensus 200 ~~lg-~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~l-pae~--~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 200 PELG-GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEML-PAEH--LKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred hhhc-chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhh-HHHH--hcccccceeeeccccccc-cCchHHH
Confidence 8777 7778888888888887 555 777888888888888887744 4322 367888999999999998 8888887
Q ss_pred hcccccceeecccCcCcccCcccccccCCcceEecCCccceecc------------------------------------
Q 041479 269 NFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI------------------------------------ 312 (771)
Q Consensus 269 ~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~------------------------------------ 312 (771)
-+. +|++||+|+|.|+ .+|.+++++ .|+.|-+.+|.+.+.-
T Consensus 273 lLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t 349 (565)
T KOG0472|consen 273 LLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMT 349 (565)
T ss_pred Hhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCC
Confidence 775 7999999999998 678888988 8888888888652110
Q ss_pred --Ccccc---CCCC--------------------------CCEEEccCCcccccCCccccccccccc-ccccCccceecC
Q 041479 313 --PISVG---YLLK--------------------------LQVLSLFENNISREIPSSLGNFTFLTE-LNLCGNSIRGSV 360 (771)
Q Consensus 313 --p~~~~---~l~~--------------------------L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~ 360 (771)
+..|. .+.+ .+..+++.|++. .+|..+..++.+.+ +.+++|.+. -+
T Consensus 350 ~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv 427 (565)
T KOG0472|consen 350 LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FV 427 (565)
T ss_pred CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cc
Confidence 00000 0111 344556666665 45555555544433 333334333 56
Q ss_pred Ccccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhh--------------------hcccc
Q 041479 361 PSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWI--------------------FGYIS 419 (771)
Q Consensus 361 p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~--------------------~~~l~ 419 (771)
|..+..++.+ .|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|...... ..++.
T Consensus 428 ~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~ 505 (565)
T KOG0472|consen 428 PLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMR 505 (565)
T ss_pred hHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhh
Confidence 6666667777 6777777776 56777777777777777777665 555432210 23678
Q ss_pred cccEEECcCCCCCCCCCccccccccccccccCCCcc
Q 041479 420 IFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKL 455 (771)
Q Consensus 420 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l 455 (771)
+|..|||.+|.+...+|......++..+.+.|||+.
T Consensus 506 nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 506 NLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 888888888888855554445677777888888765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.42 Aligned_cols=219 Identities=22% Similarity=0.230 Sum_probs=176.3
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|+|.+|+||+|++..+++.||+|++... .......+.+|+.++++++|||||++++++.+.+ ..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence 58999999999999998889999999653 2344567889999999999999999999987766 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 148 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---- 148 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC----
Confidence 99999765 34688999999999999999999985 899999999999999999999999999985432211
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCchhhhcCcccccc
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQILQVLDPLFLVG 745 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 745 (771)
.....+||+.|+||| +||++|||++|+.||.+.. ..+..... .+...+..+++.+...
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l 223 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPLRFPDGFDRDAKDL 223 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 123456999999999 6999999999999996532 11222211 1233445566666677
Q ss_pred CcccChhchhhcCC---HHHHH
Q 041479 746 GVQEGEETAEENIK---KGQIR 764 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt---~~~vl 764 (771)
..+||..||++||+ +.+++
T Consensus 224 i~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 224 LIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHcCCCHHHcCCCCCHHHHH
Confidence 77999999999985 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.35 Aligned_cols=223 Identities=23% Similarity=0.255 Sum_probs=178.1
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+++.+.+++.||||++.... ......+.+|++++++++||||+++++++.+.+ ..|+||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e~ 76 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVMEY 76 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEeC
Confidence 3789999999999999999999999997542 334567889999999999999999999988776 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 149 (323)
T cd05571 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---- 149 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----
Confidence 999999665 34688999999999999999999986 99999999999999999999999999987532211
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......+||+.|+||| +||++|||++|+.||.+... ....+..... ....+..+++.+....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~~~~~-~~~~p~~~~~~~~~li 226 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILME-EIRFPRTLSPEAKSLL 226 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHHHHHcC-CCCCCCCCCHHHHHHH
Confidence 1122356999999999 69999999999999964211 1122221111 1223344566666677
Q ss_pred cccChhchhhcC-----CHHHHHH
Q 041479 747 VQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+||+.||++|| ++.++++
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 227 AGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHccCCHHHcCCCCCCCHHHHHc
Confidence 799999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=284.92 Aligned_cols=233 Identities=21% Similarity=0.258 Sum_probs=182.9
Q ss_pred cccccccccceEEEEEec---CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.-.+|+|.+|.||+|.++ ..+..||+|.++... ....+.|.+|+.++++++||||+++++++...+ ..++|
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 84 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN-----TMMIV 84 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-----CcEEE
Confidence 345899999999999875 345689999997543 334568999999999999999999999987765 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999766 23578999999999999999999985 89999999999999999999999999876432211
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
........++..|+||| |||++||+++ |+.||.+... ....+......+...+..++..
T Consensus 162 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05064 162 ---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--QDVIKAVEDGFRLPAPRNCPNL 236 (266)
T ss_pred ---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCCCCCCCCCCHH
Confidence 11111234567899999 6999999876 9999975422 2233333333332334445555
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+.....+||+.+|++|||+.++.+.|.+++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~~ 266 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSILSKMV 266 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence 666777999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.17 Aligned_cols=229 Identities=20% Similarity=0.296 Sum_probs=194.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc----chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH----QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|.|.+-|||||.+..+|..||.-.++.. .+...++|..|+.+|+.|+|||||+++.+|.+... ...-+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~i 121 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINFI 121 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceeeee
Confidence 45689999999999999999989997666433 34567899999999999999999999999988763 257899
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 677 (771)
.|.|..|+|.++ .++++......+++||++||.|||++ .|+|+|||||.+||+|.. .|.+||+|.|+|..+....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999888 45688889999999999999999997 689999999999999974 6899999999998765433
Q ss_pred CCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
. ...+|||-||||| ||++++||+|+..||++.........+...+.-|..+..+-||.++
T Consensus 201 a------ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 201 A------KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred c------ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 2 2367999999999 7999999999999998864444433344444456778888899999
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.++.+|+.. .++|||+.|++.
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhh
Confidence 999999999 999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=285.75 Aligned_cols=225 Identities=23% Similarity=0.238 Sum_probs=177.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
-.+|+|.+|+||+|.+..+++.||||.+.... ......+.+|++++++++|+||+++++++.+.+ ..++|||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~~lv~e 80 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----ALCLVLT 80 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eEEEEEE
Confidence 35799999999999999888999999986542 233456889999999999999999999987766 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999654 23578899999999999999999985 999999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHH--hhCCCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--MALPDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 741 (771)
.....||+.||||| +||++|||++|+.||....... ....... ...+......+++.
T Consensus 158 -----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 231 (285)
T cd05631 158 -----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKEDQEEYSEKFSED 231 (285)
T ss_pred -----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhhcccccCCccCCHH
Confidence 12346899999999 6999999999999997532211 1111111 11112233345556
Q ss_pred ccccCcccChhchhhcCC-----HHHHHH
Q 041479 742 FLVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
+..+..+||+.||++||+ ++++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 666677999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=305.80 Aligned_cols=231 Identities=18% Similarity=0.181 Sum_probs=182.7
Q ss_pred ccccccccccccceEEEEEecCC-CeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLD-QTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+...-.+|.|.+|+||+|....+ ++.||+|.+..........+.+|+++++.++|||||++++++...+ ..|+|
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~lv 143 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLLI 143 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEEE
Confidence 34455689999999999998777 7789999886665555677889999999999999999999998776 78999
Q ss_pred EEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||+++|+|.+. ...+++.++..++.|++.||+|+|+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999653 22478888999999999999999985 99999999999999999999999999998654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
.... .......+||+.|+||| +||++|||++|+.||.+.... ..+.....+.. ...+..++
T Consensus 221 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~-~~~~~~~s 296 (478)
T PTZ00267 221 DSVS--LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQVLYGKY-DPFPCPVS 296 (478)
T ss_pred Cccc--cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC-CCCCccCC
Confidence 3221 11233457999999999 699999999999999653211 11222222222 22333455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||.+||++||++.+++.
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 56666777999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=279.10 Aligned_cols=226 Identities=20% Similarity=0.211 Sum_probs=184.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+....++|.|.+|.|-+|.....++.||||.++.. ++++.-.+.+||+||+.++||||+.++++|...+ .+.
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-----KIv 129 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-----KIV 129 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-----eEE
Confidence 34456799999999999998888889999999655 3455667899999999999999999999998877 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||||..+|+|.++ .+.+++.+..+++.||..|+.|+|.+ +++|||+|.+|||+|+++.+||+|||++-.+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999988 56799999999999999999999986 9999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ...++||+|-|.+|| +||++|-++.|..||++- .....+.++..+.+.+..... |
T Consensus 207 k-----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~GaYrEP~~PS-d- 278 (668)
T KOG0611|consen 207 K-----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISRGAYREPETPS-D- 278 (668)
T ss_pred c-----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhcccccCCCCCc-h-
Confidence 2 345678999999999 799999999999999762 223334445555544221111 1
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
-...+..|+..+|++|.|+.||..
T Consensus 279 -A~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 279 -ASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -HHHHHHHHHhcCcccchhHHHHhh
Confidence 112233777889999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=263.64 Aligned_cols=229 Identities=22% Similarity=0.248 Sum_probs=190.3
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
..++.-.-.+|.|.||.||.|+.+.+.-.||+|++...+ .+..+++.+|++|-+.++||||+++++++.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~----- 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK----- 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-----
Confidence 345556667899999999999999999999999997654 344578999999999999999999999998877
Q ss_pred eEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 597 FRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
..|+++||.+.|++... ...+++.....++.|+|.|+.|+|. ++|+||||||+|+|++..+..||+|||.+.
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 78999999999998654 4468888899999999999999997 499999999999999999999999999986
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
.-+. ......|||.-|.+|| +||+.||++.|.+||.... .+....++.+..+.. +.
T Consensus 173 ~~p~------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~--p~ 243 (281)
T KOG0580|consen 173 HAPS------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKF--PS 243 (281)
T ss_pred ecCC------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccC--Cc
Confidence 4332 1234578999999999 6999999999999997653 334455555554432 25
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+....++...+|+.++|.+|.+..|+++
T Consensus 244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 244 TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 55555666677999999999999999875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=305.60 Aligned_cols=239 Identities=21% Similarity=0.183 Sum_probs=187.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEE-EeecCCCCC-ceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIIT-ACSTSDFQG-NYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~-~~~~~~~~~-~~~~~lv~ 602 (771)
..-+.||+||.||.|+...++..||+|++...++...+...+||++|++|+ |||||.+++ ........+ .++.+|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 345789999999999999887899999998888888999999999999997 999999999 443332223 46889999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+||.|-++ ...|++.++++|+.++|+|+++||.. +++|||||||.+||||+.++..|+||||.|.-.....
T Consensus 122 EyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred hhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 99999999776 34599999999999999999999985 7899999999999999999999999999986322111
Q ss_pred CCc-----ccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCch
Q 041479 678 SSN-----QCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQI 734 (771)
Q Consensus 678 ~~~-----~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 734 (771)
... ........-|+.|+||| +||++|-|+....||++.-...+ +.+.+..+.
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-----lng~Y~~P~ 275 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-----LNGNYSFPP 275 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-----EeccccCCC
Confidence 000 00011223589999999 69999999999999986422222 233332222
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.....++.++..||+.||.+||++.+|+..+.++
T Consensus 276 ~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 276 FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 233344555566699999999999999999988765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=285.99 Aligned_cols=229 Identities=19% Similarity=0.196 Sum_probs=177.5
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.++.....+|.|+||.||.|+-+++|..+|+|+++... ..+++..+.|-.+|....+|+||+|+..|.+.+ +
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~-----~ 215 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE-----Y 215 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC-----e
Confidence 44555667899999999999999999999999997553 566788999999999999999999999987776 8
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
+||||||++|||+..+ ...|++..+..++.+++.|++.+|+. |+|||||||+|+|||..|++|++|||++..+.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999998766 55788999999999999999999986 99999999999999999999999999996432
Q ss_pred cc---------------c----CCc-c-----------------------cccccccccccccchh--------------
Q 041479 675 EV---------------M----SSN-Q-----------------------CSSVGLKGTVGYATPE-------------- 697 (771)
Q Consensus 675 ~~---------------~----~~~-~-----------------------~~~~~~~gt~~y~aPE-------------- 697 (771)
.. . ... . ......+|||-|||||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0 000 0 0012467999999999
Q ss_pred -HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCchhhhcCccccccCcccChhchhhcCC
Q 041479 698 -YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQILQVLDPLFLVGGVQEGEETAEENIK 759 (771)
Q Consensus 698 -~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt 759 (771)
+|||+|||+.|.+||....+.. .+.+++... +..+....+.++-++.+.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQE-TYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 6999999999999996543222 233333333 2222222223333445557776 9999974
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=293.95 Aligned_cols=229 Identities=26% Similarity=0.337 Sum_probs=181.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++|+||+++++++...+ ..++|
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 150 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EIQVL 150 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eEEEE
Confidence 334456899999999999999888899999996543 344578999999999999999999999987766 68999
Q ss_pred EEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 602 ~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|||+++|+|.... ..++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 151 ~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--- 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--- 223 (353)
T ss_pred EecCCCCcccccc-cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc---
Confidence 9999999997642 346677889999999999999986 899999999999999999999999999986543221
Q ss_pred cccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHH---HHhhCCCchhhhc
Q 041479 682 CSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNF---VKMALPDQILQVL 738 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 738 (771)
......||..|+||| |||++|||++|+.||..... ..+... .....+......+
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhccCCCCCCCcc
Confidence 112346899999999 69999999999999963211 112221 1122223334455
Q ss_pred CccccccCcccChhchhhcCCHHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
+..+.....+||+.||++|||+.|+++.
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6666677779999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-34 Score=278.31 Aligned_cols=228 Identities=21% Similarity=0.219 Sum_probs=190.1
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|++|.||||.+++.|+.||||.+... .+.++..+|+.+|+++..|+||++||.|+... ..|+|||
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIVME 108 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIVME 108 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEeehh
Confidence 3456789999999999999999999999998654 35688999999999999999999999987665 5799999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||..|+..+. .+.+++.++..+....++||+|||.. .=+|||||+.|||+..+|.+|++|||.|..+.+...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999998776 56799999999999999999999986 679999999999999999999999999987765432
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 743 (771)
...++.|||.||||| +|++..||..|++||+|+.+....+. +-....| .+-++..+..+.
T Consensus 185 ---KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred ---hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-ccCCCCCCCCChHhhhhHHH
Confidence 345678999999999 69999999999999999876544321 1111112 344555666666
Q ss_pred ccCcccChhchhhcCCHHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
....+|+.++|++|-|+-++++.
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhh
Confidence 67779999999999999887753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=277.23 Aligned_cols=236 Identities=26% Similarity=0.314 Sum_probs=177.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhc--cCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN--IRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.-.|+|.||+||||.+.+ +.||||++... ..+.|..|-+|.+. ++|+||++++++-...... ...++||+||
T Consensus 216 eli~~Grfg~V~KaqL~~--~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywLVt~f 289 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWLVTEF 289 (534)
T ss_pred HHhhcCccceeehhhccC--ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeEEeee
Confidence 346899999999998864 58999999644 44778888888776 4799999999986544322 4467999999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHH------CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
.+.|+|.++ ....+|.+..+|+.-+++||+|||+. .+++|+|||||+.|||+..|+.+.|+|||+|..+...
T Consensus 290 h~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 290 HPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred ccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 999999988 44689999999999999999999974 4689999999999999999999999999999988765
Q ss_pred cCCcccccccccccccccchh---------------------HHHHHHHHHhCCC------------CCCccccCCcc--
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKR------------PTSDMFTEGLD-- 721 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~------------P~~~~~~~~~~-- 721 (771)
.... ...+.+||.+||||| .|.|+||++++-. ||+........
T Consensus 370 ~~~~--d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 370 KPQG--DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCc--chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 4432 233478999999999 4999999999633 22211111111
Q ss_pred -HHHHH-HhhCCCchhhhcCcc-----ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 722 -LHNFV-KMALPDQILQVLDPL-----FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 722 -~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.+.+ ..+.++.+++.+-.. +....+.||..||+.|.|+.-|-+++.++
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 22222 222223333222211 11344599999999999999999988775
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=290.39 Aligned_cols=223 Identities=22% Similarity=0.242 Sum_probs=177.3
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+++.+.+++.||+|++.... ......+.+|++++++++||||+++++++...+ ..|+||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E~ 76 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVMEY 76 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEeC
Confidence 3789999999999999888899999997542 334567889999999999999999999987766 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 149 (323)
T cd05595 77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---- 149 (323)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----
Confidence 999999655 34688999999999999999999985 99999999999999999999999999987532211
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
.......||+.|+||| +||++|||++|+.||.+.... .......... ...+..+++.+....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~--~~~p~~~~~~~~~li 226 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEE--IRFPRTLSPEAKSLL 226 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC--CCCCCCCCHHHHHHH
Confidence 1122356999999999 699999999999999643111 1111111111 223344566666677
Q ss_pred cccChhchhhcC-----CHHHHHH
Q 041479 747 VQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+||..||++|| ++.++++
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 227 AGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHccCCHHHhCCCCCCCHHHHHc
Confidence 799999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=290.90 Aligned_cols=228 Identities=20% Similarity=0.230 Sum_probs=181.6
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
..++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN----- 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----
Confidence 344555667899999999999999999999999996542 234567899999999999999999999988776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 78999999999999765 34578888899999999999999986 8999999999999999999999999999865
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ...+||+.|+||| +||++|||++|+.||.+... ....+..... ....+..+
T Consensus 169 ~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~-~~~~p~~~ 238 (329)
T PTZ00263 169 PDRT-------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FRIYEKILAG-RLKFPNWF 238 (329)
T ss_pred CCCc-------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HHHHHHHhcC-CcCCCCCC
Confidence 4321 1246899999999 69999999999999965321 1111111111 12233445
Q ss_pred CccccccCcccChhchhhcCC-----HHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
+..+.....+||+.||++||+ +.+++.
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 666666777999999999997 577663
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=289.18 Aligned_cols=236 Identities=20% Similarity=0.259 Sum_probs=183.9
Q ss_pred cccccccccccccceEEEEEecCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQT----FIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
++.....+|+|.+|+||+|++..+++ .||||++.... ....+++..|+.+++.++||||++++|+|....
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~----- 82 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST----- 82 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC-----
Confidence 34455678999999999999866554 38999986442 345678999999999999999999999987643
Q ss_pred eEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 597 FRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.++|+||+++|+|.++ ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 83 -~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred -ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 5799999999999765 33578888999999999999999985 899999999999999999999999999987
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
....... ....+..++..|+||| |||++||+++ |+.||.+.... .+.++.........+.
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 234 (316)
T cd05108 159 LGADEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERLPQPP 234 (316)
T ss_pred ccCCCcc--eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCCCCCCCC
Confidence 6543221 1112233567899999 6999999998 99999764221 2333333333222333
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+..+...+.+||..+|++|||+.+++..+.++
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4455555667799999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-34 Score=269.39 Aligned_cols=226 Identities=21% Similarity=0.278 Sum_probs=183.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.|+.||++.++.+++.+|+|++.... ....+++.+|++|.+.++|||||+|.+.+.+.+ +.|+|+|
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-----~~ylvFe 90 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----FHYLVFD 90 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-----eeEEEEe
Confidence 456899999999999999999999999996542 346688999999999999999999999877666 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCccc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 677 (771)
+|+||+|..- ....++..+-+++.||++||.|+|.. +|||||+||+|+++.+ ..-+|++|||+|..+..
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-- 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-- 165 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence 9999999432 23457777889999999999999996 9999999999999954 34699999999987763
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcCc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLDP 740 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 740 (771)
.....+.+|||+||||| -||++|-++.|..||.+..... .+.++..+.+ +.+..+.+.+
T Consensus 166 ---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 166 ---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred ---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhccccCCCCcccCcCCH
Confidence 23455788999999999 4999999999999997632221 2334444443 3445666777
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.-+....+|+..||++|.|+.|++.
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhC
Confidence 7766777999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=292.61 Aligned_cols=223 Identities=24% Similarity=0.286 Sum_probs=178.0
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCcee
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~ 597 (771)
++...-.+|.|.||+|+.+..+.+++.||||+++.. ..++++..+.|.+|+.... ||.++.++..|.+.+ +
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~-----~ 443 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE-----H 443 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC-----e
Confidence 344445689999999999999999999999999766 3567889999999998885 999999999977766 8
Q ss_pred EEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 598 RALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
.|+||||+.|||+..+ .+.+++.++..|+.+|+.||+|||+. +|||||||-+|||+|.+|.+||+|||+++.-..
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999997655 46799999999999999999999996 999999999999999999999999999985332
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHH-HHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHN-FVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 739 (771)
.+ ....++||||.||||| |||++|||+.|+.||.+. ++.++.+ ++.-... .+..++
T Consensus 521 ~g----~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~~~--yP~~ls 592 (694)
T KOG0694|consen 521 QG----DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDEVR--YPRFLS 592 (694)
T ss_pred CC----CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCC--CCCccc
Confidence 22 2345689999999999 799999999999999752 2222222 2221111 122223
Q ss_pred ccccccCcccChhchhhcCCH
Q 041479 740 PLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
.+...++.+.+.++|++|.-+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHHhccCcccccCC
Confidence 333344558889999999865
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=290.14 Aligned_cols=223 Identities=23% Similarity=0.242 Sum_probs=177.5
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+++.+.+++.||||++.... ......+.+|+++++.++||||+++++++.+.+ ..|+||||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~Ey 76 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVMEY 76 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEeC
Confidence 3689999999999999999999999996542 334568889999999999999999999988776 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++|+|... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---- 149 (328)
T cd05593 77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---- 149 (328)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----
Confidence 999999655 34688999999999999999999985 99999999999999999999999999987532211
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......+||+.|+||| +||++|||++|+.||.+... ....+.... .....+..+++.+....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~~~~~~~~-~~~~~p~~~~~~~~~li 226 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM-EDIKFPRTLSADAKSLL 226 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HHHHHHhcc-CCccCCCCCCHHHHHHH
Confidence 1122356999999999 69999999999999964211 111111111 11223344555666667
Q ss_pred cccChhchhhcC-----CHHHHHH
Q 041479 747 VQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+|+++||++|| ++.++++
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 227 SGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHhc
Confidence 799999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=279.84 Aligned_cols=234 Identities=22% Similarity=0.325 Sum_probs=187.0
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|.++..++.||+|.+.... ...+++.+|++++++++||||+++++++...+ ..++|||
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 82 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYIITE 82 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcEEEEE
Confidence 34456899999999999999888899999986433 34578999999999999999999999987766 6799999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.++ ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999765 23578899999999999999999985 899999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.......+++.|+||| |||++|||++ |..||.+.. .....+......+...+..+++.+
T Consensus 160 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (263)
T cd05052 160 ---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKGYRMERPEGCPPKV 234 (263)
T ss_pred ---eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCHHH
Confidence 1111223467899999 6999999998 999986531 122333333333334444556666
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.....+||..+|++|||+.++++.|+.++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 67777999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=266.88 Aligned_cols=229 Identities=22% Similarity=0.252 Sum_probs=186.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQ 593 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 593 (771)
......+|.|..++|.++.++.+++.+|+|++.... ..-.+.-.+|+.|++++ .||+|+.+.++|.+..
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s-- 96 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA-- 96 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc--
Confidence 344556788999999999999999999999996543 12345678899999998 4999999999988877
Q ss_pred CceeEEEEEEeccCCCCCCCc---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 594 GNYFRALVYEFMHHGSLESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 594 ~~~~~~lv~e~~~~g~L~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
+.++|+|.|+.|.|.++. -.+++.+..+|+.|+..|++|||.. .|||||+||+|||+|++..+||+|||+|
T Consensus 97 ---F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 ---FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred ---hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence 689999999999999883 3588999999999999999999985 8999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 729 (771)
..+.+... ....||||+|.||| .||++|-++.|-+||-.-- .-..+..+..+.
T Consensus 171 ~~l~~Gek-----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-QmlMLR~ImeGk 244 (411)
T KOG0599|consen 171 CQLEPGEK-----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-QMLMLRMIMEGK 244 (411)
T ss_pred eccCCchh-----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-HHHHHHHHHhcc
Confidence 98766432 33578999999999 4999999999999984311 011234444555
Q ss_pred CC--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 LP--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+. .+.++-++...+....+|++.||++|.|++|+++
T Consensus 245 yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 54 3344455556666777999999999999999985
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=281.33 Aligned_cols=229 Identities=31% Similarity=0.381 Sum_probs=176.1
Q ss_pred ccccccccceEEEEEec----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILD----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|.||+|.+. ..+..||||.+.... ....+.|.+|++.+++++||||++++|++...+ ..++|
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~lv 79 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLFLV 79 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEEEE
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----ccccc
Confidence 46899999999999998 445789999996543 344789999999999999999999999998555 57999
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||+++|+|.++ ...+++..+..|+.|+|.||+|||+. +|+|+||+++||++++++.+||+|||+++.....
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999776 24688999999999999999999985 8999999999999999999999999999866322
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ........+...|+||| ||+++||+++ |+.||.+... ..+.+......+...+..++.
T Consensus 157 ~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T PF07714_consen 157 SK--YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQRLPIPDNCPK 232 (259)
T ss_dssp SS--EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEETTSBTTSBH
T ss_pred cc--ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccceeccchhH
Confidence 11 11122234678899999 7999999999 7899876522 223333333333334555566
Q ss_pred cccccCcccChhchhhcCCHHHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.+...+..||..||++|||+.++++.|
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 676777899999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=295.38 Aligned_cols=236 Identities=25% Similarity=0.275 Sum_probs=183.4
Q ss_pred ccccccccccceEEEEEecCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCcee
Q 041479 525 LNVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQ-RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~ 597 (771)
....+|+|.+|+||+|++... ...||||++.... ....+.+.+|+++++++. |||||+++++|.+.+ .
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~-----~ 115 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG-----P 115 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----c
Confidence 345689999999999987432 3479999996543 344578999999999996 999999999997766 6
Q ss_pred EEEEEEeccCCCCCCCc---------------------------------------------------------------
Q 041479 598 RALVYEFMHHGSLESCP--------------------------------------------------------------- 614 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~--------------------------------------------------------------- 614 (771)
.|+|||||++|+|.++.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 89999999999985430
Q ss_pred ------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 041479 615 ------------------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658 (771)
Q Consensus 615 ------------------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~ 658 (771)
+.+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 1367778899999999999999985 8999999999999999
Q ss_pred CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccH
Q 041479 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDL 722 (771)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~ 722 (771)
++.+|++|||+++....... ........+++.||||| |||++|||++ |..||.+..... .+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TF 349 (400)
T ss_pred CCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HH
Confidence 99999999999986543221 11122335678899999 6999999997 999997643222 23
Q ss_pred HHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 723 HNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
........+...+..+++.+...+.+||+.||++|||+.+|.+.|++++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 3333333333334445556666777999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=289.33 Aligned_cols=177 Identities=24% Similarity=0.320 Sum_probs=152.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|.||+++++.++..||+|.+.... ....+++.+|++++++++||||+++++++...+ ..++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 83 (331)
T cd06649 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICME 83 (331)
T ss_pred EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EEEEEee
Confidence 3456899999999999999999999999997653 344578999999999999999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 9999999876 34578889999999999999999984 369999999999999999999999999997653321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.....||+.|+||| +||++|||++|+.||..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12346899999999 69999999999999954
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=295.67 Aligned_cols=233 Identities=21% Similarity=0.246 Sum_probs=194.9
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
..-|...+.+|+|+||.||||+.++++-..|-|+|........++|+.||+|++.+.||+||+|++.|+..+ .++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceE
Confidence 344566788999999999999999999888999998888888999999999999999999999999988776 689
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|..|||.||-.+.. .+.+.+.++.-++.|++.||.|||++ .|||||||+.|||+.-+|.++++|||.+.....
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999999988655 67899999999999999999999997 899999999999999999999999999753322
Q ss_pred ccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-ch
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD-QI 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~ 734 (771)
......++.|||+||||| ||+++.||..+.+|..+....- .+.++.+...|. ..
T Consensus 183 ----t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-VllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 183 ----TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLLQ 257 (1187)
T ss_pred ----HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-HHHHHhhcCCCcccC
Confidence 123345688999999999 6999999999999987754433 244555555552 23
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+..+...+.+...+|+.++|..||+++++++
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 4445555556667999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=281.26 Aligned_cols=236 Identities=23% Similarity=0.326 Sum_probs=186.3
Q ss_pred ccccccccccccceEEEEEecCCC-----eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ-----TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|.||+|.....+ ..||+|.+.... ....++|.+|++++++++||||+++++++....
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~----- 81 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ----- 81 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC-----
Confidence 334556899999999999876554 689999986443 344567999999999999999999999987665
Q ss_pred eEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 041479 597 FRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~ 657 (771)
..+++|||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 679999999999986551 3477888999999999999999985 899999999999999
Q ss_pred CCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCcc
Q 041479 658 NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLD 721 (771)
Q Consensus 658 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~ 721 (771)
+++.+||+|||+++....... ........+++.|+||| +||++|||++ |..||.+... ..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~ 234 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QE 234 (283)
T ss_pred CCCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HH
Confidence 999999999999976533221 11122345688999999 6999999998 9999975432 22
Q ss_pred HHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 722 LHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.+..........+..+.+.+..+..+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 3344433333334445566666777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=275.57 Aligned_cols=225 Identities=22% Similarity=0.282 Sum_probs=170.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
--+|.|+||+||+|...++++.||||++....+. --+|+++|+++.|||||+|..+|......+..+..+|||||+
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 4479999999999999999899999999654331 236999999999999999999987665444456789999998
Q ss_pred CCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCccccCcccC
Q 041479 607 HGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 607 ~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 678 (771)
. +|.+. .+.++...+.-+..|+.+||.|||+. +|+||||||+|+|+|.+ |.+||||||.|+.+.....
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 6 66544 34677778889999999999999985 99999999999999965 9999999999998766543
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCC--Cc------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALP--DQ------ 733 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~--~~------ 733 (771)
. .+...|+.|+||| .|||+.||+.|++-|.+..+ ...+.++++. +.| ++
T Consensus 182 n-----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 182 N-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred c-----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhhcCc
Confidence 3 2345799999999 39999999999998865321 1123332221 111 01
Q ss_pred ------------------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ------------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ------------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++..+...++++.+|.+|.++.|+++
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11112222223344999999999999999875
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=275.59 Aligned_cols=231 Identities=23% Similarity=0.284 Sum_probs=181.7
Q ss_pred cccccccceEEEEEec--CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILD--LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|.||+|+++ .++..||||++.... ....+.|.+|++++++++||||+++++++... ..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE------ALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC------CeEEEEEe
Confidence 4799999999999875 445579999996553 33456799999999999999999999987543 46899999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++|+|.++ ...+++.++.+++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.........
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999999875 33588999999999999999999985 89999999999999999999999999998654332211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
.......+++.|+||| |||++||+++ |..||.+... ......+....+...+....+.+..
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05115 153 -KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEVMSFIEQGKRLDCPAECPPEMYA 229 (257)
T ss_pred -eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1112223467899999 6999999997 9999976432 2233444443433444455566666
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+||..+|++||++.+|.+.|+.+
T Consensus 230 li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 230 LMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 77799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=289.27 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.+....-.+|-|.+|.||.|+|+...-.||||.++. +....++|++|+.+|+.++|||+|+|+|+|.... ..|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeE
Confidence 3455667789999999999999999999999999954 4456799999999999999999999999998765 579
Q ss_pred EEEEeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 600 LVYEFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 600 lv~e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
||.|||.+|+|.++. ..++.-..+.++.||+.|++||.. +.+|||||.++|+|+.++..+||+|||+++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999997762 345556678899999999999997 489999999999999999999999999999987
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ...+..-...|.||| |||++||+.| |..||.++-- -..+..+...++-..++.+
T Consensus 417 gDTYT---AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--SqVY~LLEkgyRM~~PeGC 491 (1157)
T KOG4278|consen 417 GDTYT---AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYGLLEKGYRMDGPEGC 491 (1157)
T ss_pred CCcee---cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHHhccccccCCCCC
Confidence 64422 122333467899999 8999999999 9999976522 2355666777776777888
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.+..++..||+++|++||+.+|+-+.++.+
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 88888888899999999999999999998876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=288.20 Aligned_cols=227 Identities=22% Similarity=0.225 Sum_probs=179.6
Q ss_pred ccccccccccccccceEEEEEecCCC-eEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQ-TFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~-~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.++ ..||||++.... ....+.+.+|+++++.++|||||++++++.+.+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----- 104 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES----- 104 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-----
Confidence 34445567899999999999876654 689999996432 334567889999999999999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 78999999999999766 34688889999999999999999985 9999999999999999999999999999865
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ...+||+.||||| +||++|||++|+.||.+.... .......... ...+..+
T Consensus 182 ~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~--~~~p~~~ 251 (340)
T PTZ00426 182 DTRT-------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGI--IYFPKFL 251 (340)
T ss_pred CCCc-------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCC--CCCCCCC
Confidence 4321 2346999999999 699999999999999753211 1112222211 1233445
Q ss_pred CccccccCcccChhchhhcC-----CHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
++.......+|++.||++|+ |+.++++
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 55555667799999999995 7888764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=275.94 Aligned_cols=230 Identities=20% Similarity=0.272 Sum_probs=180.7
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
.+|+|.+|+||+|+++.+++.||+|.+.... ......+.+|++++++++||||+++++++.... ..++||||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELVQ 76 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeecc
Confidence 3789999999999999888899999885432 345578999999999999999999999987766 6799999999
Q ss_pred CCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 607 HGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 607 ~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++........ .
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~ 151 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--S 151 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc--c
Confidence 9999766 23578999999999999999999985 8999999999999999999999999998754432111 0
Q ss_pred ccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......++..|+||| +||++||+++ |..||...... ..........+...+...+..+....
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li 229 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVRLPCPELCPDAVYRLM 229 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCCCcccCCHHHHHHH
Confidence 011112345799999 6999999998 88888653221 12223333333334444555666677
Q ss_pred cccChhchhhcCCHHHHHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.+|++.+|++|||+.++++.|++
T Consensus 230 ~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 230 ERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHcCCChhhCcCHHHHHHHHhC
Confidence 79999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=284.72 Aligned_cols=222 Identities=23% Similarity=0.258 Sum_probs=178.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|+.+.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..|+||
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~ 80 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-----FLYMLM 80 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-----eEEEEE
Confidence 345799999999999999888899999996542 234567889999999999999999999887665 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ .+.+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 99999999766 34678889999999999999999985 99999999999999999999999999998653321
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
...+||+.|+||| +||++|||++|+.||.+..... ......... ...+..+++.+..
T Consensus 156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~--~~~~~~~~~~~~~ 227 (291)
T cd05612 156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKILAGK--LEFPRHLDLYAKD 227 (291)
T ss_pred -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC--cCCCccCCHHHHH
Confidence 2346899999999 6999999999999997532111 112222221 2233344666666
Q ss_pred cCcccChhchhhcCC-----HHHHHH
Q 041479 745 GGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
...+|++.||++||+ +.|+++
T Consensus 228 li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 228 LIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHHcCCCHHHccCCccCCHHHHhc
Confidence 777999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=288.55 Aligned_cols=224 Identities=23% Similarity=0.255 Sum_probs=177.7
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+++.+.+++.||+|++.... ......+..|+++++.++||||+++++++.+.+ ..|+||||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E~ 76 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVMEY 76 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEeC
Confidence 3799999999999999889999999997542 334567889999999999999999999987776 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++|+|..+ ...+++.++..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--- 151 (325)
T cd05594 77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--- 151 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---
Confidence 999999665 34688999999999999999999973 3899999999999999999999999999875322111
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......||+.||||| +||++|||++|+.||.+... ....+.... .....+..+++.+....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--~~~~~~i~~-~~~~~p~~~~~~~~~li 227 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM-EEIRFPRTLSPEAKSLL 227 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--HHHHHHHhc-CCCCCCCCCCHHHHHHH
Confidence 122346999999999 69999999999999964311 112222111 11223444566666677
Q ss_pred cccChhchhhcC-----CHHHHHH
Q 041479 747 VQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+|++.||++|+ ++.++++
T Consensus 228 ~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 228 SGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHhhcCHHHhCCCCCCCHHHHhc
Confidence 799999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=283.57 Aligned_cols=233 Identities=19% Similarity=0.242 Sum_probs=176.0
Q ss_pred ccccccccccceEEEEEecC----------------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDL----------------DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITAC 587 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~----------------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 587 (771)
....+|+|.+|.||+|+++. ++..||||.+.... .....+|.+|++++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 34458999999999998643 33479999986543 33456899999999999999999999999
Q ss_pred ecCCCCCceeEEEEEEeccCCCCCCCc----------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 041479 588 STSDFQGNYFRALVYEFMHHGSLESCP----------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIV 645 (771)
Q Consensus 588 ~~~~~~~~~~~~lv~e~~~~g~L~~~~----------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iv 645 (771)
.+.+ ..++||||+++|+|.++. ..+++..+..++.|++.||+|||+. +|+
T Consensus 89 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 89 VDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred ecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 8766 679999999999986541 2357788899999999999999985 899
Q ss_pred ecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh--C
Q 041479 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT--G 708 (771)
Q Consensus 646 Hrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t--g 708 (771)
||||||+||+++.++.+||+|||+++....... ........++..||||| |||++|||++ +
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999986543221 11112234678899999 6999999987 5
Q ss_pred CCCCCccccCCccHHHHHHhhCC-------CchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 709 KRPTSDMFTEGLDLHNFVKMALP-------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 709 ~~P~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
..||.+.... ...+....... ...+..+...+...+.+||+.||++|||+.+|.+.|++
T Consensus 239 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTDE--QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCHH--HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6677653211 12222211111 11122334455566779999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=271.79 Aligned_cols=234 Identities=22% Similarity=0.259 Sum_probs=178.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEee--ccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLF--LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|.|++|.|.+|.++.+++.||||++. ....-..++..+|+.+++.++|+|||.+++++..+....-...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 466899999999999999999999999996 444556788999999999999999999999987633222236799999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+|+ .||.+. .+.++......+..|+++||.|+|+. +|+|||+||+|++++.+..+||+|||+|+..... ..
T Consensus 107 lMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~--~~ 180 (359)
T KOG0660|consen 107 LME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF--FE 180 (359)
T ss_pred HHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc--Cc
Confidence 994 577766 33488888899999999999999997 9999999999999999999999999999987654 22
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccc--------------cCCccHH-------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMF--------------TEGLDLH------- 723 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~--------------~~~~~~~------- 723 (771)
....++.+.|.+|+||| .||++.||++|+.-|.+.- +....+.
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 33446678899999999 4999999999998775310 0000111
Q ss_pred -HHHHhhCC---Cc---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 724 -NFVKMALP---DQ---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 724 -~~~~~~~~---~~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.+...+ .. .-...++.-....++|++.||.+|+|++|+++
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111110 01 11122222223445999999999999999985
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.98 Aligned_cols=238 Identities=24% Similarity=0.315 Sum_probs=185.7
Q ss_pred ccccccccceEEEEEecCCC---eEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEE
Q 041479 527 VSYESLVKATVYKGILDLDQ---TFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRAL 600 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~l 600 (771)
-.+|+|.+|+||+|....++ ..||||++.... ....+.+.+|++.++.++||||+++++++.+.+. .+....++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 35799999999999886543 689999997543 3345689999999999999999999999876542 23335799
Q ss_pred EEEeccCCCCCCC---------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 601 VYEFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 601 v~e~~~~g~L~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
+|||+++|+|..+ ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcccee
Confidence 9999999998644 23578889999999999999999985 89999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
......... ......++..|+||| +||++||+++ |..||.+... ..+.+..........+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 237 (273)
T cd05035 162 KIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHGNRLKQP 237 (273)
T ss_pred ecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCC
Confidence 654332211 111223567899999 6999999999 8899866422 2344444443333444
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..++..+.....+||+.||++|||+.|+++.|++++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 455666666777999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=275.19 Aligned_cols=230 Identities=21% Similarity=0.265 Sum_probs=182.5
Q ss_pred cccccccceEEEEEe--cCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGIL--DLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~--~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|++ ..+++.||||+++... ....+++.+|+.++++++||||+++++++... ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CcEEEEe
Confidence 479999999999976 3456799999986443 34567899999999999999999999987543 3589999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ ...+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999999766 34578999999999999999999985 89999999999999999999999999998664432211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
. ......+++.|+||| |||++||+++ |+.||.+... ..+.+..........+..+++.+..
T Consensus 153 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05116 153 K-AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGERMECPQRCPPEMYD 229 (257)
T ss_pred e-ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1 111223467899999 6999999998 9999976422 2344444443333444556677777
Q ss_pred cCcccChhchhhcCCHHHHHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
...+||+.||++||++.+|++.|++
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHhccCchhCcCHHHHHHHHhc
Confidence 7889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.06 Aligned_cols=225 Identities=20% Similarity=0.201 Sum_probs=178.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|.||+|++..+++.||||++.... ....+.+.+|++++..++||||+++++++.+.+ ..|+||
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~ 80 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----YLYLAM 80 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----EEEEEE
Confidence 446899999999999999888899999997542 234567889999999999999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 99999999876 34678889999999999999999986 899999999999999999999999999985433
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CC-Cch---hhhc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LP-DQI---LQVL 738 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~-~~~---~~~~ 738 (771)
......||+.|+||| +||++|||++|+.||.+..... ......... .. +.. ...+
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYWKETLQRPVYDDPRFNL 229 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhccccccCCCCCcccccc
Confidence 122356999999999 6999999999999997532111 111111111 11 110 1123
Q ss_pred CccccccCcccChhchhhcCCHHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
++.+.....+|+..+|++||++.++++.
T Consensus 230 s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 230 SDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 4445556669999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=277.27 Aligned_cols=238 Identities=22% Similarity=0.301 Sum_probs=180.7
Q ss_pred ccccccccceEEEEEecCCCe--EEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQT--FIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~--~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
..+|+|.+|.||+|++..++. .||||.++.. .....+.+.+|++++++++||||+++++++..... ......+++
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 347999999999999877664 6999988654 24456789999999999999999999998854321 111256899
Q ss_pred EEeccCCCCCCC---------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 602 YEFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 602 ~e~~~~g~L~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
|||+++|+|.++ ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999998654 23478889999999999999999985 899999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
....... .......+++.|+||| |||++||+++ |+.||..... ..+.+............
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 162 IYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCCCCCCCC
Confidence 6432211 1111223567899999 6999999999 8889865321 12333332222222223
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.++..+.....+||+.||++|||+.++++.|++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 34445556677999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=275.09 Aligned_cols=227 Identities=23% Similarity=0.303 Sum_probs=177.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||+++++.+. .||+|.+... ....++|.+|++++++++||||+++++++.+.+ ..++||||+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~-~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~iv~e~~ 81 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQI-KVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYIVTEFM 81 (256)
T ss_pred eeEecCCcCceEEEEEeccCc-eEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEEEEEcC
Confidence 345899999999999987654 8999988533 233568999999999999999999999987766 679999999
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce---
Confidence 99999765 23478899999999999999999985 899999999999999999999999999986533221
Q ss_pred cccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
.......++..|+||| ||+++||+++ |+.||.... .....+......+...+......+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGFRLYRPKLASMTVYEV 233 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1112234567899999 6999999999 899986532 122233333222222233344455566
Q ss_pred CcccChhchhhcCCHHHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
..+||+.+|++|||+.++++.|
T Consensus 234 i~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHccCCcccCcCHHHHHHhh
Confidence 7799999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=276.71 Aligned_cols=233 Identities=20% Similarity=0.266 Sum_probs=184.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|.||+|+...+++.||||.+... ......++.+|+++++.++||||+++++++.+.+ ..++||
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~ 81 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----ELNIVL 81 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----eEEEEE
Confidence 44579999999999999988889999988542 2344567899999999999999999999988766 679999
Q ss_pred EeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 603 EFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999754 23477888999999999999999985 999999999999999999999999999886543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 739 (771)
... ......|++.|+||| +|+++||+++|+.||.........+.+.... ..+.......+
T Consensus 159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred hhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 221 112345888999999 6999999999999985432211122222222 22333333445
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+...+.+||..+|++||++.+|++.++++
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 5566677799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=286.29 Aligned_cols=232 Identities=20% Similarity=0.287 Sum_probs=189.0
Q ss_pred cccccccccceEEEEEecCC----CeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLD----QTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.--+|+|.||.||+|++.+- .--||||.-+.. ..+..+.|+.|+.+|+.++|||||+++|+|.+.. .||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------~Wi 467 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------MWI 467 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------eeE
Confidence 34579999999999987543 346888887653 3456889999999999999999999999998864 699
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||.++-|.|..+ ...++......++.|++.||+|||+. ++|||||.++|||+.+..-+|++|||++|.+.+.
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 9999999999877 44688888899999999999999985 9999999999999999888999999999988765
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
..+ ......-...||||| |||++||+++ |.+||.+....+.. .....+-+.+.++.+.|
T Consensus 545 ~yY---kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--~~iEnGeRlP~P~nCPp 619 (974)
T KOG4257|consen 545 AYY---KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--GHIENGERLPCPPNCPP 619 (974)
T ss_pred chh---hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--EEecCCCCCCCCCCCCh
Confidence 432 122223467899999 8999999998 99999876444331 11223333445667777
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+...+.+||+.+|.+||+..++...|.+++
T Consensus 620 ~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 620 ALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred HHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 7777888999999999999999999998874
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=290.89 Aligned_cols=239 Identities=24% Similarity=0.273 Sum_probs=184.2
Q ss_pred cccccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQG 594 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 594 (771)
.....-.+|+|++|.||+|++.. .++.||||++.... ....+.+.+|++++.++. |||||+++++|.+.+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~--- 114 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG--- 114 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC---
Confidence 34445679999999999999643 34689999996543 333467999999999997 999999999998765
Q ss_pred ceeEEEEEEeccCCCCCCCc------------------------------------------------------------
Q 041479 595 NYFRALVYEFMHHGSLESCP------------------------------------------------------------ 614 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~~------------------------------------------------------------ 614 (771)
..++||||+++|+|.++.
T Consensus 115 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 115 --PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred --CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 679999999999985431
Q ss_pred -----------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 615 -----------------------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 615 -----------------------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
..+++.....++.|++.||+|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 1356677889999999999999985 89999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFT 717 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~ 717 (771)
|++++++.+|++|||+++........ .......+++.||||| |||++||+++ |..||.....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999865332211 1112335788899999 7999999998 8899865422
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.. ...+......+...+..++..+...+.+||..+|++||+++|+++.|++++
T Consensus 348 ~~-~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE-QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 22 233333333333334445566666777999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=285.24 Aligned_cols=225 Identities=21% Similarity=0.202 Sum_probs=175.3
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+++.+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~e 76 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVIE 76 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEEe
Confidence 3689999999999999999999999997542 23456688999999998 6999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|..+ .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 150 (329)
T cd05588 77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--- 150 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC---
Confidence 9999999655 35689999999999999999999985 99999999999999999999999999987422111
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC---CccHHHHHHh---hCCCchhhhcC
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE---GLDLHNFVKM---ALPDQILQVLD 739 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~ 739 (771)
......+||+.|+||| +||++||+++|+.||+..... .....++... ..+...+..++
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 229 (329)
T cd05588 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC
Confidence 1122357999999999 699999999999999632111 1111111111 11123344455
Q ss_pred ccccccCcccChhchhhcCC------HHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIK------KGQIR 764 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt------~~~vl 764 (771)
+.+.....+|++.||++||| +.+++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 55666677999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=279.26 Aligned_cols=234 Identities=24% Similarity=0.312 Sum_probs=183.4
Q ss_pred ccccccccccceEEEEEec-----CCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
....+|+|.+|+||++... .++..||+|.+........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 83 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-----PLI 83 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----ccE
Confidence 3456899999999999853 345579999997665556778999999999999999999999988766 679
Q ss_pred EEEEeccCCCCCCCc----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 041479 600 LVYEFMHHGSLESCP----------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH 663 (771)
Q Consensus 600 lv~e~~~~g~L~~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~k 663 (771)
+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 999999999986541 2388999999999999999999985 899999999999999999999
Q ss_pred EecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 041479 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVK 727 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~ 727 (771)
++|||+++....... ........+++.|+||| |||++|||++ |+.||...... ...+...
T Consensus 161 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~~i~ 236 (288)
T cd05093 161 IGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECIT 236 (288)
T ss_pred eccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 999999986533221 11112234578899999 6999999999 99998654221 1222222
Q ss_pred hhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..........+++.+.....+||+.||++|||+.++.+.|+++
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 2222223344556666777799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=275.32 Aligned_cols=235 Identities=21% Similarity=0.311 Sum_probs=184.8
Q ss_pred ccccccccccceEEEEEecCC---CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 525 LNVSYESLVKATVYKGILDLD---QTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
....+|+|.+|+||+|+++.. ...||||.++... ....++|.+|+.++++++||||+++++++.+.+ ..++
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i 82 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR-----PVMI 82 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-----ceEE
Confidence 345679999999999998654 4589999986543 344578999999999999999999999987765 6799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++|+|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999776 23588999999999999999999985 8999999999999999999999999999876521
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ........+++.|+||| +|+++||+++ |..||.+.. ...+.+..............+.
T Consensus 160 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05033 160 EA--TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAVEDGYRLPPPMDCPS 235 (266)
T ss_pred cc--ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCH
Confidence 11 11112234567899999 6999999998 999986532 1223333333222222334455
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+.....+||+.+|++||++.++++.|++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 5666777999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=278.36 Aligned_cols=224 Identities=24% Similarity=0.256 Sum_probs=175.1
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|+|.+|+||++.++.+++.||||.+.... ....+.+..|++++++++||||+++.+++.+.+ ..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence 588999999999999888899999996542 223467788999999999999999999887765 689999999
Q ss_pred cCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 606 HHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 99999643 23588999999999999999999985 999999999999999999999999999976543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 741 (771)
......||+.|+||| +||++|||++|+.||...... ....+...... +...+..+++.
T Consensus 153 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 227 (280)
T cd05608 153 ----KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPA 227 (280)
T ss_pred ----cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHhhcccCCCCcccCCHH
Confidence 122356899999999 699999999999999643111 11112221111 12223334555
Q ss_pred ccccCcccChhchhhcC-----CHHHHHH
Q 041479 742 FLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
+.....+|++.||++|| +++++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 55666799999999999 6777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=285.04 Aligned_cols=218 Identities=24% Similarity=0.217 Sum_probs=172.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+++.+++.||||++.... ....+.+..|..++... +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~E 76 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVME 76 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEEc
Confidence 3789999999999999988899999996542 33456788899998877 6999999999987776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--- 150 (320)
T cd05590 77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--- 150 (320)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---
Confidence 9999999755 34688999999999999999999985 99999999999999999999999999987532211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
.......||+.|+||| +||++|||++|+.||.+.... .+.+..... ....+..+++.+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~-~~~~~~~~~~~~~~l 226 (320)
T cd05590 151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILND-EVVYPTWLSQDAVDI 226 (320)
T ss_pred -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcC-CCCCCCCCCHHHHHH
Confidence 1123356999999999 699999999999999753211 122222111 112233345555566
Q ss_pred CcccChhchhhcCCH
Q 041479 746 GVQEGEETAEENIKK 760 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~ 760 (771)
..+|++.||++||++
T Consensus 227 i~~~L~~dP~~R~~~ 241 (320)
T cd05590 227 LKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHcccCHHHCCCC
Confidence 679999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=285.22 Aligned_cols=221 Identities=21% Similarity=0.212 Sum_probs=172.2
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+.+.+++.||+|++... .....+.+.+|+.++.++ +|||||++++++.+.+ ..|+|||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~E 76 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVIE 76 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEEe
Confidence 379999999999999999999999999754 233456678899988877 7999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|..+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--- 150 (329)
T cd05618 77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--- 150 (329)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---
Confidence 9999999655 34688999999999999999999985 99999999999999999999999999987532211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC---ccHHHHHHh---hCCCchhhhcC
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG---LDLHNFVKM---ALPDQILQVLD 739 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~ 739 (771)
.......||+.|+||| +||++|||++|+.||....... .....+... .....++..++
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~ 229 (329)
T cd05618 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC
Confidence 1122356899999999 6999999999999995321111 111111111 11123344455
Q ss_pred ccccccCcccChhchhhcCCH
Q 041479 740 PLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
..+.....+|++.||++||++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 555566779999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=270.31 Aligned_cols=232 Identities=26% Similarity=0.254 Sum_probs=187.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
....-+|.|-.|+||.++.+.++..+|+|++.... .+...+...|.+||+.+.||.+.+||+.+.++. +.|+
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-----~~cl 154 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-----YSCL 154 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-----eeEE
Confidence 33445899999999999999998999999997653 345567888999999999999999999988877 7899
Q ss_pred EEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 601 VYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 601 v~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|||||+||+|... .+.+++..+..++.+|.-||+|||-. |||+|||||+||||.++|++.++||.++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999654 56789999999999999999999986 999999999999999999999999999754311
Q ss_pred c--------------------------------c-C-------------------Ccccccccccccccccchh------
Q 041479 676 V--------------------------------M-S-------------------SNQCSSVGLKGTVGYATPE------ 697 (771)
Q Consensus 676 ~--------------------------------~-~-------------------~~~~~~~~~~gt~~y~aPE------ 697 (771)
. . . ........++||--|.|||
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0 0001224578999999999
Q ss_pred ---------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCC----HHHHH
Q 041479 698 ---------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIK----KGQIR 764 (771)
Q Consensus 698 ---------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt----~~~vl 764 (771)
|||++|||+.|..||.+.. ....+..++...+.......+....++++.+.|++||++|.- +.||-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 8999999999999998753 345688888776654333344455555666889999999986 55553
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=283.38 Aligned_cols=222 Identities=22% Similarity=0.245 Sum_probs=172.7
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|++..+++.||||++.... ....+.+..|..++... +||||+++++++...+ ..|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~e 76 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVME 76 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEEc
Confidence 3799999999999999988899999997542 23445667777777754 7999999999987766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|..+ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--- 150 (316)
T cd05592 77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--- 150 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---
Confidence 9999999765 34688889999999999999999985 99999999999999999999999999997543221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.|+||| +||++|||++|+.||.+... ..+....... ....+..++..+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~-~~~~~~~~~~~~~~l 226 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DELFDSILND-RPHFPRWISKEAKDC 226 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcC-CCCCCCCCCHHHHHH
Confidence 1122456999999999 69999999999999975321 1121111111 222334455555566
Q ss_pred CcccChhchhhcCCHH-HHH
Q 041479 746 GVQEGEETAEENIKKG-QIR 764 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~-~vl 764 (771)
..+||+.||++||++. +++
T Consensus 227 l~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 227 LSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHccCCHHHcCCChHHHH
Confidence 6799999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.60 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=182.2
Q ss_pred ccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCcee
Q 041479 525 LNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..-.+|+|.+|.||+|+... +++.||+|+++... ....+.+.+|++++.++ +||||++++++|...+. .
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~----~ 86 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG----P 86 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC----C
Confidence 34568999999999997543 34689999986443 23346788999999999 79999999998865442 5
Q ss_pred EEEEEEeccCCCCCCCc---------------------------------------------------------------
Q 041479 598 RALVYEFMHHGSLESCP--------------------------------------------------------------- 614 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~--------------------------------------------------------------- 614 (771)
.+++|||+++|+|.++.
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999985431
Q ss_pred -ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccc
Q 041479 615 -RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGY 693 (771)
Q Consensus 615 -~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y 693 (771)
..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...... .......++..|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~y 241 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLKW 241 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCCCccc
Confidence 2578889999999999999999985 9999999999999999999999999999865432211 112223467789
Q ss_pred cchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhc
Q 041479 694 ATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEEN 757 (771)
Q Consensus 694 ~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~R 757 (771)
|||| |||++||+++ |..||.+..... .+............+....+.+...+.+||+.+|++|
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 9999 6999999998 999997642222 2333333333333334445556666779999999999
Q ss_pred CCHHHHHHHHHHhC
Q 041479 758 IKKGQIRESLIAIL 771 (771)
Q Consensus 758 pt~~~vl~~L~~~l 771 (771)
|++.|+++.|++++
T Consensus 321 Ps~~ell~~l~~~~ 334 (337)
T cd05054 321 PTFSELVEILGDLL 334 (337)
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=285.25 Aligned_cols=177 Identities=24% Similarity=0.329 Sum_probs=152.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|+||+++++.+++.||+|.+.... ....+++.+|++++++++|||||++++++.+.+ ..++|||
T Consensus 9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 83 (333)
T cd06650 9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICME 83 (333)
T ss_pred eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----EEEEEEe
Confidence 3456899999999999999989899999987543 344578999999999999999999999998876 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ ...+++.....++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 9999999876 34578888899999999999999974 379999999999999999999999999987553321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.....||+.|+||| +||++||+++|+.||..
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12346899999999 69999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=286.87 Aligned_cols=235 Identities=20% Similarity=0.187 Sum_probs=174.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|+...+++.||||++... ......++.+|++++++++||||+++++++...+.......|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 34589999999999999988899999998643 2233467899999999999999999999987654333335799999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
||. ++|.+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 159 (338)
T cd07859 85 LME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT- 159 (338)
T ss_pred cCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCc-
Confidence 995 577655 34588999999999999999999986 8999999999999999999999999999854322211
Q ss_pred ccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCc--------------cHHHH----
Q 041479 681 QCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGL--------------DLHNF---- 725 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~--------------~~~~~---- 725 (771)
........||+.|+||| +||++|||++|+.||.+...... ....+
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 11123356899999999 69999999999999964211000 00000
Q ss_pred ----HH---hhCCCch---hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 726 ----VK---MALPDQI---LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 726 ----~~---~~~~~~~---~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. ...+... ....++.+.....+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 0000000 0123444445666999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=272.65 Aligned_cols=239 Identities=21% Similarity=0.262 Sum_probs=190.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhc--cCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN--IRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|-||.||+|.|+.. .||||++...+ .+.+.+|.+|.+. +||+||+.+++.-..+. .....+|+|.|
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvTd 289 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVTD 289 (513)
T ss_pred EEEecCccccceeeccccCC--ceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEeee
Confidence 34679999999999999844 79999996544 3678888888886 49999999998865543 33357899999
Q ss_pred eccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 604 FMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHH-----CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 604 ~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|.+.|||.++ ...++....++++.-+|.||+|||.+ .+|.|.|||||+.|||+..++.+.|+|+|+|-.....
T Consensus 290 YHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred cccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 9999999998 45688889999999999999999953 5789999999999999999999999999999765554
Q ss_pred cCCcccccccccccccccchh---------------------HHHHHHHHHhC----------CCCCCccccCCccHHHH
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTG----------KRPTSDMFTEGLDLHNF 725 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg----------~~P~~~~~~~~~~~~~~ 725 (771)
...........+||.+||||| ||.|+||++.+ +.||.|..+.+..+.++
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 433344556678999999999 79999999864 45898887777777776
Q ss_pred HHhhCCCchhhhcCcccc---------ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPDQILQVLDPLFL---------VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~---------~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.---.+.+..++..+. ..+..||..+|+.|-|+-.+-..|.++
T Consensus 450 rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 450 RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 544333333333333322 346699999999999998888877764
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=274.19 Aligned_cols=233 Identities=22% Similarity=0.284 Sum_probs=176.5
Q ss_pred ccccccceEEEEEecC---CCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 529 YESLVKATVYKGILDL---DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~---~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
+|+|.+|+||+|.+.+ ....||+|.+... .....+.+.+|+.+++.++||||+++++++...+. ..++||||
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~lv~e~ 78 (262)
T cd05058 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG----SPLVVLPY 78 (262)
T ss_pred ccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC----CcEEEEec
Confidence 6899999999998754 3457999998543 33456789999999999999999999998764331 46899999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++|+|.++ ....++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999776 23457778889999999999999985 89999999999999999999999999997554322111
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhC-CCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTG-KRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
........+++.|+||| |||++|||++| ..||.+.. ...+...+....+...+..+.+.+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 11122334677899999 69999999995 55665431 22233333332222223334445556
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.+||..+|++||++.++++.|+++
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 67799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.09 Aligned_cols=231 Identities=20% Similarity=0.222 Sum_probs=174.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~~lv~ 80 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----NLYFVM 80 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----EEEEEE
Confidence 345899999999999999999999999996542 334567899999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999766 34578888899999999999999985 9999999999999999999999999998643210000
Q ss_pred -------------------------------------------cccccccccccccccchh---------------HHHH
Q 041479 680 -------------------------------------------NQCSSVGLKGTVGYATPE---------------YGIL 701 (771)
Q Consensus 680 -------------------------------------------~~~~~~~~~gt~~y~aPE---------------~Gv~ 701 (771)
..+.....+||+.||||| +||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000112357999999999 6999
Q ss_pred HHHHHhCCCCCCccccCCccHHHHHHhh--CCCchhhhcCccccccCcc--cChhchhhcCCHHHHHH
Q 041479 702 LLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQILQVLDPLFLVGGVQ--EGEETAEENIKKGQIRE 765 (771)
Q Consensus 702 l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--cl~~~p~~Rpt~~~vl~ 765 (771)
+|||++|+.||....... ......... ........+++.......+ |+..+|..||++.++++
T Consensus 238 l~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTE-TQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHH-HHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999997532211 111221111 1111111234444444333 77778888999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=278.73 Aligned_cols=236 Identities=25% Similarity=0.336 Sum_probs=184.7
Q ss_pred ccccccccccccceEEEEEecC-----CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|.||+|+... +...||+|.+........+.+.+|++++++++||||+++++++...+ .
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 81 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-----P 81 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC-----c
Confidence 3345568999999999998643 34579999987665556678999999999999999999999988766 6
Q ss_pred EEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 041479 598 RALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~ 658 (771)
.++||||+++++|.++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 79999999999987651 2378899999999999999999985 8999999999999999
Q ss_pred CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccH
Q 041479 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDL 722 (771)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~ 722 (771)
++.+|++|||+++....... ........|+..|+||| |||++|||+| |+.||...... ..
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~ 234 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EV 234 (291)
T ss_pred CCcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 99999999999975543221 11122345688899999 6999999999 99998653221 12
Q ss_pred HHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 723 HNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+..............+..+.....+||++||++|||+.+|++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 233322222233334455566677799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=280.32 Aligned_cols=227 Identities=23% Similarity=0.299 Sum_probs=172.2
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|+||+|+.+.+++.||+|+++... ......+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 9 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e 83 (288)
T cd07871 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CLTLVFE 83 (288)
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eEEEEEe
Confidence 3456899999999999999998999999996543 233457889999999999999999999987765 6899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+++ +|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 9975 77654 33478888999999999999999985 99999999999999999999999999997543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh---------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--------------- 728 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--------------- 728 (771)
.......|++.|+||| +||++|||++|+.||....... .+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccc
Confidence 1122346899999999 6999999999999996432111 01111100
Q ss_pred ------hCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ------ALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ------~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+. .....+++...+...+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 000112333334555999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=268.97 Aligned_cols=232 Identities=24% Similarity=0.285 Sum_probs=174.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCC-ceeEEEEeecCCC-CCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRN-LVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~-~~~~~~~lv 601 (771)
.-.+|+|.+|+||+|+.+.+++.||+|+++...+ +......+|+.+++.++|+| ||++++++.+.+. ......++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 3448999999999999999999999999987643 45677899999999999999 9999999977552 222367899
Q ss_pred EEeccCCCCCCC----c---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC----P---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~----~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||++. +|..+ . +.++...+..++.|+++||+|||++ +|+||||||+|||++++|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999964 77555 2 3466678999999999999999996 99999999999999999999999999999554
Q ss_pred cccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccc--------------------cC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMF--------------------TE 718 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~--------------------~~ 718 (771)
-... .-+..++|.+|+||| +||+++||++++.-|.+.. +.
T Consensus 172 ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 172 IPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred CCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 2221 123457899999999 5999999999988775432 21
Q ss_pred CccHHHHHHhhCCC-----chh---hhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 719 GLDLHNFVKMALPD-----QIL---QVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 719 ~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
...+.++-. .++. ... +..++...+...+|++.+|++|.|++.++.+
T Consensus 248 v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111 0100 000 1111122233448999999999999998864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=276.58 Aligned_cols=224 Identities=21% Similarity=0.230 Sum_probs=174.3
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|+|.+|+||+++.+.+++.||+|.+.... ....+.+..|++++++++||||+++++++.+.. ..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-----HLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-----eEEEEEecC
Confidence 589999999999999989999999996432 222345677999999999999999999987765 789999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++|+|.+. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 150 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-- 150 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--
Confidence 99999654 23478888899999999999999985 999999999999999999999999999876543221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCc---hhhhcCccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQ---ILQVLDPLF 742 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 742 (771)
.....|++.|+||| +||++||+++|+.||.+... .....++........ ....+++.+
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-KVAKEELKRRTLEDEVKFEHQNFTEES 226 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-hhhHHHHHHHhhccccccccccCCHHH
Confidence 12245899999999 69999999999999965321 111222222222111 112345556
Q ss_pred cccCcccChhchhhcCCHHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.....+||+.||++||+++|+++.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhh
Confidence 667779999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=283.35 Aligned_cols=223 Identities=22% Similarity=0.229 Sum_probs=174.1
Q ss_pred cccccccceEEEEEec---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 528 SYESLVKATVYKGILD---LDQTFIAVKVLFLHQ----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.+|+|.+|+||+++.. ..++.||||++.... ......+.+|+++++.++||||+++++++.+.+ ..|+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~l 77 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KLYL 77 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eEEE
Confidence 4799999999999864 356799999996532 233456789999999999999999999988766 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+++|+|.+. ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999999765 34567788888999999999999985 99999999999999999999999999987533221
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. ......||+.|+||| +||++|||++|+.||.+.... ..+...... ....+..+++.+
T Consensus 155 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~~~--~~~~~~~~~~~~ 227 (323)
T cd05584 155 T----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKILKG--KLNLPPYLTPEA 227 (323)
T ss_pred C----cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHHcC--CCCCCCCCCHHH
Confidence 1 122356999999999 699999999999999653211 112222221 123344455666
Q ss_pred cccCcccChhchhhcC-----CHHHHHH
Q 041479 743 LVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.....+|+++||++|| ++.++++
T Consensus 228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 6677799999999999 7777764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=283.46 Aligned_cols=223 Identities=22% Similarity=0.212 Sum_probs=174.6
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+++.+++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~E 76 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVME 76 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEEe
Confidence 3799999999999999988899999996542 34456788899999876 7999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--- 150 (321)
T cd05591 77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--- 150 (321)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC---
Confidence 9999999654 34678889999999999999999986 89999999999999999999999999987532211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.|+||| +||++|||++|+.||...... ..+....... ...+..+++.+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~~~i~~~~--~~~p~~~~~~~~~l 226 (321)
T cd05591 151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLFESILHDD--VLYPVWLSKEAVSI 226 (321)
T ss_pred -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HHHHHHHcCC--CCCCCCCCHHHHHH
Confidence 1122356899999999 699999999999999753211 1111222111 11223345555566
Q ss_pred CcccChhchhhcC-------CHHHHHH
Q 041479 746 GVQEGEETAEENI-------KKGQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rp-------t~~~vl~ 765 (771)
..+|+++||++|| ++.++++
T Consensus 227 l~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 227 LKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 6799999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=305.17 Aligned_cols=238 Identities=18% Similarity=0.206 Sum_probs=178.0
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|++|+||+|++..+++.||||++.... ....++|.+|++++++++|||||++++++.+.+ ..|+|
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~lyLV 80 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----PVYYT 80 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----EEEEE
Confidence 3446899999999999999888899999996432 334568999999999999999999999988776 78999
Q ss_pred EEeccCCCCCCCc--------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecc
Q 041479 602 YEFMHHGSLESCP--------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667 (771)
Q Consensus 602 ~e~~~~g~L~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 667 (771)
|||++||+|.++. ...++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 9999999996541 2345667889999999999999985 8999999999999999999999999
Q ss_pred cCccccCcccC--------------Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC
Q 041479 668 GLTRFIPEVMS--------------SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE 718 (771)
Q Consensus 668 Gla~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~ 718 (771)
|+++....... .........+||+.||||| +||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986521110 0011112356999999999 699999999999999652211
Q ss_pred CccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcC-CHHHHHHHHHHh
Q 041479 719 GLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENI-KKGQIRESLIAI 770 (771)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp-t~~~vl~~L~~~ 770 (771)
...................+++.+.....+|+..||++|| ++.++++.|++.
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111100000011123344555566799999999996 677777777664
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=282.06 Aligned_cols=222 Identities=23% Similarity=0.253 Sum_probs=174.0
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|++..+++.||||+++... ....+.+..|..++... +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~e 76 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVME 76 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEEe
Confidence 4799999999999999988899999997542 23456677888888764 8999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|..+ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05619 77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--- 150 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---
Confidence 9999999766 24588899999999999999999985 99999999999999999999999999987432211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
.......||+.|+||| +||++|||++|+.||.+... ..+.+...... ...+..++..+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~~-~~~~~~~~~~~~~l 226 (316)
T cd05619 151 -AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDN-PCYPRWLTREAKDI 226 (316)
T ss_pred -CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-CCCCccCCHHHHHH
Confidence 1122356899999999 69999999999999965321 12222222211 12233345555566
Q ss_pred CcccChhchhhcCCHH-HHH
Q 041479 746 GVQEGEETAEENIKKG-QIR 764 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~-~vl 764 (771)
..+|++.||++||++. ++.
T Consensus 227 i~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 227 LVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHhccCHhhcCCChHHHH
Confidence 6799999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=292.36 Aligned_cols=228 Identities=22% Similarity=0.255 Sum_probs=188.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+..+|.|.+|+||.|++..+...+|||-+........+-+..||.+.++++|.|||+++|.+.+.+ +.-|.||
T Consensus 578 ~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFME 652 (1226)
T KOG4279|consen 578 NERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFME 652 (1226)
T ss_pred CceEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEee
Confidence 35678999999999999999999999999998777777788999999999999999999999987776 6789999
Q ss_pred eccCCCCCCC----cccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcc
Q 041479 604 FMHHGSLESC----PRIL--SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~ 676 (771)
-++||+|... -.++ .+...-.+..||++||.|||++ .|||||||-+|||+.. .|.+||+|||.++.+..-
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 9999999766 2344 5667888999999999999997 8999999999999974 799999999999876543
Q ss_pred cCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchhhh
Q 041479 677 MSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQV 737 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~ 737 (771)
.. + ..++.||..||||| |||++.||.||++||.+.-... ...+..+.+. ++++..
T Consensus 730 nP---~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 730 NP---C-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGMYKVHPPIPEE 803 (1226)
T ss_pred Cc---c-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--HhhhhhcceecCCCCcHH
Confidence 32 1 23467999999999 7999999999999997653222 2222233332 556666
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++..-+....+|..+||.+||++.++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6666666677999999999999999875
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=287.04 Aligned_cols=222 Identities=20% Similarity=0.209 Sum_probs=182.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.-.+|.|+||.||-|++..+.+.||||++.-.. ....+++++|+..+.+++|||+|.+.|+|.... ..|+||
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaWLVM 105 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAWLVM 105 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHHHHH
Confidence 345899999999999999999999999995443 234578999999999999999999999988766 679999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||-| +-.+. .+++.+.++..|+.+++.||+|||+. +.||||||+.|||+.+.|.||++|||.|..+.+.
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 99964 54443 67888999999999999999999997 8999999999999999999999999999865543
Q ss_pred Ccccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 679 SNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.+++|||+||||| +||+..|+...++|+..+.+... ++.++....|.-...-++.
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-LYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-HHHHHhcCCCCCCCchhHH
Confidence 3478999999999 69999999999999876544332 5555555555333333344
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+......|+++-|.+|||..+++.
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 4455566999999999999988875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=280.29 Aligned_cols=228 Identities=21% Similarity=0.234 Sum_probs=175.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..|+|||
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 80 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KLYLVFE 80 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EEEEEEe
Confidence 345799999999999999999999999996542 334567889999999999999999999987766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|++++.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 155 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-- 155 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence 9998876544 34578889999999999999999985 999999999999999999999999999986543221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHH--hhCCC-----------
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--MALPD----------- 732 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--~~~~~----------- 732 (771)
.......||+.|+||| +||++|||++|+.||.+..... .+..... +..+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccch
Confidence 1122346899999999 6999999999999996532111 0111100 00000
Q ss_pred -----------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -----------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -----------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....++..+.....+|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001123444555667999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=273.31 Aligned_cols=233 Identities=23% Similarity=0.329 Sum_probs=182.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|....+ +.||+|.+.... ...+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 80 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PIYIIT 80 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCC-ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----CcEEEE
Confidence 33455689999999999997655 489999986433 24578999999999999999999999987665 679999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999765 24578888999999999999999985 89999999999999999999999999998654322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. .......++..|+||| +||++||++| |+.||.+... ...........+......++..
T Consensus 158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05072 158 Y---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGYRMPRMENCPDE 232 (261)
T ss_pred e---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHH
Confidence 1 1112234677899999 6999999999 9999965321 1233333333332222334455
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.....+|+..+|++|||+.++++.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 55667799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=280.06 Aligned_cols=228 Identities=21% Similarity=0.246 Sum_probs=181.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|+||+|+...+++.||+|.+........+.+.+|+.+++.++||||+++++++.... ..|+||||
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~lv~e~ 98 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWVVMEY 98 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEEeecc
Confidence 3445899999999999998888899999997665555678999999999999999999999988765 78999999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~---- 171 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc----
Confidence 999999876 33578899999999999999999985 899999999999999999999999999876433221
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 746 (771)
......|++.|+||| |||++|||++|+.||.+...... +..+.....+ ...+..+++.+....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCCCCCCccccCHHHHHHH
Confidence 112345889999999 69999999999999965322111 2222221111 122333445555566
Q ss_pred cccChhchhhcCCHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+||..+|++|||+.|+++
T Consensus 251 ~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHCcCCcccCcCHHHHhh
Confidence 7999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=276.80 Aligned_cols=233 Identities=21% Similarity=0.299 Sum_probs=182.5
Q ss_pred ccccccccccceEEEEEec----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILD----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
....+|+|.+|+||+|++. .+++.||+|.+.... .....++.+|++++++++||||+++++++...+ ..|
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 83 (283)
T cd05090 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ-----PVC 83 (283)
T ss_pred eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC-----ceE
Confidence 3456899999999999853 345689999996433 334568999999999999999999999987766 679
Q ss_pred EEEEeccCCCCCCCc--------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 041479 600 LVYEFMHHGSLESCP--------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659 (771)
Q Consensus 600 lv~e~~~~g~L~~~~--------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~ 659 (771)
+||||+++|+|.++. ..+++.+...++.|++.||+|||+. +|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 999999999986541 2367888899999999999999985 89999999999999999
Q ss_pred CceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHH
Q 041479 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLH 723 (771)
Q Consensus 660 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~ 723 (771)
+.+|++|||+++....... ........++..|+||| +||++|||++ |..||.+.. ...+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~~~ 236 (283)
T cd05090 161 LHVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQEVI 236 (283)
T ss_pred CcEEeccccccccccCCcc--eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHH
Confidence 9999999999986543221 11122334677899999 6999999999 998986431 12334
Q ss_pred HHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 724 NFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+..........+..+++.+.....+||++||++||++.++.+.|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 4444333333445556666677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=285.02 Aligned_cols=239 Identities=22% Similarity=0.285 Sum_probs=181.9
Q ss_pred ccccccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|+||+|++. .+++.||||+++... ......+.+|+.++.++ +|||||++++++...+.
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--- 85 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--- 85 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC---
Confidence 334556899999999999853 346789999996543 33456789999999999 68999999998865442
Q ss_pred eeEEEEEEeccCCCCCCCc-------------------------------------------------------------
Q 041479 596 YFRALVYEFMHHGSLESCP------------------------------------------------------------- 614 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~------------------------------------------------------------- 614 (771)
..++||||+++|+|.++.
T Consensus 86 -~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 86 -PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred -ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 568999999999985431
Q ss_pred ---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccc
Q 041479 615 ---------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685 (771)
Q Consensus 615 ---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (771)
..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++....... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 239 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKG 239 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc--hhhcC
Confidence 1357778899999999999999985 999999999999999999999999999986533221 11111
Q ss_pred cccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCccc
Q 041479 686 GLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQE 749 (771)
Q Consensus 686 ~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 749 (771)
...+++.|+||| ||+++||+++ |..||.+.... ..+............+...++.+...+..|
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 234567899999 6999999997 99998754222 122233333333333444566666677799
Q ss_pred ChhchhhcCCHHHHHHHHHHhC
Q 041479 750 GEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 750 l~~~p~~Rpt~~~vl~~L~~~l 771 (771)
|+.||++|||+.|+++.|+.++
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.61 Aligned_cols=233 Identities=20% Similarity=0.245 Sum_probs=179.4
Q ss_pred ccccccccccceEEEEEecCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQT----FIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
....+|+|++|+||+|++..+++ .||+|.+.... .....++..|+.++++++||||+++++++... ..+
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~------~~~ 84 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA------SLQ 84 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC------ccE
Confidence 34568999999999999876664 47778775332 23346788899999999999999999987543 357
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+++||+++|+|.++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 89999999999866 34578999999999999999999985 899999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
... ........|+..|+||| |||++||+++ |+.||.+... ....++.........+...+
T Consensus 162 ~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05111 162 DDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGERLAQPQICT 237 (279)
T ss_pred CCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCCCCCCCC
Confidence 321 11122345778899999 6999999998 9999976422 22334444333322233334
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.....+||..||++|||+.|+++.|+.+
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 4444556699999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=288.53 Aligned_cols=232 Identities=18% Similarity=0.135 Sum_probs=179.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+++.+.+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~-----~~ 118 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK-----YL 118 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----EE
Confidence 4445566899999999999999999999999996432 233456889999999999999999999988776 78
Q ss_pred EEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 599 ALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|+||||+++|+|.++ ...++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999776 23577888889999999999999985 9999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh--
Q 041479 677 MSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL-- 735 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 735 (771)
.. ......+||+.||||| +||++|||++|+.||.+.... ..+.+..........+
T Consensus 196 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred Cc---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCcCCCCCc
Confidence 21 1122456999999999 699999999999999753211 1122222221111111
Q ss_pred hhcCccccccCcccChhchhh--cCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEE--NIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~--Rpt~~~vl~ 765 (771)
..++........+|+..+|++ |||+.|+++
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 123444445566999989988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=281.96 Aligned_cols=224 Identities=23% Similarity=0.260 Sum_probs=172.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHH---hccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQAL---RNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
..+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++ +.++||||+++++++.+.+ ..|+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~-----~~~l 79 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED-----HVCF 79 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----EEEE
Confidence 35799999999999999988999999997542 23345677776665 5668999999999988776 7899
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||||+++|+|... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 v~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG- 155 (324)
T ss_pred EEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence 9999999999655 34689999999999999999999985 99999999999999999999999999987432211
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
......+||+.||||| +||++|||++|+.||.+.... .....+.... ...+..+++.+.
T Consensus 156 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~i~~~~--~~~p~~~~~~~~ 229 (324)
T cd05589 156 ---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSIVNDE--VRYPRFLSREAI 229 (324)
T ss_pred ---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC--CCCCCCCCHHHH
Confidence 1122456999999999 699999999999999653211 1111222211 122334455555
Q ss_pred ccCcccChhchhhcC-----CHHHHHH
Q 041479 744 VGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
....+|++.||++|| ++.++++
T Consensus 230 ~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 230 SIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 667799999999999 4555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=281.13 Aligned_cols=222 Identities=22% Similarity=0.227 Sum_probs=173.8
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|.||+|+++.+++.||||+++... ....+.+..|..++... +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~E 76 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVME 76 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEEC
Confidence 3789999999999999999999999997542 23456677888888764 8999999999988766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|..+ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05620 77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--- 150 (316)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---
Confidence 9999999765 34678889999999999999999986 99999999999999999999999999987432111
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.|+||| +||++|||++|+.||.+... ..+.+...... ...+..+++.+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~l 226 (316)
T cd05620 151 -NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVDT-PHYPRWITKESKDI 226 (316)
T ss_pred -CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC-CCCCCCCCHHHHHH
Confidence 1123456999999999 69999999999999964321 11222222221 22333455556666
Q ss_pred CcccChhchhhcCCHH-HHH
Q 041479 746 GVQEGEETAEENIKKG-QIR 764 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~-~vl 764 (771)
..+|++.||++||++. ++.
T Consensus 227 i~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 227 LEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHccCCHHHcCCChHHHH
Confidence 7799999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=272.87 Aligned_cols=232 Identities=26% Similarity=0.378 Sum_probs=186.8
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|.++. ++.||+|.+.........++.+|+++++.++||||+++++++.+.+ ..++|||
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e 82 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----PVYIITE 82 (261)
T ss_pred HHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----CeEEEEe
Confidence 344567999999999999988 5699999997665555678999999999999999999999988776 6799999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999776 23578999999999999999999985 899999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
...+..++..|+||| +|+++||+++ |+.||.... ............+.......++.+
T Consensus 160 ----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 160 ----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAGYRMPCPAKCPQEI 233 (261)
T ss_pred ----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCCcCCCCCCCCHHH
Confidence 111334677899999 6999999998 899996532 122333333333333344555566
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+.+||+.||++|||+.++++.|+.+
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 6677799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=280.59 Aligned_cols=229 Identities=22% Similarity=0.264 Sum_probs=171.7
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.....+|+|.+|+||+|+.+.+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+ ..++||
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 82 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TLTLVF 82 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eEEEEE
Confidence 34456899999999999999888899999996543 223456789999999999999999999988766 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||++ +++.++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 9996 465433 34578889999999999999999986 89999999999999999999999999987543211
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCC----------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALP---------- 731 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~---------- 731 (771)
.......||+.|+||| +||++|||++|+.||.+.......+...... ..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 ---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred ---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1122346899999999 6999999999999997542211111111110 000
Q ss_pred --------------Cchhhh-----cCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 --------------DQILQV-----LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 --------------~~~~~~-----~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...... ..+.......+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 1112223455999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=281.56 Aligned_cols=223 Identities=22% Similarity=0.206 Sum_probs=175.9
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+++.+++.||||++.... ......+.+|++++..+ +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~e 76 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVME 76 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEEc
Confidence 3799999999999999988899999997542 33456778899999888 6999999999988766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 150 (318)
T cd05570 77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--- 150 (318)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---
Confidence 9999999655 34689999999999999999999985 99999999999999999999999999987432211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.|+||| +||++|||++|+.||.+... .......... ....+..++..+...
T Consensus 151 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~-~~~~~~~~~~~~~~l 226 (318)
T cd05570 151 -VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILED-EVRYPRWLSKEAKSI 226 (318)
T ss_pred -CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcC-CCCCCCcCCHHHHHH
Confidence 1122346899999999 69999999999999965321 1121211111 112233445556666
Q ss_pred CcccChhchhhcCCH-----HHHHH
Q 041479 746 GVQEGEETAEENIKK-----GQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~-----~~vl~ 765 (771)
..+||+.||++|||+ .++++
T Consensus 227 i~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 227 LKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHhc
Confidence 779999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=278.07 Aligned_cols=238 Identities=22% Similarity=0.257 Sum_probs=186.1
Q ss_pred ccccccccccccceEEEEEe-----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGIL-----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|.||+|.. ...+..||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 112 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG---- 112 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC----
Confidence 33445679999999999975 3345689999986543 34457899999999999 7999999999987766
Q ss_pred eeEEEEEEeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 596 YFRALVYEFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 113 -~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 -PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred -ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 679999999999997652 2378999999999999999999985 8999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCch
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQI 734 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 734 (771)
+........ .......++..|+||| +||++||+++ |..||.+.... ..+.+......+...
T Consensus 189 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 265 (302)
T cd05055 189 RDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHHcCCcCCC
Confidence 865432211 1112234678899999 6999999998 99998764322 223344443333333
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+...++.+.....+|+.++|++|||+.|+++.|++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 3445666667777999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.48 Aligned_cols=233 Identities=22% Similarity=0.259 Sum_probs=181.8
Q ss_pred ccccccccccceEEEEEecCCCe----EEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQT----FIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
..-.+|+|.+|+||+|++..+++ .||||++... .....+++.+|+.+++.++||||+++++++... ..+
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~ 84 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS------TVQ 84 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC------CcE
Confidence 34558999999999999876654 4899998644 334467899999999999999999999998654 357
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
++|||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999766 23578999999999999999999985 899999999999999999999999999986643
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
.... ....+..+++.|+||| |||++||+++ |..||..... ..+..+.....+...+...+
T Consensus 162 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 162 DETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGERLPQPPICT 237 (279)
T ss_pred ccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCcCCCCccCC
Confidence 2211 1112233567899999 7999999998 9999865322 22334444333333333445
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.....+||..||++||++.++++.|+++
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 5555667799999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=296.08 Aligned_cols=238 Identities=22% Similarity=0.225 Sum_probs=183.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC---CCce
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF---QGNY 596 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---~~~~ 596 (771)
.+.....+|+|.+|+||+|+...+++.||||++.... ......+.+|+.++..++|+||+++++.+...+. ....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 3444566899999999999999888999999996542 3455678999999999999999999887654331 1112
Q ss_pred eEEEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 597 FRALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
..++||||+++|+|.++ ...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 46899999999999764 23578889999999999999999985 999999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCch
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQI 734 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 734 (771)
++........ ......+||+.|+||| |||++|||++|+.||.+.... .+............
T Consensus 190 s~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 190 SKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--EVMHKTLAGRYDPL 265 (496)
T ss_pred Ceeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHhcCCCCCC
Confidence 9865433221 1123457999999999 699999999999999653111 11111111112233
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
+..+++.+.....+||+.||++||++.++++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 44556666677779999999999999999763
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=276.91 Aligned_cols=234 Identities=24% Similarity=0.290 Sum_probs=183.3
Q ss_pred cccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.+|+||+|+... +...||+|.+.... ....+++.+|+.+++.++||||+++++++...+ ..+
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 79 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-----PLL 79 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----CcE
Confidence 3457999999999998753 23579999886543 334578999999999999999999999987766 579
Q ss_pred EEEEeccCCCCCCCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 041479 600 LVYEFMHHGSLESCP---------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652 (771)
Q Consensus 600 lv~e~~~~g~L~~~~---------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~ 652 (771)
+||||+.+|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 999999999986541 2467888999999999999999985 8999999999
Q ss_pred CeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccc
Q 041479 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMF 716 (771)
Q Consensus 653 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~ 716 (771)
||++++++.+||+|||+++........ .......++..|+||| ||+++|||++ |..||.+..
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999865432221 1122234577899999 6999999999 999986532
Q ss_pred cCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 717 TEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
...+.+..........+...+..+...+.+|++.+|++||++.++++.|++++
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 --PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 22344444443333334445556666777999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.21 Aligned_cols=238 Identities=22% Similarity=0.250 Sum_probs=178.9
Q ss_pred cccccccccceEEEEEec----CCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILD----LDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|+||+|..+ .+++.||||++........+.+.+|++++++++||||+++++++...+. ...++|
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv 85 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLRLV 85 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC---CceEEE
Confidence 345899999999999853 4567999999976666667789999999999999999999998765432 257899
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 999999999876 23578999999999999999999985 99999999999999999999999999998765432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC-------C----c---cHHHHHHh
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE-------G----L---DLHNFVKM 728 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~-------~----~---~~~~~~~~ 728 (771)
..... .....++..|+||| +||++||+++|..|+...... . . .+.++...
T Consensus 163 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 163 EYYKV-REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred cceee-cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 21111 11122455699999 699999999987765322100 0 0 01112222
Q ss_pred hCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 729 ALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.........++..+.....+||..+|++||||.|+++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 222122233344555667799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=271.30 Aligned_cols=228 Identities=23% Similarity=0.299 Sum_probs=178.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|+||+|.+..+. .||||.+.... ...++|.+|+.++++++||||+++++++.+.+ ..++||||+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~-~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 81 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYIVTEYM 81 (256)
T ss_pred eeEecCcccceEEEEEecCCC-cEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEEEEEcC
Confidence 446899999999999887554 79999986433 23467999999999999999999999987665 579999999
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++|+|.++ ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 99998765 23578999999999999999999985 999999999999999999999999999876543221
Q ss_pred cccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
....+..++..|+||| |||++|||++ |+.||..... ....+......+.......+..+...
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVSQGLRLYRPHLASEKVYAI 233 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 1122334667899999 6999999999 9999865321 12223333333333333445556667
Q ss_pred CcccChhchhhcCCHHHHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
..+||+.+|++|||+.++++.|+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHhhC
Confidence 77999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.54 Aligned_cols=231 Identities=22% Similarity=0.277 Sum_probs=182.7
Q ss_pred cccccccceEEEEEecCCC---eEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQ---TFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|.||+|++...+ ..||+|.+..... ...+++.+|+++++++.|||||++++++... ..++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~v~e 75 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE------PLMLVME 75 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC------ceEEEEE
Confidence 3689999999999876554 6899999965543 3456899999999999999999999987533 4689999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~- 151 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY- 151 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc-
Confidence 9999999876 23588999999999999999999985 8999999999999999999999999999866433221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
........++..|+||| |||++||+++ |+.||.+.. +..+.+......+...+..+++.+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGERLPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11112223457899999 6999999998 999997542 23344444444333344445566667
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.+||..+|++|||+.++++.|+++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 77799999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.33 Aligned_cols=227 Identities=22% Similarity=0.247 Sum_probs=181.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||+|.+..++..||+|.+........+.+.+|+++++.++||||+++++++...+ ..|+||||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v~e~~ 84 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILIEFC 84 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEEEEec
Confidence 345899999999999999988899999997666666788999999999999999999999988766 789999999
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++|+|..+ ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99998664 34688999999999999999999985 99999999999999999999999999987543221
Q ss_pred cccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCc
Q 041479 682 CSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDP 740 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 740 (771)
.......|++.|+||| +||++|||++|+.||.+..... ..........+ ...+..++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCCCCCCccccCH
Confidence 1122346899999999 6999999999999986532211 12222222111 122233455
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||+.||++|||+.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 5666777999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=271.39 Aligned_cols=237 Identities=24% Similarity=0.375 Sum_probs=182.9
Q ss_pred ccccccccccceEEEEEecCCCe---EEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQT---FIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
....+|+|.+|.||+|+++.+++ .||||++... .....++|..|+.++++++||||+++++++.+.. ..++
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~l 82 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR-----PVMI 82 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----ceEE
Confidence 34558999999999999876653 6999998654 3445678999999999999999999999987665 6799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++|+|.++ ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999765 33578899999999999999999985 9999999999999999999999999998865432
Q ss_pred cCCcc-cccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 677 MSSNQ-CSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 677 ~~~~~-~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
..... ....+..++..|+||| +||++||+++ |..||.+... ....++.....+......++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~ 237 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDYRLPPPMDCP 237 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCcCCCcccCC
Confidence 21111 1111112245799999 6999999987 9999965321 22334443333322223334
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+.....+||..+|++||++.+++..|++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 45555667999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.39 Aligned_cols=225 Identities=24% Similarity=0.248 Sum_probs=177.3
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
-.+|+|.+|+||++....+++.||||++.... ......+.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 80 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----ALCLVLT 80 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eEEEEEe
Confidence 35799999999999998888899999996542 223456788999999999999999999987766 6899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999654 23588999999999999999999985 899999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHH--hhCCCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--MALPDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 741 (771)
.....|++.|+||| +||++||+++|+.||.+.... ....++.. ...+...+..+++.
T Consensus 158 -----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05605 158 -----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKEDQEEYSEKFSEA 231 (285)
T ss_pred -----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhcccccCcccCHH
Confidence 12346899999999 699999999999999753211 11111111 11122333445566
Q ss_pred ccccCcccChhchhhcC-----CHHHHHH
Q 041479 742 FLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
+.....+||+.||++|| +++++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 66677799999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=281.93 Aligned_cols=219 Identities=27% Similarity=0.261 Sum_probs=169.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+++.+++.||||++.... ....+++..|.. +++.++||||+++++++.+.+ ..|+|||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~e 76 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVLD 76 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEEc
Confidence 3789999999999999999999999996542 223345566655 467899999999999987766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|..+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 150 (323)
T cd05575 77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--- 150 (323)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---
Confidence 9999999655 34678888999999999999999985 99999999999999999999999999987532211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.|+||| +||++|||++|+.||.+.... ......... +......+++.+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~--~~~~~~~~~~~~~~l 226 (323)
T cd05575 151 -KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-EMYDNILNK--PLRLKPNISVSARHL 226 (323)
T ss_pred -CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-HHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 1122456999999999 699999999999999653111 111111111 222333445556666
Q ss_pred CcccChhchhhcCCHH
Q 041479 746 GVQEGEETAEENIKKG 761 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~ 761 (771)
..+|++.||++||+++
T Consensus 227 i~~~l~~~p~~R~~~~ 242 (323)
T cd05575 227 LEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHhhcCHHhCCCCC
Confidence 7799999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.01 Aligned_cols=221 Identities=22% Similarity=0.232 Sum_probs=174.1
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+.+.+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+ ..|+|||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e 76 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVIE 76 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEEe
Confidence 4799999999999999999999999997542 23456788999999888 6999999999987766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|... .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 150 (327)
T cd05617 77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--- 150 (327)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---
Confidence 9999999654 35689999999999999999999985 99999999999999999999999999987432211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC-CccHHHHH---HhhCCCchhhhcCcc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE-GLDLHNFV---KMALPDQILQVLDPL 741 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~ 741 (771)
......+||+.|+||| +||++|||++|+.||...... .....++. ....+...+..++..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 1122356999999999 699999999999999642211 11111111 112223344555666
Q ss_pred ccccCcccChhchhhcCCH
Q 041479 742 FLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~ 760 (771)
......+|++.||++||++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 6666779999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.85 Aligned_cols=229 Identities=19% Similarity=0.199 Sum_probs=189.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..-.+|.|+||.++..+++.+.+.||+|.+.... ...++....|+.++++++|||||.+.+.|++.+. +.+|||
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~----~l~Ivm 83 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ----LLCIVM 83 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc----eEEEEE
Confidence 3445799999999999999999999999997664 3345578999999999999999999999988762 489999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+||+||++.+. ...+++..+..++.|++.|+.|||+. +|+|||||+.||++..++.+|+.|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999776 34688999999999999999999975 89999999999999999999999999999887643
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. ...+.+||+.||+|| +||++|||++-+.+|...-..+ -..++.... -..++......+
T Consensus 161 ~----~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-Li~ki~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 S----LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-LILKINRGL-YSPLPSMYSSEL 234 (426)
T ss_pred h----hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-HHHHHhhcc-CCCCCccccHHH
Confidence 2 233468999999999 6999999999999997532222 122222222 345666777777
Q ss_pred cccCcccChhchhhcCCHHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
+.+...|+.++|..||++.+++.+
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhC
Confidence 777889999999999999999865
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.83 Aligned_cols=228 Identities=21% Similarity=0.254 Sum_probs=179.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|+||+|+++.+++.||+|.+........+.+.+|+.++++++|+||+++++++...+ ..++||||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG-----FFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-----EEEEEEecC
Confidence 456899999999999999888899999987666666778999999999999999999999988776 789999999
Q ss_pred cCCCCCCCc----ccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcccC
Q 041479 606 HHGSLESCP----RIL--SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~~----~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~~ 678 (771)
++++|.++. ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 999997762 234 7778889999999999999985 9999999999999976 67999999999876533221
Q ss_pred Ccccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
......|++.|+||| +|+++||+++|+.||.....................++..+++.
T Consensus 165 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 165 ----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred ----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 111235789999999 69999999999999865322111111111111223344455556
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||..+|++|||+.|+++
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHh
Confidence 666677999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.97 Aligned_cols=232 Identities=19% Similarity=0.233 Sum_probs=178.8
Q ss_pred cccccccccceEEEEEecCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.+|+||+|.+..+ ++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+ ..+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~ 84 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-----PLS 84 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-----ceE
Confidence 34579999999999987543 4689999996543 233567899999999999999999999988776 678
Q ss_pred EEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 041479 600 LVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660 (771)
Q Consensus 600 lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~ 660 (771)
+++||+++++|.++. ..+++..+..++.|++.||+|+|+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999876541 2477888999999999999999985 899999999999999999
Q ss_pred ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHH
Q 041479 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHN 724 (771)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 724 (771)
.+|++|||+++....... ........+++.|+||| +||++|||++ |..||.+... ..+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVIE 237 (283)
T ss_pred ceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 999999999886543321 11112234678899999 6999999998 8888865322 12333
Q ss_pred HHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 725 FVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
..........+..+...+.....+||+.+|++||++.++++.|+.
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 332222222333344445566679999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.64 Aligned_cols=233 Identities=21% Similarity=0.248 Sum_probs=177.1
Q ss_pred ccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|+|++|.||+|+++. .+..||||++.... .....+|.+|+.+++.++||||+++++++.+.. ..
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~~ 84 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-----PT 84 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----Ce
Confidence 34568999999999998652 34689999985432 234567899999999999999999999987665 67
Q ss_pred EEEEEeccCCCCCCCc-------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 041479 599 ALVYEFMHHGSLESCP-------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 665 (771)
++||||+++|+|.++. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999997652 1246778899999999999999985 89999999999999999999999
Q ss_pred cccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 041479 666 DFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~ 729 (771)
|||+++........ .......+++.||||| |||++||+++ |..||.+... ....+.....
T Consensus 162 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~ 237 (277)
T cd05062 162 DFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFVMEG 237 (277)
T ss_pred CCCCccccCCccee--ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcC
Confidence 99999755332211 1111234578899999 6999999999 7888865321 1222222222
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.....+......+.....+|++.||++|||+.|+++.|++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2222233344555667779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=270.82 Aligned_cols=236 Identities=19% Similarity=0.312 Sum_probs=182.3
Q ss_pred ccccccccccceEEEEEecCCCe---EEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQT---FIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~---~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
....+|+|.+|.||+|+.+.+++ .||||.+.... ....+++..|++++++++||||+++++++...+ ..++
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 83 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-----PAMI 83 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-----CcEE
Confidence 34568999999999999876543 79999986542 344678999999999999999999999987766 6799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++++|.++ ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999766 23578999999999999999999985 8999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.... ........++.|+||| +||++||+++ |+.||..... ..+........+.......+.
T Consensus 161 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 161 PEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred cccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCCCCCCCCCCCH
Confidence 2111 1111222356799999 6999999998 9999965322 122222222222222223445
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+.....+||+.+|++||++.+|++.|++++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 5556677999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.01 Aligned_cols=231 Identities=26% Similarity=0.345 Sum_probs=180.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|.||+|.+..+ +.||||.++... ...+++.+|++++++++||||+++++++...+ ..++||||
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 82 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PIYIVTEL 82 (261)
T ss_pred eEEEecccCCccEEEEEecCC-eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Ceeeeeec
Confidence 345689999999999997655 589999986543 23567999999999999999999999987766 67999999
Q ss_pred ccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++++|.++. ..+++.++..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 9999997662 3588999999999999999999985 899999999999999999999999999987653221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
....+..++..|+||| ||+++||++| |+.||.+... ...........+.......+..+.
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 159 --EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGYRMPCPPGCPKELY 234 (261)
T ss_pred --cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1112223356799999 6999999999 9999865321 112222222222222333445555
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+|++.+|++||++.++++.|+++
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 667799999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=276.44 Aligned_cols=230 Identities=22% Similarity=0.294 Sum_probs=170.0
Q ss_pred cccccccccceEEEEEec-CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhcc---CCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILD-LDQTFIAVKVLFLHQ--RGALKSFMAECQALRNI---RHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.+|+||+|++. .+++.||||++.... ......+.+|+.+++.+ +||||++++++|...........+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 345899999999999985 456789999986542 23345677788877766 699999999998654333334679
Q ss_pred EEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 600 LVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 600 lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
+||||++ ++|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161 (290)
T ss_pred EEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEecc
Confidence 9999996 577554 23478899999999999999999985 99999999999999999999999999997654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC--C----
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP--D---- 732 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~--~---- 732 (771)
... ......||+.|+||| +||++|||++|+.||.+....+ .+....... .+ .
T Consensus 162 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 162 FQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred CCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchh
Confidence 321 122346899999999 6999999999999997532211 111221110 00 0
Q ss_pred ------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011123334445566999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.33 Aligned_cols=232 Identities=26% Similarity=0.340 Sum_probs=181.6
Q ss_pred cccccccccceEEEEEecCC-----CeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.+|.||+|++... ++.||||.+...... ..+.+.+|++++++++||||+++++++.... ..+
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 84 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-----PPI 84 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC-----CeE
Confidence 44589999999999987543 468999999655433 4678999999999999999999999988775 689
Q ss_pred EEEEeccCCCCCCCc-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 041479 600 LVYEFMHHGSLESCP-----------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA 662 (771)
Q Consensus 600 lv~e~~~~g~L~~~~-----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~ 662 (771)
+||||+++|+|.++. ..+++.++..++.|++.|++|+|+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999986541 2367888999999999999999985 89999999999999999999
Q ss_pred EEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 041479 663 HMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFV 726 (771)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 726 (771)
|++|||+++....... ........+++.|+||| +||++|||++ |+.||.+... ....+..
T Consensus 162 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--EEVIECI 237 (280)
T ss_pred EECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH
Confidence 9999999975433221 11112234678899999 6999999999 9999865422 2233333
Q ss_pred HhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 727 KMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
...........++..+.....+||..||++|||+.|+++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 3322222334455566667779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=281.04 Aligned_cols=228 Identities=21% Similarity=0.187 Sum_probs=176.3
Q ss_pred cccccccccceEEEEEec---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCcee
Q 041479 526 NVSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ----RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~ 597 (771)
...+|+|.+|+||+++.. .+++.||+|++.... ....+.+..|+++++.++ ||||+++++++...+ .
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-----~ 79 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-----K 79 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC-----E
Confidence 345899999999998764 356799999996432 234567889999999994 999999999987766 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 8999999999999765 34688999999999999999999985 89999999999999999999999999998643
Q ss_pred cccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCCCchhh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALPDQILQ 736 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~ 736 (771)
.... ......+||+.||||| +||++|||+||+.||...... .....+... ......+.
T Consensus 157 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd05614 157 SEEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSRRILKCDPPFPS 232 (332)
T ss_pred ccCC---CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHHHHHhcCCCCCCC
Confidence 3221 1122356999999999 699999999999999642211 111122111 12233444
Q ss_pred hcCccccccCcccChhchhhcC-----CHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+++.+.....+|++.||++|| ++.++++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 5566666677799999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=285.09 Aligned_cols=231 Identities=17% Similarity=0.145 Sum_probs=171.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|+...+++.||||++.... ......+.+|+.++.+++||||+++++++.+.. ..|+||
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~~~lv~ 80 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----NLYLIM 80 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----eEEEEE
Confidence 345899999999999999989999999996542 234467889999999999999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999766 35688999999999999999999985 9999999999999999999999999999765321100
Q ss_pred c-------------------------------ccccccccccccccchh---------------HHHHHHHHHhCCCCCC
Q 041479 680 N-------------------------------QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 680 ~-------------------------------~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~ 713 (771)
. .......+||+.|+||| +||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0 00012457999999999 6999999999999997
Q ss_pred ccccCCccHHHHHHhhCCCchh--hhcCccccccCcc--cChhchhhcCCHHHHHH
Q 041479 714 DMFTEGLDLHNFVKMALPDQIL--QVLDPLFLVGGVQ--EGEETAEENIKKGQIRE 765 (771)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--cl~~~p~~Rpt~~~vl~ 765 (771)
+..... ..............+ ..+++.......+ |...++..||++.|+++
T Consensus 238 ~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 238 SETPQE-TYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCHHH-HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 532211 122222111111111 1123333322222 43344456789999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=285.38 Aligned_cols=232 Identities=18% Similarity=0.141 Sum_probs=175.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|.+|+||+++++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..|
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-----~~~ 119 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK-----YLY 119 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----EEE
Confidence 344556899999999999999999999999996432 233456889999999999999999999988776 789
Q ss_pred EEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 600 LVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 600 lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999999776 33578888999999999999999985 99999999999999999999999999998654322
Q ss_pred CCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh--h
Q 041479 678 SSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL--Q 736 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~ 736 (771)
. ......+||+.||||| +||++|||++|+.||.+.... ....++.........+ .
T Consensus 197 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 197 M---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred c---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCcccCCCCcc
Confidence 1 1123457999999999 599999999999999653211 1122333222111111 1
Q ss_pred hcCccccccCcccChhchhh--cCCHHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEE--NIKKGQIRES 766 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~--Rpt~~~vl~~ 766 (771)
.++.........|+..++.+ |||+.|+++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 23333444445677644443 8899998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=273.94 Aligned_cols=232 Identities=20% Similarity=0.215 Sum_probs=181.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|.||+|+...+++.||+|++..........+.+|+.++++++||||+++++++...+ ..++||
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~iv~ 85 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLWICM 85 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEEEEE
Confidence 344556899999999999998888899999997655445567889999999999999999999988766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||+++.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999765 34678899999999999999999985 999999999999999999999999999986543211
Q ss_pred cccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cc--hhhhc
Q 041479 680 NQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQ--ILQVL 738 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 738 (771)
......|++.|+||| +||++|||++|+.||.+...... ...+...... .. ....+
T Consensus 162 ---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 162 ---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred ---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCCCCCCcccccc
Confidence 112346889999999 69999999999999865322111 1111111111 11 11223
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
+..+.....+||..+|++|||++++++.|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 44555667799999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=268.75 Aligned_cols=227 Identities=20% Similarity=0.212 Sum_probs=183.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|+.+.+++.||+|.+... .....+++.+|++++++++||||+++++++.+.+ ..|+|||
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 79 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLNIVME 79 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEEEEEE
Confidence 34578999999999999998999999998643 3445678999999999999999999999988766 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++++|.++ ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999765 24578888999999999999999985 999999999999999999999999999886654321
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
......|++.|+||| |||++|||++|+.||.... ...................++..+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08529 157 ----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGVFPPVSQMYSQQLA 230 (256)
T ss_pred ----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCccccCHHHH
Confidence 112346889999999 6999999999999996432 1112222222222334445666677
Q ss_pred ccCcccChhchhhcCCHHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
....+||+.+|++||++.++++.
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhC
Confidence 77789999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=271.26 Aligned_cols=229 Identities=25% Similarity=0.286 Sum_probs=177.0
Q ss_pred cccccccceEEEEEecCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQT--FIAVKVLFLH-QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|.||+|+++.++. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEEE
Confidence 37899999999999987764 4688888643 234557899999999999 7999999999988766 5799999
Q ss_pred eccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEE
Q 041479 604 FMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHM 664 (771)
Q Consensus 604 ~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl 664 (771)
|+++|+|.++. ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEE
Confidence 99999986541 1367889999999999999999985 9999999999999999999999
Q ss_pred ecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 041479 665 GDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKM 728 (771)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~ 728 (771)
+|||+++...... .......++.|+||| |||++|||++ |..||.+... ....+....
T Consensus 154 ~dfgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~~~~~ 226 (270)
T cd05047 154 ADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQ 226 (270)
T ss_pred CCCCCccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--HHHHHHHhC
Confidence 9999986322111 111122456799999 6999999997 9999965321 112222222
Q ss_pred hCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 729 ALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.........++..+.....+||..+|.+|||+.++++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2222233344555666677999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=273.30 Aligned_cols=235 Identities=23% Similarity=0.325 Sum_probs=183.5
Q ss_pred ccccccccccccceEEEEEec-----CCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
......+|+|++|+||++... .++..||+|.+........+.+.+|++++++++||||+++++++...+ .
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 81 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-----P 81 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-----c
Confidence 334567899999999999753 245689999987666666788999999999999999999999988766 5
Q ss_pred EEEEEEeccCCCCCCCc------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 041479 598 RALVYEFMHHGSLESCP------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~ 659 (771)
.+++|||+++|+|.++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 79999999999986551 2478899999999999999999985 99999999999999999
Q ss_pred CceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHH
Q 041479 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLH 723 (771)
Q Consensus 660 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~ 723 (771)
+.+||+|||+++........ .......+++.|+||| |||++||+++ |+.||.+... ....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~ 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--TEAI 234 (280)
T ss_pred CCEEECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--HHHH
Confidence 99999999999755332211 1112233578899999 6999999999 8999865322 1222
Q ss_pred HHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 724 NFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+......+...+..+++.+.....+||+.||++||++.||++.|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 2222222333334455666677779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=287.08 Aligned_cols=230 Identities=17% Similarity=0.172 Sum_probs=175.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++..++||||+++++++.+.+ ..|+||
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~~~lv~ 80 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----YLYLIM 80 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----eEEEEE
Confidence 346899999999999999999999999997542 334567889999999999999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999776 34688999999999999999999986 8999999999999999999999999998754321110
Q ss_pred cc----------------------------------cccccccccccccchh---------------HHHHHHHHHhCCC
Q 041479 680 NQ----------------------------------CSSVGLKGTVGYATPE---------------YGILLLEIFTGKR 710 (771)
Q Consensus 680 ~~----------------------------------~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~ 710 (771)
.. ......+||+.||||| +||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00 0111346999999999 6999999999999
Q ss_pred CCCccccCCccHHHHHHhhC--CCchhhhcCccccccCcccChhchhhcCC---HHHHHH
Q 041479 711 PTSDMFTEGLDLHNFVKMAL--PDQILQVLDPLFLVGGVQEGEETAEENIK---KGQIRE 765 (771)
Q Consensus 711 P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt---~~~vl~ 765 (771)
||.+..... .......... +......+++.......+|+. +|.+|++ +.++++
T Consensus 238 Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQE-TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHHH-HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 997532111 1111111111 111111234444445557775 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.38 Aligned_cols=233 Identities=21% Similarity=0.247 Sum_probs=184.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|.||+|+...+++.||||.+... .....+++.+|+++++.++||||+++++++.+.+ ..+++|
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~~v~ 81 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----ELNIVL 81 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----eEEEEE
Confidence 34578999999999999888889999988543 2334568999999999999999999999988766 679999
Q ss_pred EeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 603 EFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||+++++|.++ ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999764 23578899999999999999999985 999999999999999999999999999876543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHH-HhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV-KMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 739 (771)
... ......|+..|+||| +|+++|||++|..||...........+.. ....+......++
T Consensus 159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 221 112346889999999 69999999999999864321111121211 1222222334455
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.+.....+||..||++||||.+|++.++++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 6666677799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=269.17 Aligned_cols=234 Identities=22% Similarity=0.275 Sum_probs=183.4
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|.||+|....+++.||+|.++.. .....+++.+|++++++++|+||+++++++.+.+ ..++|
T Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~~~lv 80 (267)
T cd08224 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----ELNIV 80 (267)
T ss_pred eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----eEEEE
Confidence 344579999999999999988889999988642 2334678999999999999999999999988765 67999
Q ss_pred EEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||+++|+|..+ ...+++.++..++.+++.|+.|||+. +|+||||||+||+++.++.++++|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999654 23478889999999999999999985 99999999999999999999999999987654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 738 (771)
.... ......|++.|+||| +||++||+++|+.||...........+.... ..++......
T Consensus 158 ~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd08224 158 SKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY 233 (267)
T ss_pred CCCc----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhc
Confidence 3221 112345888999999 6999999999999985432111111121111 1222112244
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+..+.....+||..+|++|||+.++++.|+++
T Consensus 234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 234 SEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 55555667799999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=276.72 Aligned_cols=234 Identities=25% Similarity=0.280 Sum_probs=178.9
Q ss_pred ccccccccccccceEEEEEecCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQT--FIAVKVLFLH-QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|.||+|+++.++. .+|+|.+... .....+.+.+|++++.++ +||||+++++++.+.+ ..
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~-----~~ 83 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YL 83 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-----Cc
Confidence 3445568999999999999877654 4577776543 234557889999999999 8999999999987766 67
Q ss_pred EEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 041479 599 ALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~ 659 (771)
|+||||+++|+|.++. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 9999999999986641 2468889999999999999999985 99999999999999999
Q ss_pred CceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHH
Q 041479 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLH 723 (771)
Q Consensus 660 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~ 723 (771)
+.+||+|||+++...... ......++..|+||| |||++||++| |..||.+... ....
T Consensus 161 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~ 233 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELY 233 (303)
T ss_pred CcEEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--HHHH
Confidence 999999999986432111 111123466799999 6999999998 9999864322 1222
Q ss_pred HHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 724 NFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+......+...+..+++.+.....+||+.+|++||++.++++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222222222223334555666677999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=272.36 Aligned_cols=237 Identities=22% Similarity=0.208 Sum_probs=177.7
Q ss_pred ccccccccceEEEEEe----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGIL----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|+||++.. ..+++.||+|.+.... ....+.|.+|++++++++||||+++++++...+. ...++|
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv 86 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG---KGLQLI 86 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---ceEEEE
Confidence 4579999999977653 3456689999996543 2345788999999999999999999999865432 257899
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||+++|+|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++........
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 999999999776 34689999999999999999999985 8999999999999999999999999999866432211
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCcc-------------HHHHHHhhCC
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLD-------------LHNFVKMALP 731 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~-------------~~~~~~~~~~ 731 (771)
. .......++..|+||| +|+++|||+||..|+......-.. +.+.......
T Consensus 164 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 164 Y-RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred h-ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 0 1111223567799999 699999999999998543211000 0111111111
Q ss_pred CchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+......+.....+||+.+|++|||++++++.|+++
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 112223344555667799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=278.89 Aligned_cols=219 Identities=20% Similarity=0.178 Sum_probs=171.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCC-CCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRH-RNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.+|+||+|+.+.+++.||||++.... ....+.+..|++++..++| ++|+++++++.+.+ ..|+||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 80 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----RLYFVM 80 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----EEEEEE
Confidence 45799999999999999988899999996542 3445778899999999976 46888888887766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--
Confidence 99999999765 34578899999999999999999985 99999999999999999999999999987432111
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
......+||+.|+||| +||++|||+||+.||.+.... ........ .....+..+++.+..
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~-~~~~~~~~~~~~~~~ 230 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIME-HNVSYPKSLSKEAVS 230 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHc-CCCCCCCCCCHHHHH
Confidence 1122356999999999 699999999999999753221 12111111 122233445666656
Q ss_pred cCcccChhchhhcCCH
Q 041479 745 GGVQEGEETAEENIKK 760 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~ 760 (771)
...+|+.+||++||+.
T Consensus 231 li~~~l~~~P~~R~~~ 246 (324)
T cd05587 231 ICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHhhcCHHHcCCC
Confidence 6779999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=269.52 Aligned_cols=235 Identities=22% Similarity=0.318 Sum_probs=182.1
Q ss_pred cccccccccceEEEEEecCCC---eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQ---TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|.||+|++..++ ..||+|.++... ....+.+.+|+.++++++||||+++++++.+.+ ..|+|
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 83 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-----PVMIV 83 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----ccEEE
Confidence 345799999999999886433 379999986542 334578999999999999999999999987765 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999776 23578899999999999999999985 89999999999999999999999999998765432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.. ........++..|+||| ||+++||+++ |+.||.+... ....+......+......+++.
T Consensus 161 ~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd05066 161 EA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEGYRLPAPMDCPAA 237 (267)
T ss_pred ce-eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhCCCcCCCCCCCCHH
Confidence 21 11112223456899999 6999999887 9999965422 1233333333222222334455
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+.....+|++++|++||+|.++++.|++++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 556677999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=286.24 Aligned_cols=230 Identities=20% Similarity=0.216 Sum_probs=179.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++..++||||+++++++.+.+ ..|+||
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~ 80 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----HLYLVM 80 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----eEEEEE
Confidence 446899999999999999888999999997542 244568899999999999999999999987766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC-
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS- 678 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 678 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999766 34688899999999999999999985 999999999999999999999999999986543320
Q ss_pred ------------------------Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC
Q 041479 679 ------------------------SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG 719 (771)
Q Consensus 679 ------------------------~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~ 719 (771)
..........||+.|+||| +||++|||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 0011123456999999999 699999999999999753211
Q ss_pred ccHHHHHH--hhCCCchhhhcCccccccCcccChhchhhcCC-HHHHHH
Q 041479 720 LDLHNFVK--MALPDQILQVLDPLFLVGGVQEGEETAEENIK-KGQIRE 765 (771)
Q Consensus 720 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt-~~~vl~ 765 (771)
........ ..........+++.+.....+|+. ||.+||+ +.++++
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 11222222 111111112245566666668997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.19 Aligned_cols=235 Identities=24% Similarity=0.310 Sum_probs=181.9
Q ss_pred ccccccccccceEEEEEecCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCcee
Q 041479 525 LNVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
....+|+|.+|.||++.+... ...||+|.+.... .....++.+|++++.++ +||||+++++++...+ .
T Consensus 16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~ 90 (293)
T cd05053 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG-----P 90 (293)
T ss_pred EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-----C
Confidence 345679999999999988643 3689999986532 33456789999999999 7999999999987766 6
Q ss_pred EEEEEEeccCCCCCCC-------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 041479 598 RALVYEFMHHGSLESC-------------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~-------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~ 658 (771)
.+++|||+++|+|..+ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 7999999999998644 23578889999999999999999985 9999999999999999
Q ss_pred CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccH
Q 041479 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDL 722 (771)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~ 722 (771)
++.+|++|||+++.+....... ......++..|+||| |||++||+++ |..||..... ...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYR--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EEL 243 (293)
T ss_pred CCeEEeCcccccccccccccee--ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--HHH
Confidence 9999999999998765432211 112223567899999 6999999998 9999865321 122
Q ss_pred HHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 723 HNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+..........+...+..+.....+||..||++||||.|+++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2333332222233334455556677999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.88 Aligned_cols=230 Identities=20% Similarity=0.219 Sum_probs=171.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|+...+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~~~lv~ 80 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NLYFVM 80 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----EEEEEE
Confidence 345899999999999999999999999996542 334567899999999999999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC-
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS- 678 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 678 (771)
|||++|+|.+. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999765 34578888899999999999999986 899999999999999999999999999853311000
Q ss_pred ------------------------------------------Ccccccccccccccccchh---------------HHHH
Q 041479 679 ------------------------------------------SNQCSSVGLKGTVGYATPE---------------YGIL 701 (771)
Q Consensus 679 ------------------------------------------~~~~~~~~~~gt~~y~aPE---------------~Gv~ 701 (771)
.........+||+.||||| +||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0000112357999999999 6999
Q ss_pred HHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcCccccccCcccChhchhhcCC---HHHHHH
Q 041479 702 LLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLDPLFLVGGVQEGEETAEENIK---KGQIRE 765 (771)
Q Consensus 702 l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt---~~~vl~ 765 (771)
+|||++|+.||.+..... .......... +......+++.......+++ .+|.+|++ +.++++
T Consensus 238 l~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLE-TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHH-HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999999997532211 1222222111 11111223344433333443 59999997 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.68 Aligned_cols=223 Identities=26% Similarity=0.243 Sum_probs=170.7
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+++.+++.||+|++.... ......+..|.. +++.++||||+++++++.+.+ ..|+|||
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~e 76 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVLD 76 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEEe
Confidence 4799999999999999998899999996542 222344555554 567889999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--- 150 (325)
T cd05602 77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--- 150 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC---
Confidence 9999999765 34577788888999999999999985 99999999999999999999999999997532211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.||||| +||++|||++|+.||.+... ....+.... .+......+++.+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~-~~~~~~~~~~~~~~~l 226 (325)
T cd05602 151 -GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILN-KPLQLKPNITNSARHL 226 (325)
T ss_pred -CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HHHHHHHHh-CCcCCCCCCCHHHHHH
Confidence 1123456999999999 69999999999999965321 112122211 1222333445555566
Q ss_pred CcccChhchhhcCCHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+|+++||++||++.+.+.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 227 LEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHcccCHHHCCCCCCCHH
Confidence 67999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=281.34 Aligned_cols=220 Identities=23% Similarity=0.238 Sum_probs=172.5
Q ss_pred cccccccceEEEEEe---cCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 528 SYESLVKATVYKGIL---DLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~---~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.+|+|.+|+||+++. +.+++.||||++.... ......+..|++++++++||||+++++++.+.+ ..|+||
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 77 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLIL 77 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEEE
Confidence 479999999999876 3467799999997543 223456788999999999999999999988766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999999765 34588999999999999999999985 899999999999999999999999999975433211
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
......||+.|+||| +||++|||++|+.||....... ........ ....+..+++.+..
T Consensus 154 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~i~~~--~~~~p~~~~~~~~~ 227 (318)
T cd05582 154 ---KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTMILKA--KLGMPQFLSPEAQS 227 (318)
T ss_pred ---ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-HHHHHHcC--CCCCCCCCCHHHHH
Confidence 122356899999999 6999999999999996532111 11111111 12233445666666
Q ss_pred cCcccChhchhhcCCHHH
Q 041479 745 GGVQEGEETAEENIKKGQ 762 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~ 762 (771)
...+||+.||++||++.+
T Consensus 228 li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 228 LLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHhhcCHhHcCCCCC
Confidence 677999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=268.42 Aligned_cols=228 Identities=24% Similarity=0.304 Sum_probs=178.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|.||+|.++.+ ..+|+|++.... ....+|.+|++++++++||||+++++++.+.+ ..|+||||
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~-~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~ 80 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFIVTEY 80 (256)
T ss_pred hhhhhccCCCceEEEeEecCC-ccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEEEEec
Confidence 344579999999999998754 489999985432 23467889999999999999999999987665 67999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++++|.++ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence 999999765 23578999999999999999999985 899999999999999999999999999986543211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
....+..++..|+||| ||+++||+++ |+.||..... ...........+...+...++.+..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVVESVSAGYRLYRPKLAPTEVYT 232 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 1111223456799999 6999999999 8999865322 2233333333333334455666767
Q ss_pred cCcccChhchhhcCCHHHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.+.+||..+|++|||+.|+++.|
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHh
Confidence 77899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=280.14 Aligned_cols=225 Identities=22% Similarity=0.201 Sum_probs=187.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch---hhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR---GALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
-.+|.|.||.||+++.+.+++.||+|++..... ...+.+.+|+++|+++. |||||.++++|.+.+ ..++||
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-----~~~lvm 115 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-----SVYLVM 115 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-----eEEEEE
Confidence 468999999999999999999999999965542 34578999999999998 999999999998887 789999
Q ss_pred EeccCCCCCCCc-cc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC----CceEEecccCccccCcc
Q 041479 603 EFMHHGSLESCP-RI-LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND----MTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~~-~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~~~~~ 676 (771)
|+|.||+|.+.. +. +++.....++.|++.|+.|||+. +|+|||+||+|+|+... +.+|++|||+|......
T Consensus 116 EL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 999999998772 23 89999999999999999999995 99999999999999643 47999999999977651
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
......+||+.|+||| .||++|.|+.|..||.+....+ ...++..+.+. ....+.++
T Consensus 193 -----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 193 -----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-IFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred -----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-HHHHHHcCCCCCCCCCccccC
Confidence 1233568999999999 5999999999999997653333 34455555443 34444555
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.........|+..||.+|+|+.++++
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhc
Confidence 55556667999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=312.59 Aligned_cols=234 Identities=26% Similarity=0.259 Sum_probs=190.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.+....|.|.+|.||-|+..++|+..|||-+.... ....+...+|..++..++|||+|+++|+-...+ ..+|
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----kv~I 1311 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----KVYI 1311 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----HHHH
Confidence 345567899999999999999999999999996553 344567789999999999999999999977766 6789
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
.||||++|+|.+. .+..++.-...+..|++.|+.|||++ |||||||||+||+++.+|.+|.+|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999876 45567777778889999999999997 99999999999999999999999999998776543
Q ss_pred CCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 678 SSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
........+..||+.||||| +|||+.||+||+.||...-..-. +..-+..+..+.+++-++
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~V~~gh~Pq~P~~ls 1467 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYHVAAGHKPQIPERLS 1467 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhHHhccCCCCCchhhh
Confidence 22333445678999999999 69999999999999976422222 333334444445555566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.=+...+.|++.||++|.++.++++
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 66666777999999999999988875
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.59 Aligned_cols=219 Identities=26% Similarity=0.238 Sum_probs=167.9
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|++..+++.||+|++.... .....++.+|.. +++.++|||||++++++.+.+ ..|+|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~e 76 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVLD 76 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEEc
Confidence 3789999999999999999999999996542 223445666654 578899999999999987766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 150 (321)
T cd05603 77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--- 150 (321)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---
Confidence 9999999654 34578888899999999999999985 89999999999999999999999999987532211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.|+||| +||++|||++|+.||.+... ..+.+.... .+...+...+..+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~-~~~~~~~~~~~~~~~l 226 (321)
T cd05603 151 -ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQMYDNILH-KPLQLPGGKTVAACDL 226 (321)
T ss_pred -CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHHHHHHhc-CCCCCCCCCCHHHHHH
Confidence 1123356899999999 69999999999999965311 111121111 1222233334445556
Q ss_pred CcccChhchhhcCCHH
Q 041479 746 GVQEGEETAEENIKKG 761 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~ 761 (771)
..+|++.||++||++.
T Consensus 227 i~~~l~~~p~~R~~~~ 242 (321)
T cd05603 227 LVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHccCCHhhcCCCC
Confidence 6699999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=271.03 Aligned_cols=225 Identities=24% Similarity=0.276 Sum_probs=177.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|+||+|++..+++.||+|++.... ....+++.+|++++++++||||+++++++...+ ..++||||+
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 81 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RISICTEFM 81 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEEEEEecC
Confidence 45799999999999998888899999986542 334567999999999999999999999998876 679999999
Q ss_pred cCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccc
Q 041479 606 HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685 (771)
Q Consensus 606 ~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 685 (771)
++|++..+ ..+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~------~~ 151 (279)
T cd06619 82 DGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI------AK 151 (279)
T ss_pred CCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc------cc
Confidence 99998654 3468888899999999999999985 99999999999999999999999999997553321 12
Q ss_pred cccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc-----cHHHHHHhhCCCc-hhhhcCccccc
Q 041479 686 GLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL-----DLHNFVKMALPDQ-ILQVLDPLFLV 744 (771)
Q Consensus 686 ~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~ 744 (771)
...||..|+||| +||++|||++|+.||........ ...+......+.. .....++.+..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence 346899999999 69999999999999965322111 1111111111111 12234455556
Q ss_pred cCcccChhchhhcCCHHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
...+|++.+|++||++.|+++.
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcC
Confidence 6779999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=270.48 Aligned_cols=229 Identities=23% Similarity=0.275 Sum_probs=170.5
Q ss_pred cccccccceEEEEEecC--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDL--DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|.||+|.+.. +...||+|.++... ......+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEEC
Confidence 37999999999998654 34579999986543 233457899999999999999999999987765 57999999
Q ss_pred ccCCCCCCCc--------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 605 MHHGSLESCP--------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 605 ~~~g~L~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+++|+|.++. ...++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997652 1345667788999999999999985 8999999999999999999999999999754322
Q ss_pred cCCcccccccccccccccchh----------------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHh-hC--
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKM-AL-- 730 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~-~~-- 730 (771)
.. ........|+..|+||| +|+++||+++ |+.||........ ....... ..
T Consensus 154 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 230 (269)
T cd05087 154 DY--YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQLKL 230 (269)
T ss_pred ce--eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhcccCCC
Confidence 21 11122345788899999 4999999997 9999965322211 1111111 11
Q ss_pred C-CchhhhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 731 P-DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 731 ~-~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
+ +.........+...+.+|| .+|++|||+.||++.|+
T Consensus 231 ~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 1122223333444566898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=267.71 Aligned_cols=230 Identities=24% Similarity=0.337 Sum_probs=179.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|.+..+. .||+|.+.... ...+.+.+|++++++++||||+++++++.. + ..++|||
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~v~e 80 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E-----PIYIVTE 80 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C-----CcEEEEE
Confidence 34456899999999999987765 79999885433 234678999999999999999999998743 2 4689999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999765 22478889999999999999999985 899999999999999999999999999976543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.......++..|+||| +||++||++| |+.||.+.... ...+......+.......+..+
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGYRMPCPQGCPESL 232 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCcccCHHH
Confidence 1112234677899999 6999999999 99999764322 2233333333333333445555
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.....+||.+||++||++.++++.|++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 566779999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=280.58 Aligned_cols=222 Identities=27% Similarity=0.222 Sum_probs=169.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHH-HHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|+.+.+++.||||++.... ....+.+..|.. +++.++||||+++++++...+ ..|+|||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~e 76 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVLD 76 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEEc
Confidence 3799999999999999999999999996542 233455666665 467799999999999988776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 150 (325)
T cd05604 77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--- 150 (325)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---
Confidence 9999999655 34688999999999999999999985 99999999999999999999999999987432211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......+||+.||||| +||++|||++|+.||.+.... .......... .......+..+...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~l 226 (325)
T cd05604 151 -DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYDNILHKP--LVLRPGASLTAWSI 226 (325)
T ss_pred -CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-HHHHHHHcCC--ccCCCCCCHHHHHH
Confidence 1123456999999999 699999999999999642111 1111222111 11122234444455
Q ss_pred CcccChhchhhcCCHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl 764 (771)
..+|++.+|++||++++.+
T Consensus 227 l~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHhccCHHhcCCCCCCH
Confidence 6699999999999886443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.58 Aligned_cols=229 Identities=21% Similarity=0.231 Sum_probs=181.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|+...+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ ..|+|||
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e 96 (297)
T cd06656 22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWVVME 96 (297)
T ss_pred eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEEEeec
Confidence 34456899999999999998888899999997665555678899999999999999999999998766 7899999
Q ss_pred eccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 604 FMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 604 ~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|+++++|.++ ...+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 170 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---
Confidence 9999999876 34578889999999999999999985 899999999999999999999999999876543221
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCcccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLVG 745 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 745 (771)
......|++.|+||| +||++|++++|+.||.......... .......+ ...+..++..+...
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eeccCCCCCCCCccccCHHHHHH
Confidence 112345889999999 6999999999999996532211111 11111111 12233344455556
Q ss_pred CcccChhchhhcCCHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+||..+|++||++.++++
T Consensus 249 i~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 67999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=270.69 Aligned_cols=229 Identities=23% Similarity=0.239 Sum_probs=169.4
Q ss_pred cccccccceEEEEEecC--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDL--DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+|.... ....||+|.+.... ......|.+|+++++.++||||+++++++.+.. ..++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEEe
Confidence 47999999999997644 33578899875443 334567899999999999999999999987765 67999999
Q ss_pred ccCCCCCCCc--------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 605 MHHGSLESCP--------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 605 ~~~g~L~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+++|+|.++. ...++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccc
Confidence 9999997651 2245677889999999999999985 8999999999999999999999999998754322
Q ss_pred cCCcccccccccccccccchh----------------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC---
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMAL--- 730 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~--- 730 (771)
... .......+++.|+||| +||++|||++ |..||.+..... .+........
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~ 230 (269)
T cd05042 154 DYY--ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDIKL 230 (269)
T ss_pred hhe--eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCccC
Confidence 111 1112234677899999 5999999999 788886542211 1222222211
Q ss_pred C-CchhhhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 731 P-DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 731 ~-~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
+ +.....+++.+......|| .||++|||+++|++.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 1222333444444555787 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=285.34 Aligned_cols=230 Identities=19% Similarity=0.158 Sum_probs=172.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+++.+.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~~lv~ 80 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----YLYLIM 80 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----eeEEEE
Confidence 345899999999999999999999999986532 334567889999999999999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999765 34678888899999999999999985 9999999999999999999999999999643211000
Q ss_pred c-----------c--------------------------------cccccccccccccchh---------------HHHH
Q 041479 680 N-----------Q--------------------------------CSSVGLKGTVGYATPE---------------YGIL 701 (771)
Q Consensus 680 ~-----------~--------------------------------~~~~~~~gt~~y~aPE---------------~Gv~ 701 (771)
. . ......+||+.|+||| +||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0 0001246999999999 6999
Q ss_pred HHHHHhCCCCCCccccCCccHHHHHHhhCCCchh--hhcCccccccCcccChhchhhc---CCHHHHHH
Q 041479 702 LLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL--QVLDPLFLVGGVQEGEETAEEN---IKKGQIRE 765 (771)
Q Consensus 702 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~R---pt~~~vl~ 765 (771)
+|||++|+.||.+..... .+............+ ..+++.+.....+|+. +|.+| +|+.|+++
T Consensus 238 l~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 238 MFECLIGWPPFCSENSHE-TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhcCCCCCCCCCHHH-HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999996532211 112222111111111 1234444455557886 67765 59988875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=267.34 Aligned_cols=229 Identities=26% Similarity=0.371 Sum_probs=185.5
Q ss_pred cccccccceEEEEEecCC---CeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLD---QTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|.||+|..... +..||||.+...... ..+++.+|+++++.++|+||+++++++.+.. ..++|||
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~e 76 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE-----PLYLVLE 76 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC-----ceEEEEE
Confidence 478999999999999875 779999999755432 3678999999999999999999999988755 6799999
Q ss_pred eccCCCCCCC---c---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 604 FMHHGSLESC---P---------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 604 ~~~~g~L~~~---~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
|+++|+|.++ . ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.++
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccc
Confidence 9999999765 2 5578999999999999999999985 99999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
....... ........+++.|+||| +|+++||+++ |+.||.+.. ...+.+..........+
T Consensus 154 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~ 229 (262)
T cd00192 154 DVYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKGYRLPKP 229 (262)
T ss_pred ccccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCCCCCC
Confidence 7654332 11223345788999999 6999999999 699997652 22233333333333344
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
..+++.+.....+|+..+|++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 455666667777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=267.61 Aligned_cols=230 Identities=24% Similarity=0.334 Sum_probs=178.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|+||+|++..+. .||+|++.... ...++|.+|++++++++||||+++++++.+. ..++||||
T Consensus 10 ~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~lv~e~ 81 (262)
T cd05071 10 LEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVTEY 81 (262)
T ss_pred EeeecCCCCCCcEEEEEecCCc-eEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCC------CcEEEEEc
Confidence 3445899999999999987665 79999996432 2346799999999999999999999986433 46899999
Q ss_pred ccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++|+|.++. ..+++..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999997662 3478889999999999999999985 899999999999999999999999999986543321
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
.......++..|+||| +|+++||++| |+.||.+..... ..+......+......++..+.
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~ 233 (262)
T cd05071 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMPCPPECPESLH 233 (262)
T ss_pred --ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHHHHhcCCCCCCccccCHHHH
Confidence 1112234677899999 6999999999 888986543221 2222222222222334455566
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+|++++|++|||+.++++.|++.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 677799999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=267.60 Aligned_cols=229 Identities=25% Similarity=0.327 Sum_probs=179.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|+||+|..+.+. .||+|.+..... ..+++.+|++++++++||||+++++++... ..+++|||+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~-~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~lv~e~~ 82 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNT-KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEE------PIYIVTEYM 82 (260)
T ss_pred hheeccccCceEEEEEecCCc-eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCC------CcEEEEEec
Confidence 345899999999999887554 799999865433 346799999999999999999999987432 368999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++++|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc--
Confidence 99999765 23478999999999999999999985 899999999999999999999999999986543221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
....+..++..|+||| ||+++||+++ |+.||.+... ....+......+...+...+..+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1112233567899999 6999999999 8999976422 2233333333333334444555666
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+|+.++|++|||++++.+.|++.
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 77799999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=274.38 Aligned_cols=228 Identities=22% Similarity=0.271 Sum_probs=181.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|.|.+|+||+|+...+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ ..|+||||
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~ 97 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFVVMEY 97 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEEEEEe
Confidence 3445899999999999998888999999997665555678899999999999999999999987766 78999999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+++++|..+ ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---- 170 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---- 170 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc----
Confidence 999999776 33588999999999999999999986 999999999999999999999999999876543221
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 746 (771)
......|+..|+||| +||++||+++|+.||.+..... ..........+ ...+..+++.+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 112345889999999 6999999999999996532211 11122211111 122333455555666
Q ss_pred cccChhchhhcCCHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+||..||++|||+.++++
T Consensus 250 ~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHhhcChhhCCCHHHHhh
Confidence 7999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=276.53 Aligned_cols=220 Identities=19% Similarity=0.178 Sum_probs=172.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|+||+|+.+.+++.||||++.... ....+.+..|..++..+ +|++|+++++++.+.+ ..|+|
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv 79 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----RLYFV 79 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----EEEEE
Confidence 345899999999999999998999999997542 23445677888888887 5899999999987766 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||+++|+|... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 999999999765 34688899999999999999999985 99999999999999999999999999997533211
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
......+||+.|+||| +||++|||++|+.||.+.... .....+.... ...+..+++.+.
T Consensus 156 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~--~~~p~~~s~~~~ 229 (323)
T cd05616 156 ---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHN--VAYPKSMSKEAV 229 (323)
T ss_pred ---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC--CCCCCcCCHHHH
Confidence 1122356999999999 699999999999999753221 1122222221 122334555555
Q ss_pred ccCcccChhchhhcCCH
Q 041479 744 VGGVQEGEETAEENIKK 760 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~ 760 (771)
....+|++.||++|++.
T Consensus 230 ~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 230 AICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHcccCHHhcCCC
Confidence 66779999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=267.48 Aligned_cols=234 Identities=20% Similarity=0.228 Sum_probs=183.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|.||+|....+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 78 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-----T 78 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-----e
Confidence 334567899999999999998888899999986432 223467899999999999999999999988776 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.++||||+++++|.+. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 8999999999999765 34578888999999999999999985 99999999999999999999999999997654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
..... ........|+..|+||| +|+++||+++|+.||.+.... ...............+..++
T Consensus 156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 156 TICSS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred ccccc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-HHHHHHhccCCCCCCCccCC
Confidence 32111 11112345788999999 699999999999998653211 11222222222334455566
Q ss_pred ccccccCcccChhchhhcCCHHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+.....+||..+|++|||+.++++.
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 666667779999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=272.06 Aligned_cols=230 Identities=22% Similarity=0.260 Sum_probs=183.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|.+..+++.||+|++........++|.+|++++++++||||+++++++.+.. ..|+||
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 81 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLWILI 81 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEEEEe
Confidence 334456899999999999998888899999998776666788999999999999999999999988766 689999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|..+ ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999766 34588999999999999999999986 899999999999999999999999999875433211
Q ss_pred Ccccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cchhhh
Q 041479 679 SNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQV 737 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~ 737 (771)
......|++.|+||| +|+++||+++|+.||.+.... .....+.....+ ...+..
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (280)
T cd06611 159 ----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEPPTLDQPSK 233 (280)
T ss_pred ----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCCCCcCCccc
Confidence 122346899999999 699999999999999753211 112223222222 122334
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++..+.....+||..+|++||++.++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 4555666677999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=273.56 Aligned_cols=231 Identities=23% Similarity=0.286 Sum_probs=178.8
Q ss_pred cccccccccceEEEEEecCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQT--FIAVKVLFLH-QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|++|.||+|+.+.++. .+|+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+ ..|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-----~~~lv 81 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-----YLYIA 81 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----cceEE
Confidence 4468999999999999877653 4788888643 334457899999999999 7999999999987765 67999
Q ss_pred EEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 041479 602 YEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA 662 (771)
Q Consensus 602 ~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~ 662 (771)
|||+++|+|.++. ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999986541 2477889999999999999999985 99999999999999999999
Q ss_pred EEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 041479 663 HMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFV 726 (771)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 726 (771)
||+|||++........ ......+..|+||| |||++|||++ |..||.+.... ...+..
T Consensus 159 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYVK-----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKL 231 (297)
T ss_pred EECCcCCCccccceec-----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 9999999864321110 11112355799999 6999999998 99999754321 122222
Q ss_pred HhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 727 KMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
........+..++..+.....+||..+|++|||+.++++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222222334445666667777999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=270.00 Aligned_cols=220 Identities=20% Similarity=0.275 Sum_probs=170.1
Q ss_pred cccccccceEEEEEecCC------------------------CeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeE
Q 041479 528 SYESLVKATVYKGILDLD------------------------QTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKI 583 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 583 (771)
.+|+|.+|.||+|.+..+ ...||+|++..........|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 379999999999986322 23689999876555556789999999999999999999
Q ss_pred EEEeecCCCCCceeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 041479 584 ITACSTSDFQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659 (771)
Q Consensus 584 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~ 659 (771)
++++.+.. ..++||||+++|+|..+ ...+++..+..++.|+++||+|||+. +|+||||||+||+++..
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99998776 67999999999999765 34578899999999999999999985 89999999999999754
Q ss_pred C-------ceEEecccCccccCcccCCcccccccccccccccchh----------------HHHHHHHHH-hCCCCCCcc
Q 041479 660 M-------TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIF-TGKRPTSDM 715 (771)
Q Consensus 660 ~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~-tg~~P~~~~ 715 (771)
+ .+|++|||++...... ....++..|+||| |||++||++ +|+.||.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred CcccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3 4899999988643221 1124678899999 699999995 699998654
Q ss_pred ccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHH
Q 041479 716 FTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.... ...+..... ..+....+.+...+.+||+.+|++|||+.++++.|
T Consensus 226 ~~~~--~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 226 TPSE--KERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ChHH--HHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2211 222222221 12222334555667799999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=268.78 Aligned_cols=232 Identities=23% Similarity=0.234 Sum_probs=178.6
Q ss_pred cccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.+|.||+|.+.. .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+ ..+
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 85 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-----PRF 85 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CcE
Confidence 4468999999999999987 66789999886443 334567999999999999999999999987765 568
Q ss_pred EEEEeccCCCCCCCc----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEec
Q 041479 600 LVYEFMHHGSLESCP----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---TAHMGD 666 (771)
Q Consensus 600 lv~e~~~~g~L~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---~~kl~D 666 (771)
+||||+++|+|.++. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++ .+|++|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 999999999997651 2478899999999999999999985 899999999999998654 599999
Q ss_pred ccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
||+++....... ........++..|+||| +||++|||++ |..||.+... ..+.+......
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~ 238 (277)
T cd05036 163 FGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFVTGGG 238 (277)
T ss_pred CccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC
Confidence 999986532211 11111223456899999 6999999997 9999875321 12333333322
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+...+..++..+.....+|++.+|++|||+.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 222233344555566779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=270.14 Aligned_cols=233 Identities=22% Similarity=0.249 Sum_probs=182.0
Q ss_pred ccccccccccceEEEEEecCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|+|.+|.||+|..+.. +..||+|.+.... ......+.+|+++++.++||||+++++++.... ..
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~ 84 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-----PT 84 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC-----Cc
Confidence 345689999999999988643 3789999986443 344568899999999999999999999987765 67
Q ss_pred EEEEEeccCCCCCCCc-------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 041479 599 ALVYEFMHHGSLESCP-------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 665 (771)
++||||+++|+|.++. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999997651 1367788999999999999999985 99999999999999999999999
Q ss_pred cccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhh
Q 041479 666 DFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 666 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~ 729 (771)
|||+++........ .......++..|+||| |||++||+++ |+.||.+.. .....+.....
T Consensus 162 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHHHHhcC
Confidence 99999865432211 1112234678999999 6999999998 999986532 12233333332
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.....+...+..+.....+||+.+|++|||+.++++.|++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2223334445666667779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=266.74 Aligned_cols=230 Identities=22% Similarity=0.286 Sum_probs=178.9
Q ss_pred cccccccceEEEEEecC-CC--eEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDL-DQ--TFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~-~~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|.+.. ++ ..||||.+..... ...+++.+|++++++++||||+++++++.+ . ..++|||
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-----~~~~v~e 75 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-----PLMMVTE 75 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-----eEEEEEE
Confidence 36899999999999865 33 3699999976655 567889999999999999999999999876 4 6799999
Q ss_pred eccCCCCCCC----c-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC----P-RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~----~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.+. . ..+++.....++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999765 1 3578999999999999999999985 999999999999999999999999999987654322
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHh-hCCCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKM-ALPDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 741 (771)
... ......++..|+||| +||++|||++ |+.||.+.... ...+.... ..........+..
T Consensus 153 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
T cd05040 153 HYV-MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGERLERPEACPQD 229 (257)
T ss_pred cee-cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCcCCCCccCCHH
Confidence 111 111345778899999 6999999999 99998643221 12222221 1112222233445
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+.....+|+..+|++|||+.++++.|.+
T Consensus 230 ~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 230 IYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred HHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 5556679999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=268.23 Aligned_cols=229 Identities=21% Similarity=0.224 Sum_probs=180.0
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|.||+|++..+++.||+|.++.........+.+|+.+++.++||||+++++++...+ ..|+|||
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~lv~e 86 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLWICME 86 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEEEEEe
Confidence 34456899999999999999888999999997665555567889999999999999999999987766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++++|.++ ...+++.+...++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--- 160 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence 9999999875 34688999999999999999999986 89999999999999999999999999987554321
Q ss_pred ccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cchhh--hcC
Q 041479 681 QCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQ--VLD 739 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~ 739 (771)
.......|++.|+||| +||++|||++|+.||.+...... .......... ..... .++
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCCCCCcccccCCCC
Confidence 1122346899999999 59999999999999865322111 1111111111 11111 123
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.....+|++.+|++|||+.++++
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhc
Confidence 34445666999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=280.51 Aligned_cols=223 Identities=23% Similarity=0.171 Sum_probs=169.3
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc---CCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI---RHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+|+|.+|+||+|+++.+++.||||++.... ......+..|..++.+. +||||+++++++.+.+ ..|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence 589999999999999988999999996432 22334566677777765 6999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 99999999654 34688999999999999999999985 999999999999999999999999999875322211
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
.....+||+.||||| +||++|||++|+.||....... ....+.....+. ....+++...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~-~~~~~~~~~~ 226 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNIAFGKVRF-PKNVLSDEGR 226 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHHHHcCCCCC-CCccCCHHHH
Confidence 122456999999999 6999999999999996532111 111111111111 1123445555
Q ss_pred ccCcccChhchhhcCC----HHHHHH
Q 041479 744 VGGVQEGEETAEENIK----KGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt----~~~vl~ 765 (771)
....+||..||++||+ +.++++
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 5667999999999994 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=288.03 Aligned_cols=228 Identities=21% Similarity=0.221 Sum_probs=167.8
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC---CCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF---QGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---~~~~~~~l 600 (771)
.....+|+|.+|+||+|++..+++.||||++.... ....+|+.+++.++|||||++++++..... ....+.++
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 34456899999999999999888899999885332 234579999999999999999998755432 12235789
Q ss_pred EEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccc
Q 041479 601 VYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRF 672 (771)
Q Consensus 601 v~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~ 672 (771)
||||+++ ++.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 9999986 44322 34688889999999999999999985 899999999999998654 799999999986
Q ss_pred cCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-------
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA------- 729 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~------- 729 (771)
+..... .....||+.||||| +||++|||++|+.||.+..... .+.......
T Consensus 221 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 221 LLAGQR-----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTEDQ 294 (440)
T ss_pred ccCCCC-----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHH
Confidence 543221 22346899999999 6999999999999997532111 111111100
Q ss_pred ------------CC----Cc----hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ------------LP----DQ----ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ------------~~----~~----~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++ .. ++...++.+.....+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 00 01112233444566999999999999999984
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.80 Aligned_cols=231 Identities=20% Similarity=0.194 Sum_probs=171.7
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|+||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..|+|
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~~~lv 79 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----NLYFV 79 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----EEEEE
Confidence 3456899999999999999999999999996432 234567889999999999999999999988776 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||+++|+|.++ ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|..+.....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999776 34577888889999999999999985 999999999999999999999999999853311000
Q ss_pred ---------------------------------------Ccccccccccccccccchh---------------HHHHHHH
Q 041479 679 ---------------------------------------SNQCSSVGLKGTVGYATPE---------------YGILLLE 704 (771)
Q Consensus 679 ---------------------------------------~~~~~~~~~~gt~~y~aPE---------------~Gv~l~e 704 (771)
...+.....+||+.||||| +||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001112357999999999 6999999
Q ss_pred HHhCCCCCCccccCCccHHHHHHhh--CCCchhhhcCccccccCcccChhchhhcC---CHHHHHH
Q 041479 705 IFTGKRPTSDMFTEGLDLHNFVKMA--LPDQILQVLDPLFLVGGVQEGEETAEENI---KKGQIRE 765 (771)
Q Consensus 705 l~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp---t~~~vl~ 765 (771)
|++|+.||.+...... ........ .+......+++.......+|+ .+|++|+ |+.++++
T Consensus 237 ll~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPAET-QLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHHHH-HHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999975322111 11111111 111111123333333333554 5999999 8888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=265.00 Aligned_cols=227 Identities=28% Similarity=0.298 Sum_probs=178.6
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|.||+|..+ ++.||+|.++... ..+.+.+|+.++++++|+||+++++++...+. ..++|||
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~~lv~e 80 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLYIVTE 80 (256)
T ss_pred eeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC----ceEEEEE
Confidence 34456899999999999775 4579999985432 35689999999999999999999998654331 5799999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999765 22378889999999999999999985 89999999999999999999999999987543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
....++..|+||| +||++|||++ |+.||.... ...+........+....+.+++.+
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKMDAPDGCPPVV 228 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCCHHH
Confidence 1123567899999 6999999998 999986431 112333333333444445556666
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+|+..+|++|||+.++++.|+++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 6677799999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=273.23 Aligned_cols=237 Identities=22% Similarity=0.297 Sum_probs=181.3
Q ss_pred ccccccccccccceEEEEEec-------CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCC
Q 041479 523 LLLNVSYESLVKATVYKGILD-------LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQ 593 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~-------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 593 (771)
+.....+|+|.+|.||+|++. .++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++....
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-- 94 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-- 94 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC--
Confidence 444567899999999999752 234579999986432 34457899999999999 7999999999987765
Q ss_pred CceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 041479 594 GNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNV 654 (771)
Q Consensus 594 ~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NI 654 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||
T Consensus 95 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 95 ---PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred ---ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 679999999999986541 2467888999999999999999985 999999999999
Q ss_pred eeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccC
Q 041479 655 LLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTE 718 (771)
Q Consensus 655 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~ 718 (771)
+++.++.+||+|||+++........ .......+++.|+||| ||+++||+++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 245 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 9999999999999999866433221 1112234677899999 6999999999 7888854311
Q ss_pred CccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 719 GLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+.+......+...+..++..+.....+||..+|++|||+.|+++.|++++
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 246 -EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred -HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1222333322222223334455556677999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=263.46 Aligned_cols=227 Identities=25% Similarity=0.292 Sum_probs=177.2
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
.+|+|.+|.||+|..++ ++.||+|.+.... ......+.+|++++++++||||+++++++...+ ..++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECCC
Confidence 36899999999999764 5599999986543 333457899999999999999999999987766 6799999999
Q ss_pred CCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 607 HGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 607 ~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+|+|.++ ...+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+|++|||+++........
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 149 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--- 149 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc---
Confidence 9999765 23478899999999999999999985 8999999999999999999999999998754332211
Q ss_pred ccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......+++.|+||| ||+++||+++ |..||.+... ...........+......++..+....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQAREQVEKGYRMSCPQKCPDDVYKVM 227 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 111123467799999 6999999999 9999965421 112222222322233334555666677
Q ss_pred cccChhchhhcCCHHHHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
.+|++.+|++|||+.|+++.|.
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHcccCcccCCCHHHHHHHhc
Confidence 7999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=268.46 Aligned_cols=234 Identities=20% Similarity=0.280 Sum_probs=184.2
Q ss_pred cccccccccceEEEEEecC----CCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDL----DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
...+|+|.+|+||+|.+.. ++..||+|++... .....+.+.+|+.++++++||||+++++++...+. ..++
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----~~~~ 86 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE----PPFV 86 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC----CCEE
Confidence 4557999999999999876 2568999998644 23456788999999999999999999999876431 5689
Q ss_pred EEEeccCCCCCCCc-----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 601 VYEFMHHGSLESCP-----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 601 v~e~~~~g~L~~~~-----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
++||+++|+|..+. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCC
Confidence 99999999986651 3578999999999999999999985 899999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCc
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQ 733 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 733 (771)
++.+...... .......++..|+||| +||++||+++ |+.||.+.. ...+..+.....+..
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~ 239 (280)
T cd05043 164 SRDLFPMDYH--CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGYRLA 239 (280)
T ss_pred cccccCCceE--EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCCCCC
Confidence 9865432211 1112234677899999 6999999999 999997532 223444444444333
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+++.+.....+||..||++|||+.++++.|+++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 3333455666677799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=274.37 Aligned_cols=238 Identities=25% Similarity=0.308 Sum_probs=182.7
Q ss_pred cccccccccccccceEEEEEecC-------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDL-------DQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDF 592 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~-------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 592 (771)
.+.....+|+|.+|+||++++.. ....||+|.+.... .....++.+|+++++++ +||||+++++++...+
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~- 97 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG- 97 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-
Confidence 34455678999999999998643 23479999997542 34456788999999999 7999999999998776
Q ss_pred CCceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 593 QGNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +++||||||+|
T Consensus 98 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 98 ----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 679999999999986551 2478889999999999999999985 99999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFT 717 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~ 717 (771)
|+++.++.+|++|||.++........ .......+++.|+||| +||++|||++ |..||.+...
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999999999999765432111 1111223457899999 6999999998 8888864321
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+.+......+...+..++..+.....+|+..+|++||||.++++.|++++
T Consensus 249 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred --HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1233333333333333444556666677999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=280.76 Aligned_cols=228 Identities=19% Similarity=0.123 Sum_probs=177.2
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|+||+++.+.+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..|+|
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~~~lv 79 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----NLYLV 79 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eEEEE
Confidence 3456899999999999999999999999997543 234567889999999999999999999987766 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999776 24688899999999999999999985 99999999999999999999999999998654322
Q ss_pred CCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCch
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQI 734 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~ 734 (771)
. .......||+.|+||| +||++|||++|+.||.+.... ..+........ ....
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~ 232 (330)
T cd05601 157 M---VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNFQRFLKFPE 232 (330)
T ss_pred c---eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcCCCccCCCC
Confidence 1 1222346899999999 599999999999999653211 11222221111 1111
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+++.+.....+|+. +|++|||+.++++
T Consensus 233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11234445455568887 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=267.38 Aligned_cols=232 Identities=21% Similarity=0.277 Sum_probs=182.1
Q ss_pred cccccccccceEEEEEecCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQT----FIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
...+|+|.+|+||+|.++.+++ .||+|.+.... ......+.+|+.++++++||||+++++++.. . ..++
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~~~~ 85 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S-----QVQL 85 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C-----ceEE
Confidence 3568999999999999876543 68999886553 3455789999999999999999999999876 2 5789
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++|+|.++ ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999765 23588999999999999999999985 9999999999999999999999999999876532
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
... ....+..++..|+||| ||+++||+++ |+.||.+... ..+.+......+...+...+.
T Consensus 163 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 163 EKE--YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred ccc--eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCCCCCCCCCCCH
Confidence 221 1112223467899999 6999999999 9999976422 223333333333333334445
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.....+||..+|++|||+.++++.|+++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 555566799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=269.29 Aligned_cols=224 Identities=19% Similarity=0.251 Sum_probs=178.5
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
.+|+|.+|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.... ..|+||||++
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~ 85 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT-----KLWIIMEYLG 85 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC-----ceEEEEEccC
Confidence 4789999999999999888899999986443 344568999999999999999999999987765 6899999999
Q ss_pred CCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccc
Q 041479 607 HGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684 (771)
Q Consensus 607 ~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (771)
+++|.++ ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+|++|||+++....... ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----~~ 158 (277)
T cd06642 86 GGSALDLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----KR 158 (277)
T ss_pred CCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch----hh
Confidence 9999766 34578889999999999999999985 999999999999999999999999999976543221 11
Q ss_pred ccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCccc
Q 041479 685 VGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQE 749 (771)
Q Consensus 685 ~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 749 (771)
....|+..|+||| |||++||+++|+.|+.+..... .........+.......+..+.....+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence 2245788999999 6999999999999987543221 2222222222223333444455566699
Q ss_pred ChhchhhcCCHHHHHH
Q 041479 750 GEETAEENIKKGQIRE 765 (771)
Q Consensus 750 l~~~p~~Rpt~~~vl~ 765 (771)
|..+|++||||.++++
T Consensus 237 l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 237 LNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=268.71 Aligned_cols=226 Identities=25% Similarity=0.265 Sum_probs=177.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+|+|.+|+||++.+..+++.||||.+.... ....+.+.+|+.++++++|++|+++++++.+.+ ..++|||
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e 80 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----ALCLVLT 80 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EEEEEEE
Confidence 34799999999999999999999999986542 223356788999999999999999999987766 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999765 23588889999999999999999985 999999999999999999999999999875433221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc-cHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL-DLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.....|++.|+||| +||++|||++|+.||........ ..........+......+++.+
T Consensus 158 -----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05630 158 -----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA 232 (285)
T ss_pred -----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHH
Confidence 12346899999999 69999999999999975322110 0111111112222334455566
Q ss_pred cccCcccChhchhhcCC-----HHHHHH
Q 041479 743 LVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
.....+||+.||++||| +.|+++
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 66677999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=282.27 Aligned_cols=173 Identities=22% Similarity=0.347 Sum_probs=145.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|.||+|++..+++.||+|... .+.+.+|++++++++|||||++++++.... ..++||
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~ 162 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTCLIL 162 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeEEEE
Confidence 334456899999999999999999999999753 245788999999999999999999987765 679999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+. ++|..+ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9995 576544 34688999999999999999999985 999999999999999999999999999975432211
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCC
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~ 713 (771)
......+||+.|+||| +||++|||++|+.|+.
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred --cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 1122457999999999 6999999999998764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=280.23 Aligned_cols=183 Identities=22% Similarity=0.216 Sum_probs=149.1
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~l 600 (771)
.....+|+|.+|+||++++..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+. ......|+
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 3445689999999999999988899999999643 23345678899999999999999999999865432 11125699
Q ss_pred EEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 601 v~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
||||++++........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 104 v~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--- 177 (359)
T cd07876 104 VMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--- 177 (359)
T ss_pred EEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc---
Confidence 999997654333344578888999999999999999985 99999999999999999999999999997543221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
......||+.|+||| +||++|||++|+.||.+
T Consensus 178 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 178 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred --cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 122346899999999 69999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=279.82 Aligned_cols=233 Identities=18% Similarity=0.117 Sum_probs=176.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+++++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~-----~~ 118 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-----YL 118 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----EE
Confidence 3445567899999999999999999999999996432 234456889999999999999999999988766 78
Q ss_pred EEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 599 ALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|+||||+++|+|.++ ...++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999776 33577888889999999999999985 9999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchh
Q 041479 677 MSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQIL 735 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~ 735 (771)
.. ......+||+.||||| +||++|||++|+.||.+... .....++...... ....
T Consensus 196 ~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred Cc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCcccCCCc
Confidence 21 1223457999999999 59999999999999964211 1112222222111 1111
Q ss_pred hhcCccccccCcccChhchhh--cCCHHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEE--NIKKGQIRES 766 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~--Rpt~~~vl~~ 766 (771)
..++........+|+..++.+ ||++.|+++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 233444445556888743433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=268.97 Aligned_cols=221 Identities=22% Similarity=0.266 Sum_probs=170.9
Q ss_pred cccccccceEEEEEecCCCe-------EEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 528 SYESLVKATVYKGILDLDQT-------FIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~-------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.+|.|++|.||+|..+..+. .||+|.+........+.+..|+.+++.++|||||++++++...+ ..++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcEE
Confidence 47999999999999865443 48899886655556678999999999999999999999998765 5789
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--------eEEeccc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT--------AHMGDFG 668 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~--------~kl~DfG 668 (771)
||||+++|+|.++ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +|++|||
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999766 23478899999999999999999985 9999999999999987665 6999999
Q ss_pred CccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCC-CCCCccccCCccHHHHHHhhCC
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGK-RPTSDMFTEGLDLHNFVKMALP 731 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~-~P~~~~~~~~~~~~~~~~~~~~ 731 (771)
++...... ....+++.|+||| +||++||+++|. .|+...... ........ .
T Consensus 154 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~--~ 221 (258)
T cd05078 154 ISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQFYED--R 221 (258)
T ss_pred cccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHHHHc--c
Confidence 88644321 1235788999999 699999999984 565432111 11111111 1
Q ss_pred CchhhhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
...+......+...+.+||+.||++|||++++++.|+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 2223333344556667999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=264.92 Aligned_cols=233 Identities=18% Similarity=0.174 Sum_probs=177.9
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.....+|+|.+|.||+|....+++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+... ...
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~ 81 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---KTL 81 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---CEE
Confidence 34556899999999999999888899999986432 2345678999999999999999999998765321 267
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+++|||+++++|.+. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999765 34578889999999999999999985 899999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
..... .......|+..|+||| +||++||+++|+.||.+..... ...+..........+..+++
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred ccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HHHHHhcCCCCCCCchhcCH
Confidence 21111 1112345889999999 6999999999999997542211 12222222222333444555
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.... +||..+|++||+|+|+++
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhc
Confidence 554443 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=273.56 Aligned_cols=219 Identities=19% Similarity=0.196 Sum_probs=171.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.+|+||+|+.+.+++.||||++.... ....+.+..|++++..+. |++|+++++++.+.+ ..|+||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 80 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-----RLYFVM 80 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-----EEEEEE
Confidence 45799999999999999999999999996542 334567888999998886 577888988887766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence 99999999766 34688999999999999999999985 99999999999999999999999999987532211
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
.......||+.|+||| +||++|||++|+.||.+..... ......... ...+..+++....
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~~~~--~~~p~~~~~~~~~ 230 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-LFQSIMEHN--VSYPKSLSKEAVS 230 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC--CCCCccCCHHHHH
Confidence 1122346899999999 6999999999999997532211 111222211 1223344555555
Q ss_pred cCcccChhchhhcCCH
Q 041479 745 GGVQEGEETAEENIKK 760 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~ 760 (771)
...+|++++|++|++.
T Consensus 231 li~~~l~~~p~~R~~~ 246 (323)
T cd05615 231 ICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHcccCHhhCCCC
Confidence 6679999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=273.16 Aligned_cols=227 Identities=19% Similarity=0.267 Sum_probs=180.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||++....+++.||||.+........+.+.+|+.++++++||||+++++++...+ ..|+||||+
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv~e~~ 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVVMEFL 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEEEeCC
Confidence 355899999999999998888899999997665556678999999999999999999999987766 789999999
Q ss_pred cCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccc
Q 041479 606 HHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683 (771)
Q Consensus 606 ~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (771)
++++|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----~ 174 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----K 174 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----c
Confidence 99999766 34578899999999999999999985 899999999999999999999999999875433221 1
Q ss_pred cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCch--hhhcCccccccC
Q 041479 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQI--LQVLDPLFLVGG 746 (771)
Q Consensus 684 ~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 746 (771)
.....|++.|+||| ||+++||+++|+.||.+.... ..........+... ....+..+....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCccccccccCHHHHHHH
Confidence 12346899999999 699999999999998643211 11112222222211 123344455556
Q ss_pred cccChhchhhcCCHHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.+|+..||++|||+.++++.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 253 DLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHccCChhHCcCHHHHhhC
Confidence 69999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=265.97 Aligned_cols=231 Identities=20% Similarity=0.279 Sum_probs=181.1
Q ss_pred cccccccccceEEEEEecCC---CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLD---QTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|.||+|++... ...||||...... ....+.+.+|+.++++++||||+++++++.+. ..++|
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~lv 84 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------PVWIV 84 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------CcEEE
Confidence 45679999999999987654 3479999886554 44567899999999999999999999998654 35899
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999999999776 23578999999999999999999985 89999999999999999999999999998654432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. .......++..|+||| +|+++||+++ |..||.+.... ..........+......+++.
T Consensus 162 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05056 162 Y---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIENGERLPMPPNCPPT 236 (270)
T ss_pred c---eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcCCcCCCCCCCCHH
Confidence 1 1111223567899999 6999999996 99999754221 222223222222233445566
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+...+.+|+..+|++|||+.++++.|+++
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 66677799999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=268.20 Aligned_cols=224 Identities=24% Similarity=0.248 Sum_probs=174.6
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+||+++.+++.+.+ ..++||||
T Consensus 7 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~ 81 (285)
T cd05632 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----ALCLVLTI 81 (285)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EEEEEEEe
Confidence 4799999999999999889899999996542 233456788999999999999999999987776 78999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++|+|... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 999999654 23588999999999999999999985 899999999999999999999999999875432211
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCCCchhhhcCccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALPDQILQVLDPLF 742 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 742 (771)
.....|++.|+||| +||++||+++|+.||.+.... .....+... .........+++.+
T Consensus 158 ----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 158 ----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred ----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhhccccccCccCCHHH
Confidence 12346899999999 699999999999999753211 111111111 11122333344555
Q ss_pred cccCcccChhchhhcCC-----HHHHHH
Q 041479 743 LVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
.....+|++.||++||+ +.++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 56667999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=265.58 Aligned_cols=229 Identities=22% Similarity=0.294 Sum_probs=178.7
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR---------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..+|+|.+|.||+|....+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 80 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-----H 80 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----c
Confidence 457899999999999988888999998854321 22367889999999999999999999988766 6
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.++||||+++++|.++ ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 7999999999999766 34578888999999999999999985 89999999999999999999999999998665
Q ss_pred cccCCc--ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 675 EVMSSN--QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 675 ~~~~~~--~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
...... ........|++.|+||| +||++||+++|+.||.+.... ....... .......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~ 235 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFKIG-ENASPEIPSN 235 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHHHh-ccCCCcCCcc
Confidence 321110 11112345889999999 699999999999999753211 1111111 1222333444
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++..+.....+||++||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 5555666677999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=270.80 Aligned_cols=233 Identities=23% Similarity=0.301 Sum_probs=179.9
Q ss_pred ccccccccccceEEEEEecCCCe----EEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQT----FIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
....+|+|.+|.||+|++..+++ .||+|.+.... .....++.+|+.++++++||||++++++|.... .+
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~------~~ 84 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT------IQ 84 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC------ce
Confidence 34468999999999999876664 47888885432 333457899999999999999999999986543 47
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+++||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999766 23578889999999999999999985 899999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
... .....+..++..|+||| |||++||+++ |..||.+... ....++.........+...+
T Consensus 162 ~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd05110 162 DEK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGERLPQPPICT 237 (303)
T ss_pred ccc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCC
Confidence 221 11122334677899999 6999999998 8999865321 22334443333222233344
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.....+||..+|++||+++++++.|+++
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4555566799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=265.82 Aligned_cols=220 Identities=20% Similarity=0.286 Sum_probs=168.9
Q ss_pred cccccccceEEEEEecCC------------CeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 528 SYESLVKATVYKGILDLD------------QTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
.+|+|.+|.||+|++... ...||+|.+........+.|.+|+.+++.++||||+++++++....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~---- 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV---- 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 368999999999986432 2368999987665556678999999999999999999999987765
Q ss_pred eeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-------eEE
Q 041479 596 YFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT-------AHM 664 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~-------~kl 664 (771)
..++||||+++|+|..+ ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++. +|+
T Consensus 78 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 -ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred -CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 56899999999998655 23588999999999999999999985 9999999999999986654 899
Q ss_pred ecccCccccCcccCCcccccccccccccccchh----------------HHHHHHHHH-hCCCCCCccccCCccHHHHHH
Q 041479 665 GDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIF-TGKRPTSDMFTEGLDLHNFVK 727 (771)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~-tg~~P~~~~~~~~~~~~~~~~ 727 (771)
+|||++...... ....|+..||||| |||++|||+ +|+.|+.+.... .......
T Consensus 154 ~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~ 223 (262)
T cd05077 154 SDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKERFYE 223 (262)
T ss_pred CCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHHHHHh
Confidence 999998754321 1234788899999 699999998 588887643211 1111111
Q ss_pred hhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHH
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
...+ .....++.+...+.+||+.||++||++.++++.+
T Consensus 224 ~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 1111223444566799999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=263.06 Aligned_cols=228 Identities=28% Similarity=0.368 Sum_probs=182.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|.|.+|.||+|... ++.||||.+..... ..+++.+|+.++++++|+||+++++++.+.+ ..++||
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~ 79 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN-----PLYIVT 79 (256)
T ss_pred ccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC-----CeEEEE
Confidence 334556899999999999875 55899999965543 5678999999999999999999999987755 679999
Q ss_pred EeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||+++++|.++. ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999997761 2578999999999999999999985 99999999999999999999999999998653221
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. ...++..|+||| +|+++||+++ |+.||..... ..+.+......+...+..+++.
T Consensus 157 ~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05039 157 D-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYRMEAPEGCPPE 227 (256)
T ss_pred c-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCCCCCccCCCHH
Confidence 1 123466799999 6999999998 9999865321 1233333333333334445566
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.....+|+..+|++|||+.|+++.|+.+
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 66677799999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=272.56 Aligned_cols=228 Identities=22% Similarity=0.322 Sum_probs=173.0
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.....+|+|.+|+||+|+.+.+++.||+|.++... ......+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 83 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLTLVF 83 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEEEEE
Confidence 34456899999999999999888899999996543 233457889999999999999999999988766 689999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++ ++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99975 66543 33478888999999999999999985 999999999999999999999999999975432211
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH---------------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--------------- 727 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--------------- 727 (771)
......+|+.|+||| +||++|||+||+.||.+....+ .+.....
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 ----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcc
Confidence 112245789999999 6999999999999996432111 0111110
Q ss_pred ------hhCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 728 ------MALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 728 ------~~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+. .....+++.......+|++.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00110 001123444445566999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=257.52 Aligned_cols=232 Identities=20% Similarity=0.230 Sum_probs=182.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..-+|+|.+|.|.-++...++.+||||++.......+.+..+|++++.+++ |+||+.|+++|+++. ..|+|||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~-----~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT-----RFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc-----eEEEEEec
Confidence 345899999999999999999999999998777777889999999999996 999999999988876 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEecccCccccCcccC
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---TAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~~~~~~~ 678 (771)
|.||.|-++ .+.+++.++.+++.+||.||.|||.. ||.|||+||+|||-.+.. -+|||||.++..+.....
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999766 45689999999999999999999984 999999999999996543 489999998865433221
Q ss_pred C---cccccccccccccccchh--------------------HHHHHHHHHhCCCCCCcc------ccCCcc--------
Q 041479 679 S---NQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDM------FTEGLD-------- 721 (771)
Q Consensus 679 ~---~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~------~~~~~~-------- 721 (771)
- ......+.+|+..||||| +||++|-|++|+.||.+. |..|..
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1 122234678999999999 599999999999999764 333321
Q ss_pred HHHHHHhh--CCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 722 LHNFVKMA--LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 722 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+..+..+. +|+..+..++..-+......+..||.+|.++.++++
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11122222 234444444444444455777899999999888775
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=268.03 Aligned_cols=237 Identities=20% Similarity=0.211 Sum_probs=180.6
Q ss_pred ccccccccceEEEEEecC----CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDL----DQTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|+||+|++.. +++.||||++...... ..+.|.+|++++++++||||+++++++...+. ...++|
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv 86 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---RSLRLI 86 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC---CceEEE
Confidence 457999999999999754 3679999999755443 56789999999999999999999999866331 267999
Q ss_pred EEeccCCCCCCCc----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++++|.++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+.......
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 9999999997762 2488999999999999999999985 89999999999999999999999999998765322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc-------------cHHHHHHhh
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL-------------DLHNFVKMA 729 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~-------------~~~~~~~~~ 729 (771)
... .......++..|+||| ||+++|||++|+.|+........ .+.++....
T Consensus 164 ~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 164 DYY-YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred cce-eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 211 1111223556799999 69999999999999864322111 112222222
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+..+...+..++.+||..+|++||||.||+++|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222223334455666799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=261.80 Aligned_cols=229 Identities=25% Similarity=0.310 Sum_probs=179.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
.+|+|.+|.||++.+.. ++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.. ..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~~ 75 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELVP 75 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcCC
Confidence 36899999999999887 77999999865433 35678999999999999999999999988776 6799999999
Q ss_pred CCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 607 HGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 607 ~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+++|.++ ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++....... ..
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~ 150 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TV 150 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--ee
Confidence 9999765 23578888999999999999999986 899999999999999999999999999986542211 11
Q ss_pred ccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......++..|+||| +||++||++| |..||..... ....+......+...++..+..+...+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li 228 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMPAPQLCPEEIYRLM 228 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 111123466799999 6999999999 8888865321 123333333222223344455666677
Q ss_pred cccChhchhhcCCHHHHHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.+|+..+|++|||+.|+++.|++
T Consensus 229 ~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHhccChhhCcCHHHHHHHhhC
Confidence 79999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=267.22 Aligned_cols=233 Identities=22% Similarity=0.222 Sum_probs=176.0
Q ss_pred cccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.+|.||+|..++ .+..||||.+.... .....++.+|+.++++++||||+++++++.+.+ ..|
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 85 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-----PTL 85 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----CcE
Confidence 4568999999999997653 24589999885443 233457889999999999999999999987765 579
Q ss_pred EEEEeccCCCCCCCcc-------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEec
Q 041479 600 LVYEFMHHGSLESCPR-------------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGD 666 (771)
Q Consensus 600 lv~e~~~~g~L~~~~~-------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 666 (771)
+||||+++|+|.++.+ ..++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999976621 234567788999999999999985 999999999999999999999999
Q ss_pred ccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
||+++....... ........++..|+||| +||++||+++ |+.||.+.... ...+......
T Consensus 163 fg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~~ 238 (288)
T cd05061 163 FGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVMDGG 238 (288)
T ss_pred CCcccccccccc--ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence 999986543221 11111223567899999 6999999999 78888653221 1222221111
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+...++.+.....+|++.||++|||+.++++.|++.
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1122233345566677799999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=280.52 Aligned_cols=232 Identities=18% Similarity=0.136 Sum_probs=173.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|+||+|+...+++.||||++... .....+++.+|+++++.++||||+++++++...+.......|+|||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 34589999999999999888889999998543 2334568899999999999999999999987654222235799999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+. ++|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 85 LMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred ccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 997 466443 34688999999999999999999986 899999999999999999999999999986533221
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH-----------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK----------------- 727 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~----------------- 727 (771)
.......+|+.|+||| +||++|||++|+.||.+..... .+..+..
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 159 -KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred -ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1122346889999999 6999999999999996432110 0000000
Q ss_pred -----h-hC-CCc------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 728 -----M-AL-PDQ------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 728 -----~-~~-~~~------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. .. +.. .....++.+.....+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0 00 010 11112333444566999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=269.63 Aligned_cols=227 Identities=24% Similarity=0.232 Sum_probs=179.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|.|.+|.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++.... ..|+||||+
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 91 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWIMIEFC 91 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEEEEecC
Confidence 445899999999999999988899999997776666788999999999999999999999987765 689999999
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++++..+ ...+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---- 164 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL---- 164 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc----
Confidence 99998654 34578999999999999999999985 99999999999999999999999999987543221
Q ss_pred cccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCc
Q 041479 682 CSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDP 740 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 740 (771)
.......|++.|+||| +||++|||++|+.||.+.... ....++.....+ ......++.
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCCccCCCCcccCH
Confidence 1122345788999998 699999999999998653211 112222222111 112223344
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||..+|++||++.++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 4555667999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=263.72 Aligned_cols=227 Identities=18% Similarity=0.144 Sum_probs=179.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|.||++.+..+++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+ ..|+||||
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 79 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYIVMEY 79 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEEEEee
Confidence 34589999999999999988899999998643 2345678889999999999999999999988776 78999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++|++.+. ...+++.....++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998654 23478888999999999999999985 999999999999999999999999999976543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
......|++.|+||| +|+++|+|++|+.||..... ...............+..++..+..
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (255)
T cd08219 156 ---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLILKVCQGSYKPLPSHYSYELRS 230 (255)
T ss_pred ---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHHHHHhcCCCCCCCcccCHHHHH
Confidence 112345889999999 69999999999999964211 1111111112222233444555556
Q ss_pred cCcccChhchhhcCCHHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
...+||..||++|||+.+++..
T Consensus 231 li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 231 LIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHhCCcccCCCHHHHhhc
Confidence 6679999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=266.06 Aligned_cols=230 Identities=22% Similarity=0.236 Sum_probs=176.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCC-ceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQG-NYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~-~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++......+ ....|+||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 45799999999999999999999999996543 3346788999999998 6999999999987643221 2367999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++|+|.++ ...+++..+..++.|++.|++|||+. +|+|||+||+||++++++.+||+|||+++.......
T Consensus 91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~- 166 (272)
T cd06637 91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG- 166 (272)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc-
Confidence 999999765 23578899999999999999999985 899999999999999999999999999976533221
Q ss_pred cccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 680 NQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
......|++.|+||| +||++|||++|+.||.+...... .........+......++
T Consensus 167 ---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06637 167 ---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNPAPRLKSKKWS 242 (272)
T ss_pred ---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-HHHHhcCCCCCCCCCCcC
Confidence 123356899999999 59999999999999965322111 111111111111122233
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.....+||..+|.+|||+.++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 243 KKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 44555667999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=265.41 Aligned_cols=226 Identities=19% Similarity=0.240 Sum_probs=181.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
-.+|+|.+|.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..|+||||+
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 84 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLWIIMEYL 84 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEEEEEecC
Confidence 34799999999999999888899999987543 345678999999999999999999999998776 789999999
Q ss_pred cCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccc
Q 041479 606 HHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683 (771)
Q Consensus 606 ~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (771)
++|+|.++ ...+++.+...++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++........ .
T Consensus 85 ~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 157 (277)
T cd06640 85 GGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----K 157 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----c
Confidence 99999776 34578888999999999999999985 999999999999999999999999999976543221 1
Q ss_pred cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcc
Q 041479 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQ 748 (771)
Q Consensus 684 ~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (771)
.....++..|+||| |||++|||++|+.||.+..... .........++.....++..+.....+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLFLIPKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--HhhhhhcCCCCCCchhhhHHHHHHHHH
Confidence 12245788999999 6999999999999997643221 222222222333444455555566779
Q ss_pred cChhchhhcCCHHHHHHH
Q 041479 749 EGEETAEENIKKGQIRES 766 (771)
Q Consensus 749 cl~~~p~~Rpt~~~vl~~ 766 (771)
||..+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=268.11 Aligned_cols=236 Identities=19% Similarity=0.169 Sum_probs=180.1
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.+.....+|+|.+|+||+++.+.+++.||+|++.... ....++.+|+.+++++ +||||+++++++.....+.....++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 3445567899999999999999988899999885432 2346788899999999 6999999999986544333347899
Q ss_pred EEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 601 VYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||||+++|+|.++ ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999654 24577888999999999999999985 8999999999999999999999999998765
Q ss_pred CcccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-C
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-D 732 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~ 732 (771)
..... ......|++.|+||| +||++||+++|+.||.+..... .+........+ .
T Consensus 175 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 249 (286)
T cd06638 175 TSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPRNPPPTL 249 (286)
T ss_pred ccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhccccCCCcc
Confidence 43211 122345899999998 5999999999999986532111 11111111111 1
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+...+..+...+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1222334455566779999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=266.16 Aligned_cols=238 Identities=23% Similarity=0.252 Sum_probs=179.4
Q ss_pred ccccccccceEEEEEe----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGIL----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|.||.+.+ +.+++.||+|.+.... ....+++.+|++++++++||||+++++++...+.. ..++|
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---~~~lv 86 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN---GIKLI 86 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC---ceEEE
Confidence 4579999999999985 3456799999986543 34457899999999999999999999998765321 57899
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++++|.++ ...+++.++..++.|++.||+|+|+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999776 23578999999999999999999985 99999999999999999999999999998664332
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcccc----------CCccHHHHH---Hhh
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT----------EGLDLHNFV---KMA 729 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~----------~~~~~~~~~---~~~ 729 (771)
... .......|+..|+||| +||++||++|+..|...... ......... ...
T Consensus 164 ~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 211 1112345677899999 69999999998776532111 011111111 111
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
........++..+.....+|++.+|++|||+.++++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 111222334455556677999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=263.13 Aligned_cols=228 Identities=22% Similarity=0.314 Sum_probs=179.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|+||+|..+++ +.||+|.+.... ...+++.+|++++++++||||+++++++.. + ..+++|||+
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~-~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-----~~~~v~e~~ 82 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E-----PIYIITEYM 82 (260)
T ss_pred eeeeccCccceEEeeecCCC-ceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C-----CcEEEEEcC
Confidence 44689999999999997655 589999986443 234689999999999999999999998643 2 469999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++|+|.++ ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc--
Confidence 99999765 23578899999999999999999985 899999999999999999999999999976542221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
.......++..|+||| ||+++||+++ |+.||.+.. .....+......+.......+..+..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1112334677899999 6999999999 999997542 22233333333333334444556666
Q ss_pred cCcccChhchhhcCCHHHHHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
...+|+..+|++|||+.++++.|++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhhc
Confidence 7779999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=283.94 Aligned_cols=234 Identities=22% Similarity=0.292 Sum_probs=194.0
Q ss_pred cccccccccccceEEEEEecCCC----eEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQ----TFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
...+.+|+|+||+||||.|-..+ .+||+|++... ..+...+++.|+-+|.+++|||++|++|+|.... .
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------H
Confidence 45678999999999999886544 47999998544 3456789999999999999999999999998765 5
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.||.+||+.|.|.++ ...+.....+.+..|||+|+.|||.+ ++|||||.++|||+.+-..+||.|||+|+.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 699999999999877 45677888999999999999999986 99999999999999999999999999999887
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
....... ..+..-.+.|||-| |||++||++| |..||+++... ++.+..+...+-..+++.
T Consensus 850 ~d~~ey~--~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dlle~geRLsqPpiC 925 (1177)
T KOG1025|consen 850 PDEKEYS--APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLLEKGERLSQPPIC 925 (1177)
T ss_pred ccccccc--ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHHhccccCCCCCCc
Confidence 6554322 22333467799988 8999999999 99999887543 356666665555556666
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.-++..++.+||..|++.||+++++...+.++
T Consensus 926 tiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 926 TIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 66677778899999999999999999888765
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=269.51 Aligned_cols=226 Identities=20% Similarity=0.251 Sum_probs=176.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|.||++++..++..||+|.+... .....+++.+|++++.+++||||+++++++.+.+ ..++||||
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ey 80 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EISICMEH 80 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEEEEeec
Confidence 34579999999999999998889999998654 2334567899999999999999999999998776 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++|+|.++ ...+++..+..++.|+++||.|||+. .+++||||||+||+++.++.+|++|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999776 34578888999999999999999973 389999999999999999999999999987553321
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh------------------
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM------------------ 728 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~------------------ 728 (771)
.....|++.|+||| |||++||+++|+.||..... .....+...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCC
Confidence 12346899999999 69999999999999853211 011111100
Q ss_pred ------------------hCCCch-hhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 729 ------------------ALPDQI-LQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 729 ------------------~~~~~~-~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+... ...+++.+...+.+|+..+|++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111 11234455566779999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=279.01 Aligned_cols=182 Identities=21% Similarity=0.212 Sum_probs=149.0
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
....+|+|.+|+||++.....++.||||++... .....+++.+|+.+++.++||||+++++++..... ......|+|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 345689999999999999888889999999643 23345678899999999999999999998865431 112357999
Q ss_pred EEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 602 ~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|||++++........+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 173 (355)
T cd07874 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---- 173 (355)
T ss_pred hhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc----
Confidence 99997643333345678889999999999999999985 99999999999999999999999999998654322
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
......||+.|+||| +||++|||++|+.||.+
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred -ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 122346899999999 69999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=270.14 Aligned_cols=237 Identities=22% Similarity=0.311 Sum_probs=180.0
Q ss_pred cccccccccccccceEEEEEec-------CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILD-------LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDF 592 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~-------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 592 (771)
.+.....+|+|.+|.||+|+.. .....||+|.+.... .....++..|+++++++ +||||+++++++...+
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 91 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG- 91 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC-
Confidence 3444567899999999999763 234579999986442 34456789999999999 6999999999987765
Q ss_pred CCceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 593 QGNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 92 ----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 92 ----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 679999999999986541 2478888999999999999999985 99999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFT 717 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~ 717 (771)
|+++.++.+|++|||+++.......... .....++..||||| |||++||+++ |..||.+...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999986543221111 11123456799999 6999999999 8889865321
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.+.............++..+.....+||..+|++|||+.++++.|+++
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 243 --EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 123333332222222333344555566799999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=262.91 Aligned_cols=226 Identities=23% Similarity=0.274 Sum_probs=179.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|.||+|+++.+++.||+|.+..... .+++.+|++++++++||||+++++++.+.. ..|+++||
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~ 79 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWIVMEY 79 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEEEEec
Confidence 34568899999999999998888999999865433 678999999999999999999999988775 78999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++++|.++ ...+++..+..++.|++.|+.|||+. +|+|||++|+||+++.++.+|++|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999765 34678999999999999999999986 899999999999999999999999999986543321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 744 (771)
......|+..|+||| |||++|||++|+.||........ .........+ ......++..+..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhccCCCCCCCchhhcCHHHHH
Confidence 112234788999999 69999999999999975422211 1111111111 1222334455556
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+||+.||++|||+.|+++
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhc
Confidence 667999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=270.46 Aligned_cols=234 Identities=20% Similarity=0.241 Sum_probs=175.7
Q ss_pred ccccccccccceEEEEEecCC--------------CeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeec
Q 041479 525 LNVSYESLVKATVYKGILDLD--------------QTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACST 589 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~--------------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 589 (771)
....+|+|.+|.||+++.... ...||||.+... .....++|.+|++++++++||||+++++++..
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 345689999999999987543 235999998654 23445689999999999999999999999877
Q ss_pred CCCCCceeEEEEEEeccCCCCCCCc---------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 041479 590 SDFQGNYFRALVYEFMHHGSLESCP---------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNV 654 (771)
Q Consensus 590 ~~~~~~~~~~lv~e~~~~g~L~~~~---------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NI 654 (771)
.+ ..++||||+++++|.++. ..+++.++..++.|++.|++|||+. +++||||||+||
T Consensus 89 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 89 DD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred CC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 66 679999999999986541 1367888999999999999999985 899999999999
Q ss_pred eeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh--CCCCCCcccc
Q 041479 655 LLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT--GKRPTSDMFT 717 (771)
Q Consensus 655 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t--g~~P~~~~~~ 717 (771)
++++++.+|++|||+++....... ........+++.|+||| |||++|||++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999976543221 11112234577899999 6999999998 5667764321
Q ss_pred CCccHHHHHH------hhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 718 EGLDLHNFVK------MALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 718 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
. ..+..... ..........+++.+...+.+||+.||++||||.+|++.|++
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 E-QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H-HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 11111111 001111223344556667779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.81 Aligned_cols=225 Identities=22% Similarity=0.262 Sum_probs=181.3
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++.+.. ..|+|+||+
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~ 81 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLWIIMEYC 81 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEEEEEEee
Confidence 45789999999999999989999999996543 344567899999999999999999999988765 789999999
Q ss_pred cCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccc
Q 041479 606 HHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683 (771)
Q Consensus 606 ~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (771)
++++|.++ ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~----~ 154 (274)
T cd06609 82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS----K 154 (274)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc----c
Confidence 99999776 23689999999999999999999985 899999999999999999999999999987654321 1
Q ss_pred cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh-cCccccccCc
Q 041479 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV-LDPLFLVGGV 747 (771)
Q Consensus 684 ~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 747 (771)
.....|++.|+||| |||++||++||+.||..... ...........++..... +++.+.....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIPKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence 22345888999999 69999999999999965322 112222222223322222 5556666677
Q ss_pred ccChhchhhcCCHHHHHH
Q 041479 748 QEGEETAEENIKKGQIRE 765 (771)
Q Consensus 748 ~cl~~~p~~Rpt~~~vl~ 765 (771)
+||..+|++|||++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 233 LCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=267.62 Aligned_cols=229 Identities=25% Similarity=0.299 Sum_probs=177.4
Q ss_pred ccccccceEEEEEecCCC------eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 529 YESLVKATVYKGILDLDQ------TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+|+|.+|.||+|+..+.. +.||||.+.... ......+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v 77 (269)
T cd05044 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQYII 77 (269)
T ss_pred cccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeEEE
Confidence 689999999999986533 689999885443 234578999999999999999999999987765 67999
Q ss_pred EEeccCCCCCCCc----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-----ceEEec
Q 041479 602 YEFMHHGSLESCP----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-----TAHMGD 666 (771)
Q Consensus 602 ~e~~~~g~L~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-----~~kl~D 666 (771)
|||+++|+|.++. ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .+|++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999997651 2367888999999999999999985 899999999999999877 899999
Q ss_pred ccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
||+++........ .......++..|+||| |||++|||++ |+.||..... ...........
T Consensus 155 fg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~ 230 (269)
T cd05044 155 FGLARDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAGG 230 (269)
T ss_pred ccccccccccccc--ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcCC
Confidence 9999765432211 1111234577899999 6999999998 9999865322 12223322222
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.......++..+.....+||..+|++||++.++++.|++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 222333445556667779999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=263.59 Aligned_cols=229 Identities=23% Similarity=0.269 Sum_probs=182.2
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|.||+|....+++.||+|.+........+.+.+|++++++++||||+++++++...+ ..|++||
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l~~e 80 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWIVME 80 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEEEEe
Confidence 34456899999999999998888899999998766556788999999999999999999999987766 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+++++|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999765 25688999999999999999999985 899999999999999999999999999876543221
Q ss_pred cccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC---chhhhc
Q 041479 680 NQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD---QILQVL 738 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 738 (771)
......|+..|+||| +||++|||++|+.||.+...... .........+. .....+
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 157 ---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred ---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCCCccccchhhh
Confidence 112346788999999 59999999999999976432111 22222221111 112233
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+..+.....+||..+|++|||+.+++.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 445556677999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=267.72 Aligned_cols=235 Identities=24% Similarity=0.279 Sum_probs=178.2
Q ss_pred ccccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|.||+|.++. ++..||+|++.... ....+++.+|++++++++||||+++++++...+
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~----- 81 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK----- 81 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----
Confidence 3344568999999999998753 45699999986543 334567999999999999999999999988765
Q ss_pred eEEEEEEeccCCCCCCCc-------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 041479 597 FRALVYEFMHHGSLESCP-------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~-------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~ 651 (771)
..++||||+++|+|.++. ..+++.++..++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 579999999999986552 1367788899999999999999985 899999999
Q ss_pred CCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcc
Q 041479 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDM 715 (771)
Q Consensus 652 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~ 715 (771)
+||+++.++.+|++|||+++....... ........+++.|+||| |||++|||++ |..||.+.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred hheEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999875433221 11111223467799999 6999999998 88888643
Q ss_pred ccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 716 FTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
... ..............+...+..+...+.+|++.||++|||+.|+++.|++
T Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHE--EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 221 1222221111111223344556666779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=294.35 Aligned_cols=234 Identities=22% Similarity=0.236 Sum_probs=178.7
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+.....+|.|.+|+||+|.+..+++.||+|++.... ......|..|+.++++++|||||++++++...... .+|
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~---~ly 90 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ---KLY 90 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC---EEE
Confidence 3444566899999999999999999999999986542 34457899999999999999999999988654322 679
Q ss_pred EEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCCeeeCC----------
Q 041479 600 LVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHC----KKPIVHCDLKPSNVLLDN---------- 658 (771)
Q Consensus 600 lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~----~~~ivHrdlk~~NILl~~---------- 658 (771)
+||||+++|+|.++ ...+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999765 245899999999999999999999852 136999999999999964
Q ss_pred -------CCceEEecccCccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCc
Q 041479 659 -------DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 659 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~ 714 (771)
.+.+||+|||+++.+..... .....||+.|+||| |||++|||++|+.||..
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999986543211 12346899999999 69999999999999964
Q ss_pred cccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 715 MFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..... .+....... +.......++.+..++..||..+|.+|||+.+++.
T Consensus 246 ~~~~~-qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFS-QLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHH-HHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 32111 111212111 21111233455556677999999999999999983
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=271.41 Aligned_cols=226 Identities=19% Similarity=0.264 Sum_probs=179.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||+|....+++.||||++........+.+.+|+.+++.++||||+++++++...+ ..|+||||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEEecC
Confidence 335899999999999998888899999997655555678899999999999999999999987766 789999999
Q ss_pred cCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccc
Q 041479 606 HHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683 (771)
Q Consensus 606 ~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (771)
++++|..+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----~ 173 (297)
T cd06659 101 QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----K 173 (297)
T ss_pred CCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc----c
Confidence 99999766 34578999999999999999999986 899999999999999999999999999875443221 1
Q ss_pred cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCccccccC
Q 041479 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPLFLVGG 746 (771)
Q Consensus 684 ~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 746 (771)
.....|++.|+||| +||++|||++|+.||.... ............+ ......++..+....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSPPPKLKNAHKISPVLRDFL 251 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence 22356899999999 6999999999999986421 1111222222111 112223344455566
Q ss_pred cccChhchhhcCCHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+|++.+|++||++.++++
T Consensus 252 ~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 252 ERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHhcCCcccCcCHHHHhh
Confidence 6999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=271.94 Aligned_cols=179 Identities=21% Similarity=0.180 Sum_probs=145.8
Q ss_pred cccc--ccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 529 YESL--VKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 529 l~~~--~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
+|+| .+++||+++.+.+++.||||++.... ....+.+.+|+++++.++|||||++++++.+.+ ..++||||
T Consensus 6 ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~lv~e~ 80 (327)
T cd08227 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWVVTSF 80 (327)
T ss_pred ccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEEEEec
Confidence 5666 67899999999999999999996542 334567778999999999999999999998776 78999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999765 23488999999999999999999985 8999999999999999999999999875433211110
Q ss_pred c---ccccccccccccccchh-----------------HHHHHHHHHhCCCCCCcc
Q 041479 680 N---QCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 680 ~---~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~ 715 (771)
. ........++..|+||| +||++||+++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 00111234678899999 699999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=268.43 Aligned_cols=226 Identities=19% Similarity=0.195 Sum_probs=180.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|+||++++...++.||+|.+... .......+.+|++++++++||||+++++++...+ ..|+||||
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~e~ 80 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVYMCMEY 80 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEEEEEee
Confidence 34679999999999999988889999998654 2334578999999999999999999999987765 78999999
Q ss_pred ccCCCCCCC--c----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 605 MHHGSLESC--P----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~--~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+++++|.++ . ..+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+|++|||+++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999765 1 2688999999999999999999974 4899999999999999999999999999976533211
Q ss_pred Ccccccccccccccccchh---------------------HHHHHHHHHhCCCCCCccccCCccHHH--HHHhhCCCchh
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDMFTEGLDLHN--FVKMALPDQIL 735 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~--~~~~~~~~~~~ 735 (771)
....|++.|+||| +||++||+++|+.||....... .... ......+...+
T Consensus 159 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 159 ------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLSAIVDGDPPTLP 231 (286)
T ss_pred ------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHHHHhhcCCCCCC
Confidence 1235788999999 5999999999999996432111 1111 11122233344
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..++..+.....+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 446666767777999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=265.02 Aligned_cols=227 Identities=27% Similarity=0.332 Sum_probs=176.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhh--HHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+++.+.+++.||+|++....... .....+|+.++++++||||+++++++.... ..++||||
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~v~~~ 79 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYIVMEY 79 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEEEEEE
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccccccc
Confidence 45899999999999999999999999997765332 234567999999999999999999998866 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++++|.++ ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+...... .
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~----~ 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN----N 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST----T
T ss_pred cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc----c
Confidence 999999765 35688999999999999999999996 9999999999999999999999999998754111 1
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCcccc--CCccHHHHHHhhCCCch--hhhcCcc
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFT--EGLDLHNFVKMALPDQI--LQVLDPL 741 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~ 741 (771)
.......++..|+||| +|+++|+|++|..||.+... ....+.+......+... .....+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence 1223456899999999 69999999999999976411 01111111111111111 1111245
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||+.||++|||+.++++
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 555666999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=267.43 Aligned_cols=235 Identities=21% Similarity=0.220 Sum_probs=178.3
Q ss_pred ccccccccccccceEEEEEecCCC----------------eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ----------------TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIIT 585 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~----------------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~ 585 (771)
+.....+|+|.+|.||+|++...+ ..||+|++.... ....+.+.+|++++++++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 344567899999999999876533 568999986543 345678999999999999999999999
Q ss_pred EeecCCCCCceeEEEEEEeccCCCCCCCc--------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 041479 586 ACSTSDFQGNYFRALVYEFMHHGSLESCP--------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651 (771)
Q Consensus 586 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~ 651 (771)
++...+ ..++||||+++++|.++. ..+++..+..++.|++.||+|||+. +|+||||||
T Consensus 87 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 87 VCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred EEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 987765 679999999999997651 1578899999999999999999985 899999999
Q ss_pred CCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh--CCCCCCc
Q 041479 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT--GKRPTSD 714 (771)
Q Consensus 652 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t--g~~P~~~ 714 (771)
+||+++.++.+|++|||+++........ .......+++.||||| |||++||+++ |..||..
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999765432211 1122334678899999 6999999998 6778754
Q ss_pred cccCCccHHHHHHhhC-----C--CchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 715 MFTEGLDLHNFVKMAL-----P--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 715 ~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
... ....+...... + ......++..+...+.+|++.||++|||+.++++.|++
T Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 LTD--QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cCh--HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 211 11112211110 0 11122233455566779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=261.33 Aligned_cols=225 Identities=24% Similarity=0.246 Sum_probs=180.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|.||+|+.+.+++.||+|.+.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv 80 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED-----NLYIF 80 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----eEEEE
Confidence 45799999999999998788899999986543 234578999999999999999999999987765 68999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||+++++|.++ ...+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999766 23478889999999999999999986 89999999999999999999999999987654322
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
......|+..|+||| +||++||+++|+.||.+... ......+.........+..+++.+
T Consensus 157 ----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd06632 157 ----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKELPPIPDHLSDEA 231 (258)
T ss_pred ----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHHHHHHhcccCCCcCCCcCHHH
Confidence 112345889999999 69999999999999965421 111222222122233445556666
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+||+.+|++||++.+++.
T Consensus 232 ~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 232 KDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHhhcCcccCcCHHHHhc
Confidence 66777999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=276.62 Aligned_cols=229 Identities=23% Similarity=0.281 Sum_probs=184.3
Q ss_pred ccccccccceEEEEEecCCC---eEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQ---TFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.||.|++|.|+..+ ..||||.++..... ...+|++|+.+|.+++|||+|+|||+..+. ...|||
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~mMV~ 189 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAMMVF 189 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hhhHHh
Confidence 45899999999999997642 57999999766543 678999999999999999999999998874 367999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|.++.|+|.++ ...+-......++.|||.|+.||.+. ++||||+.++|+|+.....+||+|||+.+.++...
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999765 23456677889999999999999985 99999999999999999999999999999887655
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.+.. ......-...|.||| |||++|||+| |+.||.+. .+..+.+.+..+..-..++.+...
T Consensus 267 d~Yv-m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g~qIL~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 267 DMYV-MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RGIQILKNIDAGERLPRPKYCSED 343 (1039)
T ss_pred cceE-ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CHHHHHHhccccccCCCCCCChHH
Confidence 4321 112223456799999 8999999999 99999874 344455554444333345566667
Q ss_pred ccccCcccChhchhhcCCHHHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
|..++..||...|++|||+.++++.+
T Consensus 344 IY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHHHhH
Confidence 77778899999999999999998543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=250.22 Aligned_cols=229 Identities=21% Similarity=0.209 Sum_probs=182.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
......+|.|.-|+|++++++.++...|||.+.... ....++++..++++.+.+ .|+||+.+|||.... ..++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~I 168 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVFI 168 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHHH
Confidence 344567899999999999999999999999997654 556788999999988886 899999999997765 4678
Q ss_pred EEEeccCCCCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
.||.|.. ..+. ..+++++.-.-++..-+.+||.||.+. .+|+|||+||+|||+|+.|.+|+||||++.++.+.
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc
Confidence 8998853 2222 245677777778888999999999985 49999999999999999999999999999877665
Q ss_pred cCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh--h
Q 041479 677 MSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL--Q 736 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~ 736 (771)
..+. ...|.+.||||| ||++++|++||+.||...-.+-..+..++. ..|+..+ .
T Consensus 246 kAht-----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~ 319 (391)
T KOG0983|consen 246 KAHT-----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHM 319 (391)
T ss_pred cccc-----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCccc
Confidence 4332 235889999999 799999999999999864333333444444 3332222 2
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+++.+......|+++|+.+||...++++
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 26777777788999999999999888875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=262.66 Aligned_cols=229 Identities=20% Similarity=0.239 Sum_probs=167.6
Q ss_pred cccccccceEEEEEecCCC--eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQ--TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+|+...+. ..+++|.+.... ....+.|.+|+.+++.++||||+++++++.+.. ..|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEec
Confidence 4799999999999765443 345667665433 344678999999999999999999999988765 67999999
Q ss_pred ccCCCCCCCc-------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 605 MHHGSLESCP-------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 605 ~~~g~L~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+++|+|.++. ...++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcch
Confidence 9999997652 2345666788999999999999985 89999999999999999999999999986432211
Q ss_pred CCcccccccccccccccchh----------------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC---
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALP--- 731 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~--- 731 (771)
. ........|+..|+||| |||++|||++ |..||....... .+.........
T Consensus 154 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~ 230 (268)
T cd05086 154 Y--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIKDQQVKLF 230 (268)
T ss_pred h--hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhhcccccC
Confidence 0 11122346788999998 5999999997 567876432211 12222222111
Q ss_pred -CchhhhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 732 -DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 732 -~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
+......++.+......|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2223334444444556898 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=263.35 Aligned_cols=224 Identities=20% Similarity=0.201 Sum_probs=172.1
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhc---cCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRN---IRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~---l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+|+|.+|.||++....+++.||||.+.... ......+.+|..+++. .+||||+.+++++.+.+ ..++||
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 76 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFIL 76 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEEE
Confidence 689999999999999888899999986442 1222344555544443 47999999999987766 679999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++.......
T Consensus 77 e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 77 DLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999999765 34689999999999999999999985 89999999999999999999999999987543321
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
.....|++.|+||| +||++||+++|+.||.+................+...++.+++.+.
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHH
Confidence 12245899999999 6999999999999997543222111111122223344455566666
Q ss_pred ccCcccChhchhhcC-----CHHHHHHH
Q 041479 744 VGGVQEGEETAEENI-----KKGQIRES 766 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rp-----t~~~vl~~ 766 (771)
....+|+..||++|| |+.++++.
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 677799999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=260.76 Aligned_cols=231 Identities=25% Similarity=0.345 Sum_probs=180.9
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|..+++ +.||||.+.... ...+++.+|+.++++++||||+++++++.... ..++|||
T Consensus 9 ~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e 81 (261)
T cd05034 9 KLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PIYIVTE 81 (261)
T ss_pred eeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ceEEEEe
Confidence 3345679999999999998755 589999986443 34578999999999999999999999987655 6799999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++++|.++ ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 9999999766 23578999999999999999999986 89999999999999999999999999998654321
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.....+..++..|+||| +|+++||+++ |+.||.+... ....+......+...+...+..+
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05034 158 --YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYRMPRPPNCPEEL 233 (261)
T ss_pred --hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHH
Confidence 11112233567899999 6999999999 9999965321 12223333333322233335556
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.....+|+..+|++||++.++++.|++
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 666779999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=271.49 Aligned_cols=234 Identities=23% Similarity=0.293 Sum_probs=178.8
Q ss_pred ccccccccccceEEEEEecC-------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 525 LNVSYESLVKATVYKGILDL-------DQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~-------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
....+|+|.+|.||+|++.. ....||+|.+.... ....+++.+|+++++++ +||||+++++++...+
T Consensus 16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---- 91 (334)
T cd05100 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG---- 91 (334)
T ss_pred ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC----
Confidence 34568999999999998643 22379999886432 33457899999999999 7999999999987765
Q ss_pred eeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 041479 596 YFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl 656 (771)
..+++|||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||++
T Consensus 92 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 92 -PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 679999999999986551 2367888999999999999999985 99999999999999
Q ss_pred CCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCc
Q 041479 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGL 720 (771)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~ 720 (771)
+.++.+||+|||+++........ .......++..||||| +||++|||++ |..||.+... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--E 243 (334)
T ss_pred cCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--H
Confidence 99999999999999865432211 1112233467899999 6999999999 8888865321 1
Q ss_pred cHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 721 DLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+............+......+.....+||+.+|++|||+.|+++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 22233322232223333344555566799999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=263.39 Aligned_cols=231 Identities=19% Similarity=0.243 Sum_probs=181.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
-.+|+|.+|.||+|....+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~ 80 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-----HFNL 80 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-----eEEE
Confidence 34799999999999998888899999996432 224578999999999999999999999987766 6899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~ 676 (771)
||||+++++|.++ ...+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+|++|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999776 34678899999999999999999985 999999999999998765 5999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC--ccHHHHHHhhCCCchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG--LDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 739 (771)
............|+..|+||| +|+++||+++|+.||....... ....+..........++.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 221111122346889999999 6999999999999996422111 11111112222344555566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+|+..+|++|||+.++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 77766777999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=264.39 Aligned_cols=233 Identities=17% Similarity=0.224 Sum_probs=180.7
Q ss_pred ccccccccccceEEEEEecC-----CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|.|++|+||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 83 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE-----PH 83 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC-----cc
Confidence 34458999999999999754 3458999998655433 5678999999999999999999999987765 67
Q ss_pred EEEEEeccCCCCCCC---cc---------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEec
Q 041479 599 ALVYEFMHHGSLESC---PR---------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGD 666 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~---------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 666 (771)
++||||+++|+|.++ .. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999765 12 588999999999999999999986 899999999999999999999999
Q ss_pred ccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
||+++...... ........+++.|+||| +|+++||+++ |..||.+..... ..........
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-~~~~~~~~~~ 236 (275)
T cd05046 161 LSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-VLNRLQAGKL 236 (275)
T ss_pred cccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-HHHHHHcCCc
Confidence 99987543221 11222335678899999 6999999999 888986542211 1222222222
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+......++..+.....+||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 222333455566667779999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=259.71 Aligned_cols=232 Identities=21% Similarity=0.316 Sum_probs=180.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+...-.+|+|.+|.||+|.+..+. .||+|.+... ....+.+.+|++++++++|+||+++++++.+ . ..+++|
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~-~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~-----~~~~v~ 79 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E-----PIYIIT 79 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCc-cEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C-----CeEEEE
Confidence 344556899999999999876554 7999988643 2345789999999999999999999999866 3 468999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999765 23467888999999999999999985 89999999999999999999999999997654322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. .......++..|+||| +||++||++| |+.||.+.. .....+......+..........
T Consensus 157 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05073 157 Y---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPRPENCPEE 231 (260)
T ss_pred c---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCCCCcccCCHH
Confidence 1 1112234567899999 6999999999 999986532 12233333343333333344455
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.....+|++.+|++||++.++.+.|+++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 55666799999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=265.99 Aligned_cols=229 Identities=23% Similarity=0.298 Sum_probs=169.3
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhcc---CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNI---RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|+||+|+++.+++.||+|.+.... ......+.+|+++++++ +||||+++++++...........++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 45899999999999999999999999986542 22234566777777765 69999999999876443333467999
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||+++ ++.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161 (288)
T ss_pred Eccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCc
Confidence 999975 66544 23478899999999999999999986 8999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-------CCC--
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-------LPD-- 732 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------~~~-- 732 (771)
.. .....||+.|+||| +||++|||++|+.||....... .+.+..... .+.
T Consensus 162 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 162 MA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cc-----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcccc
Confidence 21 12345899999999 6999999999999986432111 111111110 000
Q ss_pred ----------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ----------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ----------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....++..+.....+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001122333334556999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=277.25 Aligned_cols=230 Identities=18% Similarity=0.173 Sum_probs=171.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+++.+.+++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+ ..|+||
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~~~lv~ 80 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----NLYLIM 80 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----EEEEEE
Confidence 345899999999999999999999999996432 334567889999999999999999999987766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999776 34688899999999999999999985 9999999999999999999999999998754321100
Q ss_pred c-------------------------------ccccccccccccccchh---------------HHHHHHHHHhCCCCCC
Q 041479 680 N-------------------------------QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 680 ~-------------------------------~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~ 713 (771)
. .......+||+.||||| +||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0 00112357999999999 6999999999999996
Q ss_pred ccccCCccHHHHHHhhCCCch--hhhcCccccccCcccChhchhhcCC---HHHHHH
Q 041479 714 DMFTEGLDLHNFVKMALPDQI--LQVLDPLFLVGGVQEGEETAEENIK---KGQIRE 765 (771)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~cl~~~p~~Rpt---~~~vl~ 765 (771)
+..... .............. ...+++.......+|+ .||.+|++ +.|+++
T Consensus 238 ~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 238 SETPQE-TYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCHHH-HHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 532211 11112111111111 1113333333333444 49999985 566553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=263.07 Aligned_cols=221 Identities=25% Similarity=0.258 Sum_probs=177.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.-..+|.|+||.||-++.+.+|+.||.|++...+ ++...-.+.|-.++.+++.+.||.+-.+|.+.+ ..|+|
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd-----~LClV 263 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD-----ALCLV 263 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC-----ceEEE
Confidence 3446899999999999999999999999996543 334456788999999999999999998888877 78999
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|..|.||||..+ ...+++.+.+.++.+|+.||++||+. +||+||+||+|||+|++|+++|+|.|+|..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999765 34689999999999999999999986 9999999999999999999999999999877665
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 739 (771)
.. ..+.+||.+||||| +||++|||+.|+.||..- .......++-++. -+.+.++.++
T Consensus 341 ~~-----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~-KeKvk~eEvdrr~~~~~~ey~~kFS 414 (591)
T KOG0986|consen 341 KP-----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR-KEKVKREEVDRRTLEDPEEYSDKFS 414 (591)
T ss_pred Cc-----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh-hhhhhHHHHHHHHhcchhhcccccC
Confidence 43 23457999999999 699999999999999652 2222222222222 2344455556
Q ss_pred ccccccCcccChhchhhcCC
Q 041479 740 PLFLVGGVQEGEETAEENIK 759 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt 759 (771)
+..+.....-+++||++|.-
T Consensus 415 ~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHHHHHHHHHHccCHHHhcc
Confidence 66555555678999999974
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=264.73 Aligned_cols=228 Identities=21% Similarity=0.221 Sum_probs=179.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|+||++++..+++.||+|++.... ....+++.+|+++++.++||||+++++++...+ ..++||||
T Consensus 10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 84 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NICMCMEF 84 (284)
T ss_pred HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EEEEEEec
Confidence 346899999999999999888899999986543 345678999999999999999999999998776 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++|+|..+ .+.+++..+..++.+++.|+.|||+. .+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---- 158 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---- 158 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----
Confidence 999999765 34578899999999999999999973 379999999999999999999999999987543221
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC------CccHHHHHHhhCC---Cchh-h
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE------GLDLHNFVKMALP---DQIL-Q 736 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~------~~~~~~~~~~~~~---~~~~-~ 736 (771)
.....|+..|+||| |||++||+++|+.||...... ...+.++...... .... .
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 11346899999999 799999999999999753321 1112223222221 1111 1
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.++..+.....+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 134445556679999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=275.01 Aligned_cols=182 Identities=21% Similarity=0.220 Sum_probs=148.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
....+|+|.+|.||+|++...++.||||++... .....+.+.+|+.+++.++||||+++++++...+. ......|+|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 345689999999999999988889999999643 23345678899999999999999999998765431 122357999
Q ss_pred EEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 602 ~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|||++++........+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 108 ~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---- 180 (364)
T cd07875 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---- 180 (364)
T ss_pred EeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC----
Confidence 99997643333345578888999999999999999985 99999999999999999999999999998654321
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
......||+.|+||| +||++|||++|+.||..
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 181 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred -cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 122346899999999 69999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=271.08 Aligned_cols=228 Identities=19% Similarity=0.117 Sum_probs=170.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+++.+.+++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+ ..|+||
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~ 80 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----NLYLVM 80 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----eEEEEE
Confidence 456899999999999999988899999996432 234567889999999999999999999988776 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999765 34578889999999999999999985 899999999999999999999999999876543221
Q ss_pred Ccccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--C-Cchh
Q 041479 679 SNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--P-DQIL 735 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~-~~~~ 735 (771)
......+||+.||||| +||++|||++|+.||.+.... ........... + ....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 158 ---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred ---ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCcccCCCcc
Confidence 1112246899999998 699999999999999653111 11111211111 1 1111
Q ss_pred hhcCccccccCcccC--hhchhhcCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEG--EETAEENIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl--~~~p~~Rpt~~~vl~ 765 (771)
..++..+.....+|+ ..++..||++.++++
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 123333433444444 445555889988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=266.71 Aligned_cols=230 Identities=23% Similarity=0.252 Sum_probs=180.9
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||++....+++.||+|.+........+.+.+|+.++++++||||+++++++...+ ..|+|+|
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e 96 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELWVVME 96 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEEEEEe
Confidence 33456899999999999988888899999997655555678999999999999999999999987766 6799999
Q ss_pred eccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 604 FMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 604 ~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|+++++|.++ ...+++.++..++.|++.|+.|||+. +++|||+||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 9999999876 33578889999999999999999985 899999999999999999999999999875543221
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCcccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLVG 745 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 745 (771)
......|++.|+||| |||++||+++|+.||........ ...+.....+ ....+.++..+...
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhcCCCCCCCCccccCHHHHHH
Confidence 112345889999999 69999999999999965322111 1111111111 12223344455566
Q ss_pred CcccChhchhhcCCHHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+||..+|++||++.+++..
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 679999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=264.01 Aligned_cols=225 Identities=21% Similarity=0.232 Sum_probs=171.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|+.+.+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+ ..|+||||
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~ 80 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLYLIFEF 80 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEEEEEec
Confidence 35799999999999999888899999986543 233467889999999999999999999988766 78999999
Q ss_pred ccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 605 MHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
++ +++.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 566443 14588999999999999999999985 999999999999999999999999999975432211
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCc--------------------cH
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGL--------------------DL 722 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~--------------------~~ 722 (771)
......+++.|+||| +||++||++||+.||.+...... ..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 ----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 112235788999999 69999999999999864211000 00
Q ss_pred HHHHHhhCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 723 HNFVKMALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 723 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+ ....+. .....+++.+.....+||..||++|||+.+++.
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDY-KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHH-HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 000000 011123444445666999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=295.06 Aligned_cols=374 Identities=26% Similarity=0.338 Sum_probs=250.1
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCc
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPS 124 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~ 124 (771)
++.+|||++|.+. ..|..+..+.+|+.|+++.|.|.. .|.+..++.+|++|+|.+|+++ .+|.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~-vp~s~~~~~~l~~lnL~~n~l~---------------~lP~ 108 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRS-VPSSCSNMRNLQYLNLKNNRLQ---------------SLPA 108 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhh-Cchhhhhhhcchhheeccchhh---------------cCch
Confidence 4889999999988 777888899999999999999985 7888999999999999999977 6778
Q ss_pred cccCCCCCCEEecccccCcCC-----------------------CC--ccceeeecccccccccCccccCCCCCCEEecc
Q 041479 125 ELGSLLKFKGLGLANNYFTGP-----------------------IP--HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVS 179 (771)
Q Consensus 125 ~~~~l~~L~~L~Ls~N~l~~~-----------------------lp--~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls 179 (771)
++..+++|++|+++.|+|... ++ ..+.+++..|.+.+.++..+.+++. .|+|+
T Consensus 109 ~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr 186 (1081)
T KOG0618|consen 109 SISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLR 186 (1081)
T ss_pred hHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecc
Confidence 888888888888888877621 11 1344555555555555555555544 45555
Q ss_pred cCcCcccCChh-----------------hhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCccc
Q 041479 180 ENQLVGELPPH-----------------IGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDS 242 (771)
Q Consensus 180 ~N~l~g~lp~~-----------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 242 (771)
+|.+. .+.-. +...-++|+.|+.++|.++...+. + --.+|+++|+++|+++++ |+++
T Consensus 187 ~N~~~-~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~~l-p~wi-- 260 (1081)
T KOG0618|consen 187 YNEME-VLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLSNL-PEWI-- 260 (1081)
T ss_pred cchhh-hhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccc-c-ccccceeeecchhhhhcc-hHHH--
Confidence 55554 11110 011335566666666666633221 2 235678888888888765 4665
Q ss_pred ccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCcccc-----
Q 041479 243 LVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVG----- 317 (771)
Q Consensus 243 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~----- 317 (771)
..+.+|+.++..+|+|+ .+|..++... +|+.|.+..|.++ .+|+...+++.|+.|+|..|++....+..+.
T Consensus 261 -~~~~nle~l~~n~N~l~-~lp~ri~~~~-~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~ 336 (1081)
T KOG0618|consen 261 -GACANLEALNANHNRLV-ALPLRISRIT-SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNAS 336 (1081)
T ss_pred -HhcccceEecccchhHH-hhHHHHhhhh-hHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHH
Confidence 66777888888888886 7777777665 6777777777777 6677777777888888877776332221111
Q ss_pred --------------------CCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeeccc
Q 041479 318 --------------------YLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSH 376 (771)
Q Consensus 318 --------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~ 376 (771)
.+..|+.|++.+|.++...-+.+.+++.|+.|+|++|+|...+...+.++..| .|+||+
T Consensus 337 l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSG 416 (1081)
T KOG0618|consen 337 LNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSG 416 (1081)
T ss_pred HHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhccc
Confidence 12335666777777766655666677777777777777764444455666666 677777
Q ss_pred CcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCC-CCccccccccccccccCCCc
Q 041479 377 NHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGD-VPRKMIFKNASAISEAGNEK 454 (771)
Q Consensus 377 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~~~~~~~~n~~ 454 (771)
|+|+ .+|+.+.++..|++|...+|+|. ..| .++ .+++|+.+|+|.|+|+.. +|......++..+.+.||.+
T Consensus 417 NkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~----~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 417 NKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA----QLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred chhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh----hcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 7776 55677777777777777777776 555 333 667777777777777532 33333335666677777765
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=260.86 Aligned_cols=230 Identities=22% Similarity=0.253 Sum_probs=177.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|.|.+|+||+|... +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+.+ ..+
T Consensus 5 ~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 78 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN-----TIS 78 (265)
T ss_pred cceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC-----eEE
Confidence 345799999999999875 45589999986432 223457889999999999999999999998765 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||+++++|.++ ...+++..+..++.|++.|++|||+. +|+|+||||+||++++++.+|++|||+++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999876 24578888999999999999999985 8999999999999999999999999998765321
Q ss_pred cCC--cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCCCchhhhc
Q 041479 677 MSS--NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALPDQILQVL 738 (771)
Q Consensus 677 ~~~--~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 738 (771)
... .........|+..|+||| +||++||+++|+.||....... ........ ...+..+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhccCCCCCCCCCC
Confidence 110 011122346899999999 6999999999999996532111 11122211 1123344445
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+..+.....+||.++|++|||+.++++
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 555666677999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=257.97 Aligned_cols=226 Identities=23% Similarity=0.215 Sum_probs=178.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|.|.+|.||++..+.+++.||||.+.... ....+.+.+|++++++++||||+++++.+...+ ...|+||||
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~ 81 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYIVMGF 81 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEEEecc
Confidence 45789999999999999888899999996543 334567899999999999999999998865433 157899999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++++|.++ ...+++.++..++.+++.|++|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 999999765 23578999999999999999999985 899999999999999999999999999986543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
......|++.|+||| +|+++||+++|+.||....... .......... ...+..+++.+..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~ 232 (257)
T cd08223 158 ---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKL-PPMPKDYSPELGE 232 (257)
T ss_pred ---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCC-CCCccccCHHHHH
Confidence 122345889999999 6999999999999986432111 1112222222 2234455666767
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+|++.+|++|||+.++++
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHhccCcccCCCHHHHhc
Confidence 778999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=277.94 Aligned_cols=172 Identities=23% Similarity=0.328 Sum_probs=143.8
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|.||+|+++.+++.||||... ...+.+|++++++++|||||++++++...+ ..++|||
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~~lv~e 240 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LTCLVLP 240 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEEEEEE
Confidence 34456899999999999999999899999642 234678999999999999999999988776 6799999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+. ++|..+ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 995 576554 34589999999999999999999985 899999999999999999999999999986543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCC
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPT 712 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~ 712 (771)
.....+..||+.||||| |||++|||++|..|+
T Consensus 316 -~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 -TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred -cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 11123457999999999 699999999987654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=260.44 Aligned_cols=219 Identities=22% Similarity=0.294 Sum_probs=169.4
Q ss_pred cccccccceEEEEEecCCC----------eEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 528 SYESLVKATVYKGILDLDQ----------TFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.+|+|.+|.||+|+++.++ ..||+|.+...... ...|.+|+.++++++||||+++++++.. . .
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~ 74 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E 74 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence 3789999999999998766 45888887554433 6889999999999999999999999877 4 4
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-------ceEEec
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-------TAHMGD 666 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-------~~kl~D 666 (771)
.++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 5899999999999776 22578899999999999999999985 999999999999999887 799999
Q ss_pred ccCccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHh
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKM 728 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~ 728 (771)
||+++..... ....++..|+||| +||++||+++ |..|+.+.... ....+...
T Consensus 152 fg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~ 221 (259)
T cd05037 152 PGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD 221 (259)
T ss_pred CCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc
Confidence 9999864331 1234667899999 6999999999 57777654211 11122111
Q ss_pred hCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 729 ALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
. ...+......+.....+||..+|++|||+.++++.|+
T Consensus 222 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 Q--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 1111111134445666999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=257.65 Aligned_cols=225 Identities=18% Similarity=0.209 Sum_probs=180.5
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.+|+|.+|.||.++...+++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+ ..+++|||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~~~~e~~ 81 (256)
T cd08221 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLLIEMEYA 81 (256)
T ss_pred EecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEEEEEEec
Confidence 4689999999999999888999999986542 445678899999999999999999999998766 789999999
Q ss_pred cCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 606 HHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 606 ~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++|+|.++. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 999997662 3478889999999999999999985 899999999999999999999999999986543321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......|++.|+||| +|+++|||++|+.||...... ....+...+..+. ....++..+...
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-NLVVKIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCC-CccccCHHHHHH
Confidence 122346899999999 699999999999998653211 1122222222222 224445556666
Q ss_pred CcccChhchhhcCCHHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+||..+|++||++.++++.
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHcccCcccCCCHHHHhhC
Confidence 779999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=260.74 Aligned_cols=226 Identities=19% Similarity=0.243 Sum_probs=180.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|.||+|.+..+++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+ ..|+||||+
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 84 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIMEYL 84 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEEEEEEeC
Confidence 34799999999999998888899999986443 334568899999999999999999999998776 789999999
Q ss_pred cCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccc
Q 041479 606 HHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683 (771)
Q Consensus 606 ~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (771)
++|+|.++ ...+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++........ .
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----~ 157 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----K 157 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh----h
Confidence 99999776 34578999999999999999999985 999999999999999999999999999876543221 1
Q ss_pred cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcc
Q 041479 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQ 748 (771)
Q Consensus 684 ~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (771)
.....|+..|+||| +||++||+++|..||.+... ...........+......++..+.....+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--HHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 12245788999999 69999999999999965321 11222222222333344455556666779
Q ss_pred cChhchhhcCCHHHHHHH
Q 041479 749 EGEETAEENIKKGQIRES 766 (771)
Q Consensus 749 cl~~~p~~Rpt~~~vl~~ 766 (771)
||..+|++||++.++++.
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=259.40 Aligned_cols=231 Identities=18% Similarity=0.166 Sum_probs=174.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
...+|+|.+|+||+|+...+++.||||.+.... ....+.+.+|++++++++||||+++++++.+... ...++
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~ 83 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---RTLSI 83 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---ceEEE
Confidence 445789999999999999988999999985332 2345688999999999999999999998765431 15789
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+++|+|.++ ...+++....+++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999876 24578888999999999999999986 89999999999999999999999999998653221
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.. ........|+..|+||| |||++||+++|+.||.+.... ....+..........+...+..+
T Consensus 161 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 161 LS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred cc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHHHhcCCCCCCCchhhCHHH
Confidence 11 11122345889999999 699999999999999753111 11222221111222333344444
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+|+ .+|++||+++|+++
T Consensus 239 ~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 239 RDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHh-cChhhCCCHHHHhc
Confidence 44455777 48999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=260.46 Aligned_cols=231 Identities=22% Similarity=0.252 Sum_probs=178.6
Q ss_pred cccccccccceEEEEEecC-CCeEEEEEEeecc----------chhhHHHHHHHHHHHhc-cCCCCceeEEEEeecCCCC
Q 041479 526 NVSYESLVKATVYKGILDL-DQTFIAVKVLFLH----------QRGALKSFMAECQALRN-IRHRNLVKIITACSTSDFQ 593 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~-~~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~ 593 (771)
...+|+|.+|.||+|+++. +++.||||.+... ......++.+|+.++.+ ++||||+++++++.+.+
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-- 82 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND-- 82 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC--
Confidence 3457999999999999987 6779999998532 22345678889998875 79999999999988766
Q ss_pred CceeEEEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEec
Q 041479 594 GNYFRALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGD 666 (771)
Q Consensus 594 ~~~~~~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 666 (771)
..++||||+++++|.++ ...+++..+..++.|++.|+.|||+. .+++||||||+||+++.++.+|++|
T Consensus 83 ---~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 83 ---RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred ---eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEec
Confidence 78999999999999654 23578888999999999999999963 3799999999999999999999999
Q ss_pred ccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 731 (771)
||++....... ......|+..|+||| +|+++||+++|+.||...... ...........+
T Consensus 158 fg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~ 231 (269)
T cd08528 158 FGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVEAVYE 231 (269)
T ss_pred ccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhhccCC
Confidence 99998654322 122345889999999 699999999999998542111 111112222222
Q ss_pred CchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+......++.+...+.+||+.||++||++.|+.+++++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 21222445566667779999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=267.05 Aligned_cols=177 Identities=21% Similarity=0.255 Sum_probs=141.6
Q ss_pred ccccccccceEEEEEecC--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDL--DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|+.+. +++.||+|.+.... ....+.+|++++++++||||+++++++..... ...|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e~ 81 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLLFDY 81 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEEEec
Confidence 358999999999999764 45789999985432 23567889999999999999999998865431 267999999
Q ss_pred ccCCCCCCC------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEeccc
Q 041479 605 MHHGSLESC------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DNDMTAHMGDFG 668 (771)
Q Consensus 605 ~~~g~L~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfG 668 (771)
+.+ ++.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 964 55332 12478888999999999999999986 89999999999999 456789999999
Q ss_pred CccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCC
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~ 713 (771)
+|+........ ........||+.||||| +||++|||++|+.||.
T Consensus 158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99876433211 11223457899999999 6999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=258.73 Aligned_cols=237 Identities=23% Similarity=0.285 Sum_probs=177.9
Q ss_pred ccccccccceEEEEEecC---CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc-eeEEE
Q 041479 527 VSYESLVKATVYKGILDL---DQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN-YFRAL 600 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~-~~~~l 600 (771)
..+|+|++|+||+|.++. +++.||||++.... ....+++.+|++++++++||||+++++++......+. ...++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 357999999999998754 35799999996542 3446788999999999999999999998865432221 24578
Q ss_pred EEEeccCCCCCCC---------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 601 VYEFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 601 v~e~~~~g~L~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
++||+++|+|..+ ...+++.....++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccc
Confidence 9999999998543 12468888999999999999999985 89999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
....... ........+++.|++|| +||++||+++ |+.||.+... ..+.............
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 237 (273)
T cd05074 162 KIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNRLKQP 237 (273)
T ss_pred cccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCcCCCC
Confidence 6543221 11112234567899999 6999999999 8888864321 2222222222111122
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
......+...+.+||+.+|++|||+.++++.|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23344555667799999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=258.91 Aligned_cols=231 Identities=20% Similarity=0.201 Sum_probs=182.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|.|.+|+||++.+..+++.||+|++... .....+++..|++++++++||||+++++++..... ...+++|||
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~~e~ 82 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYIVMEY 82 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEEEehh
Confidence 4579999999999999988889999998643 23445678999999999999999999998765432 267999999
Q ss_pred ccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 605 MHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHC--KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 605 ~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+++++|.++ ...+++.++..++.|++.||+|||..+ ..+++||||||+||+++.++.+|++|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 999999765 246788999999999999999999332 35899999999999999999999999999986643
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
... ......|++.|+||| +|+++|++++|+.||.... ...+.+..........+...+.
T Consensus 163 ~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 163 DSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred Ccc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCCCCCccccCH
Confidence 221 112346899999999 6999999999999997532 2223333333333334444555
Q ss_pred cccccCcccChhchhhcCCHHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.+.....+|+..+|++|||+.+|++.
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhC
Confidence 66667779999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=257.79 Aligned_cols=228 Identities=24% Similarity=0.345 Sum_probs=176.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||+|.+..+ +.+|+|.+.... ....+|.+|++++++++||||+++++++.... ..++||||+
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~-~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~ 81 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PICLVFEFM 81 (256)
T ss_pred EeeecCcccceEEEEEEeCC-CeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceEEEEEcC
Confidence 44579999999999988754 489999886433 23467999999999999999999999987765 679999999
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++|+|.++ ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--- 155 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc---
Confidence 99999765 23478888999999999999999985 899999999999999999999999999875533211
Q ss_pred cccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
....+..++..|+||| +|+++||+++ |+.||.+... ..+.+..........+...+..+...
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGFRLYKPRLASQSVYEL 233 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 1112233567899999 6999999998 9999865321 11222222222222233344555566
Q ss_pred CcccChhchhhcCCHHHHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
+.+||+.+|++|||+.++++.|+
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHcccChhhCCCHHHHHHhhC
Confidence 77999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=264.64 Aligned_cols=233 Identities=20% Similarity=0.254 Sum_probs=174.3
Q ss_pred ccccccccccceEEEEEecC----------------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDL----------------DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITAC 587 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~----------------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 587 (771)
....+|+|.+|+||++.+.. +...||+|++.... ....++|.+|+++++.++||||+++++++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC 88 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 34458999999999986432 34479999996543 34457899999999999999999999998
Q ss_pred ecCCCCCceeEEEEEEeccCCCCCCCc--------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 588 STSDFQGNYFRALVYEFMHHGSLESCP--------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 588 ~~~~~~~~~~~~lv~e~~~~g~L~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
...+ ..++||||+++|+|.++. ..+++.+...++.|++.|++|||+. +|+||||||+|
T Consensus 89 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 89 ITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred ecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 7766 679999999999996551 2366778999999999999999985 89999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh--CCCCCCccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT--GKRPTSDMF 716 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t--g~~P~~~~~ 716 (771)
|+++.++.+|++|||+++.+...... .......+++.|+||| |||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999999865332211 1111223467899998 6999999998 677885432
Q ss_pred cCCccHHHHHHh----h---CCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 717 TEGLDLHNFVKM----A---LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 717 ~~~~~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
... ....... . ........+++.+...+.+||+.||++|||+.+|++.|++
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQ--VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHH--HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 1111110 0 0011122334555566779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=261.34 Aligned_cols=226 Identities=20% Similarity=0.285 Sum_probs=180.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||++..+.+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..++|+||+
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v~e~~ 98 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVVMEFL 98 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEEEecc
Confidence 457899999999999998888899999997665555677899999999999999999999987766 689999999
Q ss_pred cCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccc
Q 041479 606 HHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683 (771)
Q Consensus 606 ~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 683 (771)
++++|.++ ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+........ .
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----~ 171 (285)
T cd06648 99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----R 171 (285)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc----c
Confidence 99999776 34578889999999999999999986 899999999999999999999999998875433211 1
Q ss_pred cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh--hhcCccccccC
Q 041479 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL--QVLDPLFLVGG 746 (771)
Q Consensus 684 ~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 746 (771)
.....|++.|+||| +||++||+++|+.||.+... ...........+.... ..++..+....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 12345899999999 69999999999999864211 1122222222222221 12445566677
Q ss_pred cccChhchhhcCCHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+||..+|++|||+.++++
T Consensus 250 ~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 250 DRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHcccChhhCcCHHHHcc
Confidence 7999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=266.38 Aligned_cols=228 Identities=22% Similarity=0.277 Sum_probs=173.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|.||+|+++.+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~~lv 82 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLTLV 82 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eEEEE
Confidence 344556899999999999999888899999996543 333457889999999999999999999988766 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||++ ++|.+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 99997 477554 34578888999999999999999985 99999999999999999999999999997543221
Q ss_pred CCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-------------
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM------------- 728 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~------------- 728 (771)
. ......+++.|+||| +||++|||++|+.||....... .......
T Consensus 159 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhh
Confidence 1 112235788999999 6999999999999996431110 0000000
Q ss_pred ---------hCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ---------ALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ---------~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+. .....+++.+.....+|++.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0010 011123444445666999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=273.40 Aligned_cols=187 Identities=28% Similarity=0.327 Sum_probs=156.5
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-CCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSD-FQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~~~~~~ 599 (771)
.+...-.+|+|++|.||+|+++.+|+.||||.+... ....+++..+|+++|++++|||||+++++-.+.. ..-.....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 455667799999999999999999999999999654 3456788999999999999999999999854432 00123568
Q ss_pred EEEEeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCC--ceEEecccC
Q 041479 600 LVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD--NDM--TAHMGDFGL 669 (771)
Q Consensus 600 lv~e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~--~~~--~~kl~DfGl 669 (771)
+|||||.+|||+.. ...+++.+.+.+..+++.||.|||++ +|+||||||.||++. .+| .-||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999766 34589999999999999999999986 999999999999994 233 479999999
Q ss_pred ccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccc
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMF 716 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~ 716 (771)
||.+++.. ..++.+||+.|.+|| |||++||.+||..||...+
T Consensus 171 Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99776543 345678999999999 7999999999999996543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=258.51 Aligned_cols=231 Identities=26% Similarity=0.303 Sum_probs=180.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|+...+++.||+|.+..... ...+.+..|++++++++|+||+++++++.+.+ ..++|+|
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~lv~e 79 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVYIFME 79 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEEEEEe
Confidence 3467999999999999988888999999976543 36788999999999999999999999987665 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++++|.++ ...+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999876 23478889999999999999999985 89999999999999999999999999998764432211
Q ss_pred ccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh--cCc
Q 041479 681 QCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV--LDP 740 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 740 (771)
........+++.|+||| ||+++||+++|+.||....... ..........+...+.. +++
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcCCCCCCCcccccCH
Confidence 11112346788999999 6999999999999996532111 11111222222222222 255
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||+.+|.+|||+.|++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 5556667999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=257.16 Aligned_cols=228 Identities=27% Similarity=0.398 Sum_probs=181.2
Q ss_pred ccccccccceEEEEEecCCC----eEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQ----TFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|.|.+|.||++++...+ ..||+|++...... ..+.+..|++++..++||||+++++++.+.+ ..+++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~i 79 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----PLMIV 79 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----eeEEE
Confidence 35789999999999998765 79999999655432 5678999999999999999999999988765 67999
Q ss_pred EEeccCCCCCCCc---cc--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESCP---RI--LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~~---~~--l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||+++++|.++. .. +++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999997662 22 89999999999999999999985 9999999999999999999999999999866543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.... .....+++.|+||| +|+++|||++ |+.||... ....+.+..............+.
T Consensus 157 ~~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T smart00219 157 DYYK---KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYLKKGYRLPKPENCPP 231 (258)
T ss_pred cccc---cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHhcCCCCCCCCcCCH
Confidence 2211 11223778999999 6999999999 88888652 12223333333333333344556
Q ss_pred cccccCcccChhchhhcCCHHHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.+.....+|+..||++|||+.++++.|
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 666677799999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=260.77 Aligned_cols=229 Identities=23% Similarity=0.333 Sum_probs=176.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc----------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ----------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
...+|+|.+|.||+|....+++.||||.++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 81 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE---- 81 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC----
Confidence 446899999999999998888899999985421 112357889999999999999999999987765
Q ss_pred eeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 596 YFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
..++||||+++|+|.++ ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++.
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 -YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred -ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 67999999999999765 24578888999999999999999985 899999999999999999999999999976
Q ss_pred cCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC----C
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL----P 731 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----~ 731 (771)
...... ........|+..|+||| +|+++||+++|+.||.+.... ....+...... +
T Consensus 158 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 234 (272)
T cd06629 158 SDDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKRSAPPIP 234 (272)
T ss_pred cccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccccCCcCC
Confidence 433211 11123345889999999 699999999999998642111 11112111111 1
Q ss_pred CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......++..+.....+||..+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 2222233444555666999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=260.54 Aligned_cols=229 Identities=21% Similarity=0.199 Sum_probs=177.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|.|.+|.||++.+..+++.||+|.+.... .....++.+|++++++++||||++++++|.+... ...|+|||
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e 81 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIGIAME 81 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEEEEEE
Confidence 3456799999999999999888999999996543 2345789999999999999999999999865432 15799999
Q ss_pred eccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 604 FMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 604 ~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|+++++|.++ ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999654 23477888999999999999999985 9999999999999999999999999998754332
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcccc---CCccHHHHHHhhCCCchh---
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT---EGLDLHNFVKMALPDQIL--- 735 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~---~~~~~~~~~~~~~~~~~~--- 735 (771)
.. ....++..|+||| +||++|||++|+.||..... .......+.....+....
T Consensus 159 ~~------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 159 LA------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred cc------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 21 1234788899999 69999999999999975422 112233333322211111
Q ss_pred ---hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 ---QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ---~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...++.+.....+||..+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 112334556667999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=264.26 Aligned_cols=234 Identities=21% Similarity=0.186 Sum_probs=178.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|.||+++++..++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+ ..++||
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~ 80 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-----HLCMVM 80 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-----EEEEEE
Confidence 345789999999999999999999999986543 234567889999999999999999999987766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999766 34578888999999999999999985 8999999999999999999999999998742111000
Q ss_pred -----------cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-C
Q 041479 680 -----------NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-D 732 (771)
Q Consensus 680 -----------~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~ 732 (771)
.........|+..|+||| |||++||+++|+.||.+.... ...........+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 236 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEWP 236 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccCCC
Confidence 001111245788999999 699999999999999643111 112222222222 1
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
.....+++.+.....+||+.||++||++.++.+.|+
T Consensus 237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 122244555666777999999999999665555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=262.64 Aligned_cols=234 Identities=23% Similarity=0.166 Sum_probs=178.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|.||++....+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++...+.......|+|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 444456899999999999999888899999986432 2346778899999999 79999999999876543323367999
Q ss_pred EEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++...
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999654 34678899999999999999999985 99999999999999999999999999988654
Q ss_pred cccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-c
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD-Q 733 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~ 733 (771)
.... ......|+..|+||| +||++|||++|+.||...... ..+.++.....+. .
T Consensus 180 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 254 (291)
T cd06639 180 STRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIPRNPPPTLL 254 (291)
T ss_pred cccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHhcCCCCCCC
Confidence 3221 112345888999999 599999999999999754221 1122222221111 1
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
........+...+.+||+.+|++||++.|+++
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11122334445666999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=266.35 Aligned_cols=225 Identities=20% Similarity=0.233 Sum_probs=172.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|.|+.+.||++...+.+ .||+|++... +......|..|+..|.+++ |.+||+|++|-..++ ++|||
T Consensus 365 ilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~-----~lYmv 438 (677)
T KOG0596|consen 365 ILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG-----YLYMV 438 (677)
T ss_pred HHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-----eEEEE
Confidence 3456899999999999876555 8888887544 3456788999999999996 999999999987766 89999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||-+ -||.++ ....+...+..|..|++.|+.++|++ ||||.||||.|.|+. .|.+||+|||+|..+....
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 99753 466554 22233226889999999999999997 999999999999998 5789999999999876655
Q ss_pred CCcccccccccccccccchh--------------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 041479 678 SSNQCSSVGLKGTVGYATPE--------------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE--------------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 731 (771)
+.. ....-+||+.||+|| +||++|+|+.|+.||.+.... +.++..-.-|
T Consensus 514 TsI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~aKl~aI~~P 588 (677)
T KOG0596|consen 514 TSI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IAKLHAITDP 588 (677)
T ss_pred cce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HHHHHhhcCC
Confidence 432 234568999999999 699999999999999764211 2222221222
Q ss_pred ---CchhhhcCcc-ccccCcccChhchhhcCCHHHHHH
Q 041479 732 ---DQILQVLDPL-FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ---~~~~~~~~~~-~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
-+.+++-... +.+++..||+.||.+|||+.++++
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1233333333 446777999999999999999986
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=260.83 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=177.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccC---CCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIR---HRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.+|.||+|++..+++.||||.+... .....+++.+|++++++++ ||||+++++++.... ..|+||
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~~~lv~ 81 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----RLWIIM 81 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----EEEEEE
Confidence 3579999999999999888889999998654 2345578889999999997 999999999987765 789999
Q ss_pred EeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 603 EFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 603 e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
||+++++|.++ ...+++.....++.|++.|+.|||+. +|+||||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 99999999766 34678899999999999999999985 999999999999999999999999999986654321
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh-hhcCcccc
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL-QVLDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 743 (771)
......|+..|+||| +||++|||++|+.||.+..... .........+.... ...+..+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--AMMLIPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--hhhccccCCCCCCCcccCCHHHH
Confidence 122346889999999 6999999999999996532211 11111111122111 12444555
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.+||..||++||++.+++.
T Consensus 233 ~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 233 EFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHcCCCcccCcCHHHHhh
Confidence 5667999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=261.30 Aligned_cols=227 Identities=22% Similarity=0.230 Sum_probs=171.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHH-HhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQA-LRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|+++.+++.||+|++.... .....++..|+.+ ++..+||||+++++++...+ ..|+|||
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~~lv~e 80 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DVWICME 80 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cEEEEhh
Confidence 345799999999999999989999999996542 2234566667765 56678999999999998766 6799999
Q ss_pred eccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 604 FMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 604 ~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|++ |+|.++ ...+++..+..++.|++.|++|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 565433 23578999999999999999999974 38999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 677 MSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
. ......|+..|+||| +||++|||++|+.||.+.......+........+.-..+.
T Consensus 158 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 158 V-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred c-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 1 112235788999999 5999999999999996432111122222222222111223
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++..+.....+||..+|++|||+.++++
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4455556667999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.12 Aligned_cols=225 Identities=22% Similarity=0.242 Sum_probs=178.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||++....+++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~e 79 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-----ALMIVME 79 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC-----EEEEEEe
Confidence 345799999999999999899999999996542 344678999999999999999999999887665 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCccccCccc
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~ 677 (771)
|+++++|.++ ...+++..+..++.+++.|++|||+. +|+||||||+||+++.+ +.+|++|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999766 23478889999999999999999986 99999999999999854 468999999998654322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. .....|+..|+||| +|+++|++++|+.||..... ................+.+++.+
T Consensus 157 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l 229 (256)
T cd08220 157 K-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--PALVLKIMSGTFAPISDRYSPDL 229 (256)
T ss_pred c-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--HHHHHHHHhcCCCCCCCCcCHHH
Confidence 1 12245888999999 69999999999999865311 11222222222233344456666
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+||..+|++|||+.|+++
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhh
Confidence 66777999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=255.52 Aligned_cols=225 Identities=18% Similarity=0.176 Sum_probs=178.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+++...+++.||+|.+.... ....+++.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~ 80 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-----NLYIVMDY 80 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC-----eEEEEEec
Confidence 45799999999999999888899999996542 334568999999999999999999999987766 78999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+++++|.+. ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999998665 22468888999999999999999985 899999999999999999999999999976543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
......|++.|+||| |||++||+++|+.||...... ....++..... ...+...+..+..
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~ 231 (256)
T cd08218 157 ---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLKIIRGSY-PPVSSHYSYDLRN 231 (256)
T ss_pred ---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHHHhcCCC-CCCcccCCHHHHH
Confidence 111235788999999 699999999999998642111 11222222222 2233344555666
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+||+.+|++||+|.+|++
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhh
Confidence 677999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=264.26 Aligned_cols=230 Identities=23% Similarity=0.220 Sum_probs=178.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch---hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR---GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+|+|.+|+||+|+...+++.||+|.+..... ...+.+..|+++++.++||||+++++++.+.. ..|+|||
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e 81 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----YLCLVMD 81 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----EEEEEEE
Confidence 457999999999999998888999999965432 34567899999999999999999999987766 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+.+++|.++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999776 24588899999999999999999985 899999999999999999999999999875432211
Q ss_pred Cc-------------------------ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC
Q 041479 679 SN-------------------------QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE 718 (771)
Q Consensus 679 ~~-------------------------~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~ 718 (771)
.. ........||..|+||| +|+++||+++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~- 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR- 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-
Confidence 00 01112346899999999 69999999999999965321
Q ss_pred CccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCC----HHHHHH
Q 041479 719 GLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIK----KGQIRE 765 (771)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt----~~~vl~ 765 (771)
...+.+.............++..+.....+|++.||++||| +.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11222222222222222224556666777999999999999 666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=267.47 Aligned_cols=228 Identities=18% Similarity=0.121 Sum_probs=170.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+++++.+++.||||++.... ....+.+.+|+.++..++|+||+++++++.+.+ ..|+||
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~~~lv~ 80 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----YLYLVM 80 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----EEEEEE
Confidence 346899999999999999999999999996432 233456888999999999999999999988776 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999776 24578888999999999999999985 999999999999999999999999999976543221
Q ss_pred Ccccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh---
Q 041479 679 SNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL--- 735 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 735 (771)
......+||+.||||| +||++|||++|+.||.+.... ...........+...+
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 158 ---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred ---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHcCCCcccCCCcc
Confidence 1122346999999999 599999999999999643211 1111222111111111
Q ss_pred hhcCccccccCcccChhchhh--cCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEE--NIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~--Rpt~~~vl~ 765 (771)
..++........+|+..++++ |+++.++++
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 112333444445666654443 568887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=269.80 Aligned_cols=229 Identities=22% Similarity=0.230 Sum_probs=171.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
....+|+|.+|+||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++..... ......|++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 3456899999999999999888899999986432 2334678899999999999999999998754321 111256899
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||++ +++|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 171 (343)
T cd07878 99 TNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--- 171 (343)
T ss_pred eecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC---
Confidence 9998 6788655 34688999999999999999999986 9999999999999999999999999999865432
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-------------- 729 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------------- 729 (771)
..+..||+.|+||| +||++|||++|+.||.+..... .+..+....
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhcchh
Confidence 12346899999999 6999999999999996421100 011111000
Q ss_pred --------CC---C-c---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 --------LP---D-Q---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 --------~~---~-~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ . . .....++.+.....+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0 0 00112233334555999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=266.93 Aligned_cols=229 Identities=18% Similarity=0.111 Sum_probs=171.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+++++.+++.||+|++.... ....+.+..|+.++..++|++|+++++++.+.+ ..|+||
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~ 80 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----NLYLVM 80 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----EEEEEE
Confidence 456899999999999999999899999996432 233456889999999999999999999987766 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|.++ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999776 24578888999999999999999985 999999999999999999999999999875433221
Q ss_pred Ccccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC---Cchh
Q 041479 679 SNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP---DQIL 735 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~~ 735 (771)
......+||+.||||| |||++|||++|+.||.+.... ............ +...
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 158 ---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred ---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-HHHHHHhCCCccccCCCcc
Confidence 1122346999999999 599999999999999653111 111112111111 1111
Q ss_pred hhcCccccccCcccCh--hchhhcCCHHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGE--ETAEENIKKGQIRES 766 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~--~~p~~Rpt~~~vl~~ 766 (771)
..+++.+.....+|+. +++..|+++.|+++.
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2234444444445554 444447899988753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=263.73 Aligned_cols=223 Identities=19% Similarity=0.200 Sum_probs=173.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|+||+|+...+++.||+|.+.... ....+++.+|+++++.++||||+++++++...+ ..|+|
T Consensus 19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~~~lv 93 (307)
T cd06607 19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----TAWLV 93 (307)
T ss_pred hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----eEEEE
Confidence 3456899999999999999888899999986432 234467899999999999999999999998766 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++ ++.+. ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++.......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 999975 54332 34688999999999999999999985 89999999999999999999999999987543221
Q ss_pred CCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 678 SSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
...|++.|+||| ||+++||++||+.||.+...... .........+......++
T Consensus 170 --------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (307)
T cd06607 170 --------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSPTLSSNDWS 240 (307)
T ss_pred --------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHHhcCCCCCCCchhhC
Confidence 235788999999 69999999999999865321111 111111111211122234
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.....+||..+|++||++.+++.
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 45556667999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.26 Aligned_cols=225 Identities=23% Similarity=0.228 Sum_probs=182.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+....++|.|.||+|..|++..++..||||.++... ....+.+.+|+++|..++|||||+++.+..+.. .+|+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~-----~lyl 132 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA-----TLYL 132 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-----eeEE
Confidence 445678999999999999999999999999997664 334466999999999999999999999988776 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+.+|.++++ ..++...+...++.|+.+|++|||+. .|||||||++|||++.+..+||+|||++.++....
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999887 34566688889999999999999986 89999999999999999999999999998876433
Q ss_pred CCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
...+.+|++.|.||| +|+++|-++.|..||++.. +.+.....+. .+++-.+.
T Consensus 210 -----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-----lk~Lr~rvl~gk~rIp~~ms 279 (596)
T KOG0586|consen 210 -----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-----LKELRPRVLRGKYRIPFYMS 279 (596)
T ss_pred -----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----cccccchheeeeecccceee
Confidence 233578999999999 5999999999999998642 2222112111 22333344
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+......+.+..+|++|++++++.+
T Consensus 280 ~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 280 CDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred chhHHHHHHhhccCccccCCHHHhhh
Confidence 44444444778999999999999875
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.62 Aligned_cols=226 Identities=21% Similarity=0.247 Sum_probs=173.9
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|+++.+++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~~v~e~ 81 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KLHLVFEY 81 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EEEEEEec
Confidence 45799999999999999888899999986442 223467889999999999999999999988766 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++++.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--- 155 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc---
Confidence 999887655 33588999999999999999999985 999999999999999999999999999986644321
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-----------------
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM----------------- 728 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~----------------- 728 (771)
......++..|+||| +||++|||++|+.||.+....+. ...+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccc
Confidence 111235788999999 69999999999999965322111 1111100
Q ss_pred ----hCCCc--------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ----ALPDQ--------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ----~~~~~--------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.. ..+.++..+.....+||..+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 00122333445566999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=261.10 Aligned_cols=225 Identities=20% Similarity=0.310 Sum_probs=180.9
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
..+|+|.+|.||++..+.+++.||||++........+.+.+|+.+++.++||||+++++++...+ ..++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecCC
Confidence 45899999999999999888999999986655555678999999999999999999999988776 7899999999
Q ss_pred CCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccc
Q 041479 607 HGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684 (771)
Q Consensus 607 ~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (771)
+++|.++ ...+++.....++.|++.|++|||+. +++||||||+||+++.++.++++|||++........ ..
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~----~~ 173 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----RR 173 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc----cc
Confidence 9999766 34578899999999999999999986 899999999999999999999999999875433211 11
Q ss_pred ccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCch--hhhcCccccccCc
Q 041479 685 VGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQI--LQVLDPLFLVGGV 747 (771)
Q Consensus 685 ~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 747 (771)
....|++.|+||| +|+++||+++|+.||... .............+... ...+++.+.....
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 2345889999999 699999999999998642 11222233333333221 2234555555667
Q ss_pred ccChhchhhcCCHHHHHH
Q 041479 748 QEGEETAEENIKKGQIRE 765 (771)
Q Consensus 748 ~cl~~~p~~Rpt~~~vl~ 765 (771)
+||..+|.+||++.++++
T Consensus 252 ~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 252 RLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHhCCcccCcCHHHHhc
Confidence 999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=257.58 Aligned_cols=223 Identities=19% Similarity=0.199 Sum_probs=171.0
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccch---hhHHHHHHHHH---HHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQR---GALKSFMAECQ---ALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+|+|.+|.||+|+...+++.||+|.+..... .....+..|.. .++...||+|+++++++.+.+ ..++||
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v~ 76 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFIL 76 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEEE
Confidence 6899999999999988888999999865421 12223444443 344457999999999988766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 77 e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 77 DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999999765 34588999999999999999999985 89999999999999999999999999987553321
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
.....|+..|+||| +||++|||++|+.||.+................+...+...++.+.
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 227 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHH
Confidence 12346899999999 6999999999999997642222111111222222333444456666
Q ss_pred ccCcccChhchhhcC-----CHHHHHH
Q 041479 744 VGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
....+|+..+|++|| ++.++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 667799999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=264.15 Aligned_cols=177 Identities=21% Similarity=0.263 Sum_probs=141.4
Q ss_pred ccccccccceEEEEEecC--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDL--DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|+.++ ++..||+|.+.... ....+.+|++++++++||||+++++++..... ...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEEEee
Confidence 358999999999999765 44689999885432 23567899999999999999999999865332 267999999
Q ss_pred ccCCCCCCC------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEeccc
Q 041479 605 MHHGSLESC------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DNDMTAHMGDFG 668 (771)
Q Consensus 605 ~~~g~L~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfG 668 (771)
+++ ++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 975 44222 12478888999999999999999985 89999999999999 566789999999
Q ss_pred CccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCC
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~ 713 (771)
+++........ ........||+.|+||| +||++|||+||+.||.
T Consensus 158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ceeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 99866443221 11223456899999999 6999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=258.58 Aligned_cols=234 Identities=21% Similarity=0.227 Sum_probs=180.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCC-CCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDF-QGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~-~~~~~~~l 600 (771)
+.....+|+|.+|+||+|..+.+++.||+|++..... ..+++.+|+++++++ +||||+++++++.+... ......++
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 3445668999999999999988888999999865543 346799999999999 69999999999876542 22336799
Q ss_pred EEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 601 VYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||||+++++|.++ ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|++|||++...
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 9999999998655 24678889999999999999999985 8999999999999999999999999998765
Q ss_pred CcccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD- 732 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~- 732 (771)
..... ......|++.|+||| +||++||+++|+.||.+.... ....+......+.
T Consensus 164 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~ 238 (275)
T cd06608 164 DSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNPPPTL 238 (275)
T ss_pred ccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccCCCCC
Confidence 43221 122345889999999 599999999999999653221 1222222222211
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+..+.....+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111223445556667999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=256.28 Aligned_cols=230 Identities=23% Similarity=0.245 Sum_probs=180.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|+||+|....++..||+|++.... ....+.+.+|+++++.++|+||+++++.+...+ ..++||||
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~iv~e~ 80 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELWLVMPY 80 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEEEEEec
Confidence 345799999999999998888899999986443 235678999999999999999999999987766 78999999
Q ss_pred ccCCCCCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 605 MHHGSLESCP------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+++++|.+.. ..+++.....++.|++.|++|||+. +|+||||||+||++++++.+|++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999987662 3478889999999999999999986 899999999999999999999999999876654332
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh-----hh
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL-----QV 737 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 737 (771)
..........|+..|+||| +||++|||++|+.||.+..... .+.+......+ ... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~ 235 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP-SLETGADYKK 235 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC-CcCCcccccc
Confidence 2111223346899999999 6999999999999997543221 23333332221 111 13
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+++.+.....+|+..||++|||+.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3445556667999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=263.12 Aligned_cols=224 Identities=19% Similarity=0.199 Sum_probs=178.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|+...+++.||+|.+.... ....+++.+|++++++++|||++++++++.+.+ ..++||
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 104 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TAWLVM 104 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eEEEEE
Confidence 445899999999999998888899999986432 334567899999999999999999999998776 679999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++ ++.+. ...+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+|++|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99975 65443 34588999999999999999999985 8999999999999999999999999998754321
Q ss_pred Ccccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 679 SNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
....|++.|+||| +||++|||++|+.||.+... ......+.....+......+++
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPTLQSNEWSD 251 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhccCCCCCCccccH
Confidence 1235888999999 59999999999999865321 1123333333333333334455
Q ss_pred cccccCcccChhchhhcCCHHHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.+...+.+||+.+|.+||++.++++..
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 566667799999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=255.29 Aligned_cols=224 Identities=25% Similarity=0.353 Sum_probs=174.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|.||+|.. .++.||+|.+.... ..+.+.+|+.++++++||||+++++++.... .++|||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------~~~v~e 78 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG------LYIVME 78 (254)
T ss_pred eeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC------cEEEEE
Confidence 3445679999999999975 45589999985432 3468899999999999999999999986543 589999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.++ ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999765 22478888999999999999999985 99999999999999999999999999987543211
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.....+..|+||| +||++||+++ |+.||.+... ....+...........+.++..+
T Consensus 155 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd05083 155 ------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KEVKECVEKGYRMEPPEGCPADV 226 (254)
T ss_pred ------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhCCCCCCCCCcCCHHH
Confidence 1123456799999 6999999998 9999865322 12333333333322333445556
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
.....+||..+|++||++.++++.|++
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 667779999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=258.76 Aligned_cols=222 Identities=24% Similarity=0.236 Sum_probs=178.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||++.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..|+||
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~ 80 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----NLYLVM 80 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----eEEEEE
Confidence 356799999999999999888899999996432 234577899999999999999999999988776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999766 35688899999999999999999985 9999999999999999999999999999865432
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
.....|++.|+||| +|+++|||++|+.||.... .....+... ......+...++.+..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~-~~~~~~~~~~~~~l~~ 227 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKIL-EGKVRFPSFFSPDAKD 227 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh-cCCccCCccCCHHHHH
Confidence 12345899999999 6999999999999986432 111111111 1122334445666666
Q ss_pred cCcccChhchhhcC-----CHHHHHH
Q 041479 745 GGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
...+||..||++|| +++|+++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 228 LIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHccCCHHHccCcccCCHHHHHc
Confidence 77799999999999 7777663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.94 Aligned_cols=224 Identities=22% Similarity=0.253 Sum_probs=178.0
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|.|.+|+||+|+...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence 578999999999999888899999996532 234578999999999999999999999987766 679999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
++++|.++ ...+++..+..++.|++.||+|+|+. +++|+||||+||+++.++.+|++|||+++......
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----- 147 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----- 147 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence 99999876 33578889999999999999999985 99999999999999999999999999998664432
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCcc-HHHHHHhhCCCchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLD-LHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
......|++.|+||| +|+++||+++|+.||......... .............+...++.+....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 227 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 112235788999999 699999999999999654321111 2222211222333344466676777
Q ss_pred cccChhchhhcCC-----HHHHHH
Q 041479 747 VQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
.+||..+|++||+ +.|+++
T Consensus 228 ~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 228 KQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHccCChhhCcCCcccCHHHHhc
Confidence 8999999999999 777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.06 Aligned_cols=231 Identities=22% Similarity=0.209 Sum_probs=176.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCC-CceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQ-GNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~-~~~~~~lv~e 603 (771)
...+|+|.+|.||+|++...++.||+|++.... ....++..|+.++.++ +||||+++++++...... .....|++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 346799999999999999888899999986543 2346788999999998 699999999998643211 1236799999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+++|+|.++ ...+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.++|+|||+++.......
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 9999999765 23477888899999999999999985 899999999999999999999999999875432211
Q ss_pred Ccccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 679 SNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
......|++.|+||| +||++|||++|+.||.+...... .........+......+
T Consensus 177 ----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 251 (282)
T cd06636 177 ----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNPPPKLKSKKW 251 (282)
T ss_pred ----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-hhhHhhCCCCCCccccc
Confidence 122346899999998 59999999999999965422111 11111111122222334
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 556666777999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=257.35 Aligned_cols=227 Identities=22% Similarity=0.260 Sum_probs=180.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|.||++.++.+++.||+|.+.... ....+++.+|++++++++||||+++++++.... ..++|+||
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~lv~e~ 80 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DISICMEY 80 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEEEEEEe
Confidence 445899999999999999888899999997653 345578999999999999999999999988775 78999999
Q ss_pred ccCCCCCCCc----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++++|.++. ..+++.....++.|++.|++|+|+. .+++||||||+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 9999997762 5678888999999999999999982 38999999999999999999999999998755332211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh---hCCCchh-hhcCcc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM---ALPDQIL-QVLDPL 741 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~ 741 (771)
...|+..|+||| +|+++|++++|+.||...........+.... ..+.... ..+++.
T Consensus 158 -----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 158 -----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred -----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 145888999999 6999999999999996542211222222222 1122222 225666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||..+|++|||+.+++.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhh
Confidence 666777999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=258.67 Aligned_cols=226 Identities=18% Similarity=0.166 Sum_probs=183.7
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....++|.|-||+|-.|++--+|..||||+++...- .....+++|++-|+-++|||||+||++..+.. .+|+|
T Consensus 21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-----KlyLi 95 (864)
T KOG4717|consen 21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-----KLYLI 95 (864)
T ss_pred hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc-----eEEEE
Confidence 346789999999999999999999999999977653 34567899999999999999999999976665 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~ 676 (771)
+|.-++|+|.++ ...+.+.-..+++.||+.|+.|+|+. .+||||+||+||.+- .-|-+|++|||++-.+.+.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999887 44688888999999999999999986 899999999999875 5689999999998755443
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ...+.||+..|-||| +||++|-++.|+.||......+ .+-.+..-. ..++..++.
T Consensus 173 ~-----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-TLTmImDCK--YtvPshvS~ 244 (864)
T KOG4717|consen 173 K-----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-TLTMIMDCK--YTVPSHVSK 244 (864)
T ss_pred c-----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-hhhhhhccc--ccCchhhhH
Confidence 3 234568999999999 6999999999999998754433 233333222 233444444
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+..+..|++.||.+|.+.+|++.
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhc
Confidence 5555566999999999999999873
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=271.61 Aligned_cols=174 Identities=24% Similarity=0.288 Sum_probs=143.9
Q ss_pred ccccccccccceEEEEEecC--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDL--DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||++.... .++.||||.+... +.+.+|++++++++|||||++++++.... ..|+||
T Consensus 96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~~~lv~ 165 (392)
T PHA03207 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----TVCMVM 165 (392)
T ss_pred EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----EEEEEe
Confidence 34568999999999997643 4568999988533 34568999999999999999999987765 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+. ++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~- 240 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD- 240 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc-
Confidence 9996 566544 35689999999999999999999985 899999999999999999999999999976544322
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
........||+.|+||| +||++|||++|+.||.+
T Consensus 241 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 241 -TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred -cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 11223457999999999 69999999999999954
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=285.05 Aligned_cols=238 Identities=22% Similarity=0.262 Sum_probs=175.4
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC------
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ------ 593 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~------ 593 (771)
.++..---+|.|+||.|||++.+-+|+.||||+|.... ........+|+.++++++|||||+++..|.+....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 34444556899999999999999999999999997663 34456789999999999999999999666432210
Q ss_pred --------------------------------------------------------------------------------
Q 041479 594 -------------------------------------------------------------------------------- 593 (771)
Q Consensus 594 -------------------------------------------------------------------------------- 593 (771)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ----------------------------CceeEEEEEEeccCCCCCCC--cccC--CHHHHHHHHHHHHHHHHHHHhcCC
Q 041479 594 ----------------------------GNYFRALVYEFMHHGSLESC--PRIL--SFLRRLNIAIDVASALEYLHHHCK 641 (771)
Q Consensus 594 ----------------------------~~~~~~lv~e~~~~g~L~~~--~~~l--~~~~~~~i~~~ia~gL~~LH~~~~ 641 (771)
....+||-||||+...+.++ ...+ .....++++.+|++||.|+|++
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~-- 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ-- 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC--
Confidence 00246788888887666554 1122 3567899999999999999997
Q ss_pred CCeEecCCCCCCeeeCCCCceEEecccCccccCc--------------ccCCcccccccccccccccchh----------
Q 041479 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE--------------VMSSNQCSSVGLKGTVGYATPE---------- 697 (771)
Q Consensus 642 ~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE---------- 697 (771)
|||||||||.||++|++..+||+|||+|..... .........++.+||.-|+|||
T Consensus 717 -giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 717 -GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred -ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 899999999999999999999999999986210 0111122345778999999999
Q ss_pred --------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc---cCcccChhchhhcCCHHHHHH
Q 041479 698 --------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV---GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 698 --------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+|||++||+. ||.........+.....+.+|.. ....++.... ....+++.||++|||+.|++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5999999996 55432122223444445555544 4445555432 344788899999999999985
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=260.76 Aligned_cols=225 Identities=22% Similarity=0.282 Sum_probs=170.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|+.+.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~ 80 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLYLVFEF 80 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC-----cEEEEeec
Confidence 45789999999999999888899999986443 233467899999999999999999999987665 67999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+. ++|..+ ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 566543 24578899999999999999999985 899999999999999999999999999875543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh---------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--------------- 728 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--------------- 728 (771)
......+++.|+||| |||++||++||+.||.+..... ...+....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHH
Confidence 112234688899999 6999999999999985421110 11111110
Q ss_pred -----hCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 -----ALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 -----~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.++. .....+++.+.....+|++.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 011123344444566999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=266.40 Aligned_cols=235 Identities=20% Similarity=0.199 Sum_probs=176.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|+||+|++..+++.||||++... ......++.+|+.++++++||||+++++++...+.......|+||||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 44589999999999999988889999998643 23345678899999999999999999999876654444467999999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+++ ++.+. .+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 90 ~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~ 164 (336)
T cd07849 90 MET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TG 164 (336)
T ss_pred ccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccc-cC
Confidence 974 66544 34688999999999999999999986 8999999999999999999999999999865432211 11
Q ss_pred ccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH-------------------
Q 041479 683 SSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK------------------- 727 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~------------------- 727 (771)
......||+.|+||| +||++|||++|+.||.+..... .+..+..
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (336)
T cd07849 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNCIISLRAR 243 (336)
T ss_pred CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhchhhh
Confidence 223356899999999 6999999999999996421100 0000000
Q ss_pred ---hhCCC----c---hhhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 728 ---MALPD----Q---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 728 ---~~~~~----~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
...+. . .....++.+...+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 011224444456679999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=247.61 Aligned_cols=225 Identities=20% Similarity=0.228 Sum_probs=179.8
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|-|..|.|..+.++.+++.+|+|++... ...++|++..-+.. |||||.++++|... +++.....+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCceeeEeeeecc
Confidence 5689999999999999999999999998533 45678999887774 99999999998765 56666889999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCccc
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 677 (771)
+||+|.+. ...+++.++..|+.||+.|+.|||+. .|.||||||+|+|... +..+|++|||+|+.-..
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 99999765 34588999999999999999999996 9999999999999964 56799999999985432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc--c-HHHHHHhh--CCCchhhh
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL--D-LHNFVKMA--LPDQILQV 737 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~--~-~~~~~~~~--~~~~~~~~ 737 (771)
.....+.|-||+|.||| +||++|-|+.|.+||--.....+ . -..+..+. +|.+.++.
T Consensus 217 ---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 217 ---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred ---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 12234567899999999 69999999999999953322111 1 22333333 35666677
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++...++++...+..+|++|.|+.++++
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 7766666666778899999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=254.08 Aligned_cols=229 Identities=23% Similarity=0.275 Sum_probs=182.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|.||+|+...+++.||||++..... ...+.+.+|++++.+++||||+++++++...+ ..++||||
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~ 80 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EISIVLEY 80 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEEEEEEe
Confidence 3457899999999999999888999999976543 45678999999999999999999999988776 78999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHH-HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++++|.++ ...+++..+..++.|+++|++|+|+ . +++||||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 999999876 3568899999999999999999998 6 8999999999999999999999999999866433221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCcccc-CCccHHHHHHhhCCCchhhh-cCcccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT-EGLDLHNFVKMALPDQILQV-LDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~ 743 (771)
.....++..|+||| ||+++||+++|+.||..... ......+............. ++..+.
T Consensus 157 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 233 (264)
T cd06623 157 ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233 (264)
T ss_pred ---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence 11345788999999 69999999999999965421 11112222222222222222 455566
Q ss_pred ccCcccChhchhhcCCHHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
....+|+..+|++|||+.++++.
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 66779999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=257.18 Aligned_cols=230 Identities=21% Similarity=0.216 Sum_probs=175.2
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccch---hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQR---GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|.|.+|+||++++..+++.||+|++..... ...+.+.+|++++++++||||+++++.+.+.. ..|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-----NLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc-----EEEEEEecC
Confidence 4789999999999998888999999965432 45678999999999999999999999887665 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC---
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS--- 679 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--- 679 (771)
++++|.++ ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+|++|||++.........
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99999765 24678999999999999999999985 8999999999999999999999999998754322110
Q ss_pred -cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 -NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 -~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
.........++..|+||| +|+++||+++|+.||....... ..........+......++..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-IFQNILNGKIEWPEDVEVSDEAI 231 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCcCCCccccCCHHHH
Confidence 001122345788999999 6999999999999996532211 12222222222111111255555
Q ss_pred ccCcccChhchhhcCCHHHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
....+|++.+|++|||+.++.+.|
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHh
Confidence 667799999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=260.60 Aligned_cols=226 Identities=20% Similarity=0.258 Sum_probs=169.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|+++.+++.||+|++.... ......+.+|++++++++||||+++++++.+.. ..++|+||
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 80 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK-----KLTLVFEY 80 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC-----ceEEEEec
Confidence 34789999999999999888899999996542 233467888999999999999999999987665 68999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++ ++.+. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 975 65443 34588999999999999999999985 899999999999999999999999999986543221
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-------------CC
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-------------LP 731 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------------~~ 731 (771)
......+++.|+||| +||++|||+||..|+.........+....... .+
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 112345788999999 69999999999988643211111111110000 00
Q ss_pred C--------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 D--------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ~--------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. .....+++.+.....+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 000112333334556999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=255.89 Aligned_cols=223 Identities=24% Similarity=0.269 Sum_probs=174.5
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|+|.+|+||++....+++.||+|.+.... ....+.+..|++++++++||||+++++++...+ ..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence 478999999999999888999999996432 233456788999999999999999999987765 689999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++++|.++ ...+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+.......
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 149 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--- 149 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence 99999765 12588899999999999999999985 99999999999999999999999999987654311
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCCCchhhhcCcccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALPDQILQVLDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 743 (771)
......|+..|+||| +||++||+++|+.||...... ....+.... ..+...+..+++.+.
T Consensus 150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05577 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMAVEYPDKFSPEAK 226 (277)
T ss_pred --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhccccccccCCccCCHHHH
Confidence 112235788999999 699999999999999653211 111122111 112233444566666
Q ss_pred ccCcccChhchhhcC-----CHHHHHH
Q 041479 744 VGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
....+||+.||++|| ++.++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHh
Confidence 677799999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=276.85 Aligned_cols=175 Identities=21% Similarity=0.233 Sum_probs=139.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCC------CCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRH------RNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|+|.+|+||+|++..+++.||||+++... ....++..|+++++.++| ++|+++++++.... ...
T Consensus 133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~----~~~ 207 (467)
T PTZ00284 133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET----GHM 207 (467)
T ss_pred EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC----ceE
Confidence 3446899999999999999888899999996432 233456677777777754 45889999886543 167
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---------------
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM--------------- 660 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~--------------- 660 (771)
|+|||++ +++|.++ ...+++..+..|+.|++.||+|||+. .+||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9999998 5666554 34688999999999999999999973 3899999999999998765
Q ss_pred -ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 661 -TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 661 -~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.+||+|||.+..... .....+||+.||||| +||++|||++|+.||..
T Consensus 285 ~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 285 CRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998763221 122457999999999 69999999999999964
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=267.94 Aligned_cols=169 Identities=21% Similarity=0.329 Sum_probs=140.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|+...+++.||+|+.... ....|+.++++++|||||++++++.+.. ..++|||
T Consensus 69 ~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 137 (357)
T PHA03209 69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-----ITCMVLP 137 (357)
T ss_pred EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-----eeEEEEE
Confidence 3445689999999999999988889999975322 2356999999999999999999998776 6799999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+. |+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 995 566554 34688999999999999999999985 89999999999999999999999999997532211
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCC
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPT 712 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~ 712 (771)
...+..||+.|+||| |||++|||+++..|+
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122456899999999 799999999955544
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=259.07 Aligned_cols=227 Identities=24% Similarity=0.222 Sum_probs=172.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|+||++++..+++.||||.+.... ......+.+|+.++.++. ||||+++++++.... ..+++||
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~~~~~e 83 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DCWICME 83 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cEEEEEe
Confidence 346899999999999999999999999986543 344568899999999996 999999999987765 5789999
Q ss_pred eccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 604 FMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 604 ~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+.. ++.++ ...+++..+..++.+++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 44322 24588889999999999999999974 3899999999999999999999999999975543
Q ss_pred ccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC---Cch
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP---DQI 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~ 734 (771)
... .....|++.|+||| +||++||+++|+.||.........+.+......+ ...
T Consensus 161 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd06616 161 SIA-----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235 (288)
T ss_pred CCc-----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence 221 12235788999999 6999999999999996532100111111111111 111
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...++..+.....+||+++|++|||+.+|++
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 236 EREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1224455556677999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-31 Score=250.65 Aligned_cols=230 Identities=22% Similarity=0.182 Sum_probs=176.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
......+|.|.||+|+|..++..++..|||+++... +...++++.|.++..+- +.||||+++|+++.++ -.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWi 140 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWI 140 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceee
Confidence 344567899999999999999999999999997664 46678999999876665 6999999999988766 5799
Q ss_pred EEEeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 601 VYEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 601 v~e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.||.|+ -+++.+ ...+++.-.-+|..-...||.||-.. ..|+|||+||+|||++..|.+|+||||++..
T Consensus 141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHh
Confidence 999995 366543 33567766777777788999999986 5899999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
+.... +.+..+|...||||| +|+++||++||+.||....+--..+.+.+.+..|.-..
T Consensus 218 Lv~Si-----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 218 LVDSI-----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HHHHH-----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 64432 223346889999999 79999999999999975222112244445555542111
Q ss_pred ----hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 ----QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ----~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
-.....+......|+.+|-+.||+..++..
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 112233334455999999999999888753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=257.38 Aligned_cols=226 Identities=21% Similarity=0.240 Sum_probs=173.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++||||
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~~v~e~ 80 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFVLVMEY 80 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeEEEecc
Confidence 35799999999999998888899999997554 344578999999999999999999999988765 78999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+ +++|.++ ...+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--
Confidence 9 9999765 34588999999999999999999985 899999999999999999999999999986543321
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH-----------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK----------------- 727 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~----------------- 727 (771)
.......|+..|+||| +|+++||+++|+.||...... ..+.....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcc
Confidence 1122346899999999 699999999998777532110 00111000
Q ss_pred ----hhCCCc-------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 728 ----MALPDQ-------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 728 ----~~~~~~-------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+.. .....+..+.....+|+..+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001100 00112333334556999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=259.53 Aligned_cols=225 Identities=24% Similarity=0.259 Sum_probs=170.5
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQR-----GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.+|+|.+|.||+|....+++.||||.+..... .....+..|++++++++|+||+++++++.+.+ ..++||
T Consensus 7 ~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~ 81 (298)
T cd07841 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS-----NINLVF 81 (298)
T ss_pred eeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----EEEEEE
Confidence 47999999999999988888999999965432 23456788999999999999999999998765 789999
Q ss_pred EeccCCCCCCC---cc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC---PR-ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~---~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+ +|+|.++ .. .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 8898766 22 588999999999999999999985 899999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC----------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP---------- 731 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~---------- 731 (771)
......+++.|+||| +||++||+++|..||.+..... .+....... .+
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 158 ----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred ----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccc
Confidence 111234678899999 6999999999977775422111 111111100 00
Q ss_pred ------------Cc---hhhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 732 ------------DQ---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 732 ------------~~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.. .....+..+.....+||.+||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 001112222334569999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.99 Aligned_cols=225 Identities=20% Similarity=0.238 Sum_probs=178.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|.|.+|.||+|++..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 79 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-----NMYLVV 79 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-----eEEEEE
Confidence 345789999999999999888899999996543 245678999999999999999999999887665 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+.+++|... ...+++.++..++.|+++||.|||+. +++|+||||+||++++++.++++|||.+.......
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999766 23688899999999999999999986 89999999999999999999999999987654322
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc-cHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL-DLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
......|+..|+||| +|+++|++++|+.||........ .+.+.... .....+..++..+.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAI 230 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHH
Confidence 112345888999999 69999999999999975422111 11111111 22333344455555
Q ss_pred ccCcccChhchhhcCCH--HHHH
Q 041479 744 VGGVQEGEETAEENIKK--GQIR 764 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~--~~vl 764 (771)
....+||..||.+||++ .|++
T Consensus 231 ~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 231 DAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHccCChhHcCCccHHHHh
Confidence 66779999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=255.82 Aligned_cols=227 Identities=21% Similarity=0.259 Sum_probs=180.7
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+++|.+|.||+|.++.+++.||+|++..... ..+.+.+|++++++++|+||+++++++...+ ..|+|+||
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~ 96 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----ELWVVMEY 96 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----EEEEEEec
Confidence 34568999999999999998788999999976544 5678899999999999999999999988776 78999999
Q ss_pred ccCCCCCCC---cc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC---PR-ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~---~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++++|.++ .. .+++.++..++.|++.||+|||+. +|+|+|+||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 999999877 22 689999999999999999999985 999999999999999999999999999875433221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-chhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD-QILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 744 (771)
......|+..|+||| +||++||+++|+.||.+.... .....+.....+. .....++..+..
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 112235788999999 699999999999998653211 1122222222221 122225566666
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+|++.+|++|||+.++++
T Consensus 249 li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHhccChhhCcCHHHHhh
Confidence 777999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=256.93 Aligned_cols=178 Identities=26% Similarity=0.349 Sum_probs=147.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|+||+|..+.+++.||||.+..... .....+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 83 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TLTLVFE 83 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eEEEEEe
Confidence 44568999999999999998888999999965432 22356778999999999999999999988766 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+++ +|.++ ...+++.....++.|+++||.|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 9974 77654 33578889999999999999999985 89999999999999999999999999987542211
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCcc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~ 715 (771)
.......++..|+||| +||++|||++|+.||.+.
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1112234688899999 699999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=242.95 Aligned_cols=226 Identities=23% Similarity=0.264 Sum_probs=174.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|.|.||.|-.++-+.+++.||+|+++.. .++.+..-+.|-++++..+||.+..+...+.+.+ ..|
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d-----rlC 244 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD-----RLC 244 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-----eEE
Confidence 33445689999999999999999999999999755 3455667788999999999999999887766555 899
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||+.||.|.-+ .+.+++.+...+..+|..||.|||+. +||.||+|.+|.|+|.+|++||+|||+++.--.
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999999765 45688888899999999999999995 999999999999999999999999999983221
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHH-HhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV-KMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 740 (771)
......++||||.|.||| .||++|||+.|+.||... +...+.+.. ...+ +.+..+++
T Consensus 321 ---~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~ed~--kFPr~ls~ 393 (516)
T KOG0690|consen 321 ---YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILMEDL--KFPRTLSP 393 (516)
T ss_pred ---ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHhhhc--cCCccCCH
Confidence 122344689999999999 599999999999999642 111222221 1111 22233333
Q ss_pred cccccCcccChhchhhcC-----CHHHHH
Q 041479 741 LFLVGGVQEGEETAEENI-----KKGQIR 764 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rp-----t~~~vl 764 (771)
+-+......+.+||.+|. ++.||.
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~ 422 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIM 422 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence 333333466789999996 455554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=258.39 Aligned_cols=223 Identities=19% Similarity=0.217 Sum_probs=177.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|+...+++.||+|.+... .....+++.+|+++++.++|+|++++++++.... ..++||
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 94 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLVM 94 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----eeEEEE
Confidence 34589999999999999988889999998642 2334567889999999999999999999988766 679999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+. |++.+. ...+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9997 566443 34578889999999999999999985 8999999999999999999999999998754332
Q ss_pred Ccccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 679 SNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
....|++.|+||| +||++||+++|+.||.+.... .....+.....+.......+.
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSE 241 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCCCcCcccccH
Confidence 1235788999999 599999999999998653221 112333333333333344556
Q ss_pred cccccCcccChhchhhcCCHHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.+.....+||..+|++||++.++++.
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 66667779999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=249.48 Aligned_cols=226 Identities=26% Similarity=0.324 Sum_probs=181.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|+...+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+ ..+++||
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e 79 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLYIILE 79 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEEEEEe
Confidence 3467899999999999998888999999966543 45678999999999999999999999987765 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++++|.++ ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999766 34689999999999999999999985 9999999999999999999999999999866543221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
.....|+..|+||| +|+++||+++|+.||.+... ......... ......++.++..+...
T Consensus 156 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-MAALFRIVQ-DDHPPLPEGISPELKDF 230 (254)
T ss_pred ---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHhc-cCCCCCCCCCCHHHHHH
Confidence 22345888999999 69999999999999865321 111111111 12233444555666666
Q ss_pred CcccChhchhhcCCHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+|+..+|++|||+.+++.
T Consensus 231 i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHhCChhhCcCHHHHhc
Confidence 77999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=259.52 Aligned_cols=181 Identities=22% Similarity=0.269 Sum_probs=148.0
Q ss_pred ccccccccceEEEEEecC--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDL--DQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|.||+|..+. .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+... ...++|
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv 82 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---KSVYLL 82 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---ceEEEE
Confidence 348999999999999988 77899999997632 3445778899999999999999999999987621 168999
Q ss_pred EEeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC----CCceEEecccC
Q 041479 602 YEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN----DMTAHMGDFGL 669 (771)
Q Consensus 602 ~e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGl 669 (771)
|||+++ ++.+. ...+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+|++|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 44322 12578888999999999999999985 8999999999999999 89999999999
Q ss_pred ccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCcc
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~ 715 (771)
++........ ........+++.|+||| +||++|||++|+.||.+.
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 159 ARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9865443221 12223456889999999 699999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=261.67 Aligned_cols=227 Identities=24% Similarity=0.292 Sum_probs=173.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|.++.+++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..|+|||
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 80 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-----RLYLVFE 80 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC-----eEEEEEe
Confidence 345899999999999999888899999985432 234567889999999999999999999987665 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|++++++..+ ...+++.++..++.|++.|++|||+. +|+|||++|+||++++++.+|++|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence 9999888655 23588999999999999999999985 899999999999999999999999999876543221
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH--hh-------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--MA------------- 729 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--~~------------- 729 (771)
......|+..|+||| |||++||+++|+.||...... ..+..... ..
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence 112345788999999 699999999999988532110 00111000 00
Q ss_pred ------CCC--------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ------LPD--------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ------~~~--------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+. .....++..+.....+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 001122334445566999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-30 Score=287.17 Aligned_cols=364 Identities=27% Similarity=0.318 Sum_probs=260.4
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCC---------------
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP--------------- 109 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------------- 109 (771)
+++.|.++.|.|. ..|.+..++.+|++|+|.+|.+. ..|..+..+++|++|++|.|++. .+|
T Consensus 69 ~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s 145 (1081)
T KOG0618|consen 69 HLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAAS 145 (1081)
T ss_pred HHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhh
Confidence 4455555555554 33344555555555555555554 25555555555555555555543 222
Q ss_pred --------------cccccCCcccccCCccccCCCCCCEEecccccCc----CCC--------------------Cccce
Q 041479 110 --------------DSRLILNKLEGNIPSELGSLLKFKGLGLANNYFT----GPI--------------------PHLNM 151 (771)
Q Consensus 110 --------------~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~l--------------------p~L~~ 151 (771)
...+..|.+.+.++..+..++. .|+|++|.+. ..+ |+++.
T Consensus 146 ~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~ 223 (1081)
T KOG0618|consen 146 NNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTA 223 (1081)
T ss_pred cchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchhe
Confidence 2235556666777777776666 6788877776 122 33555
Q ss_pred eeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccc
Q 041479 152 FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS 231 (771)
Q Consensus 152 l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 231 (771)
++.++|.++...+. ..=.+|+++++|+|+++ .+|+.+. .+.+|+.++..+|+|+ .+|..+...++|+.|++.+|.
T Consensus 224 L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~-~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ne 298 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIG-ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNE 298 (1081)
T ss_pred eeeccCcceeeccc--cccccceeeecchhhhh-cchHHHH-hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhh
Confidence 55555555522111 12247899999999998 7886555 8899999999999996 688888888999999999999
Q ss_pred cCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcc-cccceeecccCcCcccCcccccccCCcceEecCCcccee
Q 041479 232 LTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS-SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310 (771)
Q Consensus 232 l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 310 (771)
+..++| .. ..+++|++|+|..|+|. .+|+.+.... ..|+.|+.+.|++....--.=..++.|+.|++.+|.++.
T Consensus 299 l~yip~-~l---e~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 299 LEYIPP-FL---EGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhCCC-cc---cccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 986544 33 56789999999999998 7887665433 237888889998884332222346778999999999988
Q ss_pred ccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCC
Q 041479 311 NIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389 (771)
Q Consensus 311 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~ 389 (771)
..-+.+.+.+.|+.|+|++|+|.......+.++..|++|+||||+++ .+|..+..+..| .|...+|+|. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 77778889999999999999998555557789999999999999999 688889999998 8999999998 566 7888
Q ss_pred CCCCCeEECCCCccccc-CCcchhhhhcccccccEEECcCCCC
Q 041479 390 PKSIPHLDLSKNELSGE-IPSSLAWIFGYISIFAKLNLSYNNL 431 (771)
Q Consensus 390 l~~L~~L~Ls~N~l~~~-~p~~l~~~~~~l~~L~~L~Ls~N~l 431 (771)
+++|+.+|+|.|+|+.. +|... ..++|++|||++|..
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~-----p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEAL-----PSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhC-----CCcccceeeccCCcc
Confidence 99999999999999843 44433 237899999999974
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=256.93 Aligned_cols=221 Identities=19% Similarity=0.205 Sum_probs=173.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+|+|.+|+||+|+...+++.||+|++.... ....+++.+|++++++++|||++++++++.+.+ ..|+|||
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 101 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAWLVME 101 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEEEEEe
Confidence 34899999999999999889999999996432 234467889999999999999999999998876 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+.+ ++.+. ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||++.....
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 9964 55433 34588999999999999999999985 899999999999999999999999999864321
Q ss_pred cccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 680 NQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.....|+..|+||| +||++|||++|+.||.+..... ..........+......++..
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 248 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDSPTLQSNEWTDS 248 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCccccCHH
Confidence 12345888999999 5999999999999986532111 122222222232223334444
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||+.+|.+||++.++++
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 555667999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.34 Aligned_cols=225 Identities=20% Similarity=0.212 Sum_probs=174.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|.|.+|.||+|..+.++..||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..++|+||
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~ 80 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLFIVMEY 80 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEEEEEec
Confidence 45789999999999999988899999996542 234567889999999999999999999987766 78999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcccC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 678 (771)
+++++|.++ ...+++..+..++.|++.|++|||+. +++|+|+||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999765 22478999999999999999999985 899999999999999875 469999999876543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
......|++.|+||| +|+++||+++|..||...... ....+...... .......+..+.
T Consensus 158 ----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~ 231 (257)
T cd08225 158 ----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-QLVLKICQGYF-APISPNFSRDLR 231 (257)
T ss_pred ----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHhcccC-CCCCCCCCHHHH
Confidence 111235889999999 699999999999998643111 11111111111 222223344455
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+|+..+|++|||+.|+++
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 232 SLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHhccChhhCcCHHHHhh
Confidence 5566999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=247.99 Aligned_cols=225 Identities=24% Similarity=0.272 Sum_probs=179.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|.||++....+++.||+|++........+.+.+|++++++++||||+++++++.... ..++++||+
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~ 79 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIVMEFC 79 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEEEecC
Confidence 345789999999999999888899999997665556688999999999999999999999987765 679999999
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++++|.++ ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999776 24679999999999999999999985 999999999999999999999999999986654321
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh--cCccccc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV--LDPLFLV 744 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 744 (771)
.....|+..|+||| +|+++|++++|+.||....... ................ ++..+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcCCCCcCcccccCHHHHH
Confidence 22345888999999 6999999999999986531111 1111111111111111 1444555
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+|+..||++|||+.++++
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 667999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=257.16 Aligned_cols=229 Identities=22% Similarity=0.229 Sum_probs=172.0
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|.||+|.++.+++.||+|.++... ......+.+|+.++++++||||+++++++...+. ...|+||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~~lv~ 85 (293)
T cd07843 9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL---DKIYMVM 85 (293)
T ss_pred hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcEEEEe
Confidence 3456799999999999999888899999997543 2234567889999999999999999999876621 1689999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++ +|.+. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.......
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99974 77544 23588999999999999999999985 899999999999999999999999999986544321
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-------------h
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-------------A 729 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-------------~ 729 (771)
......+++.|+||| +|+++|||++|+.||....... ........ .
T Consensus 162 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 162 ----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred ----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhc
Confidence 112235788999999 6999999999999986432110 01100000 0
Q ss_pred CC----------------Cchhhh-cCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 LP----------------DQILQV-LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~~----------------~~~~~~-~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++ ...+.. +++.+.....+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 011111 2333444566999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=256.05 Aligned_cols=225 Identities=21% Similarity=0.265 Sum_probs=171.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|.++.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..|++|||
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~-----~~~iv~e~ 79 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN-----KLYLVFEF 79 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC-----eEEEEEec
Confidence 35789999999999999888899999996543 233467889999999999999999999988765 78999999
Q ss_pred ccCCCCCCC---c--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC---P--RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~---~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
++ ++|.++ . ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+|++|||+++.......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 95 577655 1 2578999999999999999999985 899999999999999999999999999976543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-------------- 729 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------------- 729 (771)
......++..|+||| +|+++||+++|+.||.+..... ...++....
T Consensus 155 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 ---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred ---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhc
Confidence 111234688999999 6999999999999986432111 111111110
Q ss_pred ------CC-------CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ------LP-------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ------~~-------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ ......+++.+.....+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0011122233334555999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=250.96 Aligned_cols=223 Identities=21% Similarity=0.255 Sum_probs=170.8
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHH-hccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|.||+|.....++.||||.+.... ......+..|..++ ...+||||+++++++...+ ..|+|||
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e 77 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVME 77 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEEe
Confidence 4789999999999998888899999986443 12233455565544 4458999999999998766 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++++|.++ ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+|++|||+++....
T Consensus 78 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 78 YLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999876 34678889999999999999999985 899999999999999999999999999875432
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcCcccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 743 (771)
.....|++.|+||| +|+++||+++|..||...... ..+........ +......+++.+.
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcccCCCCcccccCCHHHH
Confidence 11235788999999 699999999999999653221 11222222221 2233334566666
Q ss_pred ccCcccChhchhhcCCHHHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
....+||+.+|++||++.++.+.|
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHH
Confidence 777799999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=249.06 Aligned_cols=231 Identities=21% Similarity=0.244 Sum_probs=182.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
-.+|+|.+|.||+|..+.+++.|++|++.... ....+.+.+|++++++++||||+++++.+.... ....++||||
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~ 82 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLNIFLEY 82 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEEEEEEe
Confidence 45789999999999999888899999996554 245678999999999999999999999987762 0167999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++++|.++ ...+++..+..++.|++.|++|||+. +++|+|++|+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999776 33688999999999999999999985 8999999999999999999999999999866543321
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccC
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGG 746 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (771)
.......++..|+||| +|+++|++++|+.||......................+...+..+....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 0122345888999999 6999999999999996542111111111111222334445566666677
Q ss_pred cccChhchhhcCCHHHHHH
Q 041479 747 VQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+|++.+|++||++.++++
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhCcCChhhCCCHHHHhh
Confidence 7999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=257.07 Aligned_cols=188 Identities=22% Similarity=0.309 Sum_probs=150.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC---Ccee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ---GNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---~~~~ 597 (771)
+.....+|+|.+|+||+|+...+++.||||.+.... ......+.+|++++++++||||+++++++...... ....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 444566899999999999999989999999986443 22345667899999999999999999998765421 1235
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+.+ ++.+. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 6999999975 66443 22578999999999999999999986 8999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
...............++..|+||| +|+++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 433221111122345788999999 69999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=249.73 Aligned_cols=232 Identities=19% Similarity=0.184 Sum_probs=178.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-----QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
....+|+|.+|.||+|++..+++.||+|.+... .....+.+.+|++++++++||||+++++++.+... ...+
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~~~~ 82 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---KKLS 82 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---CEEE
Confidence 345679999999999999988889999988532 12345688999999999999999999999865431 1578
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||+++++|.++ ...+++.....++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999766 24578888999999999999999986 8999999999999999999999999999865321
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
... ........|+..|+||| +||++||+++|+.||.+..... ...+......++..++.+++.
T Consensus 160 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHcCCCCCCCCcccCHH
Confidence 111 11112346899999999 6999999999999997542211 122222222234445556666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+|++ +|.+|||+.+++.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhc
Confidence 6666779998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=257.98 Aligned_cols=224 Identities=22% Similarity=0.210 Sum_probs=165.6
Q ss_pred ccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCC
Q 041479 533 VKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL 610 (771)
Q Consensus 533 ~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L 610 (771)
..+.||.++...+++.||||++... .....+.+.+|++++++++||||+++++++.+.+ ..+++|||+++|++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEeccCCCCH
Confidence 4456666666777889999999654 3445678999999999999999999999987766 68999999999999
Q ss_pred CCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC---ccc
Q 041479 611 ESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS---NQC 682 (771)
Q Consensus 611 ~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~---~~~ 682 (771)
.++ ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+......... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 765 23578888999999999999999986 8999999999999999999999999998754322110 111
Q ss_pred ccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-------------
Q 041479 683 SSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD------------- 732 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------------- 732 (771)
......++..|+||| +||++||+++|+.||.+...... ..+...+..+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhcCC
Confidence 123345788899999 69999999999999975321111 11111111100
Q ss_pred -------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....++..+.....+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000111122223455899999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=252.91 Aligned_cols=226 Identities=22% Similarity=0.322 Sum_probs=172.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~ 79 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLMLVFEY 79 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEEEEec
Confidence 345789999999999999889999999997553 233467788999999999999999999998776 67999999
Q ss_pred ccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 605 MHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+++ ++.++ ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++.......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 66543 13578999999999999999999985 899999999999999999999999999975533211
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--------------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-------------- 728 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-------------- 728 (771)
......+++.|+||| +||++||+++|+.||.+....+ ........
T Consensus 156 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 ----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred ----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhc
Confidence 112235788999999 6999999999999997532211 01111100
Q ss_pred ------hCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ------ALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ------~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+. ......++.+.....+|++.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 001122344445556999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=249.10 Aligned_cols=217 Identities=23% Similarity=0.241 Sum_probs=169.6
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
.+|+|.+|.||+++.+.+++.+|+|.+........ |+.....+ +||||+++++++...+ ..|+||||++
T Consensus 23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~-----~~~iv~e~~~ 92 (267)
T PHA03390 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK-----GHVLIMDYIK 92 (267)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC-----eeEEEEEcCC
Confidence 37999999999999999998999999864422111 22222222 6999999999998776 7899999999
Q ss_pred CCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcccCCccc
Q 041479 607 HGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 607 ~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~ 682 (771)
+|+|.++ ...+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++++|||+++......
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~----- 164 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----- 164 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----
Confidence 9999776 33689999999999999999999985 899999999999999888 99999999987553221
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-CCchhhhcCccccccC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-PDQILQVLDPLFLVGG 746 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 746 (771)
...|+..|+||| +||++||+++|+.||.+.........++..... +....+.+++.+....
T Consensus 165 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T PHA03390 165 ---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV 241 (267)
T ss_pred ---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHH
Confidence 235789999999 699999999999999754333333334433321 1233445667776777
Q ss_pred cccChhchhhcCC-HHHHHH
Q 041479 747 VQEGEETAEENIK-KGQIRE 765 (771)
Q Consensus 747 ~~cl~~~p~~Rpt-~~~vl~ 765 (771)
.+|++.+|.+||+ ++++++
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHhccChhhCCchHHHHhc
Confidence 7999999999996 688874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=253.91 Aligned_cols=178 Identities=26% Similarity=0.387 Sum_probs=146.4
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|.||+|..+.+++.||+|++.... ......+.+|+++++.++|+||+++++++.+.+ ..|+|||
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e 83 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TLTFVFE 83 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----eEEEEEe
Confidence 3456899999999999998888899999996543 233457789999999999999999999987765 6899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+. +++.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 996 565433 23467888889999999999999985 899999999999999999999999999975432211
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCcc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~ 715 (771)
......+++.|+||| +||++||+++|+.||.+.
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 159 ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 112335788999999 699999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=254.12 Aligned_cols=231 Identities=19% Similarity=0.195 Sum_probs=171.1
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|++..+++.||||++.... ......+.+|+.++++++ ||||+++++++...+..+....|+||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 345799999999999999889999999986543 223467889999999995 69999999998766533334579999
Q ss_pred EeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCcccc
Q 041479 603 EFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFI 673 (771)
Q Consensus 603 e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~ 673 (771)
||+++ ++.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+|++|||+++..
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 66544 13478999999999999999999985 9999999999999998 889999999998755
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-h-------
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-A------- 729 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~------- 729 (771)
..... ......+++.|+||| +|+++|||++|..||....... ........ .
T Consensus 162 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 162 SIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTEQVW 236 (295)
T ss_pred CCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCChhhC
Confidence 32211 111234688899999 6999999999999986421110 01111100 0
Q ss_pred -----------CC----C---chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 -----------LP----D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 -----------~~----~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ . .....+++.+.....+|+..||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 001123444445566999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=256.61 Aligned_cols=228 Identities=21% Similarity=0.226 Sum_probs=174.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|.++.+++.||||+++... ....+.+.+|++++++++|+||+++++++...+ ..++|||
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~iv~e 80 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RLYLVFE 80 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EEEEEEe
Confidence 345799999999999999888899999986542 334578999999999999999999999998765 6899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|++++.+..+ ...+++.++..++.|++.|++|||+. +++|||++|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 9998776543 34578899999999999999999986 899999999999999999999999999987654321
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH--h--------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--M-------------- 728 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--~-------------- 728 (771)
.......++..|+||| +|+++||+++|+.||.+....+ .+..... .
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCc
Confidence 1112346788999999 6999999999999986421110 0100000 0
Q ss_pred -----hCCC---------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 -----ALPD---------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 -----~~~~---------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..++ ..+..+++.+...+.+||..+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 011122444445666999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=262.01 Aligned_cols=234 Identities=21% Similarity=0.223 Sum_probs=175.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|.||+|+.+.+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ......|+|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e 88 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVMD 88 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceEEEEEe
Confidence 345799999999999999989999999986542 234567888999999999999999999876543 12236799999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+. |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 89 ~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 89 LME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred hhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCC
Confidence 996 577554 34588999999999999999999985 89999999999999999999999999997654332221
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH-----------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK----------------- 727 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~----------------- 727 (771)
........|+..|+||| +||++|||++|+.||.+..... .+.....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhhhhchhh
Confidence 22223456899999999 6999999999999996532110 0000000
Q ss_pred -----hhCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 728 -----MALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 728 -----~~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+. ......+..+.....+|++.+|++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00110 011223444555667999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=259.62 Aligned_cols=178 Identities=23% Similarity=0.258 Sum_probs=143.1
Q ss_pred cccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccC
Q 041479 530 ESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH 607 (771)
Q Consensus 530 ~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 607 (771)
|.|.+++||++++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..++||||+.+
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~e~~~~ 83 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVISPFMAY 83 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEEecccC
Confidence 44588899999999888999999986543 334578899999999999999999999998776 67999999999
Q ss_pred CCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc--
Q 041479 608 GSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN-- 680 (771)
Q Consensus 608 g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-- 680 (771)
|++.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 998765 23478888899999999999999985 89999999999999999999999998654322211100
Q ss_pred -ccccccccccccccchh-----------------HHHHHHHHHhCCCCCCcc
Q 041479 681 -QCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 681 -~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~ 715 (771)
........++..||||| +||++||+++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 00111123566799999 699999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=277.14 Aligned_cols=231 Identities=26% Similarity=0.302 Sum_probs=189.8
Q ss_pred cccccccceEEEEEecC-------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeE
Q 041479 528 SYESLVKATVYKGILDL-------DQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~-------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+|+|.+|.|++|.... ....||||..+... ..+.+.+..|+++|+.+ +|||||.++|+|...+ ..
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~-----~~ 377 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG-----PL 377 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC-----ce
Confidence 89999999999997541 24689999996543 35678999999999999 5999999999998855 67
Q ss_pred EEEEEeccCCCCCCC--cc-----------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 041479 599 ALVYEFMHHGSLESC--PR-----------------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~--~~-----------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~ 659 (771)
++|+||+..|+|..+ .. .+...+.+.++.|||.|++||++. ++||||+.++|||+..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 999999999999665 11 278889999999999999999985 89999999999999999
Q ss_pred CceEEecccCccccCcccCCcccccccccc--cccccchh---------------HHHHHHHHHh-CCCCCCccccCCcc
Q 041479 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKG--TVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLD 721 (771)
Q Consensus 660 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~g--t~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~ 721 (771)
..+||+|||+|+.......... .+..| ...||||| |||++||++| |..||.++. ....
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~---~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~ 530 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRT---KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEE 530 (609)
T ss_pred CEEEEccccceeccCCCCceEe---cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHH
Confidence 9999999999996544332211 11122 45699999 8999999999 999998743 2233
Q ss_pred HHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 722 LHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.++.+.+.+...+..+...+...+..||+.+|++||+..++++.++..
T Consensus 531 l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 5667777777677777788887888899999999999999999998864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=251.91 Aligned_cols=227 Identities=21% Similarity=0.252 Sum_probs=167.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|+++.+++.||||.+.... ....+.+.+|++++++++||||+++++++.... ..|+||
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 80 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RLYLVF 80 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eEEEEE
Confidence 3456789999999999999888899999986442 233467889999999999999999999988766 789999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~ 676 (771)
||+++ ++.+. ...+++.....++.|++.||+|||+. +|+||||||+||+++. ++.+|++|||+++.....
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99964 66443 12246777889999999999999985 8999999999999985 567999999999754332
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH-------------
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK------------- 727 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~------------- 727 (771)
.. ......|++.|+||| +||++||++||+.||......+. +.+...
T Consensus 157 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VR----TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGV 231 (294)
T ss_pred cc----ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhcccc
Confidence 11 112235788999999 69999999999999864211111 111110
Q ss_pred -------hhCC---Cc----hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 728 -------MALP---DQ----ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 728 -------~~~~---~~----~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+ .. ....+++.+.....+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 01122333444556999999999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=250.64 Aligned_cols=224 Identities=22% Similarity=0.178 Sum_probs=167.1
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|+.+.+++.||+|++.... ........+|+.++.++. ||||+++++++.+.... ..++||||
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~---~~~lv~e~ 81 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG---RLALVFEL 81 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC---cEEEEEec
Confidence 34789999999999999888899999986432 222334568999999986 99999999998876211 67999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++ ++.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++. +.+||+|||+++........
T Consensus 82 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 82 MDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred CCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 975 65443 23589999999999999999999985 8999999999999999 99999999999865432211
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-----------hCC-C
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-----------ALP-D 732 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-----------~~~-~ 732 (771)
....++..|+||| +||++|||++|+.||.+.... ........ ..+ .
T Consensus 156 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 156 ----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred ----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhccc
Confidence 1235788999999 699999999999999643211 11111110 000 0
Q ss_pred -----ch-----------hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -----QI-----------LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -----~~-----------~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. ...++..+.....+||+++|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 0122334445566999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=251.86 Aligned_cols=228 Identities=23% Similarity=0.278 Sum_probs=172.1
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++.... ....++||||
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~ 81 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYMVFEY 81 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEEEecc
Confidence 45789999999999999888899999997653 344567899999999999999999999987762 1168999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++ +|.+. ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.+|++|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 975 76554 23688999999999999999999985 899999999999999999999999999986644321
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh---------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--------------- 729 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--------------- 729 (771)
.......++..|+||| ||+++||+++|+.||.+.... ..+.......
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence 1112335688899999 699999999999998643211 0111111100
Q ss_pred ------CCCch--------hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ------LPDQI--------LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ------~~~~~--------~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..... .....+.+.....+||..+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 0111223334455999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=248.37 Aligned_cols=223 Identities=22% Similarity=0.233 Sum_probs=180.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+++.+.+++.||+|.+.... .....++.+|++++++++||||+++++++.+.. ..++||||
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~ 80 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-----KLCIVMEY 80 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC-----EEEEEehh
Confidence 45788999999999998888899999996542 344567889999999999999999999987765 78999999
Q ss_pred ccCCCCCCCc-------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 605 MHHGSLESCP-------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 605 ~~~g~L~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+++++|.++. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999997662 4578889999999999999999985 89999999999999999999999999998765431
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. ....|++.|+||| +|+++||+++|+.||..... ..+................+..+
T Consensus 158 ~------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd08530 158 A------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLRYKVQRGKYPPIPPIYSQDL 229 (256)
T ss_pred c------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCCchhhCHHH
Confidence 1 1235788999999 69999999999999965321 12222222222233344556666
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+|++.+|++|||+.++++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 230 QNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHhc
Confidence 67777999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=253.54 Aligned_cols=232 Identities=22% Similarity=0.214 Sum_probs=174.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
++.....+|+|.+|+||+|.++.+++.||||++.... ......+.+|+.++.+.+ ||||+++++++.+.. ..|
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~ 90 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----DVF 90 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----eEE
Confidence 3445567899999999999999888899999996543 334567778888777775 999999999998766 689
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+||||+++ ++... ...+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||+|||++.....
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99999854 55433 34588899999999999999999973 3899999999999999999999999999976543
Q ss_pred ccCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-chh
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD-QIL 735 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~ 735 (771)
.... ....++..|+||| ||+++|||++|+.||.........+..+.....+. ...
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 168 SKAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred CCcc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 2211 1234788899998 69999999999999964211111122222222111 111
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..++..+.....+||..||++||++.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1244555666779999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=253.64 Aligned_cols=231 Identities=23% Similarity=0.229 Sum_probs=170.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|.||+|.++.+++.||+|+++.... .....+.+|++++++++|+||+++++++...... ..++
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---~~~l 85 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD---SIFL 85 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC---eEEE
Confidence 3344558999999999999998888999999965432 2234567899999999999999999998754321 5799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++ +|.+. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 55433 34588999999999999999999996 8999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-----------
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA----------- 729 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~----------- 729 (771)
.. ......+++.|+||| +||++|||++|+.||.+..... .+.......
T Consensus 162 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 162 AK----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred cC----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhh
Confidence 21 111224578899999 6999999999999996432111 111111100
Q ss_pred ----------CCCc----h---hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ----------LPDQ----I---LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ----------~~~~----~---~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.. . ....++.......+|++.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0 0112333334556999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=244.83 Aligned_cols=225 Identities=22% Similarity=0.269 Sum_probs=180.1
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
-.+|.|.+|.||++.+..+++.||+|++.... ....+.+.+|++++++++|||++++++.+...+ ..++|+||
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-----~~~lv~e~ 80 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-----KLCIVMEY 80 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC-----EEEEEEEe
Confidence 34789999999999999888899999997553 245678899999999999999999999987765 78999999
Q ss_pred ccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 605 MHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 605 ~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+++++|.+. ...+++.++..++.+++.|+.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999998665 25688999999999999999999986 99999999999999999999999999998654432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. ......|++.|+||| +|+++|++++|+.||..... ..+............+...+..+
T Consensus 158 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd08215 158 D----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALKILKGQYPPIPSQYSSEL 231 (258)
T ss_pred c----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHHHHHHhcCCCCCCCCCCCHHH
Confidence 1 112246889999999 69999999999999865321 11222222222233334445555
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+||..+|++|||+.++++
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhc
Confidence 56677999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=257.57 Aligned_cols=234 Identities=24% Similarity=0.321 Sum_probs=173.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|.||+|.+..+++.||||++... .......+.+|+.+++++ +||||+++++++...+. ...|+|
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~~~~lv 87 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---KDIYLV 87 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---ceEEEE
Confidence 345579999999999999988889999998542 233446788899999999 99999999999865432 257999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||++ ++|... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 88 FEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred ecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99997 477665 23678888999999999999999985 9999999999999999999999999999865433211
Q ss_pred -cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--------------
Q 041479 680 -NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-------------- 728 (771)
Q Consensus 680 -~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-------------- 728 (771)
.........||+.|+||| +|+++|||++|+.||.+..... ........
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHHHh
Confidence 011223356899999999 6999999999999986421110 00000000
Q ss_pred --------hCC-------CchhhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 729 --------ALP-------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 729 --------~~~-------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+ ......++..+.....+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 00111123344455669999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=250.50 Aligned_cols=230 Identities=20% Similarity=0.165 Sum_probs=176.0
Q ss_pred ccccccccceEEEEEec---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeE
Q 041479 527 VSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ----RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+|+|.+|+||+++.. .+++.||||++.... ....+.+..|++++.++ +||||+++++.+.... ..
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-----~~ 80 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-----KL 80 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC-----EE
Confidence 35799999999999864 355789999986432 23346788999999999 5999999999877665 67
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
++||||+++|+|.+. ...+++.....++.|+++||+|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999765 34578889999999999999999985 899999999999999999999999999876543
Q ss_pred ccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhh
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQ 736 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~ 736 (771)
... .......|+..|+||| +|+++|||++|+.||...-. .....++..... ....+.
T Consensus 158 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 158 EEE---ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKPPFPK 233 (288)
T ss_pred ccc---cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHccCCCCCc
Confidence 321 1122345889999999 69999999999999853211 111122221111 123344
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESLI 768 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~ 768 (771)
.+++.+.....+||+.||++|||+.++.+.|+
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 45666666777999999999999888876654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=258.90 Aligned_cols=180 Identities=22% Similarity=0.234 Sum_probs=147.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv~ 602 (771)
...+|+|.+|+||+|+...+++.||||++... .....+++.+|+.++++++||||+++++++..... .+....|+||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 34579999999999999988999999998543 23345678899999999999999999998864431 1223579999
Q ss_pred EeccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 603 EFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 603 e~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
||+.+ ++.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.......
T Consensus 101 e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 173 (353)
T cd07850 101 ELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--- 173 (353)
T ss_pred eccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---
Confidence 99965 66543 33478889999999999999999986 999999999999999999999999999986543221
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.....|++.|+||| +||++|+|++|+.||..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 174 --MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred --CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 22345789999999 69999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=257.35 Aligned_cols=233 Identities=20% Similarity=0.182 Sum_probs=173.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|+||+|+...+++.||||.+... .......+.+|+.+++.++||||+++++++...........|+|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 34689999999999999998999999998643 2334567789999999999999999999876554222235799999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+. ++|.+. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 163 (337)
T cd07858 90 LMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD-- 163 (337)
T ss_pred CCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--
Confidence 996 566544 34688999999999999999999985 899999999999999999999999999986543211
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccC----------------------CccH
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTE----------------------GLDL 722 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~----------------------~~~~ 722 (771)
......|+..|+||| +||++|||++|+.||.+.... ....
T Consensus 164 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 164 --FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred --cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 112345788999999 699999999999998542100 0001
Q ss_pred HHHHHhhCC---C---chhhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 723 HNFVKMALP---D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 723 ~~~~~~~~~---~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.++...... . ...+.+++.+.....+|++.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 111110000 0 0112234444456669999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=251.43 Aligned_cols=233 Identities=22% Similarity=0.205 Sum_probs=171.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-----CCCcee
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSD-----FQGNYF 597 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~~~~ 597 (771)
....+|+|.+|+||+|.++.+++.||||+++... ......+.+|++++++++||||+++++++.+.. ..+...
T Consensus 11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 3456799999999999999888899999996543 234467889999999999999999999986643 111226
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++|+||+++ ++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred EEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 7999999986 44332 23588999999999999999999985 9999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH---hhCCCc-
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK---MALPDQ- 733 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~---~~~~~~- 733 (771)
..... .......++..|+||| +||++||+++|+.||...... ..+..+.. ...+..
T Consensus 167 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 167 NSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPCPAVW 242 (302)
T ss_pred cCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhc
Confidence 43321 1111234677899999 699999999999998642110 01111111 110000
Q ss_pred ------------------------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ------------------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ------------------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01122344445566999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=252.59 Aligned_cols=224 Identities=24% Similarity=0.269 Sum_probs=176.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.||+||-|.++.+|+.||||+++..+ .+....++.|+.|++.++||.||.+.-.|++.+ ..|.|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e-----rvFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE-----RVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc-----eEEEEeh
Confidence 456899999999999999999999999996553 455678999999999999999999999998887 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEecccCccccCc
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND---MTAHMGDFGLTRFIPE 675 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~ 675 (771)
-+. ||.-++ ..++++.....++.||+.||.|||.. +|+|+|+||+|||+.+. -.+|+||||.||++++
T Consensus 644 Kl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 644 KLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred hhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 995 454333 56788888889999999999999985 99999999999999643 4699999999999877
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. .....+|||.|.||| .||++|.-++|..||-+--... +..+-+.-++|+..+..+++
T Consensus 720 ks-----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-dQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 720 KS-----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-DQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred hh-----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-HHhhccccccCCCchhhcCH
Confidence 44 344578999999999 4999999999999995321111 12223344556555555555
Q ss_pred cccccCcccChhchhhcCCHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
.-.+.+...++..-.+|-|+...+
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhc
Confidence 554555566777777888776654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=250.27 Aligned_cols=238 Identities=19% Similarity=0.167 Sum_probs=164.0
Q ss_pred ccccccccccceEEEEEecCC---CeEEEEEEeeccchhh-----------HHHHHHHHHHHhccCCCCceeEEEEeecC
Q 041479 525 LNVSYESLVKATVYKGILDLD---QTFIAVKVLFLHQRGA-----------LKSFMAECQALRNIRHRNLVKIITACSTS 590 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 590 (771)
....+|+|++|+||+|++..+ +..+|+|+........ ......+...+..+.|+||+++++++...
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 344589999999999998877 6677777654332111 11223344556677899999999976554
Q ss_pred CCCCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecc
Q 041479 591 DFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667 (771)
Q Consensus 591 ~~~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 667 (771)
. ....+.++++|++.. ++.+. ....++..+..++.|++.|++|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 96 R-CRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred c-CCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEc
Confidence 3 122355788887743 33222 23356778889999999999999985 8999999999999999999999999
Q ss_pred cCccccCcccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHH----HH
Q 041479 668 GLTRFIPEVMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLH----NF 725 (771)
Q Consensus 668 Gla~~~~~~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~----~~ 725 (771)
|+|+......... ........||+.|+||| +||++|||++|+.||.+......... ++
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~ 250 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF 250 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH
Confidence 9998664322111 11122346999999999 79999999999999976532221111 11
Q ss_pred HHhhCCCc-hhhhcCccccccCcccChhchhhcCCHHHHHHHH
Q 041479 726 VKMALPDQ-ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 726 ~~~~~~~~-~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
........ .....++.+......|+..+|++||++.++++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 251 IKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111111 1112234455566799999999999999999876
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=254.80 Aligned_cols=229 Identities=19% Similarity=0.209 Sum_probs=169.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhh--------------HHHHHHHHHHHhccCCCCceeEEEEeecCCC
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGA--------------LKSFMAECQALRNIRHRNLVKIITACSTSDF 592 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 592 (771)
..+|+|.+|+||+|+++.+++.||||.+....... ...+.+|++++++++||||+++++++...+
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 93 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD- 93 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC-
Confidence 45899999999999999888899999986442111 125789999999999999999999988776
Q ss_pred CCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 593 QGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
..++||||++ |+|.+. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 94 ----~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 94 ----FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred ----cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccc
Confidence 7899999997 577655 34578889999999999999999985 999999999999999999999999999
Q ss_pred ccccCcccC----------Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHH
Q 041479 670 TRFIPEVMS----------SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLH 723 (771)
Q Consensus 670 a~~~~~~~~----------~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~ 723 (771)
++....... ..........+++.|+||| +||++||+++|+.||.+....+ .+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~ 244 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-QLG 244 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 976541110 0011112335688999999 6999999999999986432111 011
Q ss_pred HHHH---hh----C----------------CCchh---hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 724 NFVK---MA----L----------------PDQIL---QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 724 ~~~~---~~----~----------------~~~~~---~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.... .. + +.... ...+..+.....+|++.+|++|||+.|++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1110 00 0 00000 111233334555999999999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=219.99 Aligned_cols=176 Identities=24% Similarity=0.363 Sum_probs=148.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+||||||+.+++.+.||+|+++..+ ++.....++||++++.++|+|||++++....+. ...+|+|
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-----kltlvfe 81 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KLTLVFE 81 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-----eeEEeHH
Confidence 446899999999999999999999999997654 455678899999999999999999999977665 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||.. +|..+ ...++......++.|+.+|+.|+|++ .+.|||+||.|.||..+|+.|++|||+|+.++-..
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9964 66444 45678888999999999999999996 89999999999999999999999999999765432
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHh-CCCCCCc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFT-GKRPTSD 714 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~t-g~~P~~~ 714 (771)
.|.+ ..+-|.+|++|. -||++.|+.. |++-|.+
T Consensus 156 -rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 156 -RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred -Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 2322 235699999998 2999999988 6665543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=257.30 Aligned_cols=234 Identities=21% Similarity=0.243 Sum_probs=172.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC---------Cce
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ---------GNY 596 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---------~~~ 596 (771)
.-.+|.|.+|+||+|+...+++.||+|.+........+.+.+|++++++++||||+++++++...... ...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 44579999999999999998899999999776656667899999999999999999999887654311 112
Q ss_pred eEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~ 673 (771)
..|+||||++ ++|.+. ...+++.....++.|++.||+|||+. +|+||||||+||+++. ++.+|++|||+++..
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~ 165 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence 5789999997 577654 24588999999999999999999985 8999999999999974 567899999999765
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh---------
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--------- 728 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--------- 728 (771)
....... .......|+..|+||| +||++|||++|+.||.+...... .......
T Consensus 166 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (342)
T cd07854 166 DPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDR 243 (342)
T ss_pred CCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHh
Confidence 4322111 1112235788999999 69999999999999965321110 0000000
Q ss_pred --------------hC-C-C---chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 --------------AL-P-D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 --------------~~-~-~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. + . .....++..+.....+|++.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0 0 001123333444566999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=246.51 Aligned_cols=227 Identities=21% Similarity=0.198 Sum_probs=172.8
Q ss_pred ccccccccceEEEEEec---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeE
Q 041479 527 VSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ----RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+|+|.+|.||++... .+++.||+|++.... ....+.+.+|+++++++ +|+||+++++++.... ..
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-----~~ 80 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-----KL 80 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC-----eE
Confidence 35799999999999874 356799999996432 22346788999999999 5999999999887665 67
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+||||+++++|.++ ...+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999765 34578888889999999999999985 999999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhh
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQ 736 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~ 736 (771)
... .......|+..|+||| +|+++||+++|+.||.... ......++..... ....++
T Consensus 158 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T cd05613 158 DEV---ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-EKNSQAEISRRILKSEPPYPQ 233 (290)
T ss_pred ccc---cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC-ccccHHHHHHHhhccCCCCCc
Confidence 221 1112345889999999 6999999999999985321 1112222222211 122334
Q ss_pred hcCccccccCcccChhchhhcC-----CHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+++.+.....+|++.||++|| ++.+++.
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 4566666667799999999997 6666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=253.10 Aligned_cols=234 Identities=21% Similarity=0.175 Sum_probs=170.9
Q ss_pred ccccccccceEEEEEecCC--CeEEEEEEeecc--chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDLD--QTFIAVKVLFLH--QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|.||+++.... ++.||||++... .....+.+.+|+++++++ +||||+++++++.... ......|++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~~~~~ 84 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNELYLY 84 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCcEEEE
Confidence 3578999999999999887 889999998643 223356788999999999 4999999999765431 112256899
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+||+. ++|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 85 EELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160 (332)
T ss_pred Eeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc
Confidence 99986 577554 34688999999999999999999986 899999999999999999999999999986543322
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCc--------------cHHHHHHh
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGL--------------DLHNFVKM 728 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~--------------~~~~~~~~ 728 (771)
..........||+.|+||| +||++||+++|+.||........ .+..+...
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSP 240 (332)
T ss_pred cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhh
Confidence 1112223456899999999 69999999999999864211000 00000000
Q ss_pred ----------hCC-C---chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ----------ALP-D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ----------~~~-~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+ . ......+..+.....+|++.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 241 KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0 111122444555666999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-29 Score=235.01 Aligned_cols=239 Identities=21% Similarity=0.248 Sum_probs=177.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC---Ccee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ---GNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---~~~~ 597 (771)
.+..-..|+|.+|.||+|+.+.+++.||+|++... .++.....++|++++..++|+|++.+++.|.+.... ....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 34445679999999999999999999999988654 345667889999999999999999999988653321 2235
Q ss_pred EEEEEEeccCCCCCC----CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.|+||++|+. +|.. ...+++..++.+++.++..||.|+|.. .|+|||+||+|+||+.+|.+|++|||+|+.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 7999999986 5443 345788999999999999999999986 8999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCc--------------------ccc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD--------------------MFT 717 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~--------------------~~~ 717 (771)
..........-+..+-|.+|++|| -||++.||.||.+-+++ .|+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 554433333334556799999999 29999999999876542 343
Q ss_pred CCccHHHHHHhh---CCCchhhhc---------CccccccCcccChhchhhcCCHHHHHH
Q 041479 718 EGLDLHNFVKMA---LPDQILQVL---------DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 718 ~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.-..+.-|..-. ++......+ |+.-.+..++++..||++|+++++++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 322222222221 121111111 111113344889999999999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=240.86 Aligned_cols=219 Identities=28% Similarity=0.274 Sum_probs=173.9
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
+|+|.+|.||++.....++.||+|++.... ......+..|++++++++||||+++++.+.... ..++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE-----KLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC-----eeEEEEecC
Confidence 588999999999998888899999986543 234568899999999999999999999887665 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
++++|.++ ...+++.....++.|+++|+.|+|+. +++|+||||+||+++.++.++++|||++........
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---- 148 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC----
Confidence 99999766 33578999999999999999999985 999999999999999999999999999976543211
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCc
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGV 747 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (771)
......|+..|+||| +|+++||+++|+.||..... ....+.... .....+...+..+.....
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~l~~~i~ 225 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK-DPLRFPEFLSPEARDLIS 225 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-CCCCCCCCCCHHHHHHHH
Confidence 122345788999999 69999999999999964311 112222211 222334444555566677
Q ss_pred ccChhchhhcCCHHH
Q 041479 748 QEGEETAEENIKKGQ 762 (771)
Q Consensus 748 ~cl~~~p~~Rpt~~~ 762 (771)
+||..||++|||+.+
T Consensus 226 ~~l~~~p~~R~~~~~ 240 (250)
T cd05123 226 GLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhcCCHhhCCCccc
Confidence 999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=251.95 Aligned_cols=229 Identities=24% Similarity=0.247 Sum_probs=171.7
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC-ceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG-NYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~-~~~~~lv 601 (771)
....+|+|.+|+||+|+...+++.||||++... .....+.+.+|++++++++||||+++++++....... ....++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 345689999999999999988899999998543 2334467889999999999999999999986543211 1246899
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||+ +++|..+ ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 99 ~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 172 (343)
T cd07880 99 MPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-- 172 (343)
T ss_pred EecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc--
Confidence 9999 6787655 34688999999999999999999985 89999999999999999999999999998543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-------------- 729 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------------- 729 (771)
....+++.|+||| +||++|++++|+.||.+..... ...+.....
T Consensus 173 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 173 -----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred -----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhcch
Confidence 2345788999999 5999999999999996432110 111111100
Q ss_pred --------CC----C---chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 --------LP----D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 --------~~----~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ . .....+++.+.....+|+..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0 001122333334555899999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=253.94 Aligned_cols=229 Identities=22% Similarity=0.233 Sum_probs=171.2
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
....+|+|.+|.||+|++..+++.||||++... .......+.+|++++++++||||+++++++..... ......++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 445689999999999999888889999998643 22334678899999999999999999999865432 111246899
Q ss_pred EEeccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 602 YEFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 602 ~e~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+||+.. ++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---- 170 (342)
T cd07879 99 MPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 170 (342)
T ss_pred eccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----
Confidence 999964 66544 33688999999999999999999986 8999999999999999999999999998754321
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh----------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM---------------- 728 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~---------------- 728 (771)
.....|++.|+||| +||++|||++|+.||.+..... .+......
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcccc
Confidence 12345788999999 6999999999999996421100 01110000
Q ss_pred ------hCC----Cch---hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ------ALP----DQI---LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ------~~~----~~~---~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+ ... ....++.+.....+||+.||++||++.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 000 1123344445666999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=245.15 Aligned_cols=229 Identities=23% Similarity=0.266 Sum_probs=179.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|.||+|+.+.+++.||+|++... .....+.+.+|++++++++ ||||+++++++...+ ..++|
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~lv 80 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE-----NLYFV 80 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-----eEEEE
Confidence 44689999999999999988889999998643 2334567889999999998 999999999887665 68999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||+++++|.++ ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999776 33689999999999999999999985 899999999999999999999999999986543221
Q ss_pred Cc----------------ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 041479 679 SN----------------QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK 727 (771)
Q Consensus 679 ~~----------------~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 727 (771)
.. ........|+..|+||| +|++++|+++|+.||.... ....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~- 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL- 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH-
Confidence 10 01222345788999999 6999999999999997532 111111111
Q ss_pred hhCCCchhhhcCccccccCcccChhchhhcCCH----HHHHH
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETAEENIKK----GQIRE 765 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~----~~vl~ 765 (771)
......+..+++.+.....+||..+|++|||+ .++++
T Consensus 236 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 -KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11222333445566666779999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=244.92 Aligned_cols=225 Identities=23% Similarity=0.278 Sum_probs=173.1
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|....+++.||+|.+..... .....+.+|++++++++||||+++++++...+ ..++||||
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~ 79 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG-----DLYLVFEF 79 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC-----CEEEEEec
Confidence 357899999999999988888999999865432 34578889999999999999999999987765 68999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+++ ++.+. ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence 975 66554 23678999999999999999999986 899999999999999999999999999976654321
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh----------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM---------------- 728 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~---------------- 728 (771)
......++..|+||| +|+++|+++||+.||......+. +......
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhh
Confidence 111235788899999 69999999999999864321110 1010000
Q ss_pred -----hCC-------CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 -----ALP-------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 -----~~~-------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+ ....+.++..+.....+||.+||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0111223445556667999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=253.66 Aligned_cols=231 Identities=21% Similarity=0.236 Sum_probs=173.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~ 599 (771)
+.....+|+|.+|+||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++...+. ......+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 33456689999999999999988889999998643 23344678899999999999999999987765442 1122479
Q ss_pred EEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 600 LVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 600 lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+|+||+ +++|.+. ...+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 97 lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 97 LVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 999999 5688665 34689999999999999999999985 8999999999999999999999999999865332
Q ss_pred CCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh------------
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA------------ 729 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~------------ 729 (771)
.....++..|+||| +||++||+++|+.||.+..... .+.......
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 ------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhcc
Confidence 12235788999999 5999999999999996432110 011111000
Q ss_pred ----------CC----C---chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ----------LP----D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ----------~~----~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ . ......++.+.....+|+..||++|||+.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0 001122444445666999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=242.53 Aligned_cols=229 Identities=22% Similarity=0.276 Sum_probs=169.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhcc---CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNI---RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..+|+|.+|.||+|+++.+++.||||++.... ......+.+|+.+++++ +||||+++++++...+..+....+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 45789999999999999888899999996432 22345677788877666 59999999999987663333348999
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||+.+ +|.++ ...+++.++..++.|++.||+|||+. +++|+|+||+||+++.++.+|++|||++......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 85 FEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred ehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 999974 66543 23588999999999999999999985 8999999999999999999999999999765432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh------------
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA------------ 729 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~------------ 729 (771)
.. .....++..|+||| |||++|||++|+.||.+... ...+..+....
T Consensus 161 ~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCCCc
Confidence 21 12234788999999 69999999999999865321 11122221110
Q ss_pred ------CCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ------LPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ------~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++. .....+++.+.....+||+.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000111223334455999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=248.68 Aligned_cols=238 Identities=21% Similarity=0.234 Sum_probs=171.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC---CCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF---QGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---~~~~~ 597 (771)
+.....+|+|.+|.||+|+++.+++.||||++.... ......+.+|++++++++||||+++++++.+... .....
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 334456899999999999999888899999986543 2223567899999999999999999998765431 11235
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+.+ ++... ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+|++|||+++..
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 7999999975 44332 34689999999999999999999985 8999999999999999999999999999865
Q ss_pred CcccCCc-------ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-
Q 041479 674 PEVMSSN-------QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA- 729 (771)
Q Consensus 674 ~~~~~~~-------~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~- 729 (771)
....... ........|++.|+||| +||++|||++|+.||.+..... ....+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~ 244 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKLCG 244 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 4322111 11122346788999999 6999999999999986432111 011111000
Q ss_pred -C-----------------------CCchh---hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 -L-----------------------PDQIL---QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 -~-----------------------~~~~~---~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. +.... ....+.+.+...+|++.||++|||+.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00000 111223334556999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=251.76 Aligned_cols=234 Identities=20% Similarity=0.185 Sum_probs=174.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|.|.+|.||+|+...+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..+....|+||||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 45799999999999998888899999996543 3455789999999999999999999999876542222357999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
+++ +|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++......... .
T Consensus 86 ~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~-~ 160 (330)
T cd07834 86 MET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE-K 160 (330)
T ss_pred hhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc-c
Confidence 984 66554 23688999999999999999999985 8999999999999999999999999999865443210 0
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCc----------------------cHH
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGL----------------------DLH 723 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~----------------------~~~ 723 (771)
.......+++.|+||| +|+++|+|++|+.||.+...... ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence 1122345788999999 69999999999999964321100 000
Q ss_pred HHHHhhCC---Cc---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 724 NFVKMALP---DQ---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 724 ~~~~~~~~---~~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.++..... .. ....+++.+.....+||+++|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01110000 00 01112333445566999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=238.37 Aligned_cols=202 Identities=21% Similarity=0.096 Sum_probs=157.8
Q ss_pred cccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCC
Q 041479 532 LVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLE 611 (771)
Q Consensus 532 ~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 611 (771)
|.+|.||+++++.+++.||+|++.... .+.+|...+....||||+++++++.+.+ ..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence 778999999999999999999996543 2334555556667999999999987765 789999999999997
Q ss_pred CC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccccccc
Q 041479 612 SC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK 688 (771)
Q Consensus 612 ~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 688 (771)
+. ...+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.++++|||.+....... .+..
T Consensus 74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~~ 143 (237)
T cd05576 74 SHISKFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGEA 143 (237)
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccCC
Confidence 65 23588999999999999999999985 89999999999999999999999999886543321 1234
Q ss_pred ccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhc
Q 041479 689 GTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEET 753 (771)
Q Consensus 689 gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 753 (771)
++..|+||| +|+++||+++|+.|+....... ........+..+++.+.....+|++.|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~d 216 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTHTTLNIPEWVSEEARSLLQQLLQFN 216 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccccccCCcccCCHHHHHHHHHHccCC
Confidence 577899999 6999999999998875321110 000111233345555656667999999
Q ss_pred hhhcCCH
Q 041479 754 AEENIKK 760 (771)
Q Consensus 754 p~~Rpt~ 760 (771)
|++||++
T Consensus 217 p~~R~~~ 223 (237)
T cd05576 217 PTERLGA 223 (237)
T ss_pred HHHhcCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=259.35 Aligned_cols=235 Identities=20% Similarity=0.183 Sum_probs=187.2
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.++.-.+.|.|.+|.||+++.+..++.+|||++..... ..++...|.++++.. .|||++.++|++.-.+......+|+
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 34555678899999999999999999999999976543 336677899999887 5999999999997665555568999
Q ss_pred EEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 601 VYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 601 v~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|||||.+|+..++ ..++.|..+..|+.+++.|+.+||.. .++|||||-.|||+..++.+|++|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999998766 56788999999999999999999986 899999999999999999999999999987654
Q ss_pred ccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cch
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQI 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~ 734 (771)
.. ....+.+|||.||||| +|++..||..|.+|+.|+.+.-. +..+-+...| -.-
T Consensus 176 T~----grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-LF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 176 TV----GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNPPPKLKR 250 (953)
T ss_pred cc----ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-hccCCCCCCccccc
Confidence 32 2334568999999999 69999999999999988765322 1111111111 112
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.....+.+.+..|+.+|-.+||++.++++
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 3444455556677999999999999998875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=244.52 Aligned_cols=224 Identities=21% Similarity=0.219 Sum_probs=168.9
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|+||+|+...+++.||||++..... .......+|+..+++++ ||||+++++++...+ ..++||||
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~-----~~~lv~e~ 79 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND-----ELYFVFEY 79 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC-----cEEEEEec
Confidence 457999999999999998888999999864422 22334567999999999 999999999987755 78999999
Q ss_pred ccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 605 MHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 605 ~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+ +|++.+. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 9 7788654 13678999999999999999999985 899999999999999999999999999986543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHH------------HHHh---
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHN------------FVKM--- 728 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~------------~~~~--- 728 (771)
.....|+..|+||| ||+++||+++|+.||......+ ...+ |...
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhh
Confidence 12235788999999 6999999999999885421100 0100 0000
Q ss_pred ------hCC----Cchhh---hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ------ALP----DQILQ---VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ------~~~----~~~~~---~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+ ....+ ..+..+.....+||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 00011 11233445566999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=240.63 Aligned_cols=225 Identities=19% Similarity=0.170 Sum_probs=171.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH-----QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
...+|+|.+|+||++++...+..+++|+++.. ......++.+|+.++++++||||+++++++.+.. ..++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 79 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-----AFCI 79 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-----ceEE
Confidence 34589999999999998877666777766432 1233456778999999999999999999987665 6799
Q ss_pred EEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 601 VYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||||+++++|... ...+++.++..++.|++.|+.|||+. +++|+|+||+||++++ +.+|++|||+++..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999998654 34588999999999999999999985 9999999999999975 56999999998765
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ......|++.|+||| +|+++|++++|..||.+... ...............+..+
T Consensus 156 ~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd08222 156 MGSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIVEGPTPSLPETY 229 (260)
T ss_pred CCCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHcCCCCCCcchh
Confidence 43221 122345788999999 69999999999999864211 1111111112223334445
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+..+...+.+||..+|++||++.|+++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 230 SRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 556666677999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=234.53 Aligned_cols=181 Identities=23% Similarity=0.283 Sum_probs=146.8
Q ss_pred ccccccccccccceEEEEEecCCC----eEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ----TFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~----~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|.||||+-+++. +.+|+|+++..+ .+......+|+.+++.++|||||.|..++.+.+.
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~---- 101 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK---- 101 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc----
Confidence 445566899999999999766553 379999996553 3455778999999999999999999999877432
Q ss_pred eEEEEEEeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC----CceEE
Q 041479 597 FRALVYEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND----MTAHM 664 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~----~~~kl 664 (771)
..++++||++. ||.+. .+.++...+..|..|++.|+.|||+. =|+|||+||+|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 78999999987 65433 34678888999999999999999996 69999999999999776 89999
Q ss_pred ecccCccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCC
Q 041479 665 GDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPT 712 (771)
Q Consensus 665 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~ 712 (771)
+|||+||.+...... ......++-|.+|+||| .||++.||+|-++-|
T Consensus 178 aDlGlaR~~~~plkp-l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKP-LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ecccHHHHhhccccc-cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 999999987654321 22344567899999999 499999999987654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=266.67 Aligned_cols=139 Identities=27% Similarity=0.366 Sum_probs=123.0
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|.|.+|+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..|+|
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----~~~lV 82 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN-----NVYLV 82 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----EEEEE
Confidence 3456899999999999999888899999996442 334578899999999999999999999887766 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
|||+.+++|.++ ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999776 34578888999999999999999985 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=245.27 Aligned_cols=225 Identities=21% Similarity=0.219 Sum_probs=169.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|.|.+|.||+|..+.+++.||||++... .....+.+.+|++++++++||||+++++++..... ..|+|||
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~~lv~e 90 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE----DIYFVTE 90 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC----cEEEEee
Confidence 45679999999999999988999999988542 22345778899999999999999999999865331 5789999
Q ss_pred eccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 604 FMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 604 ~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|+ +++|.+. ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+|++|||.++......
T Consensus 91 ~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~---- 162 (328)
T cd07856 91 LL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM---- 162 (328)
T ss_pred hh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc----
Confidence 99 5577655 24577888889999999999999985 89999999999999999999999999987543211
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCc--cHH--------HHHHh-------
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGL--DLH--------NFVKM------- 728 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~--~~~--------~~~~~------- 728 (771)
.+..+++.|+||| +||++||+++|+.||........ .+. ++...
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2235788899999 69999999999999864321000 000 00000
Q ss_pred ----hC----CCch---hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 ----AL----PDQI---LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 ----~~----~~~~---~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. +... ...+++.+...+.+|++.+|++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0011 1123444555667999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=261.68 Aligned_cols=177 Identities=20% Similarity=0.243 Sum_probs=132.8
Q ss_pred ccccccccccccceEEEEEecCCCe-EEEEEE--------------ee---ccchhhHHHHHHHHHHHhccCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQT-FIAVKV--------------LF---LHQRGALKSFMAECQALRNIRHRNLVKII 584 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~-~vAvK~--------------~~---~~~~~~~~~~~~E~~~l~~l~H~nIv~l~ 584 (771)
+.....+|+|.+|+||++..+.... .+++|. +. .........+.+|++++++++|||||+++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 3344568999999999987654321 122221 10 01122346788999999999999999999
Q ss_pred EEeecCCCCCceeEEEEEEeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 041479 585 TACSTSDFQGNYFRALVYEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656 (771)
Q Consensus 585 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl 656 (771)
+++...+ ..|+|+|++.+ ++..+ .......+...++.|++.||+|||+. +|+||||||+|||+
T Consensus 230 ~~~~~~~-----~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 230 EILRSEA-----NTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred EEEEECC-----eeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9998776 67999999854 44332 11223456778999999999999985 99999999999999
Q ss_pred CCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCC
Q 041479 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711 (771)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P 711 (771)
+.++.+||+|||+++.+..... ....+.+||+.|+||| +||++|||++|..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999986643221 1223457999999999 69999999998754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=246.14 Aligned_cols=229 Identities=21% Similarity=0.217 Sum_probs=170.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
....+|+|.+|.||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++..... ......|++
T Consensus 21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 3456899999999999998888899999996432 2334678899999999999999999998864321 111246788
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+|++ +++|.+. ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--- 173 (345)
T cd07877 101 THLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 173 (345)
T ss_pred ehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc---
Confidence 8887 6788654 34588999999999999999999986 8999999999999999999999999998754321
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh----------CCC-
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA----------LPD- 732 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~----------~~~- 732 (771)
.....|+..|+||| +||++||+++|+.||....... .+....... .+.
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 174 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred ----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccH
Confidence 12345788999999 6999999999999985421111 011111100 000
Q ss_pred ---------------c---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ---------------Q---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ---------------~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. .....++.+.....+|++.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0 00112334445566999999999999999885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=242.83 Aligned_cols=225 Identities=25% Similarity=0.302 Sum_probs=171.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|.+|.||+|+...+++.||+|++.... ....+.+..|++++++++||||+++++++.+.+ ..++||||
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~~v~e~ 79 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER-----KLYLVFEY 79 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC-----ceEEEecC
Confidence 34788999999999999988899999997653 344577889999999999999999999987765 68999999
Q ss_pred ccCCCCCCCc----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++ ++|.++. ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 97 5786651 3688999999999999999999986 899999999999999999999999999986543221
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHH------------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV------------------ 726 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~------------------ 726 (771)
......++..|+||| +||++||+++|+.||......+ .+....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCcHHHHHhhcccc
Confidence 111234577899999 6999999999999985421100 000000
Q ss_pred --HhhCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 727 --KMALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 727 --~~~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+. ......+..+.....+||..||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000010 000112334445566999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=247.03 Aligned_cols=171 Identities=26% Similarity=0.342 Sum_probs=144.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-C-----CCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-H-----RNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|.|.||.|.||.+..+++.||||+++.. .....+...|+.+|..++ | -|+|++++|+...+ +.|
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-----Hlc 264 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-----HLC 264 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-----cee
Confidence 45689999999999999999999999999644 345567788999999997 4 39999999998887 889
Q ss_pred EEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEecccCccc
Q 041479 600 LVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTRF 672 (771)
Q Consensus 600 lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~ 672 (771)
||+|.++ -+|.++ ...++...+..++.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.|.+
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999985 478766 34588899999999999999999985 9999999999999975 34799999999987
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCC
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~ 713 (771)
...... ..+=++.|+||| ||||++||++|.+-|.
T Consensus 341 ~~q~vy-------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVY-------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcce-------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 655432 234578999999 7999999999987664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-27 Score=237.64 Aligned_cols=179 Identities=24% Similarity=0.290 Sum_probs=152.2
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
-...+|.|++|.|..|..+.+.+.||||+++.. +.++.+--+.|-++++-- +-|.+|.++.++.+.+ .+|+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD-----RLyF 427 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD-----RLYF 427 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-----heee
Confidence 345689999999999999999999999999654 345667778888888876 5789999999887777 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+.||+|-.. ...+.+..++.++.+||-||-|||+. +|++||||.+|||+|.+|++||+|||+++.---
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-- 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-- 502 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc--
Confidence 9999999999544 34678888999999999999999985 999999999999999999999999999983211
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~ 715 (771)
......++||||.|+||| |||++|||+.|+.||++.
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 122344689999999999 799999999999999763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-27 Score=262.46 Aligned_cols=183 Identities=23% Similarity=0.246 Sum_probs=158.4
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
..++.....+|.|+||.|..++++.+++.||+|++... .......|+.|-++|.--+.+.||.++.+|.+..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~----- 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER----- 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-----
Confidence 34566667789999999999999999999999999654 2445678999999999999999999998866655
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
+.|+|||||+||||-.. ..++++.-+..|..+|.-||.-+|+. |+|||||||+|||+|.+|++|++|||.+-.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhc
Confidence 89999999999998655 22678888899999999999999986 9999999999999999999999999999877
Q ss_pred CcccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCC
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~ 713 (771)
...+. ......+|||-|++|| +||++|||+.|..||.
T Consensus 226 ~~dG~---V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 226 DADGT---VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred CCCCc---EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 65543 2334568999999999 5999999999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=211.81 Aligned_cols=181 Identities=23% Similarity=0.261 Sum_probs=150.7
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+...-..+|.|++|.|-+-++...|+..|||++...- .+..++.++|+++..+. .+|.+|.++|.+.... ..
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-----dv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-----DV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-----cE
Confidence 34455667899999999999999999999999997653 34457888999986665 6999999999887766 67
Q ss_pred EEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 599 ALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
++.||.|.. +|..+ ....++.-.-+|+.-|..||.|||++ ..|+|||+||+|||++.+|++|+||||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999964 66554 45678888899999999999999996 689999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCc
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~ 714 (771)
.+.+.... +-..|...||||| +|+++.||++++.||+.
T Consensus 198 ~L~dSiAk-----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIAK-----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhHH-----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 76554321 1134778899999 69999999999999965
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=229.63 Aligned_cols=219 Identities=27% Similarity=0.314 Sum_probs=174.1
Q ss_pred ccceEEEEEecCCCeEEEEEEeeccchhh-HHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCC
Q 041479 533 VKATVYKGILDLDQTFIAVKVLFLHQRGA-LKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLE 611 (771)
Q Consensus 533 ~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 611 (771)
++|.||+|++..+++.||+|++....... .+.+.+|++.+++++|+||+++++++.... ..+++|||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence 36899999999878899999997655433 689999999999999999999999988765 679999999999997
Q ss_pred CCc---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccccccc
Q 041479 612 SCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK 688 (771)
Q Consensus 612 ~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 688 (771)
.+. ..+++..+..++.+++.|+.|||+. +|+|+|++|+||+++.++.++++|||.+....... ......
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~ 147 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFV 147 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----cccccc
Confidence 762 2278899999999999999999986 99999999999999999999999999998665432 122345
Q ss_pred ccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhh--cCccccccCcccCh
Q 041479 689 GTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQV--LDPLFLVGGVQEGE 751 (771)
Q Consensus 689 gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~cl~ 751 (771)
|+..|++|| +|+++||+++|..||.... ......+............. ++..+.....+|+.
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 226 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLV 226 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCCCccccccCCHHHHHHHHHHcc
Confidence 788999999 6999999999999986521 12223333332222211111 44555566779999
Q ss_pred hchhhcCCHHHHHH
Q 041479 752 ETAEENIKKGQIRE 765 (771)
Q Consensus 752 ~~p~~Rpt~~~vl~ 765 (771)
.+|++||++.++++
T Consensus 227 ~~p~~Rp~~~~~~~ 240 (244)
T smart00220 227 KDPEKRLTAEEALQ 240 (244)
T ss_pred CCchhccCHHHHhh
Confidence 99999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=244.99 Aligned_cols=221 Identities=20% Similarity=0.146 Sum_probs=174.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.......+|.|+++.|-++.+..+++..|||++.... .+-.+|+.++... +||||+++.+.+.+.- ..|+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~-----~~~~ 393 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGK-----EIYL 393 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCc-----eeee
Confidence 3445566899999999999999999999999996542 2344577676666 5999999999987765 7899
Q ss_pred EEEeccCCCCCCCc--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-CCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESCP--RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL-DNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl-~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||++.+|.+.+.. .+....++..|+.+++.|+.|||.+ ||||||+||+|||+ ++.+.++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999998875542 2222256778999999999999996 99999999999999 58899999999999866543
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
..+.+-|..|.||| ||+++|+|++|+.||.... .+ .+......+......++..-
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P-~~---~ei~~~i~~~~~s~~vS~~A 539 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP-AG---IEIHTRIQMPKFSECVSDEA 539 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC-ch---HHHHHhhcCCccccccCHHH
Confidence 22345688999999 7999999999999996532 22 33333334444456666666
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+....+|++.||.+||+|.++..
T Consensus 540 KdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 540 KDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHHhccCChhhCcChhhhcc
Confidence 67777999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=230.88 Aligned_cols=234 Identities=22% Similarity=0.236 Sum_probs=176.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.--+|.|+|+.||||.+-...+.||||+-.... +...+...+|.+|.+.+.||.||++|+|+.-+.. .+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd----sF 543 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD----SF 543 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc----cc
Confidence 345799999999999998888899999875432 2334677899999999999999999999864432 56
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEecccCccc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD---NDMTAHMGDFGLTRF 672 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~ 672 (771)
|-|+|||+|.+|+-+ .+.+++.++..|+.||+.||.||.+. +++|||-|+||.|||+. ..|.+||+|||+++.
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999766 45688999999999999999999985 78999999999999995 468899999999998
Q ss_pred cCcccCCc---ccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHH---H
Q 041479 673 IPEVMSSN---QCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV---K 727 (771)
Q Consensus 673 ~~~~~~~~---~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~---~ 727 (771)
+.+..... ........||.+|.+|| .||++|..+.|++||.........+.+-. .
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 86543221 11223457999999999 49999999999999964332221122111 1
Q ss_pred hhCCCchhhhcCccccccCcccChhchhhcCCHHHHH
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
..+..+....+.+.-...+.+|++.--++|.++.++.
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1112233344455554555688887777777666553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-26 Score=252.83 Aligned_cols=219 Identities=23% Similarity=0.283 Sum_probs=160.2
Q ss_pred ccccccce-EEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 529 YESLVKAT-VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 529 l~~~~~~~-Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
+|.|..|+ ||+|... ++.||||++-.+ ...-..+||..++.-+ |||||++++.-.+.. +.||+.|.|.
T Consensus 517 lG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q-----F~YIalELC~ 586 (903)
T KOG1027|consen 517 LGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ-----FLYIALELCA 586 (903)
T ss_pred cccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCc-----eEEEEehHhh
Confidence 45666666 8999985 558999998533 3345678999999985 999999987644444 7899999996
Q ss_pred CCCCCCCccc-------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---C--CceEEecccCccccC
Q 041479 607 HGSLESCPRI-------LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---D--MTAHMGDFGLTRFIP 674 (771)
Q Consensus 607 ~g~L~~~~~~-------l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~--~~~kl~DfGla~~~~ 674 (771)
. +|+++.+. ......+.+..|++.||++||+- +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 4 77665221 11133467789999999999994 9999999999999975 3 479999999999887
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCC-Cchhhh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALP-DQILQV 737 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~ 737 (771)
.....-.. ..+..||-+|+||| +||++|+.++ |..||.+.+..... ++.+... ......
T Consensus 663 ~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---Il~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 663 GGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---ILTGNYTLVHLEPL 738 (903)
T ss_pred CCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---hhcCccceeeeccC
Confidence 66544333 55667999999999 6999999999 59999876544322 2222222 111222
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.|..-.+.+.+|+.++|..||++.+|+.
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 2222234556999999999999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=223.52 Aligned_cols=230 Identities=20% Similarity=0.241 Sum_probs=182.4
Q ss_pred ccccccceEEEEEecCCC-----eEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 529 YESLVKATVYKGILDLDQ-----TFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~-----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.||.||.||+|.|++.. +.|-||.++.+ ++-+...++.|...+..+.|||+..+.+++.+... .++.+|
T Consensus 292 lqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~----~P~V~y 367 (563)
T KOG1024|consen 292 LQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA----TPFVLY 367 (563)
T ss_pred hhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC----cceEEE
Confidence 578999999999887653 35667766443 34456789999999999999999999999976542 678999
Q ss_pred EeccCCCCCCC-----------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 603 EFMHHGSLESC-----------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 603 e~~~~g~L~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
.++.-|+|..+ .+.+...+.+.++.|++.|++|||.. +|||.||.++|.+||+.-.+|++|-.++|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 99999998766 23466778899999999999999986 99999999999999999999999999999
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
.+-+.+. .+-..+.-....||+|| |||++|||+| |+.||.++-+.+ ...+.+.+++-..+
T Consensus 445 DLFP~DY--hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--m~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 445 DLFPGDY--HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--MEHYLKDGYRLAQP 520 (563)
T ss_pred ccCcccc--cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--HHHHHhccceecCC
Confidence 7765443 33334444578899999 8999999999 999998874433 44555555543333
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
-.+..++..++.-||+.+|++||+..+++..|.+
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 3333444456669999999999999999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=219.76 Aligned_cols=224 Identities=21% Similarity=0.214 Sum_probs=168.7
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+++...-.+|.|++|.|..++++.+.+.||+|+++.+ ...+..-...|-.+..+. +||.+|.+..++.+..
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes----- 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES----- 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc-----
Confidence 4444455679999999999999999999999999654 223344556677777776 6999999999877666
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..++|.||++||+|--+ .+.+++..+..+..+|+.||.|||+. ||+.||+|.+|||+|..|.+|++|||+++.-
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 78999999999999543 56799999999999999999999985 9999999999999999999999999999842
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc-------ccCCccHHHHHHhhCC
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM-------FTEGLDLHNFVKMALP 731 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~-------~~~~~~~~~~~~~~~~ 731 (771)
-.. .....++||||.|+||| +||+++||+.|+.||+-. ..++..+..+....++
T Consensus 402 l~~----gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 402 LGP----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred CCC----CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 111 22334689999999999 699999999999999621 1112222233333332
Q ss_pred CchhhhcCccccccCcccChhchhhcC
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENI 758 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rp 758 (771)
++..++-.-..+...-+.+||.+|.
T Consensus 478 --iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2222222222333366788999885
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=235.64 Aligned_cols=188 Identities=21% Similarity=0.247 Sum_probs=155.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+..-.++|-|.||.|..++-.++...||+|.++..+ +.+......|-+||..-..+.||+||..|.+.+ .+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-----nLY 705 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NLY 705 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-----ceE
Confidence 344567999999999999988888899999996554 344567788999999999999999999877766 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||++|||+-.+ ...+++.-+..++.++.+|+++.|.. |+|||||||+|||||.+|++|++|||++.-+...
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999998665 45677888889999999999999985 9999999999999999999999999998643211
Q ss_pred cC--------------------------------------Ccccccccccccccccchh---------------HHHHHH
Q 041479 677 MS--------------------------------------SNQCSSVGLKGTVGYATPE---------------YGILLL 703 (771)
Q Consensus 677 ~~--------------------------------------~~~~~~~~~~gt~~y~aPE---------------~Gv~l~ 703 (771)
.. +..+.....+||+.|+||| .||++|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00 0011223567999999999 399999
Q ss_pred HHHhCCCCCCccccC
Q 041479 704 EIFTGKRPTSDMFTE 718 (771)
Q Consensus 704 el~tg~~P~~~~~~~ 718 (771)
||+.|+.||-+....
T Consensus 863 em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPG 877 (1034)
T ss_pred HHhhCCCCccCCCCC
Confidence 999999999764443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=249.94 Aligned_cols=235 Identities=17% Similarity=0.139 Sum_probs=149.9
Q ss_pred ccccccccccccccceEEEEEecCC----CeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-CCCc
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLD----QTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD-FQGN 595 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~~ 595 (771)
..+.....+|+|.+|+||+|++..+ +..||||++..... .+.+..| .+....+.+++.+...+.... ....
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 3445556799999999999999988 78999998854322 1222221 112222333333222211110 0112
Q ss_pred eeEEEEEEeccCCCCCCCcc--c---------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 041479 596 YFRALVYEFMHHGSLESCPR--I---------------------LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~~--~---------------------l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~ 652 (771)
...++||||+++++|.++.. . .....+..++.|++.||+|||+. +|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence 26799999999999865411 0 01223457899999999999985 8999999999
Q ss_pred CeeeCC-CCceEEecccCccccCcccCCcccccccccccccccchh----------------------------------
Q 041479 653 NVLLDN-DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------------------------- 697 (771)
Q Consensus 653 NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------------------------- 697 (771)
|||++. ++.+||+|||+|+.+..... .......||+.|||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999985 57999999999986543221 1223457899999999
Q ss_pred ---HHHHHHHHHhCCCCCCccc--------cCCccHHHHHHhhCCC---ch---hhhcCcc---ccccCcccChhchhhc
Q 041479 698 ---YGILLLEIFTGKRPTSDMF--------TEGLDLHNFVKMALPD---QI---LQVLDPL---FLVGGVQEGEETAEEN 757 (771)
Q Consensus 698 ---~Gv~l~el~tg~~P~~~~~--------~~~~~~~~~~~~~~~~---~~---~~~~~~~---~~~~~~~cl~~~p~~R 757 (771)
+||++|||+++..|+++.. ..+.....|.....+. .. .+..|.. ......+|++.||++|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 4999999999877764321 1122233333221111 11 1111111 1134559999999999
Q ss_pred CCHHHHHH
Q 041479 758 IKKGQIRE 765 (771)
Q Consensus 758 pt~~~vl~ 765 (771)
||+.++++
T Consensus 442 ~ta~e~L~ 449 (566)
T PLN03225 442 ISAKAALA 449 (566)
T ss_pred CCHHHHhC
Confidence 99999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=239.49 Aligned_cols=224 Identities=21% Similarity=0.222 Sum_probs=173.8
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.+....-++|-|+||.|-..........+|+|+++.. +.++.+....|-++|...+.|.||++|.-|.+.. +
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k-----y 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK-----Y 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-----h
Confidence 4455667899999999998888776656899988543 3556678889999999999999999998877766 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.|+.||-|-||.+... ...++......|+..+.+|++|||+. +||+||+||+|.++|.+|.+|+.|||+|+.+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 8999999999999776 45688888999999999999999985 99999999999999999999999999999876
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 738 (771)
... ...++||||-|.||| +|+++||+++|.+||++.-+ +..+...-.++. -.++..+
T Consensus 572 ~g~-----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp--mktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 572 SGR-----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP--MKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred cCC-----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHhhhhhhhccccc
Confidence 543 234689999999999 69999999999999986432 222222222211 2222233
Q ss_pred CccccccCcccChhchhhcCC
Q 041479 739 DPLFLVGGVQEGEETAEENIK 759 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt 759 (771)
...-...+.+.+..+|++|.-
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhc
Confidence 322223333555678888863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-26 Score=244.43 Aligned_cols=234 Identities=23% Similarity=0.261 Sum_probs=179.5
Q ss_pred ccccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 519 SRKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 519 ~~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+..+++..+.+|+|.+|.|||++++..++..|||+++....+..+-...|+-+++..+|||||.++|.|...+ ..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----kl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----Cc
Confidence 4456777888999999999999999999999999999887777788889999999999999999999987776 67
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+++||||.+|+|++. ..++++.++..++++..+|+.|+|++ +=+|||||-.||++.+.|.+|++|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 999999999999887 55788999999999999999999996 779999999999999999999999999876654
Q ss_pred ccCCcccccccccccccccchhH------------------HHHHHHHHhCCCCCCccccCCccHHHHHHhhC-CCc--h
Q 041479 676 VMSSNQCSSVGLKGTVGYATPEY------------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-PDQ--I 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE~------------------Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~--~ 734 (771)
.. .....+.||++|||||. |++..|+..-+.|.-|..+... +.-+.+..+ |+. -
T Consensus 165 ti----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 165 TI----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-LFLMTKSGFQPPTLKD 239 (829)
T ss_pred hh----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-HHHhhccCCCCCcccC
Confidence 33 23445789999999992 4444444444444333221111 111111111 111 1
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+.+......|+.++|.+|||+..+++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1222333345566999999999999887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=208.28 Aligned_cols=177 Identities=21% Similarity=0.301 Sum_probs=152.7
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...-.+|.|.++.||.|..-.+.+.++||+++.-. .+...+|+.++..++ |||||+++++..++... .+.+|+
T Consensus 41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk---tpaLiF 114 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK---TPSLIF 114 (338)
T ss_pred HHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc---CchhHh
Confidence 34456899999999999988888899999996544 367889999999997 99999999998776533 567999
Q ss_pred EeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcccCCcc
Q 041479 603 EFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 603 e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
||+.+.+..+....++..++..++.+++.||.|+|++ ||+|||+||.|+++|. ..+++++|+|+|.++.+....+.
T Consensus 115 E~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV 191 (338)
T KOG0668|consen 115 EYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 191 (338)
T ss_pred hhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence 9999988887777788889999999999999999996 9999999999999995 45799999999999877665443
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
.+.+.+|.-|| |||++.+|+..+.||-.
T Consensus 192 -----RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 192 -----RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred -----eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 35688899999 69999999999999954
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-27 Score=237.18 Aligned_cols=286 Identities=19% Similarity=0.159 Sum_probs=162.4
Q ss_pred eeeecCCC---------CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEeccc-CcCc
Q 041479 36 GVTCSLKY---------QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNS-NALQ 105 (771)
Q Consensus 36 ~v~c~~~~---------~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~ 105 (771)
-|.|..+. ...+.++|..|.|+.+++.+|+.+++|++||||+|+|+.+-|++|.++.+|.+|-+-+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 37887553 4678899999999988888999999999999999999999999999999998887766 7866
Q ss_pred ccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcc
Q 041479 106 GQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVG 185 (771)
Q Consensus 106 ~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 185 (771)
..-...|++|..|+-|.+.-|++.. .....|..+++|..|.+-+|.+.
T Consensus 130 --------------~l~k~~F~gL~slqrLllNan~i~C-----------------ir~~al~dL~~l~lLslyDn~~q- 177 (498)
T KOG4237|consen 130 --------------DLPKGAFGGLSSLQRLLLNANHINC-----------------IRQDALRDLPSLSLLSLYDNKIQ- 177 (498)
T ss_pred --------------hhhhhHhhhHHHHHHHhcChhhhcc-----------------hhHHHHHHhhhcchhcccchhhh-
Confidence 2333468888888888888888873 22233444444444444444444
Q ss_pred cCChhhhhCCCCCcEEEeecCc------------ccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEE
Q 041479 186 ELPPHIGFTLPNVRILLLAGNQ------------FFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253 (771)
Q Consensus 186 ~lp~~~~~~l~~L~~L~L~~N~------------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~ 253 (771)
.++...+..+.+++.+.+..|. +....|..+++..-..-..+.++++....+..|. ..+..+..-.
T Consensus 178 ~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~--c~~esl~s~~ 255 (498)
T KOG4237|consen 178 SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFL--CSLESLPSRL 255 (498)
T ss_pred hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhh--hhHHhHHHhh
Confidence 4444334444444444444444 2223334444444444555555555544443331 0011111101
Q ss_pred ccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccc
Q 041479 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 254 Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
.+....-+..|..-+.-.++|+.|+|++|+|+++-+.+|.++..++.|+|..|++...-...|.++..|+.|+|.+|+|+
T Consensus 256 ~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it 335 (498)
T KOG4237|consen 256 SSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQIT 335 (498)
T ss_pred ccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeE
Confidence 11111222333322222224555555555555555555555555555555555554444444555555555555555555
Q ss_pred ccCCcccccccccccccccCcc
Q 041479 334 REIPSSLGNFTFLTELNLCGNS 355 (771)
Q Consensus 334 ~~~p~~~~~l~~L~~L~Ls~N~ 355 (771)
...|.+|..+.+|.+|+|-.|.
T Consensus 336 ~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 336 TVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred EEecccccccceeeeeehccCc
Confidence 5555555555555555554444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=246.03 Aligned_cols=262 Identities=27% Similarity=0.326 Sum_probs=143.0
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcc
Q 041479 46 VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSE 125 (771)
Q Consensus 46 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~ 125 (771)
-..|+|++|+|+ .+|+.+. ++|+.|++++|+|+. +|.. .++|++|+|++|+|+ .+|..
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt---------------sLP~l 260 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT---------------SLPVL 260 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC---------------cccCc
Confidence 445677777777 4555554 367777777777774 5532 456677777777665 22321
Q ss_pred ccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
.++|+.|++++|.|+ .+|.. .++|+.|++++|+++ .+|. .+++|+.|+|++
T Consensus 261 ---p~sL~~L~Ls~N~L~------------------~Lp~l---p~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~ 311 (788)
T PRK15387 261 ---PPGLLELSIFSNPLT------------------HLPAL---PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSD 311 (788)
T ss_pred ---ccccceeeccCCchh------------------hhhhc---hhhcCEEECcCCccc-cccc----cccccceeECCC
Confidence 235556666666554 12221 134556666666666 5553 234566666666
Q ss_pred CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 206 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
|+|++ +|... .+|+.|++++|+|+++ |.. ..+|+.|+|++|+|+ .+|.. +++|+.|++++|+|+
T Consensus 312 N~L~~-Lp~lp---~~L~~L~Ls~N~L~~L-P~l------p~~Lq~LdLS~N~Ls-~LP~l----p~~L~~L~Ls~N~L~ 375 (788)
T PRK15387 312 NQLAS-LPALP---SELCKLWAYNNQLTSL-PTL------PSGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLT 375 (788)
T ss_pred Ccccc-CCCCc---ccccccccccCccccc-ccc------ccccceEecCCCccC-CCCCC----Ccccceehhhccccc
Confidence 66653 33221 2455556666666542 211 134555556655555 34431 124555555555555
Q ss_pred ccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccc
Q 041479 286 GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALG 365 (771)
Q Consensus 286 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 365 (771)
+ +|. . ..+|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|....
T Consensus 376 ~-LP~------------------------l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~~ 422 (788)
T PRK15387 376 S-LPA------------------------L---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLPS 422 (788)
T ss_pred c-Ccc------------------------c---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcchh
Confidence 2 232 1 1346666666666663 4432 2456666777776663 443322
Q ss_pred cccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcch
Q 041479 366 SCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSL 411 (771)
Q Consensus 366 ~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 411 (771)
.| .|++++|+|+ .+|..+..+++|+.|+|++|+|++..|..+
T Consensus 423 ---~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 423 ---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred ---hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 23 4666666666 456666677777777777777776665544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=246.20 Aligned_cols=244 Identities=27% Similarity=0.324 Sum_probs=177.4
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|++++|+|+. +|. .+++|++|+|++|+|++ +|.. .++|+.|++++|.|+ .+|
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~---------------~Lp 278 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT---------------HLP 278 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh---------------hhh
Confidence 478999999999995 443 36899999999999996 6753 468999999999976 344
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
..+ .+|+.|++++|+|+ .+|. .+++|+.|+|++|+|+ .+|.. ..+|+.|++
T Consensus 279 ~lp---~~L~~L~Ls~N~Lt------------------~LP~---~p~~L~~LdLS~N~L~-~Lp~l----p~~L~~L~L 329 (788)
T PRK15387 279 ALP---SGLCKLWIFGNQLT------------------SLPV---LPPGLQELSVSDNQLA-SLPAL----PSELCKLWA 329 (788)
T ss_pred hch---hhcCEEECcCCccc------------------cccc---cccccceeECCCCccc-cCCCC----ccccccccc
Confidence 322 56788999999887 3343 2468999999999999 68752 246889999
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
++|+|++ +|.. ..+|+.|+|++|+|+++ |... .+|+.|++++|+|+ .+|.. .++|+.|++++|+
T Consensus 330 s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~lp------~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~ 393 (788)
T PRK15387 330 YNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTLP------SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNR 393 (788)
T ss_pred ccCcccc-cccc---ccccceEecCCCccCCC-CCCC------cccceehhhccccc-cCccc----ccccceEEecCCc
Confidence 9999985 5542 25899999999999975 4322 56788899999999 57753 2479999999999
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcc
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
|++ +|... ++|+.|++++|.+.+ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+..
T Consensus 394 Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 394 LTS-LPVLP---SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred ccC-CCCcc---cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 994 55432 456666777766643 4432 234566666666665 45666666666666666666666555444
Q ss_pred c
Q 041479 364 L 364 (771)
Q Consensus 364 ~ 364 (771)
+
T Consensus 465 L 465 (788)
T PRK15387 465 L 465 (788)
T ss_pred H
Confidence 4
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=236.89 Aligned_cols=239 Identities=17% Similarity=0.168 Sum_probs=159.7
Q ss_pred ccccccccccccccceEEEEEec----------------CCCeEEEEEEeeccchhhHH--------------HHHHHHH
Q 041479 521 KDLLLNVSYESLVKATVYKGILD----------------LDQTFIAVKVLFLHQRGALK--------------SFMAECQ 570 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~----------------~~~~~vAvK~~~~~~~~~~~--------------~~~~E~~ 570 (771)
.++.....+|+|.||+||+|.+. ..++.||||++........+ .+..|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 34455667899999999999752 23457999999654333223 3445777
Q ss_pred HHhccCCCCc-----eeEEEEeecCCCC---CceeEEEEEEeccCCCCCCCc---------------------------c
Q 041479 571 ALRNIRHRNL-----VKIITACSTSDFQ---GNYFRALVYEFMHHGSLESCP---------------------------R 615 (771)
Q Consensus 571 ~l~~l~H~nI-----v~l~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~~---------------------------~ 615 (771)
++.+++|.++ ++++++|...... .....++||||+++|+|.++. .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7888876554 7788887543111 112579999999999985431 1
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccc
Q 041479 616 ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYAT 695 (771)
Q Consensus 616 ~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~a 695 (771)
.+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+|+.|+|
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y~a 378 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRYSP 378 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccCCCcceeC
Confidence 235667888999999999999985 899999999999999999999999999975533221 11112235789999
Q ss_pred hh-------------------------------------HHHHHHHHHhCCC-CCCccccCC-------ccHHHHHH---
Q 041479 696 PE-------------------------------------YGILLLEIFTGKR-PTSDMFTEG-------LDLHNFVK--- 727 (771)
Q Consensus 696 PE-------------------------------------~Gv~l~el~tg~~-P~~~~~~~~-------~~~~~~~~--- 727 (771)
|| +||++|||++|.. |+.+..... .....|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99 2999999999875 665422111 11222221
Q ss_pred hhCCCchhhhcCccccccCcccChhch---hhcCCHHHHHH
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETA---EENIKKGQIRE 765 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p---~~Rpt~~~vl~ 765 (771)
..+.....+.+++..+.+..+++.++| .+|+|+.|+++
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111112222333333445557787655 78999999985
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=254.26 Aligned_cols=348 Identities=18% Similarity=0.251 Sum_probs=187.9
Q ss_pred CcEEEEEcCCCCCcc--cCCccccCCCCCcEEEcCCCc------ccccCCccccCCC-CCCEEecccCcCcccCCccccc
Q 041479 44 QRVILLNLSGQNLTG--TASPYIGNLTFLRLINLQQNN------FSSNIPHEIGRLF-RLRHIIFNSNALQGQIPDSRLI 114 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~l~ 114 (771)
.++..+.+..+.+.. ..+.+|.++++|+.|.+..+. +...+|+.|..++ +|+.|++.+|.++
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~--------- 602 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR--------- 602 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC---------
Confidence 355555554444432 345678899999999987664 3335777787774 6999999998876
Q ss_pred CCcccccCCccccCCCCCCEEecccccCcC------CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCC
Q 041479 115 LNKLEGNIPSELGSLLKFKGLGLANNYFTG------PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELP 188 (771)
Q Consensus 115 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~------~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 188 (771)
.+|..| ...+|+.|++++|++.. .+++|+.++++.+...+.+| .+..+++|+.|+|++|.....+|
T Consensus 603 ------~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp 674 (1153)
T PLN03210 603 ------CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELP 674 (1153)
T ss_pred ------CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccc
Confidence 566666 46788899999888762 23445555555544333444 24555556666665554333555
Q ss_pred hhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhh
Q 041479 189 PHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268 (771)
Q Consensus 189 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 268 (771)
..+. .+++|+.|++++|...+.+|..+ ++++|+.|+|++|...+.+|.. .++|+.|++++|.+. .+|..+
T Consensus 675 ~si~-~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~------~~nL~~L~L~~n~i~-~lP~~~- 744 (1153)
T PLN03210 675 SSIQ-YLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI------STNISWLDLDETAIE-EFPSNL- 744 (1153)
T ss_pred hhhh-ccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc------cCCcCeeecCCCccc-cccccc-
Confidence 5544 55556666665543333444433 4555566666555433333321 234555556655554 455433
Q ss_pred hcccccceeecccCcCc-------ccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccc
Q 041479 269 NFSSHLRYLYMSANPIS-------GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341 (771)
Q Consensus 269 ~l~~~L~~L~Ls~N~l~-------~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 341 (771)
.+. +|++|++.++... ...|..+...++|+.|++++|.....+|.+++++++|+.|++++|..-+.+|..+
T Consensus 745 ~l~-~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~- 822 (1153)
T PLN03210 745 RLE-NLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI- 822 (1153)
T ss_pred ccc-ccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-
Confidence 222 4555555542211 1111122223455666666655555556666666666666665543223444443
Q ss_pred cccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCC-CcccccCCcchhhhhcccc
Q 041479 342 NFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSK-NELSGEIPSSLAWIFGYIS 419 (771)
Q Consensus 342 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~~~~~l~ 419 (771)
.+++|+.|+|++|..-..+|... ..+ .|+|++|.++ .+|..+..+++|+.|+|++ |+++ .+|..+. .++
T Consensus 823 ~L~sL~~L~Ls~c~~L~~~p~~~---~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~----~L~ 893 (1153)
T PLN03210 823 NLESLESLDLSGCSRLRTFPDIS---TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNIS----KLK 893 (1153)
T ss_pred CccccCEEECCCCCccccccccc---cccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccc----ccc
Confidence 45566666666554333333322 223 4556666655 3455555566666666655 3444 3333322 455
Q ss_pred cccEEECcCC
Q 041479 420 IFAKLNLSYN 429 (771)
Q Consensus 420 ~L~~L~Ls~N 429 (771)
.|+.++++++
T Consensus 894 ~L~~L~l~~C 903 (1153)
T PLN03210 894 HLETVDFSDC 903 (1153)
T ss_pred CCCeeecCCC
Confidence 5555555554
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=247.83 Aligned_cols=326 Identities=21% Similarity=0.329 Sum_probs=259.5
Q ss_pred CcEEEEEcCCCC------CcccCCccccCCC-CCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCC
Q 041479 44 QRVILLNLSGQN------LTGTASPYIGNLT-FLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILN 116 (771)
Q Consensus 44 ~~l~~L~Ls~n~------l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n 116 (771)
.++..|.+.++. +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|+.|++++|++.
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~----------- 624 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE----------- 624 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-----------
Confidence 466777775543 3335677777764 5999999999998 478887 5799999999999976
Q ss_pred cccccCCccccCCCCCCEEecccccCcC------CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChh
Q 041479 117 KLEGNIPSELGSLLKFKGLGLANNYFTG------PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPH 190 (771)
Q Consensus 117 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~------~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~ 190 (771)
.++..+..+++|+.|+|+++.... .+++|+.|++++|..-..+|..+.++++|+.|++++|...+.+|..
T Consensus 625 ----~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 625 ----KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred ----ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc
Confidence 567778889999999999875332 3556899999998877789999999999999999997544589976
Q ss_pred hhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccc---c---cCC
Q 041479 191 IGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS---G---TLP 264 (771)
Q Consensus 191 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~---~---~~p 264 (771)
+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.++.+ |..+ .+++|+.|++.++... + .++
T Consensus 701 i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~----~l~~L~~L~l~~~~~~~l~~~~~~l~ 770 (1153)
T PLN03210 701 I--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNL----RLENLDELILCEMKSEKLWERVQPLT 770 (1153)
T ss_pred C--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccc----cccccccccccccchhhccccccccc
Confidence 5 7899999999999766666643 46899999999999754 4432 5678888888774322 1 122
Q ss_pred hhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCccccccc
Q 041479 265 NSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344 (771)
Q Consensus 265 ~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 344 (771)
.......++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|... .+++|+.|++++|.....+|.. .+
T Consensus 771 ~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~ 846 (1153)
T PLN03210 771 PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---ST 846 (1153)
T ss_pred hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---cc
Confidence 2223334589999999998888899999999999999999987777888776 7999999999998655556643 36
Q ss_pred ccccccccCccceecCCcccccccce-eeeccc-CcccCCCCcCCCCCCCCCeEECCCCc
Q 041479 345 FLTELNLCGNSIRGSVPSALGSCHQL-WLDLSH-NHLTGPIPLAVGNPKSIPHLDLSKNE 402 (771)
Q Consensus 345 ~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 402 (771)
+|+.|+|++|.|+ .+|.++..++.| .|++++ |++. .+|..+..+++|+.++++++.
T Consensus 847 nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 847 NISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 8999999999998 688889999999 999998 5666 577788899999999999874
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=239.78 Aligned_cols=325 Identities=20% Similarity=0.301 Sum_probs=222.8
Q ss_pred cHHHHHHHHhcCCCCCCCCCCC----CCCCCCCcccee----------------eeecCCCCcEEEEEcCCCCCcccC--
Q 041479 3 DKQALLAFKSKVDDDPFGALST----WNDSVNFCQWLG----------------VTCSLKYQRVILLNLSGQNLTGTA-- 60 (771)
Q Consensus 3 ~~~~l~~~~~~~~~~~~~~~~~----w~~~~~~c~w~~----------------v~c~~~~~~l~~L~Ls~n~l~~~~-- 60 (771)
|.+.+++..+.+.- .+.+.+ |.+.+++|.-.. |.|.. ..++.+..-+.......
T Consensus 64 ~~~~~~~~~~~l~~--p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~~~~~~~~ 139 (754)
T PRK15370 64 EIKSKFECLRMLAF--PAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESEQASSASG 139 (754)
T ss_pred HHHHHHHHHHHhcC--CchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCC--CcccccccccccccccCCC
Confidence 55778888888853 345666 988889995333 56654 45555554332211100
Q ss_pred C--------------------------ccc-----cCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCC
Q 041479 61 S--------------------------PYI-----GNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP 109 (771)
Q Consensus 61 ~--------------------------~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 109 (771)
+ .++ .-..+...|+++++++++ +|..+. ++|+.|+|++|+|+
T Consensus 140 ~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt---- 212 (754)
T PRK15370 140 SKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK---- 212 (754)
T ss_pred CCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC----
Confidence 0 000 112457899999999985 777664 57999999999987
Q ss_pred cccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCCh
Q 041479 110 DSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPP 189 (771)
Q Consensus 110 ~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~ 189 (771)
.+|..+. .+|+.|++++|+|+ .+|..+. .+|+.|+|++|+++ .+|.
T Consensus 213 -----------sLP~~l~--~nL~~L~Ls~N~Lt------------------sLP~~l~--~~L~~L~Ls~N~L~-~LP~ 258 (754)
T PRK15370 213 -----------SLPENLQ--GNIKTLYANSNQLT------------------SIPATLP--DTIQEMELSINRIT-ELPE 258 (754)
T ss_pred -----------cCChhhc--cCCCEEECCCCccc------------------cCChhhh--ccccEEECcCCccC-cCCh
Confidence 3454443 47899999999887 2333332 36888888888888 7887
Q ss_pred hhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhh
Q 041479 190 HIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN 269 (771)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 269 (771)
.+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|+|+++ |..+ .++|+.|++++|+++ .+|..+.
T Consensus 259 ~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l-----p~sL~~L~Ls~N~Lt-~LP~~l~- 324 (754)
T PRK15370 259 RLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL-PAHL-----PSGITHLNVQSNSLT-ALPETLP- 324 (754)
T ss_pred hHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccC-cccc-----hhhHHHHHhcCCccc-cCCcccc-
Confidence 664 47888888888888 4566554 5788889999888864 4333 146788888888888 5665543
Q ss_pred cccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccc
Q 041479 270 FSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTEL 349 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 349 (771)
++|+.|++++|.+++ +|..+. ++|+.|++++|++. .+|..+ .++|+.|+|++|+|+ .+|..+. .+|+.|
T Consensus 325 --~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~L 393 (754)
T PRK15370 325 --PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENLP--AALQIM 393 (754)
T ss_pred --ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHH
Confidence 478889999998884 666554 68888999888875 466555 368999999999998 4666554 478999
Q ss_pred cccCccceecCCccccc----ccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccc
Q 041479 350 NLCGNSIRGSVPSALGS----CHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405 (771)
Q Consensus 350 ~Ls~N~l~~~~p~~~~~----l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 405 (771)
++++|+|+ .+|..+.. ++.+ .|++.+|.++. ..+.+|+.| ++.+.+.|
T Consensus 394 dLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 394 QASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred hhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 99999998 55654433 3555 78999998872 234555555 44454443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=221.02 Aligned_cols=159 Identities=23% Similarity=0.253 Sum_probs=133.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch--------hhHHHHHHHHHHHhccC---CCCceeEEEEeecCCCC
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--------GALKSFMAECQALRNIR---HRNLVKIITACSTSDFQ 593 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~ 593 (771)
-...+|+|++|.|+.|+++.....|+||.+...+- ...-..-.||+||..++ |+||++++++|++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd-- 642 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD-- 642 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC--
Confidence 34578999999999999999999999999965531 11223456999999997 999999999998888
Q ss_pred CceeEEEEEEecc-CCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 594 GNYFRALVYEFMH-HGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 594 ~~~~~~lv~e~~~-~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
++|++||-.. +-+|.++ ...+++.+...|+.||+-|+++||++ +|||||||-+||.++.+|-+|++|||.
T Consensus 643 ---~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 ---YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ---eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 7899999763 3455555 56789999999999999999999997 999999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE 697 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE 697 (771)
|........ ..++||..|.|||
T Consensus 717 aa~~ksgpf------d~f~gtv~~aape 738 (772)
T KOG1152|consen 717 AAYTKSGPF------DVFVGTVDYAAPE 738 (772)
T ss_pred hhhhcCCCc------ceeeeeccccchh
Confidence 876544322 2367999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-24 Score=206.82 Aligned_cols=186 Identities=20% Similarity=0.229 Sum_probs=149.5
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+....-++|-|.||.||..+++.+++.||.|++.-- +-...+++.+|+.++.-++|.||+..+++-.-.....-.++
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3445566789999999999999999999999998432 23456889999999999999999999887644332111246
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|.+.|.|.. +|... .+.++...+.-+..||++||.|||+. +|.||||||.|.|+.++..+||||||+|+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 788999854 77665 45677777888889999999999996 999999999999999999999999999997654
Q ss_pred ccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~ 713 (771)
... ...+..+-|-+|+||| .||++.|++.++.-|.
T Consensus 209 d~~---~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDR---LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhh---hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 432 2233445788999999 4999999999887764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-23 Score=199.20 Aligned_cols=225 Identities=20% Similarity=0.217 Sum_probs=161.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|-||.+-.++++...+.+|+|.+..... ..++|.+|..---.+ .|.||+.-|+..... ...+++++||
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~YvF~qE~ 103 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAYVFVQEF 103 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhc----CceEEEeecc
Confidence 3468999999999999999999999999865443 457899988654444 499999988764332 2277899999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD--NDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
++.|||..- ...+.+....+++.|+++|++|||+. .+||||||.+||||- +..++|+||||..+..+.....
T Consensus 104 aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~- 179 (378)
T KOG1345|consen 104 APRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY- 179 (378)
T ss_pred CccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehh-
Confidence 999999765 33467788899999999999999985 999999999999994 3458999999998855443221
Q ss_pred ccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHH---HHhhCCCchhhh
Q 041479 681 QCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNF---VKMALPDQILQV 737 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~---~~~~~~~~~~~~ 737 (771)
..-+-.|.||| ||+++|..+||+.||...+..+....+| ..+..+ ..++.
T Consensus 180 ------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~~P~~ 252 (378)
T KOG1345|consen 180 ------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-ALPKK 252 (378)
T ss_pred ------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-cCchh
Confidence 12355688888 7999999999999998666555544444 444333 22222
Q ss_pred c---CccccccCcccChhchhhcCCHHHHHHH
Q 041479 738 L---DPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 738 ~---~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
+ ++.....-.+-+..+|.+|-.+.++-.+
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 2 2221111114456677777555554443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=198.78 Aligned_cols=205 Identities=28% Similarity=0.380 Sum_probs=160.7
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccC
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH 607 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 607 (771)
+|+|.+|.||+++...+++.++||++...... ..+.+.+|++.++.++|++|+++++++.... ..+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-----HLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----eEEEEEecCCC
Confidence 47899999999999887889999999765432 4578999999999999999999999988765 67999999999
Q ss_pred CCCCCCc----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcccCCccc
Q 041479 608 GSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 608 g~L~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
++|.++. ..+++..+..++.+++++++|||+. +++|+|++|.||+++. ++.++++|||.+........
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9998772 2578999999999999999999986 9999999999999998 89999999999986544321
Q ss_pred ccccccccccccchhHHHHHHHHHhCC---CCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCC
Q 041479 683 SSVGLKGTVGYATPEYGILLLEIFTGK---RPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIK 759 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE~Gv~l~el~tg~---~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt 759 (771)
......+...|++|| ...+. .+..|.|..+..+.++ ..+.....+|+..+|++||+
T Consensus 149 ~~~~~~~~~~~~~pe-------~~~~~~~~~~~~D~~~lg~~~~~l--------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 149 LLKTIVGTPAYMAPE-------VLLGKGYYSEKSDIWSLGVILYEL--------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred hhhcccCCCCccChh-------HhcccCCCCchhhhHHHHHHHHHH--------------HHHHHHHHHHhhCCcccCcC
Confidence 112234678899997 22211 1223455444433333 33334455999999999999
Q ss_pred HHHHHHH
Q 041479 760 KGQIRES 766 (771)
Q Consensus 760 ~~~vl~~ 766 (771)
+.++++.
T Consensus 208 ~~~l~~~ 214 (215)
T cd00180 208 AKEILEH 214 (215)
T ss_pred HHHHhhC
Confidence 9999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=209.06 Aligned_cols=160 Identities=23% Similarity=0.132 Sum_probs=122.6
Q ss_pred ccccccccccccceEEEEEecC-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDL-DQTFIAVKVLFLH-----QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|+++. +++.||||++... .....+.|.+|++++++++|+|||+.+..+ +
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~----- 91 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G----- 91 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C-----
Confidence 3445568999999999999876 6777899987533 123456799999999999999999633221 2
Q ss_pred eEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeeCCCCceEEecccCccccCc
Q 041479 597 FRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL-KPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
..|+||||++|++|.... .. ....++.++++||+|||+. +|+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 92 ~~~LVmE~~~G~~L~~~~-~~---~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR-PH---GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHHhC-cc---chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 358999999999996321 11 1256788999999999985 9999999 99999999999999999999997655
Q ss_pred ccCCcc----cccccccccccccchh
Q 041479 676 VMSSNQ----CSSVGLKGTVGYATPE 697 (771)
Q Consensus 676 ~~~~~~----~~~~~~~gt~~y~aPE 697 (771)
...... .......+++.|+|||
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe 190 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPD 190 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcc
Confidence 432211 1123567899999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-23 Score=201.68 Aligned_cols=177 Identities=23% Similarity=0.235 Sum_probs=139.8
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc-eeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN-YFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~-~~~~lv~e 603 (771)
..++.|.. .|-.|-+.-.++.||+|++.... ....++..+|...+..+.|+||++++.++.-...... ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34556665 66677777777899999985432 2345678899999999999999999999864432111 24689999
Q ss_pred eccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccc
Q 041479 604 FMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682 (771)
Q Consensus 604 ~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 682 (771)
||. ++|.+. .-.++..+...+..|++.|++|+|+. +|+||||||+||++..++.+||.|||+|+..... .
T Consensus 102 ~m~-~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-----~ 172 (369)
T KOG0665|consen 102 LMD-ANLCQVILMELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-----F 172 (369)
T ss_pred hhh-hHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-----c
Confidence 995 466554 34578888999999999999999996 9999999999999999999999999999854332 1
Q ss_pred ccccccccccccchh---------------HHHHHHHHHhCCCCCC
Q 041479 683 SSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 683 ~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~ 713 (771)
..+..+.|..|+||| .||++.||++|..-|.
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 234457899999999 5999999999988664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=230.61 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=161.7
Q ss_pred eeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCC
Q 041479 37 VTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILN 116 (771)
Q Consensus 37 v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n 116 (771)
..|.. .+.+.|++++++++ .+|..+. ++|+.|+|++|+|++ +|..+. ++|++|++++|+|+
T Consensus 173 ~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt----------- 233 (754)
T PRK15370 173 RDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT----------- 233 (754)
T ss_pred Hhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-----------
Confidence 34543 35677777777777 3454442 467778888887774 565543 47778888877765
Q ss_pred cccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCC
Q 041479 117 KLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLP 196 (771)
Q Consensus 117 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~ 196 (771)
.+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+|+ .+|..+. +
T Consensus 234 ----sLP~~l~--~~L~~L~Ls~N~L~------------------~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~ 283 (754)
T PRK15370 234 ----SIPATLP--DTIQEMELSINRIT------------------ELPERLP--SALQSLDLFHNKIS-CLPENLP---E 283 (754)
T ss_pred ----cCChhhh--ccccEEECcCCccC------------------cCChhHh--CCCCEEECcCCccC-ccccccC---C
Confidence 2333332 25677777777766 2333332 36777888888777 6776543 4
Q ss_pred CCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccce
Q 041479 197 NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRY 276 (771)
Q Consensus 197 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~ 276 (771)
+|+.|++++|+|++ +|..+. ++|+.|++++|+++.+ |..+ .++|+.|++++|.++ .+|..+. ++|+.
T Consensus 284 sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L-P~~l-----~~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~ 350 (754)
T PRK15370 284 ELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL-PETL-----PPGLKTLEAGENALT-SLPASLP---PELQV 350 (754)
T ss_pred CCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC-Cccc-----cccceeccccCCccc-cCChhhc---CcccE
Confidence 67788888887774 444432 4677777888877754 3322 256777778888777 4665543 36778
Q ss_pred eecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccc----ccccccccccc
Q 041479 277 LYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG----NFTFLTELNLC 352 (771)
Q Consensus 277 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~Ls 352 (771)
|++++|+|+ .+|..+. ++|+.|++++|.+. .+|..+. ..|+.|++++|+|+ .+|..+. .++++..|+|.
T Consensus 351 L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~ 423 (754)
T PRK15370 351 LDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVE 423 (754)
T ss_pred EECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEee
Confidence 888888777 4565543 57777888877775 3455443 35777778888776 4554433 34667777888
Q ss_pred Cccce
Q 041479 353 GNSIR 357 (771)
Q Consensus 353 ~N~l~ 357 (771)
+|.++
T Consensus 424 ~Npls 428 (754)
T PRK15370 424 YNPFS 428 (754)
T ss_pred CCCcc
Confidence 88776
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=202.87 Aligned_cols=171 Identities=19% Similarity=0.228 Sum_probs=140.2
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-C-C----CceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-H-R----NLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.-.+|+|.+|.|-.+.+...+..||||+++.- .+..+..+-|++++.++. + | -+|.+.+++...+ +.|
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg-----hiC 167 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG-----HIC 167 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC-----ceE
Confidence 45689999999999999999899999999533 345678888999999994 3 2 4778877776555 789
Q ss_pred EEEEeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC----------------
Q 041479 600 LVYEFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---------------- 658 (771)
Q Consensus 600 lv~e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---------------- 658 (771)
||+|.+ |-++.++. .+++...+..|+.|++++++|||+. +++|-|+||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999988 55777763 3588899999999999999999996 8999999999999932
Q ss_pred ----CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCC
Q 041479 659 ----DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 659 ----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~ 713 (771)
+..+|++|||.|++-.+.. ...+.|..|+||| +||+++|+.||..-|.
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 1248999999998654433 2356899999999 6999999999998775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=191.91 Aligned_cols=177 Identities=32% Similarity=0.408 Sum_probs=150.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchh-hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+++|.+|+||++....+++.||+|.+...... ..+.+.+|++.+++++|+|++++++++.... ..++++||+
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v~e~~ 79 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLVMEYC 79 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEEEecc
Confidence 4578999999999999987889999999766544 6789999999999999999999999987765 679999999
Q ss_pred cCCCCCCCc---cc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESCP---RI-LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~~---~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++++|.++. .. +++.....++.+++.++.|+|+. +++|+|++|+||+++.++.++++|||.+.........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--
Confidence 999997762 23 78889999999999999999985 9999999999999999999999999999866543200
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
......++..|++|| +|++++|+++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112345778899999 49999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-23 Score=207.94 Aligned_cols=256 Identities=20% Similarity=0.205 Sum_probs=165.0
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccc-cccCCCCCcCcccccCCCCCc
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFAN-NSLTGLIPEDLDSLVNCTYLE 250 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~l~~L~ 250 (771)
.-+.++|..|+|+ .||+..|..+++|+.|||++|+|+.+-|++|.++.+|..|-+.+ |+|+.++-..| .+|.+|+
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F---~gL~slq 143 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAF---GGLSSLQ 143 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHh---hhHHHHH
Confidence 4567788888888 88888888888888888888888888888888888877766655 88887766666 6667788
Q ss_pred EEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccc------------eeccCccccC
Q 041479 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL------------IRNIPISVGY 318 (771)
Q Consensus 251 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l------------~~~~p~~~~~ 318 (771)
.|.+.-|++.-...+.|..+. +|..|.+-+|.+..+--.+|.++.+++.+++..|.+ ....|..++.
T Consensus 144 rLllNan~i~Cir~~al~dL~-~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsg 222 (498)
T KOG4237|consen 144 RLLLNANHINCIRQDALRDLP-SLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSG 222 (498)
T ss_pred HHhcChhhhcchhHHHHHHhh-hcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccc
Confidence 888888888755555566665 688888888888843334788888888888877762 2333444444
Q ss_pred CCCCCEEEccCCcccccCCc--------------------------ccccccccccccccCccceecCCcccccccce-e
Q 041479 319 LLKLQVLSLFENNISREIPS--------------------------SLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-W 371 (771)
Q Consensus 319 l~~L~~L~Ls~N~l~~~~p~--------------------------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~ 371 (771)
..-..-..+.++++..+.+. .|..+++|+.|+|++|+|+++-+.+|.....+ .
T Consensus 223 arc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e 302 (498)
T KOG4237|consen 223 ARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE 302 (498)
T ss_pred ceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence 44444444444444332222 34455555666666666655555555555555 5
Q ss_pred eecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCC
Q 041479 372 LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436 (771)
Q Consensus 372 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p 436 (771)
|.|..|+|.......|.++.+|+.|+|.+|+|+..-|.+|. .+..|.+|+|-.|++.|.+-
T Consensus 303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~----~~~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ----TLFSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc----ccceeeeeehccCcccCccc
Confidence 55555555555555555555555566666665555555433 44555555555555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-21 Score=201.35 Aligned_cols=175 Identities=21% Similarity=0.238 Sum_probs=139.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC------CCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR------HRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.....|.|+|++|.+|.+...+..||||+|+-. +-..+.=++|+++|++++ --++++|+..|...+ ++
T Consensus 436 V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn-----HL 509 (752)
T KOG0670|consen 436 VQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN-----HL 509 (752)
T ss_pred EEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc-----ee
Confidence 345679999999999999988889999999644 333466678999999995 248999988887766 89
Q ss_pred EEEEEeccCCCCCCC----c--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCcc
Q 041479 599 ALVYEFMHHGSLESC----P--RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTR 671 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~ 671 (771)
|||+|-+. -+|.++ + -.|....+..|+.|+..||..|-.. +|+|.||||.|||+.+ ...+||||||.|.
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 99999774 355444 1 2366778899999999999999974 9999999999999985 4578999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~ 715 (771)
........ ...-+..|.||| .||++||+.||+.-|.+-
T Consensus 586 ~~~eneit------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 586 FASENEIT------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccc------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 76654321 123467899999 399999999999887653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.1e-21 Score=183.03 Aligned_cols=224 Identities=21% Similarity=0.280 Sum_probs=176.3
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.+.+--.|..|+|+|... .+++|++...+ ....++|..|.-.++.+.||||++++|+|.... ...++..||
T Consensus 197 kl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~isq~m 269 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIISQYM 269 (448)
T ss_pred hhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEeeeec
Confidence 455666788999999755 46678875543 344578999999999999999999999998775 678999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEe--cccCccccCcccC
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG--DFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~--DfGla~~~~~~~~ 678 (771)
+.|+|+.. .-..+..+.++++.++|+|++|||+. .+-|.--.+.+..|++|++..++|+ |--++-
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 99999765 22467788999999999999999996 3455556788999999999988876 221111
Q ss_pred Ccccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 679 SNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
...+..-+|.||+|| |.+++||+.|++.||.|..+.+. -.++.-.+++..++..+.+
T Consensus 342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-gmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-GMKIALEGLRVHIPPGISR 416 (448)
T ss_pred ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-hhhhhhccccccCCCCccH
Confidence 112234578899999 89999999999999998655443 2344555666677777788
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+...+.-|+..||.+||..+.++..|+++.
T Consensus 417 hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 7777888999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=224.97 Aligned_cols=184 Identities=16% Similarity=0.177 Sum_probs=120.8
Q ss_pred ccCC-CCceeEEEEeecCCCCC--ceeEEEEEEeccCCCCCCCc----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 041479 574 NIRH-RNLVKIITACSTSDFQG--NYFRALVYEFMHHGSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646 (771)
Q Consensus 574 ~l~H-~nIv~l~~~~~~~~~~~--~~~~~lv~e~~~~g~L~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 646 (771)
.++| +||+++++++......+ ....+.+|||+ +++|.++. ..+++.++..++.||++||+|||+. +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4556 68888888873322111 12456778987 55887662 3488999999999999999999985 9999
Q ss_pred cCCCCCCeeeCC-------------------CCceEEecccCccccCcccCC------------cccccccccccccccc
Q 041479 647 CDLKPSNVLLDN-------------------DMTAHMGDFGLTRFIPEVMSS------------NQCSSVGLKGTVGYAT 695 (771)
Q Consensus 647 rdlk~~NILl~~-------------------~~~~kl~DfGla~~~~~~~~~------------~~~~~~~~~gt~~y~a 695 (771)
|||||+|||++. ++.+|++|||+++........ ........+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 445666667766542110000 0001112468999999
Q ss_pred hh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCH
Q 041479 696 PE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 696 PE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
|| |||++|||++|..|+.... ..+..+.....++..... .+.....+.+||+++|.+||||
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPPQILLN-WPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcChhhhhc-CHHHHHHHHHhCCCChhhCcCh
Confidence 99 7999999999988875321 112222222223211111 1112233458999999999999
Q ss_pred HHHHH
Q 041479 761 GQIRE 765 (771)
Q Consensus 761 ~~vl~ 765 (771)
.|+++
T Consensus 260 ~eil~ 264 (793)
T PLN00181 260 SELLQ 264 (793)
T ss_pred HHHhh
Confidence 99975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-20 Score=189.46 Aligned_cols=180 Identities=23% Similarity=0.341 Sum_probs=148.2
Q ss_pred cccccccccccceEEEEEecC---CCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEE
Q 041479 524 LLNVSYESLVKATVYKGILDL---DQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...-.+|+|.|++||+|.+.. ..+.||+|.+...+. ..+...|++++..+. |.||+++.+++...+ ...
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd-----~v~ 111 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND-----QVA 111 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC-----eeE
Confidence 345568999999999999887 778999999976543 467889999999996 999999999987776 789
Q ss_pred EEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCccc-
Q 041479 600 LVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVM- 677 (771)
Q Consensus 600 lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~- 677 (771)
+|+||+++.+-.++...++..++..+...+..||+++|+. |||||||||+|+|.+. .++-.+.|||+|.......
T Consensus 112 ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999988877777888999999999999999999986 9999999999999984 5788999999997211000
Q ss_pred ------------C---------------------------Ccccccccccccccccchh----------------HHHHH
Q 041479 678 ------------S---------------------------SNQCSSVGLKGTVGYATPE----------------YGILL 702 (771)
Q Consensus 678 ------------~---------------------------~~~~~~~~~~gt~~y~aPE----------------~Gv~l 702 (771)
. ..........||++|+||| -||++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0001112456999999999 39999
Q ss_pred HHHHhCCCCCC
Q 041479 703 LEIFTGKRPTS 713 (771)
Q Consensus 703 ~el~tg~~P~~ 713 (771)
+-+++++.||-
T Consensus 269 Lslls~~~PFf 279 (418)
T KOG1167|consen 269 LSLLSRRYPFF 279 (418)
T ss_pred ehhhccccccc
Confidence 99999999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=175.21 Aligned_cols=135 Identities=17% Similarity=0.081 Sum_probs=104.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchh--h-------HHH-----------------HHHHHHHHhccCCCCc
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRG--A-------LKS-----------------FMAECQALRNIRHRNL 580 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~nI 580 (771)
..+|+|++|.||+|+.+ +++.||||+++..... . ..+ ...|++++.++.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999997 6779999999754211 0 112 2349999999988776
Q ss_pred eeEEEEeecCCCCCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeee
Q 041479 581 VKIITACSTSDFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLH-HHCKKPIVHCDLKPSNVLL 656 (771)
Q Consensus 581 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrdlk~~NILl 656 (771)
.....+... ..++||||++++++... ...++..+...++.|++.+|+|+| +. +|+||||||+||++
T Consensus 82 ~~p~~~~~~-------~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILLK-------SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEec-------CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 443332221 23799999998876543 346788889999999999999995 53 89999999999999
Q ss_pred CCCCceEEecccCcccc
Q 041479 657 DNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 657 ~~~~~~kl~DfGla~~~ 673 (771)
+ ++.++++|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=170.82 Aligned_cols=137 Identities=18% Similarity=0.108 Sum_probs=108.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchh--------------------------hHHHHHHHHHHHhccCCCCc
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRG--------------------------ALKSFMAECQALRNIRHRNL 580 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~nI 580 (771)
..+|+|.+|.||+|++. +++.||||+++..... ....+.+|.+.+.++.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45899999999999987 6779999999754210 01234689999999999988
Q ss_pred eeEEEEeecCCCCCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeee
Q 041479 581 VKIITACSTSDFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHH-HCKKPIVHCDLKPSNVLL 656 (771)
Q Consensus 581 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~NILl 656 (771)
.....+.... .|+||||++++++... ...++..+...++.|++.++.|+|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~~-------~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLKK-------NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEecC-------CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 6555443322 3799999998855322 2346777889999999999999998 5 99999999999999
Q ss_pred CCCCceEEecccCccccCc
Q 041479 657 DNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~ 675 (771)
+ ++.++++|||+|+....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-20 Score=169.58 Aligned_cols=131 Identities=23% Similarity=0.427 Sum_probs=66.9
Q ss_pred CCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCC
Q 041479 66 NLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGP 145 (771)
Q Consensus 66 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 145 (771)
++.+.+.|-||+|+++ .+|..++.+.+|+.|++++|+++ .+|..++++++|+.|+++-|++.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie---------------~lp~~issl~klr~lnvgmnrl~-- 92 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE---------------ELPTSISSLPKLRILNVGMNRLN-- 92 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh---------------hcChhhhhchhhhheecchhhhh--
Confidence 4445555555555555 34555555555555555555554 45555555555555555555554
Q ss_pred CCccceeeecccccccccCccccCCCCCCEEecccCcCc-ccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCE
Q 041479 146 IPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLV-GELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEW 224 (771)
Q Consensus 146 lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 224 (771)
..|..|+.++.|+.|||++|++. ..+|..+| .+..|+.|+|+.|.+. ++|+.++.+++|+.
T Consensus 93 ----------------~lprgfgs~p~levldltynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lqi 154 (264)
T KOG0617|consen 93 ----------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQI 154 (264)
T ss_pred ----------------cCccccCCCchhhhhhccccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcceeE
Confidence 44555555555555555555554 23444433 4444444444444444 34444444444444
Q ss_pred EEcccccc
Q 041479 225 LDFANNSL 232 (771)
Q Consensus 225 L~Ls~N~l 232 (771)
|.+..|.+
T Consensus 155 l~lrdndl 162 (264)
T KOG0617|consen 155 LSLRDNDL 162 (264)
T ss_pred EeeccCch
Confidence 44444444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-20 Score=197.39 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=149.0
Q ss_pred ccccCCCCCCEEecccCcCcc----cCChhhhhCCCCCcEEEeecCcccc------cCCccccCCCCCCEEEccccccCC
Q 041479 165 IQLLNITSMEYFHVSENQLVG----ELPPHIGFTLPNVRILLLAGNQFFG------NIPHSISNASKLEWLDFANNSLTG 234 (771)
Q Consensus 165 ~~~~~l~~L~~L~Ls~N~l~g----~lp~~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~ 234 (771)
..+..+..|+.|+++++.++. .++..+. ..++++.|++++|.+.+ .++..+..+++|+.|++++|.+.+
T Consensus 17 ~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~-~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~ 95 (319)
T cd00116 17 ELLPKLLCLQVLRLEGNTLGEEAAKALASALR-PQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGP 95 (319)
T ss_pred HHHHHHhhccEEeecCCCCcHHHHHHHHHHHh-hCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCCh
Confidence 344556667788888777742 2343433 55667788887777752 233456667788888888887765
Q ss_pred CCCcCcccccCCCCCcEEEccCccccc----cCChhhhhcccccceeecccCcCccc----CcccccccCCcceEecCCc
Q 041479 235 LIPEDLDSLVNCTYLEVVSLSVNSLSG----TLPNSLANFSSHLRYLYMSANPISGS----IPTEIGNLKNLIIIAIEKF 306 (771)
Q Consensus 235 ~~p~~~~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~n 306 (771)
..+..+..+...++|++|++++|++++ .+...+..+.++|+.|++++|.+++. ++..+..+++|+.|++++|
T Consensus 96 ~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n 175 (319)
T cd00116 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANN 175 (319)
T ss_pred hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCC
Confidence 544444322221447888888887762 22233344423678888888877732 2334556667777777777
Q ss_pred ccee----ccCccccCCCCCCEEEccCCccccc----CCcccccccccccccccCccceecCCccccc-----ccce-ee
Q 041479 307 ILIR----NIPISVGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSIRGSVPSALGS-----CHQL-WL 372 (771)
Q Consensus 307 ~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~l-~L 372 (771)
.+.+ .++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|.+++.....+.. ...| .|
T Consensus 176 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L 255 (319)
T cd00116 176 GIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255 (319)
T ss_pred CCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEE
Confidence 7653 2333445556777777777777532 2334455667777777777776422222211 1334 55
Q ss_pred ecccCcccC----CCCcCCCCCCCCCeEECCCCcccccCCcchhhhhccc-ccccEEECcCCC
Q 041479 373 DLSHNHLTG----PIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYI-SIFAKLNLSYNN 430 (771)
Q Consensus 373 ~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l-~~L~~L~Ls~N~ 430 (771)
++++|.++. .+...+..+++|+++++++|.++..-...++...... +.|+.|++.+|+
T Consensus 256 ~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred EccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 555555541 1122333445566666666666533222222222222 455555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-18 Score=167.51 Aligned_cols=136 Identities=18% Similarity=0.122 Sum_probs=103.4
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccccccccccccc
Q 041479 615 RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYA 694 (771)
Q Consensus 615 ~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~ 694 (771)
..+++.++..++.|++.||+|||+. + ||+||+++.++.+|+ ||+++...... ..||+.||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---------~~g~~~y~ 71 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---------SRVDPYFM 71 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---------CCCccccc
Confidence 3589999999999999999999986 3 999999999999999 99988654321 25899999
Q ss_pred chh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-----chhhhcCc--cccccCcccChh
Q 041479 695 TPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD-----QILQVLDP--LFLVGGVQEGEE 752 (771)
Q Consensus 695 aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~cl~~ 752 (771)
||| |||++|||+||+.||.+.......+..+.....+. .....+.. .+.....+||..
T Consensus 72 aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~ 151 (176)
T smart00750 72 APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR 151 (176)
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence 999 69999999999999976433333333443333322 11122222 455667799999
Q ss_pred chhhcCCHHHHHHHHHHh
Q 041479 753 TAEENIKKGQIRESLIAI 770 (771)
Q Consensus 753 ~p~~Rpt~~~vl~~L~~~ 770 (771)
+|++|||+.++++.+..+
T Consensus 152 ~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 152 LPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccccccCHHHHHHHHHHH
Confidence 999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-20 Score=168.41 Aligned_cols=159 Identities=31% Similarity=0.516 Sum_probs=147.1
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|-||+|+++ ..|+.+..|.+|+.|++++|+|. .+|..++++++|+.|+++-|++. .+|
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~---------------~lp 95 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN---------------ILP 95 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh---------------cCc
Confidence 68899999999999 77889999999999999999999 48999999999999999999987 889
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
..|++++.|+.|||.+|.+.+ ..+|..|..++.|+.|+|++|.+. .+|+.++ .+++|+.|.+
T Consensus 96 rgfgs~p~levldltynnl~e----------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg-~lt~lqil~l 157 (264)
T KOG0617|consen 96 RGFGSFPALEVLDLTYNNLNE----------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-KLTNLQILSL 157 (264)
T ss_pred cccCCCchhhhhhcccccccc----------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-hhcceeEEee
Confidence 999999999999999998873 267888999999999999999999 9999998 9999999999
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE 238 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 238 (771)
..|.+- ..|..++.++.|++|++.+|+++-++|+
T Consensus 158 rdndll-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 158 RDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred ccCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 999998 6899999999999999999999866553
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-19 Score=193.28 Aligned_cols=259 Identities=19% Similarity=0.241 Sum_probs=128.9
Q ss_pred EEEcCCCCCcc-cCCccccCCCCCcEEEcCCCcccc----cCCccccCCCCCCEEecccCcCcccCCcccccCCcccccC
Q 041479 48 LLNLSGQNLTG-TASPYIGNLTFLRLINLQQNNFSS----NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNI 122 (771)
Q Consensus 48 ~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~ 122 (771)
.|+|..+++++ .....|..+++|+.|+++++.++. .++..+...++|++|+++++.+.+ .+. .-..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~-------~~~~~ 73 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPR-------GLQSL 73 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cch-------HHHHH
Confidence 36777777763 344556677778888888887743 245556667777788877776542 011 01123
Q ss_pred CccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCC---CCCCEEecccCcCcc----cCChhhhhCC
Q 041479 123 PSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNI---TSMEYFHVSENQLVG----ELPPHIGFTL 195 (771)
Q Consensus 123 p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l---~~L~~L~Ls~N~l~g----~lp~~~~~~l 195 (771)
+..+..+++|+.|++++|.+.+ ..+..+..+ ++|++|++++|++++ .+...+. .+
T Consensus 74 ~~~l~~~~~L~~L~l~~~~~~~-----------------~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~-~~ 135 (319)
T cd00116 74 LQGLTKGCGLQELDLSDNALGP-----------------DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK-DL 135 (319)
T ss_pred HHHHHhcCceeEEEccCCCCCh-----------------hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHH-hC
Confidence 4455566677777777776652 111122222 336666666666652 1112222 33
Q ss_pred -CCCcEEEeecCcccc----cCCccccCCCCCCEEEccccccCCCCCc-CcccccCCCCCcEEEccCccccccC----Ch
Q 041479 196 -PNVRILLLAGNQFFG----NIPHSISNASKLEWLDFANNSLTGLIPE-DLDSLVNCTYLEVVSLSVNSLSGTL----PN 265 (771)
Q Consensus 196 -~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~l~~L~~L~Ls~N~l~~~~----p~ 265 (771)
++|+.|++++|.+++ .++..+..+++|++|++++|.+++.... ....+..+++|+.|++++|.+++.. +.
T Consensus 136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 215 (319)
T cd00116 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE 215 (319)
T ss_pred CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH
Confidence 566666666666652 1233445555666666666666531100 0111233456666666666654221 12
Q ss_pred hhhhcccccceeecccCcCcccCcccccc-----cCCcceEecCCccce----eccCccccCCCCCCEEEccCCccc
Q 041479 266 SLANFSSHLRYLYMSANPISGSIPTEIGN-----LKNLIIIAIEKFILI----RNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 266 ~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~l~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
.+..+ ++|++|++++|.+++.....+.. .+.|+.|++++|.+. ..+...+..+++|+.+++++|.++
T Consensus 216 ~~~~~-~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 216 TLASL-KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred Hhccc-CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 22222 24666666666555322211111 234444444444443 112223333345555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=163.52 Aligned_cols=136 Identities=16% Similarity=0.177 Sum_probs=104.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-----CCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-----RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
...+|+|.++.||. ++.+... +||++........+++.+|+++++.+ .||||++++|++.+....+ ....+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g-~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG-YVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe-EEEEE
Confidence 45689999999995 7766644 79999766555567899999999999 5799999999998763211 22348
Q ss_pred EEEe--ccCCCCCCCcc--cCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeeeCC----CCceEEecccCc
Q 041479 601 VYEF--MHHGSLESCPR--ILSFLRRLNIAIDVASAL-EYLHHHCKKPIVHCDLKPSNVLLDN----DMTAHMGDFGLT 670 (771)
Q Consensus 601 v~e~--~~~g~L~~~~~--~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivHrdlk~~NILl~~----~~~~kl~DfGla 670 (771)
|+|| +++|+|.++.+ .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||+-+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 55789987732 34443 45677888777 999996 8999999999999974 347999994434
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.8e-17 Score=156.10 Aligned_cols=169 Identities=18% Similarity=0.052 Sum_probs=123.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch----hhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR----GALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.-.++.++||+||.+.. ++..|+.+.+..... -....|.+|+++|++++ |++|.+++++ + ..|+
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-----~~~l 75 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-----GRHL 75 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-----CEEE
Confidence 45678999999997654 454777676643321 11235889999999995 5889999886 1 3589
Q ss_pred EEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL-KPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 601 v~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl-k~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+|||+.|.+|.+.. +. ....++.|++.+++++|++ +|+|||| ||+|||++.++.++|+|||+|.........
T Consensus 76 vmeyI~G~~L~~~~---~~-~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 76 DRSYLAGAAMYQRP---PR-GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred EEeeecCccHHhhh---hh-hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999999986542 11 2346788999999999996 9999999 799999999999999999999854432210
Q ss_pred ----ccc-----ccccccccccccchh-----------------HHHHHHHHHhCCCCC
Q 041479 680 ----NQC-----SSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPT 712 (771)
Q Consensus 680 ----~~~-----~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~ 712 (771)
... ...-...++.|++|+ -|.-+|.++|+..|.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 000 000123678899997 399999999987765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-18 Score=196.53 Aligned_cols=231 Identities=19% Similarity=0.145 Sum_probs=163.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeec---c--c-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFL---H--Q-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~---~--~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
..-+|+|.+|.|+........+.++.|.... . . ......+..|..+-..++|||++..+..+.+.. ..+
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~~~ 397 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----GIL 397 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----cch
Confidence 3446778888777777666665566665431 1 1 122233677888888999999988877765544 233
Q ss_pred EEEEeccCCCCCCCc---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
-+||||++ ||..+. ..+...++..++.|+..|+.|+|+. ||.|||+|++|+++..+|.+||+|||.+....-.
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 44999999 997772 2588889999999999999999996 9999999999999999999999999999866544
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC------CCch
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL------PDQI 734 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~------~~~~ 734 (771)
.........+.+|+-.|+||| -|+++..|.+|+.||.........+.+...... +..+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 443345667889999999999 399999999999998543322221111110000 1112
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+....+..+.++++.||.+|.||.+|++
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 2222222223344889999999999999985
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=169.46 Aligned_cols=238 Identities=22% Similarity=0.182 Sum_probs=165.3
Q ss_pred ccccccccccccceEEEEEecCCC-eEEEEEEeeccchhhHHHHHHHHHHHhccCC----CCceeEEEEee-cCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ-TFIAVKVLFLHQRGALKSFMAECQALRNIRH----RNLVKIITACS-TSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~~-~~~~~~~~ 596 (771)
+.....+|+|.+|.||++....++ ..+|+|............+..|+.++..+.+ +++..+++... ...
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~----- 94 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED----- 94 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc-----
Confidence 445567899999999999987764 6889998865533322378889999998873 68899988874 444
Q ss_pred eEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-----CceEEec
Q 041479 597 FRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-----MTAHMGD 666 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-----~~~kl~D 666 (771)
+.|+||+.+ |.+|.++ .+.++..+..+|+.|+..+|+++|+. |++||||||+|+++... ..+.+.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 679999987 7788765 26788999999999999999999985 99999999999999754 4699999
Q ss_pred ccCccccC--cccCC--ccc-c-cccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHH
Q 041479 667 FGLTRFIP--EVMSS--NQC-S-SVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNF 725 (771)
Q Consensus 667 fGla~~~~--~~~~~--~~~-~-~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 725 (771)
||+|+... ..... ... . .....||..|+++. ++-++.|+..|..||....... ...+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-~~~~~ 249 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-LKSKF 249 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-hHHHH
Confidence 99998332 21111 111 1 23466999999997 6888999999999996543211 12222
Q ss_pred HHhhCCCchh---hhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPDQIL---QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~~~~---~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.......... ......+......+-..+...+|....+...++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111111111 11111222222233346888899888888877653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9e-17 Score=152.71 Aligned_cols=183 Identities=23% Similarity=0.308 Sum_probs=144.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCC-CCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRH-RNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..-.+|+|+||.+|.|..-..++.||||+-..... ..++..|..+.+.++| ..|-.+..|..+.+ +-.+|||
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-----ynvlVMd 91 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKD-----YNVLVMD 91 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccc-----cceeeee
Confidence 34568999999999999999999999998754322 2467789999999975 56666666666665 4589999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEecccCccccCcc
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD---NDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~ 676 (771)
.. |.+|++. .+.++..+++-.+-|+..-++|+|.. +++||||||+|.|.. ...++.++|||+|+.+.+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 88 7788775 67788999999999999999999985 899999999999995 3457999999999877554
Q ss_pred cCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC
Q 041479 677 MSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE 718 (771)
Q Consensus 677 ~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~ 718 (771)
.+.. ........||..|.+-- .|-++...-.|..||.++.+.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3322 22334567999998764 588888888899999886543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9e-16 Score=164.26 Aligned_cols=228 Identities=27% Similarity=0.327 Sum_probs=167.8
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchh---hHHHHHHHHHHHhccCCC-CceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRG---ALKSFMAECQALRNIRHR-NLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|.|.++.||++.+. ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++.+++.... ..++++
T Consensus 6 ~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~ 77 (384)
T COG0515 6 RKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SLYLVM 77 (384)
T ss_pred EeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EEEEEE
Confidence 35678999999999987 58999999655432 467899999999999988 7999999985554 469999
Q ss_pred EeccCCCCCCCcc------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCc
Q 041479 603 EFMHHGSLESCPR------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~~~------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~ 675 (771)
||+.++++.+... .+.......+..|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999975521 578889999999999999999986 799999999999999888 799999999985544
Q ss_pred ccCCcc--cccccccccccccchh------------------HHHHHHHHHhCCCCCCccccC--CccHHHHHHhhCCCc
Q 041479 676 VMSSNQ--CSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTE--GLDLHNFVKMALPDQ 733 (771)
Q Consensus 676 ~~~~~~--~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~--~~~~~~~~~~~~~~~ 733 (771)
...... .......||..|+||| +|++++++++|..|+...... .....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 332111 1234567999999999 489999999999997543221 111222222222110
Q ss_pred hhhhcC--------ccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ILQVLD--------PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ~~~~~~--------~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...... ..+......|+..+|..|.++.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 111111 12223444888889999998887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.6e-16 Score=155.27 Aligned_cols=135 Identities=19% Similarity=0.123 Sum_probs=103.9
Q ss_pred ccccccccceEEEEE-ecCCCeEEEEEEeeccchh------------------------hHHHHHHHHHHHhccCCC--C
Q 041479 527 VSYESLVKATVYKGI-LDLDQTFIAVKVLFLHQRG------------------------ALKSFMAECQALRNIRHR--N 579 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~-~~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~--n 579 (771)
..+|+|.+|.||+|+ ...+++.||||+++..... ....+.+|++++.++.+. .
T Consensus 34 ~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~ 113 (237)
T smart00090 34 GCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVP 113 (237)
T ss_pred CeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458999999999998 5567779999999654210 113467899999999763 3
Q ss_pred ceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCee
Q 041479 580 LVKIITACSTSDFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKP-IVHCDLKPSNVL 655 (771)
Q Consensus 580 Iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrdlk~~NIL 655 (771)
+.+.+++ . ..++||||++++++... .......+...++.|++.+++|||+. + |+|||+||+||+
T Consensus 114 ~p~~~~~---~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl 181 (237)
T smart00090 114 VPKPIAW---R------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL 181 (237)
T ss_pred CCeeeEe---c------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence 3444442 1 23799999999888654 12344555678999999999999986 7 999999999999
Q ss_pred eCCCCceEEecccCccccC
Q 041479 656 LDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 656 l~~~~~~kl~DfGla~~~~ 674 (771)
++ +++++++|||.|....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=151.93 Aligned_cols=180 Identities=18% Similarity=0.256 Sum_probs=144.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.||.++.|+.--.++.||||.-...++ ..++..|.+..+.+. .+.|-..+.|..++- +-.||||.+
T Consensus 34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~-----~NiLVidLL 106 (449)
T KOG1165|consen 34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK-----YNILVIDLL 106 (449)
T ss_pred cccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccc-----hhhhhhhhh
Confidence 357999999999999988899999998755443 246667888877775 688888877755544 457999988
Q ss_pred cCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-----CceEEecccCccccCcc
Q 041479 606 HHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-----MTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 606 ~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-----~~~kl~DfGla~~~~~~ 676 (771)
|.+|+++ .+.++...+.-||.|+..-++|+|+. .+|.|||||+|.||..- ..+.|+|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 7788775 77899999999999999999999985 89999999999999643 35899999999987554
Q ss_pred cCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCcccc
Q 041479 677 MSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT 717 (771)
Q Consensus 677 ~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~ 717 (771)
.+.. ........||.+||+-- +|-++++.+.|..||.+.-+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 3322 22334567999999974 79999999999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=152.87 Aligned_cols=134 Identities=19% Similarity=0.213 Sum_probs=108.2
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+|+|.+|.||+|++ .+..|+||+..... .....++.+|++++..++|++|.....++...+ ..+
T Consensus 3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 75 (211)
T PRK14879 3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NFI 75 (211)
T ss_pred ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CCE
Confidence 479999999999988 34479999864322 112356889999999999999887776665544 458
Q ss_pred EEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 600 LVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 600 lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
+||||++|++|.+......+ ++..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.++..
T Consensus 76 lv~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999999776433333 7789999999999999986 899999999999999 788999999998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.6e-15 Score=172.09 Aligned_cols=123 Identities=31% Similarity=0.515 Sum_probs=89.7
Q ss_pred ccHHHHHHHHhcCCCCCCCCCCCCCCCCCCc-----cceeeeecCCC----CcEEEEEcCCCCCcccCCccccCCCCCcE
Q 041479 2 PDKQALLAFKSKVDDDPFGALSTWNDSVNFC-----QWLGVTCSLKY----QRVILLNLSGQNLTGTASPYIGNLTFLRL 72 (771)
Q Consensus 2 ~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c-----~w~~v~c~~~~----~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~ 72 (771)
.|.+||+++|+.+. ++. ..+|.. ++| .|.||.|.... ..++.|+|++|.++|.+|+.|+.+++|+.
T Consensus 372 ~~~~aL~~~k~~~~-~~~--~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 372 EEVSALQTLKSSLG-LPL--RFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred hHHHHHHHHHHhcC-Ccc--cCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 57899999999984 332 248953 444 79999996321 24888888888888888888888888888
Q ss_pred EEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCc
Q 041479 73 INLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFT 143 (771)
Q Consensus 73 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 143 (771)
|+|++|+|++.+|..|+.+++|+.|+|++|+++ |.+|+.++++++|+.|+|++|+++
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~ls--------------g~iP~~l~~L~~L~~L~Ls~N~l~ 503 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN--------------GSIPESLGQLTSLRILNLNGNSLS 503 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCC--------------CCCchHHhcCCCCCEEECcCCccc
Confidence 888888888888888888888888888888754 344545555555555555554444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=146.23 Aligned_cols=132 Identities=19% Similarity=0.146 Sum_probs=102.9
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch----------------------hhHHHHHHHHHHHhccCCC--Ccee
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR----------------------GALKSFMAECQALRNIRHR--NLVK 582 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--nIv~ 582 (771)
-.+|+|.+|.||++..+ +++.||||++..... .....+.+|+.++.++.|+ .+.+
T Consensus 21 ~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 21 NQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 45899999999999886 566999998764321 0112467899999999887 4444
Q ss_pred EEEEeecCCCCCceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 041479 583 IITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA 662 (771)
Q Consensus 583 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~ 662 (771)
.++. . ..++||||++++++...... .....++.+++.++.++|+. +|+||||||+||+++.++.+
T Consensus 100 ~~~~----~-----~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 100 PIDW----N-----RHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred eeec----C-----CceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcE
Confidence 4432 1 34899999999998765321 34567889999999999985 99999999999999999999
Q ss_pred EEecccCccccC
Q 041479 663 HMGDFGLTRFIP 674 (771)
Q Consensus 663 kl~DfGla~~~~ 674 (771)
+|+|||.+....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.9e-15 Score=146.04 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=105.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch---hhHHH------HHHHHHHHhccCCCCceeEEEEeecCCCCC--
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR---GALKS------FMAECQALRNIRHRNLVKIITACSTSDFQG-- 594 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~------~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~-- 594 (771)
.-.+++|.+|.||.+.. + +..+|||.+..... ...+. +.+|++.+.+++||+|....+++.......
T Consensus 36 ~~~l~~~~f~~v~l~~~-~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-D-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEecCCCceEEEEEec-C-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 34578999999999654 3 44899999965432 22223 689999999999999999999866443211
Q ss_pred -ceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 595 -NYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 595 -~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
....++||||++|.+|.+... ++. ....+++.++..+|+. +++|||+||+||+++.++ ++++|||..+..
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~-~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE-ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT 184 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh-ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence 124689999999999977522 222 3456999999999986 999999999999999888 999999987644
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.5e-15 Score=146.76 Aligned_cols=130 Identities=20% Similarity=0.232 Sum_probs=100.4
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+|+|.+|+||+|.+. +..|++|+..... ....+++.+|++++..++|+++.....++...+ ..++
T Consensus 2 ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~l 74 (199)
T TIGR03724 2 IAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKTI 74 (199)
T ss_pred CCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCEE
Confidence 689999999999864 4579999864321 112367889999999999887554444444433 3589
Q ss_pred EEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||||++|++|.+....- .. .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||+++..
T Consensus 75 v~e~~~g~~l~~~~~~~---~~-~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEG---ND-ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEECCccHHHHHhhc---HH-HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999986542111 11 7899999999999985 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5e-15 Score=160.44 Aligned_cols=190 Identities=27% Similarity=0.348 Sum_probs=139.3
Q ss_pred HhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 041479 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647 (771)
Q Consensus 572 l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 647 (771)
|+.+.|.|+.+++|.+.++. ..+.|.+||+.|+|.+. ...++|.....+..+++.|++|+|+- +.-.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeee
Confidence 45789999999999999885 67999999999999877 34588889999999999999999984 334999
Q ss_pred CCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh----------------------HHHHHHHH
Q 041479 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------------YGILLLEI 705 (771)
Q Consensus 648 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el 705 (771)
.+++.|.++|....+|++|||+............. ....-..-|.||| ||++++|+
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~--~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAH--HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccccccccc--chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999999999999998876431110000 0111234588888 79999999
Q ss_pred HhCCCCCCccccCCc--cHHHHHHh-hCC---Cchhh--hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 706 FTGKRPTSDMFTEGL--DLHNFVKM-ALP---DQILQ--VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 706 ~tg~~P~~~~~~~~~--~~~~~~~~-~~~---~~~~~--~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
++.+.||+....... .+...+.. ..+ +.+.. ...+.+...+..||..+|++||+++.|...++.+
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred HhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999999976433222 23333333 221 11111 1122233445599999999999999998877653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.6e-15 Score=167.72 Aligned_cols=132 Identities=20% Similarity=0.223 Sum_probs=105.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeecc--c------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLH--Q------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
...+|+|.+|+||+|.+.... +++|+.... . ....+++.+|++++++++|++|+....++.... .
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~ 410 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-----E 410 (535)
T ss_pred cceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-----C
Confidence 345799999999999886554 444433211 1 122357899999999999999998877776644 4
Q ss_pred EEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+++++|.++.. ....++.++++++.|||+. +|+|||+||+||++ +++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 589999999999976422 4678899999999999986 99999999999999 5779999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.8e-15 Score=150.51 Aligned_cols=188 Identities=24% Similarity=0.242 Sum_probs=123.9
Q ss_pred CCCCceeEEEEeecCCC----------------------CCceeEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHH
Q 041479 576 RHRNLVKIITACSTSDF----------------------QGNYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVAS 631 (771)
Q Consensus 576 ~H~nIv~l~~~~~~~~~----------------------~~~~~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~ 631 (771)
+|||||++.++|.+.-. ......|+||.-.+. +|.++ .+..+...+.-+..|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 58888888877654311 112356888876643 66665 445666677788899999
Q ss_pred HHHHHHhcCCCCeEecCCCCCCeeeC--CCC--ceEEecccCccccCcccCC--cccccccccccccccchh--------
Q 041479 632 ALEYLHHHCKKPIVHCDLKPSNVLLD--NDM--TAHMGDFGLTRFIPEVMSS--NQCSSVGLKGTVGYATPE-------- 697 (771)
Q Consensus 632 gL~~LH~~~~~~ivHrdlk~~NILl~--~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE-------- 697 (771)
|+.|||.+ +|.|||+|++|||+. +++ .+.|+|||++-.-...+-. .........|.-.-||||
T Consensus 353 av~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 353 AVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999987 999999999999993 333 5789999997532221110 011122334677789999
Q ss_pred -------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHH
Q 041479 698 -------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 698 -------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
-|.+.||+++...||..--..-.+...+....+| ..++.+.+..++.....++.||++||+..-..
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 3999999999999995411111223333333443 23444455555555577899999999977665
Q ss_pred HHHH
Q 041479 765 ESLI 768 (771)
Q Consensus 765 ~~L~ 768 (771)
..|+
T Consensus 509 Nvl~ 512 (598)
T KOG4158|consen 509 NVLN 512 (598)
T ss_pred hHHH
Confidence 5543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=135.42 Aligned_cols=132 Identities=18% Similarity=0.197 Sum_probs=111.2
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCC--CCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRH--RNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.+++|..+.||++.... ..++||....... ..++.+|+.+++.++| +.+.+++++....+ ..+++|||+
T Consensus 5 ~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~-----~~~~v~e~~ 75 (155)
T cd05120 5 LLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG-----WSYLLMEWI 75 (155)
T ss_pred ecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-----ccEEEEEec
Confidence 46889999999999865 4899999855433 5678999999999986 58999988876554 579999999
Q ss_pred cCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 606 HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 606 ~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
+++.+... +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 76 ~g~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99888654 6667788899999999999986555799999999999999989999999998874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-15 Score=172.01 Aligned_cols=228 Identities=17% Similarity=0.191 Sum_probs=157.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHH---HHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSF---MAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+......+|++-|-.|.+|++++| .|+||++.... .-..+.| ++|++ ..-.+|||++++...-.+.. .
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k-----A 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK-----A 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH-----H
Confidence 345566789999999999998866 59999996654 2233333 44455 55568999999876643332 4
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc--
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF-- 672 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~-- 672 (771)
.|||=+|..+ +|.+. ..-+...+..-|+.|+..|+.-+|.. +|+|+|||.+|||+.+-..+.++||..-+.
T Consensus 96 AylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCcc
Confidence 5788888865 77665 22345566778899999999999986 999999999999999999999999987653
Q ss_pred cCcccCCc--ccccccccccccccchh--------------------------HHHHHHHHHh-CCCCCCccccCCccHH
Q 041479 673 IPEVMSSN--QCSSVGLKGTVGYATPE--------------------------YGILLLEIFT-GKRPTSDMFTEGLDLH 723 (771)
Q Consensus 673 ~~~~~~~~--~~~~~~~~gt~~y~aPE--------------------------~Gv~l~el~t-g~~P~~~~~~~~~~~~ 723 (771)
++...... ....+... -.-|.||| .||+++|+++ |++||.-. .+.
T Consensus 172 LPeDNPadf~fFFDTSrR-RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~ 245 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRR-RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLL 245 (1431)
T ss_pred CCCCCcccceEEEecCCc-eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHH
Confidence 22221111 11111111 22499999 4999999999 78888521 122
Q ss_pred HHHHhh-C-C-CchhhhcCccccccCcccChhchhhcCCHHHHHHHH
Q 041479 724 NFVKMA-L-P-DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 724 ~~~~~~-~-~-~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.+..+. . + ....++-|..++.....|++.||++|.++++.++.=
T Consensus 246 aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred hHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 222221 1 1 224455566676666799999999999999999863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-16 Score=168.22 Aligned_cols=215 Identities=31% Similarity=0.470 Sum_probs=155.6
Q ss_pred EecccCcCcccCChhhh-hCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEc
Q 041479 176 FHVSENQLVGELPPHIG-FTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254 (771)
Q Consensus 176 L~Ls~N~l~g~lp~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~L 254 (771)
|.|++-++. .+|-..+ ..+..-...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|+.+ .++..|.+|||
T Consensus 55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i---~~L~~lt~l~l 128 (722)
T KOG0532|consen 55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAI---CNLEALTFLDL 128 (722)
T ss_pred cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhh---hhhhHHHHhhh
Confidence 344444444 4443222 23445566677777776 56777777777777777777776 345555 56677777777
Q ss_pred cCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccc
Q 041479 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISR 334 (771)
Q Consensus 255 s~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 334 (771)
+.|+++ .+|..+..++ |+.|.+++|+++ .+|..+ +.+..|..||.+.|++.
T Consensus 129 s~NqlS-~lp~~lC~lp--Lkvli~sNNkl~-~lp~~i------------------------g~~~tl~~ld~s~nei~- 179 (722)
T KOG0532|consen 129 SSNQLS-HLPDGLCDLP--LKVLIVSNNKLT-SLPEEI------------------------GLLPTLAHLDVSKNEIQ- 179 (722)
T ss_pred ccchhh-cCChhhhcCc--ceeEEEecCccc-cCCccc------------------------ccchhHHHhhhhhhhhh-
Confidence 777777 7777777764 788888888877 455444 44456667777777776
Q ss_pred cCCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhh
Q 041479 335 EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWI 414 (771)
Q Consensus 335 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~ 414 (771)
.+|..++++.+|+.|++..|++. .+|..+..++...||+|+|+++ .+|..|..|+.|++|-|.+|.|+ ..|..++ .
T Consensus 180 slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC-~ 255 (722)
T KOG0532|consen 180 SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC-E 255 (722)
T ss_pred hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH-h
Confidence 67888999999999999999998 5667777777779999999998 78999999999999999999998 7777665 2
Q ss_pred hcccccccEEECcCC
Q 041479 415 FGYISIFAKLNLSYN 429 (771)
Q Consensus 415 ~~~l~~L~~L~Ls~N 429 (771)
-+...-.++|+..-.
T Consensus 256 kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 256 KGKVHIFKYLSTQAC 270 (722)
T ss_pred ccceeeeeeecchhc
Confidence 344555667776655
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.7e-14 Score=148.87 Aligned_cols=130 Identities=25% Similarity=0.355 Sum_probs=108.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-----C---CCceeEEEEeecCCCCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-----H---RNLVKIITACSTSDFQG 594 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~~~~~~ 594 (771)
+...-.||=|-|+|||.|.+..+.+.||+|+.+.. ....+..+.||+++++++ | ..||+|+++|...+..+
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 34455688899999999999999999999998643 345688899999999984 2 47999999998776554
Q ss_pred ceeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 041479 595 NYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~ 657 (771)
. +.|||+||+ |-+|-.+ .+.++...+.+|+.||+.||.|||..| +|||-||||+|||+.
T Consensus 159 ~-HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 159 Q-HVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred c-EEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 3 689999999 4455333 456888899999999999999999986 999999999999994
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-15 Score=164.21 Aligned_cols=170 Identities=26% Similarity=0.238 Sum_probs=135.2
Q ss_pred ccccccceEEE---EEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEE
Q 041479 529 YESLVKATVYK---GILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 529 l~~~~~~~Vy~---~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+|+|.+|.|+. +.-.+.++.||+|+.+.... +.......|-.++..++ ||.+|++..++.+.. ..++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~-----kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG-----KLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc-----chhHhh
Confidence 57788887653 33344567899998864421 11225667888899997 999999998877666 679999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+|..+|++... ...+.+.....+..+++-|++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-+...
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999999766 23455666677778899999999985 999999999999999999999999999986543221
Q ss_pred cccccccccccccccchh-------------HHHHHHHHHhCCCCCCc
Q 041479 680 NQCSSVGLKGTVGYATPE-------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE-------------~Gv~l~el~tg~~P~~~ 714 (771)
.|||.-||||| ||++.+||+||-.||..
T Consensus 153 -------~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------cccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17999999999 79999999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.3e-14 Score=137.19 Aligned_cols=134 Identities=20% Similarity=0.171 Sum_probs=95.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccchh--hHHH----------------------HHHHHHHHhccCCCC--ce
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQRG--ALKS----------------------FMAECQALRNIRHRN--LV 581 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--Iv 581 (771)
.+|+|.+|+||+|+.. +++.||||++...... .... ...|.+.+.++++.. +.
T Consensus 4 ~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 4 PIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred ccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 4799999999999987 5669999998653211 1111 135666666665432 44
Q ss_pred eEEEEeecCCCCCceeEEEEEEeccCCCCCCC-cccCCH-HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 041479 582 KIITACSTSDFQGNYFRALVYEFMHHGSLESC-PRILSF-LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659 (771)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-~~~l~~-~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~ 659 (771)
+.+++. ..++||||++++.+... ...... .+...++.+++.++.++|+. .+|+|||+||+||+++ +
T Consensus 83 ~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 83 KPIDLN---------RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-D 150 (187)
T ss_pred ceEecC---------CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-C
Confidence 444431 24899999999654321 111111 56788999999999999982 3899999999999999 8
Q ss_pred CceEEecccCccccC
Q 041479 660 MTAHMGDFGLTRFIP 674 (771)
Q Consensus 660 ~~~kl~DfGla~~~~ 674 (771)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.7e-13 Score=137.75 Aligned_cols=136 Identities=17% Similarity=0.080 Sum_probs=101.2
Q ss_pred cccc-ccccceEEEEEecCCCeEEEEEEeeccc-------------hhhHHHHHHHHHHHhccCCCCc--eeEEEEeecC
Q 041479 527 VSYE-SLVKATVYKGILDLDQTFIAVKVLFLHQ-------------RGALKSFMAECQALRNIRHRNL--VKIITACSTS 590 (771)
Q Consensus 527 ~~l~-~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~ 590 (771)
..+| .|+.|+||+.... +..+|||.+.... .....++.+|++++.+++|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3465 7889999998775 4489999885421 1223578899999999998775 6777765433
Q ss_pred CCCCceeEEEEEEeccC-CCCCCCcc--cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecc
Q 041479 591 DFQGNYFRALVYEFMHH-GSLESCPR--ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667 (771)
Q Consensus 591 ~~~~~~~~~lv~e~~~~-g~L~~~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 667 (771)
.. ..+..++||||+++ .+|.++.. .++. ..+.+++.++.+||+. ||+|||+||+|||++.++.++++||
T Consensus 115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~~~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 115 HG-LFYRADILIERIEGARDLVALLQEAPLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cC-cceeeeEEEEecCCCCCHHHHHhcCCCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence 21 11234699999997 57765522 2332 2367899999999986 9999999999999998889999999
Q ss_pred cCccc
Q 041479 668 GLTRF 672 (771)
Q Consensus 668 Gla~~ 672 (771)
|.++.
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.3e-13 Score=136.91 Aligned_cols=182 Identities=24% Similarity=0.279 Sum_probs=117.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCC----------CCceeEEEEeec
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRH----------RNLVKIITACST 589 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~~ 589 (771)
......+|.|.++.||.+++.++++.+|||+..... ....+++.+|.-....+.+ -.++--++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445566899999999999999999999999996543 3346777777755555432 122222222211
Q ss_pred CC---------CCCce---eEEEEEEeccCCCCCCCc----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 041479 590 SD---------FQGNY---FRALVYEFMHHGSLESCP----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647 (771)
Q Consensus 590 ~~---------~~~~~---~~~lv~e~~~~g~L~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 647 (771)
.. ....+ -.+++|+-+ .+||.++. ..+....+..+..|+.+.++++|+. ||+|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 10 01111 236778877 45776551 1233455677779999999999996 99999
Q ss_pred CCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh-----------------------HHHHHHH
Q 041479 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------------YGILLLE 704 (771)
Q Consensus 648 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------------~Gv~l~e 704 (771)
||||+|++++.+|.++++||+.....+.... + ...+..|.+|| +|+++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee---c----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999997765443221 1 12356788887 6999999
Q ss_pred HHhCCCCCCcc
Q 041479 705 IFTGKRPTSDM 715 (771)
Q Consensus 705 l~tg~~P~~~~ 715 (771)
+..|+.||...
T Consensus 243 lWC~~lPf~~~ 253 (288)
T PF14531_consen 243 LWCGRLPFGLS 253 (288)
T ss_dssp HHHSS-STCCC
T ss_pred HHHccCCCCCC
Confidence 99999999754
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.5e-14 Score=153.33 Aligned_cols=200 Identities=33% Similarity=0.469 Sum_probs=121.9
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCC-CCCEEecccccCcCCCCccc
Q 041479 72 LINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLL-KFKGLGLANNYFTGPIPHLN 150 (771)
Q Consensus 72 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~lp~L~ 150 (771)
.++++.|.+.. .+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++.
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~---------------~i~~~~~~~~~nL~~L~l~~N~i~------- 153 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT---------------DIPPLIGLLKSNLKELDLSDNKIE------- 153 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc---------------cCccccccchhhcccccccccchh-------
Confidence 56777776642 3444555667777777777765 4555555553 6777777777666
Q ss_pred eeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcccc
Q 041479 151 MFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN 230 (771)
Q Consensus 151 ~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 230 (771)
.+|..+..+++|+.|++++|+++ .+|.... .+++|+.|++++|+++ .+|........|++|++++|
T Consensus 154 -----------~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 154 -----------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219 (394)
T ss_pred -----------hhhhhhhccccccccccCCchhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence 34445666667777777777776 6666543 5566777777777776 45554445555777777777
Q ss_pred ccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcccee
Q 041479 231 SLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310 (771)
Q Consensus 231 ~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 310 (771)
++... +.. +.++.++..+.+.+|++. .++..+..+. ++++|++++|.++. ++. ++.+.+++.|++++|.+..
T Consensus 220 ~~~~~-~~~---~~~~~~l~~l~l~~n~~~-~~~~~~~~l~-~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 220 SIIEL-LSS---LSNLKNLSGLELSNNKLE-DLPESIGNLS-NLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred cceec-chh---hhhcccccccccCCceee-eccchhcccc-ccceeccccccccc-ccc-ccccCccCEEeccCccccc
Confidence 43222 222 255566666666777665 4455555554 47777777777763 333 6667777777777776665
Q ss_pred ccCccc
Q 041479 311 NIPISV 316 (771)
Q Consensus 311 ~~p~~~ 316 (771)
.+|...
T Consensus 292 ~~~~~~ 297 (394)
T COG4886 292 ALPLIA 297 (394)
T ss_pred cchhhh
Confidence 554433
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-14 Score=153.56 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=156.1
Q ss_pred EEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEec
Q 041479 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAI 303 (771)
Q Consensus 224 ~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 303 (771)
.|.|++-+++..+-.++ . ..++--...||+.|++. .+|..+..+. .|+.|.|..|.|. .+|..++++..|+++++
T Consensus 54 ~l~Ls~rrlk~fpr~a~-~-~~ltdt~~aDlsrNR~~-elp~~~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~lt~l~l 128 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAA-S-YDLTDTVFADLSRNRFS-ELPEEACAFV-SLESLILYHNCIR-TIPEAICNLEALTFLDL 128 (722)
T ss_pred ccccccchhhcCCCccc-c-ccccchhhhhccccccc-cCchHHHHHH-HHHHHHHHhccce-ecchhhhhhhHHHHhhh
Confidence 34455555553322222 1 44555566788888887 7787777665 5888888888888 78888888888888888
Q ss_pred CCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCC
Q 041479 304 EKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGP 382 (771)
Q Consensus 304 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~ 382 (771)
+.|.+ ..+|..+..++ |+.|-+++|+++ .+|+.++.+..|..||.+.|.|. .+|..++.+..+ .|++..|++..
T Consensus 129 s~Nql-S~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~- 203 (722)
T KOG0532|consen 129 SSNQL-SHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED- 203 (722)
T ss_pred ccchh-hcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-
Confidence 88887 34566666554 899999999998 78999999999999999999999 688888888888 89999999995
Q ss_pred CCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccc
Q 041479 383 IPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 383 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
+|.....+ .|..||+|+|+++ .+|-.|. .|+.|++|-|.+|+|+ .+|..+
T Consensus 204 lp~El~~L-pLi~lDfScNkis-~iPv~fr----~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 204 LPEELCSL-PLIRLDFSCNKIS-YLPVDFR----KMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred CCHHHhCC-ceeeeecccCcee-ecchhhh----hhhhheeeeeccCCCC-CChHHH
Confidence 45555544 5899999999999 8898776 9999999999999998 556544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.8e-13 Score=151.16 Aligned_cols=186 Identities=35% Similarity=0.501 Sum_probs=137.4
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCC-CCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLP-NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN 245 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 245 (771)
+..++.++.|++.+|.++ .+|+... .+. +|+.|++++|++. .+|..+..+++|+.|++++|+++.+.+. . ..
T Consensus 112 ~~~~~~l~~L~l~~n~i~-~i~~~~~-~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~-~---~~ 184 (394)
T COG4886 112 LLELTNLTSLDLDNNNIT-DIPPLIG-LLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKL-L---SN 184 (394)
T ss_pred hhcccceeEEecCCcccc-cCccccc-cchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhhh-h---hh
Confidence 444567778888888887 7777665 553 7888888888887 4556677888888888888888765432 1 26
Q ss_pred CCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEE
Q 041479 246 CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVL 325 (771)
Q Consensus 246 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L 325 (771)
++.|+.|++++|+++ .+|...... .+|++|++++|++. ..+..+..+.++..+.+.+|.+.. ++..++.+++++.|
T Consensus 185 ~~~L~~L~ls~N~i~-~l~~~~~~~-~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L 260 (394)
T COG4886 185 LSNLNNLDLSGNKIS-DLPPEIELL-SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETL 260 (394)
T ss_pred hhhhhheeccCCccc-cCchhhhhh-hhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhcccccccee
Confidence 678888888888888 777754333 35888888888654 466777888888888877777643 36677788888999
Q ss_pred EccCCcccccCCcccccccccccccccCccceecCCcccc
Q 041479 326 SLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALG 365 (771)
Q Consensus 326 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 365 (771)
++++|.++. ++. +..+.+|+.|++++|.+...+|....
T Consensus 261 ~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 261 DLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ccccccccc-ccc-ccccCccCEEeccCccccccchhhhc
Confidence 999999874 443 88888899999999988866665443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.6e-13 Score=154.70 Aligned_cols=116 Identities=33% Similarity=0.520 Sum_probs=86.9
Q ss_pred cccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEE
Q 041479 346 LTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKL 424 (771)
Q Consensus 346 L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L 424 (771)
++.|+|++|.+++.+|..++.++.| .|+|++|++++.+|..++.+++|+.|+|++|+++|.+|+.+. .+++|+.|
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~----~L~~L~~L 495 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG----QLTSLRIL 495 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh----cCCCCCEE
Confidence 6677777777777777777777777 778888888777887788888888888888888888887655 77788888
Q ss_pred ECcCCCCCCCCCccccc--cccccccccCCCcccCCCCCCCCCCCC
Q 041479 425 NLSYNNLDGDVPRKMIF--KNASAISEAGNEKLCGGISELKLPPCT 468 (771)
Q Consensus 425 ~Ls~N~l~~~~p~~~~~--~~~~~~~~~~n~~lc~~~~~~~~~~~~ 468 (771)
+|++|+++|.+|..+.. .+...+.+.+|+.+|+.+. .++|.
T Consensus 496 ~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~ 538 (623)
T PLN03150 496 NLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG 538 (623)
T ss_pred ECcCCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence 88888888888865431 2344567889999998532 45674
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.8e-12 Score=139.79 Aligned_cols=141 Identities=20% Similarity=0.160 Sum_probs=98.3
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhh----------------------------------------HHHH
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGA----------------------------------------LKSF 565 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~----------------------------------------~~~~ 565 (771)
..++|+++.|.||+|+++++ +.||||+.+.+.... .-+|
T Consensus 122 ~~plasaSigQVh~A~l~~G-~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDG-KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEecCC-CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35789999999999999865 599999986542100 0146
Q ss_pred HHHHHHHhccC----CCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCCcc--cCCHHHHHHHHHHHHH-HHHHHHh
Q 041479 566 MAECQALRNIR----HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPR--ILSFLRRLNIAIDVAS-ALEYLHH 638 (771)
Q Consensus 566 ~~E~~~l~~l~----H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~--~l~~~~~~~i~~~ia~-gL~~LH~ 638 (771)
.+|++.+.+++ |.+-|.+-.++.+... ..++||||++|+++.+... .... .+..++..++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHh
Confidence 66777777763 3333444333332111 3589999999999977521 1111 24456666665 4677787
Q ss_pred cCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 639 ~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
. |++|+|+||.||+++.+++++++|||++..+++
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-12 Score=149.24 Aligned_cols=161 Identities=19% Similarity=0.180 Sum_probs=111.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC---CCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR---HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|++|+||+|...+ ++.||+|+=+.... =+|.--.+++.+++ -+-|..+..++...+ .-+
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-----~S~ 770 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQN-----ASV 770 (974)
T ss_pred EEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCC-----cce
Confidence 3345678999999999999988 67999998754431 01111223344444 122333333333222 347
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-------CCCceEEecccC
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-------NDMTAHMGDFGL 669 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-------~~~~~kl~DfGl 669 (771)
+|+||.+.|+|.++ .+.++|.-+..++.|++.-+++||.+ +|||+||||+|.||. ....++|+|||.
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 99999999999877 56788999999999999999999986 999999999999993 234699999999
Q ss_pred ccccCcccCCcccccccccccccccchh
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE 697 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE 697 (771)
+-.+..-.. ...-.+.++|-.+-.+|
T Consensus 848 siDm~lfp~--~~~F~~~~~td~f~C~E 873 (974)
T KOG1166|consen 848 SIDMKLFPD--GTKFKAVWHTDLFDCIE 873 (974)
T ss_pred ceeeeEcCC--CcEEeeeeccccchhHH
Confidence 875532211 12223455677776664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-13 Score=151.81 Aligned_cols=230 Identities=20% Similarity=0.156 Sum_probs=166.2
Q ss_pred cccccccccceEEEEEec-CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILD-LDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
..++|+|.++.|-..... +....+|+|.+.... ....+....|..+-..+. |+|++++++.....+ ..+++
T Consensus 25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-----~~~~~ 99 (601)
T KOG0590|consen 25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-----SYLLS 99 (601)
T ss_pred cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-----ccccc
Confidence 345788888887766553 334567777775443 334455566888888887 999999999987776 67999
Q ss_pred EEeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCc
Q 041479 602 YEFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPE 675 (771)
Q Consensus 602 ~e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~ 675 (771)
+||..+|++.... ...+......+..|+..|+.|+|.. .++.|||+||+|.+++..+ ..|++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999987653 1345567788999999999999932 4899999999999999999 999999999987655
Q ss_pred -ccCCcccccccccc-cccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchh
Q 041479 676 -VMSSNQCSSVGLKG-TVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQIL 735 (771)
Q Consensus 676 -~~~~~~~~~~~~~g-t~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~ 735 (771)
... .......+| ++.|+||| .|+++.-+++|..||+...........|...... ....
T Consensus 178 ~~g~--~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 178 KNGA--ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cCCc--ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 332 223334567 99999999 3999999999999997654444334444433211 2222
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
..++........+++..+|+.|.+.+++-
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccCChhhhhcccccccCCchhcccccccc
Confidence 33333333344477889999999988764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.2e-13 Score=140.87 Aligned_cols=156 Identities=24% Similarity=0.298 Sum_probs=111.3
Q ss_pred eEEEEEEeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 597 FRALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
+.||.|++|...+|.++ ....++.....++.|++.|++| . +.+|||+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999887 2346677889999999999999 2 8999999999999999999999999998
Q ss_pred cccCcccCC--cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCC
Q 041479 671 RFIPEVMSS--NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 671 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
..+....+. .....+.-+||..||+|| +|++++|+++ -..+++- ...+.++..+.+|+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPP 479 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCCh
Confidence 765543311 112234557999999999 6999999998 3333322 12244445555553
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQI 763 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~v 763 (771)
....-.... .....+++.+.|.+||++.++
T Consensus 480 ~~~~d~p~e-~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 480 EFLQDYPEE-YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHhhcCcHH-HHHHHHhcCCCcccCchHHHH
Confidence 322221111 123347889999999955544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.8e-11 Score=114.51 Aligned_cols=129 Identities=17% Similarity=0.106 Sum_probs=94.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCcee-EEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVK-IITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..++.|..+.||+++.. ++.|++|....... ....+.+|+.+++.+.+.++++ ++++..+ ..++||||+
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~e~i 73 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLITEFI 73 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEEEec
Confidence 34678889999999865 55899999754422 2345678999999987655554 4443221 237999999
Q ss_pred cCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 606 HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHC--KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 606 ~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
+|.++... ......+..+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 74 ~G~~l~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99888653 1112345678999999999862 22369999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.6e-12 Score=128.09 Aligned_cols=189 Identities=19% Similarity=0.219 Sum_probs=121.5
Q ss_pred HHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 041479 571 ALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKP 643 (771)
Q Consensus 571 ~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ 643 (771)
.+-++-|.|||+++.|+.+..+.+.....++.|||+.|++.++ ...+......+++.||..||.|||+ |.|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 4455679999999999987765555677899999999999877 3346666778899999999999998 5799
Q ss_pred eEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhC
Q 041479 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTG 708 (771)
Q Consensus 644 ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg 708 (771)
|+|+++..+-|.+..+|-+|+.--.-...-...............|-++|.||| ||+...||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999888887522111100000110111111234678899999 57777777666
Q ss_pred CCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 709 KRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 709 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.-.....+ .. ..+..............+ +....+|++..|..||+|++++.
T Consensus 279 Eiq~tnseS-~~-~~ee~ia~~i~~len~lq---r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSES-KV-EVEENIANVIIGLENGLQ---RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcc-ee-ehhhhhhhheeeccCccc---cCcCcccccCCCCCCcchhhhhc
Confidence 543211100 00 001000001111111111 23345999999999999999864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=129.58 Aligned_cols=139 Identities=17% Similarity=0.094 Sum_probs=92.1
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchh----------------------------------hH------HHHH
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRG----------------------------------AL------KSFM 566 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~----------------------------------~~------~~~~ 566 (771)
.++|+++.|.||+|+++++|+.||||+.+.+... .. -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 5799999999999999987789999999754210 00 1356
Q ss_pred HHHHHHhccC----CCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCCc----ccCCHHHHHHHHHHHHHH-HHHHH
Q 041479 567 AECQALRNIR----HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCP----RILSFLRRLNIAIDVASA-LEYLH 637 (771)
Q Consensus 567 ~E~~~l~~l~----H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~----~~l~~~~~~~i~~~ia~g-L~~LH 637 (771)
+|+..+.+++ +...|.+-.++.+-.. ..++||||++|+.+.+.. ...+ +..++...+.. +.-++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 6776666663 4444554444433111 358999999999986541 1111 11222222111 12223
Q ss_pred hcCCCCeEecCCCCCCeeeCCCC----ceEEecccCccccCc
Q 041479 638 HHCKKPIVHCDLKPSNVLLDNDM----TAHMGDFGLTRFIPE 675 (771)
Q Consensus 638 ~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~~~~~ 675 (771)
. .|++|+|+||.||+++.++ ++++.|||++..+++
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 3899999999999999887 999999999987654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.6e-12 Score=130.35 Aligned_cols=206 Identities=20% Similarity=0.288 Sum_probs=112.4
Q ss_pred CcEEEEEcCCCCCcccCC--ccccCCCCCcEEEcCCCccccc--CCccccCCCCCCEEecccCcCcccCCcccccCCccc
Q 041479 44 QRVILLNLSGQNLTGTAS--PYIGNLTFLRLINLQQNNFSSN--IPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLE 119 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~ 119 (771)
++++.+.|.+..+. ..+ .....|++++.||||+|-|+.- +-.-...|++|+.|+|+.|++.-..
T Consensus 121 kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~----------- 188 (505)
T KOG3207|consen 121 KKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFI----------- 188 (505)
T ss_pred HhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCc-----------
Confidence 44555555555554 222 2444566666666666655531 2223445566666666666643100
Q ss_pred ccCCccccCCCCCCEEecccccCcCCCCccceeeeccccccc-ccCccccCCCCCCEEecccCcCcc--cCChhhhhCCC
Q 041479 120 GNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTG-SIPIQLLNITSMEYFHVSENQLVG--ELPPHIGFTLP 196 (771)
Q Consensus 120 ~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g--~lp~~~~~~l~ 196 (771)
.+..++.+++|+.|.++.|.++. .+-..+..+++|+.|+|+.|...+ ..+.. .+.
T Consensus 189 -------------------~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~---i~~ 246 (505)
T KOG3207|consen 189 -------------------SSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTK---ILQ 246 (505)
T ss_pred -------------------cccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhh---hhh
Confidence 00011233445555555555542 122234567778888888774221 22222 346
Q ss_pred CCcEEEeecCcccccCC--ccccCCCCCCEEEccccccCCCC-CcC--cccccCCCCCcEEEccCccccccCC--hhhhh
Q 041479 197 NVRILLLAGNQFFGNIP--HSISNASKLEWLDFANNSLTGLI-PED--LDSLVNCTYLEVVSLSVNSLSGTLP--NSLAN 269 (771)
Q Consensus 197 ~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~-p~~--~~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~ 269 (771)
.|+.|||++|++.. .+ ...+.++.|+.|+++.+.|+.+. |+. .+....+++|++|+++.|++. ..+ ..+..
T Consensus 247 ~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~ 324 (505)
T KOG3207|consen 247 TLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRT 324 (505)
T ss_pred HHhhccccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhc
Confidence 67888888887763 33 34567777888888888777542 211 122345678888888888885 332 12333
Q ss_pred cccccceeecccCcCcc
Q 041479 270 FSSHLRYLYMSANPISG 286 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~~ 286 (771)
+ .+|+.|.+..|.|+.
T Consensus 325 l-~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 325 L-ENLKHLRITLNYLNK 340 (505)
T ss_pred c-chhhhhhcccccccc
Confidence 3 368888888888873
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-11 Score=115.99 Aligned_cols=63 Identities=21% Similarity=0.355 Sum_probs=16.3
Q ss_pred CCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccccccC
Q 041479 170 ITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIP-HSISNASKLEWLDFANNSLT 233 (771)
Q Consensus 170 l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 233 (771)
++.|++|++++|.|+ .+++.+...+|+|+.|+|++|+|..... ..+..+++|+.|+|.+|.++
T Consensus 63 L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 63 LPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred hhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 344444444444444 3433222234444444444444432111 22333444444444444443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-11 Score=138.94 Aligned_cols=192 Identities=23% Similarity=0.219 Sum_probs=116.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+........|++|.||..+++.+.+.+|+|+-+ .. -+.+- ++.....|.+| =
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv--------------------g 136 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV--------------------G 136 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee--------------------c
Confidence 334445678899999999999999999995432 11 01110 22222333333 1
Q ss_pred EeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC---
Q 041479 603 EFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS--- 679 (771)
Q Consensus 603 e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--- 679 (771)
+ ..++......++. +.+.+++|+|+- +|+|||+||+|.+|..-|++|++|||+++.--.....
T Consensus 137 D---c~tllk~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 D---CATLLKNIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred h---hhhhcccCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 1 1122111222322 237899999985 9999999999999999999999999998742111100
Q ss_pred --------cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCch
Q 041479 680 --------NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQI 734 (771)
Q Consensus 680 --------~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~ 734 (771)
......+++||+.|+||| +|+++||.+-|..||.+-..++. +-+++.-. +++.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i~wpE~- 280 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEWPEE- 280 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhhcccccc-
Confidence 011123578999999999 59999999999999975422211 22222111 1222
Q ss_pred hhhcCccccccCcccChhchhhcC
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENI 758 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rp 758 (771)
.+...++.+..+.+.++.+|..|-
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 333333333344466677777774
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.6e-12 Score=138.04 Aligned_cols=196 Identities=25% Similarity=0.339 Sum_probs=119.7
Q ss_pred CCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCc
Q 041479 128 SLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQ 207 (771)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~ 207 (771)
.+..++.+++..|.++ .+-..+..+++|+.|++.+|+|. .+...+. .+++|++|++++|+
T Consensus 70 ~l~~l~~l~l~~n~i~------------------~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~-~~~~L~~L~ls~N~ 129 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA------------------KILNHLSKLKSLEALDLYDNKIE-KIENLLS-SLVNLQVLDLSFNK 129 (414)
T ss_pred HhHhHHhhccchhhhh------------------hhhcccccccceeeeeccccchh-hcccchh-hhhcchheeccccc
Confidence 4455566667777665 12233667788889999999988 5554333 67889999999999
Q ss_pred ccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChh-hhhcccccceeecccCcCcc
Q 041479 208 FFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNS-LANFSSHLRYLYMSANPISG 286 (771)
Q Consensus 208 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~~L~~L~Ls~N~l~~ 286 (771)
|+.+. .+..++.|+.|++++|.|+.+ ..+..++.|+.+++++|.+. .+... ...+. +++.+++++|.+..
T Consensus 130 I~~i~--~l~~l~~L~~L~l~~N~i~~~-----~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~-~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 130 ITKLE--GLSTLTLLKELNLSGNLISDI-----SGLESLKSLKLLDLSYNRIV-DIENDELSELI-SLEELDLGGNSIRE 200 (414)
T ss_pred ccccc--chhhccchhhheeccCcchhc-----cCCccchhhhcccCCcchhh-hhhhhhhhhcc-chHHHhccCCchhc
Confidence 88654 356677788899999988754 33355788888888888887 33331 24444 68888888888863
Q ss_pred cCcccccccCCcceEecCCccceeccCccccCCC--CCCEEEccCCcccccCCcccccccccccccccCccce
Q 041479 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLL--KLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 287 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
...+..+..+..+++..|.+...-+. ..+. .|+.+++++|.+. ..+..+..+..+..|++.+|++.
T Consensus 201 --i~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 201 --IEGLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred --ccchHHHHHHHHhhcccccceeccCc--ccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 23334444444445555555332211 1111 2455555555554 22234444455555555555554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.7e-12 Score=130.32 Aligned_cols=162 Identities=27% Similarity=0.317 Sum_probs=85.2
Q ss_pred cCCCCCCEEecccCcCcccCCh-hhhhCCCCCcEEEeecCcccccCC--ccccCCCCCCEEEccccccCCCCCcCccccc
Q 041479 168 LNITSMEYFHVSENQLVGELPP-HIGFTLPNVRILLLAGNQFFGNIP--HSISNASKLEWLDFANNSLTGLIPEDLDSLV 244 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~-~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (771)
.++.+|+...|.+.... ..+. .....+++++.|||++|-|....| .....|++|+.|+|+.|++......... .
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~--~ 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT--L 194 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch--h
Confidence 45667777777777665 3332 223367777777777777764332 2245667777777777777633222111 2
Q ss_pred CCCCCcEEEccCcccccc-CChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCC
Q 041479 245 NCTYLEVVSLSVNSLSGT-LPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQ 323 (771)
Q Consensus 245 ~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 323 (771)
.++.|+.|.|+.|.|+.. +-..+..++ +|+.|+|..|...... ..+...+..|+
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fP-sl~~L~L~~N~~~~~~------------------------~~~~~i~~~L~ 249 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFP-SLEVLYLEANEIILIK------------------------ATSTKILQTLQ 249 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCC-cHHHhhhhccccccee------------------------cchhhhhhHHh
Confidence 345556666666655521 111122222 4555555555422122 22233344556
Q ss_pred EEEccCCcccccCC--cccccccccccccccCcccee
Q 041479 324 VLSLFENNISREIP--SSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 324 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
+|||++|++- ..+ ...+.++.|..|+++.+.|..
T Consensus 250 ~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~s 285 (505)
T KOG3207|consen 250 ELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIAS 285 (505)
T ss_pred hccccCCccc-ccccccccccccchhhhhccccCcch
Confidence 6666666554 222 244556666666666666653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=106.38 Aligned_cols=133 Identities=18% Similarity=0.107 Sum_probs=94.6
Q ss_pred ccccccccceEEEEEecC------CCeEEEEEEeeccc------------h----------hhHHHH----HHHHHHHhc
Q 041479 527 VSYESLVKATVYKGILDL------DQTFIAVKVLFLHQ------------R----------GALKSF----MAECQALRN 574 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~------~~~~vAvK~~~~~~------------~----------~~~~~~----~~E~~~l~~ 574 (771)
+.+++|..|.||.|...+ .+..+|||+.+... . ...+.+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 457889999999998654 24599999995321 0 012222 389999999
Q ss_pred cC--CCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC-c--ccCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 041479 575 IR--HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC-P--RILSFLRRLNIAIDVASALEYL-HHHCKKPIVHCD 648 (771)
Q Consensus 575 l~--H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-~--~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrd 648 (771)
+. .-++-+.+++ .. -++||||+.++.+... . ..++..+...+..+++.++..+ |.. +|||+|
T Consensus 83 l~~~Gv~vP~pi~~--~~-------~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL--KK-------HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe--cC-------CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 85 3466666654 22 3799999976544211 1 1234445667788999999999 553 999999
Q ss_pred CCCCCeeeCCCCceEEecccCccc
Q 041479 649 LKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 649 lk~~NILl~~~~~~kl~DfGla~~ 672 (771)
+++.||+++ ++.+.++|||-|..
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCcee
Confidence 999999997 46899999997753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-11 Score=136.78 Aligned_cols=247 Identities=26% Similarity=0.306 Sum_probs=143.3
Q ss_pred cCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCC
Q 041479 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 247 (771)
..+..++.+++..|.+. .+-..+. .+.+|+.|++..|+|..+. ..+..+++|++|++++|+|+.+. ++..++
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~-~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~-----~l~~l~ 140 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLS-KLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLE-----GLSTLT 140 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccc-cccceeeeeccccchhhcc-cchhhhhcchheecccccccccc-----chhhcc
Confidence 34566777778888887 4333343 6778888888888888433 33677888888888888887653 336667
Q ss_pred CCcEEEccCccccccCChhhhhcccccceeecccCcCcccCccc-ccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 248 YLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTE-IGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 248 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
.|+.|++++|.|+ .+.. +..+. +|+.+++++|++...-+ . ...+.+++.+++.+|.+... ..+..+..+..++
T Consensus 141 ~L~~L~l~~N~i~-~~~~-~~~l~-~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~ 214 (414)
T KOG0531|consen 141 LLKELNLSGNLIS-DISG-LESLK-SLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIREI--EGLDLLKKLVLLS 214 (414)
T ss_pred chhhheeccCcch-hccC-Cccch-hhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhcc--cchHHHHHHHHhh
Confidence 7888888888887 4332 33333 68888888888874433 2 46666777777777766432 2333444555556
Q ss_pred ccCCcccccCCccccccc--ccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcc
Q 041479 327 LFENNISREIPSSLGNFT--FLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 403 (771)
+..|+++..-+ +..+. .|+.+++++|++. ..+..+..+..+ .+++++|++...-. +.....+..+.++.|++
T Consensus 215 l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 215 LLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKL 289 (414)
T ss_pred cccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc--ccccchHHHhccCcchh
Confidence 77777764322 22222 2677777777776 232334444444 56666666653221 23344455555555555
Q ss_pred cccCCcchhhhhcccccccEEECcCCCCCC
Q 041479 404 SGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 404 ~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
....-..-.......+.++.+.+.+|++..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 290 ALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred cchhhhhccccccccccccccccccCcccc
Confidence 421100000001234455555555555543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=6e-11 Score=128.93 Aligned_cols=227 Identities=24% Similarity=0.173 Sum_probs=166.8
Q ss_pred cccc--cccceEEEEEe--cCCCeEEEEEEeec--cchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEE
Q 041479 528 SYES--LVKATVYKGIL--DLDQTFIAVKVLFL--HQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 528 ~l~~--~~~~~Vy~~~~--~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.+|. |.+|.||++.. +.+...+|+|+-+. .......+=.+|+....+++ |+|.|+.+..+.+.+ ..|+
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~-----~lfi 195 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG-----ILFI 195 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC-----ccee
Confidence 3455 99999999998 88888999998532 22344455567888888886 999999888877776 6788
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVAS----ALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLTR 671 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~ 671 (771)
-.|++. .++.++ ...++....+.+..+..+ |+.++|+. .++|-|+||.||....+ ...+.+|||+..
T Consensus 196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeE
Confidence 889885 566555 233667777888888888 99999985 89999999999999988 889999999998
Q ss_pred ccCcccCCcccc-cccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 672 FIPEVMSSNQCS-SVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 672 ~~~~~~~~~~~~-~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
.+.......... .....|...|++|| +|.+..|...+..+...-+ ...+.+...+..+.+..+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK--NSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC--CCCccccccccCchhhhc
Confidence 776654322211 12224677899999 5999999988876654211 123444455556666665
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+..+.....+++..+|-.|++..++.+
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 55666655566889999999999877653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-10 Score=110.15 Aligned_cols=83 Identities=36% Similarity=0.476 Sum_probs=22.7
Q ss_pred CCCCCcEEEeecCcccccCCcccc-CCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhh-hcc
Q 041479 194 TLPNVRILLLAGNQFFGNIPHSIS-NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA-NFS 271 (771)
Q Consensus 194 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~ 271 (771)
+...++.|+|++|+|+.+. .++ .+.+|+.|||++|.|+.+ ..+..+++|++|++++|+|+ .++..+. .++
T Consensus 17 n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l-----~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKL-----EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S-------TT----TT--EEE--SS----S-CHHHHHH-T
T ss_pred ccccccccccccccccccc--chhhhhcCCCEEECCCCCCccc-----cCccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 3445677777777776432 344 466777777777777744 23466677777777777777 5554443 343
Q ss_pred cccceeecccCcCc
Q 041479 272 SHLRYLYMSANPIS 285 (771)
Q Consensus 272 ~~L~~L~Ls~N~l~ 285 (771)
+|+.|++++|+|.
T Consensus 89 -~L~~L~L~~N~I~ 101 (175)
T PF14580_consen 89 -NLQELYLSNNKIS 101 (175)
T ss_dssp -T--EEE-TTS---
T ss_pred -cCCEEECcCCcCC
Confidence 6777777777776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.4e-11 Score=117.69 Aligned_cols=130 Identities=26% Similarity=0.333 Sum_probs=77.5
Q ss_pred CCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhccccc
Q 041479 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHL 274 (771)
Q Consensus 195 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 274 (771)
...|+.+|||+|.|+ .+..+..-+++++.|++|+|.|+.+ +++..+++|+.||||+|.++ .+..+-..+- ++
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-----~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLG-NI 354 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-----QNLAELPQLQLLDLSGNLLA-ECVGWHLKLG-NI 354 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-----hhhhhcccceEeecccchhH-hhhhhHhhhc-CE
Confidence 345666666666666 4555566666666666666666532 33455666666666666665 3333333333 56
Q ss_pred ceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccC-CcccccccccccccccC
Q 041479 275 RYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREI-PSSLGNFTFLTELNLCG 353 (771)
Q Consensus 275 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~ 353 (771)
+.|.|++|.|.. + ..+..+-+|..||+++|+|.... -..+++++-|++|.|.+
T Consensus 355 KtL~La~N~iE~-----L---------------------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~ 408 (490)
T KOG1259|consen 355 KTLKLAQNKIET-----L---------------------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTG 408 (490)
T ss_pred eeeehhhhhHhh-----h---------------------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcC
Confidence 666666666651 1 12334556666777777765321 23677788888888888
Q ss_pred cccee
Q 041479 354 NSIRG 358 (771)
Q Consensus 354 N~l~~ 358 (771)
|.|.+
T Consensus 409 NPl~~ 413 (490)
T KOG1259|consen 409 NPLAG 413 (490)
T ss_pred CCccc
Confidence 88873
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=9.1e-11 Score=115.49 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=96.1
Q ss_pred ccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCccccc
Q 041479 165 IQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLV 244 (771)
Q Consensus 165 ~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (771)
..+..+..|+++|||+|.|+ .+.+++. -+|.++.|++|+|.|..+ +.+..+++|+.||||+|.++.... +- .
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvK-L~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~G-wh---~ 349 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVK-LAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVG-WH---L 349 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhh-hccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhh-hH---h
Confidence 34445667888888888887 7777665 678888888888888732 347778888888888888875421 21 4
Q ss_pred CCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccC-cccccccCCcceEecCCcccee
Q 041479 245 NCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI-PTEIGNLKNLIIIAIEKFILIR 310 (771)
Q Consensus 245 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~ 310 (771)
.+-+.+.|.|+.|.|. .+ ..+..+- +|.+||+++|+|...- -..+++++.|+.+.|.+|.+.+
T Consensus 350 KLGNIKtL~La~N~iE-~L-SGL~KLY-SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIE-TL-SGLRKLY-SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhcCEeeeehhhhhHh-hh-hhhHhhh-hheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 5667788888888876 33 2355555 5888888888887322 2467888888888888887754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.1e-09 Score=104.19 Aligned_cols=141 Identities=18% Similarity=0.113 Sum_probs=107.8
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCC--CCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRH--RNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.++.|..+.||+++..+ ++.|++|....... ....++.+|+++++.+++ ..+.+++.+....... ...++||||
T Consensus 5 ~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~--~~~~~v~e~ 81 (223)
T cd05154 5 QLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL--GTPFYVMER 81 (223)
T ss_pred ecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc--CCceEEEEE
Confidence 46888899999998765 35899999854432 234678999999999975 4467777776543211 134899999
Q ss_pred ccCCCCCCCc--ccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 041479 605 MHHGSLESCP--RILSFLRRLNIAIDVASALEYLHHHC------------------------------------------ 640 (771)
Q Consensus 605 ~~~g~L~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------ 640 (771)
++|+++.... ..++..+...++.++++++.+||+..
T Consensus 82 i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 82 VDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred eCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9999887653 35777888899999999999999531
Q ss_pred -----------CCCeEecCCCCCCeeeCC--CCceEEecccCcc
Q 041479 641 -----------KKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTR 671 (771)
Q Consensus 641 -----------~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~ 671 (771)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 5678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.6e-10 Score=79.90 Aligned_cols=40 Identities=55% Similarity=1.076 Sum_probs=31.1
Q ss_pred CccHHHHHHHHhcCCCCCCCCCCCCCCC--CCCccceeeeec
Q 041479 1 EPDKQALLAFKSKVDDDPFGALSTWNDS--VNFCQWLGVTCS 40 (771)
Q Consensus 1 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~--~~~c~w~~v~c~ 40 (771)
++|++||++||+++..+|.+.+++|... .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 3689999999999987788899999876 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.6e-09 Score=116.18 Aligned_cols=161 Identities=18% Similarity=0.240 Sum_probs=116.3
Q ss_pred EE-EEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCCcc
Q 041479 537 VY-KGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPR 615 (771)
Q Consensus 537 Vy-~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 615 (771)
+| .|..+.++.+|.|...+.......+...+.++.++.+|||||+++++.+.+.+ ..|+|.|-+.- |..+.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-----~~ylvTErV~P--l~~~lk 99 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-----TLYLVTERVRP--LETVLK 99 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-----ceEEEeecccc--HHHHHH
Confidence 44 46667777799999997766545566778889999999999999999987776 78999998752 222222
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccc--
Q 041479 616 ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGY-- 693 (771)
Q Consensus 616 ~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y-- 693 (771)
.+......-.+.||+.||.|||+.| +++|++|.-+.|.++..|..||.+|-++............ ..---.|
T Consensus 100 ~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~----~~~~~s~~~ 173 (690)
T KOG1243|consen 100 ELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS----LYLIESFDD 173 (690)
T ss_pred HhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc----chhhhcccC
Confidence 3344445555789999999999864 8999999999999999999999999887543332210000 0000112
Q ss_pred --------cchh---HHHHHHHHHhCCC
Q 041479 694 --------ATPE---YGILLLEIFTGKR 710 (771)
Q Consensus 694 --------~aPE---~Gv~l~el~tg~~ 710 (771)
+++| |||+++|++.|..
T Consensus 174 P~~~~~s~~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 174 PEEIDPSEWSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhhcCccccchhhhhHHHHHHHHhCccc
Confidence 3344 8999999999933
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-10 Score=117.36 Aligned_cols=248 Identities=22% Similarity=0.266 Sum_probs=151.7
Q ss_pred cccCCCCCCEEecccCcCccc----CChhhhhCCCCCcEEEeecCc---ccccCC-------ccccCCCCCCEEEccccc
Q 041479 166 QLLNITSMEYFHVSENQLVGE----LPPHIGFTLPNVRILLLAGNQ---FFGNIP-------HSISNASKLEWLDFANNS 231 (771)
Q Consensus 166 ~~~~l~~L~~L~Ls~N~l~g~----lp~~~~~~l~~L~~L~L~~N~---l~~~~p-------~~~~~l~~L~~L~Ls~N~ 231 (771)
.+..+.+++.++||+|-+... +.+.+. +.++|+..+++.=- ....+| +++.+.++|++||||+|.
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~-~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLA-SKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHh-hcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 455678899999999998521 222223 55677777776532 222233 334566789999999998
Q ss_pred cCCCCCcCccc-ccCCCCCcEEEccCccccccCChhhhh------------cccccceeecccCcCccc----Ccccccc
Q 041479 232 LTGLIPEDLDS-LVNCTYLEVVSLSVNSLSGTLPNSLAN------------FSSHLRYLYMSANPISGS----IPTEIGN 294 (771)
Q Consensus 232 l~~~~p~~~~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~------------l~~~L~~L~Ls~N~l~~~----~p~~~~~ 294 (771)
+..--++.|.. +.+++.|++|.|.+|.+...--..++. .+++|+.++.++|++... +...|..
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~ 183 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQS 183 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHh
Confidence 87444444432 356788999999999875111111111 123678888888877632 2234556
Q ss_pred cCCcceEecCCccceec----cCccccCCCCCCEEEccCCccccc----CCcccccccccccccccCccceecCCccccc
Q 041479 295 LKNLIIIAIEKFILIRN----IPISVGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSIRGSVPSALGS 366 (771)
Q Consensus 295 l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 366 (771)
.+.|+.+.++.|.+... +-.++..+++|+.|||.+|.++.. +...++.+++|+.|+++++.+...-..+|..
T Consensus 184 ~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~ 263 (382)
T KOG1909|consen 184 HPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD 263 (382)
T ss_pred ccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH
Confidence 67777777777766321 223456677777777777776632 2334555666677777666665322222111
Q ss_pred ccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCC
Q 041479 367 CHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 367 l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
.++ ...++|++|.|.+|.|+..--..+.......+.|..|+|++|.+.
T Consensus 264 -----------al~-------~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 264 -----------ALK-------ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred -----------HHh-------ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 011 225789999999999984333333334446788999999999984
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-09 Score=85.35 Aligned_cols=59 Identities=36% Similarity=0.573 Sum_probs=31.1
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccc
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS 231 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 231 (771)
+|++|++++|+++ .+|+..|..+++|++|++++|+|+.+.|+.|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4455555555555 4555444455555555555555555555555555555555555554
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.5e-09 Score=84.79 Aligned_cols=60 Identities=30% Similarity=0.384 Sum_probs=45.3
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcC
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNAL 104 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 104 (771)
+++.|++++|+++.+.+..|.++++|++|++++|+|+...|++|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 567777777777766667777777777777777777776677777777777777777764
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-10 Score=117.58 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=129.6
Q ss_pred cccCCCCCcEEEcCCCcccc----cCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecc
Q 041479 63 YIGNLTFLRLINLQQNNFSS----NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLA 138 (771)
Q Consensus 63 ~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls 138 (771)
.+.....++.|+||+|.|.. .+...+.+.++|+.-++|.-- +|.+.+.+...-+ .+...+...++|++||||
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~f-tGR~~~Ei~e~L~---~l~~aL~~~~~L~~ldLS 100 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMF-TGRLKDEIPEALK---MLSKALLGCPKLQKLDLS 100 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhh-cCCcHHHHHHHHH---HHHHHHhcCCceeEeecc
Confidence 44556667777777777753 244556666777777766432 3221111000000 112234445577777777
Q ss_pred cccCcCC-CCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhh-h------------hCCCCCcEEEee
Q 041479 139 NNYFTGP-IPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHI-G------------FTLPNVRILLLA 204 (771)
Q Consensus 139 ~N~l~~~-lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~-~------------~~l~~L~~L~L~ 204 (771)
+|.|-.. ++- +-.-+..++.|++|.|.+|.+. ..-... + ..-+.|+++...
T Consensus 101 DNA~G~~g~~~--------------l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~ 165 (382)
T KOG1909|consen 101 DNAFGPKGIRG--------------LEELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKLRVFICG 165 (382)
T ss_pred ccccCccchHH--------------HHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcceEEEEee
Confidence 7776411 110 1112345677888888888775 211111 0 023456666666
Q ss_pred cCccccc----CCccccCCCCCCEEEccccccCCCCC-cCcccccCCCCCcEEEccCccccccCChhhhhcccccceeec
Q 041479 205 GNQFFGN----IPHSISNASKLEWLDFANNSLTGLIP-EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYM 279 (771)
Q Consensus 205 ~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L 279 (771)
+|++... +...|...+.|+.+.++.|.|...-- -.+..+..+++|++|||..|-++..-..
T Consensus 166 rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~-------------- 231 (382)
T KOG1909|consen 166 RNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV-------------- 231 (382)
T ss_pred ccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH--------------
Confidence 6666521 11234455566666666665541100 0112335556666666666655421110
Q ss_pred ccCcCcccCcccccccCCcceEecCCccceeccCccc-----cCCCCCCEEEccCCccccc----CCccccccccccccc
Q 041479 280 SANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISV-----GYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELN 350 (771)
Q Consensus 280 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ 350 (771)
.+...+..+++|+.|+++++.+...-..+| ...++|++|.|.+|.++.. +...+...+.|..|+
T Consensus 232 -------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLn 304 (382)
T KOG1909|consen 232 -------ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLN 304 (382)
T ss_pred -------HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhc
Confidence 111223333444444444444432222221 2367888999999988742 223445578999999
Q ss_pred ccCccce
Q 041479 351 LCGNSIR 357 (771)
Q Consensus 351 Ls~N~l~ 357 (771)
|++|++.
T Consensus 305 LngN~l~ 311 (382)
T KOG1909|consen 305 LNGNRLG 311 (382)
T ss_pred CCccccc
Confidence 9999993
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=6.1e-08 Score=90.70 Aligned_cols=129 Identities=22% Similarity=0.215 Sum_probs=88.9
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCC--ceeEEEEeecCCCCCceeE
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRN--LVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~~~~~ 598 (771)
..+|+.+.+|.+.+... .+++|.=..+. .--.++..+|++++.+++--. +-.++++ +.+ ..
T Consensus 4 i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~-----~~ 74 (204)
T COG3642 4 IKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPD-----NG 74 (204)
T ss_pred hhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCC-----CC
Confidence 45788888999877432 45555432211 112357788999999986433 3334443 333 34
Q ss_pred EEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.|+|||.+|..|.+....- +..++..+-.-+.-||.. +|+|+|+.++||++.... +.++|||++.+-.
T Consensus 75 ~I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EEEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 7999999987776542111 356667777778889986 999999999999998664 9999999998543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8e-08 Score=93.00 Aligned_cols=123 Identities=22% Similarity=0.209 Sum_probs=80.0
Q ss_pred EEEEEecCCCeEEEEEEeeccc--------------h------------hhHHHHHHHHHHHhccCCC--CceeEEEEee
Q 041479 537 VYKGILDLDQTFIAVKVLFLHQ--------------R------------GALKSFMAECQALRNIRHR--NLVKIITACS 588 (771)
Q Consensus 537 Vy~~~~~~~~~~vAvK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 588 (771)
||.|...++. .||||+.+... . .......+|.+.|.++..- ++-+.+++
T Consensus 2 Vy~~~~~~~~-~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 2 VYHAIDPDGE-EVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEECTTE-EEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred EEEEECCCCC-EEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 8999887665 99999996421 0 0124567899999999755 45566554
Q ss_pred cCCCCCceeEEEEEEecc--CCCCCCCcc-cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 041479 589 TSDFQGNYFRALVYEFMH--HGSLESCPR-ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665 (771)
Q Consensus 589 ~~~~~~~~~~~lv~e~~~--~g~L~~~~~-~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~ 665 (771)
..+ ++||||++ |..+..... .++..+...++.++...+..+++. .+|+|+|+.+.||+++++ .+.++
T Consensus 79 ~~~-------~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 NRN-------VIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ETT-------EEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEEE-
T ss_pred eCC-------EEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEEEE
Confidence 222 79999998 544544311 122345667778888867765432 499999999999999977 89999
Q ss_pred cccCccc
Q 041479 666 DFGLTRF 672 (771)
Q Consensus 666 DfGla~~ 672 (771)
|||-+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-07 Score=100.10 Aligned_cols=169 Identities=19% Similarity=0.222 Sum_probs=121.3
Q ss_pred cccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccC-CCC
Q 041479 532 LVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH-GSL 610 (771)
Q Consensus 532 ~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-g~L 610 (771)
....+.||+....+|..|+.|++...+.........-++..+++.|+|||++.+++.+..+. .-.+++||+|.++ ++|
T Consensus 287 ~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~-D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 287 LFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFG-DLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccC-cceEEEEEecCCCCchH
Confidence 46688999999999999999999443333333344567889999999999999998755433 3357999999985 344
Q ss_pred CCC------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 611 ESC------------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 611 ~~~------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.+. ....++...+.++.|+..||.++|+. |..-+-+.+.+|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 222 22456788999999999999999996 888899999999999988999988887654
Q ss_pred cCcccCCcccccccccccccccchhHHHHHHHHHhCCC
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKR 710 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE~Gv~l~el~tg~~ 710 (771)
+............. --.. -+|.+++.+.||..
T Consensus 443 l~~d~~~~le~~Qq--~D~~----~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDPTEPLESQQQ--NDLR----DLGLLLLALATGTE 474 (655)
T ss_pred ecCCCCcchhHHhh--hhHH----HHHHHHHHHhhccc
Confidence 43322000000000 0000 17999999999943
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-08 Score=118.18 Aligned_cols=203 Identities=22% Similarity=0.296 Sum_probs=101.2
Q ss_pred CCCcEEEcCCCcccccCCccccCCCCCCEEecccCc--CcccCCcccccCCcccccCCc-cccCCCCCCEEecccccCcC
Q 041479 68 TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNA--LQGQIPDSRLILNKLEGNIPS-ELGSLLKFKGLGLANNYFTG 144 (771)
Q Consensus 68 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~l~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 144 (771)
...++..+.+|++.. ++..... ++|++|-+..|. +. .++. .|..++.|+.|||++|.=-
T Consensus 523 ~~~rr~s~~~~~~~~-~~~~~~~-~~L~tLll~~n~~~l~---------------~is~~ff~~m~~LrVLDLs~~~~l- 584 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEH-IAGSSEN-PKLRTLLLQRNSDWLL---------------EISGEFFRSLPLLRVLDLSGNSSL- 584 (889)
T ss_pred hheeEEEEeccchhh-ccCCCCC-CccceEEEeecchhhh---------------hcCHHHHhhCcceEEEECCCCCcc-
Confidence 555666666666552 3333322 256666666664 11 2222 2455666666666654210
Q ss_pred CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCE
Q 041479 145 PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEW 224 (771)
Q Consensus 145 ~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 224 (771)
+.+|..+++|-+|++|++++..++ .+|..+. +|..|.+|++..+.-...+|+....+++|++
T Consensus 585 ----------------~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~-~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~ 646 (889)
T KOG4658|consen 585 ----------------SKLPSSIGELVHLRYLDLSDTGIS-HLPSGLG-NLKKLIYLNLEVTGRLESIPGILLELQSLRV 646 (889)
T ss_pred ----------------CcCChHHhhhhhhhcccccCCCcc-ccchHHH-HHHhhheeccccccccccccchhhhcccccE
Confidence 145666666666666666666666 6666665 6666777777666655455666666677777
Q ss_pred EEccccccCCCCCcCcccccCCCCCcEEEccCccccccCC--hhhhhcccccceeecccCcCcccCcccccccCCcceEe
Q 041479 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLP--NSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIA 302 (771)
Q Consensus 225 L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 302 (771)
|.+..-..... ......+.++.+|+.+........ .+- .....+.+..+.+.+.++... ..+..+..+.+|+.|.
T Consensus 647 L~l~~s~~~~~-~~~l~el~~Le~L~~ls~~~~s~~-~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~ 723 (889)
T KOG4658|consen 647 LRLPRSALSND-KLLLKELENLEHLENLSITISSVL-LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELS 723 (889)
T ss_pred EEeeccccccc-hhhHHhhhcccchhhheeecchhH-hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEE
Confidence 66655432110 111222344444544444333220 000 111111112223333332222 3445566666677766
Q ss_pred cCCccce
Q 041479 303 IEKFILI 309 (771)
Q Consensus 303 l~~n~l~ 309 (771)
+.++.+.
T Consensus 724 i~~~~~~ 730 (889)
T KOG4658|consen 724 ILDCGIS 730 (889)
T ss_pred EEcCCCc
Confidence 6665553
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.6e-08 Score=116.72 Aligned_cols=88 Identities=27% Similarity=0.403 Sum_probs=72.9
Q ss_pred cCCCCcEEEEEcCCCC--CcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCc
Q 041479 40 SLKYQRVILLNLSGQN--LTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNK 117 (771)
Q Consensus 40 ~~~~~~l~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~ 117 (771)
....+.+++|-+..|. +..+.++.|..++.|+.||||+|.=-+.+|..++.|-+|++|+|++..++
T Consensus 541 ~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~------------ 608 (889)
T KOG4658|consen 541 SSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS------------ 608 (889)
T ss_pred CCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc------------
Confidence 3333568888888886 66566667889999999999998654579999999999999999999976
Q ss_pred ccccCCccccCCCCCCEEecccccC
Q 041479 118 LEGNIPSELGSLLKFKGLGLANNYF 142 (771)
Q Consensus 118 l~~~~p~~~~~l~~L~~L~Ls~N~l 142 (771)
.+|..+.+|.+|.+|++..+.-
T Consensus 609 ---~LP~~l~~Lk~L~~Lnl~~~~~ 630 (889)
T KOG4658|consen 609 ---HLPSGLGNLKKLIYLNLEVTGR 630 (889)
T ss_pred ---ccchHHHHHHhhheeccccccc
Confidence 7889999999999999987754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.5e-07 Score=91.22 Aligned_cols=131 Identities=15% Similarity=0.025 Sum_probs=89.6
Q ss_pred EEEEEecCCCeEEEEEEeeccchh-hH----------HHHHHHHHHHhccC--CCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 537 VYKGILDLDQTFIAVKVLFLHQRG-AL----------KSFMAECQALRNIR--HRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 537 Vy~~~~~~~~~~vAvK~~~~~~~~-~~----------~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
|++..+ +|+.|.||+....... .. ..+.+|...+.++. .-.+.+.+++............++|||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 556654 4558999977433211 11 24788999988884 333444555553321111124689999
Q ss_pred eccCC-CCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-------CCceEEecccCc
Q 041479 604 FMHHG-SLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-------DMTAHMGDFGLT 670 (771)
Q Consensus 604 ~~~~g-~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-------~~~~kl~DfGla 670 (771)
++++. +|.++. ...+...+..++.+++..+.-||.. ||+|+|++++|||++. ++.+.++||+.+
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99875 665552 2234456778999999999999996 9999999999999975 468999999988
Q ss_pred cc
Q 041479 671 RF 672 (771)
Q Consensus 671 ~~ 672 (771)
+.
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.2e-07 Score=84.65 Aligned_cols=134 Identities=21% Similarity=0.207 Sum_probs=88.4
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+-+|+.|.|+++.+. |+...||.=.... .-..++..+|++.+.+++--.|.--.-++.+.. .-.|
T Consensus 15 ikQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----~~~i 87 (229)
T KOG3087|consen 15 IKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----GGQI 87 (229)
T ss_pred eeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----CCeE
Confidence 457888899999876 4345555432221 223467889999999986333322222222222 2269
Q ss_pred EEEeccCC-CCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEecccCcc
Q 041479 601 VYEFMHHG-SLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---TAHMGDFGLTR 671 (771)
Q Consensus 601 v~e~~~~g-~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~ 671 (771)
+|||.+|- ++.++ ............+..+-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99999763 34433 11122222367788888999999986 899999999999997554 45899999986
Q ss_pred c
Q 041479 672 F 672 (771)
Q Consensus 672 ~ 672 (771)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.1e-09 Score=116.36 Aligned_cols=108 Identities=30% Similarity=0.424 Sum_probs=50.8
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCc-cccCCCCCCEEEccccccCCCCCcCcccccC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPH-SISNASKLEWLDFANNSLTGLIPEDLDSLVN 245 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 245 (771)
+.-++.|+.|+||+|+++ .+. .+. .++.|++|||++|++.. +|. ...++ .|..|.|++|.++.+ .++.+
T Consensus 183 Lqll~ale~LnLshNk~~-~v~-~Lr-~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~lrnN~l~tL-----~gie~ 252 (1096)
T KOG1859|consen 183 LQLLPALESLNLSHNKFT-KVD-NLR-RLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNLRNNALTTL-----RGIEN 252 (1096)
T ss_pred HHHHHHhhhhccchhhhh-hhH-HHH-hcccccccccccchhcc-ccccchhhh-hheeeeecccHHHhh-----hhHHh
Confidence 334455555555555555 332 222 45555555555555552 222 12222 255555555555532 22345
Q ss_pred CCCCcEEEccCccccccCC-hhhhhcccccceeecccCcCc
Q 041479 246 CTYLEVVSLSVNSLSGTLP-NSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 246 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
|.+|+.||+++|-|.+.-. ..++.+. .|+.|+|.+|.+.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs-~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLS-SLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHH-HHHHHhhcCCccc
Confidence 5555555555555543211 1122332 4556666666554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.7e-09 Score=116.76 Aligned_cols=129 Identities=28% Similarity=0.257 Sum_probs=79.9
Q ss_pred cceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccceeeecccC
Q 041479 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHN 377 (771)
Q Consensus 298 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N 377 (771)
|...+.++|.+. ....++.-++.|+.|+|++|+++... .+..++.|++|||+.|.++.+.--....+....|.+++|
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN 242 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNN 242 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeeccc
Confidence 333344444442 23344555667777777777776443 667777788888888877733322333444226788888
Q ss_pred cccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCC
Q 041479 378 HLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGD 434 (771)
Q Consensus 378 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~ 434 (771)
.++... .+.++++|+.|||++|-|.+--.-.+-| .+..|+.|+|.+|++.+.
T Consensus 243 ~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLw---sLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 243 ALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLW---SLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred HHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHH---HHHHHHHHhhcCCccccC
Confidence 877432 3567888888888888887432222222 556778888899888653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.2e-08 Score=106.38 Aligned_cols=144 Identities=25% Similarity=0.228 Sum_probs=110.6
Q ss_pred ccccccccccccccceEEEEEec-CCCeEEEEEEeeccchhhH--HHHHHHHHHHhccC-CCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILD-LDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIR-HRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~-~~~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....++++.++.||+...+ .++..||+|.+........ ..-..|+.+...+. |.++++.+..|..-.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r----- 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR----- 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-----
Confidence 34455667888888888887765 6777999998855433222 22345666666664 888999877765544
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~ 672 (771)
..|+=-|||++++.... ...+++..++++..|++.|+.++|+ +.++|+|+||+||++..+ +..++.|||++..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence 45788999999987654 3457788899999999999999997 489999999999999876 8899999999864
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.9e-08 Score=88.44 Aligned_cols=108 Identities=25% Similarity=0.303 Sum_probs=54.5
Q ss_pred CCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceE
Q 041479 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIII 301 (771)
Q Consensus 222 L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 301 (771)
+..+||+.++|. .+++....+.....|...+|++|.+. .+|+.|....+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 345555555553 23444433344455555666666665 556555544334666666666666 445555555555555
Q ss_pred ecCCccceeccCccccCCCCCCEEEccCCccc
Q 041479 302 AIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 302 ~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
+++.|.+. ..|..+..+.+|-.|+..+|.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 55444442 22333333444444444444443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.3e-08 Score=89.39 Aligned_cols=118 Identities=19% Similarity=0.306 Sum_probs=87.0
Q ss_pred eecCCCCcEEEEEcCCCCCcccCCc---cccCCCCCcEEEcCCCcccccCCccccC-CCCCCEEecccCcCcccCCcccc
Q 041479 38 TCSLKYQRVILLNLSGQNLTGTASP---YIGNLTFLRLINLQQNNFSSNIPHEIGR-LFRLRHIIFNSNALQGQIPDSRL 113 (771)
Q Consensus 38 ~c~~~~~~l~~L~Ls~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~l 113 (771)
+|.+. .-+-.+||+++.|- .++. .+....+|+..+|++|.+.. .|+.|.. .+-+++|+|++|+|+
T Consensus 22 rceda-kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-------- 90 (177)
T KOG4579|consen 22 RCEDA-KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-------- 90 (177)
T ss_pred hhHHH-HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh--------
Confidence 45543 45567888888775 3333 34566778888999999985 5655544 457888899999876
Q ss_pred cCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhh
Q 041479 114 ILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIG 192 (771)
Q Consensus 114 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~ 192 (771)
.+|.++..++.|+.|+++.|.|. ..|..+..|.++.+|+..+|.+. ++|-.++
T Consensus 91 -------dvPeE~Aam~aLr~lNl~~N~l~------------------~~p~vi~~L~~l~~Lds~~na~~-eid~dl~ 143 (177)
T KOG4579|consen 91 -------DVPEELAAMPALRSLNLRFNPLN------------------AEPRVIAPLIKLDMLDSPENARA-EIDVDLF 143 (177)
T ss_pred -------hchHHHhhhHHhhhcccccCccc------------------cchHHHHHHHhHHHhcCCCCccc-cCcHHHh
Confidence 67888888888888888888876 56666667788888888888877 7776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.9e-06 Score=83.52 Aligned_cols=129 Identities=21% Similarity=0.142 Sum_probs=90.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch----------------------hhHHHHHHHHHHHhccCCC--Ccee
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR----------------------GALKSFMAECQALRNIRHR--NLVK 582 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--nIv~ 582 (771)
-.+|.|..+.||.|..+.+. ++|||.=+.+.. -.+....+|.++|.++.-. .|-+
T Consensus 97 ~~IGvGKEsdVY~~~~~~g~-~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~ 175 (304)
T COG0478 97 TKIGVGKESDVYVAIDPKGR-KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK 175 (304)
T ss_pred cccccCccceEEEEECCCCC-EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 45789999999999998776 999997654321 1124567899999998754 6666
Q ss_pred EEEEeecCCCCCceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCce
Q 041479 583 IITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA 662 (771)
Q Consensus 583 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~ 662 (771)
-+++- ..++||||.+|-.|.... ++....-.+...|.+-+.-.-. .||||+|+.+=||+++++|.+
T Consensus 176 P~~~n---------RHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 176 PIAWN---------RHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred ccccc---------cceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCE
Confidence 65541 458999999997776542 1223333333344333332223 389999999999999999999
Q ss_pred EEecccCc
Q 041479 663 HMGDFGLT 670 (771)
Q Consensus 663 kl~DfGla 670 (771)
.++||-=+
T Consensus 242 ~vIDwPQ~ 249 (304)
T COG0478 242 VVIDWPQA 249 (304)
T ss_pred EEEeCccc
Confidence 99999643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.27 E-value=6e-06 Score=82.07 Aligned_cols=107 Identities=24% Similarity=0.250 Sum_probs=81.2
Q ss_pred HHHHHHHHHHHhccC--CCCceeEEEEeecCCCCCceeEEEEEEeccCC-CCCCCcc---cCCHHHHHHHHHHHHHHHHH
Q 041479 562 LKSFMAECQALRNIR--HRNLVKIITACSTSDFQGNYFRALVYEFMHHG-SLESCPR---ILSFLRRLNIAIDVASALEY 635 (771)
Q Consensus 562 ~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~~~---~l~~~~~~~i~~~ia~gL~~ 635 (771)
..++.+|...+..++ .-.+.+.+++......-. ...++|+|++++. +|.++.. ..+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 346788888888775 344556666665533211 3568999999874 6766532 25566778999999999999
Q ss_pred HHhcCCCCeEecCCCCCCeeeCCCC---ceEEecccCccc
Q 041479 636 LHHHCKKPIVHCDLKPSNVLLDNDM---TAHMGDFGLTRF 672 (771)
Q Consensus 636 LH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~ 672 (771)
||.. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9996 999999999999999876 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-05 Score=89.85 Aligned_cols=137 Identities=22% Similarity=0.224 Sum_probs=89.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch----------------------h------------------hHHHHH
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR----------------------G------------------ALKSFM 566 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~----------------------~------------------~~~~~~ 566 (771)
.+++..+-|.||+|+++++ +.||||+.+.+-. . ..-++.
T Consensus 131 ~PiAsASIaQVH~A~L~sG-~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKSG-EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecCC-CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4567788889999999985 5999999964310 0 011456
Q ss_pred HHHHHHhccC-----CCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHH-HHHH
Q 041479 567 AECQALRNIR-----HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASA-LEYL 636 (771)
Q Consensus 567 ~E~~~l~~l~-----H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~g-L~~L 636 (771)
+|+..+.+++ .|+ +++=.+|++-.. ...++|||++|-.+.+. ....+ +..++.-++++ +..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhccC----CcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 6777777763 343 333333332111 35899999999888766 12233 23333333322 1112
Q ss_pred HhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 637 HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 637 H~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
-. -+++|.|..|.||+++.+|+....|||+...+++
T Consensus 282 ~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred Hh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 12 2899999999999999999999999999887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.9e-07 Score=104.73 Aligned_cols=225 Identities=20% Similarity=0.169 Sum_probs=135.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
+...+.++.++-+.-...+...++|+..... ....+...++-.+.-..+||-+++...-+.-.. -.++|++|
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs-----P~~L~~~~ 885 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS-----PLPLVGHY 885 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-----CcchhhHH
Confidence 4556666666666555555455555543221 112233333444444455677776544322222 45899999
Q ss_pred ccCCCCCCCc---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc-----
Q 041479 605 MHHGSLESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV----- 676 (771)
Q Consensus 605 ~~~g~L~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~----- 676 (771)
..++++.... ...+..........+.++.+|||.. .+.|||++|.|++...++..+++|||........
T Consensus 886 ~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9998886652 2233334455566788899999984 5899999999999999999999999854322110
Q ss_pred ----------------cC----C--cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC
Q 041479 677 ----------------MS----S--NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG 719 (771)
Q Consensus 677 ----------------~~----~--~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~ 719 (771)
.. . .........||+.|.||| .|++++|.++|..||.+.....
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 00 0 001123457899999999 5999999999999997654332
Q ss_pred ccHHHHHHhhCC-CchhhhcCccccccCcccChhchhhcCCHH
Q 041479 720 LDLHNFVKMALP-DQILQVLDPLFLVGGVQEGEETAEENIKKG 761 (771)
Q Consensus 720 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~ 761 (771)
+ +..+..+..+ ...+...++.......+-+..+|.+|-.|.
T Consensus 1043 ~-f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 I-FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h-hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2 3334444443 222233333333333355566777776554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.1e-07 Score=89.05 Aligned_cols=213 Identities=21% Similarity=0.267 Sum_probs=115.7
Q ss_pred ccceeeeecCCCCcEEEEEcCCCCCcccCC-ccc-cCCCCCcEEEcCCCcccc--cCCccccCCCCCCEEecccCcCccc
Q 041479 32 CQWLGVTCSLKYQRVILLNLSGQNLTGTAS-PYI-GNLTFLRLINLQQNNFSS--NIPHEIGRLFRLRHIIFNSNALQGQ 107 (771)
Q Consensus 32 c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~-~~~-~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~ 107 (771)
|+..||..- ..+..|.+.++.|..... ..| ...+.++.|||.+|+|+. .+-.-+.+|+.|++|+|+.|.+...
T Consensus 36 ~s~~~v~s~---ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~ 112 (418)
T KOG2982|consen 36 LSYLGVSSL---RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSD 112 (418)
T ss_pred cceeeeccc---cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCc
Confidence 455555321 234445555555553221 123 356778888888888874 3444467788888888888886632
Q ss_pred CCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcc--
Q 041479 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVG-- 185 (771)
Q Consensus 108 ~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-- 185 (771)
|. ..| ..+.+|+.|-|.+..+.- ......+.+++.+++|++|.|.+..
T Consensus 113 I~-----------~lp---~p~~nl~~lVLNgT~L~w----------------~~~~s~l~~lP~vtelHmS~N~~rq~n 162 (418)
T KOG2982|consen 113 IK-----------SLP---LPLKNLRVLVLNGTGLSW----------------TQSTSSLDDLPKVTELHMSDNSLRQLN 162 (418)
T ss_pred cc-----------cCc---ccccceEEEEEcCCCCCh----------------hhhhhhhhcchhhhhhhhccchhhhhc
Confidence 21 122 345677777777766541 0112234455555666666653320
Q ss_pred -------cCChhh--hhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccC
Q 041479 186 -------ELPPHI--GFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSV 256 (771)
Q Consensus 186 -------~lp~~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~ 256 (771)
...+.+ ...++.+..++++-|++..+. +++..+-+..|.|.....+ .+...++++..|+|+.
T Consensus 163 ~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~F-------pnv~sv~v~e~PlK~~s~e--k~se~~p~~~~LnL~~ 233 (418)
T KOG2982|consen 163 LDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIF-------PNVNSVFVCEGPLKTESSE--KGSEPFPSLSCLNLGA 233 (418)
T ss_pred cccccccccchhhhhhhcCCcHHHHHHHHHhHHhhc-------ccchheeeecCcccchhhc--ccCCCCCcchhhhhcc
Confidence 111111 012344555555556665332 5567777777776643221 2224456666778888
Q ss_pred cccccc-CChhhhhcccccceeecccCcCccc
Q 041479 257 NSLSGT-LPNSLANFSSHLRYLYMSANPISGS 287 (771)
Q Consensus 257 N~l~~~-~p~~~~~l~~~L~~L~Ls~N~l~~~ 287 (771)
|+|..- --+.+.+++ +|..|.+++|.+...
T Consensus 234 ~~idswasvD~Ln~f~-~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 234 NNIDSWASVDALNGFP-QLVDLRVSENPLSDP 264 (418)
T ss_pred cccccHHHHHHHcCCc-hhheeeccCCccccc
Confidence 887521 112344454 688888888888743
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.4e-05 Score=73.56 Aligned_cols=125 Identities=19% Similarity=0.241 Sum_probs=77.0
Q ss_pred EEEEecCCCeEEEEEEeeccchhhHHH---------HHHHHHHHhccC---CCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 538 YKGILDLDQTFIAVKVLFLHQRGALKS---------FMAECQALRNIR---HRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 538 y~~~~~~~~~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
|.+...-+++.+.+|..+.......+. ..+++..+.+++ -...+.++.+.......-....+++|||+
T Consensus 46 ~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYI 125 (229)
T PF06176_consen 46 YVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYI 125 (229)
T ss_pred EEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEe
Confidence 333334445688888875543222222 233444444443 23333433333322222222457899999
Q ss_pred cCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 606 HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 606 ~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
+|..|.+... ++. .++..+++++.-+|.. |++|+|..|.|++++.+ .+++.||+..+
T Consensus 126 eG~~l~d~~~-i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 126 EGVELNDIED-IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred cCeecccchh-cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 9988876532 222 3445677889999986 99999999999999855 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 771 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-27 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-27 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-22 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 4e-89
Identities = 120/414 (28%), Positives = 184/414 (44%), Gaps = 37/414 (8%)
Query: 49 LNLSGQNLTGT-ASPYIGNLTFLRLINLQQNNFSSNIPHEI---GRLFRLRHIIFNSNAL 104
LN+S L L L +++L N+ S L+H+ + N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 105 QGQIPDSRLI--------LNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP-------HL 149
G + SR + N IP LG + L ++ N +G L
Sbjct: 191 SGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 150 NMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFF 209
+ +S G IP L S++Y ++EN+ GE+P + + L L+GN F+
Sbjct: 250 KLLNISSNQFVGPIPPLPL--KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN 269
G +P + S LE L ++N+ +G +P D+L+ L+V+ LS N SG LP SL N
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPM--DTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 270 FSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN-----IPISVGYLLKLQV 324
S+ L L +S+N SG I + +++ L N IP ++ +L
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPK---NTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 325 LSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPI 383
L L N +S IPSSLG+ + L +L L N + G +P L L L L N LTG I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 384 PLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437
P + N ++ + LS N L+GEIP + G + A L LS N+ G++P
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWI----GRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 287 bits (738), Expect = 4e-86
Identities = 121/453 (26%), Positives = 186/453 (41%), Gaps = 62/453 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTF-LRLINLQQNNFSSNIPHEIGRLFR--LRHIIFNSNALQ 105
L+LS +G + NL+ L ++L NNFS I + + + L+ + +N
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 106 GQIPDS--------RLIL--NKLEGNIPSELGSLLKFKGLGLANNYFTGPIP-------H 148
G+IP + L L N L G IPS LGSL K + L L N G IP
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 149 LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF 208
L + LTG IP L N T++ + +S N+L GE+P IG L N+ IL L+ N F
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG-RLENLAILKLSNNSF 526
Query: 209 FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268
GNIP + + L WLD N G IP + ++ N ++G +
Sbjct: 527 SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG-------KIAANFIAGKRYVYIK 579
Query: 269 NFSS-HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSL 327
N + + G ++ L ++
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLST------------------------RNPCNI 615
Query: 328 FENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLA 386
+ N + L++ N + G +P +GS L+ L+L HN ++G IP
Sbjct: 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
Query: 387 VGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASA 446
VG+ + + LDLS N+L G IP +++ +++ +++LS NNL G +P F+
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMS----ALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731
Query: 447 ISEAGNEKLCGGISELKLPPCTPSELKKREKSK 479
N LCG LP C PS +
Sbjct: 732 AKFLNNPGLCGYP----LPRCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-82
Identities = 113/458 (24%), Positives = 182/458 (39%), Gaps = 79/458 (17%)
Query: 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLT--- 57
+ L++FK + D L W+ + N C + GVTC +V ++LS + L
Sbjct: 11 YREIHQLISFKDVLPDK--NLLPDWSSNKNPCTFDGVTCRD--DKVTSIDLSSKPLNVGF 66
Query: 58 GTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNK 117
S + +LT L + L ++ + ++ L
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS--------------------- 104
Query: 118 LEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFH 177
L L+ N +GP+ L + + +++ +
Sbjct: 105 -----------------LDLSRNSLSGPVTT---------------LTSLGSCSGLKFLN 132
Query: 178 VSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI---SNASKLEWLDFANNSLTG 234
VS N L G L ++ +L L+ N G +L+ L + N ++G
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 235 LIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGN 294
+ + C LE + +S N+ S +P L + S+ L++L +S N +SG I
Sbjct: 193 DVD-----VSRCVNLEFLDVSSNNFSTGIP-FLGDCSA-LQHLDISGNKLSGDFSRAIST 245
Query: 295 LKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSL-GNFTFLTELNLCG 353
L ++ I + IP L LQ LSL EN + EIP L G LT L+L G
Sbjct: 246 CTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG 303
Query: 354 NSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAV-GNPKSIPHLDLSKNELSGEIPSSL 411
N G+VP GSC L L LS N+ +G +P+ + + LDLS NE SGE+P SL
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
Query: 412 AWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISE 449
+ + L+LS NN G + + + + E
Sbjct: 364 TNLSASLLT---LDLSSNNFSGPILPNLCQNPKNTLQE 398
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-69
Identities = 84/372 (22%), Positives = 138/372 (37%), Gaps = 73/372 (19%)
Query: 3 DKQALLAFKSKVDDDPFGALSTWNDSVNFCQ--WLGVTCSLKYQ--RVILLNLSGQNLTG 58
DKQALL K + + LS+W + + C WLGV C Q RV L+LSG NL
Sbjct: 7 DKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 59 TA--SPYIGNLTFLRLINLQ-QNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLIL 115
+ NL +L + + NN IP I +L +L ++
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH-------------- 110
Query: 116 NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEY 175
+ G IP L + L + N +L+G++P + ++ ++
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYN-----------------ALSGTLPPSISSLPNLVG 153
Query: 176 FHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGL 235
N++ G +P G + ++ N+ G IP + +N + L ++D + N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212
Query: 236 IPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNL 295
+ + + L+ NSL+ L + + L L + N I G++P + L
Sbjct: 213 ASV---LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKN-LNGLDLRNNRIYGTLPQGLTQL 267
Query: 296 KNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNS 355
K L L++ NN+ EIP GN N
Sbjct: 268 KF------------------------LHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
Query: 356 IRGSVPSALGSC 367
P L +C
Sbjct: 303 CLCGSP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-59
Identities = 72/291 (24%), Positives = 125/291 (42%), Gaps = 41/291 (14%)
Query: 206 NQFFGNIPHSISNASKLEWLDFANNSLTG--LIPEDLDSLVNCTYLEVVSLS-VNSLSGT 262
+ G + + + ++ LD + +L IP SL N YL + + +N+L G
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP---SSLANLPYLNFLYIGGINNLVGP 92
Query: 263 LPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKL 322
+P ++A + L YLY++ +SG+IP + +K L+ + L +P S+ L L
Sbjct: 93 IPPAIAKLT-QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 323 QVLSLFENNISREIPSSLGNFTFL-TELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTG 381
++ N IS IP S G+F+ L T + + N + G +P + + ++DLS N L G
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 382 PIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNN----------- 430
+ G+ K+ + L+KN L+ ++ G L+L N
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGK-----VGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 431 -------------LDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCT 468
L G++P+ + + A N+ LCG LP CT
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPACT 313
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 7e-57
Identities = 58/429 (13%), Positives = 126/429 (29%), Gaps = 56/429 (13%)
Query: 41 LKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFN 100
+ +I ++ + I NN + + + RL +LR
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214
Query: 101 SNALQGQIPDSRLILNKLE-----GNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVS 155
++ + E + +L + + N
Sbjct: 215 NSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC--------------- 259
Query: 156 VYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFT-------LPNVRILLLAGNQF 208
+P L + M+ +V+ N+ + + ++I+ + N
Sbjct: 260 --PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 209 F-GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSL 267
+ S+ KL L+ N L G +P + L ++L+ N ++ +P +
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLPA----FGSEIKLASLNLAYNQITE-IPANF 372
Query: 268 ANFSSHLRYLYMSANPISG-SIPTEIGNLKNLIIIAIEK-------FILIRNIPISVGYL 319
F+ + L + N + + ++ + I + +
Sbjct: 373 CGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 320 LKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG-------SVPSALGSCHQL-W 371
+ + ++L N IS+ + L+ +NL GN + + + L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 372 LDLSHNHLTG-PIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWI--FGYISIFAKLNLSY 428
+DL N LT + +DLS N S P+ I + +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 429 NNLDGDVPR 437
N + P
Sbjct: 552 NRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-48
Identities = 61/406 (15%), Positives = 117/406 (28%), Gaps = 57/406 (14%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
N T NL L + + + +P + L ++ I N
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS- 287
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
K + ++ K + + + N T + L
Sbjct: 288 -----GEQLKDDWQALADAPVGEKIQIIYIGYNNLK----------------TFPVETSL 326
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
+ + NQL G P G + + L LA NQ + ++E L F
Sbjct: 327 QKMKKLGMLECLYNQLEG-KLPAFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSF 384
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS------SHLRYLYMSA 281
A+N L IP + + + + S N + + ++ + +S
Sbjct: 385 AHNKLKY-IPNIF-DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442
Query: 282 NPISGSIPTEIGNLKNLIIIAIEK-------FILIRNIPISVGYLLKLQVLSLFENNISR 334
N IS L I + +++ + L + L N ++
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT- 501
Query: 335 EIPSSL--GNFTFLTELNLCGNSIRGSVPSALGSCHQL-------WLDLSHNHLTGPIPL 385
++ +L ++L NS P+ + L D N P
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 386 AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ S+ L + N++ + I IS+ L++ N
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VNEK---ITPNISV---LDIKDNPN 599
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-44
Identities = 72/395 (18%), Positives = 117/395 (29%), Gaps = 63/395 (15%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS--------NIPHEIGRLFRLRHIIFN 100
+ + ++ L ++LIN+ N S + +++ I
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 101 SNALQ-GQIPDS--------RLIL--NKLEGNIPSELGSLLKFKGLGLANNYFTGPIP-- 147
N L+ + S L N+LEG +P GS +K L LA N T
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANF 372
Query: 148 -----HLNMFQVSVYSLTG-SIPIQLLNITSMEYFHVSENQLVG-------ELPPHIGFT 194
+ + L +++ M S N++ L P
Sbjct: 373 CGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF-K 431
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL----DSLVNCTYLE 250
NV + L+ NQ S S L ++ N LT + L ++ N L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310
+ L N L+ + A +L + +S N S PT+ N L
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK----------- 539
Query: 311 NIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370
N RE P + LT+L + N IR V + +
Sbjct: 540 -------GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITP--NI 589
Query: 371 -WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
LD+ N V L ++
Sbjct: 590 SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-38
Identities = 54/451 (11%), Positives = 120/451 (26%), Gaps = 134/451 (29%)
Query: 3 DKQALLAFKSKVDDDP-------FGALSTWNDSVNFCQW---LGVTCSLKYQRVILLNLS 52
D AL ++ + WN + W GV+
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL------------- 77
Query: 53 GQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSR 112
+ + ++L+ S +P IG+L L + S+ +
Sbjct: 78 ------------NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF- 124
Query: 113 LILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITS 172
P + + + + ++ + +
Sbjct: 125 ---------GPKGISANMSDEQKQKMRMHYQKTFVDY---------------DPREDFSD 160
Query: 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSL 232
+ + + +I S K + +N++
Sbjct: 161 LIK-------------------------DCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 233 TGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292
T + ++ + LR YM +P E
Sbjct: 196 TFV----------------------------SKAVMRLTK-LRQFYMGNSPFVAENICEA 226
Query: 293 GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352
+N E + + L L + ++ ++P+ L + +N+
Sbjct: 227 WENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 353 GNSIR--------GSVPSALGSCHQL-WLDLSHNHL-TGPIPLAVGNPKSIPHLDLSKNE 402
N + ++ + + +N+L T P+ ++ K + L+ N+
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341
Query: 403 LSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
L G++P+ FG A LNL+YN +
Sbjct: 342 LEGKLPA-----FGSEIKLASLNLAYNQITE 367
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 32/260 (12%), Positives = 68/260 (26%), Gaps = 35/260 (13%)
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG-LIPEDLDSLVNCTYLEVVS 253
V L L G G +P +I ++LE L ++ + E
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 254 LSVNSLSGTLPNSLANFS-SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI 312
T + S L ++++P SI
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT----------------- 182
Query: 313 PISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWL 372
LK + NNI+ + ++ T L + + +
Sbjct: 183 -------LKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN----E 230
Query: 373 DLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
+ + L N K + +++ ++P+ L + +N++ N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL----KALPEMQLINVACNRGI 286
Query: 433 GDVPRKMIFKNASAISEAGN 452
K ++ +
Sbjct: 287 SGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 16/116 (13%), Positives = 33/116 (28%), Gaps = 5/116 (4%)
Query: 335 EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSI 393
N+ F EL++ G +L S ++ L L +G +P A+G +
Sbjct: 52 FGTQPGANWNFNKELDMWGAQP----GVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107
Query: 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISE 449
L L + + + ++ S + +
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 72/256 (28%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 528 SYESLVKAT----------------VYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQ 570
S L A+ VYKG L D T +AVK L + G F E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 571 ALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC-------PRILSFLRRL 623
+ HRNL+++ C T R LVY +M +GS+ SC L + +R
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683
IA+ A L YLH HC I+H D+K +N+LLD + A +GDFGL + + +
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH---V 191
Query: 684 SVGLKGTVGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKM 728
+ ++GT+G+ PEY G++LLE+ TG+R D +
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 729 ALP----DQILQVLDP 740
++ ++D
Sbjct: 252 VKGLLKEKKLEALVDV 267
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 5e-51
Identities = 73/467 (15%), Positives = 148/467 (31%), Gaps = 63/467 (13%)
Query: 2 PDKQALLAFKSKVDD----------DPFGALSTWNDSVNFCQWLGVTCS--LKYQRVILL 49
D +AL A +D + WN + W RV L
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 50 NLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP 109
+L+G G IG LT L++++ ++ + + + +
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI----- 383
Query: 110 DSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTG------SI 163
R+ K+ + L +L + N PI + + + I
Sbjct: 384 --RMHYKKMFLDYDQRL-NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223
+ +T ++ + + + + + + + N S SN L
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTY-DNIAVDWED-----ANSDYAKQYENEELSWSNLKDLT 494
Query: 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG---------TLPNSLANFSSHL 274
++ N +P D L + L+ ++++ N L + +
Sbjct: 495 DVELYNCPNMTQLP---DFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK-I 550
Query: 275 RYLYMSANPISG-SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333
+ YM N + + + L ++ +R++ + G +KL L L N I
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCV-HNKVRHLE-AFGTNVKLTDLKLDYNQIE 608
Query: 334 REIPSSLGNFT-FLTELNLCGNSIRGSVPSA--LGSCHQL-WLDLSHNHLTG-----PIP 384
EIP FT + L N ++ +P+ S + + +D S+N +
Sbjct: 609 -EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 385 LAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ + + LS NE+ +F S + + LS N +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTE----LFATGSPISTIILSNNLM 709
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-44
Identities = 57/406 (14%), Positives = 114/406 (28%), Gaps = 59/406 (14%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
N NL L + L + +P + L L+ + N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS- 529
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
+ + + + K + + N P L
Sbjct: 530 AAQLKADWT----RLADDEDTGPKIQIFYMGYNNLEE-FP---------------ASASL 569
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLD 226
+ + N++ G T + L L NQ IP + ++E L
Sbjct: 570 QKMVKLGLLDCVHNKV--RHLEAFG-TNVKLTDLKLDYNQ-IEEIPEDFCAFTDQVEGLG 625
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS----HLRYLYMSAN 282
F++N L IP + + + V S N + N + + + +S N
Sbjct: 626 FSHNKLKY-IPNIF-NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 283 PISGSIPTEIGNLKNLIII--------AIEKFILIRNIPISVGYLLKLQVLSLFENNISR 334
I + I +I + L + + L + L N ++
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSL-KPKDGNYKNTYLLTTIDLRFNKLT- 741
Query: 335 EIPSSL--GNFTFLTELNLCGNSIRGSVPSALGSCHQLW-------LDLSHNHLTGPIPL 385
+ +L+ +++ N S P+ + QL D N + P
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 386 AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ S+ L + N++ ++ L L+++ N
Sbjct: 801 GITTCPSLIQLQIGSNDIR-KVDEKL------TPQLYILDIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 7e-16
Identities = 32/252 (12%), Positives = 63/252 (25%), Gaps = 64/252 (25%)
Query: 40 SLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS-------NIPHEIGRLF 92
K + LS + + + + I L N +S +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 93 RLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMF 152
L I N L + D +L + ++ N F+
Sbjct: 729 LLTTIDLRFNKLTS-LSDD------------FRATTLPYLSNMDVSYNCFS--------- 766
Query: 153 QVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNI 212
S P Q LN + ++ F + GN+
Sbjct: 767 ---------SFPTQPLNSSQLKAFGIRHQ-------------------RDAEGNRILRQW 798
Query: 213 PHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL-SGTLPNSLANFS 271
P I+ L L +N + + + L ++ ++ N S + +
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRKVDEKLTPQ------LYILDIADNPNISIDVTSVCPYIE 852
Query: 272 SHLRYLYMSANP 283
+ + L
Sbjct: 853 AGMYVLLYDKTQ 864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 9e-51
Identities = 85/443 (19%), Positives = 145/443 (32%), Gaps = 47/443 (10%)
Query: 40 SLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIF 99
LK+ + +L+LS NL + L L L+ NN H + LF +R++
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 100 NSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSL 159
+ + I L L L + L + +N G ++
Sbjct: 304 KRSFTKQSIS-----LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM---------- 348
Query: 160 TGSIPIQLLNITSMEYFHVSENQLVGELPPHIGF---TLPNVRILLLAGNQFFGNIPHSI 216
+ +++Y +S + + F + IL L N+ +
Sbjct: 349 -------FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401
Query: 217 SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRY 276
S LE LD N + + + + LS N NS A S L+
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQ--EWRGLENIFEIYLSYNKYLQLTRNSFALVPS-LQR 458
Query: 277 LYMSANPISG--SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISR 334
L + + S P+ L+NL I+ + + + L KL++L L NN++R
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 335 --------EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPL 385
L + L LNL N +L +DL N+L
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 386 AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP-----RKMI 440
N S+ L+L KN ++ F ++ L++ +N D I
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE---LDMRFNPFDCTCESIAWFVNWI 635
Query: 441 FKNASAISEAGNEKLCGGISELK 463
+ + I E + LC
Sbjct: 636 NETHTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-48
Identities = 69/418 (16%), Positives = 140/418 (33%), Gaps = 47/418 (11%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
LNL+ L + + L +++ N S P +L L+ + N L
Sbjct: 30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89
Query: 109 PDS----------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYS 158
+ L+ N ++ + L L++N +
Sbjct: 90 DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT--------- 140
Query: 159 LTGSIPIQLLNITSMEYFHVSENQLVGELPPHIG-FTLPNVRILLLAGNQFFGNIPHSIS 217
+ + +++ +S N++ + F +++ L L+ NQ P
Sbjct: 141 --------QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192
Query: 218 NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS-SHLRY 276
+L L N L + E L + T + +SLS + LS T + ++L
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252
Query: 277 LYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN------ 330
L +S N ++ L L +E + S+ L ++ L+L +
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 331 ---NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIP-- 384
++ + S L LN+ N I G + L +L LS++ +
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372
Query: 385 --LAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI 440
+ L+L+KN++S + F ++ L+L N + ++ +
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISKIESDA----FSWLGHLEVLDLGLNEIGQELTGQEW 426
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-44
Identities = 67/421 (15%), Positives = 127/421 (30%), Gaps = 61/421 (14%)
Query: 38 TCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHI 97
T S + + S LT P T + ++NL N R +L +
Sbjct: 3 TVSHEV-----ADCSHLKLT--QVP-DDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSL 54
Query: 98 IFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVY 157
N + P+ L K L L +N +
Sbjct: 55 DVGFNTISKLEPEL--------------CQKLPMLKVLNLQHNELSQLSDKT-------- 92
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSIS 217
T++ H+ N + + + N+ L L+ N +
Sbjct: 93 ---------FAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 218 NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277
L+ L +NN + L E+LD + L+ + LS N + P L L
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIF-ANSSLKKLELSSNQIKEFSPGCFHAI-GRLFGL 200
Query: 278 YMSANPISGSIPTEIG---NLKNLIIIAIEKFILIRNIPISVGYL--LKLQVLSLFENNI 332
+++ + S+ ++ ++ +++ L + L L +L L NN+
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260
Query: 333 SREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL----------WLDLSHNHLTGP 382
+ S L L N+I+ +L + +S L
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
Query: 383 IPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFK 442
+ K + HL++ N++ G + F + L+LS + F
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNM----FTGLINLKYLSLSNSFTSLRTLTNETFV 376
Query: 443 N 443
+
Sbjct: 377 S 377
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 55/270 (20%)
Query: 513 TSSESSSRKDLLLNVSYESLVKAT----------------VYKGILDLDQTFIAVKVLFL 556
S S V L +AT VYKG+L D +A+K
Sbjct: 15 ALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTP 73
Query: 557 HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLES---- 612
++ F E + L RH +LV +I C + N L+Y++M +G+L+
Sbjct: 74 ESSQGIEEFETEIETLSFCRHPHLVSLIGFCD----ERNE-MILIYKYMENGNLKRHLYG 128
Query: 613 ---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669
+S+ +RL I I A L YLH I+H D+K N+LLD + + DFG+
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185
Query: 670 TRFIPEVMSSNQCSSVGLKGTVGYATPEY---------------GILLLEIFTGKRPTSD 714
++ E+ ++ S +KGT+GY PEY G++L E+ +
Sbjct: 186 SKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 715 MFTEGLDLHNFVKMALP----DQILQVLDP 740
+ N + A+ Q+ Q++DP
Sbjct: 244 SLPRE--MVNLAEWAVESHNNGQLEQIVDP 271
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-45
Identities = 61/235 (25%), Positives = 92/235 (39%), Gaps = 45/235 (19%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNIRHRNLVKIITACSTSD 591
VYKG ++ T +AVK L + F E + + +H NLV+++ S D
Sbjct: 46 VVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD 103
Query: 592 FQGNYFRALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
LVY +M +GSL LS+ R IA A+ + +LH + +
Sbjct: 104 D-----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HI 155
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------- 698
H D+K +N+LLD TA + DFGL R + + S + GT Y PE
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRI--VGTTAYMAPEALRGEITP 213
Query: 699 -------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-----DQILQVLDPL 741
G++LLEI TG + + + I +D
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREP----QLLLDIKEEIEDEEKTIEDYIDKK 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-42
Identities = 64/402 (15%), Positives = 127/402 (31%), Gaps = 34/402 (8%)
Query: 49 LNLSGQNLTGTASPY-IGNLTFLRLINLQQNNFSSNI---PHEIGRLFRLRHIIFNSNAL 104
L L + I L L + L F + + L L ++ L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 105 QGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQ-----VSVYSL 159
L+ +I L L + F +
Sbjct: 265 AY--------LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 160 TGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQ--FFGNIPHSIS 217
++L ++ + + E+ LP++ L L+ N F G S
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVD------LPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 218 NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277
+ L++LD + N + + + + LE + ++L S+ +L YL
Sbjct: 371 GTTSLKYLDLSFNGVITMSS----NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 278 YMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI-PISVGYLLKLQVLSLFENNISREI 336
+S + L +L ++ + N P L L L L + + +
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 337 PSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN-PKSIP 394
P++ + + L LN+ N+ + L LD S NH+ + + P S+
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546
Query: 395 HLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436
L+L++N+ + +I +L + ++ P
Sbjct: 547 FLNLTQNDFACTCE--HQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-37
Identities = 64/423 (15%), Positives = 121/423 (28%), Gaps = 77/423 (18%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L+LS L S + L++++L + + L L +I N
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN------ 86
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
++ L + L +L +
Sbjct: 87 --------PIQSLALGAFSGLSSLQKLVAVET-----------------NLASLENFPIG 121
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEW---- 224
++ +++ +V+ N + P L N+ L L+ N+ + ++
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN-- 282
LD + N + + P + L ++L N S + + + L +
Sbjct: 182 LDLSLNPMNFIQPGAFKEI----RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 283 ----PISGSIPTEIGNLKNLII--IAIEKFILIRNIPISV-GYLLKLQVLSLFENNISRE 335
+ + + L NL I + + I + L + SL I R
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 336 IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL--------------------WLDLS 375
S L L L S +L +LDLS
Sbjct: 298 KDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 376 HNHLT--GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
N L+ G + S+ +LDLS N + + G + L+ ++NL
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN----FLGLEQLEH-LDFQHSNLKQ 410
Query: 434 DVP 436
Sbjct: 411 MSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-31
Identities = 48/265 (18%), Positives = 93/265 (35%), Gaps = 41/265 (15%)
Query: 186 ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN 245
++P ++ + + L L+ N +S + +L+ LD + + + + +
Sbjct: 21 KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED---GAYQS 74
Query: 246 CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEK 305
++L + L+ N + + + SS L+ L ++ IG+LK
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSS-LQKLVAVETNLASLENFPIGHLKT-------- 125
Query: 306 FILIRNIPISVGYLLKLQVLSLFENNISR-EIPSSLGNFTFLTELNLCGNSIRGSVPSAL 364
L+ L++ N I ++P N T L L+L N I+ + L
Sbjct: 126 ----------------LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 365 GSCHQL-----WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYIS 419
HQ+ LDLS N + P A + L L N S + + ++
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT---CIQGLA 225
Query: 420 IFAKLNLSYNNLDGDVPRKMIFKNA 444
L + + K+A
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 45/246 (18%), Positives = 88/246 (35%), Gaps = 36/246 (14%)
Query: 48 LLNLSGQNLT--GTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQ 105
L+LS L+ G S T L+ ++L N + + L +L H+ F + L+
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 106 GQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPI 165
S SL L +++ + +
Sbjct: 410 QMSE-------------FSVFLSLRNLIYLDISHTHTRVAFNGI---------------- 440
Query: 166 QLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWL 225
++S+E ++ N P I L N+ L L+ Q P + ++ S L+ L
Sbjct: 441 -FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 226 DFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285
+ ++N+ L L+V+ S+N + + L +F S L +L ++ N +
Sbjct: 500 NMSHNNFFSLDT---FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
Query: 286 GSIPTE 291
+ +
Sbjct: 557 CTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 33/185 (17%), Positives = 68/185 (36%), Gaps = 2/185 (1%)
Query: 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310
V +++ + N + L +S NP+ + L ++ + + +
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 311 NIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370
+ L L L L N I + + L +L ++ +G L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 371 -WLDLSHNHLTG-PIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSY 428
L+++HN + +P N ++ HLDLS N++ + L + + L+LS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 429 NNLDG 433
N ++
Sbjct: 187 NPMNF 191
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 65/391 (16%), Positives = 124/391 (31%), Gaps = 29/391 (7%)
Query: 40 SLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIG--RLFRLRHI 97
SL+ + LNL+G N P + + +N I + + L
Sbjct: 175 SLQQATNLSLNLNG-NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 98 IFNSNALQGQIPDSRLIL------------NKLEGNIPSELGSLLKFKGLGLANNYFT-- 143
F + P L + + + L L + +
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293
Query: 144 ----GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR 199
+ L +S I N S+ + + N EL L N+R
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 200 ILLLAGNQ--FFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVN 257
L L+ + + N S L+ L+ + N L E LE++ L+
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ---LELLDLAFT 410
Query: 258 SLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVG 317
L S L+ L +S + + S L L + ++ +
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 318 ---YLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDL 374
L +L++L L ++S + + + ++L N + S AL ++L+L
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNL 530
Query: 375 SHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405
+ NH++ +P + ++L +N L
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 75/403 (18%), Positives = 130/403 (32%), Gaps = 40/403 (9%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L ++ + N L + L N+ SS + +L+ + F +NA+
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 109 PDS----------RLILNKLE-GNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVY 157
+ L LN + I F+ L I
Sbjct: 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK--------- 220
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHI--GFTLPNVRILLLAGNQFFGNIPHS 215
++ I S+ + ++ P + G +V + L + FF ++
Sbjct: 221 ------GLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLR 275
S L+ LD L+ L LV + L+ + LS N S +NF S L
Sbjct: 274 FHCFSGLQELDLTATHLSEL----PSGLVGLSTLKKLVLSANKFENLCQISASNFPS-LT 328
Query: 276 YLYMSANPISGSIPTE-IGNLKNLIIIAIE--KFILIRNIPISVGYLLKLQVLSLFENNI 332
+L + N + T + NL+NL + + + + L LQ L+L N
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP 388
Query: 333 SREIPSSLGNFTFLTELNLCGNSIRGSVP-SALGSCHQL-WLDLSHNHLTGPIPLAVGNP 390
+ L L+L ++ S + H L L+LSH+ L
Sbjct: 389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448
Query: 391 KSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
++ HL+L N + L LS+ +L
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTN-SLQTLGRLEILVLSFCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 66/400 (16%), Positives = 126/400 (31%), Gaps = 47/400 (11%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
N L + L N + RL L + +
Sbjct: 17 YNCENLGLNEIPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
D+ S + L L N L L
Sbjct: 74 EDT--------------FQSQHRLDTLVLTAN-----------------PLIFMAETALS 102
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
++++ + + + + L L N KL+ LDF
Sbjct: 103 GPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI 288
NN++ L ED+ SL T L ++L+ N ++G P + S+ + L I
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLS-LNLNGNDIAGIEPGAFD--SAVFQSLNFGGTQNLLVI 218
Query: 289 PTEIGN--LKNLIIIAIE--KFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344
+ N +++L + E I + ++ ++L ++ ++ F+
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 345 FLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403
L EL+L + +PS L L L LS N ++ N S+ HL + N
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 404 SGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKN 443
E+ + + +L+LS+++++ + +N
Sbjct: 338 RLELGTG---CLENLENLRELDLSHDDIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-18
Identities = 39/240 (16%), Positives = 69/240 (28%), Gaps = 34/240 (14%)
Query: 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
+ N L IP L + E + S N L + + +L +L ++ I
Sbjct: 17 YNCENLGLNE-IPGTLPN-----STECLEFSFNVLPTIQNTTFSRLI-NLTFLDLTRCQI 69
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344
+ L L L N + ++L
Sbjct: 70 YWIHEDTFQSQHRL------------------------DTLVLTANPLIFMAETALSGPK 105
Query: 345 FLTELNLCGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403
L L I L + L L L NH++ + + LD N +
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 404 SGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
++ + + LNL+ N++ G P +++ G + L LK
Sbjct: 166 HYLSKEDMSSLQQ--ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 35/204 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
TV++ + +AVK+L A + F+ E ++ +RH N+V + A +
Sbjct: 51 GTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--- 105
Query: 593 QGNYFRALVYEFMHHGSL------ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
N ++V E++ GSL L RRL++A DVA + YLH+ PIVH
Sbjct: 106 PPNL--SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------- 697
+LK N+L+D T + DFGL+R + +S SS GT + PE
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSR----LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 698 ------YGILLLEIFTGKRPTSDM 715
+G++L E+ T ++P ++
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNL 242
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 51/213 (23%), Positives = 81/213 (38%), Gaps = 35/213 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+K L ++AVK+ + + + + E +L ++H N+++ I A
Sbjct: 38 GCVWKAQLL--NEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGT-SV 93
Query: 595 NYFRALVYEFMHHGSLES--CPRILSFLRRLNIAIDVASALEYLHHH-------CKKPIV 645
+ L+ F GSL ++S+ +IA +A L YLH K I
Sbjct: 94 DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------- 698
H D+K NVLL N++TA + DFGL S+ GT Y PE
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--VGTRRYMAPEVLEGAINF 211
Query: 699 -------------GILLLEIFTGKRPTSDMFTE 718
G++L E+ + E
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 40/203 (19%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V K +A+K + K+F+ E + L + H N+VK+ AC +
Sbjct: 22 GVVCKAKWR--AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC-LNPV-- 74
Query: 595 NYFRALVYEFMHHGSL------ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
LV E+ GSL + ++ + + + YLH K ++H D
Sbjct: 75 ----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 649 LKPSNVLLDNDMT-AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------- 697
LKP N+LL T + DFG I M++N KG+ + PE
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------KGSAAWMAPEVFEGSNYSEK 183
Query: 698 -----YGILLLEIFTGKRPTSDM 715
+GI+L E+ T ++P ++
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEI 206
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 48/214 (22%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ-------RGALKSFMAECQALRNIRHRNLVKIITAC 587
V+KG L D++ +A+K L L + F E + N+ H N+VK+
Sbjct: 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 588 STSDFQGNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKP 643
+V EF+ G L + + +L + +D+A +EY+ + P
Sbjct: 93 HNPPR-------MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPP 144
Query: 644 IVHCDLKPSNVLLDN-----DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE- 697
IVH DL+ N+ L + + A + DFGL++ +S G + PE
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-------LGNFQWMAPET 197
Query: 698 ----------------YGILLLEIFTGKRPTSDM 715
+ ++L I TG+ P +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 30/201 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
++KG I VKVL + + F EC LR H N++ ++ AC S
Sbjct: 24 GELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC-QSPP 80
Query: 593 QGNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
+ L+ +M +GSL E ++ + + A+D+A + +LH + I
Sbjct: 81 APHP--TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRH 137
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFI-------------PEVMSSNQCSSVGLKGTVGYA 694
L +V++D DMTA + + PE + + + ++
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM-WS 196
Query: 695 TPEYGILLLEIFTGKRPTSDM 715
+ +LL E+ T + P +D+
Sbjct: 197 ---FAVLLWELVTREVPFADL 214
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 56/202 (27%), Positives = 80/202 (39%), Gaps = 21/202 (10%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQ--ALRNIRHRNLVKIITACSTSDF 592
VYKG LD + +AVKV R ++F+ E + + H N+ + I
Sbjct: 27 GAVYKGSLD--ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81
Query: 593 QGNYFRALVYEFMHHGSLES--CPRILSFLRRLNIAIDVASALEYLH------HHCKKPI 644
G LV E+ +GSL ++ +A V L YLH H K I
Sbjct: 82 DGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFI----PEVMSSNQCSSVGLKGTVGYATPEY-- 698
H DL NVL+ ND T + DFGL+ + +++ GT+ Y PE
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201
Query: 699 GILLLEIFTGKRPTSDMFTEGL 720
G + L DM+ GL
Sbjct: 202 GAVNLRDXESALKQVDMYALGL 223
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 47/210 (22%), Positives = 77/210 (36%), Gaps = 42/210 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVL----FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VY+ +AVK +++ E + ++H N++ + C
Sbjct: 21 GKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78
Query: 591 DFQGNYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
N LV EF G L + + +N A+ +A + YLH PI+H D
Sbjct: 79 P---NL--CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133
Query: 649 LKPSNVLLDNDMTAHM--------GDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
LK SN+L+ + DFGL R ++ + + G + PE
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREW------HRTTKMSAAGAYAWMAPEVIR 187
Query: 698 ------------YGILLLEIFTGKRPTSDM 715
YG+LL E+ TG+ P +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 38/204 (18%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
TVYKG D +AVK+L + L++F E LR RH N++ + +
Sbjct: 39 TVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL- 94
Query: 594 GNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
A+V ++ SL + ++IA A ++YLH K I+H DL
Sbjct: 95 -----AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------ 697
K +N+ L D T +GDFGL S+Q L G++ + PE
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE--QLSGSILWMAPEVIRMQDSNPYSF 204
Query: 698 ------YGILLLEIFTGKRPTSDM 715
+GI+L E+ TG+ P S++
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 47/230 (20%), Positives = 81/230 (35%), Gaps = 41/230 (17%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
K + +K L ++F+ E + +R + H N++K I
Sbjct: 25 QAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK---DKR 81
Query: 596 YFRALVYEFMHHGSLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+ E++ G+L S + +R++ A D+AS + YLH I+H DL
Sbjct: 82 LN--FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNS 136
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK----------GTVGYATPE---- 697
N L+ + + DFGL R + + + + K G + PE
Sbjct: 137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196
Query: 698 -----------YGILLLEIFTGKRPTSDMF----TEGLDLHNFVKMALPD 732
+GI+L EI D GL++ F+ P
Sbjct: 197 RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 55/312 (17%), Positives = 102/312 (32%), Gaps = 26/312 (8%)
Query: 116 NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTG--SIP--IQLLNIT 171
L L + + + N Q+ + + ++
Sbjct: 23 TALR-PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQP 81
Query: 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS 231
+ L + P L +++ + + +P ++ + LE L A N
Sbjct: 82 GRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNP 138
Query: 232 LTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS--------SHLRYLYMSANP 283
L L P S+ + L +S+ LP LA+ +L+ L +
Sbjct: 139 LRAL-PA---SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF 343
I S+P I NL+NL + I + + ++ +L KL+ L L R P G
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNS-PLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 344 TFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN- 401
L L L S ++P + QL LDL +P + + + + +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 402 --ELSGEIPSSL 411
+L P +
Sbjct: 313 QAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 55/337 (16%), Positives = 113/337 (33%), Gaps = 38/337 (11%)
Query: 58 GTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD-SRLILN 116
G++ + + + + Q + + + R + N + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 117 KLEGN----IPSELGSL--LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNI 170
G L L L + P Q +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP------------------QFPDQAFRL 103
Query: 171 TSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN 230
+ +++ + L+ ELP + + L LA N +P SI++ ++L L
Sbjct: 104 SHLQHMTIDAAGLM-ELPDTMQ-QFAGLETLTLARNPL-RALPASIASLNRLRELSIRAC 160
Query: 231 SLTGLIPEDL------DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
+PE L L+ + L + +LP S+AN + L+ L + +P+
Sbjct: 161 PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN-LKSLKIRNSPL 218
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344
S ++ I +L L + + +RN P G L+ L L + + +P + T
Sbjct: 219 S-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 345 FLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380
L +L+L G +PS + + + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 47/307 (15%), Positives = 103/307 (33%), Gaps = 54/307 (17%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLI--NLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQ 105
+ +G+ L TA + + T + L+ P + RL L+H+ ++ L
Sbjct: 60 IETRTGRALKATADL-LEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM 117
Query: 106 GQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPI 165
+P + + L LA N ++P
Sbjct: 118 ---------------ELPDTMQQFAGLETLTLARNPLR------------------ALPA 144
Query: 166 QLLNITSMEYFHVSENQLVGELPPHIG--------FTLPNVRILLLAGNQFFGNIPHSIS 217
+ ++ + + + ELP + L N++ L L ++P SI+
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIA 203
Query: 218 NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277
N L+ L N+ L+ L ++ + LE + L + P + L+ L
Sbjct: 204 NLQNLKSLKIRNSPLSAL----GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP-LKRL 258
Query: 278 YMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN---NISR 334
+ ++P +I L L + + + + +P + L ++ + + + +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
Query: 335 EIPSSLG 341
P +
Sbjct: 319 HRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 28/229 (12%), Positives = 62/229 (27%), Gaps = 40/229 (17%)
Query: 209 FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268
G+ H ++S E L F ++ + D L + + NS
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTA---LRPYHDVLSQWQRHYNADRNRWHSAWRQANS-- 55
Query: 269 NFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328
++ + + + + + + L L
Sbjct: 56 ---NNPQIETRTGRALK-ATADLLEDAT----------------------QPGRVALELR 89
Query: 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAV 387
+ + P + L + + + +P + L L L+ N L +P ++
Sbjct: 90 SVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASI 146
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFA-----KLNLSYNNL 431
+ + L + E+P LA L L + +
Sbjct: 147 ASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 45/211 (21%), Positives = 73/211 (34%), Gaps = 36/211 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQ--ALRNIRHRNLVKIITACSTSDF 592
V++G +AVK+ KS+ E + +RH N++ I + TS
Sbjct: 22 GEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDMTSRH 76
Query: 593 QGNYFRALVYEFMHHGSLES--CPRILSFLRRLNIAIDVASALEYLH-----HHCKKPIV 645
L+ + GSL L + L I + +AS L +LH K I
Sbjct: 77 SSTQL-WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H DLK N+L+ + + D GL + + + GT Y PE
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 698 -------------YGILLLEIFTGKRPTSDM 715
+G++L E+ +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 45/212 (21%), Positives = 77/212 (36%), Gaps = 43/212 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY G + +A++++ + + LK+F E A R RH N+V + AC +
Sbjct: 47 GQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--- 100
Query: 593 QGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
+ A++ +L S +L + IA ++ + YLH K I+H D
Sbjct: 101 PPHL--AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKD 155
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV-GLKGTVGYATPE---------- 697
LK NV DN + DFGL + + + + G + + PE
Sbjct: 156 LKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 698 --------------YGILLLEIFTGKRPTSDM 715
G + E+ + P
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 69/410 (16%), Positives = 126/410 (30%), Gaps = 56/410 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS-NIPHEIGRLFRLRHIIFNSNALQGQ 107
L L S IG L L+ +N+ N S +P L L H+ + N +Q
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 108 IPDSRLILNKLEGN-------------IPSELGSLLKFKGLGLANNYFTGPIPHLNMFQV 154
+ L + I + +K L L N+ + I
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIM------- 221
Query: 155 SVYSLTGSIPIQLLNITSMEYFHVSENQLVGE-----LPPHIGFTLPNVRI--LLLAGNQ 207
L N+ + + + E P I L +V I L
Sbjct: 222 ---------KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 208 FFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSL 267
F + + + + A S+ L+ + + +S+ L L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIK-----YLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 268 ANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIE--KFILIRNIPISVGYLLKLQVL 325
L+ L ++ N S I + L +L + + S L+ L
Sbjct: 328 ----PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 326 SLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVP-SALGSCHQL-WLDLSHNHLTGPI 383
L N + ++ L L+ ++++ SA S +L +LD+S+ +
Sbjct: 382 DLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 384 PLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
S+ L ++ N S+ +F + L+LS L+
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSN---VFANTTNLTFLDLSKCQLEQ 487
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 67/420 (15%), Positives = 132/420 (31%), Gaps = 55/420 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQ---QNNFSSNIPHEIGRLFRLRHIIFNSNALQ 105
++LS + + L +NL N I + + +L + N
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNS 217
Query: 106 GQIPDS-----------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQV 154
I + RLIL + + E+ +GL ++ F++
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL---------CDVTIDEFRL 268
Query: 155 SVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFT-------------------L 195
+ + ++ + ++ ++ + L L
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 196 PNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
P ++ L L N+ G+I L +LD + N+L+ L L + LS
Sbjct: 328 PFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL-GTNSLRHLDLS 384
Query: 256 VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTE-IGNLKNLIIIAIEKFILIRNIPI 314
N + + L++L + + +L+ L+ + I +
Sbjct: 385 FNGAI-IMSANFMGLEE-LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 315 SVGYLLKLQVLSLFENNISREIPSS-LGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WL 372
L L L + N+ S+ N T LT L+L + + H+L L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502
Query: 373 DLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
++SHN+L S+ LD S N + ++ NL+ N++
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH-FPKSLAF---FNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 74/417 (17%), Positives = 133/417 (31%), Gaps = 47/417 (11%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
++LS L S N + L+ ++L + + L L ++I N +Q
Sbjct: 37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 96
Query: 109 PDS--------RLIL--NKLEGNIPSELGSLLKFKGLGLANNYFTG--------PIPHLN 150
P S L+ KL +G L+ K L +A+N+ + +L
Sbjct: 97 PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 156
Query: 151 MFQVSVYSLTGSIPIQLLNITSM----EYFHVSENQLVGELPPHIGFTLPNVRILLLAGN 206
+S + L + +S N + + F + L L GN
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQA-FQGIKLHELTLRGN 214
Query: 207 QFFGNIP-HSISNASKLEWLD------FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259
NI + N + L +L P ++ L + T E L+ +
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF-RLTYTND 273
Query: 260 SGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYL 319
+ ++ + ++ I + ++ I + L
Sbjct: 274 FSDDIVKFHCLA-NVSAMSLAGVSI-----KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 320 LKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA---LGSCHQLWLDLSH 376
L+ L+L N S I L+ L+L N++ S + LG+ LDLS
Sbjct: 328 PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 377 NHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
N + + + HLD + L S F + L++SY N
Sbjct: 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSA---FLSLEKLLYLDISYTNTKI 438
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 58/396 (14%), Positives = 118/396 (29%), Gaps = 62/396 (15%)
Query: 49 LNLSGQNLTGTASPYI-GNL-TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQG 106
Q L+ + ++ + + I+L N + L+ + + ++
Sbjct: 16 YQCMDQKLS-----KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 107 QIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQ 166
+ L L L N + P
Sbjct: 71 IEDKA--------------WHGLHHLSNLILTGN-----------------PIQSFSPGS 99
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFG-NIPHSISNASKLEWL 225
+TS+E E +L L L ++ L +A N +P SN + L +
Sbjct: 100 FSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 226 DFANNSLTGLIPEDLDSLVNCTYLEVV-SLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
D + N + + DL L + + +S+N + + L L + N
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK--LHELTLRGNFN 216
Query: 285 SGSIP-TEIGNLKNLIIIAIEKFILIRNIPISVGYL--------LKLQVLSLFENNISRE 335
S +I T + NL L + + + + + + L N +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 336 IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPH 395
++ ++L G SI+ + L + L + +
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKS 332
Query: 396 LDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
L L+ N+ S+++ + + L+LS N L
Sbjct: 333 LTLTMNKG------SISFKKVALPSLSYLDLSRNAL 362
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 45/232 (19%), Positives = 79/232 (34%), Gaps = 41/232 (17%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
+P I S + +D + N L L S N + L+ + LS + +
Sbjct: 26 VPDDIP--SSTKNIDLSFNPLKILKS---YSFSNFSELQWLDLSRCEIETIEDKAWHGLH 80
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
HL L ++ NPI P L +L + L E
Sbjct: 81 -HLSNLILTGNPIQSFSPGSFSGLTSL------------------------ENLVAVETK 115
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRG-SVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
++ +G L +LN+ N I +P+ + L +DLS+N++ +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
Query: 390 ----PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437
P+ LD+S N + F I + +L L N ++ +
Sbjct: 176 LRENPQVNLSLDMSLNPIDFIQDQ----AFQGIKLH-ELTLRGNFNSSNIMK 222
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 44/211 (20%), Positives = 72/211 (34%), Gaps = 36/211 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAEC--QALRNIRHRNLVKIITACSTSDF 592
V++G +AVK+ + +S+ E +RH N++ I A + +
Sbjct: 56 GEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 593 QGNYFRALVYEFMHHGSLES--CPRILSFLRRLNIAIDVASALEYLH-----HHCKKPIV 645
LV ++ HGSL ++ + +A+ AS L +LH K I
Sbjct: 111 TWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H DLK N+L+ + T + D GL + + GT Y PE
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 698 -------------YGILLLEIFTGKRPTSDM 715
G++ EI
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 45/209 (21%), Positives = 68/209 (32%), Gaps = 36/209 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQ--ALRNIRHRNLVKIITACSTSDF 592
V+ G +AVKV F + S+ E + +RH N++ I A
Sbjct: 51 GEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTG 105
Query: 593 QGNYFRALVYEFMHHGSLES--CPRILSFLRRLNIAIDVASALEYLH-----HHCKKPIV 645
L+ ++ +GSL L L +A S L +LH K I
Sbjct: 106 SWTQL-YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H DLK N+L+ + T + D GL + GT Y PE
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 698 -------------YGILLLEIFTGKRPTS 713
+G++L E+
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 90/407 (22%), Positives = 147/407 (36%), Gaps = 45/407 (11%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L + + L L IN N + P + L +L I+ N+N +
Sbjct: 51 LQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106
Query: 109 PDSRL----ILNKLEGN---IPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTG 161
P + L L L N L +L L L++N + + + S
Sbjct: 107 PLANLTNLTGLT-LFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN 165
Query: 162 SI--PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNA 219
+ L N+T++E +S N++ + L N+ L+ NQ P +
Sbjct: 166 QVTDLKPLANLTTLERLDISSNKVSD--ISVLA-KLTNLESLIATNNQISDITP--LGIL 220
Query: 220 SKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYM 279
+ L+ L N L D+ +L + T L + L+ N +S P L+ + L L +
Sbjct: 221 TNLDELSLNGNQLK-----DIGTLASLTNLTDLDLANNQISNLAP--LSGLTK-LTELKL 272
Query: 280 SANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSS 339
AN IS P + L L + + + L PI L L L+L+ NNIS P
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP-- 326
Query: 340 LGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDL 398
+ + T L L N + S+L + + WL HN ++ PL N I L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGL 382
Query: 399 SKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNAS 445
+ + + A + + N N + I S
Sbjct: 383 NDQAWTNAPVNYKANV-------SIPNTVKNVTGALIAPATISDGGS 422
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 82/374 (21%), Positives = 137/374 (36%), Gaps = 56/374 (14%)
Query: 64 IGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123
L L + N + + L ++ + + +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI----------------KSI 61
Query: 124 SELGSLLKFKGLGLANNYFTGPIP-----HLNMFQVSVYSLTGSIPIQLLNITSMEYFHV 178
+ L + +NN T P L ++ + P+ N+T++ +
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTL 119
Query: 179 SENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE 238
NQ+ + L N+ L L+ N + ++S + L+ L F N
Sbjct: 120 FNNQITD--IDPLK-NLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVT------ 168
Query: 239 DLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNL 298
DL L N T LE + +S N +S + LA ++ L L + N IS P +G L NL
Sbjct: 169 DLKPLANLTTLERLDISSNKVSD--ISVLAKLTN-LESLIATNNQISDITP--LGILTNL 223
Query: 299 IIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358
+++ +++I ++ L L L L N IS P L T LTEL L N I
Sbjct: 224 DELSLNG-NQLKDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279
Query: 359 SVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGY 417
S L L L+L+ N L P+ N K++ +L L N +S P
Sbjct: 280 I--SPLAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP------VSS 329
Query: 418 ISIFAKLNLSYNNL 431
++ +L N +
Sbjct: 330 LTKLQRLFFYNNKV 343
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-24
Identities = 81/401 (20%), Positives = 148/401 (36%), Gaps = 47/401 (11%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
+ ++ + + NLT L + L N + P + L L + +SN +
Sbjct: 95 ILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS 150
Query: 109 PDSRLI-LNKLE--GNI--PSELGSLLKFKGLGLANNYFTGP-----IPHLNMFQVSVYS 158
S L L +L + L +L + L +++N + + +L +
Sbjct: 151 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ 210
Query: 159 LTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISN 218
++ P+ +L T+++ ++ NQL + +L N+ L LA NQ P +S
Sbjct: 211 ISDITPLGIL--TNLDELSLNGNQLKD--IGTLA-SLTNLTDLDLANNQISNLAP--LSG 263
Query: 219 ASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278
+KL L N ++ + P L T L + L+ N L P ++N + L YL
Sbjct: 264 LTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISP--ISNLKN-LTYLT 315
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRN---IPISVGYLLKLQVLSLFENNISRE 335
+ N IS P + +L L ++ N S+ L + LS N IS
Sbjct: 316 LYFNNISDISP--VSSLTKL-----QRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDL 368
Query: 336 IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPH 395
P L N T +T+L L + + + + + P + + S
Sbjct: 369 TP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA-PATISDGGSYTE 425
Query: 396 LDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436
D++ N S + +++ F S + G V
Sbjct: 426 PDITWNLPS--YTNEVSYTF---SQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-17
Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 38/237 (16%)
Query: 215 SISNASKLEWLDFANNSLTGLIP-----------------EDLDSLVNCTYLEVVSLSVN 257
+ + ++ ++T + + +D + L ++ S N
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNN 78
Query: 258 SLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVG 317
L+ P L N + L + M+ N I+ P + NL NL + + I +I +
Sbjct: 79 QLTDITP--LKNLTK-LVDILMNNNQIADITP--LANLTNLTGLTLF-NNQITDID-PLK 131
Query: 318 YLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSH 376
L L L L N IS S+L T L +L+ GN + L + L LD+S
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTD--LKPLANLTTLERLDISS 186
Query: 377 NHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
N ++ L ++ L + N++S P G ++ +L+L+ N L
Sbjct: 187 NKVSDISVL--AKLTNLESLIATNNQISDITP------LGILTNLDELSLNGNQLKD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 76/389 (19%), Positives = 140/389 (35%), Gaps = 66/389 (16%)
Query: 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNA 103
I L ++T L + + + +S I I L L ++ N N
Sbjct: 22 AEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQ 77
Query: 104 LQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSI 163
+ P L +L+K L + N T
Sbjct: 78 ITDISP----------------LSNLVKLTNLYIGTNKITDISA---------------- 105
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223
L N+T++ +++E+ + + L + L L N ++ +SN + L
Sbjct: 106 ---LQNLTNLRELYLNEDNISD--ISPLA-NLTKMYSLNLGANHNLSDLS-PLSNMTGLN 158
Query: 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283
+L + + + P + N T L +SL+ N + + LA+ +S L Y N
Sbjct: 159 YLTVTESKVKDVTP-----IANLTDLYSLSLNYNQIED--ISPLASLTS-LHYFTAYVNQ 210
Query: 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF 343
I+ P + N+ L + I I ++ + L +L L + N IS +++ +
Sbjct: 211 ITDITP--VANMTRLNSLKIGN-NKITDLS-PLANLSQLTWLEIGTNQISD--INAVKDL 264
Query: 344 TFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNE 402
T L LN+ N I S L + QL L L++N L +G ++ L LS+N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 403 LSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
++ P +S + + +
Sbjct: 323 ITDIRP------LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 62/320 (19%), Positives = 124/320 (38%), Gaps = 36/320 (11%)
Query: 124 SELGSLLKFKGLGLANNYFTGPIP-----HLNMFQVSVYSLTGSIPIQLLNITSMEYFHV 178
L + L T + + V+ + I+ L T++EY ++
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASIQGIEYL--TNLEYLNL 73
Query: 179 SENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE 238
+ NQ+ + L + L + N+ ++ N + L L ++++ + P
Sbjct: 74 NGNQITD--ISPLS-NLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP- 127
Query: 239 DLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNL 298
L N T + ++L N + + L+N + L YL ++ + + P I NL +L
Sbjct: 128 ----LANLTKMYSLNLGANHNL-SDLSPLSNMTG-LNYLTVTESKVKDVTP--IANLTDL 179
Query: 299 IIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358
+++ I +I + L L + + N I+ P + N T L L + N I
Sbjct: 180 YSLSLNY-NQIEDIS-PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235
Query: 359 SVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGY 417
S L + QL WL++ N ++ + + + L++ N++S +I
Sbjct: 236 L--SPLANLSQLTWLEIGTNQISDINAV--KDLTKLKMLNVGSNQIS-DISV-----LNN 285
Query: 418 ISIFAKLNLSYNNLDGDVPR 437
+S L L+ N L +
Sbjct: 286 LSQLNSLFLNNNQLGNEDME 305
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 6e-10
Identities = 34/161 (21%), Positives = 59/161 (36%), Gaps = 17/161 (10%)
Query: 277 LYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREI 336
L PI+ P +L I ++K + + L + L + ++
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS-- 58
Query: 337 PSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPH 395
+ T L LNL GN I S L + +L L + N +T L N ++
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDISAL--QNLTNLRE 114
Query: 396 LDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436
L L+++ +S P ++ LNL N+ D+
Sbjct: 115 LYLNEDNISDISP------LANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 44/196 (22%), Positives = 74/196 (37%), Gaps = 20/196 (10%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L ++ + I NLT L ++L N P + L L + N +
Sbjct: 160 LTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215
Query: 109 PDSRLI-LNKL--EGN---IPSELGSLLKFKGLGLANNYFTGPIP-----HLNMFQVSVY 157
P + + LN L N S L +L + L + N + L M V
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSIS 217
++ + N++ + ++ NQL E IG L N+ L L+ N P ++
Sbjct: 276 QISDISVLN--NLSQLNSLFLNNNQLGNEDMEVIG-GLTNLTTLFLSQNHITDIRP--LA 330
Query: 218 NASKLEWLDFANNSLT 233
+ SK++ DFAN +
Sbjct: 331 SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 12/111 (10%), Positives = 33/111 (29%), Gaps = 13/111 (11%)
Query: 322 LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380
L+ I++ P + L S+ + L ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 381 GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ ++ +L+L+ N+++ P + L + N +
Sbjct: 58 SIQGI--EYLTNLEYLNLNGNQITDISP------LSNLVKLTNLYIGTNKI 100
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 83/436 (19%), Positives = 149/436 (34%), Gaps = 57/436 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS-NIPHEIGRLFRLRHIIFNSNALQGQ 107
L NL + IG+L L+ +N+ N S +P L L H+ +SN +Q
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 108 IPDSRLILNKLEGN-------------IPSELGSLLKFKGLGLANNYFTGPIP------- 147
+L+++ I ++ L L NN+ + +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGL 224
Query: 148 -HLNMFQVSVYSLTGSIPIQLLNIT--------SMEYFHVSENQLVGELPPHIGFTLPNV 198
L + ++ + ++ + + ++E F ++ + + L NV
Sbjct: 225 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284
Query: 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSL--------------- 243
L S + L+ N L SL
Sbjct: 285 SSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342
Query: 244 -VNCTYLEVVSLSVNSLSGTLPNSLANFS-SHLRYLYMSANPISGSIPTEIGNLKNLIII 301
V+ LE + LS N LS S ++F + L+YL +S N + ++ + L+ L +
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 302 AIEKFILIRNIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSV 360
+ L + SV L L L + + + L L + GNS + +
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 361 PS-ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYI 418
L +LDLS L P A + S+ L+++ N+L +P IF +
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDG---IFDRL 517
Query: 419 SIFAKLNLSYNNLDGD 434
+ K+ L N D
Sbjct: 518 TSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-21
Identities = 66/394 (16%), Positives = 117/394 (29%), Gaps = 59/394 (14%)
Query: 50 NLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP 109
N + L +L N + L+ + + +Q I
Sbjct: 13 QCMELNFYKIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIE 68
Query: 110 DSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLN 169
SL L L N +
Sbjct: 69 -------------DGAYQSLSHLSTLILTGN-----------------PIQSLALGAFSG 98
Query: 170 ITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF-FGNIPHSISNASKLEWLDFA 228
++S++ E L L L ++ L +A N +P SN + LE LD +
Sbjct: 99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVV-SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
+N + + DL L L + LS+N ++ P + L L + N S +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR--LHKLTLRNNFDSLN 215
Query: 288 IP-TEIGNLKNLII--IAIEKFILIRNI-PISVGYLLKLQVLSLFENNISR------EIP 337
+ T I L L + + + +F N+ L L L++ E ++ +I
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII 275
Query: 338 SSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLD 397
T ++ +L +I V + L+L + KS+ L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLT 331
Query: 398 LSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ N+ + L+LS N L
Sbjct: 332 FTSNKGGNAFS------EVDLPSLEFLDLSRNGL 359
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 54/235 (22%), Positives = 80/235 (34%), Gaps = 41/235 (17%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
IP ++ + LD + N L L S L+V+ LS + + + S
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPE---LQVLDLSRCEIQTIEDGAYQSLS 76
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
HL L ++ NPI L +L Q L E N
Sbjct: 77 -HLSTLILTGNPIQSLALGAFSGLSSL------------------------QKLVAVETN 111
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIR-GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
++ +G+ L ELN+ N I+ +P + L LDLS N + +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 390 ----PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI 440
P LDLS N ++ I F I KL L N +V + I
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPG---AFKEIR-LHKLTLRNNFDSLNVMKTCI 221
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 43/219 (19%), Positives = 83/219 (37%), Gaps = 36/219 (16%)
Query: 49 LNLSGQNLT--GTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQG 106
L+LS L+ G S T L+ ++L N + + L +L H+ F + L+
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK- 409
Query: 107 QIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQ 166
Q+ + + L+ L +L+ L +++ + +
Sbjct: 410 QMSEFSVFLS---------LRNLIY---LDISHTHTRVAFNGI----------------- 440
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLD 226
++S+E ++ N P I L N+ L L+ Q P + ++ S L+ L+
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPN 265
A+N L + D L + L+ + L N + P
Sbjct: 501 MASNQLKSVPDGIFDRLTS---LQKIWLHTNPWDCSCPR 536
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 60/395 (15%), Positives = 121/395 (30%), Gaps = 57/395 (14%)
Query: 49 LNLSGQN-LTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQ-- 105
L + + LT L + ++ + + + + + H+ + +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 106 --------GQIPDSRLILNKLEGNIPSELG--------SLLKFKGLGLANNYFTG----- 144
+ L L S L L F+G L + F
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 145 -PIPHLNMFQVSVYSLTGSIPIQL-----------LNITSMEYFHVSENQLVGELPPHIG 192
I L+ + +L G + ++ H+ + L +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL-FYDLSTVY 306
Query: 193 FTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVV 252
L V+ + + ++ F + LE+LD + N + ++ L+ +
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366
Query: 253 SLSVNSLSGTLPNSLANFSS--HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL-- 308
LS N L ++ + + +L L +S N +P + + + L
Sbjct: 367 VLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL-----NLSS 419
Query: 309 --IRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGS 366
IR + L+VL + NN+ L L EL + N ++ ++P A
Sbjct: 420 TGIRVVK--TCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDASLF 472
Query: 367 CHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
L + +S N L S+ + L N
Sbjct: 473 PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 85/429 (19%), Positives = 153/429 (35%), Gaps = 60/429 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L+LS +T + L+++ L+ + ++ L L H+ + N L +
Sbjct: 31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SL 89
Query: 109 PDS-----------RLILNKL-EGNIPSELGSLLKFKGLGLANNYFT--------GPIPH 148
S L+ N + S +L + L + N +
Sbjct: 90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149
Query: 149 LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQ- 207
LN ++ SL L +I + + + ++ L L +VR L L
Sbjct: 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNL 208
Query: 208 --FFGNIPHSISNASKLEWLDFANNSLTGL----IPEDLDSLVNCTYLEVVSLSVNSLSG 261
F + +S ++ L F + LT + + L ++ + +E ++N L
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268
Query: 262 TLPNSLANFS-------SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPI 314
P+ S +R L++ + + T L+ + I +E + +P
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS-KVFLVPC 327
Query: 315 SVGYLLK-LQVLSLFENNISREI---PSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370
S LK L+ L L EN + E + G + L L L N +R S+ L
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTL 386
Query: 371 ----WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS---GEIPSSLAWIFGYISIFAK 423
LD+S N P+P + P+ + L+LS + IP +L
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEV---------- 435
Query: 424 LNLSYNNLD 432
L++S NNLD
Sbjct: 436 LDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 54/330 (16%), Positives = 116/330 (35%), Gaps = 36/330 (10%)
Query: 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFR----LRHIIF 99
+ + L + + + P + ++ + + + + +E+ +L R L + F
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 100 NSNALQGQIPDSRLILNKLEGNIPSELGSL--LKFKGLGLANNYFTGPIPHLNMFQVSVY 157
+ L G N E ++ SELG + + + L + Y + + V
Sbjct: 259 DDCTLNGL-----GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 158 SLT------GSIPIQLL-NITSMEYFHVSENQLVGELPPHIGF--TLPNVRILLLAGNQF 208
+T +P ++ S+E+ +SEN +V E + P+++ L+L+ N
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 209 --FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNS 266
+ L LD + N+ +P+ + ++LS + +
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEK---MRFLNLSSTGIR-VVKTC 428
Query: 267 LANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326
+ L L +S N + S + L+ L I ++ +P L V+
Sbjct: 429 I---PQTLEVLDVSNNNLD-SFSLFLPRLQELYI----SRNKLKTLP-DASLFPVLLVMK 479
Query: 327 LFENNISREIPSSLGNFTFLTELNLCGNSI 356
+ N + T L ++ L N
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 38/192 (19%), Positives = 70/192 (36%), Gaps = 13/192 (6%)
Query: 244 VNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAI 303
++C V S + ++P + ++ ++ L +S N I+ ++ NL ++ +
Sbjct: 2 LSCDASGVCDGRSRSFT-SIP---SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 304 EKFILIRNIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG-SVP 361
+ I I L L+ L L +N++S S G + L LNL GN + V
Sbjct: 58 K-SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 362 SALGSCHQL-WLDLSHNHLTGPIP-LAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYIS 419
S + L L + + I + S+ L++ L S I
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQ---SLKSIR 172
Query: 420 IFAKLNLSYNNL 431
L L +
Sbjct: 173 DIHHLTLHLSES 184
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 80/389 (20%), Positives = 146/389 (37%), Gaps = 61/389 (15%)
Query: 61 SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEG 120
+P + TFL+ +N + +P E + + + P ++
Sbjct: 4 NPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 121 NIPSELGSLLKFKGLGLANNYFT---GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFH 177
+ + + L L N + PHL S SLT +P ++ S+ +
Sbjct: 63 SRLRDC-LDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 178 VSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP 237
+ L +LP P + L ++ NQ +P + N+S L+ +D NNSL L
Sbjct: 121 NNLKAL-SDLP-------PLLEYLGVSNNQ-LEKLP-ELQNSSFLKIIDVDNNSLKKLPD 170
Query: 238 ---------------EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN 282
E+L L N +L + NSL LP+ + L + N
Sbjct: 171 LPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLS----LESIVAGNN 225
Query: 283 PISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGN 342
+ E+ NL L I + L++ +P L+ L++ +N ++ ++P +
Sbjct: 226 IL--EELPELQNLPFLTTIYADNN-LLKTLPDLPP---SLEALNVRDNYLT-DLPELPQS 278
Query: 343 FTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNE 402
TFL + + +P L L+ S N + + P S+ L++S N+
Sbjct: 279 LTFLDVSENIFSGLS-ELPPNLYY-----LNASSNEIRS-LC---DLPPSLEELNVSNNK 328
Query: 403 LSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
L E+P+ +L S+N+L
Sbjct: 329 LI-ELPAL-------PPRLERLIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 75/388 (19%), Positives = 125/388 (32%), Gaps = 68/388 (17%)
Query: 64 IGNLTFLRLINLQQNNFSSNIPHEIGRL-------------FRLRHIIFNSNALQGQIPD 110
N+ + + N P G + + N+ L +P+
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 111 S-----RLIL--NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSI 163
L+ N L +P SL + P L VS L +
Sbjct: 89 LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KL 146
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223
P +L N + ++ V N L +LP P++ + NQ + N L
Sbjct: 147 P-ELQNSSFLKIIDVDNNSLK-KLPD----LPPSLEFIAAGNNQL--EELPELQNLPFLT 198
Query: 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283
+ NNSL L ++ + N L L N L +Y N
Sbjct: 199 AIYADNNSLKKLPDL----PLSLESI---VAGNNIL--EELPELQNLPF-LTTIYADNNL 248
Query: 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF 343
+ ++P +L+ L + + ++P L L V + +S P+
Sbjct: 249 LK-TLPDLPPSLEALNVR----DNYLTDLPELPQSLTFLDVSENIFSGLSELPPN----- 298
Query: 344 TFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403
L LN N IR S+ S L++S+N L +P + L S N L
Sbjct: 299 --LYYLNASSNEIR-SLCDLPPSLE--ELNVSNNKLIE-LPALPPRLE---RLIASFNHL 349
Query: 404 SGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ E+P + +L++ YN L
Sbjct: 350 A-EVPELPQNL-------KQLHVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 74/391 (18%), Positives = 134/391 (34%), Gaps = 68/391 (17%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPH---------------EIGRLFR 93
L S +LT +L L + N S P E+
Sbjct: 96 LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSF 154
Query: 94 LRHIIFNSNALQGQIPDS-----RLIL--NKLEGNIPSELGSLLKFKGLGLANNYFT--- 143
L+ I ++N+L+ ++PD + N+LE +P EL +L + NN
Sbjct: 155 LKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLP 211
Query: 144 GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203
L ++ +P +L N+ + + N L LP ++ L +
Sbjct: 212 DLPLSLESIVAG-NNILEELP-ELQNLPFLTTIYADNNLLK-TLPDLPP----SLEALNV 264
Query: 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP--EDLDSLVN--------CTYLEVVS 253
N ++P + + L+ + + L+ L P L++ N LE ++
Sbjct: 265 RDNYL-TDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN 323
Query: 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP 313
+S N L LP L L S N ++ +P NLK L + ++ +R P
Sbjct: 324 VSNNKLI-ELPALPPR----LERLIASFNHLA-EVPELPQNLKQLHV----EYNPLREFP 373
Query: 314 ISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLD 373
+ L++ N+ E+P N L +L++ N +R P S L
Sbjct: 374 DIPESVEDLRM-----NSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPESVEDL--R 422
Query: 374 LSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
++ + P A + +
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-19
Identities = 43/255 (16%), Positives = 80/255 (31%), Gaps = 40/255 (15%)
Query: 187 LPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN- 245
+ P + ++ L + +P N A + P
Sbjct: 3 INPRN-VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 246 ---------CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLK 296
+ L+ LS +LP HL L S N ++ +P +LK
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQSLK 114
Query: 297 NLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSI 356
+L++ L P L+ L + N + ++P L N +FL +++ NS+
Sbjct: 115 SLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL 165
Query: 357 RGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFG 416
+ +P S + +N L L N + + N L ++P +
Sbjct: 166 K-KLPDLPPSLEF--IAAGNNQLEELPEL--QNLPFLTAIYADNNSLK-KLPDLPLSL-- 217
Query: 417 YISIFAKLNLSYNNL 431
+ N L
Sbjct: 218 -----ESIVAGNNIL 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 61/286 (21%), Positives = 101/286 (35%), Gaps = 29/286 (10%)
Query: 162 SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK 221
+I N + V+++ L + + + NV+ L L+GN ++ +K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA 281
LE L+ ++N L DL+SL L + L+ N + L + L+ +
Sbjct: 60 LELLNLSSNVLYET--LDLESLST---LRTLDLNNNYVQ-ELLV-----GPSIETLHAAN 108
Query: 282 NPISGSIPTEIG-NLKNLIIIAIEKFILIRNIP-ISVGYLLKLQVLSLFENNISR-EIPS 338
N IS + G KN+ + I + + G ++Q L L N I
Sbjct: 109 NNIS-RVSCSRGQGKKNIYL----ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 339 SLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLD 397
+ L LNL N I V +L LDLS N L + + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220
Query: 398 LSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKN 443
L N+L I + + +L N R KN
Sbjct: 221 LRNNKLV-LIEKA----LRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 53/364 (14%), Positives = 115/364 (31%), Gaps = 74/364 (20%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
+ ++ +L + + ++ ++L N S ++ +L + +SN L
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE- 72
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
+L SL + L L NNY +L
Sbjct: 73 ---------------TLDLESLSTLRTLDLNNNYVQ----------------------EL 95
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
L S+E H + N + + + + LA N+ S++++LD
Sbjct: 96 LVGPSIETLHAANNNI-SRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
N + + +L + + LE ++L N + + + + L+ L +S+N ++
Sbjct: 152 KLNEIDTVNFAELAA--SSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKLA-F 205
Query: 288 IPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLT 347
+ E + + +SL N + I +L L
Sbjct: 206 MGPEFQSAAG------------------------VTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 348 ELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEI 407
+L GN S +Q ++ + + ++P L ++
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 408 PSSL 411
P+
Sbjct: 300 PAPF 303
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 51/208 (24%), Positives = 82/208 (39%), Gaps = 47/208 (22%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
V+ G L D T +AVK + F+ E + L+ H N+V++I C+
Sbjct: 130 VFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-- 184
Query: 593 QGNYFRALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
Q Y +V E + G + L L + D A+ +EYL K +H D
Sbjct: 185 QPIY---IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFI--------------------PEVMSSNQCSSVGLK 688
L N L+ + DFG++R PE ++ + SS +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS---E 295
Query: 689 GTVGYATPEYGILLLEIFT-GKRPTSDM 715
V ++ +GILL E F+ G P ++
Sbjct: 296 SDV-WS---FGILLWETFSLGASPYPNL 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 63/348 (18%), Positives = 114/348 (32%), Gaps = 71/348 (20%)
Query: 70 LRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS-----RLIL--NKLEGNI 122
++N+ ++ ++ +P + + ++ N L +P L + N+L ++
Sbjct: 42 NAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLEVSGNQLT-SL 96
Query: 123 PSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQ 182
P LL+ + L + LT S+P+ + + VS+NQ
Sbjct: 97 PVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQ 152
Query: 183 LVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDS 242
L LP + L NQ ++P S L+ L ++N L L P
Sbjct: 153 L-ASLPALPS----ELCKLWAYNNQL-TSLPMLPSG---LQELSVSDNQLASL-PTLPSE 202
Query: 243 LVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIA 302
L L N L+ +LP + L+ L +S N ++ S+P LK L
Sbjct: 203 L---YKLW---AYNNRLT-SLPALPSG----LKELIVSGNRLT-SLPVLPSELKEL---- 246
Query: 303 IEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPS 362
+ N + +P L L++ N + +P
Sbjct: 247 -----------------------MVSGNRL-TSLPMLPSG---LLSLSVYRNQLT-RLPE 278
Query: 363 ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPS 409
+L ++L N L+ A+ S P S
Sbjct: 279 SLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 6e-17
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 38/212 (17%)
Query: 220 SKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYM 279
+ L+ + LT L P+ L ++ + + N+L+ +LP LR L +
Sbjct: 40 NGNAVLNVGESGLTTL-PDCL-----PAHITTLVIPDNNLT-SLPALPPE----LRTLEV 88
Query: 280 SANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSS 339
S N ++ S+P L L I + + ++P L L +F N ++ +P
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNP----LTHLPAL---PSGLCKLWIFGNQLT-SLPVL 139
Query: 340 LGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLS 399
L EL++ N + S+P+ +LW +N LT +P+ + L +S
Sbjct: 140 PPG---LQELSVSDNQLA-SLPALPSELCKLW--AYNNQLTS-LPMLPSGLQE---LSVS 189
Query: 400 KNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
N+L+ +P+ S KL N L
Sbjct: 190 DNQLA-SLPTL-------PSELYKLWAYNNRL 213
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 71/417 (17%), Positives = 123/417 (29%), Gaps = 66/417 (15%)
Query: 38 TCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHI 97
+CS + + NLT P L + L N + L +L+ +
Sbjct: 1 SCSFDGR---IAFYRFCNLT--QVP--QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 98 IFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVY 157
S I +L + L L ++
Sbjct: 54 ELGSQYTPLTID-------------KEAFRNLPNLRILDLGSSKIY-------------- 86
Query: 158 SLTGSIPIQLL-NITSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFG-NIPH 214
+ + + + L + F L + L L+ NQ +
Sbjct: 87 ----FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 215 SISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS-- 272
S + L+ +DF++N + + +L+ L T L SL+ NSL + +
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT-LSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 273 ---HLRYLYMSANPISGSIP---------TEIGNLKNLIIIAIEKFIL--IRNIPISVGY 318
L L +S N + I ++ +L I F I++ +
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 319 LLK---LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW-LDL 374
L ++ L L + L LNL N I A L L+L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 375 SHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
S+N L + ++DL KN ++ I + L+L N L
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQT---LDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-23
Identities = 84/518 (16%), Positives = 168/518 (32%), Gaps = 81/518 (15%)
Query: 49 LNLSGQNLTGTASPYIGNLTF--LRLINLQQNNFSSNIPHEIGRLF------RLRHIIFN 100
++ S + + L L +L N+ S + + G+ L + +
Sbjct: 153 IDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS 212
Query: 101 SNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP------------- 147
N I N + + L G G + P
Sbjct: 213 GNGWTVDITG--NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 148 ----HLNMFQVSVYSLTGSIPIQLLNI----------------TSMEYFHVSENQLVGEL 187
H +F ++ +++LN+ +++ ++S N L GEL
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL-GEL 329
Query: 188 PPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247
+ LP V + L N + KL+ LD +N+LT ++
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--------TIHFIP 381
Query: 248 YLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG-SIPTEIGNLKNLIIIAIEK- 305
+ + LS N L +L + +++S N + I + + +L I+ + +
Sbjct: 382 SIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
Query: 306 FILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTF-----LTELNLCGNSIRGSV 360
+ + L+ L L EN + + L F L L L N +
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496
Query: 361 PSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYIS 419
P L L L+ N LT + P ++ LD+S+N+L P +
Sbjct: 497 PGVFSHLTALRGLSLNSNRLTV-LSHND-LPANLEILDISRNQLLAPNPDVFVSL----- 549
Query: 420 IFAKLNLSYNNLDGDVP----RKMIFKNASAISEAGNEKLCGG---ISELKLPPCTPSEL 472
+ L++++N + + I+ + C S + L +
Sbjct: 550 --SVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGC 607
Query: 473 KKREKSKGFKLMILLLSGLVGLILVMSLLIINRLRRQR 510
+ E K K + ++ + + +M++L + + R
Sbjct: 608 DEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFC 645
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 51/396 (12%), Positives = 113/396 (28%), Gaps = 49/396 (12%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
+ ++ +L + + ++ ++L N S ++ +L + +SN L +
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-E 72
Query: 108 IPD----SRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSI 163
D S L L N EL + L ANN + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS------------------RV 114
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFG-NIPHSISNASKL 222
+ +++ N++ L V+ L L N+ N +++ L
Sbjct: 115 SCSRG--QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 223 EWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN 282
E L+ N + D+ V L+ + LS N L+ + + + + ++ + N
Sbjct: 172 EHLNLQYNFIY-----DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAG-VTWISLRNN 224
Query: 283 PISGSIPTEIGNLKNLIIIAIEK-FILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341
+ I + +NL + + ++Q ++ + + +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEE 281
Query: 342 NFTFLTELNLCGNSIRGSVPSALGSCHQL------WLDLSHNHLTGPIPLAVGNPKSIPH 395
T T + L L + + N
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQRE 340
Query: 396 LDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+D K + + + L L
Sbjct: 341 IDALKEQYR-TVIDQ---VTLRKQAKITLEQKKKAL 372
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 49/266 (18%), Positives = 98/266 (36%), Gaps = 25/266 (9%)
Query: 162 SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK 221
+I N + V+++ L + + + NV+ L L+GN ++ +K
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 222 LEWLDFANNSLTGLIP-------EDLD-------SLVNCTYLEVVSLSVNSLSGTLPNSL 267
LE L+ ++N L + LD L+ +E + + N++S +
Sbjct: 60 LELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRG 119
Query: 268 ANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEK-FILIRNIPISVGYLLKLQVLS 326
+ +Y++ N I+ + G + + ++ I N L+ L+
Sbjct: 120 QG----KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPL 385
L N I ++ + F L L+L N + + S + W+ L +N L I
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEK 231
Query: 386 AVGNPKSIPHLDLSKNELSGEIPSSL 411
A+ +++ H DL N
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-21
Identities = 46/341 (13%), Positives = 100/341 (29%), Gaps = 49/341 (14%)
Query: 64 IGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123
N ++ + ++ + + ++ + + N L QI
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS-------------A 51
Query: 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQL 183
++L K + L L++N + L +++++ ++ N +
Sbjct: 52 ADLAPFTKLELLNLSSNVLYETLD-------------------LESLSTLRTLDLNNNYV 92
Query: 184 VGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSL 243
EL P++ L A N + S + + ANN +T L D
Sbjct: 93 -QELLV-----GPSIETLHAANNN-ISRVS--CSRGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 244 VNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAI 303
++ + L +N + LA S L +L + N I + ++ L + +
Sbjct: 144 SR---VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDL 198
Query: 304 EKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363
+ + + +SL N + I +L L +L GN
Sbjct: 199 S-SNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 364 LGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
S +Q ++ +
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 53/435 (12%), Positives = 115/435 (26%), Gaps = 42/435 (9%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
LNLS L T + +L+ LR ++L N E+ + + +N + ++
Sbjct: 63 LNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114
Query: 109 PDS------RLIL--NKLEGNIPSELGSLLKFKGLGLANN--------YFTGPIPHLNMF 152
S + L NK+ + G + + L L N L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 153 QVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNI 212
+ + + + ++ +S N+L + P + V + L N+ I
Sbjct: 175 NLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKL-VLI 229
Query: 213 PHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS 272
++ + LE D N D ++ V+ +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 273 HLRYLYMSANPISGSIPTEIGNLKNLIIIAIE-KFILIRNIPISVGYLLKLQVLSLFENN 331
Y + + LK + + + + + + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL----WLDLSHNHLTGPIP--- 384
I L ++ V + + +L + L
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 385 ---LAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIF 441
L K + + + + + A+ N L+G+ +
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALAS 467
Query: 442 KNASAISEAGNEKLC 456
NA+ E+
Sbjct: 468 ANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 23/116 (19%), Positives = 51/116 (43%), Gaps = 16/116 (13%)
Query: 319 LLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHN 377
+ ++ + ++++ + + S + + EL+L GN + + L +L L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 378 HLTGPIPLAVGNPKSIPHLDLSKNELSGEIP--SSLAWIFGYISIFAKLNLSYNNL 431
L + L + ++ LDL+ N + E+ S+ L+ + NN+
Sbjct: 69 VLYETLDL--ESLSTLRTLDLNNNYVQ-ELLVGPSI----------ETLHAANNNI 111
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 53/212 (25%), Positives = 80/212 (37%), Gaps = 48/212 (22%)
Query: 536 TVYKGIL---DLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
V +G +AVK L L Q A+ F+ E A+ ++ HRNL+++ T
Sbjct: 33 VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHH 639
+ +V E GSL L LR+ A+ VA + YL
Sbjct: 93 PPMK------MVTELAPLGSL------LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-- 697
+H DL N+LL +GDFGL R +P+ + K + PE
Sbjct: 141 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEHRKVPFAWCAPESL 196
Query: 698 -------------YGILLLEIFT-GKRPTSDM 715
+G+ L E+FT G+ P +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 45/206 (21%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
VY+G+ +AVK L ++ F+ E ++ I+H NLV+++ C+ Y
Sbjct: 236 VYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFY 292
Query: 597 FRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKPIV 645
++ EFM +G+L L +LR L +A ++SA+EYL KK +
Sbjct: 293 ---IITEFMTYGNL------LDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H +L N L+ + + DFGL+R + + G K + + PE
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 698 -------YGILLLEIFT-GKRPTSDM 715
+G+LL EI T G P +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 29/194 (14%)
Query: 535 ATVYKGI-LDLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
+Y + +++ + +K L A MAE Q L + H ++V+I +D
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153
Query: 593 QGNYFRALVYEFMHHGSL-ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
G+ +V E++ SL S + L + +++ AL YLH +V+ DLKP
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKP 210
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------Y- 698
N++L + + D G I N + GT G+ PE Y
Sbjct: 211 ENIMLTEE-QLKLIDLGAVSRI------NSFGYLY--GTPGFQAPEIVRTGPTVATDIYT 261
Query: 699 -GILLLEIFTGKRP 711
G L +
Sbjct: 262 VGRTLAALTLDLPT 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 44/207 (21%), Positives = 72/207 (34%), Gaps = 45/207 (21%)
Query: 536 TVYKGILDLDQ----TFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+V D +AVK L + F E Q L+ + +VK
Sbjct: 38 SVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HHC 640
Q LV E++ G L FL+R L + + +EYL C
Sbjct: 98 RQSLR---LVMEYLPSGCL------RDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
VH DL N+L++++ + DFGL + +P + + + PE
Sbjct: 149 ----VHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLS 203
Query: 698 ------------YGILLLEIFT-GKRP 711
+G++L E+FT +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 50/212 (23%)
Query: 536 TVYKGILDLD----QTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
TVYKG+ + + +A+K L A K + E + ++ + ++ +++ C TS
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHH 639
Q L+ + M G L L ++R LN + +A + YL
Sbjct: 90 TVQ------LITQLMPFGCL------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-- 697
VH DL NVL+ + DFGL + + + + G K + + E
Sbjct: 138 L----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESI 191
Query: 698 -------------YGILLLEIFT-GKRPTSDM 715
YG+ + E+ T G +P +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 50/212 (23%), Positives = 76/212 (35%), Gaps = 46/212 (21%)
Query: 536 TVYKGILDLDQ----TFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
V D + +AVK L + E + LRN+ H N+VK C+
Sbjct: 36 KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HH 639
G L+ EF+ GSL +L + L A+ + ++YL
Sbjct: 96 GGNGIK---LIMEFLPSGSL------KEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-- 697
VH DL NVL++++ +GDFGLT+ I V + PE
Sbjct: 147 Y----VHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDRDSPVFWYAPECL 201
Query: 698 -------------YGILLLEIFT-GKRPTSDM 715
+G+ L E+ T +S M
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 48/208 (23%), Positives = 91/208 (43%), Gaps = 51/208 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ + T +AVK + + G+ +++F+AE ++ ++H LVK+ +
Sbjct: 204 VWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY- 258
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKP 643
++ EFM GSL L FL+ ++ + +A + ++ ++
Sbjct: 259 -----IITEFMAKGSL------LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRN 304
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
+H DL+ +N+L+ + + DFGL R I + + + G K + + PE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGS 361
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+GILL+EI T G+ P M
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 62/418 (14%), Positives = 129/418 (30%), Gaps = 88/418 (21%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEI-GRLFRLRHIIFNSNALQGQ 107
+ + + + + + L+NL I ++ + NA++
Sbjct: 50 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-- 106
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
L ++ + L L L N + S+P +
Sbjct: 107 ---------YLPPHVFQNVPLL---TVLVLERNDLS------------------SLPRGI 136
Query: 168 L-NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLD 226
N + +S N L + +++ L L+ N+ ++ +S L +
Sbjct: 137 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHAN 192
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286
+ N L+ +L +E + S NS++ + + L L + N +
Sbjct: 193 VSYNLLS--------TLAIPIAVEELDASHNSIN-VVR---GPVNVELTILKLQHNNL-- 238
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFL 346
T+ L N L + L N + + + L
Sbjct: 239 ---TDTAWLLNYP---------------------GLVEVDLSYNELEKIMYHPFVKMQRL 274
Query: 347 TELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405
L + N + ++ L LDLSHNHL + + +L L N +
Sbjct: 275 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV- 331
Query: 406 EIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
+ L LS+N+ D + + +F+N + + ++ C +L+
Sbjct: 332 TLK------LSTHHTLKNLTLSHNDWDCN-SLRALFRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 63/368 (17%), Positives = 133/368 (36%), Gaps = 58/368 (15%)
Query: 66 NLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSE 125
+++ E L + + F ++ ++ KL +
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-----------KLPAALLDS 67
Query: 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVG 185
+ + L L + I F +++ ++ N +
Sbjct: 68 FRQV---ELLNLNDLQIEE-IDT-YAFA---------------YAHTIQKLYMGFNAIR- 106
Query: 186 ELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLV 244
LPPH+ +P + +L+L N ++P I N KL L +NN+L + + +
Sbjct: 107 YLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 165
Query: 245 NCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIE 304
+ L+ + LS N L+ + + + L + +S N + + + + +
Sbjct: 166 S---LQNLQLSSNRLTHVDLSLIPS----LFHANVSYNLL-----STLAIPIAVEELDAS 213
Query: 305 KFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSAL 364
I + V ++L +L L NN++ + L N+ L E++L N + +
Sbjct: 214 -HNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 365 GSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAK 423
+L L +S+N L + L ++ LDLS N L + + + +
Sbjct: 269 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQ---PQFDRL-EN 322
Query: 424 LNLSYNNL 431
L L +N++
Sbjct: 323 LYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 29/151 (19%), Positives = 52/151 (34%), Gaps = 5/151 (3%)
Query: 282 NPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341
P I + + + I+ L ++++ + + + + L
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 342 NFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSK 400
+F + LNL I A H + L + N + P N + L L +
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126
Query: 401 NELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
N+LS +P IF L++S NNL
Sbjct: 127 NDLS-SLPRG---IFHNTPKLTTLSMSNNNL 153
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/247 (14%), Positives = 77/247 (31%), Gaps = 55/247 (22%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
N+S L+ + + ++ N+ + + + L + N L
Sbjct: 191 ANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLT--- 239
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
+ L + + L+ N I
Sbjct: 240 ------------DTAW-LLNYPGLVEVDLSYNELE------------------KIMYHPF 268
Query: 169 -NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
+ +E ++S N+LV L + +P +++L L+ N ++ + +LE L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQ-PIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYL 325
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
+NS+ L +L N ++LS N NSL ++ +
Sbjct: 326 DHNSIVTLKLSTHHTLKN------LTLSHNDWD---CNSLRALFRNVARPAVDDADQHCK 376
Query: 288 IPTEIGN 294
I ++ +
Sbjct: 377 IDYQLEH 383
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 51/208 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G + T +AVK L ++G++ +F+AE ++ ++H+ LV++ + +
Sbjct: 29 VWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EP 81
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKP 643
Y ++ E+M +GSL + FL+ L++A +A + ++ ++
Sbjct: 82 IY---IITEYMENGSL------VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
+H DL+ +N+L+ + ++ + DFGL R I + + + G K + + PE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+GILL EI T G+ P M
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 46/200 (23%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
Y + D +AVK L L+ F E + L++++H N+VK C ++ +
Sbjct: 30 RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89
Query: 597 FRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HHCKKPIV 645
L+ E++ +GSL +L++ L + +EYL +
Sbjct: 90 ---LIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY----I 136
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ---CSSVGLKGTVGYATPE----- 697
H DL N+L++N+ +GDFGLT+ +P+ ++ + + + PE
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQ----DKEFFKVKEPGESPIFWYAPESLTES 192
Query: 698 ----------YGILLLEIFT 707
+G++L E+FT
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 48/211 (22%)
Query: 536 TVYKGILDLD----QTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
TV+KG+ + + + +KV+ R + ++ A+ ++ H ++V+++ C S
Sbjct: 28 TVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS 87
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHC 640
Q LV +++ GSL L +R+ LN + +A + YL H
Sbjct: 88 SLQ------LVTQYLPLGSL------LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
+VH +L NVLL + + DFG+ +P Q K + + E
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP--DDKQLLYSEAKTPIKWMALESIH 190
Query: 698 ------------YGILLLEIFT-GKRPTSDM 715
YG+ + E+ T G P + +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 49/207 (23%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V G Q +AVK++ + G++ F E Q + + H LVK CS
Sbjct: 24 VKLGKWK-GQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YP 77
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCKKPI 644
Y +V E++ +G L L++LR L + DV + +L
Sbjct: 78 IY---IVTEYISNGCL------LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------- 697
+H DL N L+D D+ + DFG+TR++ + SSVG K V ++ PE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 698 --------YGILLLEIFT-GKRPTSDM 715
+GIL+ E+F+ GK P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLY 209
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 12/265 (4%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
N+ ++ + N+L +P + L N+ L ++ N+ + + + L+ L+
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI 288
+N L + L + LE ++L +L+ +L++ L L + I+ +I
Sbjct: 137 DNDLVYISHRAFSGLNS---LEQLTLEKCNLTSIPTEALSHLHG-LIVLRLRHLNIN-AI 191
Query: 289 PTEI-GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLT 347
L L ++ I + + + + Y L L LS+ N++ ++ + +L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR 251
Query: 348 ELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406
LNL N I S L +L + L L P A + L++S N+L+
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-T 310
Query: 407 IPSSLAWIFGYISIFAKLNLSYNNL 431
+ S +F + L L N L
Sbjct: 311 LEES---VFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 65/343 (18%), Positives = 119/343 (34%), Gaps = 57/343 (16%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L+L + + L + L +N S+ P LF LR + SN L+ I
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LI 95
Query: 109 PDS---------RLIL--NKLEGNIPSEL-GSLLKFKGLGLANNYFTGPIPHLNMFQVSV 156
P +L + NK+ + + L K L + +N
Sbjct: 96 PLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV------------- 141
Query: 157 YSLTGSIPIQLL-NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHS 215
I + + S+E + + L +P L + +L L +S
Sbjct: 142 -----YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLR 275
+L+ L+ ++ + + +N T L S++ +L+ +P +LR
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL---SITHCNLT-AVPYLAVRHLVYLR 251
Query: 276 YLYMSANPISGSIPTEI-GNLKNLIIIAIEKFIL----IRNIPISV-GYLLKLQVLSLFE 329
+L +S NPIS +I + L L ++ L + + L L+VL++
Sbjct: 252 FLNLSYNPIS-TIEGSMLHELLRL-----QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305
Query: 330 NNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWL 372
N ++ S + L L L N + C LW+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA-------CDCRLLWV 341
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 46/200 (23%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
Y + D +AVK L L+ F E + L++++H N+VK C ++ +
Sbjct: 61 RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120
Query: 597 FRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HHCKKPIV 645
L+ E++ +GSL +L++ L + +EYL +
Sbjct: 121 ---LIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY----I 167
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ---CSSVGLKGTVGYATPE----- 697
H DL N+L++N+ +GDFGLT+ +P+ ++ + + + PE
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQ----DKEYYKVKEPGESPIFWYAPESLTES 223
Query: 698 ----------YGILLLEIFT 707
+G++L E+FT
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 49/207 (23%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G L++ +A+K + + GA+ + F+ E + + + H LV++ C
Sbjct: 24 VHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--AP 77
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCKKPI 644
LV EFM HG L +LR L + +DV + YL + +
Sbjct: 78 IC---LVTEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACV 125
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------- 697
+H DL N L+ + + DFG+TRF+ + SS G K V +A+PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 698 --------YGILLLEIFT-GKRPTSDM 715
+G+L+ E+F+ GK P +
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENR 209
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 51/208 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V G Q +A+K++ + G++ F+ E + + N+ H LV++ C+ +
Sbjct: 40 VKYGKWR-GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RP 93
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHHCKKP 643
+ ++ E+M +G L L++LR L + DV A+EYL
Sbjct: 94 IF---IITEYMANGCL------LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
+H DL N L+++ + DFGL+R++ + SSVG K V ++ PE
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+G+L+ EI++ GK P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERF 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/211 (25%), Positives = 75/211 (35%), Gaps = 50/211 (23%)
Query: 536 TVYKGILDLDQ----TFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
V D +AVK L + E LR + H +++K C +
Sbjct: 46 KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR--------LNIAIDVASALEYLH-HHCK 641
LV E++ GSL +L R L A + + YLH H
Sbjct: 106 GAASLQ---LVMEYVPLGSL------RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHY- 155
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG---YATPE- 697
+H DL NVLLDND +GDFGL + +PE ++ V G YA PE
Sbjct: 156 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYA-PEC 208
Query: 698 --------------YGILLLEIFT-GKRPTS 713
+G+ L E+ T S
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 49/208 (23%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGAL--KSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VY+G+ +AVK L + + + F+ E ++ I+H NLV+++ C+
Sbjct: 29 VYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PP 83
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKP 643
Y ++ EFM +G+L L +LR L +A ++SA+EYL KK
Sbjct: 84 FY---IITEFMTYGNL------LDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
+H DL N L+ + + DFGL+R + + G K + + PE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+G+LL EI T G P +
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGI 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 46/210 (21%), Positives = 81/210 (38%), Gaps = 47/210 (22%)
Query: 536 TVYKGILDLDQTFI--AVKVL--FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
TV KG + + AVK+L + +AE ++ + + +V++I C
Sbjct: 32 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 91
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR---------LNIAIDVASALEYL-HHHCK 641
+ LV E G L +L++ + + V+ ++YL +
Sbjct: 92 WM------LVMEMAELGPL------NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
VH DL NVLL A + DFGL++ + + + K V + PE
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINY 194
Query: 698 -----------YGILLLEIFT-GKRPTSDM 715
+G+L+ E F+ G++P M
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 51/212 (24%)
Query: 537 VYKGIL---DLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNIRHRNLVKIITACST 589
V G L +A+K L + G + F++E + H N++++ +
Sbjct: 65 VCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHH 639
+ +V E+M +GSL +FLR + + V + + YL
Sbjct: 122 G--RLAM---IVTEYMENGSL------DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS-- 168
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-- 697
VH DL NVL+D+++ + DFGL+R + E ++ G K + + PE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 698 -------------YGILLLEIFT-GKRPTSDM 715
+G+++ E+ G+RP +M
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-22
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 51/208 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKS--FMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G + T +A+K L + G + F+ E Q ++ +RH LV++ S
Sbjct: 200 VWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-- 253
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKP 643
Y +V E+M GSL L FL+ +++A +AS + Y+ +
Sbjct: 254 -Y---IVTEYMSKGSL------LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 300
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
VH DL+ +N+L+ ++ + DFGL R I + + + G K + + PE
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGR 357
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+GILL E+ T G+ P M
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 49/212 (23%)
Query: 537 VYKGIL---DLDQTFIAVKVL--FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V +G L D +AVK + + ++ F++E +++ H N+++++ C
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 592 FQGNYFRALVYEFMHHGSL---------ESCPRILSFLRRLNIAIDVASALEYL-HHHCK 641
QG ++ FM +G L E+ P+ + L +D+A +EYL + +
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF- 168
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG------YAT 695
+H DL N +L +DMT + DFGL++ I +G + A
Sbjct: 169 ---LHRDLAARNCMLRDDMTVCVADFGLSKKIYS-------GDYYRQGRIAKMPVKWIA- 217
Query: 696 PE---------------YGILLLEIFT-GKRP 711
E +G+ + EI T G P
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 6e-22
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 37/268 (13%)
Query: 149 LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF 208
N F ++ + N+ V L + + L L
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL---INQFSELQLNRLNL 71
Query: 209 FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268
++P ++ ++ L+ N+L L PE SL YL+ N LS TLP A
Sbjct: 72 -SSLPDNL--PPQITVLEITQNALISL-PELPASL---EYLD---ACDNRLS-TLPELPA 120
Query: 269 NFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328
+ L++L + N ++ +P L+ + + +P L+VLS+
Sbjct: 121 S----LKHLDVDNNQLT-MLPELPALLEYINA----DNNQLTMLPEL---PTSLEVLSVR 168
Query: 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-----WLDLSHNHLTGPI 383
N + +P + L L++ N + S+P+ H + N +T I
Sbjct: 169 NNQL-TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-I 222
Query: 384 PLAVGNPKSIPHLDLSKNELSGEIPSSL 411
P + + + L N LS I SL
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESL 250
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-20
Identities = 65/336 (19%), Positives = 105/336 (31%), Gaps = 64/336 (19%)
Query: 64 IGNLTFLRLINLQQNNFSSNIPHEIGRLF----RLRHIIFNSNALQGQIPDSRL----IL 115
I N L N S + + + N N + + + L
Sbjct: 7 INNN--FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 116 NKLEGN----IPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNIT 171
L +P L + L + N S+P
Sbjct: 65 Q-LNRLNLSSLPDNLPPQITV--LEITQNALI------------------SLPEL---PA 100
Query: 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS 231
S+EY +N+L LP +++ L + NQ +P + LE+++ NN
Sbjct: 101 SLEYLDACDNRLS-TLPELPA----SLKHLDVDNNQL-TMLPELPAL---LEYINADNNQ 151
Query: 232 LTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTE 291
LT L PE SL EV+S+ N L+ LP + L L +S N + S+P
Sbjct: 152 LTML-PELPTSL------EVLSVRNNQLT-FLPELPES----LEALDVSTNLLE-SLPAV 198
Query: 292 IGNLKNLIIIAIEKFI---LIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE 348
+ I I +IP ++ L + L +N +S I SL T +
Sbjct: 199 PVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD 258
Query: 349 LNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIP 384
+ S + H+ D
Sbjct: 259 YHGPRIYFSMS-DGQQNTLHRPLADAVTAWFPENKQ 293
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 2e-19
Identities = 45/255 (17%), Positives = 88/255 (34%), Gaps = 37/255 (14%)
Query: 159 LTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISN 218
+ L+ ++ L LP ++ P + +L + N ++P ++
Sbjct: 49 AVSLLKECLI--NQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNAL-ISLPELPAS 101
Query: 219 ASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278
LE+LD +N L+ L PE + +L + N L+ LP A L Y+
Sbjct: 102 ---LEYLDACDNRLSTL-PE---LPASLKHL---DVDNNQLT-MLPELPAL----LEYIN 146
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPS 338
N ++ +P +L+ L + + + +P L+ L + N + +P+
Sbjct: 147 ADNNQLT-MLPELPTSLEVLSV----RNNQLTFLPELPE---SLEALDVSTNLLE-SLPA 197
Query: 339 SLGNFTFLTE----LNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSI 393
E N I +P + S + L N L+ I ++ +
Sbjct: 198 VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 394 PHLDLSKNELSGEIP 408
P + S
Sbjct: 257 PDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 5e-18
Identities = 40/222 (18%), Positives = 75/222 (33%), Gaps = 31/222 (13%)
Query: 211 NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANF 270
+ + K N L+ E L + L+ +LS +LP++L
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKECL-----INQFSELQLNRLNLS-SLPDNLP-- 79
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
+ L ++ N + S+P +L+ L + +P L+ L + N
Sbjct: 80 -PQITVLEITQNALI-SLPELPASLEYLDA----CDNRLSTLPEL---PASLKHLDVDNN 130
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
++ +P L +N N + +P S L L + +N LT +P +
Sbjct: 131 QLT-MLPELPAL---LEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPELPES 181
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ LD+S N L +P+ N +
Sbjct: 182 LE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 46/211 (21%), Positives = 82/211 (38%), Gaps = 48/211 (22%)
Query: 536 TVYKGILDLD----QTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
TVYKG+ + + +A+K L A K + E + ++ + ++ +++ C TS
Sbjct: 30 TVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHC 640
Q L+ + M G L L ++R LN + +A + YL
Sbjct: 90 TVQ------LITQLMPFGCL------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
+VH DL NVL+ + DFGL + + + + G K + + E
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESIL 192
Query: 698 ------------YGILLLEIFT-GKRPTSDM 715
YG+ + E+ T G +P +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 47/215 (21%), Positives = 92/215 (42%), Gaps = 54/215 (25%)
Query: 536 TVYKGILDLD----QTFIAVKVL----FLHQRGALKSFMAECQALRNIRHRNLVKIITAC 587
VYKG+L + +A+K L QR F+ E + H N++++
Sbjct: 59 EVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNIIRLEGVI 115
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL- 636
S + ++ E+M +G+L FLR + + +A+ ++YL
Sbjct: 116 SKY--KPMM---IITEYMENGAL------DKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 637 HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATP 696
+ + VH DL N+L+++++ + DFGL+R + + ++ G K + + P
Sbjct: 165 NMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWTAP 219
Query: 697 E---------------YGILLLEIFT-GKRPTSDM 715
E +GI++ E+ T G+RP ++
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 44/211 (20%), Positives = 80/211 (37%), Gaps = 50/211 (23%)
Query: 536 TVYKGILDLD---QTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V++GI +A+K + F+ E +R H ++VK+I + +
Sbjct: 30 DVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 89
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHHC 640
++ E G L SFL+ + A +++AL YL
Sbjct: 90 VW------IIMELCTLGEL------RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
VH D+ NVL+ ++ +GDFGL+R++ + S + K + + PE
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPESIN 190
Query: 698 ------------YGILLLEIFT-GKRPTSDM 715
+G+ + EI G +P +
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 51/208 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKS--FMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G + T +A+K L + G + F+ E Q ++ +RH LV++ S
Sbjct: 283 VWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-- 336
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKP 643
Y +V E+M GSL L FL+ +++A +AS + Y+ +
Sbjct: 337 -Y---IVTEYMSKGSL------LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 383
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
VH DL+ +N+L+ ++ + DFGL R I + + + G K + + PE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGR 440
Query: 698 ---------YGILLLEIFT-GKRPTSDM 715
+GILL E+ T G+ P M
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 45/206 (21%)
Query: 537 VYKGIL---DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY G L D + AVK L + G + F+ E +++ H N++ ++ C S+
Sbjct: 41 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HHCK 641
+V +M HG L +F+R + + VA ++YL
Sbjct: 101 S----PLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
VH DL N +LD T + DFGL R + + + + G K V + E
Sbjct: 150 ---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 698 -----------YGILLLEIFT-GKRP 711
+G+LL E+ T G P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 61/411 (14%), Positives = 124/411 (30%), Gaps = 88/411 (21%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEI-GRLFRLRHIIFNSNALQGQ 107
+ + + + + + L+NL I ++ + NA++
Sbjct: 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-- 112
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
L ++ + L L L N + S+P +
Sbjct: 113 ---------YLPPHVFQNVPLL---TVLVLERNDLS------------------SLPRGI 142
Query: 168 L-NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLD 226
N + +S N L + +++ L L+ N+ ++ +S L +
Sbjct: 143 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHAN 198
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286
+ N L+ +L +E + S NS++ L L + N +
Sbjct: 199 VSYNLLS--------TLAIPIAVEELDASHNSINVVRGPVNVE----LTILKLQHNNL-- 244
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFL 346
T+ L N L + L N + + + L
Sbjct: 245 ---TDTAWLLNYP---------------------GLVEVDLSYNELEKIMYHPFVKMQRL 280
Query: 347 TELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405
L + N + ++ L LDLSHNHL + + +L L N +
Sbjct: 281 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV- 337
Query: 406 EIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLC 456
+ L LS+N+ D + + +F+N + + ++ C
Sbjct: 338 TLK------LSTHHTLKNLTLSHNDWDCN-SLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 45/238 (18%), Positives = 85/238 (35%), Gaps = 42/238 (17%)
Query: 194 TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253
TL N +I+ + + + ++E L+ + + + ++ +
Sbjct: 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHT---IQKLY 105
Query: 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP 313
+ N++ LP + L L + N +S S+P I F
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI-------------F------- 143
Query: 314 ISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLD 373
KL LS+ NN+ R + T L L L N + S + S +
Sbjct: 144 ---HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF--HAN 198
Query: 374 LSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+S+N L+ + P ++ LD S N ++ + + ++I L L +NNL
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP---VNVELTI---LKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 41/212 (19%), Positives = 79/212 (37%), Gaps = 20/212 (9%)
Query: 225 LDFANNSLTGLIPEDLDSL--VNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN 282
F + + + + ++V+ +++ L +F + L ++
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ-VELLNLNDL 85
Query: 283 PISGSIPTEI-GNLKNLIIIAIEKFILIRNIPISV-GYLLKLQVLSLFENNISREIPSSL 340
I I T + + + F IR +P V + L VL L N++S
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMG-FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 143
Query: 341 GNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLS 399
N LT L++ N++ + L L LS N LT + + S+ H ++S
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVS 200
Query: 400 KNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
N LS + +A +L+ S+N++
Sbjct: 201 YNLLS-TLAIPIA--------VEELDASHNSI 223
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 31/162 (19%), Positives = 54/162 (33%), Gaps = 5/162 (3%)
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
RY P I + + + I+ L ++++ +
Sbjct: 2 GGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS 61
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
+ + + L +F + LNL I A H + L + N + P N
Sbjct: 62 TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ L L +N+LS +P IF L++S NNL
Sbjct: 122 VPLLTVLVLERNDLS-SLPRG---IFHNTPKLTTLSMSNNNL 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 42/325 (12%), Positives = 96/325 (29%), Gaps = 65/325 (20%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
N+S L+ + + ++ N+ + + + L + N L
Sbjct: 197 ANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLT--- 245
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
+ L + + L+ N I
Sbjct: 246 ------------DTAW-LLNYPGLVEVDLSYNELE------------------KIMYHPF 274
Query: 169 -NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
+ +E ++S N+LV L + +P +++L L+ N ++ + +LE L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQ-PIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYL 331
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
+NS+ L +L N ++LS N NSL ++ +
Sbjct: 332 DHNSIVTLKLSTHHTLKN------LTLSHNDWD---CNSLRALFRNVARPAVDDADQHCK 382
Query: 288 IPTEIGN----------LKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIP 337
I ++ + + ++ I ++ + + G ++ ++
Sbjct: 383 IDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQ 442
Query: 338 SSLGNFTFLTELNLCGNSIRGSVPS 362
+L N +R V
Sbjct: 443 QGGVPLQGNEQLEAEVNELRAEVQQ 467
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 47/210 (22%)
Query: 536 TVYKGIL--DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
+V +G+ Q +A+KVL ++ + M E Q + + + +V++I C
Sbjct: 25 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL 84
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHHCK 641
LV E G L FL + V+ ++YL +
Sbjct: 85 M------LVMEMAGGGPL------HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
VH DL NVLL N A + DFGL++ + S + K + + PE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYAPECINF 187
Query: 698 -----------YGILLLEIFT-GKRPTSDM 715
YG+ + E + G++P M
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-21
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 45/209 (21%)
Query: 536 TVYKGILDLD--QTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
+V +G+ + Q +A+KVL ++ + M E Q + + + +V++I C
Sbjct: 351 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL 410
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLHHHCKK 642
LV E G L FL + V+ ++YL +K
Sbjct: 411 M------LVMEMAGGGPL------HKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----- 697
VH +L NVLL N A + DFGL++ + S + K + + PE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYAPECINFR 514
Query: 698 ----------YGILLLEIFT-GKRPTSDM 715
YG+ + E + G++P M
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 42/211 (19%), Positives = 85/211 (40%), Gaps = 50/211 (23%)
Query: 536 TVYKGIL---DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
VY+G+ ++ +AVK + FM+E ++N+ H ++VK+I
Sbjct: 27 EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP 86
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHHC 640
++ E +G L +L R + ++ + A+ YL +C
Sbjct: 87 TW------IIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
VH D+ N+L+ + +GDFGL+R+I + + + + + + +PE
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSRYIED---EDYYKASVTRLPIKWMSPESIN 187
Query: 698 ------------YGILLLEIFT-GKRPTSDM 715
+ + + EI + GK+P +
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 53/213 (24%)
Query: 537 VYKGIL---DLDQTFIAVKVL----FLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
V G L + +A+K L QR + F+ E + H N++++ +
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HH 638
S + +V E+M +GSL SFLR+ + + +AS ++YL
Sbjct: 118 S--KPVM---IVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE- 697
VH DL N+L+++++ + DFGL R + E ++ G K + + +PE
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 698 --------------YGILLLEIFT-GKRPTSDM 715
YGI+L E+ + G+RP +M
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 45/210 (21%)
Query: 537 VYKGIL---DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY G L D + AVK L + G + F+ E +++ H N++ ++ C S+
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHHCK 641
+V +M HG L +F+R + + VA +++L
Sbjct: 165 S----PLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
VH DL N +LD T + DFGL R + + + + G K V + E
Sbjct: 214 ---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 698 -----------YGILLLEIFT-GKRPTSDM 715
+G+LL E+ T G P D+
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 45/206 (21%)
Query: 537 VYKGIL---DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY G ++ A+K L + + +++F+ E +R + H N++ +I
Sbjct: 37 VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-- 94
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HHHCK 641
+G ++ +M HG L L F+R ++ + VA +EYL
Sbjct: 95 EGLPH--VLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF- 145
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697
VH DL N +LD T + DFGL R I + + + V + E
Sbjct: 146 ---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 698 -----------YGILLLEIFT-GKRP 711
+G+LL E+ T G P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 48/213 (22%), Positives = 78/213 (36%), Gaps = 50/213 (23%)
Query: 537 VYKGIL---DLDQTFIAVKVL--FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V + L D +AVK+L + ++ F+ E ++ H ++ K++ S
Sbjct: 39 VREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98
Query: 592 FQGNYFRAL-VYEFMHHGSL---------ESCPRILSFLRRLNIAIDVASALEYL-HHHC 640
+G + + FM HG L P L + +D+A +EYL +
Sbjct: 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG------YA 694
+H DL N +L DMT + DFGL+R I +G A
Sbjct: 159 ----IHRDLAARNCMLAEDMTVCVADFGLSRKIYS-------GDYYRQGCASKLPVKWLA 207
Query: 695 TPE---------------YGILLLEIFT-GKRP 711
E +G+ + EI T G+ P
Sbjct: 208 -LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 51/206 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
V G +AVK + ++F+AE + +RH NLV+++ +G
Sbjct: 209 VMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGL 262
Query: 597 FRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKPIV 645
+ +V E+M GSL + +LR L ++DV A+EYL V
Sbjct: 263 Y--IVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFI---------------PEVMSSNQCSSVGLKGT 690
H DL NVL+ D A + DFGLT+ PE + + S+ K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST---KSD 368
Query: 691 VGYATPEYGILLLEIFT-GKRPTSDM 715
V +GILL EI++ G+ P +
Sbjct: 369 VW----SFGILLWEIYSFGRVPYPRI 390
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 535 ATVYKGI-LDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
+TVY L+ +A+K + + LK F E + H+N+V +I
Sbjct: 25 STVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI---DVD 80
Query: 591 DFQGNYFRALVYEFMHHGSLESCPR---ILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
+ Y+ LV E++ +L LS +N + +++ H IVH
Sbjct: 81 EEDDCYY--LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHR 135
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------- 697
D+KP N+L+D++ T + DFG+ + + E S Q + V GTV Y +PE
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHV--LGTVQYFSPEQAKGEATDEC 192
Query: 698 ---Y--GILLLEIFTGKRP 711
Y GI+L E+ G+ P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 16/175 (9%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
+ V D F A+K + H++ + E R H N+++++ C
Sbjct: 43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102
Query: 595 NYFRALVYEFMHHGSL----ESCPRILSFL---RRLNIAIDVASALEYLHHHCKKPIVHC 647
+ L+ F G+L E +FL + L + + + LE +H K H
Sbjct: 103 HEAW-LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHR 158
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTR-FIPEVMSSNQCSSVGL----KGTVGYATPE 697
DLKP+N+LL ++ + D G V S Q ++ + T+ Y PE
Sbjct: 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 51/206 (24%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
V G +AVK + ++F+AE + +RH NLV+++ +G
Sbjct: 37 VMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGL 90
Query: 597 FRALVYEFMHHGSLESCPRILSFLRR-----------LNIAIDVASALEYLHHHCKKPIV 645
+ +V E+M GSL + +LR L ++DV A+EYL V
Sbjct: 91 Y--IVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------- 697
H DL NVL+ D A + DFGLT+ + K V + PE
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASS-------TQDTGKLPVKWTAPEALREKKFS 192
Query: 698 -------YGILLLEIFT-GKRPTSDM 715
+GILL EI++ G+ P +
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRI 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 30/200 (15%)
Query: 535 ATVYKGI-LDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
+ V+ L + +AVKVL F E Q + H +V +
Sbjct: 26 SEVHLARDLRDHRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 591 DFQGN-YFRALVYEFMHHGSLESCPR---ILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
G + +V E++ +L ++ R + + D AL + H + I+H
Sbjct: 85 TPAGPLPY--IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIH 139
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------- 697
D+KP+N+++ + DFG+ R I + +S ++ + GT Y +PE
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDA 198
Query: 698 ----Y--GILLLEIFTGKRP 711
Y G +L E+ TG+ P
Sbjct: 199 RSDVYSLGCVLYEVLTGEPP 218
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 44/220 (20%), Positives = 85/220 (38%), Gaps = 62/220 (28%)
Query: 537 VYKGIL-------DLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
++KG+ L +T + +KVL R +SF + + H++LV C
Sbjct: 24 IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYL-HH 638
N LV EF+ GSL ++L++ L +A +A+A+ +L +
Sbjct: 84 G--DENI---LVQEFVKFGSL------DTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMG--------DFGLTRFI--------------PEV 676
+H ++ N+LL + G D G++ + PE
Sbjct: 133 TL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 677 MSSNQCSSVGLKGTVGYATPEYGILLLEIFT-GKRPTSDM 715
+ + + ++ ++ +G L EI + G +P S +
Sbjct: 189 IENPKNLNL--ATDK-WS---FGTTLWEICSGGDKPLSAL 222
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 42/239 (17%), Positives = 78/239 (32%), Gaps = 32/239 (13%)
Query: 167 LLNITSMEYFHVSENQL-VGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWL 225
+T + +S N L F +++ L L+ N + + +LE L
Sbjct: 48 FDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHL 106
Query: 226 DFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285
DF +++L + + ++ L + +S SS L L M+ N
Sbjct: 107 DFQHSNLKQMSEFSV--FLSLRNLIYLDISHTHTRVAFNGIFNGLSS-LEVLKMAGNSFQ 163
Query: 286 GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTF 345
+ L L L L + + + P++ + +
Sbjct: 164 ENFLP--DIFTELR---------------------NLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 346 LTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAV--GNPKSIPHLDLSKN 401
L LN+ N+ + L LD S NH+ P S+ L+L++N
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 51/251 (20%), Positives = 88/251 (35%), Gaps = 14/251 (5%)
Query: 186 ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN 245
+P I + L L N+ ++L L ++N L+ S
Sbjct: 21 SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFG 76
Query: 246 CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIE 304
T L+ + LS N + T+ ++ L +L + + + +L+NLI + I
Sbjct: 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134
Query: 305 KFILIRNIPISV-GYLLKLQVLSLFENNISREIPS-SLGNFTFLTELNLCGNSIRGSVPS 362
R + L L+VL + N+ LT L+L + P+
Sbjct: 135 -HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 193
Query: 363 ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIF 421
A S L L++SHN+ S+ LD S N + L ++
Sbjct: 194 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF- 252
Query: 422 AKLNLSYNNLD 432
LNL+ N+
Sbjct: 253 --LNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 43/250 (17%), Positives = 88/250 (35%), Gaps = 34/250 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNN--FSSNIPHEIGRLFRLRHIIFNSNALQG 106
L L L LT L ++L N F L+++ + N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 91
Query: 107 QIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLT------ 160
+ S L + + L ++ + ++F S+ +L
Sbjct: 92 --------------TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFL-SLRNLIYLDISH 135
Query: 161 ---GSIPIQLL-NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIP-HS 215
+ ++S+E ++ N P I L N+ L L+ Q + +
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTA 194
Query: 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLR 275
++ S L+ L+ ++N+ L L + L+V+ S+N + + L +F S L
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNS---LQVLDYSLNHIMTSKKQELQHFPSSLA 251
Query: 276 YLYMSANPIS 285
+L ++ N +
Sbjct: 252 FLNLTQNDFA 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 40/233 (17%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
TVYKG+ +A L + + + F E + L+ ++H N+V+ + ++
Sbjct: 41 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRRL---------NIAIDVASALEYLHHHCKKPI 644
LV E M G+L ++L+R + + L++LH PI
Sbjct: 101 KKCI-VLVTELMTSGTL------KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPI 152
Query: 645 VHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----- 698
+H DLK N+ + + +GD GL + ++ +V GT + PE
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAV--IGTPEFMAPEMYEEKY 206
Query: 699 ---------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742
G+ +LE+ T + P S+ P +V P
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 9e-20
Identities = 44/211 (20%), Positives = 80/211 (37%), Gaps = 50/211 (23%)
Query: 536 TVYKGILDLD---QTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V++GI +A+K + F+ E +R H ++VK+I + +
Sbjct: 405 DVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 464
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRR----------LNIAIDVASALEYLH-HHC 640
++ E G L SFL+ + A +++AL YL
Sbjct: 465 VW------IIMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--- 697
VH D+ NVL+ ++ +GDFGL+R++ + S + K + + PE
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPESIN 565
Query: 698 ------------YGILLLEIFT-GKRPTSDM 715
+G+ + EI G +P +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 25/251 (9%)
Query: 186 ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN 245
++P + P+ +L L N+ N L L NN ++ + P LV
Sbjct: 45 KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 246 CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIE 304
LE + LS N L LP + + L+ L + N I+ + + L +I++ +
Sbjct: 102 ---LERLYLSKNQLK-ELPEKM--PKT-LQELRVHENEIT-KVRKSVFNGLNQMIVVELG 153
Query: 305 KFILIRNIPISVGY---LLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVP 361
+++ I G + KL + + + NI+ IP L LTEL+L GN I
Sbjct: 154 TN-PLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDA 209
Query: 362 SALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISI 420
++L + L L LS N ++ ++ N + L L+ N+L ++P L + I
Sbjct: 210 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL---ADHKYI 265
Query: 421 FAKLNLSYNNL 431
+ L NN+
Sbjct: 266 -QVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 57/282 (20%), Positives = 98/282 (34%), Gaps = 41/282 (14%)
Query: 166 QLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNA--SKLE 223
N+ ++ + N++ ++ P L + L L+ NQ + L+
Sbjct: 71 DFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL-----KELPEKMPKTLQ 124
Query: 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTL--PNSLANFSSHLRYLYMSA 281
L N +T + + L + VV L N L + + L Y+ ++
Sbjct: 125 ELRVHENEITKVRKSVFNGLNQ---MIVVELGTNPLKSSGIENGAFQGMKK-LSYIRIAD 180
Query: 282 NPISGSIPTEI-GNLKNL-----IIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISRE 335
I+ +IP + +L L I ++ L L L L L N+IS
Sbjct: 181 TNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKG--------LNNLAKLGLSFNSISAV 231
Query: 336 IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTG------PIPLAVG 388
SL N L EL+L N + VP L + + L +N+++ P
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290
Query: 389 NPKSIPHLDLSKNELS-GEIPSSLAWIFGYISIFAKLNLSYN 429
S + L N + EI S F + + A + L
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPS---TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/317 (19%), Positives = 103/317 (32%), Gaps = 53/317 (16%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
LL+L +T NL L + L N S P L +L + + N L+
Sbjct: 56 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-- 113
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
+L +P L L + N T + ++F
Sbjct: 114 ---------ELPEKMPKTLQELR------VHENEITK-VRK-SVFN-------------- 142
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFGNIPHSISNASKLEWLD 226
+ M + N L + F + + + +A IP + L L
Sbjct: 143 -GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGLP--PSLTELH 198
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286
N +T + L L N L + LS NS+S SLAN HLR L+++ N +
Sbjct: 199 LDGNKITKVDAASLKGLNN---LAKLGLSFNSISAVDNGSLANT-PHLRELHLNNNKLV- 253
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISV-------GYLLKLQVLSLFENNIS-REIPS 338
+P + + K + ++ + I I + +SLF N + EI
Sbjct: 254 KVPGGLADHKYIQVVYLHN-NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
Query: 339 SL-GNFTFLTELNLCGN 354
S + L
Sbjct: 313 STFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 30/123 (24%), Positives = 46/123 (37%), Gaps = 8/123 (6%)
Query: 322 LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380
+L L N I+ N L L L N I P A +L L LS N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 381 GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI 440
L PK++ L + +NE++ ++ S+ F ++ + L N L
Sbjct: 114 E---LPEKMPKTLQELRVHENEIT-KVRKSV---FNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 441 FKN 443
F+
Sbjct: 167 FQG 169
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 49/228 (21%), Positives = 75/228 (32%), Gaps = 39/228 (17%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNI-RHRNLVKIITACSTSDF 592
V+K D AVK RG +AE + + +H V++ A +
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----W 126
Query: 593 QGNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
+ L E SL E+ L + D AL +LH + +VH D
Sbjct: 127 EEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLD 182
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----Y----- 698
+KP+N+ L +GDFGL + + V +G Y PE Y
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLV----ELGTAGAGEV-QEGDPRYMAPELLQGSYGTAAD 237
Query: 699 ----GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742
G+ +LE+ G + LP + L
Sbjct: 238 VFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPEFTAGLSSEL 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 6e-19
Identities = 29/252 (11%), Positives = 57/252 (22%), Gaps = 68/252 (26%)
Query: 535 ATVYKGI-LDLDQTFIAVKVLF---LHQRGALKSFMAECQALRNIRHRNLVKIITAC--- 587
+ V+ ++ + F A+KV + R L+ A + + +
Sbjct: 76 SVVFLVRDVERLEDF-ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 588 --------------------STSDFQGNYFRALVYEFMHHGSLES----------CPRIL 617
NY L+ LE
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYL--LLMPAAS-VDLELLFSTLDFVYVFRGDE 191
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
L + + L +VH P N+ + D +GD +
Sbjct: 192 GILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG 248
Query: 678 SSNQCSSVGLKGTVGYATPEY-----------------GILLLEIFTGKRPTSDMFTEGL 720
+ V YA E+ G+ + ++ P +
Sbjct: 249 PA-------SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 721 DLHNFVKMALPD 732
+ +P
Sbjct: 302 GSWKRPSLRVPG 313
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 57/281 (20%), Positives = 102/281 (36%), Gaps = 44/281 (15%)
Query: 179 SENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE 238
S+ L +P I P+ +L L N L L NN ++ + +
Sbjct: 41 SDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK 96
Query: 239 DLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKN 297
L L+ + +S N L +P +L SS L L + N I +P + L+N
Sbjct: 97 AFSPLRK---LQKLYISKNHLV-EIPPNL--PSS-LVELRIHDNRIR-KVPKGVFSGLRN 148
Query: 298 LIIIAIEKFILIRNIPISVGYL--LKLQVLSLFENNIS---REIPSSL------------ 340
+ I + + N G LKL L + E ++ +++P +L
Sbjct: 149 MNCIEMGGN-PLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQA 207
Query: 341 ------GNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSI 393
++ L L L N IR +L L L L +N L+ +P + + K +
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLL 266
Query: 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKL-NLSYNNLDG 433
+ L N ++ ++ + F + K + +L
Sbjct: 267 QVVYLHTNNIT-KVGVN---DFCPVGFGVKRAYYNGISLFN 303
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 62/352 (17%), Positives = 118/352 (33%), Gaps = 65/352 (18%)
Query: 38 TCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHI 97
C L+ + S L + T L +LQ N+ S + L L +
Sbjct: 32 HCHLRV-----VQCSDLGLKAVPKEISPDTTLL---DLQNNDISELRKDDFKGLQHLYAL 83
Query: 98 IFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVY 157
+ +N + K+ S L L + L ++ N+
Sbjct: 84 VLVNNKIS-----------KIHEKAFSPLRKL---QKLYISKNHLV-------------- 115
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF-FGNIPHSI 216
IP L +S+ + +N++ ++P + L N+ + + GN
Sbjct: 116 ----EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 217 SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRY 276
+ KL +L + LTG+ + ++ L + L N + L +S L
Sbjct: 169 FDGLKLNYLRISEAKLTGIPKDLPET------LNELHLDHNKIQAIELEDLLRYSK-LYR 221
Query: 277 LYMSANPISGSIPTEI-GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISRE 335
L + N I I L L + ++ + +P + L LQV+ L NNI+ +
Sbjct: 222 LGLGHNQIR-MIENGSLSFLPTLRELHLD-NNKLSRVPAGLPDLKLLQVVYLHTNNIT-K 278
Query: 336 IPSS-------LGNFTFLTELNLCGNSIR-GSVPSALGSC--HQLWLDLSHN 377
+ + + ++L N + V A C +L + +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 26/123 (21%), Positives = 41/123 (33%), Gaps = 8/123 (6%)
Query: 322 LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380
+L L N+IS L L L N I A +L L +S NHL
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 381 GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI 440
+ P S+ L + N + ++P + F + + + N L+
Sbjct: 116 E---IPPNLPSSLVELRIHDNRIR-KVPKGV---FSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 441 FKN 443
F
Sbjct: 169 FDG 171
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 64/377 (16%), Positives = 125/377 (33%), Gaps = 56/377 (14%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L+ ++T I LT L + NN ++ ++ + L ++ +SN L +
Sbjct: 47 LDCHNSSITDM--TGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLT-NL 100
Query: 109 PDSRLIL--------NKLEGNIPSELGSLLKFKGLGLANNYFT----GPIPHLNMFQVSV 156
+ L NKL S+ L L A N T L +
Sbjct: 101 DVTPLTKLTYLNCDTNKLTKLDVSQNPLL---TYLNCARNTLTEIDVSHNTQLTELDCHL 157
Query: 157 YSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFGNIPHS 215
+ + T + S N++ + + + L N +
Sbjct: 158 NKKITKLDVT--PQTQLTTLDCSFNKIT-----ELDVSQNKLLNRLNCDTNNIT-KLD-- 207
Query: 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLR 275
++ +L +LD ++N LT + + T L SVN L+ L S S L
Sbjct: 208 LNQNIQLTFLDCSSNKLTEI------DVTPLTQLTYFDCSVNPLT-ELDVST---LSKLT 257
Query: 276 YLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISRE 335
L+ + I + + LI E I+ + ++ + +L +L I+ E
Sbjct: 258 TLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT-E 311
Query: 336 IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIP 394
+ L L L L + + + +L L + H+ +VG ++
Sbjct: 312 LD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALN 364
Query: 395 HLDLSKNELSGEIPSSL 411
+ ++ + +L
Sbjct: 365 NNFEAEGQTITMPKETL 381
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 67/396 (16%), Positives = 129/396 (32%), Gaps = 58/396 (14%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
+ + T + L L ++ ++ + + I +L L +I SN + +
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT-TL 79
Query: 109 PDSRLIL--------NKLEGNIPSELGSLLKFKGLGLANNYFT----GPIPHLNMFQVSV 156
S+ NKL N+ + L K L N T P L +
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCAR 136
Query: 157 YSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI 216
+LT I + + T + N+ + +L + L + N+ + +
Sbjct: 137 NTLT---EIDVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNK-ITELD--V 187
Query: 217 SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRY 276
S L L+ N++T L L L + S N L+ + + + L Y
Sbjct: 188 SQNKLLNRLNCDTNNITKL------DLNQNIQLTFLDCSSNKLT-EID--VTPLTQ-LTY 237
Query: 277 LYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREI 336
S NP++ + + L L I + + I ++ + +L +E+
Sbjct: 238 FDCSVNPLTELDVSTLSKLTTLHCIQTD----LLEIDLT--HNTQLIYFQAEGCRKIKEL 291
Query: 337 PSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPH 395
+ + T L L+ I + L +L +L L++ LT L V + +
Sbjct: 292 D--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE---LDVSHNTKLKS 343
Query: 396 LDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
L + + S G I +
Sbjct: 344 LSCVNAHIQ-DFSS-----VGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 28/215 (13%)
Query: 193 FTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVV 252
F N + A + S + L LD N+S+T D+ + T L +
Sbjct: 15 FPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-----DMTGIEKLTGLTKL 69
Query: 253 SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN- 311
+ N+++ TL S ++L YL +N ++ ++ + L L N
Sbjct: 70 ICTSNNIT-TLDLSQN---TNLTYLACDSNKLT-NLD--VTPLTKL-----TYLNCDTNK 117
Query: 312 -IPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370
+ V L L+ N ++ EI + + T LTEL+ N + QL
Sbjct: 118 LTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQL 172
Query: 371 -WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
LD S N +T L V K + L+ N ++
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 52/369 (14%), Positives = 106/369 (28%), Gaps = 95/369 (25%)
Query: 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107
L L + T L ++ N + ++ + L + ++N +
Sbjct: 150 LTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-- 204
Query: 108 IPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
+ L ++ L ++N T I +
Sbjct: 205 -------------KLD--LNQNIQLTFLDCSSNKLT------------------EIDVT- 230
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
+T + YF S N L EL TL + L I +++ ++L +
Sbjct: 231 -PLTQLTYFDCSVNPL-TELDVS---TLSKLTTLHCIQTD-LLEID--LTHNTQLIYFQA 282
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
+ + + T L ++ ++ L L+ L YLY++ ++
Sbjct: 283 EGCRKIKELD-----VTHNTQLYLLDCQAAGIT-ELD--LSQNPK-LVYLYLNNTELT-- 331
Query: 288 IPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLT 347
+ +S + KL+ LS +I + S+G L
Sbjct: 332 -----------------------ELDVS--HNTKLKSLSCVNAHIQ-DFS-SVGKIPALN 364
Query: 348 ELNLCGNSIRGSVPSALGSCHQL-------WLDLSHNHLTGPIPLAVGNPKSIPHLDLSK 400
++P + + L LD N + I G ++
Sbjct: 365 NNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITW 421
Query: 401 NELSGEIPS 409
LS + P+
Sbjct: 422 ENLSTDNPA 430
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 40/202 (19%), Positives = 73/202 (36%), Gaps = 40/202 (19%)
Query: 535 ATVYKGI-LDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VY+ ++ +A+K++ E + ++ ++V I
Sbjct: 48 GDVYEAEDTVRERI-VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH---DFG 103
Query: 591 DFQGNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
+ G + + ++ L P L+ R + I + SAL+ H
Sbjct: 104 EIDGQLY--VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG-LKGTVGYATPE------- 697
H D+KP N+L+ D A++ DFG+ + + + +G GT+ Y PE
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS----ATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 698 ------Y--GILLLEIFTGKRP 711
Y +L E TG P
Sbjct: 213 TYRADIYALTCVLYECLTGSPP 234
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 48/210 (22%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
VY G +Q IA+K + + E ++++H+N+V+ S +
Sbjct: 37 IVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----YLGSFSENG 92
Query: 596 YFRALVYEFMHHGSLESC------------PRILSFLRRLNIAIDVASALEYLHHHCKKP 643
+ + + E + GSL + I + + + L+YLH +
Sbjct: 93 FIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK------QILEGLKYLHDNQ--- 142
Query: 644 IVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----- 697
IVH D+K NVL++ + DFG ++ + + + GT+ Y PE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE----TFTGTLQYMAPEIIDKG 198
Query: 698 ---Y---------GILLLEIFTGKRPTSDM 715
Y G ++E+ TGK P ++
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFYEL 228
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 47/251 (18%), Positives = 81/251 (32%), Gaps = 29/251 (11%)
Query: 201 LLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS 260
L + I + L+ L + I ++ + L+ ++L ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 261 GTLPNSLANFS-SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN----IPIS 315
GT P L + L L + + + L+ + ++ + +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 316 VGYLLK-LQVLSLFENNISREIPSS----LGNFTFLTELNLCGN---SIRGSVPSALGSC 367
+ L L L +N E F L L L + G + +
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 368 HQL-WLDLSHNHLTG-PIPLAVGNPKSIPHLDLSKNELS---GEIPSSLAWIFGYISIFA 422
QL LDLSHN L + P + L+LS L +P+ L+
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---------- 277
Query: 423 KLNLSYNNLDG 433
L+LSYN LD
Sbjct: 278 VLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 48/328 (14%), Positives = 90/328 (27%), Gaps = 67/328 (20%)
Query: 65 GNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPS 124
G + L+ +I + L+ + + + +I L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGAL----------- 89
Query: 125 ELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLV 184
+ + + L L N TG P P+ + ++
Sbjct: 90 RVLGISGLQELTLENLEVTGTAP---------------PPLLEATGPDLNILNLRNVSWA 134
Query: 185 G---ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG------- 234
L + P +++L +A + L LD ++N G
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 235 LIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGN 294
L P +L L + + + + SG A L+ L +S N + +
Sbjct: 195 LCPLKFPTL---QVLALRNAGMETPSGVCSALAAARVQ-LQGLDLSHNSLRDAAG----- 245
Query: 295 LKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGN 354
S + +L L+L + ++P L L+ L+L N
Sbjct: 246 ------------------APSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYN 284
Query: 355 SIRGSVPSALGSCHQLWLDLSHNHLTGP 382
+ PS L L N
Sbjct: 285 RLD-RNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 36/236 (15%), Positives = 63/236 (26%), Gaps = 32/236 (13%)
Query: 41 LKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFS-SNIPHEIGRLFRLRHIIF 99
L + L L +TGTA P + T L L N S + + L +
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
Query: 100 NSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP------------ 147
++ ++ L L++N G
Sbjct: 152 KVLSIAQ---------AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
Query: 148 --HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205
L + + + +G ++ +S N L + L L+
Sbjct: 203 LQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262
Query: 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG 261
+P + +KL LD + N L S + +SL N
Sbjct: 263 TG-LKQVPKGLP--AKLSVLDLSYNRLDR-----NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 42/201 (20%), Positives = 62/201 (30%), Gaps = 16/201 (7%)
Query: 238 EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKN 297
D S NC V L S L+ + A+ + + +LK
Sbjct: 22 PDWSSAFNCLGAADVELYGGGRS---------LEYLLKRVDTEADLGQFTDIIKSLSLKR 72
Query: 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTF--LTELNLCGNS 355
L + A I + V + LQ L+L ++ P L T L LNL S
Sbjct: 73 LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132
Query: 356 I--RGSVPSALGSCHQL---WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSS 410
R + + L + L ++ H V ++ LDLS N GE
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 411 LAWIFGYISIFAKLNLSYNNL 431
A L L +
Sbjct: 193 SALCPLKFPTLQVLALRNAGM 213
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 22/213 (10%), Positives = 57/213 (26%), Gaps = 37/213 (17%)
Query: 26 NDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIP 85
WL + +L+++ + + + L ++L N
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 86 HEI----GRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNY 141
+ L+ + + + G + + ++ +GL L++N
Sbjct: 191 LISALCPLKFPTLQVLALRNAG-----------METPSGVCSALAAARVQLQGLDLSHNS 239
Query: 142 FTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRIL 201
+ + ++S L ++P + + +L
Sbjct: 240 LRDAAG----------------APSCDWPSQLNSLNLSFTGLK-QVPKGL---PAKLSVL 279
Query: 202 LLAGNQFFGNIPHSISNASKLEWLDFANNSLTG 234
L+ N+ P S ++ L N
Sbjct: 280 DLSYNR-LDRNP-SPDELPQVGNLSLKGNPFLD 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 8e-18
Identities = 39/238 (16%), Positives = 65/238 (27%), Gaps = 74/238 (31%)
Query: 535 ATVYKGI-LDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIR-------------- 576
+ + ++F V V + + A+K E LR +R
Sbjct: 92 YAYLEATDQETGESF-EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 577 --------HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLE----------SCPRILS 618
K+I R +Y M +L+ S + L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLV 209
Query: 619 FLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678
RL + + V L LHH+ +VH L+P +++LD + F
Sbjct: 210 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV 266
Query: 679 SNQCSSVGLKGTVGYATPEY-------------------------GILLLEIFTGKRP 711
S G+A PE G+ + I+ P
Sbjct: 267 S--------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 54/219 (24%), Positives = 79/219 (36%), Gaps = 63/219 (28%)
Query: 537 VYKGIL-----DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VY+G + D +AVK L + F+ E + H+N+V+ I S
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------------LNIAIDVASALE 634
+ ++ E M G L SFLR L++A D+A +
Sbjct: 106 --LPRF---ILMELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 635 YL-HHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT 690
YL +H +H D+ N LL A +GDFG+ R I G
Sbjct: 155 YLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKGGCAM 206
Query: 691 --VGYATPE---------------YGILLLEIFT-GKRP 711
V + PE +G+LL EIF+ G P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 43/180 (23%), Positives = 70/180 (38%), Gaps = 18/180 (10%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQ 593
A VY+ A+K L ++ ++ + E ++ + H N+V+ +A S +
Sbjct: 42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101
Query: 594 GNYFRALVYEFMHH--GSL------ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
+ +A G L LS L I A++++H K PI+
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPII 160
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRF----IPEVMSSNQCSSVGLK----GTVGYATPE 697
H DLK N+LL N T + DFG S+ + + V + T Y TPE
Sbjct: 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 54/219 (24%), Positives = 79/219 (36%), Gaps = 63/219 (28%)
Query: 537 VYKGIL-----DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VY+G + D +AVK L + F+ E + H+N+V+ I S
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR----------------LNIAIDVASALE 634
+ ++ E M G L SFLR L++A D+A +
Sbjct: 147 --LPRF---ILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 635 YL-HHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT 690
YL +H +H D+ N LL A +GDFG+ R I G
Sbjct: 196 YLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKGGCAM 247
Query: 691 --VGYATPE---------------YGILLLEIFT-GKRP 711
V + PE +G+LL EIF+ G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 61/220 (27%)
Query: 537 VYKGIL-----DLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V+ + D+ +AVK L A + F E + L ++H+++V+ C+
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 592 FQGNYFRALVYEFMHHGSL------------------ESCPRILSFLRRLNIAIDVASAL 633
+V+E+M HG L + P L + L +A VA+ +
Sbjct: 117 P-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 634 EYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG 692
YL H VH DL N L+ + +GDFG++R I + G
Sbjct: 172 VYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-------TDYYRVGGRT 220
Query: 693 -----YATPE---------------YGILLLEIFT-GKRP 711
+ PE +G++L EIFT GK+P
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 62/346 (17%), Positives = 109/346 (31%), Gaps = 25/346 (7%)
Query: 47 ILLNLSGQNLTGTASPYIGNLTF--LRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNAL 104
+LL L + + L ++ F + + + L
Sbjct: 143 VLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLE 202
Query: 105 QGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLT---- 160
+ IL KL+ N +L + + + H ++ S+ ++
Sbjct: 203 DNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ 262
Query: 161 ---GSIPIQLLNITSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFGNIPHSI 216
++ ++ V + P + N+ I +
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 217 SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS--SHL 274
S S LDF+NN LT + E+ L L L +N L L + L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETL---ILQMNQLK-ELSKIAEMTTQMKSL 376
Query: 275 RYLYMSANPISGSIPTEI-GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333
+ L +S N +S K+L+ + + IL I +++VL L N I
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC--LPPRIKVLDLHSNKIK 434
Query: 334 REIPSSLGNFTFLTELNLCGNSIRGSVP-SALGSCHQL-WLDLSHN 377
IP + L ELN+ N ++ SVP L + L N
Sbjct: 435 S-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 66/403 (16%), Positives = 133/403 (33%), Gaps = 35/403 (8%)
Query: 49 LNLSGQNLTG-TASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQ-- 105
L+LS GN++ L+ + L + + I L + ++
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154
Query: 106 ---GQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG--PIPHLNMFQVSVYSLT 160
+ D + E +L +AN + + N + L
Sbjct: 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA 214
Query: 161 GSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRI--LLLAGNQFFGNIPHSISN 218
L+ ++ + N + L T+ I + L G F + +S ++
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274
Query: 219 ASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278
L ++ + N + +V+ + + S +L
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIK---NFTVSGTR-MVHMLCPSKISPFLHLD 330
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRN----IPISVGY---LLKLQVLSLFENN 331
S N ++ ++ G+L L E IL N + + LQ L + +N+
Sbjct: 331 FSNNLLTDTVFENCGHLTEL-----ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 332 ISREIPSSL-GNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
+S + L LN+ N + ++ L ++ LDL N + IP V
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVK 442
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
+++ L+++ N+L +P IF ++ K+ L N D
Sbjct: 443 LEALQELNVASNQLK-SVPDG---IFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-16
Identities = 77/417 (18%), Positives = 145/417 (34%), Gaps = 43/417 (10%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
LN+S ++ + I +L+ LR++ + N L ++ + N L I
Sbjct: 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-I 84
Query: 109 PDSRL----ILNKLEGN------IPSELGSLLKFKGLGLANNYFT----GPIPHLNMFQV 154
L+ L N I E G++ + K LGL+ + PI HLN+ +V
Sbjct: 85 SCHPTVNLKHLD-LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143
Query: 155 SVY---SLTGSIPIQLLNITSMEYFHV--SENQLVGELPPHIGFTLPNVRILLLAGNQFF 209
+ + + L + E H+ N+ + T+ N+ + +
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203
Query: 210 GNIPHSISNASKLEW------LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTL 263
+ +S +KL+ L N T + LV T + S+S L G L
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263
Query: 264 PNSLANFSSH-LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVG---YL 319
++S L+ L + + + + I+ F + + + +
Sbjct: 264 DFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI 323
Query: 320 LKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL----WLDLS 375
L N ++ + + G+ T L L L N ++ + Q+ LD+S
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDIS 382
Query: 376 HNHLTGPIPLAV-GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
N ++ KS+ L++S N L+ I L L+L N +
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP------PRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 53/402 (13%), Positives = 119/402 (29%), Gaps = 61/402 (15%)
Query: 47 ILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQG 106
L++ S L P ++N+ QN S +I L +LR +I + N +Q
Sbjct: 3 FLVDRSKNGLI--HVP-KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 107 QIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQ 166
L+ ++ L + L L++N I
Sbjct: 59 ----------YLDISVFKFNQEL---EYLDLSHNKLV------------------KISCH 87
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFGNIPHSISNASKLEWL 225
++++ +S N LP F + ++ L L+ + I++ + + L
Sbjct: 88 PT--VNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVL 144
Query: 226 DFANNSLTGLIPEDLDSLVNCTYLEV-VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
+ ED + L + + + N + + ++L +
Sbjct: 145 LVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLE 202
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLK---------LQVLSLFENNISRE 335
+ L L + + NI + ++ + S+ + +
Sbjct: 203 DNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ 262
Query: 336 IPSSLGNFTF-----LTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
+ +++ L+ + + + + + + L
Sbjct: 263 LDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSK 322
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
HLD S N L+ + G+++ L L N L
Sbjct: 323 ISPFLHLDFSNNLLTDTVFE----NCGHLTELETLILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 39/242 (16%), Positives = 76/242 (31%), Gaps = 36/242 (14%)
Query: 196 PNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
IL ++ N I + SKL L ++N + L YL+ LS
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLD---LS 77
Query: 256 VNSLSGTLPNSLANFSSHLRYLYMSANPI-SGSIPTEIGNLKNLIIIAIEKFILIRNIPI 314
N L + N L++L +S N + I E GN+
Sbjct: 78 HNKLVKISCHPTVN----LKHLDLSFNAFDALPICKEFGNMSQ----------------- 116
Query: 315 SVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE-LNLCGNSIRGSVPSALGSCHQLWLD 373
L+ L L ++ + + + L L P L + L
Sbjct: 117 -------LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169
Query: 374 L---SHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNN 430
+ ++ + ++V ++ ++ + L+ + + NL+ NN
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 431 LD 432
++
Sbjct: 230 IE 231
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 53/316 (16%), Positives = 104/316 (32%), Gaps = 21/316 (6%)
Query: 322 LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380
+L++ +N IS S + + + L L + N I+ S +L +LDLSHN L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 381 GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI 440
++ ++ HLDLS N +P + FG +S L LS +L+ +
Sbjct: 83 K---ISCHPTVNLKHLDLSFNAFD-ALP--ICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 441 FKNASAISEAGNEKLCGGISELKLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSL 500
N S + E L L + IL +S L +S
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 501 LIINRLRRQRTVTSSESSS-------RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKV 553
+ + + S + L N+ + + + + ++
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 554 LFLHQRGALKSFMAECQALRNIRHRNL-VKIITACSTSDFQGNYFRALVYEFMHHGSLES 612
+ L + + F +L+ + + + + ++ F + +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI--FSNMNIKNFTVSGTRM 314
Query: 613 ----CPRILSFLRRLN 624
CP +S L+
Sbjct: 315 VHMLCPSKISPFLHLD 330
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 69/222 (31%)
Query: 537 VYKGIL-----DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VY+G+ D +T +A+K + F+ E ++ ++V+++ S
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR-------------------LNIAIDVAS 631
++ E M G L S+LR + +A ++A
Sbjct: 101 QP-----TLVIMELMTRGDL------KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTV 691
+ YL+ VH DL N ++ D T +GDFG+TR I E + KG
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-------TDYYRKGGK 199
Query: 692 GY------ATPE---------------YGILLLEIFT-GKRP 711
G + PE +G++L EI T ++P
Sbjct: 200 GLLPVRWMS-PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 75/412 (18%), Positives = 140/412 (33%), Gaps = 66/412 (16%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEI-GRLFRLRHIIFNSNALQGQ 107
++LS ++ L L+ + ++Q I + L L + + N
Sbjct: 35 VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-- 92
Query: 108 IPDSRLILNKLEGNIPSE-LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQ 166
+ + L + L L G + N F+
Sbjct: 93 -------------QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK------------- 126
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFGNIPHSI---SNASKL 222
+TS+E + +N + ++ P F + +L L N+ +I
Sbjct: 127 --PLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHF 182
Query: 223 EWLDFANNSLTGLIPEDLDSL-----VNCTYLEVVSLSVNSLSGTLP----NSLANFSSH 273
L ++ +L + L T + + LS N ++ +++A
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
Query: 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL---------IRNIPISV-GYLLKLQ 323
L S N S T + N +E + I + SV + L+
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE 302
Query: 324 VLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPS-ALGSCHQL-WLDLSHNHLTG 381
L+L +N I++ ++ T L +LNL N + GS+ S + +L LDLS+NH+
Sbjct: 303 QLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRA 361
Query: 382 PIPLAV-GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
+ ++ L L N+L +P IF ++ K+ L N D
Sbjct: 362 -LGDQSFLGLPNLKELALDTNQLK-SVPDG---IFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 55/251 (21%), Positives = 86/251 (34%), Gaps = 32/251 (12%)
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA 281
+ ++D + NS+ L L + +L + + + N+ S L L +
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFL---KVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 282 NPISGSIPTEI-GNLKNLIIIAIEKFIL----IRNIPISVGY---LLKLQVLSLFENNIS 333
N + T L NL E L + +S + L L++L L +NNI
Sbjct: 89 NQFL-QLETGAFNGLANL-----EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 334 REIPSSL-GNFTFLTELNLCGNSIRGSVPS----ALGSCHQLWLDLSHNHLT-----GPI 383
+ P+S N L+L N ++ S+ H L LS L
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 384 PLAVGNP---KSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI 440
GNP SI LDLS N E + + + L LS + G
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 441 FKNASAISEAG 451
FK+ + G
Sbjct: 261 FKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 36/165 (21%), Positives = 62/165 (37%), Gaps = 7/165 (4%)
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISV-GYLLKLQVLSLFEN 330
+H+ Y+ +S N I+ T L++L + +E+ I + L L +L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSV--PSALGSCHQL-WLDLSHNHLTGPIPLAV 387
+ + L L L ++ G+V + L L L N++ P +
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 388 -GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
N + LDL+ N++ I + F L LS L
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEE-DLLNFQGKHFTLLRLSSITL 192
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 51/233 (21%), Positives = 93/233 (39%), Gaps = 9/233 (3%)
Query: 171 TSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN 230
T+ ++ ENQ+ + + L ++ IL L+ N + + + L L+ +N
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 231 SLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPT 290
LT + L L+ + L N + ++P+ N LR L + I
Sbjct: 123 RLTTIPNGAFVYLSK---LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISE 178
Query: 291 EI-GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTEL 349
L NL + + +R IP ++ L+KL L L N++S P S L +L
Sbjct: 179 GAFEGLSNLRYLNLA-MCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236
Query: 350 NLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
+ + I+ +A + L ++L+HN+LT + + L N
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 43/214 (20%), Positives = 78/214 (36%), Gaps = 33/214 (15%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
+ ++ + +N+L +P L ++ L L N +IP + L LD
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDL 167
Query: 228 A-NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS--SHLRYLYMSANPI 284
L+ + + L N YL +L++ +L + N + L L +S N +
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYL---NLAMCNLR-----EIPNLTPLIKLDELDLSGNHL 219
Query: 285 SGSIPTEI-GNLKNLIIIAIEKFIL----IRNIPISV-GYLLKLQVLSLFENNISREIPS 338
S +I L +L +K + I+ I + L L ++L NN++
Sbjct: 220 S-AIRPGSFQGLMHL-----QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 339 SLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWL 372
L ++L N +C LWL
Sbjct: 274 LFTPLHHLERIHLHHNPWN-------CNCDILWL 300
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 45/222 (20%), Positives = 75/222 (33%), Gaps = 38/222 (17%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
+P IS + L+ N + + L + LE++ LS N + + +
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRH---LEILQLSRNHIRTIEIGAFNGLA 112
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
+ L L + N ++ +IP G L KL+ L L N
Sbjct: 113 N-LNTLELFDNRLT-TIPN--GAFVYLS---------------------KLKELWLRNNP 147
Query: 332 ISREIPSSLGNFTFLTELNLCG-NSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
I + L L+L + A L +L+L+ +L IP +
Sbjct: 148 IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTP 205
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ LDLS N LS I F + KL + + +
Sbjct: 206 LIKLDELDLSGNHLS-AIRPG---SFQGLMHLQKLWMIQSQI 243
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 45/214 (21%), Positives = 74/214 (34%), Gaps = 39/214 (18%)
Query: 220 SKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYM 279
++ + +L +P+ + + N L +L N + NS + L L +
Sbjct: 43 NQFSKVICVRKNLRE-VPDGIST--NTRLL---NLHENQIQIIKVNSFKHLRH-LEILQL 95
Query: 280 SANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSS 339
S N I +I G L L L LF+N ++ +
Sbjct: 96 SRNHIR-TIEI--GAFNGLA---------------------NLNTLELFDNRLTTIPNGA 131
Query: 340 LGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSH-NHLTGPIPLAVGNPKSIPHLD 397
+ L EL L N I A L LDL L+ A ++ +L+
Sbjct: 132 FVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 398 LSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
L+ L EIP+ + +L+LS N+L
Sbjct: 192 LAMCNLR-EIPN-----LTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 34/211 (16%), Positives = 62/211 (29%), Gaps = 60/211 (28%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L L + S + LR ++L + S I A +G
Sbjct: 141 LWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS---------------EGAFEG-- 183
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
L+ L L LA + +
Sbjct: 184 ------LSNLR--------------YLNLAMC----NLREIPNLT--------------- 204
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
+ ++ +S N L + P L +++ L + +Q ++ N L ++ A
Sbjct: 205 PLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259
+N+LT L + L + LE + L N
Sbjct: 264 HNNLTLLPHDLFTPLHH---LERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 45/234 (19%), Positives = 90/234 (38%), Gaps = 11/234 (4%)
Query: 171 TSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNI-PHSISNASKLEWLDFAN 229
++ Y ++ EN + + L ++ +L L N I + + + L L+ +
Sbjct: 75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132
Query: 230 NSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP 289
N LT + + L L + L N + ++P+ N L L + I
Sbjct: 133 NWLTVIPSGAFEYLSK---LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYIS 188
Query: 290 TEI-GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE 348
L NL + + I+++P ++ L+ L+ L + N+ P S + L +
Sbjct: 189 EGAFEGLFNLKYLNLG-MCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 349 LNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
L + + + +A L L+L+HN+L+ + + L L N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 42/222 (18%), Positives = 76/222 (34%), Gaps = 38/222 (17%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
+P I S +L+ N++ + + L +LEV+ L NS+ + +
Sbjct: 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHL---HHLEVLQLGRNSIRQIEVGAFNGLA 123
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
S L L + N ++ IP+ + L KL+ L L N
Sbjct: 124 S-LNTLELFDNWLT-VIPSGA--FEYLS---------------------KLRELWLRNNP 158
Query: 332 ISREIPSSLGNFTFLTELNL-CGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGN 389
I + L L+L + A L +L+L ++ +P +
Sbjct: 159 IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTP 216
Query: 390 PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ L++S N EI F +S KL + + +
Sbjct: 217 LVGLEELEMSGNHFP-EIRPGS---FHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 42/199 (21%), Positives = 69/199 (34%), Gaps = 26/199 (13%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
+ S+ + +N L +P L +R L L N +IP + L LD
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDL 178
Query: 228 AN-NSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS--SHLRYLYMSANPI 284
L + + L N L+ ++L + ++ + N + L L MS N
Sbjct: 179 GELKKLEYISEGAFEGLFN---LKYLNLGMCNIK-----DMPNLTPLVGLEELEMSGNHF 230
Query: 285 SGSIPTE-IGNLKNLIIIAIEKFIL----IRNIPISV-GYLLKLQVLSLFENNISREIPS 338
I L +L +K + + I + L L L+L NN+S
Sbjct: 231 P-EIRPGSFHGLSSL-----KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 339 SLGNFTFLTELNLCGNSIR 357
+L EL+L N
Sbjct: 285 LFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 40/186 (21%), Positives = 68/186 (36%), Gaps = 14/186 (7%)
Query: 249 LEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL 308
V + LS +P S+ RYL + N I +L +L ++ + +
Sbjct: 56 FSKVVCTRRGLS-EVP---QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN-S 110
Query: 309 IRNIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSC 367
IR I + L L L LF+N ++ + + L EL L N I A
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 368 HQL-WLDLSH-NHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLN 425
L LDL L A ++ +L+L + ++P+ + +L
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-----LTPLVGLEELE 224
Query: 426 LSYNNL 431
+S N+
Sbjct: 225 MSGNHF 230
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 27/112 (24%), Positives = 42/112 (37%), Gaps = 8/112 (7%)
Query: 321 KLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHL 379
+ + +S +P + + LNL N+I+ H L L L N +
Sbjct: 55 QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 380 TGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
A S+ L+L N L+ IPS F Y+S +L L N +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGA---FEYLSKLRELWLRNNPI 159
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 50/244 (20%), Positives = 89/244 (36%), Gaps = 14/244 (5%)
Query: 196 PNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
V+ L L+ N+ I +S L+ L +N + + + SL + LE + L
Sbjct: 52 EAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS---LEHLDL 107
Query: 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI--GNLKNLIIIAIEKFILIRNI 312
S N LS L +S S L +L + NP ++ +L L I+ + I
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 313 PISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL- 370
L L+ L + +++ P SL + ++ L L + + +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 371 WLDLSHNHLTGPIP--LAVGNPKSIPHL-DLSKNELSGEIPSSLAWIFGYISIFAKLNLS 427
L+L L L+ G S+ +++ E + + IS +L S
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285
Query: 428 YNNL 431
N L
Sbjct: 286 RNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 47/317 (14%), Positives = 102/317 (32%), Gaps = 58/317 (18%)
Query: 68 TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG 127
++ ++L N + ++ R L+ ++ SN + +E + S LG
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-----------TIEEDSFSSLG 100
Query: 128 SLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL-NITSMEYFHVSENQLVGE 186
SL + L L+ NY + ++ ++S+ + ++ N
Sbjct: 101 SL---EHLDLSYNYLS------------------NLSSSWFKPLSSLTFLNLLGNPYK-T 138
Query: 187 LPPHIGFT-LPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLV 244
L F+ L ++IL + F I + + LE L+ + L P+ L S+
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198
Query: 245 NCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIE 304
N + + L + L + +S + L + + + L
Sbjct: 199 N---VSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF------HFSELSTGETN 248
Query: 305 KFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSAL 364
I + + + + ++ ++ L + L EL N ++
Sbjct: 249 SLI----------KKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLKSVPDGIF 297
Query: 365 GSCHQL-WLDLSHNHLT 380
L + L N
Sbjct: 298 DRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 39/220 (17%), Positives = 77/220 (35%), Gaps = 37/220 (16%)
Query: 242 SLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIII 301
+ ++C + S SL+ ++P + + ++ L +S N I+ +++ NL +
Sbjct: 26 ASLSCDRNGICKGSSGSLN-SIP---SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQAL 81
Query: 302 AIEKFILIRNIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSV 360
+ I I L L+ L L N +S S + LT LNL GN +
Sbjct: 82 VLT-SNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLG 140
Query: 361 PSA------------LGSCHQL---------------WLDLSHNHLTGPIPLAVGNPKSI 393
++ +G+ L++ + L P ++ + +++
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNV 200
Query: 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
HL L + + S L L +LD
Sbjct: 201 SHLILHMKQHI-LLL---EIFVDVTSSVECLELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 31/210 (14%), Positives = 68/210 (32%), Gaps = 34/210 (16%)
Query: 66 NLTFLRLINLQQNNFSSNIPHEI-GRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPS 124
L+ L +NL N + + + L +L+ + + +I +
Sbjct: 122 PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR----------KDFA 171
Query: 125 ELGSLLKFKGLGLANNYFT-------GPIPHLNMFQVSVYSLTGSIPIQLL-NITSMEYF 176
L L + L + + I +++ + + + + +S+E
Sbjct: 172 GLTFL---EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 177 HVSENQLVG----ELPPHIGFTLPNV---RILLLAGNQFFGNIPHSISNASKLEWLDFAN 229
+ + L EL +L R + + F + ++ S L L+F+
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 230 NSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259
N L + D L + L+ + L N
Sbjct: 287 NQLKSVPDGIFDRLTS---LQKIWLHTNPW 313
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 42/213 (19%), Positives = 73/213 (34%), Gaps = 16/213 (7%)
Query: 196 PNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
+ + L GN+ S L L +N L + L LE + LS
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL---LEQLDLS 88
Query: 256 VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIEKFIL----IR 310
N+ ++ + + L L++ + + + L L + L ++
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL-----QYLYLQDNALQ 142
Query: 311 NIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQ 369
+P L L L L N IS + L L L N + P A +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 370 L-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
L L L N+L+ A+ +++ +L L+ N
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 41/196 (20%), Positives = 70/196 (35%), Gaps = 18/196 (9%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
++ + N L + L + L L+ N ++ + +L L
Sbjct: 54 ACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
L L P L L+ + L N+L LP+ +L +L++ N IS S
Sbjct: 113 DRCGLQELGPGLFRGLAA---LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-S 167
Query: 288 IPTEI-GNLKNLIIIAIEKFIL----IRNIPISV-GYLLKLQVLSLFENNISREIPSSLG 341
+P L +L ++ +L + ++ L +L L LF NN+S +L
Sbjct: 168 VPERAFRGLHSL-----DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 342 NFTFLTELNLCGNSIR 357
L L L N
Sbjct: 223 PLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 45/237 (18%), Positives = 76/237 (32%), Gaps = 39/237 (16%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
+ L G ++ + L ++ L N + L L + + NA
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA----- 91
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
L ++ LG L L L + L
Sbjct: 92 -----QLRSVDPATFHGLGRL---HTLHLDRCGLQ------------------ELGPGLF 125
Query: 169 -NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLD 226
+ +++Y ++ +N L LP L N+ L L GN+ ++P L+ L
Sbjct: 126 RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLL 183
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283
N + + P L L + L N+LS LP L+YL ++ NP
Sbjct: 184 LHQNRVAHVHPHAFRDLGR---LMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNP 236
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 31/124 (25%), Positives = 42/124 (33%), Gaps = 12/124 (9%)
Query: 310 RNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQ 369
IP + Q + L N IS +S LT L L N + +A
Sbjct: 28 VGIPAA------SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 370 L-WLDLSHNHLTGPIPLAV-GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLS 427
L LDLS N + A + L L + L E+ L F ++ L L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL---FRGLAALQYLYLQ 137
Query: 428 YNNL 431
N L
Sbjct: 138 DNAL 141
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 47/204 (23%), Positives = 72/204 (35%), Gaps = 37/204 (18%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
K D + K L + ++E LR ++H N+V+ D
Sbjct: 21 RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD--RIIDRT 78
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRR---------LNIAIDVASALEYLH--HHCKK 642
+V E+ G L S I + L + + AL+ H
Sbjct: 79 NTTLY-IVMEYCEGGDLAS--VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----- 697
++H DLKP+NV LD +GDFGL R +++ + + GT Y +PE
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 698 -Y---------GILLLEIFTGKRP 711
Y G LL E+ P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 9e-17
Identities = 37/237 (15%), Positives = 62/237 (26%), Gaps = 71/237 (29%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQR---GALKSFMAECQALRNIR--------------- 576
+ V V + +R A+K E LR +R
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 577 -------HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLR-------- 621
K+I R +Y M +LS
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206
Query: 622 -RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680
RL + + V L LHH+ +VH L+P +++LD + F + S+
Sbjct: 207 ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS 263
Query: 681 QCSSVGLKGTVGYATPEY--------------------------GILLLEIFTGKRP 711
+ G+ PE G+++ I+ P
Sbjct: 264 --------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 78/229 (34%)
Query: 537 VYKGIL-----DLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V+ D+ +AVK L A K F E + L N++H ++VK C D
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 592 --FQGNYFRALVYEFMHHGSLESCPRILSFLRR-------------------------LN 624
+V+E+M HG L FLR L+
Sbjct: 91 PLI-------MVFEYMKHGDL------NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 625 IAIDVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI---------- 673
IA +AS + YL H VH DL N L+ ++ +GDFG++R +
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 674 ----------PEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFT-GKRP 711
PE + + ++ + V ++ +G++L EIFT GK+P
Sbjct: 194 HTMLPIRWMPPESIMYRKFTT---ESDV-WS---FGVILWEIFTYGKQP 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 65/224 (29%)
Query: 533 VKATVYKGILDLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKIITAC 587
V+AT + + +AVK+L + A ++ M+E + + ++ +H N+V ++ AC
Sbjct: 63 VEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR-----------------------LN 624
+ G ++ E+ +G L L+FLRR L+
Sbjct: 120 TH---GGPVL--VITEYCCYGDL------LNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 625 IAIDVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCS 683
+ VA + +L +C +H D+ NVLL N A +GDFGL R I SN
Sbjct: 169 FSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMN--DSNYIV 222
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFT-GKRP 711
+ V + PE YGILL EIF+ G P
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 41/203 (20%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRG---ALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY+ LD +A+K + + A + E L+ + H N++K + F
Sbjct: 47 EVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----F 101
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR---------LNIAIDVASALEYLHHHCKKP 643
+ +V E G L I F ++ + + SALE++H +
Sbjct: 102 IEDNELNIVLELADAGDLSR--MIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
++H D+KP+NV + +GD GL R SS ++ L GT Y +PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGR----FFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 698 Y---------GILLLEIFTGKRP 711
Y G LL E+ + P
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 55/229 (24%), Positives = 86/229 (37%), Gaps = 71/229 (31%)
Query: 533 VKATVYKGILDLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKIITAC 587
V+AT Y I +AVK+L + A ++ M+E + L + H N+V ++ AC
Sbjct: 40 VEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR------------------------- 622
+ G ++ E+ +G L L+FLRR
Sbjct: 97 TI---GGPTL--VITEYCCYGDL------LNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 623 --LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE--VMS 678
L+ + VA + +L K +H DL N+LL + + DFGL R I
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRP 711
+ + +K PE YGI L E+F+ G P
Sbjct: 203 VKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 39/173 (22%), Positives = 71/173 (41%), Gaps = 26/173 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNL--VKIITACSTS 590
+ V++ L+ + A+K + L + L S+ E L ++ + +++ T
Sbjct: 42 SKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPI 644
+ +V E + L S L + ++ ++ A+ +H H I
Sbjct: 101 Q---YIY--MVMEC-GNIDLNS---WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 148
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
VH DLKP+N L+ + M + DFG+ + +S S GTV Y PE
Sbjct: 149 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS--QVGTVNYMPPE 198
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 51/228 (22%), Positives = 83/228 (36%), Gaps = 73/228 (32%)
Query: 537 VYKGIL-----DLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKIITA 586
V + +AVK+L + GA ++ M+E + L +I H N+V ++ A
Sbjct: 43 VIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99
Query: 587 CSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR------------------------ 622
C+ G ++ EF G+L ++LR
Sbjct: 100 CTKPG--GPLM--VIVEFCKFGNL------STYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 623 -LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE--VMSS 679
+ + VA +E+L + +H DL N+LL + DFGL R I +
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRP 711
+ + LK PE +G+LL EIF+ G P
Sbjct: 207 KGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 45/212 (21%), Positives = 76/212 (35%), Gaps = 43/212 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+K +D +K + + A + E +AL + H N+V D+
Sbjct: 25 GQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCWDGFDYDP 80
Query: 595 NYFRA-----------LVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHH 638
+ EF G+LE L + L + + ++Y+H
Sbjct: 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH- 139
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE- 697
K +++ DLKPSN+ L + +GDFGL + N KGT+ Y +PE
Sbjct: 140 --SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-----KNDGKRTRSKGTLRYMSPEQ 192
Query: 698 -----Y---------GILLLEIFTGKRPTSDM 715
Y G++L E+ +
Sbjct: 193 ISSQDYGKEVDLYALGLILAELLHVCDTAFET 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 38/173 (21%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRG--ALKSFMAECQALRNIRHRNL--VKIITACSTS 590
+ V++ L+ + A+K + L + L S+ E L ++ + +++ T
Sbjct: 70 SKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPI 644
+ +V E + L S L + ++ ++ A+ +H H I
Sbjct: 129 Q---YIY--MVMEC-GNIDLNS---WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
VH DLKP+N L+ + M + DFG+ + +S S G V Y PE
Sbjct: 177 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ--VGAVNYMPPE 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 38/200 (19%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
D +K + + + + + E L N++H N+V+ + F+
Sbjct: 39 KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES-----FE 93
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRR-------LNIAIDVASALEYLHHHCKKPIVH 646
N +V ++ G L RI + L+ + + AL+++H + I+H
Sbjct: 94 ENGSLYIVMDYCEGGDLFK--RINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------Y-- 698
D+K N+ L D T +GDFG+ R V++S + GT Y +PE Y
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIAR----VLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 699 -------GILLLEIFTGKRP 711
G +L E+ T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 50/223 (22%), Positives = 83/223 (37%), Gaps = 70/223 (31%)
Query: 537 VYKGILDLDQTFI--AVKVL-FLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDF 592
V K + D + A+K + + + F E + L + H N++ ++ AC
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE---- 96
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRR-------------------------LNIAI 627
Y L E+ HG+L L FLR+ L+ A
Sbjct: 97 HRGYLY-LAIEYAPHGNL------LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 628 DVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI------------- 673
DVA ++YL +H DL N+L+ + A + DFGL+R
Sbjct: 150 DVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 674 ----PEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFT-GKRP 711
E ++ + ++ V ++ YG+LL EI + G P
Sbjct: 206 RWMAIESLNYSVYTT---NSDV-WS---YGVLLWEIVSLGGTP 241
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 39/173 (22%), Positives = 71/173 (41%), Gaps = 26/173 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRG--ALKSFMAECQALRNIRHRNL--VKIITACSTS 590
+ V++ L+ + A+K + L + L S+ E L ++ + +++ T
Sbjct: 23 SKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPI 644
+ +V E + L S L + ++ ++ A+ +H H I
Sbjct: 82 Q---YIY--MVMEC-GNIDLNS---WLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
VH DLKP+N L+ + M + DFG+ + +S S GTV Y PE
Sbjct: 130 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ--VGTVNYMPPE 179
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 50/237 (21%), Positives = 80/237 (33%), Gaps = 83/237 (35%)
Query: 536 TVYKGIL-----DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
V K T +AVK+L L+ ++E L+ + H +++K+ ACS
Sbjct: 38 KVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRR--------------------------- 622
G L+ E+ +GSL FLR
Sbjct: 98 ---DGPLL--LIVEYAKYGSL------RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 623 ------LNIAIDVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
++ A ++ ++YL VH DL N+L+ + DFGL+R + E
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 676 VMSSNQCSSVGLKGTVG-----YATPE---------------YGILLLEIFT-GKRP 711
+K + G + E +G+LL EI T G P
Sbjct: 203 -------EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/236 (21%), Positives = 83/236 (35%), Gaps = 86/236 (36%)
Query: 536 TVYKGIL-------DLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKI 583
V + +AVK+L + A L ++E + ++ I +H+N++ +
Sbjct: 50 QVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 584 ITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR--------------------- 622
+ AC+ G + ++ E+ G+L +LR
Sbjct: 107 LGACTQ---DGPLY--VIVEYASKGNL------REYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 623 ----LNIAIDVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
++ +A +EYL C +H DL NVL+ + + DFGL R I
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN-- 209
Query: 678 SSNQCSSVGLKGTVGY------ATPE---------------YGILLLEIFT-GKRP 711
K T G A PE +G+L+ EIFT G P
Sbjct: 210 -----IDYYKKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 42/206 (20%), Positives = 69/206 (33%), Gaps = 45/206 (21%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
V++ AVK + L + E A + +V + + +G
Sbjct: 73 EVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYG----AVREGP 123
Query: 596 YFRALVYEFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
+ + E + GSL R L +L LEYLH I+H
Sbjct: 124 WVN-IFMELLEGGSLGQLIKQMGCLPEDRALYYLG------QALEGLEYLHTRR---ILH 173
Query: 647 CDLKPSNVLLDND-MTAHMGDFGL-TRFIPEVMSSNQCSSVGLKGTVGYATPE------Y 698
D+K NVLL +D A + DFG P+ + + + + GT + PE
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 699 ---------GILLLEIFTGKRPTSDM 715
++L + G P +
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQY 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 54/234 (23%), Positives = 84/234 (35%), Gaps = 84/234 (35%)
Query: 537 VYKGIL-------DLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKII 584
V T +AVK+L + A L ++E + ++ I +H+N++ ++
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141
Query: 585 TACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR---------------------- 622
AC+ G + ++ E+ G+L +L+
Sbjct: 142 GACTQ---DGPLY--VIVEYASKGNL------REYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 623 ---LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679
++ A VA +EYL K +H DL NVL+ D + DFGL R I
Sbjct: 191 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH---- 243
Query: 680 NQCSSVGLKGTVGY------ATPE---------------YGILLLEIFT-GKRP 711
K T G A PE +G+LL EIFT G P
Sbjct: 244 ---IDYYKKTTNGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 39/203 (19%), Positives = 74/203 (36%), Gaps = 41/203 (20%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596
K +L+ + F + + F E Q + +I++ + + D
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD---EV 118
Query: 597 FRALVYEFMHHGSL-----------ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
+ ++YE+M + S+ ++ + I V ++ Y+H+ K I
Sbjct: 119 Y--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNIC 174
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------Y 698
H D+KPSN+L+D + + DFG + ++ + GT + PE Y
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR------GTYEFMPPEFFSNESSY 228
Query: 699 ----------GILLLEIFTGKRP 711
GI L +F P
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVP 251
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 45/201 (22%), Positives = 76/201 (37%), Gaps = 30/201 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
A V++G A+KV + M E + L+ + H+N+VK+ A
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIEEETTT 81
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRR--------LNIAIDVASALEYLHHHCKKPIV 645
+ L+ EF GSL + + L + DV + +L + IV
Sbjct: 82 RHKV--LIMEFCPCGSLYT--VLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIV 134
Query: 646 HCDLKPSNVLL----DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGIL 701
H ++KP N++ D + DFG R + + Q S L GT Y P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVS--LYGTEEYLHPD---- 185
Query: 702 LLEIFTGKRPTSDMFTEGLDL 722
+ E ++ + +DL
Sbjct: 186 MYERAVLRKDHQKKYGATVDL 206
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 46/237 (19%), Positives = 79/237 (33%), Gaps = 85/237 (35%)
Query: 537 VYKGIL-----DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VYKG L +A+K L + + F E ++H N+V ++ +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR-------------------------LNI 625
Q +++ + HG L FL +++
Sbjct: 85 --QPLS---MIFSYCSHGDL------HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 626 AIDVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI----------- 673
+A+ +EYL HH VH DL NVL+ + + + D GL R +
Sbjct: 134 VAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 674 ---------PEVMSSNQCSSVGLKGTVGYATPE-----YGILLLEIFT-GKRPTSDM 715
PE + + S + YG++L E+F+ G +P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSI------------DSDIWSYGVVLWEVFSYGLQPYCGY 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 45/185 (24%), Positives = 76/185 (41%), Gaps = 25/185 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRG-ALKSFMAECQALRNIRHRNLVK----IITACST 589
V++ +D A+K + L R A + M E +AL + H +V+ + +T
Sbjct: 19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 590 SDFQGNYFRALVY---EFMHHGSLE---SCPRILSFLRR---LNIAIDVASALEYLHHHC 640
Q + + +Y + +L+ + + R L+I + +A A+E+LH
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--- 135
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI--------PEVMSSNQCSSVGLKGTVG 692
K ++H DLKPSN+ D +GDFGL + G GT
Sbjct: 136 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 693 YATPE 697
Y +PE
Sbjct: 196 YMSPE 200
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 41/201 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLF---LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
VY + +A+KVLF L + G E + ++RH N++++ +
Sbjct: 23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIV 645
+ L+ E+ G++ L L + + ++A+AL Y H K ++
Sbjct: 83 ---RVY--LILEYAPLGTVYR---ELQKLSKFDEQRTATYITELANALSYCH---SKRVI 131
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------Y- 698
H D+KP N+LL + + DFG + P ++ C GT+ Y PE +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMIEGRMHD 185
Query: 699 --------GILLLEIFTGKRP 711
G+L E GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 36/177 (20%), Positives = 64/177 (36%), Gaps = 34/177 (19%)
Query: 535 ATVYKGILDLDQTFIAVKVLF---LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
A ++ + A K++ L + + E R++ H+++V +D
Sbjct: 55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIV 645
F +V E SL + + L + +YLH + ++
Sbjct: 115 ---FVF--VVLELCRRRSLL---ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK-----GTVGYATPE 697
H DLK N+ L+ D+ +GDFGL + + G + GT Y PE
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIAPE 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 56/234 (23%), Positives = 86/234 (36%), Gaps = 76/234 (32%)
Query: 533 VKATVYKGILDLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKIITAC 587
+ AT Y +AVK+L + A ++ M+E + + + H N+V ++ AC
Sbjct: 62 MNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR------------------------- 622
+ G + L++E+ +G L L++LR
Sbjct: 119 TL---SGPIY--LIFEYCCYGDL------LNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 623 -------LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
L A VA +E+L K VH DL NVL+ + + DFGL R I
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 676 --VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRP 711
+ + +K PE YGILL EIF+ G P
Sbjct: 225 DSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 50/236 (21%), Positives = 83/236 (35%), Gaps = 86/236 (36%)
Query: 536 TVYKGIL-------DLDQTFIAVKVLFLHQRGA----LKSFMAECQALRNI-RHRNLVKI 583
V + +AVK+L + A L ++E + ++ I +H+N++ +
Sbjct: 96 QVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKHKNIINL 152
Query: 584 ITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRR--------------------- 622
+ AC+ G + ++ E+ G+L +LR
Sbjct: 153 LGACTQ---DGPLY--VIVEYASKGNL------REYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 623 ----LNIAIDVASALEYL-HHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
++ +A +EYL C +H DL NVL+ + + DFGL R I
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN-- 255
Query: 678 SSNQCSSVGLKGTVGY------ATPE---------------YGILLLEIFT-GKRP 711
K T G A PE +G+L+ EIFT G P
Sbjct: 256 -----IDYYKKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 54/236 (22%), Positives = 84/236 (35%), Gaps = 83/236 (35%)
Query: 537 VYKGIL-----DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
V++ T +AVK+L F E + + N+VK++ C+
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRILSFLRR---------------------------- 622
G L++E+M +G L FLR
Sbjct: 121 --VGKPM-CLLFEYMAYGDL------NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 623 -----LNIAIDVASALEYLH-HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI--- 673
L IA VA+ + YL VH DL N L+ +M + DFGL+R I
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 674 -----------------PEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFT-GKRP 711
PE + N+ ++ + V +A YG++L EIF+ G +P
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTT---ESDV-WA---YGVVLWEIFSYGLQP 276
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 40/208 (19%), Positives = 74/208 (35%), Gaps = 38/208 (18%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALR-NIRHRNLVKIITACSTSDFQGN 595
V++G + AVK + + E + L + H N+++ + +T F
Sbjct: 32 VFQGSFQ-GRPV-AVKRM---LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL-- 84
Query: 596 YFRALVYEFM---------HHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
Y + E + ++ +++ +AS + +LH I+H
Sbjct: 85 Y---IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138
Query: 647 CDLKPSNVLLDNDMTAHMG-------------DFGLTRFIPEVMSSNQCSSVGLKGTVGY 693
DLKP N+L+ DFGL + + SS + + GT G+
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 694 ATPEY--GILLLEIFTGKRPTSDMFTEG 719
PE L+ + D+F+ G
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMG 226
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 52/197 (26%), Positives = 77/197 (39%), Gaps = 35/197 (17%)
Query: 537 VYKGILDLDQTFIAVKVLFLHQRGALKSFMA----ECQALRNI-RHRNLVKIITACSTSD 591
VY+G+ D +AVK + L + E Q LR H N+++
Sbjct: 41 VYRGMFD--NRDVAVKRI-------LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 592 FQGNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
FQ Y + E +L E L + + S L +LH IVH
Sbjct: 92 FQ--Y---IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHR 142
Query: 648 DLKPSNVLLDN-----DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILL 702
DLKP N+L+ + A + DFGL + + S S G+ GT G+ PE +L
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS-GVPGTEGWIAPE--MLS 199
Query: 703 LEIFTGKRPTSDMFTEG 719
+ T D+F+ G
Sbjct: 200 EDCKENPTYTVDIFSAG 216
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-15
Identities = 36/177 (20%), Positives = 64/177 (36%), Gaps = 34/177 (19%)
Query: 535 ATVYKGILDLDQTFIAVKVLF---LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
A ++ + A K++ L + + E R++ H+++V +D
Sbjct: 29 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIV 645
F +V E SL + + L + +YLH + ++
Sbjct: 89 ---FVF--VVLELCRRRSLL---ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK-----GTVGYATPE 697
H DLK N+ L+ D+ +GDFGL + + G + GT Y PE
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIAPE 185
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 49/209 (23%), Positives = 74/209 (35%), Gaps = 46/209 (22%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACST-SDF 592
V + I +A+K + + E Q ++ + H N+V
Sbjct: 28 GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87
Query: 593 QGNYFRALVYEFMHHGSL-------ESCPR-----ILSFLRRLNIAIDVASALEYLHHHC 640
N L E+ G L E+C I + L D++SAL YLH +
Sbjct: 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------DISSALRYLHENR 141
Query: 641 KKPIVHCDLKPSNVLLD---NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
I+H DLKP N++L + + D G + + + C+ GT+ Y PE
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTE--FVGTLQYLAPE 193
Query: 698 ------Y---------GILLLEIFTGKRP 711
Y G L E TG RP
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 28/241 (11%)
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLD 226
+ + ++ + + L + L G I + + L L+
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLE 69
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS--HLRYLYMSANPI 284
+N +T DL L N T + + LS N L +++ + ++ L +++ I
Sbjct: 70 LKDNQIT-----DLAPLKNLTKITELELSGNPLK-----NVSAIAGLQSIKTLDLTSTQI 119
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344
+ P + L NL ++ ++ I NI + L LQ LS+ +S ++ + L N +
Sbjct: 120 TDVTP--LAGLSNLQVLYLDL-NQITNIS-PLAGLTNLQYLSIGNAQVS-DL-TPLANLS 173
Query: 345 FLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403
LT L N I S S L S L + L +N ++ PLA N ++ + L+ +
Sbjct: 174 KLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTI 229
Query: 404 S 404
+
Sbjct: 230 T 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 33/160 (20%), Positives = 64/160 (40%), Gaps = 17/160 (10%)
Query: 273 HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNI 332
+ + + ++ ++ +L + ++ + I V YL L L L +N I
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT-GVTTIE-GVQYLNNLIGLELKDNQI 75
Query: 333 SREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPK 391
+ + L N T +TEL L GN + SA+ + LDL+ +T PLA
Sbjct: 76 TD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLA--GLS 129
Query: 392 SIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
++ L L N+++ I ++ L++ +
Sbjct: 130 NLQVLYLDLNQIT-NISP-----LAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 56/305 (18%), Positives = 111/305 (36%), Gaps = 47/305 (15%)
Query: 46 VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQ 105
I + N+T T +L + ++ ++ I + L L + N
Sbjct: 21 AIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDN--- 73
Query: 106 GQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFT-----GPIPHLNMFQVSVYSLT 160
QI D + L +L K L L+ N + + ++ +T
Sbjct: 74 -QITD------------LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120
Query: 161 GSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNAS 220
P+ L ++++ ++ NQ+ + P + L N++ L + Q ++ ++N S
Sbjct: 121 DVTPLAGL--SNLQVLYLDLNQIT-NISP-LA-GLTNLQYLSIGNAQV-SDLT-PLANLS 173
Query: 221 KLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMS 280
KL L +N ++ D+ L + L V L N +S P LAN S+ L + ++
Sbjct: 174 KLTTLKADDNKIS-----DISPLASLPNLIEVHLKNNQISDVSP--LANTSN-LFIVTLT 225
Query: 281 ANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSL 340
I+ NL ++ I IS + N++ + S +
Sbjct: 226 NQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDN-------GTYASPNLTWNLTSFI 278
Query: 341 GNFTF 345
N ++
Sbjct: 279 NNVSY 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 39/185 (21%), Positives = 70/185 (37%), Gaps = 26/185 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITA-----CST 589
V K LD + A+K + + L + ++E L ++ H+ +V+ A
Sbjct: 20 GQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78
Query: 590 SDFQGNYFRALVY---EFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKK 642
++ ++ E+ +G+L S + + AL Y+H +
Sbjct: 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQ 135
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK----------GTVG 692
I+H DLKP N+ +D +GDFGL + + + + S L GT
Sbjct: 136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAM 195
Query: 693 YATPE 697
Y E
Sbjct: 196 YVATE 200
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 40/210 (19%), Positives = 65/210 (30%), Gaps = 39/210 (18%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL--HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
TV ++ V+ + L + E + H N+V F
Sbjct: 41 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT-----F 95
Query: 593 QGNYFRALVYEFMHHGSLES--CPRILSFLRRLNIAI---DVASALEYLHHHCKKPIVHC 647
+ +V FM +GS + C + + L IA V AL+Y+HH VH
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHR 152
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATP----------- 696
+K S++L+ D ++ + + K +V
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK--VLPWLSPEVLQQN 210
Query: 697 --EY---------GILLLEIFTGKRPTSDM 715
Y GI E+ G P DM
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 44/184 (23%), Positives = 71/184 (38%), Gaps = 33/184 (17%)
Query: 506 LRRQRTVTSSESSSRKDLLLNVSYESLVK------ATVYKGILDLDQTFIAVKVLFLHQR 559
+ +S + L+ Y+ L K VYK D +A+K + L
Sbjct: 1 MHHHHHHSSGRENLYFQGLME-KYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAE 58
Query: 560 --GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCP 614
G + + E L+ + H N+V +I + LV+EFM L+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER---CLT--LVFEFMEKDLKKVLDENK 113
Query: 615 RIL------SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG 668
L +L +L + + H H I+H DLKP N+L+++D + DFG
Sbjct: 114 TGLQDSQIKIYLYQL------LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG 164
Query: 669 LTRF 672
L R
Sbjct: 165 LARA 168
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNL 580
+Y L K ATVYKG L +A+K + L GA + + E L++++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 581 VKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRIL------SFLRRLNIAIDVAS 631
V + T + + LV+E++ L+ C I+ FL +L
Sbjct: 63 VTLHDIIHT---EKSLT--LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LR 111
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672
L Y H ++H DLKP N+L++ + DFGL R
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 53/241 (21%), Positives = 92/241 (38%), Gaps = 55/241 (22%)
Query: 506 LRRQRTVTSSESSSRKDLLLNVSYESLVKA---------TVYKGILDLDQTFIAVKVLFL 556
L Q+ ++K + + + K V+K +A K++ L
Sbjct: 9 LDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68
Query: 557 -HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA----LVYEFMHHGSLE 611
+ + E Q L +V F G ++ + E M GSL+
Sbjct: 69 EIKPAIRNQIIRELQVLHECNSPYIVG---------FYGAFYSDGEISICMEHMDGGSLD 119
Query: 612 SCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG 665
++L R+ ++I V L YL K I+H D+KPSN+L+++ +
Sbjct: 120 ---QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 174
Query: 666 DFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------Y---------GILLLEIFTGKR 710
DFG++ +++ S S V GT Y +PE Y G+ L+E+ G+
Sbjct: 175 DFGVSG---QLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 711 P 711
P
Sbjct: 229 P 229
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 44/201 (21%), Positives = 76/201 (37%), Gaps = 30/201 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
A V++G A+KV + M E + L+ + H+N+VK+ + +
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRR--------LNIAIDVASALEYLHHHCKKPIV 645
L+ EF GSL + + L + DV + +L + IV
Sbjct: 83 HKV---LIMEFCPCGSLYT--VLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIV 134
Query: 646 HCDLKPSNVLL----DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGIL 701
H ++KP N++ D + DFG R + + Q S L GT Y P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVS--LYGTEEYLHPD---- 185
Query: 702 LLEIFTGKRPTSDMFTEGLDL 722
+ E ++ + +DL
Sbjct: 186 MYERAVLRKDHQKKYGATVDL 206
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 44/188 (23%), Positives = 72/188 (38%), Gaps = 41/188 (21%)
Query: 548 FIAVKVLF---LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
+A+KVLF L + G E + ++RH N++++ + L+ EF
Sbjct: 41 IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK---RIY--LMLEF 95
Query: 605 MHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658
G L L R + ++A AL Y H ++ ++H D+KP N+L+
Sbjct: 96 APRGELYK---ELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGY 149
Query: 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------Y---------GILLL 703
+ DFG + P + C GT+ Y PE + G+L
Sbjct: 150 KGELKIADFGWSVHAPSLRRRTMC------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCY 203
Query: 704 EIFTGKRP 711
E G P
Sbjct: 204 EFLVGMPP 211
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 7e-14
Identities = 57/302 (18%), Positives = 103/302 (34%), Gaps = 26/302 (8%)
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGF--TLPNVRILLLAGNQFFGNIPHSISNASKLEW 224
+ S++ + + + + LPNV L L GN+ +I ++N L W
Sbjct: 39 QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLFLNGNKL-TDIK-PLTNLKNLGW 91
Query: 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
L N + DL SL + L+ +SL N +S + L + L LY+ N I
Sbjct: 92 LFLDENKIK-----DLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQ-LESLYLGNNKI 143
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344
+ I + L L +++E I +I + L KLQ L L +N+IS ++ +L
Sbjct: 144 T-DITV-LSRLTKLDTLSLED-NQISDIV-PLAGLTKLQNLYLSKNHIS-DL-RALAGLK 197
Query: 345 FLTELNLCGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNEL 403
L L L + + + + L P ++ + ++ +
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLP 255
Query: 404 SGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
S + AK + + + I+ K
Sbjct: 256 EFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPK 315
Query: 464 LP 465
P
Sbjct: 316 PP 317
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 49/272 (18%), Positives = 95/272 (34%), Gaps = 46/272 (16%)
Query: 94 LRHIIFNSNALQGQIPDS------RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP 147
+ I S ++ PD + L K L + N+
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK---- 56
Query: 148 HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQ 207
S+ G + + ++ ++ N+L ++ P L N+ L L N+
Sbjct: 57 ----------SVQG-----IQYLPNVTKLFLNGNKLT-DIKP--LTNLKNLGWLFLDENK 98
Query: 208 FFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSL 267
++ S+ + KL+ L +N ++ D++ LV+ LE + L N ++ +
Sbjct: 99 I-KDLS-SLKDLKKLKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKIT-----DI 146
Query: 268 ANFS--SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVL 325
S + L L + N IS I + L L + + K I ++ ++ L L VL
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK-NHISDLR-ALAGLKNLDVL 202
Query: 326 SLFENNISREIPSSLGNFTFLTELNLCGNSIR 357
LF + + N + S+
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 54/313 (17%), Positives = 98/313 (31%), Gaps = 78/313 (24%)
Query: 42 KYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNS 101
+ I NL +++T L + I ++ S + I L + + N
Sbjct: 19 AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNG 74
Query: 102 NALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTG 161
N L +I L +L L L N
Sbjct: 75 NKLT---------------DI-KPLTNLKNLGWLFLDEN--------------------- 97
Query: 162 SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK 221
I + L ++ L L N +I + + +
Sbjct: 98 -------KIKDLSSLK----------------DLKKLKSLSLEHNG-ISDING-LVHLPQ 132
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA 281
LE L NN +T D+ L T L+ +SL N +S + LA + L+ LY+S
Sbjct: 133 LESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTK-LQNLYLSK 184
Query: 282 NPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341
N IS + + LKNL ++ + + L+ + + ++ P +
Sbjct: 185 NHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIIS 240
Query: 342 NFTFLTELNLCGN 354
+ + N+ +
Sbjct: 241 DDGDYEKPNVKWH 253
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-14
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 31/161 (19%)
Query: 529 YESLVK------ATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNL 580
YE L K TV+K +A+K + L G S + E L+ ++H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 581 VKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRIL------SFLRRLNIAIDVAS 631
V++ + LV+EF +SC L SFL +L
Sbjct: 64 VRLHDVLHSDK---KLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LK 112
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672
L + H ++H DLKP N+L++ + + +FGL R
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 34/165 (20%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQRGALKS---FMA--ECQALRNIR 576
YE L ATVYK +A+K + L R K A E + L+ +
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 577 HRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRIL------SFLRRLNIAI 627
H N++ ++ A N LV++FM ++ +L +++
Sbjct: 71 HPNIIGLLDAFGHKS---NIS--LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT---- 121
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672
LEYLH H I+H DLKP+N+LLD + + DFGL +
Sbjct: 122 --LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 46/258 (17%), Positives = 94/258 (36%), Gaps = 40/258 (15%)
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
L + + + ++ + N+ + + + + + L
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLFL 75
Query: 255 SVNSLSGTLPNSLANFSS--HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL---- 308
+ N L+ + ++ +L +L++ N + ++ +LK+L ++ L
Sbjct: 76 NGNKLT-----DIKPLANLKNLGWLFLDENKV-----KDLSSLKDLK--KLKSLSLEHNG 123
Query: 309 IRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH 368
I +I + +L +L+ L L N I+ + L T L L+L N I S L
Sbjct: 124 ISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--SDIVPLAGLT 178
Query: 369 QL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLS 427
+L L LS NH++ LA K++ L+L E + + + S N
Sbjct: 179 KLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPIN-------HQSNLVVPNTV 229
Query: 428 YNNLDGDVPRKMIFKNAS 445
N V ++I +
Sbjct: 230 KNTDGSLVTPEIISDDGD 247
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 29/195 (14%), Positives = 61/195 (31%), Gaps = 42/195 (21%)
Query: 238 EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKN 297
+ + S +L S++ + + + + + + I + ++
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDI-----KSVQGIQY 66
Query: 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357
L + L L N ++ L N L L L N +
Sbjct: 67 LP---------------------NVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKV- 102
Query: 358 GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFG 416
S+L +L L L HN ++ L + + L L N+++ +I
Sbjct: 103 -KDLSSLKDLKKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKIT-DITV-----LS 153
Query: 417 YISIFAKLNLSYNNL 431
++ L+L N +
Sbjct: 154 RLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 45/260 (17%), Positives = 85/260 (32%), Gaps = 52/260 (20%)
Query: 42 KYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNS 101
+ I NL +++T L + I ++ S + I L + + N
Sbjct: 22 AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNG 77
Query: 102 NALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTG 161
N ++ D L +L L L N L+
Sbjct: 78 N----KLTDI------------KPLANLKNLGWLFLDENKVK--------------DLSS 107
Query: 162 SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK 221
L ++ ++ + N + ++ + LP + L L N+ +I +S +K
Sbjct: 108 -----LKDLKKLKSLSLEHNGIS-DINGLVH--LPQLESLYLGNNKIT-DIT-VLSRLTK 157
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA 281
L+ L +N ++ D+ L T L+ + LS N +S LA + L L + +
Sbjct: 158 LDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKN-LDVLELFS 209
Query: 282 NPISGSIPTEIGNLKNLIII 301
NL +
Sbjct: 210 QECLNKPINHQSNLVVPNTV 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 29/165 (17%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMA--ECQALRNIRHRN 579
YE L K V+K +A+K + + A E + L+ ++H N
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 580 LVKIITACSTSDFQGNYFRA---LVYEFMHH---GSLESCPRIL------SFLRRLNIAI 627
+V +I C T N + LV++F H G L + ++ L
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL--- 134
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672
+ L Y+H + I+H D+K +NVL+ D + DFGL R
Sbjct: 135 ---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 37/242 (15%), Positives = 74/242 (30%), Gaps = 65/242 (26%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNI-RHRNLVKIITACSTSDF 592
+V+K + LD A+K G+ ++ + E A + +H ++V+ +A +
Sbjct: 26 SVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA-----W 80
Query: 593 QGNYFRALVYEFMHHGSLES-------CPRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
+ + E+ + GSL ++ + V L Y+H +V
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLV 137
Query: 646 HCDLKPSNVLLDND-------------------MTAHMGDFGLTRFIPEVMSSNQCSSVG 686
H D+KPSN+ + + +GD G I
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-------- 189
Query: 687 LKGTVGYATPE-------Y---------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL 730
+G + E + + ++ + G H + L
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRNGDQWHEIRQGRL 245
Query: 731 PD 732
P
Sbjct: 246 PR 247
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 36/162 (22%)
Query: 529 YESLVK------ATVYKGILDLDQT--FIAVKVLFLHQR--GALKSFMAECQALRNIRHR 578
Y L K VYK + A+K + L + G + + E L+ ++H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 579 NLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRIL------SFLRRLNIAIDV 629
N+VK+ T LV+E + L+ C L SFL +L
Sbjct: 61 NIVKLYDVIHTKK---RLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------ 109
Query: 630 ASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ + Y H ++H DLKP N+L++ + + DFGL R
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 41/206 (19%), Positives = 81/206 (39%), Gaps = 48/206 (23%)
Query: 535 ATVYKGILDLDQTFIAVKVLF---LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
A VY+ +A+K++ +++ G ++ E + ++H +++++ S+
Sbjct: 25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIV 645
+ LV E H+G + + + ++ + + + + YLH H I+
Sbjct: 85 ---YVY--LVLEMCHNGEMNR--YLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK-----GTVGYATPE--- 697
H DL SN+LL +M + DFGL + Q K GT Y +PE
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGL---------ATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 698 ---Y---------GILLLEIFTGKRP 711
+ G + + G+ P
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 4e-13
Identities = 105/681 (15%), Positives = 199/681 (29%), Gaps = 188/681 (27%)
Query: 41 LKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFN 100
+Y+ ++ + ++ N + ++ ++ S EI HII +
Sbjct: 16 YQYKDILSVFED---------AFVDNFDCKDVQDMPKSILSKE---EI------DHIIMS 57
Query: 101 SNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNY----------FTGPIPHLN 150
+A+ G + + L E+ + KF L NY P
Sbjct: 58 KDAVSG----TLRLFWTLLSK-QEEM--VQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR 110
Query: 151 MFQVSVYSL-TGSIPIQLLNITSMEYFHVSENQLVGELPPH--------IGF-------- 193
M+ L + N++ ++ + L+ EL P +G
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL-ELRPAKNVLIDGVLGSGKTWVALD 169
Query: 194 TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253
+ ++ + F WL+ N + + E L L ++
Sbjct: 170 VCLSYKVQCKMDFKIF--------------WLNLKNCNSPETVLEMLQKL--LYQIDPNW 213
Query: 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKN-LIII-------AIEK 305
S + S + + + + LR L S +N L+++ A
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSK------------PYENCLLVLLNVQNAKAWNA 261
Query: 306 F-----ILI--RNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE--LNLCGNSI 356
F IL+ R QV + I + T + +L
Sbjct: 262 FNLSCKILLTTRFK----------QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK-- 309
Query: 357 RGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE-IPSSLA-WI 414
+LD L P + NP LS + E I LA W
Sbjct: 310 --------------YLDCRPQDL--PREVLTTNP-----RRLS---IIAESIRDGLATWD 345
Query: 415 F----GYISIFAKLNLSYNNLDGDVPRKM-----IFKNASAISEAGNEKLCGGISEL--- 462
+ + S N L+ RKM +F ++ I + + +
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 463 ----KLPPCTPSELKKREKSKGFKLMILLLSGLVGLILVMSL--LIINRLRRQRTVTSSE 516
KL S ++K+ K + + L V L +L I++ +T S +
Sbjct: 406 VVVNKL--HKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463
Query: 517 SSSRKDLLLNVSYESLVKATVY--KGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN 574
L Y + + K I + + +++FL R F+ +
Sbjct: 464 LI--PPYLDQYFYSHI----GHHLKNI-EHPERMTLFRMVFLDFR-----FLE-----QK 506
Query: 575 IRHRNLVKIITACSTSDFQG-NYFRALVYEFMHHGSLESCPR-ILSFLRRLNIAIDVASA 632
IRH + + + Q +++ Y + E IL FL ++
Sbjct: 507 IRHDSTAWNASGSILNTLQQLKFYKP--YICDNDPKYERLVNAILDFLPKIE-------- 556
Query: 633 LEYLHHHCKKPIVHCDLKPSN 653
E L ++ L +
Sbjct: 557 -ENLICSKYTDLLRIALMAED 576
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 32/162 (19%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRN 579
+++ + K VYK L +A+K + L G + + E L+ + H N
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 580 LVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPR-------ILSFLRRLNIAIDV 629
+VK++ T + + LV+EF+H +++ I S+L +L
Sbjct: 64 IVKLLDVIHTEN---KLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL------ 112
Query: 630 ASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
L + H H ++H DLKP N+L++ + + DFGL R
Sbjct: 113 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 27/190 (14%), Positives = 59/190 (31%), Gaps = 46/190 (24%)
Query: 535 ATVYKGI-LDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
++ + LD+ +A+ + + L+ ++ L I + +++ T
Sbjct: 45 LQFWQALDTALDRQ-VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103
Query: 591 DFQGNYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
G +V E++ GSL ++ P + + +A+A + H +
Sbjct: 104 A--GGL---VVAEWIRGGSLQEVADTSPSPV---GAIRAMQSLAAAADAAHRA---GVAL 152
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---Y--GIL 701
PS V + D + T+ A P+ G
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYP---------------------ATMPDANPQDDIRGIGAS 191
Query: 702 LLEIFTGKRP 711
L + + P
Sbjct: 192 LYALLVNRWP 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 35/166 (21%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRN 579
Y + K VYK I + +A+K + L G + + E L+ ++HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 580 LVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRIL-----SFLRRLNIAIDVAS 631
++++ + + L++E+ + ++ P + SFL +L +
Sbjct: 95 IIELKSVIHHNH---RLH--LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------IN 143
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMG-----DFGLTRF 672
+ + H +H DLKP N+LL + DFGL R
Sbjct: 144 GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 37/171 (21%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVK-VLFLHQRGALKSFMAECQALRNI----- 575
YE + + TVYK F+A+K V + G +R +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--PISTVREVALLRR 67
Query: 576 ----RHRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPR-------ILSFLR 621
H N+V+++ C+TS LV+E + L+ P I +R
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 622 RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672
+ L++LH +C IVH DLKP N+L+ + T + DFGL R
Sbjct: 128 QF------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 40/194 (20%), Positives = 74/194 (38%), Gaps = 28/194 (14%)
Query: 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS--H 273
+ + S+T DL S + ++ + +++ SLA +
Sbjct: 15 DPGLANAVKQNLGKQSVT-----DLVSQKELSGVQNFNGDNSNIQ-----SLAGMQFFTN 64
Query: 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN--IPISVGYLLKLQVLSLFENN 331
L+ L++S N I +++ LK+L +E+ + RN ++ L L L N
Sbjct: 65 LKELHLSHNQI-----SDLSPLKDLT--KLEELSVNRNRLKNLNGIPSACLSRLFLDNNE 117
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNP 390
+ SL + L L++ N + LG +L LDL N +T L
Sbjct: 118 LRD--TDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNTGGLT--RL 171
Query: 391 KSIPHLDLSKNELS 404
K + +DL+ +
Sbjct: 172 KKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 29/168 (17%), Positives = 56/168 (33%), Gaps = 15/168 (8%)
Query: 238 EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKN 297
+ +L S++ + S ++ + I S+ + N
Sbjct: 10 NQVFPDPGLANAVKQNLGKQSVTDLVS--QKEL-SGVQNFNGDNSNIQ-SL-AGMQFFTN 64
Query: 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357
L + + I ++ + L KL+ LS+ N + L+ L L N +
Sbjct: 65 LKELHLSHN-QISDLS-PLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNEL- 118
Query: 358 GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
+L L L + +N L + L + LDL NE++
Sbjct: 119 -RDTDSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 14/149 (9%)
Query: 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLD 226
L ++T +E V+ N+L L + L L N+ S+ + LE L
Sbjct: 81 LKDLTKLEELSVNRNRLK-NLNG---IPSACLSRLFLDNNEL--RDTDSLIHLKNLEILS 134
Query: 227 FANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286
NN L + L + LEV+ L N ++ T L + ++ ++
Sbjct: 135 IRNNKLK-----SIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKK-VNWIDLTGQKCVN 186
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIPIS 315
L + I IS
Sbjct: 187 EPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 39/170 (22%)
Query: 528 SYESLVK------ATVYKGILDLDQT--FIAVKVLFLHQRG------ALK--SFMAECQA 571
YE + + V+K DL F+A+K + + ++ + +
Sbjct: 12 QYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPR-------ILSFLR 621
L H N+V++ C+ S LV+E + L+ P I +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 622 RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+L L++LH H +VH DLKP N+L+ + + DFGL R
Sbjct: 128 QL------LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 38/180 (21%), Positives = 67/180 (37%), Gaps = 31/180 (17%)
Query: 535 ATVYKGILDLDQTFIAVKV-----LFLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
+ V + I AVK+ + + E ++H ++V+++ S+
Sbjct: 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRRL---------NIAIDVASALEYLHHHC 640
+ +V+EFM L C I+ + + AL Y H +
Sbjct: 98 DG---MLY--MVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 641 KKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
I+H D+KP VLL +N +G FG+ + E + + G GT + PE
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVAGGRVGTPHFMAPE 203
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 57/348 (16%), Positives = 108/348 (31%), Gaps = 40/348 (11%)
Query: 40 SLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFR--LRHI 97
SL+ +L+L + + ++ L + L + + R
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 98 IFNSNALQGQIPDSRLILNKLEGNIPSELGSL----LKFKGLGLANN--YFTGPIPHLNM 151
+ LQ + + + P + L L Y + L +
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309
Query: 152 FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGN 211
V S M +S + + + + L N F +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDT-PFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
+ S +L+ L N L + N + LE + +S+NSL+ + ++
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLKNF-FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
+ L +S+N ++GS+ + K++VL L N
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--------------------------PPKVKVLDLHNNR 461
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVP-SALGSCHQL-WLDLSHN 377
I IP + + L ELN+ N ++ SVP L ++ L N
Sbjct: 462 IM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 73/442 (16%), Positives = 147/442 (33%), Gaps = 42/442 (9%)
Query: 29 VNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEI 88
+G + +++ S +NLT P + ++L QN+ S +I
Sbjct: 16 CALALIVGSMTPFSNELESMVDYSNRNLT--HVP-KDLPPRTKALSLSQNSISELRMPDI 72
Query: 89 GRLFRLRHIIFNSNALQGQIPDS---------RLIL--NKLEGNIPSELGSLLKFKGLGL 137
L LR + + N ++ + L + N+L+ NI + + L L
Sbjct: 73 SFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDL 128
Query: 138 ANNYFTGPIPHLNMFQVSVYSLTG---------SIPIQLLNITSMEYFHVSENQLVGELP 188
+ N F +P F ++ LT + + + + + +
Sbjct: 129 SFNDFDV-LPVCKEFG-NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGG 186
Query: 189 PHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY 248
+PN +L L + + + L L +N L + L + ++
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246
Query: 249 --LEVVSLSVNSLSGTLPNSLANFS----SHLRYLYMSANPISGSIPTEIGN-----LKN 297
++++++ + T S+ F + YL + I+ I E LK+
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306
Query: 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357
L+I ++ + + + ++ + L ++ + + T LN N
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366
Query: 358 GSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFG 416
SV + +L L L N L K++ L+ L+ +
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425
Query: 417 YISIFAKLNLSYNNLDGDVPRK 438
+ LNLS N L G V R
Sbjct: 426 WAESILVLNLSSNMLTGSVFRC 447
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 61/399 (15%), Positives = 124/399 (31%), Gaps = 55/399 (13%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS-NIPHEIGRLFRLRHIIFNSNALQGQ 107
L++S L + + LR ++L N+F + E G L +L + ++ +
Sbjct: 105 LDVSHNRLQ---NISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 108 IPDS--RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVY--SLTGSI 163
L L+ + ++ S + + L + N + H N S+
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 164 PIQLLNITSMEYFHVSENQLVGEL---PPHIGFTLPNVRILLLAGNQFFGNIPHSISNAS 220
+QL NI + + EL P + TL ++ + F
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR----- 276
Query: 221 KLEWLDFANNSLTGLIPEDLDSLVNCT--YLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278
+E+L+ N ++T I + + L + + +L + + +
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKM 335
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPS 338
+S + + + ++ L+ +N + +
Sbjct: 336 LSIS-----------DTPFIHMVCP-------------PSPSSFTFLNFTQNVFTDSVFQ 371
Query: 339 SLGNFTFLTELNLCGNSIRGSVPSALGSCHQL----WLDLSHNHLT-GPIPLAVGNPKSI 393
L L L N ++ + + LD+S N L +SI
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
L+LS N L+G + L L+L N +
Sbjct: 431 LVLNLSSNMLTGSVFRCLP------PKVKVLDLHNNRIM 463
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 48/175 (27%), Positives = 70/175 (40%), Gaps = 25/175 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQ 593
A V I + AVK++ E + L + HRN++++I F+
Sbjct: 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF-----FE 81
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRRL-------NIAIDVASALEYLHHHCKKPIVH 646
LV+E M GS+ S I RR + DVASAL++LH+ I H
Sbjct: 82 EEDRFYLVFEKMRGGSILS--HIHK--RRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 647 CDLKPSNVLL---DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY 698
DLKP N+L + + DF L I + S+ L G + EY
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG--SAEY 187
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 26/172 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
+ V+ L A+K + S E L+ I+H N+V + ++
Sbjct: 23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--- 79
Query: 595 NYFRALVYEFMHHGSL-ESCPRIL---SFLRRL--NIAIDVASALEYLHHHCKKPIVHCD 648
+Y+ LV + + G L + RIL + + + V SA++YLH + IVH D
Sbjct: 80 HYY--LVMQLVSGGELFD---RILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRD 131
Query: 649 LKPSNVLL---DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
LKP N+L + + + DFGL++ + S C GT GY PE
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC------GTPGYVAPE 177
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 44/189 (23%), Positives = 74/189 (39%), Gaps = 43/189 (22%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A+K+L + + + E + + H VK+ FQ + +
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAK 113
Query: 607 HGSLESCPRILSFLRRLNI---------AIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657
+G L L ++R++ ++ SALEYLH K I+H DLKP N+LL+
Sbjct: 114 NGEL------LKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLN 164
Query: 658 NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILL 702
DM + DFG + + + +S GT Y +PE G ++
Sbjct: 165 EDMHIQITDFGTAKVLSPESKQARANS--FVGTAQYVSPELLTEKSACKSSDLWALGCII 222
Query: 703 LEIFTGKRP 711
++ G P
Sbjct: 223 YQLVAGLPP 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 31/162 (19%)
Query: 529 YESLVK------ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNL 580
YE+L V K +A+K + K M E + L+ +RH NL
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 581 VKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRIL------SFLRRLNIAIDVAS 631
V ++ C + ++ LV+EF+ H LE P L +L ++ +
Sbjct: 87 VNLLEVCKK---KKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI------IN 135
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
+ + H H I+H D+KP N+L+ + DFG R +
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 47/219 (21%), Positives = 79/219 (36%), Gaps = 55/219 (25%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA-LKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
A V + +A+K + L + + + E QA+ H N+V +
Sbjct: 29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS---------YY 79
Query: 594 GNYFRA----LVYEFMHHGSL-----ESCPRILSFLRRLN---IAI---DVASALEYLHH 638
++ LV + + GS+ + L+ IA +V LEYLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 639 HCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT-VGYATP- 696
+ + +H D+K N+LL D + + DFG++ F+ + + T VG TP
Sbjct: 140 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV---RKTFVG--TPC 191
Query: 697 -----------EY---------GILLLEIFTGKRPTSDM 715
Y GI +E+ TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 35/166 (21%)
Query: 528 SYESLVK------ATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNL 580
++ L K ATVYKG+ ++A+K + L G + + E ++ ++H N+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 581 VKIITACSTSDFQGNYFRALVYEFMHH--------GSLESCPRIL------SFLRRLNIA 626
V++ T + LV+EFM + ++ + PR L F +L
Sbjct: 66 VRLYDVIHTEN---KLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--- 117
Query: 627 IDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672
L + H + I+H DLKP N+L++ +GDFGL R
Sbjct: 118 ---LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 34/193 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKS---------FMAECQALRNI-RHRNLVKII 584
+ V + I AVK++ + G+ + + E LR + H N++++
Sbjct: 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90
Query: 585 TACSTSDFQGNYFRALVYEFMHHGSLESCPRILS---FLRR--LNIAIDVASALEYLHHH 639
T+ +F LV++ M G L + + I + + LH
Sbjct: 91 DTYETNT---FFF--LVFDLMKKGELFD--YLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPEY 698
IVH DLKP N+LLD+DM + DFG + + P C GT Y PE
Sbjct: 144 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC------GTPSYLAPE- 193
Query: 699 GILLLEIFTGKRP 711
I+ +
Sbjct: 194 -IIECSMNDNHPG 205
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 25/177 (14%), Positives = 67/177 (37%), Gaps = 37/177 (20%)
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI 288
+S + ++SL TY+ + +++V L+G + + ++ L ++
Sbjct: 32 QSSTANITEAQMNSL---TYITLANINVTDLTG-----IEYAHN-IKDLTINNIHA---- 78
Query: 289 PTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE 348
T + L L+ L + +++ + +L T LT
Sbjct: 79 -TNYNPISGLS---------------------NLERLRIMGKDVTSDKIPNLSGLTSLTL 116
Query: 349 LNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
L++ ++ S+ + + + ++ +DLS+N I + + L++ + +
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 22/158 (13%), Positives = 57/158 (36%), Gaps = 14/158 (8%)
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPS 338
+ A+ + +IP K + + + I+ + L ++L N++ ++ +
Sbjct: 8 LKASQDNVNIPDS--TFKAYLNGLLGQ---SSTANITEAQMNSLTYITLANINVT-DL-T 60
Query: 339 SLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLD 397
+ + +L + + + + L L + +T + S+ LD
Sbjct: 61 GIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 398 LSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDV 435
+S + I + + + ++LSYN D+
Sbjct: 119 ISHSAHDDSILTKIN----TLPKVNSIDLSYNGAITDI 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 31/140 (22%)
Query: 194 TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253
L N+ L + G + ++S + L LD ++++ I +++L + +
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK---VNSID 142
Query: 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP 313
LS N + L L+ L + + + + +++
Sbjct: 143 LSYNGAITDIMP-LKTLPE-LKSLNIQFDGV-----HDYRGIEDFP-------------- 181
Query: 314 ISVGYLLKLQVLSLFENNIS 333
KL L F I
Sbjct: 182 -------KLNQLYAFSQTIG 194
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 38/182 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVL--------FLHQRGALKSFMAECQALRNIRHRNLVKIITA 586
V +A++++ + + E + L+ + H ++KI
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208
Query: 587 CSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHC 640
D+ Y +V E M G L +++ +RL + A++YLH +
Sbjct: 209 FDAEDY---Y---IVLELMEGGELFD--KVVG-NKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 641 KKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPE--VMSSNQCSSVGLKGTVGYAT 695
I+H DLKP NVLL + D + DFG ++ + E +M + C GT Y
Sbjct: 260 ---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LC------GTPTYLA 309
Query: 696 PE 697
PE
Sbjct: 310 PE 311
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 34/156 (21%), Positives = 60/156 (38%), Gaps = 19/156 (12%)
Query: 529 YESLVK------ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNL 580
YE + K V+K +A+K + K + E + L+ ++H NL
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 581 VKIITACSTSDFQGNYFRALVYEFMHH---GSLESCPRILSFLRRLNIAIDVASALEYLH 637
V ++ + LV+E+ H L+ R + +I A+ + H
Sbjct: 65 VNLLEVFRR---KRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 638 HHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673
H +H D+KP N+L+ + DFG R +
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 45/205 (21%), Positives = 74/205 (36%), Gaps = 50/205 (24%)
Query: 535 ATVYKGILDLDQTFIAVKVL--------FLHQRGALKSFMAECQALRNIRHRNLVKIITA 586
V +A+K++ + + E + L+ + H ++KI
Sbjct: 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83
Query: 587 CSTSDFQGNYFRALVYEFMHHGSL-----------ESCPRILSFLRRLNIAIDVASALEY 635
D+ Y +V E M G L E+ + + A++Y
Sbjct: 84 FDAEDY---Y---IVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQY 129
Query: 636 LHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPE--VMSSNQCSSVGLKGT 690
LH + I+H DLKP NVLL + D + DFG ++ + E +M + C GT
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LC------GT 179
Query: 691 VGYATPEYGILLLEIFTGKRPTSDM 715
Y PE +L+ G D
Sbjct: 180 PTYLAPE--VLVSVGTAGYNRAVDC 202
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 32/216 (14%), Positives = 63/216 (29%), Gaps = 49/216 (22%)
Query: 535 ATVYKGI-----LDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
A VY+ ++ +KV + F Q + ++ + S
Sbjct: 79 AQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135
Query: 590 SDFQGNYFRALVYEFMHHGSL--------ESCPRILSFLRRLNIAIDVASALEYLHHHCK 641
FQ LV E +G+L + +++ ++ A+ + +E +H
Sbjct: 136 HLFQNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---D 190
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMG-----------DFGLTRFIPEVMSSNQCSSVGLKGT 690
I+H D+KP N +L N D G + + ++ T
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK--CET 248
Query: 691 VGYATPE---------------YGILLLEIFTGKRP 711
G+ E + + G
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 38/163 (23%), Positives = 63/163 (38%), Gaps = 30/163 (18%)
Query: 550 AVKVL----FLHQRGALKSFMAECQALRNIRHRNLVK---IITACSTSDFQGNYFRALVY 602
AVK+L + E Q LR +RH+N+++ ++ Y +V
Sbjct: 34 AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM---Y---MVM 87
Query: 603 EFMHHGSLESCPRILSFLRRLNIAIDVA--------SALEYLHHHCKKPIVHCDLKPSNV 654
E+ G E + +R + A LEYLH IVH D+KP N+
Sbjct: 88 EYCVCGMQEMLDSVPE--KRFPV--CQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNL 140
Query: 655 LLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
LL T + G+ + + + C + +G+ + PE
Sbjct: 141 LLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPE 181
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 49/186 (26%), Positives = 71/186 (38%), Gaps = 38/186 (20%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A K L + +R + E Q L + R +V + A ++ LV M+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMN 267
Query: 607 HGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
G L R + A ++ LE LH ++ IV+ DLKP N+LLD+
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGH 324
Query: 662 AHMGDFGLTRFIPEVMSSNQ-CSSVGLKGTVGYATPE---------------YGILLLEI 705
+ D GL +PE + GTVGY PE G LL E+
Sbjct: 325 IRISDLGLAVHVPEGQTIKGRV------GTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 706 FTGKRP 711
G+ P
Sbjct: 379 IAGQSP 384
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 48/217 (22%), Positives = 76/217 (35%), Gaps = 62/217 (28%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
VYK A KV+ L+ ++ E + L H +VK G
Sbjct: 34 KVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK---------LLGA 84
Query: 596 YFRA----LVYEFMHHGSLESCPRILSFLRRLN---IAI---DVASALEYLHHHCKKPIV 645
Y+ ++ EF G++++ +L R L I + + AL +LH K I+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLH---SKRII 139
Query: 646 HCDLKPSNVLLDNDMTAHMGDFG----LTR-------FI-------PEVMSSNQCSSVGL 687
H DLK NVL+ + + DFG + FI PEV+
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP- 198
Query: 688 KGTVGYATPEY---------GILLLEIFTGKRPTSDM 715
Y GI L+E+ + P ++
Sbjct: 199 ----------YDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 44/213 (20%), Positives = 75/213 (35%), Gaps = 47/213 (22%)
Query: 536 TVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQ 593
V K +AVK + K + + ++R + V F
Sbjct: 22 VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---------FY 72
Query: 594 GNYFR----ALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKP 643
G FR + E M + +++ + + IA+ + ALE+LH
Sbjct: 73 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
++H D+KPSNVL++ M DFG++ ++ V + G Y PE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDA---GCKPYMAPERINPEL 185
Query: 698 ----Y---------GILLLEIFTGKRPTSDMFT 717
Y GI ++E+ + P T
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 53/231 (22%), Positives = 75/231 (32%), Gaps = 54/231 (23%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
IP ++ + LD + N L L S L LS + T+ +
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL---DLSRCEIQ-TIEDGAYQSL 75
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
SHL L ++ NPI S+ F L LQ L E N
Sbjct: 76 SHLSTLILTGNPIQ-SLALGA-------------F----------SGLSSLQKLVAVETN 111
Query: 332 ISREIPSSL-GNFTFLTELNLCGNSIRGSVPSALGSCHQL----WLDLSHNHLTGPIPLA 386
++ + + G+ L ELN+ N I+ S L LDLS N + I
Sbjct: 112 LAS-LENFPIGHLKTLKELNVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQS-IYCT 167
Query: 387 V-----GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
P LDLS N ++ I F ++ L LD
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMN-FIQP---------GAFKEIRLKELALD 208
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 34/193 (17%), Positives = 73/193 (37%), Gaps = 15/193 (7%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
+ ++ +S ++ + +L ++ L+L GN ++ S S L+ L
Sbjct: 50 SFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVA 107
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS--HLRYLYMSANPIS 285
+L L + L L +++ N + + FS+ +L +L +S+N I
Sbjct: 108 VETNLASLENFPIGHLKTLKEL---NVAHNLIQ-SFKLPEY-FSNLTNLEHLDLSSNKIQ 162
Query: 286 GSIPTEI-GNLKNLIIIAIEKFIL---IRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341
SI L + ++ + + + I ++L+ L+L N +
Sbjct: 163 -SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221
Query: 342 NFTFLTELNLCGN 354
T L ++ L N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 50/251 (19%), Positives = 75/251 (29%), Gaps = 41/251 (16%)
Query: 158 SLTGSIPIQLLNI-TSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI 216
+ IP N+ S + +S N L L + F+ P +++L L+ + I
Sbjct: 18 NFY-KIPD---NLPFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEI-QTIEDGA 71
Query: 217 -SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLR 275
+ S L L N + L L + L +L+ +L N L+
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL---VAVETNLA-SLENFPIGHLKTLK 127
Query: 276 YLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISRE 335
L ++ N I S NL L+ L L N I
Sbjct: 128 ELNVAHNLIQ-SFKLP-EYFSNLT---------------------NLEHLDLSSNKIQS- 163
Query: 336 IP----SSLGNFTFLT-ELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNP 390
I L L L+L N + P A L L N L
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRL 223
Query: 391 KSIPHLDLSKN 401
S+ + L N
Sbjct: 224 TSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 45/237 (18%), Positives = 75/237 (31%), Gaps = 38/237 (16%)
Query: 68 TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG 127
+ ++L N + L+ + + +Q +E L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-----------TIEDGAYQSLS 76
Query: 128 SLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGEL 187
L L L N SL L +S++ E L L
Sbjct: 77 HL---STLILTGNPIQ--------------SLALGAFSGL---SSLQKLVAVETNLA-SL 115
Query: 188 PPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLVNC 246
L ++ L +A N SN + LE LD ++N + + DL L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 247 TYLEVV-SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIII 301
L + LS+N ++ P + L+ L + N + S+P I L +L I
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEI--RLKELALDTNQLK-SVPDGIFDRLTSLQKI 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 41/193 (21%), Positives = 70/193 (36%), Gaps = 51/193 (26%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A+K + +R +++ E Q ++ + H LV + + FQ +V + +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYS-----FQDEEDMFMVVDLLL 98
Query: 607 HGSLESCPRILSFLRRLNI---------AIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657
G L L++ ++ AL+YL + I+H D+KP N+LLD
Sbjct: 99 GGDL------RYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLD 149
Query: 658 NDMTAHMGDFGL-TRFIPEVMSSNQCSSVGLKGTVGYATPE------------------Y 698
H+ DF + E + GT Y PE
Sbjct: 150 EHGHVHITDFNIAAMLPRETQITTMA------GTKPYMAPEMFSSRKGAGYSFAVDWWSL 203
Query: 699 GILLLEIFTGKRP 711
G+ E+ G+RP
Sbjct: 204 GVTAYELLRGRRP 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 30/116 (25%), Positives = 46/116 (39%), Gaps = 26/116 (22%)
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQC 682
L+I I +A A+E+LH ++H DLKPSN+ D +GDFGL + +
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 683 SSVGLK--------GTVGYATPE------Y---------GILLLEIFTGKRPTSDM 715
+ GT Y +PE Y G++L E+ +
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER 279
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 35/193 (18%)
Query: 535 ATVYKGILDLDQTFIAVKVL--------FLHQRGALKSFMAECQALRNIR-HRNLVKIIT 585
+ V + + AVK++ ++ E LR + H +++ +I
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSL-ESCPRILS---FLRR--LNIAIDVASALEYLHHH 639
+ +S F LV++ M G L + + + +I + A+ +LH +
Sbjct: 168 SYESSS---FMF--LVFDLMRKGELFD---YLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPEY 698
IVH DLKP N+LLD++M + DFG + + P C GT GY PE
Sbjct: 220 N---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC------GTPGYLAPE- 269
Query: 699 GILLLEIFTGKRP 711
IL +
Sbjct: 270 -ILKCSMDETHPG 281
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 52/300 (17%)
Query: 196 PNVRILLLAGNQFFGN-----IPHSISNASKLEWLDFANNSLTGLIPEDL-------DSL 243
+V+ ++L+GN G + +I++ LE +F++ + E +L
Sbjct: 32 DSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQAL 90
Query: 244 VNCTYLEVVSLSVNSLSGTLPNSLANF---SSHLRYLYMSANPISGSIPTEIGNLKNLII 300
+ C L V LS N+ T L +F + L +LY+ N +
Sbjct: 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG-----PQA------G 139
Query: 301 IAIEKFILIRNIPISVGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSI 356
I + + + L+ + N + + + L + + N I
Sbjct: 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 199
Query: 357 R-----GSVPSALGSCHQL-WLDLSHNHLT--GPIPLA--VGNPKSIPHLDLSKNELSGE 406
R + L C +L LDL N T G LA + + ++ L L+ LS
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259
Query: 407 IPSSLAWIFGYISIFA--KLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKL 464
+++ F + L L YN ++ D + +EK+ + L+L
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELDA--------VRTLKTVIDEKMP-DLLFLEL 310
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 42/262 (16%), Positives = 78/262 (29%), Gaps = 61/262 (23%)
Query: 222 LEWLDFANNSLTGLIPED----LDSLVNCTYLEVVSLSVNSLSGT----LPNSLANFSSH 273
+E +++T ED L+ ++ + LS N++ L ++A+
Sbjct: 6 IEGKSLKLDAIT---TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS-KKD 61
Query: 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFI--LIRNIPISVGYLLKLQVLSLFENN 331
L S G +K+ I A+ + L++ KL + L +N
Sbjct: 62 LEIAEFSDI--------FTGRVKDEIPEALRLLLQALLKCP--------KLHTVRLSDNA 105
Query: 332 IS----REIPSSLGNFTFLTELNLCGNSIR----GSVPSALGSCHQL----------WLD 373
+ L T L L L N + + AL +
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 374 LSHNHLTGP----IPLAVGNPKSIPHLDLSKNELSGE-IPSSLAWIFGYISIFAKLNLSY 428
N L + + + + + +N + E I L Y L+L
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 429 NNLDGDVPRKMIFKNASAISEA 450
N +SA++ A
Sbjct: 226 NTFTHLG--------SSALAIA 239
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 28/161 (17%), Positives = 47/161 (29%), Gaps = 23/161 (14%)
Query: 322 LQVLSLFENNIS----REIPSSLGNFTFLTELNLCGNSI--RGSVP--SALGSCHQL-WL 372
++ SL + I+ + + + L + E+ L GN+I + + S L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 373 DLSHNHLTGPIPL----------AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFA 422
+ S A+ + + LS N L +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 423 KLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELK 463
L L N L G I A A+ E K L+
Sbjct: 126 HLYLHNNGL-GPQAGAKI---ARALQELAVNKKAKNAPPLR 162
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 48/188 (25%), Positives = 73/188 (38%), Gaps = 39/188 (20%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM- 605
A K L L +R + M E + L + R +V + A F+ LV M
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA-----FETKTDLCLVMTIMN 268
Query: 606 ------HHGSLESCPRILSFLR-RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658
H +++ R A + S LE+LH ++ I++ DLKP NVLLD+
Sbjct: 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDD 324
Query: 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLL 703
D + D GL E+ + + G GT G+ PE G+ L
Sbjct: 325 DGNVRISDLGLAV---ELKAGQTKTK-GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 704 EIFTGKRP 711
E+ + P
Sbjct: 381 EMIAARGP 388
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 40/187 (21%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF-- 604
A+K+L + + + + E + L+N RH L + + FQ + V E+
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVMEYAN 231
Query: 605 ----MHHGSLESCPRILSFLR-RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659
H S E R+ S R R A ++ SAL+YLH +K +V+ DLK N++LD D
Sbjct: 232 GGELFFHLSRE---RVFSEDRARFYGA-EIVSALDYLHS--EKNVVYRDLKLENLMLDKD 285
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLE 704
+ DFGL + E + GT Y PE G+++ E
Sbjct: 286 GHIKITDFGLCK---EGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 705 IFTGKRP 711
+ G+ P
Sbjct: 342 MMCGRLP 348
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 48/172 (27%), Positives = 70/172 (40%), Gaps = 27/172 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
+ VY+ Q A+KVL + K E L + H N++K+ T
Sbjct: 67 SIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT--- 121
Query: 595 NYFRALVYEFMHHGSLESCPRIL---SFLRR--LNIAIDVASALEYLHHHCKKPIVHCDL 649
LV E + G L RI+ + R + + A+ YLH + IVH DL
Sbjct: 122 EIS--LVLELVTGGEL--FDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDL 174
Query: 650 KPSNVLL---DNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
KP N+L D + DFGL++ + +V+ C GT GY PE
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC------GTPGYCAPE 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 39/190 (20%), Positives = 64/190 (33%), Gaps = 45/190 (23%)
Query: 550 AVKVL---FLHQRGALKSFMAECQAL---RNIRHRNLVKIITACSTSDFQGNYFRALVYE 603
A+K L + + + E L +V + A F + + +
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFILD 272
Query: 604 FMHHGSLESCPRILSFLRRLNI------AIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657
M+ G L LS + A ++ LE++H+ +V+ DLKP+N+LLD
Sbjct: 273 LMNGGDLHY---HLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLD 326
Query: 658 NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGIL 701
+ D GL + GT GY PE G +
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVAYDSSADWFSLGCM 380
Query: 702 LLEIFTGKRP 711
L ++ G P
Sbjct: 381 LFKLLRGHSP 390
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 35/173 (20%), Positives = 69/173 (39%), Gaps = 24/173 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
+ V + + L A ++ + + E + R ++H N+V++ + S
Sbjct: 25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG- 83
Query: 593 QGNYFRALVYEFMHHGSLESCPRIL---SFLRR--LNIAIDVASALEYLHHHCKKPIVHC 647
+++ L+++ + G L I+ + + + A+ + H +VH
Sbjct: 84 --HHY--LIFDLVTGGEL--FEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHR 134
Query: 648 DLKPSNVLL---DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
+LKP N+LL + DFGL + Q + G GT GY +PE
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVE----GEQQAWFGFAGTPGYLSPE 183
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 41/198 (20%), Positives = 69/198 (34%), Gaps = 39/198 (19%)
Query: 535 ATVYKGILDLDQTFIAVKVL--------FLHQRGALKSFMAECQALRNIRHRNLVKIITA 586
V+ + + VK + + L E L + H N++K++
Sbjct: 38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97
Query: 587 CSTSDFQGNYFRALVYEFMHHGS-----LESCPRILSFLRRLNIAIDVASALEYLHHHCK 641
F + LV E G ++ PR+ L I + SA+ YL
Sbjct: 98 FENQGF---FQ--LVMEKHGSGLDLFAFIDRHPRLDEPLAS-YIFRQLVSAVGYLRLKD- 150
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPEYGI 700
I+H D+K N+++ D T + DFG ++ + C GT+ Y P
Sbjct: 151 --IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC------GTIEYCAP---- 198
Query: 701 LLLEIFTGKR---PTSDM 715
E+ G P +M
Sbjct: 199 ---EVLMGNPYRGPELEM 213
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 47/217 (21%), Positives = 73/217 (33%), Gaps = 58/217 (26%)
Query: 536 TVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQ 593
+V K + +AVK + K + + +R+ +V+ F
Sbjct: 37 SVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---------FY 87
Query: 594 GNYFRA----LVYEFMHHGSLESCPRILSFLR--RLN------IAIDVASALEYLHHHCK 641
G FR + E M S + + + + + I + AL +L + K
Sbjct: 88 GALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFG----LTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
I+H D+KPSN+LLD + DFG L S + G Y PE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDA---GCRPYMAPE 195
Query: 698 ----------Y---------GILLLEIFTGKRPTSDM 715
Y GI L E+ TG+ P
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 58/213 (27%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA-LKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V+KGI + Q +A+K++ L + ++ E L + K +
Sbjct: 36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK---------YY 86
Query: 594 GNYFRA----LVYEFMHHGS----LESCPRILSFLRRLNIAI---DVASALEYLHHHCKK 642
G+Y + ++ E++ GS LE P L IA ++ L+YLH K
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSEKK- 140
Query: 643 PIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK-----GTVGYATPE 697
+H D+K +NVLL + DFG+ + Q + +K GT + PE
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGV---------AGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 698 ------Y---------GILLLEIFTGKRPTSDM 715
Y GI +E+ G+ P S++
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 32/140 (22%), Positives = 57/140 (40%), Gaps = 27/140 (19%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRIL---SFLRR-- 622
E + R ++H N+V++ + ++ LV++ + G L I+ +
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEES---FHY--LVFDLVTGGEL--FEDIVAREFYSEADA 130
Query: 623 LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPE--VM 677
+ + ++ Y H + IVH +LKP N+LL + DFGL + +
Sbjct: 131 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 678 SSNQCSSVGLKGTVGYATPE 697
G GT GY +PE
Sbjct: 188 H-------GFAGTPGYLSPE 200
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 39/172 (22%), Positives = 64/172 (37%), Gaps = 25/172 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V + + A K + + + F E + ++++ H N++++ +
Sbjct: 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT--- 79
Query: 595 NYFRALVYEFMHHGSLESCPRIL---SFLRR--LNIAIDVASALEYLHHHCKKPIVHCDL 649
+ + LV E G L R++ F I DV SA+ Y H + H DL
Sbjct: 80 DIY--LVMELCTGGELFE--RVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDL 132
Query: 650 KPSNVLLDN---DMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
KP N L D + DFGL P M + GT Y +P+
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV------GTPYYVSPQ 178
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 34/173 (19%), Positives = 64/173 (36%), Gaps = 27/173 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++ + K + + E + + H L+ + A F+
Sbjct: 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FED 119
Query: 595 NYFRALVYEFMHHGSL-ESCPRILSFLRRL------NIAIDVASALEYLHHHCKKPIVHC 647
Y L+ EF+ G L + RI + ++ N L+++H + IVH
Sbjct: 120 KYEMVLILEFLSGGELFD---RIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 173
Query: 648 DLKPSNVLLDNDMTAHM--GDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
D+KP N++ + + + DFGL + P+ + T +A PE
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT------ATAEFAAPE 220
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 27/155 (17%), Positives = 58/155 (37%), Gaps = 25/155 (16%)
Query: 535 ATVYKGILDLDQT--FIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYK + A+K + G S E LR ++H N++ + +
Sbjct: 35 GHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKVFLSHAD 92
Query: 593 QGNYFRALVYEFMHH---GSLESCPRILSFLRRLNIAIDVA--------SALEYLHHHCK 641
+ + L++++ H ++ + + + + + + YLH +
Sbjct: 93 RKVW---LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 148
Query: 642 KPIVHCDLKPSNVLLDNDMTAH----MGDFGLTRF 672
++H DLKP+N+L+ + + D G R
Sbjct: 149 --VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 31/136 (22%), Positives = 49/136 (36%), Gaps = 22/136 (16%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRL-------N 624
+ ++V I+ ++ E M G L S RI +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGELFS--RIQERGDQAFTEREAAE 132
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPEVMSSNQ 681
I D+ +A+++LH H I H D+KP N+L + D + DFG + +
Sbjct: 133 IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP 189
Query: 682 CSSVGLKGTVGYATPE 697
C T Y PE
Sbjct: 190 C------YTPYYVAPE 199
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 33/142 (23%), Positives = 62/142 (43%), Gaps = 24/142 (16%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
TVY + +A++ + L Q+ + + E +R ++ N+V + +
Sbjct: 35 TVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN---------YLDS 85
Query: 596 YFRA----LVYEFMHHGSLESCPRILSF--LRRLNIAI---DVASALEYLHHHCKKPIVH 646
Y +V E++ GSL +++ + IA + ALE+LH ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD---VVTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 647 CDLKPSNVLLDNDMTAHMGDFG 668
D+K N+LL D + + DFG
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFG 161
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 28/144 (19%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
V +AVK++ L ++ + E +R+ +H N+V+ +
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKS 110
Query: 596 YFRA----LVYEFMHHGSL----ESCPRILSFLRRLNIAI---DVASALEYLHHHCKKPI 644
Y ++ EF+ G+L L IA V AL YLH + +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH---AQGV 162
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFG 668
+H D+K ++LL D + DFG
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFG 186
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 37/176 (21%), Positives = 68/176 (38%), Gaps = 31/176 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+ V + + A K++ L R + E + R ++H N+V++ +
Sbjct: 20 SVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES 78
Query: 592 FQGNYFRALVYEFMHHGSLESCPRIL---SFLRR--LNIAIDVASALEYLHHHCKKPIVH 646
++ LV++ + G L I+ + + + ++ Y H + IVH
Sbjct: 79 ---FHY--LVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVH 128
Query: 647 CDLKPSNVLL---DNDMTAHMGDFGLTRFIPE--VMSSNQCSSVGLKGTVGYATPE 697
+LKP N+LL + DFGL + + G GT GY +PE
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-------GFAGTPGYLSPE 177
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 42/178 (23%), Positives = 67/178 (37%), Gaps = 32/178 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V+ +K + + + ++ AE + L+++ H N++KI
Sbjct: 36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-- 93
Query: 594 GNYFRALVYEFMHHGSL-ESCPRILSFLRRL---------NIAIDVASALEYLHHHCKKP 643
N + +V E G L E RI+S R + + +AL Y H
Sbjct: 94 -NMY--IVMETCEGGELLE---RIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---H 144
Query: 644 IVHCDLKPSNVLLDN---DMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
+VH DLKP N+L + + DFGL + S+N GT Y PE
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA------GTALYMAPE 196
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 42/193 (21%), Positives = 70/193 (36%), Gaps = 35/193 (18%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPE-DLDSLVNCTYLEVVSLSVNSLSGTLPNSLANF 270
+P S+ S LD ++N+L+ L E L N L LS N L+ +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSL---LLSHNHLNFISSEAFVPV 87
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
+ LRYL +S+N + ++ + +L L+VL L+ N
Sbjct: 88 PN-LRYLDLSSNHLH-TLDEFL--FSDLQ---------------------ALEVLLLYNN 122
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL----WLDLSHNHLTGPIPLA 386
+I ++ + L +L L N I + ++L LDLS N L
Sbjct: 123 HIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 387 VGNPKSIPHLDLS 399
+ + L
Sbjct: 183 LQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 24/118 (20%), Positives = 46/118 (38%), Gaps = 4/118 (3%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
+ ++ Y +S N L L + L + +LLL N + + + ++L+ L
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQLQKLYL 143
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS-HLRYLYMSANPI 284
+ N ++ E + L ++ LS N L L + LY+ NP+
Sbjct: 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 42/224 (18%), Positives = 74/224 (33%), Gaps = 17/224 (7%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
IP + L F L + + LE + +S N + + + +
Sbjct: 24 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGD---LEKIEISQNDVLEVIEADVFSNL 78
Query: 272 SHLRYLYMS-ANPISGSIPTEI-GNLKNLIIIAIEKFILIRNIPISV-GYLLKLQVLSLF 328
L + + AN + I E NL NL + I I+++P + L+ +L +
Sbjct: 79 PKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISN-TGIKHLPDVHKIHSLQKVLLDIQ 136
Query: 329 ENNISREIPSSL--GNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSH-NHLTGPIPL 385
+N I + G L L N I+ SA L+LS N+L
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND 196
Query: 386 AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYN 429
LD+S+ + +PS + + +
Sbjct: 197 VFHGASGPVILDISRTRIH-SLPS---YGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 32/212 (15%), Positives = 65/212 (30%), Gaps = 10/212 (4%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
+E +S+N ++ + + LP + + + I N L++L
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLP-NSLANFSSHLRYLYMSANPISG 286
+N + L + L+ + N T+ NS S L+++ N I
Sbjct: 112 SNTGIKHLPDVHKIHSLQKVLLD---IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTF 345
I N L + + + +P V +L + I L N
Sbjct: 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 227
Query: 346 LTELNLCGNSIRGSVPSALGSCHQLWLDLSHN 377
L + +P+ + L++
Sbjct: 228 LRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 45/310 (14%), Positives = 83/310 (26%), Gaps = 69/310 (22%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
+T S N L L I + N
Sbjct: 14 FLCQESKVTEIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQND----- 65
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
+L +E ++ S L L + + + N I +
Sbjct: 66 -----VLEVIEADVFSNLPKLHE---IRIEKA---------NNLL--------YINPEAF 100
Query: 169 -NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISN--ASKLEWL 225
N+ +++Y +S + LP +L + N I + + + L
Sbjct: 101 QNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159
Query: 226 DFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285
N + + + E+ N+L + S L +S I
Sbjct: 160 WLNKNGIQEIHNSAFNGTQL---DELNLSDNNNLEELPNDVFHGA-SGPVILDISRTRIH 215
Query: 286 GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTF 345
S+P+ L+N L KL+ S + +++P +L
Sbjct: 216 -SLPSYG--LEN---------------------LKKLRARSTYNL---KKLP-TLEKLVA 247
Query: 346 LTELNLCGNS 355
L E +L S
Sbjct: 248 LMEASLTYPS 257
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 47/238 (19%), Positives = 81/238 (34%), Gaps = 41/238 (17%)
Query: 217 SNASKLEWLDFANNSLTGLIPEDLDSL--VNCTYLEVVSLSVNSLSGT----LPNSLANF 270
+ + + L+ + NSL ++L + + ++LS N LS L +LA
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
+ L + N S +E N+P S + L+L N
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQA-------------FSNLPAS------ITSLNLRGN 148
Query: 331 NISRE----IPSSLGNF-TFLTELNLCGNSIRGSVPSALGS------CHQLWLDLSHNHL 379
++ + + L + LNL GN++ + L LDLS N L
Sbjct: 149 DLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLL 208
Query: 380 T--GPIPLA---VGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
LA P + L+L N L G +L + + + L Y+ +
Sbjct: 209 GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 54/223 (24%), Positives = 78/223 (34%), Gaps = 31/223 (13%)
Query: 243 LVNCTYLEVVSLSVNSLSGT----LPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNL 298
+ + LS+N+L L + AN + + L +S N + E+ +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 299 IIIAIEKFILIRNI--PISVGYL--------LKLQVLSLFENNISREIPSSLG-----NF 343
I + L N S L + VL L N+ S + S
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 344 TFLTELNLCGNSIRGSVPSALGS------CHQLWLDLSHNHLT--GPIPLAVG---NPKS 392
+T LNL GN + L + L+L N+L LA P S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 393 IPHLDLSKNELSGEIPSSLAWIFGYISI-FAKLNLSYNNLDGD 434
+ LDLS N L + + LA+IF I LNL N L G
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 44/270 (16%), Positives = 80/270 (29%), Gaps = 51/270 (18%)
Query: 169 NITSMEYFHVSENQL----VGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNA----- 219
S+ ++S N L EL + NV L L+GN +
Sbjct: 49 TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108
Query: 220 SKLEWLDFANNSLTGLIPEDL-DSLVNC-TYLEVVSLSVNSLSGT----LPNSLANFSSH 273
+ LD N + + + N + ++L N L L LA ++
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333
+ L + N + + KF+ + L L N +
Sbjct: 169 VNSLNLRGNNL-----ASKN------CAELAKFLASIP--------ASVTSLDLSANLLG 209
Query: 334 REIPSSLG-----NFTFLTELNLCGNSIRGS----VPSALGSCHQL-WLDLSHNHLTGP- 382
+ + L + LNLC N + G + S L + L ++ +
Sbjct: 210 LKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMS 269
Query: 383 ------IPLAVGNPKSIPHLDLSKNELSGE 406
+ A N + I +D + E+
Sbjct: 270 KEQCKALGAAFPNIQKIILVDKNGKEIHPS 299
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 51/223 (22%), Positives = 76/223 (34%), Gaps = 67/223 (30%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQG 594
VYKG A+KV+ + + E L+ HRN+ + G
Sbjct: 39 QVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIAT---------YYG 88
Query: 595 NYFRA----------LVYEFMHHGSLESCPRILSF--LRRLNIAI---DVASALEYLHHH 639
+ + LV EF GS+ + L+ IA ++ L +LH H
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 640 CKKPIVHCDLKPSNVLLDNDMTAHMGDFG----LTR-------FI-------PEVMSSNQ 681
+H D+K NVLL + + DFG L R FI PEV++ ++
Sbjct: 149 KV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 682 CSSVGLKGTVGYATPEY---------GILLLEIFTGKRPTSDM 715
Y GI +E+ G P DM
Sbjct: 206 NPDAT-----------YDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 35/171 (20%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A+K+L + +R F E + +V++ A FQ + + +V E+M
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMP 152
Query: 607 HGSLESCPRILSFLRRLNIAIDVA--------SALEYLHHHCKKPIVHCDLKPSNVLLDN 658
G L ++ + ++ A AL+ +H +H D+KP N+LLD
Sbjct: 153 GGDL------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDK 203
Query: 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGK 709
+ DFG + + ++VG TP+Y + E+ +
Sbjct: 204 SGHLKLADFGTCMKMNKEGMVRCDTAVG--------TPDY--ISPEVLKSQ 244
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 54/211 (25%)
Query: 550 AVKVLFLHQRGALKSFMA-----ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604
A+K++ + L E + ++ + H N+VK+ T + L+ E+
Sbjct: 44 AIKII---DKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK---TLY--LIMEY 95
Query: 605 ----------MHHGSL-ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653
+ HG + E R S R++ SA++Y H IVH DLK N
Sbjct: 96 ASGGEVFDYLVAHGRMKEKEAR--SKFRQI------VSAVQYCHQKR---IVHRDLKAEN 144
Query: 654 VLLDNDMTAHMGDFGL-TRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFTGKR-- 710
+LLD DM + DFG F C G YA P E+F GK+
Sbjct: 145 LLLDADMNIKIADFGFSNEFTVGGKLDAFC------GAPPYAAP-------ELFQGKKYD 191
Query: 711 -PTSDMFTEGLDLHNFVKMALP--DQILQVL 738
P D+++ G+ L+ V +LP Q L+ L
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 42/212 (19%), Positives = 73/212 (34%), Gaps = 51/212 (24%)
Query: 536 TVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQ 593
V+K IAVK + + K + + + ++ +V+
Sbjct: 40 QVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---------CF 90
Query: 594 GNYFRA----LVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKP 643
G + + E M + + + + + + AL YL K
Sbjct: 91 GTFITNTDVFIAMELMGTCAEK---LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------ 697
++H D+KPSN+LLD + DFG++ + V + S G Y PE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSA---GCAAYMAPERIDPPD 200
Query: 698 -----Y---------GILLLEIFTGKRPTSDM 715
Y GI L+E+ TG+ P +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNC 232
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 38/213 (17%), Positives = 64/213 (30%), Gaps = 58/213 (27%)
Query: 535 ATVYKGILDLDQTFIAVKV-----LFLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
V I + + A+K+ + ++ E + ++ + H N+ ++
Sbjct: 40 GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 590 SDFQGNYFRALVYEFMHHGSL------------------------ESCPRILSFLRRL-- 623
LV E H G L CP
Sbjct: 100 EQ---YIC--LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 624 -----------------NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHM-- 664
NI + SAL YLH + I H D+KP N L + + +
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 665 GDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697
DFGL++ ++ + GT + PE
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 35/142 (24%), Positives = 61/142 (42%), Gaps = 32/142 (22%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSL----------ESCPRIL 617
E L+ + H N+VK++ + Y +V+E ++ G + E R
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLY---MVFELVNQGPVMEVPTLKPLSEDQAR-- 140
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI--PE 675
+ + D+ +EYLH+ I+H D+KPSN+L+ D + DFG++ +
Sbjct: 141 FYFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 676 VMSSNQCSSVGLKGTVGYATPE 697
+ SN GT + PE
Sbjct: 192 ALLSNTV------GTPAFMAPE 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 28/174 (16%)
Query: 536 TVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
V + AVKV+ + Q+ +S + E Q L+ + H N++K+
Sbjct: 41 EVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG- 99
Query: 593 QGNYFRALVYEFMHHGSLESCPRILS---FLRRL--NIAIDVASALEYLHHHCKKPIVHC 647
++ LV E G L I+S F I V S + Y+H + IVH
Sbjct: 100 --YFY--LVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHR 150
Query: 648 DLKPSNVLLDN---DMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
DLKP N+LL++ D + DFGL+ ++ GT Y PE
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI------GTAYYIAPE 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 41/195 (21%), Positives = 70/195 (35%), Gaps = 50/195 (25%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A+K+L + +R F E L N + + + A FQ + LV ++
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA-----FQDDNNLYLVMDYYV 157
Query: 607 HGSLESCPRILSFLRRLNIAID----------VASALEYLHHHCKKPIVHCDLKPSNVLL 656
G L L+ L + + + A++ +H VH D+KP N+L+
Sbjct: 158 GGDL------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM 208
Query: 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------------- 697
D + + DFG ++M S GT Y +PE
Sbjct: 209 DMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 698 -YGILLLEIFTGKRP 711
G+ + E+ G+ P
Sbjct: 266 SLGVCMYEMLYGETP 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 34/174 (19%), Positives = 66/174 (37%), Gaps = 30/174 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMA-ECQALRNIRHRNLVKIITACSTSDFQ 593
V++ + + K F+ +G + + E L RHRN++ + + + +
Sbjct: 19 GIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME-- 74
Query: 594 GNYFRALVYEFMHHGSL-ESCPRILSFLRRL------NIAIDVASALEYLHHHCKKPIVH 646
+++EF+ + E RI + L + V AL++LH H I H
Sbjct: 75 -ELV--MIFEFISGLDIFE---RINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 647 CDLKPSNVLLDNDMTAHM--GDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
D++P N++ ++ + +FG R + P Y PE
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF------TAPEYYAPE 173
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 39/173 (22%), Positives = 65/173 (37%), Gaps = 27/173 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++ A K + ++ E Q + +RH LV + A F+
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FED 225
Query: 595 NYFRALVYEFMHHGSL-ESCPRILSFLRRL------NIAIDVASALEYLHHHCKKPIVHC 647
+ ++YEFM G L E ++ ++ V L ++H + VH
Sbjct: 226 DNEMVMIYEFMSGGELFE---KVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 279
Query: 648 DLKPSNVLLDNDMTAHM--GDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
DLKP N++ + + DFGLT + P+ GT +A PE
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT------GTAEFAAPE 326
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 31/214 (14%), Positives = 70/214 (32%), Gaps = 33/214 (15%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDF 227
N+ ++ +VS + + +L H + L V + + + I L++L
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLP-NSLANFSSHLRYLYMSANPISG 286
N L DL + + ++ ++ N ++P N+ + L + N +
Sbjct: 113 FNTGLKMF--PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSL--GNFT 344
++ KL + L +N I G ++
Sbjct: 170 ------------------------SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 345 FLTELNLCGNSIRGSVPS-ALGSCHQLWLDLSHN 377
+ L++ S+ ++PS L +L +
Sbjct: 206 GPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 33/195 (16%), Positives = 66/195 (33%), Gaps = 15/195 (7%)
Query: 195 LPNVRILLLAGNQFFGNIP-HSISNASKLEWLDFA-NNSLTGLIPEDLDSLVNCTYLEVV 252
P+ + L L IP H+ SN + + + + +L L +L + +
Sbjct: 30 PPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK---VTHI 85
Query: 253 SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP--TEIGNLKNLIIIAIEKFILIR 310
+ + L++L + + P T++ + I+ I +
Sbjct: 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMT 144
Query: 311 NIPISV--GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSAL--GS 366
+IP++ G + L L+ N + + N T L + L N + G
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 367 CHQL-WLDLSHNHLT 380
LD+S +T
Sbjct: 204 YSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 35/218 (16%), Positives = 69/218 (31%), Gaps = 41/218 (18%)
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA 281
+ L L + +L ++ +Y+S
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNL----------------------------PNISRIYVSI 64
Query: 282 NPISGSIPTEI-GNLKNLIIIAIEKFILIRNIPISV-GYLLKLQVLSLFENNISREIP-- 337
+ + + NL + I I + I L L+ L +F + + P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDL 123
Query: 338 SSLGNFTFLTELNLCGNSIRGSVPSAL--GSCHQL-WLDLSHNHLTGPIPLAVGNPKSIP 394
+ + + L + N S+P G C++ L L +N T + N +
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLD 182
Query: 395 HLDLSKNELSGEIPSSLAWIF-GYISIFAKLNLSYNNL 431
+ L+KN+ I F G S + L++S ++
Sbjct: 183 AVYLNKNKYLTVIDKD---AFGGVYSGPSLLDVSQTSV 217
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 43/213 (20%), Positives = 76/213 (35%), Gaps = 58/213 (27%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGA---LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VY + +A+K + + + + + E + L+ +RH N ++ +
Sbjct: 69 AVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------Y 119
Query: 593 QGNYFRA----LVYEFMHHGSLESCPRILSFLRRLNIAI---DVASALEYLHHHCKKPIV 645
+G Y R LV E+ + + L+ + IA L YLH ++
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 176
Query: 646 HCDLKPSNVLLDNDMTAHMGDFG----LTR---FI-------PEVMSSNQCSSVGLKGTV 691
H D+K N+LL +GDFG + F+ PEV+ +
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG-------- 228
Query: 692 GYATPEY---------GILLLEIFTGKRPTSDM 715
+Y GI +E+ K P +M
Sbjct: 229 -----QYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 45/170 (26%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNI 625
+ E + L+ + LVK+ + F+ N +V E++ G + S LRR+
Sbjct: 89 LNEKRILQAVNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM------FSHLRRIGR 137
Query: 626 ---------AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676
A + EYLH +++ DLKP N+L+D + DFG + +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
Query: 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ L GT PE G+L+ E+ G P
Sbjct: 195 TWT-------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 45/175 (25%), Positives = 69/175 (39%), Gaps = 29/175 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V K + Q AVKV+ + + + E + L+ + H N++K+ S
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSS 94
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILS---FLRR--LNIAIDVASALEYLHHHCKKPIVH 646
+++ +V E G L I+ F I V S + Y+H H IVH
Sbjct: 95 ---SFY--IVGELYTGGELFD--EIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVH 144
Query: 647 CDLKPSNVLL---DNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
DLKP N+LL + D + DFGL+ ++ GT Y PE
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------GTAYYIAPE 193
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 32/150 (21%), Positives = 54/150 (36%), Gaps = 21/150 (14%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVK---IITACSTSDF 592
TV G +A+K + R + Q L + H N+V+ D
Sbjct: 38 TVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDR 96
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVA----------SALEYLHHHCKK 642
+ Y +V E++ ++ R R +A ++ LH
Sbjct: 97 RDIYLN-VVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN 151
Query: 643 PIVHCDLKPSNVLLD-NDMTAHMGDFGLTR 671
+ H D+KP NVL++ D T + DFG +
Sbjct: 152 -VCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 43/175 (24%), Positives = 69/175 (39%), Gaps = 32/175 (18%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQ 593
+ K + AVK++ + E AL+ H N+VK+
Sbjct: 25 SICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFHDQL-- 79
Query: 594 GNYFRALVYEFMHHGSLESCPRIL---SFLRR--LNIAIDVASALEYLHHHCKKPIVHCD 648
+ F LV E ++ G L RI F I + SA+ ++H +VH D
Sbjct: 80 -HTF--LVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRD 131
Query: 649 LKPSNVLL---DNDMTAHMGDFGLTRFIP---EVMSSNQCSSVGLKGTVGYATPE 697
LKP N+L ++++ + DFG R P + + + C T+ YA PE
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PC------FTLHYAAPE 179
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 28/144 (19%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595
+VYK I +A+K + + L+ + E ++ ++VK + G+
Sbjct: 44 SVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK---------YYGS 92
Query: 596 YFRA----LVYEFMHHGSL----ESCPRILSFLRRLNIAI---DVASALEYLHHHCKKPI 644
YF+ +V E+ GS+ + L+ IA LEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT---EDEIATILQSTLKGLEYLH---FMRK 146
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFG 668
+H D+K N+LL+ + A + DFG
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 54/232 (23%), Positives = 81/232 (34%), Gaps = 53/232 (22%)
Query: 179 SENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE 238
+ L LPP + + IL L+ N + ++ ++L L+ LT L +
Sbjct: 18 DKRNL-TALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--Q 71
Query: 239 DLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI----GN 294
+L L + LS N L +LP L L +S N ++ S+P G
Sbjct: 72 VDGTLPV---LGTLDLSHNQLQ-SLPLLGQTLP-ALTVLDVSFNRLT-SLPLGALRGLGE 125
Query: 295 LKNLIIIAIEKFILIRN----IPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTEL 349
L+ L L N +P + KL+ LSL NN+ E+P+ G L L
Sbjct: 126 LQELY--------LKGNELKTLPPGLLTPTPKLEKLSLANNNL-TELPA--GLLNGLENL 174
Query: 350 NLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
+ L L N L IP +P L N
Sbjct: 175 D--------------------TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 37/227 (16%)
Query: 66 NLTFLRLINLQQNNFSS---NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNI 122
+ +N + N ++ ++P + L L N L
Sbjct: 8 KVASHLEVNCDKRNLTALPPDLPKDTTILH--------------------LSENLLYTFS 47
Query: 123 PSELGSLLKFKGLGLANNYFT-----GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFH 177
+ L + L L T G +P L +S L S+P+ + ++
Sbjct: 48 LATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106
Query: 178 VSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLI 236
VS N+L LP L ++ L L GN+ +P + + KLE L ANN+LT L
Sbjct: 107 VSFNRLT-SLPLGALRGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELP 164
Query: 237 PEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283
L+ L N L+ + L NSL T+P S L + ++ NP
Sbjct: 165 AGLLNGLEN---LDTLLLQENSLY-TIPKGFFG-SHLLPFAFLHGNP 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 336 IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIP 394
+P L T L+L N + + L +L L+L LT + G +
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLG 80
Query: 395 HLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
LDLS N+L SL + + L++S+N L
Sbjct: 81 TLDLSHNQLQ-----SLPLLGQTLPALTVLDVSFNRL 112
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 41/175 (23%), Positives = 64/175 (36%), Gaps = 31/175 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
V+K +A K + RG + E + + H NL+++ A F
Sbjct: 103 GQVHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----F 155
Query: 593 QGNYFRALVYEFMHHGSL-ESCPRI------LSFLRRLNIAIDVASALEYLHHHCKKPIV 645
+ LV E++ G L + RI L+ L + + + ++H I+
Sbjct: 156 ESKNDIVLVMEYVDGGELFD---RIIDESYNLTELDTILFMKQICEGIRHMHQM---YIL 209
Query: 646 HCDLKPSNVLLDNDMTAH--MGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
H DLKP N+L N + DFGL R P GT + PE
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF------GTPEFLAPE 258
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 25/106 (23%), Positives = 38/106 (35%), Gaps = 12/106 (11%)
Query: 572 LRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLNI 625
L + H N++ I Y LV E M + ++S
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLY---LVTELMRTDLAQVIHDQRIVISPQHIQYF 139
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ L LH + +VH DL P N+LL ++ + DF L R
Sbjct: 140 MYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR 182
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 30/141 (21%), Positives = 54/141 (38%), Gaps = 13/141 (9%)
Query: 572 LRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLNI 625
L + H ++VK I+ F Y +V E + P L+ L +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELY---VVLEIADSDFKKLFRT-PVYLTELHIKTL 161
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685
++ ++Y+H I+H DLKP+N L++ D + + DFGL R + + N +
Sbjct: 162 LYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 686 GLKGTVGYATPEYGILLLEIF 706
+ L+
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQ 239
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 49/201 (24%), Positives = 73/201 (36%), Gaps = 41/201 (20%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V + A+K++ + + E L+ + H N++K+
Sbjct: 52 EVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-- 109
Query: 594 GNYFRALVYEFMHHGSLESCPRILS---FLRR--LNIAIDVASALEYLHHHCKKPIVHCD 648
NY+ LV E G L I+ F I V S + YLH H IVH D
Sbjct: 110 -NYY--LVMECYKGGELFD--EIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRD 161
Query: 649 LKPSNVLLDN---DMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE-----Y- 698
LKP N+LL++ D + DFGL+ + + GT Y PE Y
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL------GTAYYIAPEVLRKKYD 215
Query: 699 --------GILLLEIFTGKRP 711
G++L + G P
Sbjct: 216 EKCDVWSIGVILFILLAGYPP 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 34/148 (22%), Positives = 62/148 (41%), Gaps = 23/148 (15%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITA-CSTSDFQG 594
VY+ L +A+K + +R + E Q +R + H N+V++ S+ + +
Sbjct: 69 VVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKD 124
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRRLNIAID----------VASALEYLHHHCKKPI 644
+ LV +++ E+ R+ R + + +L Y+H I
Sbjct: 125 EVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---I 177
Query: 645 VHCDLKPSNVLLDNDMTA-HMGDFGLTR 671
H D+KP N+LLD D + DFG +
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 45/189 (23%), Positives = 74/189 (39%), Gaps = 19/189 (10%)
Query: 197 NVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
+ + L L N+ ++P +KL L +N L L L N LE + ++
Sbjct: 38 DTKKLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN---LETLWVT 93
Query: 256 VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIEKFIL----IR 310
N L LP + + +L L + N + S+P + +L L L ++
Sbjct: 94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKL-----TYLSLGYNELQ 146
Query: 311 NIPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQ 369
++P V L L+ L L+ N + R + T L L L N ++ A S +
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 370 L-WLDLSHN 377
L L L N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 31/126 (24%), Positives = 53/126 (42%), Gaps = 19/126 (15%)
Query: 311 NIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370
NIP + L L N +S + T L L L N ++ ++P+ G +L
Sbjct: 34 NIPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA--GIFKEL 84
Query: 371 ----WLDLSHNHLTGPIPLAV-GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLN 425
L ++ N L +P+ V ++ L L +N+L +P +F ++ L+
Sbjct: 85 KNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPR---VFDSLTKLTYLS 139
Query: 426 LSYNNL 431
L YN L
Sbjct: 140 LGYNEL 145
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 33/134 (24%), Positives = 60/134 (44%), Gaps = 11/134 (8%)
Query: 171 TSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFAN 229
++E V++N+L LP + L N+ L L NQ ++P + + +KL +L
Sbjct: 85 KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQ-LKSLPPRVFDSLTKLTYLSLGY 142
Query: 230 NSLTGLIPEDL-DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI 288
N L L P+ + D L + L L N L +P + + L+ L + N + +
Sbjct: 143 NELQSL-PKGVFDKLTSLKEL---RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RV 196
Query: 289 PTEI-GNLKNLIII 301
P +L+ L ++
Sbjct: 197 PEGAFDSLEKLKML 210
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 5e-09
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 45/170 (26%)
Query: 566 MAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNI 625
E L + H ++++ FQ ++ +++ G L S LR+
Sbjct: 54 NDERLMLSIVTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGEL------FSLLRKSQR 102
Query: 626 ---------AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676
A +V ALEYLH I++ DLKP N+LLD + + DFG +++P+V
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159
Query: 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
+ L GT Y PE +GIL+ E+ G P
Sbjct: 160 TYT-------LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 49/201 (24%), Positives = 77/201 (38%), Gaps = 54/201 (26%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF-- 604
A+K+L + + + + E + L+N RH L + A FQ + V E+
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDRLCFVMEYAN 88
Query: 605 ----MHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660
H L R A ++ SALEYLH + +V+ D+K N++LD D
Sbjct: 89 GGELFFH--LSRERVFTEERARFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDG 142
Query: 661 TAHMGDFGLTRFIPEVMSSNQ-----CSSVGLKGTVGYATPE---------------YGI 700
+ DFGL + E +S C GT Y PE G+
Sbjct: 143 HIKITDFGLCK---EGISDGATMKTFC------GTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 701 LLLEIFTGKRP-----TSDMF 716
++ E+ G+ P +F
Sbjct: 194 VMYEMMCGRLPFYNQDHERLF 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 46/200 (23%), Positives = 73/200 (36%), Gaps = 58/200 (29%)
Query: 550 AVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
A+K++ + +RG + F E L N R + ++ A FQ + LV E+
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA-----FQDENYLYLVMEYYV 144
Query: 607 HGSLESCPRILSFLRRLNIAID----------VASALEYLHHHCKKPIVHCDLKPSNVLL 656
G L L+ L + I + A++ +H + VH D+KP N+LL
Sbjct: 145 GGDL------LTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILL 195
Query: 657 DNDMTAHMGDFGL-TRFIPE--VMSSNQCSSVGLKGTVGYATPE---------------- 697
D + DFG + + V S GT Y +PE
Sbjct: 196 DRCGHIRLADFGSCLKLRADGTVRSLVAV------GTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 698 ------YGILLLEIFTGKRP 711
G+ E+F G+ P
Sbjct: 250 ECDWWALGVFAYEMFYGQTP 269
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 36/175 (20%), Positives = 61/175 (34%), Gaps = 22/175 (12%)
Query: 576 RHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEY 635
R L I ++ S++ ++L + L+ + + VA +E+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGL-------- 687
L + +H DL N+LL + DFGL R I + + L
Sbjct: 209 L---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 688 -----KGTVGYATPEYGILLLEIFT-GKRPTSDMFTEGLDLHNFVK----MALPD 732
T+ +G+LL EIF+ G P + + +K M PD
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRAPD 319
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 29/174 (16%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V K + Q AVKV+ + + E + L+ + H N++K+ S
Sbjct: 37 EVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-- 94
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRRLN------IAIDVASALEYLHHHCKKPIVHC 647
+++ +V E G L I+ +R + I V S + Y+H H IVH
Sbjct: 95 -SFY--IVGELYTGGELFD--EIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IVHR 145
Query: 648 DLKPSNVLLDN---DMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
DLKP N+LL++ D + DFGL+ ++ GT Y PE
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------GTAYYIAPE 193
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 30/138 (21%), Positives = 49/138 (35%), Gaps = 25/138 (18%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRL-------N 624
R + ++V+I+ +V E + G L S RI +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCL-LIVMECLDGGELFS--RIQDRGDQAFTEREASE 165
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIP--EVMSS 679
I + A++YLH I H D+KP N+L + + DFG + +++
Sbjct: 166 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 680 NQCSSVGLKGTVGYATPE 697
C T Y PE
Sbjct: 223 -PC------YTPYYVAPE 233
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 35/229 (15%), Positives = 77/229 (33%), Gaps = 16/229 (6%)
Query: 154 VSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIP 213
V + + +S + L + + ++ L I
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELE-SCKELQELEPENKWCLLTII 389
Query: 214 HSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSH 273
+ L + + L + +D + ++ S + S +
Sbjct: 390 LLMRALDPLLYEKETLQYFSTL--KAVDPMRAAYLDDLRSKFLLENSVLK-----MEYAD 442
Query: 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333
+R L+++ ++ + + L + + + +R +P ++ L L+VL +N +
Sbjct: 443 VRVLHLAHKDLT-VLC-HLEQLLLVTHLDLS-HNRLRALPPALAALRCLEVLQASDNALE 499
Query: 334 REIPSSLGNFTFLTELNLCGNSIRG-SVPSALGSCHQL-WLDLSHNHLT 380
+ N L EL LC N ++ + L SC +L L+L N L
Sbjct: 500 N--VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 45/320 (14%), Positives = 97/320 (30%), Gaps = 52/320 (16%)
Query: 22 LSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFS 81
L +++ +W + V L +L +L + + + + ++
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334
Query: 82 S----NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGL 137
+ +L + + +L+ P LL L
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 138 ANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPN 197
A + L F +L P++ + + + EN ++ +
Sbjct: 394 ALDPLLYEKETLQYFS----TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV------ 443
Query: 198 VRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVN 257
R+L LA + H + + LD ++N L +P L +L L S N
Sbjct: 444 -RVLHLAHKDL-TVLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL---QASDN 496
Query: 258 SLSGTLPNSLANFSS--HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPIS 315
+L ++ ++ L+ L + N + I L +
Sbjct: 497 ALE-----NVDGVANLPRLQELLLCNNRLQQ--SAAIQPLVSCP---------------- 533
Query: 316 VGYLLKLQVLSLFENNISRE 335
+L +L+L N++ +E
Sbjct: 534 -----RLVLLNLQGNSLCQE 548
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 4e-06
Identities = 36/264 (13%), Positives = 72/264 (27%), Gaps = 35/264 (13%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
++ + E L + +LL+ + ++ +
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSH---LRYLYMSANPIS 285
+ L + + S L P S+ L +S +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST 362
Query: 286 GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISR----------- 334
+ +E+ + K L + E + I + + L L + +
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 335 -------------EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380
E + + L+L + +V L + LDLSHN L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR 476
Query: 381 GPIPLAVGNPKSIPHLDLSKNELS 404
+P A+ + + L S N L
Sbjct: 477 A-LPPALAALRCLEVLQASDNALE 499
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 37/159 (23%), Positives = 58/159 (36%), Gaps = 26/159 (16%)
Query: 548 FIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
FI + +RG + E LR + H N++ + ++ L+ E +
Sbjct: 44 FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVS 98
Query: 607 HGSL-ESCPRILSFLRR--LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DND 659
G L + + S + + + YLH K I H DLKP N++L
Sbjct: 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY 698
+ DFGL I + V K G TPE+
Sbjct: 156 PHIKLIDFGLAHEIED--------GVEFKNIFG--TPEF 184
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 38/151 (25%)
Query: 572 LRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMH---HGSLESCP----RILSF-- 619
L++ +H N++ I S +F Y ++ E M H + + I F
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVY---IIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 620 --LRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
LR A++ LH ++H DLKPSN+L++++ + DFGL R I E
Sbjct: 120 QTLR----------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 678 SSNQCSSVGLKGTVGY-AT-----PEYGILL 702
+ N + G V + AT PE ++L
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPE--VML 195
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 29/139 (20%), Positives = 52/139 (37%), Gaps = 13/139 (9%)
Query: 572 LRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLNI 625
L ++ +++ +I F Y +V E ++ P L+ I
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELY---IVLEIADSDLKKLFKT-PIFLTEEHIKTI 134
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSV 685
++ ++H + I+H DLKP+N LL+ D + + DFGL R I +N + +
Sbjct: 135 LYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 686 GLKGTVGYATPEYGILLLE 704
G L
Sbjct: 192 EENEEPGPHNKNLKKQLTS 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 37/159 (23%), Positives = 58/159 (36%), Gaps = 26/159 (16%)
Query: 548 FIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
FI + +RG + E LR + H N++ + ++ L+ E +
Sbjct: 44 FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVS 98
Query: 607 HGSL-ESCPRILSFLRR--LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DND 659
G L + + S + + + YLH K I H DLKP N++L
Sbjct: 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY 698
+ DFGL I + V K G TPE+
Sbjct: 156 PHIKLIDFGLAHEIED--------GVEFKNIFG--TPEF 184
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 45/190 (23%), Positives = 74/190 (38%), Gaps = 46/190 (24%)
Query: 550 AVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605
AVK+L + Q ++ M E + L + L ++ + FQ V E++
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDRLYFVMEYV 424
Query: 606 HHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661
+ G L + R A ++A L +L K I++ DLK NV+LD++
Sbjct: 425 NGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 480
Query: 662 AHMGDFGLTRFIPEVMSSNQ-----CSSVGLKGTVGYATPE---------------YGIL 701
+ DFG+ + E + C GT Y PE +G+L
Sbjct: 481 IKIADFGMCK---ENIWDGVTTKTFC------GTPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 702 LLEIFTGKRP 711
L E+ G+ P
Sbjct: 532 LYEMLAGQAP 541
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 59/290 (20%), Positives = 92/290 (31%), Gaps = 48/290 (16%)
Query: 171 TSMEYFHVSENQLVGELPPHIGFTL---PNVRILLLAGNQF----FGNIPHSI-SNASKL 222
+E + L + L P+ + L ++ N + + + +L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 223 EWLDFANNSLTGLIPEDLDS-LVNCTYLEVVSLSVNSLSGT----LPNSLANFSSHLRYL 277
E L + +T DL + + L ++L N L L L + SS LR L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 278 YMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIP 337
++ I T G + +L L+ LSL N + E
Sbjct: 262 WIWECGI-----TAKG----CGDLC---RVLRAKE--------SLKELSLAGNELGDEGA 301
Query: 338 SSLG-----NFTFLTELNLCGNSIRG----SVPSALGSCHQL-WLDLSHNHLT--GPIPL 385
L L L + S S L L L +S+N L G L
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361
Query: 386 AVG---NPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432
G + L L+ ++S SSLA +L+LS N L
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 42/235 (17%), Positives = 76/235 (32%), Gaps = 40/235 (17%)
Query: 217 SNASKLEWLDFANNSLTGLIPEDL-DSLVNCTYLEVVSLSVNSLSGT----LPNSLANFS 271
+ + K++ L N LTG L +L L+ + LS N L L L +
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
L L + +S + + ++ L + L++ N+
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASV------------LRAKP--------DFKELTVSNND 181
Query: 332 IS----REIPSSLGNFTF-LTELNLCGNSIR----GSVPSALGSCHQL-WLDLSHNHLT- 380
I+ R + L + L L L + + + S L L L N L
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241
Query: 381 -GPIPLAVG---NPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
G L G + L + + ++ + L + +L+L+ N L
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 43/240 (17%), Positives = 75/240 (31%), Gaps = 31/240 (12%)
Query: 220 SKLEWLDFANNSLTGLIPEDLDSLVNC-TYLEVVSLSVNSLSGTLPNSLAN---FSSHLR 275
++ LD L+ L+ +VV L L+ +++ + L
Sbjct: 3 LDIQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 276 YLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGY-----LLK----LQVLS 326
L + +N + + I+K L G L+ LQ L
Sbjct: 60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 327 LFENNISREIPSSLG-----NFTFLTELNLCGNSIR----GSVPSALGSCHQL-WLDLSH 376
L +N + L L +L L S+ + S L + L +S+
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 377 NHL--TGPIPLAVG---NPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
N + G L G +P + L L ++ + L I + +L L N L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 25/150 (16%)
Query: 557 HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRI 616
+ + E L+++ H N++K+ ++ LV EF G L +I
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK---YFY--LVTEFYEGGELFE--QI 137
Query: 617 LSFLRR-----LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFG 668
++ + NI + S + YLH H IVH D+KP N+LL+N + + DFG
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 669 LTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
L+ F + ++ GT Y PE
Sbjct: 195 LSSFFSKDYKLRDRL------GTAYYIAPE 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 14/106 (13%)
Query: 572 LRNIRHRNLVK---IITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLNI 625
L RH N++ II A + + Y +V + M + L++ + LS
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVY---IVQDLMETDLYKLLKT--QHLSNDHICYF 133
Query: 626 AIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671
+ L+Y+H ++H DLKPSN+LL+ + DFGL R
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 29/113 (25%), Positives = 53/113 (46%), Gaps = 15/113 (13%)
Query: 572 LRNIRHRNLVKIIT----ACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLN 624
L++++H N++ ++ A S +F Y LV M + ++ + L+
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVY---LVTHLMGADLNNIVKC--QKLTDDHVQF 136
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
+ + L+Y+H I+H DLKPSN+ ++ D + DFGL R + M
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 35/159 (22%), Positives = 55/159 (34%), Gaps = 26/159 (16%)
Query: 548 FIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
FI + +RG + E L+ I+H N++ + ++ L+ E +
Sbjct: 43 FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-----YENKTDVILILELVA 97
Query: 607 HGSL-ESCPRILSFLRR--LNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DND 659
G L + S + + + YLH I H DLKP N++L
Sbjct: 98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 660 MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY 698
+ DFGL I K G TPE+
Sbjct: 155 PRIKIIDFGLAHKIDF--------GNEFKNIFG--TPEF 183
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 18/71 (25%), Positives = 34/71 (47%), Gaps = 10/71 (14%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGL 687
V A+ + H+ ++H D+K N+L+D N + DFG + + + ++
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----- 209
Query: 688 KGTVGYATPEY 698
GT Y+ PE+
Sbjct: 210 -GTRVYSPPEW 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 39/168 (23%), Positives = 60/168 (35%), Gaps = 44/168 (26%)
Query: 548 FIAVKVLFLHQRGALK-SFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606
FI + L +RG + E LR IRH N++ + + L+ E +
Sbjct: 37 FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT---DVV--LILELVS 91
Query: 607 HGSL-ESCPRILS-----------FLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNV 654
G L + + FL+ + + YLH K I H DLKP N+
Sbjct: 92 GGELFD---FLAEKESLTEDEATQFLK------QILDGVHYLH---SKRIAHFDLKPENI 139
Query: 655 LLDNDMTAH----MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY 698
+L + + + DFG+ I K G TPE+
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHKIEA--------GNEFKNIFG--TPEF 177
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 30/141 (21%), Positives = 58/141 (41%), Gaps = 18/141 (12%)
Query: 571 ALRNIR-------HRNLVKIITACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFL 620
R I H N+V ++ + + Y LV+++M H + + IL +
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVY---LVFDYMETDLHAVIRA--NILEPV 109
Query: 621 RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680
+ + + ++YLH ++H D+KPSN+LL+ + + DFGL+R +
Sbjct: 110 HKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 681 QCSSVGLKGTVGYATPEYGIL 701
+ + + IL
Sbjct: 167 NNIPLSINENTENFDDDQPIL 187
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 29/118 (24%), Positives = 50/118 (42%), Gaps = 15/118 (12%)
Query: 587 CSTSDFQGNYFRALVYEFMHHG-SLES----CPRILSFLRRLNIAIDVASALEYLHHHCK 641
D G +R ++ + G L+ + S L +++ + LEY+H H
Sbjct: 116 SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE- 172
Query: 642 KPIVHCDLKPSNVLLD--NDMTAHMGDFGL-TRFIPEVMSS--NQCSSVGLKGTVGYA 694
VH D+K SN+LL+ N ++ D+GL R+ PE + GT+ +
Sbjct: 173 --YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 31/148 (20%), Positives = 54/148 (36%), Gaps = 36/148 (24%)
Query: 211 NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANF 270
+ ++S + L + N++ + L + N L SL N + + N L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRIL---SLGRNLIK-KIEN-LDAV 91
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
+ L L++S N I+ +L + L+ L+VL + N
Sbjct: 92 ADTLEELWISYNQIA--------SLSGI------------------EKLVNLRVLYMSNN 125
Query: 331 NIS--REIPSSLGNFTFLTELNLCGNSI 356
I+ EI L L +L L GN +
Sbjct: 126 KITNWGEI-DKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 18/119 (15%)
Query: 194 TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253
+ N+RIL L N I + + A LE L + N + L + L V+
Sbjct: 68 GMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQI-----ASLSGIEKLVNLRVLY 121
Query: 254 LSVNSLSGTLP-NSLANFSSHLRYLYMSANPISGSIPTE----------IGNLKNLIII 301
+S N ++ + LA L L ++ NP+ + L NL +
Sbjct: 122 MSNNKITNWGEIDKLAAL-DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/110 (29%), Positives = 47/110 (42%), Gaps = 21/110 (19%)
Query: 194 TLPNVRILLLAGNQFFGNIPHSISNAS---KLEWLDFANNSLTGLIPEDLDSLVNCTYLE 250
TL + L L+ N IS+ S L L N + + E+LD++ + LE
Sbjct: 46 TLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKKI--ENLDAVADT--LE 96
Query: 251 VVSLSVNSLSGTLPNSLANFSSH--LRYLYMSANPISGSIPTEIGNLKNL 298
+ +S N ++ SL+ LR LYMS N I+ EI L L
Sbjct: 97 ELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITN--WGEIDKLAAL 139
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 320 LKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNH 378
+ L I + + ++L L L N+I S+L L L L N
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNL 81
Query: 379 LTGPIPLAVGNPKSIPHLDLSKNELS 404
+ L ++ L +S N+++
Sbjct: 82 IKKIENLD-AVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 6/97 (6%)
Query: 309 IRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH 368
I + ++ L + L+L NNI + I SSL L L+L N I+ + +
Sbjct: 37 IEKMDATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRNLIK-KIENLDAVAD 93
Query: 369 QL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
L L +S+N + + ++ L +S N+++
Sbjct: 94 TLEELWISYNQIASLSGIE--KLVNLRVLYMSNNKIT 128
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 8/137 (5%)
Query: 196 PNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
+ + L N IP S KL +D +NN ++ L P+ L + L L
Sbjct: 32 ETITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL---VL 87
Query: 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIEKFILIRNIP 313
N ++ LP SL L+ L ++AN I+ + + +L NL ++++ L
Sbjct: 88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAK 145
Query: 314 ISVGYLLKLQVLSLFEN 330
+ L +Q + L +N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 30/167 (17%), Positives = 54/167 (32%), Gaps = 39/167 (23%)
Query: 211 NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANF 270
N+P +I+ + N++ + P + LS N +S L
Sbjct: 29 NLPETITE------IRLEQNTIKVIPPGAFSPYKKLRRI---DLSNNQIS-ELAPDAFQG 78
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
L L + N I+ +P + F L LQ+L L N
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSL-------------F----------EGLFSLQLLLLNAN 114
Query: 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVP----SALGSCHQLWLD 373
I+ + + L L+L N ++ ++ S L + + L
Sbjct: 115 KINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLA 160
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 35/183 (19%), Positives = 65/183 (35%), Gaps = 37/183 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVL---------FLHQRGALKSFMAECQALRNIR----HRNLV 581
TV+ G D+ +A+KV+ L E L + H ++
Sbjct: 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGAGGGHPGVI 101
Query: 582 KIITACSTSDFQGNYFRALVYEFMHHGS-----LESCPRILSFLRRLNIAIDVASALEYL 636
+++ T + + LV E + + R V +A+++
Sbjct: 102 RLLDWFETQE---GFM--LVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155
Query: 637 HHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYAT 695
H +VH D+K N+L+D A + DFG + + ++ GT Y+
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD------GTRVYSP 206
Query: 696 PEY 698
PE+
Sbjct: 207 PEW 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 30/113 (26%), Positives = 48/113 (42%), Gaps = 15/113 (13%)
Query: 572 LRNIRHRNLVKIIT----ACSTSDFQGNYFRALVYEFMH---HGSLESCPRILSFLRRLN 624
L+++RH N++ ++ + DF Y LV FM ++ L R
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFY---LVMPFMGTDLGKLMKH--EKLGEDRIQF 132
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
+ + L Y+H I+H DLKP N+ ++ D + DFGL R M
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 27/137 (19%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRIL---SFLRR--LNIA 626
LR +H N++ + + +V E M G L +IL F R +
Sbjct: 70 LRYGQHPNIITLKDVYDDGK---YVY--VVTELMKGGELLD--KILRQKFFSEREASAVL 122
Query: 627 IDVASALEYLHHHCKKPIVHCDLKPSNVLL----DNDMTAHMGDFGLTRFI--PEVMSSN 680
+ +EYLH +VH DLKPSN+L N + + DFG + + +
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 681 QCSSVGLKGTVGYATPE 697
C T + PE
Sbjct: 180 PC------YTANFVAPE 190
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 50/178 (28%), Positives = 73/178 (41%), Gaps = 37/178 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V G L +AVK+L + + E Q L+ RH +++K+ ST
Sbjct: 25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84
Query: 592 FQGNYFRALVYEFMHHGSL-----------ESCPRILSFLRRLNIAIDVASALEYLHHHC 640
++F +V E++ G L E R +++ SA++Y H H
Sbjct: 85 ---DFF--MVMEYVSGGELFDYICKHGRVEEMEAR--RLFQQI------LSAVDYCHRHM 131
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR-FIPEVMSSNQCSSVGLKGTVGYATPE 697
+VH DLKP NVLLD M A + DFGL+ C G+ YA PE
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC------GSPNYAAPE 180
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITA-CSTSDFQG 594
V++ ++ +A+K + +R + E Q +R ++H N+V + S D +
Sbjct: 55 VVFQAK-LVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 595 NYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVA----------SALEYLHHHCKKPI 644
F LV E++ E+ R +L + + +L Y+H I
Sbjct: 110 EVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---I 162
Query: 645 VHCDLKPSNVLLD-NDMTAHMGDFGLTR-FIP-EVMSSNQCS 683
H D+KP N+LLD + DFG + I E S CS
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 38/175 (21%), Positives = 64/175 (36%), Gaps = 29/175 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHR-NLVKIITACSTSD 591
A V + I A K L +RG + E L + ++ +
Sbjct: 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV----- 97
Query: 592 FQGNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
++ L+ E+ G + ++S + + + + YLH + IVH
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVH 154
Query: 647 CDLKPSNVLLDNDMTAHM---GDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY 698
DLKP N+LL + DFG++R I + L+ +G TPEY
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--------ACELREIMG--TPEY 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 37/143 (25%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF---------MHHGSL-ESCPRIL 617
E L+ +RH +++K+ +T + +V E+ + + E R
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPT---DIV--MVIEYAGGELFDYIVEKKRMTEDEGR-- 111
Query: 618 SFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
F +++ A+EY H H IVH DLKP N+LLD+++ + DFGL
Sbjct: 112 RFFQQI------ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL-------- 154
Query: 678 SSNQCSSVGLK---GTVGYATPE 697
S+ LK G+ YA PE
Sbjct: 155 SNIMTDGNFLKTSCGSPNYAAPE 177
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 48/178 (26%), Positives = 72/178 (40%), Gaps = 37/178 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V G +L +AVK+L + + E Q L+ RH +++K+ ST
Sbjct: 30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSF---LRRLNIAIDVA--------SALEYLHHHC 640
+ F +V E++ G L F + + + S ++Y H H
Sbjct: 90 ---DIF--MVMEYVSGGEL--------FDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI-PEVMSSNQCSSVGLKGTVGYATPE 697
+VH DLKP NVLLD M A + DFGL+ + C G+ YA PE
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC------GSPNYAAPE 185
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 60/210 (28%), Positives = 88/210 (41%), Gaps = 61/210 (29%)
Query: 545 DQTFIAVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGN---YF 597
++ F AVKVL + ++ K M+E L +N++H LV + + FQ YF
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYF 116
Query: 598 RALVYEF------MHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
V ++ +H L+ L R A ++ASAL YLH IV+ DLKP
Sbjct: 117 ---VLDYINGGELFYH--LQRERCFLEPRARFYAA-EIASALGYLH---SLNIVYRDLKP 167
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ-----CSSVGLKGTVGYATPE--------- 697
N+LLD+ + DFGL + E + N C GT Y PE
Sbjct: 168 ENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFC------GTPEYLAPEVLHKQPYDR 218
Query: 698 ------YGILLLEIFTGKRP-----TSDMF 716
G +L E+ G P T++M+
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 28/108 (25%), Positives = 50/108 (46%), Gaps = 10/108 (9%)
Query: 572 LRNIRHRNLVKIIT----ACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAI 627
++ + H+N++ ++ + +FQ Y LV E M + L R +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVY---LVMELMDANLCQVIQMELDHERMSYLLY 171
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
+ +++LH I+H DLKPSN+++ +D T + DFGL R
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 28/116 (24%), Positives = 49/116 (42%), Gaps = 12/116 (10%)
Query: 587 CSTSDFQGNYFRALVYEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKP 643
++F+G +R +V E + L+ L + I + LEY+H +
Sbjct: 116 SGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--- 171
Query: 644 IVHCDLKPSNVLLD--NDMTAHMGDFGL-TRFIPEVMSSN--QCSSVGLKGTVGYA 694
VH D+K +N+LL N ++ D+GL R+ P + G GT+ +
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 32/113 (28%), Positives = 49/113 (43%), Gaps = 37/113 (32%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ-----CS 683
+A AL++LH I++ DLKP N+LLD + + DFGL++ E + + C
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFC- 187
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP-----TSDMF 716
GTV Y PE +G+L+ E+ TG P +
Sbjct: 188 -----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 24/115 (20%)
Query: 572 LRNIRHRNLVKIIT----ACSTSDFQGNYFRALVYEFMH-------HGSLESCPRILSFL 620
++ + H+N++ ++ S +FQ Y +V E M L+ R+ L
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVY---IVMELMDANLCQVIQMELDH-ERMSYLL 133
Query: 621 RRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675
++ +++LH I+H DLKPSN+++ +D T + DFGL R
Sbjct: 134 YQM------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 22/116 (18%)
Query: 572 LRNIRHRNLVKI----ITACSTSDFQGNYFRALVYEFM----HH--GSLESCPRILSFLR 621
L++++H N++ + A S +F Y LV FM G S +I +
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 622 RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677
++ L+Y+H +VH DLKP N+ ++ D + DFGL R M
Sbjct: 134 QM------LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 37/163 (22%), Positives = 52/163 (31%), Gaps = 36/163 (22%)
Query: 550 AVKVLFLHQRGALKSFMA----ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605
AVK++ E + + H N+VK + Q L E+
Sbjct: 36 AVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ-----YLFLEYC 87
Query: 606 HHGSLESCPRILSFLRRLNIAIDVA--------SALEYLHHHCKKPIVHCDLKPSNVLLD 657
G L RI + + A + + YLH I H D+KP N+LLD
Sbjct: 88 SGGELFD--RIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLD 139
Query: 658 NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVG---YATPE 697
+ DFGL + L G Y PE
Sbjct: 140 ERDNLKISDFGLAT-----VFRYNNRERLLNKMCGTLPYVAPE 177
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 35/186 (18%), Positives = 64/186 (34%), Gaps = 39/186 (20%)
Query: 188 PPHIGFTLPNVRILLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLVNC 246
P HI L L N+F I +L ++F+NN +T + +
Sbjct: 27 PEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 247 TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKF 306
+ L+ N L + + + L+ L + +N I+ + +
Sbjct: 84 NEI---LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI------------ 126
Query: 307 ILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGS 366
L +++LSL++N I+ P + L+ LNL N +
Sbjct: 127 -----------GLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN-------CN 168
Query: 367 CHQLWL 372
C+ WL
Sbjct: 169 CYLAWL 174
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 28/145 (19%), Positives = 52/145 (35%), Gaps = 15/145 (10%)
Query: 158 SLTGSIPIQLLNI-TSMEYFHVSENQLVGELPPHIGFT-LPNVRILLLAGNQFFGNIPHS 215
L IP +I ++ N+ L F LP +R + + N+ +I
Sbjct: 22 KLN-KIPE---HIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNK-ITDIEEG 75
Query: 216 I-SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHL 274
AS + + +N L + + L + L L N ++ + N S +
Sbjct: 76 AFEGASGVNEILLTSNRLENVQHKMFKGLESLKTL---MLRSNRIT-CVGNDSFIGLSSV 131
Query: 275 RYLYMSANPISGSIPTEI-GNLKNL 298
R L + N I+ ++ L +L
Sbjct: 132 RLLSLYDNQIT-TVAPGAFDTLHSL 155
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 27/154 (17%), Positives = 50/154 (32%), Gaps = 34/154 (22%)
Query: 225 LDFANNSLTGLIPEDL-DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283
L NN T L + L + + S N ++ + +S + + +++N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKI---NFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92
Query: 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF 343
+ ++ ++ K L L+ L L N I+ S
Sbjct: 93 LE-NVQHKM--FKGLE---------------------SLKTLMLRSNRITCVGNDSFIGL 128
Query: 344 TFLTELNLCGNSIRGSVP----SALGSCHQLWLD 373
+ + L+L N I +V L S L L
Sbjct: 129 SSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLL 161
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 50/192 (26%)
Query: 550 AVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFRALVYEF- 604
AVK+L + Q ++ M E + L + L ++ + FQ V E+
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDRLYFVMEYV 103
Query: 605 -----MHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND 659
M+H ++ R A ++A L +L K I++ DLK NV+LD++
Sbjct: 104 NGGDLMYH--IQQVGRFKEPHAVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE 157
Query: 660 MTAHMGDFGLTRFIPEVMSSNQ-----CSSVGLKGTVGYATPE---------------YG 699
+ DFG+ + E + C GT Y PE +G
Sbjct: 158 GHIKIADFGMCK---ENIWDGVTTKTFC------GTPDYIAPEIIAYQPYGKSVDWWAFG 208
Query: 700 ILLLEIFTGKRP 711
+LL E+ G+ P
Sbjct: 209 VLLYEMLAGQAP 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 47/210 (22%), Positives = 76/210 (36%), Gaps = 54/210 (25%)
Query: 532 LVKATVYKGILDLDQTFIAVKVL----FLHQRGALKSFMAECQALRNIRHRNLVKIITAC 587
V+ A+KVL + AE L ++H +V +I A
Sbjct: 35 QVRKVTGAN----TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA- 89
Query: 588 STSDFQGNYFRALVYEF------MHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCK 641
FQ L+ E+ LE + +A +++ AL +LH +
Sbjct: 90 ----FQTGGKLYLILEYLSGGELFMQ--LEREGIFMEDTACFYLA-EISMALGHLH---Q 139
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ-----CSSVGLKGTVGYATP 696
K I++ DLKP N++L++ + DFGL + E + C GT+ Y P
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFC------GTIEYMAP 190
Query: 697 E---------------YGILLLEIFTGKRP 711
E G L+ ++ TG P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 21/70 (30%), Positives = 27/70 (38%), Gaps = 11/70 (15%)
Query: 631 SALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGT 690
+ + YLH I H D+KP N+LLD + DFGL + L
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT-----VFRYNNRERLLNKM 167
Query: 691 VG---YATPE 697
G Y PE
Sbjct: 168 CGTLPYVAPE 177
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 39/143 (27%), Positives = 51/143 (35%), Gaps = 34/143 (23%)
Query: 568 ECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAI 627
E R++RH N+V+ T A++ E+ G L RI + R +
Sbjct: 66 EIINHRSLRHPNIVRFKEVILTPTHL-----AIIMEYASGGELYE--RICNA-GRFSE-- 115
Query: 628 DVA--------SALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHM--GDFGLTRFIPEVM 677
D A S + Y H I H DLK N LLD + DFG
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY-------- 164
Query: 678 SSNQCSSVGLKGTVG---YATPE 697
S + K TVG Y PE
Sbjct: 165 SKSSVLHSQPKSTVGTPAYIAPE 187
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 24/146 (16%), Positives = 44/146 (30%), Gaps = 38/146 (26%)
Query: 215 SISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS-- 272
+NA + LD + + E+L + + + S N + L F
Sbjct: 14 QYTNAVRDRELDLRGYKIPVI--ENLGA--TLDQFDAIDFSDNEIR-----KLDGFPLLR 64
Query: 273 HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNI 332
L+ L ++ N I L +L L L N++
Sbjct: 65 RLKTLLVNNNRICRIGEGLDQALPDL------------------------TELILTNNSL 100
Query: 333 S--REIPSSLGNFTFLTELNLCGNSI 356
++ L + LT L + N +
Sbjct: 101 VELGDL-DPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 24/141 (17%), Positives = 47/141 (33%), Gaps = 30/141 (21%)
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
R L L G + I + + + + +DF++N + L + L L +
Sbjct: 18 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL---V 71
Query: 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPI 314
+ N + + L L L ++ N + E+G+L L
Sbjct: 72 NNNRIC-RIGEGLDQALPDLTELILTNNSLV-----ELGDLDPL---------------- 109
Query: 315 SVGYLLKLQVLSLFENNISRE 335
L L L + N ++ +
Sbjct: 110 --ASLKSLTYLCILRNPVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 16/98 (16%), Positives = 29/98 (29%), Gaps = 5/98 (5%)
Query: 308 LIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSC 367
LI ++ + L L I I + ++ N IR
Sbjct: 8 LIEQAA-QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--KLDGFPLL 63
Query: 368 HQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
+L L +++N + + L L+ N L
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 13/100 (13%)
Query: 190 HIGFTLPNVRILLLAGNQF--FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247
++G TL + + N+ P +L+ L NN + + +L +
Sbjct: 36 NLGATLDQFDAIDFSDNEIRKLDGFPLL----RRLKTLLVNNNRICRIGEGLDQALPD-- 89
Query: 248 YLEVVSLSVNSLS--GTLPNSLANFSSHLRYLYMSANPIS 285
L + L+ NSL G L + LA+ L YL + NP++
Sbjct: 90 -LTELILTNNSLVELGDL-DPLASL-KSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 20/120 (16%), Positives = 31/120 (25%), Gaps = 28/120 (23%)
Query: 238 EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKN 297
E N + L + + +L + S N I ++
Sbjct: 10 EQAAQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEI-----RKLDGFPL 62
Query: 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357
L +L+ L + N I R LTEL L NS+
Sbjct: 63 LR---------------------RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 32/125 (25%), Positives = 59/125 (47%), Gaps = 29/125 (23%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLK 688
+ ALE+LH K I++ D+K N+LLD++ + DFGL++ E ++ +
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAYDFC 221
Query: 689 GTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731
GT+ Y P+ G+L+ E+ TG P FT + ++ +++
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEIS-- 275
Query: 732 DQILQ 736
+IL+
Sbjct: 276 RRILK 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 32/103 (31%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ-----CS 683
++ AL YLH ++ I++ DLK NVLLD++ + D+G+ + E + C
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC- 214
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE G+L+ E+ G+ P
Sbjct: 215 -----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 26/115 (22%), Positives = 41/115 (35%), Gaps = 19/115 (16%)
Query: 572 LRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRL-------N 624
R + ++V+I+ +V E + G L S RI +
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCL-LIVMECLDGGELFS--RIQDRGDQAFTEREASE 121
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPEV 676
I + A++YLH I H D+KP N+L + + DFG E
Sbjct: 122 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA---KET 170
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 32/103 (31%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ-----CS 683
++ AL YLH ++ I++ DLK NVLLD++ + D+G+ + E + C
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFC- 171
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP 711
GT Y PE G+L+ E+ G+ P
Sbjct: 172 -----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 9e-07
Identities = 33/113 (29%), Positives = 47/113 (41%), Gaps = 37/113 (32%)
Query: 629 VASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ-----CS 683
+ SAL +LH K I++ DLK NVLLD++ + DFG+ + E + + C
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFC- 185
Query: 684 SVGLKGTVGYATPE---------------YGILLLEIFTGKRP-----TSDMF 716
GT Y PE G+LL E+ G P D+F
Sbjct: 186 -----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 32/146 (21%), Positives = 57/146 (39%), Gaps = 25/146 (17%)
Query: 552 KVLFLHQRGALKSFMAECQALRNIRHRNLVKII------------TACSTSDFQGNYFRA 599
K++ + + E + +R + H N+VK+ S ++ Y
Sbjct: 43 KIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY--- 98
Query: 600 LVYEFMH---HGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
+V E+M LE L + L+Y+H ++H DLKP+N+ +
Sbjct: 99 IVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFI 153
Query: 657 D-NDMTAHMGDFGLTRFIPEVMSSNQ 681
+ D+ +GDFGL R + S
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKG 179
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 49/205 (23%), Positives = 74/205 (36%), Gaps = 61/205 (29%)
Query: 550 AVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGN---YFRALVY 602
A+K L + ++ M E + L H L + FQ +F V
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKENLFF---VM 97
Query: 603 EF------MHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656
E+ M+H R A ++ L++LH K IV+ DLK N+LL
Sbjct: 98 EYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILL 151
Query: 657 DNDMTAHMGDFGLTRFIPEVMSSNQ-----CSSVGLKGTVGYATPE-------------- 697
D D + DFG+ + E M + C GT Y PE
Sbjct: 152 DKDGHIKIADFGMCK---ENMLGDAKTNTFC------GTPDYIAPEILLGQKYNHSVDWW 202
Query: 698 -YGILLLEIFTGKRP-----TSDMF 716
+G+LL E+ G+ P ++F
Sbjct: 203 SFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 29/150 (19%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 556 LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG-SLES-- 612
QR A + + + L + + + + +R LV + G SL+S
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMG----FGVHQDKYRFLVLPSL--GRSLQSAL 148
Query: 613 --CPR-ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL--DNDMTAHMGDF 667
P+ +LS L +A + ALE+LH + VH ++ N+ + ++ + +
Sbjct: 149 DVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 668 GL-TRFIPEV--MSSNQCSSVGLKGTVGYA 694
G R+ P ++ + S +G + +
Sbjct: 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 26/151 (17%), Positives = 55/151 (36%), Gaps = 36/151 (23%)
Query: 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660
+ + P L ++++ I+ + L+Y+H C I+H D+KP NVL++
Sbjct: 116 LLALIKKYEHRGIP--LIYVKQ--ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169
Query: 661 TAH------MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YG 699
+ + D G + E +++ + Y +PE
Sbjct: 170 SPENLIQIKIADLGNACWYDEHYTNSIQTRE-------YRSPEVLLGAPWGCGADIWSTA 222
Query: 700 ILLLEIFTGKR--PTSDMFTEGLDLHNFVKM 728
L+ E+ TG + + D + ++
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 32/147 (21%), Positives = 52/147 (35%), Gaps = 30/147 (20%)
Query: 190 HIGFTLPNVRILLLAGNQF-FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY 248
T +V+ L+L ++ G + +LE+L N LT + +L
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNK 65
Query: 249 LEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL 308
L+ + LS N +SG L + L +L +S N I + I LK L
Sbjct: 66 LKKLELSDNRVSGGLEVLAEKCPN-LTHLNLSGNKIKD--LSTIEPLKKLE--------- 113
Query: 309 IRNIPISVGYLLKLQVLSLFENNISRE 335
L+ L LF ++
Sbjct: 114 ------------NLKSLDLFNCEVTNL 128
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 18/86 (20%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 321 KLQVLSLFENNISR-EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNH 378
++ L L + + ++ F L L+ + S+ + L ++L L+LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75
Query: 379 LTGPIPLAVGNPKSIPHLDLSKNELS 404
++G + + ++ HL+LS N++
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 45/184 (24%), Positives = 68/184 (36%), Gaps = 37/184 (20%)
Query: 223 EWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN 282
E LD + L L L T+L +L N L TL + + + L L ++ N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWL---NLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93
Query: 283 PISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGN 342
++ S+P + + +L +L L L N + +PS G
Sbjct: 94 QLA-SLPLGVFD-----------------------HLTQLDKLYLGGNQLKS-LPS--GV 126
Query: 343 F---TFLTELNLCGNSIRGSVPS-ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLD 397
F T L EL L N ++ S+P+ A L L LS N L A + +
Sbjct: 127 FDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 398 LSKN 401
L N
Sbjct: 186 LFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 41/167 (24%), Positives = 59/167 (35%), Gaps = 22/167 (13%)
Query: 197 NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSV 256
+ L L + +KL WL+ N L L D L L + L+
Sbjct: 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGLAN 92
Query: 257 NSLSGTLPNSLANFSSHLRYLYMSANPISGSIP----TEIGNLKNLIIIAIEKFILIRN- 311
N L+ +LP + + + L LY+ N + S+P + LK L L N
Sbjct: 93 NQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL--------RLNTNQ 142
Query: 312 ---IPISV-GYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGN 354
IP L LQ LSL N + + L + L GN
Sbjct: 143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 33/112 (29%), Positives = 50/112 (44%), Gaps = 15/112 (13%)
Query: 197 NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSV 256
+V L L GNQF +P +SN L +D +NN ++ L + ++ L LS
Sbjct: 32 DVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL---ILSY 87
Query: 257 NSLSGTLP----NSLANFSSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAI 303
N L +P + L + LR L + N IS +P +L L +AI
Sbjct: 88 NRLR-CIPPRTFDGLKS----LRLLSLHGNDIS-VVPEGAFNDLSALSHLAI 133
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 32/201 (15%), Positives = 75/201 (37%), Gaps = 13/201 (6%)
Query: 190 HIGFTLPNVRILLLAGNQFFGN--IPHSISNASKLEWLDFANNSLTGLIPEDLDSLV-NC 246
I + N ++L+L+ + F + + L+ LD + + + L
Sbjct: 124 LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183
Query: 247 TYLEVVSLS--VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIE 304
T L +++S + +S + L +L+ L ++ + T + L +
Sbjct: 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG 243
Query: 305 KFILIRN------IPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358
+ + +++ +L+ LS F + + +P+ + LT LNL +++
Sbjct: 244 GYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQS 303
Query: 359 -SVPSALGSCHQL-WLDLSHN 377
+ L C +L L +
Sbjct: 304 YDLVKLLCQCPKLQRLWVLDY 324
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 33/147 (22%), Positives = 50/147 (34%), Gaps = 30/147 (20%)
Query: 190 HIGFTLPNVRILLLAGNQF-FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY 248
T VR L+L + G I + LE+L N L + +L L
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75
Query: 249 LEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL 308
LE LS N + + LA +L +L +S N + +I L+ L
Sbjct: 76 LE---LSENRIF-GGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPL---------- 116
Query: 309 IRNIPISVGYLLKLQVLSLFENNISRE 335
L L+ L LF ++
Sbjct: 117 --------KKLECLKSLDLFNCEVTNL 135
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 324 VLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGP 382
VL ++N +I F L L+L + SV S L +L L+LS N + G
Sbjct: 30 VLDNCKSNDG-KIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86
Query: 383 IPLAVGNPKSIPHLDLSKNELS 404
+ + ++ HL+LS N+L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLK 108
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 34/174 (19%), Positives = 65/174 (37%), Gaps = 34/174 (19%)
Query: 545 DQTFIAVKVLFLHQRGALKSFMAECQALRNIR-----HRNLVKIITACSTSDFQGNY--F 597
+ F+A+KV+ + ++ + E + L+++R N ++ G
Sbjct: 61 GKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH 119
Query: 598 RALVYEFMHHGSLESCPRILSFLRRLN-----------IAIDVASALEYLHHHCKKPIVH 646
+V+E + H L L ++ + N I V L+YLH C+ I+H
Sbjct: 120 ICMVFEVLGH-HL------LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIH 170
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGI 700
D+KP N+LL + + + R E + + G+ P
Sbjct: 171 TDIKPENILL------SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/169 (21%), Positives = 64/169 (37%), Gaps = 27/169 (15%)
Query: 519 SRKDLLLNVSYESLVK------ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQAL 572
S L++ ++ K + G ++A+K + E +
Sbjct: 1 SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFY 58
Query: 573 RNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHHG-SLE----SCPRILSFLRRLNIAI 627
+ + + + + G Y A+V E + G SLE C R S L IAI
Sbjct: 59 KQLGSGDGIPQVYYFGP---CGKY-NAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAI 112
Query: 628 DVASALEYLHHHCKKPIVHCDLKPSNVLL-----DNDMTAHMGDFGLTR 671
+ S +EY+H K +++ D+KP N L+ H+ DF L +
Sbjct: 113 QLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 34/130 (26%), Positives = 51/130 (39%), Gaps = 39/130 (30%)
Query: 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660
+YE + + L +R+ A + L+ LH + I+HCDLKP N+LL
Sbjct: 185 LYELIKKNKFQGFS--LPLVRK--FAHSILQCLDALHKNR---IIHCDLKPENILLKQQG 237
Query: 661 TAHM--GDFGL-------------TRF--IPEVMSSNQCSSVGLKGTVGYATP----EYG 699
+ + DFG +RF PEV+ +G Y P G
Sbjct: 238 RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVI-------LGA----RYGMPIDMWSLG 286
Query: 700 ILLLEIFTGK 709
+L E+ TG
Sbjct: 287 CILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 19/114 (16%)
Query: 593 QGNYFRALVYEFMHHGSLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
+G+Y +V E + SLE C R S L +A + S +EY+H +H D
Sbjct: 76 EGDY-NVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130
Query: 649 LKPSNVLLDNDMTAH---MGDFGL-TRFIPEVMSSNQC----SSVGLKGTVGYA 694
+KP N L+ + + DFGL ++ ++Q + L GT YA
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYR--DARTHQHIPYRENKNLTGTARYA 182
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 25/128 (19%), Positives = 46/128 (35%), Gaps = 14/128 (10%)
Query: 319 LLKLQVLSLFENNIS----REIPSSL-GNFTFLTELNLCGNSIRGS----VPSALGSCHQ 369
L+ + L L N++ +++ L + +T L L N + + + L
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 370 L-WLDLSHNHLT--GPIPLAVG--NPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKL 424
+ L L H L G LA + + L+++ N +LA L
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELL 244
Query: 425 NLSYNNLD 432
+L +N L
Sbjct: 245 HLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 35/178 (19%), Positives = 59/178 (33%), Gaps = 37/178 (20%)
Query: 217 SNASKLEWLDFANNSLTGLIPEDLDSLVNC-TYLEVVSLSVNSLSGT----LPNSLANFS 271
S L+ ++ A+ L P L +L+ + L +NSL L + L +
Sbjct: 98 SGRHALDEVNLASCQLD---PAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQ 154
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
+ L +S NP++ + + L N + LSL
Sbjct: 155 CQITTLRLSNNPLTAAGVAVLME------------GLAGNT--------SVTHLSLLHTG 194
Query: 332 ISRE----IPSSLGNFTFLTELNLCGNSIRGS----VPSALGSCHQL-WLDLSHNHLT 380
+ E + + L L ELN+ N + + A L L L N L+
Sbjct: 195 LGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 32/146 (21%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKII-TACSTSDFQ 593
V++ I + + VK+L ++ K E + L N+R N++ +
Sbjct: 51 EVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRT 107
Query: 594 GNYFRALVYEFMHHGSLESCPRILS------FLRRLNIAIDVASALEYLHHHCKKPIVHC 647
ALV+E +++ + + L+ ++ + AL+Y H I+H
Sbjct: 108 ----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI------LKALDYCHSMG---IMHR 154
Query: 648 DLKPSNVLLDND-MTAHMGDFGLTRF 672
D+KP NV++D++ + D+GL F
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEF 180
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 20/131 (15%), Positives = 36/131 (27%), Gaps = 15/131 (11%)
Query: 319 LLKLQVLSLFENNISREIPSSLG--NFTFLTELNLCGNSIRGSVPSALGSCHQL------ 370
L+ L + + + + + L +L L + L
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 371 ----WLDLSHNHLTGPIPLAVGNPKSIPHL---DLSKNELSGEIPSSLAWIFGYISIFAK 423
WL + + +P L D+S L+ E L I
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 424 LNLSYNNLDGD 434
+N+ YN L +
Sbjct: 312 INMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 7e-05
Identities = 23/116 (19%), Positives = 36/116 (31%), Gaps = 17/116 (14%)
Query: 314 ISVGYLLKLQVLSLF---ENNISREIPSSL------GNFTFLTELNLCGNSIRGSVPSAL 364
I L L+ L L+ E+ + F L L + + V
Sbjct: 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272
Query: 365 GSCHQL----WLDLSHNHLT--GPIPLAVGNP--KSIPHLDLSKNELSGEIPSSLA 412
L +D+S LT G L K + +++ N LS E+ L
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 6e-04
Identities = 25/221 (11%), Positives = 60/221 (27%), Gaps = 32/221 (14%)
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
E ++ + L + +L + N+ L+ L+
Sbjct: 141 FEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEI 200
Query: 228 ANNSLTGLIPEDLDS--LVNCTYLEVVSLSVNSLSGTLPNSLANFSS-----HLRYLYMS 280
+ L + ED+ L N L + + N S +L++L +
Sbjct: 201 ISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIV 260
Query: 281 ANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS----REI 336
+ L +L+ + + ++ R +
Sbjct: 261 DAEEQNVVVEMFLESDILP---------------------QLETMDISAGVLTDEGARLL 299
Query: 337 PSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHN 377
+ L +N+ N + + L + +D+S +
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDS 340
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 7/79 (8%)
Query: 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660
+EF+ + + P L +R +A + AL +LH + + H DLKP N+L N
Sbjct: 108 TFEFLKENNFQPYP--LPHVRH--MAYQLCHALRFLHENQ---LTHTDLKPENILFVNSE 160
Query: 661 TAHMGDFGLTRFIPEVMSS 679
+ + + V ++
Sbjct: 161 FETLYNEHKSCEEKSVKNT 179
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 5/65 (7%)
Query: 617 LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH--MGDFGLTRFIP 674
L+ R+ A + +AL +L + I+HCDLKP N+LL N + + DFG + +
Sbjct: 156 LNLTRK--FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
Query: 675 EVMSS 679
+ +
Sbjct: 213 QRIYQ 217
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 27/104 (25%)
Query: 609 SLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTA-- 662
SLE C R S A + + ++ +H +K +V+ D+KP N L+ +
Sbjct: 91 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNA 147
Query: 663 ---HMGDFGLTRF---------IPEVMSSNQCSSVGLKGTVGYA 694
++ DFG+ +F IP L GT Y
Sbjct: 148 NMIYVVDFGMVKFYRDPVTKQHIP------YREKKNLSGTARYM 185
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 7/88 (7%)
Query: 601 VYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660
+YE + + + ++ I++ AL YL + H DLKP N+LLD+
Sbjct: 122 LYEIITRNNYNGFH--IEDIKL--YCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174
Query: 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLK 688
+ + + S G+K
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIK 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 14/74 (18%), Positives = 25/74 (33%), Gaps = 4/74 (5%)
Query: 600 LVYEFMHHGSL--ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657
+V EF G + ++ S +I + ++L + H DL NVLL
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLK 196
Query: 658 NDMTAHMGDFGLTR 671
+ +
Sbjct: 197 KTSLKKLHYTLNGK 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 19/114 (16%)
Query: 593 QGNYFRALVYEFMHHGSLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
+G+Y LV + + SLE C R LS L +A + + +E++H K +H D
Sbjct: 74 EGDY-NVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 649 LKPSNVLLDNDMTAH---MGDFGLT-RFIPEVMSSNQC----SSVGLKGTVGYA 694
+KP N L+ A+ + DFGL ++ S++Q + L GT YA
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYR--DTSTHQHIPYRENKNLTGTARYA 180
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 18/95 (18%), Positives = 38/95 (40%), Gaps = 1/95 (1%)
Query: 287 SIPTEIGNLKNLIIIAIEKFILIRNIP-ISVGYLLKLQVLSLFENNISREIPSSLGNFTF 345
+ +NL + IE ++++ + L +L+ L++ ++ + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 346 LTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLT 380
L+ LNL N++ + L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 23/106 (21%), Positives = 35/106 (33%), Gaps = 12/106 (11%)
Query: 330 NNISREIPSSLGNFTFLTELNLCGNSIRGSVPS-ALGSCHQLW-LDLSHNHLTGPIPLAV 387
+ + + L LTEL + + L +L L + + L P A
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
+ L+LS N L SL+W L+L L G
Sbjct: 77 HFTPRLSRLNLSFNAL-----ESLSW-----KTVQGLSLQELVLSG 112
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 26/176 (14%), Positives = 56/176 (31%), Gaps = 47/176 (26%)
Query: 536 TVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIIT--------AC 587
V + A+K + R + E ++ + H N++K++
Sbjct: 22 IVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFYTTGDEEP 77
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAID------------------- 628
++ + + +S S + LN+ ++
Sbjct: 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRS 137
Query: 629 ------------VASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTR 671
+ A+ ++H I H D+KP N+L++ D T + DFG +
Sbjct: 138 IPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 15/139 (10%)
Query: 197 NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSV 256
N +IL L NQ P + L+ L +N L L DSL T L L
Sbjct: 41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL---DLGT 97
Query: 257 NSLSGTLPN----SLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI 312
N L+ LP+ L + L+ L+M N ++ +P I L +L +A+++ L ++I
Sbjct: 98 NQLT-VLPSAVFDRLVH----LKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSI 150
Query: 313 PISV-GYLLKLQVLSLFEN 330
P L L LF N
Sbjct: 151 PHGAFDRLSSLTHAYLFGN 169
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 9e-04
Identities = 11/56 (19%), Positives = 24/56 (42%), Gaps = 3/56 (5%)
Query: 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679
+A + ++ +LH + + H DLKP N+L + + R +++
Sbjct: 122 KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 771 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.65 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.34 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.0 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.74 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.7 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.6 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.31 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.28 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.13 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.75 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.15 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.11 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.97 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.87 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.97 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.67 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.91 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.91 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.72 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.95 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.9 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-61 Score=572.62 Aligned_cols=457 Identities=30% Similarity=0.485 Sum_probs=306.2
Q ss_pred CccHHHHHHHHhcCCCCCCCCCCCCCCCCCCccceeeeecCCCCcEEEEEcCCCCCccc---CC----------------
Q 041479 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGT---AS---------------- 61 (771)
Q Consensus 1 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~---~~---------------- 61 (771)
|+|++|||+||+++. ||. .+++|..++|||+|.||+|+ .++|+.|||+++.+.|. +|
T Consensus 11 ~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~ 86 (768)
T 3rgz_A 11 YREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSN 86 (768)
T ss_dssp HHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTT
T ss_pred HHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcC
Confidence 468999999999996 677 89999888899999999998 37999999999888875 32
Q ss_pred -------ccccCCCCCcEEEcCCCcccccCCc--cccCCCCCCEEecccCcCcccCCccc--------------------
Q 041479 62 -------PYIGNLTFLRLINLQQNNFSSNIPH--EIGRLFRLRHIIFNSNALQGQIPDSR-------------------- 112 (771)
Q Consensus 62 -------~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------------- 112 (771)
+.|+.+++|++|||++|.+++.+|. .|+++++|++|+|++|.+++.+|...
T Consensus 87 ~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 166 (768)
T 3rgz_A 87 SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166 (768)
T ss_dssp SCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEE
T ss_pred CCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCc
Confidence 4677788888888888888877777 67777777777777666554333210
Q ss_pred ----------------------------------------ccCCcccc-----------------------cCCccccCC
Q 041479 113 ----------------------------------------LILNKLEG-----------------------NIPSELGSL 129 (771)
Q Consensus 113 ----------------------------------------l~~n~l~~-----------------------~~p~~~~~l 129 (771)
+..|++++ .+|..|+++
T Consensus 167 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l 246 (768)
T 3rgz_A 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTC 246 (768)
T ss_dssp THHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHTTTC
T ss_pred CChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHHhcC
Confidence 11222223 333334444
Q ss_pred CCCCEEecccccCcCC------------------------------CCccceeeecccccccccCccccCCCCCCEEecc
Q 041479 130 LKFKGLGLANNYFTGP------------------------------IPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVS 179 (771)
Q Consensus 130 ~~L~~L~Ls~N~l~~~------------------------------lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls 179 (771)
++|++|++++|++++. ++.|+.|+++.|.+++.+|..|.++++|++|+++
T Consensus 247 ~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 326 (768)
T 3rgz_A 247 TELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326 (768)
T ss_dssp SSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECC
T ss_pred CCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECC
Confidence 4444444444433321 1334555555555555555555566666666666
Q ss_pred cCcCcccCChhhhhCCCCCcEEEeecCccc--------------------------------------------------
Q 041479 180 ENQLVGELPPHIGFTLPNVRILLLAGNQFF-------------------------------------------------- 209 (771)
Q Consensus 180 ~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~-------------------------------------------------- 209 (771)
+|+++|.+|...+..+++|++|++++|+++
T Consensus 327 ~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l 406 (768)
T 3rgz_A 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406 (768)
T ss_dssp SSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEE
T ss_pred CCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcc
Confidence 666655555543224444444444444333
Q ss_pred -ccCCccccCCCCCCEEEccccccCCCCCcCccc---------------------ccCCCCCcEEEccCccccccCChhh
Q 041479 210 -GNIPHSISNASKLEWLDFANNSLTGLIPEDLDS---------------------LVNCTYLEVVSLSVNSLSGTLPNSL 267 (771)
Q Consensus 210 -~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---------------------l~~l~~L~~L~Ls~N~l~~~~p~~~ 267 (771)
+.+|..|.++++|++|+|++|++++.+|..|.. +..+++|++|++++|++++.+|..+
T Consensus 407 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l 486 (768)
T 3rgz_A 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486 (768)
T ss_dssp EEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred ccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHH
Confidence 334444445555555555555555554444311 1233444445555555554555555
Q ss_pred hhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCccc-------
Q 041479 268 ANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSL------- 340 (771)
Q Consensus 268 ~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------- 340 (771)
..+. +|++|++++|++++.+|..|+.+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|..+
T Consensus 487 ~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~ 565 (768)
T 3rgz_A 487 SNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI 565 (768)
T ss_dssp GGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCB
T ss_pred hcCC-CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchh
Confidence 5543 46666666666666666666666666666666666666666666666666666666666665555432
Q ss_pred ---------------------------------------------------------------ccccccccccccCccce
Q 041479 341 ---------------------------------------------------------------GNFTFLTELNLCGNSIR 357 (771)
Q Consensus 341 ---------------------------------------------------------------~~l~~L~~L~Ls~N~l~ 357 (771)
..+++|+.|||++|+++
T Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~ 645 (768)
T 3rgz_A 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645 (768)
T ss_dssp CCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCB
T ss_pred hhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccc
Confidence 23456777788888888
Q ss_pred ecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCC
Q 041479 358 GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436 (771)
Q Consensus 358 ~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p 436 (771)
|.+|..++.++.| .|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..+. .++.|+.|||++|+++|.+|
T Consensus 646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~----~l~~L~~L~ls~N~l~g~iP 721 (768)
T 3rgz_A 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS----ALTMLTEIDLSNNNLSGPIP 721 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGG----GCCCCSEEECCSSEEEEECC
T ss_pred ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHh----CCCCCCEEECcCCcccccCC
Confidence 8888888888888 899999999999999999999999999999999999998766 88999999999999999999
Q ss_pred ccccccccccccccCCCcccCCCCCCCCCCCCCC
Q 041479 437 RKMIFKNASAISEAGNEKLCGGISELKLPPCTPS 470 (771)
Q Consensus 437 ~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~~~~~ 470 (771)
...++.++...++.||+.+||.+ +++|.+.
T Consensus 722 ~~~~~~~~~~~~~~gN~~Lcg~~----l~~C~~~ 751 (768)
T 3rgz_A 722 EMGQFETFPPAKFLNNPGLCGYP----LPRCDPS 751 (768)
T ss_dssp SSSSGGGSCGGGGCSCTEEESTT----SCCCCSC
T ss_pred CchhhccCCHHHhcCCchhcCCC----CcCCCCC
Confidence 98889999999999999999975 3578654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=494.76 Aligned_cols=438 Identities=21% Similarity=0.279 Sum_probs=360.5
Q ss_pred ccHHHHHHHHhcCCCCCCC-------CCCCCCCCCCCccc---eeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCc
Q 041479 2 PDKQALLAFKSKVDDDPFG-------ALSTWNDSVNFCQW---LGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLR 71 (771)
Q Consensus 2 ~~~~~l~~~~~~~~~~~~~-------~~~~w~~~~~~c~w---~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~ 71 (771)
.|++||.+|++++..+.+. ..++|+.+++||.| .||+|+.. ++|+.|+|++|+++|.+|++|+.|++|+
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L~ 108 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELE 108 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTCC
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccce
Confidence 4889999999998665444 23489988999999 99999876 7999999999999999999999999999
Q ss_pred EEEcCCCc------------------------------------------------------------------------
Q 041479 72 LINLQQNN------------------------------------------------------------------------ 79 (771)
Q Consensus 72 ~L~Ls~N~------------------------------------------------------------------------ 79 (771)
+|+|++|.
T Consensus 109 ~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l 188 (636)
T 4eco_A 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188 (636)
T ss_dssp EEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTT
T ss_pred EEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhh
Confidence 99999994
Q ss_pred ------ccccCCccccCCCCCCEEecccCcCccc-CCcccc--cCCcccccCCcccc--CCCCCCEEecccccCcCCCC-
Q 041479 80 ------FSSNIPHEIGRLFRLRHIIFNSNALQGQ-IPDSRL--ILNKLEGNIPSELG--SLLKFKGLGLANNYFTGPIP- 147 (771)
Q Consensus 80 ------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~l--~~n~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~lp- 147 (771)
+++ +|.+|+++++|++|+|++|++++. ++..+. ..+...+.+|..++ ++++|++|+|++|++.+.+|
T Consensus 189 ~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp TCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred ccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH
Confidence 445 788899999999999999998762 221111 01122233888888 99999999999998886554
Q ss_pred ------ccceeeecccc-ccc-ccCccccCC------CCCCEEecccCcCcccCCh--hhhhCCCCCcEEEeecCccccc
Q 041479 148 ------HLNMFQVSVYS-LTG-SIPIQLLNI------TSMEYFHVSENQLVGELPP--HIGFTLPNVRILLLAGNQFFGN 211 (771)
Q Consensus 148 ------~L~~l~l~~n~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~g~lp~--~~~~~l~~L~~L~L~~N~l~~~ 211 (771)
.|+.|+++.|+ ++| .+|..+.++ ++|++|++++|+++ .+|. .+. .+++|+.|++++|+++|.
T Consensus 268 ~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~-~l~~L~~L~L~~N~l~g~ 345 (636)
T 4eco_A 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQ-KMKKLGMLECLYNQLEGK 345 (636)
T ss_dssp TTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHT-TCTTCCEEECCSCCCEEE
T ss_pred HHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhc-cCCCCCEEeCcCCcCccc
Confidence 58899999998 888 888888776 89999999999998 8988 665 889999999999999988
Q ss_pred CCccccCCCCCCEEEccccccCCCCCcCcccccCCCC-CcEEEccCccccccCChhhhhcc-cccceeecccCcCcccCc
Q 041479 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY-LEVVSLSVNSLSGTLPNSLANFS-SHLRYLYMSANPISGSIP 289 (771)
Q Consensus 212 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~-~~L~~L~Ls~N~l~~~~p 289 (771)
+| .|..+++|++|+|++|+++ .+|..+ .++++ |++|++++|+++ .+|..+.... ++|++|++++|++++.+|
T Consensus 346 ip-~~~~l~~L~~L~L~~N~l~-~lp~~l---~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p 419 (636)
T 4eco_A 346 LP-AFGSEIKLASLNLAYNQIT-EIPANF---CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419 (636)
T ss_dssp CC-CCEEEEEESEEECCSSEEE-ECCTTS---EEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTT
T ss_pred hh-hhCCCCCCCEEECCCCccc-cccHhh---hhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcch
Confidence 88 8999999999999999998 556555 67788 999999999998 7888765532 269999999999999888
Q ss_pred cccc-------ccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCc-ccccc-------cccccccccCc
Q 041479 290 TEIG-------NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPS-SLGNF-------TFLTELNLCGN 354 (771)
Q Consensus 290 ~~~~-------~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l-------~~L~~L~Ls~N 354 (771)
..|. .+++|+.|++++|.+.+..+..+..+++|++|+|++|+++ .+|. .+..+ ++|++|+|++|
T Consensus 420 ~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N 498 (636)
T 4eco_A 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFN 498 (636)
T ss_dssp CSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSS
T ss_pred hhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCC
Confidence 8888 7889999999999997544444567899999999999998 4554 44333 28999999999
Q ss_pred cceecCCcccc--cccce-eeecccCcccCCCCcCCCCCCCCCeEEC------CCCcccccCCcchhhhhcccccccEEE
Q 041479 355 SIRGSVPSALG--SCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDL------SKNELSGEIPSSLAWIFGYISIFAKLN 425 (771)
Q Consensus 355 ~l~~~~p~~~~--~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~l~~~~~~l~~L~~L~ 425 (771)
+|+ .+|..+. .++.| .|+|++|++++ +|..+..+++|++|+| ++|++.+.+|..+. .+++|+.|+
T Consensus 499 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~----~l~~L~~L~ 572 (636)
T 4eco_A 499 KLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT----LCPSLTQLQ 572 (636)
T ss_dssp CCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG----GCSSCCEEE
T ss_pred cCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHh----cCCCCCEEE
Confidence 999 6777776 88888 89999999997 7888889999999999 56788888898766 789999999
Q ss_pred CcCCCCCCCCCccccccccccccccCCCcccCC
Q 041479 426 LSYNNLDGDVPRKMIFKNASAISEAGNEKLCGG 458 (771)
Q Consensus 426 Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 458 (771)
|++|++ +.+|..+. .++..+.+.+|+..|-.
T Consensus 573 Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 573 IGSNDI-RKVNEKIT-PNISVLDIKDNPNISID 603 (636)
T ss_dssp CCSSCC-CBCCSCCC-TTCCEEECCSCTTCEEE
T ss_pred CCCCcC-CccCHhHh-CcCCEEECcCCCCcccc
Confidence 999999 67887644 77888888999887743
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=486.14 Aligned_cols=428 Identities=20% Similarity=0.267 Sum_probs=343.3
Q ss_pred ccHHHHHHHHhcCCCCCCCCCCCCCCCC-----CC--ccc------------eeeeecCCCCcEEEEEcCCCCCcccCCc
Q 041479 2 PDKQALLAFKSKVDDDPFGALSTWNDSV-----NF--CQW------------LGVTCSLKYQRVILLNLSGQNLTGTASP 62 (771)
Q Consensus 2 ~~~~~l~~~~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~~v~c~~~~~~l~~L~Ls~n~l~~~~~~ 62 (771)
+|++||++||+++. +| +|+.+. +| |+| .||+|+. .++|+.|+|++|+++|.+|+
T Consensus 269 ~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 269 KDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred HHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 58999999999984 44 786543 56 999 9999986 48999999999999999999
Q ss_pred cccCCCCCcEEEc-CCCccccc----------------------------------------------------------
Q 041479 63 YIGNLTFLRLINL-QQNNFSSN---------------------------------------------------------- 83 (771)
Q Consensus 63 ~~~~l~~L~~L~L-s~N~l~~~---------------------------------------------------------- 83 (771)
+|+.|++|++|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 88766544
Q ss_pred ------------------CCccccCCCCCCEEecccCcCcc-cCCccc--ccCCcccccCCcccc--CCCCCCEEecccc
Q 041479 84 ------------------IPHEIGRLFRLRHIIFNSNALQG-QIPDSR--LILNKLEGNIPSELG--SLLKFKGLGLANN 140 (771)
Q Consensus 84 ------------------~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~--l~~n~l~~~~p~~~~--~l~~L~~L~Ls~N 140 (771)
+|.+|+++++|++|+|++|+|++ .+|..+ ...|.+++.+|..++ ++++|+.|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 78899999999999999999987 233221 223556667888877 8999999999999
Q ss_pred cCcCCCC-------ccceeeecccc-ccc-ccCccccCCC-------CCCEEecccCcCcccCCh--hhhhCCCCCcEEE
Q 041479 141 YFTGPIP-------HLNMFQVSVYS-LTG-SIPIQLLNIT-------SMEYFHVSENQLVGELPP--HIGFTLPNVRILL 202 (771)
Q Consensus 141 ~l~~~lp-------~L~~l~l~~n~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~g~lp~--~~~~~l~~L~~L~ 202 (771)
.+.+.+| .|+.|+++.|+ ++| .+|..+.+++ +|++|+|++|+++ .+|. .+. .+++|+.|+
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~-~L~~L~~L~ 579 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQ-KMVKLGLLD 579 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHT-TCTTCCEEE
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhh-cCCCCCEEE
Confidence 8876555 58889999998 888 7887666554 8999999999998 8888 565 888999999
Q ss_pred eecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCC-CcEEEccCccccccCChhhhhcc-cccceeecc
Q 041479 203 LAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY-LEVVSLSVNSLSGTLPNSLANFS-SHLRYLYMS 280 (771)
Q Consensus 203 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~-~~L~~L~Ls 280 (771)
|++|+|+ .+| .|..+++|+.|+|++|+++ .+|..+ .++++ |+.|+|++|+++ .+|..+.... ++|+.|+|+
T Consensus 580 Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l---~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls 652 (876)
T 4ecn_A 580 CVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDF---CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFS 652 (876)
T ss_dssp CTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTS---CEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECC
T ss_pred CCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHH---hhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECc
Confidence 9999998 677 8888999999999999988 566555 67787 999999999988 7887765543 248899999
Q ss_pred cCcCcccCcccc---c--ccCCcceEecCCccceeccCccc-cCCCCCCEEEccCCcccccCCccccc--------cccc
Q 041479 281 ANPISGSIPTEI---G--NLKNLIIIAIEKFILIRNIPISV-GYLLKLQVLSLFENNISREIPSSLGN--------FTFL 346 (771)
Q Consensus 281 ~N~l~~~~p~~~---~--~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L 346 (771)
+|++++.+|... . .+.+|+.|++++|.+. .+|..+ ..+++|+.|+|++|+|+ .+|..+.. +++|
T Consensus 653 ~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L 730 (876)
T 4ecn_A 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL 730 (876)
T ss_dssp SSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGC
T ss_pred CCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCc
Confidence 999987666432 2 3458889999998887 455544 47889999999999998 55554433 2389
Q ss_pred ccccccCccceecCCcccc--cccce-eeecccCcccCCCCcCCCCCCCCCeEECCC------CcccccCCcchhhhhcc
Q 041479 347 TELNLCGNSIRGSVPSALG--SCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSK------NELSGEIPSSLAWIFGY 417 (771)
Q Consensus 347 ~~L~Ls~N~l~~~~p~~~~--~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~l~~~~~~ 417 (771)
+.|+|++|+|+ .+|..+. .++.| .|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..+. .
T Consensus 731 ~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~----~ 804 (876)
T 4ecn_A 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT----T 804 (876)
T ss_dssp CEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGG----G
T ss_pred cEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHh----c
Confidence 99999999998 6777776 78888 89999999987 688888899999999876 778888888765 7
Q ss_pred cccccEEECcCCCCCCCCCccccccccccccccCCCcc
Q 041479 418 ISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKL 455 (771)
Q Consensus 418 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l 455 (771)
+++|+.|+|++|++ +.+|..+ ..++..+.+.+|+..
T Consensus 805 L~~L~~L~Ls~N~L-~~Ip~~l-~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 805 CPSLIQLQIGSNDI-RKVDEKL-TPQLYILDIADNPNI 840 (876)
T ss_dssp CSSCCEEECCSSCC-CBCCSCC-CSSSCEEECCSCTTC
T ss_pred CCCCCEEECCCCCC-CccCHhh-cCCCCEEECCCCCCC
Confidence 88999999999999 6788764 367777788888754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=464.25 Aligned_cols=379 Identities=32% Similarity=0.505 Sum_probs=339.5
Q ss_pred CCCcEEEEEcCCCCCcccCCccccCC-CCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc---------
Q 041479 42 KYQRVILLNLSGQNLTGTASPYIGNL-TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------- 111 (771)
Q Consensus 42 ~~~~l~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--------- 111 (771)
...+++.|+|++|++++.+|..+..+ ++|++|+|++|++++.+|..|+++++|++|+|++|.++|.+|..
T Consensus 267 ~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~ 346 (768)
T 3rgz_A 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346 (768)
T ss_dssp CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCC
T ss_pred ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCC
Confidence 34678888888888888888887765 99999999999999889999999999999999999998877753
Q ss_pred --cccCCcccccCCccccCCC-CCCEEecccccCcCC---------CCccceeeecccccccccCccccCCCCCCEEecc
Q 041479 112 --RLILNKLEGNIPSELGSLL-KFKGLGLANNYFTGP---------IPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVS 179 (771)
Q Consensus 112 --~l~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~---------lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls 179 (771)
.+..|.+++.+|..+.+++ +|+.|++++|++++. .+.|+.|+++.|.+++.+|..+.++++|++|+++
T Consensus 347 ~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 426 (768)
T 3rgz_A 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426 (768)
T ss_dssp EEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECC
T ss_pred EEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECc
Confidence 2667888889999998887 899999999998753 4569999999999999999999999999999999
Q ss_pred cCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccc
Q 041479 180 ENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259 (771)
Q Consensus 180 ~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l 259 (771)
+|++++.+|..+. .+++|+.|++++|++++.+|..|..+++|++|+|++|++++.+|..+ .++++|++|+|++|++
T Consensus 427 ~N~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~L~~N~l 502 (768)
T 3rgz_A 427 FNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL---SNCTNLNWISLSNNRL 502 (768)
T ss_dssp SSEEESCCCGGGG-GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG---GGCTTCCEEECCSSCC
T ss_pred CCcccCcccHHHh-cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHH---hcCCCCCEEEccCCcc
Confidence 9999988888876 89999999999999999999999999999999999999999988877 7889999999999999
Q ss_pred cccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccc-----------------------
Q 041479 260 SGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISV----------------------- 316 (771)
Q Consensus 260 ~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~----------------------- 316 (771)
++.+|..+..+. +|++|++++|++++.+|..++++++|+.|++++|.+.+.+|..+
T Consensus 503 ~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (768)
T 3rgz_A 503 TGEIPKWIGRLE-NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKND 581 (768)
T ss_dssp CSCCCGGGGGCT-TCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECC
T ss_pred CCcCChHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccc
Confidence 999999999886 79999999999999999999999999999999999987777543
Q ss_pred -----------------------------------------------cCCCCCCEEEccCCcccccCCcccccccccccc
Q 041479 317 -----------------------------------------------GYLLKLQVLSLFENNISREIPSSLGNFTFLTEL 349 (771)
Q Consensus 317 -----------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 349 (771)
..+++|+.|||++|++++.+|..++.+++|+.|
T Consensus 582 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 661 (768)
T 3rgz_A 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661 (768)
T ss_dssp SCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEE
T ss_pred cccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEE
Confidence 335789999999999999999999999999999
Q ss_pred cccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcC
Q 041479 350 NLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSY 428 (771)
Q Consensus 350 ~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~ 428 (771)
+|++|+++|.+|..++.++.| .|||++|+++|.+|..++.+++|++|||++|+++|.+|..- .+..+....+.+
T Consensus 662 ~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~-----~~~~~~~~~~~g 736 (768)
T 3rgz_A 662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG-----QFETFPPAKFLN 736 (768)
T ss_dssp ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSS-----SGGGSCGGGGCS
T ss_pred eCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCch-----hhccCCHHHhcC
Confidence 999999999999999999999 99999999999999999999999999999999999999752 334444455667
Q ss_pred CC
Q 041479 429 NN 430 (771)
Q Consensus 429 N~ 430 (771)
|+
T Consensus 737 N~ 738 (768)
T 3rgz_A 737 NP 738 (768)
T ss_dssp CT
T ss_pred Cc
Confidence 75
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=429.61 Aligned_cols=404 Identities=20% Similarity=0.168 Sum_probs=304.7
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCc----------ccc
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD----------SRL 113 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----------~~l 113 (771)
.+++.|+|++|+++++.|.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|. ..+
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 5677777777777766666777777777777777777766666677777777777777766652111 123
Q ss_pred cCCcccccCCccccCCCCCCEEecccccCcC-------CCCc--------------------------------------
Q 041479 114 ILNKLEGNIPSELGSLLKFKGLGLANNYFTG-------PIPH-------------------------------------- 148 (771)
Q Consensus 114 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-------~lp~-------------------------------------- 148 (771)
..|.+++..+..+..+++|+.|++++|++++ .++.
T Consensus 137 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~ 216 (606)
T 3t6q_A 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLL 216 (606)
T ss_dssp CSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHH
T ss_pred CCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHH
Confidence 4445544332333335555555555555542 1222
Q ss_pred ---------------------------------------cceeeecccccccccCccccCCCCCCEEecccCcCcccCCh
Q 041479 149 ---------------------------------------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPP 189 (771)
Q Consensus 149 ---------------------------------------L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~ 189 (771)
++.++++.|.+++..+..|.++++|++|++++|+++ .+|+
T Consensus 217 ~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~ 295 (606)
T 3t6q_A 217 VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295 (606)
T ss_dssp HHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCS
T ss_pred HHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCCh
Confidence 334445555555555555777788888888888887 7887
Q ss_pred hhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccC--Chhh
Q 041479 190 HIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTL--PNSL 267 (771)
Q Consensus 190 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~--p~~~ 267 (771)
.+. .+++|++|++++|++++..|..+..+++|++|++++|.+.+.+|.. .+..+++|++|++++|.+++.. |..+
T Consensus 296 ~l~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 372 (606)
T 3t6q_A 296 GLV-GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG--CLENLENLRELDLSHDDIETSDCCNLQL 372 (606)
T ss_dssp SCC-SCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSS--TTTTCTTCCEEECCSSCCCEEEESTTTT
T ss_pred hhc-ccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchh--hhhccCcCCEEECCCCccccccCcchhc
Confidence 765 7888888888888888777788888888888888888887655542 2377888999999999988654 6677
Q ss_pred hhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCcc-ccCCCCCCEEEccCCcccccCCccccccccc
Q 041479 268 ANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPIS-VGYLLKLQVLSLFENNISREIPSSLGNFTFL 346 (771)
Q Consensus 268 ~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 346 (771)
..+. +|++|++++|++++..|..|..+++|+.|++++|.+.+..|.. +..+++|++|++++|++++..|..+..+++|
T Consensus 373 ~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 451 (606)
T 3t6q_A 373 RNLS-HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL 451 (606)
T ss_dssp TTCT-TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC
T ss_pred ccCC-CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC
Confidence 7775 7999999999999888889999999999999999988776654 8889999999999999988888889999999
Q ss_pred ccccccCccceec---CCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhccccccc
Q 041479 347 TELNLCGNSIRGS---VPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFA 422 (771)
Q Consensus 347 ~~L~Ls~N~l~~~---~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~ 422 (771)
++|++++|++++. .+..+..++.| .|++++|++++..|..|..+++|++|+|++|++++..|..+. .++.|
T Consensus 452 ~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~----~l~~L- 526 (606)
T 3t6q_A 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS----HLKGI- 526 (606)
T ss_dssp CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGT----TCCSC-
T ss_pred CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhC----ccccc-
Confidence 9999999999862 33568888888 899999999988899999999999999999999988887765 88889
Q ss_pred EEECcCCCCCCCCCccc-cccccccccccCCCcccC
Q 041479 423 KLNLSYNNLDGDVPRKM-IFKNASAISEAGNEKLCG 457 (771)
Q Consensus 423 ~L~Ls~N~l~~~~p~~~-~~~~~~~~~~~~n~~lc~ 457 (771)
.|+|++|++++.+|..+ ...++..+.+.+|++.|.
T Consensus 527 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 99999999997776643 356778889999998884
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=395.24 Aligned_cols=237 Identities=24% Similarity=0.302 Sum_probs=194.3
Q ss_pred cccccccccccccceEEEEEecC-----CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 522 DLLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+......+|+|.||+||+|++.. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~----- 88 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD----- 88 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----
Confidence 34445679999999999999753 46789999998766667789999999999999999999999998876
Q ss_pred eEEEEEEeccCCCCCCCc----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 041479 597 FRALVYEFMHHGSLESCP----------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~ 660 (771)
..|+|||||++|+|.++. ..++|.++.+|+.|+|+||+|||+. +|+||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 689999999999997762 3589999999999999999999985 899999999999999999
Q ss_pred ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHH
Q 041479 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHN 724 (771)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 724 (771)
.+||+|||+|+....... .......+||+.||||| |||++|||+| |+.||.+... ..+..
T Consensus 166 ~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~ 241 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIE 241 (299)
T ss_dssp CEEECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH
T ss_pred cEEECCcccceecCCCCc--eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence 999999999986654332 12223456999999999 7999999999 9999976432 22334
Q ss_pred HHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 725 FVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+........++.+++.+..++.+||+.||++||||.||++.|+++
T Consensus 242 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 4444433444556677777788899999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=400.06 Aligned_cols=238 Identities=23% Similarity=0.338 Sum_probs=190.2
Q ss_pred ccccccccccccccceEEEEEecC-----CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 521 KDLLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
.+......+|+|.||+||+|+++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR---- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 344455679999999999999763 56799999998776677789999999999999999999999998876
Q ss_pred eeEEEEEEeccCCCCCCC------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 041479 596 YFRALVYEFMHHGSLESC------------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~ 657 (771)
..|||||||++|+|.++ ...++|.++..|+.|||+||+|||+. +||||||||+|||++
T Consensus 117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 68999999999999764 13589999999999999999999985 899999999999999
Q ss_pred CCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCcc
Q 041479 658 NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLD 721 (771)
Q Consensus 658 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~ 721 (771)
+++.+||+|||+|+....... .......+||+.||||| |||++|||+| |+.||.+... ..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~ 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TE 268 (329)
T ss_dssp TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HH
T ss_pred CCCcEEEcccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HH
Confidence 999999999999987644322 12223457999999999 7999999999 8999976432 23
Q ss_pred HHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 722 LHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.+.+....+...++.+++.+..++.+||+.||++||||.||++.|+.+
T Consensus 269 ~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 3444444444455666777787888899999999999999999999876
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=424.79 Aligned_cols=411 Identities=18% Similarity=0.165 Sum_probs=331.5
Q ss_pred ceeeeecCC---------CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcC
Q 041479 34 WLGVTCSLK---------YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNAL 104 (771)
Q Consensus 34 w~~v~c~~~---------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 104 (771)
+..+.|... ..+++.|||++|+++++.|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 445777533 25799999999999999899999999999999999999998999999999999999999999
Q ss_pred cccCCccc----------ccCCcccccCCccccCCCCCCEEecccccCcCC-------CCccceeeecccccccccCccc
Q 041479 105 QGQIPDSR----------LILNKLEGNIPSELGSLLKFKGLGLANNYFTGP-------IPHLNMFQVSVYSLTGSIPIQL 167 (771)
Q Consensus 105 ~~~~p~~~----------l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-------lp~L~~l~l~~n~l~~~~p~~~ 167 (771)
++..|..+ +..|.+++..|..|+++++|++|++++|++++. ++.|+.|++++|.+++..|..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 87666432 667888877788899999999999999999852 3569999999999998888889
Q ss_pred cCCCCCC--EEecccCcCcccCChhhhhC-------------------------------------------------C-
Q 041479 168 LNITSME--YFHVSENQLVGELPPHIGFT-------------------------------------------------L- 195 (771)
Q Consensus 168 ~~l~~L~--~L~Ls~N~l~g~lp~~~~~~-------------------------------------------------l- 195 (771)
..+++|+ .|++++|.+++..| ..+.. +
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~-~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEP-GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECT-TTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccCh-hHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 9999999 89999999985433 33211 0
Q ss_pred -CCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhccccc
Q 041479 196 -PNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHL 274 (771)
Q Consensus 196 -~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 274 (771)
.+|+.|++++|++++..+..|..+++|++|++++|+++. +|..+ .++++|++|++++|++++..|..+..++ +|
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-lp~~l---~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L 327 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL---VGLSTLKKLVLSANKFENLCQISASNFP-SL 327 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSC-CCSSC---CSCTTCCEEECTTCCCSBGGGGCGGGCT-TC
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCC-CChhh---cccccCCEEECccCCcCcCchhhhhccC-cC
Confidence 167788888888888778888889999999999999884 45555 7778899999999998876677777775 78
Q ss_pred ceeecccCcCcccCcc-cccccCCcceEecCCccceecc--CccccCCCCCCEEEccCCcccccCCcccccccccccccc
Q 041479 275 RYLYMSANPISGSIPT-EIGNLKNLIIIAIEKFILIRNI--PISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNL 351 (771)
Q Consensus 275 ~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 351 (771)
++|++++|.+.+.+|. .|..+++|+.|++++|.+.+.. |..+..+++|++|++++|++++..|..|..+++|++|++
T Consensus 328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 407 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407 (606)
T ss_dssp SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence 8999998888866654 4888888888888888887665 777888888888888888888888888888888888888
Q ss_pred cCccceecCCc-ccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc-CC--cchhhhhcccccccEEEC
Q 041479 352 CGNSIRGSVPS-ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE-IP--SSLAWIFGYISIFAKLNL 426 (771)
Q Consensus 352 s~N~l~~~~p~-~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p--~~l~~~~~~l~~L~~L~L 426 (771)
++|++++..|. .+..++.| .|++++|.+++..|..|..+++|++|++++|++++. +| .. +..+++|+.|+|
T Consensus 408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----~~~l~~L~~L~L 483 (606)
T 3t6q_A 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS----LQTLGRLEILVL 483 (606)
T ss_dssp TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCG----GGGCTTCCEEEC
T ss_pred CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchh----hccCCCccEEEC
Confidence 88888876554 47788888 888888888888888888888888888888888762 22 33 337788888888
Q ss_pred cCCCCCCCCCccc-cccccccccccCCCc
Q 041479 427 SYNNLDGDVPRKM-IFKNASAISEAGNEK 454 (771)
Q Consensus 427 s~N~l~~~~p~~~-~~~~~~~~~~~~n~~ 454 (771)
++|++++..|..+ ...++..+.+.+|..
T Consensus 484 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCccChhhhccccCCCEEECCCCcc
Confidence 8888887666543 245566666666643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=440.36 Aligned_cols=412 Identities=20% Similarity=0.194 Sum_probs=289.3
Q ss_pred ccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccC-CccccCCCCCCEEecccCcCcccCCc
Q 041479 32 CQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNI-PHEIGRLFRLRHIIFNSNALQGQIPD 110 (771)
Q Consensus 32 c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 110 (771)
|+|..|-+ ...+++.|||++|.++++.|..|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 35666655 3367777777777777766666666666666666666443333 55666666666666666666654443
Q ss_pred cc----------ccCCcccccCCcc--ccCCCCCCEEecccccCcCC--------CCccceeeecccccccccC------
Q 041479 111 SR----------LILNKLEGNIPSE--LGSLLKFKGLGLANNYFTGP--------IPHLNMFQVSVYSLTGSIP------ 164 (771)
Q Consensus 111 ~~----------l~~n~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~--------lp~L~~l~l~~n~l~~~~p------ 164 (771)
.+ +..|.+++.+|.. |+++++|+.|+|++|++++. +++|+.|+++.|.+++..|
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 22 3444555444433 55555555555555555421 2335555555555544444
Q ss_pred --------------------ccccCCCC------CCEEecccCcCcccCChhhhhC------------------------
Q 041479 165 --------------------IQLLNITS------MEYFHVSENQLVGELPPHIGFT------------------------ 194 (771)
Q Consensus 165 --------------------~~~~~l~~------L~~L~Ls~N~l~g~lp~~~~~~------------------------ 194 (771)
..+..+.+ |+.|++++|.+++.+|..+...
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 33333333 6777777776665555433211
Q ss_pred -------------CCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccc
Q 041479 195 -------------LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG 261 (771)
Q Consensus 195 -------------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 261 (771)
.++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..| .++++|++|+|++|++++
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---~~l~~L~~L~Ls~N~l~~ 328 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF---YGLDNLQVLNLSYNLLGE 328 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTT---TTCSSCCEEEEESCCCSC
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHh---cCCCCCCEEECCCCCCCc
Confidence 2578888888888888888888888888888888888888777666 677888888888888886
Q ss_pred cCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceecc------------------Cc---------
Q 041479 262 TLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI------------------PI--------- 314 (771)
Q Consensus 262 ~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~------------------p~--------- 314 (771)
..|..+..++ +|++|++++|+|++..+..|.++++|+.|++++|.+.+.. |.
T Consensus 329 ~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ 407 (844)
T 3j0a_A 329 LYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH 407 (844)
T ss_dssp CCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEE
T ss_pred cCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceee
Confidence 6677777775 7888888888888777778888888888888888765321 10
Q ss_pred -------------cccCCCCCCEEEccCCcccccCCc-ccccccccccccccCccce-----ecCCcccccccce-eeec
Q 041479 315 -------------SVGYLLKLQVLSLFENNISREIPS-SLGNFTFLTELNLCGNSIR-----GSVPSALGSCHQL-WLDL 374 (771)
Q Consensus 315 -------------~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~l-~L~L 374 (771)
.+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|..++.| .|+|
T Consensus 408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L 487 (844)
T 3j0a_A 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487 (844)
T ss_dssp CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence 123567777777777777654333 3556778888888888886 3445668888888 8999
Q ss_pred ccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccccccccccccccCCCc
Q 041479 375 SHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEK 454 (771)
Q Consensus 375 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 454 (771)
++|+|++.+|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++..|.. +.++..+.+.+||+
T Consensus 488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~------~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~ 559 (844)
T 3j0a_A 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP------ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKF 559 (844)
T ss_dssp CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC------SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECC
T ss_pred CCCcccccChhHccchhhhheeECCCCCCCccChhhhh------ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCc
Confidence 99999999999999999999999999999976666532 78999999999999988865 45788889999999
Q ss_pred ccC
Q 041479 455 LCG 457 (771)
Q Consensus 455 lc~ 457 (771)
.|+
T Consensus 560 ~C~ 562 (844)
T 3j0a_A 560 ICE 562 (844)
T ss_dssp CCS
T ss_pred ccc
Confidence 984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=390.76 Aligned_cols=234 Identities=25% Similarity=0.345 Sum_probs=183.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+......+|+|++|+||+|+++. .||||+++... ....++|.+|++++++++|||||+++|++.+. ..|
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------~~~ 107 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------NLA 107 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCE
T ss_pred HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------eEE
Confidence 33445568999999999998753 59999996543 44567899999999999999999999998654 368
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||||||++|+|.++ ...++|.++..|+.|||+||+|||+. +||||||||+|||+++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999775 34689999999999999999999985 899999999999999999999999999987644
Q ss_pred ccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-C---c
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-D---Q 733 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~---~ 733 (771)
... .......+||+.||||| |||++|||+||+.||.+..... .+...+..... + .
T Consensus 185 ~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 185 WSG--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYASPDLSK 261 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCCCCSTT
T ss_pred CCc--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCCccc
Confidence 322 12233467999999999 7999999999999997643222 23333333322 2 2
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+++.+..++.+||+.||++||||.||++.|+.+
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3344556666777899999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=391.57 Aligned_cols=233 Identities=20% Similarity=0.244 Sum_probs=190.7
Q ss_pred cccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 526 NVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
...+|+|.||+||+|++. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+ ..+
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-----~~~ 105 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-----PLS 105 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-----EEE
Confidence 346999999999999974 356799999996543 344678999999999999999999999998776 579
Q ss_pred EEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 041479 600 LVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660 (771)
Q Consensus 600 lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~ 660 (771)
+|||||++|+|.++. ..++|.++.+|+.|||+||+|||+. +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999997652 3589999999999999999999996 899999999999999999
Q ss_pred ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHH
Q 041479 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHN 724 (771)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 724 (771)
.+||+|||+|+....... .......+||+.||||| |||++|||+| |+.||.+... ..+.+
T Consensus 183 ~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~ 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVE 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHH
T ss_pred CEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence 999999999987654332 12233457999999999 7999999999 8999976432 23444
Q ss_pred HHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 725 FVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+......+.++.+++.+..++.+||+.||++||||.||++.|+.+
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 4444444445556677777788899999999999999999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=421.45 Aligned_cols=404 Identities=20% Similarity=0.181 Sum_probs=300.2
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCccc----------c
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSR----------L 113 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------l 113 (771)
.+++.|+|++|++++..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|.+++..|..+ +
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 578888888888888877788888888888888888888778888888888888888888876555432 4
Q ss_pred cCCcccccCCccccCCCCCCEEecccccCcC-C-------CCccceeeecccccccccCccccCCCCCC----EEecccC
Q 041479 114 ILNKLEGNIPSELGSLLKFKGLGLANNYFTG-P-------IPHLNMFQVSVYSLTGSIPIQLLNITSME----YFHVSEN 181 (771)
Q Consensus 114 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~-------lp~L~~l~l~~n~l~~~~p~~~~~l~~L~----~L~Ls~N 181 (771)
..|.+++..|..|+++++|++|++++|++++ . +++|+.|++++|.+++..|..+..+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 4455555555666666666666666666653 2 33466666666666665555554443332 4555555
Q ss_pred cCcccCChhhhh--------------------------------------------------------------------
Q 041479 182 QLVGELPPHIGF-------------------------------------------------------------------- 193 (771)
Q Consensus 182 ~l~g~lp~~~~~-------------------------------------------------------------------- 193 (771)
.++ .+|+..+.
T Consensus 192 ~l~-~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 192 PID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCC-EECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred Ccc-eeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 444 33333321
Q ss_pred ------------CCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcC-----------------ccccc
Q 041479 194 ------------TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPED-----------------LDSLV 244 (771)
Q Consensus 194 ------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-----------------~~~l~ 244 (771)
.+++|+.|++++|.+. .+| .+..+++|+.|++++|.++ .+|.. -..+.
T Consensus 271 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~~~~~~~~ 347 (606)
T 3vq2_A 271 TNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGSISFKKV 347 (606)
T ss_dssp CTTCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSSCEECCCC
T ss_pred cccccccccccccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccCc-ccccCCCCccceeeccCCcCccchhhc
Confidence 1233333333333333 122 4555555666666666553 23310 00234
Q ss_pred CCCCCcEEEccCcccccc--CChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccC-ccccCCCC
Q 041479 245 NCTYLEVVSLSVNSLSGT--LPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP-ISVGYLLK 321 (771)
Q Consensus 245 ~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~ 321 (771)
.+++|++|++++|++++. +|..+..+. +|++|++++|.+++ +|..|.++++|+.|++++|.+.+..| ..+..+++
T Consensus 348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~-~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 425 (606)
T 3vq2_A 348 ALPSLSYLDLSRNALSFSGCCSYSDLGTN-SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425 (606)
T ss_dssp CCTTCCEEECCSSCEEEEEECCHHHHCCS-CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTT
T ss_pred cCCCCCEEECcCCccCCCcchhhhhccCC-cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcccc
Confidence 678888899999988855 377777775 79999999999984 66889999999999999999988887 68899999
Q ss_pred CCEEEccCCcccccCCcccccccccccccccCcccee-cCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECC
Q 041479 322 LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG-SVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLS 399 (771)
Q Consensus 322 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 399 (771)
|++|++++|++++..|..+..+++|++|++++|++++ .+|..++.++.| .|++++|++++..|..|..+++|++|+|+
T Consensus 426 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 505 (606)
T 3vq2_A 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505 (606)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECC
Confidence 9999999999998899999999999999999999997 478899999999 89999999999999999999999999999
Q ss_pred CCcccccCCcchhhhhcccccccEEECcCCCCCCCCCcccc-cc-ccccccccCCCcccCC
Q 041479 400 KNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMI-FK-NASAISEAGNEKLCGG 458 (771)
Q Consensus 400 ~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~-~~~~~~~~~n~~lc~~ 458 (771)
+|++++.+|..+. .+++|+.|+|++|+++ .+|..+. +. ++..+.+.+|++.|+.
T Consensus 506 ~N~l~~~~~~~~~----~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 506 HNNLLFLDSSHYN----QLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp SSCCSCEEGGGTT----TCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CCcCCCcCHHHcc----CCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 9999988888765 8899999999999998 5555432 32 4778899999999854
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=420.27 Aligned_cols=182 Identities=20% Similarity=0.163 Sum_probs=131.0
Q ss_pred ccceeecccCcCcccCcccccccCCcceEecCCccce--eccCccccCCCCCCEEEccCCcccccCCccccccccccccc
Q 041479 273 HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILI--RNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELN 350 (771)
Q Consensus 273 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 350 (771)
+|++|++++|++++..+..|..+++|+.|++++|.+. +.+|..+..+++|+.|++++|++++..|..|.++++|++|+
T Consensus 431 ~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~ 510 (680)
T 1ziw_A 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILD 510 (680)
T ss_dssp TCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEe
Confidence 3444444444444444444444444444444444443 34567777888888888888888877777788888888888
Q ss_pred ccCccceecCC--------cccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccc
Q 041479 351 LCGNSIRGSVP--------SALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIF 421 (771)
Q Consensus 351 Ls~N~l~~~~p--------~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L 421 (771)
|++|++++..+ ..+..++.| .|+|++|+++...+..|..+++|+.|+|++|+|++..+..+ ..+++|
T Consensus 511 Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~----~~l~~L 586 (680)
T 1ziw_A 511 LQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF----NNQVSL 586 (680)
T ss_dssp CCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT----TTCTTC
T ss_pred CCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHh----CCCCCC
Confidence 88888876432 236777778 88899998886666678999999999999999996555543 488999
Q ss_pred cEEECcCCCCCCCCCccc--cccccccccccCCCcccCC
Q 041479 422 AKLNLSYNNLDGDVPRKM--IFKNASAISEAGNEKLCGG 458 (771)
Q Consensus 422 ~~L~Ls~N~l~~~~p~~~--~~~~~~~~~~~~n~~lc~~ 458 (771)
+.|+|++|+|++..|..+ .+.++..+.+.+||+.|+-
T Consensus 587 ~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 587 KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp CEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred CEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 999999999997666544 3678888999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=379.12 Aligned_cols=230 Identities=21% Similarity=0.301 Sum_probs=187.0
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
..+|+|++|+||+|+++.+++.||||++.... ....++|.+|++++++++|||||+++++|.+.. .+....||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lvmEy 110 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEEEeC
Confidence 35899999999999999999999999996543 345678999999999999999999999986532 122367999999
Q ss_pred ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|++|+|.++ ...+++..+..++.||+.||+|||+. .++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 111 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---- 185 (290)
T 3fpq_A 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---- 185 (290)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----
Confidence 999999877 45689999999999999999999986 234999999999999984 789999999999854332
Q ss_pred ccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHH-HhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV-KMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 745 (771)
...+.+||+.||||| +||++|||+||+.||.+..... .+...+ ....|...+..+++.+..+
T Consensus 186 --~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred --ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 123468999999999 7999999999999997542222 222333 3333445566667777777
Q ss_pred CcccChhchhhcCCHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+||++||++|||+.|+++
T Consensus 263 i~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 263 IEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 88999999999999999985
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=396.63 Aligned_cols=374 Identities=18% Similarity=0.196 Sum_probs=317.2
Q ss_pred CCCcccee--eeecCCC--------CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccC-CccccCCCCCCEE
Q 041479 29 VNFCQWLG--VTCSLKY--------QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNI-PHEIGRLFRLRHI 97 (771)
Q Consensus 29 ~~~c~w~~--v~c~~~~--------~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L 97 (771)
...|.|.+ |.|+... .+++.|||++|++++..|..|+.+++|++|+|++|.+.+.+ |..|.++++|++|
T Consensus 5 ~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 5 TSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp --CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred cceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 34566665 7776543 57899999999999888889999999999999999987544 6679999999999
Q ss_pred ecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCc--cccCCCCCCE
Q 041479 98 IFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPI--QLLNITSMEY 175 (771)
Q Consensus 98 ~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~--~~~~l~~L~~ 175 (771)
+|++|+++ +..|..|+++++|++|+|++|++++ ..|. .+.++++|++
T Consensus 85 ~Ls~n~l~--------------~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~~~l~~L~~ 133 (455)
T 3v47_A 85 KLDYNQFL--------------QLETGAFNGLANLEVLTLTQCNLDG-----------------AVLSGNFFKPLTSLEM 133 (455)
T ss_dssp ECTTCTTC--------------EECTTTTTTCTTCCEEECTTSCCBT-----------------HHHHSSTTTTCTTCCE
T ss_pred eCCCCccC--------------ccChhhccCcccCCEEeCCCCCCCc-----------------cccCcccccCcccCCE
Confidence 99999865 4567788899999999999988874 2233 3888999999
Q ss_pred EecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCC--CCCCEEEccccccCCCCCcCcc-----cccCCCC
Q 041479 176 FHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNA--SKLEWLDFANNSLTGLIPEDLD-----SLVNCTY 248 (771)
Q Consensus 176 L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~-----~l~~l~~ 248 (771)
|+|++|++++..|..++..+++|++|++++|++++..|..+..+ .+|+.|++++|.+++..+..+. .+..+++
T Consensus 134 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~ 213 (455)
T 3v47_A 134 LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213 (455)
T ss_dssp EECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCE
T ss_pred EECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccce
Confidence 99999999966677756689999999999999999999988877 7899999999999987655431 2346789
Q ss_pred CcEEEccCccccccCChhhhhcc--cccceeecccCcCccc----------Cccccccc--CCcceEecCCccceeccCc
Q 041479 249 LEVVSLSVNSLSGTLPNSLANFS--SHLRYLYMSANPISGS----------IPTEIGNL--KNLIIIAIEKFILIRNIPI 314 (771)
Q Consensus 249 L~~L~Ls~N~l~~~~p~~~~~l~--~~L~~L~Ls~N~l~~~----------~p~~~~~l--~~L~~L~l~~n~l~~~~p~ 314 (771)
|++|++++|++++..|..+.... ++|+.|++++|.+.+. .+..|.++ ++|+.|++++|.+.+.+|.
T Consensus 214 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 293 (455)
T 3v47_A 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS 293 (455)
T ss_dssp EEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTT
T ss_pred eeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchh
Confidence 99999999999988888776641 3799999999866532 22233333 6899999999999999999
Q ss_pred cccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCC
Q 041479 315 SVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSI 393 (771)
Q Consensus 315 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L 393 (771)
.+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..++.| .|+|++|++++..|..|..+++|
T Consensus 294 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 373 (455)
T 3v47_A 294 VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373 (455)
T ss_dssp TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccc
Confidence 99999999999999999999889999999999999999999999989999999999 99999999999999999999999
Q ss_pred CeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCc
Q 041479 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 394 ~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
++|+|++|+|++..+..+ ..+++|+.|+|++|+++|.+|.
T Consensus 374 ~~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 374 KELALDTNQLKSVPDGIF----DRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CEEECCSSCCSCCCTTTT----TTCTTCCEEECCSSCBCCCTTT
T ss_pred cEEECCCCccccCCHhHh----ccCCcccEEEccCCCcccCCCc
Confidence 999999999997655544 4889999999999999999995
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=384.35 Aligned_cols=231 Identities=20% Similarity=0.162 Sum_probs=187.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|++|+||+|+++.+++.||||+++.... +.+|+.++++++|||||++++++.+.+ ..|||||||
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~ivmEy~ 132 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-----WVNIFMELL 132 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT-----EEEEEECCC
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEEEecc
Confidence 3458999999999999999999999999975432 246999999999999999999998876 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcccCCc-
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMSSN- 680 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~- 680 (771)
+||+|.++ ...+++.++..|+.|++.||+|||+. +||||||||+|||++.++ ++||+|||+|+.+.......
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999887 35699999999999999999999986 999999999999999887 69999999998765433211
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 744 (771)
.......+||+.||||| +||++|||+||+.||.+..... .+..+.....+ ...++.+++.+..
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCCchhcCccCCHHHHH
Confidence 12233467999999999 7999999999999997654333 34444444333 2345566777777
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+||++||++|||+.|+++.|.++
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 77899999999999999999988765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=386.06 Aligned_cols=229 Identities=20% Similarity=0.277 Sum_probs=192.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+++.||||++........+.+.+|+++|++++|||||++++++.+.+ ..||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~ivm 150 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVM 150 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEEE
Confidence 444456999999999999999999999999998766556678999999999999999999999998877 789999
Q ss_pred EeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 603 EFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 603 e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|||++|+|.++ ...+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence 99999999876 45689999999999999999999996 999999999999999999999999999987654322
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCcccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 743 (771)
...+.+||+.||||| +||++|||++|+.||.+.. .....+......+ ......+++.+.
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~~~ 301 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHKVSPSLK 301 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSSCCCCSCGGGSCHHHH
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 223568999999999 6999999999999997532 1223333333333 233445667777
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+..+||++||++|||+.|+++
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 7778999999999999999875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=406.59 Aligned_cols=382 Identities=18% Similarity=0.164 Sum_probs=312.1
Q ss_pred CCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc----------
Q 041479 42 KYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS---------- 111 (771)
Q Consensus 42 ~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---------- 111 (771)
...+++.|+|++|+++++.|.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|.+++..+..
T Consensus 54 ~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 133 (606)
T 3vq2_A 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133 (606)
T ss_dssp TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEE
T ss_pred CCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEE
Confidence 3478999999999999888889999999999999999999888999999999999999999998654332
Q ss_pred cccCCcccc-cCCccccCCCCCCEEecccccCcCCCCc-----------cceeeecccccccccCc--------------
Q 041479 112 RLILNKLEG-NIPSELGSLLKFKGLGLANNYFTGPIPH-----------LNMFQVSVYSLTGSIPI-------------- 165 (771)
Q Consensus 112 ~l~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~lp~-----------L~~l~l~~n~l~~~~p~-------------- 165 (771)
.+..|.+.+ .+|..|+++++|+.|++++|++++..|. +..++++.|.+++..+.
T Consensus 134 ~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~ 213 (606)
T 3vq2_A 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRG 213 (606)
T ss_dssp ECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEES
T ss_pred eCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccC
Confidence 266777776 5799999999999999999998854332 12455554444432221
Q ss_pred --------------------------------------------------------------------------------
Q 041479 166 -------------------------------------------------------------------------------- 165 (771)
Q Consensus 166 -------------------------------------------------------------------------------- 165 (771)
T Consensus 214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~ 293 (606)
T 3vq2_A 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293 (606)
T ss_dssp CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEE
T ss_pred CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEec
Confidence
Q ss_pred --------cccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCC-
Q 041479 166 --------QLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLI- 236 (771)
Q Consensus 166 --------~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~- 236 (771)
.+..+++|+.|++++|++ +.+|. + .+++|+.|++++|+..+.. .+..+++|++|++++|++++..
T Consensus 294 ~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~-~--~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~ 367 (606)
T 3vq2_A 294 GVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPT-L--DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGC 367 (606)
T ss_dssp SCCCCCCCCCCTTCCCSEEEEESCCC-SSCCC-C--CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEE
T ss_pred CccchhhhhccccccCCEEEcccccC-ccccc-C--CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcc
Confidence 223334555555555555 25552 2 5566666666666444333 5667888888888888888663
Q ss_pred -CcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCc-ccccccCCcceEecCCccceeccCc
Q 041479 237 -PEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP-TEIGNLKNLIIIAIEKFILIRNIPI 314 (771)
Q Consensus 237 -p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~ 314 (771)
|..+ ..+++|++|++++|.++ .+|..+..+. +|+.|++++|++++..| ..|.++++|+.|++++|.+.+..|.
T Consensus 368 ~~~~~---~~~~~L~~L~L~~n~l~-~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 442 (606)
T 3vq2_A 368 CSYSD---LGTNSLRHLDLSFNGAI-IMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442 (606)
T ss_dssp CCHHH---HCCSCCCEEECCSCSEE-EECCCCTTCT-TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTT
T ss_pred hhhhh---ccCCcccEeECCCCccc-cchhhccCCC-CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchh
Confidence 5444 77899999999999998 5777788876 89999999999998887 7899999999999999999999999
Q ss_pred cccCCCCCCEEEccCCcccc-cCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCC
Q 041479 315 SVGYLLKLQVLSLFENNISR-EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKS 392 (771)
Q Consensus 315 ~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~ 392 (771)
.+..+++|++|++++|++++ .+|..|..+++|++|+|++|++++..|..+..++.| .|++++|++++..|..|..+++
T Consensus 443 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 522 (606)
T 3vq2_A 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522 (606)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTT
T ss_pred hhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCc
Confidence 99999999999999999997 479999999999999999999999999999999999 9999999999999999999999
Q ss_pred CCeEECCCCcccccCCcchhhhhcccc-cccEEECcCCCCCCCCCccc
Q 041479 393 IPHLDLSKNELSGEIPSSLAWIFGYIS-IFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 393 L~~L~Ls~N~l~~~~p~~l~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~ 439 (771)
|++|+|++|+|+ .+|..+. .++ +|+.|++++|++.|.++..+
T Consensus 523 L~~L~l~~N~l~-~~p~~~~----~l~~~L~~l~l~~N~~~c~c~~~~ 565 (606)
T 3vq2_A 523 LSTLDCSFNRIE-TSKGILQ----HFPKSLAFFNLTNNSVACICEHQK 565 (606)
T ss_dssp CCEEECTTSCCC-CEESCGG----GSCTTCCEEECCSCCCCCSSTTHH
T ss_pred CCEEECCCCcCc-ccCHhHh----hhcccCcEEEccCCCcccCCccHH
Confidence 999999999999 6666554 665 69999999999999988654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=381.78 Aligned_cols=230 Identities=18% Similarity=0.178 Sum_probs=183.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+.....+|+|++|+||+|+++.+++.||||++.... ....+.|.+|++++++++|||||++++++.+.+ ..|
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~~y 99 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----SLY 99 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEE
Confidence 3445567999999999999999999999999997543 445678999999999999999999999998876 789
Q ss_pred EEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 600 LVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 600 lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
||||||+||+|.++ ...+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999776 23468889999999999999999996 99999999999999999999999999999765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
.... .....+||+.||||| +||++|||+||+.||.+... ...+..+.....+ ..+..++
T Consensus 177 ~~~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~-~~~~~~s 250 (350)
T 4b9d_A 177 STVE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVLKIISGSFP-PVSLHYS 250 (350)
T ss_dssp HHHH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCC-CCCTTSC
T ss_pred CCcc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCCCC-CCCccCC
Confidence 4221 123457999999999 69999999999999975321 1123334444433 3444566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+..+..+||++||++|||+.|+++
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67777778999999999999999985
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=402.68 Aligned_cols=409 Identities=19% Similarity=0.181 Sum_probs=312.8
Q ss_pred CccceeeeecCC-----------CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEec
Q 041479 31 FCQWLGVTCSLK-----------YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIF 99 (771)
Q Consensus 31 ~c~w~~v~c~~~-----------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 99 (771)
.|.|.|+ |+.. ..+++.|+|++|++++..|..|..+++|++|+|++|+|++..|++|+++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5999998 8643 248999999999999998999999999999999999999988899999999999999
Q ss_pred ccCcCcccCCcc----------cccCCcccc-cCCccccCCCCCCEEecccccCcC--------CCCccceeeecccccc
Q 041479 100 NSNALQGQIPDS----------RLILNKLEG-NIPSELGSLLKFKGLGLANNYFTG--------PIPHLNMFQVSVYSLT 160 (771)
Q Consensus 100 s~N~l~~~~p~~----------~l~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~--------~lp~L~~l~l~~n~l~ 160 (771)
++|++++..|.. .+..|.+++ ..|..|+++++|+.|++++|++.+ .++.|+.|+++.|.++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 999998655432 255566665 356677788888888888887432 2445778888888888
Q ss_pred cccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccC---CccccCCCCCCEEEccccccCCCCC
Q 041479 161 GSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNI---PHSISNASKLEWLDFANNSLTGLIP 237 (771)
Q Consensus 161 ~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~Ls~N~l~~~~p 237 (771)
+..|..+..+++|+.|+++.|.+. .+|..++..+++|++|++++|++++.. ......+++|+.|++++|.+++..+
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 240 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred ccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence 777888888888888888888876 677666656788888888888887642 1223456778888888776653211
Q ss_pred cCc----------------------------------ccc--------------------------cCCCCCcEEEccCc
Q 041479 238 EDL----------------------------------DSL--------------------------VNCTYLEVVSLSVN 257 (771)
Q Consensus 238 ~~~----------------------------------~~l--------------------------~~l~~L~~L~Ls~N 257 (771)
..+ ..+ ..+.+|+.|++++|
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence 100 000 11246777888888
Q ss_pred cccccCChhhh-hcccccceeecccCcCcccCc---ccccccCCcceEecCCccceeccC--ccccCCCCCCEEEccCCc
Q 041479 258 SLSGTLPNSLA-NFSSHLRYLYMSANPISGSIP---TEIGNLKNLIIIAIEKFILIRNIP--ISVGYLLKLQVLSLFENN 331 (771)
Q Consensus 258 ~l~~~~p~~~~-~l~~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~n~l~~~~p--~~~~~l~~L~~L~Ls~N~ 331 (771)
+++ .+|..++ .+ ++|++|++++|++++.+| ..++.+++|+.|++++|.+.+..+ ..+..+++|++|++++|+
T Consensus 321 ~l~-~ip~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~ 398 (549)
T 2z81_A 321 KVF-LVPCSFSQHL-KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398 (549)
T ss_dssp CCC-CCCHHHHHHC-TTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCC
T ss_pred ccc-cCCHHHHhcC-ccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCC
Confidence 877 7787775 45 479999999999987664 347888999999999998866543 457888999999999999
Q ss_pred ccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcc
Q 041479 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSS 410 (771)
Q Consensus 332 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 410 (771)
++ .+|..+..+++|++|++++|++++ +|..+. +.| .||+++|++++.+ ..+++|++|+|++|+|+ .+|..
T Consensus 399 l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~~ 469 (549)
T 2z81_A 399 FH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPDA 469 (549)
T ss_dssp CC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCCG
T ss_pred Cc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCCc
Confidence 98 678888889999999999999884 443332 456 7899999998643 57889999999999998 67763
Q ss_pred hhhhhcccccccEEECcCCCCCCCCCccc-cccccccccccCCCcccC
Q 041479 411 LAWIFGYISIFAKLNLSYNNLDGDVPRKM-IFKNASAISEAGNEKLCG 457 (771)
Q Consensus 411 l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~~~~~~~~~n~~lc~ 457 (771)
. .+++|+.|+|++|++++.+|..+ ...++..+.+.+|++.|.
T Consensus 470 -~----~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 470 -S----LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp -G----GCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred -c----cCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 2 67899999999999998777643 356777888999988774
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=372.60 Aligned_cols=242 Identities=21% Similarity=0.203 Sum_probs=178.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|+||+||+|+++ ++.||||++..... ....+.+|+..+.+++|||||+++|+|.+.+. .....||||||
T Consensus 7 L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV~Ey 82 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEEecC
Confidence 3456899999999999984 67999999965432 22334456666778999999999999986542 12257999999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHH-----CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|++|+|.++ ...++|.++.+++.|+|+||+|||+. +.++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 999999887 45689999999999999999999975 24589999999999999999999999999998765433
Q ss_pred CCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCC----------ccccCCccHHHHH
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTS----------DMFTEGLDLHNFV 726 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~----------~~~~~~~~~~~~~ 726 (771)
..........+||+.||||| |||++|||+||..|+. +.........++.
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 242 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH
Confidence 22222334567999999999 6999999999977653 2222222233332
Q ss_pred Hh----hCCCchhhhc-----CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 727 KM----ALPDQILQVL-----DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 727 ~~----~~~~~~~~~~-----~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.. ..++.++... ...+...+.+||+.||++||||.||++.|+++
T Consensus 243 ~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22 2222222211 12344566799999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=383.52 Aligned_cols=240 Identities=22% Similarity=0.264 Sum_probs=196.1
Q ss_pred cccccccccccccceEEEEEecCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCC-CCceeEEEEeecCCCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQ-RGALKSFMAECQALRNIRH-RNLVKIITACSTSDFQG 594 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~ 594 (771)
.+.....+|+|+||+||+|++... ++.||||++.... ....++|.+|+++|++++| ||||+++|+|.+.+.
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~-- 142 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-- 142 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS--
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC--
Confidence 334445689999999999998654 3689999997553 3446789999999999965 999999999876431
Q ss_pred ceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 041479 595 NYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVL 655 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NIL 655 (771)
..|+|||||++|+|.++. ..+++.++..|+.|||+||+|||+. +||||||||+|||
T Consensus 143 --~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 143 --PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp --CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred --EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 579999999999997652 2378999999999999999999996 8999999999999
Q ss_pred eCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCC
Q 041479 656 LDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEG 719 (771)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~ 719 (771)
+++++.+||+|||+|+.+..... .......+||+.||||| |||++|||+| |+.||.+....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~- 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred eCCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999997654332 22233467999999999 7999999998 99999875322
Q ss_pred ccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 720 LDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+...+....+...++.+++.+...+.+||+.||++|||+.||++.|+++|
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 3355555555555566677788888888999999999999999999998874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=411.66 Aligned_cols=349 Identities=20% Similarity=0.263 Sum_probs=305.8
Q ss_pred CCcccCCccccCCCCCcEEEcCCCccccc-----------------CCcccc--CCCCCCEEecccCcCcccCCcccccC
Q 041479 55 NLTGTASPYIGNLTFLRLINLQQNNFSSN-----------------IPHEIG--RLFRLRHIIFNSNALQGQIPDSRLIL 115 (771)
Q Consensus 55 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~l~~ 115 (771)
++++ +|++|+++++|++|+|++|+|++. +|..++ ++++|++|+|++|.+.
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~---------- 262 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL---------- 262 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC----------
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC----------
Confidence 3445 788999999999999999999986 999999 9999999999999965
Q ss_pred CcccccCCccccCCCCCCEEeccccc-CcC-CC-------------CccceeeecccccccccCc--cccCCCCCCEEec
Q 041479 116 NKLEGNIPSELGSLLKFKGLGLANNY-FTG-PI-------------PHLNMFQVSVYSLTGSIPI--QLLNITSMEYFHV 178 (771)
Q Consensus 116 n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~l-------------p~L~~l~l~~n~l~~~~p~--~~~~l~~L~~L~L 178 (771)
+.+|..|+++++|+.|++++|+ +++ .+ +.|+.|++++|+++ .+|. .+.++++|++|++
T Consensus 263 ----~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L 337 (636)
T 4eco_A 263 ----TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLEC 337 (636)
T ss_dssp ----SSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEEC
T ss_pred ----ccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeC
Confidence 5788899999999999999998 876 22 67999999999999 8888 8999999999999
Q ss_pred ccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCC-CCEEEccccccCCCCCcCcccccCCCCCcEEEccCc
Q 041479 179 SENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK-LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVN 257 (771)
Q Consensus 179 s~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N 257 (771)
++|+++|.+| .+. .+++|++|+|++|+++ .+|..|..+++ |++|++++|+++ .+|..+.. ..+++|+.|++++|
T Consensus 338 ~~N~l~g~ip-~~~-~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~-~~l~~L~~L~Ls~N 412 (636)
T 4eco_A 338 LYNQLEGKLP-AFG-SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA-KSVSVMSAIDFSYN 412 (636)
T ss_dssp CSCCCEEECC-CCE-EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT-TCSSCEEEEECCSS
T ss_pred cCCcCccchh-hhC-CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhh-cccCccCEEECcCC
Confidence 9999999999 554 8999999999999999 78888999999 999999999999 56766522 23458999999999
Q ss_pred cccccCChhhh-------hcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccc-cCC-------CCC
Q 041479 258 SLSGTLPNSLA-------NFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISV-GYL-------LKL 322 (771)
Q Consensus 258 ~l~~~~p~~~~-------~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~-~~l-------~~L 322 (771)
++++.+|..+. .+. +|++|+|++|+|++..+..+..+++|+.|++++|.+. .+|..+ ... ++|
T Consensus 413 ~l~~~~p~~l~~~~~~~~~~~-~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L 490 (636)
T 4eco_A 413 EIGSVDGKNFDPLDPTPFKGI-NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLL 490 (636)
T ss_dssp CTTTTTTCSSCTTCSSCCCCC-CEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGC
T ss_pred cCCCcchhhhcccccccccCC-CCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCc
Confidence 99998888877 554 7999999999999554455677999999999999998 555543 333 399
Q ss_pred CEEEccCCcccccCCcccc--cccccccccccCccceecCCcccccccce-eeec------ccCcccCCCCcCCCCCCCC
Q 041479 323 QVLSLFENNISREIPSSLG--NFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDL------SHNHLTGPIPLAVGNPKSI 393 (771)
Q Consensus 323 ~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~L------s~N~l~~~~p~~~~~l~~L 393 (771)
+.|+|++|+++ .+|..+. .+++|++|+|++|+|++ +|..+..++.| .|+| ++|++.+.+|..+..+++|
T Consensus 491 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 99999999999 7888887 99999999999999997 89999999999 8999 5688899999999999999
Q ss_pred CeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCC
Q 041479 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDV 435 (771)
Q Consensus 394 ~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 435 (771)
++|+|++|+| +.+|..+. ++|+.|||++|++.+.-
T Consensus 569 ~~L~Ls~N~l-~~ip~~~~------~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 569 TQLQIGSNDI-RKVNEKIT------PNISVLDIKDNPNISID 603 (636)
T ss_dssp CEEECCSSCC-CBCCSCCC------TTCCEEECCSCTTCEEE
T ss_pred CEEECCCCcC-CccCHhHh------CcCCEEECcCCCCcccc
Confidence 9999999999 58888642 78999999999987543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=404.44 Aligned_cols=255 Identities=21% Similarity=0.201 Sum_probs=140.8
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcc------------------------------cccCCC
Q 041479 198 VRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLD------------------------------SLVNCT 247 (771)
Q Consensus 198 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------------~l~~l~ 247 (771)
|+.|+|++|++++..|..|..+++|++|++++|++++..|..|. .+..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 66666666666666666666666666666666666655544331 223445
Q ss_pred CCcEEEccCccccccCChhhhhcc---------------------------cccceeecccCcCcccCcccccccCCcce
Q 041479 248 YLEVVSLSVNSLSGTLPNSLANFS---------------------------SHLRYLYMSANPISGSIPTEIGNLKNLII 300 (771)
Q Consensus 248 ~L~~L~Ls~N~l~~~~p~~~~~l~---------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 300 (771)
+|++|++++|++++..|..+..+. ++|+.|++++|++++..|..|..+++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 566666666666544444443332 12333344444444444555555555555
Q ss_pred EecCCccceeccC-ccccCCCCCCEEEccCCcccccCCcccccccccccccccCccce--ecCCcccccccce-eeeccc
Q 041479 301 IAIEKFILIRNIP-ISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR--GSVPSALGSCHQL-WLDLSH 376 (771)
Q Consensus 301 L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~l-~L~Ls~ 376 (771)
|++++|.+.+.+| ..+..+++|++|++++|++++..+..|..+++|+.|++++|.++ +..|..+..++.| .|++++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 5555555554443 44555555555555555555555555555555555555555554 3455666666666 667777
Q ss_pred CcccCCCCcCCCCCCCCCeEECCCCcccccCCcchh----hhhcccccccEEECcCCCCCCCCCcc-c-ccccccccccc
Q 041479 377 NHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLA----WIFGYISIFAKLNLSYNNLDGDVPRK-M-IFKNASAISEA 450 (771)
Q Consensus 377 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----~~~~~l~~L~~L~Ls~N~l~~~~p~~-~-~~~~~~~~~~~ 450 (771)
|++++..|..|..+++|++|+|++|++++..+..+. ..|..+++|+.|+|++|+++ .+|.. + ...++..+.+.
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls 568 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLG 568 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECC
Confidence 776666666666667777777777766643221110 11346666777777777766 34432 1 23344555555
Q ss_pred CCC
Q 041479 451 GNE 453 (771)
Q Consensus 451 ~n~ 453 (771)
+|.
T Consensus 569 ~N~ 571 (680)
T 1ziw_A 569 LNN 571 (680)
T ss_dssp SSC
T ss_pred CCC
Confidence 553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=371.26 Aligned_cols=230 Identities=20% Similarity=0.242 Sum_probs=190.2
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|++|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~ 107 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----KL 107 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----EE
Confidence 4555567999999999999999999999999997542 345678999999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+|||||+||+|.++ .+.+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999877 45699999999999999999999996 999999999999999999999999999997654
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
... .....+.+||+.||||| +||++|||++|+.||.+... ...+..+....+ ..++.+++
T Consensus 185 ~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~--~~p~~~s~ 259 (311)
T 4aw0_A 185 ESK--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKIIKLEY--DFPEKFFP 259 (311)
T ss_dssp TTT--CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC--CCCTTCCH
T ss_pred CCC--cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC--CCCcccCH
Confidence 322 12234568999999999 69999999999999975321 112333333332 33445667
Q ss_pred cccccCcccChhchhhcCCHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
.......+||++||++|||+.|+.
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHHHHccCCHhHCcChHHHc
Confidence 777777799999999999998863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=387.60 Aligned_cols=231 Identities=20% Similarity=0.271 Sum_probs=192.6
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
..+.....+|+|++|+||+|+++.+++.||||++........+.+.+|+++|++++|||||++++++.+.+ ..||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence 33445567999999999999999999999999998766556678999999999999999999999998877 7899
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||||+||+|.++ ...+++.++..|+.|++.||+|||+. +||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999877 45689999999999999999999996 999999999999999999999999999987654322
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 741 (771)
...+.+||+.||||| +||++|||++|+.||.+.. ............+ ......+++.
T Consensus 303 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~~~~~~s~~ 376 (423)
T 4fie_A 303 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLKNLHKVSPS 376 (423)
T ss_dssp ----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSCTTSSCHH
T ss_pred ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCCCCcccccCCHH
Confidence 233568999999999 6999999999999997532 1223333333333 2233456666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+..+..+||+.||++|||+.|+++
T Consensus 377 ~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 377 LKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 777777999999999999999975
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=372.50 Aligned_cols=293 Identities=27% Similarity=0.451 Sum_probs=217.9
Q ss_pred CccHHHHHHHHhcCCCCCCCCCCCCCCCCCCcc--ceeeeecCCC--CcEEEEEcCCCCCcc--cCCccccCCCCCcEEE
Q 041479 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFCQ--WLGVTCSLKY--QRVILLNLSGQNLTG--TASPYIGNLTFLRLIN 74 (771)
Q Consensus 1 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c~--w~~v~c~~~~--~~l~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~ 74 (771)
++|++||++||+++. ||. .+++|..+++||. |.||+|+... .+|+.|+|++|++++ .+|+.|..+++|++|+
T Consensus 5 ~~~~~aL~~~k~~~~-~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~ 82 (313)
T 1ogq_A 5 PQDKQALLQIKKDLG-NPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp HHHHHHHHHHHHHTT-CCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred HHHHHHHHHHHHhcC-Ccc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence 368999999999984 565 7899988889998 9999998654 799999999999998 8899999999999999
Q ss_pred cCC-CcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceee
Q 041479 75 LQQ-NNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQ 153 (771)
Q Consensus 75 Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~ 153 (771)
|++ |++.+.+|.+|+++++|++|+|++|+++ +.+|..|.++++|++|+|++|+|++
T Consensus 83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~--------------~~~p~~~~~l~~L~~L~Ls~N~l~~--------- 139 (313)
T 1ogq_A 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVS--------------GAIPDFLSQIKTLVTLDFSYNALSG--------- 139 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCE--------------EECCGGGGGCTTCCEEECCSSEEES---------
T ss_pred CCCCCcccccCChhHhcCCCCCEEECcCCeeC--------------CcCCHHHhCCCCCCEEeCCCCccCC---------
Confidence 995 9999889999999999999999999854 4667777778888888877776653
Q ss_pred ecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCC-CCcEEEeecCcccccCCccccCCCCCCEEEcccccc
Q 041479 154 VSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLP-NVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSL 232 (771)
Q Consensus 154 l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 232 (771)
.+|..+.++++|++|++++|+++|.+|..++ .++ +|+.|++++|++++.+|..|..++ |++|++++|++
T Consensus 140 --------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 140 --------TLPPSISSLPNLVGITFDGNRISGAIPDSYG-SFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp --------CCCGGGGGCTTCCEEECCSSCCEEECCGGGG-CCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred --------cCChHHhcCCCCCeEECcCCcccCcCCHHHh-hhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 4566677777777777777777767776665 555 677777777777766676666665 67777777666
Q ss_pred CCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceecc
Q 041479 233 TGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI 312 (771)
Q Consensus 233 ~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 312 (771)
++..|..| ..+++|+.|+|++|++++.+|. +..+++|+.|++++|.+.+.+
T Consensus 210 ~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~--------------------------~~~l~~L~~L~Ls~N~l~~~~ 260 (313)
T 1ogq_A 210 EGDASVLF---GSDKNTQKIHLAKNSLAFDLGK--------------------------VGLSKNLNGLDLRNNRIYGTL 260 (313)
T ss_dssp EECCGGGC---CTTSCCSEEECCSSEECCBGGG--------------------------CCCCTTCCEEECCSSCCEECC
T ss_pred cCcCCHHH---hcCCCCCEEECCCCceeeecCc--------------------------ccccCCCCEEECcCCcccCcC
Confidence 66655544 4555566666666655533332 334444555555555554555
Q ss_pred CccccCCCCCCEEEccCCcccccCCcccccccccccccccCcc-cee
Q 041479 313 PISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNS-IRG 358 (771)
Q Consensus 313 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 358 (771)
|..+..+++|+.|+|++|++++.+|.. ..+++|+.|++++|+ +.|
T Consensus 261 p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 261 PQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred ChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 666666677777777777777777765 777888888888887 444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=398.89 Aligned_cols=400 Identities=17% Similarity=0.146 Sum_probs=274.7
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCccc----------c
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSR----------L 113 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----------l 113 (771)
.+++.|||++|+++++.+.+|.++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..+ +
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 579999999999998888899999999999999999998888899999999999999999774333221 3
Q ss_pred cCCcccccCCccccCCCCCCEEecccccCcC-C-------CCccceeeecccccccccCccccCCCCC----CEEecccC
Q 041479 114 ILNKLEGNIPSELGSLLKFKGLGLANNYFTG-P-------IPHLNMFQVSVYSLTGSIPIQLLNITSM----EYFHVSEN 181 (771)
Q Consensus 114 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~-------lp~L~~l~l~~n~l~~~~p~~~~~l~~L----~~L~Ls~N 181 (771)
..|++++..+..|+++++|++|++++|++++ . +++|+.|++++|.+++..|..+..+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 3344443333345555555555555555442 1 2335555555555555444445554444 45555555
Q ss_pred cCcccCChhhhhCCCCCcEEEeecC-------------------------------------------------------
Q 041479 182 QLVGELPPHIGFTLPNVRILLLAGN------------------------------------------------------- 206 (771)
Q Consensus 182 ~l~g~lp~~~~~~l~~L~~L~L~~N------------------------------------------------------- 206 (771)
.++ .+++..+ ...+|+.|++++|
T Consensus 188 ~l~-~~~~~~~-~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 188 PMN-FIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCC-EECTTTT-TTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred Cce-ecCHHHh-ccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 555 2333333 2224555555554
Q ss_pred ---cccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhh----------------
Q 041479 207 ---QFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSL---------------- 267 (771)
Q Consensus 207 ---~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~---------------- 267 (771)
.+.+..|..|..+++|+.|++++|.+++ +|..+ ..+ +|+.|++++|.+. .+|...
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~---~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~ 339 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFS---YNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGN 339 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCC---SCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCC
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchh-hhhhh---ccC-CccEEeeccCccc-ccCcccccccCEEeCcCCcccc
Confidence 2334455666777888888888888875 44444 333 5555555555554 333211
Q ss_pred ----hhcccccceeecccCcCcccC--cccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCC-ccc
Q 041479 268 ----ANFSSHLRYLYMSANPISGSI--PTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIP-SSL 340 (771)
Q Consensus 268 ----~~l~~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~ 340 (771)
..+ ++|++|++++|++++.. |..+.++++|+.|++++|.+.+..+. +..+++|+.|++++|++++..| ..+
T Consensus 340 ~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~ 417 (570)
T 2z63_A 340 AFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVF 417 (570)
T ss_dssp BCCCCBC-TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTT
T ss_pred ccccccC-CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhh
Confidence 223 36777777777777543 56677788888888888877665444 7788888888888888876655 467
Q ss_pred ccccccccccccCccceecCCcccccccce-eeecccCccc-CCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhccc
Q 041479 341 GNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT-GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYI 418 (771)
Q Consensus 341 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l 418 (771)
..+++|++|++++|.+.+..|..+..++.| .|++++|+++ +.+|..|..+++|++|+|++|++++..|..+. .+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l 493 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN----SL 493 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT----TC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh----cc
Confidence 788888888888888888888888888888 7888888887 56788888888888888888888877777654 77
Q ss_pred ccccEEECcCCCCCCCCCccc-cccccccccccCCCcccC
Q 041479 419 SIFAKLNLSYNNLDGDVPRKM-IFKNASAISEAGNEKLCG 457 (771)
Q Consensus 419 ~~L~~L~Ls~N~l~~~~p~~~-~~~~~~~~~~~~n~~lc~ 457 (771)
++|+.|++++|++++..|..+ ...++..+.+.+|+..|.
T Consensus 494 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 888888888888887666533 345667777888877764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=416.17 Aligned_cols=383 Identities=19% Similarity=0.191 Sum_probs=298.6
Q ss_pred CCcEEEEEcCCCCCcccC-CccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc----------
Q 041479 43 YQRVILLNLSGQNLTGTA-SPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS---------- 111 (771)
Q Consensus 43 ~~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---------- 111 (771)
..+++.|||++|+..+.+ |.+|.++++|++|+|++|+|++..|.+|+++++|++|+|++|.+++.+|..
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 356677777777544433 556777777777777777777666777777777777777777766544332
Q ss_pred --cccCCcccccCC-ccccCCCCCCEEecccccCcCC--------------------------CC-------------cc
Q 041479 112 --RLILNKLEGNIP-SELGSLLKFKGLGLANNYFTGP--------------------------IP-------------HL 149 (771)
Q Consensus 112 --~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~--------------------------lp-------------~L 149 (771)
.+..|.+++..+ ..|+++++|+.|+|++|.+++. .| .|
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L 206 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCB
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCce
Confidence 144555655443 4567777777777777766432 11 16
Q ss_pred ceeeecccccccccCccccC--------------------------------------CCCCCEEecccCcCcccCChhh
Q 041479 150 NMFQVSVYSLTGSIPIQLLN--------------------------------------ITSMEYFHVSENQLVGELPPHI 191 (771)
Q Consensus 150 ~~l~l~~n~l~~~~p~~~~~--------------------------------------l~~L~~L~Ls~N~l~g~lp~~~ 191 (771)
+.++++.|.+++..|..+.. .++|+.|++++|.+++ +++..
T Consensus 207 ~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~-~~~~~ 285 (844)
T 3j0a_A 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRV 285 (844)
T ss_dssp SEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE-ECSCC
T ss_pred eEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccc-cChhh
Confidence 78888888777655544432 2689999999999995 44444
Q ss_pred hhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcc
Q 041479 192 GFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271 (771)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 271 (771)
+..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++..|..| .++++|+.|++++|++++..+..+..+.
T Consensus 286 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 362 (844)
T 3j0a_A 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF---YGLPKVAYIDLQKNHIAIIQDQTFKFLE 362 (844)
T ss_dssp SSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSC---SSCTTCCEEECCSCCCCCCCSSCSCSCC
T ss_pred hhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHh---cCCCCCCEEECCCCCCCccChhhhcCCC
Confidence 5589999999999999999999999999999999999999999888777 7889999999999999966666676665
Q ss_pred cccceeecccCcCcccC------------------cc----------------------cccccCCcceEecCCccceec
Q 041479 272 SHLRYLYMSANPISGSI------------------PT----------------------EIGNLKNLIIIAIEKFILIRN 311 (771)
Q Consensus 272 ~~L~~L~Ls~N~l~~~~------------------p~----------------------~~~~l~~L~~L~l~~n~l~~~ 311 (771)
+|++|+|++|.+++.. |. .+.++++|+.|++++|.+.+.
T Consensus 363 -~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~ 441 (844)
T 3j0a_A 363 -KLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441 (844)
T ss_dssp -CCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCC
T ss_pred -CCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccc
Confidence 7999999999887421 11 134788999999999999765
Q ss_pred cCc-cccCCCCCCEEEccCCccc-----ccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCC
Q 041479 312 IPI-SVGYLLKLQVLSLFENNIS-----REIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIP 384 (771)
Q Consensus 312 ~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p 384 (771)
.+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|..++.| .|+|++|+|++..|
T Consensus 442 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~ 521 (844)
T 3j0a_A 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521 (844)
T ss_dssp CSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCC
T ss_pred ccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccCh
Confidence 443 4567899999999999997 4445678999999999999999999999999999999 99999999998888
Q ss_pred cCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccc
Q 041479 385 LAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 385 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
..+. ++|+.|+|++|+|++.+|..+ .+|+.|++++|++.|.++-.+
T Consensus 522 ~~~~--~~L~~L~Ls~N~l~~~~~~~~-------~~L~~l~l~~Np~~C~c~~~~ 567 (844)
T 3j0a_A 522 NDLP--ANLEILDISRNQLLAPNPDVF-------VSLSVLDITHNKFICECELST 567 (844)
T ss_dssp CCCC--SCCCEEEEEEECCCCCCSCCC-------SSCCEEEEEEECCCCSSSCCS
T ss_pred hhhh--ccccEEECCCCcCCCCChhHh-------CCcCEEEecCCCcccccccHH
Confidence 8776 899999999999999888753 478999999999999888543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=360.75 Aligned_cols=226 Identities=22% Similarity=0.235 Sum_probs=173.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|++|+||+|+++.+++.||||++.... ....+++.+|++++++++|||||++++++.+.+ ..|
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~ 89 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD-----EII 89 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EEE
Confidence 444557899999999999999999999999996542 344578999999999999999999999998876 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||| +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999999 6788665 45799999999999999999999996 9999999999999999999999999999865442
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ...+.+||+.||||| +||++|||+||+.||.+... ...+..+.... ...++.+++
T Consensus 166 ~-----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~~~i~~~~--~~~p~~~s~ 237 (275)
T 3hyh_A 166 N-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLFKNISNGV--YTLPKFLSP 237 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTC--CCCCTTSCH
T ss_pred C-----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCC--CCCCCCCCH
Confidence 2 223467999999999 69999999999999975321 11122222222 233455677
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||++||++|||+.|+++
T Consensus 238 ~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 238 GAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHc
Confidence 7777778999999999999999986
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=393.06 Aligned_cols=388 Identities=19% Similarity=0.197 Sum_probs=304.4
Q ss_pred CCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCc----------c
Q 041479 42 KYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPD----------S 111 (771)
Q Consensus 42 ~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----------~ 111 (771)
..++++.|||++|+++++.+..|.++++|++|+|++|++++..|.+|+++++|++|++++|++++..+. .
T Consensus 50 ~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L 129 (570)
T 2z63_A 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129 (570)
T ss_dssp TCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEE
T ss_pred CCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEE
Confidence 347899999999999988888999999999999999999988889999999999999999998853331 2
Q ss_pred cccCCcccc-cCCccccCCCCCCEEecccccCcCCCC-------cc----ceeeecccccccccCccccCCCCCCEEecc
Q 041479 112 RLILNKLEG-NIPSELGSLLKFKGLGLANNYFTGPIP-------HL----NMFQVSVYSLTGSIPIQLLNITSMEYFHVS 179 (771)
Q Consensus 112 ~l~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~lp-------~L----~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls 179 (771)
.+..|.+++ .+|..|+++++|+.|++++|++++..+ .| ..++++.|.+++..|..+..+ +|+.|+++
T Consensus 130 ~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~ 208 (570)
T 2z63_A 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLR 208 (570)
T ss_dssp ECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEE
T ss_pred ecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecc
Confidence 366677776 479999999999999999999985433 24 677888887776655544433 44455444
Q ss_pred cC----------------------------------------------------------cCcccCChhhhhCCCCCcEE
Q 041479 180 EN----------------------------------------------------------QLVGELPPHIGFTLPNVRIL 201 (771)
Q Consensus 180 ~N----------------------------------------------------------~l~g~lp~~~~~~l~~L~~L 201 (771)
+| .+.+.+|..+. .+++|+.|
T Consensus 209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~-~l~~L~~L 287 (570)
T 2z63_A 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN-CLTNVSSF 287 (570)
T ss_dssp SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTG-GGTTCSEE
T ss_pred cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhc-CcCcccEE
Confidence 44 11122222222 44555555
Q ss_pred EeecCcccccCCccccCCCCCCEEEccccccCCCCCcCccc----------------ccCCCCCcEEEccCccccccC--
Q 041479 202 LLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDS----------------LVNCTYLEVVSLSVNSLSGTL-- 263 (771)
Q Consensus 202 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~----------------l~~l~~L~~L~Ls~N~l~~~~-- 263 (771)
++++|.++ .+|..+..+ +|+.|++++|.++.+.+..+.. ...+++|+.|++++|++++..
T Consensus 288 ~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 365 (570)
T 2z63_A 288 SLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365 (570)
T ss_dssp EEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEE
T ss_pred EecCccch-hhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccc
Confidence 55555554 344444444 5555555555444222211110 156789999999999998543
Q ss_pred ChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccC-ccccCCCCCCEEEccCCcccccCCccccc
Q 041479 264 PNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP-ISVGYLLKLQVLSLFENNISREIPSSLGN 342 (771)
Q Consensus 264 p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 342 (771)
|..+..+. +|++|++++|.+++..+. |..+++|+.|++++|.+.+..| ..+..+++|++|++++|++++..|..|..
T Consensus 366 ~~~~~~~~-~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 443 (570)
T 2z63_A 366 SQSDFGTT-SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443 (570)
T ss_dssp EHHHHTCS-CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred cccccccC-ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc
Confidence 67777776 899999999999965554 9999999999999999988766 57899999999999999999999999999
Q ss_pred ccccccccccCccce-ecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhccccc
Q 041479 343 FTFLTELNLCGNSIR-GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISI 420 (771)
Q Consensus 343 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~ 420 (771)
+++|++|++++|+++ +.+|..+..++.| .|++++|++++..|..|..+++|++|++++|++++..|..+. .+++
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l~~ 519 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD----RLTS 519 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT----TCTT
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhh----cccC
Confidence 999999999999998 5789999999999 999999999999899999999999999999999987777654 8999
Q ss_pred ccEEECcCCCCCCCCCccc
Q 041479 421 FAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 421 L~~L~Ls~N~l~~~~p~~~ 439 (771)
|+.|++++|+++|.+|...
T Consensus 520 L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 520 LQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp CCEEECCSSCBCCCTTTTH
T ss_pred CcEEEecCCcccCCCcchH
Confidence 9999999999999999754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=408.04 Aligned_cols=345 Identities=20% Similarity=0.272 Sum_probs=298.7
Q ss_pred CCccccCCCCCcEEEcCCCcccc-----------------cCCcccc--CCCCCCEEecccCcCcccCCcccccCCcccc
Q 041479 60 ASPYIGNLTFLRLINLQQNNFSS-----------------NIPHEIG--RLFRLRHIIFNSNALQGQIPDSRLILNKLEG 120 (771)
Q Consensus 60 ~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~ 120 (771)
+|+.|+++++|++|+|++|+|++ .+|..++ ++++|++|+|++|.+. +
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~--------------~ 505 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM--------------T 505 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTC--------------C
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCC--------------c
Confidence 78889999999999999999998 3899987 9999999999999955 5
Q ss_pred cCCccccCCCCCCEEeccccc-CcC-CC--------------CccceeeecccccccccCc--cccCCCCCCEEecccCc
Q 041479 121 NIPSELGSLLKFKGLGLANNY-FTG-PI--------------PHLNMFQVSVYSLTGSIPI--QLLNITSMEYFHVSENQ 182 (771)
Q Consensus 121 ~~p~~~~~l~~L~~L~Ls~N~-l~~-~l--------------p~L~~l~l~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~ 182 (771)
.+|..|+++++|+.|+|++|+ |++ .+ |.|+.|++++|.++ .+|. .+.++++|+.|+|++|+
T Consensus 506 ~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~ 584 (876)
T 4ecn_A 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNK 584 (876)
T ss_dssp SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSC
T ss_pred cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCC
Confidence 788899999999999999998 876 33 37999999999999 8888 89999999999999999
Q ss_pred CcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCC-CCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccc
Q 041479 183 LVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK-LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG 261 (771)
Q Consensus 183 l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 261 (771)
++ .+| .+. .+++|+.|+|++|+|+ .+|..|..+++ |+.|+|++|+|+ .+|..+.. ...++|+.|+|++|++++
T Consensus 585 l~-~lp-~~~-~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~-~~~~~L~~L~Ls~N~l~g 658 (876)
T 4ecn_A 585 VR-HLE-AFG-TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA-KSVYVMGSVDFSYNKIGS 658 (876)
T ss_dssp CC-BCC-CCC-TTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCT-TCSSCEEEEECCSSCTTT
T ss_pred cc-cch-hhc-CCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhc-cccCCCCEEECcCCcCCC
Confidence 99 999 554 8999999999999999 78889999999 999999999999 55766522 223459999999999998
Q ss_pred cCChhh---h--hcccccceeecccCcCcccCccc-ccccCCcceEecCCccceeccCccccCC--------CCCCEEEc
Q 041479 262 TLPNSL---A--NFSSHLRYLYMSANPISGSIPTE-IGNLKNLIIIAIEKFILIRNIPISVGYL--------LKLQVLSL 327 (771)
Q Consensus 262 ~~p~~~---~--~l~~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~n~l~~~~p~~~~~l--------~~L~~L~L 327 (771)
.+|... . .. .+|+.|+|++|+|+. +|.. +..+++|+.|++++|.+. .+|..+... ++|+.|+|
T Consensus 659 ~ip~l~~~l~~~~~-~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~L 735 (876)
T 4ecn_A 659 EGRNISCSMDDYKG-INASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDL 735 (876)
T ss_dssp TSSSCSSCTTTCCC-CCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEEC
T ss_pred ccccchhhhccccC-CCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEEC
Confidence 766322 2 22 279999999999994 5554 568999999999999997 566654432 39999999
Q ss_pred cCCcccccCCcccc--cccccccccccCccceecCCcccccccce-eeeccc------CcccCCCCcCCCCCCCCCeEEC
Q 041479 328 FENNISREIPSSLG--NFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSH------NHLTGPIPLAVGNPKSIPHLDL 398 (771)
Q Consensus 328 s~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~------N~l~~~~p~~~~~l~~L~~L~L 398 (771)
++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..++.| .|+|++ |++.+.+|..|..+++|+.|+|
T Consensus 736 s~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~L 813 (876)
T 4ecn_A 736 RFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813 (876)
T ss_dssp CSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEEC
T ss_pred CCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEEC
Confidence 999999 7888887 99999999999999997 78889999999 899976 8899999999999999999999
Q ss_pred CCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCc
Q 041479 399 SKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 399 s~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
++|+| +.+|..+. ++|+.|||++|++...-+.
T Consensus 814 s~N~L-~~Ip~~l~------~~L~~LdLs~N~l~~i~~~ 845 (876)
T 4ecn_A 814 GSNDI-RKVDEKLT------PQLYILDIADNPNISIDVT 845 (876)
T ss_dssp CSSCC-CBCCSCCC------SSSCEEECCSCTTCEEECG
T ss_pred CCCCC-CccCHhhc------CCCCEEECCCCCCCccChH
Confidence 99999 68888743 6899999999999755444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=380.84 Aligned_cols=381 Identities=18% Similarity=0.232 Sum_probs=212.9
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
++++.|+|++|++++..|..|..+++|++|+|++|+|++..|.+|+++++|++|+|++|+++ .+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~---------------~lp 85 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV---------------KIS 85 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC---------------EEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee---------------ecC
Confidence 45555555555555555555555555555555555555555555555555555555555544 222
Q ss_pred ccccCCCCCCEEecccccCcC-C-------CCccceeeecccccccccCccccCCCCC--CEEecccCcC--cccCChhh
Q 041479 124 SELGSLLKFKGLGLANNYFTG-P-------IPHLNMFQVSVYSLTGSIPIQLLNITSM--EYFHVSENQL--VGELPPHI 191 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~-~-------lp~L~~l~l~~n~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~g~lp~~~ 191 (771)
.. .+++|++|+|++|++++ . ++.|+.|+++.|.+++ ..+..+++| ++|++++|.+ .+..|..+
T Consensus 86 ~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l 160 (520)
T 2z7x_B 86 CH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGL 160 (520)
T ss_dssp CC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTT
T ss_pred cc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccc
Confidence 22 45556666666665543 1 2235555555555554 234444444 5555555555 33333332
Q ss_pred hh-------------------------CCCCCcEEEeecCc-------ccccCCccccCCC-------------------
Q 041479 192 GF-------------------------TLPNVRILLLAGNQ-------FFGNIPHSISNAS------------------- 220 (771)
Q Consensus 192 ~~-------------------------~l~~L~~L~L~~N~-------l~~~~p~~~~~l~------------------- 220 (771)
.. .+++|+.|++++|. +.+.+| .|..++
T Consensus 161 ~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~ 239 (520)
T 2z7x_B 161 QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIR 239 (520)
T ss_dssp TTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHH
T ss_pred cccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHH
Confidence 21 13334444444433 222222 222222
Q ss_pred --------CCCEEEccccccCCCCCcCcccc--cCCCCCcEEEccCccccccCC-hhhhhcc--cccceeecccCcCccc
Q 041479 221 --------KLEWLDFANNSLTGLIPEDLDSL--VNCTYLEVVSLSVNSLSGTLP-NSLANFS--SHLRYLYMSANPISGS 287 (771)
Q Consensus 221 --------~L~~L~Ls~N~l~~~~p~~~~~l--~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~--~~L~~L~Ls~N~l~~~ 287 (771)
+|++|++++|++++.+|..+..+ .++++|+.+++++|.+ .+| ..+..+. .+|+.|++++|.+...
T Consensus 240 ~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~ 317 (520)
T 2z7x_B 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317 (520)
T ss_dssp HHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC
T ss_pred HHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc
Confidence 45555555555554444433111 3445555555555555 333 2232220 1355555655555422
Q ss_pred CcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccc--cCCcccccccccccccccCccceecCC-ccc
Q 041479 288 IPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISR--EIPSSLGNFTFLTELNLCGNSIRGSVP-SAL 364 (771)
Q Consensus 288 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~ 364 (771)
. .+..+++|+.|++++|.+.+.+|..+..+++|++|++++|++++ .+|..+..+++|++|++++|++++.+| ..+
T Consensus 318 ~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~ 395 (520)
T 2z7x_B 318 L--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395 (520)
T ss_dssp C--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSC
T ss_pred c--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchh
Confidence 1 12567777777777777777777777777777777777777765 345667777777777777777776343 346
Q ss_pred ccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCcc-c-cc
Q 041479 365 GSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRK-M-IF 441 (771)
Q Consensus 365 ~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~-~~ 441 (771)
..++.| .|++++|++++..|..+. ++|++|+|++|+|+ .+|..+. .+++|+.|+|++|+|+ .+|.. + ..
T Consensus 396 ~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~----~l~~L~~L~L~~N~l~-~l~~~~~~~l 467 (520)
T 2z7x_B 396 SWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV----KLEALQELNVASNQLK-SVPDGIFDRL 467 (520)
T ss_dssp CCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGG----GCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred ccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhh----cCCCCCEEECCCCcCC-ccCHHHhccC
Confidence 666667 677777777766666553 67777777777777 6666543 6677777777777777 34443 1 24
Q ss_pred cccccccccCCCcccC
Q 041479 442 KNASAISEAGNEKLCG 457 (771)
Q Consensus 442 ~~~~~~~~~~n~~lc~ 457 (771)
.++..+.+.+|+..|.
T Consensus 468 ~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 468 TSLQKIWLHTNPWDCS 483 (520)
T ss_dssp TTCCEEECCSSCBCCC
T ss_pred CcccEEECcCCCCccc
Confidence 4556666777776663
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=386.49 Aligned_cols=417 Identities=19% Similarity=0.192 Sum_probs=283.6
Q ss_pred CCCCCCCCC----CCCccce----eeeecCCC---------CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccc
Q 041479 20 GALSTWNDS----VNFCQWL----GVTCSLKY---------QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS 82 (771)
Q Consensus 20 ~~~~~w~~~----~~~c~w~----~v~c~~~~---------~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 82 (771)
..+++|... -++|.|. .+.|.... ..++.|||++|+|+++.+.+|.++++|++|||++|+|++
T Consensus 11 ~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~ 90 (635)
T 4g8a_A 11 DKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 90 (635)
T ss_dssp --------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred chhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC
Confidence 345555432 2456543 36786432 478999999999998888899999999999999999999
Q ss_pred cCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcC-------CCCccceeeec
Q 041479 83 NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG-------PIPHLNMFQVS 155 (771)
Q Consensus 83 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-------~lp~L~~l~l~ 155 (771)
+.|++|+++++|++|+|++|+|++. .+..|.++++|++|+|++|+|++ .++.|+.|+++
T Consensus 91 i~~~~f~~L~~L~~L~Ls~N~l~~l--------------~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 91 IEDGAYQSLSHLSTLILTGNPIQSL--------------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEE--------------CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred cChhHhcCCCCCCEEEccCCcCCCC--------------CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 8888999999999999999998742 23345555555555555555542 22335555555
Q ss_pred cccccc-ccCccccCCCCCCEEecccCcCccc---------------------------CChhhhhCCCCCcEEEeecCc
Q 041479 156 VYSLTG-SIPIQLLNITSMEYFHVSENQLVGE---------------------------LPPHIGFTLPNVRILLLAGNQ 207 (771)
Q Consensus 156 ~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~---------------------------lp~~~~~~l~~L~~L~L~~N~ 207 (771)
+|.+++ ..|..+.++++|++|++++|++++. +++..+ ....++.+++.+|.
T Consensus 157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNF 235 (635)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCC
T ss_pred cCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhccc
Confidence 555543 2344455555555555555555422 222211 11112223332221
Q ss_pred cccc----------------------------------------------------------------------------
Q 041479 208 FFGN---------------------------------------------------------------------------- 211 (771)
Q Consensus 208 l~~~---------------------------------------------------------------------------- 211 (771)
....
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence 1100
Q ss_pred ----CCccccCCCCCCEEEccccccCCCCCcCcc----------------cccCCCCCcEEEccCccccc--cCChhhhh
Q 041479 212 ----IPHSISNASKLEWLDFANNSLTGLIPEDLD----------------SLVNCTYLEVVSLSVNSLSG--TLPNSLAN 269 (771)
Q Consensus 212 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----------------~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~ 269 (771)
....+....+|+.|++++|.+.+..+..+. ....+++|+.|++++|.+.. ..+..+..
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhh
Confidence 001123334566666666666544332221 11346778888888887752 34555555
Q ss_pred cccccceeecccCcCcccCcccccccCCcceEecCCccceeccC-ccccCCCCCCEEEccCCcccccCCccccccccccc
Q 041479 270 FSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP-ISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTE 348 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 348 (771)
.. +|++|+++.|.+. ..+..|..+++|+.+++..++.....+ ..+..+.+++.+++++|++++..|..+..+++|+.
T Consensus 396 ~~-~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~ 473 (635)
T 4g8a_A 396 TI-SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 473 (635)
T ss_dssp CS-CCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred hh-hhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 54 6888888888777 455677888888888888887766554 45778889999999999998888888889999999
Q ss_pred ccccCccc-eecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEEC
Q 041479 349 LNLCGNSI-RGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNL 426 (771)
Q Consensus 349 L~Ls~N~l-~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~L 426 (771)
|+|++|++ .+..|..|..++.| .|||++|+|++..|..|.++++|++|+|++|+|++..|..+. .+++|+.|||
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~----~l~~L~~L~L 549 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK----CLNSLQVLDY 549 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGT----TCTTCCEEEC
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHh----CCCCCCEEEC
Confidence 99999874 44678888888888 899999999988889999999999999999999977777654 8889999999
Q ss_pred cCCCCCCCCCcccc-c-cccccccccCCCcccC
Q 041479 427 SYNNLDGDVPRKMI-F-KNASAISEAGNEKLCG 457 (771)
Q Consensus 427 s~N~l~~~~p~~~~-~-~~~~~~~~~~n~~lc~ 457 (771)
++|+|++..|..+. + .++..+.+.+||+.|+
T Consensus 550 s~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 550 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999988777653 2 4677788899999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=359.95 Aligned_cols=229 Identities=23% Similarity=0.224 Sum_probs=177.4
Q ss_pred cccccccccccccceEEEEEec---CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 522 DLLLNVSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
++.....+|+|++|+||+|+.. .+++.||||++.... .....++.+|++++++++|||||++++++.+.+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 99 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG----- 99 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT-----
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----
Confidence 3455567999999999999874 356799999996542 223457889999999999999999999998877
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+|||||+||+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 78999999999999876 35689999999999999999999996 9999999999999999999999999999865
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ...+.+||+.||||| +||++|||+||+.||.+.... ..+..+.... ...++.+
T Consensus 177 ~~~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~--~~~p~~~ 249 (304)
T 3ubd_A 177 IDHEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMILKAK--LGMPQFL 249 (304)
T ss_dssp ----C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC--CCCCTTS
T ss_pred cCCCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCC--CCCCCcC
Confidence 43221 223468999999999 699999999999999753211 1122333322 2344566
Q ss_pred CccccccCcccChhchhhcCCH-----HHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKK-----GQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~-----~~vl~ 765 (771)
++.+.....+||++||++|||+ +|+++
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 7777777889999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.58 Aligned_cols=235 Identities=22% Similarity=0.270 Sum_probs=168.9
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-------CCc
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDF-------QGN 595 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-------~~~ 595 (771)
.....+|+|++|+||+|+++.+++.||||++.... ....+++.+|+++|++++|||||++++++.+.+. ...
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 33456899999999999999999999999997543 3456789999999999999999999999876442 122
Q ss_pred eeEEEEEEeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 596 YFRALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
.+.|+|||||++|+|.++ ....++..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCcc
Confidence 357999999999999776 12345666889999999999999996 999999999999999999999999999
Q ss_pred ccccCcccCCc--------ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHH
Q 041479 670 TRFIPEVMSSN--------QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV 726 (771)
Q Consensus 670 a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 726 (771)
|+......... .....+.+||+.||||| +||++|||++ ||.........+....
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 98765432211 11234568999999999 7999999996 7754221111122222
Q ss_pred HhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 727 KMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....|+ ......+.......+||++||++|||+.|+++
T Consensus 242 ~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 242 NLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp TTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333332 22223344445566999999999999999986
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=381.00 Aligned_cols=372 Identities=19% Similarity=0.230 Sum_probs=303.1
Q ss_pred CCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccc
Q 041479 41 LKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEG 120 (771)
Q Consensus 41 ~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~ 120 (771)
....+++.|+|++|++++..|..|+.+++|++|+|++|+|++ +|.. .+++|++|+|++|++++ .
T Consensus 42 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~-------------~ 105 (520)
T 2z7x_B 42 LSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDA-------------L 105 (520)
T ss_dssp TTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSSCCSS-------------C
T ss_pred cccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCCcccc-------------c
Confidence 345789999999999999889999999999999999999995 6666 89999999999999752 1
Q ss_pred cCCccccCCCCCCEEecccccCcC----CCCcc--ceeeeccccc--ccccCccccC-----------------------
Q 041479 121 NIPSELGSLLKFKGLGLANNYFTG----PIPHL--NMFQVSVYSL--TGSIPIQLLN----------------------- 169 (771)
Q Consensus 121 ~~p~~~~~l~~L~~L~Ls~N~l~~----~lp~L--~~l~l~~n~l--~~~~p~~~~~----------------------- 169 (771)
.+|..|+++++|++|++++|+|++ .++.| +.++++.|.+ .+..|..+..
T Consensus 106 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~ 185 (520)
T 2z7x_B 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185 (520)
T ss_dssp CCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCC
T ss_pred cchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhh
Confidence 367899999999999999999974 45567 9999999999 6666665554
Q ss_pred ---CCCCCEEecccCc------------------------------CcccCChhhh--hCCCCCcEEEeecCcccccCCc
Q 041479 170 ---ITSMEYFHVSENQ------------------------------LVGELPPHIG--FTLPNVRILLLAGNQFFGNIPH 214 (771)
Q Consensus 170 ---l~~L~~L~Ls~N~------------------------------l~g~lp~~~~--~~l~~L~~L~L~~N~l~~~~p~ 214 (771)
+++|+.|++++|. +++..+..+. ...++|++|++++|++++.+|.
T Consensus 186 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~ 265 (520)
T 2z7x_B 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265 (520)
T ss_dssp CTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCC
T ss_pred hhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCcccc
Confidence 4455555555554 3321111111 0135899999999999989999
Q ss_pred cc-----cCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCc
Q 041479 215 SI-----SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP 289 (771)
Q Consensus 215 ~~-----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p 289 (771)
.+ ..+++|+.+++++|.+ ..++..+..+..-.+|+.|++++|.+.+ ++. ...+ ++|++|++++|++++.+|
T Consensus 266 ~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~-~~~-~~~l-~~L~~L~Ls~n~l~~~~~ 341 (520)
T 2z7x_B 266 RDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVH-MLC-PSKI-SPFLHLDFSNNLLTDTVF 341 (520)
T ss_dssp CCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCC-CCC-CSSC-CCCCEEECCSSCCCTTTT
T ss_pred chhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccc-ccc-hhhC-CcccEEEeECCccChhhh
Confidence 88 9999999999999999 3332444322223679999999999873 331 1344 479999999999999899
Q ss_pred ccccccCCcceEecCCcccee--ccCccccCCCCCCEEEccCCcccccCCc-ccccccccccccccCccceecCCccccc
Q 041479 290 TEIGNLKNLIIIAIEKFILIR--NIPISVGYLLKLQVLSLFENNISREIPS-SLGNFTFLTELNLCGNSIRGSVPSALGS 366 (771)
Q Consensus 290 ~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 366 (771)
..|+.+++|+.|++++|.+.+ .+|..+..+++|++|++++|++++.+|. .+..+++|++|++++|++++..|..+.
T Consensus 342 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~- 420 (520)
T 2z7x_B 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP- 420 (520)
T ss_dssp TTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred hhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence 999999999999999999986 6678899999999999999999974555 588999999999999999988877664
Q ss_pred ccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccc
Q 041479 367 CHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 367 l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
+.| .|++++|+++ .+|..+..+++|++|+|++|+|+ .+|.. .|..+++|+.|++++|+++|.++..+
T Consensus 421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~---~~~~l~~L~~L~l~~N~~~c~c~~~~ 488 (520)
T 2z7x_B 421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDG---IFDRLTSLQKIWLHTNPWDCSCPRID 488 (520)
T ss_dssp -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTT---TTTTCTTCCEEECCSSCBCCCHHHHH
T ss_pred -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHH---HhccCCcccEEECcCCCCcccCCchH
Confidence 567 8999999999 67777779999999999999999 56654 24488999999999999999887543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=367.95 Aligned_cols=371 Identities=18% Similarity=0.140 Sum_probs=313.3
Q ss_pred EEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcccc
Q 041479 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG 127 (771)
Q Consensus 48 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~ 127 (771)
.++.++++++. +|. + .++|++|+|++|+|++..|..|+++++|++|+|++|.+.+. ..|..|.
T Consensus 14 ~~~c~~~~l~~-lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~-------------i~~~~~~ 76 (455)
T 3v47_A 14 NAICINRGLHQ-VPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV-------------IRNNTFR 76 (455)
T ss_dssp EEECCSSCCSS-CCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE-------------ECTTTTT
T ss_pred ccCcCCCCccc-CCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce-------------ECccccc
Confidence 58889999984 444 3 38899999999999998899999999999999999996521 2356788
Q ss_pred CCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChh-hhhCCCCCcEEEeecC
Q 041479 128 SLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPH-IGFTLPNVRILLLAGN 206 (771)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~-~~~~l~~L~~L~L~~N 206 (771)
++++|++|+|++|++++ ..|..|.++++|++|++++|++++.+|.. .+..+++|++|+|++|
T Consensus 77 ~l~~L~~L~Ls~n~l~~-----------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n 139 (455)
T 3v47_A 77 GLSSLIILKLDYNQFLQ-----------------LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139 (455)
T ss_dssp TCTTCCEEECTTCTTCE-----------------ECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSS
T ss_pred ccccCCEEeCCCCccCc-----------------cChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCC
Confidence 99999999999998873 55778999999999999999998655543 2448999999999999
Q ss_pred cccccCCcc-ccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhh--------hhccccccee
Q 041479 207 QFFGNIPHS-ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSL--------ANFSSHLRYL 277 (771)
Q Consensus 207 ~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~--------~~l~~~L~~L 277 (771)
+|++..|.. |.++++|++|++++|++++..|..+..+.. .+|+.|++++|.+.+..+..+ ..+. +|++|
T Consensus 140 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~-~L~~L 217 (455)
T 3v47_A 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG-KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT-SITTL 217 (455)
T ss_dssp BCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTT-CEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC-EEEEE
T ss_pred ccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccc-ccccccccccCcccccchhhccccccccccccc-eeeeE
Confidence 999888876 899999999999999999998887744422 689999999999985443322 2333 79999
Q ss_pred ecccCcCcccCccccccc---CCcceEecCCccceec----------cCccccC--CCCCCEEEccCCcccccCCccccc
Q 041479 278 YMSANPISGSIPTEIGNL---KNLIIIAIEKFILIRN----------IPISVGY--LLKLQVLSLFENNISREIPSSLGN 342 (771)
Q Consensus 278 ~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~~----------~p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~ 342 (771)
++++|++++..|..|..+ ++|+.|++++|...+. .+..+.. .++|+.|++++|++++..|..|..
T Consensus 218 ~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 297 (455)
T 3v47_A 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH 297 (455)
T ss_dssp ECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTT
T ss_pred ecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhccc
Confidence 999999999888887765 8999999998865432 1122222 368999999999999999999999
Q ss_pred ccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccc
Q 041479 343 FTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIF 421 (771)
Q Consensus 343 l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L 421 (771)
+++|++|+|++|++++..|..+..++.| .|+|++|++++..|..|..+++|++|+|++|++++..|..+. .+++|
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L 373 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL----GLPNL 373 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT----TCTTC
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc----ccccc
Confidence 9999999999999999999999999999 999999999988899999999999999999999988888765 89999
Q ss_pred cEEECcCCCCCCCCCccc-cccccccccccCCCcccCC
Q 041479 422 AKLNLSYNNLDGDVPRKM-IFKNASAISEAGNEKLCGG 458 (771)
Q Consensus 422 ~~L~Ls~N~l~~~~p~~~-~~~~~~~~~~~~n~~lc~~ 458 (771)
+.|+|++|++++..+..+ ...++..+.+.+|+..|..
T Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 374 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred cEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 999999999997555432 3567888899999988854
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=380.40 Aligned_cols=378 Identities=18% Similarity=0.190 Sum_probs=296.9
Q ss_pred CCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcc-cCCcc---------
Q 041479 42 KYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQG-QIPDS--------- 111 (771)
Q Consensus 42 ~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~--------- 111 (771)
...+++.|+|++|++++..|.+|+.+++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|..
T Consensus 48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 34789999999999999989999999999999999999998777779999999999999999986 23432
Q ss_pred -cccCCcccccC-CccccCCCCCCEEecccccCcCC-------CCccceeeecccccccccCccccCCCCCCEEecccCc
Q 041479 112 -RLILNKLEGNI-PSELGSLLKFKGLGLANNYFTGP-------IPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQ 182 (771)
Q Consensus 112 -~l~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~-------lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 182 (771)
.+..|.+.+.+ +..|+++++|++|++++|++++. ++.|+.|+++.|.+....+..+..+++|++|++++|+
T Consensus 128 L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~ 207 (549)
T 2z81_A 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207 (549)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCB
T ss_pred EECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCc
Confidence 24556634444 46899999999999999999864 4458999999998864433334679999999999999
Q ss_pred CcccC--ChhhhhCCCCCcEEEeecCccc----------------------------ccC--------------------
Q 041479 183 LVGEL--PPHIGFTLPNVRILLLAGNQFF----------------------------GNI-------------------- 212 (771)
Q Consensus 183 l~g~l--p~~~~~~l~~L~~L~L~~N~l~----------------------------~~~-------------------- 212 (771)
+++.. |..+...+++|+.|++++|+++ +..
T Consensus 208 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~ 287 (549)
T 2z81_A 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287 (549)
T ss_dssp CTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEE
T ss_pred cccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccc
Confidence 98521 2222223444555555544443 210
Q ss_pred ---------------CccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChh---hhhccccc
Q 041479 213 ---------------PHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNS---LANFSSHL 274 (771)
Q Consensus 213 ---------------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~~L 274 (771)
+..+....+|+.|++++|+++. +|..+ +.++++|++|++++|++++.+|.. +..++ +|
T Consensus 288 l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~-~L 363 (549)
T 2z81_A 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSF--SQHLKSLEFLDLSENLMVEEYLKNSACKGAWP-SL 363 (549)
T ss_dssp EESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHH--HHHCTTCCEEECCSSCCCHHHHHHHTCTTSST-TC
T ss_pred ccccccchhhhcccchhhhhhcccceEEEeccCcccc-CCHHH--HhcCccccEEEccCCccccccccchhhhhccc-cC
Confidence 0001223567888888888874 44433 146899999999999999877543 45554 89
Q ss_pred ceeecccCcCcccCc--ccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCccccccccccccccc
Q 041479 275 RYLYMSANPISGSIP--TEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352 (771)
Q Consensus 275 ~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 352 (771)
++|++++|+|++..+ ..+..+++|+.|++++|.+. .+|..+..+++|++|++++|+++ .+|..+. ++|++|+|+
T Consensus 364 ~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls 439 (549)
T 2z81_A 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVS 439 (549)
T ss_dssp CEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECC
T ss_pred cEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECC
Confidence 999999999996543 56899999999999999997 68889999999999999999998 4554442 689999999
Q ss_pred CccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCC
Q 041479 353 GNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431 (771)
Q Consensus 353 ~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l 431 (771)
+|+|++.+ ..++.| .|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..+. .+++|+.|++++|++
T Consensus 440 ~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~~L~l~~N~~ 509 (549)
T 2z81_A 440 NNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD----RLTSLQKIWLHTNPW 509 (549)
T ss_dssp SSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG----GCTTCCEEECCSSCB
T ss_pred CCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHh----cCcccCEEEecCCCc
Confidence 99999643 466778 8999999999 5565 46789999999999999988887665 889999999999999
Q ss_pred CCCCCc
Q 041479 432 DGDVPR 437 (771)
Q Consensus 432 ~~~~p~ 437 (771)
+|.+|.
T Consensus 510 ~~~~~~ 515 (549)
T 2z81_A 510 DCSCPR 515 (549)
T ss_dssp CCCHHH
T ss_pred cCCCcc
Confidence 999984
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=371.33 Aligned_cols=153 Identities=16% Similarity=0.207 Sum_probs=113.7
Q ss_pred EEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccc
Q 041479 47 ILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSEL 126 (771)
Q Consensus 47 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~ 126 (771)
+.+|+++|++++ +|..+. ++|++|+|++|+|++..|.+|+++++|++|+|++|+++ +..|+.|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~--------------~~~~~~~ 96 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR--------------SLDFHVF 96 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCC--------------EECTTTT
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCC--------------cCCHHHh
Confidence 678888888885 454443 78888888888888777778888888888888888854 4556778
Q ss_pred cCCCCCCEEecccccCcC----CCCccceeeeccccccc-ccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC--c
Q 041479 127 GSLLKFKGLGLANNYFTG----PIPHLNMFQVSVYSLTG-SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV--R 199 (771)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~----~lp~L~~l~l~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L--~ 199 (771)
.++++|++|+|++|+|+. .++.|+.|++++|.+++ .+|..|.++++|++|++++|++++. .+ ..+++| +
T Consensus 97 ~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~-~~l~~L~L~ 172 (562)
T 3a79_B 97 LFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DL-LPVAHLHLS 172 (562)
T ss_dssp TTCTTCCEEECTTSCCCEECSCCCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TT-GGGTTSCEE
T ss_pred CCCCCCCEEECCCCcCCccCccccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---ch-hhhhhceee
Confidence 888888888888888873 34568888888888876 4467888888888888888888742 12 244555 8
Q ss_pred EEEeecCcc--cccCCccccCCC
Q 041479 200 ILLLAGNQF--FGNIPHSISNAS 220 (771)
Q Consensus 200 ~L~L~~N~l--~~~~p~~~~~l~ 220 (771)
.|++++|++ ++..|..|..+.
T Consensus 173 ~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 173 CILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp EEEEEESSCCCCSSSCCEEEECC
T ss_pred EEEeecccccccccCcccccccC
Confidence 888888888 666666665543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=374.64 Aligned_cols=384 Identities=21% Similarity=0.233 Sum_probs=262.3
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc--------cccC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS--------RLIL 115 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--------~l~~ 115 (771)
++++.|+|++|++++..+..|..+++|++|+|++|+|++..|++|+++++|++|+|++|+++ .+|.. .+..
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~Ls~ 130 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLDLSF 130 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSCCCTTCSEEECCS
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCccccccCCEEECCC
Confidence 68999999999999888899999999999999999999988999999999999999999998 44432 2566
Q ss_pred Ccccc-cCCccccCCCCCCEEecccccCcC----CCCcc--ceeeeccccc--ccccCccccCCC-CCCEEecccCcCcc
Q 041479 116 NKLEG-NIPSELGSLLKFKGLGLANNYFTG----PIPHL--NMFQVSVYSL--TGSIPIQLLNIT-SMEYFHVSENQLVG 185 (771)
Q Consensus 116 n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~----~lp~L--~~l~l~~n~l--~~~~p~~~~~l~-~L~~L~Ls~N~l~g 185 (771)
|++++ .+|..|+++++|++|++++|++++ .++.| +.++++.|.+ ++..|..+..+. +.-.++++.|.+.+
T Consensus 131 N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~ 210 (562)
T 3a79_B 131 NDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210 (562)
T ss_dssp SCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCC
T ss_pred CCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchh
Confidence 77776 356888889999999999998874 33445 8888888888 777777666543 11122334444433
Q ss_pred cCChhhhhCCCCCcEEEeecC----------------------------ccccc----CCccccCCCCCCEEEccccccC
Q 041479 186 ELPPHIGFTLPNVRILLLAGN----------------------------QFFGN----IPHSISNASKLEWLDFANNSLT 233 (771)
Q Consensus 186 ~lp~~~~~~l~~L~~L~L~~N----------------------------~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 233 (771)
.++...+..+++|+.|++++| .+++. .+.. ...++|++|++++|.++
T Consensus 211 ~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~ 289 (562)
T 3a79_B 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTIT 289 (562)
T ss_dssp CCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEEC
T ss_pred hhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEee
Confidence 333322223333333333333 22110 0001 11235566666666665
Q ss_pred CCCCcCcccc--cCC--------------------------CCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 234 GLIPEDLDSL--VNC--------------------------TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 234 ~~~p~~~~~l--~~l--------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+.+|..+... .++ .+|+.|++++|.+.. .+. ...+ ++|++|++++|+++
T Consensus 290 ~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~-~~~-~~~l-~~L~~L~l~~n~l~ 366 (562)
T 3a79_B 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH-MVC-PPSP-SSFTFLNFTQNVFT 366 (562)
T ss_dssp SCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCC-CCC-CSSC-CCCCEEECCSSCCC
T ss_pred ccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccc-ccC-ccCC-CCceEEECCCCccc
Confidence 5555433100 122 346666777776652 210 1233 36888888888888
Q ss_pred ccCcccccccCCcceEecCCcccee--ccCccccCCCCCCEEEccCCcccccCCc-ccccccccccccccCccceecCCc
Q 041479 286 GSIPTEIGNLKNLIIIAIEKFILIR--NIPISVGYLLKLQVLSLFENNISREIPS-SLGNFTFLTELNLCGNSIRGSVPS 362 (771)
Q Consensus 286 ~~~p~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~ 362 (771)
+.+|..|.++++|+.|++++|.+.+ .+|..+..+++|++|++++|++++.+|. .+..+++|++|++++|++++..|.
T Consensus 367 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 446 (562)
T 3a79_B 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446 (562)
T ss_dssp TTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGS
T ss_pred cchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhh
Confidence 7778888888888888888888765 3456677888888888888888763443 577788888888888888776666
Q ss_pred ccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccc
Q 041479 363 ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 363 ~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
.+. +.| .|+|++|+++ .+|..+..+++|++|+|++|+|+ .+|.. .|..+++|+.|+|++|+++|.+|..+
T Consensus 447 ~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~---~~~~l~~L~~L~l~~N~~~c~c~~~~ 517 (562)
T 3a79_B 447 CLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG---VFDRLTSLQYIWLHDNPWDCTCPGIR 517 (562)
T ss_dssp SCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTT---STTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred hhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHH---HHhcCCCCCEEEecCCCcCCCcchHH
Confidence 554 455 7888888887 45555558888888888888888 45544 13377888888888888888777543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=364.58 Aligned_cols=342 Identities=21% Similarity=0.210 Sum_probs=205.4
Q ss_pred EEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccC
Q 041479 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGS 128 (771)
Q Consensus 49 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~ 128 (771)
++.++++++ .+|..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|.++ +..|..|.+
T Consensus 16 v~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~--------------~~~~~~~~~ 78 (477)
T 2id5_A 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS--------------AVEPGAFNN 78 (477)
T ss_dssp EECCSCCCS-SCCSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC--------------EECTTTTTT
T ss_pred EEeCCCCcC-cCCCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccC--------------EeChhhhhC
Confidence 444556676 445544 368999999999999888889999999999999999865 455667777
Q ss_pred CCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcc
Q 041479 129 LLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF 208 (771)
Q Consensus 129 l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l 208 (771)
+++|++|+|++|++++ ..+..|.++++|++|+|++|++++..|. .+..+++|+.|+|++|++
T Consensus 79 l~~L~~L~L~~n~l~~-----------------~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 79 LFNLRTLGLRSNRLKL-----------------IPLGVFTGLSNLTKLDISENKIVILLDY-MFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp CTTCCEEECCSSCCCS-----------------CCTTSSTTCTTCCEEECTTSCCCEECTT-TTTTCTTCCEEEECCTTC
T ss_pred CccCCEEECCCCcCCc-----------------cCcccccCCCCCCEEECCCCccccCChh-HccccccCCEEECCCCcc
Confidence 8888888887777762 2223456677777777777777633333 333666777777777777
Q ss_pred cccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccC
Q 041479 209 FGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI 288 (771)
Q Consensus 209 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~ 288 (771)
++..|..|.++++|+.|+|++|+++++.+..| .++++|+.|++++|.+++..+..+..+. +|++|++++|.+.+.+
T Consensus 141 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l---~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~~~~~~~~ 216 (477)
T 2id5_A 141 VYISHRAFSGLNSLEQLTLEKCNLTSIPTEAL---SHLHGLIVLRLRHLNINAIRDYSFKRLY-RLKVLEISHWPYLDTM 216 (477)
T ss_dssp CEECTTSSTTCTTCCEEEEESCCCSSCCHHHH---TTCTTCCEEEEESCCCCEECTTCSCSCT-TCCEEEEECCTTCCEE
T ss_pred ceeChhhccCCCCCCEEECCCCcCcccChhHh---cccCCCcEEeCCCCcCcEeChhhcccCc-ccceeeCCCCcccccc
Confidence 66666666667777777777776665544433 4555666666666666544444444443 4555555555554444
Q ss_pred cccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCccccccc
Q 041479 289 PTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH 368 (771)
Q Consensus 289 p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 368 (771)
|..+ ....+|+.|+|++|+++...+..|..+++|+.|+|++|++++..+..|..+.
T Consensus 217 ~~~~------------------------~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 272 (477)
T 2id5_A 217 TPNC------------------------LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272 (477)
T ss_dssp CTTT------------------------TTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCT
T ss_pred Cccc------------------------ccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccc
Confidence 4433 3334555555555555533223455555555555555555555555555555
Q ss_pred ce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccccccccccc
Q 041479 369 QL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAI 447 (771)
Q Consensus 369 ~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~ 447 (771)
.| .|+|++|++++..|..|..+++|+.|+|++|+|++..+..+ ..+++|+.|+|++|++.|.++..+.+......
T Consensus 273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~ 348 (477)
T 2id5_A 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF----HSVGNLETLILDSNPLACDCRLLWVFRRRWRL 348 (477)
T ss_dssp TCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGB----SCGGGCCEEECCSSCEECSGGGHHHHTTTTSS
T ss_pred cCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHc----CCCcccCEEEccCCCccCccchHhHHhhhhcc
Confidence 55 55555555555555566666666666666666664333332 25566666666666666655544433333333
Q ss_pred cccCCCcccC
Q 041479 448 SEAGNEKLCG 457 (771)
Q Consensus 448 ~~~~n~~lc~ 457 (771)
.+.++...|.
T Consensus 349 ~~~~~~~~C~ 358 (477)
T 2id5_A 349 NFNRQQPTCA 358 (477)
T ss_dssp CCTTCCCBEE
T ss_pred ccCccCceeC
Confidence 4444545554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.52 Aligned_cols=238 Identities=18% Similarity=0.179 Sum_probs=180.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-CCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSD-FQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~~~~~~ 599 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+++|++++|||||++++++.... +......|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 344557999999999999999999999999996442 344578999999999999999999999986542 22334689
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||||+ |+|.++ .+.+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 136 ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp EEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 9999996 677655 45799999999999999999999996 9999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC----------
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL---------- 730 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~---------- 730 (771)
.........+.+||+.||||| +||++|||++|+.||.+.... ..+..+.....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGGTC--
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhhh
Confidence 322233345678999999999 699999999999999653111 11222211111
Q ss_pred ------------CC----c---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 ------------PD----Q---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ------------~~----~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+. . ....+++....+..+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 10 0 01123444445566999999999999999875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=368.05 Aligned_cols=376 Identities=16% Similarity=0.115 Sum_probs=297.3
Q ss_pred CCCCCCCCCCCCCCcc----ceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCC
Q 041479 18 PFGALSTWNDSVNFCQ----WLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFR 93 (771)
Q Consensus 18 ~~~~~~~w~~~~~~c~----w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 93 (771)
....+++|..+.+||. |.++.|+. + ++....... ....-..+++++.|++++|.+++..+..|.++++
T Consensus 5 ~~~~l~~~~~~~~C~~~~~~~~c~~~~~---~---i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~ 76 (597)
T 3oja_B 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDV---H---IDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76 (597)
T ss_dssp ------CCCSEECCCCC--CCSEEECSC---E---ECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred ccccccCCCCCCcCcccCcCceeEecCc---e---ecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence 3446789988878874 55554432 1 222222221 1112235788999999999999866777899999
Q ss_pred CCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCC
Q 041479 94 LRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSM 173 (771)
Q Consensus 94 L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L 173 (771)
|++|+|++|.++ +..|..|+.+++|+.|+|++|.|++ ..|..|.++++|
T Consensus 77 L~~L~L~~n~l~--------------~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~l~~L 125 (597)
T 3oja_B 77 VELLNLNDLQIE--------------EIDTYAFAYAHTIQKLYMGFNAIRY-----------------LPPHVFQNVPLL 125 (597)
T ss_dssp CSEEECTTSCCC--------------EECTTTTTTCTTCCEEECCSSCCCC-----------------CCTTTTTTCTTC
T ss_pred CcEEECCCCCCC--------------CCChHHhcCCCCCCEEECCCCcCCC-----------------CCHHHHcCCCCC
Confidence 999999999965 4566688999999999999998873 445668899999
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEE
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~ 253 (771)
++|+|++|.++ .+|+.++..+++|++|+|++|.|++..|..|.++++|+.|+|++|.+++..+ ..+++|+.|+
T Consensus 126 ~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------~~l~~L~~L~ 198 (597)
T 3oja_B 126 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL------SLIPSLFHAN 198 (597)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG------GGCTTCSEEE
T ss_pred CEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh------hhhhhhhhhh
Confidence 99999999999 7888876689999999999999999999999999999999999999987632 5568899999
Q ss_pred ccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccc
Q 041479 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 254 Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
+++|.+++. + . +.+|+.|++++|.++...+. + .++|+.|++++|.+.+ +..+..+++|+.|+|++|.++
T Consensus 199 l~~n~l~~l-~----~-~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~ 267 (597)
T 3oja_B 199 VSYNLLSTL-A----I-PIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267 (597)
T ss_dssp CCSSCCSEE-E----C-CTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred cccCccccc-c----C-CchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccC
Confidence 999999842 2 1 23799999999999854433 3 2689999999999976 477889999999999999999
Q ss_pred ccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchh
Q 041479 334 REIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLA 412 (771)
Q Consensus 334 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 412 (771)
+..|..|..+++|+.|+|++|++++ +|..+..++.| .|+|++|+++ .+|..+..+++|+.|+|++|+|++..+
T Consensus 268 ~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~---- 341 (597)
T 3oja_B 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKL---- 341 (597)
T ss_dssp EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCC----
T ss_pred CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcCh----
Confidence 9999999999999999999999996 46666778888 8999999999 567778889999999999999985432
Q ss_pred hhhcccccccEEECcCCCCCCCCCccccccccccccccCCCcccCCCC
Q 041479 413 WIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGIS 460 (771)
Q Consensus 413 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~ 460 (771)
..+++|+.|+|++|+++|..+..+ +.......+.++...|+...
T Consensus 342 ---~~~~~L~~L~l~~N~~~~~~~~~~-~~~~~~~~~~~~~~~C~~~~ 385 (597)
T 3oja_B 342 ---STHHTLKNLTLSHNDWDCNSLRAL-FRNVARPAVDDADQHCKIDY 385 (597)
T ss_dssp ---CTTCCCSEEECCSSCEEHHHHHHH-TTTCCTTTBCCCCCCCCTTC
T ss_pred ---hhcCCCCEEEeeCCCCCChhHHHH-HHHHhhhccccccccCCcch
Confidence 267899999999999998765433 44555566778888887644
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.70 Aligned_cols=373 Identities=17% Similarity=0.149 Sum_probs=288.2
Q ss_pred CCCCCCCCCCcc-ceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecc
Q 041479 22 LSTWNDSVNFCQ-WLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFN 100 (771)
Q Consensus 22 ~~~w~~~~~~c~-w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 100 (771)
+++|....+||. |.+..|.....++ +-..... .....-..+++|++|++++|.++...+..|..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~~~~--~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI---DMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEESCEE---CSSCCCC--EESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceeeeee---ecccccc--cccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 678988888874 5555554321111 1111111 122223467899999999999997656668999999999999
Q ss_pred cCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEeccc
Q 041479 101 SNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSE 180 (771)
Q Consensus 101 ~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 180 (771)
+|.++ +..+..|..+++|++|+|++|++++ ..|..|.++++|++|++++
T Consensus 78 ~n~i~--------------~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~l~~L~~L~L~~ 126 (390)
T 3o6n_A 78 DLQIE--------------EIDTYAFAYAHTIQKLYMGFNAIRY-----------------LPPHVFQNVPLLTVLVLER 126 (390)
T ss_dssp TSCCC--------------EECTTTTTTCTTCCEEECCSSCCCC-----------------CCTTTTTTCTTCCEEECCS
T ss_pred CCccc--------------ccChhhccCCCCcCEEECCCCCCCc-----------------CCHHHhcCCCCCCEEECCC
Confidence 99965 3555688999999999999998873 4456688999999999999
Q ss_pred CcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccc
Q 041479 181 NQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS 260 (771)
Q Consensus 181 N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~ 260 (771)
|+++ .+|..++..+++|++|++++|++++..|..|..+++|++|++++|++++.. +..+++|+.|++++|.++
T Consensus 127 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD------LSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC------GGGCTTCSEEECCSSCCS
T ss_pred CccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc------cccccccceeeccccccc
Confidence 9998 899887668999999999999999888889999999999999999998753 256688999999999998
Q ss_pred ccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCccc
Q 041479 261 GTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSL 340 (771)
Q Consensus 261 ~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 340 (771)
+ ++. ..+|++|++++|.++.. |..+ .++|+.|++++|.+.+. ..+..+++|++|++++|++++..|..|
T Consensus 200 ~-~~~-----~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~ 268 (390)
T 3o6n_A 200 T-LAI-----PIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPF 268 (390)
T ss_dssp E-EEC-----CSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred c-cCC-----CCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHc
Confidence 4 221 23799999999999854 4432 47899999999999764 578899999999999999998889999
Q ss_pred ccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccc
Q 041479 341 GNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYIS 419 (771)
Q Consensus 341 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~ 419 (771)
..+++|++|+|++|++++ +|..+..++.| .|++++|+++ .+|..+..+++|++|+|++|+|+.. | +..++
T Consensus 269 ~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~------~~~~~ 339 (390)
T 3o6n_A 269 VKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K------LSTHH 339 (390)
T ss_dssp TTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C------CCTTC
T ss_pred cccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C------chhhc
Confidence 999999999999999986 45566778888 8999999998 4566678889999999999999844 3 22678
Q ss_pred cccEEECcCCCCCCCCCccccccccccccccCCCcccCC
Q 041479 420 IFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGG 458 (771)
Q Consensus 420 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 458 (771)
+|+.|++++|++++..... .+..+....+.+++..|..
T Consensus 340 ~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 340 TLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCT
T ss_pred cCCEEEcCCCCccchhHHH-HHHHHHhhcccccCceecc
Confidence 9999999999998765433 2344444555666666654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=359.44 Aligned_cols=230 Identities=19% Similarity=0.202 Sum_probs=185.5
Q ss_pred ccccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHH---HHHHHHHhccCCCCceeEEEEeecCCC
Q 041479 519 SRKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSF---MAECQALRNIRHRNLVKIITACSTSDF 592 (771)
Q Consensus 519 ~~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~ 592 (771)
...++...-.+|+|++|+||+|+++.+++.||||++.... ......+ ..++.+++.++|||||++++++.+.+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~- 265 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD- 265 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC-
Confidence 3456666678999999999999999999999999996542 1222333 34467777889999999999998877
Q ss_pred CCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 593 QGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
..|+|||||+||+|.++ ...+++..+..|+.||+.||+|||+. +||||||||+|||++.+|.+||+|||+
T Consensus 266 ----~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 266 ----KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ----EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence 78999999999999876 35689999999999999999999986 999999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHH--HhhCC
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV--KMALP 731 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~--~~~~~ 731 (771)
|+...... ..+.+||+.||||| +||++|||++|+.||.+..... ..+.. ....+
T Consensus 339 A~~~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~~~i~~~~ 410 (689)
T 3v5w_A 339 ACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMA 410 (689)
T ss_dssp CEECSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHHHHHHHCC
T ss_pred eeecCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhhcCCC
Confidence 98765432 23468999999999 6999999999999997643222 22222 22233
Q ss_pred CchhhhcCccccccCcccChhchhhcCC-----HHHHH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIK-----KGQIR 764 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt-----~~~vl 764 (771)
...+..+++....+..+||++||++|++ +.||.
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 4455667777777788999999999998 56765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=361.53 Aligned_cols=384 Identities=19% Similarity=0.183 Sum_probs=292.2
Q ss_pred CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc----------c
Q 041479 43 YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS----------R 112 (771)
Q Consensus 43 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~ 112 (771)
.++++.|||++|+|+++.+.+|.++++|++|+|++|+|++..|++|.++++|++|+|++|++++..+.. .
T Consensus 75 l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 468999999999999988889999999999999999999877788999999999999999988533321 1
Q ss_pred ccCCcccc-cCCccccCCCCCCEEecccccCcCCCCc-----------cceeeecccccccccCccccCCCCCCEEeccc
Q 041479 113 LILNKLEG-NIPSELGSLLKFKGLGLANNYFTGPIPH-----------LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSE 180 (771)
Q Consensus 113 l~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~lp~-----------L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 180 (771)
+..|.+++ ..|..++.+++|+.|++++|+|++..+. ...++++.|.++...+..+.. ..++.+++++
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~ 233 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRN 233 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEES
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhc
Confidence 44455544 3456666667777777777766643221 224555555554322221111 1112222222
Q ss_pred C-------------------------------------------------------------------------------
Q 041479 181 N------------------------------------------------------------------------------- 181 (771)
Q Consensus 181 N------------------------------------------------------------------------------- 181 (771)
|
T Consensus 234 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~ 313 (635)
T 4g8a_A 234 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSL 313 (635)
T ss_dssp CCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEE
T ss_pred ccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccc
Confidence 2
Q ss_pred ---cCcccCChhhhhCCCCCcEEEeecCcccccCC-------------------ccccCCCCCCEEEccccccCCC--CC
Q 041479 182 ---QLVGELPPHIGFTLPNVRILLLAGNQFFGNIP-------------------HSISNASKLEWLDFANNSLTGL--IP 237 (771)
Q Consensus 182 ---~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p-------------------~~~~~l~~L~~L~Ls~N~l~~~--~p 237 (771)
.+. .++. + ....+|+.|++.+|.+.+..+ ..+..+++|+.|++++|.+... .+
T Consensus 314 ~~~~~~-~~~~-~-~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~ 390 (635)
T 4g8a_A 314 VSVTIE-RVKD-F-SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 390 (635)
T ss_dssp ESCEEE-ECGG-G-GSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECC
T ss_pred cccccc-cccc-c-ccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccc
Confidence 111 1111 1 123455666666665543322 2334678899999999988643 23
Q ss_pred cCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCc-ccccccCCcceEecCCccceeccCccc
Q 041479 238 EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP-TEIGNLKNLIIIAIEKFILIRNIPISV 316 (771)
Q Consensus 238 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~ 316 (771)
.. ...+.+|++++++.|.+. .++..+..+. +|+.++++.|.+....+ ..|.++++++.++++.|.+....|..+
T Consensus 391 ~~---~~~~~~L~~L~~~~~~~~-~~~~~~~~l~-~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~ 465 (635)
T 4g8a_A 391 QS---DFGTISLKYLDLSFNGVI-TMSSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 465 (635)
T ss_dssp HH---HHSCSCCCEEECCSCSEE-EECSCCTTCT-TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTT
T ss_pred cc---hhhhhhhhhhhccccccc-cccccccccc-cccchhhhhcccccccccccccccccccccccccccccccccccc
Confidence 32 356789999999999998 5566677765 79999999998876554 568999999999999999999999999
Q ss_pred cCCCCCCEEEccCCcc-cccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCC
Q 041479 317 GYLLKLQVLSLFENNI-SREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIP 394 (771)
Q Consensus 317 ~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~ 394 (771)
..++.|+.|++++|++ ....|..|..+++|++|+|++|+|++..|..|..++.| .|+|++|+|++..|..|..+++|+
T Consensus 466 ~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~ 545 (635)
T 4g8a_A 466 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 545 (635)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCC
T ss_pred ccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCC
Confidence 9999999999999985 44678899999999999999999999999999999999 999999999999999999999999
Q ss_pred eEECCCCcccccCCcchhhhhccc-ccccEEECcCCCCCCCCCccc
Q 041479 395 HLDLSKNELSGEIPSSLAWIFGYI-SIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 395 ~L~Ls~N~l~~~~p~~l~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
+|||++|+|++..|..+. .+ ++|+.|+|++|+|+|.+.-.+
T Consensus 546 ~L~Ls~N~l~~~~~~~l~----~l~~~L~~L~L~~Np~~C~C~~~~ 587 (635)
T 4g8a_A 546 VLDYSLNHIMTSKKQELQ----HFPSSLAFLNLTQNDFACTCEHQS 587 (635)
T ss_dssp EEECTTSCCCBCCSSCTT----CCCTTCCEEECTTCCBCCSGGGHH
T ss_pred EEECCCCcCCCCCHHHHH----hhhCcCCEEEeeCCCCcccCCcHH
Confidence 999999999998898765 65 689999999999999987543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=350.80 Aligned_cols=343 Identities=25% Similarity=0.296 Sum_probs=244.3
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCC-------------CEEecccCcCcc--cC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRL-------------RHIIFNSNALQG--QI 108 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~--~~ 108 (771)
.+++.|++++|++ +.+|++|+.+++|++|++++|++++.+|.+++++++| ++|++++|.+++ .+
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 6899999999999 6899999999999999999999999999999999875 999999999987 22
Q ss_pred Cc----ccccCCcccccCCccccCCCCCCEEecccccCcC--CC-CccceeeecccccccccCccccCCCCCCEEecccC
Q 041479 109 PD----SRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG--PI-PHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSEN 181 (771)
Q Consensus 109 p~----~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~l-p~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N 181 (771)
|. ..+..|.+++ +|.. +++|+.|++++|++++ .+ +.|+.|++++|.+++ +| .+.++++|++|++++|
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N 163 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNN 163 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCC
Confidence 22 2367788887 6654 4789999999999986 33 579999999999997 67 6999999999999999
Q ss_pred cCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccc
Q 041479 182 QLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG 261 (771)
Q Consensus 182 ~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 261 (771)
+++ .+|.. .++|++|++++|++++ +| .|.++++|++|++++|+++++ |.. .++|++|++++|.++
T Consensus 164 ~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~------~~~L~~L~l~~n~l~- 228 (454)
T 1jl5_A 164 SLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL------PLSLESIVAGNNILE- 228 (454)
T ss_dssp CCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC------CTTCCEEECCSSCCS-
T ss_pred cCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC------cCcccEEECcCCcCC-
Confidence 998 57753 3589999999999996 56 699999999999999999874 432 257889999999988
Q ss_pred cCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccc
Q 041479 262 TLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341 (771)
Q Consensus 262 ~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 341 (771)
.+|. +..+. +|++|++++|++++ +|.. +++|+.|++++|.+.+ +|.. +++|+.|++++|++++. |..
T Consensus 229 ~lp~-~~~l~-~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~-- 295 (454)
T 1jl5_A 229 ELPE-LQNLP-FLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL-- 295 (454)
T ss_dssp SCCC-CTTCT-TCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC--
T ss_pred cccc-cCCCC-CCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc--
Confidence 7774 66665 79999999999985 4543 3788888998888865 4543 37788888888888752 221
Q ss_pred cccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhccccc
Q 041479 342 NFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISI 420 (771)
Q Consensus 342 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~ 420 (771)
.++|++|++++|++++. +.. ...+ .|++++|++++ +|.. +++|++|++++|+++ .+|. .+++
T Consensus 296 -~~~L~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~-------~l~~ 358 (454)
T 1jl5_A 296 -PPNLYYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE-------LPQN 358 (454)
T ss_dssp -CTTCCEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC-------CCTT
T ss_pred -CCcCCEEECcCCcCCcc-cCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc-------hhhh
Confidence 15677777777777752 211 1245 67777777775 4443 467777777777777 4554 2456
Q ss_pred ccEEECcCCCCCC--CCCcc
Q 041479 421 FAKLNLSYNNLDG--DVPRK 438 (771)
Q Consensus 421 L~~L~Ls~N~l~~--~~p~~ 438 (771)
|+.|++++|++++ .+|..
T Consensus 359 L~~L~L~~N~l~~l~~ip~~ 378 (454)
T 1jl5_A 359 LKQLHVEYNPLREFPDIPES 378 (454)
T ss_dssp CCEEECCSSCCSSCCCCCTT
T ss_pred ccEEECCCCCCCcCCCChHH
Confidence 7777777777776 55554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.00 Aligned_cols=181 Identities=23% Similarity=0.312 Sum_probs=150.9
Q ss_pred cccccccccccceEEEEEec---CCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEE
Q 041479 524 LLNVSYESLVKATVYKGILD---LDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.....+|+|.+|+||+|+++ .+++.||||++.... ...++.+|+++++.+ +|||||++++++.+.+ ..|
T Consensus 24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~-----~~~ 96 (361)
T 4f9c_A 24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND-----HVV 96 (361)
T ss_dssp EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT-----EEE
T ss_pred EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC-----EEE
Confidence 34456899999999999875 346799999986543 346788999999998 6999999999998876 789
Q ss_pred EEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCccccCcccC
Q 041479 600 LVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 600 lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~~~~~~ 678 (771)
+|||||++|+|.++.+.+++.++..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 97 lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999998878899999999999999999999996 99999999999999876 7999999999986543211
Q ss_pred C------------------------cccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 679 S------------------------NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 679 ~------------------------~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
. ........+||+.||||| +||++|||++|+.||..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 0 001123457999999999 69999999999999953
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=358.00 Aligned_cols=229 Identities=21% Similarity=0.200 Sum_probs=189.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.||+||+|+++.+++.||||++........+.+.+|+++|+.++|||||++++++.+.+ ..|+||
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~iv~ 233 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMVMIY 233 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEE
Confidence 334456899999999999999999999999997766666788999999999999999999999998876 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND--MTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~--~~~kl~DfGla~~~~~~ 676 (771)
|||+||+|.++ ...+++.++..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999665 34688999999999999999999996 99999999999999854 89999999999976543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 739 (771)
.. ....+||+.||||| +||++|||++|+.||.+.... ..+..+..... +......++
T Consensus 311 ~~-----~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 311 QS-----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp SE-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCCCSGGGTTSC
T ss_pred Cc-----eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHhCCCCCCcccccCCC
Confidence 22 22457999999999 699999999999999764221 12333333332 344445566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+....+..+||+.||++|||+.|+++
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 66667777999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=347.54 Aligned_cols=342 Identities=18% Similarity=0.186 Sum_probs=249.0
Q ss_pred cceeeeecCC---------CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCc
Q 041479 33 QWLGVTCSLK---------YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNA 103 (771)
Q Consensus 33 ~w~~v~c~~~---------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 103 (771)
.|..|.|... ..+++.|+|++|++++..+..|..+++|++|+|++|.|++..|.+|+++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 4778888643 2578999999999999989999999999999999999999889999999999999999999
Q ss_pred CcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcC
Q 041479 104 LQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQL 183 (771)
Q Consensus 104 l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 183 (771)
++ +..+..|.++++|+.|+|++|++++ ..|..|.++++|++|++++|.+
T Consensus 92 l~--------------~~~~~~~~~l~~L~~L~Ls~n~i~~-----------------~~~~~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 92 LK--------------LIPLGVFTGLSNLTKLDISENKIVI-----------------LLDYMFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp CC--------------SCCTTSSTTCTTCCEEECTTSCCCE-----------------ECTTTTTTCTTCCEEEECCTTC
T ss_pred CC--------------ccCcccccCCCCCCEEECCCCcccc-----------------CChhHccccccCCEEECCCCcc
Confidence 76 2334468899999999999998873 4566788889999999999998
Q ss_pred cccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccC
Q 041479 184 VGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTL 263 (771)
Q Consensus 184 ~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~ 263 (771)
++ +++..+..+++|+.|+|++|++++..+..|.++++|+.|+|++|.++++.+..| ..+++|+.|++++|.+.+.+
T Consensus 141 ~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~---~~l~~L~~L~l~~~~~~~~~ 216 (477)
T 2id5_A 141 VY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF---KRLYRLKVLEISHWPYLDTM 216 (477)
T ss_dssp CE-ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCS---CSCTTCCEEEEECCTTCCEE
T ss_pred ce-eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhc---ccCcccceeeCCCCcccccc
Confidence 84 444444488899999999999987777778899999999999999988777665 77788999999998887788
Q ss_pred ChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccc
Q 041479 264 PNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF 343 (771)
Q Consensus 264 p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 343 (771)
|....... +|++|++++|+|++..+..|..+++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..|..|..+
T Consensus 217 ~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 295 (477)
T 2id5_A 217 TPNCLYGL-NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295 (477)
T ss_dssp CTTTTTTC-CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC
T ss_pred CcccccCc-cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc
Confidence 87776655 78899999988885444556666666655555555555444445555555555555555554444455555
Q ss_pred cccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccE
Q 041479 344 TFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAK 423 (771)
Q Consensus 344 ~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~ 423 (771)
++|+.|+|++|+ |++..+..|..+++|++|+|++|+++...+ +.|.+.. +..
T Consensus 296 ~~L~~L~L~~N~-----------------------l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~--~~~~~~~---~~~ 347 (477)
T 2id5_A 296 NYLRVLNVSGNQ-----------------------LTTLEESVFHSVGNLETLILDSNPLACDCR--LLWVFRR---RWR 347 (477)
T ss_dssp TTCCEEECCSSC-----------------------CSCCCGGGBSCGGGCCEEECCSSCEECSGG--GHHHHTT---TTS
T ss_pred ccCCEEECCCCc-----------------------CceeCHhHcCCCcccCEEEccCCCccCccc--hHhHHhh---hhc
Confidence 555544444444 444444556666677777777777764322 2333322 233
Q ss_pred EECcCCCCCCCCCcc
Q 041479 424 LNLSYNNLDGDVPRK 438 (771)
Q Consensus 424 L~Ls~N~l~~~~p~~ 438 (771)
+++.++...|..|..
T Consensus 348 ~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 348 LNFNRQQPTCATPEF 362 (477)
T ss_dssp SCCTTCCCBEEESGG
T ss_pred cccCccCceeCCchH
Confidence 445566666655554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=339.07 Aligned_cols=338 Identities=26% Similarity=0.349 Sum_probs=275.1
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|+++++.++.. | .+..+++|++|+|++|.+++. |. |.++++|++|++++|.++ .++
T Consensus 46 ~~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~---------------~~~ 106 (466)
T 1o6v_A 46 DQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA---------------DIT 106 (466)
T ss_dssp HTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC---------------CCG
T ss_pred ccccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccc---------------cCh
Confidence 5789999999999854 3 488999999999999999974 44 999999999999999976 233
Q ss_pred ccccCCCCCCEEecccccCcC-----CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC
Q 041479 124 SELGSLLKFKGLGLANNYFTG-----PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV 198 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~-----~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L 198 (771)
. ++++++|++|++++|++++ .++.|+.|+++.|.+++. + .+.++++|++|+++ |.+. .+++ + ..+++|
T Consensus 107 ~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~-~~~~-~-~~l~~L 179 (466)
T 1o6v_A 107 P-LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVT-DLKP-L-ANLTTL 179 (466)
T ss_dssp G-GTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCC-CCGG-G-TTCTTC
T ss_pred h-hcCCCCCCEEECCCCCCCCChHHcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Cccc-Cchh-h-ccCCCC
Confidence 3 8899999999999999874 456788889998888763 3 48888999999986 5665 3443 4 388899
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceee
Q 041479 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278 (771)
Q Consensus 199 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~ 278 (771)
+.|++++|++++. ..+..+++|++|++++|.+++..| + ..+++|+.|++++|++++ ++ .+..+. +|++|+
T Consensus 180 ~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~---~~l~~L~~L~l~~n~l~~-~~-~l~~l~-~L~~L~ 249 (466)
T 1o6v_A 180 ERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--L---GILTNLDELSLNGNQLKD-IG-TLASLT-NLTDLD 249 (466)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G---GGCTTCCEEECCSSCCCC-CG-GGGGCT-TCSEEE
T ss_pred CEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--c---cccCCCCEEECCCCCccc-ch-hhhcCC-CCCEEE
Confidence 9999999998754 358888999999999999887655 3 667889999999999883 43 466664 799999
Q ss_pred cccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCcccee
Q 041479 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 279 Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
+++|.+++..| +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 250 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 250 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred CCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence 99999986554 8888999999999998876544 7888999999999999986544 7888999999999999987
Q ss_pred cCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCC
Q 041479 359 SVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 359 ~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
..| +..++.| .|++++|++++. ..+..+++|+.|++++|++++..| +. .+++|+.|++++|++++
T Consensus 324 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~----~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 324 ISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LA----NLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GT----TCTTCCEEECCCEEEEC
T ss_pred chh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hh----cCCCCCEEeccCCcccC
Confidence 665 6778888 899999998865 467888999999999999987766 33 78889999999998886
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.64 Aligned_cols=333 Identities=20% Similarity=0.236 Sum_probs=233.0
Q ss_pred CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccC
Q 041479 43 YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNI 122 (771)
Q Consensus 43 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~ 122 (771)
..+++.|+|++|++++. | .|+.+++|++|+|++|+|++ +| |+.+++|++|++++|++++ +
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~---------------~ 100 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN---------------L 100 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC---------------C
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce---------------e
Confidence 37899999999999975 4 79999999999999999997 45 9999999999999999762 3
Q ss_pred CccccCCCCCCEEecccccCcC----CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC
Q 041479 123 PSELGSLLKFKGLGLANNYFTG----PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV 198 (771)
Q Consensus 123 p~~~~~l~~L~~L~Ls~N~l~~----~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L 198 (771)
| ++++++|++|++++|++++ .++.|+.|+++.|.+++. .+.++++|++|++++|+..+.++ +. .+++|
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~l~~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~--~~-~l~~L 172 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VT-PQTQL 172 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSCCCCTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC--CT-TCTTC
T ss_pred e--cCCCCcCCEEECCCCcCCeecCCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc--cc-cCCcC
Confidence 3 8889999999999999984 456788888888888874 37788888888888886655663 33 77888
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceee
Q 041479 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278 (771)
Q Consensus 199 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~ 278 (771)
+.|++++|+|++ +| +..+++|+.|++++|++++. . +..+++|+.|++++|++++ +| +..+. +|++|+
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~---l~~l~~L~~L~Ls~N~l~~-ip--~~~l~-~L~~L~ 239 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---D---LNQNIQLTFLDCSSNKLTE-ID--VTPLT-QLTYFD 239 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---C---CTTCTTCSEEECCSSCCSC-CC--CTTCT-TCSEEE
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---c---cccCCCCCEEECcCCcccc-cC--ccccC-CCCEEE
Confidence 888888888886 44 77888888888888888875 1 3677888888888888885 66 55654 788888
Q ss_pred cccCcCcccCcccccccC-------CcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccc
Q 041479 279 MSANPISGSIPTEIGNLK-------NLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNL 351 (771)
Q Consensus 279 Ls~N~l~~~~p~~~~~l~-------~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 351 (771)
+++|++++..+..+.+++ +|+.|++++|.+.+.+| ++.+++|+.|++++|.+.+.+|.. ..+|+.|++
T Consensus 240 l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L~~L~l 314 (457)
T 3bz5_A 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGITELDL 314 (457)
T ss_dssp CCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCCSCCCC
T ss_pred eeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcceEech
Confidence 888888876544444443 34445555555444444 344556666666666554444421 122222222
Q ss_pred cCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhh---------hcccccc
Q 041479 352 CGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWI---------FGYISIF 421 (771)
Q Consensus 352 s~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~---------~~~l~~L 421 (771)
+ .++.| .|++++|+|++. + ++.+++|+.|++++|+|++ +|. +..+ ...+..|
T Consensus 315 ~-------------~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l~~-L~~L~l~~n~l~g~~~~~~l 376 (457)
T 3bz5_A 315 S-------------QNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITM 376 (457)
T ss_dssp T-------------TCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-CTT-GGGSSGGGTSEEEEEEEEEC
T ss_pred h-------------hcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-ccc-cccccccCCcEEecceeeec
Confidence 2 22344 566666666653 2 5566666666666666664 221 1000 0133556
Q ss_pred cEEECcCCCCCCCCCccc
Q 041479 422 AKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 422 ~~L~Ls~N~l~~~~p~~~ 439 (771)
..+++++|+++|.+|..+
T Consensus 377 ~~l~l~~N~l~g~ip~~~ 394 (457)
T 3bz5_A 377 PKETLTNNSLTIAVSPDL 394 (457)
T ss_dssp CCBCCBTTBEEEECCTTC
T ss_pred CccccccCcEEEEcChhH
Confidence 777888888888888653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.42 Aligned_cols=237 Identities=22% Similarity=0.347 Sum_probs=191.5
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|++..+++.||||++........+.|.+|++++++++||||+++++++.+.+ ..++|
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv 85 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLNFI 85 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeEEE
Confidence 3445567899999999999999999999999997666667789999999999999999999999998776 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999776 35689999999999999999999996 89999999999999999999999999998664332
Q ss_pred CCc----------ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC----CccHHHHHHh
Q 041479 678 SSN----------QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE----GLDLHNFVKM 728 (771)
Q Consensus 678 ~~~----------~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~----~~~~~~~~~~ 728 (771)
... .......+||+.|+||| +||++||+++|..|+.+.... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 01112457999999999 799999999999998653322 2233333333
Q ss_pred hCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 729 ALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+ ..+++.+.....+||+.||++|||+.++++.|+++
T Consensus 243 ~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 243 YCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp TCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 333 33445555666799999999999999999999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.10 Aligned_cols=320 Identities=26% Similarity=0.403 Sum_probs=276.8
Q ss_pred CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccC
Q 041479 43 YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNI 122 (771)
Q Consensus 43 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~ 122 (771)
..+++.|+|++|++++..+ +..+++|++|+|++|++++..| |+++++|++|++++|.++ .+
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~---------------~~ 127 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT---------------DI 127 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC---------------CC
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCC---------------CC
Confidence 4689999999999997654 9999999999999999997544 999999999999999976 23
Q ss_pred CccccCCCCCCEEecccccCcC-----CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCC
Q 041479 123 PSELGSLLKFKGLGLANNYFTG-----PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPN 197 (771)
Q Consensus 123 p~~~~~l~~L~~L~Ls~N~l~~-----~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~ 197 (771)
+. +.++++|+.|++++|++++ .++.|+.++++ |.+.+..+ +.++++|++|++++|.++ .++. + ..+++
T Consensus 128 ~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~-~~~~-l-~~l~~ 200 (466)
T 1o6v_A 128 DP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS-DISV-L-AKLTN 200 (466)
T ss_dssp GG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-G-GGCTT
T ss_pred hH-HcCCCCCCEEECCCCccCCChhhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCC-CChh-h-ccCCC
Confidence 33 8899999999999999874 46679999996 55654433 889999999999999998 5654 4 48999
Q ss_pred CcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhccccccee
Q 041479 198 VRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277 (771)
Q Consensus 198 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L 277 (771)
|++|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|.+++..| +..+. +|++|
T Consensus 201 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-----~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L 270 (466)
T 1o6v_A 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-----GTLASLTNLTDLDLANNQISNLAP--LSGLT-KLTEL 270 (466)
T ss_dssp CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCGG--GTTCT-TCSEE
T ss_pred CCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-----hhhhcCCCCCEEECCCCccccchh--hhcCC-CCCEE
Confidence 9999999999997665 78899999999999999865 234788999999999999995444 66665 89999
Q ss_pred ecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccce
Q 041479 278 YMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 278 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 271 ~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred ECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccC
Confidence 999999996554 8999999999999999977554 8899999999999999997665 889999999999999999
Q ss_pred ecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCc
Q 041479 358 GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPS 409 (771)
Q Consensus 358 ~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 409 (771)
+. ..+..++.| .|++++|++++..| +..+++|+.|++++|++++ .|.
T Consensus 345 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~ 392 (466)
T 1o6v_A 345 DV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APV 392 (466)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCB
T ss_pred Cc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cch
Confidence 65 468889999 89999999998877 8899999999999999995 444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.82 Aligned_cols=231 Identities=21% Similarity=0.245 Sum_probs=189.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|++..+++.||||++........+.+.+|+.++++++|||||++++++...+ ..|+|
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv 95 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWVV 95 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEEEE
Confidence 3444556899999999999999999999999998776666788999999999999999999999998876 78999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999999877 34588999999999999999999996 999999999999999999999999999986554322
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 743 (771)
.....+||+.|+||| +||++|||++|+.||.+..... ..........+ ...+..+++.+.
T Consensus 172 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 172 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp ---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred ---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCCCCccccCHHHH
Confidence 223457999999999 6999999999999997532211 12222222222 333455666666
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+||+.||++|||+.|+++
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhh
Confidence 6777999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=323.97 Aligned_cols=239 Identities=22% Similarity=0.299 Sum_probs=192.3
Q ss_pred ccccccccccccccceEEEEEec-------CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILD-------LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSD 591 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~-------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 591 (771)
..+.....+|+|.+|+||+|++. .++..||||++.... ....+++.+|+++++++ +|||||++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 34445567999999999999874 245689999996543 44567899999999999 8999999999998766
Q ss_pred CCCceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 041479 592 FQGNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652 (771)
Q Consensus 592 ~~~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~ 652 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+
T Consensus 161 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 232 (370)
T 2psq_A 161 -----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232 (370)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred -----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence 679999999999997651 2478899999999999999999996 9999999999
Q ss_pred CeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccc
Q 041479 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMF 716 (771)
Q Consensus 653 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~ 716 (771)
|||++.++.+||+|||+++........ .......||+.|+||| |||++|||++ |+.||.+..
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999999866543221 1223345789999999 6999999999 999997642
Q ss_pred cCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 717 TEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
. ..+............+..+++.+...+.+||+.||++|||+.|+++.|++++
T Consensus 311 ~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 311 V--EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp G--GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2 2344444444444445556666767777999999999999999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.65 Aligned_cols=308 Identities=16% Similarity=0.174 Sum_probs=266.8
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|++++|.++.+++..|..+++|++|+|++|.+++..|.+|+.+++|++|+|++|.++ +..|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--------------~~~~ 110 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR--------------YLPP 110 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC--------------CCCT
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC--------------cCCH
Confidence 68899999999999777777899999999999999999888889999999999999999965 3556
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCcc-ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEE
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQ-LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILL 202 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~ 202 (771)
..|+++++|++|+|++|+++ .+|.. |.++++|++|++++|+++ .+++..+..+++|++|+
T Consensus 111 ~~~~~l~~L~~L~L~~n~l~------------------~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 111 HVFQNVPLLTVLVLERNDLS------------------SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp TTTTTCTTCCEEECCSSCCC------------------CCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTSSCTTCCEEE
T ss_pred HHhcCCCCCCEEECCCCccC------------------cCCHHHhcCCCCCcEEECCCCccC-ccChhhccCCCCCCEEE
Confidence 77899999999999999987 34444 688999999999999999 56555455899999999
Q ss_pred eecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccC
Q 041479 203 LAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSAN 282 (771)
Q Consensus 203 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N 282 (771)
+++|++++. .+..+++|+.|++++|.+++. ...++|+.|++++|.++ .+|.... ++|+.|++++|
T Consensus 172 l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~--------~~~~~L~~L~l~~n~l~-~~~~~~~---~~L~~L~l~~n 236 (390)
T 3o6n_A 172 LSSNRLTHV---DLSLIPSLFHANVSYNLLSTL--------AIPIAVEELDASHNSIN-VVRGPVN---VELTILKLQHN 236 (390)
T ss_dssp CCSSCCSBC---CGGGCTTCSEEECCSSCCSEE--------ECCSSCSEEECCSSCCC-EEECCCC---SSCCEEECCSS
T ss_pred CCCCcCCcc---ccccccccceeeccccccccc--------CCCCcceEEECCCCeee-ecccccc---ccccEEECCCC
Confidence 999999865 366789999999999998754 23467999999999998 4454332 47999999999
Q ss_pred cCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCc
Q 041479 283 PISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPS 362 (771)
Q Consensus 283 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 362 (771)
.+++. ..+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|.
T Consensus 237 ~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~ 312 (390)
T 3o6n_A 237 NLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 312 (390)
T ss_dssp CCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGG
T ss_pred CCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCc
Confidence 99864 578999999999999999999999999999999999999999985 5777788999999999999999 5677
Q ss_pred ccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc
Q 041479 363 ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406 (771)
Q Consensus 363 ~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 406 (771)
.+..++.| .|++++|+++.. | +..+++|+.|++++|+++..
T Consensus 313 ~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 313 NQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp GHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence 78888889 899999999865 3 67789999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.64 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=189.3
Q ss_pred ccccccccccccceEEEEEecCCC---eEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ---TFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|++..++ ..||||++... .....+.|.+|++++++++|||||++++++.+.+ ..
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 125 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-----LA 125 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-----CC
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----cc
Confidence 444567899999999999997544 46999999754 3445678999999999999999999999987765 67
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999776 24689999999999999999999996 99999999999999999999999999998765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ........+|+.|+||| +||++|||++ |+.||.+... ...............+..+
T Consensus 203 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 279 (325)
T 3kul_A 203 DDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRLPAPMGC 279 (325)
T ss_dssp ----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTCCCCCCTTC
T ss_pred cCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCCCCCCCCc
Confidence 43221 12233445788999999 6999999999 9999976422 2233333333333444556
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
++.+...+.+||..||++|||+.++++.|++++
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 666667777999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=325.77 Aligned_cols=237 Identities=24% Similarity=0.295 Sum_probs=191.4
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.+.....+|+|.+|+||+|+++.+++.||||++.... ....++|.+|++++++++|||||++++++...+ ..|+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 189 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYI 189 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-----SCEE
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-----CcEE
Confidence 3444567899999999999999888899999986542 334567999999999999999999999997765 5799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999776 34589999999999999999999996 8999999999999999999999999999864332
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ........+++.|+||| |||++||++| |+.||.+... ....+.+....+...+..+++
T Consensus 267 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 267 VY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRLPCPELCPD 342 (377)
T ss_dssp EE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCCCCCCTTCCH
T ss_pred ce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCH
Confidence 11 11111223678899999 7999999999 9999976422 224444444444444555666
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+...+.+||+.||++|||+.++++.|+++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 666777899999999999999999999876
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=325.53 Aligned_cols=308 Identities=19% Similarity=0.220 Sum_probs=189.8
Q ss_pred CcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEE
Q 041479 56 LTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGL 135 (771)
Q Consensus 56 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L 135 (771)
..+..+..++.+++|++|+|++|.|++ +| +|+.+++|++|+|++|++++ +| ++.+++|++|
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~---------------~~--~~~l~~L~~L 90 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT---------------LD--LSQNTNLTYL 90 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC---------------CC--CTTCTTCSEE
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe---------------Ec--cccCCCCCEE
Confidence 344556678999999999999999997 46 79999999999999999762 33 8889999999
Q ss_pred ecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCcc
Q 041479 136 GLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHS 215 (771)
Q Consensus 136 ~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~ 215 (771)
++++|+|++ +| +.++++|++|++++|+++ .+| +. .+++|++|++++|+|++. +
T Consensus 91 ~Ls~N~l~~------------------~~--~~~l~~L~~L~L~~N~l~-~l~--~~-~l~~L~~L~l~~N~l~~l-~-- 143 (457)
T 3bz5_A 91 ACDSNKLTN------------------LD--VTPLTKLTYLNCDTNKLT-KLD--VS-QNPLLTYLNCARNTLTEI-D-- 143 (457)
T ss_dssp ECCSSCCSC------------------CC--CTTCTTCCEEECCSSCCS-CCC--CT-TCTTCCEEECTTSCCSCC-C--
T ss_pred ECcCCCCce------------------ee--cCCCCcCCEEECCCCcCC-eec--CC-CCCcCCEEECCCCcccee-c--
Confidence 999999984 11 444555555555555555 233 22 455555555555555542 1
Q ss_pred ccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCccccccc
Q 041479 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNL 295 (771)
Q Consensus 216 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l 295 (771)
+..+++|++|++++|+..+.++ +..+++|+.|++++|++++ +| +..+. +|+.|++++|++++. .++.+
T Consensus 144 l~~l~~L~~L~l~~n~~~~~~~-----~~~l~~L~~L~ls~n~l~~-l~--l~~l~-~L~~L~l~~N~l~~~---~l~~l 211 (457)
T 3bz5_A 144 VSHNTQLTELDCHLNKKITKLD-----VTPQTQLTTLDCSFNKITE-LD--VSQNK-LLNRLNCDTNNITKL---DLNQN 211 (457)
T ss_dssp CTTCTTCCEEECTTCSCCCCCC-----CTTCTTCCEEECCSSCCCC-CC--CTTCT-TCCEEECCSSCCSCC---CCTTC
T ss_pred cccCCcCCEEECCCCCcccccc-----cccCCcCCEEECCCCccce-ec--cccCC-CCCEEECcCCcCCee---ccccC
Confidence 4455555555555553322221 2444555555555555552 33 33332 455555555555532 24555
Q ss_pred CCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCccccccc-------ccccccccCccceecCCccccccc
Q 041479 296 KNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT-------FLTELNLCGNSIRGSVPSALGSCH 368 (771)
Q Consensus 296 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~ 368 (771)
++|+.|++++|.+.+ +| +..+++|+.|++++|++++..+..+..++ +|+.|++++|.+.+.+| ++.++
T Consensus 212 ~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~ 286 (457)
T 3bz5_A 212 IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCR 286 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCT
T ss_pred CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccc
Confidence 555555555555544 33 44555555555555555544333333333 34555555655554444 34455
Q ss_pred ce-eeecccCcccCCCCc--------CCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCC
Q 041479 369 QL-WLDLSHNHLTGPIPL--------AVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 369 ~l-~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
.| .|++++|.+.+.+|. .++.+++|++|++++|+|++. | + +.+++|+.|++++|+|++
T Consensus 287 ~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l----~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 287 KIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--V----SHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp TCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--C----TTCTTCSEEECCSSCCCB
T ss_pred cCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--c----ccCCcCcEEECCCCCCCC
Confidence 55 566666655444432 255668999999999999973 3 3 388999999999999997
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.39 Aligned_cols=233 Identities=19% Similarity=0.203 Sum_probs=188.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+ ..|+|
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv 83 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQYLF 83 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEEE
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eEEEE
Confidence 444567899999999999999899999999996553 233467899999999999999999999998776 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999877 33689999999999999999999985 999999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.......+||+.|+||| +||++|||++|+.||.+..........+............+++.+
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 161 --ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp --ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred --ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 11223457999999999 699999999999999765444444555554444433345566666
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+||+.||++|||+.|+++
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhhCcCHHHHhh
Confidence 66777999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=315.79 Aligned_cols=229 Identities=22% Similarity=0.203 Sum_probs=186.4
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+.....+|+|.+|+||+|++..+++.||||++.... ....+++.+|+++++.++||||+++++++.+.+ ..
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~ 89 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK-----TL 89 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EE
Confidence 34455667899999999999999899999999996553 345678999999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999776 35689999999999999999999996 999999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
.. .....+||+.|+||| +||++|||++|+.||.+... ..+.+..... ....+..++
T Consensus 167 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~-~~~~p~~~s 238 (328)
T 3fe3_A 167 GG-----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KELRERVLRG-KYRIPFYMS 238 (328)
T ss_dssp SC-----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC-CCCCCTTSC
T ss_pred CC-----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC-CCCCCCCCC
Confidence 22 123457999999999 69999999999999975321 1122222111 122333455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 239 ~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 239 TDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 66666677999999999999999975
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.84 Aligned_cols=275 Identities=17% Similarity=0.223 Sum_probs=213.0
Q ss_pred CccHHHHHHHHhcCCCCCCCCCCCC----CCCCCCccceeeeec--------CCCCcEEEEEcCCCCCcccCCccccCCC
Q 041479 1 EPDKQALLAFKSKVDDDPFGALSTW----NDSVNFCQWLGVTCS--------LKYQRVILLNLSGQNLTGTASPYIGNLT 68 (771)
Q Consensus 1 ~~~~~~l~~~~~~~~~~~~~~~~~w----~~~~~~c~w~~v~c~--------~~~~~l~~L~Ls~n~l~~~~~~~~~~l~ 68 (771)
++|++||++||+.+..|+.+.+++| ....++|.|.|+.|. ....+|+.|+|++|+++ .+|+.++.++
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~ 104 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGT
T ss_pred chHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCC
Confidence 4689999999998877777777899 456789999999994 33478999999999999 7788899999
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCc
Q 041479 69 FLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH 148 (771)
Q Consensus 69 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~ 148 (771)
+|++|+|++|.|+ .+|..|+++++|++|+|++|+++ .+|..|+++++|+.|+|++|++.+.+|.
T Consensus 105 ~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~---------------~lp~~l~~l~~L~~L~L~~n~~~~~~p~ 168 (328)
T 4fcg_A 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR---------------ALPASIASLNRLRELSIRACPELTELPE 168 (328)
T ss_dssp TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC---------------CCCGGGGGCTTCCEEEEEEETTCCCCCS
T ss_pred CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc---------------cCcHHHhcCcCCCEEECCCCCCccccCh
Confidence 9999999999999 68999999999999999999975 6788899999999999999887765553
Q ss_pred -cceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEc
Q 041479 149 -LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227 (771)
Q Consensus 149 -L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 227 (771)
+... ..+..+.++++|++|++++|+++ .+|..+. .+++|++|+|++|++++ +|..|..+++|++|+|
T Consensus 169 ~~~~~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~-~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 169 PLAST---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236 (328)
T ss_dssp CSEEE---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGG-GCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred hHhhc---------cchhhhccCCCCCEEECcCCCcC-cchHhhc-CCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence 1111 12234556788888888888887 7777765 77788888888888874 5556777788888888
Q ss_pred cccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcc
Q 041479 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFI 307 (771)
Q Consensus 228 s~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 307 (771)
++|.+.+.+|..| .++++|++|+|++|.+.+.+|..+..+. +|++|++++|++.+.+|..++++++|+.+++..+.
T Consensus 237 s~n~~~~~~p~~~---~~l~~L~~L~L~~n~~~~~~p~~~~~l~-~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 237 RGCTALRNYPPIF---GGRAPLKRLILKDCSNLLTLPLDIHRLT-QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp TTCTTCCBCCCCT---TCCCCCCEEECTTCTTCCBCCTTGGGCT-TCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred cCCcchhhhHHHh---cCCCCCCEEECCCCCchhhcchhhhcCC-CCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 8877777777655 5667777777777777777777776665 67777777777777777777766666666665543
Q ss_pred c
Q 041479 308 L 308 (771)
Q Consensus 308 l 308 (771)
+
T Consensus 313 ~ 313 (328)
T 4fcg_A 313 Q 313 (328)
T ss_dssp S
T ss_pred H
Confidence 3
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=310.28 Aligned_cols=239 Identities=28% Similarity=0.429 Sum_probs=188.2
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|+++. ++.||||++........+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 113 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN-----EMILI 113 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTT-CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT-----CCEEE
T ss_pred ccCccceeecCCCeeEEEEEECC-CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eEEEE
Confidence 34455668999999999999764 5699999997766666788999999999999999999999987766 67999
Q ss_pred EEeccCCCCCCCc-------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESCP-------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999998762 2488999999999999999999995 99999999999999999999999999998654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC-CccHHHHHHhhCC-Cchhhh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE-GLDLHNFVKMALP-DQILQV 737 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~-~~~~~~~~~~~~~-~~~~~~ 737 (771)
.... ........||+.|+||| +||++|||++|+.||.+.... .....+|...... ......
T Consensus 191 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 191 ELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp SSSC--CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccc--cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 3221 11223456899999999 699999999999999754332 2334444322211 112222
Q ss_pred cCc------------cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 738 LDP------------LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 738 ~~~------------~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+++ .+.....+||+.||++|||+.|+++.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222 2223445999999999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.02 Aligned_cols=235 Identities=26% Similarity=0.346 Sum_probs=181.1
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.++.....+|+|.+|+||+|++ .++.||||++.... ....+++.+|++++++++|||||++++++.+.+ ..
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 109 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-----NL 109 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-----CC
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----ce
Confidence 3444556789999999999987 46689999996543 344578999999999999999999999998766 67
Q ss_pred EEEEEeccCCCCCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCceEEecccCc
Q 041479 599 ALVYEFMHHGSLESCP------RILSFLRRLNIAIDVASALEYLHHHCKKP--IVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
++||||+++|+|.++. ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 9999999999997762 2388999999999999999999986 6 999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHH-HhhCCCch
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV-KMALPDQI 734 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~ 734 (771)
+...... .......||+.|+||| +||++|||++|+.||.+.... ...... ........
T Consensus 187 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 187 RLKASTF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKCKRLEI 260 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSCCCCCC
T ss_pred ccccccc----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcCCCCCC
Confidence 8543322 1223456999999999 699999999999999764221 122222 22223445
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+..+++.+.....+||+.||++|||+.++++.|++++
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5666777777788999999999999999999998763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.17 Aligned_cols=225 Identities=20% Similarity=0.263 Sum_probs=185.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
..+|+|.+|+||+|+++.+++.||||++........+.+.+|+.++++++|||||++++++...+ ..++||||++
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~ 125 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----ELWVLMEFLQ 125 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEEECCCC
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEEEEecCC
Confidence 36899999999999999888899999998766666788999999999999999999999998876 7899999999
Q ss_pred CCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccc
Q 041479 607 HGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684 (771)
Q Consensus 607 ~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (771)
+|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 126 ~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----~~ 198 (321)
T 2c30_A 126 GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----KR 198 (321)
T ss_dssp SCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----CB
T ss_pred CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc----cc
Confidence 9999776 34689999999999999999999995 999999999999999999999999999986544321 12
Q ss_pred ccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC--chhhhcCccccccCc
Q 041479 685 VGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD--QILQVLDPLFLVGGV 747 (771)
Q Consensus 685 ~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 747 (771)
....||+.|+||| +||++|||++|+.||.+... ...........+. .....+++.+.....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 3457999999999 69999999999999965321 1222222222222 223345556666777
Q ss_pred ccChhchhhcCCHHHHHH
Q 041479 748 QEGEETAEENIKKGQIRE 765 (771)
Q Consensus 748 ~cl~~~p~~Rpt~~~vl~ 765 (771)
+||+.||++|||+.|+++
T Consensus 277 ~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 277 RMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSCSSTTTSCCHHHHHT
T ss_pred HHccCChhhCcCHHHHhc
Confidence 999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=330.38 Aligned_cols=236 Identities=22% Similarity=0.323 Sum_probs=195.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
++.....+|+|.+|+||+|+++.+++.||||++.... ...++|.+|++++++++|||||+++++|.+.+ ..|+|
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv 294 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYII 294 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEEEE
Confidence 3445567999999999999999888899999996543 34678999999999999999999999998766 57999
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999776 23588999999999999999999996 8999999999999999999999999999876432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. .....+..+++.|+||| |||++|||++ |+.||.+... ..+.+.+....+...+..+++
T Consensus 372 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 372 T---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRMERPEGCPE 446 (495)
T ss_dssp C---EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCCCCCTTCCH
T ss_pred c---eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCH
Confidence 2 12223445788999999 7999999999 9999976432 235555555555445556666
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+..++.+||+.||++|||+.++++.|++++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 7777778999999999999999999998763
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.83 Aligned_cols=325 Identities=25% Similarity=0.343 Sum_probs=149.5
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCccc--CC----cccccCCcc
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ--IP----DSRLILNKL 118 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p----~~~l~~n~l 118 (771)
+++.|++++|++++.+ . ..++|++|++++|++++ +|.. +++|++|++++|++++. +| ...+..|++
T Consensus 72 ~l~~L~l~~~~l~~lp-~---~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 72 QAHELELNNLGLSSLP-E---LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQL 143 (454)
T ss_dssp TCSEEECTTSCCSCCC-S---CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCC
T ss_pred CCCEEEecCCccccCC-C---CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCCC
Confidence 4577777777777532 2 13677777777777776 5543 36777777777777641 11 112333444
Q ss_pred cccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC
Q 041479 119 EGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV 198 (771)
Q Consensus 119 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L 198 (771)
++ +| .|+++++|++|++++|+++ + +|.. ..+|++|++++|+++ .+| .+. .+++|
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~-----------------~-lp~~---~~~L~~L~L~~n~l~-~l~-~~~-~l~~L 197 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLK-----------------K-LPDL---PPSLEFIAAGNNQLE-ELP-ELQ-NLPFL 197 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCS-----------------C-CCCC---CTTCCEEECCSSCCS-SCC-CCT-TCTTC
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCc-----------------c-cCCC---cccccEEECcCCcCC-cCc-ccc-CCCCC
Confidence 43 33 3445555555555555444 3 3322 135555555555555 244 222 55555
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceee
Q 041479 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278 (771)
Q Consensus 199 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~ 278 (771)
+.|++++|++++ +|... ++|++|++++|+++. +|. + ..+++|++|++++|+++ .+|..+ ++|++|+
T Consensus 198 ~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~-lp~-~---~~l~~L~~L~l~~N~l~-~l~~~~----~~L~~L~ 263 (454)
T 1jl5_A 198 TAIYADNNSLKK-LPDLP---LSLESIVAGNNILEE-LPE-L---QNLPFLTTIYADNNLLK-TLPDLP----PSLEALN 263 (454)
T ss_dssp CEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSS-CCC-C---TTCTTCCEEECCSSCCS-SCCSCC----TTCCEEE
T ss_pred CEEECCCCcCCc-CCCCc---CcccEEECcCCcCCc-ccc-c---CCCCCCCEEECCCCcCC-cccccc----cccCEEE
Confidence 555555555553 22221 355555555555552 231 2 44555555555555555 233321 2455555
Q ss_pred cccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccc-cccccccccCccce
Q 041479 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF-TFLTELNLCGNSIR 357 (771)
Q Consensus 279 Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 357 (771)
+++|++++ +|.. .++|+.|++++|.+.+. |. ..++|+.|++++|++++ ++ .+ ++|++|++++|+++
T Consensus 264 l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~ 330 (454)
T 1jl5_A 264 VRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLI 330 (454)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCS
T ss_pred CCCCcccc-cCcc---cCcCCEEECcCCccCcc-cC---cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCccc
Confidence 55555553 3332 24555555555555431 11 01355555555555553 11 12 35555555555555
Q ss_pred ecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccc--cCCcchhhh---------hcccccccEEE
Q 041479 358 GSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG--EIPSSLAWI---------FGYISIFAKLN 425 (771)
Q Consensus 358 ~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~~---------~~~l~~L~~L~ 425 (771)
+ +|.. ++.| .|++++|++++ +|. .+++|++|++++|++++ .+|.++..+ ...+++|+.||
T Consensus 331 ~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ 402 (454)
T 1jl5_A 331 E-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLH 402 (454)
T ss_dssp C-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC----------------
T ss_pred c-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEE
Confidence 3 3332 2333 45555555553 333 24555556666555555 444443310 00127899999
Q ss_pred CcCCCCCC--CCCcc
Q 041479 426 LSYNNLDG--DVPRK 438 (771)
Q Consensus 426 Ls~N~l~~--~~p~~ 438 (771)
+++|++++ .+|..
T Consensus 403 ls~N~l~~~~~iP~s 417 (454)
T 1jl5_A 403 VETNPLREFPDIPES 417 (454)
T ss_dssp ---------------
T ss_pred CCCCcCCccccchhh
Confidence 99999987 66653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.94 Aligned_cols=236 Identities=22% Similarity=0.349 Sum_probs=183.8
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.....+|+|.+|+||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+ ..|+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~l 88 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-----CYYL 88 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-----EEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-----eEEE
Confidence 3445689999999999999999999999998543 2345678999999999999999999999988776 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999876 34689999999999999999999986 89999999999999999999999999998664332
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC---chhhhcC
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD---QILQVLD 739 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 739 (771)
. .......||+.|+||| +|+++|||++|+.||.+...... .........+. .....++
T Consensus 166 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 166 L---TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-AIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-HHHHHSSCCCCHHHHSCTTSC
T ss_pred c---cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhhccCCCcchhcccCCC
Confidence 1 1223356999999999 69999999999999975322111 11222222221 1223344
Q ss_pred ccccccCcccChhchhhcC-CHHHHHHHHHHhC
Q 041479 740 PLFLVGGVQEGEETAEENI-KKGQIRESLIAIL 771 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rp-t~~~vl~~L~~~l 771 (771)
+.+.....+|+++||++|| ++.++.+.|++++
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 5555666799999999999 9999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.55 Aligned_cols=242 Identities=22% Similarity=0.274 Sum_probs=183.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhc--cCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN--IRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+.. ......++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l 83 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL 83 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence 44456789999999999988 4679999998644 33556667777766 78999999999976542 22236799
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHC-----KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||||+++|+|.++ ...+++..+..++.|++.||+|||+.. +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 9999999999876 446899999999999999999999210 249999999999999999999999999999765
Q ss_pred CcccCCcccccccccccccccchh---------------------HHHHHHHHHhC----------CCCCCccccCCccH
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTG----------KRPTSDMFTEGLDL 722 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg----------~~P~~~~~~~~~~~ 722 (771)
...............||+.|+||| +||++|||++| +.||.+........
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 443322222233457999999999 59999999999 88887665554444
Q ss_pred HHHHHhhCC----Cch-----hhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 723 HNFVKMALP----DQI-----LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 723 ~~~~~~~~~----~~~-----~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
......... ... .....+.+.....+||+.||++|||+.++++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 444332221 111 112233455567799999999999999999999976
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=309.96 Aligned_cols=302 Identities=25% Similarity=0.365 Sum_probs=164.4
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|++++|.++.. + .+..+++|++|+|++|++++ +|. |..+++|++|++++|.++ .+
T Consensus 44 ~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~---------------~~- 103 (347)
T 4fmz_A 44 ESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKIT---------------DI- 103 (347)
T ss_dssp TTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC---------------CC-
T ss_pred ccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCccc---------------Cc-
Confidence 5666666666666633 2 36666666666666666664 333 666666666666666654 12
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
..+.++++|++|++++|++++ ++. +..+++|++|++++|.....++. +. .+++|++|++
T Consensus 104 ~~~~~l~~L~~L~l~~n~i~~------------------~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~-~l~~L~~L~l 162 (347)
T 4fmz_A 104 SALQNLTNLRELYLNEDNISD------------------ISP-LANLTKMYSLNLGANHNLSDLSP-LS-NMTGLNYLTV 162 (347)
T ss_dssp GGGTTCTTCSEEECTTSCCCC------------------CGG-GTTCTTCCEEECTTCTTCCCCGG-GT-TCTTCCEEEC
T ss_pred hHHcCCCcCCEEECcCCcccC------------------chh-hccCCceeEEECCCCCCcccccc-hh-hCCCCcEEEe
Confidence 235566666666666666551 222 45566666666666644423332 32 5566666666
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++. +. +..+. +|++|++++|+
T Consensus 163 ~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~-----~~~l~~L~~L~l~~n~l~~~-~~-~~~~~-~L~~L~l~~n~ 232 (347)
T 4fmz_A 163 TESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-----LASLTSLHYFTAYVNQITDI-TP-VANMT-RLNSLKIGNNK 232 (347)
T ss_dssp CSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG-----GGGCTTCCEEECCSSCCCCC-GG-GGGCT-TCCEEECCSSC
T ss_pred cCCCcCCchh--hccCCCCCEEEccCCccccccc-----ccCCCccceeecccCCCCCC-ch-hhcCC-cCCEEEccCCc
Confidence 6666654332 5556666666666666654322 24555566666666655522 22 33333 45555555555
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcc
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
+++..+ +.. +++|++|++++|+++.. +.+..+++|++|++++|++++. ..
T Consensus 233 l~~~~~--~~~------------------------l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~ 282 (347)
T 4fmz_A 233 ITDLSP--LAN------------------------LSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SV 282 (347)
T ss_dssp CCCCGG--GTT------------------------CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GG
T ss_pred cCCCcc--hhc------------------------CCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hh
Confidence 553222 444 44555555555555432 2344555555555555555532 23
Q ss_pred cccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCC
Q 041479 364 LGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 364 ~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
+..++.| .|++++|++++..|..|..+++|++|++++|++++..| +. .+++|+.|++++|+|+
T Consensus 283 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~----~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA----SLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GG----GCTTCSEESSSCC---
T ss_pred hcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hh----hhhccceeehhhhccc
Confidence 4445555 55555555555555556666666777777776665444 22 5666777777777654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.30 Aligned_cols=305 Identities=24% Similarity=0.339 Sum_probs=216.0
Q ss_pred cccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccC
Q 041479 63 YIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYF 142 (771)
Q Consensus 63 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 142 (771)
.+..+++|++|++++|.+.. +| .|..+++|++|++++|+++ .+|. +..+++|++|++++|.+
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~---------------~~~~-~~~l~~L~~L~L~~n~i 100 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT---------------DISP-LSNLVKLTNLYIGTNKI 100 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC---------------CCGG-GTTCTTCCEEECCSSCC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc---------------cchh-hhcCCcCCEEEccCCcc
Confidence 35678888888888888875 44 4888888888888888865 2333 67777777777777776
Q ss_pred cCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCC
Q 041479 143 TGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKL 222 (771)
Q Consensus 143 ~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 222 (771)
++ + ..+.++++|++|++++|.++ .+|. + ..+++|+.|++++|.....+ ..+..+++|
T Consensus 101 ~~------------------~-~~~~~l~~L~~L~l~~n~i~-~~~~-~-~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L 157 (347)
T 4fmz_A 101 TD------------------I-SALQNLTNLRELYLNEDNIS-DISP-L-ANLTKMYSLNLGANHNLSDL-SPLSNMTGL 157 (347)
T ss_dssp CC------------------C-GGGTTCTTCSEEECTTSCCC-CCGG-G-TTCTTCCEEECTTCTTCCCC-GGGTTCTTC
T ss_pred cC------------------c-hHHcCCCcCCEEECcCCccc-Cchh-h-ccCCceeEEECCCCCCcccc-cchhhCCCC
Confidence 62 2 23666777777777777776 4554 3 36667777777766544333 336666666
Q ss_pred CEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEe
Q 041479 223 EWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIA 302 (771)
Q Consensus 223 ~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 302 (771)
++|++++|.+++..+ +..+++|+.|++++|.++ .++. +..+. +|+.|++++|.++
T Consensus 158 ~~L~l~~~~~~~~~~-----~~~l~~L~~L~l~~n~l~-~~~~-~~~l~-~L~~L~l~~n~l~----------------- 212 (347)
T 4fmz_A 158 NYLTVTESKVKDVTP-----IANLTDLYSLSLNYNQIE-DISP-LASLT-SLHYFTAYVNQIT----------------- 212 (347)
T ss_dssp CEEECCSSCCCCCGG-----GGGCTTCSEEECTTSCCC-CCGG-GGGCT-TCCEEECCSSCCC-----------------
T ss_pred cEEEecCCCcCCchh-----hccCCCCCEEEccCCccc-cccc-ccCCC-ccceeecccCCCC-----------------
Confidence 666666666654432 245555555566555555 2222 33332 4555555555444
Q ss_pred cCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccC
Q 041479 303 IEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTG 381 (771)
Q Consensus 303 l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~ 381 (771)
+..+ +..+++|++|++++|+++...+ +..+++|++|++++|.+++. ..+..++.| .|++++|++++
T Consensus 213 -------~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~ 279 (347)
T 4fmz_A 213 -------DITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD 279 (347)
T ss_dssp -------CCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred -------CCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC
Confidence 3322 5677888899999999985443 88999999999999999864 468888889 89999999997
Q ss_pred CCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccccccccccccccCCC
Q 041479 382 PIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNE 453 (771)
Q Consensus 382 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~ 453 (771)
. ..+..+++|+.|++++|++++..|..+. .+++|+.|++++|++++..| ...+..+..+.+.+|+
T Consensus 280 ~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~----~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 280 I--SVLNNLSQLNSLFLNNNQLGNEDMEVIG----GLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCGGGHHHHH----TCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred C--hhhcCCCCCCEEECcCCcCCCcChhHhh----ccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence 5 4588999999999999999987777655 89999999999999997766 4456677778887775
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.75 Aligned_cols=309 Identities=16% Similarity=0.142 Sum_probs=267.8
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|++++|.++.+++..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.++ +..|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--------------~~~~ 116 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR--------------YLPP 116 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC--------------CCCT
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC--------------CCCH
Confidence 57889999999999887778999999999999999999988889999999999999999965 4566
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
..|+++++|++|+|++|.|++ ..+..|.++++|++|+|++|.+++ +++..+..+++|++|+|
T Consensus 117 ~~~~~l~~L~~L~L~~n~l~~-----------------l~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L 178 (597)
T 3oja_B 117 HVFQNVPLLTVLVLERNDLSS-----------------LPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQL 178 (597)
T ss_dssp TTTTTCTTCCEEECCSSCCCC-----------------CCTTTTTTCTTCCEEECCSSCCCB-CCTTTTTTCTTCCEEEC
T ss_pred HHHcCCCCCCEEEeeCCCCCC-----------------CCHHHhccCCCCCEEEeeCCcCCC-CChhhhhcCCcCcEEEC
Confidence 778999999999999998872 223346899999999999999995 44444448999999999
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
++|+|++.. +..+++|+.|++++|.+++. ...++|+.|++++|.++ .+|..+. ++|+.|+|++|.
T Consensus 179 ~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l--------~~~~~L~~L~ls~n~l~-~~~~~~~---~~L~~L~L~~n~ 243 (597)
T 3oja_B 179 SSNRLTHVD---LSLIPSLFHANVSYNLLSTL--------AIPIAVEELDASHNSIN-VVRGPVN---VELTILKLQHNN 243 (597)
T ss_dssp TTSCCSBCC---GGGCTTCSEEECCSSCCSEE--------ECCTTCSEEECCSSCCC-EEECSCC---SCCCEEECCSSC
T ss_pred cCCCCCCcC---hhhhhhhhhhhcccCccccc--------cCCchhheeeccCCccc-ccccccC---CCCCEEECCCCC
Confidence 999999753 56688999999999998754 33467999999999998 4444332 479999999999
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcc
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
+++ +..+..+++|+.|++++|.+.+.+|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..
T Consensus 244 l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~ 319 (597)
T 3oja_B 244 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 319 (597)
T ss_dssp CCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGG
T ss_pred CCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcc
Confidence 986 4789999999999999999999999999999999999999999985 5777888999999999999999 57777
Q ss_pred cccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc
Q 041479 364 LGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406 (771)
Q Consensus 364 ~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 406 (771)
+..++.| .|+|++|++++.. +..+++|+.|+|++|++++.
T Consensus 320 ~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 320 QPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp HHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred cccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence 8889999 9999999998653 66789999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.52 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=192.3
Q ss_pred ccccccccccccccceEEEEE-----ecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGI-----LDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQ 593 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~-----~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 593 (771)
..+.....+|+|.+|+||+|+ ...+++.||||++.... ....+.+.+|+++++++ +|||||++++++.+.+.
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~- 100 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 100 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS-
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC-
Confidence 334455678999999999999 44566899999997543 34457899999999999 79999999999877542
Q ss_pred CceeEEEEEEeccCCCCCCCcc----------------------------------------------------------
Q 041479 594 GNYFRALVYEFMHHGSLESCPR---------------------------------------------------------- 615 (771)
Q Consensus 594 ~~~~~~lv~e~~~~g~L~~~~~---------------------------------------------------------- 615 (771)
..++||||+++|+|.++..
T Consensus 101 ---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 101 ---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp ---CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred ---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 4789999999999865511
Q ss_pred -----------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCccccc
Q 041479 616 -----------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684 (771)
Q Consensus 616 -----------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 684 (771)
.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 252 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRK 252 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT--CEEC
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc--chhc
Confidence 188899999999999999999996 899999999999999999999999999986643322 1223
Q ss_pred ccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcc
Q 041479 685 VGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQ 748 (771)
Q Consensus 685 ~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (771)
....||+.|+||| +||++|||+| |+.||.+.... ..+............+..+++.+.....+
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 3456899999999 6999999999 99999764322 23444444444444555667777777789
Q ss_pred cChhchhhcCCHHHHHHHHHHhC
Q 041479 749 EGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 749 cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
||+.||++|||+.|+++.|++++
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.38 Aligned_cols=243 Identities=24% Similarity=0.292 Sum_probs=184.4
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|++. ++.||||++.... .....+.+|+.++++++|||||++++++...... ....++|
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~~~~~lv 100 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV-DVDLWLI 100 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS-SEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC-CceEEEE
Confidence 3445567899999999999876 5799999996543 3345667799999999999999999999775421 2257999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHH-------CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~-------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. ++++|+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 999999999877 34589999999999999999999974 123899999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCC-----------cc
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEG-----------LD 721 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~-----------~~ 721 (771)
...... .......+||+.|+||| +||++|||+||+.||.+..... ..
T Consensus 181 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 181 FEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp ECTTSC--CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccC--ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 654332 11233457999999999 6999999999999996532211 11
Q ss_pred HHHHHHhhCC----Cchhhhc-----CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 722 LHNFVKMALP----DQILQVL-----DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 722 ~~~~~~~~~~----~~~~~~~-----~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+...... +...... .+.+...+.+||+.||++|||+.|+++.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2222221111 1111111 11244556699999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.07 Aligned_cols=237 Identities=22% Similarity=0.323 Sum_probs=175.9
Q ss_pred ccccccccccccceEEEEEec---CCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILD---LDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|+++ .++..||||++... .....++|.+|++++++++|||||++++++.+.+ ..
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 121 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-----PV 121 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----SC
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----ce
Confidence 444556899999999999987 44568999999755 3445678999999999999999999999998765 67
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999876 23689999999999999999999986 89999999999999999999999999998765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ........+|+.|+||| |||++||+++ |+.||.+... ..+.+.+...........+
T Consensus 199 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 199 DDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHTTEECCCCTTC
T ss_pred cCCcc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCccc
Confidence 43221 11122334678899999 7999999998 9999975422 2233333333222223344
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+...+.+||+.||++|||+.++++.|+++
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 55566667799999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.53 Aligned_cols=241 Identities=21% Similarity=0.254 Sum_probs=185.4
Q ss_pred ccccccccccccceEEEEE----ecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGI----LDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|+ ...+++.||||++........+++.+|++++++++||||+++++++...+.. ..
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---~~ 88 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR---NL 88 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT---SC
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC---ce
Confidence 3445678999999999998 4567889999999776666678899999999999999999999998654311 46
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 899999999999876 33589999999999999999999986 99999999999999999999999999998765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC----------Cc----cHHHH
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE----------GL----DLHNF 725 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~----------~~----~~~~~ 725 (771)
..... ........|++.|+||| +|+++||++||..|+...... .. ...+.
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 166 QDKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CCcce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 43221 11222345788899999 699999999999998542110 00 11122
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.........+..+++.+...+.+||+.||++|||+.|+++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 222223333445566666777799999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.49 Aligned_cols=232 Identities=23% Similarity=0.263 Sum_probs=180.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccch--------------------------hhHHHHHHHHHHHhcc
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--------------------------GALKSFMAECQALRNI 575 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~~l 575 (771)
.+.....+|+|.+|+||+|+++.+++.||||++..... ...+++.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 34455678999999999999999999999999965421 1235789999999999
Q ss_pred CCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 576 RHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 576 ~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
+||||+++++++.+... ...|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 94 ~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp CCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 99999999999876321 168999999999999877 44689999999999999999999996 99999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCcc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~ 715 (771)
|+++.++.+||+|||+++....... ......||+.|+||| +||++|||++|+.||.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999986543321 122356999999999 699999999999999753
Q ss_pred ccCCccHHH-HHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 716 FTEGLDLHN-FVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 716 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. ..+.. ......+......+++.+.....+||+.||++|||+.|+++
T Consensus 244 ~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI--MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH--HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH--HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 11222 22222222222345556666777999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.17 Aligned_cols=239 Identities=24% Similarity=0.304 Sum_probs=193.4
Q ss_pred ccccccccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
..+.....+|+|.+|+||+|++. .+++.||||++.... ....+++.+|++++++++|||||++++++.+.+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 99 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--- 99 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC---
Confidence 34455567899999999999873 455799999997543 445678999999999999999999999987766
Q ss_pred ceeEEEEEEeccCCCCCCCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 041479 595 NYFRALVYEFMHHGSLESCP---------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~~---------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 647 (771)
..++||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 100 --PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred --ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 679999999999997651 2378899999999999999999996 89999
Q ss_pred CCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCC
Q 041479 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRP 711 (771)
Q Consensus 648 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P 711 (771)
||||+||+++.++.+||+|||+++....... ........||+.|+||| +||++|||++ |+.|
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999986644322 11223345788999999 6999999999 9999
Q ss_pred CCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 712 TSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
|.+... ..+.+..........+..+++.+.....+||+.||++|||+.|+++.|++++
T Consensus 253 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 253 YPGIPP--ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp STTCCG--GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCH--HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 976432 2344455444444445556667777778999999999999999999999863
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.58 Aligned_cols=255 Identities=28% Similarity=0.500 Sum_probs=157.1
Q ss_pred CCCCEEecccCcCcc--cCChhhhhCCCCCcEEEeec-CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCC
Q 041479 171 TSMEYFHVSENQLVG--ELPPHIGFTLPNVRILLLAG-NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247 (771)
Q Consensus 171 ~~L~~L~Ls~N~l~g--~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 247 (771)
.+++.|+|++|.++| .+|+.+. .+++|++|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..| .+++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~-~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~---~~l~ 125 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL---SQIK 125 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGG---GGCT
T ss_pred ceEEEEECCCCCccCCcccChhHh-CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHH---hCCC
Confidence 345556666666555 5555544 555555555553 55555555555555555555555555555555444 4445
Q ss_pred CCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEc
Q 041479 248 YLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSL 327 (771)
Q Consensus 248 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 327 (771)
+|++|++++|.+++.+|..+..+. +|++|++++|++++.+|..|+.++ ++|++|++
T Consensus 126 ~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~-----------------------~~L~~L~L 181 (313)
T 1ogq_A 126 TLVTLDFSYNALSGTLPPSISSLP-NLVGITFDGNRISGAIPDSYGSFS-----------------------KLFTSMTI 181 (313)
T ss_dssp TCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCEEECCGGGGCCC-----------------------TTCCEEEC
T ss_pred CCCEEeCCCCccCCcCChHHhcCC-CCCeEECcCCcccCcCCHHHhhhh-----------------------hcCcEEEC
Confidence 555555555555555555555443 455555555555544444444444 05555555
Q ss_pred cCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc
Q 041479 328 FENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406 (771)
Q Consensus 328 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 406 (771)
++|++++.+|..+..++ |++|++++|++++.+|..+..++.| .|++++|++++.+|. +..+++|++|+|++|+|++.
T Consensus 182 ~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~ 259 (313)
T 1ogq_A 182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp CSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEEC
T ss_pred cCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCc
Confidence 55555555555555554 5555555555555555555555555 555566655554444 66678888888888888888
Q ss_pred CCcchhhhhcccccccEEECcCCCCCCCCCccccccccccccccCCCcccCCC
Q 041479 407 IPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGI 459 (771)
Q Consensus 407 ~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 459 (771)
+|..+. .+++|+.|+|++|++++.+|....+.++..+.+.+|+.+||.+
T Consensus 260 ~p~~l~----~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 260 LPQGLT----QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCGGGG----GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CChHHh----cCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 887765 7788888888888888888877667778888889999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=301.88 Aligned_cols=234 Identities=24% Similarity=0.340 Sum_probs=189.3
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|++.. ++.||||++..... ..+++.+|++++++++||||+++++++.+.+ ..++|
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 83 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLV 83 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEEEE
T ss_pred hceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceEEE
Confidence 34445678999999999999875 45899999965432 3478999999999999999999999988766 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999766 33588999999999999999999986 89999999999999999999999999998654432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
........||+.|+||| +|+++|||++ |+.||.+... ....+......+...+...++.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYKPRLASTH 235 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTSCHH
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhcCccCCCCCcCCHH
Confidence 12223445788999999 6999999999 9999975322 2233333333344444555666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.....+||+.||++|||+.++++.|+++
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 66777799999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.24 Aligned_cols=225 Identities=19% Similarity=0.164 Sum_probs=180.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
..+|+|.+|+||+|++..+++.||||++........+.+.+|++++++++|||||++++++.+.+ ..++||||++
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~E~~~ 169 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVMEYVD 169 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEECCT
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEeCCC
Confidence 35899999999999999989999999998766566788999999999999999999999998776 7899999999
Q ss_pred CCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--CCCCceEEecccCccccCcccCCc
Q 041479 607 HGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL--DNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 607 ~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl--~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
+|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9999665 34589999999999999999999986 89999999999999 5678999999999987654322
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCcccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPLFL 743 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 743 (771)
....+||+.|+||| +||++|||++|+.||.+... ...+..+.....+ ......+++.+.
T Consensus 245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCChhhhccCCHHHH
Confidence 12346999999999 69999999999999965321 1123334333332 333345566666
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+||+.||++|||+.|+++
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 7777999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.73 Aligned_cols=234 Identities=26% Similarity=0.313 Sum_probs=187.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|+++. +..||||++..... ..+++.+|++++++++||||+++++++.+.+ ..++|
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 81 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-----PIYIV 81 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEEEE
T ss_pred heeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----ceEEE
Confidence 34445678999999999998875 45899999965432 3477999999999999999999999987765 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999876 34589999999999999999999996 99999999999999999999999999998654432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.....+..||+.|+||| +|+++||+++ |+.||...... ..........+...+...++.
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 159 ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHRLYRPHLASDT 233 (268)
T ss_dssp ---EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCCCCCTTSCHH
T ss_pred ---hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCCCCCCCcChHH
Confidence 12223445788899999 6999999999 99999753221 122222333333334445666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.....+||+.||++|||+.++++.|+++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 66677799999999999999999999876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.84 Aligned_cols=229 Identities=23% Similarity=0.249 Sum_probs=184.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+|+.+.+++.||||++... .....+.+.+|+++++.++||||+++++++.+.+ ..
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----~~ 80 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RL 80 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----EE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-----EE
Confidence 344556789999999999999999999999999754 2345678999999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+||||+++|+|..+ .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999766 34688999999999999999999986 999999999999999999999999999985432
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ......+||+.|+||| +||++|||++|+.||.+... ..+.+.... .....+..+++
T Consensus 158 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~-~~~~~p~~~s~ 230 (337)
T 1o6l_A 158 DG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM-EEIRFPRTLSP 230 (337)
T ss_dssp TT----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-CCCCCCTTSCH
T ss_pred CC----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHc-CCCCCCCCCCH
Confidence 21 1223467999999999 69999999999999965311 112222111 12223445566
Q ss_pred cccccCcccChhchhhcC-----CHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+.....+||+.||++|| ++.|+++
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 666677799999999999 8998875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.89 Aligned_cols=236 Identities=25% Similarity=0.264 Sum_probs=186.2
Q ss_pred ccccccccccccceEEEEEe-----cCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGIL-----DLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|++ ..+++.||||++... ......++.+|+.++++++|||||++++++.+..
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 147 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL----- 147 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----
Confidence 44455689999999999994 446678999999643 3445568999999999999999999999988766
Q ss_pred eEEEEEEeccCCCCCCCc----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceE
Q 041479 597 FRALVYEFMHHGSLESCP----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---TAH 663 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---~~k 663 (771)
..++||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 569999999999997661 3488999999999999999999996 999999999999999554 599
Q ss_pred EecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 041479 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVK 727 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~ 727 (771)
|+|||+|+....... ........||+.|+||| +||++|||++ |+.||.+.. ...+.+...
T Consensus 225 L~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~~~~~~i~ 300 (367)
T 3l9p_A 225 IGDFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFVT 300 (367)
T ss_dssp ECCCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHH
T ss_pred ECCCccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH
Confidence 999999985533221 11222346899999999 6999999998 999997532 223344444
Q ss_pred hhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.......+..+++.+...+.+||+.||++|||+.++++.|+.+
T Consensus 301 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4333334445566666777799999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.57 Aligned_cols=229 Identities=19% Similarity=0.197 Sum_probs=185.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 88 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT----- 88 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC-----
Confidence 3345568999999999999999999999999975432 13578999999999999999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEecccC
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM----TAHMGDFGL 669 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGl 669 (771)
..|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 78999999999999776 34689999999999999999999996 999999999999998776 799999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--C
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--D 732 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~ 732 (771)
++....... ....+||+.|+||| +||++|||++|+.||.+.... ..+..+...... .
T Consensus 166 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 166 AHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITAVSYDFDE 239 (361)
T ss_dssp CEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCCCH
T ss_pred ceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCc
Confidence 986654221 23457999999999 699999999999999653211 112233333222 2
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||..||++|||+.|+++
T Consensus 240 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 333455666666777999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.54 Aligned_cols=235 Identities=20% Similarity=0.257 Sum_probs=183.2
Q ss_pred ccccccccccccceEEEEEecCCCeE----EEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTF----IAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~----vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++..+++. ||+|.+... .....++|.+|+.++++++|||||+++++|.+..
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 90 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------ 90 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS------
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC------
Confidence 44456789999999999998777654 577777533 2345678999999999999999999999998754
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++|+||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5799999999999766 34689999999999999999999996 9999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
..... ........||+.|+||| +||++||+++ |+.||.+... ..+.+..........+..
T Consensus 168 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (327)
T 3poz_A 168 GAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQPPI 243 (327)
T ss_dssp TTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCCTT
T ss_pred cCCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHcCCCCCCCcc
Confidence 54332 12223445788999999 6999999999 9999976422 335555555444444555
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+..+...+.+||+.||++|||+.++++.|+++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 666666777799999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.59 Aligned_cols=230 Identities=17% Similarity=0.243 Sum_probs=185.2
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..+.....+|+|++|+||+|+++.+++.||||++.... ....+.+.+|+++++.++|||||++++++.+.+ .
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-----D 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----E
Confidence 44555667899999999999999999999999996542 344678999999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.|+||||+++|+|..+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 8999999999999766 34689999999999999999999996 99999999999999999999999999998664
Q ss_pred cccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCc-cHHHHHHhhCCCchh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGL-DLHNFVKMALPDQIL 735 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~ 735 (771)
... .....+||+.|+||| +||++|||++|+.||........ .+..... ......+
T Consensus 167 ~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p 240 (384)
T 4fr4_A 167 RET-----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYP 240 (384)
T ss_dssp TTC-----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCC
T ss_pred CCC-----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCC
Confidence 322 223467999999999 69999999999999964322221 1111111 1222334
Q ss_pred hhcCccccccCcccChhchhhcCC-HHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIK-KGQIR 764 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt-~~~vl 764 (771)
..+++.+.....+||+.||++||+ +.++.
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 455666666777999999999998 66665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.15 Aligned_cols=226 Identities=15% Similarity=0.172 Sum_probs=183.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|+||+|+++.+++.||+|++.... ...+.+.+|+++++.++|||||++++++.+.+ ..++||||
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~ 82 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELVMIFEF 82 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEEEEECC
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEEEEEEe
Confidence 3456899999999999999999999999996543 34567899999999999999999999998776 78999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEecccCccccCcccC
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~~ 678 (771)
+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 999999765 23589999999999999999999996 9999999999999987 78999999999987644221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 741 (771)
.....||+.|+||| +||++|||++|+.||.+.... ..+..+.....+ ......+++.
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 160 -----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCCCChhhhccCCHH
Confidence 22346899999999 699999999999999753221 122333333332 2223445666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+|+..||++|||+.|+++
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc
Confidence 666777999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.18 Aligned_cols=232 Identities=23% Similarity=0.332 Sum_probs=187.7
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchh-------hHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRG-------ALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
.+.....+|+|.+|+||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 96 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--- 96 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT---
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC---
Confidence 344456789999999999999989999999999644321 1268999999999999999999999986554
Q ss_pred ceeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeeCCCCc-----eE
Q 041479 595 NYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKP--IVHCDLKPSNVLLDNDMT-----AH 663 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrdlk~~NILl~~~~~-----~k 663 (771)
++||||+++|+|.+. ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 97 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 ----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999654 34689999999999999999999986 6 999999999999988776 99
Q ss_pred EecccCccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHH-H
Q 041479 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHN-F 725 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~-~ 725 (771)
|+|||+++..... .....||+.|+||| +||++|||++|+.||.+.......... .
T Consensus 170 l~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 170 VADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp ECCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred eCCCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 9999999744321 22356899999999 699999999999999764332222222 2
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+...+..+++.+.....+||+.||++|||+.|+++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 333444555566677777778899999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.66 Aligned_cols=238 Identities=22% Similarity=0.257 Sum_probs=189.0
Q ss_pred cccccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 522 DLLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
.+.....+|+|.+|+||+|++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 123 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK---- 123 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC----
Confidence 34445668999999999999973 44799999997543 345678999999999999999999999998765
Q ss_pred eeEEEEEEeccCCCCCCCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 041479 596 YFRALVYEFMHHGSLESCP---------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~---------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrd 648 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+|||
T Consensus 124 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 124 -PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp -SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred -ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 679999999999997651 4588999999999999999999996 999999
Q ss_pred CCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCC
Q 041479 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPT 712 (771)
Q Consensus 649 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~ 712 (771)
|||+||+++.++.+||+|||+++....... ........||+.|+||| +||++|||++ |+.||
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999999999999999986543321 11223346899999999 6999999999 99999
Q ss_pred CccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 713 SDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+... ...............+..+++.+.....+||+.||++|||+.++++.|+++.
T Consensus 278 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAH--EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSCH--HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCh--HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 75422 1222223222223334455666667777999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.46 Aligned_cols=233 Identities=21% Similarity=0.315 Sum_probs=188.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+ +.||||++.... ...++|.+|++++++++|||||++++++... ..|+||
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~~lv~ 261 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE------PIYIIT 261 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTT-EEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEE
T ss_pred eEEEEEcccCCceEEEEEEECCc-cEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC------ccEEEE
Confidence 44455789999999999998754 589999997543 3468899999999999999999999998633 468999
Q ss_pred EeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999998772 2578889999999999999999996 89999999999999999999999999998764322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.....+..+|+.|+||| |||++|||+| |+.||.+... ....+.+........+..+++.
T Consensus 339 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 339 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMPRPENCPEE 413 (454)
T ss_dssp ---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCCCCCCTTSCHH
T ss_pred ---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHH
Confidence 11223345788999999 7999999999 9999976422 2233444444443344555666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+...+.+||+.||++|||+.+|++.|+++.
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 767778999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.95 Aligned_cols=235 Identities=20% Similarity=0.252 Sum_probs=186.8
Q ss_pred ccccccccccccceEEEEEecCCCeE----EEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTF----IAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++..+++. ||+|.+.... ....+.+.+|+.++++++|||||++++++.+. .
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 88 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS------S 88 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS------S
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC------c
Confidence 44456789999999999999877654 7777774332 23345778899999999999999999998643 4
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 6899999999999766 34688999999999999999999996 8999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
...... .......||+.|+||| +||++||+++ |+.||.+.. .....+..........+..
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 166 PPDDKQ--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPDLLEKGERLAQPQI 241 (325)
T ss_dssp CCCTTC--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHHHHHTTCBCCCCTT
T ss_pred Cccccc--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHHHHHcCCCCCCCCc
Confidence 543321 1223446788999999 6999999999 999997642 2234444444444444555
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+++.+...+.+||..||++|||+.++++.|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 667777777899999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.80 Aligned_cols=236 Identities=23% Similarity=0.332 Sum_probs=187.5
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
..+.....+|+|.+|+||+|.++. +..||||++..... ..+++.+|++++++++||||+++++++.+.+ ..++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 96 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFI 96 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEEE
T ss_pred HHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-----CeEE
Confidence 344455678999999999998874 45899999975432 3477999999999999999999999997766 6799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999776 34689999999999999999999986 9999999999999999999999999999865433
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ........||+.|+||| +|+++|||++ |+.||.+... ....+..........+...++
T Consensus 174 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T 3gen_A 174 E---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLYRPHLASE 248 (283)
T ss_dssp H---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCH
T ss_pred c---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--hHHHHHHhcccCCCCCCcCCH
Confidence 2 12223345788999999 6999999999 9999975322 223333333333344455566
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+.....+||+.||++|||+.++++.|++++
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 6666777999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.11 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=175.9
Q ss_pred cccccccccceEEEEEecCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLD---QTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|+||+|++..+ ...||||.+... .....++|.+|+.++++++|||||++++++.+.+. ..++|
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~----~~~lv 169 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----SPLVV 169 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS----CCEEE
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC----CeEEE
Confidence 34689999999999987543 246899998643 34556889999999999999999999999765431 56899
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999776 24578889999999999999999996 99999999999999999999999999998664433
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
........+..||+.|+||| |||++|||+| |..||.+.... ..........+...+..+++.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQGRRLLQPEYCPDP 324 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHcCCCCCCCCCCCHH
Confidence 22222233456788999999 7999999999 77788664322 233333333333334455666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+...+.+||+.||++|||+.|+++.|+++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 66677799999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.53 Aligned_cols=238 Identities=24% Similarity=0.291 Sum_probs=191.4
Q ss_pred cccccccccccccceEEEEEecC-------CCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDL-------DQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDF 592 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~-------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 592 (771)
.+.....+|+|.+|+||+|++.. .+..||||++.... ....+++.+|+++++++ +|||||++++++.+.+
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~- 148 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG- 148 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC-
Confidence 34445679999999999999753 33589999996543 44567899999999999 8999999999998766
Q ss_pred CCceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 593 QGNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
..++||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 149 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 149 ----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp ----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 579999999999997651 2489999999999999999999996 99999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFT 717 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~ 717 (771)
|+++.++.+||+|||+++....... ........||+.|+||| +||++|||++ |+.||.+...
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEcCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999986654322 12223346789999999 6999999999 9999975421
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+.+..........+..+++.+.....+||+.||++|||+.|+++.|++++
T Consensus 300 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 300 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp --HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2244444444444444556666667777999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.66 Aligned_cols=228 Identities=19% Similarity=0.165 Sum_probs=183.6
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+ .
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 88 (326)
T 2y0a_A 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-----D 88 (326)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----E
Confidence 344568999999999999999999999999965432 13678999999999999999999999998766 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEecccCc
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM----TAHMGDFGLT 670 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 670 (771)
.++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 8999999999999776 34688999999999999999999986 999999999999998877 7999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQ 733 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~ 733 (771)
+....... .....||+.|+||| +||++|||++|+.||.+.... ..+......... ..
T Consensus 166 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 239 (326)
T 2y0a_A 166 HKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYEFEDE 239 (326)
T ss_dssp EECCTTSC-----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHTCCCCCHH
T ss_pred eECCCCCc-----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHhcCCCcCcc
Confidence 86643221 22356999999999 699999999999999653211 112222222222 22
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33445555666677999999999999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.20 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=156.4
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcc
Q 041479 46 VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSE 125 (771)
Q Consensus 46 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~ 125 (771)
++.+++++++++ .+|..+. ++|++|+|++|+|++..|.+|.++++|++|+|++|+++ +..|..
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--------------~~~~~~ 97 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS--------------KIHEKA 97 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC--------------EECGGG
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC--------------ccCHhH
Confidence 345666677776 4444442 57788888888887766677777777777777777754 234455
Q ss_pred ccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
|+++++|++|++++|+++ .+|..++ ++|++|++++
T Consensus 98 ~~~l~~L~~L~L~~n~l~------------------------------------------~l~~~~~---~~L~~L~l~~ 132 (332)
T 2ft3_A 98 FSPLRKLQKLYISKNHLV------------------------------------------EIPPNLP---SSLVELRIHD 132 (332)
T ss_dssp STTCTTCCEEECCSSCCC------------------------------------------SCCSSCC---TTCCEEECCS
T ss_pred hhCcCCCCEEECCCCcCC------------------------------------------ccCcccc---ccCCEEECCC
Confidence 566666666666665554 3333322 3445555555
Q ss_pred CcccccCCccccCCCCCCEEEccccccCC--CCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 206 NQFFGNIPHSISNASKLEWLDFANNSLTG--LIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 206 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
|+|++..+..|.++++|+.|++++|.++. ..|..| ..+ +|+.|++++|+++ .+|..+. ++|++|++++|.
T Consensus 133 n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~---~~l-~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~ 204 (332)
T 2ft3_A 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF---DGL-KLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNK 204 (332)
T ss_dssp SCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSS---CSC-CCSCCBCCSSBCS-SCCSSSC---SSCSCCBCCSSC
T ss_pred CccCccCHhHhCCCccCCEEECCCCccccCCCCcccc---cCC-ccCEEECcCCCCC-ccCcccc---CCCCEEECCCCc
Confidence 55544444445555555555555555532 333333 333 5555556666555 3444433 357777777777
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcc
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
+++..+..|.++++|+.|++++|.+.+..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++..+..
T Consensus 205 i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~ 283 (332)
T 2ft3_A 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283 (332)
T ss_dssp CCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhH
Confidence 77666666777777777777777776666667777777888888888887 67777788888888888888887665555
Q ss_pred ccc
Q 041479 364 LGS 366 (771)
Q Consensus 364 ~~~ 366 (771)
|..
T Consensus 284 ~~~ 286 (332)
T 2ft3_A 284 FCP 286 (332)
T ss_dssp SSC
T ss_pred ccc
Confidence 543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.71 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=177.4
Q ss_pred cccccccccccccceEEEEEecCCCe---EEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc-
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQT---FIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN- 595 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~---~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~- 595 (771)
.+.....+|+|.+|+||+|+++.++. .||||++... .....+++.+|++++++++||||+++++++......+.
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 34445678999999999999887764 7999999654 34456889999999999999999999999877652211
Q ss_pred eeEEEEEEeccCCCCCCCc---------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEec
Q 041479 596 YFRALVYEFMHHGSLESCP---------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGD 666 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~D 666 (771)
...++||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 2348999999999997661 1488999999999999999999996 999999999999999999999999
Q ss_pred ccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhC
Q 041479 667 FGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 667 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
||+++....... ........+|+.|+||| +||++|||++ |+.||.+... ...........
T Consensus 181 fg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~ 256 (323)
T 3qup_A 181 FGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLIGGN 256 (323)
T ss_dssp CCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTC
T ss_pred cccccccccccc--ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--HHHHHHHhcCC
Confidence 999986644322 11222345788999999 6999999999 9999976432 23444433333
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.......+++.+.....+||+.||++|||+.++++.|++++
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33334455566666777999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.36 Aligned_cols=229 Identities=22% Similarity=0.297 Sum_probs=184.1
Q ss_pred ccccccccccccceEEEEEecCCC-------eEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ-------TFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|+||+|+++.++ +.||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 85 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD---- 85 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT----
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC----
Confidence 444566899999999999988766 579999997776677789999999999999999999999998766
Q ss_pred eeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--------eE
Q 041479 596 YFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT--------AH 663 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~--------~k 663 (771)
..++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +|
T Consensus 86 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 86 -ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp -CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred -CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 56899999999999876 23489999999999999999999996 8999999999999988876 99
Q ss_pred EecccCccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCC-CCCccccCCccHHHHH
Q 041479 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKR-PTSDMFTEGLDLHNFV 726 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~-P~~~~~~~~~~~~~~~ 726 (771)
|+|||+++...... ...||+.|+||| +||++|||++|.. |+... .. .......
T Consensus 162 l~Dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-~~-~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPKD--------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-DS-QRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSCHH--------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CH-HHHHHHH
T ss_pred eccCcccccccCcc--------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-ch-HHHHHHh
Confidence 99999997543321 235789999999 6999999999554 44332 11 1111111
Q ss_pred HhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 727 KMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
......+...++.+.....+||+.||++|||+.++++.|++++
T Consensus 232 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 232 --EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp --HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred --hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1222333444666667777999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.87 Aligned_cols=238 Identities=23% Similarity=0.271 Sum_probs=189.9
Q ss_pred ccccccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|+||+|++. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~---- 122 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG---- 122 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC----
Confidence 344557899999999999973 355689999996542 33457899999999999 8999999999998766
Q ss_pred eeEEEEEEeccCCCCCCCc--------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 041479 596 YFRALVYEFMHHGSLESCP--------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~--------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl 649 (771)
..++||||+++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||
T Consensus 123 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 123 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred -ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 679999999999997651 1378899999999999999999996 9999999
Q ss_pred CCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCC
Q 041479 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTS 713 (771)
Q Consensus 650 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~ 713 (771)
||+||+++.++.+||+|||+++....... ........||+.|+||| +||++|||+| |+.||.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcc--ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999986644322 12223446788999999 6999999998 999997
Q ss_pred ccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 714 DMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+... ...+............+..+++.+.....+||+.||++|||+.++++.|+.++
T Consensus 277 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 277 GIPV-DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TCCC-SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCc-HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 6432 23344555555544445556667777778999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.48 Aligned_cols=230 Identities=23% Similarity=0.202 Sum_probs=181.2
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++... .....+.+.+|+++++.+ +|||||++++++.+.+
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----- 97 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD----- 97 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC-----
Confidence 3455566799999999999999999999999999754 234567789999999998 6999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+|||||++|+|..+ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 78999999999999766 35689999999999999999999996 9999999999999999999999999999853
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ......+||+.|+||| +||++|||++|+.||.+.... ..+..+..... ..+..+
T Consensus 175 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~--~~p~~~ 247 (353)
T 3txo_A 175 ICNG----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAILNDEV--VYPTWL 247 (353)
T ss_dssp CC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--CCCTTS
T ss_pred ccCC----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC--CCCCCC
Confidence 3221 1233467999999999 699999999999999753211 11222322222 223345
Q ss_pred CccccccCcccChhchhhcCCH------HHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKK------GQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~------~~vl~ 765 (771)
++.+.....+|+++||++||++ .|+++
T Consensus 248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 5556666779999999999998 66653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.72 Aligned_cols=234 Identities=23% Similarity=0.282 Sum_probs=177.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|++. ++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+ ..
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 81 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-----NL 81 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-------C
T ss_pred eeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----ce
Confidence 344556899999999999975 6689999986543 233578999999999999999999999998766 67
Q ss_pred EEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--------CCceEEeccc
Q 041479 599 ALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--------DMTAHMGDFG 668 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--------~~~~kl~DfG 668 (771)
++||||+++|+|.++ .+.+++..+..++.|++.||+|||+....+|+||||||+||+++. ++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999776 457899999999999999999999973233999999999999986 6789999999
Q ss_pred CccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCc
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQ 733 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 733 (771)
+++....... ....||+.|+||| +|+++||+++|+.||.+..... ..........+..
T Consensus 162 ~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 162 LAREWHRTTK------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-VAYGVAMNKLALP 234 (271)
T ss_dssp C-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-HHHHHHTSCCCCC
T ss_pred cccccccccc------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHhhhcCCCCCC
Confidence 9986543221 2346899999999 6999999999999997642211 1222223333344
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+..+++.+.....+||+.||++|||+.|+++.|+++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 4555666677777799999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.08 Aligned_cols=227 Identities=19% Similarity=0.184 Sum_probs=182.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-----GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|+++++.++|||||++++++.+.+ ..|
T Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 102 (351)
T 3c0i_A 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG-----MLY 102 (351)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----EEE
Confidence 34568999999999999999999999999965421 24678999999999999999999999998876 789
Q ss_pred EEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEecccC
Q 041479 600 LVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT---AHMGDFGL 669 (771)
Q Consensus 600 lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl 669 (771)
+|||||++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999654 22478999999999999999999986 9999999999999986554 99999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--C
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--D 732 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~ 732 (771)
++....... .....+||+.|+||| +||++|||++|+.||.+.. ...+..+...... .
T Consensus 180 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 180 AIQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNP 253 (351)
T ss_dssp CEECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCCCCH
T ss_pred eeEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCCCCc
Confidence 986654321 123457999999999 6999999999999997531 1122233333332 2
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 223445666666777999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=312.33 Aligned_cols=238 Identities=31% Similarity=0.487 Sum_probs=185.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+++. ++.||||++..... .....+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 32 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 105 (326)
T 3uim_A 32 FSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERLLV 105 (326)
T ss_dssp SCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS-----CCEEE
T ss_pred cccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC-----ceEEE
Confidence 3345568999999999998764 56999999965432 22347899999999999999999999998766 57899
Q ss_pred EEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence 999999999765 2248999999999999999999999766699999999999999999999999999998664
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc---ccCCccHHHHHHhhCCC-chh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM---FTEGLDLHNFVKMALPD-QIL 735 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~---~~~~~~~~~~~~~~~~~-~~~ 735 (771)
.... .......||+.|+||| +||++|||++|+.||... ........+|....... ...
T Consensus 186 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 186 YKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp SSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred cccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 3322 1223356999999999 699999999999999632 12334466666554432 222
Q ss_pred hhcC------------ccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 736 QVLD------------PLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 736 ~~~~------------~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
...+ +.+...+.+||+.||++|||+.||++.|++
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2222 223344559999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.67 Aligned_cols=229 Identities=20% Similarity=0.259 Sum_probs=184.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~l 105 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----FHYL 105 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEE
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----EEEE
Confidence 334556899999999999999999999999997543 345578999999999999999999999998776 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEecccCccccC
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND---MTAHMGDFGLTRFIP 674 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~ 674 (771)
||||+++|+|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++...
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999665 34688999999999999999999996 99999999999999865 459999999998665
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQV 737 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~ 737 (771)
.... ....+||+.|+||| +||++|||++|+.||.+... ......+..... +......
T Consensus 183 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 183 DSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp TCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCCTTGGGG
T ss_pred CCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCCCCCcccccC
Confidence 3221 22457999999999 69999999999999965321 111222333322 2333345
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+++.+.....+||+.||++|||+.++++
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 6666767777999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.30 Aligned_cols=235 Identities=22% Similarity=0.264 Sum_probs=189.3
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
...+.....+|+|.+|+||+|+++ ++.||||++.... ....+.|.+|+.++++++||||+++++++.+.+.. .
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP---H 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS---S
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC---C
Confidence 344555667899999999999985 6689999997553 34557899999999999999999999998776211 6
Q ss_pred EEEEEEeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 598 RALVYEFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.++||||+++|+|.++. ..+++.++..++.|++.||+|||+. .++|+||||||+||+++.++.++++|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 79999999999997761 2489999999999999999999985 12399999999999999999999999998764
Q ss_pred cCcccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCch
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQI 734 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 734 (771)
... ....||+.|+||| +||++|||++|+.||.+..... ..........+...
T Consensus 163 ~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 163 FQS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-IGMKVALEGLRPTI 232 (271)
T ss_dssp TSC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-HHHHHHHSCCCCCC
T ss_pred ecc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-HHHHHHhcCCCCCC
Confidence 221 2246899999999 6999999999999997642211 12333334444455
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+..+++.+.....+||+.||++|||+.++++.|+++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 566677777777899999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=316.29 Aligned_cols=229 Identities=19% Similarity=0.199 Sum_probs=184.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.....+|+|.+|+||+|+++.+++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+|
T Consensus 14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lv 88 (444)
T 3soa_A 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-----HHYLI 88 (444)
T ss_dssp EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-----EEEEE
T ss_pred EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-----EEEEE
Confidence 34456899999999999999999999999996543 344578999999999999999999999998776 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEecccCccccCc
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD---NDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~ 675 (771)
||||++|+|.+. ...+++.++..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999765 45689999999999999999999996 999999999999998 467899999999986654
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchhhhc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVL 738 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 738 (771)
... ...+.+||+.|+||| +||++|||++|+.||.+... ...+..+...... ....+.+
T Consensus 166 ~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 166 EQQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp TCC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCCCCTTTTTTS
T ss_pred CCc----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCCCCccccccC
Confidence 321 223457999999999 69999999999999965321 1112333333332 3333456
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||++|||+.|+++
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 667777777999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=299.70 Aligned_cols=235 Identities=22% Similarity=0.320 Sum_probs=194.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|+++.+++.||||++... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v 87 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYII 87 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEEEE
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CEEEE
Confidence 344456789999999999999999999999999644 335678999999999999999999999987766 67999
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999776 23488999999999999999999997 8999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. .......||+.|+||| +|+++|||++ |..||.+.. .....+..........+..+++
T Consensus 165 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 165 TY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp SS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCCCCCCTTCCH
T ss_pred cc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhccCCCCCCCCCCH
Confidence 21 2223445788999999 6999999999 999997642 2234555555554444555666
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.....+|+..||++|||+.++++.|+++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 777777799999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.83 Aligned_cols=227 Identities=23% Similarity=0.291 Sum_probs=182.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+++++.++|||||++++++.+.+ ..
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~ 84 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT-----DI 84 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----EE
Confidence 3445667899999999999999999999999996542 223468899999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
++||||+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999999 6787665 45689999999999999999999997 899999999999999999999999999986544
Q ss_pred ccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
... ....+||+.|+||| +||++|||++|+.||.+...... .... . ......++.++
T Consensus 161 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i-~-~~~~~~p~~~s 232 (336)
T 3h4j_B 161 GNF-----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FKKV-N-SCVYVMPDFLS 232 (336)
T ss_dssp SBT-----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-BCCC-C-SSCCCCCTTSC
T ss_pred Ccc-----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-HHHH-H-cCCCCCcccCC
Confidence 321 23457999999999 69999999999999976432211 0000 0 01122344456
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 233 ~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 233 PGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 66666777999999999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=311.30 Aligned_cols=229 Identities=17% Similarity=0.173 Sum_probs=185.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+++.||+|++..........+.+|++++++++|||||++++++.+.. ..++||
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~lv~ 127 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMVLIL 127 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEEEEE
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-----EEEEEE
Confidence 444556899999999999999999999999997665555678999999999999999999999998766 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~ 676 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++. .+.+||+|||+++.....
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999765 23689999999999999999999986 9999999999999974 578999999999866443
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 739 (771)
.. ....+||+.|+||| +||++|||++|+.||.+.... ..+..+..... +......++
T Consensus 205 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 205 EI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp SC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCCCSSTTTTSC
T ss_pred cc-----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCccccccCC
Confidence 21 12346899999999 699999999999999753211 11222222222 233334556
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 66667777999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.18 Aligned_cols=239 Identities=21% Similarity=0.252 Sum_probs=192.8
Q ss_pred cccccccccccccceEEEEEe-----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCC
Q 041479 522 DLLLNVSYESLVKATVYKGIL-----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 594 (771)
.+.....+|+|.+|+||+|++ ..+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--- 100 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG--- 100 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC---
Confidence 344456789999999999985 4466799999997553 34567899999999999 8999999999998766
Q ss_pred ceeEEEEEEeccCCCCCCCcc---------------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 595 NYFRALVYEFMHHGSLESCPR---------------------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~~~---------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
..++||||+++|+|.++.. .+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 101 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 101 --PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp --SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred --CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 5799999999999976511 388999999999999999999996 99999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFT 717 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~ 717 (771)
|+++.++.+||+|||+++....... ........||+.|+||| +|+++|||++ |+.||.+...
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999987654332 11223345788999999 6999999999 9999976432
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
............+...+..+++.+.....+||+.||++|||+.|+++.|++++
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 254 -DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp -SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 22344455554444444555666667777999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.79 Aligned_cols=230 Identities=22% Similarity=0.304 Sum_probs=176.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|++. ++.||||++... ...+.|.+|++++++++|||||++++++.+. .++||
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-------~~lv~ 78 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VCLVM 78 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-------TEEEE
T ss_pred eeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-------cEEEE
Confidence 444556899999999999885 568999998543 3457899999999999999999999987632 48999
Q ss_pred EeccCCCCCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-eEEecccCccccCc
Q 041479 603 EFMHHGSLESCP------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT-AHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~-~kl~DfGla~~~~~ 675 (771)
||+++|+|.++. ..+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999997661 23678889999999999999999854358999999999999988876 79999999975433
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ....||+.|+||| +||++|||++|+.||.+.......................+++
T Consensus 159 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 159 HM-------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCH
T ss_pred cc-------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCH
Confidence 21 1235899999999 7999999999999997643222222222223333334445566
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.....+||+.||++|||+.++++.|+++
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 666677799999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=317.12 Aligned_cols=229 Identities=28% Similarity=0.304 Sum_probs=186.7
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|.+. ++.||||+++... ..++|.+|++++++++|||||++++++.+... ..|+|
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~iv 265 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLYIV 265 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS----CEEEE
T ss_pred HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC----ceEEE
Confidence 3444567899999999999886 5699999996543 45789999999999999999999999876541 47999
Q ss_pred EEeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999998762 2368899999999999999999996 8999999999999999999999999999854321
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ....+++.|+||| |||++|||+| |+.||.+.... .....+....+...+..+++
T Consensus 343 ~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 343 Q-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPP 413 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCCCCCCTTCCH
T ss_pred c-------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCCCCCcCCH
Confidence 1 1225788999999 7999999999 99999765332 34444444444445556677
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+...+.+||+.||++|||+.++++.|+++
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 777778899999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.57 Aligned_cols=235 Identities=20% Similarity=0.280 Sum_probs=177.7
Q ss_pred ccccccccccccceEEEEEecCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLD---QTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|++..+ +..||||++... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 90 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PV 90 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS------SC
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC------cc
Confidence 44456689999999999998653 457999998654 334567899999999999999999999997543 46
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 899999999999776 23588999999999999999999996 99999999999999999999999999998764
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... .......+|+.|+||| +|+++||+++ |+.||.+.... ..........+...+..+
T Consensus 168 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 242 (281)
T 1mp8_A 168 DSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENGERLPMPPNC 242 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTCCCCCCTTC
T ss_pred cccc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcCCCCCCCCCC
Confidence 4321 1122335788999999 6999999997 99999764322 233333333333344556
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
++.+.....+||+.||++|||+.++++.|++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 666767777999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.67 Aligned_cols=227 Identities=22% Similarity=0.217 Sum_probs=179.7
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|..++.++ +|||||++++++.+.+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~----- 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----- 126 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC-----
Confidence 44555667999999999999999999999999997543 23345688999999887 8999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+|||||++|+|..+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 78999999999999766 35689999999999999999999996 9999999999999999999999999999853
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC------cc-HHHHHHhhCC
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG------LD-LHNFVKMALP 731 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~------~~-~~~~~~~~~~ 731 (771)
.... ......+||+.|+||| +||++|||++|+.||....... .. +.+.. ...+
T Consensus 204 ~~~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~ 278 (396)
T 4dc2_A 204 LRPG----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQ 278 (396)
T ss_dssp CCTT----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-HHCC
T ss_pred ccCC----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-hccc
Confidence 2221 1233467999999999 6999999999999996421110 01 11111 1222
Q ss_pred CchhhhcCccccccCcccChhchhhcCCH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
...+..+++.+.....+||+.||++||++
T Consensus 279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 33444566666677779999999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.76 Aligned_cols=232 Identities=19% Similarity=0.205 Sum_probs=189.1
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+ ..|+||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 84 (276)
T 2yex_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQYLFL 84 (276)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-----EEEEEE
Confidence 34456899999999999999888899999997553 345678999999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 160 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-
Confidence 99999999877 33588999999999999999999986 999999999999999999999999999986543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
........||+.|+||| +|+++|||++|+.||.........+..+............+++.+.
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred -hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 11123456899999999 6999999999999997654433344445443333333345566666
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+||+.||++|||+.|+++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHCCCCchhCCCHHHHhc
Confidence 6777999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.64 Aligned_cols=243 Identities=19% Similarity=0.160 Sum_probs=192.5
Q ss_pred cccccccccccccceEEEEE----ecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 522 DLLLNVSYESLVKATVYKGI----LDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.+.....+|+|.+|+||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++...+. ..
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~ 100 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---QS 100 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS---CE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC---ce
Confidence 34456679999999999999 456788999999987766667889999999999999999999999875432 26
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 7999999999999876 34589999999999999999999986 9999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC----------C---ccHHHH
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE----------G---LDLHNF 725 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~----------~---~~~~~~ 725 (771)
...... ........||+.|+||| +|+++|||++|+.||...... . ....+.
T Consensus 178 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 543221 11223346889999999 699999999999998542110 0 112222
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.....+...+..+++.+.....+||+.||++|||+.++++.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2233333344555666667777999999999999999999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.01 Aligned_cols=239 Identities=23% Similarity=0.311 Sum_probs=184.3
Q ss_pred cccccccccccceEEEEEecCCC---eEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQ---TFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.....+|+|.+|+||+|++..++ ..||||.+... .....+.+.+|+.++++++||||+++++++.+.+. ..+
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~ 103 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----SPL 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----CCE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC----ceE
Confidence 34456899999999999975433 46899998653 34456789999999999999999999999765432 568
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999776 34578999999999999999999986 999999999999999999999999999987655
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
..........+..||+.|+||| +|+++||+++ |..||.+... ...............+..++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTTCCCCCCTTCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcCCCCCCCccCC
Confidence 4332233344556889999999 6999999999 5556654322 22333333333333344455
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+.+.....+||+.||++|||+.|+++.|++++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 66666777999999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=304.83 Aligned_cols=238 Identities=22% Similarity=0.300 Sum_probs=188.8
Q ss_pred cccccccccccccceEEEEEec-------CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILD-------LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDF 592 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~-------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 592 (771)
.+.....+|+|.+|+||+|++. .+++.||||++.... ....+++.+|+++++++ +||||+++++++.+.+
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~- 114 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG- 114 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC-
Confidence 3445567899999999999975 345689999996543 34567899999999999 8999999999997766
Q ss_pred CCceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 041479 593 QGNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~N 653 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 115 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 115 ----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp ----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 679999999999997651 1378899999999999999999996 99999999999
Q ss_pred eeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCcccc
Q 041479 654 VLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFT 717 (771)
Q Consensus 654 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~ 717 (771)
|+++.++.+||+|||+++....... ........||+.|+||| +||++|||++ |+.||.+...
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEcCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9999999999999999986654322 11223345788999999 6999999999 9999975421
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+............+..+++.+.....+||+.||++|||+.|+++.|++++
T Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 266 --EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp --HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2233334444333444455666666777999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.00 Aligned_cols=244 Identities=18% Similarity=0.174 Sum_probs=190.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+++...+++.||||++........+.+.+|++++++++||||+++++++.... ......++||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~ 109 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEEEE
Confidence 334556899999999999998888999999997766667788999999999999999999999986421 1223679999
Q ss_pred EeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 603 EFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999765 24589999999999999999999996 999999999999999999999999999876532
Q ss_pred ccCCc-----ccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC
Q 041479 676 VMSSN-----QCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 676 ~~~~~-----~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
..... ........||+.|+||| +||++|||++|+.||....................
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 266 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence 21110 00112345799999999 69999999999999975443333444444433333
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+++.+.....+||+.||++|||+.++++.|+++
T Consensus 267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 33344556666677799999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.21 Aligned_cols=233 Identities=25% Similarity=0.340 Sum_probs=183.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+ ..||||++.... ...++|.+|++++++++|||||++++++.+. ..|+||
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~iv~ 257 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVT 257 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEE
T ss_pred ceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCC------ceEEEe
Confidence 44455689999999999999865 479999997543 2357899999999999999999999998653 468999
Q ss_pred EeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999998772 3488999999999999999999996 89999999999999999999999999998664322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. ....+..+++.|+||| |||++|||++ |+.||.+... ....+.+....+...+..+++.
T Consensus 335 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 335 Y---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCPPECPES 409 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTSCHH
T ss_pred e---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHH
Confidence 1 1223345788999999 7999999999 9999976422 1233333444333344455666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+...+.+||+.||++|||+.++++.|++++
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 667777999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.21 Aligned_cols=223 Identities=19% Similarity=0.215 Sum_probs=181.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|+||+|+...+++.||||++.... ....+++.+|++++++++|||||++++++.+.+ ..++|
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv 132 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLV 132 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----eEEEE
Confidence 3456899999999999999899999999996542 334568999999999999999999999998776 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+. |++.+. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99997 566443 45689999999999999999999996 8999999999999999999999999999865432
Q ss_pred CCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 678 SSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
...+||+.|+||| +||++|||++|+.||.+..... .+........+......++
T Consensus 208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWS 279 (348)
T ss_dssp -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCCCTTSC
T ss_pred -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCCCC
Confidence 2346999999999 6999999999999996532211 1233333333333344456
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.++++
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 66666777999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=299.77 Aligned_cols=238 Identities=21% Similarity=0.242 Sum_probs=189.0
Q ss_pred cccccccccceEEEEEecCCCe---EEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQT---FIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~---~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|+||+|++..+++ .||||++.... ....+.+.+|++++++++||||+++++++.+.+. ..++|
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~~v 101 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG----LPHVL 101 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----CCEEE
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC----CcEEE
Confidence 3568999999999999765543 79999996543 3456789999999999999999999999876542 34899
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+.+|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999776 34578899999999999999999996 89999999999999999999999999998665433
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
...........||+.|+||| +|+++|||++|..|+.... .............+...+..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhhcCCCCCCCccchHHH
Confidence 22222333456899999999 6999999999655543322 2233445554444444455566667
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.....+||+.||++|||+.++++.|++++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 67777999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=304.11 Aligned_cols=236 Identities=20% Similarity=0.242 Sum_probs=177.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC---------
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDF--------- 592 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--------- 592 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+...
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 334456899999999999999888899999997543 3456889999999999999999999999865431
Q ss_pred -------------------------------------------CCceeEEEEEEeccCCCCCCC------cccCCHHHHH
Q 041479 593 -------------------------------------------QGNYFRALVYEFMHHGSLESC------PRILSFLRRL 623 (771)
Q Consensus 593 -------------------------------------------~~~~~~~lv~e~~~~g~L~~~------~~~l~~~~~~ 623 (771)
....+.++|||||++|+|.++ ....++..+.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 111247999999999999766 2335666789
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc--------ccccccccccccccc
Q 041479 624 NIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN--------QCSSVGLKGTVGYAT 695 (771)
Q Consensus 624 ~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~~~~gt~~y~a 695 (771)
.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......... .......+||+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 9999999999999986 99999999999999999999999999998765432111 112234579999999
Q ss_pred hh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCH
Q 041479 696 PE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 696 PE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
|| +||++|||++|..|+.+.. ........... +.......+.+.....+||+.||++|||+
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 320 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVRNLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEA 320 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---HHHHHHHTTCC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---HHHHHhhccCC-CcccccCChhHHHHHHHHccCCCCcCCCH
Confidence 99 6999999999987754311 11111222222 22233334455556679999999999999
Q ss_pred HHHHH
Q 041479 761 GQIRE 765 (771)
Q Consensus 761 ~~vl~ 765 (771)
.|+++
T Consensus 321 ~~~l~ 325 (332)
T 3qd2_B 321 TDIIE 325 (332)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 99986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=308.51 Aligned_cols=228 Identities=22% Similarity=0.227 Sum_probs=168.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ..+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 127 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----EISLVL 127 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-----eEEEEE
Confidence 334556899999999999999988899999996543 3467889999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~ 676 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999765 34588999999999999999999986 8999999999999975 889999999999865432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
. .....+||+.|+||| +||++|||++|+.||.+.......+..+...... ......++
T Consensus 205 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 205 V-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred c-----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 2 122356999999999 6999999999999997543222223333333222 22234455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.....+||+.||++|||+.|+++
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56666677999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.62 Aligned_cols=226 Identities=22% Similarity=0.288 Sum_probs=184.3
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+|+.+.+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+ ..
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~-----~~ 81 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----QI 81 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----EE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-----EE
Confidence 4445567899999999999999999999999997542 234678889999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999876 34688999999999999999999985 999999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ....+||+.|+||| +||++|||++|+.||.+.... .....+..... ..+..+++
T Consensus 159 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~--~~p~~~~~ 228 (318)
T 1fot_A 159 V-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAEL--RFPPFFNE 228 (318)
T ss_dssp C-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCC--CCCTTSCH
T ss_pred c-------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC--CCCCCCCH
Confidence 2 12357999999999 699999999999999653211 11222322222 23344566
Q ss_pred cccccCcccChhchhhcC-----CHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+.....+|+..||++|| ++.|+++
T Consensus 229 ~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 666677799999999999 8888874
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=298.03 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=159.6
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcc
Q 041479 46 VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSE 125 (771)
Q Consensus 46 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~ 125 (771)
++.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|+++++|++|+|++|+++ +..|..
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~--------------~~~~~~ 95 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS--------------KISPGA 95 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC--------------CBCTTT
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCC--------------eeCHHH
Confidence 345666677777 4455443 68899999999999877778999999999999999865 345677
Q ss_pred ccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
|+++++|++|++++|+++ .+|..+. ++|++|++++|+++ .++...+..+++|+.|++++
T Consensus 96 ~~~l~~L~~L~Ls~n~l~------------------~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~ 154 (330)
T 1xku_A 96 FAPLVKLERLYLSKNQLK------------------ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGT 154 (330)
T ss_dssp TTTCTTCCEEECCSSCCS------------------BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCS
T ss_pred hcCCCCCCEEECCCCcCC------------------ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCC
Confidence 778888888888888776 2333332 56777777777776 45555444667777777777
Q ss_pred Ccccc--cCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 206 NQFFG--NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 206 N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
|++.. ..+..|.++++|++|++++|.++.+ |..+. ++|++|++++|+
T Consensus 155 n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l----------------------------~~~~~---~~L~~L~l~~n~ 203 (330)
T 1xku_A 155 NPLKSSGIENGAFQGMKKLSYIRIADTNITTI----------------------------PQGLP---PSLTELHLDGNK 203 (330)
T ss_dssp SCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC----------------------------CSSCC---TTCSEEECTTSC
T ss_pred CcCCccCcChhhccCCCCcCEEECCCCccccC----------------------------Ccccc---ccCCEEECCCCc
Confidence 76642 4555666666666666666666543 22221 234555555555
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcc
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
+++..|..|.++++|+.|++++|.+.+..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..+..
T Consensus 204 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~ 282 (330)
T 1xku_A 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282 (330)
T ss_dssp CCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred CCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhh
Confidence 55444444555555555555555554444455556666666677777666 56666667777777777777776554444
Q ss_pred c
Q 041479 364 L 364 (771)
Q Consensus 364 ~ 364 (771)
|
T Consensus 283 f 283 (330)
T 1xku_A 283 F 283 (330)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=306.15 Aligned_cols=229 Identities=23% Similarity=0.274 Sum_probs=183.8
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+..|.+++..+ +||||+++++++.+.+
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~----- 91 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----- 91 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-----
Confidence 44555667899999999999999999999999997542 34457788999999987 8999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 78999999999999776 34689999999999999999999996 9999999999999999999999999999854
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ......+||+.|+||| +||++|||++|+.||.+... ..+.+..... ....+..+
T Consensus 169 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~-~~~~p~~~ 241 (345)
T 1xjd_A 169 MLGD----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMD-NPFYPRWL 241 (345)
T ss_dssp CCTT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC-CCCCCTTS
T ss_pred ccCC----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhC-CCCCCccc
Confidence 3221 1223467999999999 69999999999999965321 1122222221 12233445
Q ss_pred CccccccCcccChhchhhcCCHH-HHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKG-QIR 764 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~-~vl 764 (771)
++.+.....+||+.||++||++. ++.
T Consensus 242 s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 242 EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 66666677799999999999987 554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.25 Aligned_cols=236 Identities=18% Similarity=0.136 Sum_probs=182.0
Q ss_pred cccccccccccc--ccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESL--VKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~--~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
..+.....+|+| .+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 99 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN----- 99 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC-----
Confidence 344555678999 99999999999999999999997653 345678889999999999999999999998876
Q ss_pred eEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 597 FRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
..|+|||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 78999999999999776 25689999999999999999999996 89999999999999999999999999986
Q ss_pred ccCcccCC---cccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 041479 672 FIPEVMSS---NQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731 (771)
Q Consensus 672 ~~~~~~~~---~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 731 (771)
........ ........+||+.|+||| +||++|||++|+.||.+...... +.+......+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHhcCCCC
Confidence 54322110 111122347899999999 69999999999999976422221 1111111110
Q ss_pred --------------------------------------------CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 --------------------------------------------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 --------------------------------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+++.+.....+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0122334444555667999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=328.80 Aligned_cols=232 Identities=21% Similarity=0.280 Sum_probs=185.2
Q ss_pred ccccccccceEEEEEecC--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDL--DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+|+|.+|+||+|+++. ++..||||+++... ....++|.+|++++++++|||||++++++... ..++|||
T Consensus 342 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~lv~E 415 (613)
T 2ozo_A 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVME 415 (613)
T ss_dssp EEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS------SEEEEEE
T ss_pred cEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC------CeEEEEE
Confidence 368999999999998863 45679999997543 34578999999999999999999999998753 4699999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 9999999765 34589999999999999999999996 9999999999999999999999999999876543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
........+|+.|+||| |||++|||++ |+.||.+.. ...+.+.+....+...+..+++.+.
T Consensus 493 -~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 493 -YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11122334678999999 7999999998 999997643 2334445544444444556667777
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.++.+||..||++|||+.++++.|+++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 778899999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=306.75 Aligned_cols=234 Identities=21% Similarity=0.266 Sum_probs=181.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 102 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ-----Y 102 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC-----e
Confidence 344567899999999999999999999999996542 345678999999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCCcc-------------------------------------------cCCHHHHHHHHHHHHHHHH
Q 041479 598 RALVYEFMHHGSLESCPR-------------------------------------------ILSFLRRLNIAIDVASALE 634 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~~-------------------------------------------~l~~~~~~~i~~~ia~gL~ 634 (771)
.++||||+++|+|.++.. .+++..+..++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 899999999999865421 1246677889999999999
Q ss_pred HHHhcCCCCeEecCCCCCCeeeCCCC--ceEEecccCccccCcccCCcccccccccccccccchh---------------
Q 041479 635 YLHHHCKKPIVHCDLKPSNVLLDNDM--TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------------- 697 (771)
Q Consensus 635 ~LH~~~~~~ivHrdlk~~NILl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE--------------- 697 (771)
|||+. +|+||||||+||+++.++ .+||+|||+++.................||+.|+|||
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99996 899999999999998766 8999999999865443222222334567999999999
Q ss_pred --HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 698 --YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 698 --~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+||++|||++|+.||.+.... ............ ......+++.+.....+||+.||++|||+.++++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 699999999999999754222 123333333332 2333345667777778999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.93 Aligned_cols=227 Identities=22% Similarity=0.196 Sum_probs=180.4
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.+++++ +|||||++++++.+.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----- 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----- 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-----
Confidence 34555667899999999999999999999999997542 34456788999999988 8999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 78999999999999766 34689999999999999999999996 9999999999999999999999999999853
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC----c---cHHHHHHhhCC
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG----L---DLHNFVKMALP 731 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~----~---~~~~~~~~~~~ 731 (771)
.... ......+||+.|+||| +||++|||++|+.||....... . .+.+.... ..
T Consensus 161 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~ 235 (345)
T 3a8x_A 161 LRPG----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQ 235 (345)
T ss_dssp CCTT----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CC
T ss_pred cCCC----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CC
Confidence 3221 1223457999999999 6999999999999996421110 0 11111111 12
Q ss_pred CchhhhcCccccccCcccChhchhhcCCH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
...+..+++.+.....+||+.||++||++
T Consensus 236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 23344556666667779999999999996
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.43 Aligned_cols=232 Identities=21% Similarity=0.297 Sum_probs=185.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|+||+|++..++..||+|++.... ....+.+.+|+.++++++||||+++++++.... .+....++|||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e 109 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTE 109 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEEEE
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEEEEEE
Confidence 446899999999999999999999999997543 445678999999999999999999999986542 22336799999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+++|+|.++ ...+++..+..++.|++.||+|||+. .++|+||||||+||+++ .++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 186 (290)
T 1t4h_A 110 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-- 186 (290)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--
T ss_pred ecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc--
Confidence 9999999877 35688999999999999999999986 12399999999999998 78999999999997543322
Q ss_pred cccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 680 NQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
.....||+.|+||| +||++|||++|+.||.+................+.......++.+...
T Consensus 187 ----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 262 (290)
T 1t4h_A 187 ----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp ----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred ----cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence 12346899999999 699999999999999764322222222223333444555566667777
Q ss_pred CcccChhchhhcCCHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+||+.||++|||+.|+++
T Consensus 263 i~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 263 IEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhhCCCHHHHhh
Confidence 78999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.56 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=179.6
Q ss_pred ccccccccccccceEEEEEecC---CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDL---DQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+...
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 3344568999999999998865 44589999996542 345678999999999999999999999998765433335
Q ss_pred EEEEEEeccCCCCCCC---------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEeccc
Q 041479 598 RALVYEFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG 668 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 668 (771)
.++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 6999999999999655 24589999999999999999999985 89999999999999999999999999
Q ss_pred CccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCC
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
+++....... ........+++.|+||| +|+++|||++ |+.||.+... ....+........
T Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~ 268 (313)
T 3brb_A 193 LSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGHRL 268 (313)
T ss_dssp CC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC
T ss_pred cceecccccc--cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHHcCCCC
Confidence 9986544321 11122345788999999 6999999999 8899876422 2334444333333
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+..+++.+.....+||..||++|||+.++++.|++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 444555666666777999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.00 Aligned_cols=232 Identities=22% Similarity=0.276 Sum_probs=187.9
Q ss_pred ccccccccceEEEEEec--CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILD--LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+|+|.+|+||+|+++ .+++.||||++.... ....+++.+|++++++++||||+++++++... ..++|||
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e 89 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVME 89 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC------CcEEEEE
Confidence 37899999999999864 456789999997643 44567899999999999999999999998433 4699999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999775 34589999999999999999999996 9999999999999999999999999999876443221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
........||+.|+||| +|+++|||++ |+.||.+.. ............+...+..+++.+.
T Consensus 167 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 167 -YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRMECPPECPPELY 243 (287)
T ss_dssp -ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHhcCCcCCCCCCcCHHHH
Confidence 11222345789999999 6999999999 999997642 2234444444443444555667777
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+||+.||++|||+.++++.|+++
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 777899999999999999999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.35 Aligned_cols=229 Identities=18% Similarity=0.200 Sum_probs=176.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..++||
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 80 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KLTLVF 80 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EEEEEE
Confidence 3456899999999999999999999999996543 344578899999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||++++.+..+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 99986443322 45689999999999999999999996 999999999999999999999999999986543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cc--------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQ-------- 733 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~-------- 733 (771)
......||+.|+||| +||++|||++|..|+.........+..+...... ..
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ---cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 122356899999999 6999999999888864322211122222221111 00
Q ss_pred -----------------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 -----------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 -----------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 01112333334556999999999999999985
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.96 Aligned_cols=281 Identities=21% Similarity=0.242 Sum_probs=211.7
Q ss_pred CccceeeeecCC---------CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEeccc
Q 041479 31 FCQWLGVTCSLK---------YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNS 101 (771)
Q Consensus 31 ~c~w~~v~c~~~---------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 101 (771)
.|+|..+.|... ..+++.|+|++|++++..+..|..+++|++|+|++|++++..|.+|+++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 478999999742 25789999999999988888999999999999999999998899999999999999999
Q ss_pred CcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccC
Q 041479 102 NALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSEN 181 (771)
Q Consensus 102 N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N 181 (771)
|+++ .+|..+. ++|++|++++|++++ ..+..+.++++|++|++++|
T Consensus 110 n~l~---------------~l~~~~~--~~L~~L~l~~n~l~~-----------------~~~~~~~~l~~L~~L~l~~n 155 (330)
T 1xku_A 110 NQLK---------------ELPEKMP--KTLQELRVHENEITK-----------------VRKSVFNGLNQMIVVELGTN 155 (330)
T ss_dssp SCCS---------------BCCSSCC--TTCCEEECCSSCCCB-----------------BCHHHHTTCTTCCEEECCSS
T ss_pred CcCC---------------ccChhhc--ccccEEECCCCcccc-----------------cCHhHhcCCccccEEECCCC
Confidence 9986 3444443 688889888888762 44556889999999999999
Q ss_pred cCcc--cCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccc
Q 041479 182 QLVG--ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259 (771)
Q Consensus 182 ~l~g--~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l 259 (771)
.++. ..+..+ ..+++|+.|++++|+++. +|..+. ++|++|++++|++++..|..| ..+++|+.|++++|.+
T Consensus 156 ~l~~~~~~~~~~-~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l 228 (330)
T 1xku_A 156 PLKSSGIENGAF-QGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASL---KGLNNLAKLGLSFNSI 228 (330)
T ss_dssp CCCGGGBCTTGG-GGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGG---TTCTTCCEEECCSSCC
T ss_pred cCCccCcChhhc-cCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHh---cCCCCCCEEECCCCcC
Confidence 9962 344444 489999999999999995 555543 899999999999998877666 7778899999999999
Q ss_pred cccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccC------CCCCCEEEccCCccc
Q 041479 260 SGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGY------LLKLQVLSLFENNIS 333 (771)
Q Consensus 260 ~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~------l~~L~~L~Ls~N~l~ 333 (771)
++..+..+..+. +|++|++++|+++ .+|..+..+++|+.|++++|.+.+..+..|.. ...|+.|++++|.+.
T Consensus 229 ~~~~~~~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 229 SAVDNGSLANTP-HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CEECTTTGGGST-TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ceeChhhccCCC-CCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 866666777765 7888888888888 56666766666666666666665544444432 234455555555543
Q ss_pred c--cCCcccccccccccccccCc
Q 041479 334 R--EIPSSLGNFTFLTELNLCGN 354 (771)
Q Consensus 334 ~--~~p~~~~~l~~L~~L~Ls~N 354 (771)
. ..|..|..+.+|+.++|++|
T Consensus 307 ~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 307 YWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp GGGSCGGGGTTCCCGGGEEC---
T ss_pred ccccCccccccccceeEEEeccc
Confidence 2 23344444444555554444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.51 Aligned_cols=236 Identities=20% Similarity=0.296 Sum_probs=186.4
Q ss_pred ccccccccccccccceEEEEEecCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLD---QTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
..+.....+|+|.+|+||+|++..+ +..||||.+... .....+++.+|++++++++||||+++++++.+..
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 86 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP----- 86 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS-----
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----
Confidence 3444556789999999999987643 346999999754 3345678999999999999999999999976543
Q ss_pred eEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 597 FRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 87 -TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp -CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred -CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4899999999999776 34589999999999999999999986 999999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
...... .......||+.|+||| +|+++|||++ |+.||..... ...............+.
T Consensus 163 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 237 (281)
T 3cc6_A 163 IEDEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKGDRLPKPD 237 (281)
T ss_dssp C------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHHHTCCCCCCT
T ss_pred cccccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHhcCCCCCCCC
Confidence 644321 1122345788999999 6999999998 9999975322 23444444443333445
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+++.+.....+||..||++|||+.|+++.|+++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 5666676777799999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.82 Aligned_cols=243 Identities=17% Similarity=0.171 Sum_probs=183.3
Q ss_pred ccccccccccccceEEEEEecCC-----CeEEEEEEeeccchh-----------hHHHHHHHHHHHhccCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQRG-----------ALKSFMAECQALRNIRHRNLVKIITA 586 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~ 586 (771)
+.....+|+|.+|+||+|+++.+ ++.||||++...... ....+..|+..++.++|||||+++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 34455689999999999999775 468999998654321 11234567777888899999999999
Q ss_pred eecCCCCCceeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCC
Q 041479 587 CSTSDFQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD--NDM 660 (771)
Q Consensus 587 ~~~~~~~~~~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~--~~~ 660 (771)
+.... .+..+.|+||||+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++ .++
T Consensus 117 ~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 117 GLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeecc-CCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 87642 2233689999999 9999876 35689999999999999999999996 999999999999998 889
Q ss_pred ceEEecccCccccCcccCCcc---cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccH
Q 041479 661 TAHMGDFGLTRFIPEVMSSNQ---CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDL 722 (771)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~ 722 (771)
.+||+|||+++.+........ ......+||+.||||| |||++|||+||+.||.+.... ...
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-PKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-HHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-HHH
Confidence 999999999987654332211 1123456999999999 799999999999999864332 223
Q ss_pred HHHHHhhCCCchhh---------hcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 723 HNFVKMALPDQILQ---------VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 723 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
........+..... .+.+.+...+..||+.||++||++.++++.|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 33333222222222 22444555667999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.12 Aligned_cols=236 Identities=18% Similarity=0.223 Sum_probs=185.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++..... .+.+.+|+++++++ +||||+++++++...+ ..++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~~lv 83 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-----YNAMV 83 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-----EEEEE
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-----ccEEE
Confidence 3345568999999999999999999999999865432 34688999999999 8999999999998876 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-----eEEecccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT-----AHMGDFGLTRF 672 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGla~~ 672 (771)
|||+ +|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 8999776 35789999999999999999999996 9999999999999998887 99999999986
Q ss_pred cCcccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc--cHHHHHHhhCCC
Q 041479 673 IPEVMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL--DLHNFVKMALPD 732 (771)
Q Consensus 673 ~~~~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~ 732 (771)
........ .......+||+.|+||| +||++|||++|+.||.+...... .+..+.....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 54432211 11124567999999999 79999999999999976432221 112222222221
Q ss_pred ch---hhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 733 QI---LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 733 ~~---~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.. .... +.+......||+.||++||++.++++.|+++
T Consensus 240 ~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 240 PIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp CHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 11 1112 2555667799999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=313.30 Aligned_cols=232 Identities=18% Similarity=0.133 Sum_probs=182.5
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.++..++|||||++++++.+.+ ..
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-----~~ 149 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN-----NL 149 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS-----EE
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----EE
Confidence 3444567899999999999999999999999996532 222345889999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
|+|||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 999999999999766 35689999999999999999999986 89999999999999999999999999997654
Q ss_pred cccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCC-
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALP- 731 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~- 731 (771)
.... ......+||+.||||| +||++|||++|+.||.+.... .....+... .++
T Consensus 227 ~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 227 EDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKERFQF 302 (437)
T ss_dssp TTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHCCC
T ss_pred cCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhccccccC
Confidence 4321 2223457999999999 699999999999999753211 112222221 121
Q ss_pred CchhhhcCccccccCcccChhchhh--cCCHHHHHH
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEE--NIKKGQIRE 765 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~--Rpt~~~vl~ 765 (771)
+.....+++.......+|+..+|++ ||++.|+++
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111234555556666888888888 999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.81 Aligned_cols=233 Identities=18% Similarity=0.131 Sum_probs=186.0
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+ .
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~ 143 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-----Y 143 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----E
Confidence 34555667999999999999999999999999996532 223356889999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 598 RALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
.|+|||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 8999999999999776 34588999999999999999999996 999999999999999999999999999986544
Q ss_pred ccCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCch
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQI 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~ 734 (771)
.. .......+||+.|+||| +||++|||++|+.||.+.... .....+.... .+...
T Consensus 221 ~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 221 EG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp TS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHHCCCCT
T ss_pred CC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhccccccCCC
Confidence 32 12233567999999999 699999999999999653211 1223333322 22222
Q ss_pred hhhcCccccccCcccChhchhh--cCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEE--NIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~--Rpt~~~vl~ 765 (771)
...+++.+.....+|++.+|.+ ||++.|+++
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 3345566666677999999988 999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.70 Aligned_cols=229 Identities=25% Similarity=0.315 Sum_probs=186.8
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+ .
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~-----~ 90 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-----D 90 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----E
Confidence 44555677999999999999999889999999996543 234578999999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 8999999999999776 34689999999999999999999985 99999999999999999999999999998654
Q ss_pred cccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
... .....+||+.|+||| +||++|||++|+.||.+.... .....+..+.. ..+..+
T Consensus 168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~--~~p~~~ 239 (476)
T 2y94_A 168 DGE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFKKICDGIF--YTPQYL 239 (476)
T ss_dssp TTC-----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HHHHHHHTTCC--CCCTTC
T ss_pred ccc-----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCCc--CCCccC
Confidence 422 122357999999999 699999999999999763211 11222222222 223445
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||++|||+.|+++
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 666666777999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=304.86 Aligned_cols=235 Identities=23% Similarity=0.241 Sum_probs=190.5
Q ss_pred ccccccccccceEEEEEecCCC-----eEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCcee
Q 041479 525 LNVSYESLVKATVYKGILDLDQ-----TFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
....+|+|.+|+||+|++..++ +.||||++.... ....+.+.+|+++++++ +||||+++++++.+.+ .
T Consensus 50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~ 124 (333)
T 2i1m_A 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG-----P 124 (333)
T ss_dssp EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC-----c
Confidence 3456899999999999987654 379999996543 34567899999999999 8999999999998766 6
Q ss_pred EEEEEEeccCCCCCCCc-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 041479 598 RALVYEFMHHGSLESCP-----------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM 660 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~-----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~ 660 (771)
.++||||+++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 79999999999997651 2468899999999999999999996 999999999999999999
Q ss_pred ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHH
Q 041479 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHN 724 (771)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 724 (771)
.+||+|||+++....... ........||+.|+||| +||++|||+| |..||.+.... ..+..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~ 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYK 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHH
T ss_pred eEEECccccccccccccc--eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHH
Confidence 999999999986543322 11223345788999999 6999999999 99999764322 23445
Q ss_pred HHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 725 FVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
......+...+...++.+.....+||+.||++|||+.++++.|+++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 5555555444555566666777799999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.47 Aligned_cols=242 Identities=23% Similarity=0.223 Sum_probs=187.0
Q ss_pred ccccccccccccceEEEEE----ecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGI----LDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~----~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|+ ...+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.. .
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---~ 99 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN---G 99 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C---C
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc---e
Confidence 3345678999999999999 45678899999996543 34567899999999999999999999999875322 5
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 7899999999999876 34689999999999999999999996 9999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcccc----------CCcc---HHHH
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT----------EGLD---LHNF 725 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~----------~~~~---~~~~ 725 (771)
...... ........||..|+||| +|+++|||++|..|+...+. .... +...
T Consensus 177 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 177 ETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred cCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 543221 12233456889999999 69999999999998643211 1111 1122
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.....+...+..+++.+.....+||+.||++|||+.++++.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222233334455666667777999999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.45 Aligned_cols=228 Identities=20% Similarity=0.181 Sum_probs=186.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|+++.+++.||+|++........+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 86 (277)
T 3f3z_A 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----DIYLVME 86 (277)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEEEEEE
T ss_pred EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----eEEEEEe
Confidence 34456899999999999999999999999997765566788999999999999999999999998776 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCccccCccc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~~ 677 (771)
|+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999765 44689999999999999999999986 89999999999999 788899999999998654332
Q ss_pred CCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 741 (771)
. .....||+.|+||| +|+++|||++|+.||.+.... .....+.....+ ......+++.
T Consensus 164 ~-----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 164 M-----MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred c-----hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCchhhhcCCHH
Confidence 1 22346899999999 699999999999999764221 122233333332 2222345666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+|++.||++|||+.++++
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 667777999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.86 Aligned_cols=228 Identities=20% Similarity=0.151 Sum_probs=173.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+++++.+++.||||++..... ..+.+.+|+.+++.++|||||++++++.+.+ ..|+||
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv~ 95 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIIM 95 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-----EEEEEE
Confidence 3445568999999999999999999999999965432 3467889999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--eEEecccCccccCccc
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT--AHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~~~~~~ 677 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++......
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999776 35689999999999999999999986 8999999999999987665 9999999997432221
Q ss_pred CCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh----hCCCchhhh
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM----ALPDQILQV 737 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~----~~~~~~~~~ 737 (771)
.....+||+.|+||| +||++|||++|+.||.+..... ........ .........
T Consensus 173 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 173 -----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCCCCCTTSC
T ss_pred -----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCCCCCCcCC
Confidence 122356999999999 6999999999999997643222 23222222 222222223
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+++.+.....+||+.||++|||+.|+++
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 4556666777999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.50 Aligned_cols=237 Identities=22% Similarity=0.252 Sum_probs=183.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...+.. ..++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---~~~lv 87 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR---HKVLI 87 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC---CEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc---eEEEE
Confidence 334556899999999999999988999999996543 34467889999999999999999999998765422 57999
Q ss_pred EEeccCCCCCCCcc------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEecccCcc
Q 041479 602 YEFMHHGSLESCPR------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DNDMTAHMGDFGLTR 671 (771)
Q Consensus 602 ~e~~~~g~L~~~~~------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGla~ 671 (771)
|||+++|+|.++.. .+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999977621 289999999999999999999996 99999999999999 778889999999998
Q ss_pred ccCcccCCcccccccccccccccchh-----------------------HHHHHHHHHhCCCCCCccccC---CccHHHH
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE-----------------------YGILLLEIFTGKRPTSDMFTE---GLDLHNF 725 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------------~Gv~l~el~tg~~P~~~~~~~---~~~~~~~ 725 (771)
....... .....||+.|+||| +||++|||++|+.||...... ...+...
T Consensus 165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp ECCTTCC-----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ecCCCCc-----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 6654321 22356999999999 599999999999999643221 1122333
Q ss_pred HHhhCCC-----------------------chhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPD-----------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~-----------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+. ...+.+++.+.....+||+.||++|||+.|+++..++-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 3332211 11122222333445599999999999999999988763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.83 Aligned_cols=242 Identities=20% Similarity=0.234 Sum_probs=180.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc--CCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI--RHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++..... .....|+
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l 112 (337)
T 3mdy_A 39 IQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL 112 (337)
T ss_dssp CEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred eEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence 334556899999999999886 6799999996443 34555666666655 89999999999877631 1126799
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHC-----KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||||+++|+|.++ ...+++..+..++.|++.||+|||+.+ +++|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 9999999999877 346899999999999999999999741 238999999999999999999999999999766
Q ss_pred CcccCCcccccccccccccccchh---------------------HHHHHHHHHhC----------CCCCCccccCCccH
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTG----------KRPTSDMFTEGLDL 722 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg----------~~P~~~~~~~~~~~ 722 (771)
..............+||+.|+||| +||++|||+|| +.||.+........
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 272 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence 543322222233457999999999 59999999999 77776654444433
Q ss_pred HHHHHhhC----CCchh-----hhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 723 HNFVKMAL----PDQIL-----QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 723 ~~~~~~~~----~~~~~-----~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+..... ....+ +.+.+.+...+.+||+.||++|||+.++++.|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 33332221 11111 12233455566799999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=297.14 Aligned_cols=228 Identities=21% Similarity=0.231 Sum_probs=178.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+.+.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv 98 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NMYIV 98 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEEEE
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-----eEEEE
Confidence 444567899999999999999999999999997654 334678999999999999999999999998766 78999
Q ss_pred EEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCcc
Q 041479 602 YEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTR 671 (771)
Q Consensus 602 ~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~ 671 (771)
|||+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999765 25689999999999999999999986 99999999999999 456789999999998
Q ss_pred ccCcccCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQIL 735 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~ 735 (771)
....... .....||+.|+||| +|+++|||++|+.||.+.... ..........+ ....
T Consensus 176 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 176 LFKSDEH-----STNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEPNYAVEC 248 (285)
T ss_dssp C---------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCCCC--
T ss_pred ecCCccc-----CcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccCCccccccc
Confidence 6544221 22346899999999 699999999999999753211 12222222222 1112
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+++.+.....+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234555556677999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.16 Aligned_cols=228 Identities=18% Similarity=0.143 Sum_probs=186.3
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
...+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----- 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----
Confidence 445566677999999999999999999999999996543 244678999999999999999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence 78999999999999776 34689999999999999999999986 9999999999999999999999999999865
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
... ....+||+.|+||| +||++|||++|+.||.+.... .....+..... ..+..+
T Consensus 192 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~--~~p~~~ 261 (350)
T 1rdq_E 192 KGR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV--RFPSHF 261 (350)
T ss_dssp SSC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--CCCTTC
T ss_pred cCC-------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCC--CCCCCC
Confidence 432 12357999999999 699999999999999653211 11222333222 233445
Q ss_pred CccccccCcccChhchhhcCC-----HHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
++.+.....+||+.||++||+ +.|+++
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 666666777999999999998 888764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=301.23 Aligned_cols=223 Identities=20% Similarity=0.155 Sum_probs=177.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|.+|+||+|+++.+++.||||++.... .....++..|+..+.++ +|||||+++++|.+.+ ..|+|
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-----~~~lv 135 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----ILYLQ 135 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-----EEEEE
Confidence 3446899999999999999888899999985432 33445666777766666 8999999999998776 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+ +|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 6677655 34689999999999999999999996 89999999999999999999999999998654322
Q ss_pred CCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
. .....||+.|+||| +||++|||++|..|+.+. .....+.....+......+++.+.
T Consensus 212 ~-----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 212 A-----GEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELR 282 (311)
T ss_dssp --------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHH
T ss_pred C-----CcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHH
Confidence 1 22346999999999 799999999997765431 223344444445555566677777
Q ss_pred ccCcccChhchhhcCCHHHHHH
Q 041479 744 VGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+||+.||++|||+.|+++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 7778999999999999999985
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=297.01 Aligned_cols=243 Identities=21% Similarity=0.259 Sum_probs=152.6
Q ss_pred ccceeeeecCC---------CCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccC
Q 041479 32 CQWLGVTCSLK---------YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSN 102 (771)
Q Consensus 32 c~w~~v~c~~~---------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 102 (771)
|.|..+.|... ..+++.|+|++|++++..+..|..+++|++|+|++|+|++..|.+|+++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 78999999643 257999999999999888889999999999999999999988999999999999999999
Q ss_pred cCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCc
Q 041479 103 ALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQ 182 (771)
Q Consensus 103 ~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 182 (771)
+++ .+|..+. ++|++|++++|++++ ..+..|.++++|+.|++++|.
T Consensus 113 ~l~---------------~l~~~~~--~~L~~L~l~~n~i~~-----------------~~~~~~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 113 HLV---------------EIPPNLP--SSLVELRIHDNRIRK-----------------VPKGVFSGLRNMNCIEMGGNP 158 (332)
T ss_dssp CCC---------------SCCSSCC--TTCCEEECCSSCCCC-----------------CCSGGGSSCSSCCEEECCSCC
T ss_pred cCC---------------ccCcccc--ccCCEEECCCCccCc-----------------cCHhHhCCCccCCEEECCCCc
Confidence 986 3444433 567777777776652 223345566666666666666
Q ss_pred Ccc-cCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccc
Q 041479 183 LVG-ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG 261 (771)
Q Consensus 183 l~g-~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~ 261 (771)
++. .+++..+..+ +|+.|++++|++++ +|..+. ++|++|++++|.+++..+..| ..+++
T Consensus 159 l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l---~~l~~------------- 218 (332)
T 2ft3_A 159 LENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDL---LRYSK------------- 218 (332)
T ss_dssp CBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSS---TTCTT-------------
T ss_pred cccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHh---cCCCC-------------
Confidence 641 1222222233 55555555555553 333222 445555555555554444333 33444
Q ss_pred cCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccc
Q 041479 262 TLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341 (771)
Q Consensus 262 ~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 341 (771)
|++|++++|++++..+..|..+++|+.|++++|.+. .+|..+..+++|+.|++++|+++...+..|.
T Consensus 219 ------------L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 219 ------------LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp ------------CSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred ------------CCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 455555555554444444555555555555555443 3444555555666666666666554444444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.52 Aligned_cols=236 Identities=20% Similarity=0.309 Sum_probs=180.0
Q ss_pred cccccccccccceEEEEEecCCC----eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQ----TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.....+|+|.+|+||+|+++.++ ..||||++.... .....++.+|++++++++||||+++++++.+.+ ..
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 121 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-----PM 121 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC-----Cc
Confidence 34456899999999999987543 469999997543 345568999999999999999999999987765 67
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999876 24689999999999999999999996 89999999999999999999999999998765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ........+|+.|+||| +||++||+++ |+.||.+... ..+.+.............+
T Consensus 199 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 199 DDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFRLPTPMDC 275 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTC
T ss_pred ccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHCCCcCCCcccC
Confidence 43211 11222345688999999 6999999999 9999975422 1233333333332333445
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
++.+.....+||+.||++|||+.++++.|+++
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 55666677799999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=330.14 Aligned_cols=232 Identities=21% Similarity=0.225 Sum_probs=184.9
Q ss_pred ccccccccceEEEEEec--CCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILD--LDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~--~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.+|+||+|.+. ..++.||||+++... ....+++.+|++++++++|||||++++++... ..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence 36899999999999654 456799999997543 34468899999999999999999999998654 368999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||++|+|.++ ...+++.++..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999876 44689999999999999999999996 9999999999999999999999999999876543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
........||+.|+||| |||++|||++ |+.||.+... ..+.+.+........+..+++.+.
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~ 602 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMY 602 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11223345788999999 7999999999 9999976422 234444444444445556667777
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.++.+||+.||++|||+.+|++.|+++
T Consensus 603 ~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 603 DLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 777899999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.48 Aligned_cols=233 Identities=24% Similarity=0.327 Sum_probs=187.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|++.. ++.||||++..... ..+++.+|++++++++||||+++++++.+.+ ..++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 82 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVT 82 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred eeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeEEEE
Confidence 3445568999999999999874 45899999965432 3478999999999999999999999998765 579999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 99999999876 24588999999999999999999986 89999999999999999999999999998654322
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
........||+.|+||| +|+++|||++ |+.||.+... ....+......+...+...++.+
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~l 234 (267)
T 3t9t_A 159 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYKPRLASTHV 234 (267)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTSCHHH
T ss_pred --ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCcCCCCccCcHHH
Confidence 11223345788999999 6999999999 8999975321 12333333333333444556666
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+||+.||++|||+.++++.|+++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 6677799999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=298.37 Aligned_cols=234 Identities=25% Similarity=0.336 Sum_probs=175.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|++.. .||||++.... ....+.|.+|++++++++||||+++++++... ..++
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~l 96 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAI 96 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEE
T ss_pred eeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC------ccEE
Confidence 3445668999999999998643 59999996543 44567899999999999999999999976443 3689
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999998655 34688999999999999999999996 8999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCCC---ch
Q 041479 677 MSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALPD---QI 734 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~---~~ 734 (771)
.. ........||+.|+||| +|+++|||++|+.||.+..... .+.+.... ..+. ..
T Consensus 174 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 174 SG--SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTSCCCCTTSS
T ss_pred cc--cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccccCcchhhc
Confidence 21 11223356899999999 6999999999999997643322 23333332 2222 22
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
...+++.+.....+||+.||++|||+.++++.|+++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 3344556666777999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.36 Aligned_cols=237 Identities=20% Similarity=0.249 Sum_probs=178.2
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+.....+|+|.+|+||+|+...+++.||||++... .....+++.+|++++++++||||+++++++.+.+ ..
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 107 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----EL 107 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----cE
Confidence 344556789999999999999888889999999653 2445678999999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 599 ALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 999999999999765 23488999999999999999999986 99999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHH-HhhCCCchh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV-KMALPDQIL 735 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~ 735 (771)
....... ......||+.|+||| +|+++|||++|+.||.+.......+.... ....+....
T Consensus 185 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 185 FFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 260 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT
T ss_pred eecCCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc
Confidence 6543221 122346899999999 69999999999999965322211222222 222333233
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+++.+.....+||..||++|||+.++++.|+++
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 44566666677799999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.97 Aligned_cols=231 Identities=21% Similarity=0.228 Sum_probs=184.0
Q ss_pred cccccccceEEEEEe--cCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGIL--DLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~--~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.+|+||+|.+ +.+++.||||++.... ....+++.+|++++++++||||+++++++... ..++|||
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e 97 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVME 97 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEEE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCC------CcEEEEE
Confidence 689999999999954 5567899999996543 33467899999999999999999999998433 4689999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 173 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 173 (291)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-
T ss_pred eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc-
Confidence 9999999876 34588999999999999999999996 9999999999999999999999999999866443221
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
........||+.|+||| +|+++|||++ |+.||.+... ....+......+...+..+++.+..
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11122334678999999 6999999999 9999976422 2234444444334445556667777
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+||+.||++|||+.++++.|+++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 77899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.44 Aligned_cols=228 Identities=20% Similarity=0.231 Sum_probs=175.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ......+.+|++++++++|||||++++++...
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---- 212 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---- 212 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS----
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 334456899999999999999999999999996542 11223588999999999999999999997543
Q ss_pred ceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEeccc
Q 041479 595 NYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND---MTAHMGDFG 668 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfG 668 (771)
..|+|||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 213 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp --EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred --ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 46899999999999776 45689999999999999999999986 89999999999999754 459999999
Q ss_pred CccccCcccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-h
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-A 729 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~ 729 (771)
+|+...... .....+||+.|+||| +||++|||++|+.||.+..... .+.+.... .
T Consensus 288 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~i~~~~ 361 (419)
T 3i6u_A 288 HSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGK 361 (419)
T ss_dssp TTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHHHHHHTTC
T ss_pred cceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHHHHHhcCC
Confidence 998765422 122457999999999 6999999999999997643332 23333333 2
Q ss_pred CC--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 LP--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ ......+++.+.....+||+.||++|||+.|+++
T Consensus 362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22 2233445666666777999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=301.78 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=190.2
Q ss_pred ccccccccccccceEEEEEe-----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGIL-----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|+||+|++ ..+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--- 105 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG--- 105 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS---
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC---
Confidence 44456789999999999985 3456899999996543 34457899999999999 79999999999876542
Q ss_pred eeEEEEEEeccCCCCCCCcc-------------------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 041479 596 YFRALVYEFMHHGSLESCPR-------------------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL 656 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~~-------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl 656 (771)
..++||||+++|+|.++.. .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 106 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~ 181 (316)
T 2xir_A 106 -PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 181 (316)
T ss_dssp -CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred -ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEE
Confidence 4799999999999976511 178899999999999999999996 99999999999999
Q ss_pred CCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCc
Q 041479 657 DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGL 720 (771)
Q Consensus 657 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~ 720 (771)
+.++.+||+|||+++....... ........||+.|+||| +||++|||+| |+.||.+.... .
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~ 258 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-E 258 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-H
T ss_pred CCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh-H
Confidence 9999999999999986644322 12223456889999999 6999999998 99999764322 2
Q ss_pred cHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 721 DLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+........+...+..+++.+.....+||+.||++|||+.|+++.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 333444444444445556667777777999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.73 Aligned_cols=238 Identities=18% Similarity=0.178 Sum_probs=185.6
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ .
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~ 108 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG-----Q 108 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-----e
Confidence 34555667899999999999999999999999996543 334578999999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.|+||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 8999999999999876 34589999999999999999999996 89999999999999999999999999998654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchhhh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQV 737 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~ 737 (771)
.... .......||+.|+||| +|+++|||++|+.||.+.... .+........+ ......
T Consensus 186 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 186 DEKL---TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCCGGGTSTT
T ss_pred cccc---ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCCccccCCC
Confidence 3221 1122346899999999 699999999999999753211 22222232222 223344
Q ss_pred cCccccccCcccChhchhhcC-CHHHHHHHHHHhC
Q 041479 738 LDPLFLVGGVQEGEETAEENI-KKGQIRESLIAIL 771 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rp-t~~~vl~~L~~~l 771 (771)
+++.+.....+||+.||++|| |+.++++.|++++
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 566666677799999999999 9999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=305.27 Aligned_cols=237 Identities=20% Similarity=0.222 Sum_probs=176.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++|||||++++++...... ....|
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~~~~~ 92 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA-GPLPY 92 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT-EEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC-CcccE
Confidence 444566899999999999999999999999996542 34456899999999999999999999998765421 12459
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 99999999999876 34689999999999999999999986 8999999999999999999999999999866543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
... ........||+.|+||| +||++|||++|+.||.+...... .......... ......++
T Consensus 170 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 170 GNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCCCHHHHSTTCC
T ss_pred ccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCCCCCcccccCCCC
Confidence 221 11223456899999999 69999999999999975322111 1222222221 11223455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++||++.++++
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 66666777999999999997776653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=302.94 Aligned_cols=235 Identities=20% Similarity=0.250 Sum_probs=183.1
Q ss_pred ccccccccccccceEEEEEecCCCeE----EEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTF----IAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~----vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++..+++. ||+|.+... .....+.+.+|+.++++++||||+++++++....
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 90 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------ 90 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS------
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC------
Confidence 44456789999999999998877654 466666433 2345688999999999999999999999998654
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++|+||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5899999999999776 34588999999999999999999996 9999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
..... ........||+.|+||| +||++|||++ |+.||.+... ..+.+..........+..
T Consensus 168 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (327)
T 3lzb_A 168 GAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQPPI 243 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCCTT
T ss_pred cCccc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCCcc
Confidence 44322 12223345788999999 6999999999 9999976432 335555555544444555
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+++.+.....+||+.||++|||+.|+++.|+++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 666677777799999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.65 Aligned_cols=228 Identities=20% Similarity=0.242 Sum_probs=181.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
...+|+|.+|+||+|++..+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+ ..++||||+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 101 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIKIFMEQV 101 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEEEECC
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEEEEEEeC
Confidence 346899999999999999999999999997766666788999999999999999999999998776 789999999
Q ss_pred cCCCCCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccccCcccC
Q 041479 606 HHGSLESCP------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~~~~~~ 678 (771)
++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999997661 2456888899999999999999986 9999999999999987 89999999999986543221
Q ss_pred Ccccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
......||+.|+||| +|+++|||++|+.||.+....................+..+++.
T Consensus 179 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T 2clq_A 179 ----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 254 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHH
T ss_pred ----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHH
Confidence 122346899999999 69999999999999965322111122222223334445556666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||+.||++|||+.++++
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHccCChhhCCCHHHHhc
Confidence 667777999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.68 Aligned_cols=233 Identities=23% Similarity=0.328 Sum_probs=186.7
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+.....+|+|.+|+||+|++.. ++.||||++.... ...+.+.+|++++++++||||+++++++... ..++|
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~v 85 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYII 85 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEE
T ss_pred hhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC------CcEEE
Confidence 34455678999999999999864 4589999996543 2457899999999999999999999997643 36899
Q ss_pred EEeccCCCCCCCcc-----cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESCPR-----ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~~~-----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||+++|+|.++.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999987632 588999999999999999999986 9999999999999999999999999999866543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
. ........|++.|+||| +|+++|||++ |+.||.+... ....+..........+..+++
T Consensus 163 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 163 E---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp C---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCH
T ss_pred c---cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHHHhcccCCCCcccccH
Confidence 2 12223345788999999 6999999999 9999975322 123333333333333445566
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.....+|++.||++|||+.++++.|+++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 666677799999999999999999999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.18 Aligned_cols=237 Identities=20% Similarity=0.246 Sum_probs=186.6
Q ss_pred ccccccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|+++ .+++.||||++.... .....++.+|++++++++||||+++++++.+.+
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 101 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ----- 101 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS-----
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC-----
Confidence 344566899999999999887 346789999996543 344567999999999999999999999987765
Q ss_pred eEEEEEEeccCCCCCCCc-------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceE
Q 041479 597 FRALVYEFMHHGSLESCP-------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAH 663 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~k 663 (771)
..++||||+++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence 579999999999997762 3458889999999999999999996 999999999999999999999
Q ss_pred EecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHH
Q 041479 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVK 727 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~ 727 (771)
|+|||+++....... ........||+.|+||| +|+++|||++ |+.||.+... ........
T Consensus 179 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~ 254 (322)
T 1p4o_A 179 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVM 254 (322)
T ss_dssp ECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHHHH
T ss_pred ECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHHHHHH
Confidence 999999986544322 11222345789999999 6999999999 8999865321 12222222
Q ss_pred hhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 728 MALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..........+++.+.....+||+.||++|||+.|+++.|++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 22222233445555666677999999999999999999998763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=292.88 Aligned_cols=231 Identities=28% Similarity=0.377 Sum_probs=180.8
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeecc----chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLH----QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.+|+||+|++ +++.||||++... .....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 37 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 109 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD-----DLCLVY 109 (307)
T ss_dssp CEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred CccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCC-----ceEEEE
Confidence 5689999999999987 3558999999643 2345678999999999999999999999998766 679999
Q ss_pred EeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 99999999765 23589999999999999999999986 9999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCCCchhhhc--
Q 041479 677 MSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALPDQILQVL-- 738 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~-- 738 (771)
.. ........||+.|+||| +|+++|||++|+.||.+...... +..+... .......+.+
T Consensus 187 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 187 AQ--TVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp SS--CEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCS
T ss_pred cc--cccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHHHHHhhhhhhhhhhhccc
Confidence 21 11223356899999999 79999999999999976432221 2122111 1111122222
Q ss_pred ---------CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 ---------DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ---------~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+.....+||+.||++|||+.++++.|+++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22333455699999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=299.24 Aligned_cols=231 Identities=23% Similarity=0.224 Sum_probs=177.7
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|+||+|++..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+ ..|+||||+
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~ 93 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-----RFYLVFEKM 93 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEEEECC
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----EEEEEEEcC
Confidence 4589999999999999988899999999766555678899999999985 7999999999998876 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEecccCccccCcccCC
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT---AHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~~~~~~~~ 679 (771)
++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++........
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 94 RGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999776 34689999999999999999999996 9999999999999987765 999999999865432111
Q ss_pred ---cccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCC-------------ccHH
Q 041479 680 ---NQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEG-------------LDLH 723 (771)
Q Consensus 680 ---~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~-------------~~~~ 723 (771)
........+||+.|+||| +||++|||++|+.||.+..... ..+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 011122356999999999 5999999999999997542211 0111
Q ss_pred H-HHHhhCC--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 724 N-FVKMALP--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 724 ~-~~~~~~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+ +...... ......+++.+.....+||+.||++|||+.|+++
T Consensus 251 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1 2222221 1222345566666777999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.53 Aligned_cols=237 Identities=14% Similarity=0.160 Sum_probs=187.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ..+.+.+|+++++++ +|+||+++++++.+.. ..++|
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~lv 84 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HNVLV 84 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-----eeEEE
Confidence 344556899999999999998899999999986443 235688899999999 7999999999987766 78999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc-----eEEecccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT-----AHMGDFGLTRF 672 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~-----~kl~DfGla~~ 672 (771)
|||+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 9999876 33589999999999999999999985 9999999999999987765 99999999987
Q ss_pred cCcccCCcc---cccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc--cHHHHHHhhCC-
Q 041479 673 IPEVMSSNQ---CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL--DLHNFVKMALP- 731 (771)
Q Consensus 673 ~~~~~~~~~---~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~~- 731 (771)
......... .......||+.|+||| +||++|||++|+.||.+...... .+........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 654322111 1234567999999999 69999999999999976432211 11222222221
Q ss_pred --CchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 732 --DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 732 --~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
......+++.+.....+||+.||++|||+.++++.|+++
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 222334566666777799999999999999999999886
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.60 Aligned_cols=229 Identities=19% Similarity=0.195 Sum_probs=183.5
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|.+++..+ +||||+++++++.+.+
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----- 94 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----- 94 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS-----
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC-----
Confidence 34555667999999999999999989999999997542 34567889999999988 7999999999988776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 78999999999999776 34689999999999999999999996 9999999999999999999999999999853
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ......+||+.|+||| +||++|||++|+.||.+.... ..+..+..... ..+..+
T Consensus 172 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~--~~p~~~ 244 (353)
T 2i0e_A 172 IWDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNV--AYPKSM 244 (353)
T ss_dssp CCTT----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--CCCTTS
T ss_pred ccCC----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCC--CCCCCC
Confidence 3221 1223467999999999 699999999999999753211 11222222222 233455
Q ss_pred CccccccCcccChhchhhcCC-----HHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIK-----KGQIR 764 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt-----~~~vl 764 (771)
++.+.....+||..||++||+ +.+++
T Consensus 245 s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 666666777999999999996 46665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=291.59 Aligned_cols=228 Identities=21% Similarity=0.263 Sum_probs=181.7
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 83 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----R 83 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-----E
Confidence 44555667999999999999999999999999996543 233567999999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.++||||+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 8999999999999766 34688999999999999999999985 99999999999999999999999999986543
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
... .....||+.|+||| +|+++|||++|+.||...... ...+.. .......++.++
T Consensus 161 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~~~~~~~ 231 (279)
T 3fdn_A 161 SSR------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRI-SRVEFTFPDFVT 231 (279)
T ss_dssp -------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH-HHTCCCCCTTSC
T ss_pred ccc------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHH-HhCCCCCCCcCC
Confidence 322 12346899999999 699999999999999753211 111111 112223344455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 232 ~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 232 EGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 66666677999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=322.44 Aligned_cols=233 Identities=25% Similarity=0.340 Sum_probs=188.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|++..+ ..||||++.... ...++|.+|+++|++++|||||++++++.+. ..|+||
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~lv~ 340 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVT 340 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEE
T ss_pred hhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeec------cceEee
Confidence 34455689999999999999865 489999997543 2357899999999999999999999998653 468999
Q ss_pred EeccCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999998772 3488999999999999999999986 89999999999999999999999999998764322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.....+..++..|+||| |||++|||++ |+.||.+... ..+.+.+........+..++..
T Consensus 418 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 418 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCPPECPES 492 (535)
T ss_dssp ---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHH
T ss_pred ---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCHH
Confidence 11223345788999999 7999999999 9999976422 1233334444333344455666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+..++.+||+.||++|||+.+|++.|++++
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 667777999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=316.88 Aligned_cols=230 Identities=25% Similarity=0.294 Sum_probs=186.4
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~l 259 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 259 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----EE
Confidence 3445567899999999999999999999999996542 334567899999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 599 ALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
|+|||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999765 22489999999999999999999996 9999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC--ccHHHHHHhhCCCchhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG--LDLHNFVKMALPDQILQ 736 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~ 736 (771)
..... ....+||+.|+||| +||++|||++|+.||.+..... ..+... ....+...+.
T Consensus 337 ~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~-i~~~~~~~p~ 410 (576)
T 2acx_A 337 PEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVPEEYSE 410 (576)
T ss_dssp CTTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH-HHHCCCCCCT
T ss_pred ccCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH-hhcccccCCc
Confidence 44321 22357999999999 6999999999999997542211 112222 2233444455
Q ss_pred hcCccccccCcccChhchhhcC-----CHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+++.+.....+||+.||++|| ++.|+++
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 6677777777899999999999 7788864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.02 Aligned_cols=238 Identities=23% Similarity=0.257 Sum_probs=185.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+.. ..++|
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~---~~~lv 87 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR---HKVLI 87 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC---CEEEE
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC---eeEEE
Confidence 344556899999999999999989999999996543 34467889999999999999999999998765422 56999
Q ss_pred EEeccCCCCCCCcc------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEecccCcc
Q 041479 602 YEFMHHGSLESCPR------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DNDMTAHMGDFGLTR 671 (771)
Q Consensus 602 ~e~~~~g~L~~~~~------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGla~ 671 (771)
|||+++|+|.++.. .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999977622 289999999999999999999996 89999999999999 777889999999998
Q ss_pred ccCcccCCcccccccccccccccchh-----------------------HHHHHHHHHhCCCCCCccccCCc---cHHHH
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE-----------------------YGILLLEIFTGKRPTSDMFTEGL---DLHNF 725 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------------~Gv~l~el~tg~~P~~~~~~~~~---~~~~~ 725 (771)
....... .....||+.|+||| +||++|||++|+.||........ .+...
T Consensus 165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp ECCCGGG-----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred EccCCCc-----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 6644321 22356999999999 59999999999999964322211 12222
Q ss_pred HHhhCCCc-----------------------hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 726 VKMALPDQ-----------------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 726 ~~~~~~~~-----------------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+..+.. ....+++.+.....+||+.||++|||+.++++.++++|
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 22222111 11222223334455999999999999999999998864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.01 Aligned_cols=236 Identities=25% Similarity=0.292 Sum_probs=185.6
Q ss_pred ccccccccccccccceEEEEEecCCCeEE--EEEEeecc-chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFI--AVKVLFLH-QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~v--AvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.++..+ |||.+... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-----
Confidence 34555667899999999999998888755 99988643 234456899999999999 8999999999998776
Q ss_pred eEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 041479 597 FRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD 657 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~ 657 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 789999999999997651 2588999999999999999999986 999999999999999
Q ss_pred CCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCcc
Q 041479 658 NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLD 721 (771)
Q Consensus 658 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~ 721 (771)
.++.+||+|||+++...... ......+++.|+||| +||++|||++ |+.||.+... ..
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~ 249 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AE 249 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH
T ss_pred CCCeEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--HH
Confidence 99999999999997433221 112235788999999 6999999998 9999975321 12
Q ss_pred HHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 722 LHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+.+..........+..+++.+.....+||+.||++|||+.++++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33333333333344455666667777999999999999999999998863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=295.57 Aligned_cols=228 Identities=21% Similarity=0.234 Sum_probs=173.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++. ++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~l 96 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-----CLTL 96 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-----CEEE
T ss_pred hHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-----EEEE
Confidence 3445668999999999999975 5699999996543 334578899999999999999999999988766 6899
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||+++ ++.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999985 55443 34588999999999999999999986 9999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC---CCch---
Q 041479 677 MSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL---PDQI--- 734 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~--- 734 (771)
.. ......||+.|+||| +||++|||++|+.||.+..... .+..+..... +...
T Consensus 173 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 173 VR----SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGG
T ss_pred cc----cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhh
Confidence 21 122346899999999 6999999999999997643332 2333222111 1110
Q ss_pred ----------------------hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 ----------------------LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ----------------------~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+++.+.....+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0112233334556999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.52 Aligned_cols=230 Identities=23% Similarity=0.245 Sum_probs=174.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+.....+|+|.+|+||+|+++.+++.||||++... .......+.+|+++++.++||||+++++++.+.+ ..
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~~ 223 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RL 223 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----EE
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----EE
Confidence 344456789999999999999999999999999754 2334567889999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+|||||++|+|..+ ...+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999766 35689999999999999999999972 3899999999999999999999999999985432
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ......+||+.|+||| +||++|||++|+.||.+... ..+.+.... .....+..+++
T Consensus 302 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~-~~~~~p~~~~~ 374 (446)
T 4ejn_A 302 DG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM-EEIRFPRTLGP 374 (446)
T ss_dssp ---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH-CCCCCCTTSCH
T ss_pred CC----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHh-CCCCCCccCCH
Confidence 22 1223467999999999 69999999999999965321 112222211 12223445566
Q ss_pred cccccCcccChhchhhcC-----CHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+.....+||+.||++|| |+.|+++
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 666777799999999999 9999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.82 Aligned_cols=228 Identities=24% Similarity=0.330 Sum_probs=168.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~ 82 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-----KLTLVF 82 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-----EEEEEE
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-----eEEEEE
Confidence 34456899999999999999989999999997553 234578899999999999999999999988766 789999
Q ss_pred EeccCCCCCCC---------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 603 EFMHHGSLESC---------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 603 e~~~~g~L~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
||++ |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 577654 13588999999999999999999986 9999999999999999999999999999865
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC-C---
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP-D--- 732 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~-~--- 732 (771)
..... ......||+.|+||| +||++|||++|+.||.+..... .+..+.... .+ .
T Consensus 159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 159 GIPVN----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TSCCC----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTC
T ss_pred CCCcc----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHh
Confidence 43221 122346899999999 6999999999999997532211 122221110 00 0
Q ss_pred -------------------c--------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -------------------Q--------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -------------------~--------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. ....+++.+.....+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 01122333444556999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.24 Aligned_cols=232 Identities=21% Similarity=0.191 Sum_probs=182.8
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.++..++|||||++++++.+.+ .
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~-----~ 135 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN-----Y 135 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS-----E
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----E
Confidence 34455567899999999999999999999999996532 233456889999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.|+|||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheec
Confidence 8999999999999876 24689999999999999999999986 9999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh----------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-- 729 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-- 729 (771)
..... ......+||+.|+||| +||++|||++|+.||.+.... .....+....
T Consensus 213 ~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~ 288 (412)
T 2vd5_A 213 RADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYKEH 288 (412)
T ss_dssp CTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH
T ss_pred cCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC
Confidence 44321 1223457999999999 599999999999999653211 1122333211
Q ss_pred CC-CchhhhcCccccccCcccChhchhhc---CCHHHHHH
Q 041479 730 LP-DQILQVLDPLFLVGGVQEGEETAEEN---IKKGQIRE 765 (771)
Q Consensus 730 ~~-~~~~~~~~~~~~~~~~~cl~~~p~~R---pt~~~vl~ 765 (771)
.. +.....+++.+.....+||. +|++| |++.|+++
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 22 22234556666667779998 99998 58988864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.71 Aligned_cols=231 Identities=26% Similarity=0.247 Sum_probs=174.1
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHH-HhccCCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQA-LRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|..+ ++.++|||||++++++.+.+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~----- 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----- 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS-----
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC-----
Confidence 44556667899999999999999999999999997553 2344567778877 57789999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 78999999999999766 34588899999999999999999986 9999999999999999999999999999853
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ......+||+.|+||| +||++|||++|+.||.+.... .....+... +...+..+
T Consensus 190 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~--~~~~~~~~ 262 (373)
T 2r5t_A 190 IEHN----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNK--PLQLKPNI 262 (373)
T ss_dssp BCCC----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-HHHHHHHHS--CCCCCSSS
T ss_pred ccCC----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhc--ccCCCCCC
Confidence 3221 1233467999999999 699999999999999653211 112222222 22233445
Q ss_pred CccccccCcccChhchhhcCCHHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
++.+.....+||+.||++||++.+.++.
T Consensus 263 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 263 TNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred CHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 5566666779999999999998644433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=314.71 Aligned_cols=184 Identities=21% Similarity=0.208 Sum_probs=149.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~ 599 (771)
+.....+|+|.+|+||+|++..+++.||||++... .....+++.+|+.+++.++|||||++++++..... ......|
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 33455689999999999999999999999999654 34456789999999999999999999999866532 1223679
Q ss_pred EEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 600 LVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 600 lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
+|||||+++.+......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 144 lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 218 (464)
T 3ttj_A 144 LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 218 (464)
T ss_dssp EEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC--
T ss_pred EEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--
Confidence 9999998764444455689999999999999999999996 99999999999999999999999999998654322
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.....+||+.|+||| +||++|||++|+.||.+
T Consensus 219 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 219 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp ---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 223457999999999 69999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=299.39 Aligned_cols=241 Identities=20% Similarity=0.242 Sum_probs=187.7
Q ss_pred ccccccccccccceEEEEEe----cCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGIL----DLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++...+. ...
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~ 119 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNL 119 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------CC
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC---Cce
Confidence 34456689999999999984 55788999999977666667889999999999999999999999865432 156
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 899999999999776 24589999999999999999999986 99999999999999999999999999998765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcccc-------CC---c----cHHHH
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFT-------EG---L----DLHNF 725 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~-------~~---~----~~~~~ 725 (771)
..... ........++..|+||| +|+++|||+||..|+..... .. . .+.+.
T Consensus 197 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 197 QDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred ccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 43221 11122345788899999 69999999999998753210 00 0 11222
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+........+..+++.+...+.+||+.||++|||+.|+++.|+++
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222222333445556666677799999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.13 Aligned_cols=224 Identities=21% Similarity=0.192 Sum_probs=165.3
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|+||+|+++.+++.||||++... ....+.+|+.+++.++ |||||++++++.+.. ..|+||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-----~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-----HTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----EEEEEEEcc
Confidence 4689999999999999999999999999643 3467789999999997 999999999998776 789999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceEEecccCccccCcccCC
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---TAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---~~kl~DfGla~~~~~~~~~ 679 (771)
++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 89 NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp CSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99999776 45689999999999999999999986 999999999999997665 899999999986543221
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC--CccHHHH----HHhhCC--Cchhh
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE--GLDLHNF----VKMALP--DQILQ 736 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~--~~~~~~~----~~~~~~--~~~~~ 736 (771)
.....+||+.|+||| +||++|||++|+.||...... .....+. ..+..+ .....
T Consensus 165 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 165 ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred ---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence 123356899999999 699999999999999753211 1111222 222222 22334
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+++.+.....+||+.||++|||+.|+++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 55666667777999999999999998863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.11 Aligned_cols=228 Identities=19% Similarity=0.199 Sum_probs=183.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 89 (321)
T 2a2a_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-----D 89 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----E
Confidence 345568999999999999999899999999965432 13678999999999999999999999998776 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEecccCc
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM----TAHMGDFGLT 670 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 670 (771)
.++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 8999999999999776 34578999999999999999999996 999999999999999887 7999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQ 733 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~ 733 (771)
+....... .....||+.|+||| +||++|||++|+.||.+.... ..+..+..... +..
T Consensus 167 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 167 HEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITSVSYDFDEE 240 (321)
T ss_dssp EECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCCCHH
T ss_pred eecCcccc-----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcccccChh
Confidence 86554221 22346899999999 699999999999999653211 11222222222 222
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33445556666777999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=306.60 Aligned_cols=229 Identities=19% Similarity=0.241 Sum_probs=177.9
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccC--CCCceeEEEEeecCCCCCceeEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIR--HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.....+|+|.+|+||+|.+.. ++.||||++.... ....+.+.+|++++++++ |||||++++++...+ ..|
T Consensus 59 ~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-----~~~ 132 (390)
T 2zmd_A 59 SILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-----YIY 132 (390)
T ss_dssp EEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEE
T ss_pred EEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-----EEE
Confidence 344568999999999999876 6699999996543 445678999999999996 599999999998876 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||| +.+|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 567888766 34678889999999999999999986 899999999999996 588999999999876543
Q ss_pred cCCcccccccccccccccchh--------------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE--------------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE--------------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
.. .......+||+.|+||| +||++|||++|+.||.+.......+........
T Consensus 208 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 208 TT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred Cc--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 22 11223457999999999 599999999999999764322122333333333
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+...+..+..+..+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 33344444555666777999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=298.18 Aligned_cols=240 Identities=23% Similarity=0.229 Sum_probs=187.1
Q ss_pred cccccccccccceEEEEEe----cCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 524 LLNVSYESLVKATVYKGIL----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.....+|+|.+|+||++.+ ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.. ..
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~---~~ 110 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA---SL 110 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT---EE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc---eE
Confidence 3456789999999988765 3467899999997553 34567899999999999999999999999875322 67
Q ss_pred EEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 599 ALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999877 33589999999999999999999996 8999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC---------C----ccHHHHHHh
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE---------G----LDLHNFVKM 728 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~---------~----~~~~~~~~~ 728 (771)
... ........||+.|+||| +|+++|||++|+.||...... + ..+.+....
T Consensus 188 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred ccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 221 11223345888999999 699999999999998642110 0 012222233
Q ss_pred hCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 729 ALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.........+++.+.....+||+.||++|||+.|+++.|+++
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 333344455566666777799999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=305.10 Aligned_cols=225 Identities=16% Similarity=0.141 Sum_probs=171.2
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN-IRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|+||+|+++.+++.||||++... ..+.+|++++.+ .+|||||++++++.... .+....|+|||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEEEEeC
Confidence 3589999999999999999999999999532 456788888754 58999999999986521 1223689999999
Q ss_pred cCCCCCCCc-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCccc
Q 041479 606 HHGSLESCP-----RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 606 ~~g~L~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 677 (771)
++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 999997662 2489999999999999999999986 9999999999999997 7899999999998654322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc---cHHHHHHhhCC--Cchhhh
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL---DLHNFVKMALP--DQILQV 737 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~---~~~~~~~~~~~--~~~~~~ 737 (771)
.....+||+.|+||| +||++|||++|+.||.+...... ....+...... ......
T Consensus 219 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 219 -----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred -----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 123457899999999 69999999999999975432221 12233333332 222344
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+++.+..+..+||+.||++|||+.|+++
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5666666777999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.75 Aligned_cols=220 Identities=19% Similarity=0.217 Sum_probs=179.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch--------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----- 102 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG----- 102 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC-----
Confidence 44568999999999999999999999999965421 13356788999999999999999999998776
Q ss_pred eEEEEEEeccCC-CCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 597 FRALVYEFMHHG-SLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g-~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
..++||||+.+| +|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 789999999777 77665 34689999999999999999999996 999999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
...... ....+||+.|+||| +||++|||++|+.||.+.... ... ....+.
T Consensus 180 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~--~~~~~~ 245 (335)
T 3dls_A 180 LERGKL-----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VEA--AIHPPY 245 (335)
T ss_dssp CCTTCC-----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TTT--CCCCSS
T ss_pred CCCCCc-----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------Hhh--ccCCCc
Confidence 654321 22356999999999 699999999999999753211 011 112223
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
.+++.+.....+||+.||++|||+.++++.
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 355566666779999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=293.35 Aligned_cols=229 Identities=18% Similarity=0.231 Sum_probs=187.1
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++||
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 99 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIM 99 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEEE
Confidence 34456899999999999999888899999997553 345688999999999999999999999998776 789999
Q ss_pred EeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 603 EFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 603 e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
||+++++|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 174 (303)
T ss_dssp ECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence 99999999776 34688999999999999999999996 999999999999999999999999999986543321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
......||+.|+||| +|+++|||++|+.||.+... ...........+......+++.+...
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHhhcCCCCCCccccCHHHHHH
Confidence 123356899999999 69999999999999975322 12222333333344444556666667
Q ss_pred CcccChhchhhcCCHHHHHHH
Q 041479 746 GVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
..+||+.||++|||+.++++.
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCChhhCcCHHHHhhC
Confidence 779999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=305.83 Aligned_cols=184 Identities=25% Similarity=0.368 Sum_probs=143.6
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.....+|+|.+|+||+|+++.+++.||||++... .....+++.+|+.+++.++ |||||++++++...+.. ..|+
T Consensus 12 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~l 88 (388)
T 3oz6_A 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR---DVYL 88 (388)
T ss_dssp EEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS---CEEE
T ss_pred EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC---EEEE
Confidence 3445689999999999999999999999998543 3445678899999999997 99999999998764422 5799
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|||||+ |+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 89 v~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 999997 577655 34688999999999999999999996 999999999999999999999999999986533110
Q ss_pred C-----------------cccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 679 S-----------------NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 679 ~-----------------~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
. ........+||+.|+||| +||++|||++|+.||.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 0 011223457999999999 69999999999999965
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=290.27 Aligned_cols=228 Identities=20% Similarity=0.262 Sum_probs=183.0
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v 83 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----FHYLV 83 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEEE
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-----EEEEE
Confidence 34556899999999999999999999999996553 344578899999999999999999999998776 67999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEecccCccccCc
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT---AHMGDFGLTRFIPE 675 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGla~~~~~ 675 (771)
|||+++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999665 44589999999999999999999996 8999999999999986655 99999999976543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVL 738 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 738 (771)
... .....||+.|+||| +|+++|||++|+.||.+.... ........... +......+
T Consensus 161 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 161 SEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp SCB-----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCTTTTTTS
T ss_pred Ccc-----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhccccCCchhhccc
Confidence 221 22356899999999 699999999999999653211 11222222222 22233455
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||++|||+.|+++
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 666666777999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.38 Aligned_cols=229 Identities=20% Similarity=0.246 Sum_probs=177.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCC--CCceeEEEEeecCCCCCceeEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRH--RNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.....+|+|.+|+||+|.+.. ++.||||++.... ....+.+.+|++++++++| |||+++++++.+.+ ..|
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-----~~~ 85 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-----YIY 85 (343)
T ss_dssp EEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEE
T ss_pred EEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-----EEE
Confidence 344568999999999999865 5699999996543 3455789999999999986 99999999998776 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+|||| .+|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99995 57788776 45688999999999999999999996 899999999999997 678999999999876543
Q ss_pred cCCcccccccccccccccchh--------------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE--------------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL 730 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE--------------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 730 (771)
.. .......+||+.|+||| +||++|||++|+.||.+.......+........
T Consensus 161 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 161 TT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 22 11223457999999999 599999999999999764332222333333333
Q ss_pred CCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+...+...++.+.....+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 34444555556666777999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=296.84 Aligned_cols=241 Identities=23% Similarity=0.205 Sum_probs=172.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCC---CCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDF---QGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~---~~~~~~ 598 (771)
+.....+|+|.+|+||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++..... ......
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 334556899999999999999888999999997666666788999999999996 9999999999853221 233467
Q ss_pred EEEEEeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 599 ALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
++||||+. |+|.++ ...+++.++..++.|++.||+|||+. .++|+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 99999996 677654 23589999999999999999999986 12399999999999999999999999999987
Q ss_pred cCcccCCc--------ccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHH
Q 041479 673 IPEVMSSN--------QCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV 726 (771)
Q Consensus 673 ~~~~~~~~--------~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 726 (771)
........ ........||+.|+||| +||++|||++|+.||.+... .+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~ 262 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-----LRIV 262 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-----HHhh
Confidence 65432111 01112346899999999 69999999999999965321 1223
Q ss_pred HhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 727 KMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.............+.+.....+||+.||++|||+.|+++.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 33333333344455565667799999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=303.16 Aligned_cols=243 Identities=18% Similarity=0.189 Sum_probs=178.9
Q ss_pred ccccccccccccceEEEEEecC---CCeEEEEEEeeccchh-----------hHHHHHHHHHHHhccCCCCceeEEEEee
Q 041479 523 LLLNVSYESLVKATVYKGILDL---DQTFIAVKVLFLHQRG-----------ALKSFMAECQALRNIRHRNLVKIITACS 588 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~---~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 588 (771)
+.....+|+|.+|+||+|++.. ++..||||++...... ..+.+.+|+..++.++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 3445568999999999999986 6679999999654311 1235778999999999999999999987
Q ss_pred cCCCCCceeEEEEEEeccCCCCCCCc---ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC--ceE
Q 041479 589 TSDFQGNYFRALVYEFMHHGSLESCP---RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM--TAH 663 (771)
Q Consensus 589 ~~~~~~~~~~~lv~e~~~~g~L~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~--~~k 663 (771)
+.. .+....|+||||+ +++|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 119 ~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 119 TEF-KGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EES-SSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred ccc-CCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence 732 2233789999999 99997762 3689999999999999999999996 999999999999998877 999
Q ss_pred EecccCccccCcccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHH
Q 041479 664 MGDFGLTRFIPEVMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNF 725 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 725 (771)
|+|||+++.+....... ........||+.|+||| +||++|||++|+.||.+...........
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999998765432211 11123457999999999 6999999999999996533222212211
Q ss_pred H---HhhCCCchhh-----hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 726 V---KMALPDQILQ-----VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 726 ~---~~~~~~~~~~-----~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
. ....+..... .+++.+.....+||+.||++|||+.++++.|+++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1 1222222211 3444555667799999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=295.98 Aligned_cols=230 Identities=21% Similarity=0.209 Sum_probs=172.2
Q ss_pred ccccccccccccccceEEEEEec---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 593 (771)
..+.....+|+|.+|+||+|+.. .+++.||||++.... ......+.+|++++++++|||||++++++.+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 94 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG-- 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC--
Confidence 34455567899999999999985 567799999996542 234567889999999999999999999998776
Q ss_pred CceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 594 GNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 594 ~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 95 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 ---KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred ---EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 68999999999999766 34578899999999999999999996 9999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
+....... .....+||+.|+||| +||++|||++|+.||.+.... ..+....... ...+
T Consensus 169 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~--~~~p 241 (327)
T 3a62_A 169 KESIHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKCK--LNLP 241 (327)
T ss_dssp --------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTC--CCCC
T ss_pred cccccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCC--CCCC
Confidence 75432221 123457999999999 699999999999999753211 1122222222 2233
Q ss_pred hhcCccccccCcccChhchhhcC-----CHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
..+++.+.....+||+.||++|| ++.|+++
T Consensus 242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 44556666677799999999999 6777764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.12 Aligned_cols=228 Identities=18% Similarity=0.195 Sum_probs=184.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|.+|+||+|+++.+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+ ..+
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 91 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----FVF 91 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----EEE
Confidence 344556899999999999999999999999996542 345678999999999999999999999998776 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999776 34689999999999999999999996 9999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.. ......||+.|+||| +|+++|||++|+.||.+..... ........ ....+..+++.
T Consensus 169 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~~~ 241 (294)
T 2rku_A 169 GE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKN--EYSIPKHINPV 241 (294)
T ss_dssp TC----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT--CCCCCTTSCHH
T ss_pred cc----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhc--cCCCccccCHH
Confidence 21 122346899999999 6999999999999997532111 11122121 12233455666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||+.||++|||+.|+++
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHHHcccChhhCcCHHHHhh
Confidence 666777999999999999999885
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=296.35 Aligned_cols=229 Identities=19% Similarity=0.178 Sum_probs=180.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++... ..+.+.+|++++++++ ||||+++++++.+... ...++|
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~~~~lv 111 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALV 111 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CCEEEE
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---CceEEE
Confidence 44456789999999999999999999999999643 3467899999999997 9999999999886431 167999
Q ss_pred EEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcccCCc
Q 041479 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 602 ~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 680 (771)
|||+++++|.++.+.+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--
Confidence 99999999988878899999999999999999999986 899999999999999776 899999999986544322
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH------------hhC--
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK------------MAL-- 730 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~------------~~~-- 730 (771)
.....||+.|+||| +||++|||++|+.||.........+..... ...
T Consensus 187 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 187 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred ---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 12346899999999 699999999999999542221111111111 000
Q ss_pred ---------------------CCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 ---------------------PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ---------------------~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+......+++.+.....+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111224555555667999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.24 Aligned_cols=240 Identities=22% Similarity=0.260 Sum_probs=182.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhc--cCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRN--IRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|++. ++.||||++... ..+.+.+|++++.. ++||||+++++++...+.. ....++||
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~-~~~~~lv~ 119 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT-WTQLWLVS 119 (342)
T ss_dssp EEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS-CCCEEEEE
T ss_pred EEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc-cceeEEEE
Confidence 3456899999999999884 679999999643 34678889999887 7899999999998765421 12579999
Q ss_pred EeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 603 EFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHC-----KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+.. +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 120 e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 120 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199 (342)
T ss_dssp CCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred eecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence 99999999877 346899999999999999999999310 14899999999999999999999999999986544
Q ss_pred ccCCcccccccccccccccchh---------------------HHHHHHHHHhC----------CCCCCccccCCccHHH
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTG----------KRPTSDMFTEGLDLHN 724 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg----------~~P~~~~~~~~~~~~~ 724 (771)
.............||+.|+||| +||++|||+|| +.||.+..........
T Consensus 200 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 279 (342)
T 1b6c_B 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279 (342)
T ss_dssp TTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred cccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHH
Confidence 3321111233457999999999 59999999999 7788765444433444
Q ss_pred HHHhh----CCCchhh-----hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 725 FVKMA----LPDQILQ-----VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 725 ~~~~~----~~~~~~~-----~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.... .+...+. .....+...+.+||+.||++|||+.+|++.|+++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 33322 1222221 1112344566699999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=313.44 Aligned_cols=227 Identities=22% Similarity=0.200 Sum_probs=179.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.. ..|+||
T Consensus 41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv~ 115 (494)
T 3lij_A 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----NYYLVM 115 (494)
T ss_dssp EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----EEEEEE
Confidence 3456899999999999999999999999996543 334578999999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND---MTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~~ 676 (771)
|||++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.. +.+||+|||+++.....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999665 34688999999999999999999986 99999999999999764 55999999999866432
Q ss_pred cCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 740 (771)
. .....+||+.|+||| +||++|||++|+.||.+.... ..+..+.....+ ......+++
T Consensus 193 ~-----~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 193 K-----KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp B-----CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCSGGGTTSCH
T ss_pred c-----cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCchhcccCCH
Confidence 2 123456999999999 699999999999999764221 123333333333 233345566
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||+.||++|||+.++++
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhhCccHHHHhc
Confidence 6666777999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.78 Aligned_cols=228 Identities=18% Similarity=0.199 Sum_probs=184.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|.+|+||++++..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+ ..|
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 117 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-----FVF 117 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eEE
Confidence 34455689999999999999999999999999654 2345678999999999999999999999998776 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999776 34689999999999999999999996 9999999999999999999999999999865432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.. ......||+.|+||| +|+++|||++|+.||....... ....+... ....+..+++.
T Consensus 195 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~--~~~~~~~~~~~ 267 (335)
T 2owb_A 195 GE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKN--EYSIPKHINPV 267 (335)
T ss_dssp TC----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT--CCCCCTTSCHH
T ss_pred cc----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcC--CCCCCccCCHH
Confidence 21 122356899999999 6999999999999996532111 11122222 12233455666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||+.||++|||+.|+++
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 666777999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=289.00 Aligned_cols=229 Identities=20% Similarity=0.268 Sum_probs=170.1
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 86 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-----YV 86 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-----EE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-----eE
Confidence 3444567899999999999998888899999996543 233578999999999999999999999998766 78
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999766 24689999999999999999999996 99999999999999999999999999998654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
.... ......||+.|+||| +|+++|||++|+.||....... .+...... ....+..++
T Consensus 164 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--~~~~~~~~~ 236 (278)
T 3cok_A 164 MPHE----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVLA--DYEMPSFLS 236 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSC
T ss_pred CCCC----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhhc--ccCCccccC
Confidence 3221 112346899999999 6999999999999997532211 11111111 112233445
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.++++
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 55556677999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=310.63 Aligned_cols=182 Identities=22% Similarity=0.305 Sum_probs=138.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++.+++.||||++... .....+++.+|++++++++|||||++++++...+.+.....|+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 44456689999999999999999999999999543 3345678999999999999999999999997665444447899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+. |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 135 v~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 135 VLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 999985 677655 34589999999999999999999996 99999999999999999999999999998764321
Q ss_pred CCc-----------------------ccccccccccccccchh----------------HHHHHHHHHhC
Q 041479 678 SSN-----------------------QCSSVGLKGTVGYATPE----------------YGILLLEIFTG 708 (771)
Q Consensus 678 ~~~-----------------------~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg 708 (771)
... .....+.+||+.|+||| +||++|||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 110 01234567899999999 69999999994
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=288.72 Aligned_cols=230 Identities=29% Similarity=0.308 Sum_probs=179.2
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
..+.....+|+|.+|+||+|.+. ++.||||++.... ..+++.+|++++++++||||+++++++.+.+. ..++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~l 92 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLYI 92 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC----ceEE
Confidence 34555667899999999999875 6699999996443 45789999999999999999999999765431 5699
Q ss_pred EEEeccCCCCCCCcc-----cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 601 VYEFMHHGSLESCPR-----ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 601 v~e~~~~g~L~~~~~-----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||||+++|+|.++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999987722 378889999999999999999986 899999999999999999999999999975433
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
.. ....+++.|+||| +|+++|||++ |+.||..... ...........+......++
T Consensus 170 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 240 (278)
T 1byg_A 170 TQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDAPDGCP 240 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTCCCCCCTTCC
T ss_pred cc-------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCCCCCCcccCC
Confidence 21 1235788999999 6999999998 9999976422 22333343333344445556
Q ss_pred ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.+.....+||+.||++|||+.++++.|+++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 6666777799999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=294.53 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=177.3
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHH--HhccCCCCceeEEEEeecCCCCCcee
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQA--LRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
...+.....+|+|.+|+||+|++ +++.||||++..... ..+..|.++ +..++||||+++++++......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 34455566789999999999977 467999999965432 344444444 55589999999998776544444557
Q ss_pred EEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 598 RALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHC------KKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
.++||||+++|+|.++ ....++..+..++.|++.||+|||+.+ +++|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 7999999999999877 345688999999999999999999852 23899999999999999999999999999
Q ss_pred ccccCcccCC----cccccccccccccccchh----------------------HHHHHHHHHhCCCCCCccccC-C---
Q 041479 670 TRFIPEVMSS----NQCSSVGLKGTVGYATPE----------------------YGILLLEIFTGKRPTSDMFTE-G--- 719 (771)
Q Consensus 670 a~~~~~~~~~----~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el~tg~~P~~~~~~~-~--- 719 (771)
++........ ........+||+.|+||| +||++|||++|..|+...... .
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 9876533211 111223457999999999 699999999997776321110 0
Q ss_pred ---------ccHHHHHH----hhCCCchhhh------cCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 720 ---------LDLHNFVK----MALPDQILQV------LDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 720 ---------~~~~~~~~----~~~~~~~~~~------~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.....+.. .......+.. .++.+.....+||+.||++|||+.|+++.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 01111111 0111111111 1223555667999999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=291.46 Aligned_cols=232 Identities=21% Similarity=0.181 Sum_probs=172.4
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.++...++.++||||+++++++.+.+ ..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~~ 81 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----DV 81 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----SE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----CE
Confidence 34445567899999999999999999999999996542 222334455555688899999999999998766 67
Q ss_pred EEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 599 ALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
++||||+++ +|.++ ...+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999974 66443 34689999999999999999999984 389999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
....... .....||+.|+||| +||++|||++|+.||.........+.+......+.
T Consensus 159 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 159 YLVDDVA-----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC
T ss_pred ccccccc-----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC
Confidence 6544321 12236899999999 59999999999999975322222333444444443
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 334455666667777999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=290.51 Aligned_cols=236 Identities=21% Similarity=0.202 Sum_probs=183.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++||||+++++++..... ...|+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~l 84 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYI 84 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ceEEE
Confidence 444567899999999999999989999999997543 3456789999999999999999999998754321 16799
Q ss_pred EEEeccCCCCCCCc-------ccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 601 VYEFMHHGSLESCP-------RILSFLRRLNIAIDVASALEYLHHHC--KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 601 v~e~~~~g~L~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
||||+++|+|.++. ..+++..+..++.|++.||+|||+.. ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999997762 23899999999999999999999971 0129999999999999999999999999997
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
....... ......||+.|+||| +|+++|||++|+.||.+... ..+.+..........+.
T Consensus 165 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~ 238 (279)
T 2w5a_A 165 ILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIPY 238 (279)
T ss_dssp HC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTCCCCCCT
T ss_pred eeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcccccCCc
Confidence 6543221 112346899999999 69999999999999975421 12233333333333444
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESL 767 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L 767 (771)
.+++.+.....+||+.||++|||+.|+++.+
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 5566666677799999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.08 Aligned_cols=226 Identities=21% Similarity=0.270 Sum_probs=170.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 6 ~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~ 79 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RLVLVF 79 (288)
T ss_dssp EEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CEEEEE
T ss_pred hhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eEEEEE
Confidence 3456899999999999984 55699999996543 233478899999999999999999999998766 689999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++ +|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 99975 76544 35688999999999999999999996 999999999999999999999999999976543211
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC--C-------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP--D------- 732 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~--~------- 732 (771)
......||+.|+||| +||++|||++|+.||.+..... .+....... .+ .
T Consensus 156 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 ----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGG
T ss_pred ----ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhc
Confidence 122346899999999 6999999999999997532211 122222111 00 0
Q ss_pred -----------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -----------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -----------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001122333334556999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=311.74 Aligned_cols=228 Identities=23% Similarity=0.197 Sum_probs=184.2
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.. ..|+|
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv 99 (486)
T 3mwu_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----SFYIV 99 (486)
T ss_dssp EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEEE
T ss_pred EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-----EEEEE
Confidence 34556899999999999999889999999996542 334678999999999999999999999998776 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEecccCccccCc
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD---NDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~ 675 (771)
||||++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999665 45689999999999999999999996 999999999999995 456799999999986544
Q ss_pred ccCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
.. .....+||+.|+||| +||++|||++|+.||.+.... ..+..+.....+ ......++
T Consensus 177 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 177 NT-----KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C---------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSCSGGGGGSC
T ss_pred CC-----ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCCcccCCCC
Confidence 22 122356999999999 699999999999999653221 123333333333 23334566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.++++
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 66767777999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.52 Aligned_cols=227 Identities=18% Similarity=0.223 Sum_probs=178.0
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+++.+++.||||++..... .+.+|++++.++ +|||||++++++.+.+ ..|+|
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv 94 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK-----YVYVV 94 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-----EEEEE
Confidence 4445578999999999999999999999999965432 345688888888 7999999999998776 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC----CceEEecccCccccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND----MTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~~~ 674 (771)
||||++|+|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||++.+. +.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999765 34689999999999999999999996 99999999999998533 359999999998654
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCC-cc-HHHHHHhhCC--Cchh
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEG-LD-LHNFVKMALP--DQIL 735 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~-~~-~~~~~~~~~~--~~~~ 735 (771)
.... .....+||+.|+||| +||++|||++|+.||.+..... .. +..+.....+ ....
T Consensus 172 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 172 AENG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp CTTC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CCCC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 3221 123457899999999 6999999999999997532111 11 2222222222 2233
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+++.+.....+||..||++|||+.++++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 455666666777999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=296.62 Aligned_cols=237 Identities=25% Similarity=0.273 Sum_probs=181.5
Q ss_pred cccccccccccccceEEEEEe-----cCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 522 DLLLNVSYESLVKATVYKGIL-----DLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~-----~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
.+.....+|+|.+|+||+|++ ..+++.||||++... ......++.+|+.++++++||||+++++++.+.+
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 106 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL---- 106 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC----
Confidence 344456689999999999994 456679999999643 3445678999999999999999999999988766
Q ss_pred eeEEEEEEeccCCCCCCCc----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCce
Q 041479 596 YFRALVYEFMHHGSLESCP----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTA 662 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~ 662 (771)
..|+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++. +..+
T Consensus 107 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 107 -PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp -SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred -CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 569999999999997661 3488899999999999999999986 9999999999999984 4469
Q ss_pred EEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHH
Q 041479 663 HMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFV 726 (771)
Q Consensus 663 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 726 (771)
||+|||+++....... ........||+.|+||| +|+++|||+| |+.||.+.. .....+..
T Consensus 183 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~ 258 (327)
T 2yfx_A 183 KIGDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFV 258 (327)
T ss_dssp EECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH
T ss_pred EECccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHHHHHH
Confidence 9999999975433221 11122345799999999 6999999998 999997532 12233444
Q ss_pred HhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 727 KMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...........+++.+.....+||+.||++|||+.++++.|+.+
T Consensus 259 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 43333334445566666677799999999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=299.37 Aligned_cols=239 Identities=20% Similarity=0.224 Sum_probs=179.5
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC---Cce
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ---GNY 596 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---~~~ 596 (771)
.+.....+|+|.+|+||+|+++.+++.||||++.... ......+.+|++++++++||||+++++++.+.... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 3445567899999999999999889999999985543 23356788999999999999999999998764310 012
Q ss_pred eEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 597 FRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
..|+||||+++ ++.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 57999999985 44332 35689999999999999999999996 999999999999999999999999999987
Q ss_pred cCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHH--hhCCCch
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK--MALPDQI 734 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~--~~~~~~~ 734 (771)
................||+.|+||| +||++|||++|+.||.+..... .+..+.. +..+...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhh
Confidence 6543332233334567899999999 6999999999999997532211 1111111 1111111
Q ss_pred hhh----------------------------cCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQV----------------------------LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~----------------------------~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
... .++.+.....+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111 1333445566999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=293.31 Aligned_cols=233 Identities=24% Similarity=0.299 Sum_probs=176.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccC---CCCceeEEEEeecCCCCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----RGALKSFMAECQALRNIR---HRNLVKIITACSTSDFQG 594 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~ 594 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ......+.+|++++++++ ||||+++++++.......
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 334556899999999999999999999999996442 122356777887777764 999999999998766444
Q ss_pred ceeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 595 NYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
....++||||+. |+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 91 EIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred ceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 456799999997 588665 22389999999999999999999996 899999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC--
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP-- 731 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~-- 731 (771)
++....... ....+||+.|+||| +||++|||++|+.||.+..... .+..+.... .+
T Consensus 167 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCCC-----SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred ccccCCCcc-----cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence 986543221 23457899999999 6999999999999996532211 122222211 11
Q ss_pred Cc----------------------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 DQ----------------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ~~----------------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. ....+++.+.....+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 01112333334556999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.02 Aligned_cols=227 Identities=20% Similarity=0.199 Sum_probs=179.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~ 83 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT-----DV 83 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC-----eE
Confidence 34568999999999999998888999999965421 23678999999999999999999999998766 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEecccCcc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM----TAHMGDFGLTR 671 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla~ 671 (771)
++||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999876 34689999999999999999999986 999999999999998877 89999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCch
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQI 734 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~ 734 (771)
....... .....||+.|+||| +|+++|||++|+.||.+.... ..+..+..... +...
T Consensus 161 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (283)
T 3bhy_A 161 KIEAGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNYDFDEEY 234 (283)
T ss_dssp ECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCCCCCHHH
T ss_pred eccCCCc-----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhcccCCcchh
Confidence 6543221 12346899999999 699999999999999753211 11222222222 1223
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+++.+.....+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 3444555666677999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=293.41 Aligned_cols=228 Identities=19% Similarity=0.185 Sum_probs=173.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 81 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----RLHLVF 81 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----eEEEEE
Confidence 3456899999999999999988999999985443 334577899999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||+++++|..+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999988665 45689999999999999999999986 999999999999999999999999999986543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCCCc--------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALPDQ-------- 733 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~~~-------- 733 (771)
......||+.|+||| +|+++|||++|+.||.+...... ....... ...+.
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 ---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTC
T ss_pred ---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccccccccccc
Confidence 122346899999999 69999999999999965322111 1111110 00000
Q ss_pred -------------------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 -------------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 -------------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00122333344566999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=309.86 Aligned_cols=227 Identities=22% Similarity=0.229 Sum_probs=181.3
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
..+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~ 259 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-----D 259 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----E
Confidence 34445566899999999999999989999999996543 234578999999999999999999999988776 7
Q ss_pred EEEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 598 RALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
.|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeeccee
Confidence 8999999999999654 23588999999999999999999996 9999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hCCCc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--ALPDQ 733 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~~~~ 733 (771)
+....... .....+||+.|+||| +||++|||++|+.||.+.... ....++... ..+..
T Consensus 337 ~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 337 VELKAGQT----KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVT 411 (543)
T ss_dssp EECCTTCC----CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHHHCCCC
T ss_pred eeccCCCc----ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHhhcccC
Confidence 86544321 123357999999999 699999999999999753211 112222211 11223
Q ss_pred hhhhcCccccccCcccChhchhhcCCH
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKK 760 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~ 760 (771)
.+..+++.+.....+||+.||++||++
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 344556666667779999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.17 Aligned_cols=225 Identities=19% Similarity=0.198 Sum_probs=178.7
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..+|+|.+|+||+|+++.+++.||||++.... ......+.+|+.++++++ ||||+++++++.+.+ ..++|||
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~-----~~~lv~e 109 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS-----EIILILE 109 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEEEEEE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC-----eEEEEEE
Confidence 46899999999999999999999999997543 234678999999999995 699999999998776 7899999
Q ss_pred eccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCc
Q 041479 604 FMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 604 ~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~ 675 (771)
|+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999999776 25689999999999999999999986 9999999999999987 78999999999986643
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCchhhhc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQILQVL 738 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 738 (771)
... .....||+.|+||| +||++|||++|+.||....... ......... .+......+
T Consensus 187 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 187 ACE-----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp ------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTTTTTS
T ss_pred ccc-----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHhcccccCchhhccc
Confidence 221 22356999999999 6999999999999996532211 122222222 223333445
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||++|||+.++++
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 566666777999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=286.01 Aligned_cols=228 Identities=21% Similarity=0.263 Sum_probs=183.6
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.++.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK-----R 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----E
Confidence 34555667899999999999999999999999996542 233578999999999999999999999998766 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
.++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 8999999999999766 34588999999999999999999985 99999999999999999999999999987544
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
... .....||+.|+||| +|+++||+++|+.||....... ........ ....+..++
T Consensus 166 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~--~~~~~~~~~ 236 (284)
T 2vgo_A 166 SLR------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNV--DLKFPPFLS 236 (284)
T ss_dssp SSC------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT--CCCCCTTSC
T ss_pred ccc------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhcc--ccCCCCcCC
Confidence 321 12346899999999 6999999999999996532111 11112211 122334455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+.....+|++.||++|||+.++++
T Consensus 237 ~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 237 DGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 56666677999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-33 Score=289.33 Aligned_cols=228 Identities=21% Similarity=0.251 Sum_probs=181.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-----------
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF----------- 592 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----------- 592 (771)
.....+|+|.+|+||+|++..+++.||||++.... +.+.+|++++++++||||+++++++....+
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 34456899999999999999888899999996543 356789999999999999999998854211
Q ss_pred CCceeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecc
Q 041479 593 QGNYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 667 (771)
......++||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence 112357999999999999876 24688999999999999999999986 9999999999999999999999999
Q ss_pred cCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC
Q 041479 668 GLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
|+++....... .....||+.|+||| +|+++|||++|..|+.+.. ........ .
T Consensus 167 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~----~ 234 (284)
T 2a19_B 167 GLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLRD----G 234 (284)
T ss_dssp TTCEESSCCSC-----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHHHT----T
T ss_pred hhheecccccc-----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHhhc----c
Confidence 99986654321 22346899999999 6999999999998874321 11111111 2
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+++.+.....+||+.||++|||+.|+++.|+.+
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23344555566667799999999999999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=313.39 Aligned_cols=228 Identities=22% Similarity=0.193 Sum_probs=185.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+
T Consensus 29 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 103 (484)
T 3nyv_A 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG-----YFYL 103 (484)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEE
T ss_pred EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----EEEE
Confidence 34456899999999999999999999999996542 345678999999999999999999999998776 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCccccC
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~ 674 (771)
||||+.+|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999665 45689999999999999999999996 89999999999999 467899999999998654
Q ss_pred cccCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 738 (771)
.... ....+||+.|+||| +||++|||++|+.||.+.... ..+..+.....+ ......+
T Consensus 181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 181 ASKK-----MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CCCS-----HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCSGGGGGS
T ss_pred cccc-----cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCCCcccccC
Confidence 4321 22346999999999 699999999999999753221 123333333333 2333456
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||++|||+.|+++
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 666667777999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=298.26 Aligned_cols=226 Identities=23% Similarity=0.293 Sum_probs=181.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
...+|+|.+|.||+|+++.+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 173 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS----- 173 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS-----
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC-----
Confidence 456899999999999999888899999996543 12356788999999999 7999999999998766
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 78999999999999776 34689999999999999999999986 9999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
..... ....+||+.|+||| +||++|||++|+.||.+.... ..+..........
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 251 EPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRMIMEGQYQF 324 (365)
T ss_dssp CTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCC
T ss_pred CCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCC
Confidence 54321 22357999999999 599999999999999653211 1122222333322
Q ss_pred c--hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 Q--ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~--~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. ....+++.+.....+||+.||++|||+.++++
T Consensus 325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 22334555656677999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-33 Score=291.07 Aligned_cols=238 Identities=18% Similarity=0.220 Sum_probs=184.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|++..+++.||||++..... .+++.+|+++++.++|++++..++++..... ..++||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~----~~~lv~ 84 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD----YNVMVM 84 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT----EEEEEE
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC----ceEEEE
Confidence 3345568999999999999999999999998754432 2468889999999999888887777644331 679999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCccccCc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~ 675 (771)
||+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 8999776 35689999999999999999999996 89999999999999 7889999999999987654
Q ss_pred ccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC--CccHHHHHHhhCCCc--
Q 041479 676 VMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE--GLDLHNFVKMALPDQ-- 733 (771)
Q Consensus 676 ~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~--~~~~~~~~~~~~~~~-- 733 (771)
..... ........||+.|+||| +||++|||++|+.||.+.... ...+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 32211 11223457999999999 699999999999999764322 122333333333222
Q ss_pred -hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 734 -ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 734 -~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
....+++.+.....+||+.||++|||+.++++.|+++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 2244466666777799999999999999999999886
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-33 Score=294.69 Aligned_cols=230 Identities=21% Similarity=0.221 Sum_probs=180.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+++.||+|++........+++.+|++++++++||||+++++++...+ ..++||
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 95 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----KLWIMI 95 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEEEE
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----eEEEEE
Confidence 444566899999999999999988899999997666666789999999999999999999999998766 679999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999765 35689999999999999999999996 99999999999999999999999999876332111
Q ss_pred Ccccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cchhhh
Q 041479 679 SNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQV 737 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~ 737 (771)
.......||+.|+||| +|+++|||++|+.||.+..... ..........+ ...+..
T Consensus 172 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (302)
T 2j7t_A 172 ---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPPTLLTPSK 247 (302)
T ss_dssp ---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSSGGG
T ss_pred ---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCcccCCccc
Confidence 1122346899999999 5999999999999997542211 12223332222 123344
Q ss_pred cCccccccCcccChhchhhcCCHHHHHH
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++..+.....+||+.||++|||+.++++
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 5556666777999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=285.51 Aligned_cols=222 Identities=19% Similarity=0.209 Sum_probs=180.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
+.....+|+|.+|+||+|++..+++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+ ..+
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~-----~~~ 87 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD-----HML 87 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-----EEE
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----eEE
Confidence 334456899999999999999888899999997542 34467889999999999 8999999999998776 789
Q ss_pred EEEEeccCCCCCCCc-------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--------------
Q 041479 600 LVYEFMHHGSLESCP-------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-------------- 658 (771)
Q Consensus 600 lv~e~~~~g~L~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-------------- 658 (771)
+||||+++|+|.++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999998762 4589999999999999999999996 9999999999999984
Q ss_pred -----CCceEEecccCccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCcccc
Q 041479 659 -----DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFT 717 (771)
Q Consensus 659 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~ 717 (771)
...+||+|||.++...... ...||+.|+||| +||++||+++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--- 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN--- 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS---
T ss_pred cccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc---
Confidence 4479999999998654322 235899999999 69999999999877643
Q ss_pred CCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 718 EGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+..... ...+..+++.+.....+||+.||++|||+.|+++
T Consensus 234 -~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 -GDQWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -SHHHHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hhHHHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 122333333332 3344556666767777999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=288.30 Aligned_cols=238 Identities=18% Similarity=0.218 Sum_probs=185.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|++..+++.||||++..... .+++.+|+.+++.++|++++..++++...+. ..++||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~----~~~lv~ 84 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD----YNVMVM 84 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT----EEEEEE
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC----ceEEEE
Confidence 3345568999999999999999999999999865432 2468899999999999887777777644331 679999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCccccCc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~ 675 (771)
||+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 8999766 34689999999999999999999996 99999999999999 4788999999999987654
Q ss_pred ccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccC--CccHHHHHHhhCCC---
Q 041479 676 VMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTE--GLDLHNFVKMALPD--- 732 (771)
Q Consensus 676 ~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~--~~~~~~~~~~~~~~--- 732 (771)
..... ........||+.|+||| +||++|||++|+.||.+.... ...+..+.....+.
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 32211 11223457999999999 699999999999999764321 12233333332222
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+++.+.....+||+.||++|||+.++++.|+++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 22344566666777799999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=284.47 Aligned_cols=228 Identities=25% Similarity=0.315 Sum_probs=177.2
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
.+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+ ..
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 86 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-----DF 86 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----eE
Confidence 3444567899999999999999888899999996543 234578999999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999776 34688999999999999999999996 899999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcC
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLD 739 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (771)
... .....||+.|+||| +|+++|||++|+.||.+... ....+...... ...+..++
T Consensus 164 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~~~~~~~ 235 (276)
T 2h6d_A 164 GEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGV-FYIPEYLN 235 (276)
T ss_dssp ------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-CCCCTTSC
T ss_pred Ccc-----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCc-ccCchhcC
Confidence 221 12346899999999 69999999999999975321 11222222221 12234455
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHh
Confidence 56666677999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=312.00 Aligned_cols=229 Identities=21% Similarity=0.197 Sum_probs=182.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccch-------------hhHHHHHHHHHHHhccCCCCceeEEEEeec
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-------------GALKSFMAECQALRNIRHRNLVKIITACST 589 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 589 (771)
+.....+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|++++++++|||||++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3345578999999999999999999999999965421 335789999999999999999999999987
Q ss_pred CCCCCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---ceE
Q 041479 590 SDFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---TAH 663 (771)
Q Consensus 590 ~~~~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---~~k 663 (771)
.. ..|+|||||++|+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 118 ~~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 118 KK-----YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp SS-----EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred CC-----EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 76 78999999999999765 35689999999999999999999996 999999999999998765 699
Q ss_pred EecccCccccCcccCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 041479 664 MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 664 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 729 (771)
|+|||+++...... .....+||+.|+||| +||++|||++|+.||.+.... ..+..+....
T Consensus 190 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~ 263 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKKVEKGK 263 (504)
T ss_dssp ECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC
T ss_pred EEECCCCEEcCCCC-----ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC
Confidence 99999998665432 122356999999999 699999999999999763221 1123333333
Q ss_pred CC--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 LP--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. ......+++.+.....+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 32 2233455666667777999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=292.26 Aligned_cols=228 Identities=20% Similarity=0.221 Sum_probs=180.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|++..+++.||||++........+.+.+|++++++++||||+++++++.+.+ ..|+||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 85 (304)
T 2jam_A 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----HYYLVM 85 (304)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred ceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----EEEEEE
Confidence 334556899999999999999888899999997655445577899999999999999999999998766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~~~ 676 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999766 34688999999999999999999986 99999999999999 77889999999999754332
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
. .....||+.|+||| +||++|||++|+.||.+.... .....+.....+ ......++
T Consensus 163 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 163 I------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp T------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCCCCTTTTTTSC
T ss_pred c------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCCccccccCC
Confidence 1 12346899999999 699999999999999753221 112222232222 23334556
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+|+..||++|||+.++++
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 66666777999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=293.89 Aligned_cols=227 Identities=21% Similarity=0.246 Sum_probs=177.7
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCc
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~ 595 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 88 (322)
T 2ycf_A 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---- 88 (322)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS----
T ss_pred eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc----
Confidence 34456899999999999999999999999996432 122346889999999999999999999986543
Q ss_pred eeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEecccC
Q 041479 596 YFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT---AHMGDFGL 669 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl 669 (771)
.|+||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 89 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 --YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp --EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred --eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5899999999999765 34688999999999999999999986 9999999999999987654 99999999
Q ss_pred ccccCcccCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hC
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-AL 730 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~ 730 (771)
++...... ......||+.|+||| +||++|||++|+.||.+..... .+...... ..
T Consensus 164 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 237 (322)
T 2ycf_A 164 SKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLKDQITSGKY 237 (322)
T ss_dssp CEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHHHHHHHTCC
T ss_pred ceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHHHHHHhCcc
Confidence 98654321 112346899999999 6999999999999997643322 23333332 22
Q ss_pred C--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 P--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+ ......+++.+.....+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2 2233445566666777999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=289.71 Aligned_cols=237 Identities=25% Similarity=0.280 Sum_probs=176.8
Q ss_pred ccccccccccccceEEEEEecCC-C--eEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDLD-Q--TFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~-~--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|++... + ..||||++... .....+++.+|++++++++||||+++++++.+..
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 94 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP----- 94 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-----
Confidence 44455689999999999987542 2 36999998654 2345678999999999999999999999987653
Q ss_pred eEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 597 FRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 5899999999999776 34588999999999999999999996 999999999999999999999999999987
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
....... ........||+.|+||| +|+++|||++ |+.||.+.... ...........+.....
T Consensus 171 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 171 LPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPE 248 (291)
T ss_dssp CCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTSCCCCCCCT
T ss_pred ccccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHccCCCCCCCc
Confidence 6543221 11122345788999999 6999999999 99999754221 11222222222333344
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+++.+.....+||+.||++|||+.++++.|+++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 4556666677799999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=300.56 Aligned_cols=231 Identities=22% Similarity=0.257 Sum_probs=180.7
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.+.....+|+|.+|+||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+ ..++
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 108 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISI 108 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----EEEE
Confidence 344556789999999999999999999999999765 3445678999999999999999999999998876 7899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||+++|+|.++ ...+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999876 34688999999999999999999983 279999999999999999999999999997543221
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc----------------------
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL---------------------- 720 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~---------------------- 720 (771)
.....||+.|+||| +||++|||++|+.||........
T Consensus 187 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 187 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 12346899999999 69999999999999964321110
Q ss_pred ------------------cHHHHHHhhCC-CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 721 ------------------DLHNFVKMALP-DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 721 ------------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+......+ ......++..+.....+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00011111111 1112233445555667999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=303.45 Aligned_cols=187 Identities=20% Similarity=0.239 Sum_probs=150.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++.+++.||||++... .....+++.+|++++++++|||||++++++...+.......|+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 34455689999999999999999999999999643 3345678999999999999999999999997765433336899
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||++ |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 108 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 999996 588665 34589999999999999999999996 99999999999999999999999999998764332
Q ss_pred CCc------------------ccccccccccccccchh----------------HHHHHHHHHhCCCCCC
Q 041479 678 SSN------------------QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTS 713 (771)
Q Consensus 678 ~~~------------------~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~ 713 (771)
... .......+||+.|+||| +||++|||++|..||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 110 01224567999999999 6999999998766553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=296.15 Aligned_cols=230 Identities=20% Similarity=0.245 Sum_probs=169.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..+
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 109 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-----RLH 109 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-----EEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-----EEE
Confidence 3445567899999999999999999999999996543 233567889999999999999999999998876 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-----CCCCceEEecccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL-----DNDMTAHMGDFGLTR 671 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl-----~~~~~~kl~DfGla~ 671 (771)
+||||+++ +|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||++ +..+.+||+|||+++
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999984 87665 34688999999999999999999996 99999999999999 445569999999998
Q ss_pred ccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-hCCC--
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-ALPD-- 732 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~-- 732 (771)
....... ......||+.|+||| +||++|||++|+.||.+..... .+...... ..+.
T Consensus 186 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 186 AFGIPIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred ccCCccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchh
Confidence 6543221 122346899999999 6999999999999996532211 12222211 1110
Q ss_pred -------------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -------------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 011113444445566999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=294.82 Aligned_cols=232 Identities=20% Similarity=0.246 Sum_probs=177.0
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 99 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-----RW 99 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----EE
Confidence 44555667999999999999999989999999986543 334567889999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
++||||++++++..+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999888665 45689999999999999999999996 999999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCC-----
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPD----- 732 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~----- 732 (771)
... ......||+.|+||| +||++|||++|+.||.+..... .+..+.... .++
T Consensus 177 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PGE----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHH
T ss_pred Ccc----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhH
Confidence 221 122346899999999 6999999999999996532111 111111110 000
Q ss_pred ----------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ----------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ----------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001123444445566999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=295.83 Aligned_cols=237 Identities=19% Similarity=0.169 Sum_probs=183.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...........|+|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 334456899999999999999999999999996433 3445789999999999999999999999977654444467999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||++ |+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 109 ~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 99997 477665 34689999999999999999999996 9999999999999999999999999999876543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-----------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD----------- 732 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~----------- 732 (771)
.......+||+.|+||| +||++|||++|+.||.+..... .+..+......+
T Consensus 185 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 185 -TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp -CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHHHTCCCH
T ss_pred -cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhhhh
Confidence 11123457999999999 6999999999999997532221 122221111000
Q ss_pred ------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011223444555666999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=290.72 Aligned_cols=227 Identities=21% Similarity=0.253 Sum_probs=179.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ..+++.+|+.++++++||||+++++++.+.+ ..|+||
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 103 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWIVM 103 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEEEEe
Confidence 334456899999999999999988899999996543 3467899999999999999999999998766 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999876 34689999999999999999999986 999999999999999999999999999976543221
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCcc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDPL 741 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 741 (771)
......||+.|+||| +|+++|||++|+.||.+..... .........+ ......+++.
T Consensus 181 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T 3com_A 181 ----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPPPTFRKPELWSDN 254 (314)
T ss_dssp ----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCCSSGGGSCHH
T ss_pred ----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCCcccCCcccCCHH
Confidence 122356899999999 6999999999999997532211 1111112222 2234445666
Q ss_pred ccccCcccChhchhhcCCHHHHHH
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.....+||+.||++|||+.++++
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHccCChhhCcCHHHHHh
Confidence 666777999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=294.43 Aligned_cols=227 Identities=20% Similarity=0.249 Sum_probs=180.5
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhh-----------------HHHHHHHHHHHhccCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGA-----------------LKSFMAECQALRNIRHRNLVKII 584 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l~ 584 (771)
.+.....+|+|.+|+||+|++ +++.||||++....... .+.+.+|++++++++||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 444556789999999999998 67799999996543211 27899999999999999999999
Q ss_pred EEeecCCCCCceeEEEEEEeccCCCCCCC-----------cccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCC
Q 041479 585 TACSTSDFQGNYFRALVYEFMHHGSLESC-----------PRILSFLRRLNIAIDVASALEYLHH-HCKKPIVHCDLKPS 652 (771)
Q Consensus 585 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivHrdlk~~ 652 (771)
+++.+.+ ..|+||||+++|+|.++ ...+++..+..++.|++.||+|||+ . +|+||||||+
T Consensus 110 ~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 110 GIITNYD-----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp EEEESSS-----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred EEEeeCC-----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 9998876 78999999999999876 4568899999999999999999998 5 9999999999
Q ss_pred CeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCcc
Q 041479 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 653 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~ 715 (771)
||+++.++.+||+|||+++..... ......||+.|+||| +||++|||++|+.||...
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999865432 122346899999999 699999999999999754
Q ss_pred ccCCccHHHHHH-hhCCCch-----------------hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 716 FTEGLDLHNFVK-MALPDQI-----------------LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 716 ~~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
... ....+... ...+... ...+++.+.....+||+.||++|||+.|+++
T Consensus 256 ~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 256 ISL-VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCS-HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcH-HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 221 22222222 2111110 0334555556667999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=299.67 Aligned_cols=236 Identities=17% Similarity=0.168 Sum_probs=181.4
Q ss_pred ccccccccccccceEEEEEecC--------CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCcee------------
Q 041479 523 LLLNVSYESLVKATVYKGILDL--------DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVK------------ 582 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~------------ 582 (771)
+.....+|+|.+|+||+|++.. .++.||||++... +.+.+|++++++++|||||+
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 4445678999999999999987 3679999999643 46889999999999999998
Q ss_pred ---EEEEeecCCCCCceeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 041479 583 ---IITACSTSDFQGNYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNV 654 (771)
Q Consensus 583 ---l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NI 654 (771)
+++++...+ ...|+||||+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||
T Consensus 119 i~~~~~~~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 119 IPTCMGFGVHQD----KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CCCCCEEEEETT----TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred ccchhhccccCC----cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 566765522 1689999999 9999877 25689999999999999999999996 999999999999
Q ss_pred eeCCCC--ceEEecccCccccCcccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 655 LLDNDM--TAHMGDFGLTRFIPEVMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 655 Ll~~~~--~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
+++.++ .+||+|||+++......... ........||+.|+||| +||++|||++|+.||.+
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999988 89999999998765433211 11123457999999999 69999999999999976
Q ss_pred cccCCccHHHHHHh--hCCCchh------hhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 715 MFTEGLDLHNFVKM--ALPDQIL------QVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 715 ~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.......+...... ..+.... ..+++.+.....+||+.||++|||+.++++.|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 53222222222221 1111111 123555666777999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=297.22 Aligned_cols=234 Identities=20% Similarity=0.191 Sum_probs=183.2
Q ss_pred ccccccccccccccceEEEEEec---CCCeEEEEEEeeccc----hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILD---LDQTFIAVKVLFLHQ----RGALKSFMAECQALRNI-RHRNLVKIITACSTSDF 592 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 592 (771)
..+.....+|+|.+|+||+|+.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 132 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 132 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc-
Confidence 34445567899999999999984 467799999996432 23446778899999999 6999999999998776
Q ss_pred CCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 593 QGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
..++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 ----KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ----eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 78999999999999776 34689999999999999999999986 899999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--hC
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--AL 730 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--~~ 730 (771)
++....... ......+||+.|+||| +||++|||++|+.||....... ...++... ..
T Consensus 206 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS 281 (355)
T ss_dssp EEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC
T ss_pred CeecccCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc
Confidence 986543221 1223457999999999 6999999999999996432221 22222222 11
Q ss_pred CCchhhhcCccccccCcccChhchhhcC-----CHHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENI-----KKGQIRES 766 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~~ 766 (771)
....+..+++.+.....+||+.||++|| |+.|+++.
T Consensus 282 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 2233344555555667799999999999 99998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=295.97 Aligned_cols=227 Identities=23% Similarity=0.290 Sum_probs=168.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccch-hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|+||+|++..+++.||||++..... .....+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 80 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLTLVFE 80 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEEEEEE
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEEEEec
Confidence 34568999999999999998889999999965432 22235668999999999999999999998776 6899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|++ |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 997 477554 34588999999999999999999986 999999999999999999999999999985543221
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-C--Cch------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-P--DQI------ 734 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~--~~~------ 734 (771)
......||+.|+||| +||++|||++|+.||.+..... .+..+..... + ...
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcc
Confidence 122346899999999 6999999999999997532211 1111111110 0 000
Q ss_pred -------------------hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 -------------------LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 -------------------~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+++.+.....+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1123344445566999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=316.52 Aligned_cols=232 Identities=20% Similarity=0.271 Sum_probs=183.1
Q ss_pred cccccccccceEEEEEecCC---CeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLD---QTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
...+|+|.+|+||+|++..+ +..||||++... .....+.|.+|+.++++++|||||++++++.+. ..|+|
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~lv 468 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PVWII 468 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEE
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC------ceEEE
Confidence 44589999999999998643 467999998654 334557899999999999999999999998543 36899
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 999999999876 23588999999999999999999996 99999999999999999999999999998764432
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. .......||+.||||| +||++|||++ |..||.+... ...........+...+..+++.
T Consensus 546 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 546 Y---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHHTCCCCCCTTCCHH
T ss_pred c---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCCCCCCCccccHH
Confidence 1 1122345788999999 6999999997 9999976422 1233333333333344556667
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+...+.+||+.||++|||+.++++.|++++
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 777778999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=284.68 Aligned_cols=230 Identities=21% Similarity=0.233 Sum_probs=183.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---------hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---------RGALKSFMAECQALRNIR-HRNLVKIITACSTSD 591 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 591 (771)
.+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++ ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 3444566899999999999999999999999996542 233567899999999996 999999999998766
Q ss_pred CCCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEeccc
Q 041479 592 FQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG 668 (771)
Q Consensus 592 ~~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 668 (771)
..++||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 98 -----FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp -----EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred -----eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 78999999999999876 34689999999999999999999986 99999999999999999999999999
Q ss_pred CccccCcccCCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCCccccCCccHHHHHH
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVK 727 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 727 (771)
+++....... .....||+.|+||| +|+++|||++|+.||.+.... ........
T Consensus 170 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~ 243 (298)
T 1phk_A 170 FSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMS 243 (298)
T ss_dssp TCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred chhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhc
Confidence 9986543221 22346899999999 599999999999999653211 11222222
Q ss_pred hhCC--CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 728 MALP--DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 728 ~~~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.... ......+++.+.....+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2222 2222345556666777999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=293.56 Aligned_cols=238 Identities=21% Similarity=0.246 Sum_probs=179.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... .....++.+|++++++++||||+++++++....+......|+|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 344566899999999999999999999999996433 3455788999999999999999999999876654444478999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||++ |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 93 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp ECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 99997 577665 34689999999999999999999986 9999999999999999999999999999876532211
Q ss_pred c------ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh---------
Q 041479 680 N------QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--------- 728 (771)
Q Consensus 680 ~------~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--------- 728 (771)
. .......+||+.|+||| +||++|||++|+.||.+..... .+..+...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTPHSDND 247 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCSTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCchhcc
Confidence 1 11123457899999999 6999999999999996532110 01111100
Q ss_pred --------------hCC----C---chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 --------------ALP----D---QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 --------------~~~----~---~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+ . .....+++.+.....+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0 011233444555666999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=316.31 Aligned_cols=229 Identities=19% Similarity=0.185 Sum_probs=184.2
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
.++.....+|+|.+|+||+|+++.+++.||||++... .....+.+..|..++..+ +||+|+++++++.+.+
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~----- 415 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD----- 415 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS-----
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC-----
Confidence 3445556799999999999999999999999999754 234557889999999988 6999999999987766
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+||||+++|+|.++ ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 78999999999999776 35689999999999999999999996 9999999999999999999999999999853
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ......+||+.||||| +||++|||++|+.||.+... ...+..+.... ...+..+
T Consensus 493 ~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~--~~~p~~~ 565 (674)
T 3pfq_A 493 IWDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHN--VAYPKSM 565 (674)
T ss_dssp CCTT----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHSSC--CCCCTTS
T ss_pred ccCC----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-HHHHHHHHhCC--CCCCccC
Confidence 3222 1233467999999999 69999999999999975321 11122222222 2234456
Q ss_pred CccccccCcccChhchhhcCCH-----HHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKK-----GQIR 764 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~-----~~vl 764 (771)
++.+..+..+||++||++||++ .||+
T Consensus 566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred CHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 6666677779999999999997 6665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=292.89 Aligned_cols=285 Identities=15% Similarity=0.197 Sum_probs=217.4
Q ss_pred CCCCCCCCCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccC
Q 041479 23 STWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSN 102 (771)
Q Consensus 23 ~~w~~~~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 102 (771)
..|.....+|.|.|+ |+ +++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 456556678999988 74 4678888 4555444 58999999999999877778999999999999999
Q ss_pred cCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCc-cccCCCCCCEEecccC
Q 041479 103 ALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPI-QLLNITSMEYFHVSEN 181 (771)
Q Consensus 103 ~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~-~~~~l~~L~~L~Ls~N 181 (771)
+++ +..|..|.++++|++|+|++|+++ .+|. .|.++++|++|++++|
T Consensus 87 ~l~--------------~~~~~~~~~l~~L~~L~Ls~n~l~------------------~~~~~~~~~l~~L~~L~L~~n 134 (353)
T 2z80_A 87 GIN--------------TIEEDSFSSLGSLEHLDLSYNYLS------------------NLSSSWFKPLSSLTFLNLLGN 134 (353)
T ss_dssp CCC--------------EECTTTTTTCTTCCEEECCSSCCS------------------SCCHHHHTTCTTCSEEECTTC
T ss_pred ccC--------------ccCHhhcCCCCCCCEEECCCCcCC------------------cCCHhHhCCCccCCEEECCCC
Confidence 965 455677899999999999999887 3443 3788999999999999
Q ss_pred cCcccCCh-hhhhCCCCCcEEEeecC-cccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccc
Q 041479 182 QLVGELPP-HIGFTLPNVRILLLAGN-QFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259 (771)
Q Consensus 182 ~l~g~lp~-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l 259 (771)
+++ .+|. ..+..+++|++|++++| .+.+..+..|.++++|++|++++|++++..|..| ..+++|++|++++|++
T Consensus 135 ~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l---~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 135 PYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL---KSIQNVSHLILHMKQH 210 (353)
T ss_dssp CCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT---TTCSEEEEEEEECSCS
T ss_pred CCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHH---hccccCCeecCCCCcc
Confidence 998 7887 55558999999999999 5887778899999999999999999998888776 7789999999999999
Q ss_pred cccCChhhhhcccccceeecccCcCcccCccccc---ccCCcceEecCCcccee----ccCccccCCCCCCEEEccCCcc
Q 041479 260 SGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG---NLKNLIIIAIEKFILIR----NIPISVGYLLKLQVLSLFENNI 332 (771)
Q Consensus 260 ~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l 332 (771)
+ .+|..+....++|++|++++|++++..+..+. ....++.+++.++.+.+ .+|..+..+++|+.|++++|++
T Consensus 211 ~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l 289 (353)
T 2z80_A 211 I-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289 (353)
T ss_dssp T-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCC
T ss_pred c-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCC
Confidence 7 66666554345899999999999976655443 34556666776666644 3566666777777777777777
Q ss_pred cccCCcccccccccccccccCcccee
Q 041479 333 SREIPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 333 ~~~~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
+...+..|..+++|++|+|++|++.+
T Consensus 290 ~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 290 KSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CccCHHHHhcCCCCCEEEeeCCCccC
Confidence 63333334677777777777777664
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=284.50 Aligned_cols=231 Identities=21% Similarity=0.226 Sum_probs=178.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ----RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+. ...
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~ 83 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---QKM 83 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------CE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---CeE
Confidence 334556899999999999999999999999996543 2346789999999999999999999999854331 167
Q ss_pred EEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 599 ALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
|+||||+++| +.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999877 3322 34688999999999999999999996 9999999999999999999999999999865
Q ss_pred CcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
...... .......||+.|+||| +|+++|||++|+.||.+... ....+..... ....+.
T Consensus 160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~-~~~~~~ 234 (305)
T 2wtk_C 160 HPFAAD--DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGKG-SYAIPG 234 (305)
T ss_dssp CTTCSS--CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHC-CCCCCS
T ss_pred Cccccc--cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhcC-CCCCCC
Confidence 432221 1122346899999999 69999999999999975311 1122222111 122233
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+++.+.....+||..||++|||+.|+++
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 44555656677999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=296.82 Aligned_cols=230 Identities=24% Similarity=0.254 Sum_probs=171.2
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC-CceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ-GNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~~~~~~l 600 (771)
.....+|+|.+|+||+|++..+++.||||++... .....+++.+|+++++.++||||+++++++...... .....|+
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 3445689999999999999999999999999543 234567899999999999999999999998765321 1124699
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||||+ +++|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 v~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-- 181 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 181 (367)
T ss_dssp EEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred EEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc--
Confidence 99999 7888766 34688999999999999999999996 9999999999999999999999999999865432
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-------------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA------------- 729 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~------------- 729 (771)
....+||+.|+||| +||++|||++|+.||.+..... .+..+....
T Consensus 182 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 182 -----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhh
Confidence 22356899999999 6999999999999996532111 111111110
Q ss_pred ---------CC----Cc---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 ---------LP----DQ---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ---------~~----~~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ .. .....++.+.....+|++.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11 00 11122333444556999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-33 Score=293.02 Aligned_cols=234 Identities=23% Similarity=0.270 Sum_probs=160.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+++.+|++++++++||||+++++++...+ ..++|
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 91 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----ELWLV 91 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CEEEE
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----CcEEE
Confidence 444567899999999999998888899999986543 334578899999999999999999999998776 67999
Q ss_pred EEeccCCCCCCCc-----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 602 YEFMHHGSLESCP-----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 602 ~e~~~~g~L~~~~-----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
|||+++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999997652 3488999999999999999999986 9999999999999999999999999999
Q ss_pred cccCcccCC-cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-
Q 041479 671 RFIPEVMSS-NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD- 732 (771)
Q Consensus 671 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~- 732 (771)
+........ .........||+.|+||| +|+++|||++|+.||.+..... ..........+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-VLMLTLQNDPPSL 247 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHTSSCCCT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-HHHHHhccCCCcc
Confidence 765432211 111123456899999999 6999999999999997642221 122222211111
Q ss_pred -------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111223334445566999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=295.35 Aligned_cols=229 Identities=24% Similarity=0.235 Sum_probs=173.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-----GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 86 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----N 86 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----C
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC-----c
Confidence 3344568999999999999998888999999965321 12347889999999999999999999987765 6
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.++||||+++ +|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 7999999986 66444 33588899999999999999999996 8999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC--Cch
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP--DQI 734 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~--~~~ 734 (771)
..... .....+||+.|+||| +||++|||++|..||.+.... ..+..+.... .+ ...
T Consensus 163 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 163 GSPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TSCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred cCCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhh
Confidence 43221 122356899999999 699999999999998653211 1122222211 11 000
Q ss_pred -----------------------hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 -----------------------LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 -----------------------~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+++.+.....+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0222334445566999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=292.57 Aligned_cols=175 Identities=26% Similarity=0.311 Sum_probs=150.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-----CCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-----HRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|.+|+||+|++..+++.||||++... ....+.+..|++++++++ |||||++++++...+ .
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~-----~ 110 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD-----H 110 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT-----E
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC-----e
Confidence 33455689999999999999989999999999643 334567888999999996 999999999998876 7
Q ss_pred EEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--------------
Q 041479 598 RALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-------------- 658 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-------------- 658 (771)
.++||||+ +++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence 89999999 8899766 23488999999999999999999986 9999999999999975
Q ss_pred -----------CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCC
Q 041479 659 -----------DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPT 712 (771)
Q Consensus 659 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~ 712 (771)
++.+||+|||+|+...... ....||+.|+||| +||++|||++|+.||
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 7889999999998543321 2346899999999 699999999999999
Q ss_pred Cc
Q 041479 713 SD 714 (771)
Q Consensus 713 ~~ 714 (771)
..
T Consensus 260 ~~ 261 (360)
T 3llt_A 260 RT 261 (360)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=286.12 Aligned_cols=235 Identities=20% Similarity=0.243 Sum_probs=173.5
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC---------CC
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF---------QG 594 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---------~~ 594 (771)
.....+|+|.+|+||+|++..+++.||||++........+++.+|++++++++||||+++++++..... ..
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 344568999999999999999899999999987766677899999999999999999999999854321 12
Q ss_pred ceeEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEecccCcc
Q 041479 595 NYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTR 671 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~ 671 (771)
....|+||||++ |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred cCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 236799999997 588765 34688999999999999999999996 999999999999997 56799999999998
Q ss_pred ccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC----
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP---- 731 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~---- 731 (771)
........ ........||+.|+||| +||++|||++|+.||.+..... ....... ..+
T Consensus 170 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~~~ 246 (320)
T 2i6l_A 170 IMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILE-SIPVVHE 246 (320)
T ss_dssp CC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-HSCCCCH
T ss_pred ccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCCCch
Confidence 76432211 11223345799999999 6999999999999997532111 1111111 111
Q ss_pred -------------------------CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 -------------------------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 -------------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+++.+.....+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0011234455556667999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=294.19 Aligned_cols=183 Identities=21% Similarity=0.227 Sum_probs=144.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~ 599 (771)
+.....+|+|.+|+||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+. ......|
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 34455689999999999999999999999999653 23455788999999999999999999999876531 1223679
Q ss_pred EEEEeccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 600 LVYEFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 600 lv~e~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+||||+++ +|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 107 lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 181 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 181 (371)
T ss_dssp EEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred EEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc-
Confidence 99999975 55443 45688999999999999999999996 99999999999999999999999999998654321
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.....+||+.|+||| +||++|||++|+.||.+
T Consensus 182 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 182 ----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 122356899999999 69999999999999965
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=301.90 Aligned_cols=237 Identities=17% Similarity=0.226 Sum_probs=183.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCC-CCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRH-RNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++..... .+++.+|+++++.++| ++|..+..++.+.+ ..++|
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-----~~~lv 81 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGD-----YNVLV 81 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT-----EEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC-----EEEEE
Confidence 3445568999999999999998889999998865432 2468899999999987 55555555555554 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL---DNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl---~~~~~~kl~DfGla~~~~ 674 (771)
|||+ +++|.++ ...+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 8999776 45689999999999999999999996 99999999999999 578999999999998765
Q ss_pred cccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc--cHHHHHHhhCC---
Q 041479 675 EVMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL--DLHNFVKMALP--- 731 (771)
Q Consensus 675 ~~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~~--- 731 (771)
...... ........||+.|+||| |||++|||++|+.||.+...... .+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 433211 11223567999999999 79999999999999986533221 12222222222
Q ss_pred CchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 732 DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 732 ~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
......+.+.+..++..||+.||++||++.+|++.|+++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 223344556666777799999999999999999999886
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=296.82 Aligned_cols=229 Identities=19% Similarity=0.183 Sum_probs=171.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC----------
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF---------- 592 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---------- 592 (771)
+.....+|+|.+|+||+|++..+++.||||++..... ...+|+++++.++|||||++++++.....
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3445568999999999999999999999999864432 23479999999999999999999865431
Q ss_pred -----------------------CCceeEEEEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041479 593 -----------------------QGNYFRALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKK 642 (771)
Q Consensus 593 -----------------------~~~~~~~lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 642 (771)
.+..+.++||||+++ +|.+. ...+++..+..++.|++.||+|||+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--- 160 (383)
T ss_dssp -------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Confidence 222357899999984 65433 35689999999999999999999985
Q ss_pred CeEecCCCCCCeeeC-CCCceEEecccCccccCcccCCcccccccccccccccchh----------------HHHHHHHH
Q 041479 643 PIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEI 705 (771)
Q Consensus 643 ~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el 705 (771)
+|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+||| +||++|||
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 999999999999997 688999999999986544322 22346899999999 69999999
Q ss_pred HhCCCCCCccccCCccHHHHHHhhC-C----------------------Cc----hhhhcCccccccCcccChhchhhcC
Q 041479 706 FTGKRPTSDMFTEGLDLHNFVKMAL-P----------------------DQ----ILQVLDPLFLVGGVQEGEETAEENI 758 (771)
Q Consensus 706 ~tg~~P~~~~~~~~~~~~~~~~~~~-~----------------------~~----~~~~~~~~~~~~~~~cl~~~p~~Rp 758 (771)
++|+.||.+..... .+.++..... | .. .+...++.+.....+||+.||++||
T Consensus 236 l~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 236 ILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99999997532211 1222222111 0 00 1112333344556699999999999
Q ss_pred CHHHHHH
Q 041479 759 KKGQIRE 765 (771)
Q Consensus 759 t~~~vl~ 765 (771)
|+.|+++
T Consensus 315 t~~e~l~ 321 (383)
T 3eb0_A 315 NPYEAMA 321 (383)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=288.23 Aligned_cols=234 Identities=22% Similarity=0.234 Sum_probs=178.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCC-ceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQG-NYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~-~~~~~l 600 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++......+ ....|+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 344566899999999999998888899999996543 2347889999999999 7999999999997643111 126799
Q ss_pred EEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 601 VYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 601 v~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||||+++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 9999999999776 24588999999999999999999996 899999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
... ......||+.|+||| +||++|||++|+.||.+..... ..........+....
T Consensus 182 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~ 256 (326)
T 2x7f_A 182 TVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRNPAPRLKS 256 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSC
T ss_pred Ccc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCccccCCc
Confidence 221 122346899999999 5999999999999997542211 122222222232233
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+++.+.....+||..||++|||+.++++
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 444556666677999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=299.98 Aligned_cols=229 Identities=20% Similarity=0.215 Sum_probs=171.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ..+.+|++++++++|||||++++++..... .+..+.++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 344556899999999999999888899999986432 223479999999999999999999865321 233467899
Q ss_pred EEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CceEEecccCcccc
Q 041479 602 YEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-MTAHMGDFGLTRFI 673 (771)
Q Consensus 602 ~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-~~~kl~DfGla~~~ 673 (771)
|||+++ ++.+. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 44322 35688999999999999999999985 99999999999999955 67899999999865
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-CC----
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-PD---- 732 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~---- 732 (771)
..... ....+||+.|+||| +||++|||++|+.||.+.... ..+.++....- |.
T Consensus 208 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 208 VRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred ccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 43221 22356899999999 699999999999999753211 11222222110 00
Q ss_pred ------------------c----hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ------------------Q----ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ------------------~----~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. ....+++.+..+..+||+.||++|||+.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 01122334445566999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=293.20 Aligned_cols=231 Identities=21% Similarity=0.225 Sum_probs=163.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-CCCceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSD-FQGNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~~~~~~ 599 (771)
+.....+|+|.+|+||+|++..+++.||||++... .....+++.+|+++++.++||||+++++++.... .......|
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 33445689999999999999999999999999643 2345678899999999999999999999986542 11112569
Q ss_pred EEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 600 LVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 600 lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
+||||+ +++|.++ ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp EEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 999999 6888876 34689999999999999999999986 9999999999999999999999999999865432
Q ss_pred CCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CC---------
Q 041479 678 SSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LP--------- 731 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~--------- 731 (771)
....+||+.|+||| +||++|||++|+.||.+..... .+..+.... .|
T Consensus 186 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 186 ------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHTTCC
T ss_pred ------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHhh
Confidence 22356899999999 6999999999999997532111 111111110 00
Q ss_pred ----------------Cc---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 ----------------DQ---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ----------------~~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. .....++.+.....+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 01122334445566999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=297.10 Aligned_cols=227 Identities=15% Similarity=0.080 Sum_probs=171.6
Q ss_pred cccccccccccceEEEEE-----ecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC---CCCceeEEEEeecCCCCCc
Q 041479 524 LLNVSYESLVKATVYKGI-----LDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR---HRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~~ 595 (771)
.....+|+|.+|+||+|+ ...+++.||||++.... ..++.+|++++++++ |+||+++++++...+
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~---- 140 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN---- 140 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS----
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC----
Confidence 334568999999999994 55667899999996543 457788888888887 999999999998876
Q ss_pred eeEEEEEEeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---------
Q 041479 596 YFRALVYEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--------- 658 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--------- 658 (771)
..|+|||||++|+|.++ ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 141 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 141 -GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp -CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred -CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 67999999999999776 23589999999999999999999985 8999999999999998
Q ss_pred --CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCcc
Q 041479 659 --DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLD 721 (771)
Q Consensus 659 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~ 721 (771)
++.+||+|||+|+.+..... .......+||+.||||| +||++|||+||+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 89999999999975532221 12234467999999999 799999999999998543221110
Q ss_pred HHHHHHhhCCCchhhhcCccccccCcccChhchhhc-CCHHHHHHHHHHh
Q 041479 722 LHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEEN-IKKGQIRESLIAI 770 (771)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~R-pt~~~vl~~L~~~ 770 (771)
. ...++.. ..+..+......|++.+|.+| |++.++.+.|+++
T Consensus 295 ~----~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 P----EGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E----CSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred e----chhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 0000000 011122233448899999998 6788888888775
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=281.03 Aligned_cols=286 Identities=19% Similarity=0.202 Sum_probs=209.4
Q ss_pred ccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc
Q 041479 32 CQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS 111 (771)
Q Consensus 32 c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 111 (771)
|.|.+|.|+. ++++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|+++
T Consensus 7 C~~~~l~c~~------------~~l~-~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~------ 65 (306)
T 2z66_A 7 CSGTEIRCNS------------KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS------ 65 (306)
T ss_dssp EETTEEECCS------------SCCS-SCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC------
T ss_pred eCCCEEEcCC------------CCcc-cCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccC------
Confidence 7888887764 4565 344433 368999999999999755556899999999999999976
Q ss_pred cccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCCh-h
Q 041479 112 RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPP-H 190 (771)
Q Consensus 112 ~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~-~ 190 (771)
-.+..|..+..+++|++|++++|.++ .+|..+..+++|++|++++|+++ .++. .
T Consensus 66 ------~~~~~~~~~~~~~~L~~L~Ls~n~i~------------------~l~~~~~~l~~L~~L~l~~n~l~-~~~~~~ 120 (306)
T 2z66_A 66 ------FKGCCSQSDFGTTSLKYLDLSFNGVI------------------TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS 120 (306)
T ss_dssp ------EEEEEEHHHHSCSCCCEEECCSCSEE------------------EEEEEEETCTTCCEEECTTSEEE-SSTTTT
T ss_pred ------cccCcccccccccccCEEECCCCccc------------------cChhhcCCCCCCCEEECCCCccc-ccccch
Confidence 12233566777888999999888876 45666788889999999999988 4554 4
Q ss_pred hhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCC-CCCcCcccccCCCCCcEEEccCccccccCChhhhh
Q 041479 191 IGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG-LIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN 269 (771)
Q Consensus 191 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 269 (771)
.+..+++|++|++++|++.+..+..|.++++|++|++++|.+++ ..|..| ..+++|++|++++|++++..|..+..
T Consensus 121 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~ 197 (306)
T 2z66_A 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF---TELRNLTFLDLSQCQLEQLSPTAFNS 197 (306)
T ss_dssp TTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCC---TTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred hhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHH---hhCcCCCEEECCCCCcCCcCHHHhcC
Confidence 44578888888888888888888888888888888888888876 456555 67788888888888888666777777
Q ss_pred cccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCC-CCCEEEccCCcccccCC--ccccccccc
Q 041479 270 FSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLL-KLQVLSLFENNISREIP--SSLGNFTFL 346 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L 346 (771)
+. +|++|++++|++++..+..|..+++|+.|++++|.+.+..|..+..++ +|++|+|++|.++...+ .....+...
T Consensus 198 l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~ 276 (306)
T 2z66_A 198 LS-SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 276 (306)
T ss_dssp CT-TCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHT
T ss_pred CC-CCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhh
Confidence 65 688888888888876666777777777777777777777777777663 77777777777764321 112234455
Q ss_pred ccccccCccceecCCcccccc
Q 041479 347 TELNLCGNSIRGSVPSALGSC 367 (771)
Q Consensus 347 ~~L~Ls~N~l~~~~p~~~~~l 367 (771)
+.+.+..+.+....|..+.+.
T Consensus 277 ~~~~~~~~~~~C~~p~~~~g~ 297 (306)
T 2z66_A 277 RQLLVEVERMECATPSDKQGM 297 (306)
T ss_dssp GGGBSCGGGCBEEESGGGTTC
T ss_pred hhhhccccccccCCchhhCCc
Confidence 555666666665555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-34 Score=321.38 Aligned_cols=357 Identities=19% Similarity=0.144 Sum_probs=193.7
Q ss_pred CcEEEEEcCCCCCcccCCcc-ccCCCCCcEEEcCCCcccc----cCCccccCCCCCCEEecccCcCcccCCcccccCCcc
Q 041479 44 QRVILLNLSGQNLTGTASPY-IGNLTFLRLINLQQNNFSS----NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKL 118 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l 118 (771)
++++.|||++|+++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~------------ 70 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD------------ 70 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHH------------
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCCh------------
Confidence 57899999999998654443 7889999999999999985 357788999999999999999752
Q ss_pred cccCCcc-ccCCC----CCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhh-
Q 041479 119 EGNIPSE-LGSLL----KFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIG- 192 (771)
Q Consensus 119 ~~~~p~~-~~~l~----~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~- 192 (771)
..+.. +..+. +|++|+|++|++++.- .+.++..+..+++|++|++++|.+++..+..+.
T Consensus 71 --~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~-------------~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 71 --VGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG-------------CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp --HHHHHHHHTTCSTTCCCCEEECTTSCCBGGG-------------HHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred --HHHHHHHHHHhhCCCceeEEEccCCCCCHHH-------------HHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 11112 22344 6999999999887200 012344455555555555555555422222221
Q ss_pred ---hCCCCCcEEEeecCcccccC----CccccCCCCCCEEEccccccCCCCCcCccc-c-cCCCCCcEEEccCcccccc-
Q 041479 193 ---FTLPNVRILLLAGNQFFGNI----PHSISNASKLEWLDFANNSLTGLIPEDLDS-L-VNCTYLEVVSLSVNSLSGT- 262 (771)
Q Consensus 193 ---~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-~~l~~L~~L~Ls~N~l~~~- 262 (771)
...++|++|+|++|++++.. +..+..+++|++|++++|.++...+..+.. + ..+++|++|++++|.+++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 12334555555555555422 334444555555555555554322211100 0 0133555555555555532
Q ss_pred ---CChhhhhcccccceeecccCcCcccC-----cccccccCCcceEecCCccceec----cCccccCCCCCCEEEccCC
Q 041479 263 ---LPNSLANFSSHLRYLYMSANPISGSI-----PTEIGNLKNLIIIAIEKFILIRN----IPISVGYLLKLQVLSLFEN 330 (771)
Q Consensus 263 ---~p~~~~~l~~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~Ls~N 330 (771)
++..+..+. +|++|++++|.+++.. +..+..+++|+.|++++|.+... ++..+..+++|++|++++|
T Consensus 216 ~~~l~~~l~~~~-~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n 294 (461)
T 1z7x_W 216 CRDLCGIVASKA-SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294 (461)
T ss_dssp HHHHHHHHHHCT-TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTC
T ss_pred HHHHHHHHHhCC-CccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCC
Confidence 334444333 4555555555554321 12222355555555555555432 3444455555555555555
Q ss_pred cccccCCcccccc-----cccccccccCccceec----CCcccccccce-eeecccCcccCCCCcCCCC-----CCCCCe
Q 041479 331 NISREIPSSLGNF-----TFLTELNLCGNSIRGS----VPSALGSCHQL-WLDLSHNHLTGPIPLAVGN-----PKSIPH 395 (771)
Q Consensus 331 ~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~-----l~~L~~ 395 (771)
.++...+..+... ++|++|++++|.+++. ++..+..++.| .|++++|++++..+..+.. .++|++
T Consensus 295 ~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~ 374 (461)
T 1z7x_W 295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374 (461)
T ss_dssp CCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred CCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEE
Confidence 5543333223221 4555556665555533 23334444555 5556666555433322221 445666
Q ss_pred EECCCCcccc----cCCcchhhhhcccccccEEECcCCCCC
Q 041479 396 LDLSKNELSG----EIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 396 L~Ls~N~l~~----~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
|+|++|++++ .+|..+. .+++|++|+|++|+++
T Consensus 375 L~L~~n~i~~~~~~~l~~~l~----~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 375 LWLADCDVSDSSCSSLAATLL----ANHSLRELDLSNNCLG 411 (461)
T ss_dssp EECTTSCCCHHHHHHHHHHHH----HCCCCCEEECCSSSCC
T ss_pred EECCCCCCChhhHHHHHHHHH----hCCCccEEECCCCCCC
Confidence 6666666653 3333332 4566666666666655
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=279.96 Aligned_cols=227 Identities=22% Similarity=0.195 Sum_probs=181.6
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
....+|+|.+|+||+|+.+.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~ 100 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----SFYIVG 100 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC-----eEEEEE
Confidence 3456899999999999999888899999996543 345678999999999999999999999998766 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND---MTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~---~~~kl~DfGla~~~~~~ 676 (771)
||+++++|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999665 34689999999999999999999986 99999999999999754 46999999999865432
Q ss_pred cCCcccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC--chhhhcCc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD--QILQVLDP 740 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 740 (771)
.. .....||+.|+||| +|+++|||++|+.||.+.... .....+.....+. .....+++
T Consensus 178 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 178 TK-----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp SS-----CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCSGGGTTSCH
T ss_pred Cc-----cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCchhhhhcCH
Confidence 21 12345899999999 699999999999999753211 1122222333322 22234556
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||+.||++|||+.|+++
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhc
Confidence 6666777999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=294.93 Aligned_cols=229 Identities=19% Similarity=0.192 Sum_probs=172.1
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|++..++ .||+|++..... ...+|+++++.++|||||++++++...+. .+..+.++|
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 344556899999999999998877 599998854332 22369999999999999999999865442 333467899
Q ss_pred EEeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEecccCccccC
Q 041479 602 YEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 602 ~e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~ 674 (771)
|||++++.+... ...+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+|+...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 999987544322 45688999999999999999999996 999999999999999 79999999999998664
Q ss_pred cccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-C------
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-P------ 731 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~------ 731 (771)
.... .....||+.|+||| +||++|||++|+.||.+..... .+.++..... |
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 194 AGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred CCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 3322 22356899999999 6999999999999997532111 1222222110 0
Q ss_pred ----------------Cc----hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 ----------------DQ----ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ----------------~~----~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. ....+++.+.....+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 01113344445666999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=298.94 Aligned_cols=225 Identities=17% Similarity=0.194 Sum_probs=165.9
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHH---HHHhccCCCCceeEE-------EEee
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAEC---QALRNIRHRNLVKII-------TACS 588 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~~~ 588 (771)
.+.....+|+|.+|+||+|++..+++.||||++... .....+.+.+|+ +++++++|||||+++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 344456799999999999999888889999999743 344568899999 555666899999998 5555
Q ss_pred cCCC---------CCc---eeEEEEEEeccCCCCCCCcc---cC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 041479 589 TSDF---------QGN---YFRALVYEFMHHGSLESCPR---IL-------SFLRRLNIAIDVASALEYLHHHCKKPIVH 646 (771)
Q Consensus 589 ~~~~---------~~~---~~~~lv~e~~~~g~L~~~~~---~l-------~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 646 (771)
+.+. .+. ...|+||||+ +|+|.++.. .+ ++..+..|+.|++.||+|||+. +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 4421 000 1268999999 689977621 23 3477888999999999999996 8999
Q ss_pred cCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh--------------------------HHH
Q 041479 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE--------------------------YGI 700 (771)
Q Consensus 647 rdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE--------------------------~Gv 700 (771)
|||||+|||++.++.+||+|||+|+.... .....+| +.|+||| |||
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999985332 1223467 9999999 599
Q ss_pred HHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 701 LLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 701 ~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++|||++|+.||.+...... . ... . .....+++.+.....+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~-~-~~~---~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG-S-EWI---F--RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC-S-GGG---G--SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc-h-hhh---h--hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999965322111 0 000 0 011233455556667999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.95 Aligned_cols=235 Identities=18% Similarity=0.202 Sum_probs=171.6
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC--------CCc
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF--------QGN 595 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--------~~~ 595 (771)
.....+|+|.+|+||+|++..+++.||||++... ....+.+.+|++++++++||||+++++++.+... .+.
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 3345689999999999999988899999999643 3456789999999999999999999999865321 223
Q ss_pred eeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 596 YFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
...|+||||+++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred CceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 477999999999999876 23567888999999999999999996 89999999999999999999999999998
Q ss_pred ccCcccCC----------cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHH
Q 041479 672 FIPEVMSS----------NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNF 725 (771)
Q Consensus 672 ~~~~~~~~----------~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 725 (771)
........ .........||+.|+||| +||++|||++ ||............+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~ 241 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence 65432110 011123456899999999 6999999998 553211111111111
Q ss_pred HHh--hCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 726 VKM--ALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 726 ~~~--~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
... ..+........+.+.....+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111 1223333333344555667999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=295.21 Aligned_cols=174 Identities=20% Similarity=0.261 Sum_probs=147.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc------CCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI------RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|+|.+|+||+|++..+++.||||++... ....+.+.+|+++++.+ +|+||+++++++...+ ..
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-----~~ 174 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN-----HI 174 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT-----EE
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC-----eE
Confidence 345689999999999999999999999999654 33456788888888887 5779999999998776 78
Q ss_pred EEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc--eEEecccCcc
Q 041479 599 ALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT--AHMGDFGLTR 671 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~ 671 (771)
++||||+. |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+|+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 577654 23489999999999999999999996 8999999999999999887 9999999997
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~ 715 (771)
..... ....+||+.|+||| +||++|||++|+.||.+.
T Consensus 251 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 54332 12346899999999 699999999999999653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=296.35 Aligned_cols=232 Identities=13% Similarity=-0.007 Sum_probs=161.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhcc--CCCCceeEE-------EEeecC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI--RHRNLVKII-------TACSTS 590 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~~~~ 590 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+.+++.+ +|||||+++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 445567999999999999999999999999997643 23456778885544444 699988865 333322
Q ss_pred CCC------------CceeEEEEEEeccCCCCCCCc----ccCCHHHH------HHHHHHHHHHHHHHHhcCCCCeEecC
Q 041479 591 DFQ------------GNYFRALVYEFMHHGSLESCP----RILSFLRR------LNIAIDVASALEYLHHHCKKPIVHCD 648 (771)
Q Consensus 591 ~~~------------~~~~~~lv~e~~~~g~L~~~~----~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~ivHrd 648 (771)
+.. .....|+|||||+ |+|.++. ..+++..+ ..++.|++.||+|||+. +|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 210 0124799999998 8998762 23455556 78889999999999986 899999
Q ss_pred CCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCC
Q 041479 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRP 711 (771)
Q Consensus 649 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P 711 (771)
|||+|||++.++.+||+|||+|+....... ...||+.|+||| +||++|||++|+.|
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEEE-------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCcc-------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999986543211 234679999999 69999999999999
Q ss_pred CCccccCCccHH------HHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 712 TSDMFTEGLDLH------NFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 712 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
|.+......... ..............+++.+.....+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 976533211100 000011111222344556666677999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=291.04 Aligned_cols=232 Identities=20% Similarity=0.180 Sum_probs=168.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-----------RGALKSFMAECQALRNIRHRNLVKIITACSTSD 591 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-----------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 591 (771)
+.....+|+|.+|+||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred eEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 3345568999999999999876 5699999995432 223478999999999999999999999986654
Q ss_pred CCCceeEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecc
Q 041479 592 FQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDF 667 (771)
Q Consensus 592 ~~~~~~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~Df 667 (771)
.......|+||||++ |++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence 333447899999998 566544 33589999999999999999999996 8999999999999999999999999
Q ss_pred cCccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC
Q 041479 668 GLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP 731 (771)
Q Consensus 668 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 731 (771)
|+++...... ......||+.|+||| +||++|||++|+.||.+..... .+..+......
T Consensus 179 g~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~ 252 (362)
T 3pg1_A 179 NLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNKIVEVVGT 252 (362)
T ss_dssp TC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCC
T ss_pred Cccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCC
Confidence 9997543322 122346899999999 6999999999999997532111 11111111110
Q ss_pred C------------------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 D------------------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ~------------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. ......++.+.....+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0 011122344445566999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.61 Aligned_cols=177 Identities=20% Similarity=0.240 Sum_probs=133.2
Q ss_pred cccccccceEEEEEec--CCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 528 SYESLVKATVYKGILD--LDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.+|+|.+|+||+|+++ .+++.||||++.... ..+.+.+|++++++++|||||++++++...... ..|+||||+
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~---~~~lv~e~~ 102 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR---KVWLLFDYA 102 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT---EEEEEEECC
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC---eEEEEEeCC
Confidence 5899999999999976 356799999996443 235788999999999999999999998653211 689999999
Q ss_pred cCCCCCCCc------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCceEEecccC
Q 041479 606 HHGSLESCP------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL----DNDMTAHMGDFGL 669 (771)
Q Consensus 606 ~~g~L~~~~------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl----~~~~~~kl~DfGl 669 (771)
++ +|.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 75 654431 1488999999999999999999996 89999999999999 6778999999999
Q ss_pred ccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCc
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~ 714 (771)
|+........ .......+||+.|+||| +||++|||++|+.||..
T Consensus 179 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 179 ARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp CC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9876532211 12223457999999999 69999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=291.21 Aligned_cols=230 Identities=22% Similarity=0.244 Sum_probs=174.3
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC-CceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ-GNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~~~~~~l 600 (771)
.....+|+|.+|+||+|+++.+++.||||++... .....+++.+|+.+++.++||||+++++++...+.. .....|+
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 3445689999999999999999999999999654 234467899999999999999999999998765521 1123489
Q ss_pred EEEeccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 601 VYEFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 601 v~e~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||||+. |+|.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 125 v~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--- 197 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 197 (371)
T ss_dssp EEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred EEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC---
Confidence 999997 566554 45689999999999999999999996 9999999999999999999999999999855432
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-------------- 729 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-------------- 729 (771)
....+||+.|+||| +||++|||++|+.||.+..... .+.......
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTTCSCH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHHHhhhh
Confidence 22356899999999 6999999999999997532111 111111110
Q ss_pred --------CC----Cc---hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 --------LP----DQ---ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 --------~~----~~---~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+ .. ....+++.+.....+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 00 11123444555666999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=290.48 Aligned_cols=237 Identities=21% Similarity=0.224 Sum_probs=179.7
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+.....+|+|.+|+||+|+++. .||||++.... ....+.+.+|+.++++++||||+++++++.+.+ ..
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 104 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP-----HL 104 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----CE
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----ce
Confidence 344556678999999999998863 49999996542 233467889999999999999999999998776 67
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999766 23588999999999999999999996 999999999999998 6799999999987653
Q ss_pred cccCC-cccccccccccccccchh------------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 041479 675 EVMSS-NQCSSVGLKGTVGYATPE------------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 675 ~~~~~-~~~~~~~~~gt~~y~aPE------------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 729 (771)
..... .........||+.|+||| +||++|||++|+.||.+..... .........
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~ 259 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-IIWQMGTGM 259 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-HHHHHHTTC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhccCC
Confidence 22111 111222346899999999 5999999999999997532211 122222222
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+......+++.+.....+||..||++|||+.++++.|+++
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 23222334556666677799999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.91 Aligned_cols=231 Identities=23% Similarity=0.247 Sum_probs=175.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCC-CceeEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ-GNYFRA 599 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~~~~~~ 599 (771)
+.....+|+|.+|+||+|+++.+++.||||++... .....+++.+|+.+++.++||||+++++++...+.. .....|
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 44456689999999999999999999999999653 234467899999999999999999999998765421 112358
Q ss_pred EEEEeccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 600 LVYEFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 600 lv~e~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+||||++ |+|.+. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 106 lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 179 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179 (353)
T ss_dssp EEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred EEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence 9999997 588766 44689999999999999999999996 9999999999999999999999999999864332
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh--------------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-------------- 728 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-------------- 728 (771)
.....||+.|+||| +||++|||++|+.||.+..... .+......
T Consensus 180 -----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 180 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHHhh
Confidence 12346899999999 6999999999999997532111 11111111
Q ss_pred --------hCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 --------ALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 --------~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+. .....+++.+.....+|++.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0110 011223444445666999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=281.78 Aligned_cols=230 Identities=19% Similarity=0.239 Sum_probs=175.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccC--CCCceeEEEEeecCCCCCceeE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIR--HRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.....+|+|.+|+||+|++.. ++.||||++.... ....+.+.+|++++++++ ||||+++++++.+.+ ..
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~-----~~ 103 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-----YI 103 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS-----EE
T ss_pred EEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC-----EE
Confidence 3445578999999999999876 5699999996543 345678999999999997 599999999998876 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+||| +.+++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++++ +.+||+|||+++....
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99999 557888766 34688999999999999999999996 9999999999999974 8999999999987644
Q ss_pred ccCCcccccccccccccccchh--------------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE--------------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE--------------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 729 (771)
... ........||+.|+||| +||++|||++|+.||.+.......+.......
T Consensus 179 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 179 DTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred ccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 322 11122346899999999 59999999999999976432222223333333
Q ss_pred CCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+...+..+.....+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 333344444555666677999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=285.94 Aligned_cols=231 Identities=21% Similarity=0.212 Sum_probs=162.3
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHH-HHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQ-ALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+.....+|+|.+|+||+|+++.+++.||||++.... .....++.+|+. +++.++||||+++++++.+.+ ..+
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-----~~~ 97 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----DCW 97 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----EEE
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----ceE
Confidence 3445566899999999999999899999999997543 334456667776 777789999999999998776 789
Q ss_pred EEEEeccCCCCCCC--------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 600 LVYEFMHHGSLESC--------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 600 lv~e~~~~g~L~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
+||||+++ +|.++ ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 99999985 55433 34688999999999999999999984 389999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh-------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE-------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP- 731 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE-------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~- 731 (771)
....... .....||+.|+||| +||++|||++|+.||.+.......+........+
T Consensus 175 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 175 QLVDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp C-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred ecccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 6543221 12236899999999 6999999999999997532111111111111111
Q ss_pred --CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 --DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 --~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+++.+.....+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1112234555656677999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=288.18 Aligned_cols=235 Identities=17% Similarity=0.127 Sum_probs=164.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC--CCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF--QGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++.+++.||||++.... ....++.+|++.++.++|||||++++++...+. ....+.++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 444567899999999999999988999999985432 334567788888999999999999999866432 22235789
Q ss_pred EEEeccCCCCCC------CcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCcccc
Q 041479 601 VYEFMHHGSLES------CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRFI 673 (771)
Q Consensus 601 v~e~~~~g~L~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~~ 673 (771)
||||++++.+.. ....+++..+..++.|++.||.|||.+ +.+|+||||||+||+++. ++.+||+|||+++..
T Consensus 104 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 104 VMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred EeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 999998753221 134678889999999999999999921 249999999999999996 899999999999876
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC--ch-
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD--QI- 734 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~--~~- 734 (771)
..... .....||+.|+||| +||++|||++|+.||.+.... ..+..+....... ..
T Consensus 183 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 183 SPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred CCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHcCCCCHHHH
Confidence 54322 22346899999999 699999999999999753221 1122222211100 00
Q ss_pred --------------------hhh-------cCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 --------------------LQV-------LDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 --------------------~~~-------~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
... .++.+.....+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 1223344566999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=282.57 Aligned_cols=224 Identities=18% Similarity=0.205 Sum_probs=153.7
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEeccC
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFMHH 607 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 607 (771)
.+|+|.+|+||+|+++.+++.||||++..... ..+ .....++.++||||+++++++.... .+....++||||+++
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQ---EVDHHWQASGGPHIVCILDVYENMH-HGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHH---HHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCTT
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHH---HHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEEEeccCC
Confidence 48999999999999999899999999964321 112 2223356678999999999986532 122367999999999
Q ss_pred CCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCcccCC
Q 041479 608 GSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 608 g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-- 185 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence 999766 23589999999999999999999996 9999999999999976 4559999999998554322
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCcc---HHHHH--HhhCCCchhhhcC
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLD---LHNFV--KMALPDQILQVLD 739 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~ 739 (771)
....+||+.|+||| +||++|||++|+.||.+....... ..... ....+......++
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 186 ----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred ----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence 12346899999999 699999999999999653222110 11111 1112222334456
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 66666777999999999999999986
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=294.67 Aligned_cols=281 Identities=15% Similarity=0.232 Sum_probs=181.0
Q ss_pred CCCCCCCCCCCC--CCCCccceeeeecCCCCcEEEEEcCCCCCccc----CCccc--cCCCCCcEEEcCCCcccccCCcc
Q 041479 16 DDPFGALSTWND--SVNFCQWLGVTCSLKYQRVILLNLSGQNLTGT----ASPYI--GNLTFLRLINLQQNNFSSNIPHE 87 (771)
Q Consensus 16 ~~~~~~~~~w~~--~~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~ 87 (771)
.|+..++.+|.. ..|+|.|.+..|...... -.-+...|. .+..+ ...++++.|+|++|+++ .+|..
T Consensus 26 ~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~-----~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 26 RPYHDVLSQWQRHYNADRNRWHSAWRQANSNN-----PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp CCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTC-----TTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred chHHHHHHHHHHhccCCchhhhhhhccccccc-----ccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 445556778865 358999999988422110 011122221 11111 24578999999999998 57888
Q ss_pred ccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccc
Q 041479 88 IGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167 (771)
Q Consensus 88 ~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~ 167 (771)
+.++++|++|+|++|.++ .+|..++++++|++|+|++|+|+ .+|..+
T Consensus 100 l~~l~~L~~L~L~~n~l~---------------~lp~~~~~l~~L~~L~Ls~n~l~------------------~lp~~l 146 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM---------------ELPDTMQQFAGLETLTLARNPLR------------------ALPASI 146 (328)
T ss_dssp GGGGTTCSEEEEESSCCC---------------CCCSCGGGGTTCSEEEEESCCCC------------------CCCGGG
T ss_pred hhhCCCCCEEECCCCCcc---------------chhHHHhccCCCCEEECCCCccc------------------cCcHHH
Confidence 888999999999999865 67777888888888888888876 567778
Q ss_pred cCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCC
Q 041479 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 247 (771)
.++++|++|++++|++.+.+|..+. . ...++.|.++++|++|+|++|+|+ .+|..+ .+++
T Consensus 147 ~~l~~L~~L~L~~n~~~~~~p~~~~-~---------------~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l---~~l~ 206 (328)
T 4fcg_A 147 ASLNRLRELSIRACPELTELPEPLA-S---------------TDASGEHQGLVNLQSLRLEWTGIR-SLPASI---ANLQ 206 (328)
T ss_dssp GGCTTCCEEEEEEETTCCCCCSCSE-E---------------EC-CCCEEESTTCCEEEEEEECCC-CCCGGG---GGCT
T ss_pred hcCcCCCEEECCCCCCccccChhHh-h---------------ccchhhhccCCCCCEEECcCCCcC-cchHhh---cCCC
Confidence 8888888888888877778877553 1 011223444555555555555555 334333 4455
Q ss_pred CCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEc
Q 041479 248 YLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSL 327 (771)
Q Consensus 248 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 327 (771)
+|++|+|++|+++ .+|..+..+. +|++|++++|.+.+.+|..|+++++|+.|++++|++.+.+|..+..+++|++|+|
T Consensus 207 ~L~~L~L~~N~l~-~l~~~l~~l~-~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L 284 (328)
T 4fcg_A 207 NLKSLKIRNSPLS-ALGPAIHHLP-KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284 (328)
T ss_dssp TCCEEEEESSCCC-CCCGGGGGCT-TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEEC
T ss_pred CCCEEEccCCCCC-cCchhhccCC-CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeC
Confidence 5555555555555 3444455543 5666666666666666666666666666666666666666666666666666666
Q ss_pred cCCcccccCCcccccccccccccccCccce
Q 041479 328 FENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 328 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
++|++.+.+|..++.+++|+.+++..|.+.
T Consensus 285 ~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 666666666666666666666666666554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=280.20 Aligned_cols=231 Identities=21% Similarity=0.172 Sum_probs=163.3
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccch--hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+.....+|+|.+|+||+|+++.+++.||||++..... ...+.+..+..+++.++||||+++++++.+.+ ..+
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~-----~~~ 100 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT-----DVF 100 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----EEE
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----cEE
Confidence 34445578999999999999998888999999975532 22334445556788889999999999998776 789
Q ss_pred EEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 600 LVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 600 lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
+||||+ ++.+... ...+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999999 4444333 34688999999999999999999983 2899999999999999999999999999976543
Q ss_pred ccCCcccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-ch
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD-QI 734 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~ 734 (771)
... .....||+.|+||| +||++|||++|+.||.+.......+........+. ..
T Consensus 178 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 178 DKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS
T ss_pred Ccc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc
Confidence 221 12346899999999 69999999999999975322212222222222221 11
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+++.+.....+||+.||++|||+.++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1234556666777999999999999999985
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-33 Score=318.01 Aligned_cols=360 Identities=18% Similarity=0.141 Sum_probs=271.4
Q ss_pred CCCCcEEEcCCCcccccCCcc-ccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCC
Q 041479 67 LTFLRLINLQQNNFSSNIPHE-IGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGP 145 (771)
Q Consensus 67 l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 145 (771)
+++|++|||++|+++...... |..+++|++|+|++|.+++... ..++..+..+++|++|+|++|++++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~----------~~l~~~l~~~~~L~~L~Ls~n~l~~- 70 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC----------KDISSALRVNPALAELNLRSNELGD- 70 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHH----------HHHHHHHHTCTTCCEEECTTCCCHH-
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHH----------HHHHHHHHhCCCcCEEeCCCCcCCh-
Confidence 467899999999998644333 8899999999999999762100 1356678888999999999998863
Q ss_pred CCccceeeecccccccccCcc-ccCCC----CCCEEecccCcCcc----cCChhhhhCCCCCcEEEeecCcccccCCccc
Q 041479 146 IPHLNMFQVSVYSLTGSIPIQ-LLNIT----SMEYFHVSENQLVG----ELPPHIGFTLPNVRILLLAGNQFFGNIPHSI 216 (771)
Q Consensus 146 lp~L~~l~l~~n~l~~~~p~~-~~~l~----~L~~L~Ls~N~l~g----~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 216 (771)
..+.. +..+. +|++|+|++|+++. .+|..+. .+++|++|+|++|++++..+..+
T Consensus 71 ----------------~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~-~~~~L~~L~Ls~n~i~~~~~~~l 133 (461)
T 1z7x_W 71 ----------------VGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR-TLPTLQELHLSDNLLGDAGLQLL 133 (461)
T ss_dssp ----------------HHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTT-SCTTCCEEECCSSBCHHHHHHHH
T ss_pred ----------------HHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHc-cCCceeEEECCCCcCchHHHHHH
Confidence 11111 12333 79999999999983 4566555 89999999999999986544433
Q ss_pred c-----CCCCCCEEEccccccCCCCCcCc-ccccCCCCCcEEEccCccccccCChhhhh----cccccceeecccCcCcc
Q 041479 217 S-----NASKLEWLDFANNSLTGLIPEDL-DSLVNCTYLEVVSLSVNSLSGTLPNSLAN----FSSHLRYLYMSANPISG 286 (771)
Q Consensus 217 ~-----~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~----l~~~L~~L~Ls~N~l~~ 286 (771)
. ..++|++|+|++|++++.....+ ..+..+++|++|++++|.+++..+..+.. ..++|++|++++|.+++
T Consensus 134 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 213 (461)
T 1z7x_W 134 CEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS 213 (461)
T ss_dssp HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBT
T ss_pred HHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcH
Confidence 3 36789999999999986432221 12366789999999999998654444433 12379999999999986
Q ss_pred c----CcccccccCCcceEecCCccceecc-----CccccCCCCCCEEEccCCccccc----CCcccccccccccccccC
Q 041479 287 S----IPTEIGNLKNLIIIAIEKFILIRNI-----PISVGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCG 353 (771)
Q Consensus 287 ~----~p~~~~~l~~L~~L~l~~n~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~ 353 (771)
. ++..+..+++|+.|++++|.+.... +..+..+++|++|++++|+++.. ++..+..+++|++|++++
T Consensus 214 ~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~ 293 (461)
T 1z7x_W 214 DNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293 (461)
T ss_dssp THHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCC
Confidence 4 5778889999999999999886542 22334689999999999999864 577788899999999999
Q ss_pred ccceecCCcccccc-----cce-eeecccCcccCC----CCcCCCCCCCCCeEECCCCcccccCCcchhhhhcc-ccccc
Q 041479 354 NSIRGSVPSALGSC-----HQL-WLDLSHNHLTGP----IPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGY-ISIFA 422 (771)
Q Consensus 354 N~l~~~~p~~~~~l-----~~l-~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~-l~~L~ 422 (771)
|.+++..+..+... +.| .|++++|.+++. ++..+..+++|++|+|++|++++..+..+...+.. .++|+
T Consensus 294 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~ 373 (461)
T 1z7x_W 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373 (461)
T ss_dssp CCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred CCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceE
Confidence 99986554444432 467 899999999865 45667778999999999999997666655533332 67999
Q ss_pred EEECcCCCCCC----CCCccc-cccccccccccCCCc
Q 041479 423 KLNLSYNNLDG----DVPRKM-IFKNASAISEAGNEK 454 (771)
Q Consensus 423 ~L~Ls~N~l~~----~~p~~~-~~~~~~~~~~~~n~~ 454 (771)
.|+|++|++++ .+|..+ ...++..+.+.+|+.
T Consensus 374 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp EEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred EEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 99999999985 455432 245677778888753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=280.64 Aligned_cols=233 Identities=22% Similarity=0.278 Sum_probs=173.5
Q ss_pred ccccccccccccceEEEEEec-CCCeEEEEEEeeccch--hhHHHHHHHHHHHhcc---CCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILD-LDQTFIAVKVLFLHQR--GALKSFMAECQALRNI---RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|++. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++.........
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 444567899999999999995 6778999999965432 2234567788777766 899999999998733222234
Q ss_pred eEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 597 FRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
..++||||++ |+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 588665 23488999999999999999999996 99999999999999999999999999998
Q ss_pred ccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh-CCC---
Q 041479 672 FIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA-LPD--- 732 (771)
Q Consensus 672 ~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~-~~~--- 732 (771)
...... ......||+.|+||| +||++|||++|+.||.+..... .+....... .+.
T Consensus 169 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGG
T ss_pred cccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCccc
Confidence 654322 223456899999999 6999999999999997532211 122222111 110
Q ss_pred ---------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ---------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ---------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011122333334556999999999999999984
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=299.82 Aligned_cols=292 Identities=25% Similarity=0.295 Sum_probs=198.7
Q ss_pred CCCCCCCCCCCCCCCccceeeee------cCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccC
Q 041479 17 DPFGALSTWNDSVNFCQWLGVTC------SLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGR 90 (771)
Q Consensus 17 ~~~~~~~~w~~~~~~c~w~~v~c------~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 90 (771)
+....+++|....+||.|.|..| .....+++.|++++|+|+ .+|..+. ++|++|+|++|+|++ +|. .
T Consensus 7 ~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~ 79 (622)
T 3g06_A 7 EYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---L 79 (622)
T ss_dssp ---CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---C
T ss_pred HHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---c
Confidence 34556788987789999977432 222246889999999999 6666655 899999999999985 665 5
Q ss_pred CCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCC
Q 041479 91 LFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNI 170 (771)
Q Consensus 91 l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l 170 (771)
+++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+
T Consensus 80 l~~L~~L~Ls~N~l~---------------~lp~---~l~~L~~L~Ls~N~l~~------------------l~~---~l 120 (622)
T 3g06_A 80 PPELRTLEVSGNQLT---------------SLPV---LPPGLLELSIFSNPLTH------------------LPA---LP 120 (622)
T ss_dssp CTTCCEEEECSCCCS---------------CCCC---CCTTCCEEEECSCCCCC------------------CCC---CC
T ss_pred CCCCCEEEcCCCcCC---------------cCCC---CCCCCCEEECcCCcCCC------------------CCC---CC
Confidence 789999999999976 3444 56788888888887772 333 45
Q ss_pred CCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCc
Q 041479 171 TSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLE 250 (771)
Q Consensus 171 ~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~ 250 (771)
++|+.|++++|+++ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|.|+++ | ..+++|+
T Consensus 121 ~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l-~------~~~~~L~ 184 (622)
T 3g06_A 121 SGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTSL-P------MLPSGLQ 184 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-C------CCCTTCC
T ss_pred CCcCEEECCCCCCC-cCCC----CCCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCCC-c------ccCCCCc
Confidence 77888888888887 5775 34778888888888874 343 246677888888887754 3 2346677
Q ss_pred EEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCC
Q 041479 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330 (771)
Q Consensus 251 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N 330 (771)
.|++++|+|+ .+|..+ ++|+.|++++|.|+. +|. .+++|+.|+|++|
T Consensus 185 ~L~Ls~N~l~-~l~~~~----~~L~~L~L~~N~l~~-l~~---------------------------~~~~L~~L~Ls~N 231 (622)
T 3g06_A 185 ELSVSDNQLA-SLPTLP----SELYKLWAYNNRLTS-LPA---------------------------LPSGLKELIVSGN 231 (622)
T ss_dssp EEECCSSCCS-CCCCCC----TTCCEEECCSSCCSS-CCC---------------------------CCTTCCEEECCSS
T ss_pred EEECCCCCCC-CCCCcc----chhhEEECcCCcccc-cCC---------------------------CCCCCCEEEccCC
Confidence 7777777777 455432 357777777777762 322 1245666666666
Q ss_pred cccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCc
Q 041479 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPS 409 (771)
Q Consensus 331 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 409 (771)
+|++ +| ..+++|+.|+|++|+|++ +|. .++.| .|+|++|+|+ .+|..|..+++|+.|+|++|++++.+|.
T Consensus 232 ~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 232 RLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 6663 44 344667777777777663 333 23444 5666677666 4566677777888888888888777766
Q ss_pred chh
Q 041479 410 SLA 412 (771)
Q Consensus 410 ~l~ 412 (771)
.+.
T Consensus 303 ~l~ 305 (622)
T 3g06_A 303 ALR 305 (622)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=280.86 Aligned_cols=220 Identities=19% Similarity=0.172 Sum_probs=177.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhccC--CCCceeEEEEeecCCCCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNIR--HRNLVKIITACSTSDFQG 594 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~ 594 (771)
+.....+|+|.+|+||+|++..+++.||||++..... ...+.+.+|+.++++++ ||||+++++++...+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~--- 121 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD--- 121 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS---
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC---
Confidence 3445568999999999999999999999999965432 12356778999999996 599999999998776
Q ss_pred ceeEEEEEEeccC-CCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEecccC
Q 041479 595 NYFRALVYEFMHH-GSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGL 669 (771)
Q Consensus 595 ~~~~~lv~e~~~~-g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGl 669 (771)
..++||||+.+ ++|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+
T Consensus 122 --~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 122 --SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp --EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred --cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 78999999976 788766 34688999999999999999999986 999999999999999 788999999999
Q ss_pred ccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCc
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQ 733 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 733 (771)
++...... .....||+.|+||| +||++|||++|+.||... .+...... .
T Consensus 197 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-------~~~~~~~~--~ 261 (320)
T 3a99_A 197 GALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQV--F 261 (320)
T ss_dssp CEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHCCC--C
T ss_pred cccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-------hhhhcccc--c
Confidence 98665322 12346899999999 699999999999999642 11222111 1
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22344555666677999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=288.79 Aligned_cols=180 Identities=21% Similarity=0.258 Sum_probs=147.2
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC--------CCCceeEEEEeecCCCCCc
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR--------HRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~~~~~~~~ 595 (771)
.....+|+|.+|+||+|++..+++.||||++... ....+.+.+|+++++.++ ||||+++++++..... ..
T Consensus 40 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~-~~ 117 (397)
T 1wak_A 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV-NG 117 (397)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET-TE
T ss_pred EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC-CC
Confidence 3345689999999999999999999999999643 345678899999999996 7889999999873321 12
Q ss_pred eeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----------
Q 041479 596 YFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM---------- 660 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~---------- 660 (771)
...|+||||+. |++.+. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 118 THICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred ceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 36899999995 454332 245899999999999999999999842 899999999999999775
Q ss_pred ---------------------------------------ceEEecccCccccCcccCCcccccccccccccccchh----
Q 041479 661 ---------------------------------------TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---- 697 (771)
Q Consensus 661 ---------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---- 697 (771)
.+||+|||+++..... ....+||+.|+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCCHHHHHT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccCChhhcC
Confidence 7999999999865432 12346899999999
Q ss_pred -----------HHHHHHHHHhCCCCCCcc
Q 041479 698 -----------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 698 -----------~Gv~l~el~tg~~P~~~~ 715 (771)
+||++|||++|+.||...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 699999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=280.84 Aligned_cols=219 Identities=20% Similarity=0.175 Sum_probs=173.2
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhcc----CCCCceeEEEEeecCCCC
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNI----RHRNLVKIITACSTSDFQ 593 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l----~H~nIv~l~~~~~~~~~~ 593 (771)
.....+|+|.+|+||+|++..+++.||||++..... .....+.+|+.++.++ +||||+++++++.+.+
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~-- 111 (312)
T 2iwi_A 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE-- 111 (312)
T ss_dssp EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC------
T ss_pred EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC--
Confidence 344568999999999999998899999999965432 1234567899999998 8999999999987765
Q ss_pred CceeEEEEEEe-ccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEeccc
Q 041479 594 GNYFRALVYEF-MHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFG 668 (771)
Q Consensus 594 ~~~~~~lv~e~-~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfG 668 (771)
..++|||| +.+++|.++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||
T Consensus 112 ---~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 112 ---GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ---eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 67999999 788999776 34589999999999999999999996 899999999999999 88999999999
Q ss_pred CccccCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC
Q 041479 669 LTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD 732 (771)
Q Consensus 669 la~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 732 (771)
+++...... .....||+.|+||| +|+++||+++|+.||... .+..... .
T Consensus 186 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~--~ 250 (312)
T 2iwi_A 186 SGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------QEILEAE--L 250 (312)
T ss_dssp SCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHTC--C
T ss_pred hhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------HHHhhhc--c
Confidence 998665422 12346899999999 699999999999999642 1222221 1
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223345556666677999999999999999986
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=275.11 Aligned_cols=251 Identities=21% Similarity=0.214 Sum_probs=191.8
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCC--CcCcccccCCCCCcE
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLI--PEDLDSLVNCTYLEV 251 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~l~~L~~ 251 (771)
+.++++++.++ .+|..+. ++|++|+|++|+|+.+.+..|.++++|++|+|++|+++... |..+ ..+++|++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---~~~~~L~~ 82 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD---FGTTSLKY 82 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHH---HSCSCCCE
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccc---ccccccCE
Confidence 46777777777 7776543 57788888888887655556778888888888888776331 3333 45677888
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcccCc-ccccccCCcceEecCCccceeccCccccCCCCCCEEEccCC
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP-TEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N 330 (771)
|++++|.++ .+|..+..+. +|++|++++|++++..+ ..|..+++|+.|++++|.+.+..|..+..+++|++|++++|
T Consensus 83 L~Ls~n~i~-~l~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 83 LDLSFNGVI-TMSSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EECCSCSEE-EEEEEEETCT-TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EECCCCccc-cChhhcCCCC-CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 888888877 5666666665 68888888888875554 56778888888888888887777777888888888888888
Q ss_pred cccc-cCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCC
Q 041479 331 NISR-EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIP 408 (771)
Q Consensus 331 ~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 408 (771)
++++ ..|..+..+++|++|+|++|++++..|..+..++.| .|++++|++++..+..|..+++|++|+|++|++++..|
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSS
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCH
Confidence 8875 577788888888888888888887778888888888 78888888887777778888888888888888887777
Q ss_pred cchhhhhccc-ccccEEECcCCCCCCCCCc
Q 041479 409 SSLAWIFGYI-SIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 409 ~~l~~~~~~l-~~L~~L~Ls~N~l~~~~p~ 437 (771)
..+. .+ ++|+.|+|++|+++|.++.
T Consensus 241 ~~~~----~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 241 QELQ----HFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp SSCC----CCCTTCCEEECTTCCEECSGGG
T ss_pred HHHH----hhhccCCEEEccCCCeecccCh
Confidence 7654 55 4788888888888877654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=304.96 Aligned_cols=227 Identities=20% Similarity=0.240 Sum_probs=178.0
Q ss_pred ccccccccccccceEEEEEecC-CCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDL-DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|++.. +++.||||++... .....+.+.+|++++++++|||||++++++...+..+....|+
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 3445568999999999999976 6789999998643 3445678999999999999999999999998766434444799
Q ss_pred EEEeccCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 601 VYEFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 601 v~e~~~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||||+++++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.+ .+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--- 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--- 234 (681)
T ss_dssp EEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---
T ss_pred EEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC---
Confidence 9999999999877 44789999999999999999999996 89999999999999975 8999999999865432
Q ss_pred cccccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcccccc
Q 041479 680 NQCSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVG 745 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (771)
....||+.|+||| |||++|||++|..|+.+.+..... ........++.+..+
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------EDDPVLKTYDSYGRL 300 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------TTCHHHHHCHHHHHH
T ss_pred -----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccccc---------ccccccccCHHHHHH
Confidence 2346999999999 799999999999988764433221 011111123444456
Q ss_pred CcccChhchhhcCC-HHHHHHHHHHh
Q 041479 746 GVQEGEETAEENIK-KGQIRESLIAI 770 (771)
Q Consensus 746 ~~~cl~~~p~~Rpt-~~~vl~~L~~~ 770 (771)
..+||+.||++||+ +.++.+.|.++
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHH
Confidence 66999999999995 56666666543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=283.50 Aligned_cols=177 Identities=24% Similarity=0.313 Sum_probs=147.3
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CC-----CceeEEEEeecCCCCCcee
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HR-----NLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~~~~~~~ 597 (771)
.....+|+|.+|+||+|+++.+++.||||++... ....+++.+|+++++.++ |+ +|+++++++...+ .
T Consensus 57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-----~ 130 (382)
T 2vx3_A 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN-----H 130 (382)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT-----E
T ss_pred EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC-----c
Confidence 3445689999999999999999999999999643 334567888999998885 55 4999999998776 7
Q ss_pred EEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEecccCc
Q 041479 598 RALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD--NDMTAHMGDFGLT 670 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla 670 (771)
.|+||||++ |+|.++ ...+++..+..++.|++.||+|||++ ..+|+||||||+|||++ .++.+||+|||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 899999996 487665 24588999999999999999999953 35899999999999994 4788999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCcc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~ 715 (771)
+...... ....||+.|+||| +||++|||++|+.||.+.
T Consensus 209 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQRI-------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc-------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8654321 2346899999999 699999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=292.68 Aligned_cols=224 Identities=21% Similarity=0.247 Sum_probs=160.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|.+|+||.+.. .+++.||||++.... .+.+.+|+++++++ +|||||++++++.+.+ ..|+||||
T Consensus 20 ~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~~~lv~E~ 90 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYIALEL 90 (434)
T ss_dssp EEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEEEECC
T ss_pred cCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----eEEEEEec
Confidence 35589999999986544 456699999986532 35678999999986 8999999999987766 78999999
Q ss_pred ccCCCCCCCcc----------cCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-------------Cc
Q 041479 605 MHHGSLESCPR----------ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDND-------------MT 661 (771)
Q Consensus 605 ~~~g~L~~~~~----------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~-------------~~ 661 (771)
|. |+|.++.. ..++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 68866511 112334578999999999999986 99999999999999754 48
Q ss_pred eEEecccCccccCcccCCcccccccccccccccchh----------------------HHHHHHHHHh-CCCCCCccccC
Q 041479 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE----------------------YGILLLEIFT-GKRPTSDMFTE 718 (771)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------------~Gv~l~el~t-g~~P~~~~~~~ 718 (771)
+||+|||+++................+||+.|+||| +||++|||++ |+.||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543322111223457999999999 5999999999 99999764322
Q ss_pred CccHHHHHHhhCC-Cch----hhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 719 GLDLHNFVKMALP-DQI----LQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 719 ~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+...... ... ...+++.+.....+||+.||++|||+.++++
T Consensus 247 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1233333222 111 1122344455667999999999999999985
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=297.97 Aligned_cols=235 Identities=18% Similarity=0.185 Sum_probs=167.6
Q ss_pred CCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCC
Q 041479 170 ITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYL 249 (771)
Q Consensus 170 l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L 249 (771)
+++|++|+|++|.+++ +++..+..+++|++|+|++|.|++..| |..+++|++|+|++|.|+++.+ .++|
T Consensus 33 ~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~--------~~~L 101 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV--------GPSI 101 (487)
T ss_dssp GGGCCEEECCSSCCCC-CCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE--------CTTC
T ss_pred CCCccEEEeeCCcCCC-CCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC--------CCCc
Confidence 3478888888888884 444444478888888888888876555 7888888888888888875432 2678
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCcccc-CCCCCCEEEcc
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVG-YLLKLQVLSLF 328 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~Ls 328 (771)
++|++++|.|++..+.. + ++|+.|+|++|.|++..|..|+++++|+.|++++|.+.+.+|..+. .+++|+.|+|+
T Consensus 102 ~~L~L~~N~l~~~~~~~---l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls 177 (487)
T 3oja_A 102 ETLHAANNNISRVSCSR---G-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (487)
T ss_dssp CEEECCSSCCCCEEECC---C-SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred CEEECcCCcCCCCCccc---c-CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecC
Confidence 88888888887554432 2 3688888888888877777888888888888888888777777775 67888888888
Q ss_pred CCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccc-cc
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS-GE 406 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ 406 (771)
+|.|++..+ +..+++|++|+|++|+|++.+| .+..++.| .|+|++|+|++ +|..+..+++|+.|++++|++. +.
T Consensus 178 ~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 178 YNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp TSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred CCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence 888876532 3357788888888888876444 36677777 77777777774 5666777777777777777776 44
Q ss_pred CCcchhhhhcccccccEEECc
Q 041479 407 IPSSLAWIFGYISIFAKLNLS 427 (771)
Q Consensus 407 ~p~~l~~~~~~l~~L~~L~Ls 427 (771)
+|..+. .++.|+.++++
T Consensus 254 ~~~~~~----~l~~L~~l~~~ 270 (487)
T 3oja_A 254 LRDFFS----KNQRVQTVAKQ 270 (487)
T ss_dssp HHHHHT----TCHHHHHHHHH
T ss_pred hHHHHH----hCCCCcEEecc
Confidence 444332 45555554443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=277.42 Aligned_cols=175 Identities=20% Similarity=0.247 Sum_probs=147.1
Q ss_pred ccccccccccccceEEEEEe-cCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCC------CceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGIL-DLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHR------NLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|+||+|++ +.+++.||||++... ....+.+.+|+++++.++|+ +|+++++++.+.+
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~---- 90 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG---- 90 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT----
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC----
Confidence 34455689999999999998 567889999999643 33457889999999998765 4999999998776
Q ss_pred eeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC------------
Q 041479 596 YFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN------------ 658 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~------------ 658 (771)
..++||||+ +++|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 91 -~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 -HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp -EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred -cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 789999999 7888665 22578999999999999999999996 9999999999999987
Q ss_pred -------CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 659 -------DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 659 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
++.+||+|||+++...... ....||+.|+||| +||++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 6689999999998643321 2346899999999 69999999999999965
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=280.02 Aligned_cols=278 Identities=18% Similarity=0.179 Sum_probs=201.5
Q ss_pred CCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccc
Q 041479 130 LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFF 209 (771)
Q Consensus 130 ~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~ 209 (771)
+.....++++|.++ .+|..+. ++|++|++++|+++ .+|...+..+++|++|+|++|+|+
T Consensus 31 ~~~~~c~~~~~~l~------------------~iP~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~ 89 (353)
T 2z80_A 31 DRNGICKGSSGSLN------------------SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN 89 (353)
T ss_dssp CTTSEEECCSTTCS------------------SCCTTCC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCC
T ss_pred CCCeEeeCCCCCcc------------------ccccccc--ccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccC
Confidence 33445666666666 4555443 47888888888887 566644457788888888888888
Q ss_pred ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCCh--hhhhcccccceeecccC-cCcc
Q 041479 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPN--SLANFSSHLRYLYMSAN-PISG 286 (771)
Q Consensus 210 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~~L~~L~Ls~N-~l~~ 286 (771)
+..|..|.++++|++|+|++|+|+++.+..| .++++|++|++++|+++ .+|. .+..+. +|++|++++| .+++
T Consensus 90 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~-~L~~L~l~~n~~~~~ 164 (353)
T 2z80_A 90 TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWF---KPLSSLTFLNLLGNPYK-TLGETSLFSHLT-KLQILRVGNMDTFTK 164 (353)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSSCCHHHH---TTCTTCSEEECTTCCCS-SSCSSCSCTTCT-TCCEEEEEESSSCCE
T ss_pred ccCHhhcCCCCCCCEEECCCCcCCcCCHhHh---CCCccCCEEECCCCCCc-ccCchhhhccCC-CCcEEECCCCccccc
Confidence 7777778888888888888888876655444 66778888888888887 4554 455554 7888888887 4666
Q ss_pred cCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCccccc
Q 041479 287 SIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGS 366 (771)
Q Consensus 287 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 366 (771)
..|..|.++++|+.|++++|.+.+..|..+..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+..
T Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 244 (353)
T 2z80_A 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244 (353)
T ss_dssp ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----
T ss_pred cCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc
Confidence 66777888888888888888887777888888888888888888886443334456788888888888887655544432
Q ss_pred ---ccce-eeecccCcccC----CCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCc
Q 041479 367 ---CHQL-WLDLSHNHLTG----PIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 367 ---l~~l-~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
...+ .+++++|.+++ .+|..+..+++|++|+|++|+|+ .+|..+ |..+++|+.|+|++|+++|.+|.
T Consensus 245 ~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~---~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGI---FDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp --CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTT---TTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHH---HhcCCCCCEEEeeCCCccCcCCC
Confidence 2333 56666666654 46777888999999999999999 566542 34889999999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=270.78 Aligned_cols=222 Identities=10% Similarity=0.016 Sum_probs=169.7
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+ ..|+
T Consensus 34 ~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~~~l 108 (286)
T 3uqc_A 34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-----GGLV 108 (286)
T ss_dssp EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEE
T ss_pred EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-----cEEE
Confidence 34456899999999999999989999999997543 344578999999999999999999999998876 7899
Q ss_pred EEEeccCCCCCCCc-ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 601 VYEFMHHGSLESCP-RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 601 v~e~~~~g~L~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||||+++++|.++. ......+..+++.|++.||+|||+. +|+||||||+||+++.++.+||+++|.......
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~~~~~---- 181 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDANP---- 181 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCTTCCH----
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccCCCCc----
Confidence 99999999998762 2345667899999999999999996 999999999999999999999986653320000
Q ss_pred cccccccccccccccchhHHHHHHHHHhCCCCCCccccCCcc--HHHHHHhhCC--CchhhhcCccccccCcccChhchh
Q 041479 680 NQCSSVGLKGTVGYATPEYGILLLEIFTGKRPTSDMFTEGLD--LHNFVKMALP--DQILQVLDPLFLVGGVQEGEETAE 755 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE~Gv~l~el~tg~~P~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~cl~~~p~ 755 (771)
.+--| -+||++|||+||+.||.+....... ..+......+ ......+++.+.....+||+.||+
T Consensus 182 ---------~~Di~---slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 249 (286)
T 3uqc_A 182 ---------QDDIR---GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGG 249 (286)
T ss_dssp ---------HHHHH---HHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSS
T ss_pred ---------hhHHH---HHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCc
Confidence 00001 1899999999999999754322110 0011111111 122334555666677799999999
Q ss_pred hcCCHHHHHHHHHHh
Q 041479 756 ENIKKGQIRESLIAI 770 (771)
Q Consensus 756 ~Rpt~~~vl~~L~~~ 770 (771)
+| |+.|+++.|+++
T Consensus 250 ~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 250 IR-SASTLLNLMQQA 263 (286)
T ss_dssp CC-CHHHHHHHHHHH
T ss_pred cC-CHHHHHHHHHHH
Confidence 99 999999999875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=278.79 Aligned_cols=254 Identities=21% Similarity=0.233 Sum_probs=220.8
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcE
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEV 251 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~ 251 (771)
....++.+++.++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|+++.+..| .++++|++
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~---~~l~~L~~ 116 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF---NGLANLNT 116 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGG---TTCSSCCE
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhc---cCCccCCE
Confidence 4678899999998 8998765 689999999999998888999999999999999999998877666 77899999
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccC-ccccCCCCCCEEEccCC
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP-ISVGYLLKLQVLSLFEN 330 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N 330 (771)
|+|++|+|++..+..+..+. +|++|+|++|+|++..+..|.++++|+.|++++|+..+.++ ..|..+++|++|+|++|
T Consensus 117 L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n 195 (440)
T 3zyj_A 117 LELFDNRLTTIPNGAFVYLS-KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195 (440)
T ss_dssp EECCSSCCSSCCTTTSCSCS-SCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTS
T ss_pred EECCCCcCCeeCHhHhhccc-cCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCC
Confidence 99999999954444566665 89999999999998878889999999999999965555554 47889999999999999
Q ss_pred cccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCc
Q 041479 331 NISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPS 409 (771)
Q Consensus 331 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 409 (771)
+++ .+| .+..+++|++|+|++|+|++..|..|..++.| .|+|++|++++..+..|..+++|+.|+|++|+|++..+.
T Consensus 196 ~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 196 NLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp CCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence 998 455 58899999999999999999999999999999 899999999999999999999999999999999966665
Q ss_pred chhhhhcccccccEEECcCCCCCCCCCccc
Q 041479 410 SLAWIFGYISIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 410 ~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
.+ ..+++|+.|+|++|++.|.+.-.+
T Consensus 274 ~~----~~l~~L~~L~L~~Np~~CdC~l~~ 299 (440)
T 3zyj_A 274 LF----TPLHHLERIHLHHNPWNCNCDILW 299 (440)
T ss_dssp TT----SSCTTCCEEECCSSCEECSSTTHH
T ss_pred Hh----ccccCCCEEEcCCCCccCCCCchH
Confidence 54 488999999999999998886544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=280.09 Aligned_cols=252 Identities=21% Similarity=0.229 Sum_probs=198.2
Q ss_pred CCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEE
Q 041479 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVV 252 (771)
Q Consensus 173 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L 252 (771)
...++.+++.++ .+|..+. +++++|+|++|+|++..|..|.++++|+.|+|++|+|+++.|..| .++++|++|
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~---~~l~~L~~L 128 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF---NGLASLNTL 128 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT---TTCTTCCEE
T ss_pred CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhc---cCcccCCEE
Confidence 456777777887 7776544 578888888888888778888888888888888888887777666 677888888
Q ss_pred EccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccC-ccccCCCCCCEEEccCCc
Q 041479 253 SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIP-ISVGYLLKLQVLSLFENN 331 (771)
Q Consensus 253 ~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~ 331 (771)
+|++|+|++..+..+..+. +|++|+|++|+|++..+..|.++++|+.|++++|+..+.++ ..|..+++|++|+|++|+
T Consensus 129 ~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 129 ELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp ECCSSCCSBCCTTTSSSCT-TCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred ECCCCcCCccChhhhcccC-CCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 8888888844444455554 78888888888887777788888888888888855444444 467888888888888888
Q ss_pred ccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcc
Q 041479 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSS 410 (771)
Q Consensus 332 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 410 (771)
+++ +| .+..+++|++|+|++|+|++..|..|..++.| .|+|++|++++..|..|..+++|+.|+|++|+|++..+..
T Consensus 208 l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 208 IKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTS
T ss_pred ccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHH
Confidence 874 34 57788888888888888888888888888888 8888888888888888888888999999999888655554
Q ss_pred hhhhhcccccccEEECcCCCCCCCCCcc
Q 041479 411 LAWIFGYISIFAKLNLSYNNLDGDVPRK 438 (771)
Q Consensus 411 l~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 438 (771)
+. .+++|+.|+|++|++.|.+.-.
T Consensus 286 ~~----~l~~L~~L~L~~Np~~CdC~~~ 309 (452)
T 3zyi_A 286 FT----PLRYLVELHLHHNPWNCDCDIL 309 (452)
T ss_dssp ST----TCTTCCEEECCSSCEECSTTTH
T ss_pred hc----cccCCCEEEccCCCcCCCCCch
Confidence 43 7888888999999888877654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=288.17 Aligned_cols=224 Identities=21% Similarity=0.216 Sum_probs=159.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|+||.... .+++.||||++..... ..+.+|+++++++ +|||||++++++.+.. ..|+|||
T Consensus 28 ~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-----~~~lv~E 98 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ-----FQYIAIE 98 (432)
T ss_dssp EEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT-----EEEEEEE
T ss_pred cCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC-----EEEEEEE
Confidence 345689999999654333 3456999999964332 2356899999999 7999999999988776 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----CCceEEecccCccccC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-----DMTAHMGDFGLTRFIP 674 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGla~~~~ 674 (771)
||. |+|.++ .....+.++..++.|++.||+|||+. +|+||||||+||+++. ..++||+|||+|+...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 996 577655 22344556789999999999999996 8999999999999943 3468899999998765
Q ss_pred cccCCcccccccccccccccchh------------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCC---
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPD--- 732 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~--- 732 (771)
..... .......+||+.|+||| +||++|||++ |..||.+... ............
T Consensus 175 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 175 VGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQANILLGACSLDCL 250 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHHHHHTTCCCCTTS
T ss_pred CCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHHHHHhccCCcccc
Confidence 43211 12233467999999999 6999999999 9999864321 112222221111
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......++.+.....+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111222333445666999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=274.97 Aligned_cols=175 Identities=19% Similarity=0.255 Sum_probs=145.5
Q ss_pred ccccccccccccceEEEEEecCCC-eEEEEEEeeccchhhHHHHHHHHHHHhccCCCC------ceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ-TFIAVKVLFLHQRGALKSFMAECQALRNIRHRN------LVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|.+|+||+|++..++ +.||||++... ....+.+.+|++++++++|++ ++.+++++...+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~---- 95 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG---- 95 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT----
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC----
Confidence 334556899999999999997665 79999999643 344578889999999997766 999999988776
Q ss_pred eeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--------------
Q 041479 596 YFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLL-------------- 656 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl-------------- 656 (771)
..++||||+. |++.+. ...+++.++..++.|++.||+|||+. +|+||||||+||++
T Consensus 96 -~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 -HMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp -EEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred -eEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 7899999994 555433 23589999999999999999999985 99999999999999
Q ss_pred -----CCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 657 -----DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 657 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
+.++.+||+|||+++...... ....||+.|+||| +||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 567899999999998643321 2346899999999 69999999999999975
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=276.39 Aligned_cols=244 Identities=18% Similarity=0.181 Sum_probs=142.7
Q ss_pred EEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccC
Q 041479 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGS 128 (771)
Q Consensus 49 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~ 128 (771)
++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+++ +..|..|.+
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~--------------~~~~~~~~~ 121 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR--------------QIEVGAFNG 121 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC--------------EECTTTTTT
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC--------------CcChhhccC
Confidence 444555565 3444332 56777777777777766777777777777777777644 344455666
Q ss_pred CCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec-Cc
Q 041479 129 LLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG-NQ 207 (771)
Q Consensus 129 l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~-N~ 207 (771)
+++|++|+|++|+|++ ..+..|.++++|++|+|++|+++ .+|...+..+++|+.|++++ |.
T Consensus 122 l~~L~~L~L~~n~l~~-----------------~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~ 183 (452)
T 3zyi_A 122 LASLNTLELFDNWLTV-----------------IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183 (452)
T ss_dssp CTTCCEEECCSSCCSB-----------------CCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred cccCCEEECCCCcCCc-----------------cChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCC
Confidence 6666666666665541 22233455555555555555555 44444444555555555555 33
Q ss_pred ccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCccc
Q 041479 208 FFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287 (771)
Q Consensus 208 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~ 287 (771)
+..+.+..|.++++|++|+|++|+|+++ | . +..++ +|++|+|++|+|++.
T Consensus 184 l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~---~~~l~-------------------------~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 184 LEYISEGAFEGLFNLKYLNLGMCNIKDM-P-N---LTPLV-------------------------GLEELEMSGNHFPEI 233 (452)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSSC-C-C---CTTCT-------------------------TCCEEECTTSCCSEE
T ss_pred ccccChhhccCCCCCCEEECCCCccccc-c-c---ccccc-------------------------cccEEECcCCcCccc
Confidence 4333333455555555555555555432 1 1 13334 455555555555555
Q ss_pred CcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccce
Q 041479 288 IPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 288 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
.|..|.++++|+.|++++|.+.+..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 5555555556666666666665555666666777777777777777666666777777777777777775
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=280.18 Aligned_cols=180 Identities=21% Similarity=0.294 Sum_probs=147.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-----------CCCceeEEEEeecCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-----------HRNLVKIITACSTSD 591 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~~ 591 (771)
+.....+|+|.+|+||+|++..+++.||||++... ....+.+.+|++++++++ ||||+++++++...+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 44456789999999999999999999999999643 334577889999999886 899999999987543
Q ss_pred CCCceeEEEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC------CCC
Q 041479 592 FQGNYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD------NDM 660 (771)
Q Consensus 592 ~~~~~~~~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~------~~~ 660 (771)
......++||||+ +++|.++ ...+++..+..++.|++.||+|||+. .+|+||||||+||+++ ..+
T Consensus 100 -~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 100 -PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp -TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred -CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcc
Confidence 1223679999999 8888765 23488999999999999999999984 2899999999999994 445
Q ss_pred ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 661 TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 661 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.+||+|||+++...... ....||+.|+||| +||++|||++|+.||..
T Consensus 176 ~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 89999999998654322 2346899999999 69999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=296.96 Aligned_cols=231 Identities=21% Similarity=0.194 Sum_probs=172.2
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-CCCceeE
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSD-FQGNYFR 598 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~~~~~ 598 (771)
..+.....+|+|.+|+||+|++..+++.||||++... .....+++.+|++++++++|||||++++++.... .......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3445566789999999999999988889999998654 3445678999999999999999999999976521 1112366
Q ss_pred EEEEEeccCCCCCCCc------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc---eEEecccC
Q 041479 599 ALVYEFMHHGSLESCP------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT---AHMGDFGL 669 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~---~kl~DfGl 669 (771)
|+||||+++|+|.++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 8999999999997661 2588899999999999999999996 9999999999999987664 99999999
Q ss_pred ccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHH--------
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFV-------- 726 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~-------- 726 (771)
++....... .....||+.|+||| +||++||+++|+.||...+. ...|.
T Consensus 171 a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 171 AKELDQGEL-----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSN 241 (676)
T ss_dssp CCBTTSCCC-----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC----
T ss_pred ccccccccc-----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccc
Confidence 987654321 22356899999999 79999999999999964211 00100
Q ss_pred ---------Hhh--------CCCchhhhcCccccccCcccChhchhhcCCHHHH
Q 041479 727 ---------KMA--------LPDQILQVLDPLFLVGGVQEGEETAEENIKKGQI 763 (771)
Q Consensus 727 ---------~~~--------~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~v 763 (771)
.+. .+......+++.+.....+||..||++|||+.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 0111222233444455669999999999999874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=260.50 Aligned_cols=253 Identities=19% Similarity=0.171 Sum_probs=188.8
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEE
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~ 253 (771)
+.++.+++.++ .+|..+ .++|+.|++++|+|++..+..|..+++|++|+|++|.++++.|..| .++++|++|+
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~ 86 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF---TGLALLEQLD 86 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT---TTCTTCCEEE
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhc---CCccCCCEEe
Confidence 67888888888 788654 3688888999988888777888888889999998888888777666 6778888888
Q ss_pred ccCcc-ccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcc
Q 041479 254 LSVNS-LSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNI 332 (771)
Q Consensus 254 Ls~N~-l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 332 (771)
+++|. ++...|..+..+. +|++|++++|.+++..|..|.++++|+.|++++|.+.+..+..+..+++|++|+|++|++
T Consensus 87 l~~n~~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 165 (285)
T 1ozn_A 87 LSDNAQLRSVDPATFHGLG-RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (285)
T ss_dssp CCSCTTCCCCCTTTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCccccCHHHhcCCc-CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence 88887 7644466666665 788888888888877777788888888888888887766666677788888888888888
Q ss_pred cccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcch
Q 041479 333 SREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSL 411 (771)
Q Consensus 333 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 411 (771)
++..+..|..+++|++|++++|++++..|..+..++.| .|++++|++++..+..|..+++|+.|+|++|++....+..
T Consensus 166 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~- 244 (285)
T 1ozn_A 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR- 244 (285)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-
T ss_pred cccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-
Confidence 76666677888888888888888887777777777777 6777777777666666777777777777777776433321
Q ss_pred hhhhcccccccEEECcCCCCCCCCCccc
Q 041479 412 AWIFGYISIFAKLNLSYNNLDGDVPRKM 439 (771)
Q Consensus 412 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 439 (771)
+. ...++.+..+.|.+.|..|..+
T Consensus 245 -~~---~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 245 -PL---WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp -HH---HHHHHHCCSEECCCBEEESGGG
T ss_pred -HH---HHHHHhcccccCccccCCchHh
Confidence 11 1223444566677776666643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=272.74 Aligned_cols=270 Identities=17% Similarity=0.206 Sum_probs=208.3
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.++..++++.+++...+...+..+++|++|+|++|+|++..|..|+.+++|++|+|++|++++ ..|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~--------------~~~ 75 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--------------TLD 75 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE--------------EEE
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc--------------chh
Confidence 567888999999987777777888999999999999998778899999999999999999752 222
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
|..+++|++|++++|+|++ ++ ..++|++|++++|+++ .++.. .+++|+.|++
T Consensus 76 --~~~l~~L~~L~Ls~n~l~~------------------l~----~~~~L~~L~l~~n~l~-~~~~~---~~~~L~~L~l 127 (317)
T 3o53_A 76 --LESLSTLRTLDLNNNYVQE------------------LL----VGPSIETLHAANNNIS-RVSCS---RGQGKKNIYL 127 (317)
T ss_dssp --ETTCTTCCEEECCSSEEEE------------------EE----ECTTCCEEECCSSCCS-EEEEC---CCSSCEEEEC
T ss_pred --hhhcCCCCEEECcCCcccc------------------cc----CCCCcCEEECCCCccC-CcCcc---ccCCCCEEEC
Confidence 7889999999999998872 11 2378888888888888 44433 4578888888
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
++|+|++..+..|..+++|++|+|++|.+++..|..+. ..+++|++|+|++|.+++. |... .+ ++|++|++++|+
T Consensus 128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~~l~~L~~L~L~~N~l~~~-~~~~-~l-~~L~~L~Ls~N~ 202 (317)
T 3o53_A 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA--ASSDTLEHLNLQYNFIYDV-KGQV-VF-AKLKTLDLSSNK 202 (317)
T ss_dssp CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGG--GGTTTCCEEECTTSCCCEE-ECCC-CC-TTCCEEECCSSC
T ss_pred CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHh--hccCcCCEEECCCCcCccc-cccc-cc-ccCCEEECCCCc
Confidence 88888887777888888888888888888877665541 3568888888888888743 3322 23 378888888888
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccc-ccCCcccccccccccccccC-ccceecCC
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS-REIPSSLGNFTFLTELNLCG-NSIRGSVP 361 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p 361 (771)
|++. |..|..+++|+.|++++|.+. .+|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++ +.+++..|
T Consensus 203 l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 203 LAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 8854 445778888888888888776 45667777788888888888887 66677777788888888874 44554444
Q ss_pred c
Q 041479 362 S 362 (771)
Q Consensus 362 ~ 362 (771)
.
T Consensus 281 ~ 281 (317)
T 3o53_A 281 E 281 (317)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.74 Aligned_cols=224 Identities=18% Similarity=0.201 Sum_probs=157.3
Q ss_pred EEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccc
Q 041479 47 ILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSEL 126 (771)
Q Consensus 47 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~ 126 (771)
+.++.++++++.+ |..+ .++|++|+|++|+|++..+..|..+++|++|+|++|.++ +..|..|
T Consensus 14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~--------------~~~~~~~ 76 (285)
T 1ozn_A 14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA--------------RIDAAAF 76 (285)
T ss_dssp CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC--------------EECTTTT
T ss_pred eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccc--------------eeCHhhc
Confidence 6778888888844 4433 578999999999999877788999999999999999865 3556778
Q ss_pred cCCCCCCEEeccccc-CcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 127 GSLLKFKGLGLANNY-FTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 127 ~~l~~L~~L~Ls~N~-l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
.++++|++|++++|. +++ ..|..+.++++|++|++++|+++ .+++..+..+++|++|++++
T Consensus 77 ~~l~~L~~L~l~~n~~l~~-----------------~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~ 138 (285)
T 1ozn_A 77 TGLALLEQLDLSDNAQLRS-----------------VDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138 (285)
T ss_dssp TTCTTCCEEECCSCTTCCC-----------------CCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred CCccCCCEEeCCCCCCccc-----------------cCHHHhcCCcCCCEEECCCCcCC-EECHhHhhCCcCCCEEECCC
Confidence 888888888888886 552 23556777777777887777777 44444444677777777777
Q ss_pred CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 206 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
|++++..+..|..+++|++|+|++|+++++.+..| ..+++|+.|++++|++++..|..+..+. +|+.|++++|+++
T Consensus 139 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~ 214 (285)
T 1ozn_A 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF---RGLHSLDRLLLHQNRVAHVHPHAFRDLG-RLMTLYLFANNLS 214 (285)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT---TTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCS
T ss_pred CcccccCHhHhccCCCccEEECCCCcccccCHHHh---cCccccCEEECCCCcccccCHhHccCcc-cccEeeCCCCcCC
Confidence 77776666667777777777777777776555444 5566677777777777655566666554 5666666666666
Q ss_pred ccCcccccccCCcceEecCCccce
Q 041479 286 GSIPTEIGNLKNLIIIAIEKFILI 309 (771)
Q Consensus 286 ~~~p~~~~~l~~L~~L~l~~n~l~ 309 (771)
+..+..|..+++|+.|++++|.+.
T Consensus 215 ~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 215 ALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp CCCHHHHTTCTTCCEEECCSSCEE
T ss_pred cCCHHHcccCcccCEEeccCCCcc
Confidence 544455555555555555555553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=266.10 Aligned_cols=215 Identities=16% Similarity=0.190 Sum_probs=161.9
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHH-hccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..+|+|.+|+||+|+++.+++.||||++... ..+.+|++++ +..+||||+++++++.... .+....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEEEeec
Confidence 3589999999999999999999999999532 4567888888 5568999999999986521 1123689999999
Q ss_pred cCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCccc
Q 041479 606 HHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 606 ~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 677 (771)
++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK 174 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCG
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccccc
Confidence 99999776 23589999999999999999999996 8999999999999998 7899999999997543211
Q ss_pred CCcccccccccccccccch----hHHHHHHHHHhCCCCCCccccCCcc--H-HHHHHh--hCCCchhhhcCccccccCcc
Q 041479 678 SSNQCSSVGLKGTVGYATP----EYGILLLEIFTGKRPTSDMFTEGLD--L-HNFVKM--ALPDQILQVLDPLFLVGGVQ 748 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aP----E~Gv~l~el~tg~~P~~~~~~~~~~--~-~~~~~~--~~~~~~~~~~~~~~~~~~~~ 748 (771)
|... -+||++|||++|+.||.+....... . ...... ..+......+++.+.....+
T Consensus 175 ---------------~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (299)
T 3m2w_A 175 ---------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 239 (299)
T ss_dssp ---------------GGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHH
T ss_pred ---------------CCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHH
Confidence 1111 1899999999999999653211100 0 000000 11111223456666667779
Q ss_pred cChhchhhcCCHHHHHH
Q 041479 749 EGEETAEENIKKGQIRE 765 (771)
Q Consensus 749 cl~~~p~~Rpt~~~vl~ 765 (771)
||+.||++|||+.|+++
T Consensus 240 ~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 240 LLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HTCSSTTTSCCHHHHHT
T ss_pred HcccChhhCCCHHHHhc
Confidence 99999999999999986
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-28 Score=268.11 Aligned_cols=247 Identities=21% Similarity=0.213 Sum_probs=199.8
Q ss_pred CCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccccc
Q 041479 132 FKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGN 211 (771)
Q Consensus 132 L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~ 211 (771)
...++.+++.++ .+|..+. ++++.|+|++|+++ .++...+..+++|++|+|++|+|+++
T Consensus 45 ~~~v~c~~~~l~------------------~iP~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~i 103 (440)
T 3zyj_A 45 FSKVICVRKNLR------------------EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTI 103 (440)
T ss_dssp SCEEECCSCCCS------------------SCCSCCC--TTCSEEECCSCCCC-EECTTTTSSCSSCCEEECCSSCCCEE
T ss_pred CCEEEeCCCCcC------------------cCCCCCC--CCCcEEEccCCcCC-eeCHHHhhCCCCCCEEECCCCcCCcc
Confidence 456666666666 4555443 57888888888888 45544455888888888888888887
Q ss_pred CCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeeccc-CcCcccCcc
Q 041479 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA-NPISGSIPT 290 (771)
Q Consensus 212 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~-N~l~~~~p~ 290 (771)
.+..|.++++|++|+|++|+|+.+.+..| ..+++|++|+|++|++++..+..+..+. +|++|++++ |.+....+.
T Consensus 104 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~~~~l~~i~~~ 179 (440)
T 3zyj_A 104 EIGAFNGLANLNTLELFDNRLTTIPNGAF---VYLSKLKELWLRNNPIESIPSYAFNRIP-SLRRLDLGELKRLSYISEG 179 (440)
T ss_dssp CGGGGTTCSSCCEEECCSSCCSSCCTTTS---CSCSSCCEEECCSCCCCEECTTTTTTCT-TCCEEECCCCTTCCEECTT
T ss_pred ChhhccCCccCCEEECCCCcCCeeCHhHh---hccccCceeeCCCCcccccCHHHhhhCc-ccCEeCCCCCCCcceeCcc
Confidence 77888888888888888888887766555 6778888888888888855555566665 788888888 455544555
Q ss_pred cccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce
Q 041479 291 EIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370 (771)
Q Consensus 291 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 370 (771)
.|.++++|+.|++++|.+.. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..++.|
T Consensus 180 ~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 257 (440)
T 3zyj_A 180 AFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257 (440)
T ss_dssp TTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTC
T ss_pred hhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCC
Confidence 78888888888888888863 44 47888999999999999998889999999999999999999999999999999999
Q ss_pred -eeecccCcccCCCCcCCCCCCCCCeEECCCCcccc
Q 041479 371 -WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405 (771)
Q Consensus 371 -~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 405 (771)
.|+|++|+|++..+..|..+++|+.|+|++|++.-
T Consensus 258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 89999999998888899999999999999999873
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-30 Score=275.53 Aligned_cols=254 Identities=19% Similarity=0.214 Sum_probs=189.0
Q ss_pred cccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcccc-------CCCCCCEE
Q 041479 63 YIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG-------SLLKFKGL 135 (771)
Q Consensus 63 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~-------~l~~L~~L 135 (771)
.++..++|+.|++++|.+ .+|..+... |++|+|++|.++ ...+|..+. ++++|++|
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~-------------~~~~~~~~~~~~~~~~~l~~L~~L 100 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVR-------------AARIPSRILFGALRVLGISGLQEL 100 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEE-------------EEECBHHHHHHHHHHHTTSCCCEE
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--Hhhccccccccc-------------CCCcCHHHHHHHHHhcCcCCccEE
Confidence 345566677777777777 466655544 777777777753 123444443 67777777
Q ss_pred ecccccCcCCCCccceeeecccccccccCccc--cCCCCCCEEecccCcCcccCChhhhhCC-----CCCcEEEeecCcc
Q 041479 136 GLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL--LNITSMEYFHVSENQLVGELPPHIGFTL-----PNVRILLLAGNQF 208 (771)
Q Consensus 136 ~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~g~lp~~~~~~l-----~~L~~L~L~~N~l 208 (771)
+|++|++++ .+|..+ ..+++|++|+|++|++++ +|..+. .+ ++|++|+|++|+|
T Consensus 101 ~L~~n~l~~-----------------~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~-~l~~~~~~~L~~L~L~~N~l 161 (312)
T 1wwl_A 101 TLENLEVTG-----------------TAPPPLLEATGPDLNILNLRNVSWAT-RDAWLA-ELQQWLKPGLKVLSIAQAHS 161 (312)
T ss_dssp EEEEEBCBS-----------------CCCCCSSSCCSCCCSEEEEESCBCSS-SSSHHH-HHHTTCCTTCCEEEEESCSC
T ss_pred EccCCcccc-----------------hhHHHHHHhcCCCccEEEccCCCCcc-hhHHHH-HHHHhhcCCCcEEEeeCCCC
Confidence 777777664 444444 678888888888888884 465554 45 8899999999999
Q ss_pred cccCCccccCCCCCCEEEccccccCCCC--CcCcccccCCCCCcEEEccCccccc--cCChhhhhcccccceeecccCcC
Q 041479 209 FGNIPHSISNASKLEWLDFANNSLTGLI--PEDLDSLVNCTYLEVVSLSVNSLSG--TLPNSLANFSSHLRYLYMSANPI 284 (771)
Q Consensus 209 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~~L~~L~Ls~N~l 284 (771)
++..|..|..+++|++|+|++|++.+.. |..+ .+..+++|++|+|++|+|++ .++..++...++|++|++++|+|
T Consensus 162 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 240 (312)
T 1wwl_A 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISAL-CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240 (312)
T ss_dssp CCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS-CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCC
T ss_pred ccchHHHhccCCCCCEEECCCCCcCcchHHHHHH-HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcC
Confidence 9888889999999999999999876542 2111 12677899999999999982 23333332224799999999999
Q ss_pred cccCc-ccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCcccee
Q 041479 285 SGSIP-TEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 285 ~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
++..| ..+..+++|+.|++++|.+. .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 241 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 241 RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 98775 56777899999999999987 6777766 8999999999999865 65 8999999999999999975
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-29 Score=268.23 Aligned_cols=263 Identities=18% Similarity=0.181 Sum_probs=208.6
Q ss_pred eeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcccc
Q 041479 151 MFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN 230 (771)
Q Consensus 151 ~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 230 (771)
..+++.+.+....+..+..+++|++|+|++|+++ .+++..+..+++|++|+|++|++++..+ |..+++|++|+|++|
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCC-CCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccC-cCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 4556666665555555667789999999999998 5555545589999999999999987654 889999999999999
Q ss_pred ccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcccee
Q 041479 231 SLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR 310 (771)
Q Consensus 231 ~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 310 (771)
+|+++. .+++|++|++++|++++..+.. + ++|++|++++|++++..|..|..+++|+.|++++|.+.+
T Consensus 91 ~l~~l~--------~~~~L~~L~l~~n~l~~~~~~~---~-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 91 YVQELL--------VGPSIETLHAANNNISRVSCSR---G-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp EEEEEE--------ECTTCCEEECCSSCCSEEEECC---C-SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE
T ss_pred cccccc--------CCCCcCEEECCCCccCCcCccc---c-CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc
Confidence 998643 2378999999999998654443 2 379999999999998888889999999999999999988
Q ss_pred ccCcccc-CCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCC
Q 041479 311 NIPISVG-YLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVG 388 (771)
Q Consensus 311 ~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~ 388 (771)
..+..+. .+++|++|+|++|++++. | ....+++|++|+|++|+|++.. ..+..++.| .|++++|+++ .+|..+.
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~ 234 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALR 234 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTCC
T ss_pred ccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHhh
Confidence 7777764 789999999999999865 3 2335889999999999999654 448888888 8999999998 4677788
Q ss_pred CCCCCCeEECCCCccc-ccCCcchhhhhcccccccEEECcC-CCCCCCCC
Q 041479 389 NPKSIPHLDLSKNELS-GEIPSSLAWIFGYISIFAKLNLSY-NNLDGDVP 436 (771)
Q Consensus 389 ~l~~L~~L~Ls~N~l~-~~~p~~l~~~~~~l~~L~~L~Ls~-N~l~~~~p 436 (771)
.+++|+.|++++|+++ +.+|..+. .+++|+.|++++ +.+++..|
T Consensus 235 ~l~~L~~L~l~~N~~~~~~~~~~~~----~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 235 FSQNLEHFDLRGNGFHCGTLRDFFS----KNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CCTTCCEEECTTCCCBHHHHHHHHH----TCHHHHHHHHHHHHHHHSSSS
T ss_pred cCCCCCEEEccCCCccCcCHHHHHh----ccccceEEECCCchhccCCch
Confidence 8999999999999998 55555544 778888888873 34444433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=265.85 Aligned_cols=246 Identities=21% Similarity=0.211 Sum_probs=140.5
Q ss_pred ccCCCCCCEEecccccCcCCCCc-----cceeeeccccc-ccccCcccc-------CCCCCCEEecccCcCcccCChhhh
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPH-----LNMFQVSVYSL-TGSIPIQLL-------NITSMEYFHVSENQLVGELPPHIG 192 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~-----L~~l~l~~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~g~lp~~~~ 192 (771)
++..++|+.|++++|.+ .+|. ++.++++.|.+ .+.+|..+. ++++|++|+|++|++++.+|..++
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred EccCCCceeEeeccccc--ccHHHHHHHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 34455566666666665 2232 33444444444 223343333 455555556655555555555442
Q ss_pred -hCCCCCcEEEeecCcccccCCccccCC-----CCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccccc--CC
Q 041479 193 -FTLPNVRILLLAGNQFFGNIPHSISNA-----SKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGT--LP 264 (771)
Q Consensus 193 -~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~--~p 264 (771)
..+++|++|+|++|+|++. |..|..+ ++|++|+|++|+|++..|..| .++++|++|++++|++.+. +|
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV---RVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTC---CCCSSCCEEECCSCTTCHHHHHH
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHh---ccCCCCCEEECCCCCcCcchHHH
Confidence 3555555555555555544 5555544 555555555555555544444 4455555555555555433 12
Q ss_pred hhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcccee--ccC-ccccCCCCCCEEEccCCcccccCC-ccc
Q 041479 265 NSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIR--NIP-ISVGYLLKLQVLSLFENNISREIP-SSL 340 (771)
Q Consensus 265 ~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~ 340 (771)
..+ .+..+++|+.|++++|.+.+ .++ ..+..+++|++|+|++|++++..| ..+
T Consensus 193 ~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 249 (312)
T 1wwl_A 193 SAL-----------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249 (312)
T ss_dssp HHS-----------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCC
T ss_pred HHH-----------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhh
Confidence 222 11444444444444444431 112 233466777777777777776554 455
Q ss_pred ccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccc
Q 041479 341 GNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405 (771)
Q Consensus 341 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 405 (771)
..+++|++|+|++|+|+ .+|..+. +.| .|||++|+|++. |. +..+++|++|+|++|+|++
T Consensus 250 ~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 66777888888888877 5566555 566 788888888866 55 7888888888888888874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-27 Score=268.60 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=182.8
Q ss_pred CCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCC
Q 041479 68 TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP 147 (771)
Q Consensus 68 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp 147 (771)
.+++.|++++|.|+ .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|+
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~---------------~lp~---~l~~L~~L~Ls~N~l~---- 94 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT---------------SLPA---LPPELRTLEVSGNQLT---- 94 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS---------------CCCC---CCTTCCEEEECSCCCS----
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC---------------CCCC---cCCCCCEEEcCCCcCC----
Confidence 45888999999988 4777665 78888888888865 3343 3566777777777665
Q ss_pred ccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEc
Q 041479 148 HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227 (771)
Q Consensus 148 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 227 (771)
.+|. .+++|++|++++|+++ .+|. .+++|+.|++++|+|++ +|.. +++|++|+|
T Consensus 95 --------------~lp~---~l~~L~~L~Ls~N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~L 148 (622)
T 3g06_A 95 --------------SLPV---LPPGLLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSV 148 (622)
T ss_dssp --------------CCCC---CCTTCCEEEECSCCCC-CCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred --------------cCCC---CCCCCCEEECcCCcCC-CCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEEC
Confidence 2333 4566777777777776 4554 34566677777776664 3332 366666666
Q ss_pred cccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcc
Q 041479 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFI 307 (771)
Q Consensus 228 s~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 307 (771)
++|+|+++ |. .+++|+.|++++|+|+ .+|.. .++|+.|++++|+|++
T Consensus 149 s~N~l~~l-~~------~~~~L~~L~L~~N~l~-~l~~~----~~~L~~L~Ls~N~l~~--------------------- 195 (622)
T 3g06_A 149 SDNQLASL-PA------LPSELCKLWAYNNQLT-SLPML----PSGLQELSVSDNQLAS--------------------- 195 (622)
T ss_dssp CSSCCSCC-CC------CCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSC---------------------
T ss_pred cCCcCCCc-CC------ccCCCCEEECCCCCCC-CCccc----CCCCcEEECCCCCCCC---------------------
Confidence 66666643 21 1245566666666665 34411 1245566666655552
Q ss_pred ceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcC
Q 041479 308 LIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLA 386 (771)
Q Consensus 308 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~ 386 (771)
+|. .+++|+.|++++|+++ .+|.. +++|+.|+|++|+|++ +| ..++.| .|+|++|+|+. +|.
T Consensus 196 ----l~~---~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~- 258 (622)
T 3g06_A 196 ----LPT---LPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM- 258 (622)
T ss_dssp ----CCC---CCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-
T ss_pred ----CCC---ccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc-
Confidence 222 2367889999999998 45543 4789999999999996 55 344667 89999999995 454
Q ss_pred CCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCcc
Q 041479 387 VGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRK 438 (771)
Q Consensus 387 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 438 (771)
.+++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++.+|..
T Consensus 259 --~~~~L~~L~Ls~N~L~-~lp~~l~----~l~~L~~L~L~~N~l~~~~~~~ 303 (622)
T 3g06_A 259 --LPSGLLSLSVYRNQLT-RLPESLI----HLSSETTVNLEGNPLSERTLQA 303 (622)
T ss_dssp --CCTTCCEEECCSSCCC-SCCGGGG----GSCTTCEEECCSCCCCHHHHHH
T ss_pred --ccccCcEEeCCCCCCC-cCCHHHh----hccccCEEEecCCCCCCcCHHH
Confidence 5789999999999999 7787765 8999999999999999877764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=270.86 Aligned_cols=223 Identities=13% Similarity=0.085 Sum_probs=161.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccC---------CCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIR---------HRNLVKIIT 585 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l~~ 585 (771)
+.....+|+|.+|+||+|++ +++.||||++.... ....+.+.+|++++++++ |||||++.+
T Consensus 22 y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred chheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 34455689999999999998 46799999997542 223478899999999886 888888888
Q ss_pred EeecCC-------------------------CCCceeEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHH-
Q 041479 586 ACSTSD-------------------------FQGNYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLH- 637 (771)
Q Consensus 586 ~~~~~~-------------------------~~~~~~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH- 637 (771)
++...+ ..+....|+|||||++|++.+. .+.+++.++..++.|++.||+|||
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~ 179 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA 179 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 753210 0012368999999999965443 356789999999999999999999
Q ss_pred hcCCCCeEecCCCCCCeeeCCCC--------------------ceEEecccCccccCcccCCcccccccccccccccchh
Q 041479 638 HHCKKPIVHCDLKPSNVLLDNDM--------------------TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE 697 (771)
Q Consensus 638 ~~~~~~ivHrdlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE 697 (771)
+. +|+||||||+|||++.++ .+||+|||+|+..... ..+||+.|||||
T Consensus 180 ~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~aPE 247 (336)
T 2vuw_A 180 SL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSMDED 247 (336)
T ss_dssp HH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTTCSG
T ss_pred hC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeecccChh
Confidence 75 899999999999999887 8999999999865431 236999999999
Q ss_pred --------------HHHH-HHHHHhCCCCCCccccCCccHHHHHHh-hC----CCchhhhcCccccccCcccChhchhhc
Q 041479 698 --------------YGIL-LLEIFTGKRPTSDMFTEGLDLHNFVKM-AL----PDQILQVLDPLFLVGGVQEGEETAEEN 757 (771)
Q Consensus 698 --------------~Gv~-l~el~tg~~P~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~cl~~~p~~R 757 (771)
+|++ .+++++|..||.+.............. .. +......+++.+.....+||+.|
T Consensus 248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 2333 666777888885421000011111111 11 12234455666667777999876
Q ss_pred CCHHHHH
Q 041479 758 IKKGQIR 764 (771)
Q Consensus 758 pt~~~vl 764 (771)
|+.|++
T Consensus 324 -sa~e~l 329 (336)
T 2vuw_A 324 -SATDLL 329 (336)
T ss_dssp -SHHHHH
T ss_pred -CHHHHH
Confidence 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=271.48 Aligned_cols=224 Identities=20% Similarity=0.184 Sum_probs=158.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCC-CCce----------e------
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRH-RNLV----------K------ 582 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-~nIv----------~------ 582 (771)
+.....+|+|.+|+||+|++..+++.||||++.... ....+.+.+|+.+++.++| +|.. .
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 334456899999999999999989999999997433 2235789999999999987 3211 1
Q ss_pred -----EEEEeecCCCCCceeEEEEEEeccCCCCCCCc----------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 041479 583 -----IITACSTSDFQGNYFRALVYEFMHHGSLESCP----------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647 (771)
Q Consensus 583 -----l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 647 (771)
+..++...........+++|+++ +++|.++. ..+++..+..++.|+++||+|||+. +|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 11111111100112356777765 57876542 3467788999999999999999986 99999
Q ss_pred CCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh-------------------------HHHHH
Q 041479 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-------------------------YGILL 702 (771)
Q Consensus 648 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-------------------------~Gv~l 702 (771)
||||+|||++.++.+||+|||+++..... ....+| +.||||| |||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999865432 223467 9999999 49999
Q ss_pred HHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 703 LEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 703 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
|||++|+.||.+...... ....++ ....+++.+.....+||+.||++|||+.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~-----~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-----SEWIFR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-----SGGGGS--SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh-----HHHHHh--hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999975432211 001111 01123344555666999999999999888753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-27 Score=241.79 Aligned_cols=217 Identities=22% Similarity=0.254 Sum_probs=160.4
Q ss_pred CCCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccC
Q 041479 29 VNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108 (771)
Q Consensus 29 ~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 108 (771)
.++|.|.|+.|... .+++.+++++++++. +|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|.++
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--- 74 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ--- 74 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS---
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC---
Confidence 48999999999754 456789999999995 555443 68999999999999877778999999999999999975
Q ss_pred CcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCC
Q 041479 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELP 188 (771)
Q Consensus 109 p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 188 (771)
...+..|.++++|++|++++|++++ ..+..|.++++|++|++++|+++ .+|
T Consensus 75 -----------~i~~~~~~~l~~L~~L~l~~n~l~~-----------------~~~~~~~~l~~L~~L~l~~n~l~-~~~ 125 (270)
T 2o6q_A 75 -----------TLPAGIFKELKNLETLWVTDNKLQA-----------------LPIGVFDQLVNLAELRLDRNQLK-SLP 125 (270)
T ss_dssp -----------CCCTTTTSSCTTCCEEECCSSCCCC-----------------CCTTTTTTCSSCCEEECCSSCCC-CCC
T ss_pred -----------eeChhhhcCCCCCCEEECCCCcCCc-----------------CCHhHcccccCCCEEECCCCccC-eeC
Confidence 2333446778888888888887762 22344667778888888888887 555
Q ss_pred hhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhh
Q 041479 189 PHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268 (771)
Q Consensus 189 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 268 (771)
+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+++.+..| .++++|++|+|++|++++..+..+.
T Consensus 126 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~ 202 (270)
T 2o6q_A 126 PRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAF---DKLTELKTLKLDNNQLKRVPEGAFD 202 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT---TTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred HHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHh---ccCCCcCEEECCCCcCCcCCHHHhc
Confidence 5555577778888888887776666667777777788887777777666555 5667777777777777743333344
Q ss_pred hcccccceeecccCcCc
Q 041479 269 NFSSHLRYLYMSANPIS 285 (771)
Q Consensus 269 ~l~~~L~~L~Ls~N~l~ 285 (771)
.+. +|+.|++++|.+.
T Consensus 203 ~l~-~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 203 SLE-KLKMLQLQENPWD 218 (270)
T ss_dssp TCT-TCCEEECCSSCBC
T ss_pred ccc-CCCEEEecCCCee
Confidence 443 5777777777665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-28 Score=270.59 Aligned_cols=254 Identities=18% Similarity=0.210 Sum_probs=171.7
Q ss_pred EcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCC
Q 041479 50 NLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSL 129 (771)
Q Consensus 50 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l 129 (771)
+++..++...+......+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++ ..| |+.+
T Consensus 16 ~~~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--------------~~~--l~~l 79 (487)
T 3oja_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--------------TLD--LESL 79 (487)
T ss_dssp SCCTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE--------------EEE--CTTC
T ss_pred cCchhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC--------------Ccc--cccC
Confidence 334444433333333445589999999999988777889999999999999998652 232 7778
Q ss_pred CCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccc
Q 041479 130 LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFF 209 (771)
Q Consensus 130 ~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~ 209 (771)
++|+.|+|++|.|++ +| ..++|++|++++|.+++ +|.. .+++|+.|+|++|.|+
T Consensus 80 ~~L~~L~Ls~N~l~~------------------l~----~~~~L~~L~L~~N~l~~-~~~~---~l~~L~~L~L~~N~l~ 133 (487)
T 3oja_A 80 STLRTLDLNNNYVQE------------------LL----VGPSIETLHAANNNISR-VSCS---RGQGKKNIYLANNKIT 133 (487)
T ss_dssp TTCCEEECCSSEEEE------------------EE----ECTTCCEEECCSSCCCC-EEEC---CCSSCEEEECCSSCCC
T ss_pred CCCCEEEecCCcCCC------------------CC----CCCCcCEEECcCCcCCC-CCcc---ccCCCCEEECCCCCCC
Confidence 888888888887762 11 12677888888888873 4432 4577888888888888
Q ss_pred ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCc
Q 041479 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP 289 (771)
Q Consensus 210 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p 289 (771)
+..|..|.++++|+.|+|++|.|++..|..+. ..+++|+.|+|++|.|++. |.. ..+ ++|++|+|++|.|++.+|
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~l~~L~~L~Ls~N~l~~~-~~~-~~l-~~L~~L~Ls~N~l~~~~~ 208 (487)
T 3oja_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA--ASSDTLEHLNLQYNFIYDV-KGQ-VVF-AKLKTLDLSSNKLAFMGP 208 (487)
T ss_dssp SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG--GGTTTCCEEECTTSCCCEE-ECC-CCC-TTCCEEECCSSCCCEECG
T ss_pred CCCchhhcCCCCCCEEECCCCCCCCcChHHHh--hhCCcccEEecCCCccccc-ccc-ccC-CCCCEEECCCCCCCCCCH
Confidence 77777777788888888888888776665541 2567777777777777744 322 223 367777777777775433
Q ss_pred ccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccc-ccCCccccccccccccccc
Q 041479 290 TEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS-REIPSSLGNFTFLTELNLC 352 (771)
Q Consensus 290 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 352 (771)
.|..+++|+.|++++|.+.+ +|..+..+++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus 209 -~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 209 -EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp -GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred -hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 36666666666666666654 5555666666777777777665 4555566666666666664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-26 Score=236.77 Aligned_cols=231 Identities=21% Similarity=0.208 Sum_probs=157.2
Q ss_pred EEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEc
Q 041479 175 YFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254 (771)
Q Consensus 175 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~L 254 (771)
..+.++.+++ .+|..+. ++|++|++++|+|++..+..|.++++|++|+|++|+++++.+..| .++++|++|++
T Consensus 11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~L 83 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY---QSLSHLSTLIL 83 (276)
T ss_dssp EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTT---TTCTTCCEEEC
T ss_pred eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHc---cCCcCCCEEEC
Confidence 4556666676 7776543 568888888888887777788888888888888888887766555 66778888888
Q ss_pred cCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceec-cCccccCCCCCCEEEccCCccc
Q 041479 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN-IPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 255 s~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
++|.+++..|..+..+. +|++|++++|++++..+..|..+++|+.|++++|.+.+. +|..+..+++|++|++++|+++
T Consensus 84 ~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 84 TGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp TTCCCCEECTTTTTTCT-TCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCccCccChhhhcCCc-cccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence 88888766666666665 688888888888766555677777777777776666542 4666666666666666666666
Q ss_pred ccCCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhh
Q 041479 334 REIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAW 413 (771)
Q Consensus 334 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 413 (771)
+..+..|..+++|+.|++ .|++++|++++..+..+.. .+|+.|+|++|+|++..+..+
T Consensus 163 ~~~~~~~~~l~~L~~l~l-------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~-- 220 (276)
T 2z62_A 163 SIYCTDLRVLHQMPLLNL-------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIF-- 220 (276)
T ss_dssp EECGGGGHHHHTCTTCCE-------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTT--
T ss_pred cCCHHHhhhhhhccccce-------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHh--
Confidence 555556665555552211 3555666665444444433 367777777777774444333
Q ss_pred hhcccccccEEECcCCCCCCCCCc
Q 041479 414 IFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 414 ~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
..+++|+.|+|++|+++|.+|.
T Consensus 221 --~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 221 --DRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp --TTCCSCCEEECCSSCBCCCTTT
T ss_pred --cccccccEEEccCCcccccCCc
Confidence 3677777777777777777764
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=233.01 Aligned_cols=224 Identities=22% Similarity=0.239 Sum_probs=148.9
Q ss_pred EEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeec
Q 041479 200 ILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYM 279 (771)
Q Consensus 200 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~L 279 (771)
..+..+..+. .+|..+. ++|++|++++|+++++.+..| .++++|++|++++|++++..+..+..+. +|++|++
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~---~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L 83 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSF---FSFPELQVLDLSRCEIQTIEDGAYQSLS-HLSTLIL 83 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTT---TTCTTCSEEECTTCCCCEECTTTTTTCT-TCCEEEC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHh---ccccCCcEEECCCCcCCccCHHHccCCc-CCCEEEC
Confidence 3445555555 3555443 467777887777776665555 5667777777777777755555555554 6777777
Q ss_pred ccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccccc-CCcccccccccccccccCcccee
Q 041479 280 SANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISRE-IPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 280 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
++|++++..+..|.++++|+.|++++|.+.+..+..+..+++|++|++++|++++. +|..|..+++|++|+|++|++++
T Consensus 84 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~ 163 (276)
T 2z62_A 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163 (276)
T ss_dssp TTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc
Confidence 77777766666666666666666666666655555566666666666666666542 35566666666666666666654
Q ss_pred cCCcccccccceeeecccCcccCCCCcCCCCCCCCC----eEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCC
Q 041479 359 SVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIP----HLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGD 434 (771)
Q Consensus 359 ~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~ 434 (771)
..+. .|..+++|+ .|++++|++++..+..+ ...+|+.|+|++|++++.
T Consensus 164 ~~~~-----------------------~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-----~~~~L~~L~L~~n~l~~~ 215 (276)
T 2z62_A 164 IYCT-----------------------DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-----KEIRLKELALDTNQLKSV 215 (276)
T ss_dssp ECGG-----------------------GGHHHHTCTTCCEEEECCSSCCCEECTTSS-----CSCCEEEEECCSSCCSCC
T ss_pred CCHH-----------------------HhhhhhhccccceeeecCCCcccccCcccc-----CCCcccEEECCCCceeec
Confidence 4443 343344444 89999999997666654 334899999999999966
Q ss_pred CCccc-cccccccccccCCCcccCC
Q 041479 435 VPRKM-IFKNASAISEAGNEKLCGG 458 (771)
Q Consensus 435 ~p~~~-~~~~~~~~~~~~n~~lc~~ 458 (771)
.+..+ ...++..+.+.+|+..|+-
T Consensus 216 ~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 216 PDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp CTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred CHhHhcccccccEEEccCCcccccC
Confidence 55432 3567788899999998853
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-28 Score=281.12 Aligned_cols=347 Identities=14% Similarity=0.090 Sum_probs=184.4
Q ss_pred CCCCCcEEEcCCCcccccCCccccCC--CCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCc
Q 041479 66 NLTFLRLINLQQNNFSSNIPHEIGRL--FRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFT 143 (771)
Q Consensus 66 ~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 143 (771)
.+++|++|+|++|.+++..+..+... .+|++|+|++|.-. -...++....++++|++|+|++|.++
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~------------~~~~l~~~~~~~~~L~~L~L~~~~~~ 177 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGF------------TTDGLLSIVTHCRKIKTLLMEESSFS 177 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEE------------EHHHHHHHHHHCTTCSEEECTTCEEE
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCc------------CHHHHHHHHhhCCCCCEEECcccccc
Confidence 56666666666666665445455443 33666666665410 00012222345677777777777764
Q ss_pred C-----------CCCccceeeecccccc----cccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcc
Q 041479 144 G-----------PIPHLNMFQVSVYSLT----GSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF 208 (771)
Q Consensus 144 ~-----------~lp~L~~l~l~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l 208 (771)
+ .+|.|+.|+++.|.++ +.++..+.++++|+.|++++|.+. .+|..+. .+++|+.|+++.+..
T Consensus 178 ~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~-~~~~L~~L~l~~~~~ 255 (592)
T 3ogk_B 178 EKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFK-AAANLEEFCGGSLNE 255 (592)
T ss_dssp CCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHH-HCTTCCEEEECBCCC
T ss_pred CcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHh-hhhHHHhhccccccc
Confidence 3 2456777777777775 334444556777777777777776 4664444 667777777764322
Q ss_pred c--------------------------ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccccc
Q 041479 209 F--------------------------GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGT 262 (771)
Q Consensus 209 ~--------------------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~ 262 (771)
. +.+|..+..+++|++|+|++|.+++.... ..+..+++|+.|+++ |.+...
T Consensus 256 ~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~--~~~~~~~~L~~L~L~-~~~~~~ 332 (592)
T 3ogk_B 256 DIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHC--TLIQKCPNLEVLETR-NVIGDR 332 (592)
T ss_dssp CTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHH--HHHTTCTTCCEEEEE-GGGHHH
T ss_pred ccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHH--HHHHhCcCCCEEecc-CccCHH
Confidence 1 12333444455555555555554322110 112445555555555 333222
Q ss_pred -CChhhhhcccccceeecc-----------cCcCcccC-cccccccCCcceEecCCccceeccCccccC-CCCCCEEEcc
Q 041479 263 -LPNSLANFSSHLRYLYMS-----------ANPISGSI-PTEIGNLKNLIIIAIEKFILIRNIPISVGY-LLKLQVLSLF 328 (771)
Q Consensus 263 -~p~~~~~l~~~L~~L~Ls-----------~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-l~~L~~L~Ls 328 (771)
++..+..+ ++|++|+++ .|.+++.. +..+.++++|+.|+++.|.+.+..+..+.. +++|+.|+++
T Consensus 333 ~l~~~~~~~-~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 333 GLEVLAQYC-KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp HHHHHHHHC-TTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred HHHHHHHhC-CCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 22222223 256666666 24444321 122334566666666666665544444443 6666666664
Q ss_pred ----CCccccc-----CCcccccccccccccccCc--cceecCCccccc-ccce-eeecccCcccC-CCCcCCCCCCCCC
Q 041479 329 ----ENNISRE-----IPSSLGNFTFLTELNLCGN--SIRGSVPSALGS-CHQL-WLDLSHNHLTG-PIPLAVGNPKSIP 394 (771)
Q Consensus 329 ----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~l-~L~Ls~N~l~~-~~p~~~~~l~~L~ 394 (771)
.|++++. ++..+.++++|++|++++| .+++..+..+.. ++.| +|++++|++++ .++..+..+++|+
T Consensus 412 ~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~ 491 (592)
T 3ogk_B 412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQ 491 (592)
T ss_dssp ECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCC
T ss_pred ecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccC
Confidence 4555532 2223455666666666532 244333333322 4556 67777777664 2334445667777
Q ss_pred eEECCCCcccccCCcchhhhhcccccccEEECcCCCCCC
Q 041479 395 HLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 395 ~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
+|+|++|++++..... ....+++|+.|+|++|+++.
T Consensus 492 ~L~l~~n~l~~~~~~~---~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 492 KLEMRGCCFSERAIAA---AVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp EEEEESCCCBHHHHHH---HHHHCSSCCEEEEESCBCCT
T ss_pred eeeccCCCCcHHHHHH---HHHhcCccCeeECcCCcCCH
Confidence 7777777765432221 12356677777777777654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-26 Score=264.96 Aligned_cols=153 Identities=16% Similarity=0.072 Sum_probs=118.8
Q ss_pred cccccceEEEEEecCCCeEEEEEEeecc----------chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeE
Q 041479 530 ESLVKATVYKGILDLDQTFIAVKVLFLH----------QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 530 ~~~~~~~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
+.+..|.+++++....++.||||++... .+...++|.+|+++|+++ +|+||+++++++.+.+ ..
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~-----~~ 317 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ-----SG 317 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-----EE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-----EE
Confidence 4455555555555556678999999643 123456899999999999 6999999999998877 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
||||||++||+|.+. ...++. .+|+.||+.||+|+|++ +||||||||+|||++++|.+||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999887 334544 46899999999999996 999999999999999999999999999987654
Q ss_pred ccCCcccccccccccccccchh
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE 697 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE 697 (771)
... ...+.+||+.|||||
T Consensus 392 ~~~----~~~t~vGTp~YmAPE 409 (569)
T 4azs_A 392 DCS----WPTNLVQSFFVFVNE 409 (569)
T ss_dssp --C----CSHHHHHHHHHHHHH
T ss_pred CCc----cccCceechhhccHH
Confidence 322 233468999999998
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=223.18 Aligned_cols=193 Identities=20% Similarity=0.202 Sum_probs=166.3
Q ss_pred CCCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccC
Q 041479 29 VNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108 (771)
Q Consensus 29 ~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 108 (771)
++||.|.|..|.. ..+.+++++++++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|+++
T Consensus 2 ~~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--- 72 (251)
T 3m19_A 2 KTCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ--- 72 (251)
T ss_dssp --CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC---
T ss_pred ccCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC---
Confidence 4789999999964 3457999999999 5555554 68999999999999988889999999999999999966
Q ss_pred CcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCC
Q 041479 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELP 188 (771)
Q Consensus 109 p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp 188 (771)
+..|..|.++++|+.|+|++|+|++ ..+..|..+++|++|+|++|+|+ .+|
T Consensus 73 -----------~~~~~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~l~~L~~L~L~~N~l~-~~~ 123 (251)
T 3m19_A 73 -----------TLSAGVFDDLTELGTLGLANNQLAS-----------------LPLGVFDHLTQLDKLYLGGNQLK-SLP 123 (251)
T ss_dssp -----------CCCTTTTTTCTTCCEEECTTSCCCC-----------------CCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred -----------ccCHhHhccCCcCCEEECCCCcccc-----------------cChhHhcccCCCCEEEcCCCcCC-CcC
Confidence 3556678999999999999998873 34456788999999999999999 788
Q ss_pred hhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccccc
Q 041479 189 PHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGT 262 (771)
Q Consensus 189 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~ 262 (771)
+..+..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+++.+..| ..+++|+.|+|++|.+++.
T Consensus 124 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 124 SGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAF---DRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT---TTCTTCCEEECCSCCBCTT
T ss_pred hhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHH---hCCCCCCEEEeeCCceeCC
Confidence 7776689999999999999998888889999999999999999998877666 7789999999999999865
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-24 Score=225.14 Aligned_cols=199 Identities=25% Similarity=0.299 Sum_probs=136.3
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.+++++|+++. +|+.+. ++|+.|+|++|+|++..|..|.++++|++|+|++|.+++ ++
T Consensus 10 ~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------~~ 71 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK---------------LQ 71 (290)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE---------------EE
T ss_pred CCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc---------------cc
Confidence 567777888888874 444443 677788888888877777778888888888888887652 12
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
. .+.+++|+.|+|++|+|+ .+|..+.++++|++|++++|+|+ .+|+..+..+++|+.|+|
T Consensus 72 ~-~~~l~~L~~L~Ls~N~l~------------------~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 72 V-DGTLPVLGTLDLSHNQLQ------------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131 (290)
T ss_dssp C-CSCCTTCCEEECCSSCCS------------------SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEEC
T ss_pred C-CCCCCcCCEEECCCCcCC------------------cCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEEC
Confidence 1 156667777777777665 45556667777777777777777 555554456777777777
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
++|+|++..+..|..+++|+.|+|++|+|+++.+..| ..+++|+.|+|++|+|+ .+|..++... +|+.|+|++|.
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~---~~l~~L~~L~L~~N~l~-~ip~~~~~~~-~L~~l~L~~Np 206 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL---NGLENLDTLLLQENSLY-TIPKGFFGSH-LLPFAFLHGNP 206 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTT---TTCTTCCEEECCSSCCC-CCCTTTTTTC-CCSEEECCSCC
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHh---cCcCCCCEEECCCCcCC-ccChhhcccc-cCCeEEeCCCC
Confidence 7777776666667777777777777777776655444 55667777777777776 6666666654 57777777776
Q ss_pred Cc
Q 041479 284 IS 285 (771)
Q Consensus 284 l~ 285 (771)
+.
T Consensus 207 ~~ 208 (290)
T 1p9a_G 207 WL 208 (290)
T ss_dssp BC
T ss_pred cc
Confidence 65
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-24 Score=221.81 Aligned_cols=204 Identities=22% Similarity=0.231 Sum_probs=136.1
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcE
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEV 251 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~ 251 (771)
+.+.+++++|+++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|+.+.+..| .++++|++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~---~~l~~L~~ 89 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF---KELKNLET 89 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT---SSCTTCCE
T ss_pred CCCEEEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhh---cCCCCCCE
Confidence 5678888888888 6776543 578888888888887777778888888888888888876655544 56677777
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCc
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 331 (771)
|++++|++++..+..+..+. +|++|++++|++++..+..|..+ ++|++|+|++|+
T Consensus 90 L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l------------------------~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 90 LWVTDNKLQALPIGVFDQLV-NLAELRLDRNQLKSLPPRVFDSL------------------------TKLTYLSLGYNE 144 (270)
T ss_dssp EECCSSCCCCCCTTTTTTCS-SCCEEECCSSCCCCCCTTTTTTC------------------------TTCCEEECCSSC
T ss_pred EECCCCcCCcCCHhHccccc-CCCEEECCCCccCeeCHHHhCcC------------------------cCCCEEECCCCc
Confidence 77777777743333344443 56777777666665544444444 455555555555
Q ss_pred ccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccC
Q 041479 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEI 407 (771)
Q Consensus 332 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 407 (771)
+++..+..|..+++|++|+|++|++++..+..|..++.| .|++++|++++..+..|..+++|+.|+|++|++...-
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 554444445555556666666665555555555555555 5666666666666667888889999999999987543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=225.74 Aligned_cols=203 Identities=23% Similarity=0.216 Sum_probs=142.3
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
+.++++++++++++|.++ .+|..++ ++++.|+|++|+|++..|..|.++++|+.|+|++|.|+++.+. ..+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~l 76 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-----GTL 76 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-----SCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-----CCC
Confidence 567888999999999998 8887664 6889999999999988888899999999999999998865432 567
Q ss_pred CCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 247 TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
++|++|++++|+|+ .+|..+..+. +|++|++++|+|++..|..|.++++|+.|++++|.+.+..+..|..+++|+.|+
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~-~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLP-ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCT-TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCEEECCCCcCC-cCchhhccCC-CCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 78888888888887 6777666665 677888888877765556666666666655555555544444445555555555
Q ss_pred ccCCcccccCCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCccc
Q 041479 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 404 (771)
|++|+|+...+..|..+++|++| +|++|+|+ .+|..+..+.+|+.|+|++|++.
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L-----------------------~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTL-----------------------LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEE-----------------------ECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCcCCccCHHHhcCcCCCCEE-----------------------ECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 55555554333344444555544 45555554 34555556678888888888886
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=220.67 Aligned_cols=207 Identities=23% Similarity=0.237 Sum_probs=137.4
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|++++|.++.. +.+..+++|++|+|++|++++ + ..+..+++|++|+|++|.++ +..+
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~--------------~~~~ 102 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQ--------------SLPN 102 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCC--------------CCCT
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccC--------------ccCh
Confidence 4566777777776632 346667777777777777765 2 36677777777777777654 2334
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
..|+++++|++|++++|++++ ..+..|.++++|++|++++|+++ .+|+..+..+++|+.|++
T Consensus 103 ~~~~~l~~L~~L~L~~n~l~~-----------------~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 103 GVFDKLTNLKELVLVENQLQS-----------------LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTTTTCTTCCEEECTTSCCCC-----------------CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred hHhcCCcCCCEEECCCCcCCc-----------------cCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEEC
Confidence 446666777777777666652 33344667777777777777777 555555446777777777
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
++|+|++..+..|..+++|++|++++|++++..|..| ..+++|+.|++++|.+.+..| +|++|+++.|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~~~~~~~--------~l~~l~~~~n~ 233 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVF---DRLTSLQYIWLHDNPWDCTCP--------GIRYLSEWINK 233 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT---TTCTTCCEEECCSSCBCCCTT--------TTHHHHHHHHH
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHH---hCCcCCCEEEccCCCccccCc--------HHHHHHHHHHh
Confidence 7777776666667777777777777777777666544 566777777777777764433 46677777777
Q ss_pred CcccCcccccccCC
Q 041479 284 ISGSIPTEIGNLKN 297 (771)
Q Consensus 284 l~~~~p~~~~~l~~ 297 (771)
++|.+|..++.+..
T Consensus 234 ~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 234 HSGVVRNSAGSVAP 247 (272)
T ss_dssp TGGGBBCTTSCBCG
T ss_pred CCCcccCcccccCC
Confidence 77777776665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=220.84 Aligned_cols=186 Identities=20% Similarity=0.194 Sum_probs=103.8
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
+..+++|++|++++|.++ .++ .+. .+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..| .++
T Consensus 59 l~~l~~L~~L~l~~n~l~-~~~-~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l 132 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLH-DIS-ALK-ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVF---DKL 132 (272)
T ss_dssp GGGCTTCCEEECTTSCCC-CCG-GGT-TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT---TTC
T ss_pred cccCCCCcEEECCCCCCC-Cch-hhc-CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHh---ccC
Confidence 455666666666666665 333 333 56666666666666665555556666666666666666665555444 455
Q ss_pred CCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 247 TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
++|++|++++|++++..|..+..+. +|++|++++|++++..+..|..+++|+.|++++|.+.+..|..+..+++|+.|+
T Consensus 133 ~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 211 (272)
T 3rfs_A 133 TNLTYLNLAHNQLQSLPKGVFDKLT-NLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 211 (272)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccCHHHhccCc-cCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEE
Confidence 6666666666666633333334443 566666666666655555555555555555555555554444455555555555
Q ss_pred ccCCcccccCCcccccccccccccccCccceecCCccccc
Q 041479 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGS 366 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 366 (771)
+++|.+.+. +++|+.|+++.|.++|.+|..++.
T Consensus 212 l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 212 LHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp CCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred ccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence 555554422 234555555555555555554443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.2e-24 Score=215.74 Aligned_cols=197 Identities=17% Similarity=0.180 Sum_probs=146.1
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCCEEecccCc-CcccCCcccccCCcccccCCccccCCCCCCEEeccc-ccCcCCC
Q 041479 69 FLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNA-LQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLAN-NYFTGPI 146 (771)
Q Consensus 69 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~l 146 (771)
+|++|+|++|+|++..+.+|+++++|++|++++|+ ++ +..+..|.++++|++|++++ |++++
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~--------------~i~~~~f~~l~~L~~L~l~~~n~l~~-- 95 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ--------------QLESHSFYNLSKVTHIEIRNTRNLTY-- 95 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC--------------EECTTTEESCTTCCEEEEEEETTCCE--
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc--------------eeCHhHcCCCcCCcEEECCCCCCeeE--
Confidence 78888888888887666678888888888888886 54 23344677888888888887 77762
Q ss_pred CccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCc---EEEeecC-cccccCCccccCCCCC
Q 041479 147 PHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVR---ILLLAGN-QFFGNIPHSISNASKL 222 (771)
Q Consensus 147 p~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L 222 (771)
..+..|.++++|++|++++|+++ .+|. + ..+++|+ +|++++| +++++.+..|.++++|
T Consensus 96 ---------------i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~-~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L 157 (239)
T 2xwt_C 96 ---------------IDPDALKELPLLKFLGIFNTGLK-MFPD-L-TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157 (239)
T ss_dssp ---------------ECTTSEECCTTCCEEEEEEECCC-SCCC-C-TTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSS
T ss_pred ---------------cCHHHhCCCCCCCEEeCCCCCCc-cccc-c-ccccccccccEEECCCCcchhhcCcccccchhcc
Confidence 33456778888888888888888 5776 3 3777777 8888888 8887777778888888
Q ss_pred C-EEEccccccCCCCCcCcccccCCCCCcEEEccCcc-ccccCChhhhhcccccceeecccCcCcccCcccccccCCcce
Q 041479 223 E-WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNS-LSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLII 300 (771)
Q Consensus 223 ~-~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 300 (771)
+ .|++++|+++.+.+..| .. ++|+.|++++|+ +++..+..+..+.++|+.|++++|+|++. |.. .+++|+.
T Consensus 158 ~~~L~l~~n~l~~i~~~~~---~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~ 230 (239)
T 2xwt_C 158 TLTLKLYNNGFTSVQGYAF---NG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKE 230 (239)
T ss_dssp EEEEECCSCCCCEECTTTT---TT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSE
T ss_pred eeEEEcCCCCCcccCHhhc---CC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCce
Confidence 8 88888888885554444 33 688888888884 87444555655513788888888888854 433 5667777
Q ss_pred EecCCc
Q 041479 301 IAIEKF 306 (771)
Q Consensus 301 L~l~~n 306 (771)
|+++++
T Consensus 231 L~l~~~ 236 (239)
T 2xwt_C 231 LIARNT 236 (239)
T ss_dssp EECTTC
T ss_pred eeccCc
Confidence 777664
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-26 Score=265.11 Aligned_cols=377 Identities=12% Similarity=0.058 Sum_probs=250.6
Q ss_pred CcEEEEEcCCCCCcccCCccccCC--CCCcEEEcCCCc-ccc-cCCccccCCCCCCEEecccCcCcccCC----------
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNL--TFLRLINLQQNN-FSS-NIPHEIGRLFRLRHIIFNSNALQGQIP---------- 109 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p---------- 109 (771)
++++.|+|++|.+++..+..+..+ ++|++|+|++|. ++. .++..+.++++|++|+|++|.+++.-.
T Consensus 112 ~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~ 191 (592)
T 3ogk_B 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191 (592)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHC
T ss_pred CCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcC
Confidence 678899999998887666666553 348888888876 221 123334577888888888887653211
Q ss_pred ----cccccCCccc----ccCCccccCCCCCCEEecccccCcC------CCCccceeeecccccc---cccCccccCCCC
Q 041479 110 ----DSRLILNKLE----GNIPSELGSLLKFKGLGLANNYFTG------PIPHLNMFQVSVYSLT---GSIPIQLLNITS 172 (771)
Q Consensus 110 ----~~~l~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~------~lp~L~~l~l~~n~l~---~~~p~~~~~l~~ 172 (771)
...+..|.++ +.++..+.++++|+.|++++|.+.+ .++.|+.++++.+... +..+..+..+++
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~ 271 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhcccc
Confidence 0112223332 2233334455666666666665543 2345566655543222 233345566677
Q ss_pred CCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccccccCCC-CCcCcccccCCCCCc
Q 041479 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIP-HSISNASKLEWLDFANNSLTGL-IPEDLDSLVNCTYLE 250 (771)
Q Consensus 173 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~l~~L~ 250 (771)
|+.|+++++... .+|..+. .+++|++|+|++|.+++... ..+..+++|+.|+++ |.+... ++.. ...+++|+
T Consensus 272 L~~L~l~~~~~~-~l~~~~~-~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~---~~~~~~L~ 345 (592)
T 3ogk_B 272 LCRLGLSYMGPN-EMPILFP-FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVL---AQYCKQLK 345 (592)
T ss_dssp CCEEEETTCCTT-TGGGGGG-GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHH---HHHCTTCC
T ss_pred ccccCccccchh-HHHHHHh-hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHH---HHhCCCCC
Confidence 777777775443 6666554 78999999999999875443 346889999999999 444422 2221 25678999
Q ss_pred EEEcc-----------CccccccCChhhhhcccccceeecccCcCcccCcccccc-cCCcceEecC----Cccceec---
Q 041479 251 VVSLS-----------VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGN-LKNLIIIAIE----KFILIRN--- 311 (771)
Q Consensus 251 ~L~Ls-----------~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~----~n~l~~~--- 311 (771)
+|+++ .|.+++.....+....++|++|+++.|.+++..+..++. +++|+.|+++ .|.+.+.
T Consensus 346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~ 425 (592)
T 3ogk_B 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD 425 (592)
T ss_dssp EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence 99999 477775433333332348999999999999877777766 8999999996 5666542
Q ss_pred --cCccccCCCCCCEEEccCC--cccccCCcccc-cccccccccccCcccee-cCCcccccccce-eeecccCcccCC-C
Q 041479 312 --IPISVGYLLKLQVLSLFEN--NISREIPSSLG-NFTFLTELNLCGNSIRG-SVPSALGSCHQL-WLDLSHNHLTGP-I 383 (771)
Q Consensus 312 --~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~l-~L~Ls~N~l~~~-~ 383 (771)
++..+..+++|+.|++++| .++...+..+. .+++|++|+|++|++++ .++..+..++.| .|++++|.+++. +
T Consensus 426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 505 (592)
T 3ogk_B 426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI 505 (592)
T ss_dssp HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence 4444677999999999854 36655554444 47899999999999986 345556778888 899999998754 3
Q ss_pred CcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCC
Q 041479 384 PLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYN 429 (771)
Q Consensus 384 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N 429 (771)
+..+..+++|++|+|++|+++..--..+ ...++.+....+..+
T Consensus 506 ~~~~~~l~~L~~L~ls~n~it~~~~~~l---~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 506 AAAVTKLPSLRYLWVQGYRASMTGQDLM---QMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHHHCSSCCEEEEESCBCCTTCTTGG---GGCCTTEEEEEECCC
T ss_pred HHHHHhcCccCeeECcCCcCCHHHHHHH---HHhCCCcEEEEecCc
Confidence 4445678999999999999985433222 235566655555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=213.17 Aligned_cols=208 Identities=17% Similarity=0.223 Sum_probs=121.8
Q ss_pred cCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccc-cCCCCCcCcccccCCCCCcEEEccC-ccc
Q 041479 182 QLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS-LTGLIPEDLDSLVNCTYLEVVSLSV-NSL 259 (771)
Q Consensus 182 ~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~l~~L~~L~Ls~-N~l 259 (771)
.++ .+|. +. ++|+.|++++|+|+++.+..|.++++|++|++++|+ ++.+.+..| .++++|++|++++ |++
T Consensus 22 ~l~-~ip~-~~---~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f---~~l~~L~~L~l~~~n~l 93 (239)
T 2xwt_C 22 DIQ-RIPS-LP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF---YNLSKVTHIEIRNTRNL 93 (239)
T ss_dssp SCS-SCCC-CC---TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTE---ESCTTCCEEEEEEETTC
T ss_pred Ccc-ccCC-CC---CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHc---CCCcCCcEEECCCCCCe
Confidence 355 6776 32 367778888888877766677777788888888776 776655555 5667777777776 777
Q ss_pred cccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCC-cccccCCc
Q 041479 260 SGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN-NISREIPS 338 (771)
Q Consensus 260 ~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~ 338 (771)
++..+..+..+. +|++|++++|++++ +|. |..+++|+ .|++|++++| ++++..+.
T Consensus 94 ~~i~~~~f~~l~-~L~~L~l~~n~l~~-lp~-~~~l~~L~---------------------~L~~L~l~~N~~l~~i~~~ 149 (239)
T 2xwt_C 94 TYIDPDALKELP-LLKFLGIFNTGLKM-FPD-LTKVYSTD---------------------IFFILEITDNPYMTSIPVN 149 (239)
T ss_dssp CEECTTSEECCT-TCCEEEEEEECCCS-CCC-CTTCCBCC---------------------SEEEEEEESCTTCCEECTT
T ss_pred eEcCHHHhCCCC-CCCEEeCCCCCCcc-ccc-cccccccc---------------------cccEEECCCCcchhhcCcc
Confidence 744444455554 67777777777764 443 55444444 0114444444 44444444
Q ss_pred ccccccccc-cccccCccceecCCcccccccce-eeecccCc-ccCCCCcCCCCC-CCCCeEECCCCcccccCCcchhhh
Q 041479 339 SLGNFTFLT-ELNLCGNSIRGSVPSALGSCHQL-WLDLSHNH-LTGPIPLAVGNP-KSIPHLDLSKNELSGEIPSSLAWI 414 (771)
Q Consensus 339 ~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~~ 414 (771)
.|..+++|+ +|++++|+++...+..+.. ..| .|++++|+ +++..+..|..+ ++|+.|++++|+|++ +|..
T Consensus 150 ~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~---- 223 (239)
T 2xwt_C 150 AFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK---- 223 (239)
T ss_dssp TTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT----
T ss_pred cccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh----
Confidence 455555555 5555555555333333333 344 55555553 554555566666 666666666666663 3332
Q ss_pred hcccccccEEECcCC
Q 041479 415 FGYISIFAKLNLSYN 429 (771)
Q Consensus 415 ~~~l~~L~~L~Ls~N 429 (771)
.+++|+.|+++++
T Consensus 224 --~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 224 --GLEHLKELIARNT 236 (239)
T ss_dssp --TCTTCSEEECTTC
T ss_pred --HhccCceeeccCc
Confidence 3456666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=235.03 Aligned_cols=263 Identities=15% Similarity=0.144 Sum_probs=182.3
Q ss_pred EEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCC----ccccCCC-CCCEEecccCcCcccCCcccccCCcccccC
Q 041479 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIP----HEIGRLF-RLRHIIFNSNALQGQIPDSRLILNKLEGNI 122 (771)
Q Consensus 48 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~ 122 (771)
..+|++|++++.+|..+...++|++|||++|.|++..+ .+|.+++ +|++|+|++|.+++ ..
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~--------------~~ 67 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF--------------KN 67 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGG--------------SC
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCH--------------HH
Confidence 46889999999888888888889999999999997666 7888998 89999999999763 33
Q ss_pred CccccCC-----CCCCEEecccccCcCCCCccceeeecccccccccCccccCC-CCCCEEecccCcCcccCChhhh---h
Q 041479 123 PSELGSL-----LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNI-TSMEYFHVSENQLVGELPPHIG---F 193 (771)
Q Consensus 123 p~~~~~l-----~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~g~lp~~~~---~ 193 (771)
+..+..+ ++|++|+|++|++++..+. .+...+..+ ++|++|+|++|++++.-+..+. .
T Consensus 68 ~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~-------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~ 134 (362)
T 3goz_A 68 SDELVQILAAIPANVTSLNLSGNFLSYKSSD-------------ELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFS 134 (362)
T ss_dssp HHHHHHHHHTSCTTCCEEECCSSCGGGSCHH-------------HHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHT
T ss_pred HHHHHHHHhccCCCccEEECcCCcCChHHHH-------------HHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHH
Confidence 4444443 8889999998888732110 111124445 7899999999999843333332 1
Q ss_pred C-CCCCcEEEeecCcccccCC----ccccCCC-CCCEEEccccccCCCCCcCcc-cccCC-CCCcEEEccCcccccc---
Q 041479 194 T-LPNVRILLLAGNQFFGNIP----HSISNAS-KLEWLDFANNSLTGLIPEDLD-SLVNC-TYLEVVSLSVNSLSGT--- 262 (771)
Q Consensus 194 ~-l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~-~l~~l-~~L~~L~Ls~N~l~~~--- 262 (771)
. .++|++|+|++|+|+...+ ..+..++ +|++|+|++|+|++..+..+. .+..+ ++|++|+|++|.|++.
T Consensus 135 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~ 214 (362)
T 3goz_A 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA 214 (362)
T ss_dssp TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH
T ss_pred hCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH
Confidence 2 2589999999999885333 3345555 899999999999876654442 22444 5899999999998842
Q ss_pred -CChhhhhcccccceeecccCcCcccCc----ccccccCCcceEecCCccceec-------cCccccCCCCCCEEEccCC
Q 041479 263 -LPNSLANFSSHLRYLYMSANPISGSIP----TEIGNLKNLIIIAIEKFILIRN-------IPISVGYLLKLQVLSLFEN 330 (771)
Q Consensus 263 -~p~~~~~l~~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~l~~n~l~~~-------~p~~~~~l~~L~~L~Ls~N 330 (771)
++..+....++|++|+|++|.|++..+ ..+..+++|+.|++++|.+... ++..+..+++|+.||+++|
T Consensus 215 ~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N 294 (362)
T 3goz_A 215 ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294 (362)
T ss_dssp HHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCC
Confidence 555565544579999999998886544 2345567777777777763222 2334556666677777777
Q ss_pred cccccCC
Q 041479 331 NISREIP 337 (771)
Q Consensus 331 ~l~~~~p 337 (771)
++....+
T Consensus 295 ~l~~~~~ 301 (362)
T 3goz_A 295 EIHPSHS 301 (362)
T ss_dssp BCCGGGC
T ss_pred cCCCcch
Confidence 7654433
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-25 Score=235.38 Aligned_cols=268 Identities=15% Similarity=0.212 Sum_probs=157.5
Q ss_pred CCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCC--CCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCccc
Q 041479 30 NFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNL--TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQ 107 (771)
Q Consensus 30 ~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 107 (771)
-|.+|.++.|+. ..++.+|+++|++. +..+..+ ++++.|++++|.+++..+. +.++++|++|+|++|.++
T Consensus 35 vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~-- 106 (336)
T 2ast_B 35 VCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE-- 106 (336)
T ss_dssp SCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC--
T ss_pred HHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC--
Confidence 355799998763 46788999998876 4567777 8899999999999875554 567888888888888854
Q ss_pred CCcccccCCccccc-CCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccC-cCcc
Q 041479 108 IPDSRLILNKLEGN-IPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSEN-QLVG 185 (771)
Q Consensus 108 ~p~~~l~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g 185 (771)
+. +|..+..+++|++|+|++|++++ ..+..+..+++|++|++++| .+++
T Consensus 107 ------------~~~~~~~~~~~~~L~~L~L~~~~l~~-----------------~~~~~l~~~~~L~~L~L~~~~~l~~ 157 (336)
T 2ast_B 107 ------------VSTLHGILSQCSKLQNLSLEGLRLSD-----------------PIVNTLAKNSNLVRLNLSGCSGFSE 157 (336)
T ss_dssp ------------HHHHHHHHTTBCCCSEEECTTCBCCH-----------------HHHHHHTTCTTCSEEECTTCBSCCH
T ss_pred ------------HHHHHHHHhhCCCCCEEeCcCcccCH-----------------HHHHHHhcCCCCCEEECCCCCCCCH
Confidence 22 45556677777777777776552 33445556667777777766 4553
Q ss_pred c-CChhhhhCCCCCcEEEeecC-ccccc-CCccccCCC-CCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccc-
Q 041479 186 E-LPPHIGFTLPNVRILLLAGN-QFFGN-IPHSISNAS-KLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS- 260 (771)
Q Consensus 186 ~-lp~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~- 260 (771)
. +|..+. .+++|+.|++++| .+++. ++..+..++ +|++|++++|.+ .++
T Consensus 158 ~~l~~~~~-~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~-------------------------~~~~ 211 (336)
T 2ast_B 158 FALQTLLS-SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK-------------------------NLQK 211 (336)
T ss_dssp HHHHHHHH-HCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG-------------------------GSCH
T ss_pred HHHHHHHh-cCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcc-------------------------cCCH
Confidence 2 333333 5566666666666 55532 344445555 555555555521 222
Q ss_pred ccCChhhhhcccccceeecccCc-CcccCcccccccCCcceEecCCcc-ceeccCccccCCCCCCEEEccCCcccccCCc
Q 041479 261 GTLPNSLANFSSHLRYLYMSANP-ISGSIPTEIGNLKNLIIIAIEKFI-LIRNIPISVGYLLKLQVLSLFENNISREIPS 338 (771)
Q Consensus 261 ~~~p~~~~~l~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 338 (771)
+.+|..+..++ +|++|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++| ++ ..
T Consensus 212 ~~l~~~~~~~~-~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~ 286 (336)
T 2ast_B 212 SDLSTLVRRCP-NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DG 286 (336)
T ss_dssp HHHHHHHHHCT-TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TT
T ss_pred HHHHHHHhhCC-CCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HH
Confidence 22333333333 45555555555 443444444555555555555543 11111123555667777777766 22 22
Q ss_pred cccccc-ccccccccCccceecCCcccc
Q 041479 339 SLGNFT-FLTELNLCGNSIRGSVPSALG 365 (771)
Q Consensus 339 ~~~~l~-~L~~L~Ls~N~l~~~~p~~~~ 365 (771)
.+..+. +|+.|++++|++++..|..++
T Consensus 287 ~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 287 TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred HHHHHHhhCcceEEecccCccccCCccc
Confidence 344442 366666777777666665544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-25 Score=238.96 Aligned_cols=263 Identities=14% Similarity=0.146 Sum_probs=147.7
Q ss_pred eeecccccccccCccccCCCCCCEEecccCcCcccCCh----hhhhCCC-CCcEEEeecCcccccCCccccCC-----CC
Q 041479 152 FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPP----HIGFTLP-NVRILLLAGNQFFGNIPHSISNA-----SK 221 (771)
Q Consensus 152 l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 221 (771)
++++.|+++|.+|..+...++|++|+|++|.++ .++. ..+..++ +|++|+|++|+|++..+..|..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 345555666666666666666888888888877 4443 3334666 78888888888877666666665 77
Q ss_pred CCEEEccccccCCCCCcCccc-ccCC-CCCcEEEccCccccccCChhhhhc----ccccceeecccCcCcccCcc----c
Q 041479 222 LEWLDFANNSLTGLIPEDLDS-LVNC-TYLEVVSLSVNSLSGTLPNSLANF----SSHLRYLYMSANPISGSIPT----E 291 (771)
Q Consensus 222 L~~L~Ls~N~l~~~~p~~~~~-l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l----~~~L~~L~Ls~N~l~~~~p~----~ 291 (771)
|++|+|++|+|++..+..+.. +..+ ++|++|+|++|++++..+..+... .++|++|+|++|.|++..+. .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 888888888877665543322 2344 677777777777775444443332 23677777777777643322 2
Q ss_pred ccccC-CcceEecCCccceeccCcccc----CC-CCCCEEEccCCccccc----CCccccc-ccccccccccCccceecC
Q 041479 292 IGNLK-NLIIIAIEKFILIRNIPISVG----YL-LKLQVLSLFENNISRE----IPSSLGN-FTFLTELNLCGNSIRGSV 360 (771)
Q Consensus 292 ~~~l~-~L~~L~l~~n~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~ 360 (771)
+..++ +|+.|++++|.+.+..+..+. .. ++|++|+|++|+++.. ++..+.. .++|++|+|++|+|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 23333 555555555555444333222 22 3555555555555431 2223332 224555555555444322
Q ss_pred CcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcch---hhhhcccccccEEECcCCCCCCC
Q 041479 361 PSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSL---AWIFGYISIFAKLNLSYNNLDGD 434 (771)
Q Consensus 361 p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l---~~~~~~l~~L~~L~Ls~N~l~~~ 434 (771)
+..+ ...+..+++|++|+|++|++.+..+..+ ...+..+++|+.||+++|++.+.
T Consensus 242 ~~~l-------------------~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENL-------------------KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHH-------------------HHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHH-------------------HHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 2111 1334556667777777777553333222 11234566677777777777654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-26 Score=265.81 Aligned_cols=212 Identities=14% Similarity=0.119 Sum_probs=113.8
Q ss_pred CccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecc---------cCc
Q 041479 213 PHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMS---------ANP 283 (771)
Q Consensus 213 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls---------~N~ 283 (771)
+..+..+++|++|+|++|.++...... .+..+++|+.|++++| ++......+....++|++|+++ .|.
T Consensus 282 ~~~~~~~~~L~~L~L~~~~l~~~~l~~--~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~ 358 (594)
T 2p1m_B 282 PAVYSVCSRLTTLNLSYATVQSYDLVK--LLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVA 358 (594)
T ss_dssp GGGHHHHTTCCEEECTTCCCCHHHHHH--HHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSC
T ss_pred HHHHHhhCCCCEEEccCCCCCHHHHHH--HHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCC
Confidence 333445667777777777655321111 1245677777777766 3322112222212357777663 344
Q ss_pred CcccCccccc-ccCCcceEecCCccceeccCcccc-CCCCCCEEEcc--C----Cccccc-----CCccccccccccccc
Q 041479 284 ISGSIPTEIG-NLKNLIIIAIEKFILIRNIPISVG-YLLKLQVLSLF--E----NNISRE-----IPSSLGNFTFLTELN 350 (771)
Q Consensus 284 l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~ 350 (771)
+++.....+. ++++|+.|.++.|.+....+..+. .+++|+.|+++ + |+++.. ++..+..+++|+.|+
T Consensus 359 l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~ 438 (594)
T 2p1m_B 359 LTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS 438 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEE
T ss_pred CCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEe
Confidence 4432222222 366777776666666554444443 46777777777 3 445421 111245566777777
Q ss_pred ccCccceecCCccccc-ccce-eeecccCcccCCCCcCC-CCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECc
Q 041479 351 LCGNSIRGSVPSALGS-CHQL-WLDLSHNHLTGPIPLAV-GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLS 427 (771)
Q Consensus 351 Ls~N~l~~~~p~~~~~-l~~l-~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls 427 (771)
|++ .+++..+..+.. ++.| .|+|++|.+++.....+ ..+++|++|+|++|++++..+..+ ...+++|+.|+++
T Consensus 439 L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~---~~~l~~L~~L~l~ 514 (594)
T 2p1m_B 439 LSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN---ASKLETMRSLWMS 514 (594)
T ss_dssp CCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT---GGGGGGSSEEEEE
T ss_pred ecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH---HHhCCCCCEEeee
Confidence 766 555443333433 5556 67777777654433333 446777777777777753322211 2346677777777
Q ss_pred CCCC
Q 041479 428 YNNL 431 (771)
Q Consensus 428 ~N~l 431 (771)
+|++
T Consensus 515 ~~~~ 518 (594)
T 2p1m_B 515 SCSV 518 (594)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 7766
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=221.14 Aligned_cols=230 Identities=18% Similarity=0.192 Sum_probs=159.4
Q ss_pred CCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccc--c
Q 041479 91 LFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL--L 168 (771)
Q Consensus 91 l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~--~ 168 (771)
...++.|.+.++.++.. .+.. +. .+..+++|++|++++|+++ +..|..+ .
T Consensus 63 ~~~l~~l~l~~~~~~~~---------~~~~-~~-~~~~~~~L~~L~l~~n~l~-----------------~~~~~~~~~~ 114 (310)
T 4glp_A 63 ALRVRRLTVGAAQVPAQ---------LLVG-AL-RVLAYSRLKELTLEDLKIT-----------------GTMPPLPLEA 114 (310)
T ss_dssp SCCCCEEEECSCCCBHH---------HHHH-HH-HHHHHSCCCEEEEESCCCB-----------------SCCCCCSSSC
T ss_pred hcceeEEEEeCCcCCHH---------HHHH-HH-HhcccCceeEEEeeCCEec-----------------cchhhhhhhc
Confidence 34577777777775410 0000 00 1122345777777766665 3566666 7
Q ss_pred CCCCCCEEecccCcCcccCCh---hhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCC---CCCcCccc
Q 041479 169 NITSMEYFHVSENQLVGELPP---HIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG---LIPEDLDS 242 (771)
Q Consensus 169 ~l~~L~~L~Ls~N~l~g~lp~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~ 242 (771)
.+++|++|+|++|.+++..|. ..+..+++|++|+|++|+|++..|..|..+++|++|+|++|++.+ ..+.. .
T Consensus 115 ~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--~ 192 (310)
T 4glp_A 115 TGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAAL--C 192 (310)
T ss_dssp CCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTS--C
T ss_pred cCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHH--h
Confidence 889999999999999865551 222368899999999999998888899999999999999998765 22221 1
Q ss_pred ccCCCCCcEEEccCccccccCChh----hhhcccccceeecccCcCcccCccccccc---CCcceEecCCccceeccCcc
Q 041479 243 LVNCTYLEVVSLSVNSLSGTLPNS----LANFSSHLRYLYMSANPISGSIPTEIGNL---KNLIIIAIEKFILIRNIPIS 315 (771)
Q Consensus 243 l~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~~~p~~ 315 (771)
+..+++|++|+|++|+++ .+|.. +..+. +|++|+|++|+|++..|..+..+ ++|+.|++++|.+. .+|..
T Consensus 193 ~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~ 269 (310)
T 4glp_A 193 PHKFPAIQNLALRNTGME-TPTGVCAALAAAGV-QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKG 269 (310)
T ss_dssp TTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC-CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSC
T ss_pred hhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC-CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhh
Confidence 256788999999999987 33332 23444 79999999999987777777666 57777777777776 45655
Q ss_pred ccCCCCCCEEEccCCcccccCCcccccccccccccccCccce
Q 041479 316 VGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 316 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus 270 ~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 270 LP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred hc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 53 6777777777777743 33 566677777777777775
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=225.32 Aligned_cols=232 Identities=16% Similarity=0.165 Sum_probs=118.5
Q ss_pred CCcEEEcCCCcccccC-C--ccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccc--cCCCCCCEEecccccCc
Q 041479 69 FLRLINLQQNNFSSNI-P--HEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSEL--GSLLKFKGLGLANNYFT 143 (771)
Q Consensus 69 ~L~~L~Ls~N~l~~~~-p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~ 143 (771)
.++.|.++++.++... . ..+..+++|++|++++|.++ +..|..+ ..+++|++|+|++|+++
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~--------------~~~~~~~~~~~~~~L~~L~Ls~n~i~ 130 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKIT--------------GTMPPLPLEATGLALSSLRLRNVSWA 130 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCB--------------SCCCCCSSSCCCBCCSSCEEESCCCS
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEec--------------cchhhhhhhccCCCCCEEEeeccccc
Confidence 4677777777765311 1 01223466888888888754 3455555 77778888888888777
Q ss_pred CCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccccc---C-CccccCC
Q 041479 144 GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGN---I-PHSISNA 219 (771)
Q Consensus 144 ~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~---~-p~~~~~l 219 (771)
+..+.+. ...+..+++|++|+|++|+++ .+|+..+..+++|++|+|++|++.+. . +..+..+
T Consensus 131 ~~~~~~~-------------~~~~~~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 131 TGRSWLA-------------ELQQWLKPGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp STTSSHH-------------HHHTTBCSCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred chhhhhH-------------HHHhhhccCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 5322100 012234455555555555554 23322222455555555555554421 1 1122445
Q ss_pred CCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcc--cccceeecccCcCcccCcccccccCC
Q 041479 220 SKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS--SHLRYLYMSANPISGSIPTEIGNLKN 297 (771)
Q Consensus 220 ~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~~L~~L~Ls~N~l~~~~p~~~~~l~~ 297 (771)
++|++|+|++|+|+...+....-+.++++|++|+|++|++++..|..+..+. ++|++|+|++|+|+ .+|..+. ++
T Consensus 197 ~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 197 PAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp CCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred CCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 5555555555555422111000013445555555555555544444444331 24555555555555 3444442 45
Q ss_pred cceEecCCccceeccCccccCCCCCCEEEccCCccc
Q 041479 298 LIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 298 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
|+.|++++|.+.+. |. +..+++|+.|+|++|.++
T Consensus 274 L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 274 LRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred CCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 55555555555432 22 455667777777777775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-25 Score=244.54 Aligned_cols=250 Identities=19% Similarity=0.210 Sum_probs=121.8
Q ss_pred CCccccCCCCCcEEEcCCCcccccC----CccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccc-------cC
Q 041479 60 ASPYIGNLTFLRLINLQQNNFSSNI----PHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSEL-------GS 128 (771)
Q Consensus 60 ~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~-------~~ 128 (771)
++..+..+++|++|+|++|.|++.. +..|..+++|++|+|++|.+. .+.+.+|..+ ..
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~-----------~l~~~~~~~~~~l~~~l~~ 92 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG-----------RVKDEIPEALRLLLQALLK 92 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT-----------SCGGGSHHHHHHHHHHHTT
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccC-----------ccccchhHHHHHHHHHHhh
Confidence 4455666777777777777776543 333667777777777776432 2333333333 45
Q ss_pred CCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhh---CC---------C
Q 041479 129 LLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGF---TL---------P 196 (771)
Q Consensus 129 l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~---~l---------~ 196 (771)
+++|++|+|++|+|++.- ...+|..+..+++|++|+|++|.+++..+..+.. .+ +
T Consensus 93 ~~~L~~L~Ls~n~l~~~~-------------~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~ 159 (386)
T 2ca6_A 93 CPKLHTVRLSDNAFGPTA-------------QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAP 159 (386)
T ss_dssp CTTCCEEECCSCCCCTTT-------------HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred CCcccEEECCCCcCCHHH-------------HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCC
Confidence 566666666666554100 0023444555556666666666554222222211 11 4
Q ss_pred CCcEEEeecCccc-ccCC---ccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccc---cCChhhhh
Q 041479 197 NVRILLLAGNQFF-GNIP---HSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG---TLPNSLAN 269 (771)
Q Consensus 197 ~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~---~~p~~~~~ 269 (771)
+|++|+|++|+|+ +.+| ..|..+++|++|+|++|+|+.. | .+|..+..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~-------------------------g~~~l~~~~l~~ 214 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE-------------------------GIEHLLLEGLAY 214 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH-------------------------HHHHHHHTTGGG
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh-------------------------HHHHHHHHHhhc
Confidence 4444444444443 1122 2333444444444444444310 1 11212333
Q ss_pred cccccceeecccCcCc----ccCcccccccCCcceEecCCccceec----cCccc--cCCCCCCEEEccCCcccc----c
Q 041479 270 FSSHLRYLYMSANPIS----GSIPTEIGNLKNLIIIAIEKFILIRN----IPISV--GYLLKLQVLSLFENNISR----E 335 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~ 335 (771)
++ +|++|+|++|.|+ +.+|..+..+++|+.|++++|.+.+. +|..+ +.+++|+.|+|++|.++. .
T Consensus 215 ~~-~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~ 293 (386)
T 2ca6_A 215 CQ-ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293 (386)
T ss_dssp CT-TCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH
T ss_pred CC-CccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHH
Confidence 32 3444444444443 23344444444444444444444332 33444 236666667777776665 3
Q ss_pred CCccc-ccccccccccccCccceec
Q 041479 336 IPSSL-GNFTFLTELNLCGNSIRGS 359 (771)
Q Consensus 336 ~p~~~-~~l~~L~~L~Ls~N~l~~~ 359 (771)
+|..+ .++++|++|+|++|++++.
T Consensus 294 l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 294 LKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp HHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHHhcCCCceEEEccCCcCCcc
Confidence 55555 4466666666666666643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=239.17 Aligned_cols=210 Identities=22% Similarity=0.324 Sum_probs=158.4
Q ss_pred CCCCCCCCCCCc-----cceee-eecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCC
Q 041479 21 ALSTWNDSVNFC-----QWLGV-TCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRL 94 (771)
Q Consensus 21 ~~~~w~~~~~~c-----~w~~v-~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 94 (771)
.+.+|....++| .|.|+ .|.. .+++.|+|++|+|++ +|+.+ +++|++|+|++|+|+ .+| ..+++|
T Consensus 32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 32 AWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCC
Confidence 456786667788 79999 7865 589999999999997 56655 388999999999999 477 557999
Q ss_pred CEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCC
Q 041479 95 RHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSME 174 (771)
Q Consensus 95 ~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~ 174 (771)
++|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+
T Consensus 103 ~~L~Ls~N~l~~---------------ip~-l~~--~L~~L~Ls~N~l~~------------------lp~---~l~~L~ 143 (571)
T 3cvr_A 103 EYLDACDNRLST---------------LPE-LPA--SLKHLDVDNNQLTM------------------LPE---LPALLE 143 (571)
T ss_dssp CEEECCSSCCSC---------------CCC-CCT--TCCEEECCSSCCSC------------------CCC---CCTTCC
T ss_pred CEEEccCCCCCC---------------cch-hhc--CCCEEECCCCcCCC------------------CCC---cCcccc
Confidence 999999999762 455 544 88888888888873 344 578889
Q ss_pred EEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCC-----
Q 041479 175 YFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYL----- 249 (771)
Q Consensus 175 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L----- 249 (771)
.|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+.+ |. |. . +|
T Consensus 144 ~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~l-p~-~~---~--~L~~~~~ 207 (571)
T 3cvr_A 144 YINADNNQLT-MLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESL-PA-VP---V--RNHHSEE 207 (571)
T ss_dssp EEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSC-CC-CC-------------
T ss_pred EEeCCCCccC-cCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCch-hh-HH---H--hhhcccc
Confidence 9999999988 5776 46788889999998886 555 65 8888888888888844 43 42 2 44
Q ss_pred --cEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccC
Q 041479 250 --EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLK 296 (771)
Q Consensus 250 --~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~ 296 (771)
+.|+|++|+|+ .+|..++.+. +|+.|+|++|+|++.+|..|..+.
T Consensus 208 ~L~~L~Ls~N~l~-~lp~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 208 TEIFFRCRENRIT-HIPENILSLD-PTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CCEEEECCSSCCC-CCCGGGGGSC-TTEEEECCSSSCCHHHHHHHHHHH
T ss_pred cceEEecCCCcce-ecCHHHhcCC-CCCEEEeeCCcCCCcCHHHHHHhh
Confidence 77777777777 5777666654 677777777777776666665543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=211.20 Aligned_cols=180 Identities=20% Similarity=0.223 Sum_probs=153.7
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcE
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEV 251 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~ 251 (771)
+.++++++++.++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..| .++++|++
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~ 87 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF---DDLTELGT 87 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT---TTCTTCCE
T ss_pred CCeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh---ccCCcCCE
Confidence 5678899999998 8887654 689999999999998888889999999999999999998877666 77889999
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCc
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 331 (771)
|+|++|++++..+..+..+. +|++|+|++|+|++..+..|..+++|+.|++++|.+.+..+..|..+++|++|+|++|+
T Consensus 88 L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 88 LGLANNQLASLPLGVFDHLT-QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp EECTTSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcccccChhHhcccC-CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 99999999855555566665 79999999999997777778889999999999998887777788889999999999999
Q ss_pred ccccCCcccccccccccccccCccceec
Q 041479 332 ISREIPSSLGNFTFLTELNLCGNSIRGS 359 (771)
Q Consensus 332 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 359 (771)
+++..+..|..+++|++|+|++|++...
T Consensus 167 l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 167 LQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9877777888999999999999998753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=218.88 Aligned_cols=238 Identities=20% Similarity=0.207 Sum_probs=148.1
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCC-cCcccccCCCCCcE-
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIP-EDLDSLVNCTYLEV- 251 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~l~~L~~- 251 (771)
++++.++|+++ ++|..+. ++++.|+|++|+|+.+.+++|.++++|++|+|++|++.+.+| .+| .++++|..
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f---~~L~~l~~~ 84 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF---SNLPKLHEI 84 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSB---CSCTTCCEE
T ss_pred CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHh---hcchhhhhh
Confidence 46777888887 7887653 578888888888887666778888888888888888765444 334 56666554
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCc-cceeccCccccCCC-CCCEEEccC
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKF-ILIRNIPISVGYLL-KLQVLSLFE 329 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~-~L~~L~Ls~ 329 (771)
+.++.|+|+...|..|..+. +|++|++++|+|++..+..+....++..+++.++ .+....+..|..+. .++.|+|++
T Consensus 85 l~~~~N~l~~l~~~~f~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~ 163 (350)
T 4ay9_X 85 RIEKANNLLYINPEAFQNLP-NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163 (350)
T ss_dssp EEEEETTCCEECTTSBCCCT-TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred hcccCCcccccCchhhhhcc-ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccc
Confidence 56666777755555566654 6888888888887666666666666777776553 34343344555543 466677777
Q ss_pred CcccccCCcccccccccccccccC-ccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCC-ccccc
Q 041479 330 NNISREIPSSLGNFTFLTELNLCG-NSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN-ELSGE 406 (771)
Q Consensus 330 N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~ 406 (771)
|+|+. +|......++|+.|++++ |.++.+.+..|..++.| .|||++|+|+...+..|. +|+.|.+.++ .++ .
T Consensus 164 N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~-~ 238 (350)
T 4ay9_X 164 NGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLK-K 238 (350)
T ss_dssp SCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCC-C
T ss_pred ccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcC-c
Confidence 77764 333333445667777653 55654444556666666 677777776654444443 3334443332 233 4
Q ss_pred CCcchhhhhcccccccEEECcCC
Q 041479 407 IPSSLAWIFGYISIFAKLNLSYN 429 (771)
Q Consensus 407 ~p~~l~~~~~~l~~L~~L~Ls~N 429 (771)
+|. + ..+++|+.++++++
T Consensus 239 lP~-l----~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 239 LPT-L----EKLVALMEASLTYP 256 (350)
T ss_dssp CCC-T----TTCCSCCEEECSCH
T ss_pred CCC-c----hhCcChhhCcCCCC
Confidence 453 2 25666666666543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-22 Score=215.49 Aligned_cols=198 Identities=16% Similarity=0.150 Sum_probs=90.1
Q ss_pred cEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccc
Q 041479 71 RLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLN 150 (771)
Q Consensus 71 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~ 150 (771)
++++-++|+++. +|..+ .+++++|+|++|+|+ ...+..|.++++|++|+|++|++.+
T Consensus 12 ~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~--------------~i~~~~f~~l~~L~~L~Ls~N~i~~------ 68 (350)
T 4ay9_X 12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLR--------------VIQKGAFSGFGDLEKIEISQNDVLE------ 68 (350)
T ss_dssp TEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCS--------------EECTTSSTTCTTCCEEEEECCTTCC------
T ss_pred CEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCC--------------CcCHHHHcCCCCCCEEECcCCCCCC------
Confidence 455666666663 56555 245666666666644 1122345555555555555555432
Q ss_pred eeeecccccccccC-ccccCCCCCCE-EecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcc
Q 041479 151 MFQVSVYSLTGSIP-IQLLNITSMEY-FHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228 (771)
Q Consensus 151 ~l~l~~n~l~~~~p-~~~~~l~~L~~-L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 228 (771)
.+| ..|.+++++.+ +.++.|+++ .+|+..+..+++|++|++++|+|++..+..+....++..|+++
T Consensus 69 -----------~i~~~~f~~L~~l~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~ 136 (350)
T 4ay9_X 69 -----------VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 136 (350)
T ss_dssp -----------EECTTSBCSCTTCCEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEE
T ss_pred -----------ccChhHhhcchhhhhhhcccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhc
Confidence 111 23444444433 334445554 3444443345555555555555554444444444444455543
Q ss_pred c-cccCCCCCcCcccccCC-CCCcEEEccCccccccCChhhhhcccccceeeccc-CcCcccCcccccccCCcceEecCC
Q 041479 229 N-NSLTGLIPEDLDSLVNC-TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA-NPISGSIPTEIGNLKNLIIIAIEK 305 (771)
Q Consensus 229 ~-N~l~~~~p~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~ 305 (771)
+ |+++.+.+..| ..+ ..++.|+|++|+|+ .+|...+... +|+.|++++ |.++.+.++.|.++++|+.|++++
T Consensus 137 ~~~~i~~l~~~~f---~~~~~~l~~L~L~~N~i~-~i~~~~f~~~-~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 137 DNINIHTIERNSF---VGLSFESVILWLNKNGIQ-EIHNSAFNGT-QLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp SCTTCCEECTTSS---TTSBSSCEEEECCSSCCC-EECTTSSTTE-EEEEEECTTCTTCCCCCTTTTTTEECCSEEECTT
T ss_pred cccccccccccch---hhcchhhhhhcccccccc-CCChhhcccc-chhHHhhccCCcccCCCHHHhccCcccchhhcCC
Confidence 3 34443333333 222 23444455555554 3333333332 344444442 333322223344444444444444
Q ss_pred ccc
Q 041479 306 FIL 308 (771)
Q Consensus 306 n~l 308 (771)
|++
T Consensus 212 N~l 214 (350)
T 4ay9_X 212 TRI 214 (350)
T ss_dssp SCC
T ss_pred CCc
Confidence 444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-24 Score=236.29 Aligned_cols=250 Identities=18% Similarity=0.183 Sum_probs=144.0
Q ss_pred ccCccccCCCCCCEEecccCcCcccCChhh---hhCCCCCcEEEeecC---cccccCCccc-------cCCCCCCEEEcc
Q 041479 162 SIPIQLLNITSMEYFHVSENQLVGELPPHI---GFTLPNVRILLLAGN---QFFGNIPHSI-------SNASKLEWLDFA 228 (771)
Q Consensus 162 ~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~---~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~Ls 228 (771)
.++..+..+++|+.|+|++|.+++..+..+ +..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455566677788888888888774433221 225777888888775 4444445444 567777778887
Q ss_pred ccccCCC----CCcCcccccCCCCCcEEEccCccccccCChhhhhcc------------cccceeecccCcCc-ccCc--
Q 041479 229 NNSLTGL----IPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS------------SHLRYLYMSANPIS-GSIP-- 289 (771)
Q Consensus 229 ~N~l~~~----~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~------------~~L~~L~Ls~N~l~-~~~p-- 289 (771)
+|.++.. +|..+ ..+++|++|+|++|.+++..+..+.... ++|++|+|++|+|+ +.+|
T Consensus 103 ~n~l~~~~~~~l~~~l---~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 179 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFL---SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179 (386)
T ss_dssp SCCCCTTTHHHHHHHH---HHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH
T ss_pred CCcCCHHHHHHHHHHH---HhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHH
Confidence 7777752 33333 5667777777777777644333333221 25677777777665 2233
Q ss_pred -ccccccCCcceEecCCcccee-----ccCccccCCCCCCEEEccCCccc----ccCCcccccccccccccccCccceec
Q 041479 290 -TEIGNLKNLIIIAIEKFILIR-----NIPISVGYLLKLQVLSLFENNIS----REIPSSLGNFTFLTELNLCGNSIRGS 359 (771)
Q Consensus 290 -~~~~~l~~L~~L~l~~n~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~ 359 (771)
..+..+++|+.|++++|.+.. ..|..+..+++|+.|+|++|.++ ..+|..+..+++|++|+|++|.|++.
T Consensus 180 ~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred HHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 344455555556555555541 22334555555555555555553 33444555555555555555555432
Q ss_pred CCcccccccceeeecccCcccCCCCcCC--CCCCCCCeEECCCCcccc----cCCcchhhhhcccccccEEECcCCCCCC
Q 041479 360 VPSALGSCHQLWLDLSHNHLTGPIPLAV--GNPKSIPHLDLSKNELSG----EIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 360 ~p~~~~~l~~l~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
... .+|..+ +.+++|++|+|++|+|++ .+|..+. ..+++|+.|+|++|++++
T Consensus 260 ~~~-------------------~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~---~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 260 GAA-------------------AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID---EKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHH-------------------HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHH---HHCTTCCEEECTTSBSCT
T ss_pred hHH-------------------HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHH---hcCCCceEEEccCCcCCc
Confidence 100 023333 336777778888887775 3555431 256777888888887775
Q ss_pred CCC
Q 041479 434 DVP 436 (771)
Q Consensus 434 ~~p 436 (771)
..|
T Consensus 318 ~~~ 320 (386)
T 2ca6_A 318 EDD 320 (386)
T ss_dssp TSH
T ss_pred chh
Confidence 543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-25 Score=258.61 Aligned_cols=182 Identities=18% Similarity=0.196 Sum_probs=101.6
Q ss_pred CCCCCcEEEccCccccccCChh-hhhcccccceeecccCcCccc-CcccccccCCcceEecC---------CccceeccC
Q 041479 245 NCTYLEVVSLSVNSLSGTLPNS-LANFSSHLRYLYMSANPISGS-IPTEIGNLKNLIIIAIE---------KFILIRNIP 313 (771)
Q Consensus 245 ~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~---------~n~l~~~~p 313 (771)
.+++|+.|++++|.+++..... +..+ ++|+.|++++| +... ++.....+++|+.|++. .+.+.....
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~-~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l 364 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQC-PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGL 364 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTC-TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcC-CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHH
Confidence 4567777777777765432222 2233 36777777776 3321 22223346777777762 233332222
Q ss_pred cccc-CCCCCCEEEccCCcccccCCcccc-ccccccccccc--C----ccceecC-----Ccccccccce-eeecccCcc
Q 041479 314 ISVG-YLLKLQVLSLFENNISREIPSSLG-NFTFLTELNLC--G----NSIRGSV-----PSALGSCHQL-WLDLSHNHL 379 (771)
Q Consensus 314 ~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~-----p~~~~~l~~l-~L~Ls~N~l 379 (771)
..+. .+++|+.|+++.|+++...+..+. .+++|+.|+++ + |.+++.. +..+..++.| .|++++ ++
T Consensus 365 ~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l 443 (594)
T 2p1m_B 365 VSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL 443 (594)
T ss_dssp HHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred HHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc
Confidence 2222 367777777777777655444443 46777777777 3 4554211 1124455666 677765 55
Q ss_pred cCCCCcCCCC-CCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCC
Q 041479 380 TGPIPLAVGN-PKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 380 ~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
++..+..+.. +++|+.|+|++|.+++..+..+ ...+++|+.|+|++|+++
T Consensus 444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l---~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHV---LSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHH---HHHCTTCCEEEEESCSCC
T ss_pred cHHHHHHHHHhchhccEeeccCCCCcHHHHHHH---HhcCCCcCEEECcCCCCc
Confidence 5443333333 6777777777777764333322 235677777888777774
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-22 Score=210.04 Aligned_cols=172 Identities=22% Similarity=0.366 Sum_probs=94.6
Q ss_pred ccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCc
Q 041479 64 IGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFT 143 (771)
Q Consensus 64 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 143 (771)
+..+++|++|++++|.++. +| .+..+++|++|+|++|.++ .++. +..+++|+.|+|++|+++
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~---------------~~~~-~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT---------------DLAP-LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC---------------CCGG-GTTCCSCCEEECCSCCCS
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC---------------CChh-HccCCCCCEEEccCCcCC
Confidence 3456666666666666664 34 4666666666666666654 2222 555666666666666555
Q ss_pred CCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCC
Q 041479 144 GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223 (771)
Q Consensus 144 ~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 223 (771)
+ ++ .+..+++|++|++++|+++ .+|. + ..+++|+.|++++|++++..+ +..+++|+
T Consensus 99 ~------------------~~-~~~~l~~L~~L~l~~n~l~-~~~~-l-~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~ 154 (308)
T 1h6u_A 99 N------------------VS-AIAGLQSIKTLDLTSTQIT-DVTP-L-AGLSNLQVLYLDLNQITNISP--LAGLTNLQ 154 (308)
T ss_dssp C------------------CG-GGTTCTTCCEEECTTSCCC-CCGG-G-TTCTTCCEEECCSSCCCCCGG--GGGCTTCC
T ss_pred C------------------ch-hhcCCCCCCEEECCCCCCC-Cchh-h-cCCCCCCEEECCCCccCcCcc--ccCCCCcc
Confidence 2 11 3455566666666666665 3443 2 255666666666666654332 55566666
Q ss_pred EEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 224 ~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
.|++++|++++..+ +..+++|+.|++++|++++ ++. +..+. +|++|++++|+++
T Consensus 155 ~L~l~~n~l~~~~~-----l~~l~~L~~L~l~~n~l~~-~~~-l~~l~-~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 155 YLSIGNAQVSDLTP-----LANLSKLTTLKADDNKISD-ISP-LASLP-NLIEVHLKNNQIS 208 (308)
T ss_dssp EEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCCC-CGG-GGGCT-TCCEEECTTSCCC
T ss_pred EEEccCCcCCCChh-----hcCCCCCCEEECCCCccCc-Chh-hcCCC-CCCEEEccCCccC
Confidence 66666666654322 2455555666666665552 222 33333 4555555555555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=224.29 Aligned_cols=215 Identities=20% Similarity=0.243 Sum_probs=141.6
Q ss_pred ccCCCCCCEEecccCcCccc-CChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcccc-ccCCC-CCcCcccc
Q 041479 167 LLNITSMEYFHVSENQLVGE-LPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN-SLTGL-IPEDLDSL 243 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~-lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l 243 (771)
+..+++|++|++++|.+++. +|..+. .+++|++|+|++|++++..+..+..+++|++|+|++| .+++. .+..+
T Consensus 89 ~~~~~~L~~L~L~~~~l~~~~~~~~~~-~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~--- 164 (336)
T 2ast_B 89 HFSPFRVQHMDLSNSVIEVSTLHGILS-QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL--- 164 (336)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHT-TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH---
T ss_pred hccCCCCCEEEccCCCcCHHHHHHHHh-hCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH---
Confidence 34566677777777776643 554443 6777777777777777667777777788888888887 56532 23223
Q ss_pred cCCCCCcEEEccCc-ccccc-CChhhhhcccccceeecccC--cCc-ccCcccccccCCcceEecCCcc-ceeccCcccc
Q 041479 244 VNCTYLEVVSLSVN-SLSGT-LPNSLANFSSHLRYLYMSAN--PIS-GSIPTEIGNLKNLIIIAIEKFI-LIRNIPISVG 317 (771)
Q Consensus 244 ~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~ 317 (771)
.++++|++|++++| .+++. ++..+..++.+|++|++++| .++ +.+|..+..+++|+.|++++|. +.+..+..+.
T Consensus 165 ~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~ 244 (336)
T 2ast_B 165 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 244 (336)
T ss_dssp HHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred hcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh
Confidence 56778888888888 77753 55556665426888888888 454 4566677778888888888887 5556677777
Q ss_pred CCCCCCEEEccCCc-ccccCCcccccccccccccccCccceecCCccccccc-ce-eeecccCcccCCCCcCCCC
Q 041479 318 YLLKLQVLSLFENN-ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH-QL-WLDLSHNHLTGPIPLAVGN 389 (771)
Q Consensus 318 ~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~l-~L~Ls~N~l~~~~p~~~~~ 389 (771)
.+++|++|++++|. ++......+..+++|+.|++++| ++ ...+..+. .+ .|++++|++++..|..++.
T Consensus 245 ~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 245 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 88888888888884 32222225677788888888877 32 22333332 23 4556666666666655543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=209.60 Aligned_cols=195 Identities=23% Similarity=0.344 Sum_probs=149.6
Q ss_pred ccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
+..+++|+.|++++|.++ .+| .+..+++|++|++++|+++ .+++ + ..+++|++|+|++
T Consensus 37 ~~~l~~L~~L~l~~~~i~------------------~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~-~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT------------------TIE-GVQYLNNLIGLELKDNQIT-DLAP-L-KNLTKITELELSG 94 (308)
T ss_dssp HHHHHTCCEEECTTSCCC------------------CCT-TGGGCTTCCEEECCSSCCC-CCGG-G-TTCCSCCEEECCS
T ss_pred HHHcCCcCEEEeeCCCcc------------------Cch-hhhccCCCCEEEccCCcCC-CChh-H-ccCCCCCEEEccC
Confidence 345667777777777665 233 4677888888888888888 5666 4 4888899999999
Q ss_pred CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 206 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
|+|++. +.+..+++|++|++++|+++++.+ +..+++|++|++++|++++ ++. +..+. +|++|++++|+++
T Consensus 95 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~-----l~~l~~L~~L~l~~n~l~~-~~~-l~~l~-~L~~L~l~~n~l~ 164 (308)
T 1h6u_A 95 NPLKNV--SAIAGLQSIKTLDLTSTQITDVTP-----LAGLSNLQVLYLDLNQITN-ISP-LAGLT-NLQYLSIGNAQVS 164 (308)
T ss_dssp CCCSCC--GGGTTCTTCCEEECTTSCCCCCGG-----GTTCTTCCEEECCSSCCCC-CGG-GGGCT-TCCEEECCSSCCC
T ss_pred CcCCCc--hhhcCCCCCCEEECCCCCCCCchh-----hcCCCCCCEEECCCCccCc-Ccc-ccCCC-CccEEEccCCcCC
Confidence 888853 368888889999999998886532 4778888888999888884 443 66665 7888899888888
Q ss_pred ccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCcccee
Q 041479 286 GSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 286 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
+..+ +..+++|+.|++++|.+.+..+ +..+++|++|+|++|++++.. .+..+++|+.|+|++|++++
T Consensus 165 ~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 165 DLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 5433 8888888888888888865443 778888888888888888544 37888888888888888874
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.1e-22 Score=195.97 Aligned_cols=180 Identities=21% Similarity=0.220 Sum_probs=105.7
Q ss_pred ccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc
Q 041479 32 CQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS 111 (771)
Q Consensus 32 c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 111 (771)
|.|.+|.|.. +.++ .+|..+ .++|++|+|++|++++..+..|+++++|++|++++|+++
T Consensus 7 C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------ 65 (208)
T 2o6s_A 7 CSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ------ 65 (208)
T ss_dssp EETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC------
T ss_pred ECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC------
Confidence 7899998865 3454 334333 468999999999999776777888999999999988865
Q ss_pred cccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhh
Q 041479 112 RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHI 191 (771)
Q Consensus 112 ~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~ 191 (771)
+..+..|..+++|++|+|++|+|++ ..+..|.++++|++|++++|+++ .+|+..
T Consensus 66 --------~~~~~~~~~l~~L~~L~Ls~n~l~~-----------------~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~ 119 (208)
T 2o6s_A 66 --------SLPNGVFNKLTSLTYLNLSTNQLQS-----------------LPNGVFDKLTQLKELALNTNQLQ-SLPDGV 119 (208)
T ss_dssp --------CCCTTTTTTCTTCCEEECCSSCCCC-----------------CCTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred --------ccChhhcCCCCCcCEEECCCCcCCc-----------------cCHhHhcCccCCCEEEcCCCcCc-ccCHhH
Confidence 2333345666666666666666552 12223455555666666655555 344443
Q ss_pred hhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhh
Q 041479 192 GFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLA 268 (771)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 268 (771)
+..+++|++|++++|+|++..+..|..+++|+.|++++|.+.+ .+++|++|+++.|+++|.+|..++
T Consensus 120 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----------~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 120 FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----------TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----------CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred hccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----------CCCCHHHHHHHHHhCCceeeccCc
Confidence 3345555555555555554444445555555555555554432 223344444444444444444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=230.61 Aligned_cols=154 Identities=14% Similarity=0.093 Sum_probs=115.8
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc--------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
..+|+|.+|+||+|... ++.+|+|+..... ....+++.+|++++++++||||+++..++...+ ..
T Consensus 342 ~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-----~~ 414 (540)
T 3en9_A 342 HLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD-----NK 414 (540)
T ss_dssp ------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-----TT
T ss_pred CEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-----cc
Confidence 46899999999999543 4589999874322 112456899999999999999995555544443 45
Q ss_pred EEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 599 ALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
|+|||||++|+|.++... +..++.|+++||+|||+. +|+||||||+|||++. .+||+|||+|+.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 899999999999876443 678999999999999986 8999999999999998 999999999997654321
Q ss_pred Ccc---cccccccccccccchh
Q 041479 679 SNQ---CSSVGLKGTVGYATPE 697 (771)
Q Consensus 679 ~~~---~~~~~~~gt~~y~aPE 697 (771)
... ......+||+.|||||
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APE 506 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDE 506 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHH
T ss_pred cccchhhhhhhhcCCCCcCCHH
Confidence 100 0123467999999999
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.3e-23 Score=240.07 Aligned_cols=231 Identities=19% Similarity=0.195 Sum_probs=127.8
Q ss_pred CccHHHHHHHHhcCCCCCCCCCCCCCCC-CCCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCc
Q 041479 1 EPDKQALLAFKSKVDDDPFGALSTWNDS-VNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNN 79 (771)
Q Consensus 1 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~-~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 79 (771)
+.++++|+++..++..+.+.....|... +.++.|.++.++. .+++.|+|++|.+... +. ..|+.++|++|.
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~ 202 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYS 202 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hh-----hHhhcCccCccc
Confidence 3578999999987655555555678543 4567899998876 6899999999998853 22 336677777777
Q ss_pred ccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeeccccc
Q 041479 80 FSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSL 159 (771)
Q Consensus 80 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l 159 (771)
|.+ ++++.|.+. ..|..|..+.+|+.|+|++|.|.
T Consensus 203 i~~--------------~~~~~n~~~---------------~~~~~~~~l~~L~~L~Ls~n~l~---------------- 237 (727)
T 4b8c_D 203 IDE--------------DDDIENRMV---------------MPKDSKYDDQLWHALDLSNLQIF---------------- 237 (727)
T ss_dssp ------------------------------------------------CCCCCCEEECTTSCCS----------------
T ss_pred ccC--------------cccccccee---------------cChhhhccCCCCcEEECCCCCCC----------------
Confidence 764 244455543 45666777777888888877776
Q ss_pred ccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcC
Q 041479 160 TGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPED 239 (771)
Q Consensus 160 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 239 (771)
.+|..+.++++|++|+|++|.|+ .+|..+. .+++|++|+|++|+|+ .+|..|.++++|++|+|++|.|+. +|..
T Consensus 238 --~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-lp~~ 311 (727)
T 4b8c_D 238 --NISANIFKYDFLTRLYLNGNSLT-ELPAEIK-NLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT-LPWE 311 (727)
T ss_dssp --CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGG-GGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC-CCSS
T ss_pred --CCChhhcCCCCCCEEEeeCCcCc-ccChhhh-CCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc-cChh
Confidence 45666667888888888888888 8888776 8889999999999998 678889999999999999999974 4655
Q ss_pred cccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCccccc
Q 041479 240 LDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG 293 (771)
Q Consensus 240 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~ 293 (771)
| .++++|++|+|++|.|++.+|..+......+..|+|++|.+++.+|..+.
T Consensus 312 ~---~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~ 362 (727)
T 4b8c_D 312 F---GNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR 362 (727)
T ss_dssp T---TSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred h---hcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc
Confidence 5 77889999999999999888888766543345688999999988876543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.4e-21 Score=188.23 Aligned_cols=180 Identities=18% Similarity=0.117 Sum_probs=128.9
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEE
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~ 253 (771)
+.++.+++.++ .+|..+. ++|++|++++|+|++..+..|..+++|++|++++|+++++.+..| ..+++|++|+
T Consensus 10 ~~v~c~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L~ 82 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF---NKLTSLTYLN 82 (208)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT---TTCTTCCEEE
T ss_pred CEEEecCCCcc-CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhc---CCCCCcCEEE
Confidence 46677777777 6776543 578888888888887777777888888888888888887666555 6677888888
Q ss_pred ccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccc
Q 041479 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 254 Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
+++|++++..+..+..+. +|++|++++|+|++..+..|..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+.
T Consensus 83 Ls~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLT-QLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCCCcCCccCHhHhcCcc-CCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 888888744444455554 6888888888887666666777777777777777776655555677777777777777665
Q ss_pred ccCCcccccccccccccccCccceecCCccccccc
Q 041479 334 REIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH 368 (771)
Q Consensus 334 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 368 (771)
+ .+++|++|+++.|+++|.+|..++.+.
T Consensus 162 ~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 162 C-------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp C-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred c-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 3 345677777777777777776666543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-20 Score=187.60 Aligned_cols=165 Identities=21% Similarity=0.199 Sum_probs=113.4
Q ss_pred CCCCCCCCCCccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEeccc
Q 041479 22 LSTWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNS 101 (771)
Q Consensus 22 ~~~w~~~~~~c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 101 (771)
..-|..++..|+|.+|.|.. ++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 9 ~~~~~~~~~~Cs~~~v~c~~------------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 73 (229)
T 3e6j_A 9 HSAACPSQCSCSGTTVDCRS------------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73 (229)
T ss_dssp --CCCCTTCEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred hhccCCCCCEEeCCEeEccC------------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCC
Confidence 45566678899999999975 4455 4454443 8899999999999998888999999999999999
Q ss_pred CcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccC
Q 041479 102 NALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSEN 181 (771)
Q Consensus 102 N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N 181 (771)
|+|+ ...+..|..+++|+.|+|++|+|++ ..+..|..+++|++|+|++|
T Consensus 74 N~l~--------------~i~~~~~~~l~~L~~L~Ls~N~l~~-----------------l~~~~~~~l~~L~~L~Ls~N 122 (229)
T 3e6j_A 74 NQLG--------------ALPVGVFDSLTQLTVLDLGTNQLTV-----------------LPSAVFDRLVHLKELFMCCN 122 (229)
T ss_dssp SCCC--------------CCCTTTTTTCTTCCEEECCSSCCCC-----------------CCTTTTTTCTTCCEEECCSS
T ss_pred CCCC--------------CcChhhcccCCCcCEEECCCCcCCc-----------------cChhHhCcchhhCeEeccCC
Confidence 9965 2233446677777777777776652 22334556666666666666
Q ss_pred cCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCC
Q 041479 182 QLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG 234 (771)
Q Consensus 182 ~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 234 (771)
+|+ .+|..+. .+++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 123 ~l~-~lp~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 123 KLT-ELPRGIE-RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCC-SCCTTGG-GCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred ccc-ccCcccc-cCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 666 6666554 56666666666666665555556666666666666666553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=213.22 Aligned_cols=196 Identities=26% Similarity=0.303 Sum_probs=102.8
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCc
Q 041479 69 FLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPH 148 (771)
Q Consensus 69 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~ 148 (771)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~---------------~ip---~~l~~L~~L~Ls~N~l~~---- 114 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI---------------SLP---ELPASLEYLDACDNRLST---- 114 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS---------------CCC---CCCTTCCEEECCSSCCSC----
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc---------------ccc---cccCCCCEEEccCCCCCC----
Confidence 66777777777765 555442 56666666666654 233 234555666666555552
Q ss_pred cceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcc
Q 041479 149 LNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228 (771)
Q Consensus 149 L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 228 (771)
+|. +.+ +|++|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|. .+++|+.|+|+
T Consensus 115 --------------ip~-l~~--~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 168 (571)
T 3cvr_A 115 --------------LPE-LPA--SLKHLDVDNNQLT-MLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVR 168 (571)
T ss_dssp --------------CCC-CCT--TCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred --------------cch-hhc--CCCEEECCCCcCC-CCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECC
Confidence 232 222 5666666666665 3554 34556666666666554 333 34555555565
Q ss_pred ccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccc
Q 041479 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL 308 (771)
Q Consensus 229 ~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 308 (771)
+|+|++ +|. | . ++|+.|+|++|+|+ .+|. +.. +| +.....|+.|++++|.+
T Consensus 169 ~N~L~~-lp~-l---~--~~L~~L~Ls~N~L~-~lp~-~~~---~L-----------------~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 169 NNQLTF-LPE-L---P--ESLEALDVSTNLLE-SLPA-VPV---RN-----------------HHSEETEIFFRCRENRI 219 (571)
T ss_dssp SSCCSC-CCC-C---C--TTCCEEECCSSCCS-SCCC-CC----------------------------CCEEEECCSSCC
T ss_pred CCCCCC-cch-h---h--CCCCEEECcCCCCC-chhh-HHH---hh-----------------hcccccceEEecCCCcc
Confidence 555554 232 3 2 45555555555555 4444 221 23 00000114555555544
Q ss_pred eeccCccccCCCCCCEEEccCCcccccCCcccccccc
Q 041479 309 IRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTF 345 (771)
Q Consensus 309 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 345 (771)
. .+|..+..+++|+.|+|++|.+++.+|..+..++.
T Consensus 220 ~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp C-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred e-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 3 34555555666777777777777666666665543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=196.71 Aligned_cols=127 Identities=18% Similarity=0.117 Sum_probs=103.7
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch------------------hhHHHHHHHHHHHhccCCCCceeEEEEee
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------------------GALKSFMAECQALRNIRHRNLVKIITACS 588 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 588 (771)
..+|+|.+|.||+|++ .+++.||||+++.... .....+.+|++++++++|+++.. ++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~---~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK---VYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC---EEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe---EEe
Confidence 5689999999999999 6778999999964321 23567999999999999544444 432
Q ss_pred cCCCCCceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEeccc
Q 041479 589 TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG 668 (771)
Q Consensus 589 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 668 (771)
.. ..|+||||+++|+|.++ ...+...++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 172 ~~------~~~lvmE~~~g~~L~~l----~~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 172 WE------GNAVLMELIDAKELYRV----RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EE------TTEEEEECCCCEEGGGC----CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred cc------ceEEEEEecCCCcHHHc----chhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 22 35899999999999873 2234567999999999999986 999999999999999 9999999999
Q ss_pred Ccc
Q 041479 669 LTR 671 (771)
Q Consensus 669 la~ 671 (771)
+|+
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 986
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=200.80 Aligned_cols=179 Identities=24% Similarity=0.155 Sum_probs=117.2
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCcccCccccc-ccCCcceEecCCccceeccCccccCCCCCCEEEcc
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIG-NLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 328 (771)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|+.|++++|.+.+..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 34555555555 4554332 2455666666666655555555 66666666666666665555666666667777777
Q ss_pred CCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCC---CCCCCCCeEECCCCccc
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAV---GNPKSIPHLDLSKNELS 404 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~ 404 (771)
+|+|+...+..|..+++|++|+|++|+|++..|..|..++.| .|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 777766556666777777777777777776666677777776 67777777775555555 56888999999999998
Q ss_pred ccCCcchhhhhccccc--ccEEECcCCCCCCCCC
Q 041479 405 GEIPSSLAWIFGYISI--FAKLNLSYNNLDGDVP 436 (771)
Q Consensus 405 ~~~p~~l~~~~~~l~~--L~~L~Ls~N~l~~~~p 436 (771)
+..+..+. .++. ++.|+|++|+|.|.+.
T Consensus 177 ~l~~~~~~----~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 177 KLPLTDLQ----KLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCCHHHHH----HSCHHHHTTEECCSSCEECCHH
T ss_pred ccCHHHhh----hccHhhcceEEecCCCccCCcC
Confidence 54444443 5555 4789999999988765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.6e-20 Score=184.84 Aligned_cols=157 Identities=17% Similarity=0.101 Sum_probs=91.9
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCcccCc-ccccccCCcceEecCCccceeccCccccCCCCCCEEEcc
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIP-TEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 328 (771)
+.+++++|.++ .+|..+. ..+++|+|++|+|++..| ..|..+++|+.|++++|.+.+..+..|..+++|++|+|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 57788888877 5676553 246777888887776543 335556655555555555555444455555555555555
Q ss_pred CCcccccCCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCC
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIP 408 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 408 (771)
+|++++..|..|..+++|++|+|++|+| ++..|..|..+++|++|+|++|+|++..|
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-----------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 146 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRI-----------------------TCVGNDSFIGLSSVRLLSLYDNQITTVAP 146 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCC-----------------------CCBCTTSSTTCTTCSEEECTTSCCCCBCT
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcC-----------------------CeECHhHcCCCccCCEEECCCCcCCEECH
Confidence 5555544444455555555555555544 44555555566666666666666665555
Q ss_pred cchhhhhcccccccEEECcCCCCCCCCCc
Q 041479 409 SSLAWIFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 409 ~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
..+. .+++|+.|+|++|+|+|.++-
T Consensus 147 ~~~~----~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 147 GAFD----TLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TTTT----TCTTCCEEECCSCCEECSGGG
T ss_pred HHhc----CCCCCCEEEecCcCCcCCCch
Confidence 5443 556666666666666665553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.6e-20 Score=199.66 Aligned_cols=176 Identities=19% Similarity=0.176 Sum_probs=142.5
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCcccc-CCCCCCEEEccccccCCCCCcCcccccCCCCCcEE
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSIS-NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVV 252 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L 252 (771)
+.+++++|+++ .+|..+. +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|+++.+..| .++++|++|
T Consensus 21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~---~~l~~L~~L 93 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF---VPVPNLRYL 93 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTT---TTCTTCCEE
T ss_pred CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhc---cCCCCCCEE
Confidence 67899999998 7887654 5688999999999988888887 89999999999999998877666 778889999
Q ss_pred EccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccc---cCCCCCCEEEccC
Q 041479 253 SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISV---GYLLKLQVLSLFE 329 (771)
Q Consensus 253 ~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~---~~l~~L~~L~Ls~ 329 (771)
+|++|+|++..+..|..+. +|++|+|++|+|++..|..|.++++|+.|+|++|.+.+..+..| ..+++|+.|+|++
T Consensus 94 ~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 94 DLSSNHLHTLDEFLFSDLQ-ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp ECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred ECCCCcCCcCCHHHhCCCc-CCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence 9999999855555666665 79999999999988888888888888888888888876544444 5688888999999
Q ss_pred CcccccCCcccccccc--cccccccCccce
Q 041479 330 NNISREIPSSLGNFTF--LTELNLCGNSIR 357 (771)
Q Consensus 330 N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~ 357 (771)
|+|+...+..|..++. |+.|+|++|.+.
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 9888655567777776 478888888886
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-23 Score=232.66 Aligned_cols=203 Identities=16% Similarity=0.105 Sum_probs=154.0
Q ss_pred cCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEe-cccccCc
Q 041479 65 GNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLG-LANNYFT 143 (771)
Q Consensus 65 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~-Ls~N~l~ 143 (771)
..+++|+.|+|++|+|+ .+|.+++++++|+.|++++|.....+|.. +..+++.+..|..++++++|+.|+ ++.|++.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-l~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-MRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-HHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-HHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence 67899999999999998 58999999999999999877632222221 122335567888899999999999 7888765
Q ss_pred CCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCC
Q 041479 144 GPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223 (771)
Q Consensus 144 ~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 223 (771)
+|..+.++.|.+++..+ ..|+.|+|++|+|+ .+|. +. .+++|+.|+|++|+|+ .+|..|+++++|+
T Consensus 424 ----~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~-~lp~-~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 489 (567)
T 1dce_A 424 ----DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLT-VLCH-LE-QLLLVTHLDLSHNRLR-ALPPALAALRCLE 489 (567)
T ss_dssp ----HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCS-SCCC-GG-GGTTCCEEECCSSCCC-CCCGGGGGCTTCC
T ss_pred ----hhhhhhhhcccccccCc------cCceEEEecCCCCC-CCcC-cc-ccccCcEeecCccccc-ccchhhhcCCCCC
Confidence 45566667777665332 24788888888888 5776 44 7888888888888888 6778888888888
Q ss_pred EEEccccccCCCCCcCcccccCCCCCcEEEccCccccccC-ChhhhhcccccceeecccCcCcccCc
Q 041479 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTL-PNSLANFSSHLRYLYMSANPISGSIP 289 (771)
Q Consensus 224 ~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~~L~~L~Ls~N~l~~~~p 289 (771)
.|+|++|+|+++ | .+ .++++|+.|+|++|+|++.. |..+..++ +|+.|+|++|+|++.+|
T Consensus 490 ~L~Ls~N~l~~l-p-~l---~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 490 VLQASDNALENV-D-GV---ANLPRLQELLLCNNRLQQSAAIQPLVSCP-RLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp EEECCSSCCCCC-G-GG---TTCSSCCEEECCSSCCCSSSTTGGGGGCT-TCCEEECTTSGGGGSSS
T ss_pred EEECCCCCCCCC-c-cc---CCCCCCcEEECCCCCCCCCCCcHHHhcCC-CCCEEEecCCcCCCCcc
Confidence 888888888863 4 34 77788888888888888655 77777775 68888888888875544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.7e-20 Score=183.20 Aligned_cols=151 Identities=22% Similarity=0.228 Sum_probs=97.5
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccC
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFE 329 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 329 (771)
+.+++++|.++ .+|..+. ++|+.|++++|+|++..+..|.++++|+.|++++|.+.+..|..|..+++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 56788888887 6776554 3688888888888876666777777777777777777666666677777777777777
Q ss_pred CcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccc
Q 041479 330 NNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404 (771)
Q Consensus 330 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 404 (771)
|+|+...+..|..+++|++|+|++|+|++..|..|..++.| .|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 77765545556666666666666666665555555555555 4555555555444444555555555555555544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=190.02 Aligned_cols=185 Identities=23% Similarity=0.335 Sum_probs=108.5
Q ss_pred EcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCC
Q 041479 50 NLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSL 129 (771)
Q Consensus 50 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l 129 (771)
.+..+.+++.. .+..+++|+.|++++|.+++ +| .+..+++|++|+|++|+++ .++. +.++
T Consensus 30 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~---------------~~~~-l~~l 89 (291)
T 1h6t_A 30 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLT---------------DIKP-LANL 89 (291)
T ss_dssp HTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC---------------CCGG-GTTC
T ss_pred HhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccC---------------CCcc-cccC
Confidence 34444544332 23456666666666666664 33 3666666666666666654 1222 5666
Q ss_pred CCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccc
Q 041479 130 LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFF 209 (771)
Q Consensus 130 ~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~ 209 (771)
++|+.|++++|++++ +| .+..+++|++|++++|+++ .++ .+. .+++|+.|++++|+|+
T Consensus 90 ~~L~~L~l~~n~l~~------------------~~-~l~~l~~L~~L~L~~n~i~-~~~-~l~-~l~~L~~L~l~~n~l~ 147 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD------------------LS-SLKDLKKLKSLSLEHNGIS-DIN-GLV-HLPQLESLYLGNNKIT 147 (291)
T ss_dssp TTCCEEECCSSCCCC------------------GG-GGTTCTTCCEEECTTSCCC-CCG-GGG-GCTTCCEEECCSSCCC
T ss_pred CCCCEEECCCCcCCC------------------Ch-hhccCCCCCEEECCCCcCC-CCh-hhc-CCCCCCEEEccCCcCC
Confidence 666666666666652 11 2556666666666666666 343 233 5666666666666666
Q ss_pred ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcc
Q 041479 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286 (771)
Q Consensus 210 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~ 286 (771)
+. ..+..+++|+.|++++|+|++..| + ..+++|+.|++++|.++ .+|. +..+. +|+.|++++|+++.
T Consensus 148 ~~--~~l~~l~~L~~L~L~~N~l~~~~~--l---~~l~~L~~L~L~~N~i~-~l~~-l~~l~-~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 148 DI--TVLSRLTKLDTLSLEDNQISDIVP--L---AGLTKLQNLYLSKNHIS-DLRA-LAGLK-NLDVLELFSQECLN 214 (291)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCC-BCGG-GTTCT-TCSEEEEEEEEEEC
T ss_pred cc--hhhccCCCCCEEEccCCccccchh--h---cCCCccCEEECCCCcCC-CChh-hccCC-CCCEEECcCCcccC
Confidence 43 456666666777777666665433 2 55666666666666666 3432 44443 56666666666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=208.15 Aligned_cols=190 Identities=23% Similarity=0.326 Sum_probs=117.6
Q ss_pred EEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcc
Q 041479 46 VILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSE 125 (771)
Q Consensus 46 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~ 125 (771)
+..+.|+.+.+....+ +..|++|+.|+|++|.|+. +| .|..+++|+.|+|++|+|++ ++.
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~---------------~~~- 82 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD---------------IKP- 82 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCC---------------CGG-
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCC---------------Chh-
Confidence 3344555555554332 4566777777777777764 33 46777777777777777542 222
Q ss_pred ccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+++ .+|. +. .+++|+.|+|++
T Consensus 83 l~~l~~L~~L~Ls~N~l~~------------------l~-~l~~l~~L~~L~Ls~N~l~-~l~~-l~-~l~~L~~L~Ls~ 140 (605)
T 1m9s_A 83 LTNLKNLGWLFLDENKIKD------------------LS-SLKDLKKLKSLSLEHNGIS-DING-LV-HLPQLESLYLGN 140 (605)
T ss_dssp GGGCTTCCEEECCSSCCCC------------------CT-TSTTCTTCCEEECTTSCCC-CCGG-GG-GCTTCSEEECCS
T ss_pred hccCCCCCEEECcCCCCCC------------------Ch-hhccCCCCCEEEecCCCCC-CCcc-cc-CCCccCEEECCC
Confidence 5666677777777776652 12 4566667777777777776 3432 33 667777777777
Q ss_pred CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 206 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
|+|++. ..|..+++|+.|+|++|+|++..| + ..+++|+.|+|++|.|++ +| .+..+. +|+.|+|++|++.
T Consensus 141 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l---~~l~~L~~L~Ls~N~i~~-l~-~l~~l~-~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 141 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L---AGLTKLQNLYLSKNHISD-LR-ALAGLK-NLDVLELFSQECL 210 (605)
T ss_dssp SCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G---TTCTTCCEEECCSSCCCB-CG-GGTTCT-TCSEEECCSEEEE
T ss_pred CccCCc--hhhcccCCCCEEECcCCcCCCchh--h---ccCCCCCEEECcCCCCCC-Ch-HHccCC-CCCEEEccCCcCc
Confidence 777654 456677777777777777766544 3 566677777777777763 33 355554 5777777777766
Q ss_pred cc
Q 041479 286 GS 287 (771)
Q Consensus 286 ~~ 287 (771)
+.
T Consensus 211 ~~ 212 (605)
T 1m9s_A 211 NK 212 (605)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=178.86 Aligned_cols=156 Identities=21% Similarity=0.178 Sum_probs=131.6
Q ss_pred CEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChh-hhhcccccceeecccCcCcccCcccccccCCcceE
Q 041479 223 EWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNS-LANFSSHLRYLYMSANPISGSIPTEIGNLKNLIII 301 (771)
Q Consensus 223 ~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 301 (771)
+.+++++|.++.+ |..+ ...+++|+|++|+|++..|.. +..+. +|++|+|++|+|++..+..|.++++|+.|
T Consensus 14 ~~l~~s~n~l~~i-P~~~-----~~~~~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 14 TTVDCSNQKLNKI-PEHI-----PQYTAELRLNNNEFTVLEATGIFKKLP-QLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TEEECCSSCCSSC-CSCC-----CTTCSEEECCSSCCCEECCCCCGGGCT-TCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CEeEeCCCCcccC-ccCC-----CCCCCEEEcCCCcCCccCchhhhccCC-CCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 5899999999875 5443 245789999999999665544 56665 89999999999998888899999999999
Q ss_pred ecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccceeeecccCcccC
Q 041479 302 AIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTG 381 (771)
Q Consensus 302 ~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~ 381 (771)
++++|.+.+..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++.
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---------------------- 144 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTV---------------------- 144 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCB----------------------
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEE----------------------
Confidence 9999999988888899999999999999999988899999999998888888877743
Q ss_pred CCCcCCCCCCCCCeEECCCCcccccCC
Q 041479 382 PIPLAVGNPKSIPHLDLSKNELSGEIP 408 (771)
Q Consensus 382 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p 408 (771)
.|..|..+++|+.|+|++|++++..+
T Consensus 145 -~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 145 -APGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp -CTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred -CHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 45566677788888888888875443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.9e-19 Score=177.37 Aligned_cols=159 Identities=21% Similarity=0.206 Sum_probs=136.4
Q ss_pred cceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccC
Q 041479 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCG 353 (771)
Q Consensus 274 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 353 (771)
-+.+++++|.++ .+|..+. ++|+.|++++|.+.+..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 367889999998 5666554 6899999999999888788899999999999999999988889999999999999999
Q ss_pred ccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCC
Q 041479 354 NSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 354 N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
|+|++..+..|..++.| .|+|++|+|++..|..|..+++|++|+|++|+|++..+..+. .+++|+.|+|++|++.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS----PLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT----TCTTCCEEECCSSCEE
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh----CCCCCCEEEeCCCCcC
Confidence 99997777778888888 899999999988889999999999999999999976666554 7889999999999998
Q ss_pred CCCCccc
Q 041479 433 GDVPRKM 439 (771)
Q Consensus 433 ~~~p~~~ 439 (771)
+.+.-.+
T Consensus 166 c~c~l~~ 172 (220)
T 2v9t_B 166 CDCHLKW 172 (220)
T ss_dssp CSGGGHH
T ss_pred CCCccHH
Confidence 8776443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-19 Score=185.74 Aligned_cols=173 Identities=28% Similarity=0.413 Sum_probs=135.3
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
+..+++|+.|++++|.++ .+|. +. .+++|+.|+|++|+|++..+ +..+++|++|+|++|+++++ | .+..+
T Consensus 42 ~~~l~~L~~L~l~~~~i~-~~~~-~~-~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~----~l~~l 111 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIK-SVQG-IQ-YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S----SLKDL 111 (291)
T ss_dssp HHHHHTCCEEECTTSCCC-CCTT-GG-GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G----GGTTC
T ss_pred hhhcCcccEEEccCCCcc-cChh-Hh-cCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h----hhccC
Confidence 346778888888888887 6654 43 78888889998888886544 88888889999998888763 2 24778
Q ss_pred CCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 247 TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
++|++|++++|++++ + +.+..+. +|++|++++|++++. ..+..+++|+.|++++|.+.+..| +..+++|+.|+
T Consensus 112 ~~L~~L~L~~n~i~~-~-~~l~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~ 184 (291)
T 1h6t_A 112 KKLKSLSLEHNGISD-I-NGLVHLP-QLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184 (291)
T ss_dssp TTCCEEECTTSCCCC-C-GGGGGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCC-C-hhhcCCC-CCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEE
Confidence 888888888888884 4 3566665 788888888888854 578888888888888888866544 78888888888
Q ss_pred ccCCcccccCCcccccccccccccccCcccee
Q 041479 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
+++|+++. +| .+..+++|+.|++++|+++.
T Consensus 185 L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 185 LSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 88888875 34 47888888888888888874
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=9.1e-22 Score=224.62 Aligned_cols=219 Identities=16% Similarity=0.116 Sum_probs=127.6
Q ss_pred cCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCC
Q 041479 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 247 (771)
...++|+.|+|++|+|+ .+|+.+. .+++|+.|++++|......|.. +..+.+.+.+|+.+ .+++
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~-~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l---~~l~ 409 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELE-SCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETL---QYFS 409 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHH-HHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHH---HHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHH-HHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHH---HHHH
Confidence 34566666666666665 6666665 5666666666554311111100 01111233334333 3344
Q ss_pred CCcEEE-ccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 248 YLEVVS-LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 248 ~L~~L~-Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
+|+.|+ ++.|.+. +|+.+++++|.|+...+ ..|+.|++++|.+.+ +|. ++.+++|+.|+
T Consensus 410 ~L~~L~~l~~n~~~------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~ 469 (567)
T 1dce_A 410 TLKAVDPMRAAYLD------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLD 469 (567)
T ss_dssp HHHHHCGGGHHHHH------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEE
T ss_pred hcccCcchhhcccc------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEee
Confidence 455444 4444332 34444455555543221 135556666665544 444 66666777777
Q ss_pred ccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCC-CcCCCCCCCCCeEECCCCccc
Q 041479 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPI-PLAVGNPKSIPHLDLSKNELS 404 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 404 (771)
|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .++.++.| .|+|++|+|++.. |..|+.+++|+.|+|++|+|+
T Consensus 470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 7777776 566677777777777777777775 44 56666666 6777777777665 777888888888888888888
Q ss_pred ccCCcchhhhhcccccccEEEC
Q 041479 405 GEIPSSLAWIFGYISIFAKLNL 426 (771)
Q Consensus 405 ~~~p~~l~~~~~~l~~L~~L~L 426 (771)
+.+| ....++..+++|+.||+
T Consensus 547 ~~~~-~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 547 QEEG-IQERLAEMLPSVSSILT 567 (567)
T ss_dssp GSSS-CTTHHHHHCTTCSEEEC
T ss_pred CCcc-HHHHHHHHCcccCccCC
Confidence 5554 33334445778888764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.8e-19 Score=201.13 Aligned_cols=180 Identities=27% Similarity=0.377 Sum_probs=131.4
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
+..+.+|+.|++++|.+. .+|. +. .+++|+.|+|++|+|++..| +..+++|+.|+|++|.|+++ | . +..+
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~~-l~-~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~---l~~l 108 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQG-IQ-YLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-S---LKDL 108 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCTT-GG-GCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-T---STTC
T ss_pred hhcCCCCCEEECcCCCCC-CChH-Hc-cCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-h---hccC
Confidence 456677788888888887 5653 43 67888888888888876544 77888888888888888753 2 2 3677
Q ss_pred CCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 247 TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
++|+.|+|++|.|++ + +.+..+. +|+.|+|++|+|++. ..|..+++|+.|+|++|.+.+..| +..+++|+.|+
T Consensus 109 ~~L~~L~Ls~N~l~~-l-~~l~~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 109 KKLKSLSLEHNGISD-I-NGLVHLP-QLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp TTCCEEECTTSCCCC-C-GGGGGCT-TCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred CCCCEEEecCCCCCC-C-ccccCCC-ccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 888888888888873 3 3466664 688888888888754 567788888888888888776655 77888888888
Q ss_pred ccCCcccccCCcccccccccccccccCccceecCCcccc
Q 041479 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALG 365 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 365 (771)
|++|+|++. ..+..+++|+.|+|++|++.+.....+.
T Consensus 182 Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~ 218 (605)
T 1m9s_A 182 LSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218 (605)
T ss_dssp CCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred CcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccc
Confidence 888888753 3577888888888888888754433333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=191.29 Aligned_cols=225 Identities=13% Similarity=0.097 Sum_probs=147.6
Q ss_pred ccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccc----cCCCCC
Q 041479 162 SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS----LTGLIP 237 (771)
Q Consensus 162 ~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~----l~~~~p 237 (771)
..+..+.++++|+.++|++ .++ .|++..|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+. ...+.+
T Consensus 92 ~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~ 169 (329)
T 3sb4_A 92 VVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH 169 (329)
T ss_dssp EETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT
T ss_pred cccccccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc
Confidence 3333444499999999998 887 7888888889999999999999988888889988888877776632 233333
Q ss_pred cCcccccCCCCCc-EEEccCccccccCChhhhhc---ccccceeecccCcCcccCcccc-cccCCcceEecCCccceecc
Q 041479 238 EDLDSLVNCTYLE-VVSLSVNSLSGTLPNSLANF---SSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIEKFILIRNI 312 (771)
Q Consensus 238 ~~~~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l---~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~ 312 (771)
.+| .++..|+ .+++.... .++..++.. ..++..+.+.++-.. .....+ ..+++|+.+++++|.+....
T Consensus 170 ~~f---~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~ 242 (329)
T 3sb4_A 170 FAF---IEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIP 242 (329)
T ss_dssp SCE---EESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEEC
T ss_pred ccc---ccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceec
Confidence 344 5566666 45554332 333333221 235666666655322 111111 23667777777777776666
Q ss_pred CccccCCCCCCEEEccCCcccccCCcccccccccc-cccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCC
Q 041479 313 PISVGYLLKLQVLSLFENNISREIPSSLGNFTFLT-ELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNP 390 (771)
Q Consensus 313 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l 390 (771)
+.+|.++++|+.|+|++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.+|..| .+++++|+++.+.+.+|.++
T Consensus 243 ~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~ 320 (329)
T 3sb4_A 243 DFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNG 320 (329)
T ss_dssp TTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTT
T ss_pred HhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCC
Confidence 667777777777777776 6656666777777777 777776 6665666677777666 66777777766666677777
Q ss_pred CCCCeEE
Q 041479 391 KSIPHLD 397 (771)
Q Consensus 391 ~~L~~L~ 397 (771)
++|+.++
T Consensus 321 ~~L~~ly 327 (329)
T 3sb4_A 321 VPSKLIY 327 (329)
T ss_dssp CCCCEEE
T ss_pred cchhhhc
Confidence 7777665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=212.42 Aligned_cols=192 Identities=20% Similarity=0.323 Sum_probs=113.4
Q ss_pred EccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCC
Q 041479 226 DFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEK 305 (771)
Q Consensus 226 ~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 305 (771)
+++.|.+. ..|+.| ..+++|+.|+|++|.+. .+|..++.+. +|++|+|++|.|+ .+|..|+++++|+.|+|++
T Consensus 207 ~~~~n~~~-~~~~~~---~~l~~L~~L~Ls~n~l~-~l~~~~~~l~-~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 279 (727)
T 4b8c_D 207 DDIENRMV-MPKDSK---YDDQLWHALDLSNLQIF-NISANIFKYD-FLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH 279 (727)
T ss_dssp -------------------CCCCCCEEECTTSCCS-CCCGGGGGCC-SCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred ccccccee-cChhhh---ccCCCCcEEECCCCCCC-CCChhhcCCC-CCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence 34445554 345444 66777888888888887 7777777765 7888888888888 7788888888888888888
Q ss_pred ccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce--eeecccCcccCCC
Q 041479 306 FILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL--WLDLSHNHLTGPI 383 (771)
Q Consensus 306 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l--~L~Ls~N~l~~~~ 383 (771)
|.+. .+|..++.+++|++|+|++|.|+ .+|..|+.+++|++|+|++|+|++.+|..+..+... .++|++|.+++.+
T Consensus 280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~ 357 (727)
T 4b8c_D 280 NRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL 357 (727)
T ss_dssp SCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred CcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence 8886 67888888888999999999887 678788889999999999999988888877665433 5788999998877
Q ss_pred CcCCCCCCCCCeEECCCC----cccccCCcchhhhhcccccccEEECcCCCCC
Q 041479 384 PLAVGNPKSIPHLDLSKN----ELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 384 p~~~~~l~~L~~L~Ls~N----~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
|.. |+.|++++| ...+.+|......+..+..+....+++|-+.
T Consensus 358 p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 358 PHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp CCC-----------------------------------------------CCC
T ss_pred ccc------cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 754 456677776 2233344333222334555566666777654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-18 Score=171.83 Aligned_cols=153 Identities=25% Similarity=0.293 Sum_probs=103.7
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcE
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEV 251 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~ 251 (771)
+.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+.+.+..| .++++|++
T Consensus 20 s~~~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~---~~l~~L~~ 92 (229)
T 3e6j_A 20 SGTTVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF---DSLTQLTV 92 (229)
T ss_dssp ETTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT---TTCTTCCE
T ss_pred eCCEeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc---ccCCCcCE
Confidence 4567888888887 7887554 778888888888888778888888888888888888877665555 66677777
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCc
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 331 (771)
|+|++|+|++..+..+..+. +|++|+|++|+|+ .+|..+.. +++|+.|+|++|+
T Consensus 93 L~Ls~N~l~~l~~~~~~~l~-~L~~L~Ls~N~l~-~lp~~~~~------------------------l~~L~~L~L~~N~ 146 (229)
T 3e6j_A 93 LDLGTNQLTVLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIER------------------------LTHLTHLALDQNQ 146 (229)
T ss_dssp EECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCC-SCCTTGGG------------------------CTTCSEEECCSSC
T ss_pred EECCCCcCCccChhHhCcch-hhCeEeccCCccc-ccCccccc------------------------CCCCCEEECCCCc
Confidence 77777777743333344444 6777777777766 44444444 4455555555555
Q ss_pred ccccCCcccccccccccccccCccce
Q 041479 332 ISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 332 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
|++..+..|..+++|+.|+|++|.+.
T Consensus 147 l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 147 LKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 55444445556666666666666655
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-19 Score=184.34 Aligned_cols=171 Identities=22% Similarity=0.309 Sum_probs=121.9
Q ss_pred CCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCC
Q 041479 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY 248 (771)
Q Consensus 169 ~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~ 248 (771)
++.+++.++++.|.++ .++ .+. .+++|+.|++++|+|+. +| .+..+++|+.|+|++|+|+++.+ + .++++
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~-~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l---~~l~~ 86 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQK-ELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--L---KDLTK 86 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHH-HHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--G---TTCSS
T ss_pred HHHHHHHHHhcCCCcc-ccc-chh-hcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--h---ccCCC
Confidence 4555666777777777 555 232 66777778888777774 44 57777778888888887776544 3 66777
Q ss_pred CcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEcc
Q 041479 249 LEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328 (771)
Q Consensus 249 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 328 (771)
|++|+|++|+++ .+|.... ++|++|++++|+|++. + .+..+++|+.|++++|.+.+. + .+..+++|+.|+|+
T Consensus 87 L~~L~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~ 158 (263)
T 1xeu_A 87 LEELSVNRNRLK-NLNGIPS---ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLH 158 (263)
T ss_dssp CCEEECCSSCCS-CCTTCCC---SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECT
T ss_pred CCEEECCCCccC-CcCcccc---CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECC
Confidence 788888888777 3444322 3688888888888753 3 477777888888888777554 3 57778888888888
Q ss_pred CCcccccCCcccccccccccccccCccceec
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGS 359 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 359 (771)
+|++++. ..+..+++|+.|++++|++++.
T Consensus 159 ~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 159 GNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 8888755 6678888888888888888754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.1e-19 Score=182.36 Aligned_cols=169 Identities=20% Similarity=0.272 Sum_probs=91.3
Q ss_pred CCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCC
Q 041479 66 NLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGP 145 (771)
Q Consensus 66 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 145 (771)
.+.++..+++++|.+++ ++ .+..+++|++|++++|.++ .+| .+..+++|+.|+|++|+|++
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~---------------~l~-~l~~l~~L~~L~L~~N~i~~- 77 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ---------------SLA-GMQFFTNLKELHLSHNQISD- 77 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC---------------CCT-TGGGCTTCCEEECCSSCCCC-
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc---------------cch-HHhhCCCCCEEECCCCccCC-
Confidence 45556666677777764 33 4666677777777777654 233 45556666666666665552
Q ss_pred CCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEE
Q 041479 146 IPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWL 225 (771)
Q Consensus 146 lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 225 (771)
++. +.++++|++|++++|+++ .+|... . ++|+.|+|++|+|++. +.+..+++|+.|
T Consensus 78 -----------------~~~-l~~l~~L~~L~L~~N~l~-~l~~~~--~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L 133 (263)
T 1xeu_A 78 -----------------LSP-LKDLTKLEELSVNRNRLK-NLNGIP--S-ACLSRLFLDNNELRDT--DSLIHLKNLEIL 133 (263)
T ss_dssp -----------------CGG-GTTCSSCCEEECCSSCCS-CCTTCC--C-SSCCEEECCSSCCSBS--GGGTTCTTCCEE
T ss_pred -----------------Chh-hccCCCCCEEECCCCccC-CcCccc--c-CcccEEEccCCccCCC--hhhcCcccccEE
Confidence 222 555666666666666665 344322 1 5556666666655542 235555555555
Q ss_pred EccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 226 DFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 226 ~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+|++|+|+++ + . +..+++|+.|++++|++++. ..+..+. +|+.|++++|+++
T Consensus 134 ~Ls~N~i~~~-~-~---l~~l~~L~~L~L~~N~i~~~--~~l~~l~-~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 134 SIRNNKLKSI-V-M---LGFLSKLEVLDLHGNEITNT--GGLTRLK-KVNWIDLTGQKCV 185 (263)
T ss_dssp ECTTSCCCBC-G-G---GGGCTTCCEEECTTSCCCBC--TTSTTCC-CCCEEEEEEEEEE
T ss_pred ECCCCcCCCC-h-H---HccCCCCCEEECCCCcCcch--HHhccCC-CCCEEeCCCCccc
Confidence 5555555543 1 1 24455555555555555532 3333333 4555555555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-18 Score=166.11 Aligned_cols=154 Identities=19% Similarity=0.228 Sum_probs=77.6
Q ss_pred cCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCC
Q 041479 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 247 (771)
..+++|+.|++++|.++ .+| .+. .+++|++|++++|.++. +..+..+++|++|++++|++++..|..+ ..++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~-~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l---~~l~ 112 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIE-YAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNL---SGLT 112 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGG-GCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCC---TTCT
T ss_pred hhcCCccEEeccCCCcc-ChH-HHh-cCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhh---cCCC
Confidence 34455555555555555 454 232 45555555555554431 2245555555555555555554333333 4444
Q ss_pred CCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEc
Q 041479 248 YLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSL 327 (771)
Q Consensus 248 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 327 (771)
+|++|++++|++++..|.. |+.+++|+.|++++|...+.+| .+..+++|+.|++
T Consensus 113 ~L~~L~Ls~n~i~~~~~~~-------------------------l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l 166 (197)
T 4ezg_A 113 SLTLLDISHSAHDDSILTK-------------------------INTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNI 166 (197)
T ss_dssp TCCEEECCSSBCBGGGHHH-------------------------HTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEEC
T ss_pred CCCEEEecCCccCcHhHHH-------------------------HhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEEC
Confidence 5555555555554434444 4444444444444444223333 4555666666666
Q ss_pred cCCcccccCCcccccccccccccccCccce
Q 041479 328 FENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 328 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
++|+++. ++ .+..+++|++|++++|+|.
T Consensus 167 ~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 167 QFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp TTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 6666653 33 5666666777777766664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.6e-18 Score=175.43 Aligned_cols=133 Identities=20% Similarity=0.164 Sum_probs=101.1
Q ss_pred ccccccccceEEEEEecCCCeE--EEEEEeeccch------------------------hhHHHHHHHHHHHhccCCCCc
Q 041479 527 VSYESLVKATVYKGILDLDQTF--IAVKVLFLHQR------------------------GALKSFMAECQALRNIRHRNL 580 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~--vAvK~~~~~~~------------------------~~~~~~~~E~~~l~~l~H~nI 580 (771)
..+|+|.+|.||+|++..+++. ||||+++.... .....+.+|++++.+++|++|
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999666778 99998754311 112468899999999988754
Q ss_pred --eeEEEEeecCCCCCceeEEEEEEeccC-C----CCCCCcccCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCC
Q 041479 581 --VKIITACSTSDFQGNYFRALVYEFMHH-G----SLESCPRILSFLRRLNIAIDVASALEYLH-HHCKKPIVHCDLKPS 652 (771)
Q Consensus 581 --v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrdlk~~ 652 (771)
...+++ . ..++||||+.+ | +|.+.....++.+...++.|++.|+.||| +. +|+||||||+
T Consensus 133 ~~p~~~~~--~-------~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~ 200 (258)
T 1zth_A 133 SVPQPYTY--M-------KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEY 200 (258)
T ss_dssp CCCCEEEE--E-------TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTT
T ss_pred CCCeEEEc--C-------CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHH
Confidence 444432 1 24899999942 4 34333222334567899999999999999 64 9999999999
Q ss_pred CeeeCCCCceEEecccCcccc
Q 041479 653 NVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 653 NILl~~~~~~kl~DfGla~~~ 673 (771)
|||++. .++|+|||+|...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999998 8999999999754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=163.01 Aligned_cols=151 Identities=13% Similarity=0.205 Sum_probs=123.2
Q ss_pred CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCE
Q 041479 145 PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEW 224 (771)
Q Consensus 145 ~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 224 (771)
.++.|+.+++++|.++ .+| .+..+++|++|++++|.++ .++ .+. .+++|++|++++|++++..|..|..+++|++
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~-~l~-~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN-PIS-GLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG-GGT-TCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch-hhh-cCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 4567999999999998 556 6899999999999999886 554 454 8999999999999999888999999999999
Q ss_pred EEccccccCCCCCcCcccccCCCCCcEEEccCcc-ccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEec
Q 041479 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNS-LSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAI 303 (771)
Q Consensus 225 L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 303 (771)
|++++|++++..|..+ ..+++|++|++++|. ++ .+| .+..++ +|++|++++|++++ ++ .+..+++|+.|++
T Consensus 117 L~Ls~n~i~~~~~~~l---~~l~~L~~L~L~~n~~i~-~~~-~l~~l~-~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l 188 (197)
T 4ezg_A 117 LDISHSAHDDSILTKI---NTLPKVNSIDLSYNGAIT-DIM-PLKTLP-ELKSLNIQFDGVHD-YR-GIEDFPKLNQLYA 188 (197)
T ss_dssp EECCSSBCBGGGHHHH---TTCSSCCEEECCSCTBCC-CCG-GGGGCS-SCCEEECTTBCCCC-CT-TGGGCSSCCEEEE
T ss_pred EEecCCccCcHhHHHH---hhCCCCCEEEccCCCCcc-ccH-hhcCCC-CCCEEECCCCCCcC-hH-HhccCCCCCEEEe
Confidence 9999999998666655 788999999999998 65 666 567765 79999999999884 33 5666666666666
Q ss_pred CCccc
Q 041479 304 EKFIL 308 (771)
Q Consensus 304 ~~n~l 308 (771)
++|++
T Consensus 189 ~~N~i 193 (197)
T 4ezg_A 189 FSQTI 193 (197)
T ss_dssp CBC--
T ss_pred eCccc
Confidence 65554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=162.53 Aligned_cols=130 Identities=22% Similarity=0.234 Sum_probs=79.0
Q ss_pred cceeecccCcCcccCcccccccCCcceEecCCccceeccCc-cccCCCCCCEEEccCCcccccCCccccccccccccccc
Q 041479 274 LRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPI-SVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352 (771)
Q Consensus 274 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 352 (771)
-+.+++++|.++ .+|..+.. +|+.|++++|.+.+..+. .+..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 367888888886 55654433 666666666666554443 35666666666666666666656666666666666666
Q ss_pred CccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc
Q 041479 353 GNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406 (771)
Q Consensus 353 ~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 406 (771)
+|+|++..+..|..++.| .|+|++|+|++..|..|..+++|++|+|++|++++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 666665555555555555 555555555555555555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=4.5e-17 Score=159.30 Aligned_cols=127 Identities=22% Similarity=0.267 Sum_probs=60.0
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCcccCcc-cccccCCcceEecCCccceeccCccccCCCCCCEEEcc
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPT-EIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 328 (771)
+.+++++|.++ .+|..+.. +|++|++++|+|++..+. .|..+++|+.|++++|.+.+..|..|..+++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~---~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL---HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT---TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC---CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 34444555443 44443321 344455555554433332 24444555555555554444444444444555555555
Q ss_pred CCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCccc
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLT 380 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~ 380 (771)
+|+|++..|..|..+++|++|+|++|+|++..|..+..++.| .|+|++|.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 555544444444444555555555555544444444444444 4455555444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-17 Score=176.79 Aligned_cols=227 Identities=12% Similarity=0.088 Sum_probs=145.7
Q ss_pred cCChhhhhC--------CCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCc
Q 041479 186 ELPPHIGFT--------LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVN 257 (771)
Q Consensus 186 ~lp~~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N 257 (771)
.+|+..|.+ +++|+.|+|++ .++.+.+.+|.++++|+.|++++|.++.+.+.+| .++.++..+.+..+
T Consensus 83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF---~~~~~l~~l~~~~~ 158 (329)
T 3sb4_A 83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEAL---ADSVTAIFIPLGSS 158 (329)
T ss_dssp EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSS---CTTTCEEEECTTCT
T ss_pred ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhh---cCCCceEEecCcch
Confidence 455666666 78888888888 7777777788888888888888888877766666 55666666665553
Q ss_pred ccc----ccCChhhhhcccccc-eeecccCcCcccCccc----ccccCCcceEecCCccceeccCccccCCCCCCEEEcc
Q 041479 258 SLS----GTLPNSLANFSSHLR-YLYMSANPISGSIPTE----IGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328 (771)
Q Consensus 258 ~l~----~~~p~~~~~l~~~L~-~L~Ls~N~l~~~~p~~----~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 328 (771)
... ..-+..|.... +|+ .+.+.... .++.. -....++..+.+.++........-...+++|+.|+|+
T Consensus 159 ~~~~~~~~i~~~~f~~~~-~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~ 234 (329)
T 3sb4_A 159 DAYRFKNRWEHFAFIEGE-PLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDIS 234 (329)
T ss_dssp HHHHTSTTTTTSCEEESC-CCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECT
T ss_pred hhhhcccccccccccccc-ccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECC
Confidence 221 00111122221 233 23232211 11111 1123444555554432111111111237889999999
Q ss_pred CCcccccCCcccccccccccccccCccceecCCcccccccce--eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL--WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l--~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 406 (771)
+|+++.+.+.+|.++++|+.|+|.+| ++.+.+.+|..|..| .+++.+ +++.+.+.+|.++++|+.+++++|+++..
T Consensus 235 ~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I 312 (329)
T 3sb4_A 235 KTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTL 312 (329)
T ss_dssp TBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEE
T ss_pred CCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCcc
Confidence 88888777778889999999999888 777788888888877 588877 77777778888888888888888888855
Q ss_pred CCcchhhhhcccccccEEEC
Q 041479 407 IPSSLAWIFGYISIFAKLNL 426 (771)
Q Consensus 407 ~p~~l~~~~~~l~~L~~L~L 426 (771)
.+.+ |.++++|+.|+.
T Consensus 313 ~~~a----F~~~~~L~~ly~ 328 (329)
T 3sb4_A 313 GDEL----FGNGVPSKLIYK 328 (329)
T ss_dssp CTTT----TCTTCCCCEEEC
T ss_pred chhh----hcCCcchhhhcc
Confidence 5554 447888887763
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.65 E-value=4.4e-15 Score=162.02 Aligned_cols=267 Identities=11% Similarity=0.071 Sum_probs=178.3
Q ss_pred cCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcC
Q 041479 65 GNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG 144 (771)
Q Consensus 65 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 144 (771)
..+..++.+.+.+ .++.+-..+|.+. +|+.+++..| ++ ..-...|.+ .+|+.+.+.+ .++
T Consensus 110 ~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~--------------~I~~~aF~~-~~L~~i~lp~-~l~- 169 (401)
T 4fdw_A 110 EILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK--------------SIGDMAFFN-STVQEIVFPS-TLE- 169 (401)
T ss_dssp EECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC--------------EECTTTTTT-CCCCEEECCT-TCC-
T ss_pred EecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc--------------EECHHhcCC-CCceEEEeCC-Ccc-
Confidence 3456677777764 3555566677774 6888887665 33 133345555 3577776654 222
Q ss_pred CCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCE
Q 041479 145 PIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEW 224 (771)
Q Consensus 145 ~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 224 (771)
..-+..|.++++|+.++++.|+++ .+|...| ...+|+.+.|..| ++.+...+|.++++|+.
T Consensus 170 ----------------~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF-~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~ 230 (401)
T 4fdw_A 170 ----------------QLKEDIFYYCYNLKKADLSKTKIT-KLPASTF-VYAGIEEVLLPVT-LKEIGSQAFLKTSQLKT 230 (401)
T ss_dssp ----------------EECSSTTTTCTTCCEEECTTSCCS-EECTTTT-TTCCCSEEECCTT-CCEECTTTTTTCTTCCC
T ss_pred ----------------EehHHHhhCcccCCeeecCCCcce-EechhhE-eecccCEEEeCCc-hheehhhHhhCCCCCCE
Confidence 233456777788888888888877 7777777 3577888888744 66677777888888888
Q ss_pred EEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCc-----ccCcccccccCCcc
Q 041479 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS-----GSIPTEIGNLKNLI 299 (771)
Q Consensus 225 L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~ 299 (771)
+++..| ++.+...+| .+ .+|+.+.+ .|.++..-+..|.++ ++|+.+++.+|.+. .+.+..|.++++|+
T Consensus 231 l~l~~~-l~~I~~~aF---~~-~~L~~i~l-p~~i~~I~~~aF~~c-~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~ 303 (401)
T 4fdw_A 231 IEIPEN-VSTIGQEAF---RE-SGITTVKL-PNGVTNIASRAFYYC-PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA 303 (401)
T ss_dssp EECCTT-CCEECTTTT---TT-CCCSEEEE-ETTCCEECTTTTTTC-TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred EecCCC-ccCcccccc---cc-CCccEEEe-CCCccEEChhHhhCC-CCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence 888765 555555555 44 56777777 344552333444444 36888888777664 45567788888888
Q ss_pred eEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCccccccc-ce-eeecccC
Q 041479 300 IIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCH-QL-WLDLSHN 377 (771)
Q Consensus 300 ~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~l-~L~Ls~N 377 (771)
.+.+.+ .+...-..+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|..+. .+ .|++..|
T Consensus 304 ~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~ 380 (401)
T 4fdw_A 304 RFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAE 380 (401)
T ss_dssp EECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred eEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHH
Confidence 888874 465666677888888888888554 666667788888 888888888888766667777664 34 5666666
Q ss_pred ccc
Q 041479 378 HLT 380 (771)
Q Consensus 378 ~l~ 380 (771)
.+.
T Consensus 381 ~~~ 383 (401)
T 4fdw_A 381 SVE 383 (401)
T ss_dssp GHH
T ss_pred HHH
Confidence 543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-16 Score=148.79 Aligned_cols=38 Identities=13% Similarity=0.127 Sum_probs=19.5
Q ss_pred CCCcEEEcCCCccc-ccCCccccCCCCCCEEecccCcCc
Q 041479 68 TFLRLINLQQNNFS-SNIPHEIGRLFRLRHIIFNSNALQ 105 (771)
Q Consensus 68 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~ 105 (771)
++|++|+|++|.++ +.+|..|..+++|++|++++|.++
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~ 62 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI 62 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC
Confidence 44555555555554 334544555555555555555543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.8e-16 Score=152.73 Aligned_cols=113 Identities=27% Similarity=0.284 Sum_probs=71.6
Q ss_pred CCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECC
Q 041479 321 KLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLS 399 (771)
Q Consensus 321 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 399 (771)
+|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|..++.| .|+|++|+|++..|..|..+++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4555555555555 445555555666666666666655555556666555 56666666666666677777777777777
Q ss_pred CCcccccCCcchhhhhcccccccEEECcCCCCCCCCCcc
Q 041479 400 KNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRK 438 (771)
Q Consensus 400 ~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 438 (771)
+|+|+...+..+. .+++|+.|+|++|++.|.+.-.
T Consensus 111 ~N~l~~~~~~~~~----~l~~L~~L~L~~N~~~C~c~l~ 145 (193)
T 2wfh_A 111 GNDISVVPEGAFN----DLSALSHLAIGANPLYCDCNMQ 145 (193)
T ss_dssp SSCCCBCCTTTTT----TCTTCCEEECCSSCEECSGGGH
T ss_pred CCCCCeeChhhhh----cCccccEEEeCCCCeecCCcCH
Confidence 7777754444433 6777777888888777766543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.3e-16 Score=146.43 Aligned_cols=108 Identities=22% Similarity=0.245 Sum_probs=68.8
Q ss_pred CCCCcEEEeecCccc-ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccc
Q 041479 195 LPNVRILLLAGNQFF-GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSH 273 (771)
Q Consensus 195 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~ 273 (771)
.++|+.|++++|+|+ +.+|..|..+++|++|++++|.|++. ..+ ..+++|++|++++|++++.+|..+..++ +
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~ 96 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNL---PKLPKLKKLELSENRIFGGLDMLAEKLP-N 96 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSC---CCCSSCCEEEEESCCCCSCCCHHHHHCT-T
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhh---ccCCCCCEEECcCCcCchHHHHHHhhCC-C
Confidence 356777777777776 55666677777777777777777755 333 6667777777777777755666655554 6
Q ss_pred cceeecccCcCcccCc-ccccccCCcceEecCCccc
Q 041479 274 LRYLYMSANPISGSIP-TEIGNLKNLIIIAIEKFIL 308 (771)
Q Consensus 274 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l 308 (771)
|++|++++|+|++..+ ..+..+++|+.|++++|.+
T Consensus 97 L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp CCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGG
T ss_pred CCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcC
Confidence 8888888887774321 3444444444444444433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.9e-15 Score=159.60 Aligned_cols=222 Identities=16% Similarity=0.148 Sum_probs=107.7
Q ss_pred ccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCccccc
Q 041479 165 IQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLV 244 (771)
Q Consensus 165 ~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (771)
..|.+. +|+.+.+..| ++ .++...|.+ .+|+.+.+.. .++.+.+.+|.++++|+.++|++|+++.+...+| .
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF---~ 201 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTF---V 201 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTT---T
T ss_pred hhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhE---e
Confidence 344442 4555555544 44 455555533 3455555553 4444555555555555555555555554444443 2
Q ss_pred CCCCCcEEEccCccccccCCh-hhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCC
Q 041479 245 NCTYLEVVSLSVNSLSGTLPN-SLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQ 323 (771)
Q Consensus 245 ~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~ 323 (771)
+++|+.+.+..+ ++ .++. .|.+. ++|+.+++..| ++.+...+|.+ .+|+.+.+. +.+...-+.+|..+++|+
T Consensus 202 -~~~L~~l~lp~~-l~-~I~~~aF~~~-~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~ 274 (401)
T 4fdw_A 202 -YAGIEEVLLPVT-LK-EIGSQAFLKT-SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELA 274 (401)
T ss_dssp -TCCCSEEECCTT-CC-EECTTTTTTC-TTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCC
T ss_pred -ecccCEEEeCCc-hh-eehhhHhhCC-CCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCC
Confidence 345555555533 44 2222 22232 24555555543 33344444544 455555552 233333444555555555
Q ss_pred EEEccCCccc-----ccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEE
Q 041479 324 VLSLFENNIS-----REIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLD 397 (771)
Q Consensus 324 ~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 397 (771)
.+++.+|.+. ...+..|.++++|+.++|. |.++.+...+|.+|..| .++|..| ++.+.+.+|.++ +|+.++
T Consensus 275 ~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~ 351 (401)
T 4fdw_A 275 EVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVK 351 (401)
T ss_dssp EEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEE
T ss_pred EEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEE
Confidence 5555554443 2344455555555555555 23444444555555555 4555333 444444455555 555555
Q ss_pred CCCCccc
Q 041479 398 LSKNELS 404 (771)
Q Consensus 398 Ls~N~l~ 404 (771)
+++|.+.
T Consensus 352 l~~n~~~ 358 (401)
T 4fdw_A 352 VEGTTPP 358 (401)
T ss_dssp ECCSSCC
T ss_pred EcCCCCc
Confidence 5555444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=147.92 Aligned_cols=126 Identities=31% Similarity=0.375 Sum_probs=86.7
Q ss_pred CEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEE
Q 041479 174 EYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVS 253 (771)
Q Consensus 174 ~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~ 253 (771)
+.+++++|+++ .+|..++ ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|+++.+..| .++++|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f---~~l~~L~~L~ 84 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF---SNMTQLLTLI 84 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTT---TTCTTCCEEE
T ss_pred CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHc---cCCCCCCEEE
Confidence 56788888887 7776554 57888888888887 566778888888888888888887766655 6667777777
Q ss_pred ccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccc
Q 041479 254 LSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL 308 (771)
Q Consensus 254 Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 308 (771)
|++|+|++..|..|..+. +|++|+|++|+|++..+..|..+++|+.|++++|.+
T Consensus 85 Ls~N~l~~i~~~~f~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 85 LSYNRLRCIPPRTFDGLK-SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCSSCCCBCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCCCccCEeCHHHhCCCC-CCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 777777755555565554 677777777777654444555555555555544444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=142.80 Aligned_cols=38 Identities=8% Similarity=0.050 Sum_probs=21.6
Q ss_pred CCCcEEEcCCCccc-ccCCccccCCCCCCEEecccCcCc
Q 041479 68 TFLRLINLQQNNFS-SNIPHEIGRLFRLRHIIFNSNALQ 105 (771)
Q Consensus 68 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~ 105 (771)
++|+.|++++|.++ +.+|..|..+++|++|++++|.++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 55 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT 55 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC
Confidence 45556666666655 445555555555555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=4.3e-15 Score=143.14 Aligned_cols=128 Identities=16% Similarity=0.155 Sum_probs=81.1
Q ss_pred CCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEE
Q 041479 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVV 252 (771)
Q Consensus 173 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L 252 (771)
.+.+++++|+++ .+|..++ ++|+.|++++|++++..+..|..+++|++|+|++|+|+++.+..| .++++|++|
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~l~~L~~L 81 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVF---DKLTKLTIL 81 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT---TTCTTCCEE
T ss_pred CCEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHc---cCCCccCEE
Confidence 466777777777 6775443 577777777777776666667777777777777777776655544 566677777
Q ss_pred EccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccc
Q 041479 253 SLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFIL 308 (771)
Q Consensus 253 ~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 308 (771)
++++|+|++..+..+..+. +|++|++++|+|++..+..|..+++|+.|++++|.+
T Consensus 82 ~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 136 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLT-QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 136 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECCCCCccccCHHHhhCCc-ccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCe
Confidence 7777777644333344443 566666666666644444444444444444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.1e-15 Score=140.89 Aligned_cols=106 Identities=25% Similarity=0.278 Sum_probs=65.6
Q ss_pred CCCcEEEeecCccc-ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhccccc
Q 041479 196 PNVRILLLAGNQFF-GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHL 274 (771)
Q Consensus 196 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L 274 (771)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. .. +..+++|++|++++|++++.+|..+..+. +|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~---~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L 90 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--AN---LPKLNKLKKLELSDNRVSGGLEVLAEKCP-NL 90 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TT---CCCCTTCCEEECCSSCCCSCTHHHHHHCT-TC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hh---hhcCCCCCEEECCCCcccchHHHHhhhCC-CC
Confidence 56777777777776 56666777777777777777777755 23 36667777777777777755665555554 67
Q ss_pred ceeecccCcCccc-CcccccccCCcceEecCCcc
Q 041479 275 RYLYMSANPISGS-IPTEIGNLKNLIIIAIEKFI 307 (771)
Q Consensus 275 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~n~ 307 (771)
++|++++|++++. .+..+..+++|+.|++++|.
T Consensus 91 ~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCG
T ss_pred CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCc
Confidence 7777777777642 12334444433333333333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=6e-15 Score=142.09 Aligned_cols=62 Identities=21% Similarity=0.204 Sum_probs=29.5
Q ss_pred eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCC
Q 041479 371 WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436 (771)
Q Consensus 371 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p 436 (771)
.|++++|++++..+..|..+++|++|+|++|+|++..+..+ ..+++|+.|+|++|+++|.+|
T Consensus 80 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 80 ILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIF----DRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT----TTCTTCCEEECCSSCBCCCHH
T ss_pred EEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHh----cCCcccCEEEecCCCeeccCc
Confidence 33333333333334444455555555555555553333222 245555555555555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.8e-17 Score=160.71 Aligned_cols=65 Identities=28% Similarity=0.294 Sum_probs=31.5
Q ss_pred cCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccccccCCC
Q 041479 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIP-HSISNASKLEWLDFANNSLTGL 235 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 235 (771)
..+++|++|++++|+++ .+| .+. .+++|++|++++|+|++..+ ..+..+++|++|++++|.+++.
T Consensus 90 ~~~~~L~~L~L~~N~l~-~l~-~~~-~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 90 AVADTLEELWISYNQIA-SLS-GIE-KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHHCSEEEEEEEECC-CHH-HHH-HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred hcCCcCCEEECcCCcCC-cCC-ccc-cCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 33444555555555554 233 222 44555555555555553222 2455555555555555555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.8e-13 Score=147.09 Aligned_cols=311 Identities=11% Similarity=0.032 Sum_probs=167.2
Q ss_pred CcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEE
Q 041479 56 LTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGL 135 (771)
Q Consensus 56 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L 135 (771)
++.+...+|.++++|+.+.|.. .++.+-..+|.++++|+.++|..+ ++ ..-...|.++.+|+.+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~--------------~I~~~aF~~c~~L~~i 122 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK--------------MIGRCTFSGCYALKSI 122 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC--------------EECTTTTTTCTTCCCC
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce--------------Eccchhhcccccchhh
Confidence 5556677888888899998874 477666778888999998888755 22 1233456677777766
Q ss_pred ecccccCc---CCCCcccee-eecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccccc
Q 041479 136 GLANNYFT---GPIPHLNMF-QVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGN 211 (771)
Q Consensus 136 ~Ls~N~l~---~~lp~L~~l-~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~ 211 (771)
.+..+--. ..+...... ......+...-...|.++++|+.+.+.++. . .++...|.++++|+.+.+..| ++.+
T Consensus 123 ~~p~~l~~i~~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~-~I~~~~F~~c~~L~~i~l~~~-~~~I 199 (394)
T 4fs7_A 123 LLPLMLKSIGVEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-E-TLHNGLFSGCGKLKSIKLPRN-LKII 199 (394)
T ss_dssp CCCTTCCEECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-C-EECTTTTTTCTTCCBCCCCTT-CCEE
T ss_pred cccCceeeecceeeecccccccccCccccccchhhhcccCCCcEEecCCcc-c-eeccccccCCCCceEEEcCCC-ceEe
Confidence 65543111 000000000 000011111223456666666666665443 3 455666656666666666655 4445
Q ss_pred CCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCCh-hhhhcccccceeecccCcCcccCcc
Q 041479 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPN-SLANFSSHLRYLYMSANPISGSIPT 290 (771)
Q Consensus 212 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~~L~~L~Ls~N~l~~~~p~ 290 (771)
...+|.++..|+.+.+..+... + .+.+ ...+.|+.+.+..+. + .+.. .+... .+|+.+.+..+... ....
T Consensus 200 ~~~~F~~~~~L~~i~~~~~~~~-i-~~~~---~~~~~l~~i~ip~~~-~-~i~~~~f~~~-~~l~~~~~~~~~~~-i~~~ 270 (394)
T 4fs7_A 200 RDYCFAECILLENMEFPNSLYY-L-GDFA---LSKTGVKNIIIPDSF-T-ELGKSVFYGC-TDLESISIQNNKLR-IGGS 270 (394)
T ss_dssp CTTTTTTCTTCCBCCCCTTCCE-E-CTTT---TTTCCCCEEEECTTC-C-EECSSTTTTC-SSCCEEEECCTTCE-ECSC
T ss_pred CchhhccccccceeecCCCceE-e-ehhh---cccCCCceEEECCCc-e-eccccccccc-ccceeEEcCCCcce-eecc
Confidence 5556666666666666554332 1 1111 233455555554332 2 2222 22232 35666666555443 4455
Q ss_pred cccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce
Q 041479 291 EIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL 370 (771)
Q Consensus 291 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 370 (771)
.|..+..++.+....+.+ ....|..+.+|+.+.+.++ ++.+...+|.++++|+.++|.++ ++.+...+|.+|..|
T Consensus 271 ~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L 345 (394)
T 4fs7_A 271 LFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL 345 (394)
T ss_dssp TTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred ccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence 566666666665554322 2234555666666666543 44444556666666666666433 554555566666665
Q ss_pred -eeecccCcccCCCCcCCCCCCCCCeEECCC
Q 041479 371 -WLDLSHNHLTGPIPLAVGNPKSIPHLDLSK 400 (771)
Q Consensus 371 -~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 400 (771)
.+++..| ++.....+|.++++|+.+++..
T Consensus 346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 346 SNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred CEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 5566544 4444455666666666666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=9.3e-15 Score=140.65 Aligned_cols=90 Identities=16% Similarity=0.269 Sum_probs=39.4
Q ss_pred CCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCc--cccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPH--SISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 169 ~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
.+++|++|++++|+++ .+|+.++..+++|++|+|++|+|+. +|. .+..+++|+.|++++|.++...+.....+..+
T Consensus 62 ~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l 139 (176)
T 1a9n_A 62 LLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKV 139 (176)
T ss_dssp CCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHC
T ss_pred cCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHC
Confidence 3444444444444444 3343333344455555555555432 222 44455555555555555543221100012444
Q ss_pred CCCcEEEccCcccc
Q 041479 247 TYLEVVSLSVNSLS 260 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~ 260 (771)
++|+.||++.|.+.
T Consensus 140 ~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 140 PQVRVLDFQKVKLK 153 (176)
T ss_dssp TTCSEETTEECCHH
T ss_pred CccceeCCCcCCHH
Confidence 55555555555543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=9.1e-15 Score=140.72 Aligned_cols=111 Identities=21% Similarity=0.211 Sum_probs=66.0
Q ss_pred cccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccC
Q 041479 166 QLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN 245 (771)
Q Consensus 166 ~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 245 (771)
.+.++.+|+.|++++|+++ .+|. +....++|++|+|++|+|++. ..|..+++|++|+|++|+|+++.+..| ..
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~---~~ 86 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLD---QA 86 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHH---HH
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchh---hc
Confidence 3556667777777777776 5553 332334677777777777654 456666666666666666665544333 44
Q ss_pred CCCCcEEEccCccccccCCh--hhhhcccccceeecccCcCc
Q 041479 246 CTYLEVVSLSVNSLSGTLPN--SLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 246 l~~L~~L~Ls~N~l~~~~p~--~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+++|++|++++|+|+ .+|. .+..++ +|+.|++++|.++
T Consensus 87 l~~L~~L~L~~N~i~-~~~~~~~l~~l~-~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 87 LPDLTELILTNNSLV-ELGDLDPLASLK-SLTYLCILRNPVT 126 (176)
T ss_dssp CTTCCEEECCSCCCC-CGGGGGGGGGCT-TCCEEECCSSGGG
T ss_pred CCCCCEEECCCCcCC-cchhhHhhhcCC-CCCEEEecCCCCC
Confidence 566666666666664 4444 444443 4666666666555
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-13 Score=148.26 Aligned_cols=311 Identities=13% Similarity=0.024 Sum_probs=212.9
Q ss_pred cccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCc-------CCCCccce
Q 041479 79 NFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFT-------GPIPHLNM 151 (771)
Q Consensus 79 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------~~lp~L~~ 151 (771)
.++.+-..+|.++++|+.+.|..+ ++ ..-..+|.++++|+.+++.++ ++ ...+.|+.
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~--------------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~ 121 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VR--------------EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKS 121 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CC--------------EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCC
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-cc--------------CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchh
Confidence 466666788999999999999754 33 244567999999999999765 33 11223333
Q ss_pred eeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccc
Q 041479 152 FQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNS 231 (771)
Q Consensus 152 l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 231 (771)
+.+.. ++...-...|.+...+...... .+. .+....|.++++|+.+.+..+. ..+....|.++.+|+.+++..|
T Consensus 122 i~~p~-~l~~i~~~aF~~~~~~~~~~~~--~~~-~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~- 195 (394)
T 4fs7_A 122 ILLPL-MLKSIGVEAFKGCDFKEITIPE--GVT-VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN- 195 (394)
T ss_dssp CCCCT-TCCEECTTTTTTCCCSEEECCT--TCC-EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-
T ss_pred hcccC-ceeeecceeeecccccccccCc--ccc-ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-
Confidence 33322 2332333445554433332222 222 4555666678888888887654 3466778888888888888776
Q ss_pred cCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceec
Q 041479 232 LTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN 311 (771)
Q Consensus 232 l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~ 311 (771)
++.+...+| .++..|+.+.+..+... +.+.++... +|+.+.+..+ ++......|.++.+|+.+.+..+.. ..
T Consensus 196 ~~~I~~~~F---~~~~~L~~i~~~~~~~~--i~~~~~~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i 267 (394)
T 4fs7_A 196 LKIIRDYCF---AECILLENMEFPNSLYY--LGDFALSKT-GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RI 267 (394)
T ss_dssp CCEECTTTT---TTCTTCCBCCCCTTCCE--ECTTTTTTC-CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EE
T ss_pred ceEeCchhh---ccccccceeecCCCceE--eehhhcccC-CCceEEECCC-ceecccccccccccceeEEcCCCcc-ee
Confidence 554545455 67777887777766543 333333333 6888887644 4435567788899999998877543 45
Q ss_pred cCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCC
Q 041479 312 IPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNP 390 (771)
Q Consensus 312 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l 390 (771)
....|..+..++.+....+.+ ....|..+.+|+.+.+.++ ++.+...+|.++..| .+++.++ ++.+...+|.++
T Consensus 268 ~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c 342 (394)
T 4fs7_A 268 GGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC 342 (394)
T ss_dssp CSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred eccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence 566788888999888877654 3457888899999999765 776778889999988 8888754 776777899999
Q ss_pred CCCCeEECCCCcccccCCcchhhhhcccccccEEECcCC
Q 041479 391 KSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYN 429 (771)
Q Consensus 391 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N 429 (771)
++|+.+++..| ++..-..+ |.++.+|+.+++..+
T Consensus 343 ~~L~~i~lp~~-l~~I~~~a----F~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 343 TSLSNINFPLS-LRKIGANA----FQGCINLKKVELPKR 376 (394)
T ss_dssp TTCCEECCCTT-CCEECTTT----BTTCTTCCEEEEEGG
T ss_pred CCCCEEEECcc-ccEehHHH----hhCCCCCCEEEECCC
Confidence 99999999877 66333444 558899999988644
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=3.8e-16 Score=153.52 Aligned_cols=156 Identities=25% Similarity=0.296 Sum_probs=79.9
Q ss_pred ccCCCCCCEEecccCcCcccCCh------hhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCc
Q 041479 167 LLNITSMEYFHVSENQLVGELPP------HIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL 240 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 240 (771)
+.....++.++++.|.++|.+|. .+. .+++|++|+|++|+|++ +| .+..+++|+.|++++|+|+. +|..+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~-~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLS-TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHH-HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHh-cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchh
Confidence 34455666666666666665554 333 55555555555555554 33 55555555555555555553 23222
Q ss_pred ccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCC
Q 041479 241 DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLL 320 (771)
Q Consensus 241 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~ 320 (771)
..+++|++|++++|++++ +| .+..+. +|++|++++|+|++..+ ...+..++
T Consensus 90 ---~~~~~L~~L~L~~N~l~~-l~-~~~~l~-~L~~L~l~~N~i~~~~~-----------------------~~~l~~l~ 140 (198)
T 1ds9_A 90 ---AVADTLEELWISYNQIAS-LS-GIEKLV-NLRVLYMSNNKITNWGE-----------------------IDKLAALD 140 (198)
T ss_dssp ---HHHHHCSEEEEEEEECCC-HH-HHHHHH-HSSEEEESEEECCCHHH-----------------------HHHHTTTT
T ss_pred ---hcCCcCCEEECcCCcCCc-CC-ccccCC-CCCEEECCCCcCCchhH-----------------------HHHHhcCC
Confidence 233445555555555542 33 233332 45555555555442111 12455556
Q ss_pred CCCEEEccCCcccccCCcc----------cccccccccccccCccce
Q 041479 321 KLQVLSLFENNISREIPSS----------LGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 321 ~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~ 357 (771)
+|++|++++|.+++..|.. +..+++|+.|| +|.++
T Consensus 141 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 141 KLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp TCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 6666666666665544432 55666666665 55554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-14 Score=153.92 Aligned_cols=130 Identities=11% Similarity=0.116 Sum_probs=93.6
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch--------------hhHH--------HHHHHHHHHhccCCCCce--
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR--------------GALK--------SFMAECQALRNIRHRNLV-- 581 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~nIv-- 581 (771)
...+|+|.+|.||+|..+. ++.||||+++.... .... ...+|...|.++.+..+.
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred cCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 4568999999999999875 55999999753210 0011 224567777777554432
Q ss_pred eEEEEeecCCCCCceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-
Q 041479 582 KIITACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM- 660 (771)
Q Consensus 582 ~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~- 660 (771)
..+++ .. .++||||++|+.+.+... ......++.|++.|+.|||+. +||||||||.|||+++++
T Consensus 179 ~p~~~--~~-------~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 179 EPIAQ--SR-------HTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CEEEE--ET-------TEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred eeeec--cC-------ceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence 22222 11 279999999988876532 223457889999999999986 899999999999998766
Q ss_pred ---------ceEEecccCcc
Q 041479 661 ---------TAHMGDFGLTR 671 (771)
Q Consensus 661 ---------~~kl~DfGla~ 671 (771)
.+.|+||+=+.
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCE
T ss_pred cccccccccceEEEEeCCcc
Confidence 38999999654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=1.8e-13 Score=130.77 Aligned_cols=108 Identities=20% Similarity=0.227 Sum_probs=75.1
Q ss_pred CCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCC
Q 041479 322 LQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSK 400 (771)
Q Consensus 322 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 400 (771)
.+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..++.| +|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 356667777766 3554442 567777777777776666667777776 677777777766666777777888888888
Q ss_pred CcccccCCcchhhhhcccccccEEECcCCCCCCCCC
Q 041479 401 NELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436 (771)
Q Consensus 401 N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p 436 (771)
|+|++..|..+. .+++|+.|+|++|++++.++
T Consensus 88 N~l~~~~~~~~~----~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFD----NLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTT----TCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhc----CCCCCCEEEeCCCCCCCCch
Confidence 888765555443 67778888888888877765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=130.49 Aligned_cols=107 Identities=26% Similarity=0.290 Sum_probs=81.3
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcE
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEV 251 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~ 251 (771)
+.+.+++++|.++ .+|..++ ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..| .++++|++
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f---~~l~~L~~ 82 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVF---DKLTQLTQ 82 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT---TTCTTCCE
T ss_pred CCCEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhc---cCCCCCCE
Confidence 3467888888887 7887653 678888888888888778888888888888888888887776655 66778888
Q ss_pred EEccCccccccCChhhhhcccccceeecccCcCcc
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~ 286 (771)
|+|++|+|++..+..+..+. +|++|+|++|.++.
T Consensus 83 L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~~~c 116 (170)
T 3g39_A 83 LSLNDNQLKSIPRGAFDNLK-SLTHIWLLNNPWDC 116 (170)
T ss_dssp EECCSSCCCCCCTTTTTTCT-TCCEEECCSSCBCT
T ss_pred EECCCCccCEeCHHHhcCCC-CCCEEEeCCCCCCC
Confidence 88888888744444465654 68888888887763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.8e-13 Score=128.93 Aligned_cols=105 Identities=23% Similarity=0.282 Sum_probs=80.5
Q ss_pred CCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEE
Q 041479 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVV 252 (771)
Q Consensus 173 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L 252 (771)
-+.+++++|+++ .+|..++ ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++++..| .++++|++|
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~---~~l~~L~~L 86 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVF---DKLTQLTQL 86 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT---TTCTTCCEE
T ss_pred CcEEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHh---CCcchhhEE
Confidence 367888888887 7887654 678888888888888778888888888888888888887766555 667888888
Q ss_pred EccCccccccCChhhhhcccccceeecccCcCc
Q 041479 253 SLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 253 ~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+|++|+|++..+..+..+. +|++|+|++|.+.
T Consensus 87 ~L~~N~l~~l~~~~~~~l~-~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 87 DLNDNHLKSIPRGAFDNLK-SLTHIYLYNNPWD 118 (174)
T ss_dssp ECCSSCCCCCCTTTTTTCT-TCSEEECCSSCBC
T ss_pred ECCCCccceeCHHHhcccc-CCCEEEeCCCCcc
Confidence 8888888843333355554 6888888888877
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.7e-13 Score=128.30 Aligned_cols=107 Identities=19% Similarity=0.212 Sum_probs=63.9
Q ss_pred CEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCC
Q 041479 323 QVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401 (771)
Q Consensus 323 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 401 (771)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..++.| +|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 3444443 556666666666665555556666666 5666666666555555666677777777777
Q ss_pred cccccCCcchhhhhcccccccEEECcCCCCCCCCC
Q 041479 402 ELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436 (771)
Q Consensus 402 ~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p 436 (771)
+|++..+..+. .+++|+.|+|++|+|.+.++
T Consensus 92 ~l~~l~~~~~~----~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFD----NLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTT----TCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhc----cccCCCEEEeCCCCcccccc
Confidence 77644443333 66667777777777765544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.34 E-value=7.3e-11 Score=128.83 Aligned_cols=324 Identities=10% Similarity=0.082 Sum_probs=189.6
Q ss_pred cccCCccccCCC-CCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEE
Q 041479 57 TGTASPYIGNLT-FLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGL 135 (771)
Q Consensus 57 ~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L 135 (771)
+.+...+|.++. .|+.+.+..+ ++.+-..+|.++++|+.+.++.|.-+ .++..-...|.++.+|+.+
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~-----------~l~~Ig~~aF~~c~~L~~i 119 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPS-----------CVKKIGRQAFMFCSELTDI 119 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCC-----------CCCEECTTTTTTCTTCCBC
T ss_pred eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCC-----------eeeEechhhchhcccceee
Confidence 344555677764 5888888754 66666778888888888888776421 1222334456667777666
Q ss_pred ecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCcc
Q 041479 136 GLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHS 215 (771)
Q Consensus 136 ~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~ 215 (771)
.+.++ ++ ..-...|.++.+|+.+.+..+ +. .++...|....+|+.+.+..+ ++.+...+
T Consensus 120 ~~~~~-~~-----------------~I~~~aF~~c~~L~~i~lp~~-~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~a 178 (394)
T 4gt6_A 120 PILDS-VT-----------------EIDSEAFHHCEELDTVTIPEG-VT-SVADGMFSYCYSLHTVTLPDS-VTAIEERA 178 (394)
T ss_dssp GGGTT-CS-----------------EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred ccCCc-cc-----------------eehhhhhhhhcccccccccce-ee-eecccceecccccccccccce-eeEecccc
Confidence 55443 11 123345666677777777543 33 466666666677777777654 44355555
Q ss_pred ccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcc-------------cccceeecccC
Q 041479 216 ISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS-------------SHLRYLYMSAN 282 (771)
Q Consensus 216 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------------~~L~~L~Ls~N 282 (771)
|.+ .+|+.+.+..+-.. +...+| .++.++.......+... .+...+.... ..+..+.+. +
T Consensus 179 F~~-~~l~~i~ip~~~~~-i~~~af---~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~ 251 (394)
T 4gt6_A 179 FTG-TALTQIHIPAKVTR-IGTNAF---SECFALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIP-N 251 (394)
T ss_dssp TTT-CCCSEEEECTTCCE-ECTTTT---TTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECC-T
T ss_pred ccc-cceeEEEECCcccc-cccchh---hhccccceecccccccc-cccceeecccccccccccccccccccceEEcC-C
Confidence 654 56777766554322 223333 55666666655544433 2221111100 012233332 2
Q ss_pred cCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCc
Q 041479 283 PISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPS 362 (771)
Q Consensus 283 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 362 (771)
.++..-..+|.++.+|+.+.+.++. ...-..+|.++.+|+.+.+. +.++.....+|.++++|+.++|..+ ++.+...
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cceEcccceeeecccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 3333445678888888888886543 34445677788888888885 4566566668888888888888754 6656677
Q ss_pred ccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCC
Q 041479 363 ALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431 (771)
Q Consensus 363 ~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l 431 (771)
+|.+|..| .+.+..+ ++.+...+|.++++|+.+++.+|.... . .|.....|+.+.+..|.+
T Consensus 329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~----~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---N----AISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---H----TCBCCCCC----------
T ss_pred HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---h----hhhccCCCCEEEeCCCCE
Confidence 88888877 7777644 665666788888888888888776541 1 233566777777766654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.33 E-value=7.8e-11 Score=128.60 Aligned_cols=313 Identities=10% Similarity=0.047 Sum_probs=216.8
Q ss_pred cEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCc---ccccCCccccCCCCCCEEecccCcCcccCCcccccCCccccc
Q 041479 45 RVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNN---FSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGN 121 (771)
Q Consensus 45 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~ 121 (771)
.++.+.+.. .++.+...+|.++++|+.+.++.|. ++.+-..+|.++.+|+.+.+..+-- ..
T Consensus 65 ~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~~~---------------~I 128 (394)
T 4gt6_A 65 VLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDSVT---------------EI 128 (394)
T ss_dssp CCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTTCS---------------EE
T ss_pred cCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCccc---------------ee
Confidence 477788875 4777888899999999999999875 7766678899999999888766532 24
Q ss_pred CCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEE
Q 041479 122 IPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRIL 201 (771)
Q Consensus 122 ~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L 201 (771)
-...|.++.+|+.+.+..+.-. .....|.++.+|+.+.+..+ ++ .+....| .-.+|+.+
T Consensus 129 ~~~aF~~c~~L~~i~lp~~~~~------------------I~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF-~~~~l~~i 187 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEGVTS------------------VADGMFSYCYSLHTVTLPDS-VT-AIEERAF-TGTALTQI 187 (394)
T ss_dssp CTTTTTTCTTCCEEECCTTCCE------------------ECTTTTTTCTTCCEEECCTT-CC-EECTTTT-TTCCCSEE
T ss_pred hhhhhhhhcccccccccceeee------------------ecccceecccccccccccce-ee-Eeccccc-cccceeEE
Confidence 4567888999999998654322 33456788899999998765 55 6777777 45789999
Q ss_pred EeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcc----------cccCCCCCcEEEccCccccccCChhhhhcc
Q 041479 202 LLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLD----------SLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271 (771)
Q Consensus 202 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----------~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 271 (771)
.+..+-.. +...+|.++.+|+......+.........+. .+.....+..+.+.. .++..-...|...
T Consensus 188 ~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c- 264 (394)
T 4gt6_A 188 HIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSC- 264 (394)
T ss_dssp EECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTC-
T ss_pred EECCcccc-cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeec-
Confidence 99876554 6778899999999888776655422111110 011222333444332 2331223334444
Q ss_pred cccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccc
Q 041479 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNL 351 (771)
Q Consensus 272 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 351 (771)
.+|+.+.+.++..+ +....|.++++|+.+.+.. .+......+|.++.+|+.+++..+ ++.+...+|.++++|+.+.+
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 37889988766554 6677899999999999864 555556678889999999999865 66666779999999999999
Q ss_pred cCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccc
Q 041479 352 CGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404 (771)
Q Consensus 352 s~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 404 (771)
..+ ++.+...+|.+|..| .+++.+|.... ..|....+|+.+.+..|.+.
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 655 776777899999999 89998886542 46778889999988777653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.9e-12 Score=135.66 Aligned_cols=107 Identities=14% Similarity=0.189 Sum_probs=85.1
Q ss_pred ccceeeeecCCCCcEEEEEcCCC-CCcccCCccccCCCCCcEEEcCC-CcccccCCccccCCCCCCEEecccCcCcccCC
Q 041479 32 CQWLGVTCSLKYQRVILLNLSGQ-NLTGTASPYIGNLTFLRLINLQQ-NNFSSNIPHEIGRLFRLRHIIFNSNALQGQIP 109 (771)
Q Consensus 32 c~w~~v~c~~~~~~l~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 109 (771)
|.|..|.|+ ++ +|++ +|+ |..+++|+.|+|++ |+|++..|..|+++++|++|+|++|+|+
T Consensus 8 C~~~~v~~~------------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~---- 69 (347)
T 2ifg_A 8 HGSSGLRCT------------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR---- 69 (347)
T ss_dssp SSSSCEECC------------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC----
T ss_pred ccCCEEEcC------------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccc----
Confidence 777776665 34 7874 566 99999999999996 9999888889999999999999999965
Q ss_pred cccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCc-cccCCCCCCEEecccCcCcc
Q 041479 110 DSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPI-QLLNITSMEYFHVSENQLVG 185 (771)
Q Consensus 110 ~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g 185 (771)
+..|..|.+|++|+.|+|++|+|++ +|. .|..++ |+.|+|++|.+..
T Consensus 70 ----------~~~~~~~~~l~~L~~L~l~~N~l~~------------------~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 70 ----------FVAPDAFHFTPRLSRLNLSFNALES------------------LSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp ----------EECTTGGGSCSCCCEEECCSSCCSC------------------CCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ----------eeCHHHhcCCcCCCEEeCCCCccce------------------eCHHHcccCC-ceEEEeeCCCccC
Confidence 4667788889999999999888873 333 334444 8888888888873
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.8e-13 Score=147.85 Aligned_cols=97 Identities=21% Similarity=0.112 Sum_probs=44.1
Q ss_pred ccCCCCCCEEEccCCccccc----CCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCC
Q 041479 316 VGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPK 391 (771)
Q Consensus 316 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~ 391 (771)
+...++|++|+|++|+|+.. ++..+...++|++|+|++|.|++.... .++..+...+
T Consensus 179 L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~-------------------~l~~~L~~~~ 239 (372)
T 3un9_A 179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL-------------------ALARAAREHP 239 (372)
T ss_dssp HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH-------------------HHHHHHHHCS
T ss_pred HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH-------------------HHHHHHHhCC
Confidence 34455566666666655432 123344445555555555555421111 1122233456
Q ss_pred CCCeEECCCCcccccCCcchhhhhcccc--cccEEE--CcCCCCC
Q 041479 392 SIPHLDLSKNELSGEIPSSLAWIFGYIS--IFAKLN--LSYNNLD 432 (771)
Q Consensus 392 ~L~~L~Ls~N~l~~~~p~~l~~~~~~l~--~L~~L~--Ls~N~l~ 432 (771)
+|++|+|++|.|+..-...+.... ... .|+.+. +..|.++
T Consensus 240 ~L~~L~Ls~N~i~~~g~~~L~~~~-~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 240 SLELLHLYFNELSSEGRQVLRDLG-GAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp SCCEEECTTSSCCHHHHHHHHHCC-------CEEECCCC----CH
T ss_pred CCCEEeccCCCCCHHHHHHHHHHh-cCCCccchhhHhhhcCCccC
Confidence 778888888887754333333211 111 155665 5555553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.1e-11 Score=129.37 Aligned_cols=93 Identities=19% Similarity=0.170 Sum_probs=72.3
Q ss_pred ccCccccCCCCCCEEeccc-CcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCc
Q 041479 162 SIPIQLLNITSMEYFHVSE-NQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL 240 (771)
Q Consensus 162 ~~p~~~~~l~~L~~L~Ls~-N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 240 (771)
.+|. +..+++|+.|+|++ |+|+ .+|+..+..+++|+.|+|++|+|+++.|..|.++++|+.|+|++|+|+++++..|
T Consensus 23 ~ip~-l~~~~~L~~L~l~~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 100 (347)
T 2ifg_A 23 SLHH-LPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV 100 (347)
T ss_dssp TTTT-SCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTT
T ss_pred ccCC-CCCCCCeeEEEccCCCCCC-CcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHc
Confidence 4666 77888888888885 8887 5665555588888888888888888888888888888888888888887766655
Q ss_pred ccccCCCCCcEEEccCcccc
Q 041479 241 DSLVNCTYLEVVSLSVNSLS 260 (771)
Q Consensus 241 ~~l~~l~~L~~L~Ls~N~l~ 260 (771)
..++ |+.|+|++|.+.
T Consensus 101 ---~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 101 ---QGLS-LQELVLSGNPLH 116 (347)
T ss_dssp ---CSCC-CCEEECCSSCCC
T ss_pred ---ccCC-ceEEEeeCCCcc
Confidence 3334 888888888876
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=4.2e-13 Score=144.89 Aligned_cols=169 Identities=12% Similarity=0.089 Sum_probs=101.6
Q ss_pred CCCCcEEEccCccccccCChhhhhc----ccccceeecccCcCcccCcccc-cccCCcceEecCCccceeccCccc----
Q 041479 246 CTYLEVVSLSVNSLSGTLPNSLANF----SSHLRYLYMSANPISGSIPTEI-GNLKNLIIIAIEKFILIRNIPISV---- 316 (771)
Q Consensus 246 l~~L~~L~Ls~N~l~~~~p~~~~~l----~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~n~l~~~~p~~~---- 316 (771)
+++|+.|+|++|.|+......+... .++|++|+|++|.|+......+ ..+++|+.|+|++|.+.......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3567888888888874433333332 1368888888888764332222 235566666666666643332222
Q ss_pred -cCCCCCCEEEccCCccccc----CCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCC
Q 041479 317 -GYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPK 391 (771)
Q Consensus 317 -~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~ 391 (771)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++.... .++..+..++
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~-------------------~L~~~L~~~~ 211 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE-------------------LLAAQLDRNR 211 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH-------------------HHHHHGGGCS
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH-------------------HHHHHHhcCC
Confidence 1345566666666666431 222334455556666555555421100 1234455677
Q ss_pred CCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCC
Q 041479 392 SIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 392 ~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
+|++|+|++|.|+..-...+...+...++|++|||++|+|+.
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 899999999999864444454445567899999999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=3.7e-10 Score=115.79 Aligned_cols=134 Identities=15% Similarity=0.096 Sum_probs=101.0
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEeccC
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFMHH 607 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~ 607 (771)
.+.+..+.||+.... ++.|++|+..........++.+|+++++.+. |..+.++++++...+ ..|+||||++|
T Consensus 22 ~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~-----~~~lv~e~i~G 94 (263)
T 3tm0_A 22 TEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-----WSNLLMSEADG 94 (263)
T ss_dssp CSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-----EEEEEEECCSS
T ss_pred ccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC-----ceEEEEEecCC
Confidence 455666889998754 3589999986533233356889999999985 677888999887665 67999999999
Q ss_pred CCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 041479 608 GSLESCPRILSFLRRLNIAIDVASALEYLHHHC----------------------------------------------- 640 (771)
Q Consensus 608 g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------------------- 640 (771)
.++.+... +......++.++++++..||+..
T Consensus 95 ~~l~~~~~--~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (263)
T 3tm0_A 95 VLCSEEYE--DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp EEHHHHCC--TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHH
T ss_pred eehhhccC--CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHH
Confidence 88865311 12234578889999999999810
Q ss_pred ---------CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 641 ---------KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 641 ---------~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
...++|+|++|.||++++...+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.8e-08 Score=106.55 Aligned_cols=294 Identities=12% Similarity=0.107 Sum_probs=149.5
Q ss_pred ccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEeccccc
Q 041479 62 PYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNY 141 (771)
Q Consensus 62 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 141 (771)
+++....+|+.+.+.. .++.+-..+|.++++|+.++|..+ ++ ..-...|.+. +|+.+.+..+
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~--------------~Ig~~aF~~c-~l~~i~~~~~- 101 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VT--------------SIGDGAFADT-KLQSYTGMER- 101 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CC--------------EECTTTTTTC-CCCEEEECTT-
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ce--------------EechhhhcCC-CCceEECCce-
Confidence 3455555666666653 355445556666666666666543 22 1222334443 4444444322
Q ss_pred CcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCC
Q 041479 142 FTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK 221 (771)
Q Consensus 142 l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 221 (771)
++ ..-...|.+ .+|+.+.+..+ ++ .+....|.+ .+|+.+.+..+ ++.+....|.+..+
T Consensus 102 l~-----------------~I~~~aF~~-~~L~~i~lp~~-~~-~i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~ 159 (379)
T 4h09_A 102 VK-----------------KFGDYVFQG-TDLDDFEFPGA-TT-EIGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAEN 159 (379)
T ss_dssp CC-----------------EECTTTTTT-CCCSEEECCTT-CC-EECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTT
T ss_pred ee-----------------Eeccceecc-CCcccccCCCc-cc-ccccccccc-ceeeeeeccce-eeccccchhccccc
Confidence 11 011122332 35666666544 23 445555533 35555555443 44455666777777
Q ss_pred CCEEEccccccCCCCCcC---------cccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccc
Q 041479 222 LEWLDFANNSLTGLIPED---------LDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEI 292 (771)
Q Consensus 222 L~~L~Ls~N~l~~~~p~~---------~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~ 292 (771)
++...+..+......... ...+..+..+..+.+..+.-. .....+... .+|+.+.+..+ +.......|
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~-~~l~~i~~~~~-~~~i~~~~f 236 (379)
T 4h09_A 160 LEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYG-KNLKKITITSG-VTTLGDGAF 236 (379)
T ss_dssp CCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTC-SSCSEEECCTT-CCEECTTTT
T ss_pred ccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccc-cccceeeeccc-eeEEccccc
Confidence 777766654432111000 011123334444443333221 222222222 25666666543 333445566
Q ss_pred cccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-e
Q 041479 293 GNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-W 371 (771)
Q Consensus 293 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~ 371 (771)
.++.+|+.+.+..+ +...-..+|..+.+|+.+.+..+ ++......|.++++|+.+.+.++.++.+...+|.+|..| .
T Consensus 237 ~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~ 314 (379)
T 4h09_A 237 YGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSS 314 (379)
T ss_dssp TTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCE
T ss_pred cCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCE
Confidence 66666666666553 33444455666666666666543 443445566666677777766666665556666666666 5
Q ss_pred eecccCcccCCCCcCCCCCCCCCeEECCCC
Q 041479 372 LDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401 (771)
Q Consensus 372 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 401 (771)
++|..+ ++.+...+|.++++|+.+.+..+
T Consensus 315 i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 315 VTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp EECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred EEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 666543 55455556666666666666443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.2e-08 Score=107.12 Aligned_cols=298 Identities=9% Similarity=0.051 Sum_probs=163.4
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.+.+. ..++.+...+|.++++|+.++|..+ ++.+-..+|.+. +|+.+.+..+- + ..-.
T Consensus 46 ~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~l-~--------------~I~~ 107 (379)
T 4h09_A 46 DRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMERV-K--------------KFGD 107 (379)
T ss_dssp GGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTTC-C--------------EECT
T ss_pred cCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCcee-e--------------Eecc
Confidence 356666665 4577777889999999999999755 776777889887 68888776542 2 1223
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
..|.. .+|+.+.+..+-.. .-...|.+ .+|+...+..+ ++ .+....|....+++.+.+
T Consensus 108 ~aF~~-~~L~~i~lp~~~~~------------------i~~~~F~~-~~l~~~~~~~~-v~-~i~~~~f~~~~~l~~~~~ 165 (379)
T 4h09_A 108 YVFQG-TDLDDFEFPGATTE------------------IGNYIFYN-SSVKRIVIPKS-VT-TIKDGIGYKAENLEKIEV 165 (379)
T ss_dssp TTTTT-CCCSEEECCTTCCE------------------ECTTTTTT-CCCCEEEECTT-CC-EECSCTTTTCTTCCEEEE
T ss_pred ceecc-CCcccccCCCcccc------------------cccccccc-ceeeeeeccce-ee-ccccchhccccccccccc
Confidence 34544 47888887654221 00111111 12333332221 22 233333334444444443
Q ss_pred ecCcccc------------cCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcc
Q 041479 204 AGNQFFG------------NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271 (771)
Q Consensus 204 ~~N~l~~------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 271 (771)
..+.... .....+.....+..+.+..+.- ......+ ..+.+|+.+.+..+ +.......+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f---~~~~~l~~i~~~~~-~~~i~~~~f~~~~ 240 (379)
T 4h09_A 166 SSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVK-TVTAYGF---SYGKNLKKITITSG-VTTLGDGAFYGMK 240 (379)
T ss_dssp CTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCC-EECTTTT---TTCSSCSEEECCTT-CCEECTTTTTTCS
T ss_pred ccccceeecccceecccccceecccccccccccccccccee-EEeeccc---ccccccceeeeccc-eeEEccccccCCc
Confidence 3322110 1112333444444444433321 1222222 45566666666544 2212223333333
Q ss_pred cccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccc
Q 041479 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNL 351 (771)
Q Consensus 272 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 351 (771)
+|+.+.+..+ ++.+....|.++.+|+.+.+..+ +.......|..+.+|+.+.+.++.++.+...+|.++++|+.+.|
T Consensus 241 -~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 241 -ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp -SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred -cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 5666666654 44455566777777777776543 33444456667777777777777776556667777777777777
Q ss_pred cCccceecCCcccccccce-eeecccCcccCCCCcCCCCCC
Q 041479 352 CGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPK 391 (771)
Q Consensus 352 s~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~ 391 (771)
..+ ++.+...+|.+|..| .+.+..+ ++.+...+|.++.
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 544 555666677777777 6666544 5545556666553
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=1e-09 Score=112.20 Aligned_cols=127 Identities=17% Similarity=0.122 Sum_probs=93.7
Q ss_pred ccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCC--ceeEEEEeecCCCCCceeEEEEEEeccCC
Q 041479 531 SLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRN--LVKIITACSTSDFQGNYFRALVYEFMHHG 608 (771)
Q Consensus 531 ~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~~~~~~lv~e~~~~g 608 (771)
.|..+.||+....+ ++.|+||+.... ....+.+|+++++.+++.+ +.+++++....+ ..++||||++|.
T Consensus 30 gg~~~~v~~~~~~~-g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~-----~~~~v~e~i~G~ 100 (264)
T 1nd4_A 30 GCSDAAVFRLSAQG-RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG-----RDWLLLGEVPGQ 100 (264)
T ss_dssp TTSSCEEEEEECTT-SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----CEEEEEECCSSE
T ss_pred CCCCceEEEEecCC-CCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC-----CCEEEEEecCCc
Confidence 45568899997643 447999997543 2256788999999986544 455888776554 579999999998
Q ss_pred CCCCCcccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 041479 609 SLESCPRILSFLRRLNIAIDVASALEYLHHHC------------------------------------------------ 640 (771)
Q Consensus 609 ~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------------ 640 (771)
++. . ...+ ...++.+++..+..||+..
T Consensus 101 ~l~-~-~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 101 DLL-S-SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp ETT-T-SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred ccC-c-CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 884 2 2222 3467788889999999742
Q ss_pred -------CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 641 -------KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 641 -------~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
...++|+|++|.||+++.++.++|+|||.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.2e-08 Score=109.60 Aligned_cols=143 Identities=13% Similarity=0.140 Sum_probs=106.0
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEee--ccc-hhhHHHHHHHHHHHhccC--CCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLF--LHQ-RGALKSFMAECQALRNIR--HRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
...++.|....||+....+ ..+++|+.. ... .....++.+|+++++.++ +..+.++++++.+.+..+ ..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g--~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG--RAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS--SCEE
T ss_pred EEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC--CeEE
Confidence 3456788889999987653 378899875 332 123457888999999997 456888998887653222 4689
Q ss_pred EEEeccCCCCCC-CcccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041479 601 VYEFMHHGSLES-CPRILSFLRRLNIAIDVASALEYLHHHC--------------------------------------- 640 (771)
Q Consensus 601 v~e~~~~g~L~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------- 640 (771)
||||++|..+.+ ....++..++..++.+++..|+.||+..
T Consensus 119 vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp EEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999999988854 3445778888999999999999999731
Q ss_pred ----------------CCCeEecCCCCCCeeeCCCCc--eEEecccCccc
Q 041479 641 ----------------KKPIVHCDLKPSNVLLDNDMT--AHMGDFGLTRF 672 (771)
Q Consensus 641 ----------------~~~ivHrdlk~~NILl~~~~~--~kl~DfGla~~ 672 (771)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987653 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.1e-08 Score=109.28 Aligned_cols=203 Identities=13% Similarity=0.133 Sum_probs=122.2
Q ss_pred CcEEEEEcCCCCCcc-c-------CCccccCCCCCcEEEcCCCccc---------ccCCccccCCCCCCEEecccCc-Cc
Q 041479 44 QRVILLNLSGQNLTG-T-------ASPYIGNLTFLRLINLQQNNFS---------SNIPHEIGRLFRLRHIIFNSNA-LQ 105 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~-~-------~~~~~~~l~~L~~L~Ls~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~-l~ 105 (771)
.+|+.|.+......+ . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|. +.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 467777777665442 1 1234567788999988765431 1244556778889999988773 11
Q ss_pred ccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccc--cCCCCCCEEeccc--C
Q 041479 106 GQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL--LNITSMEYFHVSE--N 181 (771)
Q Consensus 106 ~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~--~~l~~L~~L~Ls~--N 181 (771)
++. +. +++|+.|+|..+.++. .....+ ..+++|+.|+|+. |
T Consensus 187 ----------------l~~-~~-~~~L~~L~L~~~~l~~-----------------~~l~~l~~~~lp~L~~L~L~~~~~ 231 (362)
T 2ra8_A 187 ----------------IGK-KP-RPNLKSLEIISGGLPD-----------------SVVEDILGSDLPNLEKLVLYVGVE 231 (362)
T ss_dssp ----------------CCS-CB-CTTCSEEEEECSBCCH-----------------HHHHHHHHSBCTTCCEEEEECBCG
T ss_pred ----------------ecc-cc-CCCCcEEEEecCCCCh-----------------HHHHHHHHccCCCCcEEEEecccc
Confidence 222 22 6778888887776651 111112 2567777777753 2
Q ss_pred cCccc-----CChhhh-hCCCCCcEEEeecCcccccCCcccc---CCCCCCEEEccccccCCCCCcCc-ccccCCCCCcE
Q 041479 182 QLVGE-----LPPHIG-FTLPNVRILLLAGNQFFGNIPHSIS---NASKLEWLDFANNSLTGLIPEDL-DSLVNCTYLEV 251 (771)
Q Consensus 182 ~l~g~-----lp~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~l~~L~~ 251 (771)
...|. +.+.+. ..+|+|++|+|++|.+....+..+. .+++|++|+|+.|.|+..-+..+ ..+.++++|+.
T Consensus 232 ~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~ 311 (362)
T 2ra8_A 232 DYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311 (362)
T ss_dssp GGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSE
T ss_pred ccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceE
Confidence 21111 111111 2468999999999988743333332 57889999999999875322222 12356789999
Q ss_pred EEccCccccccCChhhhhcccccceeecccCc
Q 041479 252 VSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 252 L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
|+|++|.|+...-..+... -...+++++|+
T Consensus 312 L~L~~n~i~d~~~~~l~~a--lg~~~~~~~~~ 341 (362)
T 2ra8_A 312 INMKYNYLSDEMKKELQKS--LPMKIDVSDSQ 341 (362)
T ss_dssp EECCSBBCCHHHHHHHHHH--CCSEEECCSBC
T ss_pred EECCCCcCCHHHHHHHHHH--cCCEEEecCCc
Confidence 9999998874333333321 12567888776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.70 E-value=8.7e-09 Score=110.17 Aligned_cols=117 Identities=10% Similarity=0.049 Sum_probs=61.4
Q ss_pred ccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCcccc--CCCCCCEEEccc--cccCCCC-C--
Q 041479 165 IQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSIS--NASKLEWLDFAN--NSLTGLI-P-- 237 (771)
Q Consensus 165 ~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~~-p-- 237 (771)
..+..+++|+.|+|++|.-. .+++ + .+++|+.|+|..+.+.......+. .+++|+.|+|+. |...+.. .
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~--~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~ 241 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-K--PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-C--BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-c--cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence 33455677777777776311 3443 1 367777777777776543323333 577777777753 2211110 0
Q ss_pred --cCcccccCCCCCcEEEccCccccccCChhhhh--cccccceeecccCcCcc
Q 041479 238 --EDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN--FSSHLRYLYMSANPISG 286 (771)
Q Consensus 238 --~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~~L~~L~Ls~N~l~~ 286 (771)
..+. -..+++|++|+|++|.+....+..+.. ..++|++|+|+.|.|++
T Consensus 242 l~~~l~-~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 242 FRPLFS-KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp TGGGSC-TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred HHHHHh-cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 0110 023566777777777665433333321 11356666666666653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.60 E-value=2.9e-09 Score=108.00 Aligned_cols=21 Identities=5% Similarity=-0.140 Sum_probs=15.7
Q ss_pred CccceeeeecCCCCcEEEEEc
Q 041479 31 FCQWLGVTCSLKYQRVILLNL 51 (771)
Q Consensus 31 ~c~w~~v~c~~~~~~l~~L~L 51 (771)
.|+|.|+.|.....++..+-.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~ 97 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIIN 97 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEE
T ss_pred HHhcCcEEECCCCCEEEEEEe
Confidence 678999999876667765544
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=8.6e-08 Score=100.35 Aligned_cols=135 Identities=16% Similarity=0.126 Sum_probs=96.8
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCC--ceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRN--LVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
++.|....||+.. + .+++|+.... .....+.+|+++++.+. +.. +.+.+++....+.. ...|+||||+
T Consensus 28 ~~~G~~n~v~~v~----~-~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~--~~~~~vm~~i 98 (304)
T 3sg8_A 28 SGEGNDCIAYEIN----R-DFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY--QMSFAGFTKI 98 (304)
T ss_dssp EEECSSEEEEEST----T-SEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC--SCSCEEEECC
T ss_pred cCCCCcceEEEEC----C-EEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC--CcceEEEccc
Confidence 6777888888753 3 5889986432 34578899999998884 332 34455543332211 1347999999
Q ss_pred cCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 041479 606 HHGSLESC-PRILSFLRRLNIAIDVASALEYLHHH--------------------------------------------- 639 (771)
Q Consensus 606 ~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------------------- 639 (771)
+|..+... ...++..++..++.+++..+..||+.
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 99888642 34567778888999999999999961
Q ss_pred ----------CCCCeEecCCCCCCeeeCC--CCceEEecccCccc
Q 041479 640 ----------CKKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTRF 672 (771)
Q Consensus 640 ----------~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~ 672 (771)
..+.++|+|++|.||+++. ...+.|+||+.+..
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 0135899999999999997 45689999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.43 E-value=3.7e-08 Score=99.90 Aligned_cols=85 Identities=25% Similarity=0.349 Sum_probs=55.6
Q ss_pred EecccCcCcccCChh---hhhCCCCCcEEEeecCcccc--cCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCc
Q 041479 176 FHVSENQLVGELPPH---IGFTLPNVRILLLAGNQFFG--NIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLE 250 (771)
Q Consensus 176 L~Ls~N~l~g~lp~~---~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~ 250 (771)
++++.|... .++.. +..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+..+ +|+
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l-~L~ 223 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGL-KLE 223 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTS-CCS
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccC-Ccc
Confidence 556666443 33321 22357788888888888876 3456667788888888888888765 334444444 777
Q ss_pred EEEccCccccccCC
Q 041479 251 VVSLSVNSLSGTLP 264 (771)
Q Consensus 251 ~L~Ls~N~l~~~~p 264 (771)
+|+|++|.+.+.+|
T Consensus 224 ~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 224 ELWLDGNSLCDTFR 237 (267)
T ss_dssp EEECTTSTTGGGCS
T ss_pred eEEccCCcCccccC
Confidence 77777777776555
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.31 E-value=7.5e-08 Score=92.78 Aligned_cols=44 Identities=11% Similarity=0.028 Sum_probs=26.2
Q ss_pred ccccCCCCCcEEEcCCC-cccc----cCCccccCCCCCCEEecccCcCc
Q 041479 62 PYIGNLTFLRLINLQQN-NFSS----NIPHEIGRLFRLRHIIFNSNALQ 105 (771)
Q Consensus 62 ~~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 105 (771)
..+...+.|++|+|++| .|.. .+...+...++|++|+|++|.|.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 34556666777777776 6653 13444555666666666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.28 E-value=7.9e-08 Score=92.63 Aligned_cols=123 Identities=14% Similarity=0.114 Sum_probs=67.7
Q ss_pred cccccCCcceEecCCc-cceec----cCccccCCCCCCEEEccCCccccc----CCcccccccccccccccCccceecCC
Q 041479 291 EIGNLKNLIIIAIEKF-ILIRN----IPISVGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSIRGSVP 361 (771)
Q Consensus 291 ~~~~l~~L~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p 361 (771)
.+...++|+.|+|++| .+... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|...--
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3445556666666665 54321 223334445566666666655421 12222333445555555555442110
Q ss_pred cccccccceeeecccCcccCCCCcCCCCCCCCCeEEC--CCCcccccCCcchhhhhcccccccEEECcCCCCC
Q 041479 362 SALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDL--SKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLD 432 (771)
Q Consensus 362 ~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~L--s~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~ 432 (771)
. .+...+...++|++|+| ++|.|...-...+...+...++|+.|+|++|.+.
T Consensus 111 ~-------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 L-------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp H-------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred H-------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 0 12334555678899999 7898875443445545556788999999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=9.5e-06 Score=84.75 Aligned_cols=133 Identities=15% Similarity=0.093 Sum_probs=91.5
Q ss_pred ccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCC---CceeEEEEeecCCCCCceeEEEEEEec
Q 041479 529 YESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHR---NLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 529 l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
++.|....||+. + ..++||+-. .......+.+|+++++.+.+. -|.+.+.++.... ...|+||||+
T Consensus 27 l~~G~~n~v~~v----g-~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----g~~~~v~e~i 95 (306)
T 3tdw_A 27 LGEGFRNYAILV----N-GDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----GNPFVGYRKV 95 (306)
T ss_dssp EEECSSEEEEEE----T-TTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT----SCEEEEEECC
T ss_pred cCCCcceeEEEE----C-CEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC----CceEEEEecc
Confidence 566777788887 3 368888853 233457899999999999752 3556666654221 1468999999
Q ss_pred cCCCCCCC-cccCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 041479 606 HHGSLESC-PRILSFLRRLNIAIDVASALEYLHHH--------------------------------------------- 639 (771)
Q Consensus 606 ~~g~L~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------------------- 639 (771)
+|..+... ...++..++..++.+++..|..||+.
T Consensus 96 ~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 96 QGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp CSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred CCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 99877542 22345556666666677666666642
Q ss_pred ------------CCCCeEecCCCCCCeeeCC---CCc-eEEecccCccc
Q 041479 640 ------------CKKPIVHCDLKPSNVLLDN---DMT-AHMGDFGLTRF 672 (771)
Q Consensus 640 ------------~~~~ivHrdlk~~NILl~~---~~~-~kl~DfGla~~ 672 (771)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 58999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.3e-05 Score=81.90 Aligned_cols=128 Identities=18% Similarity=0.033 Sum_probs=92.0
Q ss_pred ceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC
Q 041479 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC 613 (771)
Q Consensus 535 ~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 613 (771)
++||+.....++..++||+-... ...++.+|..+++.+. +--|-++++++.+.+ ..|+|||+++|.++.+.
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~-----~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD-----DAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-----EEEEEEECCCSEEHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-----eEEEEEEeeCCcccccc
Confidence 46999888777778999987543 3457888999998885 333567778877665 67999999998776443
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------
Q 041479 614 PRILSFLRRLNIAIDVASALEYLHHHC----------------------------------------------------- 640 (771)
Q Consensus 614 ~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------------------------- 640 (771)
... .......++.+++..+.-||+..
T Consensus 111 ~~~-~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 111 LEE-YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp HHH-CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred ccC-CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 111 12234456667777777777421
Q ss_pred --CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 641 --KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 641 --~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
.+.++|+|+.+.||+++..+.+-|+||+.+.
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987777899999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=4.4e-05 Score=81.51 Aligned_cols=140 Identities=12% Similarity=0.045 Sum_probs=86.6
Q ss_pred cccccceEEEEEec---C---CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccC-C--CCceeEEEEeecCCCCCcee
Q 041479 530 ESLVKATVYKGILD---L---DQTFIAVKVLFLHQ---RGALKSFMAECQALRNIR-H--RNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 530 ~~~~~~~Vy~~~~~---~---~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.|....+|+.... + +++.+++|+..... ......+.+|+.+++.++ + -.+.++++++.+.+..+ .
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g--~ 107 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG--T 107 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS--S
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC--C
Confidence 66777889987654 1 14578888865432 101246778888888874 3 35677888765543212 3
Q ss_pred EEEEEEeccCCCCCCCc---------ccCCHHHHHHHHHHHHHHHHHHHh------------------------------
Q 041479 598 RALVYEFMHHGSLESCP---------RILSFLRRLNIAIDVASALEYLHH------------------------------ 638 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~~---------~~l~~~~~~~i~~~ia~gL~~LH~------------------------------ 638 (771)
.|+||||++|..+.+.. ..++..++..++.++++.|.-||+
T Consensus 108 ~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (357)
T 3ats_A 108 PFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWVRS 187 (357)
T ss_dssp CEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHHHH
T ss_pred ceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHHHH
Confidence 57999999987765320 012333333333333333333331
Q ss_pred ------------------------c-------CCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 639 ------------------------H-------CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 639 ------------------------~-------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
. ....++|+|+.+.||++++...+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 188 WYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp HHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred HHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 1 13468999999999999964457999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00015 Score=78.60 Aligned_cols=75 Identities=13% Similarity=0.040 Sum_probs=47.4
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccch-------hhHHHHHHHHHHHhccCC--CCce-eEEEEeecCCCCCce
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQR-------GALKSFMAECQALRNIRH--RNLV-KIITACSTSDFQGNY 596 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~nIv-~l~~~~~~~~~~~~~ 596 (771)
..+|.|..+.||++....+++.|+||....... ....++..|+++++.+.. |..+ +++.+. .+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~----- 108 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE----- 108 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT-----
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC-----
Confidence 457889999999998766666899998643211 123467789999888742 4444 555442 22
Q ss_pred eEEEEEEeccCC
Q 041479 597 FRALVYEFMHHG 608 (771)
Q Consensus 597 ~~~lv~e~~~~g 608 (771)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 237999999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0014 Score=67.97 Aligned_cols=74 Identities=14% Similarity=0.002 Sum_probs=55.5
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC---CCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR---HRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
..++.|....+|+... ++..++||+.... ....+.+|++.|+.+. ...|.+.++++...+ ..++|||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g-----~~~lvme 111 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG-----HSFLLLE 111 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS-----EEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC-----ceEEEEE
Confidence 4467788889999875 3448889987533 3567889999988884 356778888776554 6799999
Q ss_pred eccCCCC
Q 041479 604 FMHHGSL 610 (771)
Q Consensus 604 ~~~~g~L 610 (771)
|+++..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00017 Score=67.76 Aligned_cols=82 Identities=11% Similarity=0.208 Sum_probs=36.0
Q ss_pred CCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcc-ccccCChhhhhc---ccccceeecccCc-CcccCccccccc
Q 041479 221 KLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNS-LSGTLPNSLANF---SSHLRYLYMSANP-ISGSIPTEIGNL 295 (771)
Q Consensus 221 ~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l---~~~L~~L~Ls~N~-l~~~~p~~~~~l 295 (771)
+|+.||++++.|+. ..+..+.++++|+.|+|++|. |+..--..+..+ .++|++|+|+++. |+..--..+..+
T Consensus 62 ~L~~LDLs~~~Itd---~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~ 138 (176)
T 3e4g_A 62 KIQAIDATDSCIMS---IGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHF 138 (176)
T ss_dssp CEEEEEEESCCCCG---GGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGC
T ss_pred eEeEEeCcCCCccH---HHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcC
Confidence 45555555555432 233334555556666666553 432211122221 1246666666653 543222223334
Q ss_pred CCcceEecCC
Q 041479 296 KNLIIIAIEK 305 (771)
Q Consensus 296 ~~L~~L~l~~ 305 (771)
++|+.|++++
T Consensus 139 ~~L~~L~L~~ 148 (176)
T 3e4g_A 139 RNLKYLFLSD 148 (176)
T ss_dssp TTCCEEEEES
T ss_pred CCCCEEECCC
Confidence 4444444443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0026 Score=66.99 Aligned_cols=31 Identities=19% Similarity=0.248 Sum_probs=27.6
Q ss_pred CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 641 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4689999999999999877889999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00015 Score=68.11 Aligned_cols=84 Identities=11% Similarity=0.091 Sum_probs=59.3
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCc-ccccCCccccCC----CCCCEEecccCc-CcccCCcccccCCc
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNN-FSSNIPHEIGRL----FRLRHIIFNSNA-LQGQIPDSRLILNK 117 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~l~~n~ 117 (771)
-+++.|||+++.++...-..+..+++|++|+|+++. |+..--..++.+ ++|++|+|+++. ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT------------ 128 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT------------ 128 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC------------
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC------------
Confidence 478999999988886655667888999999999984 765333445554 368899998875 44
Q ss_pred ccccCCccccCCCCCCEEeccccc
Q 041479 118 LEGNIPSELGSLLKFKGLGLANNY 141 (771)
Q Consensus 118 l~~~~p~~~~~l~~L~~L~Ls~N~ 141 (771)
..--..+..+++|+.|+|++..
T Consensus 129 --D~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 129 --DKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp --HHHHHHGGGCTTCCEEEEESCT
T ss_pred --HHHHHHHhcCCCCCEEECCCCC
Confidence 1111235667888888888763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0012 Score=58.84 Aligned_cols=61 Identities=25% Similarity=0.306 Sum_probs=45.7
Q ss_pred eeecccCccc-CCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCc
Q 041479 371 WLDLSHNHLT-GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 371 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
.++-+++.|+ ..+|..+ .++|+.|+|++|+|+...++.| ..+++|+.|+|++|++.+.+--
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f----~~l~~L~~L~L~~NP~~CdC~l 73 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLL----DALPALRTAHLGANPWRCDCRL 73 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTG----GGCTTCCEEECCSSCCBCSGGG
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhh----hhccccCEEEecCCCeeccCcc
Confidence 5788888886 3455433 4578999999999995555444 4788999999999999887654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0016 Score=66.96 Aligned_cols=75 Identities=15% Similarity=0.042 Sum_probs=51.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-C--CCceeEEEEeecCCCCCceeEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-H--RNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
...+|.|..+.||+.+..++. .|.||+-..........|.+|++.|+.+. . --+.+.+++ ..+ ++||
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~-~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~-------~lv~ 89 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGT-PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR-------TLAM 89 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSC-EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT-------EEEE
T ss_pred EEecCCCCCeEEEEEEECCCC-EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc-------eEEE
Confidence 345688888999999987654 89999875444333456788999988874 2 234455544 222 7899
Q ss_pred EeccCCCC
Q 041479 603 EFMHHGSL 610 (771)
Q Consensus 603 e~~~~g~L 610 (771)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00094 Score=59.60 Aligned_cols=56 Identities=18% Similarity=0.245 Sum_probs=30.5
Q ss_pred EEecccCcCc-ccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccC
Q 041479 175 YFHVSENQLV-GELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 233 (771)
Q Consensus 175 ~L~Ls~N~l~-g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 233 (771)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555666654 24554322 34566666666666555555555666666666655543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.006 Score=66.37 Aligned_cols=31 Identities=19% Similarity=0.414 Sum_probs=27.2
Q ss_pred CCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 641 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
.+.++|+|++|.||+++.++ ++++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 35799999999999998776 99999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00032 Score=67.11 Aligned_cols=44 Identities=9% Similarity=0.147 Sum_probs=22.1
Q ss_pred CCCCCCCCeEECCCC---cccccCCcchhhhhcccccccEEECcCCC
Q 041479 387 VGNPKSIPHLDLSKN---ELSGEIPSSLAWIFGYISIFAKLNLSYNN 430 (771)
Q Consensus 387 ~~~l~~L~~L~Ls~N---~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~ 430 (771)
+..-+.|++|+|++| ++.......++..+..-+.|+.|+++.|.
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 334455777777654 33322222233333345666677766553
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0036 Score=64.75 Aligned_cols=127 Identities=13% Similarity=0.167 Sum_probs=73.9
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCc-eeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNL-VKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...++.|....+|+. + .+++|+....... ..+..+|+.+++.+....+ .++++++.+.+ ++|+||
T Consensus 23 i~~l~gG~tN~~~~~-----~-~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~-------~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----G-DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATG-------VMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE-----T-TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTC-------CEEEEC
T ss_pred eeEcCCcccccccee-----e-eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCC-------EEEEee
Confidence 445677888889998 2 5888887543211 1123457777776642222 35555543322 689999
Q ss_pred c-cCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 041479 605 M-HHGSLESCPRILSFLRRLNIAIDVASALEYLHHH-------------------------------------------- 639 (771)
Q Consensus 605 ~-~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-------------------------------------------- 639 (771)
+ ++..+... ....+..+..++++.|+-+|+.
T Consensus 89 i~~g~~l~~~----~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 89 IAGAQTMSPE----KFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CTTCEECCHH----HHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred cCCCccCCHh----hHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 9 55444310 0000012334444444444432
Q ss_pred ------CCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 640 ------CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 640 ------~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
....++|+|+.+.||+ ..++.+.++||..+.
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 1234799999999999 556778999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.012 Score=64.61 Aligned_cols=74 Identities=14% Similarity=0.004 Sum_probs=46.3
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCc-eeEEEEeecCCCCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNL-VKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
..++.|....+|+.....++..|++|+........ -+-.+|..+++.+...++ .++++++ .+ .+||||+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~-------G~v~e~I 183 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN-------GRIEEFM 183 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT-------EEEEECC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC-------eEEEEee
Confidence 34567777889999876544688899874322111 112578888888864444 4666665 22 2599999
Q ss_pred cCCCC
Q 041479 606 HHGSL 610 (771)
Q Consensus 606 ~~g~L 610 (771)
+|..+
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0063 Score=63.44 Aligned_cols=139 Identities=12% Similarity=0.096 Sum_probs=74.4
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCC--ceeEEEEeecCCC--CCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRN--LVKIITACSTSDF--QGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~--~~~~~~~lv~e 603 (771)
.++.|....+|+....++ .+++|+..... ..+++..|+.++..++... +.+++... ++.. ......+++||
T Consensus 29 ~i~~G~~n~~~~v~~~~g--~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD--PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeCCc--cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEEE
Confidence 345667778999876543 68899886421 1234556777776664211 22222110 1100 00014589999
Q ss_pred eccCCCCCCC------------------ccc--------C---CHHHHHH------------HHHHHHHHHHHHHhc---
Q 041479 604 FMHHGSLESC------------------PRI--------L---SFLRRLN------------IAIDVASALEYLHHH--- 639 (771)
Q Consensus 604 ~~~~g~L~~~------------------~~~--------l---~~~~~~~------------i~~~ia~gL~~LH~~--- 639 (771)
|++|..+... ... . .|..... +...+...+++++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9998765321 000 0 1221100 011234455555532
Q ss_pred -CCCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 640 -CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 640 -~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
....++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12469999999999999877666899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0098 Score=64.80 Aligned_cols=72 Identities=15% Similarity=0.194 Sum_probs=47.0
Q ss_pred cccccccceEEEEEecC-------CCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCc-eeEEEEeecCCCCCceeEE
Q 041479 528 SYESLVKATVYKGILDL-------DQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNL-VKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~~~~~~ 599 (771)
.++.|....+|+..... +++.|++|+.... ...+.+.+|..+++.+...++ .++++.+. + .
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-------g 148 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G-------G 148 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T-------E
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C-------C
Confidence 45677778899998763 2458889987331 112456689999888853333 56666542 2 3
Q ss_pred EEEEeccCCCC
Q 041479 600 LVYEFMHHGSL 610 (771)
Q Consensus 600 lv~e~~~~g~L 610 (771)
+||||++|..+
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999986554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.012 Score=62.88 Aligned_cols=134 Identities=10% Similarity=0.113 Sum_probs=77.5
Q ss_pred cccccccceEEEEEecC-------CCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEE
Q 041479 528 SYESLVKATVYKGILDL-------DQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+..|....+|+....+ +++.|++|+.... ........+|.++++.+. +.-..++++++. + .
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~-------g 126 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E-------G 126 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T-------E
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C-------c
Confidence 45566677789988753 2358889986321 223456678999998885 322355665542 2 2
Q ss_pred EEEEeccCCCCCCC-------------------------cccCC--HHHHHHHHHHHH-------------------HHH
Q 041479 600 LVYEFMHHGSLESC-------------------------PRILS--FLRRLNIAIDVA-------------------SAL 633 (771)
Q Consensus 600 lv~e~~~~g~L~~~-------------------------~~~l~--~~~~~~i~~~ia-------------------~gL 633 (771)
+||||++|..+..- .+... |.+..++..++. ..+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999998665311 01111 233333333221 122
Q ss_pred HHHHh----c-CCCCeEecCCCCCCeeeCCC----CceEEecccCcc
Q 041479 634 EYLHH----H-CKKPIVHCDLKPSNVLLDND----MTAHMGDFGLTR 671 (771)
Q Consensus 634 ~~LH~----~-~~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~ 671 (771)
++|.. . ....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 33321 1 12368999999999999876 689999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0024 Score=60.98 Aligned_cols=70 Identities=16% Similarity=0.186 Sum_probs=39.0
Q ss_pred cccCCCCCCEEEcccc-ccCCCCCcC-cccccCCCCCcEEEccCccccccC----ChhhhhcccccceeecccCcCc
Q 041479 215 SISNASKLEWLDFANN-SLTGLIPED-LDSLVNCTYLEVVSLSVNSLSGTL----PNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 215 ~~~~l~~L~~L~Ls~N-~l~~~~p~~-~~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
.+.+-+.|++|+|++| +|...--.. ...+..-+.|+.|+|++|.|...- -..+..- +.|+.|+|+.|.|.
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N-~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETS-PSLRVLNVESNFLT 111 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHC-SSCCEEECCSSBCC
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcC-CccCeEecCCCcCC
Confidence 3455677888888875 664210000 112344467788888888776322 2222222 25777777777776
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.016 Score=61.71 Aligned_cols=74 Identities=11% Similarity=0.149 Sum_probs=42.9
Q ss_pred ccccccccceEEEEEecCC--------CeEEEEEEeeccchhhHHHHHHHHHHHhccCCCC-ceeEEEEeecCCCCCcee
Q 041479 527 VSYESLVKATVYKGILDLD--------QTFIAVKVLFLHQRGALKSFMAECQALRNIRHRN-LVKIITACSTSDFQGNYF 597 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~~~~ 597 (771)
..++.|....+|+.....+ ++.|++|+....... ..+...|.++++.+.... +.++++.. .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~------ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG------ 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC------
Confidence 3456777788999876542 247888887543221 123357888888775323 34666543 22
Q ss_pred EEEEEEeccCCCC
Q 041479 598 RALVYEFMHHGSL 610 (771)
Q Consensus 598 ~~lv~e~~~~g~L 610 (771)
++||||++|..+
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 589999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.73 E-value=0.045 Score=57.01 Aligned_cols=135 Identities=13% Similarity=0.063 Sum_probs=75.0
Q ss_pred cccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCC--CceeEEEEeecCCC--CCceeEEEEEEeccC
Q 041479 532 LVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHR--NLVKIITACSTSDF--QGNYFRALVYEFMHH 607 (771)
Q Consensus 532 ~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~~--~~~~~~~lv~e~~~~ 607 (771)
|....||+....++ +.+++|+..... ...+.+..|..+++.++.. .+.+++.. ++.. ......+++|||++|
T Consensus 36 g~~n~~y~v~~~~g-~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 36 SYENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp CSSSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEECCCC
T ss_pred CcccceEEEEcCCC-CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEecCC
Confidence 66678998765444 478999986332 1235667788887777421 23444332 1110 001145789999988
Q ss_pred CCCCCC-------------------c-------ccCCHHHH----HHH---------------HHHHHHHHHHHHhc---
Q 041479 608 GSLESC-------------------P-------RILSFLRR----LNI---------------AIDVASALEYLHHH--- 639 (771)
Q Consensus 608 g~L~~~-------------------~-------~~l~~~~~----~~i---------------~~~ia~gL~~LH~~--- 639 (771)
..+... . ..+++... ..+ ...+...++.+...
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 655321 0 01121110 000 01111223333321
Q ss_pred -CCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 640 -CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 640 -~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.029 Score=58.75 Aligned_cols=32 Identities=22% Similarity=0.282 Sum_probs=27.3
Q ss_pred CCCeEecCCCCCCeeeCCC----CceEEecccCccc
Q 041479 641 KKPIVHCDLKPSNVLLDND----MTAHMGDFGLTRF 672 (771)
Q Consensus 641 ~~~ivHrdlk~~NILl~~~----~~~kl~DfGla~~ 672 (771)
...++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3579999999999999874 6799999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.40 E-value=0.21 Score=52.30 Aligned_cols=31 Identities=23% Similarity=0.366 Sum_probs=27.4
Q ss_pred CCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 642 ~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999878899999987764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.91 E-value=0.31 Score=46.73 Aligned_cols=116 Identities=10% Similarity=0.133 Sum_probs=82.2
Q ss_pred cCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 041479 575 IRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652 (771)
Q Consensus 575 l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~ 652 (771)
-.||+.++. .+-.+.+ . +++.|-...+...+ .+.++...+++++..++...++++. =+|--+.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD-----~--v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRD-----S--FQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSS-----E--EEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEccc-----E--EEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 468998876 4444444 2 55555555555444 5668889999999999987766664 367789999
Q ss_pred CeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh-----HHHHHHHHHhCCCCCCccccCC
Q 041479 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----YGILLLEIFTGKRPTSDMFTEG 719 (771)
Q Consensus 653 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~Gv~l~el~tg~~P~~~~~~~~ 719 (771)
||+++.++.+++.-.|+...+.+.. +.+| |=+++..+++++..|++.+..+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~~----------------~~ee~fL~qyKAliiall~~K~~Fe~l~~G~ 164 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPLP----------------VSEAEFLTRYKALVICAFNEKQSFDALVEGN 164 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCCC----------------CCHHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred eEEEcCCCCEEEEEccCccCCCCCC----------------CCHHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence 9999999999999888754333211 1223 6888999999999987654433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.72 E-value=0.14 Score=55.38 Aligned_cols=73 Identities=14% Similarity=0.103 Sum_probs=44.6
Q ss_pred cccccccceEEEEEecCC-------CeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEE
Q 041479 528 SYESLVKATVYKGILDLD-------QTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.+..|....+|+.....+ ++.|++|+....... .-+-.+|.++++.+. +.-..++++.+ .+ +
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-------~ 146 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE-------G 146 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT-------E
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC-------C
Confidence 455677778999887631 357888886433211 123356888887774 32234555432 22 6
Q ss_pred EEEEeccCCCC
Q 041479 600 LVYEFMHHGSL 610 (771)
Q Consensus 600 lv~e~~~~g~L 610 (771)
+||||++|..+
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998665
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.95 E-value=0.96 Score=48.39 Aligned_cols=45 Identities=22% Similarity=0.307 Sum_probs=33.5
Q ss_pred eEecCCCCCCeee------CCCCceEEecccCccccCcccCCcccccccccccccccchhHHHHHHHHHh
Q 041479 644 IVHCDLKPSNVLL------DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFT 707 (771)
Q Consensus 644 ivHrdlk~~NILl------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~Gv~l~el~t 707 (771)
++|+|+.+.||++ +++..++++||-.|. ++|.+-++|..+.|.+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~-------------------~n~~~fDlan~f~ew~~ 296 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS-------------------YNYRGFDIGNHFCEWMY 296 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE-------------------EEEHHHHHHHHHHHTTE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc-------------------CCCchHhHHHHHHHHhc
Confidence 5799999999999 446679999998664 33444467777777653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.90 E-value=3 Score=40.04 Aligned_cols=111 Identities=14% Similarity=0.120 Sum_probs=74.0
Q ss_pred cCCCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCC
Q 041479 575 IRHRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALE-YLHHHCKKPIVHCDLKP 651 (771)
Q Consensus 575 l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~-~LH~~~~~~ivHrdlk~ 651 (771)
-.||.. + ..+-.+.+ . +.+.|-.......+ .+.++..++++++..++.... +++. -+|--+.|
T Consensus 47 ~~~~~f-~-~~I~~~eD-----~--~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI-V-RDIDVSED-----E--VKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp GSCSSS-E-EEEEECSS-----E--EEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred ccCCCC-C-eEEEEeCC-----E--EEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 368887 3 23333443 3 44555444344333 456788889999888887666 5553 46778899
Q ss_pred CCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh-----HHHHHHHHHhCCCCCCcc
Q 041479 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE-----YGILLLEIFTGKRPTSDM 715 (771)
Q Consensus 652 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~Gv~l~el~tg~~P~~~~ 715 (771)
+||+++.++.+++.-.|+-..+++.. +.+| |=+++..++.++..|++.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lpP~e----------------~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLPPDE----------------WDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBSSCS----------------CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred ceEEEeCCCcEEEEEcCCcccCCCCC----------------CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 99999999999999888754332211 2333 678888889988887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 771 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-33 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-32 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-30 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-28 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-26 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-04 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-23 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-22 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-22 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 38/205 (18%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGA--LKSFMAECQALRNIRHRNLVKIITACSTSDF 592
TVYKG D +AVK+L + L++F E LR RH N++ + +
Sbjct: 22 GTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---- 74
Query: 593 QGNYFRALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
A+V ++ SL ++ ++IA A ++YLH I+H D
Sbjct: 75 --APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRD 129
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
LK +N+ L D+T +GDFGL S+Q + G++ + PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKNPYS 187
Query: 699 --------GILLLEIFTGKRPTSDM 715
GI+L E+ TG+ P S++
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI 212
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 46/226 (20%), Positives = 83/226 (36%), Gaps = 28/226 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
TVYKG+ +A L + + + F E + L+ ++H N+V+ + ++
Sbjct: 23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82
Query: 593 QGNYFRALVYEFMHHGSLESCPR---ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
LV E M G+L++ + ++ + + L++LH PI+H DL
Sbjct: 83 GKKCI-VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDL 140
Query: 650 KPSNVLL-DNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
K N+ + + +GD GL + GT + PE
Sbjct: 141 KCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPEFMAPEMYEEKYDESVD 194
Query: 699 ----GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740
G+ +LE+ T + P S+ P +V P
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-36
Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 32/196 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V+K +A K++ L + + E Q L +V A +
Sbjct: 20 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 78
Query: 594 GNYFRALVYEFMHHGSLESCPR---ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
++ E M GSL+ + + ++I V L YL K I+H D+K
Sbjct: 79 ----ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVK 132
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
PSN+L+++ + DFG++ + + M+++ GT Y +PE
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDI 186
Query: 699 ---GILLLEIFTGKRP 711
G+ L+E+ G+ P
Sbjct: 187 WSMGLSLVEMAVGRYP 202
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-34
Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G + T +AVK L +F+AE ++ ++H+ LV++ +
Sbjct: 27 GEVWMGYYN-GHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-- 82
Query: 595 NYFRALVYEFMHHGSLESCPRI-----LSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
++ E+M +GSL + L+ + L++A +A + ++ +H DL
Sbjct: 83 ----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----------- 698
+ +N+L+ + ++ + DFGL R I + + + G K + + PE
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 699 ----GILLLEIFTGKRPTSDMFTEGLDLHNFVK---MALPDQILQVLDPL 741
GILL EI T R T + N + M PD + L L
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (324), Expect = 2e-33
Identities = 42/232 (18%), Positives = 72/232 (31%), Gaps = 41/232 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
VY + +A+K + + + E + L+ +RH N ++
Sbjct: 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 592 FQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
LV E+ + + + L + + L YLH H ++H D
Sbjct: 89 T-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRD 140
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
+K N+LL +GDFG + S GT + PE
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANS--------FVGTPYWMAPEVILAMDEGQYD 192
Query: 699 --------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742
GI +E+ K P +M L++ + P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYF 243
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 46/230 (20%), Positives = 78/230 (33%), Gaps = 32/230 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++G +AVK+ + + AE +RH N++ I A + +
Sbjct: 17 GEVWRGKWR--GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTW 73
Query: 595 NYFRALVYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHC-----KKPIVHC 647
LV ++ HGSL ++ + +A+ AS L +LH K I H
Sbjct: 74 TQL-WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY--------- 698
DLK N+L+ + T + D GL + + GT Y PE
Sbjct: 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 192
Query: 699 ------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736
G++ EI L ++ V + ++
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 45/205 (21%), Positives = 74/205 (36%), Gaps = 36/205 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VYK A KV+ L+ +M E L + H N+VK++ A +
Sbjct: 26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-- 83
Query: 595 NYFRALVYEFMHHGSLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
++ EF G+++ R L+ + + AL YLH + I+H DLK
Sbjct: 84 ---LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLK 137
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
N+L D + DFG++ + GT + PE
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----FIGTPYWMAPEVVMCETSKDRPYD 193
Query: 699 --------GILLLEIFTGKRPTSDM 715
GI L+E+ + P ++
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHEL 218
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 48/222 (21%), Positives = 83/222 (37%), Gaps = 36/222 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
VY + +A+KVL L + G E + ++RH N++++ +
Sbjct: 20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79
Query: 592 FQGNYFRALVYEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
L+ E+ G++ R ++A+AL Y H ++H D
Sbjct: 80 R-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRD 131
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
+KP N+LL + + DFG + P + C GT+ Y PE
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GTLDYLPPEMIEGRMHDEKV 185
Query: 699 -----GILLLEIFTGKRP-TSDMFTEGLDLHNFVKMALPDQI 734
G+L E GK P ++ + E + V+ PD +
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 227
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 7e-33
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 535 ATVYKGILDLD---QTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
V G L L + F+A+K L + + F++E + H N++ + + S
Sbjct: 40 GEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99
Query: 591 DFQGNYFRALVYEFMHHGSLESCPRI----LSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
++ EFM +GSL+S R + ++ + + +A+ ++YL VH
Sbjct: 100 TP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVH 151
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS-SNQCSSVGLKGTVGYATPEY------- 698
DL N+L+++++ + DFGL+RF+ + S S++G K + + PE
Sbjct: 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211
Query: 699 --------GILLLEIFT-GKRPTSDM 715
GI++ E+ + G+RP DM
Sbjct: 212 SASDVWSYGIVMWEVMSYGERPYWDM 237
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 35/229 (15%)
Query: 535 ATVYKGILDL--DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+V +G+ + Q +A+KVL ++ + M E Q + + + +V++I C
Sbjct: 23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 82
Query: 592 FQGNYFRALVYEFMHHGSLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
LV E G L + + V+ ++YL VH
Sbjct: 83 L------MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHR 133
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY--------- 698
DL NVLL N A + DFGL++ + S S G K + + PE
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFRKFSSR 192
Query: 699 ------GILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740
G+ + E + G++P M +G ++ F++ + P
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMECPPECPP 239
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 6e-32
Identities = 42/194 (21%), Positives = 78/194 (40%), Gaps = 29/194 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
TVY + +A++ + L Q+ + + E +R ++ N+V + + D
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 90
Query: 595 NYFRALVYEFMHHGSLES--CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652
+V E++ GSL + + + + ALE+LH + ++H D+K
Sbjct: 91 --ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSD 145
Query: 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY-------------- 698
N+LL D + + DFG I + Q + GT + PE
Sbjct: 146 NILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 699 -GILLLEIFTGKRP 711
GI+ +E+ G+ P
Sbjct: 202 LGIMAIEMIEGEPP 215
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 7e-32
Identities = 52/197 (26%), Positives = 78/197 (39%), Gaps = 38/197 (19%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V G +AVK + ++F+AE + +RH NLV+++ G
Sbjct: 21 GDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK--G 74
Query: 595 NYFRALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
+ +V E+M GSL +L L ++DV A+EYL + VH DL
Sbjct: 75 GLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDL 129
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----------- 698
NVL+ D A + DFGLT+ + + V + PE
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-------LPVKWTAPEALREKKFSTKSD 182
Query: 699 ----GILLLEIFTGKRP 711
GILL EI++ R
Sbjct: 183 VWSFGILLWEIYSFGRV 199
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 9e-32
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 33/204 (16%)
Query: 535 ATVYKGILDLDQT--FIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
TV KG + + +AVK+L +AE ++ + + +V++I C
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80
Query: 591 DFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
+ LV E G L R + + + V+ ++YL VH
Sbjct: 81 SW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHR 131
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY--------- 698
DL NVLL A + DFGL++ + + + + G K V + PE
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKFSSK 190
Query: 699 ------GILLLEIFT-GKRPTSDM 715
G+L+ E F+ G++P M
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGM 214
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-31
Identities = 46/207 (22%), Positives = 71/207 (34%), Gaps = 33/207 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
K D + K L + ++E LR ++H N+V+
Sbjct: 18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77
Query: 593 QGNYFRALVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHH--CKKP 643
Y +V E+ G L S + L L + + AL+ H
Sbjct: 78 TTLY---IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 134
Query: 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----- 698
++H DLKP+NV LD +GDFGL R + + + + GT Y +PE
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 699 ----------GILLLEIFTGKRPTSDM 715
G LL E+ P +
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAF 217
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 3e-31
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G L++ +A+K + + F+ E + + + H LV++ C
Sbjct: 19 GLVHLGY-WLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-- 74
Query: 595 NYFRALVYEFMHHGSLESCPRILSFL----RRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
LV+EFM HG L R L L + +DV + + + ++H DL
Sbjct: 75 ---ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHRDLA 128
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
N L+ + + DFG+TRF+ + ++ G K V +A+PE
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSST---GTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 699 ---GILLLEIFTGKRPTSDMFTE 718
G+L+ E+F+ + + +
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSN 208
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 8e-31
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 34/227 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V+ G + T +A+K L ++F+ E Q ++ +RH LV++ S
Sbjct: 31 GEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-- 86
Query: 595 NYFRALVYEFMHHGSLES-----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
+V E+M GSL + L + +++A +AS + Y+ VH DL
Sbjct: 87 ----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 139
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----------- 698
+ +N+L+ ++ + DFGL R I + + + G K + + PE
Sbjct: 140 RAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 699 ----GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741
GILL E+ T R L + + + L
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 46/200 (23%), Positives = 74/200 (37%), Gaps = 30/200 (15%)
Query: 535 ATVYKGIL---DLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTS 590
VY G L D + AVK L + G + F+ E +++ H N++ ++ C
Sbjct: 41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC--- 97
Query: 591 DFQGNYFRALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
+ +V +M HG L + + + + VA + K VH
Sbjct: 98 -LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVH 153
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY-------- 698
DL N +LD T + DFGL R + + + + G K V + E
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213
Query: 699 -------GILLLEIFTGKRP 711
G+LL E+ T P
Sbjct: 214 KSDVWSFGVLLWELMTRGAP 233
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 48/225 (21%), Positives = 87/225 (38%), Gaps = 33/225 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V G Q +A+K++ F+ E + + N+ H LV++ C+
Sbjct: 18 GVVKYGKWR-GQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-- 73
Query: 595 NYFRALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
++ E+M +G L + + L + DV A+EYL +H DL
Sbjct: 74 ---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 127
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
N L+++ + DFGL+R++ + SSVG K V ++ PE
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 699 ---GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740
G+L+ EI++ + + FT + + L +
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLYRPHLASE 228
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 42/229 (18%), Positives = 75/229 (32%), Gaps = 30/229 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V + + + +AVK++ + ++ E + + H N+VK + Q
Sbjct: 19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78
Query: 594 GNYFRALVYEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
L E+ G L + + + + YLH I H D+K
Sbjct: 79 -----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIK 130
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
P N+LLD + DFGL + + GT+ Y PE
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHAEPVD 188
Query: 699 ----GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743
GI+L + G+ P + ++ + + +D L
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (294), Expect = 8e-30
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 36/222 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
VY+G+ +AVK L ++ F+ E ++ I+H NLV+++ C+
Sbjct: 31 GEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-- 87
Query: 595 NYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
++ EFM +G+L E + +S + L +A ++SA+EYL +H DL
Sbjct: 88 ---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 141
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----------- 698
N L+ + + DFGL+R + + G K + + PE
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 699 ----GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736
G+LL EI T G+DL ++ D ++
Sbjct: 199 VWAFGVLLWEIATYGMS----PYPGIDLSQVYELLEKDYRME 236
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 51/254 (20%), Positives = 81/254 (31%), Gaps = 58/254 (22%)
Query: 535 ATVYKGIL-----DLDQTFIAVKVLFL-HQRGALKSFMAECQALRNI-RHRNLVKIITAC 587
V +AVK+L ++ M+E + + + H N+V ++ AC
Sbjct: 51 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110
Query: 588 STSDFQGNYFRALVYEFMHHGSL--------------------------ESCPRILSFLR 621
+ S L++E+ +G L E +L+F
Sbjct: 111 TLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 165
Query: 622 RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681
L A VA +E+L VH DL NVL+ + + DFGL R I SN
Sbjct: 166 LLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS--DSNY 220
Query: 682 CSSVGLKGTVGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFV 726
+ V + PE GILL EIF+ + + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 727 KMALPDQILQVLDP 740
+
Sbjct: 281 QNGFKMDQPFYATE 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 38/195 (19%), Positives = 66/195 (33%), Gaps = 25/195 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+TV A+K+L + + + E + + H VK+ +
Sbjct: 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+ +G L R + A + L + K I+H DLKP
Sbjct: 82 K-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 136
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------- 698
N+LL+ DM + DFG + + + +S GT Y +PE
Sbjct: 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGTAQYVSPELLTEKSACKSSDLW 194
Query: 699 --GILLLEIFTGKRP 711
G ++ ++ G P
Sbjct: 195 ALGCIIYQLVAGLPP 209
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-29
Identities = 49/202 (24%), Positives = 73/202 (36%), Gaps = 35/202 (17%)
Query: 535 ATVYKGILDLD---QTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACS 588
V +G D +AVK L L Q A+ F+ E A+ ++ HRNL+++
Sbjct: 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCP----RILSFLRRLNIAIDVASALEYLHHHCKKPI 644
T + +V E GSL A+ VA + YL
Sbjct: 82 TPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---F 132
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------ 698
+H DL N+LL +GDFGL R +P+ + K + PE
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 699 ---------GILLLEIFTGKRP 711
G+ L E+FT +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQE 213
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 40/231 (17%), Positives = 85/231 (36%), Gaps = 33/231 (14%)
Query: 535 ATVYKGILDLD----QTFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACST 589
VYKG+L + +A+K L + F+ E + H N++++ S
Sbjct: 21 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPR----ILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
++ E+M +G+L+ R S L+ + + +A+ + + V
Sbjct: 81 YKP-----MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM---KYLANMNYV 132
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------- 698
H DL N+L+++++ + DFGL+R + + ++ G K + + PE
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIRWTAPEAISYRKFT 191
Query: 699 --------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741
GI++ E+ T + + + +
Sbjct: 192 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 39/201 (19%), Positives = 71/201 (35%), Gaps = 35/201 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVL-----FLHQRGALKSFMAECQALRNIRHRNLVKIITACST 589
TVYKG+ + + + V A K + E + ++ + ++ +++ C T
Sbjct: 23 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82
Query: 590 SDFQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
S Q L+ + M G L + LN + +A + YL +V
Sbjct: 83 STVQ------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 133
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------- 698
H DL NVL+ + DFGL + + + + G K + + E
Sbjct: 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 699 --------GILLLEIFTGKRP 711
G+ + E+ T
Sbjct: 192 HQSDVWSYGVTVWELMTFGSK 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 114 bits (287), Expect = 3e-28
Identities = 42/198 (21%), Positives = 67/198 (33%), Gaps = 34/198 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++ A K + ++ E Q + +RH LV + A +
Sbjct: 40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 96
Query: 595 NYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
++YEFM G L +S + V L ++H + VH DLK
Sbjct: 97 --EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLK 151
Query: 651 PSNVLLDNDMTAH--MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
P N++ + + DFGLT + S GT +A PE
Sbjct: 152 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-----TGTAEFAAPEVAEGKPVGYYT 206
Query: 699 -----GILLLEIFTGKRP 711
G+L + +G P
Sbjct: 207 DMWSVGVLSYILLSGLSP 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 7e-28
Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 26/202 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
+ V+ +AVKVL F E Q + H +V +
Sbjct: 21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80
Query: 592 FQGNYFRALVYEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
G +V E++ +L ++ R + + D AL + H + I+H D
Sbjct: 81 PAGPLP-YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRD 136
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
+KP+N+++ + DFG+ R I + +S ++ + GT Y +PE
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-AVIGTAQYLSPEQARGDSVDARS 195
Query: 699 -----GILLLEIFTGKRPTSDM 715
G +L E+ TG+ P +
Sbjct: 196 DVYSLGCVLYEVLTGEPPFTGD 217
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 21/198 (10%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
V+K +A+K + + + G + + E + L+ ++H N+V +I C T
Sbjct: 24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83
Query: 593 QGNYFRA---LVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
N + LV++F H +L I + L L++ + I+H D+
Sbjct: 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDM 143
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----------- 698
K +NVL+ D + DFGL R +S T+ Y PE
Sbjct: 144 KAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI 203
Query: 699 -----GILLLEIFTGKRP 711
G ++ E++T
Sbjct: 204 DLWGAGCIMAEMWTRSPI 221
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 49/245 (20%), Positives = 83/245 (33%), Gaps = 48/245 (19%)
Query: 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQR-GALKSFMAECQALRNI-RHRNLVKIIT 585
++ +V+AT Y I +AVK+L ++ M+E + L + H N+V ++
Sbjct: 35 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSLESCPR---------------------ILSFLRRLN 624
AC+ ++ E+ +G L + R L L+
Sbjct: 95 ACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 625 IAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSS 684
+ VA + +L +H DL N+LL + + DFGL R I SN
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN--DSNYVVK 204
Query: 685 VGLKGTVGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729
+ V + PE GI L E+F+ + +K
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
Query: 730 LPDQI 734
Sbjct: 265 FRMLS 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (277), Expect = 2e-27
Identities = 42/199 (21%), Positives = 73/199 (36%), Gaps = 30/199 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V+ + + A+KVL + + ++ E L + H ++++ +
Sbjct: 18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+ +++ G L S R A L + K I++ DLKP
Sbjct: 78 QIFM-----IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------- 698
N+LLD + + DFG +++P+V + L GT Y PE
Sbjct: 133 ENILLDKNGHIKITDFGFAKYVPDVTYT-------LCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 699 --GILLLEIFTGKRPTSDM 715
GIL+ E+ G P D
Sbjct: 186 SFGILIYEMLAGYTPFYDS 204
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-27
Identities = 47/233 (20%), Positives = 86/233 (36%), Gaps = 38/233 (16%)
Query: 535 ATVYKGIL-DLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTS 590
V++GI + +AV + + F+ E +R H ++VK+I +
Sbjct: 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 78
Query: 591 DFQGNYFRALVYEFMHHGSLES----CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVH 646
++ E G L S L + A +++AL YL VH
Sbjct: 79 ----ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVH 131
Query: 647 CDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY-------- 698
D+ NVL+ ++ +GDFGL+R++ + S + K + + PE
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 699 -------GILLLEIFT-GKRPTSDMFTEGL--DLHNFVKMALPDQILQVLDPL 741
G+ + EI G +P + + + N ++ +P L L
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 6e-27
Identities = 47/225 (20%), Positives = 74/225 (32%), Gaps = 58/225 (25%)
Query: 535 ATVYKGILDL-----DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACS 588
V++ T +AVK+L F E + + N+VK++ C+
Sbjct: 27 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86
Query: 589 TSDFQGNYFRALVYEFMHHGSLES---------------------------CPRILSFLR 621
L++E+M +G L P LS
Sbjct: 87 VGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141
Query: 622 RLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681
+L IA VA+ + YL VH DL N L+ +M + DFGL+R I
Sbjct: 142 QLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 198
Query: 682 CSSVGLKGTVGYATPEY---------------GILLLEIFTGKRP 711
+ + + PE G++L EIF+
Sbjct: 199 DGNDA--IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-26
Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 44/242 (18%)
Query: 535 ATVYKGIL-----DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACS 588
VY+G+ D +T +A+K + F+ E ++ ++V+++ S
Sbjct: 34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCPRI-------------LSFLRRLNIAIDVASALEY 635
++ E M G L+S R S + + +A ++A + Y
Sbjct: 94 QGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 148
Query: 636 LHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYAT 695
L+ + VH DL N ++ D T +GDFG+TR I E + V + +
Sbjct: 149 LNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG--LLPVRWMS 203
Query: 696 PEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740
PE G++L EI T + L ++ L D+ D
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM 263
Query: 741 LF 742
LF
Sbjct: 264 LF 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 107 bits (269), Expect = 5e-26
Identities = 35/198 (17%), Positives = 63/198 (31%), Gaps = 34/198 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++ + K + + E + + H L+ + A
Sbjct: 43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 99
Query: 595 NYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
L+ EF+ G L +S +N L+++H H IVH D+K
Sbjct: 100 --EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIK 154
Query: 651 PSNVLLDNDMTAH--MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
P N++ + + + DFGL + + T +A PE
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKL-----NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 699 -----GILLLEIFTGKRP 711
G+L + +G P
Sbjct: 210 DMWAIGVLGYVLLSGLSP 227
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 106 bits (265), Expect = 7e-26
Identities = 69/309 (22%), Positives = 110/309 (35%), Gaps = 29/309 (9%)
Query: 3 DKQALLAFKSKVDDDPFGALSTWNDSVNFCQ--WLGVTCSL--KYQRVILLNLSGQNLTG 58
DKQALL K + + LS+W + + C WLGV C + RV L+LSG NL
Sbjct: 7 DKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 59 TAS--PYIGNLTFLRLINLQQN-NFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLIL 115
+ NL +L + + N IP I +L +L ++ + G IPD +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 116 ----------NKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPI 165
N L G +P + SL G+ N +G IP +++
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 166 QLLNITSME-----YFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNAS 220
+L V ++ + E + F + + +
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 221 KLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMS 280
L LD NN + G +P L +L +++S N+L G +P N +
Sbjct: 245 NLNGLDLRNNRIYGTLP---QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQR-FDVSAYA 299
Query: 281 ANPISGSIP 289
N P
Sbjct: 300 NNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 75/354 (21%), Positives = 126/354 (35%), Gaps = 51/354 (14%)
Query: 122 IPSELGSLLKFK-GLG----LANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYF 176
P + +LL+ K LG L++ T + V + T + + L++
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDL------ 57
Query: 177 HVSENQLVG--ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG 234
S L +P + LP + L + G + +KL L + + T
Sbjct: 58 --SGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNL--VGPIPPAIAKLTQLHYLYITHTN 112
Query: 235 LIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGN 294
+ D L L + S N+LSGTLP S+++ + + + N ISG+IP G+
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG-NRISGAIPDSYGS 171
Query: 295 LKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGN 354
L + L L + L N + + G+ +++L N
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 355 SIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWI 414
S+ + S + LDL +N + G +P + K + L++S N L GEIP
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-- 289
Query: 415 FGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCT 468
+ + A N+ LCG LP CT
Sbjct: 290 --------------------------LQRFDVSAYANNKCLCGSP----LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 19/83 (22%), Positives = 32/83 (38%), Gaps = 17/83 (20%)
Query: 68 TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG 127
L ++L+ N +P + +L L + + N L G+IP + G
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP---------------QGG 288
Query: 128 SLLKFKGLGLANNYFT--GPIPH 148
+L +F ANN P+P
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 46/245 (18%), Positives = 82/245 (33%), Gaps = 51/245 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNI-RHRNLVKIITACSTS 590
V K + D + + + + + + F E + L + H N++ ++ AC
Sbjct: 24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83
Query: 591 DFQGNYFRALVYEFMHHGSL-------------------ESCPRILSFLRRLNIAIDVAS 631
+ L E+ HG+L S LS + L+ A DVA
Sbjct: 84 GY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138
Query: 632 ALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTV 691
+ + +K +H DL N+L+ + A + DFGL+R + + V
Sbjct: 139 GM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-----RLPV 190
Query: 692 GYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736
+ E YG+LL EI + T + ++ L
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250
Query: 737 VLDPL 741
D +
Sbjct: 251 CDDEV 255
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 1e-24
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 33/206 (16%)
Query: 535 ATVYKGI-LDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNI---RHRNLVKIITACS 588
V+K L F+A+K + + + G S + E LR++ H N+V++ C+
Sbjct: 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCPRI----LSFLRRLNIAIDVASALEYLHHHCKKPI 644
S LV+E + ++ + ++ + L++LH H +
Sbjct: 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---V 137
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------ 698
VH DLKP N+L+ + + DFGL R M+ T+ Y PE
Sbjct: 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWYRAPEVLLQSSY 192
Query: 699 ---------GILLLEIFTGKRPTSDM 715
G + E+F K
Sbjct: 193 ATPVDLWSVGCIFAEMFRRKPLFRGS 218
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-24
Identities = 44/198 (22%), Positives = 74/198 (37%), Gaps = 30/198 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQR-----GALKSFMAECQALRNIRHRNLVKIITACST 589
ATVYK +A+K + L R G ++ + E + L+ + H N++ ++ A
Sbjct: 12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71
Query: 590 SDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649
+LV++FM L +I + L+ L + + I+H DL
Sbjct: 72 KSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY----------- 698
KP+N+LLD + + DFGL + + T Y PE
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ----VVTRWYRAPELLFGARMYGVGV 182
Query: 699 -----GILLLEIFTGKRP 711
G +L E+
Sbjct: 183 DMWAVGCILAELLLRVPF 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-24
Identities = 38/195 (19%), Positives = 67/195 (34%), Gaps = 22/195 (11%)
Query: 535 ATVYKGILDLDQTFIAVKVL-FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
V ++++ +A+K + + + + E + L RH N++ I +
Sbjct: 22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 594 GNYFRALVYEFMHHGSLESC-PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652
LV M + + LS + L+Y+H ++H DLKPS
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPS 138
Query: 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY-------------- 698
N+LL+ + DFGL R + T Y PE
Sbjct: 139 NLLLNTTCDLKICDFGLARVADP-DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197
Query: 699 --GILLLEIFTGKRP 711
G +L E+ + +
Sbjct: 198 SVGCILAEMLSNRPI 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 4e-23
Identities = 39/196 (19%), Positives = 73/196 (37%), Gaps = 26/196 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITAC-STSDFQ 593
VY+ L +A+K + +R E Q +R + H N+V++ S+ + +
Sbjct: 34 GVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 594 GNYFRALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
+ LV +++ + L + + +L Y+H I H
Sbjct: 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHR 146
Query: 648 DLKPSNVLLDND-MTAHMGDFGLTRFIPE-------VMSSNQCSSVGLKGTVGYATP--- 696
D+KP N+LLD D + DFG + + + S + + G Y +
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 697 -EYGILLLEIFTGKRP 711
G +L E+ G+
Sbjct: 207 WSAGCVLAELLLGQPI 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.4 bits (247), Expect = 5e-23
Identities = 41/231 (17%), Positives = 72/231 (31%), Gaps = 39/231 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL------HQRGALKSFMAECQALRNIRHRNLVKIITACS 588
VY A+K L + + +V + A
Sbjct: 18 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77
Query: 589 TSDFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIV 645
T D + + + M+ G L + S A ++ LE++H+ +V
Sbjct: 78 TPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VV 129
Query: 646 HCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------- 698
+ DLKP+N+LLD + D GL + GT GY PE
Sbjct: 130 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMAPEVLQKGVAY 183
Query: 699 ---------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740
G +L ++ G P T+ + + + + ++ P
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 97.1 bits (241), Expect = 6e-23
Identities = 46/211 (21%), Positives = 76/211 (36%), Gaps = 47/211 (22%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ---------RGALKSFMAECQALRNIR-HRNLVKII 584
+ V + I AVK++ + + ++ + E LR + H N++++
Sbjct: 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76
Query: 585 TACSTSDFQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCK 641
++ N F LV++ M G L LS I + + LH
Sbjct: 77 -----DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN- 130
Query: 642 KPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY--- 698
IVH DLKP N+LLD+DM + DFG + + + GT Y PE
Sbjct: 131 --IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-----CGTPSYLAPEIIEC 183
Query: 699 ------------------GILLLEIFTGKRP 711
G+++ + G P
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 7e-23
Identities = 32/198 (16%), Positives = 68/198 (34%), Gaps = 35/198 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
V++ + + K + + E L RHRN++ + + + +
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFESMEE-- 75
Query: 595 NYFRALVYEFMHHGSL----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
+++EF+ + + L+ ++ V AL++LH H I H D++
Sbjct: 76 ---LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIR 129
Query: 651 PSNVLLDNDMTAH--MGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
P N++ ++ + +FG R + + Y PE
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-----FTAPEYYAPEVHQHDVVSTAT 184
Query: 699 -----GILLLEIFTGKRP 711
G L+ + +G P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 32/207 (15%), Positives = 67/207 (32%), Gaps = 35/207 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
+++G L+ +A+K +R E + + + + + Q
Sbjct: 19 GVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF----GQE 72
Query: 595 NYFRALVYEFMHHGS---LESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
LV + + L+ C R S A + + ++ +H +V+ D+KP
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKP 129
Query: 652 SNVLLDNDMTAHMG-----DFGLTRFIPEVMSSNQ---CSSVGLKGTVGYATPEY----- 698
N L+ + + DFG+ +F + ++ L GT Y +
Sbjct: 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189
Query: 699 ----------GILLLEIFTGKRPTSDM 715
G + + G P +
Sbjct: 190 QSRRDDLEALGHVFMYFLRGSLPWQGL 216
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 41/229 (17%), Positives = 77/229 (33%), Gaps = 37/229 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594
+Y G +A+K+ + E + + ++ + I C
Sbjct: 21 GDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC----GAE 74
Query: 595 NYFRALVYEFMHHGSLE---SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+ +V E + + C R S L +A + S +EY+H +H D+KP
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKP 131
Query: 652 SNVL---LDNDMTAHMGDFGLTRFIPEVMSSNQ---CSSVGLKGTVGYATPE-------- 697
N L ++ DFGL + + + + L GT YA+
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
Query: 698 -------YGILLLEIFTGKRPTSDMFT----EGLDLHNFVKMALPDQIL 735
G +L+ G P + + + + KM+ P ++L
Sbjct: 192 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 2e-22
Identities = 44/199 (22%), Positives = 68/199 (34%), Gaps = 34/199 (17%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTS 590
V+ F A+K L + ++ M E + L H L + T
Sbjct: 16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75
Query: 591 DFQGNYFRALVYEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
+ V E+++ G L R A ++ L++LH IV+
Sbjct: 76 EN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYR 127
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY--------- 698
DLK N+LLD D + DFG+ + + GT Y PE
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT----FCGTPDYIAPEILLGQKYNHS 183
Query: 699 ------GILLLEIFTGKRP 711
G+LL E+ G+ P
Sbjct: 184 VDWWSFGVLLYEMLIGQSP 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 3e-22
Identities = 40/198 (20%), Positives = 71/198 (35%), Gaps = 32/198 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYK L +A+K + L G + + E L+ + H N+VK++ T +
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 593 QGNYFRALVYEFMHHGSLE----SCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
LV+EF+H + S + + + L + H H ++H D
Sbjct: 76 -----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRD 127
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
LKP N+L++ + + DFGL R + + + A
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFG---VPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 699 -----GILLLEIFTGKRP 711
G + E+ T +
Sbjct: 185 DIWSLGCIFAEMVTRRAL 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.0 bits (235), Expect = 4e-22
Identities = 37/194 (19%), Positives = 69/194 (35%), Gaps = 25/194 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
TV+K +A+K + L G S + E L+ ++H+N+V++ +
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--- 72
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652
+ LV+EF + L + + L+ L + ++H DLKP
Sbjct: 73 --DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY-------------- 698
N+L++ + + +FGL R +C S +
Sbjct: 131 NLLINRNGELKLANFGLARAFGI---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 699 -GILLLEIFTGKRP 711
G + E+ RP
Sbjct: 188 AGCIFAELANAGRP 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 95.1 bits (236), Expect = 5e-22
Identities = 37/200 (18%), Positives = 59/200 (29%), Gaps = 29/200 (14%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQ 593
+ V Q +A+K + G S E L I+H N+V + +
Sbjct: 23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH- 81
Query: 594 GNYFRALVYEFMHHGSLES---CPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
L+ + + G L + + V A++YLH
Sbjct: 82 ----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN 137
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
LD D + DFGL++ + GT GY PE
Sbjct: 138 LLYYSLDEDSKIMISDFGLSKMEDPGSVLST-----ACGTPGYVAPEVLAQKPYSKAVDC 192
Query: 699 ---GILLLEIFTGKRPTSDM 715
G++ + G P D
Sbjct: 193 WSIGVIAYILLCGYPPFYDE 212
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 9e-22
Identities = 43/246 (17%), Positives = 74/246 (30%), Gaps = 48/246 (19%)
Query: 535 ATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACS 588
V + +AVK+L ++ M+E + L +I H V +
Sbjct: 27 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 589 TSDFQGNYFRALVYEFMHHGSLESC-------------------PRILSFLRRLNIAIDV 629
T ++ EF G+L + L+ + + V
Sbjct: 87 TKPGGPLM---VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143
Query: 630 ASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKG 689
A +E+L +H DL N+LL + DFGL R I + + +
Sbjct: 144 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA--RL 198
Query: 690 TVGYATPEY---------------GILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQI 734
+ + PE G+LL EIF+ + +K +
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 258
Query: 735 LQVLDP 740
P
Sbjct: 259 PDYTTP 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 9e-22
Identities = 39/195 (20%), Positives = 69/195 (35%), Gaps = 27/195 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V + A+K+L + + + + E + L+N RH L + A T D
Sbjct: 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
V E+ + G L A + L + + +V+ D+K
Sbjct: 79 R-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------- 698
N++LD D + DFGL + ++ + GT Y PE
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKT----FCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 699 --GILLLEIFTGKRP 711
G+++ E+ G+ P
Sbjct: 190 GLGVVMYEMMCGRLP 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 41/191 (21%), Positives = 73/191 (38%), Gaps = 20/191 (10%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
VYK + +TF A+K + L + G + + E L+ ++H N+VK+ T
Sbjct: 16 GVVYKAQNNYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--- 71
Query: 593 QGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652
LV+E + + L + + L + + + ++H DLKP
Sbjct: 72 --KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG--------LKGTVGYATP----EYGI 700
N+L++ + + DFGL R + V L G+ Y+T G
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 701 LLLEIFTGKRP 711
+ E+ G
Sbjct: 190 IFAEMVNGTPL 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 1e-21
Identities = 42/234 (17%), Positives = 68/234 (29%), Gaps = 36/234 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH------QRGALKSFMAECQALRNIRHRNLVKIITACS 588
A V K A K + + + + E L+ I+H N++ +
Sbjct: 24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83
Query: 589 TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
L+ E + G L L + L +++ I H D
Sbjct: 84 NKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFD 138
Query: 649 LKPSNVLLDNDMTA----HMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------ 698
LKP N++L + + DFGL I GT + PE
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-----FGTPEFVAPEIVNYEPL 193
Query: 699 ---------GILLLEIFTGKRP-TSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742
G++ + +G P D E L + V D+ L
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 4e-21
Identities = 38/190 (20%), Positives = 67/190 (35%), Gaps = 16/190 (8%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSD- 591
V + +A+K L+ K E + L+++RH N++ ++ + +
Sbjct: 32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91
Query: 592 FQGNYFRALVYEFMHHGSLESCPR-ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
LV FM + L R + + L Y+H H DLK
Sbjct: 92 LDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLK 148
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG-----LKGTVGYATP----EYGIL 701
P N+ ++ D + DFGL R M+ + + + Y G +
Sbjct: 149 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 702 LLEIFTGKRP 711
+ E+ TGK
Sbjct: 209 MAEMITGKTL 218
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 6e-21
Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 43/206 (20%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLH------QRGALKSFMAECQALRNIR--HRNLVKIITA 586
+VY GI D +A+K + + E L+ + +++++
Sbjct: 18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 587 CSTSDFQGNYFRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKK 642
D L+ E L + V A+ +
Sbjct: 78 FERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---HNC 129
Query: 643 PIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY--- 698
++H D+K N+L+D N + DFG + + + ++ GT Y+ PE+
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRY 183
Query: 699 -------------GILLLEIFTGKRP 711
GILL ++ G P
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 92.2 bits (228), Expect = 8e-21
Identities = 40/212 (18%), Positives = 76/212 (35%), Gaps = 32/212 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQ 593
+ V++ I + + VK+L + K E + L N+R N++ + +
Sbjct: 49 SEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSR 105
Query: 594 GNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSN 653
LV+E +++ + + L+ ++ AL+Y H I+H D+KP N
Sbjct: 106 TPA---LVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHN 159
Query: 654 VLLDND-MTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY-------------- 698
V++D++ + D+GL F N + + PE
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-----VASRYFKGPELLVDYQMYDYSLDMW 214
Query: 699 --GILLLEIFTGKRPTSDMFTEGLDLHNFVKM 728
G +L + K P L K+
Sbjct: 215 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 2e-20
Identities = 36/201 (17%), Positives = 63/201 (31%), Gaps = 38/201 (18%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQAL-RNIRHRNLVKIITACSTSDFQ 593
V + Q A+K+L + E + R + ++V+I+
Sbjct: 26 GKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVYENLYAG 80
Query: 594 GNYFRALVYEFMHHGSL-----ESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
+V E + G L + + + I + A++YLH I H D
Sbjct: 81 RKCL-LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRD 136
Query: 649 LKPSNVLLD---NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------- 698
+KP N+L + + DFG + S T Y PE
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-----CYTPYYVAPEVLGPEKYD 191
Query: 699 --------GILLLEIFTGKRP 711
G+++ + G P
Sbjct: 192 KSCDMWSLGVIMYILLCGYPP 212
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.0 bits (227), Expect = 2e-20
Identities = 73/359 (20%), Positives = 119/359 (33%), Gaps = 30/359 (8%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
L + + L L IN N + P + L +L I+ N+N +
Sbjct: 49 LQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 104
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG-----PIPHLNMFQVSVYSLTGSI 163
P + L +++ + K L N I L+ G+
Sbjct: 105 PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ 164
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223
L + ++ + + L N+ L+ NQ P I + L+
Sbjct: 165 VTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLD 222
Query: 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283
L N L + +L + T L + L+ N +S P S + L L + AN
Sbjct: 223 ELSLNGNQLKDI-----GTLASLTNLTDLDLANNQISNLAPLS---GLTKLTELKLGANQ 274
Query: 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF 343
IS P + +E + L L L+L+ NNIS P + +
Sbjct: 275 ISNISPLA----GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328
Query: 344 TFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
T L L N + S+L + + WL HN ++ PL N I L L+
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.3 bits (150), Expect = 7e-11
Identities = 41/236 (17%), Positives = 77/236 (32%), Gaps = 35/236 (14%)
Query: 25 WNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNI 84
+ S N + V L L + ++ I T L ++L N
Sbjct: 180 LDISSNKVSDISVLAKLTNLES--LIATNNQISDITPLGIL--TNLDELSLNGNQLKD-- 233
Query: 85 PHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG 144
+ L L + +N + P L L K L L N +
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP----------------LSGLTKLTELKLGANQISN 277
Query: 145 PIPHLNMFQVSVYSLTGSIPIQLLNITSM---EYFHVSENQLVGELPPHIGFTLPNVRIL 201
P + ++ L + + I+++ Y + N + P +L ++ L
Sbjct: 278 ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQRL 334
Query: 202 LLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVN 257
A N+ S++N + + WL +N ++ L P L N T + + L+
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP-----LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 4e-06
Identities = 51/295 (17%), Positives = 88/295 (29%), Gaps = 66/295 (22%)
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
L V L + + L ++F+NN LT + P L N T L + +
Sbjct: 43 LDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP-----LKNLTKLVDILM 95
Query: 255 SVNSLSGTLP------------------------------------NSLANFSSHLRYLY 278
+ N ++ P N++++ S+
Sbjct: 96 NNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 155
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPS 338
+ + + ++ + + L L+ L N IS P
Sbjct: 156 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL 215
Query: 339 SLGNFTFLTELNLCGNSIRGSVPSALGSCHQLW-LDLSHNHLTGPIPLAVGNPKSIPHLD 397
T L EL+L GN ++ L S L LDL++N ++ PL + L
Sbjct: 216 G--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELK 269
Query: 398 LSKNELSGEIP----------------SSLAWIFGYISIFAKLNLSYNNLDGDVP 436
L N++S P + L L +NN+ P
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 15/91 (16%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 23 STWNDSVNFCQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS 82
+ N +N Q ++ + + L L N++ + +LT L+ + N S
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD 343
Query: 83 NIPHEIGRLFRLRHIIFNSNALQGQIPDSRL 113
+ L + + N + P + L
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTPLANL 372
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.4 bits (226), Expect = 2e-20
Identities = 45/229 (19%), Positives = 78/229 (34%), Gaps = 37/229 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVL---FLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD 591
V A+K+L + + ++ + E + L+ + LVK+ +
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-- 112
Query: 592 FQGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCD 648
N +V E++ G + S S A + EYLH +++ D
Sbjct: 113 ---NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166
Query: 649 LKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY---------- 698
LKP N+L+D + DFG + + + L GT PE
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEALAPEIILSKGYNKAV 219
Query: 699 -----GILLLEIFTGKRP-TSDMFTEGLDLHNFVKMALPDQILQVLDPL 741
G+L+ E+ G P +D + + K+ P L L
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.4 bits (223), Expect = 4e-20
Identities = 38/195 (19%), Positives = 67/195 (34%), Gaps = 26/195 (13%)
Query: 535 ATVYKGILDLDQTFIAVKVLF--LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD- 591
V + +A+K L + K E ++ + H+N++ ++ +
Sbjct: 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90
Query: 592 FQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKP 651
+ LV E M + L R + + +++LH I+H DLKP
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 652 SNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------- 698
SN+++ +D T + DFGL R T Y PE
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAGTSFMMTPY-----VVTRYYRAPEVILGMGYKENVDIW 202
Query: 699 --GILLLEIFTGKRP 711
G ++ E+ K
Sbjct: 203 SVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 1e-19
Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 25/198 (12%)
Query: 535 ATVYKGILDLDQ---TFIAVKVL----FLHQRGALKSFMAECQALRNIRHRNLVKIITAC 587
V+ A+KVL + + + E Q L +IR + +
Sbjct: 38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97
Query: 588 STSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647
FQ L+ ++++ G L + + I V + L H K I++
Sbjct: 98 ----FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG---------LKGTVGYATPE- 697
D+K N+LLD++ + DFGL++ + G ++G
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 698 ----YGILLLEIFTGKRP 711
G+L+ E+ TG P
Sbjct: 214 DWWSLGVLMYELLTGASP 231
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 2e-19
Identities = 47/220 (21%), Positives = 75/220 (34%), Gaps = 53/220 (24%)
Query: 535 ATVYKGIL-------DLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIIT 585
V T +AVK+L L ++E + ++ I +H+N++ ++
Sbjct: 27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86
Query: 586 ACSTSDFQGNYFRALVYEFMHHGSLES-------------------CPRILSFLRRLNIA 626
AC+ ++ E+ G+L LS ++ A
Sbjct: 87 ACTQDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141
Query: 627 IDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVG 686
VA +EYL +H DL NVL+ D + DFGL R I +
Sbjct: 142 YQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--IDYYKKTTN 196
Query: 687 LKGTVGYATPEY---------------GILLLEIFTGKRP 711
+ V + PE G+LL EIFT
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 4e-19
Identities = 37/197 (18%), Positives = 70/197 (35%), Gaps = 30/197 (15%)
Query: 535 ATVYKGILDLDQTFIAVKVLF--LHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDF 592
+V +AVK L K E + L++++H N++ ++ + +
Sbjct: 32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 593 QGNYFRALVYEFMHHGSLESCPR--ILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLK 650
+ + + L + + L+ + + L+Y+H H DLK
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLK 148
Query: 651 PSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY------------ 698
PSN+ ++ D + DFGL R + M+ T Y PE
Sbjct: 149 PSNLAVNEDCELKILDFGLARHTDDEMTGYVA-------TRWYRAPEIMLNWMHYNQTVD 201
Query: 699 ----GILLLEIFTGKRP 711
G ++ E+ TG+
Sbjct: 202 IWSVGCIMAELLTGRTL 218
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 5e-16
Identities = 58/273 (21%), Positives = 95/273 (34%), Gaps = 15/273 (5%)
Query: 162 SIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASK 221
+P L + N++ + L N+ L+L N+ P + + K
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSA 281
LE L + N L L + L V + + ++ N L + L +
Sbjct: 81 LERLYLSKNQLKELPEKMPK---TLQELRVHENEITKVRKSVFNGLNQM--IVVELGTNP 135
Query: 282 NPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG 341
SG +K L I I + I G L L L N I++ +SL
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLK 192
Query: 342 NFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKN 401
L +L L NSI +L + L +N+ +P + + K I + L N
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252
Query: 402 ELSGEIPSSLAWIFGYISIFAKL---NLSYNNL 431
+S I S+ GY + A +L N +
Sbjct: 253 NIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.2 bits (173), Expect = 6e-14
Identities = 30/169 (17%), Positives = 58/169 (34%), Gaps = 7/169 (4%)
Query: 268 ANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSL 327
+ L + N I+ + NLKNL + + + + P + L+KL+ L L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 328 FENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAV 387
+N + L +R SV + L + L + +G A
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 388 GNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVP 436
K + ++ ++ ++ IP L +L+L N +
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQGL------PPSLTELHLDGNKITKVDA 188
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.8 bits (164), Expect = 7e-13
Identities = 53/331 (16%), Positives = 99/331 (29%), Gaps = 46/331 (13%)
Query: 32 CQWLGVTCSLK---------YQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS 82
C V CS LL+L +T NL L + L N S
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 83 NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYF 142
P L +L + + N L+ L +L + + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR-------VHENEITKVRKSVFNG 122
Query: 143 TGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILL 202
+ + + +G + + Y +++ + +P + P++ L
Sbjct: 123 LNQMIVVELGTNP-LKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL---PPSLTELH 177
Query: 203 LAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGT 262
L GN+ S+ + L L + NS++ + SL N +L + L+ N L
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN---GSLANTPHLRELHLNNNKLVKV 234
Query: 263 LPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKL 322
+ +++ +Y+ N IS + P
Sbjct: 235 PGGLADHK--YIQVVYLHNNNISAIGSNDF------------------CPPGYNTKKASY 274
Query: 323 QVLSLFENNISRE--IPSSLGNFTFLTELNL 351
+SLF N + PS+ + L
Sbjct: 275 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.6 bits (187), Expect = 2e-15
Identities = 32/207 (15%), Positives = 72/207 (34%), Gaps = 35/207 (16%)
Query: 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACS------ 588
+TV+ ++ T +A+K++ + ++ E + L+ + + K + +
Sbjct: 27 STVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85
Query: 589 --------TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHC 640
+ ++ E + + R + + I+ + L+Y+H C
Sbjct: 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC 145
Query: 641 KKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEY- 698
I+H D+KP NVL++ D ++ + ++ T Y +PE
Sbjct: 146 G--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTREYRSPEVL 201
Query: 699 --------------GILLLEIFTGKRP 711
L+ E+ TG
Sbjct: 202 LGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 2e-14
Identities = 21/154 (13%), Positives = 40/154 (25%), Gaps = 20/154 (12%)
Query: 535 ATVYKGILDLDQTFIAVKVLFL----------HQRGALKSFMAECQALRNIRHRNLVKII 584
+ V+ VK + + F R L K+
Sbjct: 14 SAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72
Query: 585 TACSTSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPI 644
+ A++ E + + + + + +H I
Sbjct: 73 GLAVPKVYAWEGN-AVLMELIDAK----ELYRVRVENPDEVLDMILEEVAKFYHRG---I 124
Query: 645 VHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678
VH DL NVL+ + + DF + + E
Sbjct: 125 VHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (157), Expect = 4e-12
Identities = 45/273 (16%), Positives = 75/273 (27%), Gaps = 39/273 (14%)
Query: 186 ELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVN 245
+P I + + L GN+ S L L +N L + L
Sbjct: 25 AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 246 CTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEK 305
L++ N+ ++ + + L L++ + P L L + ++
Sbjct: 82 LEQLDLS---DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 306 FILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALG 365
L + L L L L N IS + L L L N + P A
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 366 SCHQLW-------------------------LDLSHNHLTGPIPLAVGNPKSIPHLDLSK 400
+L L L+ N + S
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSS 257
Query: 401 NELSGEIPSSLAWIFGYISIFAKLNLSYNNLDG 433
+E+ +P LA L+ N+L G
Sbjct: 258 SEVPCSLPQRLAGR-------DLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 1e-11
Identities = 41/248 (16%), Positives = 76/248 (30%), Gaps = 7/248 (2%)
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSIS 217
++ ++ + N L ++ L Q P +
Sbjct: 43 RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
Query: 218 NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277
+L L L L P L+ + L N+L ++ + +L +L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFR---GLAALQYLYLQDNALQALPDDTFRDLG-NLTHL 158
Query: 278 YMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIP 337
++ N IS L +L + + + + P + L +L L LF NN+S
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218
Query: 338 SSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLD 397
+L L L L N + S + + +P +
Sbjct: 219 EALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKR 275
Query: 398 LSKNELSG 405
L+ N+L G
Sbjct: 276 LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 7e-11
Identities = 46/253 (18%), Positives = 78/253 (30%), Gaps = 10/253 (3%)
Query: 212 IPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFS 271
+P I + + + N ++ + S C L ++ L N L+ + +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPA---ASFRACRNLTILWLHSNVLARIDAAAFTGLA 80
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
+ + P L L + +++ L P L LQ L L +N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWL-DLSHNHLTGPIPLAVGNP 390
+ + + LT L L GN I A H L L N + P A +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 391 KSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEA 450
+ L L N LS + L L+ N D + ++ +
Sbjct: 201 GRLMTLYLFANNLSALPT----EALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256
Query: 451 GNEKLCGGISELK 463
+E C L
Sbjct: 257 SSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (134), Expect = 4e-09
Identities = 39/249 (15%), Positives = 82/249 (32%), Gaps = 14/249 (5%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
+ L G ++ + L ++ L N + L L + + NA +
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 109 PDSRLILNKLEGNIPSELGSL-LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQL 167
+ + L +L L GL + L + +L
Sbjct: 97 DPATF-------HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
Query: 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227
++ ++ + + N++ +P L ++ LLL N+ PH+ + +L L
Sbjct: 150 RDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGS 287
N+L+ L E L L+ + L+ N + L+ S++ + S
Sbjct: 209 FANNLSALPTEALA---PLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCS 263
Query: 288 IPTEIGNLK 296
+P +
Sbjct: 264 LPQRLAGRD 272
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 8e-07
Identities = 35/211 (16%), Positives = 64/211 (30%), Gaps = 15/211 (7%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
+ S + + L LPP + + IL L+ N + ++ ++L L+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI 288
LT L L V+ S + L + + + S+
Sbjct: 64 RAELTKLQ--------VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 289 PTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFE-NNISREIPSSLGNFTFLT 347
P + K ++ +P + NN++ L L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 348 ELNLCGNSIRGSVPSALGSCHQL-WLDLSHN 377
L L NS+ ++P H L + L N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 37/221 (16%), Positives = 74/221 (33%), Gaps = 16/221 (7%)
Query: 215 SISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHL 274
+S + ++ +LT +P DL ++ LS N L +L ++ L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP-----KDTTILHLSENLLYTFSLATLMPYTR-L 57
Query: 275 RYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISR 334
L + ++ G L L + + L + + + N ++
Sbjct: 58 TQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTS 114
Query: 335 EIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDL-SHNHLTGPIPLAVGNPKSI 393
+L L EL L GN ++ P L +L ++N+LT + +++
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 394 PHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGD 434
L L +N ++ F + L N +
Sbjct: 175 DTLLLQENS-----LYTIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 6e-05
Identities = 39/211 (18%), Positives = 67/211 (31%), Gaps = 18/211 (8%)
Query: 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQI 108
+N +NLT P + +++L +N + + RL + + L
Sbjct: 15 VNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71
Query: 109 PDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLL 168
D L LG+L + +P L + VS LT L
Sbjct: 72 VDGTL----------PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFA 228
+ ++ ++ N+ + LPP + P + L LA N ++ L+ L
Sbjct: 122 GLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 229 NNSLTGLIPEDLDSLVNCTYLEVVSLSVNSL 259
NSL + L L N
Sbjct: 181 ENSLYTIPK----GFFGSHLLPFAFLHGNPW 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 9e-07
Identities = 19/83 (22%), Positives = 29/83 (34%), Gaps = 10/83 (12%)
Query: 342 NFTFLTELNLCGNSIRG----SVPSALGSCHQL-WLDLSHNHLTGPIPLAVG-----NPK 391
+ L L L + S+ + L + H L LDLS+N L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 392 SIPHLDLSKNELSGEIPSSLAWI 414
+ L L S E+ L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 21/118 (17%), Positives = 39/118 (33%), Gaps = 33/118 (27%)
Query: 271 SSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330
S ++ L + +S + E+ + L + QV+ L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAEL-----------------------LPLLQQCQVVRLDDC 37
Query: 331 NIS----REIPSSLGNFTFLTELNLCGNSIRGSVPSALG------SCHQLWLDLSHNH 378
++ ++I S+L L ELNL N + + SC L L +
Sbjct: 38 GLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 9e-05
Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 7/92 (7%)
Query: 346 LTELNLCGNSIRGS-VPSALGSCHQL-WLDLSHNHLTG----PIPLAVGNPKSIPHLDLS 399
+ L++ + + L Q + L LT I A+ ++ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 400 KNELSGEIPSSLAWIFGYISI-FAKLNLSYNN 430
NEL + S KL+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 10/90 (11%), Positives = 29/90 (32%), Gaps = 6/90 (6%)
Query: 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF----FGNIPHSISNASKLEWLDF 227
++ + +L + L +++ L +I ++ L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 228 ANNSLTGLIPEDLDSLV--NCTYLEVVSLS 255
+N L + + + ++ +SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 11/64 (17%), Positives = 20/64 (31%), Gaps = 1/64 (1%)
Query: 372 LDLSHNHLT-GPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNN 430
LD+ L+ + + + L L+ ++ A+LNL N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 431 LDGD 434
L
Sbjct: 67 LGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 14/94 (14%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 169 NITSMEYFHVSENQLVGELPPHIGFTL---PNVRILLLAGNQFFGNIPHSISNA-----S 220
+ + +++ + + TL ++R L L+ N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 221 KLEWLDFANNSLTGLIPEDLDSLV-NCTYLEVVS 253
LE L + + + + L +L + L V+S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 15/90 (16%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 222 LEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANF---SSHLRYLY 278
++ LD L+ +L L +VV L L+ +++ + L L
Sbjct: 4 IQSLDIQCEELSDARWAEL--LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 279 MSANPISGSIPTEIGNLKNLIIIAIEKFIL 308
+ +N + + I+K L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 1e-06
Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 7/109 (6%)
Query: 323 QVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGP 382
+VL L +++ + L +T L+L N +R P+ L + L + + ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 383 IPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNL 431
+ V N + L L N L LNL N+L
Sbjct: 58 VD-GVANLPRLQELLLCNNRLQQSAAIQP---LVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 20/119 (16%), Positives = 36/119 (30%), Gaps = 21/119 (17%)
Query: 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPE------------------DL 240
R+L LA + + + LD ++N L L P ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 241 DSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLI 299
D + N L+ + L N L + L L + N + L ++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 13/93 (13%)
Query: 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPN 265
N I LE L+ +NN L +P L E + S N L+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL------ERLIASFNHLA-EVPE 321
Query: 266 SLANFSSHLRYLYMSANPISGSIPTEIGNLKNL 298
N L+ L++ NP+ P ++++L
Sbjct: 322 LPQN----LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 24/87 (27%), Positives = 37/87 (42%), Gaps = 9/87 (10%)
Query: 327 LFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLA 386
+ N S EI S L ELN+ N + +P+ +L S NHL +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL--IASFNHLAE-VP-- 320
Query: 387 VGNPKSIPHLDLSKNELSG--EIPSSL 411
P+++ L + N L +IP S+
Sbjct: 321 -ELPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 19/102 (18%), Positives = 33/102 (32%), Gaps = 33/102 (32%)
Query: 272 SHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENN 331
L L +S N + +P L+ LI N+
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLI---------------------------ASFNH 315
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLD 373
++ E+P N L +L++ N +R P S L ++
Sbjct: 316 LA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMN 352
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 6e-06
Identities = 31/218 (14%), Positives = 68/218 (31%), Gaps = 17/218 (7%)
Query: 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNA 103
I + N+T T + +L + ++ ++ + L L + N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQ 74
Query: 104 LQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSI 163
+ P L + L ++ GL ++ ++ S +
Sbjct: 75 ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLP------NVRILLLAGNQFFGNIPHSIS 217
+ L IT++ N + L + L N+ P ++
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 218 NASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
+ L + NN ++ + P L N + L +V+L+
Sbjct: 193 SLPNLIEVHLKNNQISDVSP-----LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 32/219 (14%), Positives = 62/219 (28%), Gaps = 25/219 (11%)
Query: 195 LPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254
L N + + + + ++ + L +T ++ + L + L
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-----TIEGVQYLNNLIGLEL 70
Query: 255 SVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRN--- 311
N ++ P + L +S + +L I +
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 312 ----------IPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVP 361
I + L N + L N + LT L N I P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 362 SALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLS 399
L S L + L +N ++ PL N ++ + L+
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLT 225
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 35/241 (14%), Positives = 72/241 (29%), Gaps = 8/241 (3%)
Query: 158 SLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSIS 217
S + + +++ +S + + I ++ L L G + I ++++
Sbjct: 33 SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 92
Query: 218 NASKLEWLDFANNSLTGLIPE-----DLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSS 272
S L L+ + S L + + + + +
Sbjct: 93 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 152
Query: 273 HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFE-NN 331
Y S + + + +L + L LQ LSL +
Sbjct: 153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 212
Query: 332 ISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPK 391
I E LG L L + G G++ + L ++ +H T +GN K
Sbjct: 213 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH--LQINCSHFTTIARPTIGNKK 270
Query: 392 S 392
+
Sbjct: 271 N 271
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 33/212 (15%), Positives = 64/212 (30%), Gaps = 27/212 (12%)
Query: 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNA 103
I NL +++T + L + I ++ S I L + + N N
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 104 LQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSI 163
L P + L N ++ ++ SL +
Sbjct: 80 LTDIKPLANLKNLGWLFL----------------DENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 164 PIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLE 223
+ + + + L + L L NQ +P ++ +KL+
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 224 WLDFANNSLTGLIPEDLDSLVNCTYLEVVSLS 255
L + N ++ DL +L L+V+ L
Sbjct: 182 NLYLSKNHIS-----DLRALAGLKNLDVLELF 208
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 33/179 (18%), Positives = 60/179 (33%), Gaps = 31/179 (17%)
Query: 225 LDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPI 284
+D L IP D+ + + L+ N L + L HL L + N +
Sbjct: 13 VDCTGRGLKE-IPRDIP-----LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 285 SGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFT 344
+G P ++ + + + + L +L+ L+L++N IS +P S +
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 345 FL-----------------------TELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLT 380
L + +L G + R PS + DL H+
Sbjct: 127 SLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ--IKDLPHSEFK 183
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 7e-04
Identities = 36/244 (14%), Positives = 59/244 (24%), Gaps = 21/244 (8%)
Query: 32 CQWLGVTCSLKYQRVI---------LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSS 82
C C I L L L I + QN+
Sbjct: 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 83 NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYF 142
I ++ H I A + N G+ +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI-----SNTGIKHLPDVH 122
Query: 143 TGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILL 202
+ + +I S E + N+ + + F + L
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 203 LAGNQFFGNIPHSI-SNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSG 261
L+ N +P+ + AS LD + + L L+ N L S +L
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRA--RSTYNLK- 236
Query: 262 TLPN 265
LP
Sbjct: 237 KLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 15/97 (15%), Positives = 28/97 (28%), Gaps = 3/97 (3%)
Query: 308 LIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSC 367
LI ++ + L L I I + ++ N IR +
Sbjct: 7 LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLR 63
Query: 368 HQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404
L +++N + + L L+ N L
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 10/65 (15%), Positives = 23/65 (35%), Gaps = 6/65 (9%)
Query: 320 LKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG----SVPSALGSCHQL-WLDL 374
L++ ++ + + + L + E+ L GN+I + + S L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 375 SHNHL 379
S
Sbjct: 67 SDIFT 71
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 25/109 (22%), Positives = 37/109 (33%), Gaps = 4/109 (3%)
Query: 319 LLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG--SVPSALGSCHQL-WLDLS 375
VL+ ++++ + N L LNL N + + S + L L+LS
Sbjct: 41 QNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99
Query: 376 HNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKL 424
N L L + L L N LS +I F KL
Sbjct: 100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKL 148
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 771 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.05 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.95 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.1 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.86 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.33 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=367.05 Aligned_cols=233 Identities=19% Similarity=0.203 Sum_probs=188.8
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|++|+||+|+++.+++.||||++.... ....+++.+|++++++++|||||++++++.+.+ ..|+|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~~iv 81 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQYLF 81 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----eeEEE
Confidence 334456899999999999999999999999997553 334567999999999999999999999998877 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999877 34689999999999999999999986 999999999999999999999999999987644322
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
.......+||+.||||| +||++|||+||+.||............+............+++..
T Consensus 159 --~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 159 --ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp --ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred --cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 12234568999999999 699999999999999764433333333433333333445566666
Q ss_pred cccCcccChhchhhcCCHHHHHH
Q 041479 743 LVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+||+.||++|||++|+++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 66777999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=367.32 Aligned_cols=233 Identities=25% Similarity=0.354 Sum_probs=183.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|.+|+||+|+++ + .||||+++.. .....++|.+|++++++++|||||+++|++.+. ..++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~~~l 80 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--G-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAI 80 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--S-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEE
T ss_pred EEEEEEEeeCCCcEEEEEEEC--C-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------EEEE
Confidence 334456899999999999864 3 6999999654 345678999999999999999999999997654 3689
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||||++|+|.++ ...+++.++..|+.|+|+||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999775 34689999999999999999999985 8999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-CC---ch
Q 041479 677 MSSNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-PD---QI 734 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~---~~ 734 (771)
.. ........||+.||||| |||++|||+||+.||.+..... .+...+.... ++ ..
T Consensus 158 ~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 158 SG--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSCCCCGGGS
T ss_pred CC--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCCCcchhc
Confidence 22 12233457999999999 7999999999999998643222 2333333333 22 23
Q ss_pred hhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 735 LQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 735 ~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
...+++.+...+.+||+.||++||||.|+++.|+.+
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 344556666777899999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-43 Score=366.67 Aligned_cols=236 Identities=21% Similarity=0.286 Sum_probs=195.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+...-.+|+|.+|+||+|+++.+++.||||++.... ...++|.+|++++++++|||||+++|+|.+.+ ..|+||
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~iv~ 92 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYIIT 92 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----eeEEEe
Confidence 334456899999999999999999999999996543 34578999999999999999999999998776 679999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||++|+|.++ ...+++..+..++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999998765 34689999999999999999999986 89999999999999999999999999998765433
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLF 742 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (771)
. ....+..||+.||||| |||++|||++|..|+..... ...+.+.+....+...++.+++.+
T Consensus 170 ~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 170 Y---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp S---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred c---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCCCCCCccchHHH
Confidence 2 2233456899999999 79999999997776643222 223445555566656666777778
Q ss_pred cccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 743 LVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 743 ~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
...+.+||+.||++||||.||++.|+.++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 78888999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=365.81 Aligned_cols=230 Identities=21% Similarity=0.244 Sum_probs=192.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|++|+||+|+++.+++.||||++........+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~ivm 96 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWVVM 96 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEEEE
Confidence 444556999999999999999999999999998776666788999999999999999999999998877 789999
Q ss_pred EeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 603 EFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 603 e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 97 Ey~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence 99999999876 45689999999999999999999986 999999999999999999999999999987654322
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-CchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 744 (771)
.....+||+.||||| +||++|||+||+.||.+..... .+........+ ...++.+++.+..
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCCCCCCcccCCHHHHH
Confidence 223457999999999 6999999999999997532221 23333333333 3445566777777
Q ss_pred cCcccChhchhhcCCHHHHHH
Q 041479 745 GGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
...+||++||++|||+.|+++
T Consensus 249 li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 788999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=370.12 Aligned_cols=236 Identities=24% Similarity=0.368 Sum_probs=180.1
Q ss_pred cccccccccceEEEEEecCCCe---EEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQT---FIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~---~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.-.+|+|.+|+||+|+++.+++ .||||++... .....++|.+|++++++++|||||+++|+|.+.+ ..|+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~iv 105 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-----PVMII 105 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----EEEEE
Confidence 4468999999999999976653 6899988654 3455678999999999999999999999998776 67999
Q ss_pred EEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 602 YEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 602 ~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||||++|+|.++ ...+++.++..++.|+|+||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999775 34689999999999999999999985 99999999999999999999999999998765433
Q ss_pred CCc-ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 678 SSN-QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 678 ~~~-~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
... .....+..||+.||||| |||++|||+| |+.||.+... ..+...+........+..+++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCCCCTTCCH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCCCCCccchH
Confidence 211 22233456899999999 7999999998 8999976432 234444444444444455666
Q ss_pred cccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+...+.+||+.||++||||.||++.|++++
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 7777788999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=362.79 Aligned_cols=231 Identities=22% Similarity=0.280 Sum_probs=190.9
Q ss_pred cccccccceEEEEEecC--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 528 SYESLVKATVYKGILDL--DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
.+|+|.+|+||+|+++. ++..||||+++... ....++|.+|++++++++|||||+++|++.+. ..|+||||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~lvmE~ 89 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVMEM 89 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEEC
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------eEEEEEEe
Confidence 58999999999998764 34579999996543 44568899999999999999999999998654 36899999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|++|+|.++ ...+++.++..++.|+|+||+|||+. +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 165 (285)
T d1u59a_ 90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY- 165 (285)
T ss_dssp CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE-
T ss_pred CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccc-
Confidence 999999765 34689999999999999999999985 9999999999999999999999999999877553321
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
........||+.||||| |||++|||+| |+.||.+.. ...+...+....+...++.+++.+..
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 22233456899999999 7999999998 999998753 23344455544444555667777777
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
++.+||+.||++|||+.+|++.|+.+
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 88899999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=359.34 Aligned_cols=230 Identities=21% Similarity=0.292 Sum_probs=187.0
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEec
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEFM 605 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 605 (771)
.+|+|++|+||+|+++.+++.||||++.... ....+.|.+|++++++++|||||++++++.+.. .+....|+|||||
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELM 94 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEEEeCC
Confidence 5899999999999999999999999997553 345678999999999999999999999986532 2223679999999
Q ss_pred cCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCceEEecccCccccCcccCCcc
Q 041479 606 HHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD-NDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 606 ~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
++|+|.++ ...+++.++..++.|+++||+|||+. .++|+||||||+|||++ .++.+||+|||+|+......
T Consensus 95 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~---- 169 (270)
T d1t4ha_ 95 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---- 169 (270)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----
T ss_pred CCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----
Confidence 99999876 34689999999999999999999986 23499999999999996 57899999999998643322
Q ss_pred cccccccccccccchh--------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccccCc
Q 041479 682 CSSVGLKGTVGYATPE--------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGV 747 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE--------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (771)
..+.+||+.||||| +||++|||++|+.||.+................+.......++.+..+..
T Consensus 170 --~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 170 --AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp --BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred --cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence 22457999999999 79999999999999976432222222233333345566667777777888
Q ss_pred ccChhchhhcCCHHHHHH
Q 041479 748 QEGEETAEENIKKGQIRE 765 (771)
Q Consensus 748 ~cl~~~p~~Rpt~~~vl~ 765 (771)
+||++||++|||+.|+++
T Consensus 248 ~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHSCSSGGGSCCHHHHHT
T ss_pred HHccCCHhHCcCHHHHhC
Confidence 999999999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=360.81 Aligned_cols=231 Identities=23% Similarity=0.328 Sum_probs=180.2
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|+||+|+++++ +.||||++.... ...++|.+|++++++++|||||+++|+|.+.+ ..++||||
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv~E~ 81 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLVFEF 81 (263)
T ss_dssp EEEEEECCSSCCEEEEEETTT-EEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEECCC-CEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEEEEe
Confidence 344689999999999998754 589999996543 34578999999999999999999999998776 57999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|++|+|.++ ...+++..+..++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence 999999775 35688999999999999999999985 899999999999999999999999999987654332
Q ss_pred ccccccccccccccchh---------------HHHHHHHHHhC-CCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 681 QCSSVGLKGTVGYATPE---------------YGILLLEIFTG-KRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
.......||+.||||| |||++|||+|+ +.|+.+. . ...+.+.+....+...+..+++.+..
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~-~~~~~~~i~~~~~~~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-S-NSEVVEDISTGFRLYKPRLASTHVYQ 233 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-C-HHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-C-HHHHHHHHHhcCCCCCccccCHHHHH
Confidence 2223456899999999 79999999995 5555432 2 22344444555555556667777777
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHh
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.+||+.||++||||+||++.|+++
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 88899999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=359.09 Aligned_cols=234 Identities=22% Similarity=0.295 Sum_probs=188.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
.+...-.+|+|++|+||+|+++. ++.||||++.... ...++|.+|++++++++|||||+++|++.+. ..|+|
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~iv 85 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYII 85 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEE
T ss_pred HeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeEEE
Confidence 33344568999999999999874 5689999996543 3457899999999999999999999988654 35899
Q ss_pred EEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 602 YEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 602 ~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
||||++|+|.++ ...+++.++.+|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999764 23589999999999999999999985 8999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
. .....+..||+.||||| |||++|||+||..|+..... ...+.+.+....+...++.+++.
T Consensus 163 ~---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 163 E---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEE 238 (272)
T ss_dssp C---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCHH
T ss_pred c---cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCCCCcccChHH
Confidence 2 22233457899999999 79999999996665543222 22233444444444455666777
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+..++.+||+.||++||||.+|++.|+++
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 77788899999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=360.11 Aligned_cols=232 Identities=21% Similarity=0.239 Sum_probs=187.7
Q ss_pred ccccccccceEEEEEecC--CCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 527 VSYESLVKATVYKGILDL--DQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~--~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..+|+|.+|+||+|+++. .++.||||+++.. +....++|.+|++++++++|||||+++|+|.+.. .++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~------~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS------EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC------EEEEE
Confidence 358999999999998764 3468999999643 2344678999999999999999999999986543 58999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||++|+|.++ ...+++.++..++.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999876 45689999999999999999999985 8999999999999999999999999999876543321
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
........||+.||||| |||++|||+| |+.||.+... ..+...+....+...+..+++.+.
T Consensus 164 -~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~~~ 240 (277)
T d1xbba_ 164 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAGCPREMY 240 (277)
T ss_dssp -EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCCCCCCCcccCHHHH
Confidence 22233456899999999 7999999998 8999986432 234444444444455566777777
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.++.+||+.||++|||+++|++.|++.
T Consensus 241 ~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 241 DLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 788899999999999999999988763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=353.40 Aligned_cols=227 Identities=21% Similarity=0.265 Sum_probs=187.5
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|++|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 81 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----RV 81 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-----EE
Confidence 3444557899999999999999999999999996442 345678999999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+|||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999776 45689999999999999999999986 999999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ....+||+.||||| +||++|||++|+.||.+.... ..+..+.. .+...++.+++
T Consensus 159 ~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~--~~~~~p~~~s~ 229 (263)
T d2j4za1 159 SR------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISR--VEFTFPDFVTE 229 (263)
T ss_dssp CC------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHT--TCCCCCTTSCH
T ss_pred Cc------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHHc--CCCCCCccCCH
Confidence 22 12357999999999 799999999999999753211 11222222 22334455677
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||++||++|||+.|+++
T Consensus 230 ~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 230 GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 7777777999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=361.98 Aligned_cols=229 Identities=22% Similarity=0.250 Sum_probs=191.7
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|++|+||+|+++.+++.||||++........++|.+|++++++++|||||++++++.+.+ ..|+|||
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~lvmE 89 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILIE 89 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEEEEE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEEEEe
Confidence 33456999999999999999999999999998766666788999999999999999999999998877 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||++|+|.++ .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 9999999776 34689999999999999999999986 99999999999999999999999999997553321
Q ss_pred cccccccccccccccchh--------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-Cchhhhc
Q 041479 680 NQCSSVGLKGTVGYATPE--------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP-DQILQVL 738 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE--------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 738 (771)
......+||+.||||| +||++|||+||+.||.+..... .+..+.....+ ...+..+
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCCCSSGGGS
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCCCCccccC
Confidence 1223457999999999 6999999999999997643322 24444444433 2334566
Q ss_pred CccccccCcccChhchhhcCCHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
++.+.....+||+.||++|||+.|+++
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 777777778999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=350.45 Aligned_cols=232 Identities=22% Similarity=0.323 Sum_probs=193.1
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|.+|+||+|+++ +++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+.+ ..++|||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~iv~E 79 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFIITE 79 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEEEEE
Confidence 34456999999999999996 556999999976543 4578999999999999999999999998766 6799999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|+++|++.++ ...+++..+.+++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+|+.......
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence 9999998766 44688999999999999999999985 999999999999999999999999999987654332
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFL 743 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (771)
....+..||+.||||| |||++|||+| |+.||.+... ..+...+....+...+...++.+.
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i~~~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 156 --TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLYRPHLASEKVY 231 (258)
T ss_dssp --CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred --eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHHHHHhCCCCCCcccccHHHH
Confidence 2233467999999999 7999999998 8999976532 223343444444455666777777
Q ss_pred ccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 744 VGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 744 ~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.+||+.||++|||+.++++.|.+|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 788899999999999999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=9e-42 Score=360.85 Aligned_cols=293 Identities=26% Similarity=0.455 Sum_probs=196.8
Q ss_pred CccHHHHHHHHhcCCCCCCCCCCCCCCCCCCc--cceeeeecCCCC--cEEEEEcCCCCCcc--cCCccccCCCCCcEEE
Q 041479 1 EPDKQALLAFKSKVDDDPFGALSTWNDSVNFC--QWLGVTCSLKYQ--RVILLNLSGQNLTG--TASPYIGNLTFLRLIN 74 (771)
Q Consensus 1 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~c--~w~~v~c~~~~~--~l~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~ 74 (771)
|+||+||++||+.+.+ | ..+++|..++||| .|.||+|+.... +|+.|||++|+++| .+|++|++|++|++|+
T Consensus 5 ~~e~~aLl~~k~~~~~-~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 5 PQDKQALLQIKKDLGN-P-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp HHHHHHHHHHHHHTTC-C-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred HHHHHHHHHHHHHCCC-C-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 5799999999999864 3 4699999889999 499999986543 89999999999998 4688899999999999
Q ss_pred cCC-CcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceee
Q 041479 75 LQQ-NNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQ 153 (771)
Q Consensus 75 Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~ 153 (771)
|++ |+++|.+|.+|+++++|++|+|++|++. +..+..+..+.+|+.+++++|.+.+
T Consensus 83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~--------------~~~~~~~~~~~~L~~l~l~~N~~~~--------- 139 (313)
T d1ogqa_ 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVS--------------GAIPDFLSQIKTLVTLDFSYNALSG--------- 139 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCE--------------EECCGGGGGCTTCCEEECCSSEEES---------
T ss_pred cccccccccccccccccccccchhhhcccccc--------------ccccccccchhhhcccccccccccc---------
Confidence 986 7888888888888888888888888854 3455556666666666666655442
Q ss_pred ecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC-cEEEeecCcccccCCccccCCCCCCEEEcccccc
Q 041479 154 VSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV-RILLLAGNQFFGNIPHSISNASKLEWLDFANNSL 232 (771)
Q Consensus 154 l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 232 (771)
.+|..+.++++|+.+++++|.++|.+|..++ .+..+ +.+++++|++++..|..+..+..+ .+++++|
T Consensus 140 --------~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~-~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~-- 207 (313)
T d1ogqa_ 140 --------TLPPSISSLPNLVGITFDGNRISGAIPDSYG-SFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRN-- 207 (313)
T ss_dssp --------CCCGGGGGCTTCCEEECCSSCCEEECCGGGG-CCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSS--
T ss_pred --------cCchhhccCcccceeeccccccccccccccc-cccccccccccccccccccccccccccccc-ccccccc--
Confidence 4445555555666666666655555555544 33332 445555555555444444443322 3444444
Q ss_pred CCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceecc
Q 041479 233 TGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNI 312 (771)
Q Consensus 233 ~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 312 (771)
.+.+.+|..+..+. +|+.+++++|.+.+.+| .++.+++|+.|++++|++.+.+
T Consensus 208 -------------------------~~~~~~~~~~~~~~-~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~i 260 (313)
T d1ogqa_ 208 -------------------------MLEGDASVLFGSDK-NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260 (313)
T ss_dssp -------------------------EEEECCGGGCCTTS-CCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECC
T ss_pred -------------------------cccccccccccccc-ccccccccccccccccc-ccccccccccccCccCeecccC
Confidence 44444444443333 45555555555554332 3555555666666666666666
Q ss_pred CccccCCCCCCEEEccCCcccccCCcccccccccccccccCcc-cee
Q 041479 313 PISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNS-IRG 358 (771)
Q Consensus 313 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 358 (771)
|..++.+++|++|+|++|+|+|.+| .++.+++|+.+++++|+ +.|
T Consensus 261 P~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSSEEES
T ss_pred ChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCccccC
Confidence 6666777777777777777777776 35677888888888886 444
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=357.14 Aligned_cols=235 Identities=22% Similarity=0.219 Sum_probs=177.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
++.....+|+|++|+||+|+++.+++.||||++.... +...+.+.+|++++++++|||||++++++.+.... ..|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~---~~~ 81 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT---TLY 81 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC---EEE
Confidence 3445567899999999999999999999999996553 34567899999999999999999999998654311 579
Q ss_pred EEEEeccCCCCCCC-------cccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 600 LVYEFMHHGSLESC-------PRILSFLRRLNIAIDVASALEYLHHHC--KKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 600 lv~e~~~~g~L~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
+|||||++|+|.++ ...+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999876 246899999999999999999999852 125999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchh
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQIL 735 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 735 (771)
+....... ...+.+||+.||||| +||++|||+||+.||.+... ..+...+........+
T Consensus 162 ~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~~~~~~~ 235 (269)
T d2java1 162 RILNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGKFRRIP 235 (269)
T ss_dssp HHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTCCCCCC
T ss_pred eecccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcCCCCCCC
Confidence 87654321 223467999999999 79999999999999975322 1222222222223445
Q ss_pred hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+++.+.....+||+.||++|||+.|+++
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 556777777778999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-42 Score=361.62 Aligned_cols=224 Identities=18% Similarity=0.196 Sum_probs=187.7
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
....+|+|++|+||+|+++.+++.||||++.... ....+++.+|++++++++|||||++++++.+.+ ..|+|
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~iv 93 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLV 93 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----EEEEE
Confidence 3446899999999999999999999999996543 344578999999999999999999999998876 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||||++|++..+ .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999998654 45789999999999999999999996 9999999999999999999999999999865432
Q ss_pred Ccccccccccccccccchh------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 679 SNQCSSVGLKGTVGYATPE------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
...+||+.||||| +||++|||++|+.||.+.... ..+........+......+++
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~ 241 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSE 241 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSCTTSCH
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCCCCCCCH
Confidence 2346999999999 699999999999999764322 123344444444444455666
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+||+.||++|||+.|+++
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHh
Confidence 7777778999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=357.15 Aligned_cols=235 Identities=19% Similarity=0.276 Sum_probs=181.3
Q ss_pred cccccccccceEEEEEecCCC----eEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQ----TFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.--+|+|++|+||+|+++.++ ..||||++.... ....++|.+|++++++++|||||+++|++.+.+ ..++
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~-----~~~~ 86 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK-----PMMI 86 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEEE
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC-----ceEE
Confidence 345899999999999988654 479999996543 344568999999999999999999999998776 6799
Q ss_pred EEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 601 VYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 601 v~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
|||||.+|++.+. ...+++.++..++.|+|.|++|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999988664 45689999999999999999999995 8999999999999999999999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
... .....+..||+.||||| |||++|||++|..|+...... ..+.+.+....+...+..+...
T Consensus 164 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 164 PEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCCCCCCTTCBHH
T ss_pred Ccc-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccCCCCCchhhHHH
Confidence 221 22233456899999999 799999999976665432222 2344444444444445556666
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+..++.+||+.||++||||.||++.|+++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 77778899999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-42 Score=361.50 Aligned_cols=236 Identities=23% Similarity=0.269 Sum_probs=192.2
Q ss_pred ccccccccccccceEEEEEecCCC-----eEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCc
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQ-----TFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGN 595 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~ 595 (771)
+.....+|+|+||+||+|+++..+ ..||||++.... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~---- 114 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG---- 114 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC----
Confidence 334456899999999999987654 379999986442 34456899999999998 8999999999998776
Q ss_pred eeEEEEEEeccCCCCCCCc--------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 041479 596 YFRALVYEFMHHGSLESCP--------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDL 649 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~~--------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdl 649 (771)
..|+|||||++|+|.++. ..+++.++..|+.|+++||+|||+. +|+||||
T Consensus 115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 115 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred -eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 679999999999996651 2478999999999999999999985 9999999
Q ss_pred CCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCC
Q 041479 650 KPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTS 713 (771)
Q Consensus 650 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~ 713 (771)
||+||+++.++.+||+|||+|+....... .....+..||+.||||| |||++|||+| |+.||.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhccccccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999987654332 12223456899999999 7999999998 899997
Q ss_pred ccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHH
Q 041479 714 DMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIA 769 (771)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~ 769 (771)
+... ...+.+.+....+...+..+++.+..++.+||+.||++||||+||++.|..
T Consensus 269 ~~~~-~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPV-DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCC-SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCH-HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 6432 334666677666666666777788888889999999999999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=350.45 Aligned_cols=237 Identities=24% Similarity=0.308 Sum_probs=186.5
Q ss_pred ccccccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 519 SRKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 519 ~~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.+......+|+|.+|+||+|+++.+. .||||++.... ...++|.+|+.++++++|||||+++|+|.+. ..
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~ 86 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PI 86 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTE-EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCC-EEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC------Ce
Confidence 3445555667999999999999998764 79999996543 3457899999999999999999999998554 35
Q ss_pred EEEEEeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 599 ALVYEFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
++|||||++|++..+ ...++|.++..|+.|||.||+|||+. +|+||||||+|||+++++.+||+|||+|+..
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence 899999999998765 34589999999999999999999986 8999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... .......||+.|+||| |||++|||++|..|+..... ...+...+....+...+..+
T Consensus 164 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~~ 239 (285)
T d1fmka3 164 EDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPEC 239 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCCCCCTTS
T ss_pred cCCCc---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCCCCCccc
Confidence 54332 2233456899999999 79999999997666543222 22344444445555566677
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
++.+...+.+||+.||++||||.+|++.|++.
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 77777788899999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=350.50 Aligned_cols=230 Identities=20% Similarity=0.228 Sum_probs=184.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|++|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~ 83 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----KL 83 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-----EE
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-----EE
Confidence 3445567899999999999999999999999996542 345678999999999999999999999998776 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+|||||++|+|.++ .+.+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999999776 45789999999999999999999996 999999999999999999999999999987654
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
... .......+||+.||||| +||++|||++|+.||.+.... ..+..+.... ...++.+++
T Consensus 161 ~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~--~~~p~~~s~ 235 (288)
T d1uu3a_ 161 ESK--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIKLE--YDFPEKFFP 235 (288)
T ss_dssp -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTTC--CCCCTTCCH
T ss_pred CCc--ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-HHHHHHHcCC--CCCCccCCH
Confidence 322 12223457999999999 699999999999999753111 1122222222 233455667
Q ss_pred cccccCcccChhchhhcCCHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIR 764 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl 764 (771)
.+.....+||+.||++|||++|++
T Consensus 236 ~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 236 KARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHHHHHHHccCCHhHCcCHHHHc
Confidence 776777799999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=352.15 Aligned_cols=236 Identities=22% Similarity=0.279 Sum_probs=189.3
Q ss_pred cccccccceEEEEEecCCC---eEEEEEEeec-cchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQ---TFIAVKVLFL-HQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~---~~vAvK~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.+|+|.||+||+|++..++ ..||||++.. ......++|.+|++++++++|||||+++|++.+.+. ..++|||
T Consensus 34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~~lv~E 109 (311)
T d1r0pa_ 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG----SPLVVLP 109 (311)
T ss_dssp EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT----EEEEEEE
T ss_pred EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC----ceEEEEE
Confidence 4899999999999986643 3699999964 345567899999999999999999999999876432 6799999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
||++|+|.++ ....++..+.+++.|+|.||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999775 33567888999999999999999985 8999999999999999999999999999987655444
Q ss_pred cccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCccccc
Q 041479 680 NQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPLFLV 744 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (771)
.........||+.|+||| ||+++|||+||..||....... .+...+....+...++.+++.+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCCCCCcccCcHHHHH
Confidence 344445567999999999 7999999999878775433322 233333333344445556667777
Q ss_pred cCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 745 GGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 745 ~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+.+||+.||++||||.||++.|++++
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 788999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=358.75 Aligned_cols=179 Identities=23% Similarity=0.329 Sum_probs=155.6
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+++.+++.||||+++.. .....+++.+|++++++++|||||+++++|.+.+ ..|+|
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~iV 82 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISIC 82 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EEEEE
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEE
Confidence 34445689999999999999999999999999754 3445678999999999999999999999998876 78999
Q ss_pred EEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 602 YEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 602 ~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||||++|+|.++ ...+++..+..++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999876 34689999999999999999999973 279999999999999999999999999998654322
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
..+.+||+.||||| +||++|||++|+.||.+
T Consensus 160 -----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 160 -----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp -----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred -----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 23457999999999 69999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-41 Score=352.65 Aligned_cols=228 Identities=21% Similarity=0.222 Sum_probs=170.8
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lvm 86 (307)
T d1a06a_ 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-----HLYLIM 86 (307)
T ss_dssp EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-----EEEEEE
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEEE
Confidence 33456899999999999999999999999997553 233467889999999999999999999998776 789999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD---NDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~---~~~~~kl~DfGla~~~~~~ 676 (771)
|||+||+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||++. +++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999776 44689999999999999999999986 999999999999995 5789999999999865432
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 739 (771)
.. ....+||+.||||| +||++|||++|+.||.+..... ..........+ ....+.++
T Consensus 164 ~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 164 SV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCCCCCTTTTTTSC
T ss_pred Ce-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCCCCCccccCCC
Confidence 21 23457999999999 6999999999999997642211 12233333332 23344566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 66777778999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-40 Score=354.96 Aligned_cols=229 Identities=21% Similarity=0.197 Sum_probs=188.9
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|++|+||+|+++.+++.||||++........+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~ivm 102 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMVMIY 102 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEEE
Confidence 334456999999999999999999999999997766666788999999999999999999999998876 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~ 676 (771)
|||++|+|.++ ...+++.++..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999664 34689999999999999999999996 9999999999999964 678999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 739 (771)
.. ....+||+.||||| +||++|||++|+.||.+... ...+........ +......++
T Consensus 180 ~~-----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 180 QS-----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp SC-----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCSCCGGGGGCC
T ss_pred cc-----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCCcccccCCC
Confidence 22 22357999999999 69999999999999975321 112333333333 233445566
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+.....+||+.||++|||+.|+++
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 66667777999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-40 Score=353.72 Aligned_cols=229 Identities=17% Similarity=0.174 Sum_probs=189.7
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|++|+||+|+++.+++.||||++........+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~ivm 105 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMVLIL 105 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEEEE
Confidence 444567999999999999999999999999997766556678999999999999999999999998776 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCceEEecccCccccCcc
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLD--NDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~--~~~~~kl~DfGla~~~~~~ 676 (771)
|||++|+|.+. ...+++.++..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999999654 33689999999999999999999985 999999999999998 5789999999999876543
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchhhhcC
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQILQVLD 739 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 739 (771)
.. .....||+.||||| +||++|||+||+.||.+.... ..+..+..... +......++
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 183 EI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp SC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCCCSSTTTTSC
T ss_pred Cc-----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCcccccCCC
Confidence 22 22346899999999 699999999999999763221 12333333333 334445667
Q ss_pred ccccccCcccChhchhhcCCHHHHHH
Q 041479 740 PLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 740 ~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+.+..+..+||++||++|||+.|+++
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 77777788999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=350.71 Aligned_cols=235 Identities=20% Similarity=0.257 Sum_probs=187.2
Q ss_pred ccccccccccccceEEEEEecCCCe----EEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQT----FIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
+.....+|+|++|+||+|++..+++ .||||++... .....++|.+|++++++++|||||+++|+|.+.+
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------ 84 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------ 84 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS------
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC------
Confidence 3344578999999999999987764 5888888543 3445688999999999999999999999998754
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.+++|||+.+|+|.+. ...+++..+.+++.|||.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 5789999999998654 45689999999999999999999996 8999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
..... ........||+.||||| |||++|||+| |+.||.+... ..+...+....+...+..
T Consensus 162 ~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 162 GAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQPPI 237 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHTCCCCCCTT
T ss_pred ccccc--cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCCCCcc
Confidence 54332 22233456899999999 7999999999 8889876432 235555555555555566
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+++.+..++.+||+.||++|||+.|+++.|+++
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 777777788899999999999999999998764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=343.14 Aligned_cols=236 Identities=20% Similarity=0.272 Sum_probs=181.5
Q ss_pred cccccccccccccceEEEEEecCC---CeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 522 DLLLNVSYESLVKATVYKGILDLD---QTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.+...-.+|+|.+|+||+|++..+ +..||||.++... ....+.|.+|++++++++|||||+++|++.+. .
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 81 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------P 81 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS------S
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------e
Confidence 344455789999999999998654 3568999885443 44567899999999999999999999998643 4
Q ss_pred EEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 598 RALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
.|+|||||++|++.++ ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 6899999999999765 34689999999999999999999996 9999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQV 737 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (771)
..... .......||+.||||| |||++|||+| |+.||.+... ..+.+.+....+...++.
T Consensus 159 ~~~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 159 EDSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERLPMPPN 233 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCCCCTT
T ss_pred cCCcc---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCCCCC
Confidence 54322 1223346899999999 7999999998 8999976533 234444444444455666
Q ss_pred cCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 738 LDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 738 ~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+++.+..++.+||+.||++|||+.||++.|++++
T Consensus 234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 7777777888999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-40 Score=348.72 Aligned_cols=239 Identities=22% Similarity=0.252 Sum_probs=191.5
Q ss_pred ccccccccccccccceEEEEEecC-----CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
..+.....+|+|++|+||+|+++. +++.||||++.... ....++|.+|++++++++||||++++++|.+.+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--- 89 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK--- 89 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC---
Confidence 344455679999999999999863 45789999997553 345678999999999999999999999998776
Q ss_pred ceeEEEEEEeccCCCCCCCc---------------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 041479 595 NYFRALVYEFMHHGSLESCP---------------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHC 647 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~~---------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHr 647 (771)
..++||||+++|+|.++. ..+++.++..|+.|+|.||+|||+. +||||
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 90 --PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp --SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred --ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 679999999999986541 2378899999999999999999985 99999
Q ss_pred CCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCC-CC
Q 041479 648 DLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGK-RP 711 (771)
Q Consensus 648 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~-~P 711 (771)
||||+|||++.++.+||+|||+|+....... ........||+.||||| |||++|||++|. .|
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCcc--ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999986654332 12223456899999999 799999999985 56
Q ss_pred CCccccCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 712 TSDMFTEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
|.+.... .+...+........++.+.+.+..++.+||+.||++||||.||++.|++++
T Consensus 243 ~~~~~~~--e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHE--EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHH--HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7654222 233334433344455566777777888999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=346.22 Aligned_cols=240 Identities=21% Similarity=0.244 Sum_probs=184.9
Q ss_pred cccccccccccccceEEEEEecCC-----CeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCC
Q 041479 522 DLLLNVSYESLVKATVYKGILDLD-----QTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 594 (771)
.+.....+|+|+||+||+|++... ++.||||++.... ....+.+.+|..++.++ +|+|||.+++++.+.+.
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-- 91 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-- 91 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS--
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC--
Confidence 344456789999999999997643 4689999996543 34567788899888887 68999999999876542
Q ss_pred ceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 041479 595 NYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVL 655 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NIL 655 (771)
..++|||||++|+|.++. ..+++.++..++.|+++||+|||+. +|+||||||+|||
T Consensus 92 --~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 92 --PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp --CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred --eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 579999999999997651 2478999999999999999999986 8999999999999
Q ss_pred eCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhC-CCCCCccccCC
Q 041479 656 LDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTG-KRPTSDMFTEG 719 (771)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg-~~P~~~~~~~~ 719 (771)
+++++.+||+|||+|+....... .......+||+.||||| |||++|||+|| ..||.+.. ..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-ID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-CS
T ss_pred ECCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-HH
Confidence 99999999999999987654332 22233457999999999 79999999996 45776532 22
Q ss_pred ccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 720 LDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
..+...+....+...++.+++.+...+.+||+.||++|||+.|+++.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3355555555555666677777878888999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=340.95 Aligned_cols=235 Identities=25% Similarity=0.282 Sum_probs=179.7
Q ss_pred ccccccccccceEEEEEecCC---CeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 525 LNVSYESLVKATVYKGILDLD---QTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~---~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
....+|+|++|+||+|++... ...||||++... .....++|.+|+.++++++|||||+++|++.+.. .
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~------~ 85 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP------M 85 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS------C
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecc------h
Confidence 344689999999999987543 247999998643 2345678999999999999999999999997643 5
Q ss_pred EEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccC
Q 041479 599 ALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIP 674 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~ 674 (771)
++|||||++|++.+. ...+++..++.++.|+|.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 899999999998765 45699999999999999999999985 89999999999999999999999999999765
Q ss_pred cccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 675 EVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 675 ~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
..... ........||+.|+||| |||++|||+| |+.||.+..... ..............++.+
T Consensus 163 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 163 QNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp C-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSCCCCCCCTTC
T ss_pred cCCCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHHHhCCCCCCCcccc
Confidence 44322 12223446788999999 7999999998 899997642221 233333444444455566
Q ss_pred CccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 739 DPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.+.+...+.+||+.||++||||.||++.|++.
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 67777778899999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=342.35 Aligned_cols=228 Identities=19% Similarity=0.164 Sum_probs=185.8
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCcee
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ------RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
.....+|+|++|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~ 87 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-----D 87 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----E
Confidence 34456899999999999999999999999996442 224678999999999999999999999998876 7
Q ss_pred EEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----ceEEecccCc
Q 041479 598 RALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM----TAHMGDFGLT 670 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~----~~kl~DfGla 670 (771)
.|+|||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 8999999999999876 35699999999999999999999986 999999999999998776 4999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--Cc
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQ 733 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~ 733 (771)
+....... .....||+.||||| +||++|||++|+.||.+.... ..+..+.....+ ..
T Consensus 165 ~~~~~~~~-----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 165 HKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYEFEDE 238 (293)
T ss_dssp EECTTSCB-----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTTCCCCCHH
T ss_pred hhcCCCcc-----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCCCCch
Confidence 87654322 22356899999999 699999999999999753211 112333333332 33
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
....+++.+.....+||+.||++|||+.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34455666666777999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=335.56 Aligned_cols=228 Identities=28% Similarity=0.299 Sum_probs=182.3
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
+.....+|+|.+|+||+|+++ ++.||||+++.. ...++|.+|++++++++|||||+++|+|.+... ..|+||
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~----~~~lv~ 80 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG----GLYIVT 80 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEE
T ss_pred eEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC----cEEEEE
Confidence 333445899999999999985 568999999643 345789999999999999999999999865431 469999
Q ss_pred EeccCCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 603 EFMHHGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 603 e~~~~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
||+++|+|.++ ...+++..+.+++.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 99999999877 22489999999999999999999985 99999999999999999999999999998654322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
....+|+.|+||| |||++|||+| |+.||... ....+...+........+..+++.
T Consensus 158 -------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 158 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred -------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCCCccCCHH
Confidence 1235789999999 7999999998 78887654 223455666555555566667778
Q ss_pred ccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 742 FLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
+.....+||+.||++||||.|++++|+++
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 88888899999999999999999999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=338.70 Aligned_cols=242 Identities=21% Similarity=0.193 Sum_probs=177.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
....+|+|.+|+||+|++ +++.||||++..... ....+..|+..+.+++|||||+++++|.+.+. .....|+||||
T Consensus 7 l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-~~~~~~lv~Ey 82 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLVSDY 82 (303)
T ss_dssp EEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-cceEEEEEEec
Confidence 344589999999999987 467999999964432 22233445556667899999999999987642 22367999999
Q ss_pred ccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 605 MHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHH-----CKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 605 ~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|++|+|.++ ...++|.++.+++.|+|.||+|+|+. .+++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 83 HEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp CTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred ccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 999999887 34689999999999999999999974 13689999999999999999999999999998765543
Q ss_pred CCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCCcc----------ccCCccHHHHH
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDM----------FTEGLDLHNFV 726 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~----------~~~~~~~~~~~ 726 (771)
..........+||+.||||| |||++|||+||..|+... ...........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHH
Confidence 33233344567999999999 699999999998876321 11112222222
Q ss_pred Hhh----CCCchhhhcC-----ccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 727 KMA----LPDQILQVLD-----PLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 727 ~~~----~~~~~~~~~~-----~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
... .++..+.... ..+...+.+||+.||++|||+.||++.|+++
T Consensus 243 ~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 222 1111111111 1244566699999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-39 Score=341.66 Aligned_cols=226 Identities=21% Similarity=0.278 Sum_probs=185.8
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeecc---chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLH---QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|.+|+||+|+++.+++.||||++... .....+.+.+|+.++++++|||||++++++.+.+ ..
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~ 79 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----QI 79 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----EE
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-----ee
Confidence 344456789999999999999999999999999654 2345678999999999999999999999998876 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+|||||+||++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999998766 45678888899999999999999985 999999999999999999999999999987643
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
.. ...+||+.||||| +||++|||+||+.||.+.... .....+.... ...+..+++
T Consensus 157 ~~-------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~--~~~p~~~s~ 226 (316)
T d1fota_ 157 VT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAE--LRFPPFFNE 226 (316)
T ss_dssp CB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCC--CCCCTTSCH
T ss_pred cc-------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-HHHHHHHcCC--CCCCCCCCH
Confidence 22 2357999999999 799999999999999753211 1122232322 233455666
Q ss_pred cccccCcccChhchhhcC-----CHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
.+.....+|+++||++|| |++|+++
T Consensus 227 ~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 227 DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 776777799999999996 8999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=343.28 Aligned_cols=229 Identities=22% Similarity=0.232 Sum_probs=187.6
Q ss_pred cccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeE
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFR 598 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~ 598 (771)
++.....+|+|++|+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~~ 80 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RL 80 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----EE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-----cc
Confidence 3445567899999999999999999999999997542 345678999999999999999999999998877 78
Q ss_pred EEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCc
Q 041479 599 ALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 599 ~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~ 675 (771)
|+|||||++|+|.++ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999776 45688999999999999999999996 999999999999999999999999999986543
Q ss_pred ccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCc
Q 041479 676 VMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDP 740 (771)
Q Consensus 676 ~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (771)
... .....+||+.||||| +||++|||++|+.||.+..... .+..+... +...++.+++
T Consensus 158 ~~~----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~--~~~~p~~~s~ 230 (337)
T d1o6la_ 158 DGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME--EIRFPRTLSP 230 (337)
T ss_dssp TTC----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC--CCCCCTTSCH
T ss_pred CCc----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcC--CCCCCccCCH
Confidence 221 223467999999999 6999999999999997632211 12222222 2334556677
Q ss_pred cccccCcccChhchhhcCC-----HHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
.......+||++||++||+ +.|+++
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 7777778999999999995 777764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-39 Score=337.97 Aligned_cols=241 Identities=20% Similarity=0.231 Sum_probs=183.9
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
.....+|+|.+|+||+|++..+++.||||+++... ....++|.+|++++++++|||||++++++...+. .....|+
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~~~~l 88 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGPLPYI 88 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCceEEE
Confidence 33456899999999999999999999999996542 3445789999999999999999999999876542 2235799
Q ss_pred EEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCccc
Q 041479 601 VYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 601 v~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~ 677 (771)
|||||++|+|.+. .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++..+++|||.++......
T Consensus 89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 9999999999766 44689999999999999999999986 99999999999999999999999999987654332
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDP 740 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 740 (771)
.. .......+||+.||||| +||++|||+||+.||.+..... .+......... ....+.+++
T Consensus 166 ~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 166 NS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCCCGGGTSSSCCH
T ss_pred cc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCCCCchhccCCCH
Confidence 21 22234567999999999 6999999999999997532211 12222332222 223345566
Q ss_pred cccccCcccChhchhhcC-CHHHHHHHHHHh
Q 041479 741 LFLVGGVQEGEETAEENI-KKGQIRESLIAI 770 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rp-t~~~vl~~L~~~ 770 (771)
.+.....+||++||++|| |++++++.|.++
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 666777799999999999 899999988765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=342.41 Aligned_cols=238 Identities=19% Similarity=0.202 Sum_probs=195.4
Q ss_pred cccccccccccceEEEEEec-----CCCeEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCce
Q 041479 524 LLNVSYESLVKATVYKGILD-----LDQTFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~ 596 (771)
...-.+|+|++|.||+|+++ ..++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+.+
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~----- 100 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG----- 100 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----
T ss_pred EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-----
Confidence 33456899999999999874 355799999997543 44567899999999999 6999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 041479 597 FRALVYEFMHHGSLESC---------------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVL 655 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NIL 655 (771)
..++|||||++|+|.++ ...+++..+..++.|||.|++|||++ +|+||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence 67999999999998654 12488999999999999999999996 8999999999999
Q ss_pred eCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc
Q 041479 656 LDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL 720 (771)
Q Consensus 656 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~ 720 (771)
++.++.+|++|||+++....... .......+||+.|+||| |||++|||+|+..|+........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999997654332 22334567999999999 79999999995555433333344
Q ss_pred cHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 721 DLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+.+++....+...+..+++.+..++.+||+.||++||||.+|+++|+++|
T Consensus 256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 566777777776666677777877888999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=340.43 Aligned_cols=239 Identities=20% Similarity=0.235 Sum_probs=189.8
Q ss_pred ccccccccccccccceEEEEEecC-----CCeEEEEEEeecc-chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILDL-----DQTFIAVKVLFLH-QRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQG 594 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~-----~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 594 (771)
........+|+|++|+||+|+++. .++.||||+++.. .......|.+|++++++++|||||+++|+|...+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--- 96 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--- 96 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS---
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC---
Confidence 344445669999999999998853 3468999999654 3445568999999999999999999999997766
Q ss_pred ceeEEEEEEeccCCCCCCC-------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCc
Q 041479 595 NYFRALVYEFMHHGSLESC-------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMT 661 (771)
Q Consensus 595 ~~~~~lv~e~~~~g~L~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~ 661 (771)
..++|||||++|+|.++ ...+++..+..++.|+|+||.|||+. +|+||||||+|||++.++.
T Consensus 97 --~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 97 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred --ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 57999999999999765 23468899999999999999999985 8999999999999999999
Q ss_pred eEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCC-CCCCccccCCccHHHH
Q 041479 662 AHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGK-RPTSDMFTEGLDLHNF 725 (771)
Q Consensus 662 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~-~P~~~~~~~~~~~~~~ 725 (771)
+||+|||+|+....... ........||+.|+||| |||++|||+||. .||.+... ....+.
T Consensus 172 ~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~~~~ 247 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRF 247 (308)
T ss_dssp EEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHHHH
T ss_pred EEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHHHHH
Confidence 99999999987654432 22233456899999999 799999999985 67754321 122223
Q ss_pred HHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 726 VKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
+........++.+++.+...+.+||+.||++||||.+|++.|++.+
T Consensus 248 i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3232333345556677777888999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-39 Score=333.50 Aligned_cols=228 Identities=21% Similarity=0.217 Sum_probs=188.0
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc---------hhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCC
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---------RGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQ 593 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 593 (771)
.....+|+|.+|+||+|+++.+++.||||++.... ....+++.+|+.++++++ |||||++++++.+.+
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-- 83 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-- 83 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc--
Confidence 34556899999999999999999999999996542 123457899999999997 999999999998876
Q ss_pred CceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCc
Q 041479 594 GNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLT 670 (771)
Q Consensus 594 ~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla 670 (771)
..|+|||||++|+|.++ ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 84 ---~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 ---FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ---ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 78999999999999876 45789999999999999999999986 9999999999999999999999999999
Q ss_pred cccCcccCCcccccccccccccccchh---------------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh
Q 041479 671 RFIPEVMSSNQCSSVGLKGTVGYATPE---------------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA 729 (771)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 729 (771)
+....... ....+||+.|+||| +||++|||++|+.||.+..... ....+....
T Consensus 158 ~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~ 231 (277)
T d1phka_ 158 CQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGN 231 (277)
T ss_dssp EECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC
T ss_pred eEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCC
Confidence 87654322 23357999999999 6999999999999997643221 222333333
Q ss_pred C--CCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 L--PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 ~--~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. +......+++.+.....+||+.||++|||+.||++
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3 23334456777777778999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=341.38 Aligned_cols=235 Identities=25% Similarity=0.275 Sum_probs=186.6
Q ss_pred cccccccccccccceEEEEEecCCCe--EEEEEEeecc-chhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCcee
Q 041479 522 DLLLNVSYESLVKATVYKGILDLDQT--FIAVKVLFLH-QRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 522 ~~~~~~~l~~~~~~~Vy~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~ 597 (771)
++...-.+|+|.+|+||+|+++.++. .||||++... .....++|.+|+++++++ +|||||+++|+|.+.+ .
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~ 85 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----Y 85 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----E
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----e
Confidence 33344569999999999999988875 4677777543 334567899999999998 7999999999998876 7
Q ss_pred EEEEEEeccCCCCCCC-------------------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 041479 598 RALVYEFMHHGSLESC-------------------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN 658 (771)
Q Consensus 598 ~~lv~e~~~~g~L~~~-------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~ 658 (771)
.++||||+++|+|.++ ...+++.++.+++.|+|.||.|+|+. +|+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcC
Confidence 8999999999999765 24689999999999999999999996 9999999999999999
Q ss_pred CCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCC-CCCCccccCCccH
Q 041479 659 DMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGK-RPTSDMFTEGLDL 722 (771)
Q Consensus 659 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~-~P~~~~~~~~~~~ 722 (771)
++.+||+|||+|+....... .....||..|+||| |||++|||++|. .||.+. ....+
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~~~~~ 235 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAEL 235 (309)
T ss_dssp GGCEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHH
T ss_pred CCceEEcccccccccccccc-----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--CHHHH
Confidence 99999999999986544322 22346899999999 799999999975 466543 22234
Q ss_pred HHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 723 HNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.+.+....+...+..+++.+...+.+||+.||++||||.||++.|++++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 4444444444455566777777888999999999999999999998863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-39 Score=345.41 Aligned_cols=227 Identities=20% Similarity=0.218 Sum_probs=182.4
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHH---HHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFM---AECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|++|+||+|+++.+++.||||++.... ......+. .|+++++.++|||||++++++.+.+
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~----- 80 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----- 80 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS-----
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC-----
Confidence 334456899999999999999999999999996432 22223344 4467777888999999999998876
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..|+|||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 78999999999999876 44678899999999999999999996 9999999999999999999999999999866
Q ss_pred CcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC--CCchh
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL--PDQIL 735 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~~~ 735 (771)
.... ....+||+.||||| +||++|||+||+.||.+... ....+...... +...+
T Consensus 158 ~~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~ 229 (364)
T d1omwa3 158 SKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAVELP 229 (364)
T ss_dssp SSSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS--SCHHHHHHHSSSCCCCCC
T ss_pred CCCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccCCCCCC
Confidence 5432 22357999999999 69999999999999976422 22333333322 34445
Q ss_pred hhcCccccccCcccChhchhhcCC-----HHHHHH
Q 041479 736 QVLDPLFLVGGVQEGEETAEENIK-----KGQIRE 765 (771)
Q Consensus 736 ~~~~~~~~~~~~~cl~~~p~~Rpt-----~~~vl~ 765 (771)
+.+++.+.....+||+.||++||| +.|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 567777777788999999999999 577764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=337.18 Aligned_cols=239 Identities=24% Similarity=0.297 Sum_probs=189.7
Q ss_pred ccccccccccccccceEEEEEecCCC-------eEEEEEEeeccc-hhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQ-------TFIAVKVLFLHQ-RGALKSFMAECQALRNI-RHRNLVKIITACSTSD 591 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~-------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 591 (771)
..+.....+|+|+||.||+|+....+ ..||||++.... .....++.+|+..+.++ +|||||+++++|.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 34444567899999999999976543 479999996654 34567899999999998 7999999999998766
Q ss_pred CCCceeEEEEEEeccCCCCCCCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 041479 592 FQGNYFRALVYEFMHHGSLESCP-------------------RILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPS 652 (771)
Q Consensus 592 ~~~~~~~~lv~e~~~~g~L~~~~-------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~ 652 (771)
..++|||||++|+|.++. ..+++.++..++.|+|.||+|||+. +||||||||+
T Consensus 93 -----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 93 -----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp -----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred -----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 679999999999997651 3589999999999999999999996 8999999999
Q ss_pred CeeeCCCCceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHh-CCCCCCccc
Q 041479 653 NVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFT-GKRPTSDMF 716 (771)
Q Consensus 653 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~t-g~~P~~~~~ 716 (771)
|||++.++.+||+|||+++........ .......||+.|+||| |||++|||++ |..||.+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeecCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999999876554322 2233456899999999 7999999998 788887643
Q ss_pred cCCccHHHHHHhhCCCchhhhcCccccccCcccChhchhhcCCHHHHHHHHHHhC
Q 041479 717 TEGLDLHNFVKMALPDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAIL 771 (771)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~l 771 (771)
.. .+.+.+....+...+..+.+.+...+.+||+.||++||||.||++.|++++
T Consensus 243 ~~--~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 243 VE--ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH--HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 22 244444445555556666777777888999999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-38 Score=339.28 Aligned_cols=228 Identities=18% Similarity=0.131 Sum_probs=187.2
Q ss_pred cccccccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCce
Q 041479 520 RKDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 520 ~~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~ 596 (771)
...+.....+|+|.+|+||+|+++.+++.||||++.... ....+.+.+|+++++.++|||||++++++.+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----- 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----- 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-----
Confidence 445556667999999999999999999999999996542 345678999999999999999999999998776
Q ss_pred eEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCcccc
Q 041479 597 FRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFI 673 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~ 673 (771)
..++||||+.+|+|.+. ...+++.++..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+..
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 78999999999999766 45689999999999999999999986 9999999999999999999999999999876
Q ss_pred CcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhc
Q 041479 674 PEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVL 738 (771)
Q Consensus 674 ~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (771)
.... ...+||+.||||| +||++|||+||+.||.+... ...+..+.... ...+..+
T Consensus 192 ~~~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~--~~~p~~~ 261 (350)
T d1rdqe_ 192 KGRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGK--VRFPSHF 261 (350)
T ss_dssp SSCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC--CCCCTTC
T ss_pred cccc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHHhcCC--CCCCccC
Confidence 4322 2357999999999 79999999999999975321 11122222222 2334456
Q ss_pred CccccccCcccChhchhhcC-----CHHHHHH
Q 041479 739 DPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 739 ~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
++.+.....+||++||++|+ |+.|+++
T Consensus 262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 66777777799999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=335.04 Aligned_cols=227 Identities=15% Similarity=0.177 Sum_probs=184.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.....+|+|++|+||+|+++.+++.||||++..... ....+.+|+++|++++|||||++++++.+.+ ..|+|||
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~lvmE 81 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME-----ELVMIFE 81 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEe
Confidence 334578999999999999999999999999976543 3467889999999999999999999998876 7899999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCceEEecccCccccCccc
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN--DMTAHMGDFGLTRFIPEVM 677 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~--~~~~kl~DfGla~~~~~~~ 677 (771)
||+||+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++. .+.+||+|||+++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999999765 23689999999999999999999985 9999999999999985 4589999999998654322
Q ss_pred CCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC--CchhhhcCc
Q 041479 678 SSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP--DQILQVLDP 740 (771)
Q Consensus 678 ~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 740 (771)
. .....||+.|+||| +||++|||++|+.||.+.... ..+..+...... ......+++
T Consensus 159 ~-----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 159 N-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp E-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCCCHHHHTTSCH
T ss_pred c-----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCChhhccCCCH
Confidence 1 22346899999999 699999999999999753221 123333333332 333345566
Q ss_pred cccccCcccChhchhhcCCHHHHHH
Q 041479 741 LFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 741 ~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+.....+|+++||++|||+.|+++
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 6667777999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-39 Score=334.98 Aligned_cols=225 Identities=23% Similarity=0.224 Sum_probs=174.1
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQR-----GALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
-+|+|.+|+||+|+++.+++.||||++..... ...+.+.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 5 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~ivm 79 (299)
T d1ua2a_ 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NISLVF 79 (299)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCEEEE
T ss_pred EeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----ceeehh
Confidence 47999999999999999999999999965432 12357899999999999999999999998876 679999
Q ss_pred EeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 603 EFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 603 e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||.++++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 99998876543 45688899999999999999999996 999999999999999999999999999986554322
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC-----------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD----------- 732 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~----------- 732 (771)
.....+||+.||||| +||++|||+||+.||.+....+ .+..+.....++
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 ---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp ---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhcc
Confidence 223457999999999 6999999999999996532111 122222211100
Q ss_pred ---------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ---------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ---------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.+.....+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 001122334444566999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=332.94 Aligned_cols=226 Identities=23% Similarity=0.269 Sum_probs=183.4
Q ss_pred cccccccccccceEEEEEecCCCeEEEEEEeeccc---hhhHHHHHHHHHHHh-ccCCCCceeEEEEeecCCCCCceeEE
Q 041479 524 LLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ---RGALKSFMAECQALR-NIRHRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 524 ~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.....+|+|.+|+||+|+++.+++.||||+++... ....+.+.+|+.++. .++|||||++++++.+.+ ..|
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~-----~~y 79 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-----NLF 79 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----EEE
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----cee
Confidence 34457899999999999999999999999997542 344567788888766 689999999999998877 789
Q ss_pred EEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcc
Q 041479 600 LVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 600 lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~ 676 (771)
+|||||++|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+|++|||+|+.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999877 45688999999999999999999996 8999999999999999999999999999865433
Q ss_pred cCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhhhcCcc
Q 041479 677 MSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQVLDPL 741 (771)
Q Consensus 677 ~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (771)
.. .....+||+.||||| +||++|||++|+.||.+... ..+....... +...++.+++.
T Consensus 157 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~-~~~~p~~~s~~ 229 (320)
T d1xjda_ 157 DA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMD-NPFYPRWLEKE 229 (320)
T ss_dssp TC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC-CCCCCTTSCHH
T ss_pred cc----cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHcC-CCCCCccCCHH
Confidence 22 223457999999999 69999999999999975321 1122222222 23344566777
Q ss_pred ccccCcccChhchhhcCCHH-HHH
Q 041479 742 FLVGGVQEGEETAEENIKKG-QIR 764 (771)
Q Consensus 742 ~~~~~~~cl~~~p~~Rpt~~-~vl 764 (771)
+.....+||++||++|||+. +++
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHHhcccCCCCCcCHHHHHH
Confidence 77777799999999999985 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=334.21 Aligned_cols=222 Identities=18% Similarity=0.178 Sum_probs=174.8
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CCCCceeEEEEeecCCCCCceeEEEEEEecc
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNI-RHRNLVKIITACSTSDFQGNYFRALVYEFMH 606 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~ 606 (771)
.+|+|++|+||+|++..+++.||||+++.. +.+.+|++++.++ +|||||++++++.+.. ......|+|||||+
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIVMECLD 92 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCC
T ss_pred EeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEEEECCC
Confidence 489999999999999999999999998532 4577899987655 8999999999986531 11236899999999
Q ss_pred CCCCCCC-----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCcccC
Q 041479 607 HGSLESC-----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 607 ~g~L~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 678 (771)
||+|.++ ...+++.++..|+.|++.||+|||+. +|+||||||+|||++. .+.+||+|||+|+.......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc
Confidence 9999776 23589999999999999999999986 9999999999999985 56799999999986654322
Q ss_pred Ccccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-------hCCCchhh
Q 041479 679 SNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-------ALPDQILQ 736 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-------~~~~~~~~ 736 (771)
....+||+.||||| +||++|||+||+.||.+..... ....... .+|.....
T Consensus 170 -----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 170 -----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp -----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSSSCCTTHHH
T ss_pred -----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhcCCCCCCCcccc
Confidence 23457999999999 7999999999999996532211 1111111 12233344
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+++.+.....+||+.||++|||+.|+++
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 56666767777999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-38 Score=327.76 Aligned_cols=229 Identities=21% Similarity=0.254 Sum_probs=175.8
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVY 602 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~ 602 (771)
..-.+|+|.+|+||+|+++.+++.||||+++... +...+++.+|++++++++|||||++++++.+.+ ..|+||
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~~iv~ 80 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLYLVF 80 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEEE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ceeEEE
Confidence 3456899999999999999998999999996543 233578999999999999999999999998877 789999
Q ss_pred EeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 603 EFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 603 e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
||+.++.+... ...+++.++..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99987644322 45689999999999999999999986 899999999999999999999999999986543221
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-CCc--------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-PDQ-------- 733 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~-------- 733 (771)
......||+.|+||| +||++|||++|+.||.+..... .+........ +.+
T Consensus 158 ----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 158 ----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGG
T ss_pred ----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhcccccc
Confidence 223457999999999 6999999999999997532111 1222221111 100
Q ss_pred ------------------hhhhcCccccccCcccChhchhhcCCHHHHHHH
Q 041479 734 ------------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRES 766 (771)
Q Consensus 734 ------------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~ 766 (771)
....+++.+.....+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 001122233334559999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=321.88 Aligned_cols=217 Identities=18% Similarity=0.164 Sum_probs=175.5
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccch------hhHHHHHHHHHHHhccC--CCCceeEEEEeecCCCCCcee
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQR------GALKSFMAECQALRNIR--HRNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~~~~ 597 (771)
...+|+|++|+||+|++..+++.||||++..... ...+++.+|++++++++ |||||++++++.+.+ .
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~-----~ 83 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD-----S 83 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-----E
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-----e
Confidence 3468999999999999999999999999965421 12245778999999997 899999999998876 7
Q ss_pred EEEEEEeccC-CCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCceEEecccCccc
Q 041479 598 RALVYEFMHH-GSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-DMTAHMGDFGLTRF 672 (771)
Q Consensus 598 ~~lv~e~~~~-g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-~~~~kl~DfGla~~ 672 (771)
.|+||||+.+ +++.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 8999999976 455444 45689999999999999999999996 9999999999999985 57999999999986
Q ss_pred cCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCCchhh
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPDQILQ 736 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (771)
..... ....+||+.||||| +||++|||+||+.||.+. .+...... ..++
T Consensus 161 ~~~~~------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~i~~~~~--~~~~ 225 (273)
T d1xwsa_ 161 LKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQV--FFRQ 225 (273)
T ss_dssp CCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHCCC--CCSS
T ss_pred ccccc------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------hHHhhccc--CCCC
Confidence 54322 22457999999999 699999999999999642 12222222 2334
Q ss_pred hcCccccccCcccChhchhhcCCHHHHHH
Q 041479 737 VLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 737 ~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+++.+.....+||+.||++|||++|+++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 45666666777999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-37 Score=320.59 Aligned_cols=234 Identities=21% Similarity=0.252 Sum_probs=175.1
Q ss_pred ccccccccccccceEEEEEecC-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhcc---CCCCceeEEEEeecCCCCCce
Q 041479 523 LLLNVSYESLVKATVYKGILDL-DQTFIAVKVLFLHQ--RGALKSFMAECQALRNI---RHRNLVKIITACSTSDFQGNY 596 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~~~ 596 (771)
+.....+|+|.+|+||+|++.. +++.||||+++... ......+.+|+.+++.+ +|||||++++++.........
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 3344568999999999999864 46789999996543 22234567788777665 799999999998765444445
Q ss_pred eEEEEEEeccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 597 FRALVYEFMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 597 ~~~lv~e~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
..+++||||++|++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 78999999998876432 45688999999999999999999986 899999999999999999999999999986
Q ss_pred cCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhC-C-----
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMAL-P----- 731 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~----- 731 (771)
..... .....+||+.||||| +||++|||++|+.||.+.... ..+........ +
T Consensus 166 ~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGGS
T ss_pred hcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchhcc
Confidence 54322 233467999999999 699999999999999753211 11222221111 0
Q ss_pred -------------------CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 -------------------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 -------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+++.+.....+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0011122333334556999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-36 Score=317.87 Aligned_cols=229 Identities=19% Similarity=0.196 Sum_probs=178.5
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALV 601 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv 601 (771)
+.....+|+|.+|+||+|+++.+++.||||+++... .+++.+|+++|++++ ||||+++++++..... ...++|
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~~~~~v 110 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALV 110 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CSEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---CceeEE
Confidence 444567999999999999999999999999996433 467899999999996 9999999999875432 257999
Q ss_pred EEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcccCCc
Q 041479 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 602 ~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~ 680 (771)
||||++|+|....+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+|+.......
T Consensus 111 ~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-- 185 (328)
T d3bqca1 111 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 185 (328)
T ss_dssp EECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--
T ss_pred EeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc--
Confidence 99999999999888899999999999999999999996 999999999999998655 699999999986654322
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHH------------HHHhh-C-
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHN------------FVKMA-L- 730 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~------------~~~~~-~- 730 (771)
....+||+.|+||| +||++||+++|+.||............ +.... .
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 186 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred ---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 23456899999999 699999999999999643211100111 10000 0
Q ss_pred ---------------------CCchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 731 ---------------------PDQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 731 ---------------------~~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
+......+++.+.+...+|++.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111223333444556999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.2e-37 Score=317.48 Aligned_cols=226 Identities=20% Similarity=0.252 Sum_probs=172.7
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
...+|+|.+|+||+|+++. ++.||||++.... ....+++.+|+.++++++|||||++++++...+ ..+++||
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~i~~e 80 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RLVLVFE 80 (286)
T ss_dssp EEEEEEETTEEEEEEEETT-SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CEEEEEE
T ss_pred ccEEecCCCcEEEEEEeCC-CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ceeEEEE
Confidence 3458999999999999974 4699999996543 334578999999999999999999999998877 6899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+.++.+..+ .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 9988776544 55789999999999999999999986 899999999999999999999999999986543221
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCC-------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALP------------- 731 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~------------- 731 (771)
......|++.|+||| +||++|||++|+.||.+..... .+.+.......
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhh
Confidence 223346899999999 6999999999999997542111 12221111110
Q ss_pred --------------CchhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 --------------DQILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 --------------~~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
......+++.+.....+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011122233334455999999999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=321.95 Aligned_cols=236 Identities=19% Similarity=0.157 Sum_probs=177.1
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ-RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
....+|+|.+|+||+|+++.+++.||||++.... ....+++++|+++|++++|||||++++++...........|+ ++
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l-~~ 90 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL-VT 90 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE-EE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE-EE
Confidence 3456899999999999999999999999996443 445678999999999999999999999997765433334444 55
Q ss_pred eccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 604 FMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 604 ~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
|+.+|+|.++ ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 91 ~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~- 166 (345)
T d1pmea_ 91 HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT- 166 (345)
T ss_dssp ECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC-
T ss_pred eecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc-
Confidence 6779999877 45799999999999999999999986 99999999999999999999999999998765443221
Q ss_pred cccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh----------------
Q 041479 682 CSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA---------------- 729 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~---------------- 729 (771)
......+||+.|+||| +||++|||++|+.||.+...............
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence 2234467999999999 69999999999999965321111000000000
Q ss_pred -----CCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 730 -----LPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 730 -----~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.+. .....+++.+.....+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 111223344445566999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-36 Score=317.61 Aligned_cols=241 Identities=20% Similarity=0.223 Sum_probs=176.0
Q ss_pred ccccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC---CCc
Q 041479 521 KDLLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF---QGN 595 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---~~~ 595 (771)
..+.....+|+|.+|+||+|+++.+++.||||++.... ....+++.+|+++|++++||||+++++++..... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 33445567999999999999999999999999985542 3345789999999999999999999999866431 112
Q ss_pred eeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 596 YFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 596 ~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
...|+|||||+++.+... ...++..++..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 357999999988776433 45688899999999999999999986 999999999999999999999999999987
Q ss_pred cCcccCCcccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--CCCch
Q 041479 673 IPEVMSSNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--LPDQI 734 (771)
Q Consensus 673 ~~~~~~~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~~~~~ 734 (771)
...............+||+.|+||| +||++|||++|+.||.+..... .+....... .+...
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCChhh
Confidence 6544333233334567999999999 6999999999999996532111 111111111 11110
Q ss_pred h----------------------------hhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 735 L----------------------------QVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 735 ~----------------------------~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
. ...++.+.....+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 011222233455999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-36 Score=321.18 Aligned_cols=226 Identities=20% Similarity=0.229 Sum_probs=170.6
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEeecCC-CCCceeEEEEEEec
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITACSTSD-FQGNYFRALVYEFM 605 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~~~~~~lv~e~~ 605 (771)
-.+|+|++|+||+|+++.+++.||||++..... .+.+|++++++++|||||++++++.... ..+..+.|+|||||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 358999999999999999999999999965432 2347999999999999999999986543 22334679999999
Q ss_pred cCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-ceEEecccCccccCcccC
Q 041479 606 HHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM-TAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 606 ~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 678 (771)
++|.+... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 87643322 34689999999999999999999985 999999999999999775 899999999986644322
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh-----------hCC
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM-----------ALP 731 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~-----------~~~ 731 (771)
....+||+.|+||| +||++|||++|+.||....... .+..+... ..+
T Consensus 179 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 179 -----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp -----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCC
T ss_pred -----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhhhcc
Confidence 22357999999999 6999999999999996432111 12222111 000
Q ss_pred ----Cc------------hhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 732 ----DQ------------ILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 732 ----~~------------~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.. .....++.+..+..+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 01122333334555999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-35 Score=311.30 Aligned_cols=235 Identities=19% Similarity=0.245 Sum_probs=177.9
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCceeEEEEe-ecCCCCCceeEEEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNLVKIITAC-STSDFQGNYFRALVYE 603 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~~~~~~lv~e 603 (771)
..-.+|+|++|+||+|++..+++.||||++..... .+++.+|+++++.++|+|+|..++.+ .+.+ ..++|||
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~-----~~~ivme 83 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD-----YNVMVME 83 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT-----EEEEEEE
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCC-----EEEEEEE
Confidence 34568999999999999999999999999865432 24688999999999877766655554 4444 6799999
Q ss_pred eccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCceEEecccCccccCcc
Q 041479 604 FMHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN---DMTAHMGDFGLTRFIPEV 676 (771)
Q Consensus 604 ~~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~---~~~~kl~DfGla~~~~~~ 676 (771)
|+.+ ++... .+.+++..+..++.|++.||+|||+. +|+||||||+|||++. +..+|++|||+|+.....
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9954 55333 45789999999999999999999996 8999999999999863 557999999999976543
Q ss_pred cCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc--cHHHHHHhhC--C-Cc
Q 041479 677 MSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL--DLHNFVKMAL--P-DQ 733 (771)
Q Consensus 677 ~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~--~~~~~~~~~~--~-~~ 733 (771)
.... .......+||+.||||| |||++|||+||+.||.+...... ....+..... + +.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 3221 12234567999999999 79999999999999976433221 1222222222 2 22
Q ss_pred hhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 734 ILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 734 ~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
..+.+++.+...+.+||+.+|++||++.++.+.|+++
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 3345566666777799999999999999999888864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=317.55 Aligned_cols=229 Identities=24% Similarity=0.273 Sum_probs=171.5
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeecc--chhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLH--QRGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
....+|+|++|+||+|+++.+++.||||+++.. .....+.+.+|+++|++++|||||+++++|...+. ......|+|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 345689999999999999999999999999643 33456789999999999999999999999876542 122356999
Q ss_pred EEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCC
Q 041479 602 YEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSS 679 (771)
Q Consensus 602 ~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 679 (771)
|||| ++++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+|+......
T Consensus 102 ~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-- 175 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-- 175 (346)
T ss_dssp EECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC--
T ss_pred Eecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCcc--
Confidence 9999 5566554 44699999999999999999999986 99999999999999999999999999998654322
Q ss_pred cccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHh---------------
Q 041479 680 NQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKM--------------- 728 (771)
Q Consensus 680 ~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~--------------- 728 (771)
...+||+.||||| +||++|||++|+.||.+..... .+......
T Consensus 176 -----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 176 -----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp -----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTCSCH
T ss_pred -----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHHhhhcch
Confidence 2356999999999 6999999999999996531111 11111111
Q ss_pred -------hCCC-------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 729 -------ALPD-------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 729 -------~~~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
..+. .....+++.+.....+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1110 011223344444556999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-35 Score=304.16 Aligned_cols=234 Identities=14% Similarity=0.168 Sum_probs=181.8
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCC-CCceeEEEEeecCCCCCceeEEEEEEe
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRH-RNLVKIITACSTSDFQGNYFRALVYEF 604 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~~~~~~lv~e~ 604 (771)
...+|+|++|+||+|++..+++.||||++..... .+.+.+|+++++.++| +||+.+++++.+.. ..++||||
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~~vme~ 82 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HNVLVIDL 82 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EEEEEEEC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-----ccEEEEEe
Confidence 3468999999999999999999999999865432 2457789999999975 89999999988776 78999999
Q ss_pred ccCCCCCCC----cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----CCceEEecccCccccCc
Q 041479 605 MHHGSLESC----PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDN-----DMTAHMGDFGLTRFIPE 675 (771)
Q Consensus 605 ~~~g~L~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~-----~~~~kl~DfGla~~~~~ 675 (771)
+ +|+|.++ ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 6787655 45689999999999999999999986 9999999999999974 57899999999987654
Q ss_pred ccCCc---ccccccccccccccchh---------------HHHHHHHHHhCCCCCCccccCCc-c-HHHHHHhh--CC-C
Q 041479 676 VMSSN---QCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSDMFTEGL-D-LHNFVKMA--LP-D 732 (771)
Q Consensus 676 ~~~~~---~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~~~~~~~-~-~~~~~~~~--~~-~ 732 (771)
..... .......+||+.||||| +||++|||+||+.||.+...... . ...+.... .+ .
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 32211 12234567999999999 79999999999999975432221 1 11111111 11 2
Q ss_pred chhhhcCccccccCcccChhchhhcCCHHHHHHHHHHh
Q 041479 733 QILQVLDPLFLVGGVQEGEETAEENIKKGQIRESLIAI 770 (771)
Q Consensus 733 ~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~~L~~~ 770 (771)
.....+.+.+......|+..+|++||+...+.+.|+++
T Consensus 239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 23334555666666799999999999999999888875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-35 Score=304.23 Aligned_cols=228 Identities=18% Similarity=0.197 Sum_probs=177.4
Q ss_pred cccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEEEEE
Q 041479 526 NVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRALVYE 603 (771)
Q Consensus 526 ~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~lv~e 603 (771)
.-.+|+|.+|+||+|+++.+++.||||+++... ....+++.+|+.+++.++|||||++++++.+.+ ..++|||
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~iv~~ 81 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KLTLVFE 81 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ceeEEee
Confidence 346899999999999999999999999996543 345688999999999999999999999998877 7899999
Q ss_pred eccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCc
Q 041479 604 FMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSN 680 (771)
Q Consensus 604 ~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 680 (771)
|+.++++..+ .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 9999887654 55788999999999999999999986 999999999999999999999999999987654332
Q ss_pred ccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC------------
Q 041479 681 QCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD------------ 732 (771)
Q Consensus 681 ~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------------ 732 (771)
......+++.|+||| +||++|||++|+.||.+.......+........+.
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 122345788899999 69999999999999754221111122221111110
Q ss_pred ---------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 ---------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 ---------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.......+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111222223345999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=310.22 Aligned_cols=233 Identities=21% Similarity=0.200 Sum_probs=185.7
Q ss_pred ccccccccccccccceEEEEEe---cCCCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCC-CCceeEEEEeecCCC
Q 041479 521 KDLLLNVSYESLVKATVYKGIL---DLDQTFIAVKVLFLHQ----RGALKSFMAECQALRNIRH-RNLVKIITACSTSDF 592 (771)
Q Consensus 521 ~~~~~~~~l~~~~~~~Vy~~~~---~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 592 (771)
.++.....+|+|.+|+||+|+. +.+++.||||++.... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 3444556799999999999987 4467899999985432 2345678899999999976 89999999988876
Q ss_pred CCceeEEEEEEeccCCCCCCC---cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccC
Q 041479 593 QGNYFRALVYEFMHHGSLESC---PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGL 669 (771)
Q Consensus 593 ~~~~~~~lv~e~~~~g~L~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGl 669 (771)
..++|||||.+|+|.++ .+.++......++.|++.|++|+|+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ----~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 ----KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ----ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 78999999999999766 44677888999999999999999986 899999999999999999999999999
Q ss_pred ccccCcccCCcccccccccccccccchh-----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhh--C
Q 041479 670 TRFIPEVMSSNQCSSVGLKGTVGYATPE-----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMA--L 730 (771)
Q Consensus 670 a~~~~~~~~~~~~~~~~~~gt~~y~aPE-----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~--~ 730 (771)
|+.+..... .......|++.|+||| +||++|||++|+.||.+...... ..+..... .
T Consensus 176 a~~~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~ 251 (322)
T d1vzoa_ 176 SKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS 251 (322)
T ss_dssp EEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC
T ss_pred hhhhccccc---ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccC
Confidence 987654332 2233457999999999 69999999999999976543332 33333322 2
Q ss_pred CCchhhhcCccccccCcccChhchhhcC-----CHHHHHH
Q 041479 731 PDQILQVLDPLFLVGGVQEGEETAEENI-----KKGQIRE 765 (771)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~cl~~~p~~Rp-----t~~~vl~ 765 (771)
+...+..+++.+.....+||++||++|| |++|+++
T Consensus 252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2344455677777777899999999999 4788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-35 Score=311.33 Aligned_cols=182 Identities=21% Similarity=0.207 Sum_probs=146.3
Q ss_pred ccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCC-CCceeEEEE
Q 041479 525 LNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDF-QGNYFRALV 601 (771)
Q Consensus 525 ~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~~~~~~lv 601 (771)
..-.+|+|.+|+||+|+++.+++.||||++.... ....+++.+|+.++++++|||||++++++...+. +.....|+|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 3457999999999999999999999999996542 3455689999999999999999999999865432 233478999
Q ss_pred EEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcc
Q 041479 602 YEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQ 681 (771)
Q Consensus 602 ~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 681 (771)
||||.++.+......+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++......
T Consensus 101 ~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---- 173 (355)
T d2b1pa1 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---- 173 (355)
T ss_dssp EECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred EeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc----
Confidence 99998877776677899999999999999999999996 99999999999999999999999999988654422
Q ss_pred cccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 682 CSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 682 ~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.....+||+.|+||| +||++|||++|+.||.+
T Consensus 174 -~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 174 -MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 223456899999999 69999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=309.61 Aligned_cols=232 Identities=19% Similarity=0.197 Sum_probs=174.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCCCCceeEEEEeecCCCCCceeEEE
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQ--RGALKSFMAECQALRNIRHRNLVKIITACSTSDFQGNYFRAL 600 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~~~~~~l 600 (771)
+.....+|+|++|+||+|++..+++.||||++.... ....+++.+|++++++++|||||++++++...........++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 334456999999999999999999999999996543 344568899999999999999999999986543222223456
Q ss_pred EEEeccCCCCCCC--cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEecccCccccCcccC
Q 041479 601 VYEFMHHGSLESC--PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMS 678 (771)
Q Consensus 601 v~e~~~~g~L~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 678 (771)
+|||+.+|+|.++ .+.+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+|......
T Consensus 100 i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-- 174 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174 (348)
T ss_dssp EEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred EEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc--
Confidence 7788889999776 45799999999999999999999986 9999999999999999999999999999754332
Q ss_pred Ccccccccccccccccchh----------------HHHHHHHHHhCCCCCCccccCCccHHHHHHhhCCC----------
Q 041479 679 SNQCSSVGLKGTVGYATPE----------------YGILLLEIFTGKRPTSDMFTEGLDLHNFVKMALPD---------- 732 (771)
Q Consensus 679 ~~~~~~~~~~gt~~y~aPE----------------~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---------- 732 (771)
..+..||+.|+||| +||++|||++|+.||.+.... .....+.......
T Consensus 175 -----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 175 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp -----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTTCCC
T ss_pred -----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhhccc
Confidence 23456999999999 699999999999999642111 0011111111100
Q ss_pred -------------------chhhhcCccccccCcccChhchhhcCCHHHHHH
Q 041479 733 -------------------QILQVLDPLFLVGGVQEGEETAEENIKKGQIRE 765 (771)
Q Consensus 733 -------------------~~~~~~~~~~~~~~~~cl~~~p~~Rpt~~~vl~ 765 (771)
.....+++.......+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 001123444444566999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=2.6e-31 Score=280.00 Aligned_cols=258 Identities=30% Similarity=0.531 Sum_probs=167.1
Q ss_pred CCCEEecccCcCcc--cCChhhhhCCCCCcEEEeec-CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCC
Q 041479 172 SMEYFHVSENQLVG--ELPPHIGFTLPNVRILLLAG-NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTY 248 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g--~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~ 248 (771)
+++.|+|++|.++| .+|+.++ ++++|++|+|++ |+++|.+|.+|+++++|++|+|++|++++..|..+ ..+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~-~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~---~~~~~ 126 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL---SQIKT 126 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGG---GGCTT
T ss_pred EEEEEECCCCCCCCCCCCChHHh-cCccccccccccccccccccccccccccccchhhhccccccccccccc---cchhh
Confidence 56777777777776 4667666 777777777765 67777777777777777777777777776666544 55566
Q ss_pred CcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCc-ceEecCCccceeccCccccCCCCCCEEEc
Q 041479 249 LEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNL-IIIAIEKFILIRNIPISVGYLLKLQVLSL 327 (771)
Q Consensus 249 L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 327 (771)
|+.+++++|.+.+.+|..+..+. +|+.+++++|.+++.+|..+..+..+ +.++++.|++
T Consensus 127 L~~l~l~~N~~~~~~p~~l~~l~-~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l------------------- 186 (313)
T d1ogqa_ 127 LVTLDFSYNALSGTLPPSISSLP-NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL------------------- 186 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE-------------------
T ss_pred hcccccccccccccCchhhccCc-ccceeeccccccccccccccccccccccccccccccc-------------------
Confidence 67777777776666666666664 56666666666666666665555443 4444444444
Q ss_pred cCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccccc
Q 041479 328 FENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGE 406 (771)
Q Consensus 328 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 406 (771)
++..|..+..+..+ .+++++|.+.+.+|..+..+..+ .+++++|.+++.+| .++.+++|+.|+|++|+|+|.
T Consensus 187 -----~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~ 259 (313)
T d1ogqa_ 187 -----TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp -----EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEEC
T ss_pred -----cccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeeccc
Confidence 44444444443322 34555555555555555554444 45555555554433 456667777777777777777
Q ss_pred CCcchhhhhcccccccEEECcCCCCCCCCCccccccccccccccCCCcccCCCCCCCCCCCC
Q 041479 407 IPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCGGISELKLPPCT 468 (771)
Q Consensus 407 ~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~~~ 468 (771)
+|..+. .+++|++|||++|+|+|.+|......++..+.+.||+.+||.+ +|+|+
T Consensus 260 iP~~l~----~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p----lp~c~ 313 (313)
T d1ogqa_ 260 LPQGLT----QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP----LPACT 313 (313)
T ss_dssp CCGGGG----GCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT----SSCCC
T ss_pred CChHHh----CCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC----CCCCC
Confidence 777655 6777777777777777777765556677777888888889864 46774
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=2.8e-28 Score=263.91 Aligned_cols=334 Identities=24% Similarity=0.292 Sum_probs=234.9
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|++++++|+.. +.+..+++|++|+|++|+|++ +| .|+++++|++|++++|++++ ++
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~---------------i~ 104 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIAD---------------IT 104 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC---------------CG
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccc---------------cc
Confidence 5799999999999854 468899999999999999997 44 39999999999999999762 22
Q ss_pred ccccCCCCCCEEecccccCcCCC-----CccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC
Q 041479 124 SELGSLLKFKGLGLANNYFTGPI-----PHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV 198 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~l-----p~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L 198 (771)
.++++++|+.|++++|.+++.. ..+.......|.+....+..................+. .+. ..+..
T Consensus 105 -~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~~ 177 (384)
T d2omza2 105 -PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLA-NLTTL 177 (384)
T ss_dssp -GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG-----GGT-TCTTC
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-----hhc-ccccc
Confidence 3788999999999999988532 23445555555554333322222222222222221111 111 34455
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceee
Q 041479 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278 (771)
Q Consensus 199 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~ 278 (771)
.......|... ....+..+++++.+++++|.+++..|. ..+++|+.|++++|+++ .+| .+..+. +|+.|+
T Consensus 178 ~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~~-----~~~~~L~~L~l~~n~l~-~~~-~l~~l~-~L~~L~ 247 (384)
T d2omza2 178 ERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITPL-----GILTNLDELSLNGNQLK-DIG-TLASLT-NLTDLD 247 (384)
T ss_dssp CEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGGG-----GGCTTCCEEECCSSCCC-CCG-GGGGCT-TCSEEE
T ss_pred ccccccccccc--cccccccccccceeeccCCccCCCCcc-----cccCCCCEEECCCCCCC-Ccc-hhhccc-ccchhc
Confidence 55555555554 345567778888888888888766442 44577888888888877 343 455554 688888
Q ss_pred cccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCcccee
Q 041479 279 MSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRG 358 (771)
Q Consensus 279 Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 358 (771)
+++|.+++..+ +..+++|+.|++++|.+.+.. .+..++.++.+++++|++++ ...+..+++++.|++++|++++
T Consensus 248 l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~ 321 (384)
T d2omza2 248 LANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD 321 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC
T ss_pred cccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCC
Confidence 88888875433 777788888888887775533 36677788888888888864 3357778888888888888886
Q ss_pred cCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCC
Q 041479 359 SVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYN 429 (771)
Q Consensus 359 ~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N 429 (771)
.. .+..++.| .|++++|+|++ ++ .++.+++|++|++++|+|++.+| + ..+++|+.|+|++|
T Consensus 322 l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l----~~l~~L~~L~L~~N 383 (384)
T d2omza2 322 IS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--L----ANLTRITQLGLNDQ 383 (384)
T ss_dssp CG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--G----TTCTTCSEEECCCE
T ss_pred Cc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--h----ccCCCCCEeeCCCC
Confidence 43 26777777 78888888875 33 57888889999999999886544 3 37888899998887
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=2.9e-29 Score=269.93 Aligned_cols=179 Identities=20% Similarity=0.232 Sum_probs=141.2
Q ss_pred ccccccccccccceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-----------CCCceeEEEEeecCC
Q 041479 523 LLLNVSYESLVKATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-----------HRNLVKIITACSTSD 591 (771)
Q Consensus 523 ~~~~~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~~ 591 (771)
+.....+|+|++|+||+|+++.+++.||||+++... ...+.+.+|+++++.++ |+|||++++++....
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 334567999999999999999999999999996543 34567888999988875 578999999886543
Q ss_pred CCCceeEEEEEEeccCCCCCCC------cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-----
Q 041479 592 FQGNYFRALVYEFMHHGSLESC------PRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDM----- 660 (771)
Q Consensus 592 ~~~~~~~~lv~e~~~~g~L~~~------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~----- 660 (771)
.. ..+++|+++..+..... ...+++..+..++.|++.|++|||+. .+|+||||||+|||++.++
T Consensus 94 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 94 PN---GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp TT---EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cc---ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 22 55777777765543211 45678889999999999999999984 3899999999999997654
Q ss_pred -ceEEecccCccccCcccCCcccccccccccccccchh---------------HHHHHHHHHhCCCCCCc
Q 041479 661 -TAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPE---------------YGILLLEIFTGKRPTSD 714 (771)
Q Consensus 661 -~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE---------------~Gv~l~el~tg~~P~~~ 714 (771)
.+|++|||.|....... ...+||+.|+||| +||+++||++|+.||..
T Consensus 169 ~~~kl~dfg~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ceeeEeeccccccccccc-------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 49999999997543322 2356999999999 69999999999999964
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=8.1e-27 Score=244.35 Aligned_cols=268 Identities=21% Similarity=0.275 Sum_probs=194.7
Q ss_pred ccceeeeecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcc
Q 041479 32 CQWLGVTCSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDS 111 (771)
Q Consensus 32 c~w~~v~c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 111 (771)
|.|.+|.|+. ++++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+.
T Consensus 10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~------ 68 (305)
T d1xkua_ 10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS------ 68 (305)
T ss_dssp EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC------
T ss_pred ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc------
Confidence 6788888864 5566 4565553 68999999999999766668999999999999999965
Q ss_pred cccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhh
Q 041479 112 RLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHI 191 (771)
Q Consensus 112 ~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~ 191 (771)
...|..|.++++|+.|++++|+|+ .+|..+ ...+..|++++|.+. .++...
T Consensus 69 --------~i~~~~f~~l~~L~~L~l~~n~l~------------------~l~~~~--~~~l~~L~~~~n~l~-~l~~~~ 119 (305)
T d1xkua_ 69 --------KISPGAFAPLVKLERLYLSKNQLK------------------ELPEKM--PKTLQELRVHENEIT-KVRKSV 119 (305)
T ss_dssp --------CBCTTTTTTCTTCCEEECCSSCCS------------------BCCSSC--CTTCCEEECCSSCCC-BBCHHH
T ss_pred --------ccchhhhhCCCccCEecccCCccC------------------cCccch--hhhhhhhhccccchh-hhhhhh
Confidence 345677889999999999999887 334322 357788888888888 677766
Q ss_pred hhCCCCCcEEEeecCccc--ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhh
Q 041479 192 GFTLPNVRILLLAGNQFF--GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN 269 (771)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 269 (771)
+.....++.++...|... ...+..|..+++|+.+++++|.++.+ |.. .+++|+.|++++|.+++..+..+..
T Consensus 120 ~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l-~~~-----~~~~L~~L~l~~n~~~~~~~~~~~~ 193 (305)
T d1xkua_ 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQG-----LPPSLTELHLDGNKITKVDAASLKG 193 (305)
T ss_dssp HTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSS-----CCTTCSEEECTTSCCCEECTGGGTT
T ss_pred hhccccccccccccccccccCCCccccccccccCccccccCCcccc-Ccc-----cCCccCEEECCCCcCCCCChhHhhc
Confidence 656777888888877543 34456778888888888888888754 322 2467788888888887777776666
Q ss_pred cccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccc------cc
Q 041479 270 FSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLG------NF 343 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------~l 343 (771)
+. .++.|++++|.+++..+..|.++++|+.|+|++|++. .+|.++..+++|++|+|++|+|+......|. .+
T Consensus 194 ~~-~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~ 271 (305)
T d1xkua_ 194 LN-NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271 (305)
T ss_dssp CT-TCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTS
T ss_pred cc-cccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhccc
Confidence 64 6788888888888777777777777777777777664 4566777777777777777777644333332 34
Q ss_pred cccccccccCccce
Q 041479 344 TFLTELNLCGNSIR 357 (771)
Q Consensus 344 ~~L~~L~Ls~N~l~ 357 (771)
.+|+.|+|++|+++
T Consensus 272 ~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 272 ASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCCSEEECCSSSSC
T ss_pred CCCCEEECCCCcCc
Confidence 55666666666654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=3.4e-26 Score=247.44 Aligned_cols=337 Identities=25% Similarity=0.324 Sum_probs=251.0
Q ss_pred EEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccC
Q 041479 49 LNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGS 128 (771)
Q Consensus 49 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~ 128 (771)
..++.+++++.+. ...+.+|++|++++|.|+. + +.++.+++|++|+|++|+|+ .+| .+++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~---------------~l~-~l~~ 86 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT---------------DIT-PLKN 86 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC---------------CCG-GGTT
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCC---------------CCc-cccC
Confidence 3566677776544 3577889999999999986 4 46899999999999999987 233 3889
Q ss_pred CCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcc
Q 041479 129 LLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQF 208 (771)
Q Consensus 129 l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l 208 (771)
+++|++|++++|++++ ++ .+.++++|+.|++++|.++ .++... ....+..+....|.+
T Consensus 87 L~~L~~L~L~~n~i~~------------------i~-~l~~l~~L~~L~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l 144 (384)
T d2omza2 87 LTKLVDILMNNNQIAD------------------IT-PLANLTNLTGLTLFNNQIT-DIDPLK--NLTNLNRLELSSNTI 144 (384)
T ss_dssp CTTCCEEECCSSCCCC------------------CG-GGTTCTTCCEEECCSSCCC-CCGGGT--TCTTCSEEEEEEEEE
T ss_pred Cccccccccccccccc------------------cc-ccccccccccccccccccc-cccccc--ccccccccccccccc
Confidence 9999999999999873 11 2566777777777777776 343322 345666666666665
Q ss_pred cccCC-------------------ccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhh
Q 041479 209 FGNIP-------------------HSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLAN 269 (771)
Q Consensus 209 ~~~~p-------------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 269 (771)
....+ ..+...+.........|..... .....+++++.+++++|.+++..| +..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~~~~l~l~~n~i~~~~~--~~~ 217 (384)
T d2omza2 145 SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-----SVLAKLTNLESLIATNNQISDITP--LGI 217 (384)
T ss_dssp CCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-----GGGGGCTTCSEEECCSSCCCCCGG--GGG
T ss_pred cccccccccccccccccccccchhhhhccccccccccccccccccc-----cccccccccceeeccCCccCCCCc--ccc
Confidence 43222 2233444444555555544321 223678899999999999995544 233
Q ss_pred cccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccc
Q 041479 270 FSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTEL 349 (771)
Q Consensus 270 l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 349 (771)
. ++|+.|++++|+++. + +.+..+++|+.+++++|.+.+.. .+..+++|+.|++++|++++.. .+..++.++.+
T Consensus 218 ~-~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l 290 (384)
T d2omza2 218 L-TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNL 290 (384)
T ss_dssp C-TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEE
T ss_pred c-CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccc
Confidence 3 479999999999984 3 46889999999999999987654 3788999999999999998543 47889999999
Q ss_pred cccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcC
Q 041479 350 NLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSY 428 (771)
Q Consensus 350 ~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~ 428 (771)
++++|.+++. ..+..+..+ .|++++|++++..+ +..+++|++|++++|+|++ +| .+ ..+++|+.|++++
T Consensus 291 ~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l----~~l~~L~~L~l~~ 360 (384)
T d2omza2 291 ELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SL----ANLTNINWLSAGH 360 (384)
T ss_dssp ECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GG----GGCTTCCEEECCS
T ss_pred cccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hH----cCCCCCCEEECCC
Confidence 9999999853 346777788 89999999997643 7889999999999999984 44 34 4899999999999
Q ss_pred CCCCCCCCccccccccccccccCC
Q 041479 429 NNLDGDVPRKMIFKNASAISEAGN 452 (771)
Q Consensus 429 N~l~~~~p~~~~~~~~~~~~~~~n 452 (771)
|+|++..| -..+..+..+.+.+|
T Consensus 361 N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 361 NQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CcCCCChh-hccCCCCCEeeCCCC
Confidence 99996544 223445555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=3.6e-26 Score=239.33 Aligned_cols=274 Identities=18% Similarity=0.237 Sum_probs=213.3
Q ss_pred CCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC-ccccCCCCCCEEecccccCcCCCC
Q 041479 69 FLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP-SELGSLLKFKGLGLANNYFTGPIP 147 (771)
Q Consensus 69 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~lp 147 (771)
.++++|=++++++. +|..+. +++++|+|++|+|+ .+| ..|.++++|++|++++|.++.
T Consensus 11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~---------------~l~~~~f~~l~~L~~L~l~~n~~~~--- 69 (305)
T d1xkua_ 11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKIT---------------EIKDGDFKNLKNLHTLILINNKISK--- 69 (305)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCC---------------CBCTTTTTTCTTCCEEECCSSCCCC---
T ss_pred cCCEEEecCCCCCc-cCCCCC--CCCCEEECcCCcCC---------------CcChhHhhccccccccccccccccc---
Confidence 46778888889985 777764 68999999999976 444 478999999999999998873
Q ss_pred ccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEc
Q 041479 148 HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227 (771)
Q Consensus 148 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 227 (771)
..|..|.++++|++|++++|+++ .+|...+ +.++.|++++|.+.+..+..+.....+..++.
T Consensus 70 --------------i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~ 131 (305)
T d1xkua_ 70 --------------ISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131 (305)
T ss_dssp --------------BCTTTTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred --------------cchhhhhCCCccCEecccCCccC-cCccchh---hhhhhhhccccchhhhhhhhhhcccccccccc
Confidence 44677899999999999999999 7887544 68899999999999887778888899999999
Q ss_pred cccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcc
Q 041479 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFI 307 (771)
Q Consensus 228 s~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 307 (771)
..|...... .....+..+++|+.+++++|.++ .+|..+ .++|+.|++++|.+++..+..|.+++.++.|++++|.
T Consensus 132 ~~n~~~~~~-~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~ 206 (305)
T d1xkua_ 132 GTNPLKSSG-IENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206 (305)
T ss_dssp CSSCCCGGG-BCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSC
T ss_pred ccccccccC-CCccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccc
Confidence 988655322 12234477888999999999988 666654 2478999999999888888888888888888888888
Q ss_pred ceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCC
Q 041479 308 LIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAV 387 (771)
Q Consensus 308 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~ 387 (771)
+.+..+..+..+++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+....|.. +..+
T Consensus 207 l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~-----------------~~~~ 268 (305)
T d1xkua_ 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP-----------------PGYN 268 (305)
T ss_dssp CCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC-----------------SSCC
T ss_pred ccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccC-----------------cchh
Confidence 87777777788888888888888887 45777778888888888888877443333321 2334
Q ss_pred CCCCCCCeEECCCCccc
Q 041479 388 GNPKSIPHLDLSKNELS 404 (771)
Q Consensus 388 ~~l~~L~~L~Ls~N~l~ 404 (771)
..+.+|+.|+|++|+++
T Consensus 269 ~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 269 TKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTSCCCSEEECCSSSSC
T ss_pred cccCCCCEEECCCCcCc
Confidence 45667788888888775
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.4e-26 Score=233.90 Aligned_cols=223 Identities=18% Similarity=0.195 Sum_probs=163.1
Q ss_pred EEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcccc
Q 041479 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG 127 (771)
Q Consensus 48 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~ 127 (771)
.++.++++++ .+|..+. +++++|+|++|+|+++.+.+|.++++|++|++++|++. ...+..+.
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~--------------~i~~~~~~ 77 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA--------------RIDAAAFT 77 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC--------------EECTTTTT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc--------------cccccccc
Confidence 3456677787 5555443 67899999999999877778999999999999999965 34555666
Q ss_pred CCCCCCEEecc-cccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecC
Q 041479 128 SLLKFKGLGLA-NNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGN 206 (771)
Q Consensus 128 ~l~~L~~L~Ls-~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N 206 (771)
.+..++.++.. .|.++ ...|..|.++++|++|++++|.+. .++...+...++|+.+++++|
T Consensus 78 ~~~~~~~l~~~~~~~~~-----------------~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N 139 (284)
T d1ozna_ 78 GLALLEQLDLSDNAQLR-----------------SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139 (284)
T ss_dssp TCTTCCEEECCSCTTCC-----------------CCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred ccccccccccccccccc-----------------cccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccc
Confidence 77777777654 33333 244666788888888888888887 555555556777888888888
Q ss_pred cccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcc
Q 041479 207 QFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286 (771)
Q Consensus 207 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~ 286 (771)
+|+++.+..|..+++|+.|++++|+|+++.+.+| .++++|+.+++++|++++..|..|..+. +|++|++++|++.+
T Consensus 140 ~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f---~~l~~L~~l~l~~N~l~~i~~~~f~~l~-~L~~L~l~~N~i~~ 215 (284)
T d1ozna_ 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF---RGLHSLDRLLLHQNRVAHVHPHAFRDLG-RLMTLYLFANNLSA 215 (284)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT---TTCTTCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCSC
T ss_pred cccccChhHhccccchhhcccccCcccccchhhh---ccccccchhhhhhccccccChhHhhhhh-hccccccccccccc
Confidence 8887777778788888888888888877766655 6677777778887777766677766664 67777777777776
Q ss_pred cCcccccccCCcceEecCCccce
Q 041479 287 SIPTEIGNLKNLIIIAIEKFILI 309 (771)
Q Consensus 287 ~~p~~~~~l~~L~~L~l~~n~l~ 309 (771)
..|..|.++++|+.|++++|.+.
T Consensus 216 ~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 216 LPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccccccccccCEEEecCCCCC
Confidence 66666666666666666666554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.4e-26 Score=234.31 Aligned_cols=223 Identities=20% Similarity=0.164 Sum_probs=141.8
Q ss_pred EEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEc
Q 041479 175 YFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSL 254 (771)
Q Consensus 175 ~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~L 254 (771)
..+.++++++ ++|..+. +++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+ .+++.++.++.
T Consensus 15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~---~~~~~~~~l~~ 87 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF---TGLALLEQLDL 87 (284)
T ss_dssp EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT---TTCTTCCEEEC
T ss_pred EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccc---ccccccccccc
Confidence 4466777777 7776554 467888888888887777778888888888888888877666555 55566666655
Q ss_pred c-CccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCccc
Q 041479 255 S-VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNIS 333 (771)
Q Consensus 255 s-~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 333 (771)
. .|.++...|..+.++. +|++|++++|.+....+..+..+.+|+.+++++|.+.+..+..|..+++|+.|++++|+++
T Consensus 88 ~~~~~~~~l~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 88 SDNAQLRSVDPATFHGLG-RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (284)
T ss_dssp CSCTTCCCCCTTTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ccccccccccchhhcccc-cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccc
Confidence 4 4455533344555554 5777777777766555555666666666666666665555555566666666666666666
Q ss_pred ccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccc
Q 041479 334 REIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSG 405 (771)
Q Consensus 334 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 405 (771)
+..+.+|.++++|+.+++++|++++..|..|..++.+ .||+++|++.+..|..|+.+++|++|+|++|++..
T Consensus 167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 5555666666666666666666665555555555555 55555555555555555555556666666665553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.5e-24 Score=220.34 Aligned_cols=203 Identities=25% Similarity=0.292 Sum_probs=166.9
Q ss_pred ecCCCCcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcc
Q 041479 39 CSLKYQRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKL 118 (771)
Q Consensus 39 c~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l 118 (771)
|... .....+|.++++|+. +|+.+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+
T Consensus 6 ~~~~-~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~------------- 68 (266)
T d1p9ag_ 6 VSKV-ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT------------- 68 (266)
T ss_dssp EECS-TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-------------
T ss_pred Eccc-CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-------------
Confidence 4433 344556899999994 566654 68999999999999877788999999999999999976
Q ss_pred cccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCC
Q 041479 119 EGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNV 198 (771)
Q Consensus 119 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L 198 (771)
.+| .++.+++|+.|+|++|+++ ..+..+.++++|++|++++|.+. .++...+..++++
T Consensus 69 --~l~-~~~~l~~L~~L~Ls~N~l~------------------~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l 126 (266)
T d1p9ag_ 69 --KLQ-VDGTLPVLGTLDLSHNQLQ------------------SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGEL 126 (266)
T ss_dssp --EEE-CCSCCTTCCEEECCSSCCS------------------SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTC
T ss_pred --ccc-ccccccccccccccccccc------------------ccccccccccccccccccccccc-eeecccccccccc
Confidence 233 3567889999999999887 35666788899999999999988 6666666688899
Q ss_pred cEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceee
Q 041479 199 RILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLY 278 (771)
Q Consensus 199 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~ 278 (771)
+.|++++|.++...+..+..+++|+.|++++|+|+++.++.| ..+++|++|+|++|+|+ .+|+.++.+. +|+.|+
T Consensus 127 ~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~L~-~lp~~~~~~~-~L~~L~ 201 (266)
T d1p9ag_ 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLL---NGLENLDTLLLQENSLY-TIPKGFFGSH-LLPFAF 201 (266)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTT---TTCTTCCEEECCSSCCC-CCCTTTTTTC-CCSEEE
T ss_pred ccccccccccceeccccccccccchhcccccccccccCcccc---ccccccceeecccCCCc-ccChhHCCCC-CCCEEE
Confidence 999999999998888888889999999999999998877666 67788889999999988 7888888765 688888
Q ss_pred cccCcCc
Q 041479 279 MSANPIS 285 (771)
Q Consensus 279 Ls~N~l~ 285 (771)
|++|.+.
T Consensus 202 L~~Np~~ 208 (266)
T d1p9ag_ 202 LHGNPWL 208 (266)
T ss_dssp CCSCCBC
T ss_pred ecCCCCC
Confidence 8888775
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.2e-23 Score=215.10 Aligned_cols=201 Identities=22% Similarity=0.213 Sum_probs=135.5
Q ss_pred cCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCC
Q 041479 168 LNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCT 247 (771)
Q Consensus 168 ~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~ 247 (771)
.+.+++.+.+.++++|+ .+|+.+. +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.+ + ..++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~---~~l~ 77 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--D---GTLP 77 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--C---SCCT
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--c---cccc
Confidence 35566777889999998 7887654 578899999999988777888889999999999998875422 2 5677
Q ss_pred CCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEc
Q 041479 248 YLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSL 327 (771)
Q Consensus 248 ~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L 327 (771)
+|++|+|++|+++ ..+..+..+. +|++|++++|.+.+..+..+..+.++..|++++|
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~-~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n--------------------- 134 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLP-ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN--------------------- 134 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCT-TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS---------------------
T ss_pred ccccccccccccc-cccccccccc-ccccccccccccceeecccccccccccccccccc---------------------
Confidence 7888888888877 4555566654 6777777777777555555555555555555544
Q ss_pred cCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCccc
Q 041479 328 FENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELS 404 (771)
Q Consensus 328 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 404 (771)
.++...+..+..+++|+.|++++|+|++..+..|..++.| .|||++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 135 ---~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 135 ---ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ---CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ---ccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 4444444444445555555555555554444445555555 5555555555 45555666788889999999876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1.1e-19 Score=192.97 Aligned_cols=303 Identities=25% Similarity=0.300 Sum_probs=198.0
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
.+++.|||++|+|+. +|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~---------------~l~ 94 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK---------------ALS 94 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS---------------CCC
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc---------------hhh
Confidence 367899999999984 5643 578999999999999 478654 57899999999976 222
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
.. .+.|++|++++|+++ .+|. +..+++|+.|++++|.++ ..|. ....+..+.+
T Consensus 95 ~l---p~~L~~L~L~~n~l~------------------~lp~-~~~l~~L~~L~l~~~~~~-~~~~----~~~~l~~l~~ 147 (353)
T d1jl5a_ 95 DL---PPLLEYLGVSNNQLE------------------KLPE-LQNSSFLKIIDVDNNSLK-KLPD----LPPSLEFIAA 147 (353)
T ss_dssp SC---CTTCCEEECCSSCCS------------------SCCC-CTTCTTCCEEECCSSCCS-CCCC----CCTTCCEEEC
T ss_pred hh---ccccccccccccccc------------------cccc-hhhhccceeecccccccc-cccc----ccccccchhh
Confidence 11 135888999988887 3443 567889999999999887 4553 3456777887
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCc
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANP 283 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~ 283 (771)
..+... .+..+..++.++.|++++|.+..... . ....+.+..+.+.+. .+|. +..+. .|+.+++++|.
T Consensus 148 ~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~-~------~~~~~~l~~~~~~~~-~~~~-~~~l~-~L~~l~l~~n~ 215 (353)
T d1jl5a_ 148 GNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD-L------PLSLESIVAGNNILE-ELPE-LQNLP-FLTTIYADNNL 215 (353)
T ss_dssp CSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC-C------CTTCCEEECCSSCCS-SCCC-CTTCT-TCCEEECCSSC
T ss_pred cccccc--ccccccccccceeccccccccccccc-c------ccccccccccccccc-cccc-ccccc-ccccccccccc
Confidence 777665 34567788889999999988775422 1 123455666666665 4443 34443 68888888887
Q ss_pred CcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcc
Q 041479 284 ISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 284 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
.. ..|. ...++..+.+.++.+... + .....+...++..|.+.+.. .. .......++..|.+.+. +.
T Consensus 216 ~~-~~~~---~~~~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~~~~-~~- 281 (353)
T d1jl5a_ 216 LK-TLPD---LPPSLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRSL-CD- 281 (353)
T ss_dssp CS-SCCS---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSEE-CC-
T ss_pred cc-cccc---cccccccccccccccccc-c---cccccccccccccccccccc-cc---cchhcccccccCccccc-cc-
Confidence 76 3333 234566666766665432 1 22345666676666655321 10 12344556666666532 22
Q ss_pred cccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCc
Q 041479 364 LGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPR 437 (771)
Q Consensus 364 ~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~ 437 (771)
.++.| +|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.
T Consensus 282 --~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~-------~~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 282 --LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE-------LPQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp --CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC-------CCTTCCEEECCSSCCS-SCCC
T ss_pred --cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc-------ccCCCCEEECcCCcCC-CCCc
Confidence 23445 6777888777 34533 567778888888887 5664 2356778888888876 4553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=1.1e-18 Score=185.15 Aligned_cols=298 Identities=26% Similarity=0.361 Sum_probs=216.3
Q ss_pred CCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCC
Q 041479 68 TFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIP 147 (771)
Q Consensus 68 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp 147 (771)
.+|++|||++|.+++ +|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|+++.
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~---------------~lp~~---~~~L~~L~l~~n~l~~--- 92 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT---------------ELPEL---PQSLKSLLVDNNNLKA--- 92 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS---------------SCCCC---CTTCCEEECCSSCCSC---
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc---------------ccccc---hhhhhhhhhhhcccch---
Confidence 468899999999985 7854 578999999999987 45654 3578999999998872
Q ss_pred ccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEc
Q 041479 148 HLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDF 227 (771)
Q Consensus 148 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 227 (771)
++. + .+.|++|++++|.++ .+|. .. .+++|+.|++++|.+... +. ....+..+.+
T Consensus 93 ---------------l~~-l--p~~L~~L~L~~n~l~-~lp~-~~-~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~ 147 (353)
T d1jl5a_ 93 ---------------LSD-L--PPLLEYLGVSNNQLE-KLPE-LQ-NSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAA 147 (353)
T ss_dssp ---------------CCS-C--CTTCCEEECCSSCCS-SCCC-CT-TCTTCCEEECCSSCCSCC-CC---CCTTCCEEEC
T ss_pred ---------------hhh-h--ccccccccccccccc-cccc-hh-hhccceeecccccccccc-cc---ccccccchhh
Confidence 221 0 146999999999998 7886 33 789999999999999843 33 3467788888
Q ss_pred cccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCcc
Q 041479 228 ANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFI 307 (771)
Q Consensus 228 s~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 307 (771)
.++..... .. +..++.++.+++++|.+. .++... ...+.+..+++.+. .+| .+..++.|+.+++++|.
T Consensus 148 ~~~~~~~~--~~---l~~l~~l~~L~l~~n~~~-~~~~~~----~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~ 215 (353)
T d1jl5a_ 148 GNNQLEEL--PE---LQNLPFLTAIYADNNSLK-KLPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNL 215 (353)
T ss_dssp CSSCCSSC--CC---CTTCTTCCEEECCSSCCS-SCCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSC
T ss_pred cccccccc--cc---ccccccceeccccccccc-cccccc----cccccccccccccc-ccc-ccccccccccccccccc
Confidence 88776532 22 367889999999999987 444332 24567777777766 343 46789999999999987
Q ss_pred ceeccCccccCCCCCCEEEccCCcccccCCcccccccccccccccCccceecCCcccccccce-eeecccCcccCCCCcC
Q 041479 308 LIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLA 386 (771)
Q Consensus 308 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~ 386 (771)
... +| ....++..+.+.+|.+.. .+.. ..++...++..|.+.+.. ... ... ..++..|.+.+.
T Consensus 216 ~~~-~~---~~~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l~-~l~---~~~~~~~~~~~~~~~~---- 279 (353)
T d1jl5a_ 216 LKT-LP---DLPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS-ELP---PNLYYLNASSNEIRSL---- 279 (353)
T ss_dssp CSS-CC---SCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES-CCC---TTCCEEECCSSCCSEE----
T ss_pred ccc-cc---cccccccccccccccccc-cccc---cccccccccccccccccc-ccc---chhcccccccCccccc----
Confidence 643 33 345678899999999873 3333 345666666666665321 111 111 467777777643
Q ss_pred CCCCCCCCeEECCCCcccccCCcchhhhhcccccccEEECcCCCCCCCCCccccccccccccccCCCc
Q 041479 387 VGNPKSIPHLDLSKNELSGEIPSSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEK 454 (771)
Q Consensus 387 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 454 (771)
...+++|++|+|++|+|+ .+|+ .+++|+.|+|++|+|+ .+|.. ..++..+.+.+|+-
T Consensus 280 ~~~~~~L~~L~Ls~N~l~-~lp~-------~~~~L~~L~L~~N~L~-~l~~~--~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 280 CDLPPSLEELNVSNNKLI-ELPA-------LPPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPL 336 (353)
T ss_dssp CCCCTTCCEEECCSSCCS-CCCC-------CCTTCCEEECCSSCCS-CCCCC--CTTCCEEECCSSCC
T ss_pred cccCCCCCEEECCCCccC-cccc-------ccCCCCEEECCCCcCC-ccccc--cCCCCEEECcCCcC
Confidence 334689999999999999 6775 4578999999999998 67753 45788888888873
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.1e-19 Score=179.28 Aligned_cols=185 Identities=14% Similarity=0.085 Sum_probs=105.8
Q ss_pred cccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec-CcccccCCccccCCCCCCEEEccccccCCCCCcCccccc
Q 041479 166 QLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG-NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLV 244 (771)
Q Consensus 166 ~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (771)
.|.++++|++|++++|.+...+|...+..+++++.+++.. |++....+..|.++++|++|++++|.++...+ +..+.
T Consensus 48 ~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~--~~~~~ 125 (242)
T d1xwdc1 48 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD--VHKIH 125 (242)
T ss_dssp TTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCC--CTTTC
T ss_pred Hhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccc--ccccc
Confidence 4555666666666666655445555555666666666543 56666666667777777777777777664332 22234
Q ss_pred CCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcce-EecCCccceeccCccccCCCCCC
Q 041479 245 NCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLII-IAIEKFILIRNIPISVGYLLKLQ 323 (771)
Q Consensus 245 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~l~~n~l~~~~p~~~~~l~~L~ 323 (771)
.+..+..+..+++.+...-+..+..+...++.|++++|+++...+..|. ..++.. +++++|.+....+..|..+++|+
T Consensus 126 ~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~ 204 (242)
T d1xwdc1 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPV 204 (242)
T ss_dssp BSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCS
T ss_pred cccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCC
Confidence 4555666666666666333444444444567777777777744443333 333333 33444555443334566667777
Q ss_pred EEEccCCcccccCCcccccccccccccccC
Q 041479 324 VLSLFENNISREIPSSLGNFTFLTELNLCG 353 (771)
Q Consensus 324 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 353 (771)
+|+|++|+|+...+..|.++++|+.|++.+
T Consensus 205 ~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 205 ILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp EEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred EEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 777777777654455566666666666543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=1.6e-19 Score=174.26 Aligned_cols=129 Identities=18% Similarity=0.140 Sum_probs=102.8
Q ss_pred ccccccccceEEEEEecCCCeEEEEEEeeccc------------------hhhHHHHHHHHHHHhccCCCCceeEEEEee
Q 041479 527 VSYESLVKATVYKGILDLDQTFIAVKVLFLHQ------------------RGALKSFMAECQALRNIRHRNLVKIITACS 588 (771)
Q Consensus 527 ~~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 588 (771)
-.+|+|++|+||+|++.+ ++.||||+++... ......+.+|...+.++.|++++..+++.
T Consensus 6 ~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 358999999999999864 5699999875321 11124556789999999999999988762
Q ss_pred cCCCCCceeEEEEEEeccCCCCCCCcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCceEEeccc
Q 041479 589 TSDFQGNYFRALVYEFMHHGSLESCPRILSFLRRLNIAIDVASALEYLHHHCKKPIVHCDLKPSNVLLDNDMTAHMGDFG 668 (771)
Q Consensus 589 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrdlk~~NILl~~~~~~kl~DfG 668 (771)
. .+++|||++++...+ ++......++.|++.|++|||+. +|+||||||+|||++++ .++++|||
T Consensus 84 -~-------~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 -G-------NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp -T-------TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred -C-------CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence 1 279999999876644 44555678999999999999986 99999999999999965 58999999
Q ss_pred Ccccc
Q 041479 669 LTRFI 673 (771)
Q Consensus 669 la~~~ 673 (771)
.|+..
T Consensus 148 ~a~~~ 152 (191)
T d1zara2 148 QSVEV 152 (191)
T ss_dssp TCEET
T ss_pred CcccC
Confidence 98744
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=4.7e-19 Score=177.95 Aligned_cols=220 Identities=17% Similarity=0.124 Sum_probs=144.2
Q ss_pred CCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCC-CcCcccccCCCCCcE
Q 041479 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLI-PEDLDSLVNCTYLEV 251 (771)
Q Consensus 173 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~l~~L~~ 251 (771)
.+.++.++++++ .+|+.++ +++++|+|++|+|+.+.+.+|.++++|++|++++|.+...+ +.+| .+++.++.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f---~~l~~l~~ 82 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF---SNLPKLHE 82 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSE---ESCTTCCE
T ss_pred CCEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccc---cccccccc
Confidence 367788888888 8887654 57889999999998777778888999999999998887643 3334 66677777
Q ss_pred EEcc-CccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCC
Q 041479 252 VSLS-VNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFEN 330 (771)
Q Consensus 252 L~Ls-~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N 330 (771)
+.+. .|.+....+..+..+. +|++|++++|.+....+ +.. +..+..+..+..+++
T Consensus 83 l~~~~~n~l~~~~~~~~~~l~-~L~~l~l~~~~l~~~~~--~~~---------------------~~~l~~l~~~~~~n~ 138 (242)
T d1xwdc1 83 IRIEKANNLLYINPEAFQNLP-NLQYLLISNTGIKHLPD--VHK---------------------IHSLQKVLLDIQDNI 138 (242)
T ss_dssp EEEECCTTCCEECTTSEECCT-TCCEEEEESCCCCSCCC--CTT---------------------TCBSSCEEEEEESCT
T ss_pred ccccccccccccccccccccc-cccccccchhhhccccc--ccc---------------------ccccccccccccccc
Confidence 7765 3566645555555554 67777777777763222 111 122333444445555
Q ss_pred cccccCCccccccc-ccccccccCccceecCCcccccccce-eeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCC
Q 041479 331 NISREIPSSLGNFT-FLTELNLCGNSIRGSVPSALGSCHQL-WLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIP 408 (771)
Q Consensus 331 ~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~l-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 408 (771)
++....+..|.+++ .++.|++++|+++...+..+...... .+++++|+++...+..|.++++|++|+|++|+|+...+
T Consensus 139 ~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp TCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred ccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 55544555555553 66777777777775555555444334 34667778886666778888889999999988884333
Q ss_pred cchhhhhcccccccEEECc
Q 041479 409 SSLAWIFGYISIFAKLNLS 427 (771)
Q Consensus 409 ~~l~~~~~~l~~L~~L~Ls 427 (771)
.. |..+++|+.+++.
T Consensus 219 ~~----~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 219 YG----LENLKKLRARSTY 233 (242)
T ss_dssp SS----CTTCCEEESSSEE
T ss_pred HH----HcCCcccccCcCC
Confidence 33 3366666665554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=4.9e-18 Score=168.60 Aligned_cols=204 Identities=22% Similarity=0.351 Sum_probs=132.6
Q ss_pred EEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccc
Q 041479 47 ILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSEL 126 (771)
Q Consensus 47 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~ 126 (771)
..++++.+++++.. .+..+.+|+.|++++|+|++ ++ .+..+++|++|++++|++++ + ..+
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~---------------~-~~l 81 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD---------------L-APL 81 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC---------------C-GGG
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeec---------------c-ccc
Confidence 34566667766543 45667788888888888875 43 47788888888888887652 1 126
Q ss_pred cCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecC
Q 041479 127 GSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGN 206 (771)
Q Consensus 127 ~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N 206 (771)
..+++|+.+++++|.++. + ..+.++++|+.++++++... .++. + ...+.++.+.++.+
T Consensus 82 ~~l~~l~~l~~~~n~~~~------------------i-~~l~~l~~L~~l~l~~~~~~-~~~~-~-~~~~~~~~l~~~~~ 139 (227)
T d1h6ua2 82 KNLTKITELELSGNPLKN------------------V-SAIAGLQSIKTLDLTSTQIT-DVTP-L-AGLSNLQVLYLDLN 139 (227)
T ss_dssp TTCCSCCEEECCSCCCSC------------------C-GGGTTCTTCCEEECTTSCCC-CCGG-G-TTCTTCCEEECCSS
T ss_pred cccccccccccccccccc------------------c-cccccccccccccccccccc-ccch-h-ccccchhhhhchhh
Confidence 677777777777776651 1 13566777788888777776 3332 2 25667777777777
Q ss_pred cccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcc
Q 041479 207 QFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISG 286 (771)
Q Consensus 207 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~ 286 (771)
.+... ..+.+.++|+.|++++|.++...+ +.++++|+.|+|++|+++ .+|. +..++ +|++|+|++|+|++
T Consensus 140 ~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-----l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~-~L~~L~Ls~N~lt~ 209 (227)
T d1h6ua2 140 QITNI--SPLAGLTNLQYLSIGNAQVSDLTP-----LANLSKLTTLKADDNKIS-DISP-LASLP-NLIEVHLKNNQISD 209 (227)
T ss_dssp CCCCC--GGGGGCTTCCEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCC-CCGG-GGGCT-TCCEEECTTSCCCB
T ss_pred hhchh--hhhccccccccccccccccccchh-----hcccccceecccCCCccC-CChh-hcCCC-CCCEEECcCCcCCC
Confidence 77633 236667777777777777764321 366677777777777776 3433 55554 67777777777764
Q ss_pred cCcccccccCCcceEecC
Q 041479 287 SIPTEIGNLKNLIIIAIE 304 (771)
Q Consensus 287 ~~p~~~~~l~~L~~L~l~ 304 (771)
. + .+.++++|+.|+++
T Consensus 210 i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 210 V-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp C-G-GGTTCTTCCEEEEE
T ss_pred C-c-ccccCCCCCEEEee
Confidence 3 2 25566666666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=3.1e-19 Score=172.40 Aligned_cols=174 Identities=20% Similarity=0.242 Sum_probs=81.0
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCcccC-cccccccCCcceEecCCccceeccCccccCCCCCCEEEcc
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSI-PTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLF 328 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 328 (771)
+.++.++|+++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|++++|.+....+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 45556666665 5555432 35666666666665322 2334444444444444444333333333333344444444
Q ss_pred CCcccccCCcccccccccccccccCccceecCCcccccccceeeecccCcccCCCCcCCCCCCCCCeEECCCCcccccCC
Q 041479 329 ENNISREIPSSLGNFTFLTELNLCGNSIRGSVPSALGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDLSKNELSGEIP 408 (771)
Q Consensus 329 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 408 (771)
+|+|+...|.+|.++++|+ +|+|++|+|++..|++|..+++|++|+|++|.+....+
T Consensus 87 ~N~l~~l~~~~F~~l~~L~-----------------------~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLK-----------------------TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCC-----------------------EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cccccccCHHHHhCCCccc-----------------------ccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 4444333333333333333 34444444444445555666666666666666653222
Q ss_pred cchhhhhcccccccEEECcCCCCCCCCCccccccccccccccCCCcccC
Q 041479 409 SSLAWIFGYISIFAKLNLSYNNLDGDVPRKMIFKNASAISEAGNEKLCG 457 (771)
Q Consensus 409 ~~l~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 457 (771)
. .|. ...++.+.+..|.+++..|.. +.+.....+..|...|.
T Consensus 144 ~--~~~---~~~l~~~~l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 144 L--AWF---AEWLRKKSLNGGAARCGAPSK--VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp G--HHH---HHHHHHHCCSGGGCBBCSSTT--TTTSBGGGSCTTTCCCC
T ss_pred h--HHH---hhhhhhhcccCCCeEeCCChh--hcCCEeeecCHhhCcCC
Confidence 1 111 122344556666666665543 23333344555555553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=6.9e-18 Score=167.52 Aligned_cols=172 Identities=23% Similarity=0.330 Sum_probs=99.8
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
+..+.+|+.|++++|+|+ .++ .+. .+++|++|++++|+|++..| +..+++|+.+++++|.++.+ ..+.++
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~l~-~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i-----~~l~~l 106 (227)
T d1h6ua2 37 QADLDGITTLSAFGTGVT-TIE-GVQ-YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-----SAIAGL 106 (227)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-----GGGTTC
T ss_pred HHHcCCcCEEECCCCCCC-cch-hHh-cCCCCcEeecCCceeecccc--cccccccccccccccccccc-----cccccc
Confidence 355667778888888777 564 344 67788888888887775433 77777778888877777643 223667
Q ss_pred CCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEE
Q 041479 247 TYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLS 326 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 326 (771)
++|+.++++++...+. + .+.... .++.+.++++.+... ..+.++++|+.|++++|.+... ..+..+++|+.|+
T Consensus 107 ~~L~~l~l~~~~~~~~-~-~~~~~~-~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~ 179 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDV-T-PLAGLS-NLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLK 179 (227)
T ss_dssp TTCCEEECTTSCCCCC-G-GGTTCT-TCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred cccccccccccccccc-c-hhcccc-chhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecc
Confidence 7777777777776532 2 223332 566777777666532 2244555555555555544322 1244455555555
Q ss_pred ccCCcccccCCcccccccccccccccCccce
Q 041479 327 LFENNISREIPSSLGNFTFLTELNLCGNSIR 357 (771)
Q Consensus 327 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 357 (771)
|++|+++. ++ .+..+++|++|+|++|+|+
T Consensus 180 Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 180 ADDNKISD-IS-PLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp CCSSCCCC-CG-GGGGCTTCCEEECTTSCCC
T ss_pred cCCCccCC-Ch-hhcCCCCCCEEECcCCcCC
Confidence 55555542 21 2444445554444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=163.37 Aligned_cols=162 Identities=23% Similarity=0.356 Sum_probs=73.1
Q ss_pred EcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCC
Q 041479 50 NLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSL 129 (771)
Q Consensus 50 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l 129 (771)
.++.+.+++.++. ..+.+|++|++++|.+++ ++ .+..+++|++|+|++|++++ ++ .++.+
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~---------------l~-~~~~l 89 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD---------------IK-PLANL 89 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC---------------CG-GGTTC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC---------------cc-ccccC
Confidence 3444444433322 234555555666665553 22 25555555555555555431 11 23445
Q ss_pred CCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccc
Q 041479 130 LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFF 209 (771)
Q Consensus 130 ~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~ 209 (771)
++|+.|++++|+|+ .+| .+.++++|+.|++++|.+. .++. +. .+++++.+++++|.++
T Consensus 90 ~~L~~L~l~~n~i~------------------~l~-~l~~l~~L~~L~l~~~~~~-~~~~-l~-~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 90 KNLGWLFLDENKVK------------------DLS-SLKDLKKLKSLSLEHNGIS-DING-LV-HLPQLESLYLGNNKIT 147 (210)
T ss_dssp TTCCEEECCSSCCC------------------CGG-GGTTCTTCCEEECTTSCCC-CCGG-GG-GCTTCCEEECCSSCCC
T ss_pred cccccccccccccc------------------ccc-ccccccccccccccccccc-cccc-cc-cccccccccccccccc
Confidence 55555555555444 112 2444455555555555544 3322 22 3444555555555444
Q ss_pred ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccc
Q 041479 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS 260 (771)
Q Consensus 210 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~ 260 (771)
+ +..+..+++|+.+++++|+++++.+ +.++++|+.|+|++|+|+
T Consensus 148 ~--~~~~~~l~~L~~l~l~~n~l~~i~~-----l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 148 D--ITVLSRLTKLDTLSLEDNQISDIVP-----LAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCCCCGG-----GTTCTTCCEEECCSSCCC
T ss_pred c--ccccccccccccccccccccccccc-----ccCCCCCCEEECCCCCCC
Confidence 2 2234444445555555554443211 234444444444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=7.6e-20 Score=201.35 Aligned_cols=380 Identities=18% Similarity=0.146 Sum_probs=228.1
Q ss_pred CcEEEEEcCCCCCcccC-CccccCCCCCcEEEcCCCcccc----cCCccccCCCCCCEEecccCcCcccCCcccccCCcc
Q 041479 44 QRVILLNLSGQNLTGTA-SPYIGNLTFLRLINLQQNNFSS----NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKL 118 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l 118 (771)
.+|+.||+++|++++.. ..-+..+++|++|+|++|.|+. .++.++..+++|++|||++|.|+..- +
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~---------~ 72 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVG---------V 72 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHH---------H
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHH---------H
Confidence 47899999999998642 4456788999999999999873 34667889999999999999975100 0
Q ss_pred cccCCcccc-CCCCCCEEecccccCcC-----------CCCccceeeecccccccccCccc----c-CCCCCCEEecccC
Q 041479 119 EGNIPSELG-SLLKFKGLGLANNYFTG-----------PIPHLNMFQVSVYSLTGSIPIQL----L-NITSMEYFHVSEN 181 (771)
Q Consensus 119 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~-----------~lp~L~~l~l~~n~l~~~~p~~~----~-~l~~L~~L~Ls~N 181 (771)
. .+...+. ...+|+.|+|++|++++ ..+.|+.|++++|.++......+ . .............
T Consensus 73 ~-~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~ 151 (460)
T d1z7xw1 73 H-CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC 151 (460)
T ss_dssp H-HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred H-HHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccccccccccccc
Confidence 0 0111222 23468888888888863 24568888888888764222111 1 2223444444444
Q ss_pred cCcccC----ChhhhhCCCCCcEEEeecCcccccC----Cccc-cCCCCCCEEEccccccCCCCCc-CcccccCCCCCcE
Q 041479 182 QLVGEL----PPHIGFTLPNVRILLLAGNQFFGNI----PHSI-SNASKLEWLDFANNSLTGLIPE-DLDSLVNCTYLEV 251 (771)
Q Consensus 182 ~l~g~l----p~~~~~~l~~L~~L~L~~N~l~~~~----p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~l~~L~~ 251 (771)
.+...- -..+ ...+.++.++++.+.+.... ...+ ..-.....+++..+.+....-. ....+...+.++.
T Consensus 152 ~~~~~~~~~~~~~l-~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~ 230 (460)
T d1z7xw1 152 SLSAASCEPLASVL-RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 230 (460)
T ss_dssp CCBGGGHHHHHHHH-HHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCE
T ss_pred ccchhhhccccccc-ccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccc
Confidence 433110 0111 13467778888777664211 0111 1223456777777765432110 1112345567788
Q ss_pred EEccCcccccc----CChhhhhcccccceeecccCcCcccC----cccccccCCcceEecCCccceeccCccc-----cC
Q 041479 252 VSLSVNSLSGT----LPNSLANFSSHLRYLYMSANPISGSI----PTEIGNLKNLIIIAIEKFILIRNIPISV-----GY 318 (771)
Q Consensus 252 L~Ls~N~l~~~----~p~~~~~l~~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~l~~n~l~~~~p~~~-----~~ 318 (771)
+++++|++... ...........++.|++++|.+.... ...+...+.++.+++++|.+.......+ ..
T Consensus 231 l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~ 310 (460)
T d1z7xw1 231 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 310 (460)
T ss_dssp EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTST
T ss_pred cchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccc
Confidence 88888876421 11111222236888888888776332 2234567778888888887753222211 23
Q ss_pred CCCCCEEEccCCcccccCCcc----cccccccccccccCccceec----CCcccc-cccce-eeecccCcccCC----CC
Q 041479 319 LLKLQVLSLFENNISREIPSS----LGNFTFLTELNLCGNSIRGS----VPSALG-SCHQL-WLDLSHNHLTGP----IP 384 (771)
Q Consensus 319 l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~l-~L~Ls~N~l~~~----~p 384 (771)
...|+.+++++|.++...... +...++|++|+|++|+|++. ++..+. ....| +|+|++|+|+.. ++
T Consensus 311 ~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~ 390 (460)
T d1z7xw1 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 390 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence 457888888888886543222 33456788899998888642 222222 34456 789999988742 33
Q ss_pred cCCCCCCCCCeEECCCCcccccCCcchhhhhc-ccccccEEECcCCCCCCC
Q 041479 385 LAVGNPKSIPHLDLSKNELSGEIPSSLAWIFG-YISIFAKLNLSYNNLDGD 434 (771)
Q Consensus 385 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~-~l~~L~~L~Ls~N~l~~~ 434 (771)
..+..+++|++|+|++|+|+......+...+. ....|+.|++++|.+...
T Consensus 391 ~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 391 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 44556788999999999987543333322222 334689999999988643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=6.8e-18 Score=162.80 Aligned_cols=85 Identities=25% Similarity=0.327 Sum_probs=50.1
Q ss_pred ccceeecccCcCcccCcccccccCCcceEecCCccceeccCccccCCCCCCEEEccCCcccccCCccccccccccccccc
Q 041479 273 HLRYLYMSANPISGSIPTEIGNLKNLIIIAIEKFILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNFTFLTELNLC 352 (771)
Q Consensus 273 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 352 (771)
+|+.|+|++|++.+..+..|..+++|+.|++++|++....|..|.++++|++|+|++|+|++..|.+|..+++|++|+|+
T Consensus 55 ~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~ 134 (192)
T d1w8aa_ 55 HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134 (192)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECT
T ss_pred eEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccc
Confidence 45555555555554444555555555555555555555555555566666666666666666666666666666666666
Q ss_pred Cccce
Q 041479 353 GNSIR 357 (771)
Q Consensus 353 ~N~l~ 357 (771)
+|.+.
T Consensus 135 ~N~~~ 139 (192)
T d1w8aa_ 135 SNPFN 139 (192)
T ss_dssp TCCBC
T ss_pred ccccc
Confidence 66665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.2e-17 Score=160.36 Aligned_cols=164 Identities=20% Similarity=0.315 Sum_probs=135.9
Q ss_pred CcEEEEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCC
Q 041479 44 QRVILLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIP 123 (771)
Q Consensus 44 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p 123 (771)
..++.|++++|+++... .+..+++|++|+|++|+|++ ++ .++.+++|++|++++|+++ .+|
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~---------------~l~ 106 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK---------------DLS 106 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC---------------CGG
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc---------------ccc
Confidence 47889999999998643 48899999999999999997 44 4789999999999999976 334
Q ss_pred ccccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEe
Q 041479 124 SELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLL 203 (771)
Q Consensus 124 ~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L 203 (771)
.+.++++|+.|++++|.+.. ...+..+++++.++++.|.++ .++ ... .+++|+.+++
T Consensus 107 -~l~~l~~L~~L~l~~~~~~~-------------------~~~l~~l~~l~~l~~~~n~l~-~~~-~~~-~l~~L~~l~l 163 (210)
T d1h6ta2 107 -SLKDLKKLKSLSLEHNGISD-------------------INGLVHLPQLESLYLGNNKIT-DIT-VLS-RLTKLDTLSL 163 (210)
T ss_dssp -GGTTCTTCCEEECTTSCCCC-------------------CGGGGGCTTCCEEECCSSCCC-CCG-GGG-GCTTCSEEEC
T ss_pred -cccccccccccccccccccc-------------------ccccccccccccccccccccc-ccc-ccc-cccccccccc
Confidence 57889999999999998762 234778899999999999998 444 333 7899999999
Q ss_pred ecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccC
Q 041479 204 AGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSV 256 (771)
Q Consensus 204 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~ 256 (771)
++|++++.. .+.++++|++|+|++|+|+.+ | .+.++++|++|+|++
T Consensus 164 ~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l-~----~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 164 EDNQISDIV--PLAGLTKLQNLYLSKNHISDL-R----ALAGLKNLDVLELFS 209 (210)
T ss_dssp CSSCCCCCG--GGTTCTTCCEEECCSSCCCBC-G----GGTTCTTCSEEEEEE
T ss_pred ccccccccc--cccCCCCCCEEECCCCCCCCC-h----hhcCCCCCCEEEccC
Confidence 999998643 388999999999999999864 3 247889999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=5.5e-17 Score=157.28 Aligned_cols=176 Identities=30% Similarity=0.411 Sum_probs=95.1
Q ss_pred EcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCC
Q 041479 50 NLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSL 129 (771)
Q Consensus 50 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l 129 (771)
+++.+++++.++ ...+.+|++|++++|.|+. ++ .++.+++|++|++++|+++ .++ .++++
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~---------------~~~-~l~~l 83 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLT---------------DIT-PLKNL 83 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC---------------CCG-GGTTC
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCcccccccc---------------Ccc-cccCC
Confidence 344555554322 2345566666666666653 22 3556666666666666654 122 25566
Q ss_pred CCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCccc
Q 041479 130 LKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFF 209 (771)
Q Consensus 130 ~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~ 209 (771)
++|+.|++++|.+. .++ .+.++++|+.|++++|.+. .++. +. .+++|+.|++++|++.
T Consensus 84 ~~L~~L~l~~n~~~------------------~~~-~l~~l~~L~~L~l~~~~~~-~~~~-~~-~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 84 TKLVDILMNNNQIA------------------DIT-PLANLTNLTGLTLFNNQIT-DIDP-LK-NLTNLNRLELSSNTIS 141 (199)
T ss_dssp TTCCEEECCSSCCC------------------CCG-GGTTCTTCSEEECCSSCCC-CCGG-GT-TCTTCSEEECCSSCCC
T ss_pred cccccccccccccc------------------ccc-ccccccccccccccccccc-cccc-cc-hhhhhHHhhhhhhhhc
Confidence 66666666666554 122 2455666666666666655 3322 22 5666666666666665
Q ss_pred ccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhccccccee
Q 041479 210 GNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYL 277 (771)
Q Consensus 210 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L 277 (771)
. + +.+..+++|+.|++++|+++++. .+.++++|++|++++|+++ .++ .+..+. +|++|
T Consensus 142 ~-~-~~l~~~~~L~~L~l~~n~l~~l~-----~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~-~L~~L 199 (199)
T d2omxa2 142 D-I-SALSGLTSLQQLNFSSNQVTDLK-----PLANLTTLERLDISSNKVS-DIS-VLAKLT-NLESL 199 (199)
T ss_dssp C-C-GGGTTCTTCSEEECCSSCCCCCG-----GGTTCTTCCEEECCSSCCC-CCG-GGGGCT-TCSEE
T ss_pred c-c-ccccccccccccccccccccCCc-----cccCCCCCCEEECCCCCCC-CCc-cccCCC-CCCcC
Confidence 2 2 24566666666666666666432 1355666666666666665 333 344443 45543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.5e-19 Score=199.01 Aligned_cols=355 Identities=19% Similarity=0.133 Sum_probs=227.8
Q ss_pred CCCcEEEcCCCccccc-CCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcC--
Q 041479 68 TFLRLINLQQNNFSSN-IPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTG-- 144 (771)
Q Consensus 68 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-- 144 (771)
++|+.||+++|++++. +...+..+++|++|+|++|.++..- + ..+...+..+++|++|||++|+|+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~---------~-~~l~~~L~~~~~L~~LdLs~N~i~~~~ 71 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR---------C-KDISSALRVNPALAELNLRSNELGDVG 71 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHH---------H-HHHHHHHHTCTTCCEEECTTCCCHHHH
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHH---------H-HHHHHHHhcCCCCCEEECcCCcCChHH
Confidence 4689999999999863 2445777899999999999876100 0 1344567889999999999999862
Q ss_pred ------C----CCccceeeecccccccc----cCccccCCCCCCEEecccCcCccc----CChhhhhCCCCCcEEEeecC
Q 041479 145 ------P----IPHLNMFQVSVYSLTGS----IPIQLLNITSMEYFHVSENQLVGE----LPPHIGFTLPNVRILLLAGN 206 (771)
Q Consensus 145 ------~----lp~L~~l~l~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~----lp~~~~~~l~~L~~L~L~~N 206 (771)
. -+.|+.|++++|.++.. ++..+..+++|++|++++|.++.. ++..+...............
T Consensus 72 ~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~ 151 (460)
T d1z7xw1 72 VHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC 151 (460)
T ss_dssp HHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccccccccccccc
Confidence 1 13578888888877643 345566777888888888877621 11111111122333333333
Q ss_pred ccccc----CCccccCCCCCCEEEccccccCCCCCcCc-ccc-cCCCCCcEEEccCcccccc----CChhhhhcccccce
Q 041479 207 QFFGN----IPHSISNASKLEWLDFANNSLTGLIPEDL-DSL-VNCTYLEVVSLSVNSLSGT----LPNSLANFSSHLRY 276 (771)
Q Consensus 207 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l-~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~~L~~ 276 (771)
.+... .-..+.....++.++++++.+....-..+ ..+ ..-.....+++..+.+... ....+... ..++.
T Consensus 152 ~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~-~~~~~ 230 (460)
T d1z7xw1 152 SLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK-ASLRE 230 (460)
T ss_dssp CCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHC-TTCCE
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccccc-ccccc
Confidence 33211 01223455778899998887642100000 000 1223566788888876521 11122233 36899
Q ss_pred eecccCcCcc-----cCcccccccCCcceEecCCccceec----cCccccCCCCCCEEEccCCcccccCCccc-----cc
Q 041479 277 LYMSANPISG-----SIPTEIGNLKNLIIIAIEKFILIRN----IPISVGYLLKLQVLSLFENNISREIPSSL-----GN 342 (771)
Q Consensus 277 L~Ls~N~l~~-----~~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~ 342 (771)
+++++|.+.. ..+..+.....++.+++++|.+... ....+...+.++.+++++|.++......+ ..
T Consensus 231 l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~ 310 (460)
T d1z7xw1 231 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEP 310 (460)
T ss_dssp EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTST
T ss_pred cchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccc
Confidence 9999998752 2334455678899999999987543 23345668899999999999874322222 23
Q ss_pred ccccccccccCccceecCCccc----ccccce-eeecccCcccCC----CCcCC-CCCCCCCeEECCCCcccccCCcchh
Q 041479 343 FTFLTELNLCGNSIRGSVPSAL----GSCHQL-WLDLSHNHLTGP----IPLAV-GNPKSIPHLDLSKNELSGEIPSSLA 412 (771)
Q Consensus 343 l~~L~~L~Ls~N~l~~~~p~~~----~~l~~l-~L~Ls~N~l~~~----~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~ 412 (771)
...|+.+++++|.++......+ .....| +|||++|+++.. ++..+ ...+.|++|+|++|+|+..-...+.
T Consensus 311 ~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~ 390 (460)
T d1z7xw1 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 390 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence 4689999999999875433333 334567 899999999742 22233 3467899999999999853333344
Q ss_pred hhhcccccccEEECcCCCCCC
Q 041479 413 WIFGYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 413 ~~~~~l~~L~~L~Ls~N~l~~ 433 (771)
..+...++|++|||++|+|+.
T Consensus 391 ~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 391 ATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHCCCCCEEECCSSSCCH
T ss_pred HHHhcCCCCCEEECCCCcCCH
Confidence 344577999999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=7.3e-17 Score=156.39 Aligned_cols=179 Identities=24% Similarity=0.367 Sum_probs=91.7
Q ss_pred cEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccc
Q 041479 71 RLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLN 150 (771)
Q Consensus 71 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~ 150 (771)
..+.++.+++++.++ ...+.+|++|++++|.++ .+ +.+..+++|++|++++|+|++
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~---------------~l-~~l~~l~nL~~L~Ls~N~l~~------ 76 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK---------------SI-DGVEYLNNLTQINFSNNQLTD------ 76 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC---------------CC-TTGGGCTTCCEEECCSSCCCC------
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC---------------Cc-cccccCCCcCcCccccccccC------
Confidence 344455555554322 234555666666666544 11 124455556666666655541
Q ss_pred eeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcccc
Q 041479 151 MFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN 230 (771)
Q Consensus 151 ~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 230 (771)
++ .+.++++|++|++++|.+. .+|. +. .+++|+.|++++|.+... +.+..+++|+.|++++|
T Consensus 77 ------------~~-~l~~l~~L~~L~l~~n~~~-~~~~-l~-~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 77 ------------IT-PLKNLTKLVDILMNNNQIA-DITP-LA-NLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSN 138 (199)
T ss_dssp ------------CG-GGTTCTTCCEEECCSSCCC-CCGG-GT-TCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSS
T ss_pred ------------cc-cccCCcccccccccccccc-cccc-cc-cccccccccccccccccc--cccchhhhhHHhhhhhh
Confidence 11 1455566666666666655 4443 22 556666666666655532 23555566666666666
Q ss_pred ccCCCCCcCcccccCCCCCcEEEccCccccccCChhhhhcccccceeecccCcCcccCcccccccCCcceE
Q 041479 231 SLTGLIPEDLDSLVNCTYLEVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPISGSIPTEIGNLKNLIII 301 (771)
Q Consensus 231 ~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 301 (771)
++..+ + .+..+++|+.|++++|+++ .++ .+.+++ +|++|++++|+|++ ++ .++++++|+.|
T Consensus 139 ~l~~~-~----~l~~~~~L~~L~l~~n~l~-~l~-~l~~l~-~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 139 TISDI-S----ALSGLTSLQQLNFSSNQVT-DLK-PLANLT-TLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCCCC-G----GGTTCTTCSEEECCSSCCC-CCG-GGTTCT-TCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred hhccc-c----ccccccccccccccccccc-CCc-cccCCC-CCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 55432 1 1245556666666666665 232 244443 56666666666653 22 35555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.8e-15 Score=140.82 Aligned_cols=64 Identities=17% Similarity=0.309 Sum_probs=27.7
Q ss_pred CCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCC-ccccCCCCCCEEEccccccC
Q 041479 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIP-HSISNASKLEWLDFANNSLT 233 (771)
Q Consensus 169 ~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 233 (771)
.+++|++|++++|+++ .+|+.++..+++|+.|++++|+|+.... ..+..+++|++|++++|.++
T Consensus 61 ~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 61 LLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cCcchhhhhccccccc-CCCccccccccccccceeccccccccccccccccccccchhhcCCCccc
Confidence 3344444444444444 3443333344444455554444442211 23444444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.3e-14 Score=128.33 Aligned_cols=119 Identities=21% Similarity=0.341 Sum_probs=83.0
Q ss_pred EEEcCCCCCcccCCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCcccc
Q 041479 48 LLNLSGQNLTGTASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELG 127 (771)
Q Consensus 48 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~ 127 (771)
.|||++|+|+.. + .+..+++|++|||++|+|++ +|..|+.+++|++|++++|+|+ .+| .+.
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~---------------~l~-~~~ 62 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE---------------NVD-GVA 62 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC---------------CCG-GGT
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccc---------------ccC-ccc
Confidence 588888888833 3 47888888888888888884 6777888888888888888876 233 477
Q ss_pred CCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcc--cCChhhhhCCCCCcEE
Q 041479 128 SLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVG--ELPPHIGFTLPNVRIL 201 (771)
Q Consensus 128 ~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~lp~~~~~~l~~L~~L 201 (771)
.+++|+.|++++|+|++. .....+..+++|++|++++|.++. .++..+...+|+|+.|
T Consensus 63 ~l~~L~~L~l~~N~i~~~----------------~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 63 NLPRLQELLLCNNRLQQS----------------AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp TCSSCCEEECCSSCCCSS----------------STTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cccccCeEECCCCccCCC----------------CCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 778888888888877621 111346667777777777777762 1234444455666554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=1.6e-14 Score=127.63 Aligned_cols=88 Identities=27% Similarity=0.406 Sum_probs=40.0
Q ss_pred ccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCC
Q 041479 167 LLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNC 246 (771)
Q Consensus 167 ~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l 246 (771)
+..+++|++|++++|+|+ .+|+.+. .+++|+.|++++|+|++. | .|..+++|++|++++|+|+...+ +..+..+
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~-~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~--~~~l~~~ 89 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALA-ALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAA--IQPLVSC 89 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSST--TGGGGGC
T ss_pred cccCCCCCEEECCCCccC-cchhhhh-hhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCC--chhhcCC
Confidence 344444444444444444 4444333 444555555555555432 2 24445555555555555543321 1222444
Q ss_pred CCCcEEEccCcccc
Q 041479 247 TYLEVVSLSVNSLS 260 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~ 260 (771)
++|++|++++|.++
T Consensus 90 ~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 90 PRLVLLNLQGNSLC 103 (124)
T ss_dssp TTCCEEECTTSGGG
T ss_pred CCCCEEECCCCcCC
Confidence 55555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.3e-14 Score=134.92 Aligned_cols=112 Identities=21% Similarity=0.190 Sum_probs=58.9
Q ss_pred ccCCCCCCEEecccccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeec
Q 041479 126 LGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAG 205 (771)
Q Consensus 126 ~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~ 205 (771)
|.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++. + ..+++|++|++++
T Consensus 14 ~~n~~~lr~L~L~~n~I~------------------~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~-~~l~~L~~L~ls~ 72 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP------------------VIENLGATLDQFDAIDFSDNEIR-KLDG-F-PLLRRLKTLLVNN 72 (162)
T ss_dssp EECTTSCEEEECTTSCCC------------------SCCCGGGGTTCCSEEECCSSCCC-EECC-C-CCCSSCCEEECCS
T ss_pred ccCcCcCcEEECCCCCCC------------------ccCccccccccCCEEECCCCCCC-ccCC-c-ccCcchhhhhccc
Confidence 344445555555555555 23333445556666666666665 4432 2 2555666666666
Q ss_pred CcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCcEEEccCcccc
Q 041479 206 NQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLEVVSLSVNSLS 260 (771)
Q Consensus 206 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~~L~Ls~N~l~ 260 (771)
|+|+...+..+..+++|+.|++++|+|+... .+..+..+++|++|++++|.++
T Consensus 73 N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~--~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 73 NRICRIGEGLDQALPDLTELILTNNSLVELG--DLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp SCCCEECSCHHHHCTTCCEEECCSCCCCCGG--GGGGGGGCTTCCEEECCSSGGG
T ss_pred ccccCCCccccccccccccceeccccccccc--cccccccccccchhhcCCCccc
Confidence 6665544444555566666666666655331 1223345555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=2.9e-15 Score=153.47 Aligned_cols=183 Identities=20% Similarity=0.229 Sum_probs=118.8
Q ss_pred CCCCCCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEcccc-ccCCCCCcCccc-ccCC
Q 041479 169 NITSMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANN-SLTGLIPEDLDS-LVNC 246 (771)
Q Consensus 169 ~l~~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~-l~~l 246 (771)
...+|++||++++.++......++..+++|++|+|+++.++...+..+..+++|++|+++++ .++.. .+.. ..++
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~---~l~~l~~~~ 120 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF---ALQTLLSSC 120 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH---HHHHHHHHC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccccc---ccchhhHHH
Confidence 44578888888877764433445557788888888888887666777777888888888874 45421 1111 2456
Q ss_pred CCCcEEEccCc-cccc-cCChhhhhcccccceeecccC--cCccc-CcccccccCCcceEecCCcc-ceeccCccccCCC
Q 041479 247 TYLEVVSLSVN-SLSG-TLPNSLANFSSHLRYLYMSAN--PISGS-IPTEIGNLKNLIIIAIEKFI-LIRNIPISVGYLL 320 (771)
Q Consensus 247 ~~L~~L~Ls~N-~l~~-~~p~~~~~l~~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~ 320 (771)
++|++|+++++ .++. .++..+....++|+.|++++. .++.. +...+.++++|+.|+++++. +++.....+..++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 78888888875 4432 122334444456888888764 33321 22234557778888887754 5555566677778
Q ss_pred CCCEEEccC-CcccccCCcccccccccccccccCc
Q 041479 321 KLQVLSLFE-NNISREIPSSLGNFTFLTELNLCGN 354 (771)
Q Consensus 321 ~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N 354 (771)
+|++|+|++ +.++......+..+++|+.|+++++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 888888887 4566555556777778888888776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=8e-15 Score=150.14 Aligned_cols=90 Identities=17% Similarity=0.233 Sum_probs=53.8
Q ss_pred ccceeecccC-cCcccCcccccccCCcceEecCCc-cceeccCccccCCCCCCEEEccCCcccccCCcccccc-cccccc
Q 041479 273 HLRYLYMSAN-PISGSIPTEIGNLKNLIIIAIEKF-ILIRNIPISVGYLLKLQVLSLFENNISREIPSSLGNF-TFLTEL 349 (771)
Q Consensus 273 ~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L 349 (771)
+|++|++++| .+++.....+..+++|++|+++++ .++......++.+++|+.|+++++ ++ ...+..+ ..+..|
T Consensus 176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L 251 (284)
T d2astb2 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHL 251 (284)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTS
T ss_pred cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccc
Confidence 5677777664 355555566666777777777763 444444556677788888888776 22 2222222 245555
Q ss_pred cccCccceecCCccccc
Q 041479 350 NLCGNSIRGSVPSALGS 366 (771)
Q Consensus 350 ~Ls~N~l~~~~p~~~~~ 366 (771)
.+..++++...++.++.
T Consensus 252 ~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 252 QINCSHFTTIARPTIGN 268 (284)
T ss_dssp EESCCCSCCTTCSSCSS
T ss_pred cccCccCCCCCCCccCc
Confidence 66677777655555443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=3.8e-15 Score=157.26 Aligned_cols=252 Identities=18% Similarity=0.162 Sum_probs=136.9
Q ss_pred cCccccCCCCCCEEecccCcCcccCChhh---hhCCCCCcEEEeecCccccc----------CCccccCCCCCCEEEccc
Q 041479 163 IPIQLLNITSMEYFHVSENQLVGELPPHI---GFTLPNVRILLLAGNQFFGN----------IPHSISNASKLEWLDFAN 229 (771)
Q Consensus 163 ~p~~~~~l~~L~~L~Ls~N~l~g~lp~~~---~~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~Ls~ 229 (771)
+...+.....|+.|+|++|.+...-...+ ....++|+.|+++++.+... +...+...++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 34456678889999999998863211222 12567888999887765421 123345678888889988
Q ss_pred cccCCCCCcCc-ccccCCCCCcEEEccCccccccCChhhh------------hcccccceeecccCcCccc----Ccccc
Q 041479 230 NSLTGLIPEDL-DSLVNCTYLEVVSLSVNSLSGTLPNSLA------------NFSSHLRYLYMSANPISGS----IPTEI 292 (771)
Q Consensus 230 N~l~~~~p~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~------------~l~~~L~~L~Ls~N~l~~~----~p~~~ 292 (771)
|.++......+ ..+..+++|+.|++++|.+...-...+. ...+.|+.|++++|+++.. +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 88875322111 1234567888888888877522111111 0112466677777766521 12223
Q ss_pred cccCCcceEecCCccceec-----cCccccCCCCCCEEEccCCccccc----CCcccccccccccccccCccceecCCcc
Q 041479 293 GNLKNLIIIAIEKFILIRN-----IPISVGYLLKLQVLSLFENNISRE----IPSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 293 ~~l~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
...+.|+.|++++|.+... +...+...++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence 3445555555555554321 222334445555555555554321 2223334445555555555444211111
Q ss_pred cccccceeeecccCcccCCCCcCCC--CCCCCCeEECCCCcccccCCcchhhhh-cccccccEEECcCCCCCC
Q 041479 364 LGSCHQLWLDLSHNHLTGPIPLAVG--NPKSIPHLDLSKNELSGEIPSSLAWIF-GYISIFAKLNLSYNNLDG 433 (771)
Q Consensus 364 ~~~l~~l~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~~~-~~l~~L~~L~Ls~N~l~~ 433 (771)
+ -..+. ..+.|++|++++|+|+..--..+.... .+.++|+.|+|++|++..
T Consensus 263 l-------------------~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 263 V-------------------VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp H-------------------HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred H-------------------HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 1 01111 235789999999998753222333222 256789999999998864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=5.9e-14 Score=147.96 Aligned_cols=256 Identities=15% Similarity=0.145 Sum_probs=142.7
Q ss_pred cCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEecccccCcCCCCccceeeecccccccc
Q 041479 83 NIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLANNYFTGPIPHLNMFQVSVYSLTGS 162 (771)
Q Consensus 83 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~lp~L~~l~l~~n~l~~~ 162 (771)
.+...+.....|+.|+|++|.+...-. ..+-..+...++|+.|+++++.+....... ......
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~----------~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~-------~~~~~~ 84 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAA----------RWLSENIASKKDLEIAEFSDIFTGRVKDEI-------PEALRL 84 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHH----------HHHHHTTTTCTTCCEEECCSCCTTSCGGGS-------HHHHHH
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHH----------HHHHHHHHhCCCCCEEECCCCccccccccc-------chHHHH
Confidence 356678888999999999998641000 012334567788889998877654110000 000001
Q ss_pred cCccccCCCCCCEEecccCcCccc----CChhhhhCCCCCcEEEeecCcccccCCcc-------------ccCCCCCCEE
Q 041479 163 IPIQLLNITSMEYFHVSENQLVGE----LPPHIGFTLPNVRILLLAGNQFFGNIPHS-------------ISNASKLEWL 225 (771)
Q Consensus 163 ~p~~~~~l~~L~~L~Ls~N~l~g~----lp~~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L 225 (771)
+...+...++|+.|+|++|.++.. +...+. ..++|+.|++++|.+....... ....+.|+.|
T Consensus 85 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~-~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l 163 (344)
T d2ca6a1 85 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS-KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 163 (344)
T ss_dssp HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHH-HCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred HHHHHhhCCCcccccccccccccccccchhhhhc-ccccchheecccccccccccccccccccccccccccccCccccee
Confidence 223355677888888888887632 222222 5678888888888775211111 1345677788
Q ss_pred EccccccCCCCCcCc-ccccCCCCCcEEEccCcccccc-----CChhhhhcccccceeecccCcCccc----Cccccccc
Q 041479 226 DFANNSLTGLIPEDL-DSLVNCTYLEVVSLSVNSLSGT-----LPNSLANFSSHLRYLYMSANPISGS----IPTEIGNL 295 (771)
Q Consensus 226 ~Ls~N~l~~~~p~~~-~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~~L~~L~Ls~N~l~~~----~p~~~~~l 295 (771)
++++|+++...-..+ ..+..++.|+.|+|++|.+... +...+... ++|+.|+|++|.|+.. +...+..+
T Consensus 164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~-~~L~~L~Ls~N~i~~~g~~~L~~~l~~~ 242 (344)
T d2ca6a1 164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC-QELKVLDLQDNTFTHLGSSALAIALKSW 242 (344)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC-TTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcch-hhhccccccccccccccccccccccccc
Confidence 888877652211111 1124456777777777777521 12223333 3577777777776532 33445566
Q ss_pred CCcceEecCCccceeccCc----ccc--CCCCCCEEEccCCcccccC----Ccccc-cccccccccccCccce
Q 041479 296 KNLIIIAIEKFILIRNIPI----SVG--YLLKLQVLSLFENNISREI----PSSLG-NFTFLTELNLCGNSIR 357 (771)
Q Consensus 296 ~~L~~L~l~~n~l~~~~p~----~~~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~ 357 (771)
++|+.|++++|.+.+.-.. .+. ..+.|++|++++|+|+..- ...+. ++++|+.|+|++|++.
T Consensus 243 ~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred ccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 6677777777766433221 222 2345777777777765321 12221 3456666666666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=7.1e-15 Score=141.63 Aligned_cols=113 Identities=18% Similarity=0.257 Sum_probs=63.6
Q ss_pred CCccccCCCCCcEEEcCCCcccccCCccccCCCCCCEEecccCcCcccCCcccccCCcccccCCccccCCCCCCEEeccc
Q 041479 60 ASPYIGNLTFLRLINLQQNNFSSNIPHEIGRLFRLRHIIFNSNALQGQIPDSRLILNKLEGNIPSELGSLLKFKGLGLAN 139 (771)
Q Consensus 60 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 139 (771)
.+.+|..+++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..+.+|+.|++++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~---------------~i~~~~~~~~~L~~L~l~~ 102 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK---------------KIENLDAVADTLEELWISY 102 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC---------------SCSSHHHHHHHCCEEECSE
T ss_pred hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc---------------ccccccccccccccccccc
Confidence 34567777777788888777774 33 4777777777777777765 2333333344566666666
Q ss_pred ccCcCCCCccceeeecccccccccCccccCCCCCCEEecccCcCcccCCh-hhhhCCCCCcEEEeecCccc
Q 041479 140 NYFTGPIPHLNMFQVSVYSLTGSIPIQLLNITSMEYFHVSENQLVGELPP-HIGFTLPNVRILLLAGNQFF 209 (771)
Q Consensus 140 N~l~~~lp~L~~l~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~lp~-~~~~~l~~L~~L~L~~N~l~ 209 (771)
|+|+. + ..+..+++|++|++++|+++ .++. ..+..+++|+.|+|++|.+.
T Consensus 103 N~i~~------------------l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 103 NQIAS------------------L-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EECCC------------------H-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccc------------------c-ccccccccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 65541 1 12344455555555555554 3332 11224555555555555544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=5.8e-14 Score=135.08 Aligned_cols=103 Identities=24% Similarity=0.327 Sum_probs=51.1
Q ss_pred CCCEEecccC--cCcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCC
Q 041479 172 SMEYFHVSEN--QLVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYL 249 (771)
Q Consensus 172 ~L~~L~Ls~N--~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L 249 (771)
.++.++++.+ .+. .+|..+. .+++|++|+|++|+|+. ++ .|.++++|+.|+|++|+|+.+ |..+ ..+++|
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~-~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i-~~~~---~~~~~L 95 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLS-TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKI-ENLD---AVADTL 95 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHH-HTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSC-SSHH---HHHHHC
T ss_pred ccceeeeecccCchh-hhhhHHh-cccccceeECcccCCCC-cc-cccCCccccChhhcccccccc-cccc---cccccc
Confidence 3444555443 233 4444444 56666666666666653 22 355566666666666666533 2111 223345
Q ss_pred cEEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 250 EVVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 250 ~~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+.|++++|+++ .++ .+..+. +|+.|++++|+|+
T Consensus 96 ~~L~l~~N~i~-~l~-~~~~l~-~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 96 EELWISYNQIA-SLS-GIEKLV-NLRVLYMSNNKIT 128 (198)
T ss_dssp CEEECSEEECC-CHH-HHHHHH-HSSEEEESEEECC
T ss_pred ccccccccccc-ccc-cccccc-cccccccccchhc
Confidence 55555555555 222 234433 4555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.3e-12 Score=120.28 Aligned_cols=107 Identities=17% Similarity=0.194 Sum_probs=63.4
Q ss_pred CCCEEecccCcCcccCChhhhhCCCCCcEEEeecC-cccccCCccccCCCCCCEEEccccccCCCCCcCcccccCCCCCc
Q 041479 172 SMEYFHVSENQLVGELPPHIGFTLPNVRILLLAGN-QFFGNIPHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLE 250 (771)
Q Consensus 172 ~L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~ 250 (771)
..+.++.+++++. .+|..+. .+++|+.|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.|.+| ..+++|+
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~-~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f---~~l~~L~ 83 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLP-GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF---HFTPRLS 83 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSC-SCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGG---GSCSCCC
T ss_pred CCCeEEecCCCCc-cCccccc-CccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccc---ccccccc
Confidence 3445566666665 5555554 5566666666544 3665555566666666666666666666555555 5556666
Q ss_pred EEEccCccccccCChhhhhcccccceeecccCcCc
Q 041479 251 VVSLSVNSLSGTLPNSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 251 ~L~Ls~N~l~~~~p~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+|+|++|+|+ .+|...+... +|+.|+|++|.+.
T Consensus 84 ~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 84 RLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence 6666666666 4555444433 4666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=6.2e-12 Score=115.57 Aligned_cols=94 Identities=19% Similarity=0.140 Sum_probs=82.4
Q ss_pred ccCccccCCCCCCEEecccCc-CcccCChhhhhCCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCCCCCcCc
Q 041479 162 SIPIQLLNITSMEYFHVSENQ-LVGELPPHIGFTLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTGLIPEDL 240 (771)
Q Consensus 162 ~~p~~~~~l~~L~~L~Ls~N~-l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 240 (771)
..|..+..+++|++|++++|+ |+ .++...|.++++|+.|+|++|+|+.+.|++|.++++|++|+|++|+|+.+.+..|
T Consensus 22 ~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 100 (156)
T d2ifga3 22 DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV 100 (156)
T ss_dssp TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTT
T ss_pred cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhh
Confidence 467778889999999998765 87 8988877799999999999999999999999999999999999999998777665
Q ss_pred ccccCCCCCcEEEccCcccc
Q 041479 241 DSLVNCTYLEVVSLSVNSLS 260 (771)
Q Consensus 241 ~~l~~l~~L~~L~Ls~N~l~ 260 (771)
.. .+|+.|+|++|.+.
T Consensus 101 ---~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 101 ---QG-LSLQELVLSGNPLH 116 (156)
T ss_dssp ---CS-CCCCEEECCSSCCC
T ss_pred ---cc-ccccccccCCCccc
Confidence 33 36999999999885
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=7e-09 Score=95.36 Aligned_cols=41 Identities=34% Similarity=0.383 Sum_probs=18.9
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCCCEEEccccccCC
Q 041479 194 TLPNVRILLLAGNQFFGNIPHSISNASKLEWLDFANNSLTG 234 (771)
Q Consensus 194 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 234 (771)
.+++|+.|+|++|+|+...+-.+....+|+.|++++|.++.
T Consensus 89 ~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 89 KAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred hCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 44455555555555543333233333445555555555543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=8.5e-09 Score=94.81 Aligned_cols=86 Identities=23% Similarity=0.224 Sum_probs=51.5
Q ss_pred CCEEecccCcCcccCChhhhhCCCCCcEEEeecCcccccC--CccccCCCCCCEEEccccccCCCCCcCcccccCCCCCc
Q 041479 173 MEYFHVSENQLVGELPPHIGFTLPNVRILLLAGNQFFGNI--PHSISNASKLEWLDFANNSLTGLIPEDLDSLVNCTYLE 250 (771)
Q Consensus 173 L~~L~Ls~N~l~g~lp~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~L~ 250 (771)
+..++.+.|... .+ ..++..+++|++|+|++|+|+... +..+..+++|+.|||++|.|+.+.+-.+ ....+|+
T Consensus 44 ~~~l~~~~~~~~-~l-~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~---l~~~~L~ 118 (162)
T d1koha1 44 DVVLNRRSSMAA-TL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK---IKGLKLE 118 (162)
T ss_dssp CCCTTSHHHHHH-HH-HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHH---HTTCCCS
T ss_pred hhhcchhhhHhh-hh-HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhh---hhccccc
Confidence 333444444333 23 333446777777777777777542 3446677888888888888875533222 2334677
Q ss_pred EEEccCccccccC
Q 041479 251 VVSLSVNSLSGTL 263 (771)
Q Consensus 251 ~L~Ls~N~l~~~~ 263 (771)
.|++++|.+....
T Consensus 119 ~L~L~~Npl~~~~ 131 (162)
T d1koha1 119 ELWLDGNSLSDTF 131 (162)
T ss_dssp SCCCTTSTTSSSS
T ss_pred eeecCCCCcCcCc
Confidence 7888888776443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.78 E-value=3.6e-05 Score=75.75 Aligned_cols=129 Identities=15% Similarity=0.081 Sum_probs=86.7
Q ss_pred cceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEEEEEEeccCCCCCC
Q 041479 534 KATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRALVYEFMHHGSLES 612 (771)
Q Consensus 534 ~~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 612 (771)
.+.||+... +++.++||+...........+.+|...+..+. +--+-+++++....+ ..++||++++|..+..
T Consensus 27 ~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~-----~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 27 PAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-----WSNLLMSEADGVLCSE 99 (263)
T ss_dssp SSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-----EEEEEEECCSSEEHHH
T ss_pred CCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC-----ceEEEEEecccccccc
Confidence 457998753 34478889886554444456778888887764 333556666665555 6799999999877643
Q ss_pred CcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------------
Q 041479 613 CPRILSFLRRLNIAIDVASALEYLHHHC---------------------------------------------------- 640 (771)
Q Consensus 613 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------------------- 640 (771)
.. .+......++.++++.+..||+..
T Consensus 100 ~~--~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 100 EY--EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp HT--TTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred cc--cccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 21 111223445666677777777421
Q ss_pred ----CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 641 ----KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 641 ----~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
...++|+|+.|.||++++++.+-|.||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0237999999999999977667799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.47 E-value=0.00022 Score=69.51 Aligned_cols=123 Identities=16% Similarity=0.102 Sum_probs=79.4
Q ss_pred ceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCC--CCceeEEEEeecCCCCCceeEEEEEEeccCCCCCC
Q 041479 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRH--RNLVKIITACSTSDFQGNYFRALVYEFMHHGSLES 612 (771)
Q Consensus 535 ~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 612 (771)
+.||+.....+. .+++|.-..... ..+..|+..++.+.. --+.+++++..+.+ ..++||||++|.++..
T Consensus 25 ~~v~r~~~~~~~-~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~-----~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 25 AAVFRLSAQGRP-VLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAG-----RDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CEEEEEECTTSC-CEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----CEEEEEECCSSEETTT
T ss_pred CeEEEEEeCCCC-EEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccccc-----ceEEEEEeeecccccc
Confidence 678998775544 678887654432 346677777776642 23556677766554 5789999999877754
Q ss_pred CcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------------
Q 041479 613 CPRILSFLRRLNIAIDVASALEYLHHHC---------------------------------------------------- 640 (771)
Q Consensus 613 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------------------- 640 (771)
.. .. ....+.+++..+.-||+..
T Consensus 96 ~~--~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 170 (255)
T d1nd4a_ 96 SH--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 170 (255)
T ss_dssp SC--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred cc--cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCC
Confidence 21 11 1122334444444555210
Q ss_pred ---CCCeEecCCCCCCeeeCCCCceEEecccCcc
Q 041479 641 ---KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTR 671 (771)
Q Consensus 641 ---~~~ivHrdlk~~NILl~~~~~~kl~DfGla~ 671 (771)
.+.++|+|+.|.||+++.+..+.|+||+.+.
T Consensus 171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987667899999664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00016 Score=75.56 Aligned_cols=75 Identities=12% Similarity=-0.014 Sum_probs=46.7
Q ss_pred cccccccceEEEEEecCCCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccC-C--CCceeEEEEeecCCCCCcee
Q 041479 528 SYESLVKATVYKGILDLDQTFIAVKVLFLHQ-------RGALKSFMAECQALRNIR-H--RNLVKIITACSTSDFQGNYF 597 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~~~~ 597 (771)
.+|.|..-.||+.....+++.|+||.-...- .....+...|++.++.+. + ..+.+++.+..+.
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~------- 105 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEM------- 105 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTT-------
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCC-------
Confidence 4678888889999988877789999763211 112345567888887663 2 3455666654332
Q ss_pred EEEEEEeccCCC
Q 041479 598 RALVYEFMHHGS 609 (771)
Q Consensus 598 ~~lv~e~~~~g~ 609 (771)
.++||||+++..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEeccCCcc
Confidence 379999997644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.05 E-value=6.6e-05 Score=68.29 Aligned_cols=14 Identities=29% Similarity=0.387 Sum_probs=7.0
Q ss_pred CCCcEEEccCcccc
Q 041479 247 TYLEVVSLSVNSLS 260 (771)
Q Consensus 247 ~~L~~L~Ls~N~l~ 260 (771)
+.|+.|+|++|.|+
T Consensus 72 ~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 72 PSLRVLNVESNFLT 85 (167)
T ss_dssp SSCCEEECCSSBCC
T ss_pred ccccceeeehhhcc
Confidence 44555555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.95 E-value=0.00014 Score=66.02 Aligned_cols=67 Identities=18% Similarity=0.247 Sum_probs=36.6
Q ss_pred CCCCCCEEEcccc-ccCCC-CCcCcccccCCCCCcEEEccCccccccCC----hhhhhcccccceeecccCcCc
Q 041479 218 NASKLEWLDFANN-SLTGL-IPEDLDSLVNCTYLEVVSLSVNSLSGTLP----NSLANFSSHLRYLYMSANPIS 285 (771)
Q Consensus 218 ~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~~L~~L~Ls~N~l~ 285 (771)
+.++|++|+|+++ .++.. ...-+..+...++|+.|+|++|.+..... ..+... +.|++|+|++|.|+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n-~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETS-PSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHC-SSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhc-ccccceeeehhhcc
Confidence 4577888888764 45421 00112234556677777777777763221 122222 35777777777665
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.12 E-value=0.00032 Score=63.43 Aligned_cols=119 Identities=14% Similarity=0.136 Sum_probs=56.5
Q ss_pred cccCCcceEecCCc-cceec----cCccccCCCCCCEEEccCCcccccC----CcccccccccccccccCccceecCCcc
Q 041479 293 GNLKNLIIIAIEKF-ILIRN----IPISVGYLLKLQVLSLFENNISREI----PSSLGNFTFLTELNLCGNSIRGSVPSA 363 (771)
Q Consensus 293 ~~l~~L~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 363 (771)
.+.++|+.|+++++ .+... +-.++...+.|++|++++|.++... -..+...++++.+++++|.+....-.
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~- 92 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL- 92 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH-
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH-
Confidence 34456666666652 23211 2223345556666666666654321 11223334555555555544321000
Q ss_pred cccccceeeecccCcccCCCCcCCCCCCCCCeEEC--CCCcccccCCcchhhhhcccccccEEECcCCC
Q 041479 364 LGSCHQLWLDLSHNHLTGPIPLAVGNPKSIPHLDL--SKNELSGEIPSSLAWIFGYISIFAKLNLSYNN 430 (771)
Q Consensus 364 ~~~l~~l~L~Ls~N~l~~~~p~~~~~l~~L~~L~L--s~N~l~~~~p~~l~~~~~~l~~L~~L~Ls~N~ 430 (771)
.+-..+...++|+.++| ++|++....-..++..+...++|+.|+++.|.
T Consensus 93 ------------------~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 93 ------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp ------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred ------------------HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 11123344566666444 45666532223344444466777888776654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.10 E-value=0.0062 Score=61.23 Aligned_cols=134 Identities=11% Similarity=0.059 Sum_probs=74.1
Q ss_pred ceEEEEEecCCCeEEEEEEeeccchhhHHHHHHHHHHHhccCCCCc--eeEEEEeecCCCCCceeEEEEEEeccCCCCCC
Q 041479 535 ATVYKGILDLDQTFIAVKVLFLHQRGALKSFMAECQALRNIRHRNL--VKIITACSTSDFQGNYFRALVYEFMHHGSLES 612 (771)
Q Consensus 535 ~~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 612 (771)
-.||+.+.+++. .|++|+.+.+.. ..+++..|.+.+..+....| +......-..........+.+++|++|..+..
T Consensus 36 N~vy~v~~~dg~-~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRR-RFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCC-CEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCC-EEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 479999886554 899999865432 34667788888877742221 11111100000111125688999998765532
Q ss_pred C--------------------------cccCCH-------------------HHHHHHHHHHHHHHHHHHh----cCCCC
Q 041479 613 C--------------------------PRILSF-------------------LRRLNIAIDVASALEYLHH----HCKKP 643 (771)
Q Consensus 613 ~--------------------------~~~l~~-------------------~~~~~i~~~ia~gL~~LH~----~~~~~ 643 (771)
. ....++ ..+..+...+...++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 001111 1111122222233333332 12346
Q ss_pred eEecCCCCCCeeeCCCCceEEecccCccc
Q 041479 644 IVHCDLKPSNVLLDNDMTAHMGDFGLTRF 672 (771)
Q Consensus 644 ivHrdlk~~NILl~~~~~~kl~DfGla~~ 672 (771)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998763
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.86 E-value=0.00095 Score=60.15 Aligned_cols=13 Identities=38% Similarity=0.416 Sum_probs=6.5
Q ss_pred ccceeecccCcCc
Q 041479 273 HLRYLYMSANPIS 285 (771)
Q Consensus 273 ~L~~L~Ls~N~l~ 285 (771)
+++.+++++|.+.
T Consensus 75 ~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 75 TLKSLNVESNFIS 87 (166)
T ss_dssp SCCEEECCSSCCC
T ss_pred cchhhhhcccccc
Confidence 4555555555543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.02 E-value=0.03 Score=57.61 Aligned_cols=73 Identities=12% Similarity=0.120 Sum_probs=46.1
Q ss_pred cccccccceEEEEEecCC-------CeEEEEEEeeccchhhHHHHHHHHHHHhccC-CCCceeEEEEeecCCCCCceeEE
Q 041479 528 SYESLVKATVYKGILDLD-------QTFIAVKVLFLHQRGALKSFMAECQALRNIR-HRNLVKIITACSTSDFQGNYFRA 599 (771)
Q Consensus 528 ~l~~~~~~~Vy~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~~~~~~ 599 (771)
.++.|..-.+|+...+++ .+.|.+++.- ... ...+..+|..+++.+. +.=..++++++. + .
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~-------g 117 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS--G-------G 117 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T-------E
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C-------c
Confidence 355666677999887543 3456666653 222 2345568999988885 433346777652 2 5
Q ss_pred EEEEeccCCCCC
Q 041479 600 LVYEFMHHGSLE 611 (771)
Q Consensus 600 lv~e~~~~g~L~ 611 (771)
+||||++|..+.
T Consensus 118 ~I~efi~g~~l~ 129 (395)
T d1nw1a_ 118 RLEEYIPSRPLS 129 (395)
T ss_dssp EEECCCCEEECC
T ss_pred eEEEEeccccCC
Confidence 899999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.33 E-value=0.29 Score=47.92 Aligned_cols=48 Identities=21% Similarity=0.181 Sum_probs=36.4
Q ss_pred CCCeEecCCCCCCeeeCCCCceEEecccCccccCcccCCcccccccccccccccchhHHHHHHHHHh
Q 041479 641 KKPIVHCDLKPSNVLLDNDMTAHMGDFGLTRFIPEVMSSNQCSSVGLKGTVGYATPEYGILLLEIFT 707 (771)
Q Consensus 641 ~~~ivHrdlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~Gv~l~el~t 707 (771)
..++||+|+.+.||+++.+...-|.||+.+. .+|.+=|+++++...+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~-------------------~~~~~~DLAi~~~~~~~ 229 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC-------------------NDLLAYDVSICLNAWCF 229 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE-------------------EEEHHHHHHHHHHHHSB
T ss_pred ccccccCCcchhhhhcccccceeEecccccc-------------------cchhhhhHHHHHHHHhh
Confidence 3579999999999999988777899999764 23444566666666554
|